<SEC-DOCUMENT>0000731766-23-000008.txt : 20230224
<SEC-HEADER>0000731766-23-000008.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224172840
ACCESSION NUMBER:		0000731766-23-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		129
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		23668820

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>unh-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5,d:6b660947fab7488cb4d33baca2cb3a37--><html xmlns:unh="http://www.uhc.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>unh-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF8zLTEtMS0xLTUxOTM1_d9b4e970-d03c-462f-8cee-b58fa6072f78">false</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF80LTEtMS0xLTUxOTM1_445af4b1-ad07-4e78-9981-5a70a6f4087d">2022</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF81LTEtMS0xLTUxOTM1_f37da0b3-78a0-422f-8585-cf721cbf8f29">FY</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF82LTEtMS0xLTUxOTM1_84aac7fd-d0d2-419b-ab44-6d9abf173641">0000731766</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF83LTEtMS0xLTUxOTM1_23f311e0-a29a-4eda-a556-6f28ea35ef55">12/31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8xLTEtMS0xLTY2MTI2_545fe2fc-d00e-453f-bd4b-4ba4491b8ec3">877</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8xLTMtMS0xLTY2MTI5_b2158bb1-41db-42af-8bb6-fde9bfbd78d0">954</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8yLTEtMS0xLTY2MTMx_a285ae78-23f8-47cf-a826-8a9a31f89e09">1,433</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8yLTMtMS0xLTY2MTMz_195eff6e-e463-4e6d-88ed-ef36d34f839b">993</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8zLTEtMS0xLTY2MTM1_0770cf37-46a3-425a-8de8-58a3e0f3acc4">6,930</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8zLTMtMS0xLTY2MTM5_80ca054b-92bc-44f5-8d9d-77b8ff5677ad">5,992</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF80LTEtMS0xLTY2MTQy_4d7d4ed5-521a-48b4-9482-002e9534785d">6,137</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF80LTMtMS0xLTY2MTQ1_e69e1899-a4e8-414a-a377-6394dcecf5ef">5,636</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDkvZnJhZzowNDEzZDVlMWMzNzI0MWEwOWM4MmIzYmNhMjc0YmZiMi90YWJsZTozZDNlOThkNDViZTE0YzY4YmM5MjNkODc2NzVkYTk0ZC90YWJsZXJhbmdlOjNkM2U5OGQ0NWJlMTRjNjhiYzkyM2Q4NzY3NWRhOTRkXzAtMS0xLTEtNTE5MzU_3ef67c95-993f-4f7a-9bd1-425732e886c2">10</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231" decimals="INF" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDkvZnJhZzowNDEzZDVlMWMzNzI0MWEwOWM4MmIzYmNhMjc0YmZiMi90YWJsZTozZDNlOThkNDViZTE0YzY4YmM5MjNkODc2NzVkYTk0ZC90YWJsZXJhbmdlOjNkM2U5OGQ0NWJlMTRjNjhiYzkyM2Q4NzY3NWRhOTRkXzEtMS0xLTEtNjQ3MjQ_509864c5-b1d5-4efc-97ac-0561255c309a">50</ix:nonFraction><ix:nonNumeric contextRef="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">http://fasb.org/us-gaap/2022#OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="i7dacb950b06e40cab3d250d7cdfde2ee_D20220101-20221231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMDU_6c33a52c-1144-4e22-89da-18fc6460dbfe">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i8b01b3c71cd442d4844511a24216e1d5_D20220101-20221231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMjI_945de3a2-7233-4e80-9a06-96283be1135b">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEtMC0xLTEtNTE5MzU_1fcf593b-97e3-4fdc-8b3b-53005b0552d2">1/1/2023</ix:nonNumeric><ix:nonNumeric contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEtMS0xLTEtNTE5MzU_a4beafee-2dbb-4018-b2c9-48879a12b97d">1/1/2037</ix:nonNumeric><ix:nonNumeric contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzMtMC0xLTEtNTE5MzU_8b79f4db-eabe-4fc4-9afb-6dce3861c501">1/1/2023</ix:nonNumeric><ix:nonNumeric contextRef="iaf652515b3f946d697a8265de969e276_D20220101-20221231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzMtMS0xLTEtNTE5MzU_71d7326d-da50-4575-9475-dff034ec3bdf">1/1/2042</ix:nonNumeric><ix:nonNumeric contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzYtMC0xLTEtNTE5MzU_508c77c5-15ac-40b4-b08f-f0f87e96e2e2">2017</ix:nonNumeric><ix:nonNumeric contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzYtMS0xLTEtNTE5MzU_cd69f7b9-195a-4b13-8c92-1e83e7e46879">2020</ix:nonNumeric><ix:nonNumeric contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzgtMC0xLTEtNTE5MzU_7847cd2c-e2e9-414e-8a19-4d94ce360902">2014</ix:nonNumeric><ix:nonNumeric contextRef="iaf652515b3f946d697a8265de969e276_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzgtMS0xLTEtNTE5MzU_98bad51a-8b59-44ef-943c-2eb19bed6a7c">2022</ix:nonNumeric><ix:nonNumeric contextRef="i10213ff0021745a28cd943688e293bc1_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEwLTAtMS0xLTUxOTM1_06e8d468-fd91-440a-8482-fb4766bc21f8">2015</ix:nonNumeric><ix:nonNumeric contextRef="icd5a3b32f141485db532001e40320ac0_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEwLTEtMS0xLTUxOTM1_62c41117-5839-4840-9066-7652e8283787">2022</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtMS0xLTEtNTE5MzU_3dc9af03-3d3b-4cec-8d04-5b22246cb637">0.019</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtMi0xLTEtNTE5MzU_b4f2151e-5ead-43de-8790-0eba17c87a62">0.043</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNC0xLTEtNTE5MzU_a964805a-c382-4be8-ae87-3b03e3eea080">0.007</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNS0xLTEtNTE5MzU_79dd3db8-aae1-42f1-a61b-682cc603a98a">0.012</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNy0xLTEtNTE5MzU_6a0a2fba-2a08-40cd-94cb-76331c2f2ce8">0.002</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtOC0xLTEtNTE5MzU_6ff9c569-a7ce-429a-bee6-ee1d00dcf3f2">0.014</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItMS0xLTEtNTE5MzU_819f923c-8bde-4b9d-bcee-4866c960561e">0.306</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItMi0xLTEtNTE5MzU_15a15be1-e5cb-4d97-80e0-434435c23ed3">0.308</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNC0xLTEtNTE5MzU_f902f861-a6c9-4db9-97a5-5d4cf91c54a5">0.292</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNS0xLTEtNTE5MzU_80cc383b-364c-4bc8-8518-115b962d5186">0.298</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNy0xLTEtNTE5MzU_71fcf6c2-a468-42da-8e48-0125c2a91774">0.222</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItOC0xLTEtNTE5MzU_b3ab6237-10f7-4c49-b2b5-7a870d2a4ebe">0.295</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtMS0xLTEtNTE5MzU_5b996c45-bc15-4419-961d-7ed41f2563fe">0.012</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtMi0xLTEtNTE5MzU_bb16e5b5-b009-4089-abc3-a2416ba5e24b">0.012</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNC0xLTEtNTE5MzU_322e7800-34bc-4409-8924-89e52caf5fb1">0.013</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNS0xLTEtNTE5MzU_54c90838-64d8-423e-ad71-b559b1779b7c">0.015</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNy0xLTEtNTE5MzU_40eb6c11-1efb-430a-aabb-4c7f70c185c6">0.014</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtOC0xLTEtNTE5MzU_392e7ff0-f1b8-490c-a572-f4fcf4964b33">0.017</ix:nonFraction><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtMS0xLTEtNTE5MzU_89ac1ba6-58b1-43c7-a5d9-0e9993d08b73">4.702283105022831</ix:nonNumeric><ix:nonNumeric contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtNC0xLTEtNTE5MzU_2642ae31-98dc-44b7-98e5-ad3e221d490e">4.802054794520548</ix:nonNumeric><ix:nonNumeric contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtNy0xLTEtNTE5MzU_8ed53612-22db-449d-8a31-fa168f9024b4">5.102511415525115</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzgtMS0xLTEtNTE5MzU_ac427e08-c1c1-4f4b-8e76-6e38161f4274">5.799315068493151</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzktMS0xLTEtNTE5MzU_e822140b-edb6-40c1-b246-14d471ef689b">4.401826484018265</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEwLTEtMS0xLTUxOTM1_a20890c0-9424-4144-a770-12f86d89d140">5.702283105022831</ix:nonNumeric><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEyLTEtMS0xLTUxOTM1_754625ea-1efd-4e08-b692-ef0b8843dbb3">1.2993150684931507</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="unh-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bfe1147b61f43029e188dfba9f8d0a1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i85e6f017f088486bb2c8d3093e1e73c3_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i03d7421f2e1846c2b83800db841f59f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae360a97ab14698993e6432980a16a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4783b4127e2144999741c7d04d466e2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i528146a5cf87439684c37a24329083d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d105042b9242e3a67b99461ff390ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f53e27fa72436f92deccfb277741ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75f2b5ddba14b25908ed51f2abe23fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6440bd164d594884b755b5b9ff031b02_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c689a8c0bca4e019433ec7246f933af_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6830c5f79e56472094427c9ea2e3da03_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d1d3ede72ca4733addec1bb1964c823_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07259315a0ea49d0a13dfb8fe399859f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ac1e3a85a14762b31fc51bf6a90599_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca043d8fcb44c53b5284ba8accffdaf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib659d7c82a274ea4ac648525c4eb7212_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i642edb7da896454ab4d981b104a7469f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc49c4edc654514bf73d5c1b5463ae8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8b06c57980640a89660ca89168bc707_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b41b5d5d1d4902a2666ab91615d999_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i664e92201b31457e977924ad47542638_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ff020430204014941338a161a89f7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f91212be8041f595a89ca53aaeab7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07801d8cba1b4ab3b50d8ac8a9f97af6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6eaac53b8934e608d29bd0c5b4e5994_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c1cb17ce614ea6a4262e7a44095444_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5959c75efd0045959418fd2933c336d6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357524a3e1674a958342f4b2ad6fd285_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c551595134e4820a2b39138e15877c8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2616b12a521428ba669ce47e3572232_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93029ecb097b460c94d2bd8336e2c900_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic40da61c03d244ee8b7fafcd8416abe9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d32db37f4024063a8ce510f51ab5d0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34dd7920ba894909b8d0e5c2cfaceb6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0843668ba2f34d53b6ff8c06a2fbd0b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5123593bd7e943ff983843139569f7ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b889e044c1942f18b7b6118ae4e47fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7667d069e974d27b0f62b9b62fe36f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b13550b61146f3942355d988fb9045_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4b04f90dfec4d62aef785c70b201486_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44f74baf509a410c99fa46e489fb4347_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cf18e9b55b4c90b1d62f83afeffdc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4af60408a5014dadb511e21f1afca7e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2964324674894490aab04f2d6bd37235_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b306bfc47b4634b1d61ddb91da4cb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib35aa732c7b44d8785be61e048bb0572_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb6042d781646119f05a8e3d8d9bfdc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03e24ff12c14c668abeebbd373c12f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b26ce245bd427daad3c1e0c98d2988_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8cc912aa74747edbaa48cf71f83621d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ca0721d6424e0ebe624cfdfd71cff7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:UsefulLifeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7bfd1f6234d46cca896b895ffb4eb00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef840008a9949d4bf08759afb52eeb0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice44079f0ac84af382d947db2570bb57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i862cb01850c54123912d7e326e09b865_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5723f6eb484244a1b9c07c5e1b663d23_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f37409e996040ec89badf7f24f413b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f6c70b54f343a196c9df60d4d8fdec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844bf68d4f4345e3970236cd396c9f66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541081ea074d4ecd8b8c1ce4752c8ce2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ef3e9119e24c1bbb54fbf615fcab1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife04c89dd39a402eb363a5aa452772d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95e69fa331194b15a906c00c27162164_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if05937365d074cadb89e64039541d02d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4133bc7b7654a80873db5b16de03f74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib275e6a73d0440148b42d342275a5ec2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4bf3e83c042412faa2721b20b445a19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i011f48e345274d1f9d386cb6032974c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26d227da923f4bafa3e23635ffa3e63d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9ea388a069444c4931adafec448408a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="positions"><xbrli:measure>unh:positions</xbrli:measure></xbrli:unit><xbrli:context id="idef199e9d5164b839dff15f1d15b655d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3100e960b47a458dbc9b0427cfe50a57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eacf249beb84261b10dda890a8c7b1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i398125db28a248afa78be5dde2f802de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4b697d303c246c990d7e9e55449aa31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5a2a5290514b42a50323b2c2b06755_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27447352b0ab4986955366c4e6e7c8ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188beb504ffd4cf1811a05b9122ba936_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic133da4ac5694c2ab3ebbb7920479054_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i036507f5da394189a07761f27ce7e50f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65c3951e41d5448f93f5d245e448b353_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie787f6065b7145838ac2375afc47c02e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb07718b5c854d9cbe58e30453c54be2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3373ab24aca44874b727df09174bb908_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869ae145fa344284be424032a072bd49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6663e1ca24400db968c0f30349d738_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0790ce8dc806474baab7039cd2473ef4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0485953f893b49d693502de2df2048e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief6fab63019041c7a43aa25dabe91d73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf77a1a93e4449e79e9e7ecb7ca12b9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b874edc14f445189ce46feb9f2c4f83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iece3fb1e3e9b4d8190443f2996222c31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb02468002ee402a8d58d3f0b459ea93_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1a835311424287bdea3b0f166d0ee4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id829c67b8dcc4173a26141ccf0fc20bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if14e7f1d47d24ce5849f9b9b561f7e16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5784b258ad7c4a2fb80cf028d4eabdb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c699d8d9ea945a59bfac2890b0ad12a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657a012885e24d5eaacd841fab51c280_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd889a008b09458f83587b1ac62ff127_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id88f51dc85eb4f388b644b2df135e040_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06af4dfd1cfd4c9da60ac57537b11dc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifecbdb30ca8f48bd9c6d49d82fbc8d3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10fb3889577743e99907b617e43c8ba8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443d6329218e4e968f2b21276f5ad0b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f630fda39a4043bfe6128ff91152bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f797283d0f468a9e019cd793e5de27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddcca2f61bd741edb945e23a517102e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf402af8c08c4d1cbb8e1ee5013f8985_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1029e91d76ab42b3ac1bfc3d43571bee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08f479dfe434d749660a45e73e5ae3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55ab6c56958a464c87ff17c070fbaacb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ddbe32d07a43fc9952719ea94c5a31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9058fdfbea43dabe2bae0df36bd3bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i307873d9bcfb48f8a290730f26815add_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b3392265deb4106aab31600904e9cb4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d93ef8431b471ca93d9465e2c95484_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63222ef16b814f569ad4ba0cf601d3a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib77ad19c6e4440028848176be54ff601_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibde696a897d44556b79a1a65c2668c22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47a18e6ecf3d47f986ea7a8767797311_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cad82084bb42bf84e6e79e8cf2b3de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DebtInstrumentExcludingCommercialPaperAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c131978c8aa4c9fac20a4b9db444b5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1288c646ac474cb6a528ecddc4cf9eaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ccb32154264ba6a1a64b7d12112f3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia87829c660a8467182b6e1a92c6cd8e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7837dbff77c4c7ab715987e4d24c08a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0be0aab5247d49e8bea8b75041ffa84c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f993c029dde4f2188f1debf7eab46d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e929c44eac543b9b65151f9f6e42da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie941b4c35ceb4d50a09440e37ae44046_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DebtInstrumentExcludingCommercialPaperAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5b9cb689c4849b186802ae057c4f620_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273fb22e9e294cc583d6ed2a1dccb45e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib18968b1b98748ebaf2b70232a383b48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aab5eedface463d8e9937c9f349bdb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93aff990939e4d999543f7925550419f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie588118f5a224050a60787106be9f4ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef850d28ac94a98ab6c49a6ff13ef23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954001ec6080467d9308272e6879d3cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0520b9f9d7f64354b0aa489f5bd5b095_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4082841ae445839156ed080b909db1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia71332b1e4da424482d4374941a68deb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i029dc3b772ba45fcae3cdfb1cf328398_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306fc774c45e4efda5c854e3d3882a81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38495f03da740dc92c5e3241a80f075_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73959cf508b94532976280692bebc7fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8087abc490604b24b4842f47239d6ca4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d27f00edd24f95bcc8effc5ab51935_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i497a918740ed4cf8849340ca44bb4e4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia808efbb58284bd29fa2015876ed6e9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65240804f5fe4ff18092e64dd3c64e1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd81928a29434336a9c57994d73a7bc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a9202de2dd47f3af460db253742fae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2145059193248b48874a80710b28e8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib99b38b33f024bd5b838c545e73f79f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i495eaae432e44afdb66418768a361a4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94f6f0f1fd94551b44b1faa876e0832_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37c49ae972864155b1415b8cc9d945ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7467c05cf504bf382c1187f5f7e597b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24e57b760f1943638a139219471fd6fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e95ea910ec747ac9770d7cbc2da1ce2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e6c96ce7884253a99f1fca5a7339dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5493d49ac1284b54884fdb86718f9e02_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3892320018df450c9ac4e6bf65e11fe3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7c819f8af694a74897e26538e141f60_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2367432c1c4e45439729594f68a2ec11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60e5672e23b94f19be7191790d53cc3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d9d96731c340fa9d78902e0bc3b278_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728d9550a35f4f138ff2c097381dc033_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5ef92fae8bc4c0084253bd7bb7088bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1940f3a1e6f9417694b22ff49c35186e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786714661e7f4838a42693234789771e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c66b2e1270a46d6a8d5cd1309dea3ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d9fc280e4544109fecfdc02a37666f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf8f66195a594ab1b336d142ef13ede2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb4001ca6264871a7ad00d325a345ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5000NotesDueOctober2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6383fe7786fe4e7bbdd981e396552bd7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5000NotesDueOctober2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2686d11283f46719d18fa8e4dfc6455_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i416a9d226e564e5abf36acd74b65f94f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d0059f0624475da7bd80920ef148f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5150NotesDueOctober2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9fa26a59c1843ad803fbad414557dc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5150NotesDueOctober2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d5b47862f5348ef9dcf07e7a185c79b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203f45d0024846889fd3a1fa6fffb8bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cc738c6f9848178e80519e6cbbce38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8de494dc062d4199875121594f393220_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c732b02ee74c73bbfc3705c75e0da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ac3b21a19f4ca9b38339c305baac7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ea0c95de6e4a9b9e2536e70fefb4ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82463e4fdc5489ab448089bf76d312f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21504223e65b4686844531611b0b07d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305adfb9c01244c5afe018e176540852_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a55401292cd487bab7b21375cc65e7b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3700NotesDueMay2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if181822fd1384c01988e0d46a4385545_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3700NotesDueMay2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4692ab26301b477380a51e6a6a781217_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5677b8572412413b81509f643c9ef745_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5250NotesDueFebruary2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c64464c7bc74ed6bc24597231e8ab76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5250NotesDueFebruary2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d23392f899d43788e933044d9acb8b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129276d6c48048318c0627db9c328f51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dab2cbb62404492925d5e152cd76361_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512cc51902184d4c92e7d2dd8755c1ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4155c0e3c9b946bea71e235628460254_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4000NotesDueMay2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b14d6d4df8b4cfaa24978b6086e472e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4000NotesDueMay2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34aca5e0b0748ed989035c239f6915c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86903b7949ae4788981d28620e873889_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5300NotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80a1eb5f9d341648fd7677e8828af62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5300NotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a5b0b53fa8240879de83b80861c2037_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76155e2aae45448fae0e6e595a1abba1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8de06ca26b3340e78175d0fa4155ceee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c7c9dc5c92d4b699d0ace37c4d35756_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6a66c306ca44bbbfee561f09c05af1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4200NotesDueMay2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33ebc317b78463795ee17f17e4687e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4200NotesDueMay2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if99d5f53340d46e8bd01203577453158_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5350NotesDueFebruary2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38506247ccc740b692752b50a39ff3bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5350NotesDueFebruary2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663d30885efc49f1b283db95c351ef37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e481989fbfb4b4bae07e9cdb93241db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe27021be7848fb8ac2a70eb45943d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9f537d010f04ef2b408ff0b5e4a6240_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8358f864c6a94934b2ee1ed4c5380631_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d45d08ecf834726abad93ca937d8c57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5629c7537c453dbdc9f344362a08b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950071dee1cf4f1287c79566cbab2cde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa1a2d080b742208f733a624feb7cc7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada8fff11b964f0bb11cb946276b397a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853b4b0cb13d41eab1caaefa962bea5d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i472b6a573ea24ab69839d586a4f2fc76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebaa87cecf5849d389bb300eb4709582_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaeebd9e870e4ae4a60d0c58ad726851_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd52088b565542199acbe6f00c32c2e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9cc71855ae94636a016e4748db5e5bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c68342188ac441f993ea148f6163a3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af022449e6a4052bbbe3d69f40cc5ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96339900834441a90061dd06cd0727f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0467e40cfdc04f9da3be269b79fd4132_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if241f86fec94483e9fbedb583dc64e67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ff2097150a4198a7408f57b7751209_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i178f10eeffe540c5b55f43219adb4530_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f7e1b784e143aaa8c2fb4ee90e847b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a73599312a49f2a409f094bbd99ae9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ed0e3cddfb4ccd9187bd8407096c4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3290167c6c224581a5a44faf7d6e5ef4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6269a5a11644842a3cdb93e77b08b21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa1bdbe5afa44219cc32a23f3330036_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80325b3ceb8844d0bc983f1570151700_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96f0c553fcd40a1a3f553dd366c0f73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d92492d202e4193b143e3b5fc891c52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721180c4c3834dad88660c0cb0c92351_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id511dbd83f2c482f9a759b209e1292b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff31eaf98fc4021bcccf6be5c93a0d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c973547dd8641f8bb987bf6ab8add1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcfbf9e7699242f79053b6b8ba023aeb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452493f8b4dd4009ad2e916fee82afdc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if51d52d41c444e478616b97fb188f33c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab462ccd24d47938ac7bf5582916526_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051acdfdac5443078c32017b27ef25f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48fe787e4f084d5aa237c9cb3982524d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i052454650bb34a24989f6fcdc6ad6074_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i435285040d2540dfad739c13df074973_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1cbcf2205a4446ea4843ad64f479218_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i174e953a70e649b0abb9a33cee93913f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4750NotesDueMay2052Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc19b7d8253640e1b39dcef330c1e8fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4750NotesDueMay2052Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5875NotesDueFebruary2053Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice983114f0894876a852c31fe9eeaded_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5875NotesDueFebruary2053Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73b3065191a436988023a7ff6a43503_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261cd0420bde47508c9875c124b4bfb3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f9496f2f4045c2b66ee552d15fa61e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4950NotesDueMay2062Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ed6067252342b3beb9989231672adc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4950NotesDueMay2062Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6050NotesDueFebruary2063Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d2eaa671ac44220bee9863ce3993ecf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6050NotesDueFebruary2063Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2c84ad3559147a5ab4604796f8bb30e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b889aeec8304b17a5381fabcfec7d9a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dacb950b06e40cab3d250d7cdfde2ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b90c42a12c946ec837aea2ac692cc5d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b01b3c71cd442d4844511a24216e1d5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i845de76c9b49482181876168457d3339_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbec7cfe19d43a8adf0ec061d38e36f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day60BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eb087bedb274e389574fb540aacd661_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i967155a249994885831ed4f111f8cf37_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da65d71f0dd4e81aa84de4084ebc16a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsExpirationBeginning2022Through2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if899e2bbae2a4cdcaba077976895f315_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsIndefiniteCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec27badcb0040c193fecdd2c470c893_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10213ff0021745a28cd943688e293bc1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf652515b3f946d697a8265de969e276_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5a3b32f141485db532001e40320ac0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6047cb915ab94ef08b29f7f33d60fce9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c30621aa864465bb27533b234d6d21f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i725ab79c24d84374a71ef19f38657b54_I20180601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-22</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-28</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-20</xbrli:startDate><xbrli:endDate>2022-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab961e9490f040f8918f115ab2c74510_D20221213-20221213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-13</xbrli:startDate><xbrli:endDate>2022-12-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a9c77c9d2b940b8b4fb2feac66444f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cab9cb169cd4921a81a836726f5c3e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id58b7079211c4824b326bc35e2a79767_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377663e135b146dbb9746caf29f61b57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc90f35441624e0781cac8a40b7b7e81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42347a2d22d847debe1ed99a8365998d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a75221adee4bf19a028253ecab255e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0040f0d323849ad809533e304a3b462_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibccf866bd05a4a2896a41120665646f8_D20230222-20230222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-22</xbrli:startDate><xbrli:endDate>2023-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf85f3e8a0654801b32e765fe9e7b3c6_D20221003-20221003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-03</xbrli:startDate><xbrli:endDate>2022-10-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i484b05acf027495b8f4198fab7c44136_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">unh:ChangeHealthcareClaimEditingBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8ade8a004149ceaea32126b946100e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">unh:OtherDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f48b3f3d16f409680853a60e0d463c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33c272509ca243539b39dea750264213_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i417f470589084c168d167ef0c775d160_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec887b8824d84342853f880a3d055fb6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i754570ab58fc4d7182d6cd5710942586_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891eefd12c57404d9108f080872897e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a501c583d645a99b8b9b5c5bd3990c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ecaa939f056424d93be40e9396e2d1b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5097e65e14e04df196818d6c688b1082_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5047c8cbb98d45d0ad2ec2d032462297_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2456563e97441d1bb80a0655bda7af3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97182827e3a4490ab017b6b0ccdcf452_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i732a42f2250b413f9bf4d79507a6ca84_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc651b1637d4ead98ae3d64f8fce1ac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i689a6bbc96bd48d585f1f0fbc711fc9f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e748f6babd44bad9db0b025d2907061_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f024c91b7e04d99baa714309ff7e49d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c12c65b54c4b4fa1799a4218c9359f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47084b8e436448078c0d24c71476b120_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad33ae2f3254e8eaa1c802d749df410_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d26bfed4a2840dbac69a2395c82ff6d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cb993a994a549efade727a478d56969_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0409df6d86b94be7842cd2257a37957c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248d4ab66d70471bae1895c28d10a5be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if41ca363996f43829716a67d979d12e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if345a50f546e449795e2b25318c9818f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cd0dd9677e344fda1596618b18f13c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d02f6e1b404ac4bfcb813025f3065c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0e74178d75403b9dcc51a6a87d03de_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40545db690df4fdab1edc363f3348827_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c894858093498e826481908286c841_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b418a686c3435f81ce58838debdcce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia79e6c55d1d440638042cab7fe05cad5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5c6cb54c3b4b49bb104be3515415dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5aa82904754e72bda157c7a338ea81_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36880bfb1c5e4252b9402bba5e8bb110_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d927be6127444c59445557fe053bd65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5960c3bd03745bd867211187b5890af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59011503ab204f80b7e61b66d70a9f7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic696f2244b5b45a0a03c0ca407b18556_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac00fded2bdc4a4dac5850a70ce34a56_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ac679ac440453dbbb5734791641a4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b28e9f7a35f4490a7d651ae18c391b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00c94487ebe47df9a45f96208eac209_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2342d40e00cb40539947ec67002a66b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d726a752eb3479e98a520f141c7da23_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice1915ab53004f139ae31ddb9f72017a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f4f96795bf481cb58883eb91460381_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169c3a6f69ec49c6ac21ea20f6face13_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa0861fc9d04b6b8a9cf15131f4eb4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223709dbe1e1454e8275ba382402b2fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6809afc52ece49fcacd58ddeb9beed63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd994d74ba1e442eb1b7b78abad56ccf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbb19a9943ea410184b0ee7221e62372_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if552e01372d149efa80b89bd7e2901fa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6feddcc5aa4962a0a4685dc88ff2d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d4124c98cc489db6bc12d6a7c0fa1b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec876717223b46bdb349de450e145cd6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8c8b06009844a89aad8bfadcab6675_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4aaba57e6c4369864d20305d9597f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e74aa00cb7f48a593354c1c326ec9d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4cc12cbad2f4be496364d6a29805345_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf5875ebba543508498353a5881cd21_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa3958921a164d51bdd2c4a6807a726f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159f89cf2a8346398f76a7f71b7df182_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf477982ea1a42dc804d174211e45675_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4076c2027b2e4431ac707ea49e17d9e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i504afca956b443a6a9e4f9d9b46f543c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied0c09925613478d8fc3af0f46b15762_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9491e68da6045a1a105dfe059072466_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic858c9047c604ac982e25d4ac7f8174d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa393fe15c9145e3b9ec03b58beca5dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f6e178ccba45fab8978aea98c8fff1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46ffe7b0c3c4ef38af41f18db200faa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f93fadef4f46a5bc4fb990ddee2fc8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9edf57345d9043c1b11e892820ff85bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233c15dc654d469288951d04a08c0455_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba020e43c45460cb04de6fcc9b74a76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34bb0b4a48194f55ba64445c9848a45d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i564486a1b728438ca7fbb3d76dfad1cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19bd530a243c4e92be077f1a53ed69e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d4008ea094942efa92959f01e189555_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796f9087920a40eca6b04eca756a0128_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb0b864fd8c4a6782eef98e1bafa761_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71cf336cf55d404f864835404f2b5d2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c572dcc2604feabe05f8761531ce09_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifefb573c3bb8436dbf231adeb4c351db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9734c2c7137d4a14a49e90c235063d38_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i276a8b65f2b4434dbee38c4c9687ce8d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86e84564ba4746deab13cdd483c38f04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb51ddb53efb4127a03b364bd9fb3504_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5476d1544885436791b5b43717779607_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7245c7c22b7746e094b0d6835d7ae680_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a5f2ae790b74bfabb249a00198978be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee98fc17838d4daf98c0b0585eb7ed06_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97245d594a044b1f8d34eb031374888c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dcfadfac12645d4b3082944a122cc9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0caf62223ca54bb185679fac378d4f52_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c6a40d1db7f44589224803d71e3e1e6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7465d3a1afe74c3d8718ba6192a453ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14f892617f3049c3a1e27ad2c9dec0ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i110b9761945d4e40813f9a8bbed2a310_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c821411e9b45e392b05177c8f28d1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec591a925cd42b7a547da2ee176f02d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6ee17d39bd4e0bac8d7e0aa55cc85f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia51588dda918456aa393e95440d4bdc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4c76f5de1d474bac108f73781f88df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ad8c812d379411bb81c7ce92abd8232_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f868329b34b47d3b53f4028690c339c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b5990f30984481b9bc048adaeb8fbb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2e15c2a33d49639d714c65b404e2cc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6b660947fab7488cb4d33baca2cb3a37_1"></div><div style="min-height:18pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.609%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________________________&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xNDU_3094c49a-e43d-43a8-8a73-79ba219df9e3">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________________&#160; </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.005%"><tr><td style="width:1.0%"></td><td style="width:4.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZjQ1YmM4OWFiYWU1NGM3NTljYjJhZTcwYzA4Yzk1MWMvdGFibGVyYW5nZTpmNDViYzg5YWJhZTU0Yzc1OWNiMmFlNzBjMDhjOTUxY18wLTAtMS0xLTUxOTM1_55a05a34-95d0-4219-8af3-d31d62d450ee">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF81NDk3NTU4MTc1MzY_160634fb-12be-4349-a3a9-06fa253bfa87">December 31, 2022</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.005%"><tr><td style="width:1.0%"></td><td style="width:4.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">or</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTEyZDU3NjNiMDk1NDIzMDg5ZjI1MTAyODllYzYwNDMvdGFibGVyYW5nZTphMTJkNTc2M2IwOTU0MjMwODlmMjUxMDI4OWVjNjA0M18yLTAtMS0xLTUxOTM1_0a2086f6-c7c7-4c25-b767-6bf06a65b474">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the transition period from _____ to _____</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yNjQ_7769b47e-3696-4928-918c-f9d5b2fd95ec">1-10864</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">__________________________________________________________&#160;</span></div><div style="text-align:center"><img src="unh-20221231_g1.jpg" alt="unh-20221231_g1.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:247px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zMzA_94e1aee1-9bcb-4d27-bf0d-390fe5b431b0">UnitedHealth Group Incorporated</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:0.3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.223%"><tr><td style="width:1.0%"></td><td style="width:26.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8wLTAtMS0xLTUxOTM1_7415e08b-cbe7-4954-8730-7d94366cfcd4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8wLTMtMS0xLTUxOTM1_a7a5454c-dc04-4b7a-8044-f8d1fc4f6c57">41-1321939</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8zLTAtMS0xLTUxOTM1_56b59762-93aa-4498-86f3-6757f9155e56">UnitedHealth Group Center</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8zLTMtMS0xLTUxOTM1_e9c23f3c-6f40-4639-a77f-4817c0efbe98">55343</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl80LTAtMS0xLTUxOTM1_b8b008ea-4c9d-41ef-bea5-1792fbc8b821">9900 Bren Road East</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl81LTAtMS0xLTUxOTM1_8bacb667-77fd-4b6f-b658-980cb7ab3e13">Minnetonka,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl81LTEtMS0xLTUxOTM1_cbd3b502-7dbd-40a1-a1ce-c252486ca8a3">Minnesota</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zOTI_25d06060-d678-4745-9204-cd216876128c">952</ix:nonNumeric>) <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zOTY_be1f2cc8-a989-489d-8651-af464ef0a185">936-1300</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">______________________________________________________&#160;&#160;</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.453%"><tr><td style="width:1.0%"></td><td style="width:28.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTAtMS0xLTUxOTM1_6e0c8cb5-47c7-400c-b0fa-ddfb879f9cca">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTItMS0xLTUxOTM1_b555b280-f981-4a75-9273-7e8b6cfec54f">UNH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTQtMS0xLTUxOTM1_6a323db3-1a36-4e10-8a6c-50054b0c8342">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> ________________________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">_</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF84MjE_ab8372c7-97f6-4187-aa21-e694016fdced">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF85NjY_d7ab3626-dcc5-4cc5-83fb-3881c81b4cdc">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xMzE2_4d9e98ee-3caf-4b71-83db-72f4e9b5ab7e">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xNjMx_0e8ac010-eb7d-4b26-866c-888077082a26">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.869%"><tr><td style="width:1.0%"></td><td style="width:19.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8wLTAtMS0xLTUxOTM1_9b5d750d-8272-4997-971e-03679f467b59">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8xLTEtMS0xLTUxOTM1_0e36d528-d1a6-4faa-ab98-539b4ebdf3d0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8xLTctMS0xLTUxOTM1_a9ebe594-9a8c-43b2-98c8-cafc0d25c715">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zNjEx_94cca75c-8d0e-4c46-bcc6-c95e1c7ec39f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yNjk2_916be1d4-3c27-480e-bc19-2aaca7c26232">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates of the registrant as of June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i4bfe1147b61f43029e188dfba9f8d0a1_I20220630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yODEy_cb6652b2-233b-4889-8e22-09e0826031df">479,550,880,245</ix:nonFraction> (based on the last reported sale price of $513.63 per share on June&#160;30, 2022 as reported on the New York Stock Exchange), excluding only shares of voting stock held beneficially by directors, executive officers and subsidiaries of the registrant. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of January 31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i85e6f017f088486bb2c8d3093e1e73c3_I20230131" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zMTAx_36e82fad-6365-4b61-977f-ee53e6178516">932,846,602</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $.01 par value per share, issued and outstanding.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zNjEw_49721ca8-c6e0-4cff-91aa-acbd4e3c8f97" escape="true">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#8217;s definitive proxy statement relating to its 2023 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.609%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_13">Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_13">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_25">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_25">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_28">Properties</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_28">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_31">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_31">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_34">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_34">21</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_40">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_40">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_49">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_49">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_52">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_52">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_70">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_70">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_73">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_73">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_214">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_214">66</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_217">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_217">66</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_232">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_232">69</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_235">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_235">69</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_241">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_241">69</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_244">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_244">69</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_247">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_247">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_250">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_250">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_253">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_253">70</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_259">Exhibit and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_259">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_280">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_280">79</a></span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_283">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_283">80</a></span></div></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt;text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_13"></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;BUSINESS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OUR BUSINESSES</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;its,&#8221; &#8220;UnitedHealth Group,&#8221; or the &#8220;Company&#8221; used in this report refer to UnitedHealth Group Incorporated and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group Incorporated is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability to analyze complex data and apply deep health care expertise and insights allows us to serve people, care providers, businesses, communities and governments with more innovative products and complete, end-to-end offerings for many of the biggest challenges facing health care today.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum combines clinical expertise, technology and data to empower people, partners and providers with the guidance and tools they need to achieve better health. Optum serves the broad health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its Optum Health, Optum Insight and Optum Rx businesses. These businesses improve overall health system performance by optimizing care quality and delivery, reducing costs and improving consumer and provider experience, leveraging distinctive capabilities in data and analytics, pharmacy care services, health care operations, population health and health care delivery.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. UnitedHealthcare Employer &amp; Individual serves employers ranging from sole proprietorships to large, multi-site and national employers, public sector employers and individual consumers. UnitedHealthcare Medicare&#160;&amp; Retirement delivers health and well-being benefits for Medicare beneficiaries and retirees. UnitedHealthcare Community&#160;&amp; State manages health care benefit programs on behalf of state Medicaid and community programs and their participants.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four reportable segments: </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health; </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare, which includes UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement and UnitedHealthcare Community&#160;&amp; State. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optum</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum is an information and technology-enabled health services business serving the broad health care marketplace, including:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who need care: consumers who need the right care, information, resources, products and engagement to improve their health, achieve their health goals and receive an improved patient experience that is personalized and holistic and delivered in all care settings, including in-home and virtually.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who provide care: pharmacies, hospitals, physicians and other health care facilities seeking to improve the health system and reduce the administrative burden allowing for providers to focus time on patients leading to the best possible patient care and experiences while achieving better health outcomes at lower costs. Improved health outcomes are achieved by leveraging our clinical expertise, data and analytics to better predict, prevent and intercept consumers&#8217; health conditions and ensure they receive the best evidence-based care.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who pay for care: employers; health plans; and state, federal and municipal agencies devoted to ensuring the people they sponsor receive high-quality care, administered and delivered efficiently and effectively, all while driving health equity so that every individual, family and community has access to the care they need.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.15pt">Those who innovate for care: global life sciences organizations dedicated to developing more effective approaches to care, enabling technologies and medicines to improve care delivery and health outcomes.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum operates three business segments leveraging distinctive capabilities in health care delivery, population health, health care operations, data and analytics and pharmacy care services:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health delivers care, care management, wellness and consumer engagement, and health financial services;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight offers data, analytics, research, consulting, technology and managed services solutions; and </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx provides diversified pharmacy care services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Health</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being of 102 million consumers and serves more than 100 health payer partners. We engage people in the most appropriate care settings, including clinical sites, in-home and virtual. Optum Health delivers primary, multi-specialty, behavioral, surgical and urgent care; helps patients and providers navigate and address complex, chronic and behavioral health needs; offers post-acute care planning services; and serves consumers and care providers through advanced, on-demand digital health technologies, such as telehealth and remote patient monitoring, and innovative health care financial services. Optum Health works directly with consumers, care delivery systems, providers, employers, payers, and public-sector entities to provide high quality, accessible and equitable care with improved health outcomes and reduced total cost of care. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health enables care providers to transition from traditional fee-for-service payment models to performance-based delivery and payment models designed to improve patient health outcomes and experience through value-based care. Through strategic partnerships, alliances and ownership arrangements, Optum Health helps care providers adopt new approaches and technologies improving the coordination of care across providers to serve patients more comprehensively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Optum Health offerings include fully accountable value-based arrangements, where Optum Health assumes responsibility for health care costs in exchange for a monthly premium. Offerings also include administrative fee arrangements, where Optum Health manages or administers products and services in exchange for a monthly fee, and fee-for-service arrangements, where Optum Health delivers health-related products and medical services for patients at a contracted fee.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Financial, including Optum Bank, serves consumers through nearly 20 million consumer accounts with nearly $20 billion in assets under management as of December 31, 2022. Organizations across the health system rely on Optum Financial to manage and improve payment flows through its highly automated, scalable, end-to-end digital payment systems and integrated card solutions. For financial services offerings, Optum Financial charges fees and earns investment income on managed funds.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health sells its products primarily through its direct sales force, strategic collaborations and external producers in three key areas: employers, including large, mid-sized and small employers; payers including health plans, third-party administrators (TPAs), underwriter/stop-loss carriers and individual product intermediaries; and public entities including the U.S. Departments of Health and Human Services (HHS), Veterans Affairs, Defense, and other federal, state and local health care agencies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Insight</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Insight connects the health care system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the health care system. Hospital systems, physicians, health plans, public entities, life sciences companies and other organizations comprising the health care industry depend on Optum Insight to help them improve performance and reduce costs through administrative efficiency and payment simplification, advance care quality through evidence-based standards built directly into clinical workflows, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Systems. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Serves hospitals, physicians and other care providers to improve operating performance, better coordinate care and reduce administrative costs through technology and services to improve population health management, patient engagement, revenue cycle management and strategic growth plans. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Serves health plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by improving financial performance and enhancing outcomes through proactive analytics, a comprehensive payment integrity portfolio and technology-enabled and staff-supported risk and quality services. Optum Insight helps health plans navigate a dynamic environment defined by shifts in employer vs. public-sector coverage, the demand for affordable benefit plans and the need to leverage new technology to reduce complexity. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Governments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provides advanced technology and analytics services to modernize the administration of critical safety net programs, such as Medicaid, while improving cost predictability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Sciences Companies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combines data and analytics expertise with comprehensive technologies and health care knowledge to help life sciences companies, including those in pharmaceuticals and medical technology, adopt a more comprehensive approach to advancing therapeutic discoveries and improving clinical outcomes. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of Optum Insight&#8217;s software and information products and professional services are delivered over extended periods, often several years. Optum Insight maintains an order backlog to track unearned revenues under these long-term arrangements. The backlog consists of estimated revenue from signed contracts, other legally binding agreements and anticipated contract renewals based on historical experience with Optum Insight&#8217;s customers. Optum Insight&#8217;s aggregate backlog as of December 31, 2022 was approximately $30.0 billion, of which $16.8 billion is expected to be realized within the next 12 months. The aggregate backlog includes $10.7 billion related to affiliated agreements. Optum Insight&#8217;s aggregate backlog as of December 31, 2021, was $22.4 billion, including $8.9 billion related to affiliated agreements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Insight&#8217;s products and services are sold primarily through a direct sales force. Optum Insight&#8217;s products are also supported and distributed through an array of alliances and business partnerships with other technology vendors, who integrate and interface Optum Insight&#8217;s products with their applications.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Rx</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx provides a full spectrum of pharmacy care services through its network of more than 67,000 retail pharmacies, through home delivery, specialty and community health pharmacies, the provision of in-home and community-based infusion services and through rare disease and gene therapy support services. It also offers direct-to-consumer solutions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx manages a broad range of prescription drug spend, including widely available retail drugs as well as limited and ultra-limited distribution drugs in oncology, HIV, pain management and ophthalmology. Optum Rx serves the growing pharmacy needs of people with behavioral health and substance use disorders. In 2022, Optum Rx managed $124 billion in pharmaceutical spending, including $52 billion in specialty pharmaceutical spending.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx serves health benefits providers, large national employer plans, unions and trusts, purchasing coalitions and public-sector entities. Optum Rx sells its services through direct sales, health insurance brokers and other health care consultants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx offers multiple clinical programs, digital tools and services to help clients manage overall pharmacy and health care costs in a clinically appropriate manner which are designed to deliver improved consumer experiences, better health outcomes and a lower total cost of care. Optum Rx provides various utilization management, medication management, quality assurance, adherence and counseling programs to complement each client&#8217;s plan design and clinical strategies. Optum Rx is accelerating the integration of medical, pharmacy and behavioral care and treating the whole patient by embedding our pharmacists as key members of the patient care team.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealthcare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its health benefits offerings, UnitedHealthcare is enabling better health, creating a better health care experience for its customers and helping to control rising health care costs. UnitedHealthcare&#8217;s market position is built on:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">strong local-market relationships;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the breadth of product offerings, based upon extensive expertise in distinct market segments in health care;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">service and advanced technology, including digital consumer engagement; </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">competitive medical and operating cost positions;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">effective clinical engagement; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">innovation for customers and consumers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare uses Optum&#8217;s capabilities to help coordinate and provide patient care, improve affordability of medical care, analyze cost trends, manage pharmacy care services, work with care providers more effectively and create a simpler and more satisfying consumer and physician experience.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, UnitedHealthcare arranges for discounted access to care through networks which, as of December 31, 2022, include 1.7 million physicians and other health care professionals and 6,400 hospitals and other facilities.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare is subject to extensive government regulation. See further discussion of our regulatory environment below under </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_19">&#8220;Government Regulation&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_52">Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Employer&#160;&amp; Individual</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestically, UnitedHealthcare Employer &amp; Individual offers a comprehensive array of consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, and individuals. As of December 31, 2022, UnitedHealthcare Employer &amp; Individual provides access to medical services for 26.7 million people. Globally, UnitedHealthcare Employer &amp; Individual serves nearly 7.7 million people with medical and dental benefits, typically </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in exchange for a monthly premium per member, residing principally in Brazil, Chile, Colombia and Peru, but also in more than 150 other countries. UnitedHealthcare Employer &amp; Individual offers health care delivery in our principal global markets through nearly 45 hospitals, and more than 200 outpatient and ambulatory clinics and surgery centers to UnitedHealthcare Employer &amp; Individual global members and consumers served by other payers.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its risk-based product offerings, UnitedHealthcare Employer&#160;&amp; Individual assumes the risk of both medical and administrative costs for its customers in return for a monthly premium which is typically a fixed rate per individual served for a one-year period. Through its administrative and other management services arrangements to customers who elect to self-fund the health care costs of their employees and employees&#8217; dependents, UnitedHealthcare Employer&#160;&amp; Individual receives a fixed monthly service fee per individual served. These customers retain the risk of financing medical benefits for their employees and employees&#8217; dependents, while UnitedHealthcare Employer&#160;&amp; Individual provides services such as coordination and facilitation of medical and related services to customers, consumers and health care professionals, administration of transaction processing and access to a contracted network of physicians, hospitals and other health care professionals, including dental and vision professionals. UnitedHealthcare Employer &amp; Individual is focused on providing informed benefit solutions that create customized plan designs and clinical programs for employers that contribute to well-being and reduce the total cost of care along with providing simpler consumer experiences in response to market dynamics. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Employer &amp; Individual typically distributes its products through a variety of channels, dependent upon the specific product, including: through consultants or direct sales, in collaboration with brokers and agents, through wholesale agents or agencies who contract with health insurance carriers to distribute individual or group benefits, through professional employer organizations and associations and through both multi-carrier and its own proprietary private exchange marketplaces. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Employer&#160;&amp; Individual&#8217;s major product families include consumer engagement products, such as high-deductible consumer driven benefit plans and a variety of innovative consumer centric products; traditional products; clinical and pharmacy products; and specialty benefits, such as vision, dental, hearing, accident protection, critical illness, disability and hospital indemnity offerings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement provides health and well-being services to individuals age 50 and older, addressing their unique needs. UnitedHealthcare Medicare&#160;&amp; Retirement has distinct benefit designs, pricing, underwriting, clinical program management and marketing capabilities dedicated to health products and services in this market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement offers a selection of products allowing people choice in obtaining the health coverage and services they need as their circumstances change. These offerings include care management and health system navigator services, clinical management programs, nurse health line services, 24-hour access to health care information, access to discounted health services from a network of care providers and administrative services. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement has extensive distribution capabilities and experience, including direct marketing to consumers on behalf of its key clients, including AARP, the nation&#8217;s largest membership organization dedicated to the needs of people age 50 and over, and state and U.S. government agencies. Products are also offered through agents, employer groups and digital channels.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major product categories include:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Advantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provides health care coverage for seniors and other eligible Medicare beneficiaries through the Medicare Advantage program administered by the Centers for Medicare&#160;&amp; Medicaid Services (CMS), including Medicare Advantage HMO plans, Preferred Provider Organization (PPO) plans, Point-of-Service plans, Private-Fee-for-Service plans and Special Needs Plans (SNPs). Under the Medicare Advantage program, UnitedHealthcare Medicare&#160;&amp; Retirement provides health benefits coverage in exchange for a fixed monthly premium per member from CMS plus, in some cases, monthly consumer premiums. Premium amounts received from CMS vary based on the geographic areas in which individuals reside; demographic factors such as age, gender and institutionalized status; and the health status of the individual. UnitedHealthcare Medicare&#160;&amp; Retirement served 7.1 million people through its Medicare Advantage products as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have continued to enhance our offerings, focusing on more digital and physical care resources in the home, expanding our concierge navigation services and enabling the home as a safe and effective setting of care. For example, through our HouseCalls program, nurse practitioners performed nearly 2.3 million clinical preventive home care visits in 2022 to address unmet care opportunities and close gaps in care.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Medicare Part D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Provides Medicare Part D benefits to beneficiaries through its Medicare Advantage and stand-alone Medicare Part D plans. The stand-alone Medicare Part D plans address a large spectrum of people&#8217;s needs and preferences for their prescription drug coverage, including low-cost prescription options. As of December&#160;31, 2022, UnitedHealthcare enrolled 9.6 million people in the Medicare Part D programs, including 3.3&#160;million individuals in stand-alone Medicare Part D plans, with the remainder in Medicare Advantage plans incorporating Medicare Part D coverage. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Medicare Supplement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Provides a full range of supplemental products at diverse price points. These products cover various levels of coinsurance and deductible gaps to which seniors are exposed in the traditional Medicare program. UnitedHealthcare Medicare&#160;&amp; Retirement served 4.4 million seniors nationwide through various Medicare Supplement products in association with AARP as of December 31, 2022. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues from CMS represented 38% of UnitedHealth Group&#8217;s total consolidated revenues for the year ended December&#160;31, 2022, most of which were generated by UnitedHealthcare Medicare&#160;&amp; Retirement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Community&#160;&amp; State</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State is dedicated to serving state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage, typically in exchange for a monthly premium per member from the state program. UnitedHealthcare Community &amp; State&#8217;s primary customers oversee Medicaid plans, including Temporary Assistance to Needy Families; Children&#8217;s Health Insurance Programs (CHIP); Dual SNPs (DSNPs); Long-Term Services and Supports (LTSS); Aged, Blind and Disabled; and other federal, state and community health care programs. As of December&#160;31, 2022, UnitedHealthcare Community &amp; State participated in programs in 35 states and the District of Columbia, and served 8.2 million people; including 1.5 million people through Medicaid expansion programs in 19 states under the Patient Protection and Affordable Care Act (ACA).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States using managed care services for Medicaid beneficiaries select health plans by using a formal bid process or by awarding individual contracts. These health plans and care programs are designed to address the complex needs of the populations they serve, including the chronically ill, people with disabilities and people with a higher risk of medical, behavioral and social conditions. UnitedHealthcare Community &amp; State administers benefits for the unique needs of children, pregnant women, adults, seniors and those who are institutionalized or are nursing home eligible. These individuals often live in medically underserved areas and are less likely to have a consistent relationship with the medical community or a care provider. They also often face significant social and economic challenges.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOVERNMENT REGULATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are subject to comprehensive U.S. federal and state and international laws and regulations. We are regulated by agencies which generally have discretion to issue regulations and interpret and enforce laws and rules. U.S. federal and state and international governments continue to consider and enact various legislative and regulatory proposals which could materially impact certain aspects of the health care system. New laws, regulations and rules, or changes in the interpretation of existing laws, regulations and rules, including as a result of changes in the political environment, could adversely affect our businesses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to our compliance with U.S. federal and state and international laws and regulations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Federal Laws and Regulation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we contract with the federal government, we are subject to federal laws and regulations relating to the award, administration and performance of U.S. government contracts. CMS regulates our UnitedHealthcare businesses and certain aspects of our Optum businesses. Payments by CMS to our businesses are subject to regulations, including those governing fee-for-service and the submission of information relating to the health status of enrollees for purposes of determining the amounts of certain payments to us. CMS also has the right to audit our performance to determine our compliance with CMS contracts and regulations and the quality of care we provide to Medicare beneficiaries. Our commercial business is further subject to CMS audits related to medical loss ratios (MLRs) and risk adjustment data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State has Medicaid and CHIP contracts, which are subject to federal regulations regarding services to be provided to Medicaid enrollees, payment for those services and other aspects of these programs. There are many regulations affecting Medicare and Medicaid compliance, and the regulatory environment with respect to these programs is complex. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are also subject to laws and regulations relating to consumer protection, anti-fraud and abuse, anti-kickbacks, false claims, prohibited referrals, inappropriate reduction or limitation of health care services, anti-money laundering, securities and antitrust compliance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy, Security and Data Standards Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain of our operations are subject to regulation under the administrative simplification provisions of the Health Insurance Portability and Accountability Act of 1996, as amended (HIPAA), which apply to both the group and individual health insurance markets, including self-funded employee benefit plans. Federal regulations related to HIPAA contain minimum standards for electronic transactions and code sets and for the privacy and security of protected health information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses must comply with the Health Information Technology for Economic and Clinical Health Act (HITECH) which regulates matters relating to privacy, security and data standards. HITECH imposes requirements on uses and disclosures of health information; includes contracting requirements for HIPAA business associate agreements; extends parts of HIPAA privacy and security provisions to business associates; adds federal data breach notification requirements for covered entities and business associates and reporting requirements to HHS and the Federal Trade Commission (FTC) and, in some cases, to the local media; strengthens enforcement and imposes higher financial penalties for HIPAA violations and, in certain cases, imposes criminal penalties for individuals, including employees. In the conduct of our business, depending on the circumstances, we may act as either a covered entity or a business associate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use and disclosure of individually identifiable health data by our businesses are also regulated in some instances by other federal laws, including the Gramm-Leach-Bliley Act (GLBA) or state statutes implementing GLBA. These federal laws and state statutes generally require insurers to provide customers with notice regarding how their non-public personal health and financial information is used and the opportunity to &#8220;opt out&#8221; of certain disclosures before the insurer shares such information with a third party, and generally prescribe safeguards for the protection of personal information. Neither the GLBA nor HIPAA privacy regulations preempt more stringent state laws and regulations, which may apply to us, as discussed below. Federal consumer protection laws may also apply in some instances to privacy and security practices related to personally identifiable information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ERISA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Retirement Income Security Act of 1974, as amended (ERISA), regulates how our services are provided to or through certain types of employer-sponsored health benefit plans. ERISA is a set of laws and regulations subject to interpretation by the U.S. Department of Labor (DOL) as well as the federal courts. ERISA sets forth standards on how our business units may do business with employers who sponsor employee health benefit plans, particularly those who maintain self-funded plans. Regulations established by the DOL subject us to additional requirements for administration of benefits, claims payment and member appeals under health care plans governed by ERISA. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Laws and Regulation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance and HMO subsidiaries must be licensed by the jurisdictions in which they conduct business. All of the states in which our subsidiaries offer insurance and HMO products regulate those products and operations. The states require periodic financial reports and establish minimum capital or restricted cash reserve requirements. The National Association of Insurance Commissioners (NAIC) has adopted model regulations, which require expanded governance practices and risk and solvency assessment reporting. Most states have adopted these or similar measures to expand the scope of regulations relating to corporate governance and internal control activities of HMOs and insurance companies. We are required to maintain a risk management framework and file a confidential self-assessment report with state insurance regulators. We file reports annually with Connecticut, our lead regulator, and with New York, as required by the state&#8217;s regulation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans and insurance companies are regulated under state insurance holding company regulations. Such regulations generally require registration with applicable state departments of insurance and the filing of reports describing capital structure, ownership, financial condition, certain affiliated transactions and general business operations. Most state insurance holding company laws and regulations require prior regulatory approval of acquisitions and material affiliated transfers of assets, as well as transactions between the regulated companies and their parent holding companies or affiliates. These laws may restrict the ability of our regulated subsidiaries to pay dividends to our holding companies. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our business activity is subject to other health care-related regulations and requirements, including PPO, Managed Care Organization (MCO), utilization review (UR), TPA, pharmacy care services, durable medical equipment or care provider-related regulations and licensure requirements. These regulations differ from state to state and may contain network, contracting, product and rate, licensing and financial and reporting requirements. Health care-related laws and regulations set specific standards for delivery of services, appeals, grievances and payment of claims, adequacy of health care professional networks, fraud prevention, protection of consumer health information, pricing and underwriting practices and covered benefits and services. State health care anti-fraud and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, billing for unnecessary medical services and improper marketing. Certain of our businesses are subject to state general agent, broker and sales distribution laws and regulations. UnitedHealthcare Community &amp; State and certain of our Optum businesses are subject to regulation by state Medicaid agencies which oversee the provision of benefits to our Medicaid and CHIP beneficiaries and to our beneficiaries dually eligible for Medicare and Medicaid. We also contract with state governmental entities and are subject to state laws and regulations relating to the award, administration and performance of state government contracts. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Privacy and Security Regulations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states have adopted laws and regulations which may affect our privacy and security practices, such as state laws governing the use, disclosure and protection of social security numbers and protected health information or which are designed to implement GLBA or protect credit card account data. State and local authorities increasingly focus on the importance of protecting individuals from identity theft, with a significant number of states enacting laws requiring businesses to meet minimum cyber-security standards and notify individuals of security breaches involving </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personal information. State consumer protection laws may also apply to privacy and security practices related to personally identifiable information, including information related to consumers and care providers. Different approaches to state privacy and insurance regulation and varying enforcement philosophies may materially and adversely affect our ability to standardize our products and services across state lines. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to compliance with state privacy and security regulations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine and Fee-Splitting Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses function as direct medical service providers and, as such, are subject to additional laws and regulations. Some states have corporate practice of medicine laws prohibiting specific types of entities from practicing medicine or employing physicians to practice medicine. Moreover, some states prohibit certain entities from engaging in fee-splitting practices, which involve sharing in the fees or revenues of a professional practice. These prohibitions may be statutory or regulatory, or may be imposed through judicial or regulatory interpretation. The laws, regulations and interpretations in certain states have been subject to limited judicial and regulatory interpretation and are subject to change.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy and Pharmacy Benefits Management (PBM) Regulations </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx&#8217;s businesses include home delivery, specialty and compounding pharmacies, as well as clinic-based pharmacies which must be licensed as pharmacies in the states in which they are located. Certain of our pharmacies must also register with the U.S.&#160;Drug Enforcement Administration (DEA) and individual state controlled substance authorities to dispense controlled substances. In addition to adhering to the laws and regulations in the states where our pharmacies are located, we also are required to comply with laws and regulations in some non-resident states where we deliver pharmaceuticals, including those requiring us to register with the board of pharmacy in the non-resident state. These non-resident states generally expect our  pharmacies to follow the laws of the state in which the pharmacies are located, but some non-resident states also require us to comply with their laws where pharmaceuticals are delivered. Additionally, certain of our pharmacies which participate in programs for Medicare and state Medicaid providers are required to comply with applicable Medicare and Medicaid provider rules and regulations. Other laws and regulations affecting our pharmacies include federal and state statutes and regulations governing the labeling, packaging, advertising and adulteration of prescription drugs and dispensing of controlled substances. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to our pharmacy care services businesses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state legislation regulating PBM activities affects both our ability to limit access to a pharmacy provider network or remove network providers. Additionally, many states limit our ability to manage and establish maximum allowable costs for generic prescription drugs. With respect to formulary services, a number of government entities, including CMS, HHS and state departments of insurance, regulate the administration of prescription drug benefits offered through federal or state exchanges. Many states also regulate the scope of prescription drug coverage, as well as the delivery channels to receive such prescriptions, for insurers, MCOs and Medicaid managed care plans. These regulations could limit or preclude (i) certain plan designs, (ii) limited networks, (iii) use of particular care providers or distribution channels, (iv) copayment differentials among providers and (v) formulary tiering practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation seeking to regulate PBM activities introduced or enacted at the federal or state level could impact our business practices with others in the pharmacy supply chain, including pharmaceutical manufacturers and network providers. In addition, organizations like the NAIC periodically issue model regulations while credentialing organizations, like the National Committee for Quality Assurance (NCQA) and the Utilization Review Accreditation Commission (URAC), may establish standards impacting PBM pharmacy activities. Although these model regulations and standards do not have the force of law, they may influence states to adopt their recommendations and impact the services we deliver to our clients. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Protection Laws</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses participate in direct-to-consumer activities and are subject to regulations applicable to online communications and other general consumer protection laws and regulations such as the Federal Tort Claims Act, the Federal Postal Service Act and the FTC&#8217;s Telemarketing Sales Rule. Most states also have similar consumer protection laws. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain laws, such as the Telephone Consumer Protection Act, give the FTC, the Federal Communications Commission (FCC) and state attorneys general the ability to regulate, and&#160;bring enforcement actions relating to, telemarketing practices and certain automated outbound contacts such as phone calls, texts or emails.&#160;Under certain circumstances, these laws may provide consumers with a private right of action. Violations of these laws could result in substantial statutory penalties and other sanctions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Banking Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank is subject to regulation by federal banking regulators, including the Federal Deposit Insurance Corporation (FDIC), which performs annual examinations to ensure the bank is operating in accordance with federal safety and soundness requirements, and the Consumer Financial Protection Bureau, which may perform periodic examinations to ensure the bank is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in compliance with applicable consumer protection statutes, regulations and agency guidelines.&#160;Optum Bank is also subject to supervision and regulation by the Utah State Department of Financial Institutions, which carries out annual examinations to ensure the bank is operating in accordance with state safety and soundness requirements and performs periodic examinations of the bank&#8217;s compliance with applicable state banking statutes, regulations and agency guidelines.&#160;In the event of unfavorable examination results from any of these agencies, the bank could become subject to increased operational expenses and capital requirements, enhanced governmental oversight and monetary penalties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-U.S.  Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses operate internationally and are subject to regulation in the jurisdictions in which they are organized or conduct business. These regulatory regimes vary from jurisdiction to jurisdiction. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating abroad, such as the Foreign Corrupt Practices Act (FCPA), which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COMPETITION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified health care company, we operate in highly competitive markets across the full expanse of health care benefits and services. Our competitors include organizations ranging from startups to highly sophisticated Fortune 50 global enterprises, for-profit and non-profit companies, and private and government-sponsored entities. New entrants to our markets and business combinations among our competitors and suppliers also contribute to a dynamic and competitive environment. We compete fundamentally on the quality and value we provide to those we serve which can include elements such as product and service innovation; use of technology; consumer and provider engagement and satisfaction; and sales, marketing and pricing. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional discussion of our risks related to competition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY RIGHTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained trademark registration for the UnitedHealth Group, Optum and UnitedHealthcare names and logos. We own registrations for certain of our other trademarks in the United States and abroad. We hold a portfolio of patents and have patent applications pending from time to time. We are not substantially dependent on any single patent or group of related patents.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, trademarks appearing in this report are trademarks owned by us. We disclaim any proprietary interest in the marks and names of others.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HUMAN CAPITAL RESOURCES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nearly 400,000 employees, as of December 31, 2022, including more than 140,000 clinical professionals, are guided by our mission to help people live healthier lives and help make the health system work better for everyone. Our mission and cultural values of integrity, compassion, relationships, innovation and performance align with our long-term business strategy to increase access to care, make care more affordable, enhance the care experience, improve health outcomes and advance health equity. Our mission and values attract individuals who are determined to make a difference &#8211; individuals whose talent, innovation, engagement and empowerment are critical in our ability to achieve our mission. Similar to other businesses, in 2022 we experienced moderately higher levels of employment attrition, but due to increased recruiting capacity, upgraded digital capabilities and continued investment in our workforce, we continue to be able to meet the needs of those we serve. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to developing our people and culture by creating an inclusive environment where people of diverse backgrounds, experiences and perspectives make us better. Our approach is data-driven and leader led and uses enterprise and business scorecards to ensure our leaders are accountable for a consistent focus on hiring, developing, advancing and retaining diverse talent. We have embedded inclusion and diversity throughout our culture, including in our talent acquisition and talent management practices; leadership development; careers; learning and skills; and systems and processes. We strive to maintain a sustainable and diverse talent pipeline by building strong strategic partnerships and outreach through early career programs, internships and apprenticeships. We support career coaching, mentorship and accelerated leadership development programs to ensure mobility and advancement for our diverse talent. To foster an engaged workforce and an inclusive culture, we invest in a broad array of learning and culture development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">programs. We rely on a shared leadership framework, which clearly and objectively defines our expectations, enables an environment where everyone has the opportunity to learn and grow, and helps us identify, develop and deploy talent to help achieve our mission.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prioritize pay equity by regularly evaluating and reviewing our compensation practices by gender, ethnicity and race. Receiving on-going feedback from our team members is another way to strengthen and reinforce a culture of inclusion. Our Employee Experience Index measures an employee&#8217;s sense of commitment and belonging to our company and is a metric in the Stewardship section of our annual incentive plan. Our Sustainability Report, which can be accessed on our website at www.unitedhealthgroup.com, provides further information about our people and culture.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth certain information regarding our executive officers as of February 24, 2023, including the business experience of each executive officer during the past five years:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Witty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dirk McMahon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Rex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rupert Bondy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer and Corporate Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erin McSweeney</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief People Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Roos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian Thompson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer of UnitedHealthcare</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors elects executive officers annually. Our executive officers serve until their successors are duly elected and qualified, or until their earlier death, resignation, removal or disqualification.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Andrew Witty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Chief Executive Officer and a member of the Board of Directors of UnitedHealth Group since February 2021. Previously, Andrew served as Chief Executive Officer of Optum from July 2018 to April 2021, President of UnitedHealth Group from November 2019 to February 2021 and as a UnitedHealth Group director from August 2017 to March 2018. Prior to joining UnitedHealth Group, he was Chief Executive Officer and a board member of GlaxoSmithKline, a global pharmaceutical company, from 2008 to 2017.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dirk McMahon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as President and Chief Operating Officer of UnitedHealth Group since February 2021. He previously served as Chief Executive Officer of UnitedHealthcare June 2019 to April 2021, President and Chief Operating Officer of Optum from April 2017 to June 2019 and Executive Vice President, Operations at UnitedHealth Group from November 2014 to April 2017. Dirk also served as Chief Executive Officer of Optum Rx from November 2011 to November 2014. Prior to 2011, he held various positions in UnitedHealthcare in operations, technology and finance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John Rex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President and Chief Financial Officer of UnitedHealth Group since June 2016. From March 2012 to June 2016, he served as Executive Vice President and Chief Financial Officer of Optum. Prior to joining Optum in 2012, John was a Managing Director at JP Morgan, a global financial services firm.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rupert Bondy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as Executive Vice President and Chief Legal Officer of UnitedHealth Group since March 2022 and additionally as Corporate Secretary since April 2022. Prior to joining UnitedHealth Group, Rupert served as Senior Vice President, General Counsel and Corporate Secretary at Reckitt Benckiser Group, a consumer goods group focused on hygiene, health and nutrition products, from January 2017 to February 2022. Prior to joining Reckitt Benckieser Group, he served as Group General Counsel of BP plc, an international energy company, and, among his prior positions, as Senior Vice President and General Counsel of GlaxoSmithKline, a global pharmaceutical company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erin McSweeney</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President and Chief People Officer of UnitedHealth Group since March 2022. From February 2021 to March 2022, Erin served as chief of staff to UnitedHealth Group&#8217;s Office of the Chief Executive. From January 2017 to February 2021, she served as Executive Vice President and Chief Human Resources Officer at Optum. Prior to joining UnitedHealth Group, Erin was Executive Vice President and Chief Human Resources Officer for EMC Corporation, an international technology company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tom Roos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Senior Vice President and Chief Accounting Officer of UnitedHealth Group since August 2015. Prior to joining UnitedHealth Group, Tom was a Partner at Deloitte &amp; Touche LLP, an independent registered public accounting firm.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brian Thompson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Chief Executive Officer of UnitedHealthcare since April 2021. Prior to this role, he served as Chief Executive Officer of UnitedHealthcare's government programs including Medicare &amp; Retirement and Community &amp; State from July 2019 to April 2021; as Chief Executive Officer of Medicare &amp; Retirement from April 2017 to July 2019; and as Chief Financial Officer of UnitedHealthcare&#8217;s Employer &amp; Individual and Medicare &amp; Retirement businesses from August 2010 to April 2017.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices are located at UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota 55343; our telephone number is (952)&#160;936-1300. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can access our website at www.unitedhealthgroup.com to learn more about our company. We make periodic and current reports and amendments available, free of charge, on our website, as soon as reasonably practicable after we file or furnish these reports to the Securities and Exchange Commission (SEC). Information on or linked to our website is neither part of nor incorporated by reference into this Annual Report on Form 10-K or any other SEC filings.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_22"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAUTIONARY STATEMENTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;should&#8221; or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the &#8220;safe harbor&#8221; provisions of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. Any forward-looking statement in this report speaks only as of the date of this report and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date of this report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion contains cautionary statements regarding our business, which investors and others should consider. We do not undertake to address in future filings or communications regarding our business or results of operations how any of these factors may have caused our results to differ from discussions or information contained in previous filings or communications. In addition, any of the matters discussed below may have affected past, as well as current, forward-looking statements about future results. Any or all forward-looking statements in this Annual Report on Form 10-K and in any other SEC filings or public statements we make may turn out to be wrong. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors discussed below will be important in determining our future results. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions which are difficult to predict or quantify. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Our Industry</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to estimate, price for and manage our medical costs or set benefit designs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our risk-based benefit products, we assume the risk of both medical and administrative costs for our customers in return for monthly premiums. We generally use approximately 80% to 85% of our premium revenues to pay the costs of health care services delivered to these customers. The profitability of our products depends in large part on our ability to predict, price for and effectively manage medical costs. Our Optum Health business also enters into fully accountable value-based arrangements with payers. Premium revenues from risk-based products comprise nearly 80% of our total consolidated revenues. If we fail to predict accurately, or effectively price for or manage, the costs of providing care under risk-based arrangements, our results of operations could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage medical costs through underwriting criteria, product design, negotiation of competitive provider contracts and care management programs. Total medical costs are affected by the number of individual services rendered, the cost of each service and the type of service rendered. Our premium revenue on commercial policies and Medicaid contracts is typically based on a fixed monthly rate per individual or family served for a 12-month period and is generally priced one to six months before the contract commences. Our revenue on certain Medicare policies is based on bids submitted to CMS in June of the year before the contract year. Our premium revenue on fully accountable value-based care products at Optum Health is typically based on a fixed monthly rate per individual served. Although we base the commercial, Medicaid and value-based premiums we charge and our Medicare bids on our estimates of future medical costs over the fixed contract period, many factors may cause actual costs to exceed those estimated and reflected in premiums or bids. These factors may include medical cost inflation, increased use of services, increased cost of individual services, costs to deliver care, large-scale medical emergencies, the potential effects of climate change, pandemics, the introduction of new or costly drugs, treatments and technology, new treatment guidelines, newly mandated benefits or other regulatory changes and insured population characteristics. For Optum Health&#8217;s fully accountable value-based care, our inability to provide higher-quality outcomes and better experiences at lower costs or our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inability to integrate our care delivery models could impact our results of operations, financial positions and cash flows. Relatively small differences between predicted and actual medical costs or utilization rates as a percentage of revenues can result in significant changes in our financial results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the financial results we report for any particular period include estimates of costs incurred for which claims are still outstanding. These estimates involve an extensive degree of judgment. If these estimates prove inaccurate, our results of operations could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends on the integrity and timeliness of the data we use to serve our members, customers and health care professionals and to operate our business. If the data we rely upon to run our businesses is found to be inaccurate or unreliable or if we fail to maintain or protect our information systems and data integrity effectively, we could experience failures in our health, wellness and information technology products; lose existing customers; have difficulty attracting new customers; experience problems in determining medical cost estimates and establishing appropriate pricing; have difficulty preventing, detecting and controlling fraud; have disputes with customers, physicians and other health care professionals; become subject to regulatory sanctions, penalties, investigations or audits; incur increases in operating expenses; or suffer other adverse consequences. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volume of health care data generated, and the uses of data, including electronic health records, are rapidly expanding. Our ability to implement new and innovative services, automate and deploy new technologies to simplify administrative processes and clinical decision making, price our products and services adequately, provide effective service to our customers and consumers in an efficient and uninterrupted fashion, provide timely payments to care providers, and report accurately our results of operations depends on the integrity of the data in our information systems. In addition, connectivity among technologies is becoming increasingly important and recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices. Our information systems require an ongoing commitment of significant resources to maintain, protect and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards and changing customer preferences. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically consolidate, integrate, upgrade and expand our information systems&#8217; capabilities as a result of technology initiatives, recently enacted regulations, changes in our system platforms and integration of new business acquisitions. Our process of consolidating the number of systems we operate, upgrading and expanding our information systems&#8217; capabilities, enhancing our systems and developing new systems to keep pace with continuing changes in information processing technology may not be successful. Failure to protect, consolidate and integrate our systems successfully could result in higher than expected costs and diversion of management&#8217;s time and energy, which could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses sell and install software products which may contain unexpected design defects or may encounter unexpected complications during installation or when used with other technologies utilized by the customer. A failure of our technology products to operate as intended and in a seamless fashion with other products could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain and rapidly evolving U.S. federal and state, non-U.S. and international laws and regulations related to health data and the health information technology market may alter the competitive landscape or present compliance challenges and could materially and adversely affect the configuration of our information systems and platforms, and our ability to compete in this market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we or third parties we rely on sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely process, store and transmit large amounts of data in our operations, including protected personal information subject to privacy, security or data breach notification laws, as well as proprietary or confidential information relating to our business or third parties. Some of the data we process, store and transmit may be outside of the United States due to our information technology systems and international business operations. We are regularly the target of attempted cyber-attacks and other security threats and may be subject to breaches of the information technology systems we use. We have programs in place to detect, contain and respond to data security incidents and provide employee awareness training regarding phishing, malware and other cyber risks to protect against cyber risks and security breaches. However, because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and are increasing in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sophistication, we may be unable to anticipate these techniques, detect breaches for long periods of time or implement adequate preventive measures. Experienced computer programmers and hackers may be able to penetrate our security controls and access, misappropriate or otherwise compromise protected personal information or proprietary or confidential information or that of third parties, create system disruptions or cause system shutdowns, negatively affecting our operations. They also may be able to develop and deploy viruses, worms and other malicious software programs attacking our systems or otherwise exploit any security vulnerabilities. Hardware, software, or applications we develop or procure from third parties may contain defects in design or manufacture or other problems which could unexpectedly compromise information security. Our facilities and services may also be vulnerable to security incidents or security attacks; acts of vandalism or theft; coordinated attacks by activist entities; financial fraud schemes; misplaced or lost data; human error; malicious social engineering; or other events which could negatively affect our systems, our customers&#8217; data, proprietary or confidential information relating to our business or third parties, or our operations. Moreover, there has been an increase in new financial fraud schemes and ransomware attacks on large companies, whereby cybercriminals install malicious software preventing users or the enterprise from accessing computer files, systems or networks and demand payment of a ransom for return of access. In addition, there may be a heightened vulnerability due to the lack of physical supervision and on-site infrastructure for remote workforce operations. In certain circumstances we may rely on third-party vendors to process, store and transmit large amounts of data for our business whose operations are subject to similar risks.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs to eliminate or address the foregoing security threats and vulnerabilities before or after a cyber-incident could be material. We have business continuation and resiliency plans which are maintained, updated and tested regularly in an effort to ensure successful containment and remediation of potential disruptions or cyber events. In the event that our remediation efforts may not be successful, it could result in interruptions, delays, or cessation of service and loss of existing or potential customers. In addition, breaches of our security measures and the unauthorized dissemination of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sensitive personal information, proprietary information or confidential information about us or our customers or other third parties, could expose our customers&#8217; private information and our customers to the risk of financial or medical identity theft, or expose us or other third parties to a risk of loss or misuse of this information, result in litigation and liability, including regulatory penalties, for us, damage our brand and reputation, or otherwise harm our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to compete effectively to maintain or increase our market share, including maintaining or increasing enrollments in businesses providing health benefits, our results of operations, financial position and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses face significant competition in all of the geographic markets in which we operate. In particular geographies or product segments, our competitors, compared to us, may have greater capabilities, resources or market share; a more established reputation; superior supplier or health care professional arrangements; better existing business relationships; lower profit margin or financial return expectations; or other factors which give such competitors a competitive advantage. Our competitive position may also be adversely affected by significant merger and acquisition activity in the industries in which we operate, both among our competitors and suppliers. Consolidation may make it more difficult for us to retain or increase our customer base, improve the terms on which we do business with our suppliers, or maintain or increase profitability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, our success in the health care marketplace depends on our ability to develop and deliver innovative and potentially disruptive products and services to satisfy evolving market demands. If we do not continue to innovate and provide products and services, which are useful and relevant to health care payers, consumers and our customers, we may not remain competitive and risk losing market share to existing competitors and disruptive new market entrants. For example, new direct-to-consumer business models from competing businesses may make it more difficult for us to directly engage consumers in the selection and management of their health care benefits and health care usage. We may face challenges from new technologies and market entrants which could affect our existing relationship with health plan enrollees in these areas. Any failure by us to continue to develop innovative care models, including accelerating the transition of care to value-based models achieving higher quality outcomes and better experiences at lower costs and expanding access to virtual and in-home care, could result in competitive disadvantages and loss of market share. Additionally, our competitive position could be adversely affected by a failure to develop satisfactory data and analytics capabilities or provide services focused on these capabilities to our clients. Our business, results of operations, financial position and cash flows also could be materially and adversely affected if we do not compete effectively in our markets, if we set rates too high or too low in highly competitive markets, if we do not design and price our products properly and competitively, if we are unable to innovate and deliver products and services demonstrating value to our customers, if we do not provide a satisfactory level of services, if membership or demand for other services does not increase as we expect or declines, or if we lose accounts with more profitable products while retaining or increasing membership in accounts with less profitable products. The expected resumption of Medicaid redeterminations may also impact our ability to maintain market share if we are unable to retain or add new consumers to other benefit offerings.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend substantially on our continued ability to contract with health care payers (as a service provider to those payers), as well as physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and other service providers at competitive prices. If we fail to develop and maintain satisfactory relationships with health care providers, whether in-network or out-of-network, it could materially and adversely affect our business, results of operations, financial position and cash flows. In addition, certain activities related to network design, provider participation in networks and provider payments could result in disputes, which may be costly, divert management&#8217;s attention from our operations and result in negative publicity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any particular market, physicians and health care providers could refuse to contract with us, demand higher payments, or take other actions which could result in higher medical costs, less desirable products for customers or difficulty meeting regulatory or accreditation requirements. In some markets, certain health care providers, particularly hospitals, physician and hospital organizations or multi-specialty physician groups, may have significant market positions or near monopolies which could diminish our bargaining power. In addition, Accountable Care Organizations (ACOs); physician group management services organizations (which aggregate physician practices for administrative efficiency); and other organizational structures adopted by physicians, hospitals and other care providers may change the way in which these providers do business with us and may change the competitive landscape. Such organizations or groups of physicians may compete directly with us, which could adversely affect our business, and our results of operations, financial position and cash flows by impacting our relationships with these providers or affecting the way we price our products and estimate our costs, which might require us to incur costs to change our operations. In addition, if these providers refuse to contract with us, use their market position to negotiate favorable contracts or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health care benefits businesses have risk-based arrangements with some physicians, hospitals and other health care providers. These arrangements limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical care resources of the health care provider. To the extent a risk-based health care provider organization faces financial difficulties or otherwise is unable to perform its obligations under the arrangement, we may be held responsible for unpaid health care claims which should have been the responsibility of the health care provider and for which we have already paid the provider. Further, payment or other disputes between a primary care provider and specialists with whom the primary care provider contracts could result in a disruption in the provision of services to our members or a reduction in the services available to our members. Health care providers with which we contract may not properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. Any of these events could have a material adverse effect on the provision of services to our members and our operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some providers that render services to our members do not have contracts with us. In some instances, those providers may dispute the payment for these services and may institute litigation or arbitration.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of some of our businesses, including Optum Health and UnitedHealthcare Employer &amp; Individual&#8217;s international operations, depends on maintaining satisfactory relationships with physicians as our employees, independent contractors or joint venture partners. The physicians who practice medicine or contract with our affiliated physician organizations could terminate their provider contracts or otherwise become unable or unwilling to continue practicing medicine or contracting with us. We face and will likely continue to face heightened competition to acquire or manage physician practices or to employ or contract with individual physicians. If we are unable to maintain or grow satisfactory relationships with physicians, or to acquire, recruit or, in some instances, employ physicians, or to retain enrollees following the departure of a physician, our revenues could be materially and adversely affected. In addition, our affiliated physician organizations contract with competitors of UnitedHealthcare. Our businesses could suffer if our affiliated physician organizations fail to maintain relationships with these companies, or fail to adequately price their contracts with these third-party payers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and certain health care providers are customers of our Optum businesses. Physicians also provide medical services at facilities owned by our Optum businesses. Given the importance of health care providers and other constituents to our businesses, failure to maintain satisfactory relationships with them could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are routinely subject to various legal actions, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely made party to a variety of legal actions related to, among other matters, the design, management and delivery of our product and service offerings. Any failure by us to adhere to the laws and regulations applicable to our businesses could subject us to civil and criminal penalties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal actions to which we are a party have included or in the future could include matters related to health care benefits coverage and payment of claims (including disputes with enrollees, customers and contracted and non-contracted physicians, hospitals and other health care professionals), tort claims (including claims related to the delivery of health care services, such as medical malpractice by staff at our affiliates&#8217; facilities, or by health care practitioners who are employed by us, have contractual relationships with us, or serve as providers to our managed care networks, including as a result of a failure to adhere to applicable clinical, quality and/or patient safety standards), antitrust claims (including as a result of changes in the enforcement of antitrust laws), whistleblower claims (including claims under the False Claims Act or similar statutes), contract and labor disputes, tax claims and claims related to disclosure of certain business practices. In addition, certain of our pharmacy services operations are subject to clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs, including claims related to purported dispensing and other operational errors. We may also be party to certain class action lawsuits brought by health care professional groups and consumers. We operate in jurisdictions outside of the United States where contractual rights, tax positions and applicable regulations may be subject to interpretation or uncertainty to a greater degree than in the United States, and therefore subject to dispute by customers, government authorities or others. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are largely self-insured with regard to litigation risks, including claims of medical malpractice against our affiliated physicians and us. Although we record liabilities for our estimates of the probable costs resulting from self-insured matters, it is possible the level of actual losses will significantly exceed the liabilities recorded. Additionally, physicians and other healthcare providers have become subject to an increasing number of legal actions alleging medical malpractice and general professional liabilities.  Even in states that have imposed caps on damages for such actions, litigants are seeking recoveries under new theories of liability that might not be subject to the caps on damages. These actions involve significant defense costs and could result in substantial monetary damages or damage to our reputation. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the outcome of significant legal actions in which we are involved. We incur expenses to resolve these matters and current and future legal actions could further increase our cost of doing business and materially and adversely affect our results of operations, financial position and cash flows. Moreover, certain legal actions could result in adverse publicity which could damage our reputation and materially and adversely affect our ability to retain our current business or grow our market share in some markets and businesses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to successfully manage our strategic alliances, to complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States it could materially and adversely affect our business, prospects, results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we frequently engage in discussions with third parties regarding possible investments, acquisitions, divestitures, strategic alliances, joint ventures and outsourcing transactions and often enter into agreements relating to such transactions. For example, we have a strategic alliance with AARP under which we provide AARP-branded Medicare Supplement insurance to AARP members and other AARP-branded products and services to Medicare beneficiaries.&#160;If we fail to meet the needs of our alliance or joint venture partners, including by developing additional products and services, providing high levels of service, pricing our products and services competitively or responding effectively to applicable federal and state regulatory changes, our alliances and joint ventures could be damaged or terminated, which in turn could adversely impact our reputation, business and results of operations. Further, governmental actions, such as actions by the FTC or DOJ, may affect our ability to complete our merger and acquisition transactions, which could adversely affect our future growth. If we fail to identify and successfully complete transactions to meet our strategic objectives, we may be required to expend resources to develop products and technology internally, be placed at a competitive disadvantage or we may be adversely affected by negative market perceptions, any of which may have a material adverse effect on our results of operations, financial position or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Successful acquisitions are also dependent on effectively integrating the acquired business into our existing operations, including our internal control environment and culture, or otherwise leveraging its operations which may present challenges different from those presented by organic growth and may be difficult for us to manage. In addition, even with appropriate diligence, pre-acquisition practices of an acquired business may expose us to legal challenges and investigations. For example, in January 2021, an indictment for alleged violations of antitrust laws was issued by the DOJ against our subsidiary, Surgical Care Affiliates (SCA), based on conduct alleged to have begun more than five years prior to our acquisition of SCA. We are vigorously defending this lawsuit, but if SCA is found liable, we may be subject to criminal fines or reputational harm. If we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot successfully integrate our acquired businesses and realize contemplated revenue growth opportunities, cost savings and other synergies, our business, prospects, results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand and operate our business outside of the United States, we are presented with challenges differing from those presented by acquisitions of domestic businesses, including challenges in adapting to new markets, languages, business, labor and cultural practices and regulatory environments. Adapting to these challenges could require us to devote significant senior management attention and other resources to the acquired businesses before we realize anticipated synergies or other benefits from those businesses. These challenges vary widely by country and, outside of the United States, may include political instability, government intervention, discriminatory regulation and currency exchange controls or other restrictions, which could prevent us from transferring funds from these operations out of the countries in which our acquired businesses operate, or converting local currencies we hold into U.S. dollars or other currencies. If we are unable to manage successfully our non-U.S. acquisitions, our business, prospects, results of operations and financial position could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency exchange rates and fluctuations may have an impact on our shareholders&#8217; equity from period to period, which could adversely affect our debt to debt-plus-equity ratio, and our future revenues, costs and cash flows from international operations. Any measures we may implement to reduce the effect of volatile currencies may be costly or ineffective.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events, which have and could have an adverse effect on our business, results of operations, financial condition and financial performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large-scale medical emergencies, pandemics (such as COVID-19) and other extreme events could result in public health crises or otherwise have a material adverse effect on our business operations, cash flows, financial conditions and results of operations. For example, disruptions in public and private infrastructure resulting from such events could increase our operating costs and ability to provide services to our clients and customers. Additionally, as a result of these events, the premiums and fees we charge may not be sufficient to cover our medical and administrative costs, deferred medical care could be sought in future periods at potentially higher acuity levels, we could experience reduced demand for our services, our clinical and non-clinical workforce could be impacted resulting in reduced capacity to handle demand for care or otherwise impact our business operations. For example, COVID-19 has materially impacted our results of operations in previous periods. Public health crises arising from natural disasters, such as wildfires, hurricanes, and snowstorms, or effects of climate change could impact our business operations and result in increased medical care costs. Government enaction of emergency powers in response to public health crises could disrupt our business operations, including by restricting pharmaceuticals or other supplies, and could increase the risk of shortages of necessary items. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and services are sold in part through nonexclusive producers and consultants and we compete for their services and allegiance. Our sales could be materially and adversely affected if we are unable to attract, retain and support independent producers and consultants or if our sales strategy is not appropriately aligned across distribution channels. Our relationships with producers could be materially and adversely impacted by changes in our business practices and the nature of our relationships to address these pressures, including potential reductions in commission levels.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable economic conditions may impact demand for certain of our products and services. Unfavorable economic conditions also have caused and could continue to cause employers to stop offering certain health care coverage as an employee benefit or elect to offer this coverage on a voluntary, employee-funded basis to reduce their operating costs. In addition, unfavorable economic conditions could adversely impact our ability to increase premiums or result in the cancellation by certain customers of our products and services. These conditions could lead to a decrease in people served and premium and fee revenues and could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During a prolonged unfavorable economic environment, state and federal budgets could be materially and adversely affected, resulting in reduced reimbursements or payments in our federal and state government health care coverage programs, including Medicare, Medicaid and CHIP. A reduction in state Medicaid reimbursement rates could be implemented retroactively to apply to payments already negotiated or received from the government and could materially and adversely affect our results of operations, financial position and cash flows. In addition, state and federal budgetary pressures could cause the affected governments to impose new or a higher level of taxes or assessments for our commercial programs, such as premium taxes on health insurance and surcharges or fees on select fee-for-service and capitated medical claims. Any of these developments or actions could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prolonged unfavorable economic environment could also adversely impact the financial position of hospitals and other care providers which could materially and adversely affect our contracted rates with these parties and increase our medical costs or materially and adversely affect their ability to purchase our service offerings. Further, unfavorable economic conditions could adversely impact the customers of our Optum businesses, including health plans, hospitals, care providers, employers and others which could, in turn, materially and adversely affect Optum&#8217;s financial results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on our ability to attract, develop and retain qualified employees and executives, including those with diverse backgrounds, experiences and skills, to operate and expand our business. If we are unable to attract, develop, retain and effectively manage the development and succession plans for key employees and executives, our business, results of operations and future performance could be adversely affected. Experienced and highly skilled employees and executives in the health care and technology industries are in high demand and the market for their services is extremely competitive. We may have difficulty in replacing key executives because of the limited number of qualified individuals in these industries with the breadth of skills and experience required to operate and successfully expand our business. Adverse changes to our corporate culture, which seeks to foster integrity, compassion, relationships, innovation and performance, could harm our business operations and our ability to retain key employees and executives. While we have development and succession plans in place for our key employees and executives, these plans do not guarantee that the services of our key employees and executives will continue to be available to us.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market fluctuations could impair our profitability and capital position. Volatility in interest rates affects our interest income and the market value of our investments in debt securities of varying maturities which constitute the vast majority of the fair value of our investments as of December&#160;31, 2022. In addition, a delay in payment of principal or interest by issuers, or defaults by issuers (primarily issuers of our investments in corporate and municipal bonds), could reduce our investment income and require us to write down the value of our investments which could adversely affect our profitability and equity. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments may not produce total positive returns and we may sell investments at prices which are less than their carrying values. Changes in the value of our investment assets, as a result of interest rate fluctuations, changes in issuer financial or market conditions, illiquidity or otherwise, could have an adverse effect on our equity. In addition, if it should become necessary for us to liquidate our investment portfolio on an accelerated basis, such an action could have an adverse effect on our results of operations and the capital position of our regulated subsidiaries. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our goodwill and other intangible assets had a carrying value of $108 billion, representing 44% of our total consolidated assets. We periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. The value of our goodwill may be materially and adversely impacted if businesses we acquire perform in a manner inconsistent with our assumptions. In addition, from time to time we divest businesses, and any such divestiture could result in significant asset impairment and disposition charges, including those related to goodwill and other intangible assets. Any future evaluations requiring an impairment of our goodwill and other intangible assets could materially and adversely affect our results of operations and equity in the period in which the impairment occurs. A material decrease in equity could, in turn, adversely affect our credit ratings. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our agreements with customers, confidentiality agreements with employees and third parties, and our trademarks, trade secrets, copyrights and patents to protect our proprietary rights. These legal protections and precautions may not prevent misappropriation of our proprietary information. In addition, substantial litigation regarding intellectual property rights exists in the software industry, and we expect software products to be increasingly subject to third-party infringement claims as the number of products and competitors in this industry segment grows. Such litigation and misappropriation of our proprietary information could hinder our ability to market and sell products and services which could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims paying ability, financial strength and debt ratings by nationally recognized statistical rating organizations are important factors in establishing the competitive position of insurance companies. Ratings information is broadly disseminated and generally used by customers and creditors. We believe our claims paying ability and financial strength ratings are important factors in marketing our products to certain of our customers. Our credit ratings impact both the cost and availability of future borrowings. Each of the credit rating agencies reviews its ratings periodically. Our ratings reflect each credit rating agency&#8217;s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to policyholders. We may not be able to maintain our current credit ratings in the future. Any downgrades in our credit ratings could materially increase our costs of or ability to access funds in the debt capital markets and otherwise materially increase our operating costs.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Regulation of Our Business</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business activities in the United States and other countries are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are regulated by federal, state and local governments in the United States and other countries where we do business. Our insurance and HMO subsidiaries must be licensed by and are subject to regulation in the jurisdictions in which they conduct business. For example, states require periodic financial reports and enforce minimum capital or restricted cash reserve requirements. Health plans and insurance companies are also regulated under state insurance holding company regulations and some of our activities may be subject to other health care-related regulations and requirements, including regulations and licensure requirements related to PPOs, MCOs, UR and TPAs. Under state guaranty association laws, certain insurance companies can be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of impaired or insolvent insurance companies which write the same line or similar lines of business. Any such assessment could expose our insurance entities and other insurers to the risk they would be required to pay a portion of an impaired or insolvent insurance company&#8217;s claims through state guaranty associations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses provide products or services to government agencies. For example, some of our Optum and UnitedHealthcare businesses hold government contracts or provide services related to government contracts and are subject to U.S. federal and state and non-U.S. self-referral, anti-kickback, medical necessity, risk adjustment, false claims and other laws and regulations governing government contractors and the use of government funds. Our relationships with these government agencies are subject to the terms of our contracts with the agencies and to laws and regulations regarding government contracts. Among others, certain laws and regulations restrict or prohibit companies from performing work for government agencies which might be viewed as an actual or potential conflict of interest. These laws may limit our ability to pursue and perform certain types of engagements, thereby materially and adversely affecting our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our Optum businesses are also subject to regulations distinct from those faced by our insurance and HMO subsidiaries, some of which could impact our relationships with physicians, hospitals and customers. These regulations include state telemedicine regulations; debt collection laws; banking regulations; distributor and producer licensing requirements; state corporate practice of medicine doctrines; fee-splitting rules; and health care facility licensure and certificate of need requirements. These risks and uncertainties may materially and adversely affect our ability to market or provide our products and services, or to achieve targeted operating margins, or may increase the regulatory burdens under which we operate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing our businesses and interpretations of those laws and rules are subject to frequent change. For example, legislative, administrative and public policy changes to the ACA have been and likely will continue to be considered, and we cannot predict if the ACA will be further modified. Litigation challenges have been brought seeking to invalidate the ACA in whole or in part and future litigation challenges are possible. Further, the integration of entities we acquire into our businesses may affect the way in which existing laws and rules apply to us, including by subjecting us to laws and rules which did not previously apply to us. The broad latitude given to the agencies administering, interpreting and enforcing current and future regulations governing our businesses could force us to change how we do business, restrict revenue and enrollment growth, increase our health care and administrative costs and capital requirements, or expose us to increased liability in courts for coverage determinations, contract interpretation and other actions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also must obtain and maintain regulatory approvals to market many of our products and services, increase prices for certain regulated products and services and complete certain acquisitions and dispositions or integrate certain acquisitions. For example, premium rates for our health insurance and managed care products are subject to regulatory review or approval in many states and by the federal government. Additionally, we must submit data on proposed rate increases to HHS on many of our products for monitoring purposes. Geographic and product expansions of our businesses may be subject to state and federal regulatory approvals. Delays in obtaining necessary approvals or our failure to obtain or maintain adequate approvals could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate outside of the United States and in the future may acquire or commence additional businesses based outside of the United States, increasing our exposure to non-U.S. regulatory regimes. Our failure to comply with U.S. or non-U.S. laws and regulations governing our conduct outside the United States or to establish constructive relations with non-U.S. regulators could adversely affect our ability to market our products and services or to do so at targeted operating margins, which may have a material adverse effect on our business, financial condition and results of operations. Non-U.S. regulatory regimes, which vary by jurisdiction, encompass, among other matters, local and cross-border taxation, licensing, tariffs, intellectual property, investment, capital (including minimum solvency margin and reserve requirements), management control, labor, anti-fraud, anti-corruption and privacy and data protection regulations (including requirements for cross-border data transfers). For example, our UnitedHealthcare Employer &amp; Individual international business subjects us to Brazilian laws and regulations affecting hospitals, managed care and insurance industries and to regulation by Brazilian regulators, including the national regulatory agency for private health insurance and plans, the Ag&#234;ncia Nacional de Sa&#250;de Suplementar, while our Banm&#233;dica business is subject to Chilean, Colombian and Peruvian laws, regulations and regulators applicable to hospitals and private insurance. Any international regulator may take an approach to the interpretation, implementation and enforcement of industry regulations which could differ from the approach taken by U.S. regulators. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating abroad, such as the FCPA, which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care industry is regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate surrounding industry regulation. Negative publicity may adversely affect our stock price and damage our reputation in various markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in various federal, state and local government health care benefit programs, including as a payer in Medicare Advantage, Medicare Part D, various Medicaid programs and CHIP, and receive substantial revenues from these programs. Certain of our Optum businesses also provide services to payers participating in government health care programs. A reduction or less than expected increase, or a protracted delay, in government funding for these programs or change in allocation methodologies, or termination of the contract at the option of the government, may materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government health care programs in which we participate generally are subject to frequent changes, including changes which may reduce the number of persons enrolled or eligible for coverage, reduce the amount of reimbursement or payment levels, reduce our participation in certain service areas or markets, or increase our administrative or medical costs under such programs. Revenues for these programs depend on periodic funding from the federal government or applicable state governments and allocation of the funding through various payment mechanisms. Funding for these government programs depends on many factors outside of our control, including general economic conditions and budgetary constraints at the federal or applicable state level. For example, CMS has in the past reduced or frozen Medicare Advantage benchmarks and additional cuts to Medicare Advantage benchmarks are possible. In addition, from time to time, CMS makes changes to the way it calculates Medicare Advantage risk adjustment payments.&#160;Although we have adjusted members&#8217; benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management in response to the benchmark reductions and other funding pressures, these or other strategies may not fully address the funding pressures in the Medicare Advantage program. In addition, payers in the Medicare Advantage program may be subject to reductions in payments from CMS as a result of decreased funding or recoupment pursuant to government audit. States have also made changes in rates and reimbursements for Medicaid members and audits can result in unexpected recoupments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Medicaid managed care program, state Medicaid agencies solicit bids from eligible health plans to continue their participation in the acute care Medicaid health programs. If we are not successful in obtaining renewals of state Medicaid managed care contracts, we risk losing the members who were enrolled in those Medicaid plans. Under the Medicare Part D program, to qualify for automatic enrollment of low income members, our bids must result in an enrollee premium below a regional benchmark, which is calculated by the government after all regional bids are submitted. If the enrollee premium is not below the government benchmark, we risk losing the members who were auto-assigned to us and will not have additional members auto-assigned to us. In general, our bids are based upon certain assumptions regarding enrollment, utilization, medical costs and other factors. If any of these assumptions is materially incorrect, either as a result of unforeseen changes to the programs on which we bid, implementation of material program or policy changes after our bid submission, or submission by our competitors at lower rates than our bids, our results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the government health care coverage programs we participate in are subject to the prior satisfaction of certain conditions or performance standards or benchmarks. For example, as part of the ACA, CMS has a system providing various quality bonus payments to Medicare Advantage plans meeting certain quality star ratings at the individual plan or local contract level. The star rating system considers various measures adopted by CMS, including, among others, quality of care, preventive services, chronic illness management, handling of appeals and customer satisfaction. Plans must have a rating of four stars or higher to qualify for bonus payments. If we do not maintain or continue to improve our star ratings, our plans may not be eligible for quality bonuses and we may experience a negative impact on our revenues and the benefits our plans can offer, which could materially and adversely affect the marketability of our plans, number of people we serve, and our results of operations, financial position and cash flows. Any changes in standards or care delivery models applying to government health care programs, including Medicare and Medicaid, or our inability to improve our quality scores and star ratings to meet government performance requirements&#160;or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs, which in turn could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses various payment mechanisms to allocate funding for Medicare programs, including adjustment of monthly capitation payments to Medicare Advantage plans and Medicare Part D plans according to the predicted health status of each beneficiary as supported by data from health care providers for Medicare Advantage plans, as well as, for Medicare Part D plans, risk-sharing provisions based on a comparison of costs forecasted in our annual bids to actual prescription drug costs. Some state Medicaid programs utilize a similar process. For example, our UnitedHealthcare Medicare &amp; Retirement and UnitedHealthcare Community &amp; State businesses submit information relating to the health status of enrollees to CMS or state agencies for purposes of determining the amount of certain payments to us. CMS and the Office of Inspector General for HHS periodically perform risk adjustment data validation (RADV) audits of selected Medicare health plans to validate the coding practices of and supporting documentation maintained by health care providers. Certain of our local plans have been selected for such audits, which in the past have resulted and in the future could result in retrospective adjustments to payments made to our health plans, fines, corrective action plans or other adverse action by CMS.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been involved, and in the future may become involved in routine, regular and special governmental investigations, audits, reviews and assessments. Such investigations, audits, reviews or assessments sometimes arise out of, or prompt claims by private litigants or whistleblowers who, among other allegations, may claim we failed to disclose certain business practices or, as a government contractor, submitted false or erroneous claims to the government. Governmental investigations, audits, reviews and assessments could lead to government actions, which have resulted in, and in the future could result in, adverse publicity, the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs, any of which could have a material adverse effect on our business, results of operations, financial position and cash flows. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our pharmacy care services businesses face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide pharmacy care services through our Optum Rx and UnitedHealthcare businesses. Each business is subject to federal and state anti-kickback, beneficiary inducement and other laws governing the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers and consumers. In addition, federal and state legislatures regularly consider new regulations for the industry which could materially affect current industry practices, including potential new legislation and regulations regarding the receipt or disclosure of rebates and other fees from pharmaceutical companies, the development and use of formularies and other utilization management tools, the use of average wholesale prices or other pricing benchmarks, pricing for specialty pharmaceuticals, limited access to networks and pharmacy network reimbursement methodologies. Further, various governmental agencies have conducted and continue to conduct investigations and studies into certain PBM practices, which have resulted and may result in PBMs agreeing to civil penalties, including the payment of money and entry into corporate integrity agreements, or could materially and adversely impact the PBM business model. As a provider of pharmacy benefit management services, Optum Rx is also subject to an increasing number of licensure, registration and other laws and accreditation standards. Optum Rx conducts business through home delivery, specialty and compounding pharmacies, pharmacies located in community mental health centers and home infusion, which subjects it to extensive federal, state and local laws and regulations, including those of the DEA and individual state controlled substance authorities, the Food and Drug Administration (FDA) and Boards of Pharmacy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could face potential claims in connection with purported errors by our home delivery, specialty or compounding or clinic-based pharmacies or the provision of home infusion services, claims related to the inherent risks in the packaging and distribution of pharmaceuticals and other health care products. Disruptions from any of our home delivery, specialty pharmacy or home infusion services could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our pharmacy care services businesses provide services to sponsors of health benefit plans subject to ERISA. A private party or the DOL, which is the agency that enforces ERISA, could assert the fiduciary obligations imposed by the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statute apply to some or all of the services provided by our pharmacy care services businesses even where those businesses are not contractually obligated to assume fiduciary obligations. If a court were to determine such fiduciary obligations apply, we could be subject to claims for breaches of fiduciary obligations or claims we entered into certain prohibited transactions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collection, maintenance, protection, use, transmission, disclosure and disposal of protected personal information are regulated at the federal, state, international and industry levels and addressed in requirements imposed on us by contracts with customers. These laws, rules and requirements are subject to change. Compliance with new privacy and security laws, regulations and requirements may result in increased operating costs, and may constrain or require us to alter our business model or operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, many of the jurisdictions in which we operate have established their own data security and privacy legal framework with which we or our customers must comply. We expect there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the European Union, Brazil, Chile, India and other jurisdictions, and we cannot yet determine the impacts such future laws, regulations and standards may have on our businesses or the businesses of our customers. For example, the European Union&#8217;s General Data Protection Regulation (GDPR) imposes more stringent European Union data protection requirements on us or our customers, and prescribes greater penalties for noncompliance. Brazilian privacy legislation, similar in certain respects to GDPR, took effect in September 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard designed to protect payment card account data. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA requires business associates as well as covered entities to comply with certain privacy and security requirements. While we provide for appropriate protections through our contracts with our third-party service providers and in certain cases assess their security controls, we have limited oversight or control over their actions and practices. Several of our businesses act as business associates to their covered entity customers and, as a result, collect, use, disclose and maintain protected personal information in order to provide services to these customers. HHS administers its audit program to assess HIPAA compliance efforts by covered entities and business associates. An audit resulting in findings or allegations of noncompliance could have a material adverse effect on our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Optum businesses, we maintain a database of administrative and clinical data statistically de-identified in accordance with HIPAA standards. Noncompliance or findings of noncompliance with applicable laws, regulations or requirements, or the occurrence of any privacy or security breach involving the misappropriation, loss or other unauthorized disclosure of protected personal information, whether by us or by one of our third-party service providers, could have a material adverse effect on our reputation and business and, among other consequences, could subject us to mandatory disclosure to the media, loss of existing or new customers, significant increases in the cost of managing and remediating privacy or security incidents, and material fines, penalties and litigation awards. Any of these consequences could have a material and adverse effect on our results of operations, financial position and cash flows.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we operate as a holding company, we are dependent on dividends and administrative expense reimbursements from our subsidiaries to fund our obligations. Many of these subsidiaries are regulated by state departments of insurance or similar regulatory authorities. We are also required by law or regulation to maintain specific prescribed minimum amounts of capital in these subsidiaries. The levels of capitalization required depend primarily on the volume of premium revenues generated by the applicable subsidiary. In most states, we are required to seek approval by state regulatory authorities before we transfer money or pay dividends from our regulated subsidiaries exceeding specified amounts. An inability of our regulated subsidiaries to pay dividends to their parent companies in the desired amounts or at the time of our choosing could adversely affect our ability to reinvest in our business through capital expenditures or business acquisitions, as well as our ability to maintain our corporate quarterly dividend payment, repurchase shares of our common stock and repay our debt. If we are unable to obtain sufficient funds from our subsidiaries to fund our obligations, our results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_25"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPERTIES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and lease real properties to support our business operations in the United States and other countries. Our reportable segments use these facilities for their respective business purposes, and we believe the current facilities are suitable for their respective uses and are adequate for our anticipated future needs.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_31"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 3 is incorporated herein by reference to the information set forth under the captions &#8220;Legal Matters&#8221; and &#8220;Governmental Investigations, Audits and Reviews&#8221; in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221;</a></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_34"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_37"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_40"></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MARKET AND HOLDERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange (NYSE) under the symbol UNH. On January 31, 2023, there were 10,260 holders of record of our common stock. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DIVIDEND POLICY </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share, which the Company had paid since June 2021. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities (a)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fourth Quarter 2022</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Month Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Number of Shares That May Yet Be Purchased Under The Plans or Programs</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">                   </span></div><div style="margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In November 1997, our Board of Directors adopted a share repurchase program, which the Board evaluates periodically. In June 2018, the Board of Directors renewed our share repurchase program with an authorization to repurchase up to 100 million shares of our common stock in open market purchases or other types of transactions (including prepaid or structured repurchase programs). There is no established expiration date for the program.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PERFORMANCE GRAPH</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph compares the cumulative five-year total return to shareholders on our common stock relative to the cumulative total returns of the S&amp;P Health Care Index, the Dow Jones US Industrial Average Index and the S&amp;P 500 Index for the five-year period ended December&#160;31, 2022. The comparisons assume the investment of $100 on December&#160;31, 2017 in our common stock and in each index, and dividends were reinvested when paid.</span></div><div style="margin-top:6pt;text-align:center"><img src="unh-20221231_g2.jpg" alt="unh-20221231_g2.jpg" style="height:567px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/22</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UnitedHealth Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114.52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">166.55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241.85</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258.65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Index</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128.64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145.93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">184.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">180.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dow Jones US Industrial Average</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96.52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120.98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160.55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149.53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95.62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">125.72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148.85</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156.89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The stock price performance included in this graph is not necessarily indicative of future stock price performance. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_49"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">[Reserved]</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read together with the accompanying </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_73">Consolidated Financial Statements and Notes to the Consolidated Financial Statements thereto included in Part II Item 8, &#8220;Financial Statements and Supplementary Data</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Readers are cautioned the statements, estimates, projections or outlook contained in this report, including discussions regarding financial prospects, economic conditions, trends and uncertainties contained in this Item 7, may constitute forward-looking statements within the meaning of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. A description of some of the risks and uncertainties can be found further below in this Item 7 and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Part I, Item 1A, &#8220;Risk Factors.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions of year-over-year comparisons between 2021 and 2020 are not included in this Form 10-K and can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176622000008/unh-20211231.htm">Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company&#8217;s Form 10-K for the fiscal year ended&#160;December 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group is a diversified health care company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two complementary businesses &#8212; Optum and UnitedHealthcare &#8212; are driven by this unified mission and vision to improve health care access, affordability, experiences and outcomes for the individuals and organizations we are privileged to serve.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four reportable segments across our two business platforms, Optum and UnitedHealthcare:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare, which includes UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement and UnitedHealthcare Community&#160;&amp; State.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information on our business and reportable segments is presented in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_13">Part I, Item 1, &#8220;Business&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_211"> Note 14 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Trends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses participate in the United States, South America and certain other international health markets. In the United States, health care spending has grown consistently for many years and comprises 18% of gross domestic product (GDP). We expect overall spending on health care to continue to grow in the future, due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being. The rate of market growth may be affected by a variety of factors, including macroeconomic conditions, which could impact our results of operations, including our continued efforts to control health care costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Trends.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To price our health care benefits, products and services, we start with our view of expected future costs, including inflation and labor market dynamics. We frequently evaluate and adjust our approach in each of the local markets we serve, considering relevant factors, such as product positioning, price competitiveness and environmental, competitive, legislative and regulatory considerations, including minimum medical loss ratio (MLR) thresholds and similar revenue adjustments. We will continue seeking to balance growth and profitability across all these dimensions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial risk market remains highly competitive in the small group, large group and individual segments. We expect broad-based competition to continue as the industry adapts to individual and employer needs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage funding continues to be pressured, as discussed below in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_58">&#8220;Regulatory Trends and Uncertainties.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Medicaid, we believe the payment rate environment creates the risk of continued downward pressure on Medicaid margin percentages. We continue to take a prudent, market-sustainable posture for both new business and maintenance of existing relationships. We continue to advocate for actuarially sound rates commensurate with our medical cost trends and we remain dedicated to partnering with those states that are committed to the long-term viability of their programs.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Cost Trends. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical cost trends primarily relate to changes in unit costs; care activity; and prescription drug costs. We endeavor to mitigate those increases by engaging physicians and consumers with information and helping them make clinically sound choices, with the objective of helping them achieve high-quality, affordable care.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid Redeterminations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, Congress passed the 2023 Omnibus Appropriations bill that allows states to resume Medicaid redeterminations beginning in April 2023. Redeterminations will result in a decline in people served through our Medicaid business and an expected increase in people served through our commercial and exchange-based offerings as we endeavor to ensure that people have continued access to benefits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delivery System and Payment Modernization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The health care market continues to change based on demographic shifts, new regulations, political forces and both payer and patient expectations. Health plans and care providers are being called upon to work together to close gaps in care and improve overall care quality and patient experience, improve the health of populations and reduce costs. We are working to accelerate this vision through the innovation and integration of our care delivery models including in clinic, in-home, behavioral and virtual care, and by using our data and analytics to provide clinicians with the necessary information in order to provide the best possible care in the most cost efficient setting. We continue to see a greater number of people enrolled in fully accountable value-based plans rewarding high-quality, affordable care and fostering collaboration.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This trend is creating needs for health management services which can coordinate care around the primary care physician, including new primary care channels, and for investments in new clinical and administrative information and management systems, which we believe provide growth opportunities for our Optum business platform. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Trends and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a summary of management&#8217;s view of the trends and uncertainties related to regulatory matters. For additional information regarding regulatory trends and uncertainties, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_19">Part I, Item&#160;1 &#8220;Business - Government Regulation&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_22">Item&#160;1A, &#8220;Risk Factors.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Medicare Advantage Rates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Medicare Advantage rate notices over the years have at times resulted in industry base rates well below industry forward medical trend. For example, the February 2023 Advance Notice for 2024 rates would result in an industry base rate decrease, well short of what is an increasing industry forward medical cost trend, creating continued pressure in the Medicare Advantage program. Further, proposed substantial revisions to the risk adjustment model, which serves to adjust rates to reflect a patient&#8217;s health status and care resource needs, would result in reduced funding and benefits for people, especially those with some of the greatest health and social challenges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As a result of ongoing Medicare funding pressures, there are adjustments we can make to partially offset these rate pressures and reductions for a particular period. For example, we can seek to intensify our medical and operating cost management, make changes to the size and composition of our care provider networks, adjust member benefits and implement or increase the member premiums supplementing the monthly payments we receive from the government. Additionally, we decide annually on a county-by-county basis where we will offer Medicare Advantage plans. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SELECTED OPERATING PERFORMANCE ITEMS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a summary of select 2022 year-over-year operating comparisons to 2021.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Consolidated revenues increased by 13%, UnitedHealthcare revenues increased 12% and Optum revenues grew 17%. </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare served nearly 1.1 million more people, led by growth in community-based and senior offerings.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Earnings from operations increased by 19%, including an increase of 20% at UnitedHealthcare and 17% at Optum.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Diluted earnings per common share increased 17% to $21.18. </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Cash flows from operations were $26.2 billion.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Return on equity was 27.2%.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RESULTS SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our consolidated results of operations and other financial information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.522%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages and per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,033&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,639&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,769&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.18&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.08&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.03&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical care ratio (a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings margin (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return on equity (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:underline">________ </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.13pt">Medical care ratio (MCR) is calculated as medical costs divided by premium revenue.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Net earnings margin attributable to UnitedHealth Group common shareholders.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.13pt">Return on equity is calculated as net earnings attributable to UnitedHealth Group common shareholders divided by average shareholders&#8217; equity. Average shareholders&#8217; equity is calculated using the shareholders&#8217; equity balance at the end of the preceding year and the shareholders&#8217; equity balances at the end of each of the four quarters of the year presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 RESULTS OF OPERATIONS COMPARED TO 2021 RESULTS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Results</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increases in revenues were primarily driven by growth in the number of people served through Medicare Advantage and Medicaid, pricing trends and growth across the Optum businesses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and MCR</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs increased due to growth in people served. The MCR decreased due to COVID-19 effects, partially offset by decreased prior years favorable development and business mix.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cost Ratio</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating cost ratio decreased primarily due to productivity gains, partially offset by investments and business mix.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_211">Note 14 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data &#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our segments. We utilize various metrics to evaluate and manage our reportable segments, including individuals served by UnitedHealthcare by major market segment and funding arrangement, people served by Optum Health and adjusted scripts for Optum Rx. These metrics are the main drivers of revenue, earnings and cash flows at each business. The metrics also allow management and investors to evaluate and understand business mix, including the level and scope of services provided to people and pricing trends when comparing the metrics to revenue by segment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of the reportable segment financial information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182,768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings from operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated earnings from operations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating margin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated operating margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes UnitedHealthcare revenues by business:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:48.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &amp; Individual - Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &amp; Individual - Global (a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &amp; Individual - Total (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Medicare &amp; Retirement</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community &amp; State</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)   On January 1, 2022, we realigned our operating segments to combine UnitedHealthcare Global and UnitedHealthcare Employer &amp; Individual.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of individuals served by our UnitedHealthcare businesses, by major market segment and funding arrangement:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - domestic:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-based</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total commercial - domestic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,580&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement (Standardized)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total community and senior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,790&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare - domestic medical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - global</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare - medical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D stand-alone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage increased due to growth in people served through individual and group Medicare Advantage plans. The increase in people served through Medicaid was primarily driven by states continuing to ease redetermination requirements and growth in people served through Dual Special Needs Plans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare&#8217;s revenues increased due to growth in the number of people served through Medicare Advantage and Medicaid. Earnings from operations increased due to growth in people served and COVID-19 effects, partially offset by decreased prior years favorable development.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues and earnings from operations increased due to growth across the Optum businesses. The results by segment were as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Health</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues at Optum Health increased primarily due to organic growth in patients served under value-based care arrangements and business combinations. Earnings from operations increased due to organic growth in the number of people served under value-based care arrangements, cost management initiatives, asset dispositions and COVID-19 effects. Optum Health served approximately 102 million people as of December&#160;31, 2022 compared to 100 million people as of December 31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Insight</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and earnings from operations at Optum Insight increased due to growth in technology and managed services, with managed services revenue growth driven by business combinations and new health system partnerships.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Rx</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and earnings from operations at Optum Rx increased due to higher script volumes from growth in people served, increased utilization and organic growth in pharmacy care services, including community health, specialty and home delivery pharmacies. Earnings from operations also increased as a result of continued supply chain management initiatives. Optum Rx fulfilled 1,438 million and 1,368 million adjusted scripts in 2022 and 2021, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIQUIDITY, FINANCIAL CONDITION AND CAPITAL RESOURCES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our liquidity and financial position in the context of our overall business strategy. We continually forecast and manage our cash, investments, working capital balances and capital structure to meet the short-term and long-term obligations of our businesses while seeking to maintain liquidity and financial flexibility. Cash flows generated from operating activities are principally from earnings before noncash expenses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our regulated subsidiaries generate significant cash flows from operations and are subject to, among other things, minimum levels of statutory capital, as defined by their respective jurisdictions, and restrictions on the timing and amount of dividends paid to their parent companies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. regulated subsidiaries paid their parent companies dividends of $8.8 billion and $8.0 billion in 2022 and 2021, respectively. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_196">See Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail concerning our regulated subsidiary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nonregulated businesses also generate significant cash flows from operations available for general corporate use. Cash flows generated by these entities, combined with dividends from our regulated entities and financing through the issuance of long-term debt as well as issuance of commercial paper or the ability to draw under our committed credit facilities, further strengthen our operating and financial flexibility. We use these cash flows to expand our businesses through acquisitions, reinvest in our businesses through capital expenditures, repay debt and return capital to our shareholders through dividends and repurchases of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of our Major Sources and Uses of Cash and Cash Equivalents</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sources of cash:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of long-term debt and short-term borrowings, net of repayments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common share issuances</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer funds administered</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received for dispositions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sources of cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,957&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uses of cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash assumed</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments, net of sales and maturities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total uses of cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,001)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,046)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,464)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Cash Flows Compared to 2021 Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased cash flows provided by operating activities were primarily driven by changes in working capital accounts and increased net earnings. Other significant changes in sources or uses of cash year-over-year included increased net issuances of long-term debt, customer funds administered, primarily driven by Medicare Part D timing and increased HSA deposits, cash received for dispositions and decreased purchases of redeemable noncontrolling interests, partially offset by increased cash paid for acquisitions, net purchases of investments and common stock repurchases.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Condition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our cash, cash equivalent, available-for-sale debt securities and equity securities balances of $69.4 billion included $23.4 billion of cash and cash equivalents (of which $1.3 billion was available for general corporate use), $42.3 billion of debt securities and $3.7 billion of equity securities. Given the significant portion of our portfolio held in cash equivalents, we do not anticipate fluctuations in the aggregate fair value of our financial assets to have a material impact on our liquidity or capital position. Other sources of liquidity, primarily from operating cash flows and our commercial paper program, which is fully supported by our bank credit facilities, reduce the need to sell investments during adverse market conditions. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_166">Note 4 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail concerning our fair value measurements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our available-for-sale debt portfolio had a weighted-average duration of 4.0 years and a weighted-average credit rating of &#8220;Double A&#8221; as of December&#160;31, 2022. When multiple credit ratings are available for an individual security, the average of the available ratings is used to determine the weighted-average credit rating.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources and Uses of Liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash requirements within the next twelve months include medical costs payable, accounts payable and accrued liabilities, short-term borrowings and current maturities of long-term debt, other current liabilities, and purchase commitments and other obligations. We expect the cash required to meet these obligations to be primarily generated through cash flows from current operations; cash available for general corporate use; and the realization of current assets, such as accounts receivable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term cash requirements under our various contractual obligations and commitments include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Debt obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail of our long-term debt and the timing of expected future payments. Interest coupon payments are typically paid semi-annually.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail of our obligations and the timing of expected future payments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Purchase and other obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> These include $5.6 billion, $2.9 billion of which is expected to be paid within the next twelve months, of fixed or minimum commitments under existing purchase obligations for goods and services, including agreements cancelable with the payment of an early termination penalty, and remaining capital commitments for venture capital funds and other funding commitments. These amounts exclude agreements cancelable without penalty and liabilities to the extent recorded in our Consolidated Balance Sheets as of December&#160;31, 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Other liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> These include other long-term liabilities reflected in our Consolidated Balance Sheets as of December&#160;31, 2022, including obligations associated with certain employee benefit programs, unrecognized tax benefits and various long-term liabilities, which have some inherent uncertainty in the timing of these payments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Redeemable noncontrolling interests.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_151">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_151">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_151">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail. We do not have any material expected redemptions in the next twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the cash required to meet our long-term obligations to be primarily generated through future cash flows from operations. However, we also have the ability to generate cash to satisfy both our current and long-term requirements through the issuance of commercial paper, issuance of long-term debt, or drawing under our committed credit facilities or the ability to sell investments. We believe our capital resources are sufficient to meet future, short-term and long-term, liquidity needs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revolving bank credit facilities provide liquidity support for our commercial paper borrowing program, which facilitates the private placement of senior unsecured debt through independent broker-dealers, and are available for general corporate purposes. For more information on our commercial paper and bank credit facilities, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving bank credit facilities contain various covenants, including covenants requiring us to maintain a defined debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%, subject to increase in certain circumstances set forth in the applicable credit agreement. As of December&#160;31, 2022, our debt to debt-plus-shareholders&#8217; equity ratio, as defined and calculated under the credit facilities, was 38%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Periodically, we access capital markets to issue long-term debt for general corporate purposes, such as to meet our working capital requirements, to refinance debt, to finance acquisitions or for share repurchases. For more information on our debt, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8 &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Ratings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our credit ratings as of December&#160;31, 2022 were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:22.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.653%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Moody&#8217;s</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P Global</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">A.M. Best</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Positive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMB-1+</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of financing in the form of debt or equity is influenced by many factors, including our profitability, operating cash flows, debt levels, credit ratings, debt covenants and other contractual restrictions, regulatory requirements and economic and market conditions. A significant downgrade in our credit ratings or adverse conditions in the capital markets may increase the cost of borrowing for us or limit our access to capital.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2022, we had Board of Directors&#8217; authorization to purchase up to 31 million shares of our common stock. For more information on our share repurchase program, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_196">Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share. For more information on our dividend, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_196">Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2022, we have entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $9 billion. We completed the acquisition of LHC Group, Inc. on February 22, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have other significant contractual obligations or commitments requiring cash resources. However, we continually evaluate opportunities to expand our operations, which include internal development of new products, programs and technology applications and may include acquisitions.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting estimates are those estimates requiring management to make challenging, subjective or complex judgments, often because they must estimate the effects of matters inherently uncertain and may change in subsequent periods. Critical accounting estimates involve judgments and uncertainties which are sufficiently sensitive and may result in materially different results under different assumptions and conditions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Costs Payable</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of our obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received or processed. Depending on the health care professional and type of service, the typical billing lag for services can be up to 90 days from the date of service. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each reporting period, our operating results include the effects of more completely developed medical costs payable estimates associated with previously reported periods. If the revised estimate of prior period medical costs is less than the previous estimate, we will decrease reported medical costs in the current period (favorable development). If the revised estimate of prior period medical costs is more than the previous estimate, we will increase reported medical costs in the current period (unfavorable development). Medical costs in 2022, 2021 and 2020 included favorable medical cost development related to prior years of $410 million, $1.7 billion and $880 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing our medical costs payable estimates, we apply different estimation methods depending on the month for which incurred claims are being estimated. For example, for the most recent two months, we estimate claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data is available, supplemented by a review of near-term completion factors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completion Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A completion factor is an actuarial estimate, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by us at the date of estimation. Completion factors are the most significant factors we use in developing our medical costs payable estimates for periods prior to the most recent two months. Completion factors include judgments in relation to claim submissions such as the time from date of service to claim receipt, claim levels and processing cycles, as well as other factors. If actual claims submission rates from providers (which can be influenced by a number of factors, including provider mix and electronic versus manual submissions), actual care activity incurred (which can be influenced by pandemics or seasonal illnesses, such as influenza), or our claim processing patterns are different than estimated, our reserve estimates may be significantly impacted.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the sensitivity of these factors and the estimated potential impact on our medical costs payable estimates for those periods as of December&#160;31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Completion Factors<br/>(Decrease) Increase in Factors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease)<br/>In Medical Costs Payable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.75)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Cost Per Member Per Month Trend Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Medical cost PMPM trend factors are significant factors we use in developing our medical costs payable estimates for the most recent two months. Medical cost trend factors are developed through a comprehensive analysis of claims incurred in prior months, provider contracting and expected unit costs, benefit design and a review of a broad set of health care utilization indicators. These factors include but are not limited to pharmacy utilization trends, inpatient hospital authorization data and seasonal and other incidence data from the National Centers for Disease Control. We also consider macroeconomic variables such as GDP growth, employment and disposable income. A large number of factors can cause the medical cost trend to vary from our estimates, including: our ability and practices to manage medical and pharmaceutical costs, changes in level and mix of services utilized; mix of benefits offered, including the impact of co-pays and deductibles; changes in medical practices; and catastrophes, epidemics and pandemics. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the sensitivity of these factors and the estimated potential impact on our medical costs payable estimates for the most recent two months as of December&#160;31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Cost PMPM Quarterly Trend<br/>Increase (Decrease) in Factors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease)<br/>In Medical Costs Payable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion factors and medical costs PMPM trend factors analyses above include outcomes considered reasonably likely based on our historical experience estimating liabilities for incurred but not reported benefit claims. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes the amount of medical costs payable is reasonable and adequate to cover our liability for unpaid claims as of December&#160;31, 2022; however, actual claim payments may differ from established estimates as discussed above. Assuming a hypothetical 1% difference between our December&#160;31, 2022 estimates of medical costs payable and actual medical costs payable, excluding AARP Medicare Supplement Insurance and any potential offsetting impact from premium rebates, 2022 net earnings would have increased or decreased by approximately $215 million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detail related to our medical cost estimates, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_118">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change indicating the carrying value may not be recoverable. When testing goodwill for impairment, we may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. During a qualitative analysis, we consider the impact of changes, if any, to the following factors: macroeconomic, industry and market factors; cost factors; changes in overall financial performance; and any other relevant events and uncertainties impacting a reporting unit. If our qualitative assessment indicates a goodwill impairment is more likely than not, we perform additional quantitative analyses. We may also elect to skip the qualitative testing and proceed directly to the quantitative testing. For reporting units where a quantitative analysis is performed, we perform a test measuring the fair values of the reporting units and comparing them to their carrying values, including goodwill. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of our reporting units using a discounted cash flow method which includes assumptions about a wide variety of internal and external factors. Significant assumptions used in the discounted cash flow method include financial projections of free cash flow, including revenue trends, medical costs trends, operating productivity, income taxes and capital levels; long-term growth rates for determining terminal value beyond the discretely forecasted periods; and discount rates. For each reporting unit, comparative market multiples are used to corroborate the results of our discounted cash flow test.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial projections and long-term growth rates used for our reporting units are consistent with, and use inputs from, our internal long-term business plan and strategies. Discount rates are determined for each reporting unit and include consideration of the implied risk inherent in their forecasts. Our most significant estimate in the discount rate determinations involves our adjustments to the peer company weighted average costs of capital reflecting reporting unit-specific factors. We have not made any adjustments to decrease a discount rate below the calculated peer company weighted average cost of capital for any reporting unit. Company-specific adjustments to discount rates are subjective and thus are difficult to measure with certainty. The passage of time and the availability of additional information regarding areas of uncertainty with respect to the reporting units&#8217; operations could cause these assumptions to change in the future. Additionally, as part of our quantitative impairment testing, we perform various sensitivity analyses on certain key assumptions, such as discount rates and cash flow projections to analyze the potential for a material impact. As of October 1, 2022, we completed our annual impairment tests for goodwill with all of our reporting units having fair values substantially in excess of their carrying values.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL MATTERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our legal proceedings is presented in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Note 12 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATIONS OF CREDIT RISK</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in financial instruments such as marketable securities and accounts receivable may subject us to concentrations of credit risk. Our investments in marketable securities are managed under an investment policy authorized by our Board of Directors. This policy limits the amounts which may be invested in any one issuer and generally limits our investments to U.S. government and agency securities, state and municipal securities and corporate debt obligations of investment grade. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of employer groups and other customers constituting our client base. As of December&#160;31, 2022, there were no significant concentrations of credit risk.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_70"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary market risks are exposures to changes in interest rates impacting our investment income and interest expense and the fair value of certain of our fixed-rate investments and debt, as well as foreign currency exchange rate risk of the U.S. dollar primarily to the Brazilian real and Chilean peso.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $31 billion of financial assets on which the interest rates received vary with market interest rates, which may significantly impact our investment income. Also as of December&#160;31, 2022, $16 billion of our financial liabilities, which include debt and deposit liabilities, were at interest rates which vary with market rates, either directly or through the use of related interest rate swap contracts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our fixed-rate investments and debt also varies with market interest rates. As of December&#160;31, 2022, $38 billion of our investments were fixed-rate debt securities and $43 billion of our debt was non-swapped fixed-rate term debt. An increase in market interest rates decreases the market value of fixed-rate investments and fixed-rate debt. Conversely, a decrease in market interest rates increases the market value of fixed-rate investments and fixed-rate debt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage exposure to market interest rates by diversifying investments across different fixed-income market sectors and debt across maturities, as well as by matching a portion of our floating-rate assets and liabilities, either directly or through the use of interest rate swap contracts. Unrealized gains and losses on investments in available-for-sale debt securities are reported in comprehensive income.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the impact of hypothetical changes in market interest rates across the entire yield curve by 1% point or 2% points as of December&#160;31, 2022 and 2021 on our investment income and interest expense per annum and the fair value of our investments and debt (in millions, except percentages):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease) in Market Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>Income&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Expense&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Liabilities </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 %</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,390)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,365)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,746)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease) in Market Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>Income&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Expense&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Liabilities </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,664)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Note: The impact of hypothetical changes in interest rates may not reflect the full 100 or 200 basis point change on interest income and interest expense or on the fair value of financial assets and liabilities as the rates are assumed to not fall below zero.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an exposure to changes in the value of foreign currencies, primarily the Brazilian real and the Chilean peso, to the U.S. dollar in translation of UnitedHealthcare Employer &amp; Individual&#8217;s international business operating results at the average exchange rate over the accounting period, and assets and liabilities at the exchange rate at the end of the accounting period. The gains or losses resulting from translating foreign assets and liabilities into U.S. dollars are included in equity and comprehensive income. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An appreciation of the U.S. dollar against the Brazilian real or Chilean peso reduces the carrying value of the net assets denominated in those currencies. For example, as of December&#160;31, 2022, a hypothetical 10% and 25% increase in the value of the U.S. dollar against those currencies would have caused a reduction in net assets of approximately $560 million and $1.2 billion, respectively. We manage exposure to foreign currency earnings risk primarily by conducting our international business operations in their functional currencies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183MC9mcmFnOjE4OThlOTAzOTUyNDRhNzFhNWQwYTNiNTNmOGY0NjUyL3RleHRyZWdpb246MTg5OGU5MDM5NTI0NGE3MWE1ZDBhM2I1M2Y4ZjQ2NTJfMzU0OA_ea80e291-1ec9-438c-a3ac-6a291c343771">3.7</ix:nonFraction> billion of investments in equity securities, primarily consisting of investments in employee savings plan related investments, other venture investments and non-U.S. dollar fixed-income funds. Valuations in non-U.S. dollar funds are subject to foreign exchange rates.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_73"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_76">Report of Independent Registered Public Accounting Firm (</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_76">PCAOB ID No </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183My9mcmFnOmVlNzVhZGRiODM5MjRmODE5NmI2YjJiYjNlMTI1YWY5L3RhYmxlOjdkNmIxOGE0ZDJkZDRmYjlhMzZlN2Y4OTkwMDI1N2Y3L3RhYmxlcmFuZ2U6N2Q2YjE4YTRkMmRkNGZiOWEzNmU3Zjg5OTAwMjU3ZjdfMi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjMwOWJkMDA5MDI2MzQ0YmI4YWY5Nzk4NmEyMTEwYWNlXzc0_8d782c06-09cc-4639-801c-3e1b300fb245">34</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_76">)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_76">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_103">1.     Description of Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_103">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_106">2.     Basis of Presentation, Use of Estimates and Significant Accounting Policies</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_106">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_163">3.     Investments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_163">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_166">4.     Fair Value</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_166">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_172">5.     Property, Equipment and Capitalized Software</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_172">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_175">6.     Goodwill and Other Intangible Assets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_175">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_181">7.     Medical Costs Payable</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_181">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">8.     Short-Term Borrowings and Long-Term Debt</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_190">9.     Income Taxes</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_190">56</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_196">10.   Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_196">58</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_202">11.   Share-Based Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_202">59</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">12.   Commitments and Contingencies</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">61</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_2699">13.   Business Combinations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_2699">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_211">14.   Segment Financial Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_211">64</a></span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of UnitedHealth Group Incorporated and Subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 24, 2023 expressed an unqualified opinion on the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the Audit and Finance Committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incurred but not Reported (IBNR) Claim Liability - Refer to Notes 2 and 7 to the financial statements.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable includes estimates of the Company&#8217;s obligations for medical care services rendered on behalf of insured consumers, for which claims have either not yet been received or processed. These estimates are referred to as incurred but not reported (IBNR) claim liabilities. At December 31, 2022, the Company&#8217;s IBNR balance was $20 billion. The Company develops IBNR estimates using an actuarial model that requires management to exercise certain judgments in developing its estimates. Judgments made by management include medical cost per member per month trend factors and completion factors, which include assumptions over the time from date of service to claim receipt, the impact of actual care activity, and processing cycles.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the IBNR claim liability as a critical audit matter because of the significant assumptions made by management in estimating the liability. This required complex auditor judgment, and an increased extent of effort, including the involvement of actuarial specialists in performing procedures to evaluate the reasonableness of management&#8217;s methods, assumptions and judgments in developing the liability. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures included the following, among others: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over management&#8217;s estimate of the IBNR claim liability balance, including controls over the judgments in both the completion factors and the medical cost per member per month trend factors, as well as controls over the claims and membership data used in the estimation process.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the underlying claims and membership data and other information that served as the basis for the actuarial analysis, to test that the inputs to the actuarial estimate were complete and accurate.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of actuarial specialists, we evaluated the reasonableness of the actuarial methods and assumptions used by management to estimate the IBNR claim liability by: </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Performing an overlay of the historical claims data used in management&#8217;s current year model to the data used in prior periods to validate that there were no material changes to the claims data tested in prior periods. </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Developing an independent estimate of the IBNR claim liability and comparing our estimate to management&#8217;s estimate. </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Performing a retrospective review comparing management&#8217;s prior year estimate of IBNR to claims processed in 2022 with dates of service in 2021 or prior.</span></div><div style="margin-top:3pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183Ni9mcmFnOjczZDIxNGVkOWFkYjQ0YjlhMGZiOTNkN2ZmYmYzM2I5L3RhYmxlOjhlMjc4Nzg0MmEwMzRkN2FhMjk3ODViMzkyMzJiNTA4L3RhYmxlcmFuZ2U6OGUyNzg3ODQyYTAzNGQ3YWEyOTc4NWIzOTIzMmI1MDhfMC0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg2NWIyYTA1ODI1YzQxN2FiZGZlNjYzMzc5NDY2MDFlXzg_8542e41c-29b5-44c7-82cc-ba87ccca8a33">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183Ni9mcmFnOjczZDIxNGVkOWFkYjQ0YjlhMGZiOTNkN2ZmYmYzM2I5L3RhYmxlOjhlMjc4Nzg0MmEwMzRkN2FhMjk3ODViMzkyMzJiNTA4L3RhYmxlcmFuZ2U6OGUyNzg3ODQyYTAzNGQ3YWEyOTc4NWIzOTIzMmI1MDhfMi0wLTEtMS01MTkzNQ_b40ae886-6eca-4fe5-b83c-29303a5ad1ec">Minneapolis, Minnesota</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2002.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMy0yLTEtMS01MTkzNQ_616088fa-ec78-4c3e-a5e3-097fae718923">23,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMy00LTEtMS01MTkzNQ_3f93c4d5-909c-454d-a6f4-f049cc3c973d">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNC0yLTEtMS01MTkzNQ_a4043e1f-f6f2-443b-9385-9136517cbcb5">4,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNC00LTEtMS01MTkzNQ_737e2b3b-8882-4cd7-924f-bf62dddbec11">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOmJmNjJmMzM0ODc5YjQ5YWNiN2IyZTg1NmViZTY5Mjg4Xzc2OTY1ODEzOTQ0OTU_545fe2fc-d00e-453f-bd4b-4ba4491b8ec3">877</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOmJmNjJmMzM0ODc5YjQ5YWNiN2IyZTg1NmViZTY5Mjg4Xzc2OTY1ODEzOTQ1MDI_b2158bb1-41db-42af-8bb6-fde9bfbd78d0">954</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0yLTEtMS01MTkzNQ_ba065e18-73e3-4349-8794-c2fa1a4f8455">17,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS00LTEtMS01MTkzNQ_f6a32f2f-b34f-4e2a-a69d-e48a39baadcf">14,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current receivables, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg1NzBmYjYzMmNmNjQ5ZjE5Yjc5YzMyYTMxYmZjMzZhXzc2OTY1ODEzOTQ1MDU_a285ae78-23f8-47cf-a826-8a9a31f89e09">1,433</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg1NzBmYjYzMmNmNjQ5ZjE5Yjc5YzMyYTMxYmZjMzZhXzc2OTY1ODEzOTQ1MTI_195eff6e-e463-4e6d-88ed-ef36d34f839b">993</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0yLTEtMS01MTkzNQ_2d6da204-dba0-4485-a2bc-145ce172b8fc">12,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi00LTEtMS01MTkzNQ_e737fe45-dd0f-4a0d-b333-6573879a8abf">13,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNy0yLTEtMS01MTkzNQ_e491355a-3ba1-43af-a151-b545ab7a610f">4,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNy00LTEtMS01MTkzNQ_c60dc09f-d90f-4019-bf48-244bf9fa8fe8">4,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOC0yLTEtMS01MTkzNQ_2e7d0b36-debf-4d7e-9839-c11f05ca8232">6,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOC00LTEtMS01MTkzNQ_af67c83d-a65c-4578-8e8d-26a711e7fa06">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOS0yLTEtMS01MTkzNQ_ac4162fb-1de6-4234-9306-55958f47c5db">69,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOS00LTEtMS01MTkzNQ_95c5b739-2f27-49b0-94c4-0cd6f2682bc1">61,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTAtMi0xLTEtNTE5MzU_0b1ca43d-d230-45a1-b0dd-28d78d17b71a">43,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTAtNC0xLTEtNTE5MzU_93ff0895-42e8-4ee1-bc57-4dccc36162a1">43,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjphYjcwNzI3M2NlYjg0YzQyYjhjMzYwYWZiM2RiZTExMV83Njk2NTgxMzk0NTU3_0770cf37-46a3-425a-8de8-58a3e0f3acc4">6,930</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjphYjcwNzI3M2NlYjg0YzQyYjhjMzYwYWZiM2RiZTExMV83Njk2NTgxMzk0NTY2_80ca054b-92bc-44f5-8d9d-77b8ff5677ad">5,992</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMi0xLTEtNTE5MzU_72d5cce9-7ab8-4f84-9045-a5fb9b2c7e78">10,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtNC0xLTEtNTE5MzU_9209cebe-1033-45cf-b942-70bf5a5ac76d">8,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTItMi0xLTEtNTE5MzU_ac1b5c93-463a-4097-a796-cd1a0aff0763">93,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTItNC0xLTEtNTE5MzU_e3028456-cc32-4576-aceb-3adefc52438b">75,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjozN2MzNTVmMjJiN2U0YTViYTYyZWY2YjNiMjc4OGI3MV83Njk2NTgxMzk0NTE5_4d7d4ed5-521a-48b4-9482-002e9534785d">6,137</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjozN2MzNTVmMjJiN2U0YTViYTYyZWY2YjNiMjc4OGI3MV83Njk2NTgxMzk0NTI4_e69e1899-a4e8-414a-a377-6394dcecf5ef">5,636</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMi0xLTEtNTE5MzU_9b37214f-ce4d-4a57-b29e-e9f553bc2f1e">14,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtNC0xLTEtNTE5MzU_aaba994a-bcfc-4d6d-bc6c-e54c5c0a6b32">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTQtMi0xLTEtNTE5MzU_c545b6a1-eee2-41fc-9704-186845172e92">15,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTQtNC0xLTEtNTE5MzU_b7a238de-9c71-4160-a41c-a73a2a085b13">12,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTUtMi0xLTEtNTE5MzU_c8b758cd-a0e5-4689-8ab3-8b5dbe21601d">245,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTUtNC0xLTEtNTE5MzU_49f39d10-28e5-4ce3-a5c6-409186127ac5">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, redeemable noncontrolling interests and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTgtMi0xLTEtNTE5MzU_3f701722-8f8b-4bcb-a013-47744474bd3a">29,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTgtNC0xLTEtNTE5MzU_219718d6-7036-4263-8c14-000497d27d08">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTktMi0xLTEtNTE5MzU_89a3820f-01ba-43a1-a34c-449adce21658">27,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTktNC0xLTEtNTE5MzU_8ce5862b-dfde-4d6a-8f99-34b0d9250dac">24,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjAtMi0xLTEtNTE5MzU_c13484a4-e534-4cb2-8f5d-22e6b2db712d">3,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjAtNC0xLTEtNTE5MzU_04943911-b874-4d9d-a7fd-91658ff38374">3,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjEtMi0xLTEtNTE5MzU_0ec26411-9537-497b-b9d0-1a8387676a8b">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjEtNC0xLTEtNTE5MzU_3898a4a7-ddab-461e-aa2d-0ad88f614a7f">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjItMi0xLTEtNTE5MzU_1c810ca8-8d7f-4420-b403-c3bcad502e96">26,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjItNC0xLTEtNTE5MzU_ef30296e-41db-4179-b0e2-7b908905f356">22,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjMtMi0xLTEtNTE5MzU_77a02135-0833-400f-8607-67840942ef4b">89,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjMtNC0xLTEtNTE5MzU_cc28956f-4515-474e-99e4-34ac5908a258">78,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjQtMi0xLTEtNTE5MzU_46af7479-9c07-4408-83bc-4091178e54a9">54,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjQtNC0xLTEtNTE5MzU_3b915ad9-b67f-45bb-b46f-b3512f927697">42,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjUtMi0xLTEtNTE5MzU_9c0f699a-8f2c-4b2b-aae7-dbe88c66e9b3">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjUtNC0xLTEtNTE5MzU_2835a5f4-365e-4d0e-a1d3-c8457f34db4f">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjYtMi0xLTEtNTE5MzU_8a0360bd-a03c-455a-ac2b-1c9908812b91">12,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjYtNC0xLTEtNTE5MzU_9544a769-cb5b-4fed-b653-285770d59a81">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjctMi0xLTEtNTE5MzU_b51b335a-05e2-4922-a9bc-4bd6ec57e8b8">159,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjctNC0xLTEtNTE5MzU_faabdff6-6bd8-4afb-8b97-4b1329fd20a9">135,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Commitments and contingencies (Note 12)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjgtMi0xLTEtNTE5MzU_f83097fa-e63c-4565-a967-12eb99ef48c7"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjgtNC0xLTEtNTE5MzU_7319a1b4-f7e1-44f5-b900-95601cea20bd"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjktMi0xLTEtNTE5MzU_981460fe-e6dc-44e2-8b6c-f7ef4e81cb82">4,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjktNC0xLTEtNTE5MzU_72a440c5-0afc-4b1a-8c1e-1026da9a51b8">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTM5_2a7f541c-d2a9-4297-bdfb-f08e72e65d8f"><ix:nonFraction unitRef="usdPerShare" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTM5_5b0ac684-3b4f-4454-9c51-07ff08845f86">0.001</ix:nonFraction></ix:nonFraction> par value - <ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ0_773eb662-6d8a-4dc6-a88a-f5287e5285d8"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ0_caa978fd-4c12-4d4b-b711-268b3a8d88aa">10</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_2b72dbe4-14fd-4e7a-825d-11e0eb4fa0d7"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_e01f5cd9-307b-454f-979f-c60d8162ad26"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_e631b875-21e9-4694-800f-f4973b828fff"><ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_f78796cb-a186-4625-8862-73ae6fb0d457">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMi0xLTEtNTE5MzU_36b9888f-f44f-407c-9f94-8c83a61c0cac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtNC0xLTEtNTE5MzU_d577dc9c-a36a-40e3-8fa9-288c46084f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQw_340668c6-872c-439d-baf9-4dcf625590fb"><ix:nonFraction unitRef="usdPerShare" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQw_c8ecb272-995c-4850-b02b-87b54f086e67">0.01</ix:nonFraction></ix:nonFraction> par value - <ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQ4_0dfbad99-02c8-4b64-8750-e68ba16ff27a"><ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQ4_79d10d26-59ad-47d7-9bfb-66b646670946">3,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTU0_b231a3a8-d2b6-4cc3-b2e1-7189f3304521"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTU0_e671cfad-3398-4fe1-b57a-c468617e2029">934</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTYw_39a42b5c-ba9a-40c8-979b-e206ad1c91e2"><ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTYw_7af98c72-ff45-4425-a8f9-c0d1a15a4ab0">941</ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMi0xLTEtNTE5MzU_0d0beb59-44c9-4f74-a6b1-f2e96f8ac024">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItNC0xLTEtNTE5MzU_26972b29-c656-4941-b1ce-27b3d12614c0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzQtMi0xLTEtNTE5MzU_3cce2527-6876-4db7-991e-b3f98312cffb">86,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzQtNC0xLTEtNTE5MzU_6b328e6d-12bc-4b34-b4ef-e27880d5a0b2">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzUtMi0xLTEtNTE5MzU_03737753-4e12-456f-bf5e-f1dcd49b4582">8,393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzUtNC0xLTEtNTE5MzU_4848ae1b-648e-4c15-ab27-347fae066ad9">5,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzYtMi0xLTEtNTE5MzU_40ad620f-f9a7-4383-a9d0-17af25a139db">3,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzYtNC0xLTEtNTE5MzU_3da19188-d922-46f7-a4e2-2d5f99f1d9ac">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzctMi0xLTEtNTE5MzU_1841acb0-d52c-472a-ac25-1c399baeff56">81,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzctNC0xLTEtNTE5MzU_9570e275-d0d4-44bd-9c54-43a4b73001d4">75,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzgtMi0xLTEtNTE5MzU_19387f8f-31f8-408e-ace3-94d75e757ee9">245,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzgtNC0xLTEtNTE5MzU_c9c1ca87-0100-4928-9112-e1897e46955e">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100"> Notes to the Consolidated Financial Statements </a></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy0yLTEtMS01MTkzNQ_bf54ea8b-1b85-46af-94b0-20ded80ae384">257,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy00LTEtMS01MTkzNQ_15eb6cc0-97aa-44d7-b6f5-0228b0e32e66">226,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy02LTEtMS01MTkzNQ_f7a73e8c-52c9-49c7-a019-6fccb56d61ba">201,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4783b4127e2144999741c7d04d466e2e_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC0yLTEtMS01MTkzNQ_f4bde60a-2fed-4938-bbd0-003a64a69f90">37,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528146a5cf87439684c37a24329083d0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC00LTEtMS01MTkzNQ_c18e3db6-df9b-4ee2-b502-7ff67619baa2">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d105042b9242e3a67b99461ff390ab_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC02LTEtMS01MTkzNQ_0a6469bc-61d1-4bb0-bf33-4f0a3ca2927a">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f53e27fa72436f92deccfb277741ef_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS0yLTEtMS01MTkzNQ_89396db2-0b3a-450f-981e-f6299ca29e7e">27,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75f2b5ddba14b25908ed51f2abe23fe_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS00LTEtMS01MTkzNQ_82c2b641-93f9-4744-b21c-0c211143147c">24,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6440bd164d594884b755b5b9ff031b02_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS02LTEtMS01MTkzNQ_76b38cac-915a-45a0-9ee2-e5230988ac82">20,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi0yLTEtMS01MTkzNQ_be7d6e51-1aed-416c-b5c0-2b59df9de5af">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi00LTEtMS01MTkzNQ_74dcdeba-c11a-47f0-9cf5-59ae717ad40b">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi02LTEtMS01MTkzNQ_5145e732-9ab1-45d0-92dc-302a24ff9d38">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy0yLTEtMS01MTkzNQ_a2a0e424-a40f-4fc4-81cf-ad8359881979">324,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy00LTEtMS01MTkzNQ_ac8faf32-93b1-433e-868e-98a53760ce74">287,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy02LTEtMS01MTkzNQ_7829dd87-fc84-4bd0-9410-358bac3c5e93">257,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS0yLTEtMS01MTkzNQ_8cf6dfda-38b5-428a-83c3-ef4dc26b1ea3">210,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS00LTEtMS01MTkzNQ_b0b9ebb9-1edb-4b38-a0e4-ea3b9e1c94d9">186,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS02LTEtMS01MTkzNQ_8537c6a1-3a33-4976-9349-bbc332b57b27">159,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtMi0xLTEtNTE5MzU_a846f1d2-bcdf-4d84-8a3b-291afe6c51d9">47,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtNC0xLTEtNTE5MzU_17f3223e-ed1f-4d25-a6ee-15c4bc73ed4b">42,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtNi0xLTEtNTE5MzU_a9535560-8d48-44de-abad-8f109b465ed7">41,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtMi0xLTEtNTE5MzU_3d1d5c78-195b-4e5f-a68a-d31e3390b8de">33,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtNC0xLTEtNTE5MzU_e93061f7-c1d0-4ebb-b66f-4d8a0d794702">31,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtNi0xLTEtNTE5MzU_4010f949-032c-4887-98e1-593f008d668c">30,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItMi0xLTEtNTE5MzU_742c6195-1133-4c38-882d-d633a39604e0">3,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItNC0xLTEtNTE5MzU_16fb8eed-b2fd-42ae-b722-f6f2605e65b8">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItNi0xLTEtNTE5MzU_2b93013b-b141-49e0-9f8e-5c6f16133291">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtMi0xLTEtNTE5MzU_33452e65-e6e2-40c1-acf4-85d2f69e2a6b">295,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtNC0xLTEtNTE5MzU_f286399e-b1ec-4d67-82c4-05d19c8ed5f3">263,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtNi0xLTEtNTE5MzU_f51da3cc-b842-494e-8715-7b8e2c3bc658">234,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtMi0xLTEtNTE5MzU_15461e80-89f6-4789-9c28-bb418ba877b2">28,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtNC0xLTEtNTE5MzU_36527cba-5784-4b04-92ce-02eeca50f5ab">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtNi0xLTEtNTE5MzU_eb7ddb76-d115-436c-b2fa-4418b1bdc8d4">22,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtMi0xLTEtNTE5MzU_c0c2c376-7548-4887-9b4a-5448275b7a28">2,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtNC0xLTEtNTE5MzU_b929f3dd-69d3-43ca-8b16-7388f408d5db">1,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtNi0xLTEtNTE5MzU_cbf52fa1-2ce0-4d29-a4de-74cc6971a78a">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtMi0xLTEtNTE5MzU_0b9d8b54-041e-46d7-a1df-cf6305060cea">26,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtNC0xLTEtNTE5MzU_d9ce15ba-9e7a-46fb-bea0-33f4a6da18b5">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtNi0xLTEtNTE5MzU_4ee2e052-5597-4090-a2a6-39b345eb3b52">20,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctMi0xLTEtNTE5MzU_1c0e9c4c-b154-4967-a1c4-e84e1c682a9c">5,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctNC0xLTEtNTE5MzU_007977df-835b-4c01-9a2f-8bf2b6ec4920">4,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctNi0xLTEtNTE5MzU_647ef021-36e1-4cda-b0bb-4ff477025690">4,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtMi0xLTEtNTE5MzU_ccb5d3cc-4ffd-40b9-b1e0-f5316a8b7f13">20,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtNC0xLTEtNTE5MzU_0d812d44-bbf5-4652-8877-8dd08bd312b1">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtNi0xLTEtNTE5MzU_866d2656-12b7-4a2a-b316-f17a0a48754a">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktMi0xLTEtNTE5MzU_cfe059fb-a05f-411c-8c36-fa779a91f996">519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktNC0xLTEtNTE5MzU_df19e8fc-95b1-4d74-b926-ec7cc9f40521">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktNi0xLTEtNTE5MzU_1dd74a01-a66a-403b-99d8-09cac64822f5">366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtMi0xLTEtNTE5MzU_1a9d5bca-7160-4bd9-90d4-931110c01d1e">20,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtNC0xLTEtNTE5MzU_e7a36418-623c-45f0-b36b-d15a27acdaee">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtNi0xLTEtNTE5MzU_8c2d4856-1932-4745-aaf0-207993bad738">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to UnitedHealth Group common shareholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItMi0xLTEtNTE5MzU_ed43beaa-f032-4df0-b733-3477a0caeb9c">21.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItNC0xLTEtNTE5MzU_71ff456d-15c3-4550-9a78-8604d6d2b0a7">18.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItNi0xLTEtNTE5MzU_dcb3acbf-cf66-4536-bf55-637da0407980">16.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtMi0xLTEtNTE5MzU_4ebe49b9-04ef-4731-a785-4b70caad8af6">21.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtNC0xLTEtNTE5MzU_2417d976-c3a2-489d-89fd-54aa297a8587">18.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtNi0xLTEtNTE5MzU_3cbd325e-09af-4b78-b761-5bf625090b5f">16.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted-average number of common shares outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtMi0xLTEtNTE5MzU_38d5375b-5fb9-48f6-9f45-6501ccc65411">937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtNC0xLTEtNTE5MzU_c6fea43e-2b57-4630-99af-f36fba8d9c5c">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtNi0xLTEtNTE5MzU_e2c46368-f69b-4fd5-927e-6e34f9fa10f9">949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive effect of common share equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtMi0xLTEtNTE5MzU_65523574-f926-4989-84fc-46733edb86d2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtNC0xLTEtNTE5MzU_9391b6f9-6b3b-4116-a795-eeb76d3d4dbb">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtNi0xLTEtNTE5MzU_58796974-d063-45e8-bdef-7bf5c6572216">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted-average number of common shares outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtMi0xLTEtNTE5MzU_874810fb-97a4-4c9b-905b-370b0301c1e6">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtNC0xLTEtNTE5MzU_9099bd8b-34b9-4033-b728-cd5763bf5516">956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtNi0xLTEtNTE5MzU_fc52963e-bc44-4d77-b633-5974ae596183">961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctMi0xLTEtNTE5MzU_e2fcf18c-93fb-438f-aece-0b384196bdb2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctNC0xLTEtNTE5MzU_d3a1a168-05bb-4467-b729-9298d0b674e2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctNi0xLTEtNTE5MzU_e18d12b7-4e5b-490b-8c46-c6ec735ac86e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:62.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi0yLTEtMS01MTkzNQ_545e9a03-5c42-44c6-b71d-0e3a8ee40b5e">20,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi00LTEtMS01MTkzNQ_adef770b-a3d6-4d4c-9bf9-7b2dc5f5c532">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi02LTEtMS01MTkzNQ_ee9ab9f6-7001-422a-ae38-758a7898a337">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized (losses) gains on investment securities during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC0yLTEtMS01MTkzNQ_5ea022f1-0342-4073-a237-f0ac7959c327">4,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC00LTEtMS01MTkzNQ_e0abe542-64b1-477a-b0a8-129759bcf171">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC02LTEtMS01MTkzNQ_933988a2-a550-44e7-8abd-287c767e07ab">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS0yLTEtMS01MTkzNQ_31103b90-7bf5-40dd-8487-a1ef75a5d91f">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS00LTEtMS01MTkzNQ_72bc9d22-4230-4422-87d7-d2dd3c992a54">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS02LTEtMS01MTkzNQ_d2893da8-e271-4c08-9b2e-4cc29ddd2eac">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrealized (losses) gains, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi0yLTEtMS01MTkzNQ_f7a1da11-59c1-4cde-82fe-8139545afe79">3,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi00LTEtMS01MTkzNQ_5c1ebc40-71e1-4b7d-a3c3-e5cad7f8e56d">780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi02LTEtMS01MTkzNQ_0feda877-9c57-4e5e-a03b-e89541ceb9bf">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross reclassification adjustment for net realized losses (gains) included in net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy0yLTEtMS01MTkzNQ_eb2ab43e-6803-44ac-a307-aba19a6898b7">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy00LTEtMS01MTkzNQ_796c05f1-3fb9-4033-bc84-6340fe3cab0f">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy02LTEtMS01MTkzNQ_e2924665-7f2d-4b66-892b-3eaf0af697f5">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effect</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC0yLTEtMS01MTkzNQ_f70d6224-a561-470c-8940-8c5eb5a433ff">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC00LTEtMS01MTkzNQ_b5119861-5fa5-407a-a8fe-20a813633d5d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC02LTEtMS01MTkzNQ_1cf77379-d144-4669-8a0b-69dd32e92c30">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS0yLTEtMS01MTkzNQ_a08e11e6-f4ce-4292-81e7-fb5978003742">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS00LTEtMS01MTkzNQ_67d9e9ac-6854-4e36-a32c-226f274d24a9">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS02LTEtMS01MTkzNQ_2c1c6eaf-445f-4763-81aa-192b3be4ff9c">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtMi0xLTEtNTE5MzU_025d7d0c-2eee-4607-a67e-4a245d4d1849">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtNC0xLTEtNTE5MzU_3885fd25-5d7c-4585-9aca-7e5ac5c09252">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtNi0xLTEtNTE5MzU_6dc3f4a8-70e8-480e-b47d-b113da76b969">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtMi0xLTEtNTE5MzU_04fc3dec-57d5-48f5-a542-dfca4446aa7d">3,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtNC0xLTEtNTE5MzU_3b567aac-dfe6-4164-a74d-20c9d79d07b6">1,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtNi0xLTEtNTE5MzU_5ea33df9-fd3c-45b0-b015-e6acf97b2664">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItMi0xLTEtNTE5MzU_80f612e8-9cce-431d-93db-f30f20af1e25">17,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItNC0xLTEtNTE5MzU_0b691fe5-db70-4c96-85d1-635f35dfde6d">16,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItNi0xLTEtNTE5MzU_f4710004-8e7a-4598-ba71-87e6af3aba13">15,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtMi0xLTEtNTE5MzU_a11b5ef8-28ff-4135-a03c-9c029252df53">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtNC0xLTEtNTE5MzU_eba8de6d-8bd8-4f14-ac79-55614756657b">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtNi0xLTEtNTE5MzU_8a83c8c4-3dd9-4233-8ece-655f2b6f08af">366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtMi0xLTEtNTE5MzU_6a507cf1-966e-4507-889d-8de3fd0469f3">17,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtNC0xLTEtNTE5MzU_5fcf2c11-cca9-44b4-9f3f-4ef51d381125">15,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtNi0xLTEtNTE5MzU_848beafc-b9dc-4691-b207-6de6f373f734">15,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_91"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Equity</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:25.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.154%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonredeemable<br/>Noncontrolling <br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized  Gains (Losses) on Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation (Losses) Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c689a8c0bca4e019433ec7246f933af_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0yLTEtMS01MTkzNQ_5547b0ed-600f-4b44-b42c-544f96e2aa23">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c689a8c0bca4e019433ec7246f933af_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi00LTEtMS01MTkzNQ_086ffeab-7b35-4456-9294-f3138a4f6785">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6830c5f79e56472094427c9ea2e3da03_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi02LTEtMS01MTkzNQ_8c3410ae-d5d4-4db9-bc03-d27f235fdc41">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d1d3ede72ca4733addec1bb1964c823_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi04LTEtMS01MTkzNQ_ab5bc717-db05-484b-8809-1cd291b93cbb">61,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07259315a0ea49d0a13dfb8fe399859f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xMC0xLTEtNTE5MzU_3f1bddb4-28ef-4c3a-8cb9-83450e8d12e6">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ac1e3a85a14762b31fc51bf6a90599_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xMi0xLTEtNTE5MzU_0d899504-24fe-4e0d-9857-e9724d28cf32">4,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca043d8fcb44c53b5284ba8accffdaf_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xNC0xLTEtNTE5MzU_2e39c8bc-b6c1-46dd-bd71-016049dfc8ad">2,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xNi0xLTEtNTE5MzU_9bc0b42a-8b9d-4d63-a768-f9ece9a66f22">60,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to adopt ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i642edb7da896454ab4d981b104a7469f_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMy04LTEtMS01MTkzNQ_1cab1965-6295-4b2e-a091-40d14ba2487b">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fc49c4edc654514bf73d5c1b5463ae8_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMy0xNi0xLTEtNTE5MzU_80ac73e3-3b9a-4071-a6d9-8d15b121b3a1">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC04LTEtMS01MTkzNQ_9eea1c5c-3e1b-47d7-814c-9d7250f51c4d">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC0xNC0xLTEtNTE5MzU_945b0464-5423-444d-bddd-396746552e73">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC0xNi0xLTEtNTE5MzU_f5d61094-a684-4c45-a502-63343cdc3f53">15,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b06c57980640a89660ca89168bc707_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xMC0xLTEtNTE5MzU_89339112-a0c5-497d-b66f-5fc673bebfd6">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4b41b5d5d1d4902a2666ab91615d999_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xMi0xLTEtNTE5MzU_82e3fefe-2d69-422b-8571-6cd382eac8d1">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xNi0xLTEtNTE5MzU_a2073cc4-188c-42a7-8dfc-ef7e83a1cf4b">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi0yLTEtMS01MTkzNQ_f18fdf55-6b66-46bc-af8a-e2c7031b6960">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi00LTEtMS01MTkzNQ_0172725e-78d5-449c-be3a-91f142a9db0d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi02LTEtMS01MTkzNQ_0bf6a8a6-f2bf-41c1-af59-88737e2faed3">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi0xNi0xLTEtNTE5MzU_cdf695a2-7774-4121-81ca-749f0206b9ce">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNy02LTEtMS01MTkzNQ_d68aed4a-0c18-4240-9a74-3aae6e7033d1">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNy0xNi0xLTEtNTE5MzU_66188a3a-b450-4e66-86b6-64b667aba0e3">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC0yLTEtMS01MTkzNQ_4f294d83-c45a-47a0-af8a-6c2b65aaddc9">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC00LTEtMS01MTkzNQ_40dfa3c9-6eb3-40a9-92d3-91c861039c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC02LTEtMS01MTkzNQ_5f8bbce6-2a9d-42a5-b75e-ca34cf620c55">1,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC04LTEtMS01MTkzNQ_03921823-d3cc-4c1c-bcee-129856dc8dc7">2,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC0xNi0xLTEtNTE5MzU_9fe036b8-1714-494d-83d2-78293fdcbc94">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjA1YmI1NzJjZTNlMDQzMjA5MTVjODgwZTIyMTVjOWNkXzI3NDg3NzkwNjk1MDI_62c831e6-096d-4fa1-9c80-a4eac1f054f8">4.83</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS04LTEtMS01MTkzNQ_e47292f0-493d-4ad9-a95c-de2b2881555e">4,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS0xNi0xLTEtNTE5MzU_840e61d8-00e9-41bd-81cd-f987d7e833ee">4,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests fair value and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTAtNi0xLTEtNTE5MzU_cd9f28db-cd54-43c3-92cf-d1587ac7dfe3">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTAtMTYtMS0xLTUxOTM1_fe6c2497-fdd0-4b48-9b3e-e68ff0ea68f0">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTEtMTQtMS0xLTUxOTM1_cec46fb9-66bc-4de7-8c80-c6afc927e60d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTEtMTYtMS0xLTUxOTM1_b2b6b34c-caea-4fdd-a062-8521f7ffdae1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTItMTQtMS0xLTUxOTM1_c66e54fc-8fa0-438a-ae14-950b838ec4df">277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTItMTYtMS0xLTUxOTM1_f297e143-600a-4443-aca6-fcd352fa4ecb">277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i664e92201b31457e977924ad47542638_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMi0xLTEtNTE5MzU_0f2356f1-2717-441c-8807-79f929fae42c">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664e92201b31457e977924ad47542638_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtNC0xLTEtNTE5MzU_80388260-d41d-4510-b023-e95dfe2fc2e2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ff020430204014941338a161a89f7c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtNi0xLTEtNTE5MzU_ecdf4c5a-ccab-46a4-87cc-c6e1e99d7fd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f91212be8041f595a89ca53aaeab7f_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtOC0xLTEtNTE5MzU_c0849cae-f58a-4eb3-a760-33fb0be81c55">69,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07801d8cba1b4ab3b50d8ac8a9f97af6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTAtMS0xLTUxOTM1_98728818-f61c-4d8c-8bdc-f4076141dac5">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6eaac53b8934e608d29bd0c5b4e5994_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTItMS0xLTUxOTM1_60fc91bc-26b3-49e9-967e-11dca886dbaa">5,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c1cb17ce614ea6a4262e7a44095444_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTQtMS0xLTUxOTM1_9d31ce97-2212-4c0e-a0b1-2f81922a9f54">2,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTYtMS0xLTUxOTM1_8ac87ceb-7a55-49b6-867a-40b628f01455">68,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtOC0xLTEtNTE5MzU_71a89d0b-f1f4-4b09-91eb-323ccfa61779">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtMTQtMS0xLTUxOTM1_712574ae-aadf-472d-beae-20458d407ab2">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtMTYtMS0xLTUxOTM1_922bafe4-00af-4852-9acb-68f661b8a1cd">17,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i357524a3e1674a958342f4b2ad6fd285_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTAtMS0xLTUxOTM1_b0653bb7-87d0-45ce-a601-dfb65f72e3e3">913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c551595134e4820a2b39138e15877c8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTItMS0xLTUxOTM1_2d1c46df-5a1e-488c-8e6b-759bf3b130c5">657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTYtMS0xLTUxOTM1_939a9606-4c64-4b0b-946a-dec6d7f90b65">1,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctMi0xLTEtNTE5MzU_56767ea4-a7d2-48c4-b54e-7f6f50117e84">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctNC0xLTEtNTE5MzU_14062eae-84eb-45a3-992b-daef625a9944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctNi0xLTEtNTE5MzU_b6268808-c93e-4021-b085-af1012f82ac2">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctMTYtMS0xLTUxOTM1_1a9c749b-9459-40c5-abeb-34c145a558db">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTgtNi0xLTEtNTE5MzU_670cc341-a9b5-4f9d-819f-738dfbc675b9">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTgtMTYtMS0xLTUxOTM1_d7ca2f0f-706d-434a-9fd7-2718b2c28288">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktMi0xLTEtNTE5MzU_97920d1a-b867-43fc-92a1-3d32e24617d2">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktNC0xLTEtNTE5MzU_97d45165-6091-42ba-961d-efeba3d0db58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktNi0xLTEtNTE5MzU_655908c8-73c2-4a66-a185-8e31d586d97d">940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktOC0xLTEtNTE5MzU_3c95866f-080a-4fa9-9342-c4f4fab50d95">4,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktMTYtMS0xLTUxOTM1_e4eda2eb-8f27-48d6-9622-5e913c6cc73d">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjo5OGI2NTJkNzI2Mjg0YzQxOTI3Y2IyNjZhODY1NTI4YV8yNzQ4Nzc5MDY5NTAy_8ea2fa0f-aee0-47ae-8e01-9dede6d19bc9">5.60</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtOC0xLTEtNTE5MzU_8a0b7515-dc7e-4d6f-bcf5-0a7958105f0e">5,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtMTYtMS0xLTUxOTM1_fef45884-49a9-4e19-b39c-39de45e101bb">5,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests fair value and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjEtNi0xLTEtNTE5MzU_c48ed847-b236-4358-9105-24bb183351d7">889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjEtMTYtMS0xLTUxOTM1_d3418fe3-ab40-438c-b1a2-933b2ebb69e6">995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjItMTQtMS0xLTUxOTM1_25098e1a-76fa-4ad0-b496-41cd78f93552">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjItMTYtMS0xLTUxOTM1_48ac4764-2289-48e9-b927-d25042820bf2">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjMtMTQtMS0xLTUxOTM1_f5e1ca63-d82d-42ac-ab70-049e6b7c806d">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjMtMTYtMS0xLTUxOTM1_618637a0-a55b-4423-9475-fa6a5c6e8afe">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93029ecb097b460c94d2bd8336e2c900_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMi0xLTEtNTE5MzU_98a3b74a-5ce0-43be-9275-66851889c71e">941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93029ecb097b460c94d2bd8336e2c900_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtNC0xLTEtNTE5MzU_c3d8b03c-110c-41a8-985a-46204c32369a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40da61c03d244ee8b7fafcd8416abe9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtNi0xLTEtNTE5MzU_e33a05a7-bc1f-4bf3-84d0-42c7dd1ac3c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d32db37f4024063a8ce510f51ab5d0a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtOC0xLTEtNTE5MzU_d409d8a7-39ed-4176-96e6-057ec5385f00">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34dd7920ba894909b8d0e5c2cfaceb6c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTAtMS0xLTUxOTM1_c84095cd-eab3-4391-8ccb-8cd86e1e8744">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0843668ba2f34d53b6ff8c06a2fbd0b2_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTItMS0xLTUxOTM1_0d38c51a-bfcb-4877-851a-6305f665c1b1">5,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5123593bd7e943ff983843139569f7ed_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTQtMS0xLTUxOTM1_94e8f891-3d0a-45a8-bc16-d284b4a88de4">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTYtMS0xLTUxOTM1_f649dd5d-bc17-446f-a13e-9b26ac8d657a">75,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtOC0xLTEtNTE5MzU_76113985-03bc-43c3-9c7a-67b9e3e424dd">20,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtMTQtMS0xLTUxOTM1_24cd3a5f-c427-44f3-bea6-8d530c09bdfa">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtMTYtMS0xLTUxOTM1_79f72b98-aaba-4867-b076-c4448df84429">20,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b889e044c1942f18b7b6118ae4e47fa_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTAtMS0xLTUxOTM1_bf1d8080-a2c4-4f81-9ef5-3d38cf398d83">3,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7667d069e974d27b0f62b9b62fe36f6_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTItMS0xLTUxOTM1_32216b99-ce6d-4802-979a-5ae0ea29b720">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTYtMS0xLTUxOTM1_b2183fb1-60fa-4ca0-968a-12239da59bee">3,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctMi0xLTEtNTE5MzU_c3322c26-5126-4505-b3c4-a6d7b5e533a3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctNC0xLTEtNTE5MzU_4375ae42-1c4b-4f37-82f1-310510bdca56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctNi0xLTEtNTE5MzU_39177777-eef6-46d7-ad04-5848477abde4">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctMTYtMS0xLTUxOTM1_63fdaab5-a9aa-4844-a3b9-7b2209843a5f">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjgtNi0xLTEtNTE5MzU_67b49b8b-c69e-44f6-93cc-dedbd1d3265c">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjgtMTYtMS0xLTUxOTM1_64ed0ddb-7a61-4986-8fd6-7da6f6c0dc67">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktMi0xLTEtNTE5MzU_f91fa186-06ca-4fce-afcc-8d9d57215e6d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktNC0xLTEtNTE5MzU_7c812a9c-47b9-470a-b3e0-419678ed7546">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktNi0xLTEtNTE5MzU_b4417203-46ee-4c13-b030-361007e4f469">1,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktOC0xLTEtNTE5MzU_befa078e-1867-49f8-83c1-b2be4e3fbf4c">5,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktMTYtMS0xLTUxOTM1_08014432-7958-4864-ad59-653e53232181">7,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowNmZkZjIwNzY3ODY0ZmRjOWJlOWUzNmRkNDI2NDZkY18yNzQ4Nzc5MDY5NTAy_c118495b-61e8-4023-ad36-fc0111e97a44">6.40</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtOC0xLTEtNTE5MzU_2fd32ef8-fbc9-4936-8494-bd8eb8bb43a1">5,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtMTYtMS0xLTUxOTM1_021eac04-0a1a-4d25-8793-1036c834eeb9">5,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests fair value and other adjustments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzEtNi0xLTEtNTE5MzU_29b992f0-1249-4d57-9d16-3586eb58aea1">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzEtMTYtMS0xLTUxOTM1_84d6b3b3-e846-4d55-bcb2-5ad52b9a4a36">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzItMTQtMS0xLTUxOTM1_afc8e53b-bec9-4203-8862-778dbe3129ca">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzItMTYtMS0xLTUxOTM1_c659f93c-f851-4242-b513-d0e7714ffe4e">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzMtMTQtMS0xLTUxOTM1_d74e977a-d579-4882-8c1c-247e2709558a">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzMtMTYtMS0xLTUxOTM1_65077702-c4f8-4994-b4c3-ef0b00744694">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5b13550b61146f3942355d988fb9045_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMi0xLTEtNTE5MzU_1d1dc29b-d7ca-460d-bc06-2dc6053309d2">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b13550b61146f3942355d988fb9045_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtNC0xLTEtNTE5MzU_22ccaa7e-9ba0-44f6-8316-197651bbb933">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b04f90dfec4d62aef785c70b201486_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtNi0xLTEtNTE5MzU_c364bf86-d805-4ce4-922f-cf7872d325d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f74baf509a410c99fa46e489fb4347_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtOC0xLTEtNTE5MzU_5236cd9c-ca90-4476-ab87-d43ba96a0b2c">86,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cf18e9b55b4c90b1d62f83afeffdc5_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTAtMS0xLTUxOTM1_5165187a-9cc0-4ca7-8b52-1117b297776d">2,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4af60408a5014dadb511e21f1afca7e4_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTItMS0xLTUxOTM1_7a676a74-8d82-48f0-b3ea-cc5b12a772ec">5,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2964324674894490aab04f2d6bd37235_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTQtMS0xLTUxOTM1_e1c89170-0ef1-4109-b881-cc3fe1a9e48b">3,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTYtMS0xLTUxOTM1_65c5da23-b0f8-46ba-b64a-801b1bcd58b2">81,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy0yLTEtMS01MTkzNQ_417336a6-f650-4f05-9cfa-3c5228edf3ac">20,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy00LTEtMS01MTkzNQ_76257bc2-8b45-49eb-a359-ba3596a2890e">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy02LTEtMS01MTkzNQ_56c23b13-12df-4192-8936-08a1b79d6be5">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS0yLTEtMS01MTkzNQ_0d1682ce-9dc4-43f6-a214-72f0d72935f5">3,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS00LTEtMS01MTkzNQ_d5194a2a-64f8-4517-91ca-d1b83cfa874e">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS02LTEtMS01MTkzNQ_05af463e-c57c-49d8-b156-3cef4a7e8704">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi0yLTEtMS01MTkzNQ_b246a887-9571-4284-a659-5541d11a0552">673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi00LTEtMS01MTkzNQ_d27cfd24-1976-41b5-9814-551f9caeea13">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi02LTEtMS01MTkzNQ_c8e172e5-8c65-4b3b-b3ed-d3097b395be4">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy0yLTEtMS01MTkzNQ_59f20938-816c-4fb8-bb7e-32ee06083f6b">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy00LTEtMS01MTkzNQ_84d498fd-e64e-4db7-8c2e-2d08b7fe1283">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy02LTEtMS01MTkzNQ_53ffad3b-47e3-4163-8384-f38ed80a2722">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC0yLTEtMS01MTkzNQ_c914ef52-0bb1-4abb-8e41-592c46c39ff0">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC00LTEtMS01MTkzNQ_e82b190b-75f1-4735-80a4-0d3acef99744">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC02LTEtMS01MTkzNQ_c746afb4-fadc-47c1-9056-02b1b23e6f13">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtMi0xLTEtNTE5MzU_11e721da-3429-49d0-b3e0-0bb46335529e">2,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtNC0xLTEtNTE5MzU_42ed2aa5-c049-4045-b570-2487c5b4048f">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtNi0xLTEtNTE5MzU_a239b517-6778-460f-a2d6-1ea996c1d006">688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtMi0xLTEtNTE5MzU_d5d06e96-f637-42d8-b702-5b85c3c6cd87">1,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtNC0xLTEtNTE5MzU_2a50548c-739b-4e3d-b93c-c9c2a79f6cc8">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtNi0xLTEtNTE5MzU_a24c2224-1e17-4124-92b3-37a12d8cb8ab">2,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItMi0xLTEtNTE5MzU_68b197a3-68c5-4642-864c-e61c807b4e00">4,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItNC0xLTEtNTE5MzU_2575869e-94d5-409b-a138-714dcc5bf00f">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItNi0xLTEtNTE5MzU_7c196650-8f15-485f-a9ca-369d5fc10b93">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtMi0xLTEtNTE5MzU_873cf071-55ca-4d54-95b1-5761aa2e8129">1,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtNC0xLTEtNTE5MzU_08f0a97b-c0ef-4c2f-a51c-6cd997557fd5">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtNi0xLTEtNTE5MzU_9daed054-c332-4d33-9bf8-66283ee4b520">5,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtMi0xLTEtNTE5MzU_f9316f00-e17a-47ce-9de8-998aebdb8073">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtNC0xLTEtNTE5MzU_c2571d55-68d3-47d3-84c7-9b02db5fbc34">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtNi0xLTEtNTE5MzU_063b061a-d55d-4d7a-bb1a-5311688beeaf">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtMi0xLTEtNTE5MzU_955fce02-4efa-46c9-93d2-62df38fe3bf6">26,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtNC0xLTEtNTE5MzU_1c963ec6-99be-4449-8ede-342cf7eaf73f">22,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtNi0xLTEtNTE5MzU_5ff1b553-04d7-4cac-ab5b-a416d25af279">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctMi0xLTEtNTE5MzU_39942a26-e205-454e-96af-07716736fd20">18,825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctNC0xLTEtNTE5MzU_734e0dd1-0c98-4db5-8657-526cde24dbfb">17,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctNi0xLTEtNTE5MzU_69e36765-79c2-4954-8570-f0f97c64f54d">16,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtMi0xLTEtNTE5MzU_5c843bba-d3f1-4055-96f4-74bfde438aae">5,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtNC0xLTEtNTE5MzU_3a7e5573-c540-451f-ad59-f571370fa1ac">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtNi0xLTEtNTE5MzU_d18ee8b8-9c60-4fc5-bd02-11477071f688">6,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktMi0xLTEtNTE5MzU_236f41ac-91ae-4603-bf09-8510693009dd">6,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktNC0xLTEtNTE5MzU_425adeee-3116-4e46-b883-dac48b2f95e3">8,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktNi0xLTEtNTE5MzU_ad1419b4-e170-4248-9b9e-1a753da45de0">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtMi0xLTEtNTE5MzU_7d201901-ac8a-4d3f-8aa9-ae217ebd89ba">21,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtNC0xLTEtNTE5MzU_130d5bd3-f122-41fd-a580-7a6cdd774211">4,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtNi0xLTEtNTE5MzU_22a6ff35-2152-459a-98fd-5ff56fdf08d7">7,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtMi0xLTEtNTE5MzU_15b3f09d-ef35-4f4d-9dda-6e968f17af75">2,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtNC0xLTEtNTE5MzU_4e44d84d-2ed2-488f-b2f8-a9543a65349b">2,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtNi0xLTEtNTE5MzU_7077292d-d97a-4f0e-8fc6-d631d648336d">2,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received from dispositions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItMi0xLTEtNTI3NzM_dbc5cee5-b7c3-40cd-a15a-3f3bc0bd807f">3,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNC0xLTEtNTI3NzM_ccc2cee2-af99-46ae-8267-42fd91f18e3f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNi0xLTEtNTI3OTY_410132f5-5bd8-4260-8fbd-92cafe73013b">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItMi0xLTEtNTE5MzU_9d28f507-54de-4e13-82ac-89b69d630275">793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNC0xLTEtNTE5MzU_e5db8480-8912-443c-887f-45044df0d811">1,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNi0xLTEtNTE5MzU_d5308ec3-a35d-45e1-b61d-17b2630910ff">727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtMi0xLTEtNTE5MzU_19eac471-83bc-4817-aa86-bf7f1b554e55">28,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtNC0xLTEtNTE5MzU_f0b54c3c-4b6e-4761-a2e2-82da2a875df8">10,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtNi0xLTEtNTE5MzU_16267b07-6b54-4a7f-8b36-0fde143e67c3">12,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtMi0xLTEtNTE5MzU_eb1cb64a-e877-4397-ad3a-5c31b452f50c">7,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtNC0xLTEtNTE5MzU_5444c916-1d46-4680-a622-86a55013db13">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtNi0xLTEtNTE5MzU_073bf2a1-51b2-48ba-859b-398060d4eafe">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtMi0xLTEtNTE5MzU_fa4db264-0aac-46cf-b888-0d1bd9daefa3">5,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtNC0xLTEtNTE5MzU_2ee3a3ed-4580-4299-861e-3d0ea27cbb41">5,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtNi0xLTEtNTE5MzU_c32417cf-11f5-4c78-bfdc-fbc7be68e63f">4,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctMi0xLTEtNTE5MzU_f5b0ebb9-3d18-49b7-aa66-97b7a61df0d9">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctNC0xLTEtNTE5MzU_7f298ef3-7871-4fdf-a8e0-ef2c87e75e09">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctNi0xLTEtNTE5MzU_2a393ec1-7e08-4f2d-af2b-4127ca9fe21d">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtMi0xLTEtNTE5MzU_3aa3f6e6-09d7-4528-a0b4-c5b103058d9a">3,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtNC0xLTEtNTE5MzU_9b5e6274-8147-4def-ab98-043340fd4833">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtNi0xLTEtNTE5MzU_e3a121fa-c586-4ca2-8a5b-9ae38b4287bc">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from (repayments of) short-term borrowings, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktMi0xLTEtNTE5MzU_cd6f724f-f8c8-4b05-957f-75f94efdc4a6">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktNC0xLTEtNTE5MzU_d0b5438f-be82-4a8d-b09d-90944566b218">1,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktNi0xLTEtNTE5MzU_5d214baf-2660-4517-997a-f65934ae0337">872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtMi0xLTEtNTE5MzU_38927476-fdf5-4c7d-9ac4-230511d9e99a">14,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtNC0xLTEtNTE5MzU_f96383d4-159b-4854-a554-7c446cd75e5e">6,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtNi0xLTEtNTE5MzU_65c8eb63-8dab-4c69-98b6-e503b1e0e5c6">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer funds administered</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtMi0xLTEtNTE5MzU_02ed3bad-61be-4cc5-993a-6d400ddc2ef9">5,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtNC0xLTEtNTE5MzU_24ebd7ae-20fd-482e-bb0a-ae9e5992957a">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtNi0xLTEtNTE5MzU_1943bc71-40e0-4d67-8263-81e9e25266ff">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItMi0xLTEtNTE5MzU_e059fbd7-2a35-4ab8-8694-ef62dde74ae8">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItNC0xLTEtNTE5MzU_2547a300-d24b-4488-a703-86cbb9612356">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItNi0xLTEtNTE5MzU_ae4f4fb9-70f8-4973-8fbb-c054390072e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtMi0xLTEtNTE5MzU_330976a1-a2b0-4435-9dc2-e5c01aeacd92">1,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtNC0xLTEtNTE5MzU_1e40855c-e31f-4878-a57b-f4d9abac6cd2">295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtNi0xLTEtNTE5MzU_6e88adf9-d241-49a3-aca1-6a7e6fee1d02">459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from (used for) financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtMi0xLTEtNTE5MzU_8407b0d8-07f6-4e40-b77e-702067895fef">4,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtNC0xLTEtNTE5MzU_9026cf98-1d52-4d61-b5be-e5b70d731d24">7,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtNi0xLTEtNTE5MzU_2f828a88-dafe-4191-93dd-5346c76b7b50">3,590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtMi0xLTEtNTE5MzU_9aacac72-35b2-407f-9581-2ce3acdad99b">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtNC0xLTEtNTE5MzU_13e67876-011c-4870-afec-9ab75a62b6f5">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtNi0xLTEtNTE5MzU_eb1dee6e-feaa-4b70-a5e6-9284f9d7e443">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtMi0xLTEtNTE5MzU_c4c9ed65-fcb5-4f48-ace0-70581068da3b">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtNC0xLTEtNTE5MzU_d732c6c3-0e9d-4984-a2e3-04b27617ccd3">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtNi0xLTEtNTE5MzU_1371cba2-81fd-440b-89c1-62eaf10046f5">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctMi0xLTEtNTE5MzU_3f93c4d5-909c-454d-a6f4-f049cc3c973d">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctNC0xLTEtNTE5MzU_eaf714b5-cc98-4f28-a4cc-5e641884ca61">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctNi0xLTEtNTE5MzU_a57f44d6-d940-42df-936b-474b1f62a674">10,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtMi0xLTEtNTE5MzU_7ddd4ff7-a7eb-472c-b511-35a872863068">23,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtNC0xLTEtNTE5MzU_fb01f847-f3db-4661-83fe-d3883cc44d82">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtNi0xLTEtNTE5MzU_512d65b8-6610-4112-a301-5be2bafdfcd7">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtMi0xLTEtNTE5MzU_10130b0e-6472-4044-a037-645a415fe3a4">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtNC0xLTEtNTE5MzU_fbb34cad-4f53-4ed8-a8d0-bdd69905bdfb">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtNi0xLTEtNTE5MzU_fff111b8-3050-4b44-817b-495a22606d2c">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItMi0xLTEtNTE5MzU_2e777899-c171-4c54-a7b8-5c02fd5eeb6f">5,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItNC0xLTEtNTE5MzU_dfb20e13-2515-493d-bdfb-f985a262fda5">3,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItNi0xLTEtNTE5MzU_28f18c3a-5669-4f6d-b4ae-f9f58ac57293">4,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_103"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDMvZnJhZzo2NDFkY2FmMDJmZTI0ZjhlOGZiYzg3MDQwZWVlOWI0NS90ZXh0cmVnaW9uOjY0MWRjYWYwMmZlMjRmOGU4ZmJjODcwNDBlZWU5YjQ1XzU4Mw_6f1dcfeb-3543-48f0-aa49-eeaf164d6ad6" continuedAt="i781037c2ae6148738e084e0325452028" escape="true">Description of Business</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i781037c2ae6148738e084e0325452028">UnitedHealth Group Incorporated (individually and together with its subsidiaries, &#8220;UnitedHealth Group&#8221; and &#8220;the Company&#8221;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</ix:continuation></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_106"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDYvZnJhZzo2M2M0N2NjZWVlZjI0ZDBmYTA5MGEwZTY0MDM2MWYxOC90ZXh0cmVnaW9uOjYzYzQ3Y2NlZWVmMjRkMGZhMDkwYTBlNjQwMzYxZjE4XzMxMg_355df200-dda8-4a6e-89cd-9b9b95c7cc13" continuedAt="iaa4e1bffbd594f90b37f144963c47db6" escape="true">Basis of Presentation, Use of Estimates and Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iaa4e1bffbd594f90b37f144963c47db6" continuedAt="iec0385658cbb482ca095fd9217da6772"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDYvZnJhZzo2M2M0N2NjZWVlZjI0ZDBmYTA5MGEwZTY0MDM2MWYxOC90ZXh0cmVnaW9uOjYzYzQ3Y2NlZWVmMjRkMGZhMDkwYTBlNjQwMzYxZjE4XzM2Ng_e88df875-8b47-4e2f-ad02-110715a7c6c3" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_112"></div><ix:continuation id="iec0385658cbb482ca095fd9217da6772" continuedAt="i372609201e13423fa249533e66396f71"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTIvZnJhZzo3ODE0ODIzMzUzYTY0NzFiYjI2ZDExZGI2N2EwN2VjZS90ZXh0cmVnaW9uOjc4MTQ4MjMzNTNhNjQ3MWJiMjZkMTFkYjY3YTA3ZWNlXzU1OA_c216d68a-32cc-4507-995f-c0dd2e0ba1ad" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_115"></div><ix:continuation id="i372609201e13423fa249533e66396f71" continuedAt="i19750ee196e040c78438e6bd453c3d53"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0Xzc3NDc_6eff9062-acff-4105-b0a8-01e3e506f022" continuedAt="i38e64aa87e644943971a014ad6a1305f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i19750ee196e040c78438e6bd453c3d53" continuedAt="ifa67294022084169895eb619d717a881"><ix:continuation id="i38e64aa87e644943971a014ad6a1305f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, product revenues are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue includes a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $<ix:nonFraction unitRef="usd" contextRef="i15b306bfc47b4634b1d61ddb91da4cb0_I20221231" decimals="-8" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzY5MTU_afa2cbdc-1642-431a-9d2c-142ea08cb1d7">7.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib35aa732c7b44d8785be61e048bb0572_I20211231" decimals="-8" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzY5MjI_0648eb5c-32ec-4a8f-be67-e792b1e8e52b">5.4</ix:nonFraction> billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzU0OTc1NTgyMjYyNg_36a3b9fe-2e01-42b6-9b0d-4f1dd273cb5f">12.5</ix:nonFraction> billion, of which approximately half is expected to be recognized in the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">three</span> years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_211">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div></ix:continuation></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_118"></div><ix:continuation id="ifa67294022084169895eb619d717a881" continuedAt="ia69171949d054272b523e95c34735fbf"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTgvZnJhZzpjYjhlMDhmNjQ5YjU0Njc5YmU2MWJmYTcyZWZiNmZlYy90ZXh0cmVnaW9uOmNiOGUwOGY2NDliNTQ2NzliZTYxYmZhNzJlZmI2ZmVjXzI1NzU_04bbf8c1-8bb2-4513-846e-e5142390b827" continuedAt="ib2d93fb3b4c6407aaa5555201bee1481" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately <ix:nonFraction unitRef="number" contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231" decimals="INF" name="unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTgvZnJhZzpjYjhlMDhmNjQ5YjU0Njc5YmU2MWJmYTcyZWZiNmZlYy90ZXh0cmVnaW9uOmNiOGUwOGY2NDliNTQ2NzliZTYxYmZhNzJlZmI2ZmVjXzU3Ng_7424ab9f-afd7-411c-860e-48f3216dc1d3">90</ix:nonFraction>% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="ia69171949d054272b523e95c34735fbf" continuedAt="ib29e7698657643fbbb40a191bb80b48e"><ix:continuation id="ib2d93fb3b4c6407aaa5555201bee1481"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div></ix:continuation></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_121"></div><ix:continuation id="ib29e7698657643fbbb40a191bb80b48e" continuedAt="i292e956dab974237be1197d2cd9114ef"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjEvZnJhZzoxYTc0MWIxMDEwZTU0M2IxYjk4MzAwOGU5NmZmNjNkZC90ZXh0cmVnaW9uOjFhNzQxYjEwMTBlNTQzYjFiOTgzMDA4ZTk2ZmY2M2RkXzgxNA_9c3b53c4-66d9-4642-9fa0-85b494b9e89d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_124"></div><ix:continuation id="i292e956dab974237be1197d2cd9114ef" continuedAt="i7d101cacf4c945fba007f7e823143c03"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjQvZnJhZzphNDAzNWYyMWZiZmQ0NDgyOGY2OTc3NzQxMDJkZTAxYS90ZXh0cmVnaW9uOmE0MDM1ZjIxZmJmZDQ0ODI4ZjY5Nzc3NDEwMmRlMDFhXzIzODI_de4d9506-50f8-4a2b-ad19-4345dba089fb" continuedAt="i006bbf2fefa6402681f6fdf4cf955e83" escape="true">Cash, Cash Equivalents and Investments </ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i006bbf2fefa6402681f6fdf4cf955e83">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjQvZnJhZzphNDAzNWYyMWZiZmQ0NDgyOGY2OTc3NzQxMDJkZTAxYS90ZXh0cmVnaW9uOmE0MDM1ZjIxZmJmZDQ0ODI4ZjY5Nzc3NDEwMmRlMDFhXzIzODQ_0ca5e5a9-b4f3-40f0-a179-18f1bfb8c306" continuedAt="i1064a320ae604466921ab21deda96b86" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1064a320ae604466921ab21deda96b86">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy.</ix:continuation> </span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_127"></div><ix:continuation id="i7d101cacf4c945fba007f7e823143c03" continuedAt="i9efe1cd724324c06af0bdf5e518ee335"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:AARPAssetsUnderManagementPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjcvZnJhZzoyZDcwNmNhMTRlNTE0MTczYmUxOTNhMmZlZGU1ODkyYi90ZXh0cmVnaW9uOjJkNzA2Y2ExNGU1MTQxNzNiZTE5M2EyZmVkZTU4OTJiXzE2MzY_6806a9f5-4347-4cd5-838b-d5aaca632053" continuedAt="ic461e231cf5743f6979f22c463847342" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9efe1cd724324c06af0bdf5e518ee335" continuedAt="i4b62833156164d228f0a5e98b8a0a66c"><ix:continuation id="ic461e231cf5743f6979f22c463847342">The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.</ix:continuation></ix:continuation></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_130"></div><ix:continuation id="i4b62833156164d228f0a5e98b8a0a66c" continuedAt="ibdfb30cd6d8e4cd6993d808cfed951f5"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNzk_08935d30-9580-44a1-bcb9-5da6ca82ee74" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $<ix:nonFraction unitRef="usd" contextRef="i7fb6042d781646119f05a8e3d8d9bfdc_I20221231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzEwNjA_fd924bfa-91b8-4950-aad0-9ae567245142">8.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib03e24ff12c14c668abeebbd373c12f5_I20211231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzEwNjc_762f0939-a042-4154-989f-9181068c8a66">7.2</ix:nonFraction> billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s Medicare Part D receivables amounted to $<ix:nonFraction unitRef="usd" contextRef="id3b26ce245bd427daad3c1e0c98d2988_I20221231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNTY_88a81f8b-7b10-4584-9d8d-68a44b0a5dd3">1.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib8cc912aa74747edbaa48cf71f83621d_I20211231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNjM_2f47ed6e-4173-4535-a10e-eb6a46211d89">3.4</ix:nonFraction> billion, respectively.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_2740"></div><ix:continuation id="ibdfb30cd6d8e4cd6993d808cfed951f5" continuedAt="i55a187a0a5054d4f9af0883b67dad150"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTI3_fb408010-882c-4493-bd44-f3d9830bdc5b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTA4_a0caf11c-dc4d-4dd2-b5a8-a03ea64504fb">3.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTI0_7a44283f-9655-45b1-98e5-bca1f04e2fd9">2.9</ix:nonFraction> billion as of December 31, 2022 and 2021, respectively.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_133"></div><ix:continuation id="i55a187a0a5054d4f9af0883b67dad150" continuedAt="i81c004f36c4a4261b7d08eef9d2f388c"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90ZXh0cmVnaW9uOjBkNDgwMjgzOTdlZDQxYjY5ODNhOTU4YzBlOWU3M2ZlXzc1MA_ea67578e-ca42-416a-8ead-9ab3863ec3e7" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. <ix:nonNumeric contextRef="ie2ca0721d6424e0ebe624cfdfd71cff7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90ZXh0cmVnaW9uOjBkNDgwMjgzOTdlZDQxYjY5ODNhOTU4YzBlOWU3M2ZlXzc0OQ_a801266b-8016-4ea0-91e3-d838d7e2fe06" continuedAt="i0a76388f9641438799bdbeef986dc456" escape="true">The useful lives for property, equipment and capitalized software are: </ix:nonNumeric></span><ix:continuation id="i0a76388f9641438799bdbeef986dc456"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzAtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjoyYmU0ZmY3Y2VkMWU0ZjU0YWMxOTZlYjgzOGI5YzU1MF80_49d875dd-f19d-4a92-9f83-21720ad78c90">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ib7bfd1f6234d46cca896b895ffb4eb00_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzAtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjoyYmU0ZmY3Y2VkMWU0ZjU0YWMxOTZlYjgzOGI5YzU1MF8xMA_8b6bc2b4-56ae-4e01-be6c-98d7d63cb519">10</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaef840008a9949d4bf08759afb52eeb0_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzEtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiOWJkZTc5NjlmNjU0OTdmODI2YTU5NThkNTJiN2FhN180_e4b436ac-1875-4be7-b2db-7512d67c59e7">35</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="ice44079f0ac84af382d947db2570bb57_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzEtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiOWJkZTc5NjlmNjU0OTdmODI2YTU5NThkNTJiN2FhN18xMA_286c9fe6-a302-4a19-94b9-4728ee2e0bf7">40</ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i862cb01850c54123912d7e326e09b865_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzItMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiMmU0MTU4ODczNmQ0YzcyYmY5YzAyZjdhMDJmOGI5ZF80_c159b88c-d0bf-4c2e-b87d-595b661840b9">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i5723f6eb484244a1b9c07c5e1b663d23_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzItMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiMmU0MTU4ODczNmQ0YzcyYmY5YzAyZjdhMDJmOGI5ZF8xMA_f126cd7a-c10f-40c4-b31a-7d629e24aacf">5</ix:nonNumeric> years</span></div></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_136"></div><ix:continuation id="i81c004f36c4a4261b7d08eef9d2f388c" continuedAt="i8c2cf2ab656e42d9997b1394a7f02be7"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzc0NA_42febb82-f760-45bf-ab3d-e3856f4dfc8d" continuedAt="i479169cf69e54efda69a90f388aec735" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i479169cf69e54efda69a90f388aec735">The Company&#8217;s ROU assets are included in other assets, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet</span>.</ix:continuation> </span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_139"></div><ix:continuation id="i8c2cf2ab656e42d9997b1394a7f02be7" continuedAt="iaf3149abedac404d90fb620168c2f5f3"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyODM_ebf7cc2a-440e-494e-a859-6c93a741ba69" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_757ced8b-ca6f-451b-8e7a-4f9a09077b8f"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_815a1197-f67c-4d4b-9e31-3f039eee6845"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_e4e110b8-658f-48fa-ae84-a00c364e1688">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="iaf3149abedac404d90fb620168c2f5f3" continuedAt="i89f61665ce0d473ea90e41c799d33005"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzM1Ng_fc09c4da-06f3-4aea-b5e6-aceb07cfa8db" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was <ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_08a58acd-a630-4287-a18a-c1338c0ee0e8"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_cb9087b8-1886-4d9c-941e-6f0589a08b10"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_f7f80ba8-6efc-4dfa-83c5-dbec522e53bc">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_145"></div><ix:continuation id="i89f61665ce0d473ea90e41c799d33005" continuedAt="i3ec3da3ed4a54787acd3e7ebde8d9a03"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:OtherLiabilitiesCurrentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzI5Mw_bd114980-dba2-4569-9173-a448e64dd5e6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($<ix:nonFraction unitRef="usd" contextRef="i9f37409e996040ec89badf7f24f413b6_I20221231" decimals="-8" name="us-gaap:DemandDepositAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzk5_286815db-8d27-48ee-bde9-a9a74fd65677">13.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i24f6c70b54f343a196c9df60d4d8fdec_I20211231" decimals="-8" name="us-gaap:DemandDepositAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzEwNg_7b11080a-5a49-4494-bde2-6c1631142245">11.4</ix:nonFraction> billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_148"></div><ix:continuation id="i3ec3da3ed4a54787acd3e7ebde8d9a03" continuedAt="i404cc9db40474609987dafeff35908de"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzMxOQ_2ef062ff-a149-4dbb-9880-5831e4b91b7d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzE2Nw_58ba7ae8-ad1c-49a7-8472-e9f483e07e25"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzMxOA_720dd8fb-3b09-4098-a164-51f607a6b7f5">30</ix:nonNumeric></ix:nonNumeric> days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div></ix:nonNumeric></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_151"></div><ix:continuation id="i404cc9db40474609987dafeff35908de" continuedAt="i8f87aaace4024897b72c3d7af0ce35c2"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90ZXh0cmVnaW9uOmYxNmU2ZTRlODAzZjQ0OTFiY2FjMTZjNWFhNDI3NmYxXzMzMQ_c6499b8c-ed15-4775-91f6-960dc2155c47" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside of the Company&#8217;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90ZXh0cmVnaW9uOmYxNmU2ZTRlODAzZjQ0OTFiY2FjMTZjNWFhNDI3NmYxXzMzMA_3694f179-a5b3-435f-856d-82bbaebf67c6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844bf68d4f4345e3970236cd396c9f66_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzEtMi0xLTEtNTE5MzU_bc939c22-f762-4427-830b-4a03c189a1f9">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541081ea074d4ecd8b8c1ce4752c8ce2_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzEtNC0xLTEtNTE5MzU_5cabea88-2ee8-4e33-9524-dfa0ea1bab58">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzItMi0xLTEtNTE5MzU_d7f821cd-20e5-42ea-9cd3-cdb475ed7790">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzItNC0xLTEtNTE5MzU_ec900862-add3-429f-9284-d6dfff9ae673">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzMtMi0xLTEtNTE5MzU_c241a0e4-f7c3-46e9-960d-c565857a4e32">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzMtNC0xLTEtNTE5MzU_905ad300-80c2-4106-b673-4875171e6f46">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzQtMi0xLTEtNTE5MzU_28b5b5ed-c6be-4832-9e48-175864ee4cab">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzQtNC0xLTEtNTE5MzU_a2606297-919c-4353-9a3c-5c70d551a2a4">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzUtMi0xLTEtNTE5MzU_6f134d36-efea-47f5-a968-9bdd127330e6">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzUtNC0xLTEtNTE5MzU_459f41ca-66f3-4ddb-b482-04fb6f62522d">255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzYtMi0xLTEtNTE5MzU_90f7d4c0-6271-48f9-920e-cd67289c151e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzYtNC0xLTEtNTE5MzU_13d226f9-d531-48fd-8aef-3f26babadb94">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ef3e9119e24c1bbb54fbf615fcab1f_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzctMi0xLTEtNTE5MzU_b0db5cb2-843e-4155-b5af-4e59488d5be3">4,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844bf68d4f4345e3970236cd396c9f66_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzctNC0xLTEtNTE5MzU_bc939c22-f762-4427-830b-4a03c189a1f9">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_154"></div><ix:continuation id="i8f87aaace4024897b72c3d7af0ce35c2" continuedAt="ib39a90cc374f46b5af11b75a4b792767"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzEyMjE_6d496973-19d6-4ba3-829a-5a38f71a8554" continuedAt="i87a801e314ca46e987b4a4e8d0af5b0c" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87a801e314ca46e987b4a4e8d0af5b0c">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">four</span> years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">four</span> years and may be exercised up to <ix:nonNumeric contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzYyOQ_88270c56-975d-4baf-893a-52ae6f06dc2b">10</ix:nonNumeric> years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.</ix:continuation> </span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_157"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="ib39a90cc374f46b5af11b75a4b792767" continuedAt="ic7ce82d56a554b1389f4f3c83ab92841"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTcvZnJhZzo4OTQwYWExMjk0ZGI0YzMyYjMxMTBiZjJkZGRlOTllYi90ZXh0cmVnaW9uOjg5NDBhYTEyOTRkYjRjMzJiMzExMGJmMmRkZGU5OWViXzExMzA_4b3bdec5-2667-44c8-8788-acca657d88d8" continuedAt="i58b4a83cbe4b46b5b38fbf3d825010d2" escape="true">Net Earnings Per Common Share </ix:nonNumeric></ix:continuation></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic7ce82d56a554b1389f4f3c83ab92841"><ix:continuation id="i58b4a83cbe4b46b5b38fbf3d825010d2">The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyODQ_d14c25ee-6fb6-4a65-a9fd-fe87344c4443" continuedAt="i614ee8998b9546a5baa76cdd39a48ed9" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i614ee8998b9546a5baa76cdd39a48ed9" continuedAt="ie0a2e17b0ce3429f8974ee5a7e7eba13"><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNDc_ed5cb5e9-2ac6-43a0-8877-1b748a06e8f3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtMi0xLTEtNTE5MzU_85d592ec-1df1-4bcc-b2a4-967c2e9ea5a5">4,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtNC0xLTEtNTE5MzU_0e15fe0a-f01e-4e46-9113-ae42f56e16e2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtNi0xLTEtNTE5MzU_6d315b68-fc23-448d-9d1c-abd59c5736ea">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtOC0xLTEtNTE5MzU_2048de31-97b6-4141-8c70-f90932a60070">3,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtMi0xLTEtNTE5MzU_7b4465a3-9981-4661-b2fa-c84a40a274d9">7,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtNC0xLTEtNTE5MzU_eb2e8825-20d2-4b89-9074-087e39dc2b59">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtNi0xLTEtNTE5MzU_14ec0a96-6bbf-4ab6-b152-c59a3b16602c">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtOC0xLTEtNTE5MzU_54e2df87-b0b1-46f0-9dce-859464355c43">7,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtMi0xLTEtNTE5MzU_f27a6b66-a734-473b-a7cf-58b780c994d5">23,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtNC0xLTEtNTE5MzU_8a2625ed-b626-4d45-9f10-629f49f4d051">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtNi0xLTEtNTE5MzU_9c393de4-e051-4fd0-b429-8630cbefc2ac">1,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtOC0xLTEtNTE5MzU_4d26b0d7-e78b-466a-a3e6-fe2e29a9c336">21,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtMi0xLTEtNTE5MzU_8e6f618f-de83-4726-9fb6-fc88d21732d0">7,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtNC0xLTEtNTE5MzU_e67513ce-12dd-4a2c-a23f-a5cf4d873051">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtNi0xLTEtNTE5MzU_cad8ee6f-da4d-448d-bf27-64c0fbeeb52e">808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtOC0xLTEtNTE5MzU_553cbd7f-f333-4645-b930-b1617d2ff2c0">6,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctMi0xLTEtNTE5MzU_38d415e6-7aab-4fcd-95f4-e3070763b1fa">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctNC0xLTEtNTE5MzU_ec6d59e0-c8b9-4265-bd5e-802f81418950">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctNi0xLTEtNTE5MzU_a01569be-4a2b-484f-9949-dcd2ecb8800d">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctOC0xLTEtNTE5MzU_2c255373-f603-4719-a60a-9cb02aa15704">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtMi0xLTEtNTE5MzU_1b449e68-99c5-476d-990d-62579fbebc26">45,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtNC0xLTEtNTE5MzU_945cc9ac-49d2-4c68-8231-6944e2683770">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtNi0xLTEtNTE5MzU_5da4d6e9-faac-4a95-8b96-939deca5f4ea">3,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtOC0xLTEtNTE5MzU_9610a3d5-50a0-4f62-9221-813a0a0cbae9">42,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTItMS0xLTUxOTM1_34239c1f-e88c-4eba-9f0c-15dd81419b8b">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTQtMS0xLTUxOTM1_b0020d0f-7bbf-4dcc-a9e1-82ddd9aa1856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTYtMS0xLTUxOTM1_4b04851e-6a81-4217-99db-ecd267f73a47">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTgtMS0xLTUxOTM1_d51655ed-f966-4568-8dbe-6111e20b1273">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTItMS0xLTUxOTM1_5d11a486-d1b4-4c1a-9c95-201c7246fd15">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTQtMS0xLTUxOTM1_de1f7db4-1095-4ea1-9392-e57bc297fd16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTYtMS0xLTUxOTM1_a60d8341-bb88-40c6-9dd6-7d7396d4c8e9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTgtMS0xLTUxOTM1_397a7fa3-8ec9-49b4-b845-89c2a9a318d1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTItMS0xLTUxOTM1_ae2a80f8-2faa-4f8e-ab19-218a75276ee8">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTQtMS0xLTUxOTM1_af35911c-6960-4a95-b6d7-d243bdaaec9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTYtMS0xLTUxOTM1_15b9b1cd-a339-436a-80fd-198848c8cc7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTgtMS0xLTUxOTM1_37618659-3792-44e9-8a73-8cc77aa4539f">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTItMS0xLTUxOTM1_ee0db646-a832-47c6-b22a-d0171979640a">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTQtMS0xLTUxOTM1_b3ae2349-26a9-4143-b978-6b45c22db9c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTYtMS0xLTUxOTM1_a78b4438-41ef-49d4-b422-20dfe0f8c8dc">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTgtMS0xLTUxOTM1_b6264b32-a8dd-4fce-895b-eebaa4ee4a3c">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:InvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTItMS0xLTUxOTM1_0a59c40f-efb3-420d-806e-f9dd8ed3491c">46,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:InvestmentsGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTQtMS0xLTUxOTM1_7c6e11b0-b6cc-49ad-822b-6a94f0666640">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:InvestmentsGrossUnrealizedLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTYtMS0xLTUxOTM1_250e4250-8b62-43bc-8fce-ced5e9266329">3,681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTgtMS0xLTUxOTM1_5346d822-0f72-426b-bb57-d203b17ca3bf">43,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTItMS0xLTUxOTM1_ae5a9911-41b6-4d0f-84f3-13633dc4a904">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTQtMS0xLTUxOTM1_950ed389-659e-4f43-bdd1-317222c04c8c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTYtMS0xLTUxOTM1_30f2a914-fca8-46a3-b907-5496a50d4430">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTgtMS0xLTUxOTM1_93d828cd-20e9-4cf2-b0ab-619e835955d7">3,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTItMS0xLTUxOTM1_b58953c2-00a1-486e-83c8-f1a301c96efc">6,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTQtMS0xLTUxOTM1_e40396f5-1f80-455e-8c70-062f947f48d9">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTYtMS0xLTUxOTM1_208aa8ec-4745-49ff-8f65-0f84bb4822b0">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTgtMS0xLTUxOTM1_861bb008-4490-4685-ad27-206479b0588c">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTItMS0xLTUxOTM1_039e3f4e-dcc0-4fcc-84f0-0c92b4143277">20,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTQtMS0xLTUxOTM1_ebb559bd-3ed1-4f8d-ae71-d8e727d9630c">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTYtMS0xLTUxOTM1_56812a4f-21b1-4326-a1f1-1c5c1dc2c7bb">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTgtMS0xLTUxOTM1_ac3e3970-be70-45e7-8f02-2c7ba0d4e5c9">21,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTItMS0xLTUxOTM1_5d5c5a1b-6e9a-4333-9b86-95714ee58778">5,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTQtMS0xLTUxOTM1_ccdd320b-923c-4d0b-ac1c-025301f0a681">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTYtMS0xLTUxOTM1_f3522772-1b4f-4b72-92d4-125e49613f61">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTgtMS0xLTUxOTM1_d11188f3-7b41-4f15-b199-a60a301d68cd">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTItMS0xLTUxOTM1_5dc3398a-8bba-4e4c-a7cc-c7620a9c582a">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTQtMS0xLTUxOTM1_ee0de519-e80a-451d-82c2-cb70eb08f6f7">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTYtMS0xLTUxOTM1_efa0ac74-4a20-4bd5-91e0-bead3281f083">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTgtMS0xLTUxOTM1_8c95925e-dab8-4c8d-983b-08c2d6828c65">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTItMS0xLTUxOTM1_0993ab1c-1dd4-476e-b792-9bb42d566b98">39,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTQtMS0xLTUxOTM1_f194f2f9-ee33-4551-a687-0ba09ab35e97">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTYtMS0xLTUxOTM1_5a9124b9-c2b5-4b53-aa1b-419770ba1feb">274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTgtMS0xLTUxOTM1_ab4a9489-fdca-44a6-85c2-3fec5ab790ba">40,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTItMS0xLTUxOTM1_a1d146f9-3b0b-4c44-af5e-c584ae6a1a1c">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTQtMS0xLTUxOTM1_7e6cd6d5-c390-41fa-967a-5260f9cd19a2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTYtMS0xLTUxOTM1_abe1f2a1-a9db-4299-b998-27e1426ca5e0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTgtMS0xLTUxOTM1_78c38b38-45bf-4aa2-b35e-f4a582ad9fc2">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTItMS0xLTUxOTM1_b07d0d65-c281-44c0-87f4-2cd731f0a97b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTQtMS0xLTUxOTM1_f090f77e-7da5-4b56-a222-66079f4f197c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTYtMS0xLTUxOTM1_2ae070c7-6094-4375-8bbe-8cf3c1b2ead3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTgtMS0xLTUxOTM1_70748f5b-6f54-4695-befc-270f7deec8ef">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTItMS0xLTUxOTM1_d182cc86-a2ea-47a0-88f9-a0b13cab0658">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTQtMS0xLTUxOTM1_5e77b06b-4ad5-492d-a55c-ce9952c9e6c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTYtMS0xLTUxOTM1_fe7a44d0-eea5-4cb0-92f2-8a3d98eccff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTgtMS0xLTUxOTM1_c09735a7-5456-44ae-a735-0c0aa4d768f9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTItMS0xLTUxOTM1_b79ffa79-7ea5-4a7f-9d86-0d533e5957ae">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTQtMS0xLTUxOTM1_fa8787c0-f9b1-43a5-bed8-7dea34d3f631">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTYtMS0xLTUxOTM1_f0718c2c-809b-4d5c-a455-3ac2c0337f05">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTgtMS0xLTUxOTM1_bef42427-3ed6-4d83-9926-2f48ede8c650">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:InvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTItMS0xLTUxOTM1_4a659f5f-7d31-40fd-b0e1-799fc5877c91">40,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:InvestmentsGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTQtMS0xLTUxOTM1_41660f01-355b-4075-bd78-29c6036d35bd">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:InvestmentsGrossUnrealizedLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTYtMS0xLTUxOTM1_346e96df-dfb5-4218-80a8-79ff84aa66b8">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTgtMS0xLTUxOTM1_f5bbb027-c1e7-491a-9207-5470051b6be3">40,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nearly all of the Company&#8217;s investments in mortgage-backed securities were rated &#8220;Triple A&#8221; as of December&#160;31, 2022. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company held $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIwOQ_ea80e291-1ec9-438c-a3ac-6a291c343771">3.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIxNg_fad1380e-4731-47fe-86af-920d0ef307a1">3.5</ix:nonFraction> billion of equity securities as of December&#160;31, 2022 and 2021, respectively. The Company&#8217;s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#8217;s investments included $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzU1Ng_9ce41910-5e60-4a1c-8738-e28bd0f1dd6d">1.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzU0OTc1NTgxNjIxNw_1270c581-9ac1-4605-bb5c-4c67837044b2">1.3</ix:nonFraction> billion of equity method investments in operating businesses in the health care sector, as of December&#160;31, 2022 and 2021, respectively. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2022 and 2021 was not material. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="ie0a2e17b0ce3429f8974ee5a7e7eba13"><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNjc_8b957f1f-59e9-4b5b-875b-51ede3214a44" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2022, by contractual maturity, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItMi0xLTEtNTE5MzU_9a3f1d37-f1e3-4711-ba6c-a47d08cd85d1">4,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItNC0xLTEtNTE5MzU_b3d388f2-aa58-42b5-8cde-d05c2652c5e2">4,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItNi0xLTEtNTE5MzU_5d0af63d-2649-41ab-8ce3-078e77032286">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItOC0xLTEtNTE5MzU_61daeb31-8eef-42b1-98e1-80bb055c8d35">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtMi0xLTEtNTE5MzU_d5628495-8a6e-45d8-a5f8-8cc2ad4d1ec0">13,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtNC0xLTEtNTE5MzU_e4408eeb-b46b-4736-8e8a-c5236dd160f6">12,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtNi0xLTEtNTE5MzU_47b214cf-60f6-491f-b81c-523d276c41cb">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtOC0xLTEtNTE5MzU_1d2f27d4-bdac-4a20-a71a-4b7c1c669991">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtMi0xLTEtNTE5MzU_fe0c2e72-7452-4fb7-9d8e-5f1ac5b1e120">12,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtNC0xLTEtNTE5MzU_035fc22f-03f4-428c-82d7-329d90b2007b">10,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtNi0xLTEtNTE5MzU_288c98e7-1337-4892-abdd-7d491b7cb9b1">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtOC0xLTEtNTE5MzU_88a9a103-c2f6-41b5-997b-a8e80a94029f">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtMi0xLTEtNTE5MzU_69fb1694-8942-4cfe-a920-b83a3035b5dc">5,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtNC0xLTEtNTE5MzU_5531df24-192f-4899-9d42-4a9c7be1037d">4,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtNi0xLTEtNTE5MzU_58bbc31e-328a-4f17-8cf8-1680dca6c3a0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtOC0xLTEtNTE5MzU_b42eb9f0-583b-4e90-8bc3-824aaa7a6dfb">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzYtMi0xLTEtNTE5MzU_2ed21843-60d3-48ad-a3fa-6b2917e61ce3">7,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzYtNC0xLTEtNTE5MzU_dfcfe0af-8440-497b-bbef-08c050782345">6,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzctMi0xLTEtNTE5MzU_a6157261-c6d4-41b7-a1d0-e409549c8b17">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzctNC0xLTEtNTE5MzU_48f8f0a6-fcbc-487d-97ec-c5da2fc49556">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtMi0xLTEtNTE5MzU_c29b10a2-4b71-48a8-b7e4-1866298117e0">45,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtNC0xLTEtNTE5MzU_d892410c-1f34-4ac8-a5c4-74aa02dab972">42,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtNi0xLTEtNTE5MzU_2efa5b0a-d368-4cca-915b-a3c971f5a039">696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtOC0xLTEtNTE5MzU_64404067-de13-421d-b413-3fac8ae0d0ab">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNTk_24bde963-612b-4112-8761-ab6d7d7801a6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMi0xLTEtNTE5MzU_eb2a7c47-578e-4449-8815-0bdaf6f24312">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtNC0xLTEtNTE5MzU_71e8c0f8-3e66-419e-8483-e7d02d6f4612">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtNi0xLTEtNTE5MzU_1643d923-5518-407b-9783-7e5868c45189">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtOC0xLTEtNTE5MzU_7ece395b-ac3f-498f-8e59-e8b17f9c8a73">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMTAtMS0xLTUxOTM1_036e12c2-3829-447d-9d26-f818cd21455c">3,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMTItMS0xLTUxOTM1_11227906-785e-4a72-ab57-306dd148c2f9">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMi0xLTEtNTE5MzU_07e804d8-5ea0-4bea-ad7f-614d4c3480de">4,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtNC0xLTEtNTE5MzU_8502b0ab-6804-44e0-8745-636dbcd22830">288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtNi0xLTEtNTE5MzU_6deb1651-b671-481a-aaa2-cd9aff278a4c">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtOC0xLTEtNTE5MzU_c56cdc7f-e000-40b2-9b9c-47aae776061b">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMTAtMS0xLTUxOTM1_f8b3de20-e2ef-4f5b-814e-3241c70e4839">5,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMTItMS0xLTUxOTM1_f674ff16-7603-4e3b-9c6a-994b1fa11d90">479</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMi0xLTEtNTE5MzU_2dfbbb7e-2375-43be-a3be-3b06448ffde4">13,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtNC0xLTEtNTE5MzU_04710f11-af96-4cb7-8650-53613474cb9c">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtNi0xLTEtNTE5MzU_3497ec78-98a4-485a-b597-92626d0f5a5b">6,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtOC0xLTEtNTE5MzU_de50b97e-8823-4e4f-b199-604ac09509eb">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMTAtMS0xLTUxOTM1_16b7d356-7edc-4eee-9fbc-c8610adfc889">19,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMTItMS0xLTUxOTM1_39a4fba6-edda-4c33-8c11-c56bdc1e9418">1,798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMi0xLTEtNTE5MzU_f948eaa5-d861-40f8-a153-c047d688037b">3,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtNC0xLTEtNTE5MzU_3d7dc469-4985-4754-a9d6-ba91b7a8064f">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtNi0xLTEtNTE5MzU_98130498-367d-4d3e-94df-7a9b59938526">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtOC0xLTEtNTE5MzU_ccfe82e8-b2b5-4ef3-9788-d94ea7c4ec60">463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMTAtMS0xLTUxOTM1_afe407d4-6166-4ae8-9dd7-cea896d5cc44">5,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMTItMS0xLTUxOTM1_4640e4b1-835d-42d9-9dc4-e049dee0af20">808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMi0xLTEtNTE5MzU_eba02c4a-1137-47dc-b51d-36faf155f8db">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctNC0xLTEtNTE5MzU_6908efd5-7236-4e55-b087-5003ff166d61">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctNi0xLTEtNTE5MzU_42015bf4-4efe-4ea3-a9c1-55f7f73382e2">976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctOC0xLTEtNTE5MzU_2e6fc50b-406a-48a2-9ecf-e4b71cd37287">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMTAtMS0xLTUxOTM1_ea51b8e7-96c9-4663-a526-ef9a4a0e33a7">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMTItMS0xLTUxOTM1_1d486710-be54-4d0d-9ab6-2b318e7a48b9">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMi0xLTEtNTE5MzU_f2a524bf-4c85-4079-a5c9-1c89755d63cf">24,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtNC0xLTEtNTE5MzU_f18df4af-cad5-4bf0-b0e8-783318b32074">1,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtNi0xLTEtNTE5MzU_52adbaef-d28e-4d69-9c25-cc2ae265316c">12,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtOC0xLTEtNTE5MzU_887b295e-29c8-483b-a40a-cf3bbb2891bc">1,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMTAtMS0xLTUxOTM1_58371f7e-63c5-4f16-8c42-4a8a7d1fd9ec">37,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMTItMS0xLTUxOTM1_ddc5caaa-5046-4738-b701-be67ca532f10">3,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTItMS0xLTUxOTM1_a09534a2-f6ba-40b2-a307-c45f9c50b94d">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTQtMS0xLTUxOTM1_7421282a-22c9-4232-be0f-1886a47f6fd1">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTYtMS0xLTUxOTM1_bee742c7-2596-47c5-aa5a-8f1d2b765744">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTgtMS0xLTUxOTM1_bda7a404-bfe0-4f75-8733-c6a661ae13c8">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTEwLTEtMS01MTkzNQ_84c66297-f84c-4a33-bc09-73c2ec0c8439">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTEyLTEtMS01MTkzNQ_f32c055c-b4ba-4a0a-a7ae-c1eeae3957c5">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTItMS0xLTU3NTM3_ef2b02c9-2568-49bc-9ffe-31a84e22d503">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTQtMS0xLTU3NTM3_9fed5847-3a28-4935-aa82-76292678d1a5">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTYtMS0xLTU3NTM3_0778aa4a-8dd5-45f3-8691-fc92fde5d6fb">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTgtMS0xLTU3NTM3_2d696a48-3c2a-4462-a142-17ddd69211e8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEwLTEtMS01NzUzNw_ad1da6c0-b5e0-4c57-b328-88a40d059880">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEyLTEtMS01NzUzNw_e1d6f7d2-7d3c-49d8-9efd-af0dc82e5cd3">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTItMS0xLTUxOTM1_a75ebde6-02c0-4340-8a58-b57975dfb18e">9,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTQtMS0xLTUxOTM1_0796a8bb-2e8f-4695-ae51-f76ee67f09aa">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTYtMS0xLTUxOTM1_d89a773b-c609-4f25-84c2-086c5bf414e9">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTgtMS0xLTUxOTM1_7d46836c-8f63-4626-a8b0-6f97d6d51669">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEwLTEtMS01MTkzNQ_0e7509b7-5680-4be5-9307-8edccd8176a5">9,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEyLTEtMS01MTkzNQ_1df0632f-1d95-4c8f-b05c-54e981254c22">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTItMS0xLTUxOTM1_174154e5-302c-4268-b576-16905106164f">3,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTQtMS0xLTUxOTM1_df955b3f-f059-476b-b99d-5bd5897d0a41">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTYtMS0xLTUxOTM1_2b8cae0a-18b8-4a2e-8e18-d00f1b1fd3af">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTgtMS0xLTUxOTM1_7f9a4203-dcae-4ffb-aca8-c038ec0b4175">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTEwLTEtMS01MTkzNQ_50adbee2-dfdc-46e7-a797-4859af26fc7d">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTEyLTEtMS01MTkzNQ_18008776-ad4a-47d6-93c0-3ae5bd5f8651">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTItMS0xLTUxOTM1_561e7a46-c7a2-43b6-9364-c35ced42894c">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTQtMS0xLTUxOTM1_ab97791d-77dd-4f25-9bd7-bd54943c555f">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTYtMS0xLTUxOTM1_9607cf42-2e30-4089-929f-80eaafc47c0e">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTgtMS0xLTUxOTM1_88c41c7d-b4f4-4297-8a14-13e289415a1a">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTEwLTEtMS01MTkzNQ_481eaeb5-177d-486c-b31d-b97f624adbd8">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTEyLTEtMS01MTkzNQ_720affd5-2d5f-4c57-964b-f296b078c67e">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTItMS0xLTUxOTM1_c54e6ece-e5c1-4414-b325-df390408f33c">17,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTQtMS0xLTUxOTM1_5d4be846-4830-401c-b5f4-cfb75bc9a9b9">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTYtMS0xLTUxOTM1_6365ed41-59e6-4372-9c40-eb2f896253a3">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTgtMS0xLTUxOTM1_1e235d10-74aa-4b78-8889-87e00fef33ee">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTEwLTEtMS01MTkzNQ_0f35fb64-e688-4352-88e8-d7b4b467a5df">18,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTEyLTEtMS01MTkzNQ_f75e68b4-ca93-4656-8548-9e26839946fc">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrealized losses from all securities as of December&#160;31, 2022 were generated from approximately <ix:nonFraction unitRef="positions" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzExODI_067736be-b43f-4e21-b7cc-2f2b4b56bf85">35,000</ix:nonFraction> positions out of a total of <ix:nonFraction unitRef="number" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="0" name="us-gaap:InvestmentOwnedBalanceContracts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzEyMTM_3817de09-9a77-4422-ae79-aff45c56129a">41,000</ix:nonFraction> positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#8217;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2022, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2022 and 2021 was not material.</span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_166"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NTM_4d34f3a6-3852-4a08-a599-d5667169db4f" continuedAt="ied4e662760bc414eb936ee042a3fddae" escape="true">Fair Value</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied4e662760bc414eb936ee042a3fddae" continuedAt="i89319ccf3ef845e9aaaeefc51c8bcb24"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NzI_6b30f36f-ab4a-4cfb-beae-34d5f0dad156" continuedAt="i747f9a50cea3490d821cc4ab6ea027c8" escape="true">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. </ix:nonNumeric></ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i89319ccf3ef845e9aaaeefc51c8bcb24" continuedAt="if030dddb9f864d2fa8f47c1a27944842"><ix:continuation id="i747f9a50cea3490d821cc4ab6ea027c8" continuedAt="i7bccdc98b8cf421d856b27034acead56"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_66888705-8e37-4ecb-b140-9df15828db4e"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_973335ab-9c5b-492f-861c-70caf055e30f"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_bbb66069-8060-48d7-9858-43980fb2afcb"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_c6cd9939-9cbd-4c53-a085-53cedd63d3f9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the years ended December 31, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI3MA_50d39058-74ae-4f1a-bb86-ed92938c7380">211</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI4Nw_88145a82-e90b-48b3-a27f-9c6f02530819">840</ix:nonFraction> million, respectively, of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based upon transaction of the same or similar security. There were <ix:nonFraction unitRef="usd" contextRef="idef199e9d5164b839dff15f1d15b655d_D20220101-20221231" decimals="-6" name="unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI5NQ_6c2e47e2-1920-4f0b-b52f-9e80fd49fcba"><ix:nonFraction unitRef="usd" contextRef="i3100e960b47a458dbc9b0427cfe50a57_D20210101-20211231" decimals="-6" name="unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI5NQ_f22e1136-d48c-4c6e-948f-26de1eefebcf">no</ix:nonFraction></ix:nonFraction> other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt securities and equity securities reported at fair value on a recurring basis are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities reported at fair value on a recurring basis are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="if030dddb9f864d2fa8f47c1a27944842" continuedAt="i90aa040c389b45868880c2f7073a42dc"><div style="margin-top:6pt"><ix:continuation id="i7bccdc98b8cf421d856b27034acead56"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span></ix:continuation></div><div style="margin-bottom:3pt;margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NzU_a2611d9a-cf2a-4a4b-beb1-3ab3935773cf" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItMi0xLTEtNTE5MzU_bd3c0c30-8b70-41e1-a42c-f67dbe43eb4f">23,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398125db28a248afa78be5dde2f802de_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItNC0xLTEtNTE5MzU_1d1528c2-da73-40aa-bb7d-91158a4d4f6d">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItNi0xLTEtNTE5MzU_47843101-0a11-4ab6-8890-ec6f5d558a81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItOC0xLTEtNTE5MzU_69b53e41-6d16-4a65-8056-76a843d483e3">23,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5a2a5290514b42a50323b2c2b06755_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtMi0xLTEtNTE5MzU_ebd6ef0f-98d9-4258-802a-065c1bde61d9">3,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27447352b0ab4986955366c4e6e7c8ab_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtNC0xLTEtNTE5MzU_12c15aea-f4df-45f7-a1ff-7a5c80cd0426">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188beb504ffd4cf1811a05b9122ba936_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtNi0xLTEtNTE5MzU_e487fdda-c24b-419e-b424-068ef0820f39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtOC0xLTEtNTE5MzU_c826806e-0433-4dea-bedc-79ed2072309c">3,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic133da4ac5694c2ab3ebbb7920479054_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtMi0xLTEtNTE5MzU_a0bba4f9-aae7-4b6c-9f37-30ef6cf79f89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036507f5da394189a07761f27ce7e50f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtNC0xLTEtNTE5MzU_8c0a473b-5830-44d4-85df-44aae17320f6">7,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c3951e41d5448f93f5d245e448b353_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtNi0xLTEtNTE5MzU_002de2b0-49b9-4dc4-93b9-8be49b2f76bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtOC0xLTEtNTE5MzU_7e57617c-1527-4f28-942e-4f1c14a27c66">7,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie787f6065b7145838ac2375afc47c02e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtMi0xLTEtNTE5MzU_6628ead5-ff3a-403b-aa6a-0672caaaeb9e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb07718b5c854d9cbe58e30453c54be2_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtNC0xLTEtNTE5MzU_fec567aa-5bbe-43f9-a189-892ed8888dd4">21,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3373ab24aca44874b727df09174bb908_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtNi0xLTEtNTE5MzU_2c98cbb1-03e6-4254-8909-a70110b61261">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtOC0xLTEtNTE5MzU_9807767f-74d2-41d7-8672-2c333c35431f">21,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869ae145fa344284be424032a072bd49_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctMi0xLTEtNTE5MzU_a8d46fe7-d00e-45d5-bf1a-e0cb5c85c048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b6663e1ca24400db968c0f30349d738_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctNC0xLTEtNTE5MzU_580c4d14-c495-48b2-9a5b-45e4cab8367b">6,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0790ce8dc806474baab7039cd2473ef4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctNi0xLTEtNTE5MzU_4b3b9177-1073-4dbb-9b09-38b8532a7bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctOC0xLTEtNTE5MzU_3769b429-71f6-46d7-bb49-d766c2d0b639">6,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0485953f893b49d693502de2df2048e6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtMi0xLTEtNTE5MzU_0034ff78-8729-4496-93d4-82d557122b2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6fab63019041c7a43aa25dabe91d73_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtNC0xLTEtNTE5MzU_c73c9974-4c2e-457b-b4b7-286dc98895e1">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf77a1a93e4449e79e9e7ecb7ca12b9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtNi0xLTEtNTE5MzU_442c6a56-7c14-4617-b949-e8482cd7610d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e69fa331194b15a906c00c27162164_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtOC0xLTEtNTE5MzU_98554686-c56c-4eea-abd8-e2caffbb4ef2">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b874edc14f445189ce46feb9f2c4f83_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktMi0xLTEtNTE5MzU_b9fdf42a-fc47-4a09-b6a7-82d0ee0d3080">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3fb1e3e9b4d8190443f2996222c31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktNC0xLTEtNTE5MzU_0a4dbd94-200c-4392-a6ff-817dfabb3823">38,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb02468002ee402a8d58d3f0b459ea93_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktNi0xLTEtNTE5MzU_07194180-bc20-4998-863c-dad843c645ca">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktOC0xLTEtNTE5MzU_8bbe5c8a-a1be-458a-b6b7-b33cf78ede0a">42,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTItMS0xLTUxOTM1_acc53cb4-bd8e-417a-b8a3-48f13f0aebaa">2,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398125db28a248afa78be5dde2f802de_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTQtMS0xLTUxOTM1_20969992-41e3-463f-8fa5-82cbc75c7a99">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTYtMS0xLTUxOTM1_4cadf753-a11e-4692-8b6f-e082bb7e7704">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTgtMS0xLTUxOTM1_43fc1f93-45da-4e54-8e17-4ddd45b83b8e">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTItMS0xLTUxOTM1_e997bb6f-ca83-4dd0-899f-b85f43826df5">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398125db28a248afa78be5dde2f802de_I20221231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTQtMS0xLTUxOTM1_73a4f48a-0fb1-4475-92c7-6d67c960a37c">2,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231" decimals="-6" name="unh:AarpAssetsUnderManagement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTYtMS0xLTUxOTM1_4259f92a-a4c3-4f3e-b629-f52c1997d2c3">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTgtMS0xLTUxOTM1_b999657d-31c1-4550-8338-8c1bf70be370">4,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTItMS0xLTUxOTM1_9fab9c02-52d5-4656-bf63-cff65527cda8">30,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398125db28a248afa78be5dde2f802de_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTQtMS0xLTUxOTM1_5084a58f-ed8a-4d4e-80e8-c241e929ac7c">41,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTYtMS0xLTUxOTM1_de0dbea8-0c78-4ce6-9357-284268894ab6">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTgtMS0xLTUxOTM1_a5303620-42d8-441e-be20-69ab5e9081ca">71,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTItMS0xLTUxOTM1_1a561e52-beb6-4717-8b4f-90f5794e23c8">21,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTQtMS0xLTUxOTM1_0ceb272a-c29a-4be7-8755-c39dc8c2c2ff">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTYtMS0xLTUxOTM1_b94efb24-ec63-47e1-a5ec-5209500a9198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTgtMS0xLTUxOTM1_3ab4ac20-3a26-4a30-9368-d7f5d42d6faa">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if14e7f1d47d24ce5849f9b9b561f7e16_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTItMS0xLTUxOTM1_6ba09e76-8ce2-4fd7-88ff-f51700accd64">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5784b258ad7c4a2fb80cf028d4eabdb0_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTQtMS0xLTUxOTM1_1fadd3d8-f93a-461e-99d7-761bd9f22214">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c699d8d9ea945a59bfac2890b0ad12a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTYtMS0xLTUxOTM1_6f912669-495c-40b0-b55e-7bcfe71f9b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05937365d074cadb89e64039541d02d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTgtMS0xLTUxOTM1_200cfa67-daf8-4983-8447-c1343e6b02f6">3,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657a012885e24d5eaacd841fab51c280_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTItMS0xLTUxOTM1_4549b641-5939-42df-9e3b-87ff75363830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd889a008b09458f83587b1ac62ff127_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTQtMS0xLTUxOTM1_63e29fae-3933-4791-915c-f830bb551240">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id88f51dc85eb4f388b644b2df135e040_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTYtMS0xLTUxOTM1_09c8db2d-00c5-4aaa-82d6-4c45e81a7bbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTgtMS0xLTUxOTM1_2c9bdcdf-ce5d-41f4-b21e-49c110da3983">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06af4dfd1cfd4c9da60ac57537b11dc2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTItMS0xLTUxOTM1_a91ffc70-242d-4c00-a084-9b3ddc815ad5">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecbdb30ca8f48bd9c6d49d82fbc8d3d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTQtMS0xLTUxOTM1_3911c682-8af3-4e8f-ae10-dbd46afa1b1e">20,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10fb3889577743e99907b617e43c8ba8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTYtMS0xLTUxOTM1_440bfebc-3718-4e5c-9c73-9d533e6e43ae">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTgtMS0xLTUxOTM1_538148e2-eaf2-4234-b402-44ebfdd26cae">21,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443d6329218e4e968f2b21276f5ad0b7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTItMS0xLTUxOTM1_c51215a9-e858-4592-a5be-e43c751aef7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f630fda39a4043bfe6128ff91152bb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTQtMS0xLTUxOTM1_b2d9a6f6-9027-412e-8d7d-8a223d3f553a">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f797283d0f468a9e019cd793e5de27_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTYtMS0xLTUxOTM1_b8d9dd53-5c8b-44d4-8c97-2474c1bb0015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTgtMS0xLTUxOTM1_b350e902-80b7-4dec-bdee-c76f3f909afa">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddcca2f61bd741edb945e23a517102e8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTItMS0xLTUxOTM1_aa99698e-3016-41cc-8f38-459e3de1be17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf402af8c08c4d1cbb8e1ee5013f8985_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTQtMS0xLTUxOTM1_8938c5a4-d4f0-4a2c-b16e-77c22fb6987e">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1029e91d76ab42b3ac1bfc3d43571bee_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTYtMS0xLTUxOTM1_982388f3-8f9c-41b5-b07e-fa9798d99303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTgtMS0xLTUxOTM1_7ebf60fa-5bca-4768-8898-42c1ce9de7c7">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08f479dfe434d749660a45e73e5ae3f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTItMS0xLTUxOTM1_29c7045f-7ea3-4ca6-b3bf-89a73b417890">3,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ab6c56958a464c87ff17c070fbaacb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTQtMS0xLTUxOTM1_65b45a2f-a79c-4b92-bb5a-d87bd05c9df0">36,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ddbe32d07a43fc9952719ea94c5a31_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTYtMS0xLTUxOTM1_2d01b747-3723-449c-a653-eda6f04dd5af">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ea388a069444c4931adafec448408a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTgtMS0xLTUxOTM1_a9d13433-8805-44c5-bf6b-885c32597e7e">40,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTItMS0xLTUxOTM1_ad1a9728-2eb7-42bc-ab21-a2f437038408">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTQtMS0xLTUxOTM1_e461a458-30a7-4c14-88d6-b8c30abea310">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTYtMS0xLTUxOTM1_27ef58bd-2f72-4739-8d86-81452da2a771">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTgtMS0xLTUxOTM1_14927fa3-6191-4a37-a9cf-875c06f3a20e">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTItMS0xLTUxOTM1_55352d48-ab71-4d6a-809d-906aca58bad9">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTQtMS0xLTUxOTM1_34fc2505-6226-48ae-994f-228c9750b9d5">2,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTYtMS0xLTUxOTM1_15f7b05a-bcea-4603-9443-f9a93280a7fe">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTgtMS0xLTUxOTM1_5c3dea2d-ea74-41dd-870d-8dd278f9a212">4,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTItMS0xLTUxOTM1_55e376ff-afe0-4cc9-a637-d075ec694b36">28,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTQtMS0xLTUxOTM1_3e43570e-4543-4a31-981c-45075f5172a1">39,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTYtMS0xLTUxOTM1_033b97ba-5f69-4c17-99b7-2fe9c5b4c580">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTgtMS0xLTUxOTM1_0a2e58ac-f003-4581-8bdc-907dc1e92dcd">68,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1Njk_3ea832a9-e998-43a2-8254-c74cffe1945d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9058fdfbea43dabe2bae0df36bd3bf_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItMi0xLTEtNTE5MzU_a7f8088d-6413-4f0d-8ce4-d5f5826872f0">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i307873d9bcfb48f8a290730f26815add_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItNC0xLTEtNTE5MzU_c490d12f-1248-4115-81a3-9b439d3f4a78">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3392265deb4106aab31600904e9cb4_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItNi0xLTEtNTE5MzU_866a1edf-bf18-4d3d-a3bf-613265516b04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d93ef8431b471ca93d9465e2c95484_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItOC0xLTEtNTE5MzU_a7f58ab3-da2e-402d-9579-28092bd7f909">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItMTAtMS0xLTUxOTM1_338d383a-81bb-4339-935c-6aa7e66fcb50">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63222ef16b814f569ad4ba0cf601d3a7_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtMi0xLTEtNTE5MzU_de857da9-4514-414e-b206-cf65049e5abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77ad19c6e4440028848176be54ff601_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtNC0xLTEtNTE5MzU_e20f65da-7220-408d-9ff8-3332d9a456a9">53,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde696a897d44556b79a1a65c2668c22_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtNi0xLTEtNTE5MzU_f6066dcd-4ef8-48b2-89c9-3e1cf7962210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a18e6ecf3d47f986ea7a8767797311_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtOC0xLTEtNTE5MzU_ea114870-df8e-4d40-a246-d668702c59ae">53,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cad82084bb42bf84e6e79e8cf2b3de_I20221231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtMTAtMS0xLTUxOTM1_0f1c62e5-9ffe-44e5-9659-31ec6027f719">56,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c131978c8aa4c9fac20a4b9db444b5b_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtMi0xLTEtNTE5MzU_4fee3120-8b5b-404d-8ec0-949dd95c8893">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1288c646ac474cb6a528ecddc4cf9eaf_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtNC0xLTEtNTE5MzU_646eb18c-237b-446b-a8b4-63af5618bb60">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ccb32154264ba6a1a64b7d12112f3d_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtNi0xLTEtNTE5MzU_2ae490ec-acab-4499-9292-9ec3cfb895de">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87829c660a8467182b6e1a92c6cd8e0_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtOC0xLTEtNTE5MzU_2b4d4ae0-8623-41cc-b812-fc1521bfa8eb">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtMTAtMS0xLTUxOTM1_940a3c6f-b7db-4e21-8709-01f817e87262">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7837dbff77c4c7ab715987e4d24c08a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtMi0xLTEtNTE5MzU_48e88748-f8d6-4e64-9919-adf0d7666a11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0be0aab5247d49e8bea8b75041ffa84c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtNC0xLTEtNTE5MzU_291f75e4-c37c-4aa1-9882-d865aabe6b7a">52,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f993c029dde4f2188f1debf7eab46d2_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtNi0xLTEtNTE5MzU_a879cb07-6d5f-4eac-a46d-d708cc85f448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e929c44eac543b9b65151f9f6e42da0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtOC0xLTEtNTE5MzU_e539756f-5ed1-409b-a484-b98c43f7bbab">52,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie941b4c35ceb4d50a09440e37ae44046_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtMTAtMS0xLTUxOTM1_98f8af66-fc99-46c3-90cd-e253e6fc6014">46,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i90aa040c389b45868880c2f7073a42dc">The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM1OQ_baf14b3b-6e50-4d8c-9a65-1c937fc98ca3" continuedAt="i516cd483c1794b6fab160f7e2d691786" escape="true">Property, Equipment and Capitalized Software</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i516cd483c1794b6fab160f7e2d691786" continuedAt="ief0ddf91982b48c3adf1624eb4d853a6"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM2OQ_0303561c-c8a7-4f9a-9c5f-5afb196320df" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEtMi0xLTEtNTE5MzU_b4c1634a-cca3-400f-967c-d2b361ca73bd">697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEtNC0xLTEtNTE5MzU_0c911f46-b59b-43fa-b61f-c0db8016348f">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzItMi0xLTEtNTE5MzU_adf9996d-3fb2-45b3-89ec-3ebafef70466">5,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzItNC0xLTEtNTE5MzU_56554d73-23de-4ae5-b842-322616f66035">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzMtMi0xLTEtNTE5MzU_d233fe99-3b1b-4406-8cad-e17ba56b6fee">2,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzMtNC0xLTEtNTE5MzU_d6202c37-df3e-4320-905c-f5c0bd1c1281">1,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzQtMi0xLTEtNTE5MzU_1a52af11-ff30-4988-8b90-b6caa6d80c78">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzQtNC0xLTEtNTE5MzU_7c1526d8-fe44-4fa1-8825-fc81fcef4c51">2,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzUtMi0xLTEtNTE5MzU_6c475a6d-10f6-453a-8baa-0d20ce6d67d8">4,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzUtNC0xLTEtNTE5MzU_f40412bf-1c50-49ed-9a9e-bd55876babd7">3,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzYtMi0xLTEtNTE5MzU_2d6ce81d-d1e2-4a01-8594-0ef5a31855ad">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzYtNC0xLTEtNTE5MzU_70fef6df-5d23-4178-836f-e7f0e0b38571">5,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzctMi0xLTEtNTE5MzU_39214f5f-fb27-490f-8bdc-b1538a81a097">6,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzctNC0xLTEtNTE5MzU_81d053c4-3e81-4db6-9be9-9eefd1fdf351">5,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzgtMi0xLTEtNTE5MzU_8c3449aa-70ea-4f38-92a4-fd37e1c413a3">2,431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzgtNC0xLTEtNTE5MzU_beb8b594-861d-4620-8f92-d0902b7d4078">2,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzktMi0xLTEtNTE5MzU_eb8b9925-faff-4391-a361-877bf087240c">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzktNC0xLTEtNTE5MzU_88ccc15f-a572-4ad5-96e8-e0125e7b0b10">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEwLTItMS0xLTUxOTM1_bfc71446-3b29-45d4-96cd-2285b8d8518a">10,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEwLTQtMS0xLTUxOTM1_a1ef041b-53a2-4e17-8934-1ff690c49d15">8,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"><ix:continuation id="ief0ddf91982b48c3adf1624eb4d853a6" continuedAt="i42ad28da384e4ec88344fdd726741006">&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42ad28da384e4ec88344fdd726741006">Depreciation expense for property and equipment was $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIxNg_be66f2b7-fec1-4453-bcba-5a8dbfd649e3">1.1</ix:nonFraction> billion for the year ended December&#160;31, 2022, and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIyMA_7aa7c8ef-81e9-4852-8b0b-7640b8bb043a"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIyMA_97f78df4-78bb-4127-aafa-53336cb5044f">1.0</ix:nonFraction></ix:nonFraction> billion for both years ended December 31, 2021 and 2020. Amortization expense for capitalized software for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzMyOQ_552f24a3-6eed-46a4-a18a-54e84082e5c4">1.0</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzMzMw_674a4e8d-ecac-4146-976c-0c20d7d48d12">0.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM0MA_74efbdb2-f30d-4f1d-a541-7761e201e277">0.8</ix:nonFraction> billion, respectively.</ix:continuation> </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_175"></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxNg_6232c332-b640-4e8b-97e8-4408acb680f4" continuedAt="i15a8efd0475a40f2b7b9ced993e26dd3" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i15a8efd0475a40f2b7b9ced993e26dd3" continuedAt="ib878df62f8dc485e82d99d767eb91744"><div style="margin-bottom:4pt;margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcyNg_927e5c9d-0842-4887-aa90-3377ca7ce9f4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b9cb689c4849b186802ae057c4f620_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtMi0xLTEtNTE5MzU_767f3783-42f7-420f-8b3d-2c631112f4dc">27,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273fb22e9e294cc583d6ed2a1dccb45e_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtNC0xLTEtNTE5MzU_5d9ca41c-1739-4d1c-ba06-cd4626ce4d5d">19,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18968b1b98748ebaf2b70232a383b48_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtNi0xLTEtNTE5MzU_531930fc-6170-4880-92aa-ec98f7ed6eb6">8,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aab5eedface463d8e9937c9f349bdb8_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtOC0xLTEtNTE5MzU_f424a20b-d3b4-485f-bd16-f4b00394ac13">15,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtMTAtMS0xLTUxOTM1_33b8fed8-1d6d-4d94-9e7c-371c721948f8">71,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93aff990939e4d999543f7925550419f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItMi0xLTEtNTE5MzU_9205d038-a0c6-4c41-9b5a-7c34a1e5f4e6">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie588118f5a224050a60787106be9f4ad_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItNC0xLTEtNTE5MzU_8fc38495-d08d-414b-8ad2-4ce92724fa55">4,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItNi0xLTEtNTE5MzU_c91cd59d-291b-4c76-b50f-474e9bb89a41">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItOC0xLTEtNTE5MzU_d0185656-e1d5-468d-8266-f0d2cd0bc465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItMTAtMS0xLTUxOTM1_ec6800d1-041f-485f-8872-d62cfa7949cb">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93aff990939e4d999543f7925550419f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtMi0xLTEtNTE5MzU_0faef82f-3028-41a3-87f0-d3ceacadb37a">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie588118f5a224050a60787106be9f4ad_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtNC0xLTEtNTE5MzU_7bb28409-8c2f-43ba-92da-9d007c08b5bf">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtNi0xLTEtNTE5MzU_fa39defb-8d65-4d39-90a4-56b215d95ab5">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtOC0xLTEtNTE5MzU_32dc76b5-c1d2-4357-a171-7275d6bca8c2">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtMTAtMS0xLTUxOTM1_b5c1484e-e279-470e-a590-3700692812cf">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef850d28ac94a98ab6c49a6ff13ef23_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtMi0xLTEtNTE5MzU_92779e8b-3545-455f-bf73-dbb20da4bfd6">27,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954001ec6080467d9308272e6879d3cf_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtNC0xLTEtNTE5MzU_1e5f5d5a-16f9-4e04-b19d-2c0a49ad29a9">24,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0520b9f9d7f64354b0aa489f5bd5b095_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtNi0xLTEtNTE5MzU_e1106f09-915e-46b6-a652-21e564eb7e00">8,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4082841ae445839156ed080b909db1_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtOC0xLTEtNTE5MzU_1689122a-3156-414d-a9db-30c0f564f21e">15,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtMTAtMS0xLTUxOTM1_ca391370-45cb-4eb3-8dd9-9042cb139059">75,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtMi0xLTEtNTE5MzU_ba492457-2ea8-4040-ace9-8a76a0f0d6a6">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtNC0xLTEtNTE5MzU_26dcb3b7-590a-4237-b3bb-2af1e4d192da">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71332b1e4da424482d4374941a68deb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtNi0xLTEtNTE5MzU_b6961454-376c-4616-815e-68b4b45bc246">8,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtOC0xLTEtNTE5MzU_e32bbe79-755b-40e7-b4a5-e37b1f0eacec">3,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtMTAtMS0xLTUxOTM1_0a5ebcbf-7726-43a2-a9d4-fbe1a89b3483">17,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtMi0xLTEtNTE5MzU_1ff254d8-c8fe-46f1-9180-eadecac90f8d">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtNC0xLTEtNTE5MzU_b82a20fb-8a53-4d8b-8471-6ded1fecd089">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71332b1e4da424482d4374941a68deb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtNi0xLTEtNTE5MzU_35b97e0b-0d4b-4796-896f-3b62e620e05f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtOC0xLTEtNTE5MzU_e6e514f7-17a0-4150-800a-ce61a72efdf5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtMTAtMS0xLTUxOTM1_7ed3892b-0759-43ca-99f9-a8c75585c1a1">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029dc3b772ba45fcae3cdfb1cf328398_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctMi0xLTEtNTE5MzU_8fc21e83-84c0-4340-8f60-642eabd6079a">27,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306fc774c45e4efda5c854e3d3882a81_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctNC0xLTEtNTE5MzU_92b633c3-90f1-42be-8d2d-c1eaa1c141ab">29,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38495f03da740dc92c5e3241a80f075_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctNi0xLTEtNTE5MzU_fa7a421e-c023-443b-9760-40ebe8f09b24">17,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73959cf508b94532976280692bebc7fa_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctOC0xLTEtNTE5MzU_a13c2812-494d-4ac2-a9e1-e8f2840e3d80">19,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctMTAtMS0xLTUxOTM1_7655cbc8-ef97-48bf-9887-e1d9bf56af94">93,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:12pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxMQ_734467bc-4f37-48db-8007-2f3988afb6d3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMi0xLTEtNTE5MzU_37e70295-0d2f-4399-8e93-39f5d6fbaded">16,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItNC0xLTEtNTE5MzU_4491ca74-8d38-401f-8f02-86e1fbdf7f37">5,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItNi0xLTEtNTE5MzU_0a921b7c-149c-4f17-9bab-7b6f8c29ef22">11,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItOC0xLTEtNTE5MzU_c44a23d7-caf2-42ed-b443-e1a34fbd36a7">13,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMTAtMS0xLTUxOTM1_6a1007eb-2835-4bb9-9993-46aa30e3cb6d">4,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMTItMS0xLTUxOTM1_46bbcade-f39f-465f-85fd-21f9d4bbbb23">8,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMi0xLTEtNTE5MzU_d6793e1e-fe44-41f5-bb07-948737079b5a">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtNC0xLTEtNTE5MzU_ccbda395-6120-4bcb-87f7-6d6725ee9e63">704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtNi0xLTEtNTE5MzU_84b9244f-4767-41e8-8b54-4679e15255a4">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtOC0xLTEtNTE5MzU_821c3204-f7e0-4e44-b05e-d02c80d0a47c">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMTAtMS0xLTUxOTM1_6a79602a-db10-471e-9dc3-79a6474ee452">739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMTItMS0xLTUxOTM1_4b9c16e3-ce85-4737-8a6f-a3587b56b278">891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMi0xLTEtNTE5MzU_159b33b2-f32c-429f-b300-234e2290b89a">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtNC0xLTEtNTE5MzU_ccd15ce6-5b40-4db3-aeb7-180e57d45842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtNi0xLTEtNTE5MzU_67c31fab-b3ae-40aa-80af-e00662f9f7be">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtOC0xLTEtNTE5MzU_7d8dd690-ef6d-4c16-96f1-65c22cb1d77b">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMTAtMS0xLTUxOTM1_3292b737-754b-40b3-9c47-bb665e0d60f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMTItMS0xLTUxOTM1_82613c55-55f8-4a05-aeec-52a0face73ba">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMi0xLTEtNTE5MzU_a659088f-c667-4f79-a602-9c24c56b26b2">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtNC0xLTEtNTE5MzU_a7826358-c41f-486a-a800-8a2bc01454a8">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtNi0xLTEtNTE5MzU_a17e16a5-7ada-4704-b106-9b15da0c1a0e">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtOC0xLTEtNTE5MzU_51a13332-c41e-4e8c-a233-be9f56dc53fb">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMTAtMS0xLTUxOTM1_67eeaf0e-9aab-4d45-8dd7-4012c160d849">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMTItMS0xLTUxOTM1_28687b48-4415-458a-b045-e7d429f73133">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMi0xLTEtNTE5MzU_86a5bb6d-5f29-43fc-b9e6-36c474c5e69d">20,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtNC0xLTEtNTE5MzU_45cc06f1-e003-497a-97c4-86fc7123adae">6,137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtNi0xLTEtNTE5MzU_7c10fe10-e45d-4414-a2e9-354a0c8e76c5">14,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtOC0xLTEtNTE5MzU_f57b339f-b37c-41d8-be80-8fb2e938421a">15,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMTAtMS0xLTUxOTM1_30145a30-ecd5-474e-8400-da905379aa66">5,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMTItMS0xLTUxOTM1_06fcb95c-a519-4ed9-872f-d531e522b655">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="ib878df62f8dc485e82d99d767eb91744" continuedAt="i88805848b60b4afcb235170468199e3e"><div style="margin-top:15pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcyNw_a430a2e0-a168-4d4d-8215-4ce53239e9a0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItMi0xLTEtNTE5MzU_4b7a2286-a765-4d01-9596-41ef3eb21412">3,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItNC0xLTEtNTE5MzU_ce93accc-9f78-49ed-a7e6-d132b8e17536">15</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItNi0xLTEtNTE5MzU_2a2ad881-ed81-45a1-99ac-af2aa2ebc391">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItOC0xLTEtNTE5MzU_88455aa5-234d-4e42-af8d-601ad09c3885">9</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtMi0xLTEtNTE5MzU_25e984cb-b0c6-41d1-aeb6-9e3bb3acaa94">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtNC0xLTEtNTE5MzU_8552db7e-6012-48b7-bc50-eb013caf1cd6">6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtNi0xLTEtNTE5MzU_b49d0069-2c78-4a4a-854c-149d996fcf01">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtOC0xLTEtNTE5MzU_45c8971d-c804-407f-8c7b-59401f6db9b4">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a9202de2dd47f3af460db253742fae_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtMi0xLTEtNTE5MzU_d9018391-6989-412b-b0e6-7b89750cb72e">776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i99a9202de2dd47f3af460db253742fae_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtNC0xLTEtNTE5MzU_167f707e-69fe-4b6c-996c-384256a5b992">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtNi0xLTEtNTE5MzU_2419549c-4a20-4538-ab9d-a982a8a42003">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtOC0xLTEtNTE5MzU_b3bdbd2b-788d-4bee-b551-5ee22a58e92b">11</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtMi0xLTEtNTE5MzU_72f5dd51-d6b8-4acc-a6ef-da15bd188c95">5,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtNC0xLTEtNTE5MzU_b796db5a-628d-4cc5-abd5-200b51460fff">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtNi0xLTEtNTE5MzU_4c8cdc73-e90b-4e9a-8e21-a994d42db3c0">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtOC0xLTEtNTE5MzU_c28ec358-be00-4d5b-b356-bf9e701cc75d">8</ix:nonNumeric> years</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxMw_2e5cd6fc-17a8-403b-8e7f-e471ad9c51de" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzEtMi0xLTEtNTE5MzU_874d2880-c2bf-470d-842c-b8e6fd897f57">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzItMi0xLTEtNTE5MzU_10c688b7-96c0-43ba-9c93-d1084c0dd613">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzMtMi0xLTEtNTE5MzU_19a96251-8231-4c73-8714-361574fab595">1,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzQtMi0xLTEtNTE5MzU_0d7a8b47-9809-4932-9fcc-01d4a226064f">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzUtMi0xLTEtNTE5MzU_1e199570-2c85-44e0-88e7-84487d1d0e5d">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i88805848b60b4afcb235170468199e3e">Amortization expense relating to intangible assets for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY3Nw_c63d09f2-d469-4d05-bd74-0097345bda12">1.3</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY4MQ_d274fbca-5edd-4b11-b2cf-f9508fc118c6">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY4OA_0ea5312f-4f76-408d-b49f-f12acbde73a7">1.1</ix:nonFraction> billion, respectively.</ix:continuation> </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_181"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzczNg_83610fdd-aa5a-4b95-80d1-f93c18f2bc9c" continuedAt="i7be4e0bcf6df4631bd5046ebd2c91055" escape="true">Medical Costs Payable</ix:nonNumeric></span></div><ix:continuation id="i7be4e0bcf6df4631bd5046ebd2c91055" continuedAt="i4637e9edde19447fb9c586d3eb0de77c"><div style="margin-bottom:4pt;margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzc1MA_20a3a252-f0c2-493b-8af1-47ffc3f5fa22" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtMi0xLTEtNTE5MzU_83b05bb5-e60d-438b-b4e6-5a60c42dae0a">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtNC0xLTEtNTE5MzU_7a29eea6-61a7-49a2-bce4-b36b000fa39e">21,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtNi0xLTEtNTE5MzU_a0460c9d-4563-4e97-870b-f2ae82953761">21,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItMi0xLTEtNTE5MzU_28ab5768-184e-45f6-aae3-dd3847781226">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItNC0xLTEtNTE5MzU_0242ed62-ab2f-414e-9fbf-085ba1981a5f">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItNi0xLTEtNTE5MzU_7b1cb7ed-a3c4-4590-99d6-74cf7e920cb8">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtMi0xLTEtNTE5MzU_726af1a2-8bef-440c-8548-d1e2dcacade2">211,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtNC0xLTEtNTE5MzU_65da0755-8424-4cc5-81bf-c771a2164d61">188,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtNi0xLTEtNTE5MzU_9809358e-a4c1-4e80-8088-7f775abead1b">160,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtMi0xLTEtNTE5MzU_e600a1e4-3a70-44d8-bdf2-0e72754866e0">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtNC0xLTEtNTE5MzU_82cad67a-bff9-40bb-bfe8-71cda9733975">1,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtNi0xLTEtNTE5MzU_dc32d73d-0b92-41fd-ba8a-e4f5ad0341a2">880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtMi0xLTEtNTE5MzU_034672ff-de6c-4d24-a938-491f2330ad4f">210,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtNC0xLTEtNTE5MzU_3ba7e741-9aed-4aa5-b56c-a451f61a6462">186,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtNi0xLTEtNTE5MzU_f2cf5cad-14ba-42a2-87b2-75c3e447dcae">159,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtMi0xLTEtNTE5MzU_c31759ea-ebc0-4c44-bd4d-31f5180787d9">184,049</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtNC0xLTEtNTE5MzU_faab8a54-7ec0-41f0-b9c2-5277798a3c4a">165,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtNi0xLTEtNTE5MzU_f34386dd-b4a0-42b1-99f6-c9953428311c">139,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktMi0xLTEtNTE5MzU_7637373a-34ef-4a8b-a856-1e3c459023c1">22,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktNC0xLTEtNTE5MzU_50519fef-35a0-4af2-8e49-1737909fc892">18,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktNi0xLTEtNTE5MzU_025938ac-6157-447b-bf13-4d198110719d">19,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTItMS0xLTUxOTM1_af761579-0ff0-4280-8730-24caa63cd6f6">206,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTQtMS0xLTUxOTM1_4f7aab37-ffe6-437f-a65c-0e8bb3466d7f">184,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTYtMS0xLTUxOTM1_66c85adc-414c-47f7-9cce-2b5965fa14ac">159,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTItMS0xLTUxOTM1_dc1e9f13-f7da-49ee-9b35-3578083b80ce">29,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTQtMS0xLTUxOTM1_3160ba14-1bb6-4672-8c9a-c05c3b6f63d9">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTYtMS0xLTUxOTM1_3d25b4a2-28ce-4443-98b3-7d3c5000c961">21,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December&#160;31, 2022, prior year&#8217;s medical cost reserve development included no individual factors that were significant. For the years ended December 31, 2021 and 2020, prior years&#8217; medical cost reserve development was primarily driven by lower than expected care activity. Additionally, prior years&#8217; medical cost reserve development in the year ended December 31, 2021 was driven by care patterns disrupted by COVID-19.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable included IBNR of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzUzMQ_4c55fd22-01bb-4d8c-899b-5403cb4df8b1">20.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzUzOA_a8c017da-8613-4b9c-aa4b-6762a1e28762">17.1</ix:nonFraction> billion at December&#160;31, 2022 and 2021, respectively. Substantially all of the IBNR balance as of December&#160;31, 2022 relates to the current year. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><ix:continuation id="i4637e9edde19447fb9c586d3eb0de77c"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzc0Mw_6a7e5f65-9296-4bb9-b30a-d44b032c29d4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and paid medical cost development as of December&#160;31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:54.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2145059193248b48874a80710b28e8b_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzMtMi0xLTEtNTE5MzU_fddae31e-efbe-468f-91a7-7400b2c840b2">188,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99b38b33f024bd5b838c545e73f79f5_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzMtNC0xLTEtNTE5MzU_a258a7bd-45fc-4c45-adf0-212dd081d7be">188,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495eaae432e44afdb66418768a361a4b_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzQtNC0xLTEtNTE5MzU_56ab4f31-f33f-4433-a6fe-04b8fb3967a4">211,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzUtNC0xLTEtNTE5MzU_a8ca0532-8811-42cd-981a-64ebe1c893ef">399,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2145059193248b48874a80710b28e8b_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEwLTItMS0xLTUxOTM1_5b75feb9-6a0e-46d7-bc5b-bcdace357869">165,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99b38b33f024bd5b838c545e73f79f5_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEwLTQtMS0xLTUxOTM1_a5a9a970-ffb8-423f-8e95-70af55bf65b3">186,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i495eaae432e44afdb66418768a361a4b_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzExLTQtMS0xLTUxOTM1_3ca5d8ab-a336-4d42-be37-363beafc07b0">184,049</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEyLTQtMS0xLTUxOTM1_9ff9fce6-d099-4822-86a6-be81f48fb3ee">370,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEzLTQtMS0xLTUxOTM1_2594055b-1251-4d63-ab5e-64feb1b5ffb8">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzE0LTQtMS0xLTUxOTM1_a6a994ea-1549-413c-a0f9-13e9cb8e3818">29,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1Njg_969c6572-352d-4644-a30f-b5c53c183346" continuedAt="i5b537aba6ea8484085e6c381ade025e3" escape="true">Short-Term Borrowings and Long-Term Debt </ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i5b537aba6ea8484085e6c381ade025e3" continuedAt="i4a60d0dd81ba41bebfaf078e4445a1fd"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1NjQ_078f2c29-a109-47ad-9599-67eec16e2482" continuedAt="if3ccf4acee984056a4ab45f3822530e8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94f6f0f1fd94551b44b1faa876e0832_I20221231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzItMi0xLTEtNTE5MzU_19861b0e-b011-48bc-a813-35290fcdca50">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c49ae972864155b1415b8cc9d945ec_I20211231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzItNC0xLTEtNTE5MzU_01c37017-4e71-4ad4-bf46-a4a0f3ad421c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiNDU5NGRhYTY4ZGE0YzgyOGFmMWM1OGYzOWU1OTE4NF80_50eae4d8-cebd-4b05-864f-96e4396bcabb">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiNDU5NGRhYTY4ZGE0YzgyOGFmMWM1OGYzOWU1OTE4NF8xNjQ5MjY3NDQxNjk2_dc38e8ef-aaf5-4986-9c65-f759ab494e38">2.875</ix:nonFraction>% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMi0xLTEtNTE5MzU_06b28d2b-efa9-4445-aec0-c45264588e54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7467c05cf504bf382c1187f5f7e597b_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktNC0xLTEtNTE5MzU_c7078c2e-3cd2-4cb9-a39b-f3ef887c8987">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i24e57b760f1943638a139219471fd6fb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTgzNjZlZjBhYzU1NGJhZWFmNzIyYzk4ODY4YTMyNDhfNA_66b3bd49-4b85-44d8-b2a2-015088f78e38">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i24e57b760f1943638a139219471fd6fb_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTgzNjZlZjBhYzU1NGJhZWFmNzIyYzk4ODY4YTMyNDhfMTY0OTI2NzQ0MTY5NA_e017a244-3bf3-4462-b4b3-a6a279e56611">3.350</ix:nonFraction>% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e57b760f1943638a139219471fd6fb_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTItMS0xLTUxOTM1_68e54a4e-f895-41d2-b890-4353a9dc9437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e95ea910ec747ac9770d7cbc2da1ce2_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTQtMS0xLTUxOTM1_d278c4d4-6ac5-4c0d-a01c-8b39d65258e6">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTAtMS0xLTUxOTM1L3RleHRyZWdpb246M2E3YmJiMTYwOWIwNGRiZWI5MjUyZWExYjRmYThlZDlfNA_6a25abd5-4c0f-4d1e-94b7-d33aff42f43b">900</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTAtMS0xLTUxOTM1L3RleHRyZWdpb246M2E3YmJiMTYwOWIwNGRiZWI5MjUyZWExYjRmYThlZDlfMTY0OTI2NzQ0MTY5Nw_31a774a7-bc1a-4c0b-b35e-066551349bd6">2.375</ix:nonFraction>% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTItMS0xLTUxOTM1_87ed7f76-a72a-435a-ba98-33c627c4e50b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e6c96ce7884253a99f1fca5a7339dd_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTQtMS0xLTUxOTM1_0d647245-173c-4400-8043-6a0fb9abd29a">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NzY5MmM0Yzk2NDk1NGQyMmI4YmM0MjgzOTBlOGU3YWRfNA_fd4f42fb-b7e9-4c4b-9c85-7918cdf97d04">15</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NzY5MmM0Yzk2NDk1NGQyMmI4YmM0MjgzOTBlOGU3YWRfMTY0OTI2NzQ0MTY5OA_d6c42d1d-78c1-48ac-b31e-f3ec6db01f2b">0.000</ix:nonFraction>% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTItMS0xLTUxOTM1_ab688e58-d74c-4365-bef4-7c55209e74a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3892320018df450c9ac4e6bf65e11fe3_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTQtMS0xLTUxOTM1_a3887060-bf32-4b0f-a72e-9d518d7b92f3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic7c819f8af694a74897e26538e141f60_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IxZDkzYTE3YmVjNDkzY2IyNWUxMTc5MDViMzcwNDZfNA_c6b651bd-23ec-45c5-845b-44ae7c825a17">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic7c819f8af694a74897e26538e141f60_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IxZDkzYTE3YmVjNDkzY2IyNWUxMTc5MDViMzcwNDZfMTY0OTI2NzQ0MTY5OA_18177b0f-1a99-48ab-b798-d0941934b882">2.750</ix:nonFraction>% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7c819f8af694a74897e26538e141f60_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTItMS0xLTUxOTM1_daa01cb0-a09c-4d06-9547-97a264cca3b3">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2367432c1c4e45439729594f68a2ec11_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTQtMS0xLTUxOTM1_fede50ac-9d27-40d9-9fb5-48f469c220f7">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NmYxYjJiMDQ0MWNiNDVlZjkzZWJkYzc1OWQ0MjZhNWFfNA_f61f58b6-2732-4cea-9189-3a7e977c2037">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NmYxYjJiMDQ0MWNiNDVlZjkzZWJkYzc1OWQ0MjZhNWFfMTY0OTI2NzQ0MTY5NQ_d9d07b0e-e20a-48d9-9edf-c993e937e6d7">2.875</ix:nonFraction>% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTItMS0xLTUxOTM1_34fe7516-1c8c-4ae9-9961-656732f4db83">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d9d96731c340fa9d78902e0bc3b278_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTQtMS0xLTUxOTM1_5bfcc036-8cff-4f51-a6c0-e884858bbeb5">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmYzNWFkNzVmYzg5NDA3NzliZWFjZWQ1MGI5ZTM4NGNfNA_30a656db-6714-4794-9980-e995b4bbbd95">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmYzNWFkNzVmYzg5NDA3NzliZWFjZWQ1MGI5ZTM4NGNfMTY0OTI2NzQ0MTY5NA_84c6d7b2-92f5-4579-b519-747c3f9b03aa">3.500</ix:nonFraction>% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTItMS0xLTUxOTM1_dd0d6127-2123-4e77-9f00-998276ade03b">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ef92fae8bc4c0084253bd7bb7088bf_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTQtMS0xLTUxOTM1_92f5bae2-26d6-4b2b-8283-78a3131a1196">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjQ0Y2E0MmQxNGE0NDRjYjkzODRjMDdmMzAzNjQ1MTRfNA_453f3e83-a6df-4d7c-8442-184fc0f85145">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjQ0Y2E0MmQxNGE0NDRjYjkzODRjMDdmMzAzNjQ1MTRfMTY0OTI2NzQ0MTY5OA_9cd0fc98-d146-4f84-b92d-450b052067ae">3.500</ix:nonFraction>% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTItMS0xLTUxOTM1_80bd0dd8-8d1c-4c42-8f4d-6624194c74a9">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786714661e7f4838a42693234789771e_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTQtMS0xLTUxOTM1_53ecff1b-bac7-49a2-bbd2-1685bc100b41">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDU5Yjg0ZmJlODk3NGIwZDgxNjg5MTNkMWU4YTBmODZfNA_dd796d9c-3c55-4fc6-bd32-8a9055235f92">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDU5Yjg0ZmJlODk3NGIwZDgxNjg5MTNkMWU4YTBmODZfMTY0OTI2NzQ0MTY5Mw_26082034-02df-44a8-a41d-a6f32493de76">0.550</ix:nonFraction>% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTItMS0xLTUxOTM1_7ae0dcfb-3db8-4c8b-8b0b-12f34774c5a1">998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c66b2e1270a46d6a8d5cd1309dea3ca_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTQtMS0xLTUxOTM1_f9084ff9-a492-4713-83c1-1361cb8f96ce">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODY2M2FlYjY0Yjg3NDQ3MjliMGY3NGZlMDEyN2M3MzdfNA_09dbed4f-1838-458a-8d11-9d5cc1e0e1bd">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODY2M2FlYjY0Yjg3NDQ3MjliMGY3NGZlMDEyN2M3MzdfMTY0OTI2NzQ0MTY5Ng_c7a3a924-3d96-4b95-909a-31d8ded915b7">2.375</ix:nonFraction>% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTItMS0xLTUxOTM1_d072000d-0b44-48cb-9523-95a7fecc7cb9">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8f66195a594ab1b336d142ef13ede2_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTQtMS0xLTUxOTM1_b0e034db-d141-4545-bc69-066d3853a718">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTU4ODk1L3RleHRyZWdpb246NzMwMmNhNmE4YjNlNGNkYmIyZmQ3YTVhOGMyN2YyMDdfMjc0ODc3OTA2OTUxOA_6e0b3b37-5863-4261-939e-7192b2a2f1cb">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTU4ODk1L3RleHRyZWdpb246NzMwMmNhNmE4YjNlNGNkYmIyZmQ3YTVhOGMyN2YyMDdfMTY0OTI2NzQ0MTc5NQ_5548d718-deaa-405e-a520-730cde4120ec">5.000</ix:nonFraction>% notes due October 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTItMS0xLTU4ODg4_fbebc3ba-e1ff-4dfa-84a5-fbc5f8f75b1c">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6383fe7786fe4e7bbdd981e396552bd7_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTQtMS0xLTU4ODg4_8e800c37-ea65-4a9e-b0ea-5480df83434a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2VjYTMyMjk4MGU3NDNlZDg0Y2QxYzRkNGU1ODc1MWZfNA_00ba1fd9-004b-4f25-b842-5fd6f161485b">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2VjYTMyMjk4MGU3NDNlZDg0Y2QxYzRkNGU1ODc1MWZfMTY0OTI2NzQ0MTY5NA_33d859e8-3125-471d-85f1-480dfde2ad54">3.750</ix:nonFraction>% notes due July 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTItMS0xLTUxOTM1_5b46c21e-54fc-45eb-ba9c-4acb3bb3b207">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i416a9d226e564e5abf36acd74b65f94f_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTQtMS0xLTUxOTM1_84337acb-4610-4298-a7e3-4b03ca398eed">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTU4OTExL3RleHRyZWdpb246MDJlMTQ5ODhlYTk2NDk3ODlkYTA3NjE1NmExMzRkMWFfMjc0ODc3OTA2OTQ5OA_5894a1be-6208-49e2-8d0b-06e1f2f04c1d">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTU4OTExL3RleHRyZWdpb246MDJlMTQ5ODhlYTk2NDk3ODlkYTA3NjE1NmExMzRkMWFfMTY0OTI2NzQ0MTczNw_f8dcb601-020e-4891-9edb-3327be63c4be">5.150</ix:nonFraction>% notes due October 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTItMS0xLTU4OTIy_5356b7b0-eba0-474c-b48b-36c9a06b33dd">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9fa26a59c1843ad803fbad414557dc6_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTQtMS0xLTU4OTIy_f6a4fbb5-3634-40eb-847a-a43c79b4a0b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTA1ZGU3MDc2ZjJjNGIxYWJjZTVlNTkzMDg5ZWZhOTNfNA_864f462e-8541-4308-96c5-55f0641bfe71">300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTA1ZGU3MDc2ZjJjNGIxYWJjZTVlNTkzMDg5ZWZhOTNfMTY0OTI2NzQ0MTY5OA_db0f24bf-b09d-4fd1-86dd-532808190db9">3.700</ix:nonFraction>% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTItMS0xLTUxOTM1_63a3debc-1656-4b3f-8c9f-246d3c58829a">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5b47862f5348ef9dcf07e7a185c79b_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTQtMS0xLTUxOTM1_64d5fd22-d1c7-420a-9072-37934f87335c">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjdhZTYwNTc0YmZjNGM0Y2EyMWZhYThhMTFmZDkzNDNfNA_b6750f87-45e7-4742-890c-bf74b14c31c7">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjdhZTYwNTc0YmZjNGM0Y2EyMWZhYThhMTFmZDkzNDNfMTY0OTI2NzQ0MTY5Nw_36382faf-0e7f-4d93-8a48-236abc6920bb">1.250</ix:nonFraction>% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTItMS0xLTUxOTM1_14ee971e-b590-47a1-80a3-46e2551c980b">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cc738c6f9848178e80519e6cbbce38_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTQtMS0xLTUxOTM1_03b0d332-e516-4194-820f-0626ded238b0">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8de494dc062d4199875121594f393220_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzRmYzdhMGEyZjRiNGFlMGJiMTk3ZTEzNjk1NmQ2MTlfNA_7cc37dd7-cff6-4749-b9ae-bf739b031777">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8de494dc062d4199875121594f393220_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzRmYzdhMGEyZjRiNGFlMGJiMTk3ZTEzNjk1NmQ2MTlfMTY0OTI2NzQ0MTY5NQ_1613f629-805c-4076-b35b-e03aa19b7af0">3.100</ix:nonFraction>% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de494dc062d4199875121594f393220_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTItMS0xLTUxOTM1_92da89f0-7ef7-4ed6-8984-e27f8d0ad5a3">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c732b02ee74c73bbfc3705c75e0da0_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTQtMS0xLTUxOTM1_17bc6778-db05-4131-b2d8-a144a19f6ca2">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IyOThiYTczN2FjNDA2MGE0YmQ0N2FjMTdkNGI0ZmNfNA_f59945a7-be9f-47aa-80d1-d29aabb6fcbd">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IyOThiYTczN2FjNDA2MGE0YmQ0N2FjMTdkNGI0ZmNfMTY0OTI2NzQ0MTY5Mw_c711eee4-26c4-4ae6-943f-c953fd6cc56f">1.150</ix:nonFraction>% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTItMS0xLTUxOTM1_06d6da9b-ce4a-4249-a4fe-0b1ca9019b62">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ea0c95de6e4a9b9e2536e70fefb4ab_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTQtMS0xLTUxOTM1_18c459da-8cd8-469d-988a-7b00d8d66073">972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU3NTRkY2Y3ZWZlNDliYzk1NzMxYTgzZDllMDViNjRfNA_37e3a0ae-13f9-4fcf-9bb0-12f4c5943008">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU3NTRkY2Y3ZWZlNDliYzk1NzMxYTgzZDllMDViNjRfMTY0OTI2NzQ0MTY5Nw_fa5c990a-3381-459b-9611-ea57685e6ff5">3.450</ix:nonFraction>% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTItMS0xLTUxOTM1_5aa92e05-bce2-4e84-b586-a3c0e663ace0">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21504223e65b4686844531611b0b07d5_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTQtMS0xLTUxOTM1_b8a1394e-53ad-4d52-8ccd-6fab166e36a8">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDBmMjJlZmIwOWExNGYwNjlmYTFjYTljNGQwMjI1NGZfNA_e16e93bb-2d1e-46a8-9b50-cda1333c1f38">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDBmMjJlZmIwOWExNGYwNjlmYTFjYTljNGQwMjI1NGZfMzI5ODUzNDg4MzM1OQ_f1028936-9a46-43a1-b317-9aee902221e2">3.375</ix:nonFraction>% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTItMS0xLTUxOTM1_39f4af83-c82f-491e-9b10-690a164b95af">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305adfb9c01244c5afe018e176540852_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTQtMS0xLTUxOTM1_8cca06d4-3f4c-4cdd-830e-2e7d8654a043">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTU4OTMxL3RleHRyZWdpb246Y2EzNzJkYzEwNTVmNDcxM2EwMzk5MDI5NmJmNWYzOWVfMjc0ODc3OTA2OTQ5NA_114da682-919f-4620-847e-e9106e1e5b2d">600</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTU4OTMxL3RleHRyZWdpb246Y2EzNzJkYzEwNTVmNDcxM2EwMzk5MDI5NmJmNWYzOWVfMzI5ODUzNDg4MzM5Nw_fb21fb32-59b8-4a8a-a59a-3c7e1773fa73">3.700</ix:nonFraction>% notes due May 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTItMS0xLTU4OTM4_75e85fa3-b40c-4afd-8e69-78334bb191a1">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if181822fd1384c01988e0d46a4385545_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTQtMS0xLTU4OTM4_397a6b6c-39c7-4f75-936b-fc31cc3abc46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4692ab26301b477380a51e6a6a781217_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MzE5M2IwYjMwNjQ3NGNjODg3NTEwYjNlODIyODJmNDNfNA_29286f28-5d64-4f40-8e5b-da7d046eab9d">950</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4692ab26301b477380a51e6a6a781217_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MzE5M2IwYjMwNjQ3NGNjODg3NTEwYjNlODIyODJmNDNfMzI5ODUzNDg4MzM2MQ_f89a696e-fe8b-41aa-afcc-c589fc8f6d79">2.950</ix:nonFraction>% notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4692ab26301b477380a51e6a6a781217_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTItMS0xLTUxOTM1_82175aef-ab50-495f-b37b-473df3b2aa24">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5677b8572412413b81509f643c9ef745_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTQtMS0xLTUxOTM1_322c00d4-7c89-4967-979c-b1ec810a384c">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTU4OTQ4L3RleHRyZWdpb246YWVhMTQ1YjNiNDFhNDExNmJjNWYxNzM2ZTRkNDI0Y2FfMjc0ODc3OTA2OTQ4NQ_098618bf-720b-486a-b2bb-256101f44ec4">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTU4OTQ4L3RleHRyZWdpb246YWVhMTQ1YjNiNDFhNDExNmJjNWYxNzM2ZTRkNDI0Y2FfMzI5ODUzNDg4MzM4OA_c05e6bfb-aa30-4e03-9b07-4b863e33329c">5.250</ix:nonFraction>% notes due February 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTItMS0xLTU4OTU1_6e8c1536-d875-4807-90cb-a87ef134013e">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c64464c7bc74ed6bc24597231e8ab76_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTQtMS0xLTU4OTU1_af65a515-8c47-44d9-b721-44e4ef8073c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MTg2NTdmYWY1MTdkNGY5ZGE0N2ExMDQ1Njk3NjBmNjVfNA_30e5875d-739d-4817-b5a1-497b9bc0f7bd">1,150</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MTg2NTdmYWY1MTdkNGY5ZGE0N2ExMDQ1Njk3NjBmNjVfMzI5ODUzNDg4MzM1OA_ccce6591-c354-48c1-be39-ffd865f1c138">3.850</ix:nonFraction>% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTItMS0xLTUxOTM1_b944058d-f5a1-460c-bf8b-4f3c47378f93">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i129276d6c48048318c0627db9c328f51_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTQtMS0xLTUxOTM1_26e7e22b-0029-4c2e-ba46-ea36f1f3fd2f">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDc4Njk2NjNjZWNmNDdlNGIwNmVkMGJiNDlhNWEyY2VfNA_b58289e7-e9f1-4f4d-850b-7878cbfc0f71">850</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDc4Njk2NjNjZWNmNDdlNGIwNmVkMGJiNDlhNWEyY2VfMzI5ODUzNDg4MzM2Mg_300af5c3-56d9-488c-915e-54caf6c16b74">3.875</ix:nonFraction>% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTItMS0xLTUxOTM1_88a32c4c-84af-430e-a7bb-cea5d6d44202">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512cc51902184d4c92e7d2dd8755c1ad_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTQtMS0xLTUxOTM1_1d6f355a-39a5-4476-b801-c662f1e9f80d">844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4155c0e3c9b946bea71e235628460254_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTU4OTY1L3RleHRyZWdpb246NDYyMTQyN2M1YjE1NDllMWFlYjhlMWZiNWViZTJjN2ZfMjc0ODc3OTA2OTQ3Nw_fc9266be-a7b3-4bd5-a942-ce3f91c782a6">900</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4155c0e3c9b946bea71e235628460254_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTU4OTY1L3RleHRyZWdpb246NDYyMTQyN2M1YjE1NDllMWFlYjhlMWZiNWViZTJjN2ZfMzI5ODUzNDg4MzM4Mw_2cf97778-ed18-4b36-9883-fb70e4d55cf9">4.000</ix:nonFraction>% notes due May 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4155c0e3c9b946bea71e235628460254_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTItMS0xLTU4OTcz_a34b9ee3-ebaa-4884-961a-c24e34d0e50a">849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b14d6d4df8b4cfaa24978b6086e472e_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTQtMS0xLTU4OTcz_33d6faeb-bd7a-4616-bccd-8cb82abde226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODNmMDY1NTRjMzhjNDQ3MzllMTI1MzA2ZDQ4YjVlYWNfNA_f452b6ce-4f0e-4f38-a719-c1188b01a488">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODNmMDY1NTRjMzhjNDQ3MzllMTI1MzA2ZDQ4YjVlYWNfMzI5ODUzNDg4MzM2MA_3c786027-f020-4acf-ad7c-1a929c13568e">2.875</ix:nonFraction>% notes due August 2029</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTItMS0xLTUxOTM1_55e5ff56-652c-4d3f-94df-1d86a0a68d39">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86903b7949ae4788981d28620e873889_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTQtMS0xLTUxOTM1_876ac13f-3000-426a-acec-2d089cf488a1">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTU4OTg2L3RleHRyZWdpb246MTAxM2I5MDYxM2NiNDQ2Yzk2M2I5ZTUyN2QyYzI4N2NfMjc0ODc3OTA2OTQ4NQ_f0fa19d5-9bda-4a9c-87dd-bc3f9cd22190">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTU4OTg2L3RleHRyZWdpb246MTAxM2I5MDYxM2NiNDQ2Yzk2M2I5ZTUyN2QyYzI4N2NfMzI5ODUzNDg4MzM4OA_f5f44297-c0d1-4cb4-8f2c-66194a1757f4">5.300</ix:nonFraction>% notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTItMS0xLTU4OTkz_db858a92-a083-4c6e-b38b-87eac48b27e1">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80a1eb5f9d341648fd7677e8828af62_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTQtMS0xLTU5MDAy_d5777a96-073a-4c98-a1df-7108ecf61c82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODg5ZDRkMDJkNGM5NDE2NGJiODcwYmVjMTYxYWY5MGZfNA_45e2f237-8995-41a6-914a-709664e2d106">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODg5ZDRkMDJkNGM5NDE2NGJiODcwYmVjMTYxYWY5MGZfMzI5ODUzNDg4MzM1Nw_b46ab10f-50db-4ed9-b45d-4502aa3e9475">2.000</ix:nonFraction>% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTItMS0xLTUxOTM1_26a7a22c-00b5-4d32-898f-71931559a457">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76155e2aae45448fae0e6e595a1abba1_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTQtMS0xLTUxOTM1_18918c07-707e-483e-8e39-f5e9b38a6187">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGQzODUxMzRiMmY5NDkwYWI1YTIxYWQzNmYzOWJjNjdfNA_60971582-9d41-40b5-8747-df54d611b93d">1,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGQzODUxMzRiMmY5NDkwYWI1YTIxYWQzNmYzOWJjNjdfMTY0OTI2NzQ0MTY5Mw_4d664ec5-48dc-4b45-b8ac-62ee34b90047">2.300</ix:nonFraction>% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTItMS0xLTUxOTM1_fb23bcfb-85ee-4896-8271-69d55303d951">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c7c9dc5c92d4b699d0ace37c4d35756_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTQtMS0xLTUxOTM1_f2adfb0b-29fb-4a78-8a4a-0998f611f3f3">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTU5MDMxL3RleHRyZWdpb246ZGZmZmFmOTY0NmIzNDM5MWIyZmNmZjQ5M2I3ZjVhNGVfMjc0ODc3OTA2OTQ4MA_04381cdd-92ee-4a77-b9d2-81c6389baa2f">1,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTU5MDMxL3RleHRyZWdpb246ZGZmZmFmOTY0NmIzNDM5MWIyZmNmZjQ5M2I3ZjVhNGVfMTY0OTI2NzQ0MTcxOQ_a6f50555-28bb-4bcd-8c53-09e6456221c1">4.200</ix:nonFraction>% notes due May 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTItMS0xLTU5MDE3_064045f2-1940-46c1-9565-2b7e64e95a24">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33ebc317b78463795ee17f17e4687e5_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTQtMS0xLTU5MDQw_f367e415-45f3-43fa-92d5-05ec9f283f2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if99d5f53340d46e8bd01203577453158_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTU5MDM1L3RleHRyZWdpb246OGQ1MmJkN2ViYzQ2NDIxODgxNzUwZWIzYTU3NDA4MDNfMjc0ODc3OTA2OTQ4NQ_bebf6754-d52b-47c5-9fc9-df13606a7938">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="if99d5f53340d46e8bd01203577453158_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTU5MDM1L3RleHRyZWdpb246OGQ1MmJkN2ViYzQ2NDIxODgxNzUwZWIzYTU3NDA4MDNfMTY0OTI2NzQ0MTcyNA_d22daa1f-67ac-4c8e-bc1b-2adc96616367">5.350</ix:nonFraction>% notes due February 2033</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99d5f53340d46e8bd01203577453158_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTItMS0xLTU5MDE3_8aa917c4-36ac-4c38-a8ca-9c6202f74aed">2,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38506247ccc740b692752b50a39ff3bf_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTQtMS0xLTU5MDQw_9dcb375f-c6da-4c31-aa5c-bf187e47fc69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i663d30885efc49f1b283db95c351ef37_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjY0NjAxM2YxMDE2NGI4NmE3OTQ2NDg3YmYzNzUxMzRfNA_512ea73d-5ee6-43ec-9e9c-80bfc0a8e481">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i663d30885efc49f1b283db95c351ef37_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjY0NjAxM2YxMDE2NGI4NmE3OTQ2NDg3YmYzNzUxMzRfMzI5ODUzNDg4MzM1OA_badd94bc-06fd-4edb-ba0d-4d119c11295c">4.625</ix:nonFraction>% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d30885efc49f1b283db95c351ef37_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTItMS0xLTUxOTM1_e2b07efd-bc19-4117-8a87-e83ea8340ece">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e481989fbfb4b4bae07e9cdb93241db_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTQtMS0xLTUxOTM1_70ef1052-92af-4114-8c49-2e2252dd8d2d">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjdiOTgxYmNjZmRhNGIwMDhiZWZmZjg5NDEzZDI2MzdfNA_a11eb26e-5f96-4e34-92ee-da1dce41afeb">850</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjdiOTgxYmNjZmRhNGIwMDhiZWZmZjg5NDEzZDI2MzdfMzI5ODUzNDg4MzM1OQ_c95f89dd-adb2-4862-9141-67d9820ba7cf">5.800</ix:nonFraction>% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTItMS0xLTUxOTM1_9c85e8a6-999b-49cb-88b1-d819c124c5c9">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f537d010f04ef2b408ff0b5e4a6240_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTQtMS0xLTUxOTM1_2a1630ce-f162-4ab5-b844-2a6a23d65810">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OWM5YTAxZWFlZWFkNDRiY2I3ZTExODRkNDk1YmI3OTdfNA_0551e483-b39c-4c61-87ee-73c704911873">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OWM5YTAxZWFlZWFkNDRiY2I3ZTExODRkNDk1YmI3OTdfMzI5ODUzNDg4MzM1OA_688563b9-45f5-4278-b2d8-30576330b5ed">6.500</ix:nonFraction>% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTItMS0xLTUxOTM1_97d2609d-29f9-43c7-925c-6defff196236">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d45d08ecf834726abad93ca937d8c57_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTQtMS0xLTUxOTM1_93678ce4-ecca-4f7c-b88c-5eea5ad8b294">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MWE1ZDY0NGRjODIxNDU3YjhkOTE3NTAzYmRlZmUwMzBfNA_0437a39d-6d57-428e-ae7b-cc3f825b44e9">650</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MWE1ZDY0NGRjODIxNDU3YjhkOTE3NTAzYmRlZmUwMzBfMzI5ODUzNDg4MzM2Mg_08add6b4-6fce-4ec4-90fb-62e837fb3b39">6.625</ix:nonFraction>% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTItMS0xLTUxOTM1_0469cf58-21e9-4f09-998f-e4ea3bdc493d">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950071dee1cf4f1287c79566cbab2cde_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTQtMS0xLTUxOTM1_c6b5edbc-746e-4fa7-b637-52160f77409e">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGMzYWJhNWNkYjFjNGYwOTk5ZjdmOGFiYjg2NjIwZWJfNA_bdd80a64-3844-4f4e-83be-12a57ecd1abc">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGMzYWJhNWNkYjFjNGYwOTk5ZjdmOGFiYjg2NjIwZWJfMzI5ODUzNDg4MzM2Mg_8f773cf5-1497-47f6-9ae1-93d80c53df22">6.875</ix:nonFraction>% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTItMS0xLTUxOTM1_5a8e2db2-46cf-47d8-95f5-c6d8e5f10663">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada8fff11b964f0bb11cb946276b397a_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTQtMS0xLTUxOTM1_4ab7b2dd-7f47-4f19-8bba-84165c24affb">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NGU5MWEyZWI2YzZlNDY5M2E2YTQ5ZDMzYzY5ZjYxNjFfNA_c927cbab-6b36-4c8b-9822-77b0fdb3874c">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NGU5MWEyZWI2YzZlNDY5M2E2YTQ5ZDMzYzY5ZjYxNjFfMzI5ODUzNDg4MzM2MA_b480f28e-0b70-4c65-a38c-64cbb854924e">3.500</ix:nonFraction>% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTItMS0xLTUxOTM1_074de825-c1fb-4297-b9c8-1ce9a8be900a">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472b6a573ea24ab69839d586a4f2fc76_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTQtMS0xLTUxOTM1_836c07ab-ae68-4cda-a01c-04ea038396b6">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGM5MTkwODNhNGZlNDljMzk1OTA4ZTJmNDEyOTllZDdfNA_c4e80ab2-b9c2-40a3-9cfe-a6ce4164fcf7">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGM5MTkwODNhNGZlNDljMzk1OTA4ZTJmNDEyOTllZDdfMzI5ODUzNDg4MzM1Nw_1ba2086e-6363-4623-a058-7061edadd9d9">2.750</ix:nonFraction>% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTItMS0xLTUxOTM1_895fcf0f-d507-46be-a4f7-8df5b16541fc">967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaeebd9e870e4ae4a60d0c58ad726851_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTQtMS0xLTUxOTM1_2004f76e-6d5d-4357-b26b-64d39c662d11">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OTZmMzgyZDVhZjFhNDNlMmE5ZTFiOTJjYzU4MzBhMzVfNA_e55c7860-1e12-451d-9c84-b00d0efce58e">300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OTZmMzgyZDVhZjFhNDNlMmE5ZTFiOTJjYzU4MzBhMzVfMzI5ODUzNDg4MzM2MQ_d0f234bb-7aa1-4496-bb4b-900e648e3062">5.700</ix:nonFraction>% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTItMS0xLTUxOTM1_8e992d37-3c11-447c-b731-7422ce9254ac">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9cc71855ae94636a016e4748db5e5bf_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTQtMS0xLTUxOTM1_7ed95865-ea21-436a-a71a-c1aee098db19">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGRkMTI4YmM3MGY4NDAyZmJhYjQ2ZjNjOTYwYjhjZTBfNA_c6e3f74c-491c-4f08-abbb-492aaf1d0eed">350</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGRkMTI4YmM3MGY4NDAyZmJhYjQ2ZjNjOTYwYjhjZTBfMzI5ODUzNDg4MzM2Mg_4e78bf3c-545d-4b2e-925b-105702de2295">5.950</ix:nonFraction>% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTItMS0xLTUxOTM1_63fa618d-55fd-4a9c-871c-7e9f5c88837a">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af022449e6a4052bbbe3d69f40cc5ef_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTQtMS0xLTUxOTM1_45742084-1932-45f9-9fd6-5b1c3961b35d">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if96339900834441a90061dd06cd0727f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmZlMzUzYWRmYjM1NDU5Yzk3MjJhZWZiM2RlZTlmNTFfNA_c824e452-3179-4687-84b4-13d50c607e81">1,500</ix:nonFraction> million  <ix:nonFraction unitRef="number" contextRef="if96339900834441a90061dd06cd0727f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmZlMzUzYWRmYjM1NDU5Yzk3MjJhZWZiM2RlZTlmNTFfMzI5ODUzNDg4MzM1OA_79c98417-c854-48be-b6f6-30e28df23021">3.050</ix:nonFraction>% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96339900834441a90061dd06cd0727f_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTItMS0xLTUxOTM1_062b0e1c-56c4-4794-a252-9c21e1c019f3">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0467e40cfdc04f9da3be269b79fd4132_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTQtMS0xLTUxOTM1_56199cc1-ec55-4993-bddb-9b83388005ec">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i4a60d0dd81ba41bebfaf078e4445a1fd"><div style="margin-top:6pt"><ix:continuation id="if3ccf4acee984056a4ab45f3822530e8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU1NjdhNGViODZlNGE2MGIyMWM4OTVjMjdiMzIyZWZfNA_7ebee62a-d676-469d-b28a-159eb0453983">600</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU1NjdhNGViODZlNGE2MGIyMWM4OTVjMjdiMzIyZWZfMTY0OTI2NzQ0MTY5OA_6c74a2d6-6c40-4aa6-bf7e-e1ee47bf474c">4.625</ix:nonFraction>% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTItMS0xLTUxOTM1_fbbc7328-e0b4-404d-b639-941f30dc8f87">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6ff2097150a4198a7408f57b7751209_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTQtMS0xLTUxOTM1_6c5a1234-da7b-42a0-bb66-321a67d330fc">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NTZmNzQ5OTg2MjBiNGIwMWI3OTBmZDY1YTliYTFmNDRfNA_75996dea-b2da-49e9-a617-e8897bccd2ea">502</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NTZmNzQ5OTg2MjBiNGIwMWI3OTBmZDY1YTliYTFmNDRfMTY0OTI2NzQ0MTY5NQ_0f6f12d0-e072-4d4c-96c5-7259279648d4">4.375</ix:nonFraction>% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTItMS0xLTUxOTM1_c8120461-d736-4dde-b886-852c86bd1c13">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f7e1b784e143aaa8c2fb4ee90e847b_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTQtMS0xLTUxOTM1_2d94460a-d43d-45e7-859c-83d9bfef6bb1">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzA2ZjM4ZjQyNTc5NDFkYzgzNmFlYTMxNWJjMmE1YWNfNA_d2ee322e-6efc-4cb2-ae19-1c9fc873046d">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzA2ZjM4ZjQyNTc5NDFkYzgzNmFlYTMxNWJjMmE1YWNfMTY0OTI2NzQ0MTY5Nw_9ea8e498-1bfb-4b4b-9289-c56ab0f9d8bb">3.950</ix:nonFraction>% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTItMS0xLTUxOTM1_d32add7d-c1d5-425d-9b1d-01ea06aba7b5">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ed0e3cddfb4ccd9187bd8407096c4c_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTQtMS0xLTUxOTM1_4c61921e-cadf-4121-87e7-d170edfff2c1">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjFhY2IxOGQyMzM3NDM3NjljZTkzNDIwMzdkMzI3ODRfNA_8c6cb9b8-6cbc-453b-88f8-3b41cd932324">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjFhY2IxOGQyMzM3NDM3NjljZTkzNDIwMzdkMzI3ODRfMTY0OTI2NzQ0MTY5NQ_632a5936-7164-4801-8831-1f89e69886f8">4.250</ix:nonFraction>% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTItMS0xLTUxOTM1_66f4431a-78ff-4164-a63a-218fb1e12ec5">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6269a5a11644842a3cdb93e77b08b21_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTQtMS0xLTUxOTM1_0eb1208c-86fe-4312-bf13-ad862314afdb">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZTc0MDJhMDA3YTBjNDQ1Y2E1MThmOThlMGQ4OGI0ZDZfNA_9f182f5e-32ed-47a6-b6dd-3b12effea51f">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZTc0MDJhMDA3YTBjNDQ1Y2E1MThmOThlMGQ4OGI0ZDZfMTY0OTI2NzQ0MTY5NA_819ddda3-f249-42f7-be74-6d0c4b527ffd">4.750</ix:nonFraction>% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTItMS0xLTUxOTM1_810d139d-dcbe-403e-ae41-450c64eef827">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa1bdbe5afa44219cc32a23f3330036_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTQtMS0xLTUxOTM1_1d12ac01-151f-4b94-871d-ba710e2b75ea">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmZmNDE1ZWY0MjAxNGRiMmJjN2QxZTYyMThiZmQwNjJfNA_4196d3c5-d462-4cb6-b3c6-a3c48eba0402">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmZmNDE1ZWY0MjAxNGRiMmJjN2QxZTYyMThiZmQwNjJfMTY0OTI2NzQ0MTY5Nw_e9366864-6be7-4375-a99a-ac8fd4edfcfd">4.200</ix:nonFraction>% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTItMS0xLTUxOTM1_145d8720-c145-4f09-806e-c37a27ece3e2">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96f0c553fcd40a1a3f553dd366c0f73_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTQtMS0xLTUxOTM1_0facb1e0-e3b1-4b2b-bc07-539cbe79dd26">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODQwY2U2NjlkZmVmNDEwZWFhMDAyMDM0NDc0Mjk2MWJfNA_bb6ae06b-9cbb-4471-97e0-243b2cf48428">725</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODQwY2U2NjlkZmVmNDEwZWFhMDAyMDM0NDc0Mjk2MWJfMTY0OTI2NzQ0MTY5NQ_a8bf7dbc-96cd-439c-be5d-a72bad5b5ad2">4.250</ix:nonFraction>% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTItMS0xLTUxOTM1_22923fc3-11d2-4bba-a132-8b72a74758db">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i721180c4c3834dad88660c0cb0c92351_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTQtMS0xLTUxOTM1_cf9f39b0-ce62-45f1-b5a3-eaa005be17f9">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDI2MjUzZmM3N2MxNDE3YTg2YmFkMDdkZDMzYWE5Y2ZfNA_b6457f68-02a2-44ba-8e3b-92de670f61e7">950</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDI2MjUzZmM3N2MxNDE3YTg2YmFkMDdkZDMzYWE5Y2ZfMTY0OTI2NzQ0MTY5Nw_9c79b8a3-4c22-4f6c-8517-5360657e9d54">3.750</ix:nonFraction>% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTItMS0xLTUxOTM1_d01196a4-b15c-466a-8603-febd1b99843a">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff31eaf98fc4021bcccf6be5c93a0d5_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTQtMS0xLTUxOTM1_23cda099-e02d-4c18-9352-33c11f7ab9c3">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDMxMzU1YzQ5OTA3NDMyNTk4NWVmMjNjNjdlNTRlMmNfNA_037faee6-900e-4163-b7aa-b51deb2a1e91">1,350</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDMxMzU1YzQ5OTA3NDMyNTk4NWVmMjNjNjdlNTRlMmNfMTY0OTI2NzQ0MTY5NA_e9a0ba77-8c04-4d76-82ac-d5ffb7de8582">4.250</ix:nonFraction>% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTItMS0xLTUxOTM1_83c343ab-857c-482d-8ea1-6719f1e6455c">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfbf9e7699242f79053b6b8ba023aeb_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTQtMS0xLTUxOTM1_e74bae5e-a650-4880-befa-6fbbdb62a160">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU2MDFkZDQ3YzA3NGM2OGFjZWYzYjFmZTFmNmY1NjRfNA_13fad203-c222-49fb-8679-563b891725dd">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU2MDFkZDQ3YzA3NGM2OGFjZWYzYjFmZTFmNmY1NjRfMTY0OTI2NzQ0MTY5OA_1a2680e7-6ffd-49ca-b627-463ed45ce618">4.450</ix:nonFraction>% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTItMS0xLTUxOTM1_ae0b07d5-22f2-47a6-b05a-a078fa5957f3">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if51d52d41c444e478616b97fb188f33c_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTQtMS0xLTUxOTM1_3e9567c4-1b12-4f16-8778-331fd289fa7e">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icab462ccd24d47938ac7bf5582916526_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODFmMmNjZjk1NDcwNDhjNTgxZjhlNTNiMDFjYjJlNTdfNA_b09ecfdb-f076-41e1-9a22-c8ddb996a853">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="icab462ccd24d47938ac7bf5582916526_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODFmMmNjZjk1NDcwNDhjNTgxZjhlNTNiMDFjYjJlNTdfMTY0OTI2NzQ0MTY5Ng_a89177d6-54f8-4658-b98e-55e262ae8e81">3.700</ix:nonFraction>% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab462ccd24d47938ac7bf5582916526_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTItMS0xLTUxOTM1_a1143743-2b2f-4d6c-a292-b0d2fd4b1660">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051acdfdac5443078c32017b27ef25f5_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTQtMS0xLTUxOTM1_5b08076c-993c-4d02-b82f-3254756444a1">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjViZTgwMzgxYmZhNDFiZGIwMzU2NDc4OWViNzViNjBfNA_da0d9cef-5cbb-40b7-8346-61177649ac32">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjViZTgwMzgxYmZhNDFiZGIwMzU2NDc4OWViNzViNjBfMTY0OTI2NzQ0MTY5Mw_082e309b-dad0-4fe8-8174-07e1d3330a51">2.900</ix:nonFraction>% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTItMS0xLTUxOTM1_230c9204-6c6b-4a57-81f5-5d7c4c52b623">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052454650bb34a24989f6fcdc6ad6074_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTQtMS0xLTUxOTM1_8881d0ac-624e-4532-a297-c8017ef08c66">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i435285040d2540dfad739c13df074973_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZDYxODYyMzNhYWViNGMxOWI4NjFiMmViYTFkN2MzMDNfNA_f0642a12-e077-410f-81f2-602c4d85353e">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i435285040d2540dfad739c13df074973_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZDYxODYyMzNhYWViNGMxOWI4NjFiMmViYTFkN2MzMDNfMTY0OTI2NzQ0MTY5Mw_62fbbf6b-bb03-440b-9fe9-aa9871c1d8ff">3.250</ix:nonFraction>% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435285040d2540dfad739c13df074973_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTItMS0xLTUxOTM1_0f78d39a-50a6-4ea3-9e44-883689f3b4ca">1,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1cbcf2205a4446ea4843ad64f479218_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTQtMS0xLTUxOTM1_8e134584-873b-4c56-85c9-8659c0a12f73">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTAtMS0xLTU5MDU0L3RleHRyZWdpb246NDViMDdhMmU1NWU2NDY3ZWIzZmNmN2U3NmQ2ZWRmNTBfMjc0ODc3OTA2OTQ4MA_382aeb47-954d-44a1-ab33-b9e4a36578b6">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTAtMS0xLTU5MDU0L3RleHRyZWdpb246NDViMDdhMmU1NWU2NDY3ZWIzZmNmN2U3NmQ2ZWRmNTBfMTY0OTI2NzQ0MTcxOQ_2063a9eb-6643-4d5b-b1b7-5ae7e83303df">4.750</ix:nonFraction>% notes due May 2052</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTItMS0xLTU5MDcw_23b72616-bc75-40ad-8498-c5b69beec5a3">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc19b7d8253640e1b39dcef330c1e8fd_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTQtMS0xLTU5MDcw_43c2035a-0ba1-4377-8cc1-b89260ad1b0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTAtMS0xLTU5MDYwL3RleHRyZWdpb246MTdiODJkMDhkOTI5NDBkODgwYjkxNTU4Y2VjZmM0NmZfMjc0ODc3OTA2OTQ4NA_8e4fe1ac-7c6e-450e-80f4-e7f0a58817e6">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTAtMS0xLTU5MDYwL3RleHRyZWdpb246MTdiODJkMDhkOTI5NDBkODgwYjkxNTU4Y2VjZmM0NmZfMTY0OTI2NzQ0MTcyNA_9aa3bfe8-6970-48c1-932e-1080f037d519">5.875</ix:nonFraction>% notes due February 2053</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTItMS0xLTU5MDcw_ee746243-d195-4822-96cc-e1cd43bad049">1,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice983114f0894876a852c31fe9eeaded_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTQtMS0xLTU5MDcw_539c9665-0dad-40b0-9adf-aa0ce771a52a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmM0MzAxYzE1OWI3NDUxM2ExM2U0OGZkYzI5ZDQ3MmVfNA_c5b393e6-3e1d-4f59-b84f-1e4449d1e0a8">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmM0MzAxYzE1OWI3NDUxM2ExM2U0OGZkYzI5ZDQ3MmVfMTY0OTI2NzQ0MTY5Ng_94e3cd8a-3f28-42fd-9b2b-f40a06b4c6c2">3.875</ix:nonFraction>% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTItMS0xLTUxOTM1_af82d387-2e2b-4c30-924c-a2b8de6c5196">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73b3065191a436988023a7ff6a43503_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTQtMS0xLTUxOTM1_0c003dc7-6bf8-44d6-b090-7e34767e39de">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDJlM2Q0OWQ1YWE5NDNjYjk2YWZiMDMxNzgyOGFjMjdfNA_a7f169fb-94a6-46c2-87e4-1962a30cf1c0">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDJlM2Q0OWQ1YWE5NDNjYjk2YWZiMDMxNzgyOGFjMjdfMTY0OTI2NzQ0MTY5Mw_85516d41-d2fe-4169-b193-4ba7bea0d752">3.125</ix:nonFraction>% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTItMS0xLTUxOTM1_de1b275c-7bcb-4cf6-a7dd-0ff3dca894c0">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f9496f2f4045c2b66ee552d15fa61e_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTQtMS0xLTUxOTM1_86ae341d-a263-428f-92fe-f7a78e80094a">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTAtMS0xLTU5MTI4L3RleHRyZWdpb246MmYyNjMzMDU1ZGYzNDg3Nzg1NjVjMTU0Njc1OWJkYWZfMjc0ODc3OTA2OTQ4MA_b448446b-8be2-4f49-b5e2-d1aee62799f1">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTAtMS0xLTU5MTI4L3RleHRyZWdpb246MmYyNjMzMDU1ZGYzNDg3Nzg1NjVjMTU0Njc1OWJkYWZfMTY0OTI2NzQ0MTcxOQ_4dc0d1e7-8ea1-4fc7-a234-9dcdf2e9cabc">4.950</ix:nonFraction>% notes due May 2062</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTItMS0xLTU5MTUw_5c345906-5bbb-4c5e-9d6c-8986a4a734fe">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ed6067252342b3beb9989231672adc_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTQtMS0xLTU5MTUw_e51c488e-957f-47d9-bb44-09dc2be60733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTAtMS0xLTU5MTQxL3RleHRyZWdpb246ZWVjNmM5M2Y5ZjA4NDEyODkyNDE0OTY4NWEzODEwN2VfMjc0ODc3OTA2OTQ4NQ_1af6f143-4257-429f-b35b-a6636a058c3a">1,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTAtMS0xLTU5MTQxL3RleHRyZWdpb246ZWVjNmM5M2Y5ZjA4NDEyODkyNDE0OTY4NWEzODEwN2VfMTY0OTI2NzQ0MTcyNA_8d3bdd0a-a568-44e9-a877-728c5872bf78">6.050</ix:nonFraction>% notes due February 2063</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTItMS0xLTU5MTUw_469d3890-fe1d-4b9c-a184-1e2f8f9341c3">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2eaa671ac44220bee9863ce3993ecf_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTQtMS0xLTU5MTUw_f5af7179-a2c8-468a-8e96-4a8bc77126fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTItMS0xLTUxOTM1_c0383577-5d24-4914-85f9-6f0905361f1a">56,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTQtMS0xLTUxOTM1_9982d7f8-e4db-4c04-bdde-cff9d55ea8cc">44,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt obligations also included $<ix:nonFraction unitRef="usd" contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE5Mw_b4030a30-85e0-4361-9264-5657d3c6b963">0.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzIwMA_9d354267-5549-40ff-91dc-2d396849302f">1.4</ix:nonFraction> billion of other financing obligations, of which $<ix:nonFraction unitRef="usd" contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231" decimals="-6" name="us-gaap:OtherLongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzI0NA_a8a39e04-f487-41bd-a855-9520179c0987">192</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231" decimals="-6" name="us-gaap:OtherLongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzI1MQ_cc323835-dc6c-4509-b089-c76cafd210b6">611</ix:nonFraction> million were current as of December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1ODE_4f71481b-6a0c-48ed-954e-18fbd5f26d76" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzEtMi0xLTEtNTE5MzU_1f2d5af4-9e89-4324-87cf-0bb84a7f980f">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzItMi0xLTEtNTE5MzU_92e35756-e296-4df1-832f-4402ba689171">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzMtMi0xLTEtNTE5MzU_29ddf5b0-2df2-4a68-a300-17339cabbc01">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzQtMi0xLTEtNTE5MzU_83a6dbf1-7261-4285-8942-2b5c64c38a1f">2,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzUtMi0xLTEtNTE5MzU_44d8e3dd-64b1-48e6-ad9d-97f108b9522c">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzYtMi0xLTEtNTE5MzU_0c6fd942-72d3-4655-99b9-9c6e3832abd8">43,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="i1b889aeec8304b17a5381fabcfec7d9a_I20221231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzU3Mg_54da8e69-eb67-4186-b2a1-c474f8c9a282">6.0</ix:nonFraction> billion <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMDU_6c33a52c-1144-4e22-89da-18fc6460dbfe">five</span>-year, $<ix:nonFraction unitRef="usd" contextRef="i4b90c42a12c946ec837aea2ac692cc5d_I20221231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzU4Ng_5fd99411-6bab-4e4f-a207-71cf4b9c37c8">6.0</ix:nonFraction> billion <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMjI_945de3a2-7233-4e80-9a06-96283be1135b">three</span>-year and $<ix:nonFraction unitRef="usd" contextRef="i845de76c9b49482181876168457d3339_I20221231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzYwNA_d4cadaa7-3722-4aff-8d4a-4dd15b437bbf">6.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i3fbec7cfe19d43a8adf0ec061d38e36f_D20220101-20221231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzNDM_32715365-06de-4d93-a203-f28cf8dd4c1b">364</ix:nonNumeric>-day revolving bank credit facilities with 25 banks, which mature in December 2027, December 2025 and December 2023, respectively. These facilities provide full liquidity support for the Company&#8217;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2022, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#8217;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2022, annual interest rates would have ranged from <ix:nonFraction unitRef="number" contextRef="i8eb087bedb274e389574fb540aacd661_D20220101-20221231" decimals="3" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzEyOTM_d1807cfd-5f9c-47ae-afec-7cf1e3d8b4b5">5.1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i967155a249994885831ed4f111f8cf37_D20220101-20221231" decimals="3" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzEyOTk_dd293b62-3bbf-43af-8a4f-c6e662a59a90">7.5</ix:nonFraction>%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzM0MDA_56c85904-6129-4116-b0c2-0f2c41076de3" continuedAt="i79fb452ea01c4c389cd9f88d26101ccc" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i79fb452ea01c4c389cd9f88d26101ccc" continuedAt="ica63505da6da4422b5356b31933cc535"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzg_eda5805b-620f-4a94-81de-9242c416cb3b" continuedAt="i904ea0ca06ec44788ebf5a3ee0c60f97" escape="true">The components of the provision for income taxes for the years ended December&#160;31 are as follows:</ix:nonNumeric></span><ix:continuation id="i904ea0ca06ec44788ebf5a3ee0c60f97"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:75.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItMi0xLTEtNTE5MzU_6409f33f-2509-40e4-8c4e-4cc97e968084">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItNC0xLTEtNTE5MzU_f2517050-9d60-423c-881d-997f6b321431">3,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItNi0xLTEtNTE5MzU_8ca8907e-cbc1-40f0-9570-dd393651d114">4,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtMi0xLTEtNTE5MzU_945a8307-05dc-4a85-8c59-f3169d47d185">855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtNC0xLTEtNTE5MzU_790b44fc-5bf2-4551-9161-77d0a5a99749">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtNi0xLTEtNTE5MzU_16fcc69e-5acf-4368-a344-7788eaf240ef">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtMi0xLTEtNTE5MzU_16873314-1c99-49fc-88b2-79ca92e5ef0a">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtNC0xLTEtNTE5MzU_5cef49ca-4095-4bb8-a104-a667d3ef6606">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtNi0xLTEtNTE5MzU_5459c223-0eab-4bd9-b979-f87494d57e94">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtMi0xLTEtNTE5MzU_b8057739-ad08-4312-9726-abf276bbe169">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtNC0xLTEtNTE5MzU_233c66fe-1c0d-475d-ac9b-5541a5128948">4,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtNi0xLTEtNTE5MzU_9b976601-a381-46af-82bf-7786be04f681">4,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtMi0xLTEtNTE5MzU_38af0599-1e46-4c25-9f46-53f96e20777b">673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtNC0xLTEtNTE5MzU_626d5554-b3de-45d4-8210-cab6da99c77c">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtNi0xLTEtNTE5MzU_7502939c-3aa3-4498-b73b-36ed5a962337">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctMi0xLTEtNTE5MzU_84ac5b91-d391-457c-974e-78c6ec73551f">5,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctNC0xLTEtNTE5MzU_1d2ac1e7-57da-4406-90d2-5c2fb36bb9a7">4,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctNi0xLTEtNTE5MzU_fcfa8ecf-130a-4322-b0b1-ac8f25858a5d">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzk_8956a96c-a83f-4cb9-bcf7-78d61d88fd05" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:47.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMi0xLTEtNTE5MzU_3b056348-a78f-4a10-83c5-bac5e67a47fe">5,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtNC0xLTEtNTE5MzU_30f9f66a-b8df-4620-b290-03df2d835b47">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtNi0xLTEtNTE5MzU_8a76da39-638b-4ff7-a4ab-4849e2ebfcf5">4,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtOC0xLTEtNTE5MzU_0d7d761a-e618-434f-99e1-707bdb87cbec">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMTAtMS0xLTUxOTM1_1c836022-2650-4584-931f-f6de1eafb967">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMTItMS0xLTUxOTM1_7c3e59fa-100e-4efe-aa4c-84c7db0afe9e">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMi0xLTEtNTE5MzU_5120149e-cb09-426d-84ff-079839226c67">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItNC0xLTEtNTE5MzU_f88dd4da-b0c8-40e5-b55e-015b981d0a0d">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItNi0xLTEtNTE5MzU_b98bd33e-4da6-4bce-8f51-06bc1dfbf99a">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItOC0xLTEtNTE5MzU_0caa2520-156c-431b-b619-98b43f1a56b5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMTAtMS0xLTUxOTM1_702c6c1b-c5f8-443f-8421-2d1011480731">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMTItMS0xLTUxOTM1_1c3cf8c3-c078-4f12-8779-041c20c0808b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMi0xLTEtNTE5MzU_e4d9e36f-32fb-44d1-af78-22a7002d75ab">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtNC0xLTEtNTE5MzU_d90ebddd-c269-4d29-9fe6-c6c70bb5b1b9">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtNi0xLTEtNTE5MzU_484984ca-2768-4421-8f8a-d787531714c4">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtOC0xLTEtNTE5MzU_16a453e6-0956-42f4-a6c4-c0b5931e07ea">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMTAtMS0xLTUxOTM1_86b856d6-290a-4fe4-a82e-5ffb6abae8ba">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMTItMS0xLTUxOTM1_519c9309-6373-400f-a682-f6d923b1c157">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMi0xLTEtNTE5MzU_f65676e8-2a5a-4e68-b5b8-11add98917bf">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtNC0xLTEtNTE5MzU_803db960-0fa9-4416-a4aa-6dd7fba1a483">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtNi0xLTEtNTE5MzU_0439e714-8b2c-41da-bc85-1c97e533139b">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtOC0xLTEtNTE5MzU_0559966f-9c61-44d0-a896-7a9245953c52">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMTAtMS0xLTUxOTM1_4719fdb8-6c72-4b5c-b11e-39c65530cecb">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMTItMS0xLTUxOTM1_546cd9a4-4499-4ea2-86a7-2ab744c3c727">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMi0xLTEtNTE5MzU_04bb5dd1-b1d0-4d3a-b395-e192e1ee69dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtNC0xLTEtNTE5MzU_544b7792-e497-4e88-994a-dabd5527a00d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtNi0xLTEtNTE5MzU_60ae6c7a-1a26-4f3c-a4c8-9135fc6f1b3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtOC0xLTEtNTE5MzU_0f32643b-d06e-4dfa-9d23-afd8d532f556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMTAtMS0xLTUxOTM1_89cd01a6-4343-4606-b9af-7b1616c46489">626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMTItMS0xLTUxOTM1_46da3248-cd24-4ac6-9e6e-25a2e165dc19">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMi0xLTEtNTE5MzU_079a1064-bf87-49ac-993c-335f0220dc33">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtNC0xLTEtNTE5MzU_93cad0fd-978c-482e-ab32-b7847c9d64ea">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtNi0xLTEtNTE5MzU_4d1faa24-aee1-42b4-a52a-f98bf38907ab">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtOC0xLTEtNTE5MzU_0599e90c-ddad-4e21-9954-c429ad47d109">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMTAtMS0xLTUxOTM1_175217a6-94ce-4eb8-b37d-44d40830d046">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMTItMS0xLTUxOTM1_758c63bf-5fe7-4001-84b8-99666b99420e">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMi0xLTEtNTE5MzU_e9c9b6ab-df19-4af9-b9d0-6085aa6b3148">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctNC0xLTEtNTE5MzU_820f2573-6139-4b20-9f2c-ce5742efbe8a">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctNi0xLTEtNTE5MzU_b217102a-e79c-44b4-be59-7e43a896af95">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctOC0xLTEtNTE5MzU_03b30b90-4677-4fd3-9b86-8c42b131ab95">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMTAtMS0xLTUxOTM1_327020e6-c9d4-4589-b083-aa286806fa9e">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMTItMS0xLTUxOTM1_f67563f1-5886-413d-aaa5-0cef980352e5">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMi0xLTEtNTE5MzU_aec365e6-dbf4-480a-a574-2d0ef62cd9fe">5,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtNC0xLTEtNTE5MzU_b58a1dc4-7aa9-4626-bc89-bfbf47edf3c2">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtNi0xLTEtNTE5MzU_a7d1c245-f101-47b1-8863-0f7c003ceaba">4,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtOC0xLTEtNTE5MzU_87074e59-eead-4d25-aeaa-59818d294be8">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMTAtMS0xLTUxOTM1_1811b6d7-ce33-4461-af30-703931541e97">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMTItMS0xLTUxOTM1_ee93aa4d-ecef-4568-918e-efcb15dbe014">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="ica63505da6da4422b5356b31933cc535" continuedAt="i56371c08a46545339cb217ce78ca420c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. <ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzOTY_15bf3689-81f5-42e6-8768-65e9212a0034" continuedAt="i8054fddc4d1c4b2eb0b413bac6eb82ea" escape="true">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:</ix:nonNumeric></span><ix:continuation id="i8054fddc4d1c4b2eb0b413bac6eb82ea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzItMi0xLTEtNTE5MzU_012e687a-e0e5-42e7-a7c3-1ddc5b962d44">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzItNC0xLTEtNTE5MzU_529e87b9-89ae-4bdb-957e-66cd40132daf">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzMtMi0xLTEtNTE5MzU_981683d1-c057-4007-8a31-ecc426c9d7e5">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzMtNC0xLTEtNTE5MzU_7ea6537a-962f-45fc-9a88-d86d1a790347">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzQtMi0xLTEtNTE5MzU_1bfc9ff7-c7ef-4ed3-a9cc-f24d8ad3e358">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzQtNC0xLTEtNTE5MzU_e5e9ad11-da02-4c9c-a651-22754cb14934">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzUtMi0xLTEtNTE5MzU_a8d35169-6e17-47a0-a5c1-f82757dd59c7">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzUtNC0xLTEtNTE5MzU_0e795eda-def6-4dd0-be64-31004f437f5d">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzYtMi0xLTEtNTE5MzU_b0ea3f4e-0dae-4b85-8146-a3c3f3a3af9b">631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzYtNC0xLTEtNTE5MzU_3f1983f1-a7b5-437a-9cd6-ee6288bc2904">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxAssetsLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzctMi0xLTEtNTE5MzU_e79248ca-2687-4b74-8193-9ce626e8f73d">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxAssetsLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzctNC0xLTEtNTE5MzU_2fbd8145-5290-4575-83d3-d142ff2fbc7d">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Net unrealized losses on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtMi0xLTEtNTk3MDc_e1bab5b7-802e-473b-a5f0-d7de7e2bdb7f">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtNC0xLTEtNTk3MDc_98aa30f3-e49f-4c2b-a331-9776f3a28a83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxAssetOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtMi0xLTEtNTE5MzU_38c04ade-9b82-4565-83cf-9e3e7c93b90d">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxAssetOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtNC0xLTEtNTE5MzU_b87e5576-4733-4c33-820e-a53f5a324661">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxAssetOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzktMi0xLTEtNTE5MzU_637d821d-72c8-4fff-8e78-1f1d7e9f138c">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxAssetOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzktNC0xLTEtNTE5MzU_50e98110-88bd-47d9-8d98-f2dfd72a2f21">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEwLTItMS0xLTUxOTM1_60c29908-24f1-476c-87b6-b3a08ef007a9">4,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEwLTQtMS0xLTUxOTM1_a60ad6b3-465f-493c-896f-24b5ec6f73cd">3,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzExLTItMS0xLTUxOTM1_7837d86d-4ee9-43ea-a5bf-14645cc56990">291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzExLTQtMS0xLTUxOTM1_2905866b-389a-4cb2-b774-620ed10550a1">198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEyLTItMS0xLTUxOTM1_d0de641a-8b0e-4939-99aa-f04a7b2fd37c">4,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEyLTQtMS0xLTUxOTM1_edc119ea-37c6-4fe1-b0a7-2031f84e7915">3,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE0LTItMS0xLTUxOTM1_d44b3d21-4380-4c46-9108-6f4e0c67eee2">3,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE0LTQtMS0xLTUxOTM1_09c463ca-fe2d-4c9f-b7bd-f6c8f03bbfa2">2,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE1LTItMS0xLTUxOTM1_e7d37eb1-d879-43df-8e26-4e53b9d7a398">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE1LTQtMS0xLTUxOTM1_72df2548-cbad-4dcb-993a-a27e92d9cae4">512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE2LTItMS0xLTUxOTM1_408a6436-2b76-4f81-b64e-58de09bf375f">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE2LTQtMS0xLTUxOTM1_12844cbf-78b5-444e-9868-44bc36885fc1">833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE3LTItMS0xLTUxOTM1_897db44c-ea53-4d90-bef9-07f45f5855e0">520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE3LTQtMS0xLTUxOTM1_6b64cdd3-3051-40b2-a937-a5af47dd05ef">349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE4LTItMS0xLTUxOTM1_a2193f58-1fb9-41f8-901b-23cc11794c04">275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE4LTQtMS0xLTUxOTM1_e2d8c2cb-b044-44cf-83b1-50861ef8e333">256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE5LTItMS0xLTUxOTM1_eeb284cf-1567-409b-87f5-e1e15136f2a2">653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE5LTQtMS0xLTUxOTM1_7fc410f9-164b-4998-8038-4b2ca3e18164">565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIwLTItMS0xLTUxOTM1_2e4e3c58-a9a8-4893-867a-4b6910ffd3e8">958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIwLTQtMS0xLTUxOTM1_559bd7e0-98aa-411b-97fb-f30716ccc794">1,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxLiabilityOtherDomestic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIxLTItMS0xLTUxOTM1_a5321969-534a-47ce-903a-21989b381a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxLiabilityOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIxLTQtMS0xLTUxOTM1_90f71bdb-3a96-4b47-90ac-13a73fa4c49a">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="unh:DeferredTaxLiabilityOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIyLTItMS0xLTUxOTM1_0425cac8-fcd3-4707-965a-b1a853015ae0">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="unh:DeferredTaxLiabilityOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIyLTQtMS0xLTUxOTM1_c82ff1f8-15f3-45d1-ae72-93398c830cfc">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIzLTItMS0xLTUxOTM1_10296831-57b4-43fa-b527-474bfc9f8033">7,366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIzLTQtMS0xLTUxOTM1_37421117-e07e-464c-8bd9-d0e18645a4c1">6,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzI0LTItMS0xLTUxOTM1_d588c533-8684-4447-b9a1-67a58d9e43b1">2,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzI0LTQtMS0xLTUxOTM1_ef988cf9-62e5-4ee4-b4d3-907bf276fc6a">3,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i1da65d71f0dd4e81aa84de4084ebc16a_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzEzMDA_d2fe5966-ecee-4793-96b7-4b38265adbe9">490</ix:nonFraction> million expire beginning in 2023 through 2037 and $<ix:nonFraction unitRef="usd" contextRef="if899e2bbae2a4cdcaba077976895f315_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzEzNDU_fa16c2a4-9295-4761-aeb4-9c11f34f76b9">611</ix:nonFraction> million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2023 through 2042, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company&#8217;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i56371c08a46545339cb217ce78ca420c"><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzc_c3e38837-c3b9-4962-83b8-bd2a99f51580" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:71.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtMi0xLTEtNTE5MzU_7d8613b7-41de-432d-8569-4a11b56081e8">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtNC0xLTEtNTE5MzU_fb7c1bbe-6cf9-48b8-bd6e-839b97f37b14">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtNi0xLTEtNTE5MzU_ca4004c5-67b8-498b-b504-7a965da9f507">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtMi0xLTEtNTE5MzU_d556508a-bd90-4460-8d0a-6079622a3a40">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtNC0xLTEtNTE5MzU_243e420d-def5-42ff-8ee3-68902d039298">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtNi0xLTEtNTE5MzU_071efbf0-f99d-435e-b377-ffb335f881ff">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtMi0xLTEtNTE5MzU_20d7e328-bf34-47c2-a528-aca145ca4fa4">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtNC0xLTEtNTE5MzU_11b3da8f-6a98-464f-b64a-4af3996f2b1d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtNi0xLTEtNTE5MzU_a0d8414e-cb70-4445-853f-316802beb089">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtMi0xLTEtNTE5MzU_c5eef640-3dd0-47da-b1c7-29fa4b0c0e84">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtNC0xLTEtNTE5MzU_947be618-7b0a-44eb-aa9b-9d78afeb1422">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtNi0xLTEtNTE5MzU_2f37442b-0e87-4b46-aeb2-ac07d7e4a174">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtMi0xLTEtNTE5MzU_a4759f54-359f-44bd-94c8-a4f131f02aff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtNC0xLTEtNTE5MzU_3f1df1c8-8773-4dfc-87a3-cc08acf7ff3c">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtNi0xLTEtNTE5MzU_e929a464-89d8-4297-92a2-560150ccd2e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktMi0xLTEtNTE5MzU_a2c4f2ac-d08a-423e-a774-fe19789a38f2">3,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktNC0xLTEtNTE5MzU_cb0bfb6d-5ee9-4103-a60c-31f26a15a3c4">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktNi0xLTEtNTE5MzU_1acb0782-a9f2-4a18-818d-bc5319ad8d02">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzIxMzA_953ac070-358a-4f7d-9e45-90ebba92b489">260</ix:nonFraction> million as a result of audit settlements and the expiration of statutes of limitations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0Mzc_8079ce31-cf4a-428f-abd2-f293fb1e238c">64</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0NDE_30b62149-91fb-40ba-9ca1-7bac8ea0b9ad">66</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0NDg_6859362c-9aa6-45ba-9b4b-e0cab1ed5594">52</ix:nonFraction> million of net interest and penalties, respectively. The Company had $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI1MTI_21d3e0b1-5bf2-4448-879f-6c7fd64c0699">253</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI1MTk_9fe18520-aa3f-474b-b28d-17f4111e9109">194</ix:nonFraction> million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2022 and 2021, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI2OTY_7516e5e8-ca78-44dd-a368-3b14e393464b">1.7</ix:nonFraction> billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#8217;s <ix:nonNumeric contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMwNjA_508c77c5-15ac-40b4-b08f-f0f87e96e2e2">2017</ix:nonNumeric> through <ix:nonNumeric contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMwNzE_cd69f7b9-195a-4b13-8c92-1e83e7e46879">2020</ix:nonNumeric> tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the <ix:nonNumeric contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMyNjE_7847cd2c-e2e9-414e-8a19-4d94ce360902">2014</ix:nonNumeric> tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years <ix:nonNumeric contextRef="i10213ff0021745a28cd943688e293bc1_D20220101-20221231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNjA_06e8d468-fd91-440a-8482-fb4766bc21f8">2015</ix:nonNumeric> and forward.</span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_196"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0MjE_5de072b2-f8b2-4357-893b-7f18b2533f34" continuedAt="iad412ebd217341bfb1792250fc0cf7c4" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="iad412ebd217341bfb1792250fc0cf7c4" continuedAt="i2a6c4899530049499fc7be56a0aed123"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s regulated insurance and HMO subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the NAIC. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#8217;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#8220;ordinary dividends&#8221; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#8220;extraordinary dividend&#8221; and must receive prior regulatory approval. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE0MzI_517715e5-37fd-47ae-a9d0-ccdfa7cc7181">8.8</ix:nonFraction> billion, including $<ix:nonFraction unitRef="usd" contextRef="i6047cb915ab94ef08b29f7f33d60fce9_D20220101-20221231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE0NDY_6b9fecf6-88ef-4fba-8df4-4e0760f1843c">7.4</ix:nonFraction> billion of extraordinary dividends. For the year ended December&#160;31, 2021, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE1OTU_2af5aedf-9208-4313-9928-07c609bf8ba1">8.0</ix:nonFraction> billion, including $<ix:nonFraction unitRef="usd" contextRef="i7c30621aa864465bb27533b234d6d21f_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE2MDk_37ddc447-d94a-4978-a46e-a306d2f45ecf">4.7</ix:nonFraction> billion of extraordinary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE3NTM_3dd81fb3-4805-4bd6-964d-0dbdd8805460">33.8</ix:nonFraction> billion as of December&#160;31, 2022. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE5MzI_2713fd21-56bf-4e33-bede-69c7d64c706f">15.4</ix:nonFraction> billion as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank must meet minimum capital requirements of the FDIC under the capital adequacy rules to which it is subject. At December&#160;31, 2022, the Company believes Optum Bank met the FDIC requirements to be considered &#8220;Well Capitalized.&#8221;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i2a6c4899530049499fc7be56a0aed123"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its Board of Directors&#8217; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#8217;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain restrictions. In June 2018, the Board of Directors renewed the Company&#8217;s share repurchase program with an authorization to repurchase up to <ix:nonFraction unitRef="shares" contextRef="i725ab79c24d84374a71ef19f38657b54_I20180601" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzI4NjA_c2213320-29bf-415a-9768-c96ed97d923e">100</ix:nonFraction> million shares of its common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0MjM_9b54b438-cc69-4bc3-887b-4f866342f6d8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzItNC0xLTEtNTE5MzU_89d4c2d7-ae61-451b-99a0-f89831519099">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzItNi0xLTEtNTE5MzU_a1e2ea33-62c1-4ac6-bd54-f0bb6ea1392c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzMtNC0xLTEtNTE5MzU_524c05a2-e4f9-44eb-9522-f2aee4d9248c">501.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzMtNi0xLTEtNTE5MzU_cfcdc272-cc40-4220-86ea-edd63cd237d4">389.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzQtNC0xLTEtNTE5MzU_183b71b1-995b-42f5-8912-a145a5807b9b">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzQtNi0xLTEtNTE5MzU_c61d165a-df67-4829-b04c-5055d038e04d">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzUtNC0xLTEtNTE5MzU_57b314a7-e6b8-469c-b49c-d5b05cdc7e47">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="INF" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzUtNi0xLTEtNTE5MzU_8f4bc3f7-db73-46f6-b970-cf581ed3951d">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share, which the Company had paid since June 2021. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><div style="margin-top:9pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0Mzg_b51856e8-51f4-441b-9c3d-a3c4bc3782e3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2022 dividend payments:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzItMi0xLTEtNTE5MzU_456cc796-a75b-473a-8ad3-7c9047e7c542">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzItNC0xLTEtNTE5MzU_78291d3d-7d02-404e-a81c-bc3e23e62013">1,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzMtMi0xLTEtNTE5MzU_854f10e8-98ef-4aba-9fc4-c74f1e749f4f">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzMtNC0xLTEtNTE5MzU_5430380e-7b2a-4b15-91ca-0562ed1b9a33">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzQtMi0xLTEtNTE5MzU_11c7dda8-5f6f-4e31-b2ff-937df788305c">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzQtNC0xLTEtNTE5MzU_807b4988-51bd-477c-88ee-3fbd16be3ae5">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab961e9490f040f8918f115ab2c74510_D20221213-20221213" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzUtMi0xLTEtNTE5MzU_14084934-d40b-4b25-9fc9-6a45bb725252">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab961e9490f040f8918f115ab2c74510_D20221213-20221213" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzUtNC0xLTEtNTE5MzU_46fadce5-0cde-4fd7-997c-84c55db84c17">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_202"></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNTQ_39c4902e-8109-452c-bddb-ecdc9ebcb184" continuedAt="ic98f3e1c1220494297990a3ce4959d81" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="ic98f3e1c1220494297990a3ce4959d81" continuedAt="ieca61dbd714c4ce1a348f8b9b1e560bd"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2022, the Company had <ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzE3NA_532853e2-4c97-404b-a9b3-17dc292d7527">59</ix:nonFraction> million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. As of December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i5a9c77c9d2b940b8b4fb2feac66444f5_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzM3OQ_cdadab9d-7ff8-4a59-b960-6c34b88baa16">18</ix:nonFraction>&#160;million shares of common stock available for issuance under the ESPP. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNzk_1efcf76b-a2b7-43dd-b08e-5e1c83cd8bac" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzItMS0xLTEtNTE5MzU_a8ad653b-2dd8-4409-97c0-15bab4484572">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzItMy0xLTEtNTE5MzU_fd30e70b-86ef-4c47-a20b-dac811500385">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzMtMS0xLTEtNTE5MzU_854bd3ca-0521-49e7-9ebf-7897c9e94fdf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzMtMy0xLTEtNTE5MzU_1fb89f33-43fc-432b-9aaf-78dac95ab20a">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzQtMS0xLTEtNTE5MzU_489d84bf-089d-4267-b38b-46cf5c2a525a">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzQtMy0xLTEtNTE5MzU_4ba17797-b82c-4d33-a9e6-b293e1344e5f">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzUtMS0xLTEtNTE5MzU_59603094-874b-4cf1-9d39-f4b222fba8c1">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzUtMy0xLTEtNTE5MzU_12f2c787-1fe3-4393-83dd-09d144618fb1">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtMS0xLTEtNTE5MzU_f2f9edc2-3e4f-436e-9ef4-b3d200bde893">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtMy0xLTEtNTE5MzU_6154c365-7eb7-4f1f-80ec-5c226d6c01bf">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtNy0xLTEtNTE5MzU_bf6a0b84-08fc-482a-ab00-a8144a4492af">5,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctMS0xLTEtNTE5MzU_d693e0dd-62c8-425d-b4ca-decff2cca803">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctMy0xLTEtNTE5MzU_73eecb86-f000-44d3-87ad-0516ed8548ee">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctNy0xLTEtNTE5MzU_18109026-576e-4e8b-ac7b-7f13c9b677e1">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtMS0xLTEtNTE5MzU_740821ca-7668-4911-ad2e-f88621b0a028">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtMy0xLTEtNTE5MzU_74d6373d-8162-4d5d-9ad7-b8d2784f8279">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtNy0xLTEtNTE5MzU_55347001-da2f-45a3-b1c4-7c3828abd04c">5,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="ieca61dbd714c4ce1a348f8b9b1e560bd" continuedAt="i29472b32342d4a8289959c65d9d2292f"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Shares</span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNDg_def339d9-1db0-4a2d-b9bd-5e1b7525146a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.446%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cab9cb169cd4921a81a836726f5c3e9_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzEtMi0xLTEtNTE5MzU_7f13c148-3648-42c6-8a31-1a3cb7540c31">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cab9cb169cd4921a81a836726f5c3e9_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzEtNC0xLTEtNTE5MzU_a8df50cc-9626-492d-b044-d22a6c1febef">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzItMi0xLTEtNTE5MzU_07cac772-6242-4576-8ab0-df90c5dc3aca">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzItNC0xLTEtNTE5MzU_6be32d88-dc74-456d-a3a2-be71cba2c3f8">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzMtMi0xLTEtNTE5MzU_cdfbc64b-4454-4114-a7b8-725cc6baee60">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzMtNC0xLTEtNTE5MzU_3d954e48-4ebe-4468-b46a-ad32b63426b7">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzQtMi0xLTEtNTE5MzU_fa187cc9-5caf-4bf7-820c-e6723c4b3cc0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzQtNC0xLTEtNTE5MzU_bb7ec6ce-732e-4a06-b067-d38fdcc143ed">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxODA_1b2c71e8-2064-4140-9838-0d45c29cb9ab" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtMi0xLTEtNTE5MzU_f59aa0ff-e39d-430b-befd-a6bccddb48d1">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtNC0xLTEtNTE5MzU_8aeda680-925f-4d68-8252-4914d5733ae6">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtNi0xLTEtNTE5MzU_e6828db7-f269-4337-924c-7580fa85652b">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtMi0xLTEtNTE5MzU_6f3fa73c-0a28-4a89-a6a6-3d94e9ded9b6">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtNC0xLTEtNTE5MzU_9c697f6b-8913-4dbe-bc78-3df1868ff4dc">1,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtNi0xLTEtNTE5MzU_d25928f7-e135-48a0-936d-e63d39aed0a4">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id58b7079211c4824b326bc35e2a79767_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtMi0xLTEtNTE5MzU_3c236cdb-6510-46f6-988c-c824f351645e">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i377663e135b146dbb9746caf29f61b57_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtNC0xLTEtNTE5MzU_811573ef-b362-4c7f-97c8-6b78e1f0f324">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtNi0xLTEtNTE5MzU_6518f63a-73e7-4d09-96a8-f3a757a34853">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id58b7079211c4824b326bc35e2a79767_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctMi0xLTEtNTE5MzU_f0291ddc-c8af-469b-80fa-1642be05c213">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377663e135b146dbb9746caf29f61b57_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctNC0xLTEtNTE5MzU_07caaaa6-7cdb-4616-9243-deca53c49f92">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctNi0xLTEtNTE5MzU_486a5333-ae18-4cf5-9fbb-8c116af7e304">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktMi0xLTEtNTE5MzU_b0f569eb-31bd-4a6c-b90a-1e6a3e0480f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc90f35441624e0781cac8a40b7b7e81_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktNC0xLTEtNTE5MzU_498ccb92-42c1-4bd7-8c0c-ba7b6b6396e6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42347a2d22d847debe1ed99a8365998d_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktNi0xLTEtNTE5MzU_fdf36365-792d-42e1-9c25-ed7544c39ab8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTItMS0xLTUxOTM1_44f74d4b-ea22-4dd3-8cd3-89108c610d8b">925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTQtMS0xLTUxOTM1_f374f1db-b21c-49cf-907c-e06809840654">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTYtMS0xLTUxOTM1_7a02dbb4-5b25-4291-989f-1e0c481b114c">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTItMS0xLTUxOTM1_04bb86d7-748f-4ba9-a666-e8c05c6c92ac">836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTQtMS0xLTUxOTM1_5a435ee4-ec46-4de9-8e59-bf5d3eaafa35">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTYtMS0xLTUxOTM1_34aae59f-0ee5-48ac-86db-56b74764d947">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTItMS0xLTUxOTM1_cfda2b91-8129-41c4-8eab-bf4720acc7cf">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTQtMS0xLTUxOTM1_42eea138-bfcf-4765-9fe0-1bb0ef94d747">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTYtMS0xLTUxOTM1_28c04fe8-c806-4730-90fa-65f9544d8523">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTphNDVmNTBkOTQ3MGI0YTA5YjgzMjQwMGQwMzY2ZTMyNy90YWJsZXJhbmdlOmE0NWY1MGQ5NDcwYjRhMDliODMyNDAwZDAzNjZlMzI3XzEtMi0xLTEtNTE5MzU_9117be9a-01c5-4502-beae-860699c6158b">1,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Recognition and Estimates</span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNzA_8cccc953-0a95-4344-a6f6-b84998da00ae" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9% - 4.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6% -30.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="3" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtMi0xLTEtNTE5MzU_96af3b84-0329-4c6c-9e8c-07fbd77e9033">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="3" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtNC0xLTEtNTE5MzU_835b0e65-877d-431a-9028-344e87996095">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="INF" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtNi0xLTEtNTE5MzU_a38db8ca-1bad-4615-bb43-fde027ce8580">5.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#8217;s common stock and the implied volatility from exchange-traded options on the Company&#8217;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.</span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i29472b32342d4a8289959c65d9d2292f"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Employee Benefit Plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIwOTM_07c15353-03c4-445f-8587-853f345ee198">1.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxMDA_8bd6ffa9-797f-4de4-8d1c-ba1d67badb11">1.8</ix:nonFraction> billion as of December&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_208"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU1MTc_9b2f2c73-c692-4ea1-b2e1-6336c811a124" continuedAt="i29decc26f4ba40d3867493edbb671021" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i29decc26f4ba40d3867493edbb671021" continuedAt="i7c60abd8e2eb439caa7f1d605e3510f9"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs, including immaterial variable and short-term lease costs, were $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzcz_b9e03d46-cbef-459e-8ad4-0ab1058ce2fe">1.3</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzc3_502811b2-bb1b-40b8-9d42-afc075577409">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzg0_4a259e2f-6574-4941-8ff7-dfb3b8cbe04d">1.1</ix:nonFraction> billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Cash payments made on the Company&#8217;s operating lease liabilities were $<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMyMg_27a74c93-cf88-4122-bb99-791fb04f9e3a">996</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMyNg_7c8e8420-6da7-4050-9e00-5b9586493aa6">921</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMzMw_fe3a90a6-09a2-4c4b-abe0-be72d0a29f0b">865</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2022, the Company&#8217;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were <ix:nonNumeric contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzYxMg_3a7204e8-6c62-4c31-a498-32b227f08c7e">8.6</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzYxOQ_c1b7e37f-6117-48a3-a2b9-b7a6822efacf">3.4</ix:nonFraction>%, respectively.</span></div><div style="margin-top:9pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU1MDY_d38830be-cdaa-49b7-b207-46d7047b9a25" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzEtMi0xLTEtNTE5MzU_dd457a1c-a0e9-434e-8f05-8a329be55f61">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzItMi0xLTEtNTE5MzU_99504ca4-7aad-46d4-bfb6-06b033a0e826">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzMtMi0xLTEtNTE5MzU_e447f4a4-e1d8-4207-9056-836e4910188b">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzQtMi0xLTEtNTE5MzU_f14f3acf-f63a-457a-aec6-5bac69227250">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzUtMi0xLTEtNTE5MzU_a632bc16-8159-4f6c-b702-ecfc3c7f6940">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzYtMi0xLTEtNTE5MzU_671dca26-d60a-4270-81ee-2ee1c730c321">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzctMi0xLTEtNTE5MzU_e0115685-39ec-4acd-89f4-ee25ee366407">5,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzgtMi0xLTEtNTE5MzU_92f8875d-91d5-46f3-ab54-5a472072b8db">808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzktMi0xLTEtNTE5MzU_8c50359d-03ac-4244-a547-5530bafaaf7f">4,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:OtherCommitmentsDescription" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzE2NDkyNjc0NDg2NjA_4c64bd71-2ae8-40ce-9959-5f890991c4d8">As of December&#160;31, 2022, the Company has entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions.</ix:nonNumeric> The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $<ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-9" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzE4Njc_e6616d12-8ad4-46cf-9b2c-2cdfd1fa7fe7">9</ix:nonFraction>&#160;billion. <ix:nonNumeric contextRef="ibccf866bd05a4a2896a41120665646f8_D20230222-20230222" name="us-gaap:SubsequentEventDescription" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU0OTc1NTgyMDk3NQ_007ba79c-4add-4aff-b251-97dc7b661d52">The Company completed the acquisition of LHC Group, Inc. on February 22, 2023.</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#8217;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i7c60abd8e2eb439caa7f1d605e3510f9"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Investigations, Audits and Reviews</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, Consumer Financial Protection Bureau, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#8217;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#8217;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#8217;s health plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#8217;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#8217;s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company&#8217;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#8217;s motion for partial summary judgment and dismissed the Company&#8217;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.</span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_2699"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYw_aa6dc827-30f7-415e-85a4-768ce54b5e28" continuedAt="i0b1692815d124425a504f7c203a18b06" escape="true">Business Combinations</ix:nonNumeric></span></div><ix:continuation id="i0b1692815d124425a504f7c203a18b06" continuedAt="i73aa67d9096f46fca69e0c0cc289421a"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2022, the Company acquired all of the outstanding common shares of Change Healthcare Inc. (Change) and funded Change&#8217;s payoff of its outstanding debt and credit facility for a total of $<ix:nonFraction unitRef="usd" contextRef="ibf85f3e8a0654801b32e765fe9e7b3c6_D20221003-20221003" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTU3_bd79a0ba-5007-42db-b176-a56882e5baa7">13.9</ix:nonFraction> billion in cash. The combination of the Company and Change will connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients. Change brings key technologies, connections and advanced clinical decision, administrative and financial support capabilities, enabling better workflow and transactional connectivity across the health care system.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing and as planned, the Company sold Change&#8217;s claims editing business to an affiliate of investment funds of TPG Inc. for $<ix:nonFraction unitRef="usd" contextRef="i484b05acf027495b8f4198fab7c44136_D20220101-20221231" decimals="-8" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTcz_00747611-532d-4266-9c9a-914f393e8026">2.2</ix:nonFraction> billion in cash. The net assets and net liabilities associated with this sale were classified as held-for-sale at the time of acquisition. There was no gain or loss associated with this transaction.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company completed several other business combinations for total consideration of $<ix:nonFraction unitRef="usd" contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTg5_dbc7f690-69f4-4760-84f2-955ac7c8ebfd">8.8</ix:nonFraction> billion. The Company also sold other businesses for $<ix:nonFraction unitRef="usd" contextRef="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231" decimals="-8" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MjA1_e359e8b6-e002-4786-9e45-033e8fa6538c">1.2</ix:nonFraction> billion of cash, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231" decimals="-8" name="unh:CarryingValueOfDisposition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5Mjkx_4a2eb3d7-8911-4bba-93d6-184126680c28">600</ix:nonFraction> million, and the difference reflected in the Consolidated Statement of Operations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><ix:continuation id="i73aa67d9096f46fca69e0c0cc289421a"><div style="margin-bottom:9pt;margin-top:9pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYx_a077bf0f-972f-4574-a056-54c4eb27ef27" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired assets (liabilities) at acquisition date were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTItMS0xLTU0NzMw_fcb75f7a-cbbd-4625-822c-909dbe4cb290">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTItMS0xLTU0NTk5_a4c75740-a4cc-4cdb-b857-50606eb32c03">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTYtMS0xLTU0NzMw_544ca60e-5a51-4d34-abc7-d9a6f67e9baf">745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTItMS0xLTU0NzMw_5980089a-47cb-448c-b37b-1935a366f745">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTItMS0xLTU0NTk5_2aa63d9e-4645-4182-bd1b-537e00d55346">696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTYtMS0xLTU0NzMw_79eb76b1-715d-4122-8401-39de8b6bb748">1,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTItMS0xLTU0NzMw_53c94e68-fb4e-480f-a6b4-8194d39f446b">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTQtMS0xLTU0NzMw_15d30bc3-8adc-4fc0-a5cd-1f9cb4203e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTYtMS0xLTU0NzMw_f25e79b5-9b2f-413a-bb9c-22267d4107ef">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTItMS0xLTU0NzMw_6730284b-5e39-44ea-8ca5-2a6285d90221">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTItMS0xLTU0NTk5_c7ce9afc-067a-4298-911a-ee5be973eb00">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTYtMS0xLTU0NzMw_fb1774e5-b26a-4cf0-899b-6e78fc541a00">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTItMS0xLTU0NzMw_f66df2a4-5835-4170-9135-b354803ce488">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTItMS0xLTU0NTk5_ff427ad9-b8b4-486d-acf4-705f0ef25a50">1,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTYtMS0xLTU0NzMw_af6d30fc-7cdf-4d8c-9193-b23c805ea230">5,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTItMS0xLTU0NzMw_b65cd019-cce1-42c8-95f4-aefa928dc7c9">7,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTItMS0xLTU0NTk5_fcad761a-ca4a-4a99-97f7-20dcaa33e876">4,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTYtMS0xLTU0NzMw_d64f537e-0bb1-4ad0-bd8f-743aa5e53c89">12,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTItMS0xLTU0NzMw_7dee6b54-df98-4c9b-927a-718d27517410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTItMS0xLTU0NTk5_1e3ee618-48a0-42a0-9e1c-6a6babff413c">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTYtMS0xLTU0NzMw_db468658-37e6-4e22-9903-7f0d570d215e">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTItMS0xLTU0NzMw_c5af988b-ecf8-4777-b07c-858f08ab1776">1,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTItMS0xLTU0NTk5_f996b4bb-d789-4f72-83fe-696d453478b2">843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTYtMS0xLTU0NzMw_bf2ddd10-010e-413d-bd57-9181a440e845">1,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTItMS0xLTU0NzMw_0be12049-cc8c-49f0-b86a-927794e716fa">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTQtMS0xLTU0NzMw_62cdf9e4-3afa-4d69-9f32-f955a9858e31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTYtMS0xLTU0NzMw_a786b0bb-dc68-4a27-8f29-7f358b474b46">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC0yLTEtMS01NDczMA_a127f914-acf0-41de-bbc1-86714b8c771e">1,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTItMS0xLTU0NTk5_473ee1c7-da03-4791-8297-5f9f2be6bbb9">713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC02LTEtMS01NDczMA_a63baa2e-d0cb-4d0f-b8c4-e8f679fed5cf">1,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable liabilities acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS0yLTEtMS01NDczMA_df35af77-4785-4500-a201-a142220e6550">2,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTItMS0xLTU0NTk5_2581e394-32f0-42ec-9355-c13b731c6d9b">1,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS02LTEtMS01NDczMA_301af435-6251-47eb-9fe6-678007c7a6e9">4,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net identifiable assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi0yLTEtMS01NDczMA_fc7edaf8-a8b9-4aa2-82d4-0010d55b9929">5,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC0yLTEtMS01NDU5OQ_9e5186b3-5882-4238-a4b4-fef10f7aef4a">3,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi02LTEtMS01NDczMA_8a74dbc8-eb68-49b8-998d-713e1361f9c7">8,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy0yLTEtMS01NDczMA_e6c8340b-ca7d-4725-afed-9bfa51cca2b5">8,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS0yLTEtMS01NDU5OQ_dde16251-9c01-4407-9e8f-d244c8c39d80">9,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy02LTEtMS01NDczMA_ef5cfc1d-24b5-4e6b-b996-e9032205f111">17,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="unh:BusinessCombinationsRedeemableNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC0yLTEtMS01NDczMA_acdb7aeb-9f15-4377-a62f-ce2c67864e1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="unh:BusinessCombinationsRedeemableNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi0yLTEtMS01NDU5OQ_bf1ea063-0457-49ad-8bd7-bb708db72227">3,108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="unh:BusinessCombinationsRedeemableNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC02LTEtMS01NDczMA_2e149c1b-9bce-499d-be5c-0f84490988c7">3,108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="unh:BusinessCombinationsNonredeemableNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNS0yLTEtMS01NDczMA_49674c9f-49be-487d-a8f5-e1c03b5fcdea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="unh:BusinessCombinationsNonredeemableNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy0yLTEtMS01NDU5OQ_23752e01-d228-4bac-87d4-cb9b80015c26">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="unh:BusinessCombinationsNonredeemableNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNS02LTEtMS01NDczMA_02c89b61-eaca-4447-9e5c-2c506d06f6da">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNi0yLTEtMS01NDczMA_4931b08b-eee4-4c28-9cab-c159df5d91c6">13,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC0yLTEtMS01NDU5OQ_ce794324-281c-4511-b992-58ce65680600">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNi02LTEtMS01NDczMA_79064907-289f-40db-a57c-31fd9110046e">22,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.</span></div><div style="margin-top:9pt"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="unh:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYy_1186bff1-2c3d-446d-81ce-b0b82d76c61c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8xLTItMS0xLTU0NzU2_e6bbf7a3-1a48-4845-a360-43f8ec685bf4">3,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8xLTQtMS0xLTU0NzU2_7fb3b02f-8dd4-4e60-bdf4-6c6e54b85cee">15</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTYtMS0xLTU2Mzgx_b3554a00-9458-4e11-8a45-f581eb12ccb3">864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTgtMS0xLTY2MzI3_279e9e3b-9e25-4d18-9d9f-6204cac16a86">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c272509ca243539b39dea750264213_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTEwLTEtMS01NjM4Mw_326a8881-c69b-4f2e-aab5-71444a4f296e">3,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33c272509ca243539b39dea750264213_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTEyLTEtMS02NjMzOA_eaef8ce8-96f6-4f4c-a081-b5374212f68d">15</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTItMS0xLTU0NzU2_d7223aab-e71b-46fe-9560-1e2f471a7c3f">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTQtMS0xLTU0NzU2_44a506c5-f7d9-4c35-a761-59868c68a7a6">6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTYtMS0xLTU2Mzgx_ada1db46-503d-4fa8-9f4e-eb269912d857">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTgtMS0xLTY2MzI3_c45db599-03d5-4b28-87d1-81fa43e480a6">4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTEwLTEtMS01NjM4Mw_32c604b9-4344-4edb-bfa4-9e04dbc6f565">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTEyLTEtMS02NjMzOA_bd66e269-9e45-4e90-b580-a6be2d95afce">6</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTItMS0xLTU0NzU2_f58cc533-1f5c-4209-a894-2901f97f73ee">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTQtMS0xLTU0NzU2_5a76ce01-02db-404d-9c81-02f1ebf22cdb">1</ix:nonNumeric> year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417f470589084c168d167ef0c775d160_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTYtMS0xLTU2Mzgx_8ad08b08-db98-4791-ae15-55dc1f0c749c">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i417f470589084c168d167ef0c775d160_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTgtMS0xLTY2MzI3_4e7828d7-b9d5-4e5d-8d62-56596b98b9eb">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTEwLTEtMS01NjM4Mw_3cb7df7f-5bca-4c12-a154-a28f6a4d5b5d">776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTEyLTEtMS02NjMzOA_b87989b9-5c28-4c70-8fc9-5e60478f3f61">13</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec887b8824d84342853f880a3d055fb6_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTItMS0xLTU0NzU2_346af59f-f547-4109-9677-259e9901163e">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iec887b8824d84342853f880a3d055fb6_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTQtMS0xLTU0NzU2_4ce8f4a4-13a8-4d4b-a98b-711f5b7aed7a">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTYtMS0xLTU2Mzgx_6b65658e-9c46-44e0-b70d-eeaf53483f2d">1,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTgtMS0xLTY2MzI3_ce7467df-05ee-4971-9c0d-eb490d67d193">13</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTEwLTEtMS01NjM4Mw_214167e4-e18f-4c75-9bb3-46f1d18903d0">5,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTEyLTEtMS02NjMzOA_e55f5c48-0917-4e5a-a006-2a42ffa87f8d">13</ix:nonNumeric> years</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and financial condition of acquired entities have been included in the Company&#8217;s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through December 31, 2022, acquired entities impact on revenues and net earnings was not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaudited pro forma revenues and net earnings for the years ended December 31, 2022 and 2021, as if the business combinations had occurred on January 1, 2021, were immaterial for both periods.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzU2NDA_19790612-1ebc-4d9c-9feb-2f7083b687e7" continuedAt="ia6c52bbf2b34478498f78ac6f3f1edce" escape="true">Segment Financial Information</ix:nonNumeric></span></div><ix:continuation id="ia6c52bbf2b34478498f78ac6f3f1edce" continuedAt="i32aa1009874c407ab98f6cd275f7987c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used to determine the Company&#8217;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#8217;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the types of products and services from which each of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzY0MQ_445892c6-959c-4e7e-91b3-6e285553419d">four</ix:nonFraction> reportable segments derives its revenues:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the combined results of operations of UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement and UnitedHealthcare Community&#160;&amp; State. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. Domestically, UnitedHealthcare Employer&#160;&amp; Individual offers an array of consumer-oriented health benefit plans and services for employers and individuals. Globally, UnitedHealthcare Employer &amp; Individual provides health and dental benefits and hospital and clinical services to employers and individuals in South America and other diversified global businesses. UnitedHealthcare Medicare&#160;&amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs. UnitedHealthcare Community &amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Rx </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_106">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx; care delivery, care management services and certain product offerings sold to UnitedHealthcare by Optum Health; and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#8217;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a percentage of the Company&#8217;s total consolidated revenues, premium revenues from CMS were <ix:nonFraction unitRef="number" contextRef="i754570ab58fc4d7182d6cd5710942586_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMTA_50948799-5666-4f4d-be01-13cabf595e65">38</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i891eefd12c57404d9108f080872897e0_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMTQ_1e8e15fc-a198-4d53-8f09-ca394e94efdf">36</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i50a501c583d645a99b8b9b5c5bd3990c_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMjE_69a80195-525b-4aa1-9579-8b18330ef436">36</ix:nonFraction>% for 2022, 2021 and 2020, respectively, most of which were generated by UnitedHealthcare Medicare &amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately <ix:nonFraction unitRef="number" contextRef="i6ecaa939f056424d93be40e9396e2d1b_D20210101-20211231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_7467657d-78ca-48dd-aff9-9ce0c5855297"><ix:nonFraction unitRef="number" contextRef="i5097e65e14e04df196818d6c688b1082_D20200101-20201231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_9ad968fa-4084-4e6b-8e97-f67d91689776"><ix:nonFraction unitRef="number" contextRef="i5047c8cbb98d45d0ad2ec2d032462297_D20220101-20221231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_ba53702b-42fa-4f98-baa1-c3cd1511461e">97</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of consolidated total revenues for 2022, 2021 and 2020. Long-lived fixed assets located in the United States represented approximately <ix:nonFraction unitRef="number" contextRef="if2456563e97441d1bb80a0655bda7af3_I20221231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofLongLivedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUzNzk_de9332c0-cb4b-49ee-9434-3870c28db749">81</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i97182827e3a4490ab017b6b0ccdcf452_I20211231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofLongLivedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUzODY_de043dfe-1fad-4976-8d7e-4d7f5e081076">78</ix:nonFraction>% of the total long-lived fixed assets as of December&#160;31, 2022 and 2021, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Employer &amp; Individual&#8217;s international businesses. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><ix:continuation id="i32aa1009874c407ab98f6cd275f7987c"><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzU2Mzc_92641bcd-4f23-46ab-ba52-7f66a8749cd8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMi0xLTEtNTE5MzU_cd0796f5-9d3a-4393-93e6-d8acf5c80c3a">238,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtNC0xLTEtNTE5MzU_a6cc3374-d0f2-4258-8718-749bb909c7ce">18,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtNi0xLTEtNTE5MzU_2316b8a9-8c5b-4cf4-952e-83d72c76a450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtOC0xLTEtNTE5MzU_ffea32bc-21ac-4a42-961e-2f8bf4177d58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTAtMS0xLTUxOTM1_435cbcce-fd02-4e5c-a103-591ba15f8b80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTItMS0xLTUxOTM1_3f7d513f-ce06-4db8-9817-b3998c1f4cc9">18,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTQtMS0xLTUxOTM1_027d8b40-3eee-4517-8c46-e0f5866f5fb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTYtMS0xLTUxOTM1_9e396eff-85ba-4478-9946-29cbb66e561a">257,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i732a42f2250b413f9bf4d79507a6ca84_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMi0xLTEtNTE5MzU_dddec100-efc6-43f5-a68b-5a510de57e89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc651b1637d4ead98ae3d64f8fce1ac_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtNC0xLTEtNTE5MzU_515d5401-316a-4c09-9f35-67e1662ecd35">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i689a6bbc96bd48d585f1f0fbc711fc9f_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtNi0xLTEtNTE5MzU_6d1a3afb-8687-4876-9d19-991158f2173a">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e748f6babd44bad9db0b025d2907061_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtOC0xLTEtNTE5MzU_0a19409e-d9b1-488e-8ff5-7a25f8d0c620">37,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f024c91b7e04d99baa714309ff7e49d_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTAtMS0xLTUxOTM1_f20129e0-b1ca-4040-b92d-8060d4ebefb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c12c65b54c4b4fa1799a4218c9359f_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTItMS0xLTUxOTM1_fd4c0bfb-2521-4e9b-aeb9-f90c10e3b086">37,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47084b8e436448078c0d24c71476b120_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTQtMS0xLTUxOTM1_abe62839-d92a-47cd-8769-3dd21952e606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad33ae2f3254e8eaa1c802d749df410_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTYtMS0xLTUxOTM1_035bf5a8-6958-4a65-bc08-c5a2eae3e760">37,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d26bfed4a2840dbac69a2395c82ff6d_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMi0xLTEtNTE5MzU_c7ae1b13-a645-40c2-8823-ccc5d0f22af5">10,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb993a994a549efade727a478d56969_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtNC0xLTEtNTE5MzU_1f0ffd73-34c4-4a9f-926c-cc9bf7b01f60">10,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0409df6d86b94be7842cd2257a37957c_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtNi0xLTEtNTE5MzU_8d711b68-e1a4-4cfb-8e74-538e1267abcb">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248d4ab66d70471bae1895c28d10a5be_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtOC0xLTEtNTE5MzU_1d10b9d0-9fa1-4720-ab57-fa0daa97530b">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41ca363996f43829716a67d979d12e3_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTAtMS0xLTUxOTM1_36c83ee3-118f-4828-aec7-a76cce1e7662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if345a50f546e449795e2b25318c9818f_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTItMS0xLTUxOTM1_ff91c08b-f9b2-442a-8528-71b45b59c96a">17,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd0dd9677e344fda1596618b18f13c0_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTQtMS0xLTUxOTM1_c1df27ee-bdf9-491a-9ce6-0eae6c014900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d02f6e1b404ac4bfcb813025f3065c_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTYtMS0xLTUxOTM1_cba1e344-7578-49a9-9370-bb2c942b7451">27,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMi0xLTEtNTE5MzU_64cb80f7-39b8-40bd-8bd9-cd56cf2f5522">248,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctNC0xLTEtNTE5MzU_ea8d8787-fdff-4677-8a0a-a43a4e034df4">29,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctNi0xLTEtNTE5MzU_89967b97-87c2-43dc-97a0-f9ffc0ae1365">5,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctOC0xLTEtNTE5MzU_2b9a9206-da37-45de-b10c-7e060dd5fc7a">38,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTAtMS0xLTUxOTM1_26c4d7ce-55a3-4236-b7bc-562dd7a686ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTItMS0xLTUxOTM1_26d5b388-a892-43df-917a-6e651f1cb115">73,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTQtMS0xLTUxOTM1_e21e45f8-e4b2-4e84-a6bc-261f1a023413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTYtMS0xLTUxOTM1_4baa45a3-262f-40fd-a980-ebf7925b4b42">322,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0e74178d75403b9dcc51a6a87d03de_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMi0xLTEtNTE5MzU_dccb03e1-e87d-4437-93ff-c0ec6d2e2e0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40545db690df4fdab1edc363f3348827_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtNC0xLTEtNTE5MzU_ecc0dce1-a713-4114-bdd2-c8e5f24d4e1a">40,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c894858093498e826481908286c841_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtNi0xLTEtNTE5MzU_ef45e84f-ccad-481d-ba25-523b4f0d2273">9,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b418a686c3435f81ce58838debdcce_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtOC0xLTEtNTE5MzU_0dbf5c4e-3ebd-40c1-955a-0d585a59473d">60,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia79e6c55d1d440638042cab7fe05cad5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTAtMS0xLTUxOTM1_9edddedb-f423-43ff-a4e8-2da0c12aaae8">2,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5c6cb54c3b4b49bb104be3515415dd_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTItMS0xLTUxOTM1_294bb222-4da5-43ef-99c3-828c4e642802">108,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5aa82904754e72bda157c7a338ea81_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTQtMS0xLTUxOTM1_6143a4a7-0f7c-49e7-a038-c774cf095431">108,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36880bfb1c5e4252b9402bba5e8bb110_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTYtMS0xLTUxOTM1_64424cb0-5322-4556-b928-e5833b13079b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMi0xLTEtNTE5MzU_81fce41c-2e8c-4e7e-968c-f26919afb570">923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktNC0xLTEtNTE5MzU_0444e2b5-c45e-43e4-b282-8407bb3529b3">928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktNi0xLTEtNTE5MzU_b0db7f92-0ee2-4ff0-9025-5444b9408aeb">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktOC0xLTEtNTE5MzU_62d5ca15-88f0-4a1f-aadd-2a484a0afea4">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTAtMS0xLTUxOTM1_cbf376bb-bed8-41e3-b285-c62401588a8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTItMS0xLTUxOTM1_97b3d2eb-6a3f-4519-b08b-363a8761fffc">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTQtMS0xLTUxOTM1_3fb72c83-dfaf-44f9-9db7-a690561f6c79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTYtMS0xLTUxOTM1_2af90c97-6b4a-4239-8883-f6000b943435">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTItMS0xLTUxOTM1_79f0daaf-1391-4782-85cd-e53e302fcc31">249,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTQtMS0xLTUxOTM1_785dcf8f-4c18-46e9-af01-e9e541987d1a">71,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTYtMS0xLTUxOTM1_f1340598-1c45-49c7-81a7-c60b72cfaff9">14,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTgtMS0xLTUxOTM1_53aedb58-7161-4826-9264-836d20256046">99,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTEwLTEtMS01MTkzNQ_c0dbfa53-ba7a-4df7-a989-ae0ac42b6ad8">2,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTEyLTEtMS01MTkzNQ_94756916-74bf-4c11-a517-a8440717958d">182,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTE0LTEtMS01MTkzNQ_e346d933-0474-4c51-aa90-0d7df4ccbf3e">108,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTE2LTEtMS01MTkzNQ_c7e02574-655e-4b5d-bc60-3063ec50fcd8">324,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTItMS0xLTUxOTM1_0b284ed7-81ba-4af2-b3a6-7f9b906ea612">14,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTQtMS0xLTUxOTM1_9aea0694-0d8c-4698-a769-be2593b724e0">6,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTYtMS0xLTUxOTM1_6cab2bb1-f5ce-430a-a67f-b93c4543739e">3,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTgtMS0xLTUxOTM1_29ec5d1e-d326-4187-9737-b9b9887b6da5">4,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTEwLTEtMS01MTkzNQ_8c23a35c-d197-4354-bf39-46f419706c66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTEyLTEtMS01MTkzNQ_1986d398-556d-41e1-b264-5873a6f423db">14,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTE0LTEtMS01MTkzNQ_3d1fb904-2b1a-4316-be03-1ee1265ee163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTE2LTEtMS01MTkzNQ_6e6be6f9-28ae-4a56-b0b8-a226d6a98af4">28,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTItMS0xLTUxOTM1_9b01c0e3-c02a-4816-bc59-d2723142f971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTQtMS0xLTUxOTM1_1aea3be0-9b4a-43fa-b997-d091e676ae9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTYtMS0xLTUxOTM1_38f3b73b-8936-4885-8490-fdbaf40b392a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTgtMS0xLTUxOTM1_6617a59f-4ff8-42dd-8478-6a7eb6bc1a6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTEwLTEtMS01MTkzNQ_1baa3b91-34db-4101-ad12-287d710e7708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTEyLTEtMS01MTkzNQ_5db6b33e-52a1-4b02-85f0-a00eab7c8052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTE0LTEtMS01MTkzNQ_0d556dff-fb52-4230-9b7d-bc08c81c33ba">2,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTE2LTEtMS01MTkzNQ_3e4d0c5b-041e-4185-b478-18fff7207a6e">2,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTItMS0xLTUxOTM1_91a2b2f4-4ee5-4a93-8142-735e02b4f6c9">14,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTQtMS0xLTUxOTM1_e7922e37-9bb9-4fcd-9fce-b228715a7da9">6,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTYtMS0xLTUxOTM1_50c4268c-00dc-4745-93d5-30b4669d8d61">3,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTgtMS0xLTUxOTM1_cc7e7167-655b-4821-8d96-b0c26d5eb3af">4,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTEwLTEtMS01MTkzNQ_17ca8994-9ab7-4d66-a0af-f1f61710bc06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTEyLTEtMS01MTkzNQ_d287c389-e3ed-4a43-84d5-4033887cc058">14,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTE0LTEtMS01MTkzNQ_89431cb4-37c4-45e9-bffa-0639da4d1d7f">2,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTE2LTEtMS01MTkzNQ_43914e0f-a0f4-48ab-9cf9-57dd56314ea3">26,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59011503ab204f80b7e61b66d70a9f7c_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTItMS0xLTUxOTM1_f907f9b9-c599-4ba1-a1f0-fdb1135585f5">107,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic696f2244b5b45a0a03c0ca407b18556_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTQtMS0xLTUxOTM1_222804d8-8eac-447c-ac05-159f71789ab5">68,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac00fded2bdc4a4dac5850a70ce34a56_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTYtMS0xLTUxOTM1_3987a99f-7b09-4da4-9905-7e7fabe01bba">31,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ac679ac440453dbbb5734791641a4d_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTgtMS0xLTUxOTM1_1a58e8e6-22ef-4df2-b46a-2a0de526012a">47,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b28e9f7a35f4490a7d651ae18c391b6_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTEwLTEtMS01MTkzNQ_81aea6ab-1c2e-47d0-8c31-63c4cef1201f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00c94487ebe47df9a45f96208eac209_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTEyLTEtMS01MTkzNQ_6f3a0835-036d-4512-ad1a-7e7ac5f738e0">147,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2342d40e00cb40539947ec67002a66b3_I20221231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTE0LTEtMS01MTkzNQ_eef12ac7-ce55-4e27-8ecd-5ced308ee1f3">8,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTE2LTEtMS01MTkzNQ_72f6c58a-bcfe-45f7-8f4c-e89ce00ff07d">245,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTItMS0xLTUxOTM1_0c1a3626-5421-4835-a38e-9750d4e9e6d3">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTQtMS0xLTUxOTM1_748de43c-7d1d-4c66-b393-c37a38190626">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTYtMS0xLTUxOTM1_53c6b336-4ac9-4042-adc5-cedc2957ae4c">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTgtMS0xLTUxOTM1_9a1e967b-17da-4bd4-b1ce-75e6cff4bfb6">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTEwLTEtMS01MTkzNQ_6318ba99-5314-4911-881c-7a85e6a0ad3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTEyLTEtMS01MTkzNQ_b1a2f515-af7b-4af4-a65f-e425f6ee1380">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTE0LTEtMS01MTkzNQ_6e14e822-9466-47b0-b040-3d662397fd52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTE2LTEtMS01MTkzNQ_4d63514b-0174-4bb1-94b0-588c6c4b76a8">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTItMS0xLTUxOTM1_8ecad128-0170-4878-a0b7-65548466de0a">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTQtMS0xLTUxOTM1_a3dbe046-0ee7-44e1-83e0-7725f1022510">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTYtMS0xLTUxOTM1_e61c1e8f-2633-4a51-8adc-7db1a49f3fa3">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTgtMS0xLTUxOTM1_d744ae16-cbbe-44d7-88fc-56cce5ba1e9f">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTEwLTEtMS01MTkzNQ_a208b71d-f5a4-4312-a69b-4dd98544bac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTEyLTEtMS01MTkzNQ_103a3c88-2e8c-4712-bf7c-05f3f6d2fe07">2,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTE0LTEtMS01MTkzNQ_167d21d8-7802-40bd-bc63-670a6429e5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTE2LTEtMS01MTkzNQ_0b8c930d-d2b3-41b7-bc0d-64d2887a2a67">3,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTItMS0xLTUxOTM1_2dc249c5-2573-4827-8396-8e1df129c221">212,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTQtMS0xLTUxOTM1_865ccea1-51be-4346-9924-d181b89c5c22">13,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTYtMS0xLTUxOTM1_fb976f2d-fe86-44b3-901c-daf1a53b683b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTgtMS0xLTUxOTM1_d694b85a-b9bf-44b2-9017-721cbd942453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTEwLTEtMS01MTkzNQ_8007c5aa-0145-437a-8478-7712bd0c45e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTEyLTEtMS01MTkzNQ_92ac912f-3240-4387-bd17-985c6c275c65">13,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTE0LTEtMS01MTkzNQ_95bc356f-da93-46c7-b0a5-95a0b31fe63c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTE2LTEtMS01MTkzNQ_c3f7a0d9-5805-40bd-8199-9308dabd5396">226,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d726a752eb3479e98a520f141c7da23_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTItMS0xLTUxOTM1_14c92d77-54b1-4896-9f9c-fc2501082aec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice1915ab53004f139ae31ddb9f72017a_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTQtMS0xLTUxOTM1_79fa2288-c63a-4cbb-8cbe-9a5a01869ec4">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f4f96795bf481cb58883eb91460381_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTYtMS0xLTUxOTM1_fde6f79b-e97a-4b7a-86a3-06bf6e608db0">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169c3a6f69ec49c6ac21ea20f6face13_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTgtMS0xLTUxOTM1_b99906a9-7c5e-47a7-a778-b02efd2687b7">34,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa0861fc9d04b6b8a9cf15131f4eb4c_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTEwLTEtMS01MTkzNQ_ab6ad869-a577-4875-af38-0e83e25a6676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223709dbe1e1454e8275ba382402b2fe_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTEyLTEtMS01MTkzNQ_252ef28b-4026-4ccf-afd4-e96d12d3d921">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6809afc52ece49fcacd58ddeb9beed63_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTE0LTEtMS01MTkzNQ_f962c8ed-693d-4a97-a6a4-146a2263c8d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd994d74ba1e442eb1b7b78abad56ccf_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTE2LTEtMS01MTkzNQ_4c0c06aa-2033-4940-828d-15f6ddbe2756">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb19a9943ea410184b0ee7221e62372_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTItMS0xLTUxOTM1_caedb220-37c5-4576-bbda-93921814fec7">9,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if552e01372d149efa80b89bd7e2901fa_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTQtMS0xLTUxOTM1_07e48c0e-2f63-43d0-94a8-165252b7fbbc">9,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6feddcc5aa4962a0a4685dc88ff2d8_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTYtMS0xLTUxOTM1_e5aaa18c-e123-4a04-945f-3005c04b2d8a">3,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d4124c98cc489db6bc12d6a7c0fa1b_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTgtMS0xLTUxOTM1_84c207a5-2d68-4605-9f40-5c7e5da2d742">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec876717223b46bdb349de450e145cd6_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTEwLTEtMS01MTkzNQ_01fb4d92-6d0e-4b26-b3c3-a0e58c1866ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f8c8b06009844a89aad8bfadcab6675_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTEyLTEtMS01MTkzNQ_3607c305-a929-4665-a961-036febb30050">14,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4aaba57e6c4369864d20305d9597f1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTE0LTEtMS01MTkzNQ_d2bbfc0b-4350-4f2c-bb7e-71ae5f64ac17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e74aa00cb7f48a593354c1c326ec9d4_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTE2LTEtMS01MTkzNQ_d1eebbaa-ccd8-4d1d-8baa-832aa0950575">24,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTItMS0xLTUxOTM1_272d9add-1f58-4d21-902e-dcc813de37f1">222,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTQtMS0xLTUxOTM1_a1ccbc18-c96e-42a5-a39b-2435976d5215">23,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTYtMS0xLTUxOTM1_cc1b01ec-efc3-4db9-92d5-7b99f8d7ff83">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTgtMS0xLTUxOTM1_f8e96984-7980-4a0c-80db-f1c1d789b35f">35,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTEwLTEtMS01MTkzNQ_b4e00c7b-ebff-49c3-a49c-6fb567a72844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTEyLTEtMS01MTkzNQ_34b6a0c8-4553-4bfa-b30b-4f45f9609ef2">63,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTE0LTEtMS01MTkzNQ_43b99f74-96b7-41e0-8307-c125db0746c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTE2LTEtMS01MTkzNQ_bb2b6997-49a2-47b5-ae21-511a08d3173d">285,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cc12cbad2f4be496364d6a29805345_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTItMS0xLTUxOTM1_8360d888-720b-41d4-8895-53051fce57c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf5875ebba543508498353a5881cd21_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTQtMS0xLTUxOTM1_2d2aa56f-47c4-40c3-84f5-efbe8d07c98c">29,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3958921a164d51bdd2c4a6807a726f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTYtMS0xLTUxOTM1_658ac134-1851-4d2e-8185-dbb60e138b3f">7,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i159f89cf2a8346398f76a7f71b7df182_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTgtMS0xLTUxOTM1_e4717285-6a1d-442e-a7eb-e94fc2d7e3ca">55,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf477982ea1a42dc804d174211e45675_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTEwLTEtMS01MTkzNQ_18ccb6e5-a297-4658-862d-b597a15abd26">2,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4076c2027b2e4431ac707ea49e17d9e6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTEyLTEtMS01MTkzNQ_45b8c9a3-a26a-4256-92b4-cbb5cb1385ab">90,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i504afca956b443a6a9e4f9d9b46f543c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTE0LTEtMS01MTkzNQ_cc6b3b35-2ee5-4be6-8232-e1731b130bc7">90,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0c09925613478d8fc3af0f46b15762_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTE2LTEtMS01MTkzNQ_fee6c4b3-7137-4cae-b0b6-01a12a27e205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTItMS0xLTUxOTM1_671347a7-40d2-47b6-a673-e6f64509aa92">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTQtMS0xLTUxOTM1_d88ca15b-35ed-47e1-977a-163d6df2276a">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTYtMS0xLTUxOTM1_b1dc17b6-5e36-4d6b-ae8e-aa3a6af30328">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTgtMS0xLTUxOTM1_fdb69e3b-ed3f-4b1c-8705-d7167bec6b90">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTEwLTEtMS01MTkzNQ_866ed08c-3c98-41ca-9cf2-8edc037d9949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTEyLTEtMS01MTkzNQ_3ed069fc-9822-407e-afcf-e479b9ba4fe2">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTE0LTEtMS01MTkzNQ_8552de19-7477-4501-b30b-72936a717d61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTE2LTEtMS01MTkzNQ_c48f1a34-f650-4499-9c1f-f232de93fa45">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTItMS0xLTUxOTM1_75660291-0903-4278-9ed7-0fb2c66da008">222,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTQtMS0xLTUxOTM1_2316f93b-7978-4633-adba-9cb213717f3a">54,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTYtMS0xLTUxOTM1_b7604858-14bf-4cf3-89eb-08eb5a2bac6f">12,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTgtMS0xLTUxOTM1_bf2ca69b-1d77-4949-aa08-05c104557543">91,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTEwLTEtMS01MTkzNQ_fdfdf3b1-b316-4b4d-a63e-dafcdf9cc619">2,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTEyLTEtMS01MTkzNQ_b666f8e4-ad90-4b2f-b158-8d68a2715d1e">155,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTE0LTEtMS01MTkzNQ_4271e3f8-a371-486e-a6a7-4298e409e45f">90,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTE2LTEtMS01MTkzNQ_40ed2bdc-d3de-41b8-b40d-a931ead02350">287,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTItMS0xLTUxOTM1_fed81db4-fa93-4108-8282-e53c01c2324e">11,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTQtMS0xLTUxOTM1_f8dde058-81da-4bda-81e4-cf1d8bfa66d8">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTYtMS0xLTUxOTM1_d8f6cf12-6437-4c3a-8333-e3ef97ea357b">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTgtMS0xLTUxOTM1_f3f11cb2-3ef3-494d-8002-858324e9c3be">4,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTEwLTEtMS01MTkzNQ_e6b2c45e-e978-4f48-8c1d-f83f04173f24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTEyLTEtMS01MTkzNQ_c8010ad1-e3b4-45d3-b061-82d24cae93ec">11,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTE0LTEtMS01MTkzNQ_c64ee453-7891-488a-83a2-af9bcaafa300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTE2LTEtMS01MTkzNQ_88f05238-d00e-4786-b072-399c7a1f1cb1">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTItMS0xLTUxOTM1_52e47d15-a458-484e-a92a-4fab19500375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTQtMS0xLTUxOTM1_d481d6ad-bfbb-47fb-a930-3ff27ef40580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTYtMS0xLTUxOTM1_c9cf3a7e-599b-4893-8e37-0807527b4464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTgtMS0xLTUxOTM1_edf73614-1e00-44a0-a5b0-bfb1c0087409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTEwLTEtMS01MTkzNQ_74fdd1fa-0226-4a9a-8592-e3cddad3d5c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTEyLTEtMS01MTkzNQ_755dc61a-cf2b-4406-807f-7de8d8ed0c1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTE0LTEtMS01MTkzNQ_c8d9eb0a-fd2e-48d9-ba73-612f1d56cb03">1,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTE2LTEtMS01MTkzNQ_dd7bb8aa-8b0d-4ceb-a050-f0d082bade03">1,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTItMS0xLTUxOTM1_c4a390be-edd7-4530-9f0a-f42e5a42c807">11,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTQtMS0xLTUxOTM1_2f20d66b-881b-4ccd-901d-0bcd25fe40d8">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTYtMS0xLTUxOTM1_7de82f9c-3401-4e26-981c-240185234b4b">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTgtMS0xLTUxOTM1_b1d55b3c-ca58-461b-a65b-0a494a3668bc">4,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTEwLTEtMS01MTkzNQ_fcb1da95-ecb5-45fb-9ebe-c987981a8246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTEyLTEtMS01MTkzNQ_e5b4b837-3c61-442f-8426-d04c1f0f4043">11,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTE0LTEtMS01MTkzNQ_765e559d-fe73-440b-b84b-86b21a28632b">1,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTE2LTEtMS01MTkzNQ_a6787544-9e18-4f81-b128-609343c28e23">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9491e68da6045a1a105dfe059072466_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTItMS0xLTUxOTM1_f2cfb821-5b73-4b01-922b-db1fc1e2e8ac">102,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic858c9047c604ac982e25d4ac7f8174d_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTQtMS0xLTUxOTM1_bd6711c2-a0b8-433f-8f56-aab6b2f2d265">60,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa393fe15c9145e3b9ec03b58beca5dd_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTYtMS0xLTUxOTM1_14811e03-2174-4a29-a2e3-8c75d9150fd6">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f6e178ccba45fab8978aea98c8fff1_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTgtMS0xLTUxOTM1_9aa7413e-3d28-4069-b7dc-345bd81990cf">40,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46ffe7b0c3c4ef38af41f18db200faa_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTEwLTEtMS01MTkzNQ_cb1d2a97-fd7c-46ce-8d13-759b6a237b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f93fadef4f46a5bc4fb990ddee2fc8_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTEyLTEtMS01MTkzNQ_41682798-c830-463e-893b-df1a7fc8c394">117,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9edf57345d9043c1b11e892820ff85bd_I20211231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTE0LTEtMS01MTkzNQ_3c879df5-80d7-4e9c-87c6-924c26e59125">8,284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTE2LTEtMS01MTkzNQ_263c9edf-0449-485e-9e65-423448119fb3">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTItMS0xLTUxOTM1_c74f9117-f5f1-465c-834b-11ec4c466e19">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTQtMS0xLTUxOTM1_28038215-07ef-4a81-8463-bc5c5f894d14">791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTYtMS0xLTUxOTM1_5191b1c2-6a63-4847-9da6-e1bb97461573">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTgtMS0xLTUxOTM1_574fba1e-44fb-443d-9201-a98d0208ca0e">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTEwLTEtMS01MTkzNQ_236b70b6-60b9-4f5a-a6bf-7e7ea38437e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTEyLTEtMS01MTkzNQ_0574bcf2-3cbe-4427-b5c6-96ea5c86ae8e">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTE0LTEtMS01MTkzNQ_ad57e2e1-507f-45e8-812b-8431a7c44a56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTE2LTEtMS01MTkzNQ_78f41839-312e-4762-bc1c-5131cfb12c0a">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTItMS0xLTUxOTM1_0da0906c-d808-4323-bb8f-8305a895f6ec">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTQtMS0xLTUxOTM1_9adbfedd-f315-49c0-9700-1195832ec24e">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTYtMS0xLTUxOTM1_fb659cf5-60b4-4ed4-a026-8c65106dfbd7">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTgtMS0xLTUxOTM1_a760a93d-2eca-4540-9ea8-07581556f9c4">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTEwLTEtMS01MTkzNQ_622185c1-050f-4ee6-8f66-c04e76b859f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTEyLTEtMS01MTkzNQ_01c400b8-96eb-48df-a3cd-2fcdfb755dd0">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTE0LTEtMS01MTkzNQ_0b60c75e-61ee-4db4-93d4-311323f715b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTE2LTEtMS01MTkzNQ_9fe3b674-af70-440e-b812-6c04e4adee33">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTItMS0xLTUxOTM1_47c11468-e069-4a0a-96fb-96169f64deb2">191,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTQtMS0xLTUxOTM1_e335fa35-46c0-4921-b73f-72fd210d6301">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTYtMS0xLTUxOTM1_6b893a43-47a9-4e72-9f4c-ea22a505a160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTgtMS0xLTUxOTM1_cf4f53df-aa77-4b3e-9853-b145336ef5c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTEwLTEtMS01MTkzNQ_dceb7075-44eb-4cd6-b376-75066a5a2752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233c15dc654d469288951d04a08c0455_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTEyLTEtMS01MTkzNQ_e20b56e6-a1d1-4451-b814-8f45075bb111">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTE0LTEtMS01MTkzNQ_2087e320-6b12-42fc-9fa7-f7e648f12ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTE2LTEtMS01MTkzNQ_07640f26-698e-4dc7-b518-bbd36295f9fb">201,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba020e43c45460cb04de6fcc9b74a76_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTItMS0xLTUxOTM1_b25448bf-3067-4b20-8b8d-d90ce1f39f67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34bb0b4a48194f55ba64445c9848a45d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTQtMS0xLTUxOTM1_fcb6144e-e47c-4ca4-aaba-72930edf3d6b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i564486a1b728438ca7fbb3d76dfad1cd_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTYtMS0xLTUxOTM1_9ba06bf8-7a02-4609-8329-d25f9bb5f698">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bd530a243c4e92be077f1a53ed69e2_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTgtMS0xLTUxOTM1_bb1dea96-5a8c-4c14-be35-1dd2ada92c9f">33,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4008ea094942efa92959f01e189555_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTEwLTEtMS01MTkzNQ_ab292a03-5f20-4c46-bf36-5687422cdb84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796f9087920a40eca6b04eca756a0128_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTEyLTEtMS01MTkzNQ_bf9eea9c-05da-4659-836c-ad3092ff7f12">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb0b864fd8c4a6782eef98e1bafa761_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTE0LTEtMS01MTkzNQ_a2c8d9c9-d719-4677-9e31-f5319c2801e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71cf336cf55d404f864835404f2b5d2c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTE2LTEtMS01MTkzNQ_142a23d6-6794-4027-9e87-97001d4f9cda">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c572dcc2604feabe05f8761531ce09_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTItMS0xLTUxOTM1_6838372b-d9ab-4531-9288-2dae05750ced">8,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefb573c3bb8436dbf231adeb4c351db_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTQtMS0xLTUxOTM1_85611ab4-ac4d-448b-8842-d8a6ec6a4d34">6,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9734c2c7137d4a14a49e90c235063d38_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTYtMS0xLTUxOTM1_e0986e87-f2f8-47ec-8c68-31b0cd7352e5">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i276a8b65f2b4434dbee38c4c9687ce8d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTgtMS0xLTUxOTM1_deb4f42c-b066-41ef-8507-aa9987ac11c2">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e84564ba4746deab13cdd483c38f04_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTEwLTEtMS01MTkzNQ_e01b4fb9-6620-449b-aecb-326dcf5250c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb51ddb53efb4127a03b364bd9fb3504_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTEyLTEtMS01MTkzNQ_0ce21f87-6d2f-4341-96f9-44d57d7e1a4d">11,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5476d1544885436791b5b43717779607_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTE0LTEtMS01MTkzNQ_1977d301-9ac9-4fd2-8711-dde6c95abb02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7245c7c22b7746e094b0d6835d7ae680_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTE2LTEtMS01MTkzNQ_4ecabc8f-1faf-4245-a0a7-ca9608efa7ae">20,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTItMS0xLTUxOTM1_b15ac054-561c-4630-8c3e-f42908a16cb0">200,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTQtMS0xLTUxOTM1_7d23e401-1b45-4eb5-9be0-7ab0c0915b30">16,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTYtMS0xLTUxOTM1_8cc8132d-850c-4fb4-92df-3215d9d29e83">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTgtMS0xLTUxOTM1_4e5a6569-6fae-4df9-a69c-8d9cfdc4d7fa">35,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTEwLTEtMS01MTkzNQ_53d9dc03-8ec9-4616-9bdb-1a9ac9e4df70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233c15dc654d469288951d04a08c0455_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTEyLTEtMS01MTkzNQ_40e854f8-8a3f-4995-95ca-a763295cab3f">55,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTE0LTEtMS01MTkzNQ_12f610ec-0a96-402d-aadc-39bf4484ad9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTE2LTEtMS01MTkzNQ_5bab175e-636c-4382-8792-e146f76201b6">255,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5f2ae790b74bfabb249a00198978be_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTItMS0xLTUxOTM1_649ccbed-54ea-4215-96a2-1ce828098206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee98fc17838d4daf98c0b0585eb7ed06_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTQtMS0xLTUxOTM1_19a61192-c7c2-4c18-ab7a-c2a9573956d1">22,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97245d594a044b1f8d34eb031374888c_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTYtMS0xLTUxOTM1_b5bc0d0b-d151-444e-94b8-1dda83cd400b">6,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcfadfac12645d4b3082944a122cc9e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTgtMS0xLTUxOTM1_d5d5d565-88ff-4862-8c54-da23118bdf61">52,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0caf62223ca54bb185679fac378d4f52_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTEwLTEtMS01MTkzNQ_76e60ddc-4cc4-4a0a-987c-853ef505adeb">1,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c6a40d1db7f44589224803d71e3e1e6_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTEyLTEtMS01MTkzNQ_6c7f3d71-c7f9-4501-b923-6f6ff5ecde4e">80,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7465d3a1afe74c3d8718ba6192a453ae_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTE0LTEtMS01MTkzNQ_29d4045c-fb5c-4bdb-a4f7-99a36b511ba7">80,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f892617f3049c3a1e27ad2c9dec0ec_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTE2LTEtMS01MTkzNQ_be32d420-7c8c-4102-8c7d-ef7a135f6206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTItMS0xLTUxOTM1_575ed292-1a2a-41f1-9188-a8a1701aa004">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTQtMS0xLTUxOTM1_8f21705c-720a-4e75-b6b6-efd5a97f16bd">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTYtMS0xLTUxOTM1_1846b8c5-8d74-4235-b592-a4fc7cd45997">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTgtMS0xLTUxOTM1_1e8fcab2-3b0e-4406-96a0-57e225e95fe3">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTEwLTEtMS01MTkzNQ_a59b2dbd-3bdb-4be3-93e3-ea795329a07a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTEyLTEtMS01MTkzNQ_7c468a61-d0b0-42a4-a237-68502f496638">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTE0LTEtMS01MTkzNQ_16f15e4e-5dec-4da9-84cd-613b62a689c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTE2LTEtMS01MTkzNQ_949f1c46-acf9-4189-aa1d-07eefc8ce4e8">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTItMS0xLTUxOTM1_ba17f734-fb02-40eb-beff-49aab9d1e16f">200,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTQtMS0xLTUxOTM1_b64a02a0-35e7-4e88-98be-eb97e926642e">39,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTYtMS0xLTUxOTM1_0c65db70-d566-40be-835b-a5d718ed4086">10,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTgtMS0xLTUxOTM1_9ee2f2cd-b3c4-4922-8b87-58fcee1a3bf1">87,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTEwLTEtMS01MTkzNQ_f758588b-2412-4e18-a28b-5a7133b16dd5">1,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTEyLTEtMS01MTkzNQ_c8f3217f-2871-4958-ad51-2b9229b535d7">136,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTE0LTEtMS01MTkzNQ_d3721046-fc49-4881-bf2e-ce4df9f1b00a">80,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTE2LTEtMS01MTkzNQ_e4e6b903-17de-4e36-a370-2d4114d61b0e">257,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTItMS0xLTUxOTM1_aea8bd24-9060-46ef-8cb1-a02ee24a6be1">12,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTQtMS0xLTUxOTM1_6baed609-16c7-41c4-b5c4-3df45cfcd34c">3,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTYtMS0xLTUxOTM1_36f680f3-2397-4c2d-8835-602de2d7a303">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTgtMS0xLTUxOTM1_abfb00e5-5744-4f6e-a258-e19edcc9e826">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTEwLTEtMS01MTkzNQ_96c20a49-b9d2-46c3-b554-14194feed9fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTEyLTEtMS01MTkzNQ_d48379d8-c99d-4b76-8500-fd48578c9499">10,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTE0LTEtMS01MTkzNQ_ceb6e1dd-f7ee-4405-9cfc-360ef1ff0178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTE2LTEtMS01MTkzNQ_23ea1a24-039d-4208-a4b9-146f287a0633">22,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTItMS0xLTUxOTM1_cd024dfe-e1f2-49f7-9863-1d43c7bea685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTQtMS0xLTUxOTM1_8f7b5c45-74ad-4e81-b69f-2d66bb572b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTYtMS0xLTUxOTM1_4ed459ba-09c7-4a2d-b868-ecc97e0ecb23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTgtMS0xLTUxOTM1_c89f45b8-391a-4121-bf62-f1fcd1f55b11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTEwLTEtMS01MTkzNQ_95293bd4-d037-43c2-98e3-313d7efe644d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTEyLTEtMS01MTkzNQ_60a341f0-edc8-4b91-aa10-3bac806599d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTE0LTEtMS01MTkzNQ_5064df0e-a68e-43b9-a074-7ddfb81ace87">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTE2LTEtMS01MTkzNQ_342538da-ce61-4dcf-b4ae-92f1adca308e">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTItMS0xLTUxOTM1_cd033b99-d8f2-4ac1-bfe7-c4bf48afe029">12,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTQtMS0xLTUxOTM1_8dbdec47-9eac-4003-8c57-a179e36fb67c">3,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTYtMS0xLTUxOTM1_2c0514e2-f2ad-4470-afef-e44fa1524029">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTgtMS0xLTUxOTM1_1c08e03d-4d9f-4d6b-ab70-be34e5d4129e">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTEwLTEtMS01MTkzNQ_c07d13a1-247a-472d-b210-dd0ab6edf9d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTEyLTEtMS01MTkzNQ_cda9203a-4a52-4a0d-99f3-5eb3fa6db65e">10,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTE0LTEtMS01MTkzNQ_4fcc3004-6908-4334-9b71-ae64087517af">1,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTE2LTEtMS01MTkzNQ_65d20fe5-0d6d-4370-be43-d2886f99ce0b">20,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110b9761945d4e40813f9a8bbed2a310_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTItMS0xLTUxOTM1_d39bca53-2535-45de-be7c-1e3dac8f36b2">98,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c821411e9b45e392b05177c8f28d1f_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTQtMS0xLTUxOTM1_17d074ef-107c-4a1f-b093-cc51953bd077">52,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec591a925cd42b7a547da2ee176f02d_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTYtMS0xLTUxOTM1_65b3abdb-a295-4713-b715-11778383e4e9">15,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6ee17d39bd4e0bac8d7e0aa55cc85f_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTgtMS0xLTUxOTM1_466f6c11-44fc-4c19-99be-dd4079a6dfc4">39,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51588dda918456aa393e95440d4bdc0_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTEwLTEtMS01MTkzNQ_eba90355-ddb9-446a-85cc-5fa5f188865f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4c76f5de1d474bac108f73781f88df_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTEyLTEtMS01MTkzNQ_42613caf-48ad-42ff-8b38-655d54266857">106,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ad8c812d379411bb81c7ce92abd8232_I20201231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTE0LTEtMS01MTkzNQ_b39afebe-6be5-41a3-902d-10df9632708d">7,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTE2LTEtMS01MTkzNQ_7a684d5d-017c-4a3e-a293-8721717a29f1">197,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTItMS0xLTUxOTM1_8c2d2eca-7003-4aa8-89f6-ae89a8bafb16">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTQtMS0xLTUxOTM1_590429e9-f21d-4b8b-82e2-f46a6d39da3b">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTYtMS0xLTUxOTM1_38f07e45-77d3-4cff-b698-44294f982d19">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTgtMS0xLTUxOTM1_c9c29af2-a6e7-4eb3-88e8-a9a588bd4960">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTEwLTEtMS01MTkzNQ_8f7bb437-9f5b-40ad-b39a-c2a8592e0b63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTEyLTEtMS01MTkzNQ_68752e5f-72c8-4226-8352-f0aed0d96525">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTE0LTEtMS01MTkzNQ_68c3deeb-cf10-4519-a831-bf9424349642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTE2LTEtMS01MTkzNQ_f86ee3cc-efe6-44b2-9047-3713a45bb79f">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTItMS0xLTUxOTM1_6efff960-c92c-4181-b2aa-dd426ce731a2">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTQtMS0xLTUxOTM1_31e7cd66-abd3-4086-9822-1eaeb13d6994">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTYtMS0xLTUxOTM1_0b4bb79a-3bb7-49ce-914c-6b80d9647729">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTgtMS0xLTUxOTM1_fb93df62-771c-4e73-9bb3-7bd1abb7b967">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTEwLTEtMS01MTkzNQ_30d411a2-4c0c-450b-88b0-e0c7b5833d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTEyLTEtMS01MTkzNQ_c9c684ea-1d0c-4c4e-b624-88253be1e1aa">1,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTE0LTEtMS01MTkzNQ_babb9faf-920f-4581-978b-659de631f2c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTE2LTEtMS01MTkzNQ_bd322e47-ce3a-4a92-b62b-37424707efee">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_217"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_220"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) designed to provide reasonable assurance the information required to be disclosed by us in reports we file or submit under the Exchange Act is (i)&#160;recorded, processed, summarized and reported within the time periods specified in SEC rules&#160;and forms; and (ii)&#160;accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this Annual Report on Form 10-K, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were effective at the reasonable assurance level as of December&#160;31, 2022.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_223"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the quarter ended December&#160;31, 2022 which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control Over Financial Reporting as of December&#160;31, 2022 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of UnitedHealth Group Incorporated and Subsidiaries (the Company) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company&#8217;s internal control system is designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. The Company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the consolidated financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Based on our assessment and the COSO criteria, we believe that, as of December&#160;31, 2022, the Company maintained effective internal control over financial reporting. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent registered public accounting firm has audited the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, as stated in the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_229">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, appearing under Item&#160;9A. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of UnitedHealth Group Incorporated and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by COSO.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated  February 24, 2023, expressed an unqualified opinion on those financial statements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control Over Financial Reporting as of December 31, 2022. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DELOITTE&#160;&amp; TOUCHE LLP</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_232"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_235"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_238"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_241"></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DIRECTORS OF THE REGISTRANT</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth certain information regarding our directors as of February 24, 2023, including their name and principal occupation or employment:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timothy Flynn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F. William McNabb III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retired Chair<br/>KPMG International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Chairman and Chief Executive Officer <br/>The Vanguard Group, Inc.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul Garcia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valerie Montgomery Rice, M.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retired Chair and Chief Executive Officer<br/>Global Payments Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer<br/>Morehouse School of Medicine</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kristen Gil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John Noseworthy, M.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Business Finance Officer<br/>Alphabet Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Chief Executive Officer and President</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mayo Clinic</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen Hemsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew Witty</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair<br/>UnitedHealth Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br/>UnitedHealth Group</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michele Hooper</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director<br/>UnitedHealth Group<br/>President and Chief Executive Officer<br/>The Directors&#8217; Council</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to General Instruction G(3) to Form 10-K and the Instruction to Item&#160;401 of Regulation S-K, information regarding our executive officers is provided in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_13">Part I, Item&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the caption &#8220;Information About our Executive Officers.&#8221; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of ethics applicable to our principal executive officer and other senior financial officers, who include our principal financial officer, principal accounting officer, controller and persons performing similar functions. The code of ethics, entitled Code of Conduct: Our Principles of Ethics and Integrity, is posted on our website at www.unitedhealthgroup.com. For information about how to obtain the Code of Conduct, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_13">Part I, Item 1, &#8220;Business.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We intend to satisfy the SEC&#8217;s disclosure requirements regarding amendments to, or waivers of, the code of ethics for our senior financial officers by posting such information on our website indicated above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining information required by Items 401, 405, 406 and 407(c)(3), (d)(4) and (d)(5) of Regulation S-K will be included under the headings &#8220;Corporate Governance&#8221; and &#8220;Proposal 1-Election of Directors&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_244"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Items&#160;402 and 407(e)(4) and (e)(5) of Regulation S-K will be included under the headings &#8220;Executive Compensation,&#8221; &#8220;Director Compensation,&#8221; &#8220;Corporate Governance - Risk Oversight&#8221; and &#8220;Compensation Committee Interlocks and Insider Participation&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_247"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information as of December 31, 2022, concerning shares of common stock authorized for issuance under all of our equity compensation plans:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(a)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Number of securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">to be issued upon exercise of outstanding options, warrants and rights</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(b)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Weighted-average exercise price of outstanding options, warrants and rights</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Number of securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">remaining available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">future issuance under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">equity compensation plans (excluding securities reflected in column (a))</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by shareholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of the UnitedHealth Group Incorporated 2020 Stock Incentive Plan, as amended, and the UnitedHealth Group 1993 Employee Stock Purchase Plan, as amended.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Excludes 459,000 shares underlying stock options assumed by us in connection with acquisitions. These options have a weighted-average exercise price of $358 and an average remaining term of approximately 4 years. These options are administered pursuant to the terms of the plans under which the options originally were granted. No future awards will be granted under these acquired plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 18 million shares of common stock available for future issuance under the 1993 Employee Stock Purchase Plan as of December 31, 2022, and 59 million shares available under the 2020 Stock Incentive Plan as of December 31, 2022. Shares available under the 2020 Stock Incentive Plan may become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based awards.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 403 of Regulation S-K will be included under the heading &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Shareholders, and such required information is incorporated herein by reference.</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_250"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Items 404 and 407(a) of Regulation S-K will be included under the headings &#8220;Certain Relationships and Transactions&#8221; and &#8220;Corporate Governance&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_253"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item&#160;9(e) of Schedule 14A will be included under the heading &#8220;Disclosure of Fees Paid to Independent Registered Public Accounting Firm&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_256"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i6b660947fab7488cb4d33baca2cb3a37_259"></div><div style="-sec-extract:summary;margin-top:3pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 15.&#160;&#160;&#160;&#160;EXHIBIT AND FINANCIAL STATEMENT SCHEDULES </span></div><div style="margin-top:4.5pt;padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements are included under Item&#160;8 of this report:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_76">Reports of Independent Registered Public Accounting Firm.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">Consolidated Balance Sheets as of December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79"> and 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_79">.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">Consolidated Statements of Operations for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_85">.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">Consolidated Statements of Comprehensive Income for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_88">.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">Consolidated Statements of Changes in Equity for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_91">.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">Consolidated Statements of Cash Flows for the years ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_97">.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_100">Notes to the Consolidated Financial Statements.</a></span></div><div style="margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Financial Statement Schedules </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial statement schedule of the Company is included in Item&#160;15(c): </span></div><div style="margin-top:4.5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_262">Schedule I - Condensed Financial Information of Registrant (Parent Company Only). </a></span></div><div style="margin-top:4.5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions, are inapplicable, or the required information is included in the consolidated financial statements, and therefore have been omitted.</span></div><div style="margin-top:4.5pt;padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The following exhibits are filed or incorporated by reference herein in response to Item&#160;601 of Regulation S-K. The Company files Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K pursuant to the Securities Exchange Act of 1934 under Commission File No. 1&#8209;10864.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBIT INDEX**</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm">Certificate of Incorporation of UnitedHealth Group Incorporated (incorporated by reference to Exhibit 3.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form 8-A/A, Commission File No. 1-10864, filed on July 1, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm">Amended and Restated Bylaws of UnitedHealth Group Incorporated, effective February 23, 2021 (incorporated by reference to Exhibit 3.2 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on February 26, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/0001045969-99-000009.txt">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/0001045969-99-000009.txt">Senior Indenture, dated as of November 15, 1998, between United HealthCare Corporation and The Bank of New York (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-3/A, SEC File Number 333-66013, filed on January 11, 1999)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000091205701539251/a2063056zex-4_1.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000091205701539251/a2063056zex-4_1.htm">Amendment, dated as of November 6, 2000, to Senior Indenture, dated as of November 15, 1998, between the UnitedHealth Group Incorporated and The Bank of New York (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2001)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312507171261/dex43.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312507171261/dex43.htm">Instrument of Resignation, Appointment and Acceptance of Trustee, dated January 8, 2007, pursuant to the Senior Indenture, dated as of November 15, 1988, amended as of November 6, 2000, among UnitedHealth Group Incorporated, The Bank of New York and Wilmington Trust Company (incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2007)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312508018563/dex41.htm">4.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312508018563/dex41.htm">Indenture, dated as of February 4, 2008, between UnitedHealth Group Incorporated and U.S. Bank National Association (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-3, SEC File Number 333-149031, filed on February 4, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex4512312019.htm">4.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex4512312019.htm">Description of Common Stock (incorporated by reference to Exhibit 4.5 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">UnitedHealth Group 2020 Stock Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">(incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8, SEC File Number 333-238854, filed on June 1, 2020)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/0000731766-20-000029-index.htm"> </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10212312022.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10212312022.htm">Form of Agreement for Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (2023 Version)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10312312022.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10312312022.htm">Form of Agreement for Nonqualified Stock Option Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (2023 Version)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104123122.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104123122.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (2023 Version)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10512312022.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10512312022.htm">Form of Agreement for Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (2023 Version)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10612312022.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10612312022.htm">Form of Agreement for Nonqualified Stock Option Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (2023 Version)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10712312022.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10712312022.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (2023 Version)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">Form of Agree</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">ment for Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">s 2020 Stock Incent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">ive Plan (i</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">ncorporated by reference to Exhibit 10.2 to UnitedHeal</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">th Group Incorpo</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">rated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">s Annual R</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10212312021.htm">eport on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">Form of Agreement for N</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">onquali</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">fied </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">Stock Option Award to Executives under UnitedHealth Grou</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">p Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">s 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.3 to UnitedHealth Gro</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">up Incorpo</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">ted</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">s Annual Re</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm">port on Form</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10312312021.htm"> 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm"> to Executiv</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">es under UnitedHealth Group Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">s 2020 Stock Incentive Plan (incorporated by reference to Exhibit 10.4 to UnitedHealth Group Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex104123121.htm">s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10512312021.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10512312021.htm">Form of Agreement for Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (incorporated by reference to Exhibit 10.5 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10612312021.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10612312021.htm">Form of Agreement for Nonqualified Stock Option Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (incorporated by reference to Exhibit 10.6 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10712312021.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhex10712312021.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty) (incorporated by reference to Exhibit 10.7 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176619000005/unhex10112312018.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176619000005/unhex10112312018.htm">UnitedHealth Group Incorporated 2011 Stock Incentive Plan, as amended and restated in 2018 (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1049302015.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1049302015.htm">Form of Agreement for Non-Qualified Stock Option Award to Executives under UnitedHealth Group Incorporated&#8217;s 2011 Stock Incentive Plan, as amended and restated in 2015, for awards made after January 1, 2016 (incorporated by reference to Exhibit 10.4 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1059302015.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1059302015.htm">Form of Agreement for Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2011 Stock Incentive Plan, as amended and restated in 2015, for awards made after January 1, 2016 (incorporated by reference to Exhibit 10.5 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1069302015.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1069302015.htm">Form of Agreement for Performance-based Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2011 Stock Incentive Plan, as amended and restated in 2015, for awards made after January 1, 2016 (incorporated by reference to Exhibit 10.6 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000119312511153414/dex106.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000119312511153414/dex106.htm">Form of Agreement for Deferred Stock Unit Award to Non-Employee Directors under UnitedHealth Group Incorporated&#8217;s 2011 Stock Incentive Plan (incorporated by reference to Exhibit 10.6 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on May 27, 2011)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">Form of Agreement for Deferred Stock Unit Award to Non-Employee Directors under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">Plan (incorporated by reference to Exhibit 10.11 to UnitedHealth Group Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1011.htm">s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000028/exhibit101.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000028/exhibit101.htm">20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000028/exhibit101.htm">Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on July 1, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">Amended and Restated UnitedHealth Group Incorporated Executive Incentive Plan (2009 Statement), effective as of December 31, 2008 (incorporated by reference to Exhibit 10.12 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan, effective as of December 31, 2008 (incorporated by reference to Exhibit 10.13 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">Amendment, dated as of December 21, 2012, of Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan (incorporated by reference to Exhibit 10.11 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">24</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">Second Amendment, dated as of November 5, 2015, of Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan (incorporated by reference to Exhibit 10.3 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">UnitedHealth Group Executive Savings Plan (2021 Statement) (incorporated by reference to Exhibit 10.11 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102612312022.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102612312022.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102612312022.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="unhex102612312022.htm">First Amendment </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="unhex102612312022.htm">of UnitedHealth G</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="unhex102612312022.htm">roup Executive Savings Plan (2021 Statemen</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="unhex102612312022.htm">t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="unhex102612312022.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102712312022.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102712312022.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102712312022.htm">Second Amendment of UnitedHealth Group Executive Savings Plan (2021 Statement)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102812312022.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102812312022.htm">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102812312022.htm">Executive Long-Term Disability Program, dated as of January 1, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102912312022.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102912312022.htm">29</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102912312022.htm">Summary of Non-Management Director Compensation, effective as of October</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex102912312022.htm"> 1, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">0</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">UnitedHealth Group Directors</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm"> Compensation Deferral Plan (2023 Statemen</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103012312022.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103112312022.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103112312022.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103112312022.htm">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103112312022.htm">Avery</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex103112312022.htm"> Parent Holdings, Inc. 2020 Stock Option and Grant Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">hange Healthcare Inc. 2019 Omnibus Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-3.htm">(incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-8, SEC File Number 333-267716, filed on October 3, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-4.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-4.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-4.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-4.htm">Amended and Restated HCIT Holdings, Inc. 2009 Equity Incentive Plan (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-8, SEC File Number 333-267716, filed on October 3, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000110465922105262/tm2226855d1_ex4-4.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">Audax Health Solutions, Inc. 2010 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 to Registration Statement on Form S-8, SEC File Number 333-205826, filed on February 15, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">Surgical Care Affiliates, Inc. 2016 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">Surgical Care Affiliates, Inc. 2013 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">Surgical Care Affiliates, Inc. Management Equity Incentive Plan (incorporated by reference to Exhibit 4.5 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">Surgical Care Affiliates, Inc. Directors and Consultants Equity Incentive Plan (incorporated by reference to Exhibit 4.6 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">39</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">The Advisory Board Company Amended and Restated 2009 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to The Advisory Board Company&#8217;s Current Report on Form 8-K filed on June 15, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">0</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">The Advisory Board Company 2005 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to The Advisory Board Company&#8217;s Current Report on Form 8-K filed on November 17, 2005)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">Amended and Restated Employment Agreement, effective as of June 7, 2016, between United HealthCare Services, Inc. and John Rex (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">Amended and Restated Employment Agreement, dated February 3, 2021, between the Company and Andrew P Witty (incorporated by reference to Exhibit 5.02 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on February 8, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">Amended and Restated Employment Agreement, effective as of March 16, 2015, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.44 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019) </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">Amendment to Employment Agreement, effective as of May 31, 2017, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.45 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">Amendment to Employment Agreement, effective as of March 12, 2019, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.46 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">Amended and Restated Employment Agreement, effective as of February 12, 2018, between United HealthCare Services, Inc. and Brian R. Thompso</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">(incorporated by reference to Exhibit 10.38 to UnitedHealth Group Incorporated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176622000008/unhexhibit1038.htm">s Annual Report on Form 10-K for the year ended December 31, 2021)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">Employment Agreement, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">effective as of February 28, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">, between United H</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">ealthCare Services, Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104712312022.htm">. and Rupert M. Bondy</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement regarding computation of per share earnings (incorporated by reference to the information contained under the heading &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_157">Net Earnings Per Common Share</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in Note 2 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221;)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex21112312022.htm">21.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex21112312022.htm">Subsidiaries of UnitedHealth Group Incorporated</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex23112312022.htm">23.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex23112312022.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex24112312022.htm">24.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex24112312022.htm">Power of Attorney</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex31112312022.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex31112312022.htm">Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex32112312022.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex32112312022.htm">Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and embedded within Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_______________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:3.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contracts and compensation plans in which certain directors and named executive officers participate and which are being filed pursuant to Item&#160;601(b)(10)(iii)(A) of Regulation S-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to Item&#160;601(b)(4)(iii) of Regulation S-K, copies of instruments defining the rights of certain holders of long-term debt are not filed. The Company will furnish copies thereof to the SEC upon request.</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Financial Statement Schedule </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule I - Condensed Financial Information of Registrant (Parent Company Only).</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_262"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries: </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statement Schedule</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the consolidated financial statements of UnitedHealth Group Incorporated and Subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, and for each of the three years in the period ended December 31, 2022, and the Company&#8217;s internal control over financial reporting as of December 31, 2022, and have issued our reports thereon dated February 24, 2023; such reports are included elsewhere in this Form 10-K. Our audits also included the financial statement schedule of the Company listed in the Index at Item 15. This financial statement schedule is the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statement schedule based on our audits. In our opinion, the financial statement schedule, when considered in relation to the consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DELOITTE &amp; TOUCHE LLP</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3NjY_baacb837-ec01-4e8f-bbfd-defb385d2d94" continuedAt="ife42397649fd4b76865d21dd68168f32" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3ODI_74e5583a-3943-43f7-a189-f9370877ab56" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzMtMi0xLTEtNTE5MzU_0e59b86b-b68c-4f54-aae6-fbab3474675c">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzMtNC0xLTEtNTE5MzU_debf1bf4-7105-4888-a14d-cc01c819c807">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzQtMi0xLTEtNTE5MzU_7c73f539-8fd6-4488-8d11-6a3d3460cd9c">753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzQtNC0xLTEtNTE5MzU_a9c570e9-9f88-4927-a35e-4d0e61990a31">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzUtMi0xLTEtNTE5MzU_f00f80c1-6f2e-4b92-a5c7-ef43b19bc37e">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzUtNC0xLTEtNTE5MzU_3a2e7323-a5ed-4937-a581-90c33cfaa735">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="unh:EquityinNetAssetsofSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzYtMi0xLTEtNTE5MzU_ea0a7f1d-670a-4751-853d-c283c69179c5">136,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="unh:EquityinNetAssetsofSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzYtNC0xLTEtNTE5MzU_5abedf1f-5012-410b-acbb-1f60d1c4b1c2">116,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:NotesReceivableRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzctMi0xLTEtNTE5MzU_2eade7d3-6ceb-4f41-b06b-a6bd3fbd24fc">6,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:NotesReceivableRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzctNC0xLTEtNTE5MzU_bbc0d765-e788-4ba3-bce0-c9ac76b55470">5,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzgtMi0xLTEtNTE5MzU_c2439a8e-4810-449b-9082-ccae3b0abf0a">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzgtNC0xLTEtNTE5MzU_c8c71bdf-2d6d-496d-8307-b9562e035e88">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzktMi0xLTEtNTE5MzU_d39f0860-8fb3-4eb8-a2aa-3a83449108de">144,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzktNC0xLTEtNTE5MzU_08f16ae3-3d19-44fc-a364-aea48d532744">125,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzEzLTItMS0xLTUxOTM1_cae57793-3bbb-405e-bcc6-b1ca55b49e99">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzEzLTQtMS0xLTUxOTM1_f2e2e685-b003-4aea-8726-9e1b80ff69ac">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE0LTItMS0xLTUxOTM1_0be5e2c7-07b7-4dad-a616-5578e305c631">8,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE0LTQtMS0xLTUxOTM1_aa878c18-1f6e-45b9-a71a-c077e7fe7249">8,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE1LTItMS0xLTUxOTM1_73a113b9-91c5-41f8-9261-3c1ca4c4d12d">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE1LTQtMS0xLTUxOTM1_41c38a19-54d4-4289-bcde-d7c3fd411eac">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE2LTItMS0xLTUxOTM1_6986e577-80dc-4af4-b72d-a6e26cd820d7">12,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE2LTQtMS0xLTUxOTM1_1f6be1d4-1941-4062-a41a-cb7d40647c86">11,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE3LTItMS0xLTUxOTM1_04089967-1bed-4146-aa49-79fd89d33c6a">53,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE3LTQtMS0xLTUxOTM1_091a6690-242f-4c18-8c38-624b23d56066">41,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE4LTItMS0xLTUxOTM1_911676bd-986e-45ae-a04d-09eddb1a8434">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE4LTQtMS0xLTUxOTM1_2b52ffca-7098-4f93-965b-91cdd4874daf">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE5LTItMS0xLTUxOTM1_b571616e-e935-4e40-9756-77379979835e">66,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE5LTQtMS0xLTUxOTM1_698cba12-be9b-47d4-9ca4-e203bf0032aa">53,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTUzOQ_1aecc172-2e9f-4709-80bc-d6f7fda4af4a"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTUzOQ_e4012a5a-2053-4db1-ae8a-ba76bdb3d4e9">0.001</ix:nonFraction></ix:nonFraction> par value -<ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU0Ng_c21e2761-5016-4a0a-ba9e-2e329151f4de"><ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU0Ng_c5870579-a030-426f-8558-f9475cefbc53">10</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_0af4f31c-f2b2-4a3d-9f64-e24677ba3bc0"><ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_38c7d3c9-feee-48cf-bad5-0ff13aa0da14"><ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_5add7a35-35db-4404-8277-e3324a0a3a77"><ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_785f5284-de3a-4a8a-b591-ea5c81f78931">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTItMS0xLTUxOTM1_b62d59dd-0efb-430e-b566-c78721bda7eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTQtMS0xLTUxOTM1_5077cfbe-fc39-4464-9c8d-0c8f1fe13995">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU1Mw_e5a7459c-9b2f-4279-855d-3ab31cf33b20"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU1Mw_fba8f39b-2f87-498a-aa2b-b3ff542cb806">0.01</ix:nonFraction></ix:nonFraction> par value - <ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2MQ_463e1df6-6d5a-44e7-938a-2827418626b4"><ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2MQ_bc74a5c3-3b63-41bc-acd0-238fc71b7b25">3,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2OA_bb378609-759c-48c3-86b2-393f8587d512"><ix:nonFraction unitRef="shares" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2OA_fef29353-044f-4c91-9b0e-69943a8d4624">934</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU3NA_1e0d603e-767a-46ff-9a7b-507f967a404c"><ix:nonFraction unitRef="shares" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU3NA_7a0fc801-d15d-4603-a9c4-7d1d54d130db">941</ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTItMS0xLTUxOTM1_9b8f6f41-d760-4aef-b811-306d505b0ec0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTQtMS0xLTUxOTM1_3f42af5f-c441-48b9-ab17-58924fd3516d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI1LTItMS0xLTUxOTM1_04cc2c0a-3eff-4ac6-84eb-e9ba62552ee5">86,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI1LTQtMS0xLTUxOTM1_aa784b56-c72d-4306-86a7-247500155076">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI2LTItMS0xLTUxOTM1_990bb69b-deee-4979-82c1-24dcb24f8c4a">8,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI2LTQtMS0xLTUxOTM1_5e78aad0-e1db-4d2a-b1ea-e74084959f8b">5,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI3LTItMS0xLTUxOTM1_c9d81e77-822a-40d4-9161-9f7580666621">77,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI3LTQtMS0xLTUxOTM1_6353733c-30ff-4215-9faf-d0c0649010b5">71,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI4LTItMS0xLTUxOTM1_2a626652-b84d-48b5-889a-71c75223126c">144,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI4LTQtMS0xLTUxOTM1_083dc558-5660-4b94-8d79-13329e815024">125,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_268">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ife42397649fd4b76865d21dd68168f32" continuedAt="i3d0550cccc0c4290923135c195ca9202"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="srt:CondensedStatementOfComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3Nzg_0a78c974-0a89-4950-9142-8f05910d7851" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtMi0xLTEtNTE5MzU_db2f42a3-e661-48f0-865a-7327e098ddb4">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtNC0xLTEtNTE5MzU_9cf1e23f-fc5c-4671-bd0e-e73f77bab348">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtNi0xLTEtNTE5MzU_ecf5ef47-d683-43c8-8b89-0908c6ae4932">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtMi0xLTEtNTE5MzU_8338c5dd-cf99-416e-954c-feed1694dde2">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtNC0xLTEtNTE5MzU_2ba45323-cef7-45be-a8d1-44a10a0fc26a">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtNi0xLTEtNTE5MzU_b22b295e-d891-4ad9-8cce-041a1e2a5b4c">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtMi0xLTEtNTE5MzU_366f3379-763f-4a5c-b8fe-138c4095e116">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtNC0xLTEtNTE5MzU_395ab74c-ed73-4b1b-a132-97ff176a191d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtNi0xLTEtNTE5MzU_a9ab0f0e-7d20-4b7f-b845-7b7d8dc9bdbc">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctMi0xLTEtNTE5MzU_beaa99ec-37d6-4c27-b2da-1b02867c6b75">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctNC0xLTEtNTE5MzU_9a17c5a5-0d13-47b5-b644-e5f6b8cd3762">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctNi0xLTEtNTE5MzU_ad8d8fca-5cfe-4736-a9f7-b284ac8b3d9f">1,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtMi0xLTEtNTE5MzU_d42e372c-9982-406c-a796-20ce8735a0aa">2,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtNC0xLTEtNTE5MzU_5150d6d5-8a4c-4fb0-858b-922be1fdbf1d">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtNi0xLTEtNTE5MzU_c384de20-ef2b-4bf0-ae63-d0bee69bb454">1,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktMi0xLTEtNTE5MzU_3e5be5ea-9c70-4c44-a573-4f63799ecfaf">1,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktNC0xLTEtNTE5MzU_6a2bacb8-f904-4c6b-821f-9010c261e9f4">1,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktNi0xLTEtNTE5MzU_ae101f4d-c51f-465d-a879-be82156a7423">1,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTItMS0xLTUxOTM1_9a929de4-1c66-4f82-9fd9-377ee1f80208">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTQtMS0xLTUxOTM1_046691fd-3094-4007-b339-7b4a58e66a55">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTYtMS0xLTUxOTM1_6829d4ea-8ab3-4748-aa32-7b1365552a7e">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="unh:LossofParentCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTItMS0xLTUxOTM1_8b105093-7b6f-4945-b6d6-9927713de391">1,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="unh:LossofParentCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTQtMS0xLTUxOTM1_ed0e6998-523f-4cc3-a018-3449f6e78fa5">898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="unh:LossofParentCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTYtMS0xLTUxOTM1_2f321509-6931-48f7-83a9-458a59ec9802">1,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTItMS0xLTUxOTM1_669dfdd5-48b2-48d4-8d57-c7b80cdeeb7b">21,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTQtMS0xLTUxOTM1_840e1d21-75b5-4805-8750-4ed17e6845ab">18,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTYtMS0xLTUxOTM1_b7a91b76-3736-48d4-97ae-50bc459a1c5f">16,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTItMS0xLTUxOTM1_76ea5d33-c1d5-4801-ae85-1d6bdfa67fda">20,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTQtMS0xLTUxOTM1_03252443-ef19-457a-bb41-36e0f9ecbe4c">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTYtMS0xLTUxOTM1_45ab0fea-b89f-414b-a01a-e2342ac2365d">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTItMS0xLTUxOTM1_137e83b6-df57-4fee-921a-95dbd731c42f">3,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTQtMS0xLTUxOTM1_8a409ff4-4771-4d87-8287-5abe7377f270">1,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTYtMS0xLTUxOTM1_16762ae6-fec5-4cd1-b0fd-58d1a0a23335">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTItMS0xLTUxOTM1_7f5bd2f1-a8e4-42e7-93ee-7ddb5072f22c">17,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTQtMS0xLTUxOTM1_b927680e-557b-4cdf-aef5-28311207a1d2">15,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTYtMS0xLTUxOTM1_8070d863-4537-4807-a114-16c1e215f2a2">15,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_268">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i3d0550cccc0c4290923135c195ca9202" continuedAt="i2b5b5da4dc564668b99d38d2e23acc9e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3ODQ_3c112170-b4aa-4152-9c00-5d0bd2360892" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtMi0xLTEtNTE5MzU_0fa98d1d-c8a3-4100-a470-490a9434e281">14,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtNC0xLTEtNTE5MzU_90571d70-20a8-4811-b8d5-2b225959a41b">11,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtNi0xLTEtNTE5MzU_05373122-3d57-48ea-82fa-f3dfb78257e3">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtMi0xLTEtNTE5MzU_0eeca91c-1505-4869-826f-342c12421024">567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtNC0xLTEtNTE5MzU_e483a05e-dcfe-4a9e-98a9-c22c16116589">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtNi0xLTEtNTE5MzU_909a6fc4-13c5-4ac9-ae2e-033bb4ef9ad3">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtMi0xLTEtNTE5MzU_76a85aac-50c2-4005-b2f6-88cc0642adc9">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtNC0xLTEtNTE5MzU_260744e0-e52a-4cfa-b9cd-2f3b87d5c85a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtNi0xLTEtNTE5MzU_b4a3c783-f5f9-4c71-9166-cf70fcbba6ae">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctMi0xLTEtNTE5MzU_d2efd25f-3067-4c67-b27e-89e66abc6c6d">20,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctNC0xLTEtNTE5MzU_7b1ccc3c-a419-4878-be59-0e55efb550a1">4,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctNi0xLTEtNTE5MzU_902209d7-e38f-487f-a53d-d242b099b3d8">7,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtMi0xLTEtNTE5MzU_ada44ae1-21a2-42d4-9152-8ac950b4191a">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtNC0xLTEtNTE5MzU_a080b39d-a003-4bc8-8d11-c44f90dcba3e">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtNi0xLTEtNTE5MzU_8307589f-1cf0-4978-adce-5c4ad33104a9">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktMi0xLTEtNTE5MzU_28722279-62b6-4f8d-9723-a360b8b11245">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktNC0xLTEtNTE5MzU_b43d7209-d4b9-46db-ba4c-c17e0df81e98">747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktNi0xLTEtNTE5MzU_ca5c2c3b-588e-4b03-9d5a-6f5b36ceaa16">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from dispositions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTItMS0xLTYyMjEy_485e8994-fa37-4836-afa6-6af110fc9516">2,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTQtMS0xLTYyMjEy_26256461-2634-4faa-bfa9-21afda52ee4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTYtMS0xLTYyMjEy_ba9bbfae-40af-4db3-a572-688622dea6d3">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTItMS0xLTUxOTM1_cf5b7af9-a92d-4ce6-9a1e-764ea69494af">17,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTQtMS0xLTUxOTM1_60190787-e7a4-4f4f-ae22-86503ebbcdcf">5,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTYtMS0xLTUxOTM1_942377b7-3b40-4ab6-b40f-a4044b1aaa9e">6,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTItMS0xLTUxOTM1_4e1cce62-6f07-4573-a437-72e42672f888">7,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTQtMS0xLTUxOTM1_f49965aa-49e3-4e79-8227-4d6b10c57918">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTYtMS0xLTUxOTM1_657eb1bb-006d-4d6a-8b8d-ab20c48833c8">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTItMS0xLTUxOTM1_c291842f-f5ce-4d5f-8660-37a75b046976">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTQtMS0xLTUxOTM1_7164204d-1b72-41de-b928-bbe21311fccc">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTYtMS0xLTUxOTM1_00e4e1dc-c0a7-441d-be58-d46e4a60a124">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTItMS0xLTUxOTM1_e31a0610-747b-49f8-a2b8-6be6d2ac2ff2">5,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTQtMS0xLTUxOTM1_b1eb218c-239f-4976-b2be-f4a9c500f2a5">5,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTYtMS0xLTUxOTM1_61733064-8cc1-44da-9ac9-7a36f330f74b">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceed from (repayments of) short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTItMS0xLTUxOTM1_4f9b3303-0494-4452-b0cb-65e242f3e2ca">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTQtMS0xLTUxOTM1_72c6b741-68e4-467f-90a2-b968ae029260">1,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTYtMS0xLTUxOTM1_e426fbe1-697d-4274-a2bd-23dab8915479">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTItMS0xLTUxOTM1_b26e98c6-9e28-4945-933d-756105783f43">14,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTQtMS0xLTUxOTM1_da9d5cf1-8556-48ac-a59e-2e07e97ac7ab">6,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTYtMS0xLTUxOTM1_2d5bed66-db35-4c19-aa7c-06d1a5d57298">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTItMS0xLTUxOTM1_d44c2983-a14e-451a-904e-26a8a3db9ace">3,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTQtMS0xLTUxOTM1_ee24f5cb-fa1a-47aa-b88c-78d79550eb05">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTYtMS0xLTUxOTM1_f9335627-593f-442a-bced-e773fe3bd477">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTItMS0xLTUxOTM1_b9f235ba-bb19-4ec5-aac2-50c47e55fbbb">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTQtMS0xLTUxOTM1_84350204-1c64-4fb6-81dd-cc5247e00f4c">3,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTYtMS0xLTUxOTM1_f0eac9d8-ea72-4e9a-b4f7-dd9bbaf27e99">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTItMS0xLTUxOTM1_04e62746-eb38-44a2-b1d6-b94484201cf1">674</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTQtMS0xLTUxOTM1_5b56340c-9b3b-44b7-ad73-39c7d67ecd61">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTYtMS0xLTUxOTM1_a8773ad7-a767-4bd4-ac38-d63e2c72a08b">438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from (used for) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTItMS0xLTUxOTM1_3bdf28f6-eaa1-4c09-8276-c1ffc2b2401f">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTQtMS0xLTUxOTM1_5c199a88-23d7-4850-89bb-6628e10efe03">3,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTYtMS0xLTUxOTM1_6e97e2cc-bfe7-440e-b0db-a4e50ee47800">2,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTItMS0xLTUxOTM1_60055fb7-6ef3-49bf-bfbd-1e2784d82c43">1,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTQtMS0xLTUxOTM1_d2f87eab-e69e-4cc7-8b98-349180410e17">1,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTYtMS0xLTUxOTM1_c9479806-fa89-4bd9-9414-73f49b0c6501">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTItMS0xLTUxOTM1_62306646-a9a6-4b45-9626-df418ec3837f">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b5990f30984481b9bc048adaeb8fbb_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTQtMS0xLTUxOTM1_6e256ef7-f318-45d6-b3f8-20283f55c2c2">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2e15c2a33d49639d714c65b404e2cc_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTYtMS0xLTUxOTM1_f9e4c8df-ce76-47d5-8c4b-8b511d59c454">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTItMS0xLTUxOTM1_24b52254-9395-4a1f-ace8-8d51b4b2a5f4">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTQtMS0xLTUxOTM1_69196088-3b53-4c69-8bdd-3ca83714e0ed">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b5990f30984481b9bc048adaeb8fbb_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTYtMS0xLTUxOTM1_4c9bde98-89c0-4fff-b710-942e7961474d">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTItMS0xLTUxOTM1_087d5101-212e-4359-b2f6-ca3138cfeaba">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTQtMS0xLTUxOTM1_4e06ad25-d0a4-41ab-a3b3-5076b46ad8da">1,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTYtMS0xLTUxOTM1_af42d04f-3e6e-468d-867e-03d75d7e1f14">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTItMS0xLTUxOTM1_5c2806ae-9c71-4e33-9c54-d07688df9205">4,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTQtMS0xLTUxOTM1_e1ef4199-10c5-4f84-8642-8d45fe86d7be">3,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTYtMS0xLTUxOTM1_705e407b-defa-46b1-87a4-a5cc6bd1605f">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-align:center"><ix:continuation id="i2b5b5da4dc564668b99d38d2e23acc9e" continuedAt="i88ef8164e1464792a6278858dd29ca16"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_268">Notes to the Condensed Financial Statements of Registrant</a></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_268"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i88ef8164e1464792a6278858dd29ca16" continuedAt="i8b357666e53c478baee90e2b045353e3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjgvZnJhZzo1YmJjM2I3ZDJmMGM0Zjg2OTQ2OGIxMDNkNmY5NGYyYS90ZXh0cmVnaW9uOjViYmMzYjdkMmYwYzRmODY5NDY4YjEwM2Q2Zjk0ZjJhXzYyMA_8ebf0156-2d3d-4208-b346-e20f60e483b7" continuedAt="i3cb1d757283243b99f96e6d17e2a0427" escape="true">Basis of Presentation </ix:nonNumeric></span></div><div style="margin-top:4.5pt"><ix:continuation id="i3cb1d757283243b99f96e6d17e2a0427"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_106">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></ix:continuation></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_271"></div><ix:continuation id="i8b357666e53c478baee90e2b045353e3" continuedAt="ibb9762ac433a42fc9d7e279829616703"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzU1Ng_46866d6f-0fe2-4682-b574-9b8193d2f9d1" continuedAt="i037c42e9a67c4c8faba8146b2d5ad1a7" escape="true">Subsidiary Transactions </ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i037c42e9a67c4c8faba8146b2d5ad1a7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends and Capital Distributions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends received from subsidiaries and included in Cash Flows from Operating  Activities in the Condensed Statements of Cash Flows were $<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM2NA_682283eb-2ca8-4bfd-9f89-0dc41d4aad69">15.6</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM2OA_a5feb08b-edb5-40c4-bd2c-2e84be7525c0">10.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM3NQ_02eb81f1-9b65-4264-8600-3e5f3da8541e">10.0</ix:nonFraction> billion in 2022, 2021 and 2020, respectively. Additionally, $<ix:nonFraction unitRef="usd" contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQzMA_09c34764-61cc-48c0-af3a-ceebcbca0642">1.4</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQzNA_036a73f4-dd30-4794-8d2d-1b70cf94872a">0.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQ0MQ_6e437682-2eb3-4a03-9768-40ecf7d2fac8">0.9</ix:nonFraction> billion in cash were received as a return of capital to the parent company during 2022, 2021 and 2020, respectively.</span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_274"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:continuation id="ibb9762ac433a42fc9d7e279829616703" continuedAt="ic8f65dbee5904eb5a04b04cabafd9a1f">Short-Term Borrowings and Long-Term Debt </ix:continuation></span></div><ix:continuation id="ic8f65dbee5904eb5a04b04cabafd9a1f" continuedAt="i169ac611ff2e457889ac1b3eba7ead25"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of short-term borrowings and long-term debt can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_184">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $<ix:nonFraction unitRef="usd" contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzM4Mw_b4030a30-85e0-4361-9264-5657d3c6b963">0.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzM5MA_9d354267-5549-40ff-91dc-2d396849302f">1.4</ix:nonFraction> billion at December&#160;31, 2022 and 2021.</span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzcwMg_f353fa25-153d-4678-ad75-220e7a898688" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzEtMi0xLTEtNTE5MzU_a433ed9a-c28e-470a-8310-99186e26ebac">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzItMi0xLTEtNTE5MzU_55ace68b-172a-411b-8eef-9b13822480eb">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzMtMi0xLTEtNTE5MzU_5375021c-58b0-4a70-a0c5-c435b4f434ec">3,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzQtMi0xLTEtNTE5MzU_22151592-c371-4d02-bbb6-e98737096af6">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzUtMi0xLTEtNTE5MzU_bda16aeb-aded-4edf-afc1-e24b417bcd1f">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzYtMi0xLTEtNTE5MzU_e40fbfb7-c01e-41ad-817e-333f8bb3c230">43,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company had notes payable to subsidiaries of $<ix:nonFraction unitRef="usd" contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231" decimals="-8" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzYwMw_02c827c3-b565-4439-9ab4-ac96dc8df80a">8.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231" decimals="-8" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzYxMA_59fc559e-d49a-4eb0-9e03-18ee3a3b16c1">8.1</ix:nonFraction> billion as of December 31, 2022 and 2021, respectively, which included on-demand features.</span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_277"></div><ix:continuation id="i169ac611ff2e457889ac1b3eba7ead25"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    Commitments and Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#8217;s parent company in the event of insolvency. UnitedHealth Group&#8217;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a summary of commitments and contingencies, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_208">&#8221;</a></span></div></ix:continuation><div id="i6b660947fab7488cb4d33baca2cb3a37_280"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i6b660947fab7488cb4d33baca2cb3a37_283"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6b660947fab7488cb4d33baca2cb3a37_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February 24, 2023 </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.643%"><tr><td style="width:1.0%"></td><td style="width:9.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew Witty<br/>Chief Executive Officer</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chief Executive Officer<br/>(principal executive officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew Witty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief&#160;Financial&#160;Officer<br/>(principal financial officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John Rex</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HOMAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OOS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and<br/>Chief Accounting Officer<br/>(principal accounting officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Roos</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timothy Flynn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul Garcia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kristen Gil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen Hemsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michele Hooper</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F. William McNabb III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valerie Montgomery Rice, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John Noseworthy, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.543%"><tr><td style="width:1.0%"></td><td style="width:9.896%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.904%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UAI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EONG</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kuai Leong<br/>As Attorney-in-Fact</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>unhex10212312022.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7c0372e6e1f74e638d2bbbff7c2d1424_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:center"><img alt="uhglogocleana.jpg" src="uhglogocleana.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Final Vesting Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantCustom2#</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of restricted stock units (the &#8220;RSUs&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each RSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * *</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Rights of the Participant with Respect to the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The RSUs granted pursuant to this Award certificate do not and shall not entitle Participant to any rights of a shareholder of Common Stock, except as provided below.  The rights of Participant with respect to the RSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the RSUs lapse, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of RSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No shares of Common Stock shall be issued to Participant prior to the date on which the RSUs vest, and the restrictions with respect to the RSUs lapse, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> nor any action taken pursuant to or in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be construed to create a trust of any kind.  After any RSUs vest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries, or heirs, as the case may be, in payment of such vested whole RSUs, at the times provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, as applicable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If a cash dividend is declared and paid by the Company with respect to the Common Stock, Participant shall be credited as of the applicable dividend payment date with an additional number of whole and&#47;or fractional RSUs (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend Participant would have received </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">had Participant&#8217;s RSUs (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date.  As of each vesting date pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the number of Dividend Units paid on the RSUs vesting on such vesting date shall become vested, earned, and payable in the form of shares of Common Stock&#59; provided, however, that any vested Dividend Units not converted into a whole share of Common Stock may be converted into a fractional Dividend Unit or a cash payment.  To the extent Participant&#8217;s rights to any unvested RSUs are forfeited, the Dividend Units paid on such forfeited RSUs shall also be forfeited.  The terms of this Award certificate shall apply to all Dividend Units paid on the RSUs.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award certificate, % of the RSUs shall vest, and the restrictions with respect to the RSUs shall lapse, on each of the __________ anniversaries of the grant date if Participant remains continuously employed by the Company or any Affiliate until the respective vesting dates.  Any RSUs that vest pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid to Participant no later than March 15th of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Early Vesting On Certain Terminations On or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the other vesting provisions contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, but subject to the other terms and conditions set forth herein, all of the RSUs shall become immediately and unconditionally vested if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement (as defined below), (iv) due to Participant&#8217;s Disability (as defined below), or (v) in the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; provided that in the case of a termination for Good Reason, the RSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any RSUs that vest pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid to Participant in a lump sum within thirty (30) days after the date of Participant&#8217;s Separation from Service.  For purposes of this Award&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)         &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger, or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)         &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities, or authority.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60-day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)          &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the RSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or as otherwise permitted under, and would not result in any tax, penalty, or interest under, Section 409A of the Code.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the RSUs is triggered by Participant&#8217;s Separation from Service as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the RSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Termination of Employment.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, if, prior to vesting of the RSUs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), and does not continue after such cessation of service to be either an employee of the Company or any Affiliate, then Participant&#8217;s rights to all of the unvested RSUs shall be immediately and irrevocably forfeited on the date of termination.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Death or Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant dies while employed by the Company or any Affiliate, or if Participant receives disability benefits under the long-term disability insurance program of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company or the Affiliate by which the Participant is employed for a period of at least three months (&#8220;Disability&#8221;), then all unvested RSUs shall become immediately vested, and the restrictions with respect to all of the RSUs shall lapse, as of the date of such death or Disability.  Any RSUs that vest pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid to Participant or Participant&#8217;s estate not later than 90 days after the date of such death or Disability.  Notwithstanding the foregoing, if the condition that results in Participant receiving Disability benefits is not a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, then the RSUs shall become immediately vested as provided above, but settlement shall be on the dates on which the RSUs would have vested under the original vesting schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (and other than due to Participant&#8217;s death or Disability) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply.  If Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof, then the RSUs shall continue to vest, and the restrictions with respect to the RSUs shall continue to lapse, for the period of such severance that Participant is eligible to receive.  If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate on or prior to the date hereof, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the period of such severance that Participant would be entitled to receive under that agreement as of the date hereof.  If Participant is entitled to severance or separation pay under a plan or agreement as of the date hereof, other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for three months from the date of termination, regardless of the period for which severance or separation pay is payable.  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the RSUs shall continue to vest for the period of time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any RSUs that vest pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  For avoidance of doubt, any RSUs that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> during the applicable severance or separation pay period identified above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be forfeited.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> If Participant ceases to be an employee of the Company or any Affiliate and Participant is eligible for Retirement at the time of such termination of employment, then the vesting of the RSUs shall continue as if such termination of employment had not occurred, subject to provisions set out in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below.  Any RSUs that vest pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Restriction on Transfer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant may not transfer the RSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the RSUs shall be void.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Special Restriction on Transfer for Certain Participants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon the vesting of RSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">apply to Participant&#8217;s Award.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon the vesting of RSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the applicable vesting date.  For purposes of this Award, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued upon vesting of RSUs after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local, or other payroll, withholding, income, or other applicable tax withholding required in connection with the issuance of the shares.  The restrictions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Forfeiture of RSUs and Shares of Common Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sets forth circumstances under which Participant shall forfeit all or a portion of the RSUs or be required to repay the Company for the value realized in respect of all or a portion of the RSUs.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">If a Participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding RSUs, whether or not vested, may be forfeited, and the Participant may be required to repay the amount realized upon the settlement of previously settled RSUs, to the extent and in the manner provided in the Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below, then any unvested RSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any RSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested RSUs continue to vest under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below and during which time the running of the time periods for the restrictions set forth in Sections </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are essential economic conditions to the Company&#8217;s grant of RSUs to Participant.  By receiving the grant of RSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Assignment and Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Assignment of Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant agrees to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-39.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-41.97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-41.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product, or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-39.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Geographic Scope.  </font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Participant&#8217;s obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">subsections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-39.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27pt">Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product, or service in that country.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Restriction on Protected Activities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.  If Participant is a resident of any of the states listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as of the Award Date, then the exceptions and acknowledgements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply to Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sec</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">tion 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein. If Participant is a resident of Colorado, Participant acknowledges that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> contain covenants not to compete that could restrict Participant&#8217;s options for subsequent employment following separation from the Company.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Adjustments to RSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the RSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the RSUs.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Tax Matters.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal, state, and local tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state, and local payroll, withholding, income, or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the RSUs, by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Mis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">cellaneous.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Choice of Law, Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award certificate does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award certificate shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other person.  To the extent that any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any RSUs until the requirements of any federal or state securities laws, rules, or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company.  To the extent there is any conflict between the terms contained in any copy of this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate and the provisions regarding the forfeiture of RSUs and shares of Common Stock shall survive termination of the RSUs and termination of Participant&#8217;s relationship with the Company as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;margin-top:18pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A  State Law Exceptions to Restricted Stock Unit Award </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of the following states as of the Award Date, the following exceptions and acknowledgments shall apply to Participant, notwithstanding anything to the contrary in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Restricted Stock Unit Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is attached.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CALIFORNIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of California as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COLORADO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Colorado as of the Award Date&#58; 1)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be interpreted to apply to the full extent permitted by Colo. Rev. Stat. &#167; 8-2-113 and shall not be interpreted to apply in any manner that would constitute a violation of Colorado law&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash equivalent to or greater than sixty percent (60%) of the threshold for highly compensated workers as defined by the Colorado Department of Labor&#59; 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash compensation equivalent to or greater than the threshold amount for highly compensated workers as defined by the Colorado Department of Labor&#59; and 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IDAHO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Idaho as of the Award Date, Participant acknowledges that Participant is a &#8220;key employee&#8221; as that term is defined in Idaho. Stat. &#167; 44-2702, and that if Participant became employed by or affiliated with a competitor in violation of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> it is inevitable that Participant would disclose the Company&#8217;s trade secrets or other confidential information.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ILLINOIS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Illinois as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 14 calendar days to review this Award certificate and that accepting this Award before the expiration of the 14 days shall serve as a waiver of the 14 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award&#59; 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10(a)&#59; and 5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10b).</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">LOUISIANA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Louisiana as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply only in the following parishes in the State of Louisiana&#58; Acadia, Allen, Ascension, Assumption, Avoyelles, Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia, De Soto, East Baton Rouge, East Carroll, East, Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville, Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison, Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River, Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St. Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington, Webster, West Baton Rouge, West Carroll, West Feliciana, and Winn.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MAINE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maine as of the Award Date&#58; 1) the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate regarding Participant&#8217;s post-termination obligations do not take effect until after one (1) year of Participant&#8217;s employment with the Company or a period of six (6) months from the date that Participant accepted the Award, whichever is later&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns wages over four hundred percent (400%) of the federal poverty level, as defined in 26 M.R.S.A. &#167; 599-A&#59; and 3) Participant acknowledges that the Company provided Participant with at least three (3) days to review this Award certificate before accepting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Award and that voluntarily accepting the Award before the expiration of three (3) days shall serve as a waiver of the three (3) day review period.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">**MARYLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maryland as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns compensation that is more than the amount set forth in Maryland Code, Labor and Employment, &#167; 3-716(a)(1).</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MASSACHUSETTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Massachusetts as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 10 business days to review this Award certificate and that accepting this Award before the expiration of the 10 days shall serve as a waiver of the 10 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; and 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEBRASKA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Nebraska as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEVADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Nevada as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not prohibit Participant from providing service to a former provider or customer of the Company if Participant can demonstrate that (i) Participant did not solicit the former provider or customer, (ii) the former provider or customer voluntarily chose to leave the Company and seek services from Participant, and (iii) Participant is otherwise complying with the limitations in this Award certificate other than any limitation on providing services to a former provider or customer who seeks the services of Participant without any contact instigated by Participant.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEW HAMPSHIRE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of New Hampshire as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns at least two hundred percent (200%) of the federal minimum wage.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NORTH DAKOTA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of North Dakota as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OKLAHOMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Oklahoma as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply after Participant&#8217;s employment only with respect to providers or customers of the Company that are &#8220;established customers&#8221; of the Company per Okla. Stat. Ann. tit. 15, &#167; 219A.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OREGON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Oregon as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time that Participant&#8217;s employment ends, exceed the amount set forth in Ore. Rev. Stat. &#167; 653.295(1)(e).</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RHODE ISLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Rhode Island as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns more than two hundred fifty percent (250%) of the federal poverty level for individuals as established by the United States Department of Health and Human Services federal poverty guidelines.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">VIRGINIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Virginia as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s average weekly earnings, as calculated in Va. Code &#167; 40.1-28.7&#58;8, are equal to or more than the average weekly wage of the Commonwealth as determined pursuant to subsection B of Va. Code &#167;65.2-500.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">WASHINGTON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Washington as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annualized earnings, at the time that Participant&#8217;s employment ends, exceed the amount set forth in RCW 49.62.020&#59; 2) Participant acknowledges that, by this Award certificate, the Company has notified Participant that, even if the post-employment provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are not enforceable against Participant at the time of Participant&#8217;s acceptance of the Award, those provisions may be enforceable against Participant in the future due to changes in Participant&#8217;s compensation&#59; and 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>unhex10312312022.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i958046e126884cc995ae9dde713c60a1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:center"><img alt="uhglogocleana.jpg" src="uhglogocleana.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NONQUALIFIED STOCK OPTION AWARD</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.743%"><tr><td style="width:1.0%"></td><td style="width:15.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Option Shares</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exercise Price</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">#GrantPrice#</font></div><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ExpirationDate#</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Participant&#8221;) the option (the &#8220;Option&#8221;) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), indicated above (the &#8220;Option Shares&#8221;). The Option that this Award represents will expire on the expiration date indicated above (the &#8220;Expiration Date&#8221;) unless it is terminated prior to that time in accordance with this Award. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Option Shares represented by this Award shall become exercisable as follows&#58;  __% on each of the __________ anniversaries, unless the Option shall have terminated, or the vesting shall have accelerated as provided in this Award. Once the Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may be, until the Option expires or is terminated as provided in this Award. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By accepting this Award, the Participant acknowledges that the Participant will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the &#8220;Exercise Price&#8221;) and applicable withholding taxes paid in accordance with this Award. The Participant further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), the Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nonqualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if the Participant ceases to be employed by the Company or any Affiliate, except that&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, if prior to vesting of the Option as set forth herein, the Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), then the Participant may, at any time within the period set forth in the applicable provision below, exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Participant was entitled to purchase under the Option on the date of the termination of his or her employment. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Death or Long-Term Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant dies while employed by the Company or any Affiliate, or if the Participant&#8217;s employment by the Company or any Affiliate is terminated due to the Participant&#8217;s failure to return to work as the result of a long-term disability which renders the Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then&#58; (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Participant (or the Participant&#8217;s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after the Participant&#8217;s death or Disability or for such other longer period established at the discretion of the Committee, exercise the Option. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Severance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, if Participant&#8217;s employment with the Company or an Affiliate terminates at a time when Participant is not eligible for Retirement (as defined below) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions will apply.  If the Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof and the Participant is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate on or prior to the date hereof, then the Option shall continue to vest and become exercisable for the period of such severance that Participant is entitled to receive under that agreement as in effect on the date hereof. In either case, should the Participant be paid in a lump sum versus bi-weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been paid bi-weekly. If the Participant is entitled to severance or separation pay under a plan or agreement as of the date hereof, other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the Option shall continue for three months from the date of termination, regardless of the period for which severance or separation pay is payable. Any portion of the Option that vests after the Participant&#8217;s termination of employment pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> may be exercised during the Exercise Period (as defined below).  For avoidance of doubt, any Options that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be forfeited.  For the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, &#8220;Exercise Period&#8221; shall mean the greater of&#58; (i) a period of three months after the date of termination of the Participant&#8217;s employment&#59; (ii) a period of three months after vesting ceases as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> if Participant receives severance or separation pay&#59; or (iii) such other longer period established at the discretion of the Committee, but in no event later than the Expiration Date determined without regard to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Retirement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment by the Company or any Affiliate is terminated and at the time of termination the Participant is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Participant may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       Anything else contained in this Award certificate notwithstanding, the Option shall in no event be exercisable after the Expiration Date. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)       For purposes of this Award, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.    </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       For purposes of this Award, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Manner </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  On the terms set forth herein, the Option may be exercised by the Participant in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee&#8217;s designated agent, accompanied by payment of the Exercise Price and any applicable withholding taxes in cash or its equivalent, or by any of the following methods, subject to such limitations and restrictions as the Committee may establish (i) by a cashless exercise program established pursuant to Regulation T of the Federal Reserve Board, (ii) by delivery of shares of Common Stock already owned by the Participant, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under the Option having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by a combination of any of the preceding methods or such other methods as the Committee may permit.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Automatic Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent the vested and exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award certificate), that portion of the Option will be exercised without any action by the Participant in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01 greater than the Exercise Price and the exercise will result in Participant receiving at least one Share. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Satisfaction of Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding anything to the contrary in this Award certificate, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  To the extent Participant elects to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered, the fair market value of the shares withheld may not exceed the maximum amount required to be withheld under applicable laws or regulations.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Award does not confer on the Participant any right to continued employment or any other relationship with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the Participant&#8217;s lifetime, only the Participant can exercise the Option. The Participant may not transfer the Option except by will or the laws of descent and distribution.  Notwithstanding the foregoing, the Option may be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">transferred</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Option was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.   Any attempt to otherwise transfer the Option shall be void. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">reasonably</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that the Option is exercised in whole or in part and the Company has theretofore </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">communicated the Participant&#8217;s status as a Section 16 Officer to the Participant, the following special transfer restrictions apply to any shares of Common Stock acquired upon the exercise of the Option.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Participant is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to the Option or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised.  For purposes of the Option, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and&#47;or to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option.  The restrictions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of Option and&#47;or Recoupment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This section sets forth circumstances under which the Participant shall forfeit all or a portion of the Options or be required to repay the Company for the value realized in respect of all or a portion of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Options. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        If a Participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding Options, whether or not vested, may be forfeited, and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> may be required to repay the amount realized upon the exercise of previously vested Options, to the extent and in the manner provided for in the Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant violates any provision of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate, then any (i) unvested Options and (ii) Options that vested within one year prior to the Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the &#8220;Forfeited Options&#8221;).  If any such Forfeited Options have been exercised prior to the Participant&#8217;s violation of the Restrictive Covenants, the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> net Option Shares acquired after payment of the Exercise Price and any applicable taxes (&#8220;Net Option Shares&#8221;). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (c)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This section does not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested Option Shares continue to vest under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> following the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) below and during which time the running of the time periods for the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants. The provisions in this section are essential economic conditions to the Company&#8217;s grant of Options to the Participant.  By receiving the grant of Options hereunder, the Participant agrees that the Company may deduct from any amounts it owes the Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts the Participant owes the Company under this section. The provisions of this section and any amounts repayable by the Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Information with the Participant, which the Participant agrees constitute adequate and sufficient </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">mutually</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignment of Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)    Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)      Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)       Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       Geographic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">subsections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product, or service in that country.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (f)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.  If Participant is a resident of any of the states listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as of the Award Date, then the exceptions and acknowledgements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply to Participant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">agree</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein. If Participant is a resident of Colorado, Participant acknowledges that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> contain covenants not to compete that could restrict Participant&#8217;s options for subsequent employment following separation from the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option&#59; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Participant shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award certificate and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Participant if the Participant had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not affect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, the Participant may be entitled to purchase or receive. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; provided that in the case of a termination for Good Reason, the Option shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  For purposes of this Award certificate&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.           </font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)      a material diminution in Participant&#8217;s duties, responsibilities or authority.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60-day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Possible Acceleration of Vesting&#59; Payment in Satisfaction of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Option is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Option, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Option. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> Miscellaneous. </font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       Choice of Law, Jurisdiction.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">(b)        No Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Record of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the provisions regarding the forfeiture of Options and recoupment of shares of Common Stock shall survive termination of the Option.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline"> State Law Exceptions to Nonqualified Stock Option Award</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of the following states as of the Award Date, the following exceptions and acknowledgments shall apply to Participant, notwithstanding anything to the contrary in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Nonqualified Stock Option Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is attached.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CALIFORNIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of California as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COLORADO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Colorado as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be interpreted to apply to the full extent permitted by Colo. Rev. Stat. &#167; 8-2-113 and shall not be interpreted to apply in any manner that would constitute a violation of Colorado law&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash equivalent to or greater than sixty percent (60%) of the threshold for highly compensated workers as defined by the Colorado Department of Labor&#59; 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash compensation equivalent to or greater than the threshold amount for highly compensated workers as defined by the Colorado Department of Labor&#59; and 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IDAHO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Idaho as of the Award Date, Participant acknowledges that Participant is a &#8220;key employee&#8221; as that term is defined in Idaho. Stat. &#167; 44-2702, and that if Participant became employed by or affiliated with a competitor in violation of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> it is inevitable that Participant would disclose the Company&#8217;s trade secrets or other confidential information.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ILLINOIS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Illinois as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 14 calendar days to review this Award certificate and that accepting this Award before the expiration of the 14 days shall serve as a waiver of the 14 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award&#59; 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10(a)&#59; and 5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10(b).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">LOUISIANA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Louisiana as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply only in the following parishes in the State of Louisiana&#58; Acadia, Allen, Ascension, Assumption, Avoyelles, Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia, De Soto, East Baton Rouge, East Carroll, East, Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville, Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison, Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River, Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St. Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington, Webster, West Baton Rouge, West Carroll, West Feliciana, and Winn.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MAINE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maine as of the Award Date&#58; 1) the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate regarding Participant&#8217;s post-termination obligations do not take effect until after one (1) year of Participant&#8217;s employment with the Company or a period of six (6) months from the date that Participant accepted the Award, whichever is later&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns wages over four hundred percent (400%) of the federal poverty level, as defined in 26 M.R.S.A. &#167; 599-A&#59; and 3) Participant acknowledges that the Company provided Participant with at least three (3) days to review this Award certificate before accepting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Award and that voluntarily accepting the Award before the expiration of three (3) days shall serve as a waiver of the three (3) day review period.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">**MARYLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maryland as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns compensation that is more than the amount set forth in Maryland Code, Labor and Employment, &#167; 3-716(a)(1).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MASSACHUSETTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Massachusetts as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 10 business days to review this Award certificate and that accepting this Award before the expiration of the 10 days shall serve as a waiver of the 10 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; and 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEBRASKA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Nebraska as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEVADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Nevada as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not prohibit Participant from providing service to a former provider or customer of the Company if Participant can demonstrate that (i) Participant did not solicit the former provider or customer, (ii) the former provider or customer voluntarily chose to leave the Company and seek services from Participant, and (iii) Participant is otherwise complying with the limitations in this Award certificate other than any limitation on providing services to a former provider or customer who seeks the services of Participant without any contact instigated by Participant.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEW HAMPSHIRE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of New Hampshire as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns at least two hundred percent (200%) of the federal minimum wage.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NORTH DAKOTA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of North Dakota as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OKLAHOMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Oklahoma as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply after Participant&#8217;s employment only with respect to providers or customers of the Company that are &#8220;established customers&#8221; of the Company per Okla. Stat. Ann. tit. 15, &#167; 219A.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OREGON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Oregon as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time that Participant&#8217;s employment ends, exceed the amount set forth in Ore. Rev. Stat. &#167; 653.295(1)(e).</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RHODE ISLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Rhode Island as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns more than two hundred fifty percent (250%) of the federal poverty level for individuals as established by the United States Department of Health and Human Services federal poverty guidelines.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">VIRGINIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Virginia as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s average weekly earnings, as calculated in Va. Code &#167; 40.1-28.7&#58;8, are equal to or more than the average weekly wage of the Commonwealth as determined pursuant to subsection B of Va. Code &#167;65.2-500.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">WASHINGTON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Washington as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annualized earnings, at the time that Participant&#8217;s employment ends, exceed the amount set forth in RCW 49.62.020&#59; 2) Participant acknowledges that, by this Award certificate, the Company has notified Participant that, even if the post-employment provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are not enforceable against Participant at the time of Participant&#8217;s acceptance of the Award, those provisions may be enforceable against Participant in the future due to changes in Participant&#8217;s compensation&#59; and 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>unhex104123122.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i24df16e99d70441791487974eb2052dc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogocleanb.jpg" src="uhglogocleanb.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:400px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Target Number of Performance-Based Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Period</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">01&#47;01&#47;2022 &#8211; 12&#47;31&#47;2024</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to be eligible to receive a number of Performance-Based Restricted Stock units (the &#8220;PRSUs&#8221;), the target number of which is indicated above in the box labeled &#8220;Target Number of Performance-Based Units,&#8221; each PRSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;). </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award, the Plan, pursuant to which the Company granted the Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.  </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights of the Participant with Respect to the PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The PRSUs granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common Stock. The rights of Participant with respect to the PRSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the PRSUs lapse, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of PRSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. No shares of Common Stock shall be issued to Participant prior to the date on which the PRSUs vest, and the restrictions with respect to the PRSUs lapse, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Neither this Section 1(b) nor any action taken pursuant to or in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be construed to create a trust of any kind. After any PRSUs vest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole PRSUs, such shares of Common Stock shall be issued promptly, and in any event, no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code). </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award, including without limitation the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Attachment 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the PRSUs shall vest and the restrictions with respect to the PRSUs shall lapse (i) if Participant has remained continuously employed with the Company or any Affiliate from the Award Date through and including the end of the Performance Period, and (ii) if and to the extent the Performance Vesting Criteria described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Attachment 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> have been achieved during the Performance Period.  Regardless of whether Participant meets the continuous employment or service criterion described in subpart (i) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, if and to the extent the Performance Vesting Criteria have not been achieved by the end of the Performance Period, the Participant&#8217;s rights to the PRSUs shall be immediately and irrevocably forfeited on that date.  The Committee will determine in its sole discretion the extent, if any, to which the Performance Vesting Criteria have been met, and it will retain sole discretion to reduce the number of PRSUs that would otherwise vest as a result of the performance measured against the Performance Vesting Criteria.  Any vesting that may occur pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will be effective on the date on which the Committee has certified the extent to which the Performance Vesting Criteria in subpart (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> were satisfied.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, but subject to the other terms and conditions set forth herein, the PRSUs described in this Award will become immediately and unconditionally vested, and the restrictions with respect thereto shall lapse if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; provided that in the case of a termination for Good Reason, the PRSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Upon a Change in Control, the Committee will determine&#58; (i) the extent, if any, to which the Performance Vesting Criteria have been met, and (ii) the number of the PRSUs that will vest and convert into shares of Common Stock in the event of Participant&#8217;s termination of employment in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. For purposes of this Award certificate&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.     </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;a material diminution in Participant&#8217;s duties, responsibilities, or authority.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60-day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the PRSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or as otherwise permitted under, and would not result in any tax, penalty, or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the PRSUs is triggered by Participant&#8217;s Separation from Service as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the PRSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, if, prior to vesting of the PRSUs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant ceases to be an employee of the Company or any Affiliate, for any reason (voluntary or involuntary), then Participant&#8217;s rights to all of the unvested PRSUs shall be immediately and irrevocably forfeited on the date of termination. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant dies while employed by the Company or any Affiliate, or if Participant&#8217;s employment by the Company or any Affiliate is terminated due to Participant&#8217;s failure to return to work as the result of a long-term disability which renders Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then following the end of the Performance Period, if and to the extent the Committee, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the number of PRSUs that would have vested had Participant been employed through the end of the Performance Period, and the restrictions with respect thereto will lapse.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment ends at a time when the Participant is not eligible for Retirement (as defined below) and in connection with that separation from employment the Company or an Affiliate pays the Participant severance benefits pursuant to an employment agreement with Participant that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award, then following the end of the Performance Period, if and to the extent the Committee, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in a pro rata number of PRSUs, and the restrictions with respect thereto will lapse.  Such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus the number of full months during which the Participant is entitled to receive severance or separation pay either the Company&#8217;s severance plan as in effect on the date hereof, or under an employment agreement between Participant and the Company or an Affiliate that is in effect on the date of this Award (provided that in no event shall such sum exceed the number of months in the Performance Period).  In either case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the number of full months taken into account shall be based on the period of time over which severance or separation pay would have been paid had it been paid bi-weekly.  If Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus an additional three months, but not more than the number of months in the Performance Period.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment ends and at the time of separation from employment the Participant is eligible for Retirement (the &#8220;Retirement Date&#8221;), and at least one year of the Performance Period of this Award is completed at or prior to the Retirement Date, then following the end of the Performance Period, if and to the extent the Committee, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the full number of PRSUs and the restrictions with respect thereto will lapse as if the Participant had been continuously employed throughout the entire Performance Period. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.  </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the PRSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the PRSUs shall be void.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon vesting of the PRSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award. One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon vesting of the PRSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the issuance date. For purposes of this Award certificate, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued with respect to the Award after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the issuance of the shares. The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of PRSUs and Shares of Common Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the PRSUs or be required to repay the Company for the value realized in respect of all or a portion of the PRSUs.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        If a Participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding PRSUs, whether or not vested, may be forfeited, and the Participant may be required to repay the amount realized upon the settlement of previously settled PRSUs, to the extent and in the manner provided in the Policy.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below, then any unvested PRSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any PRSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested PRSUs continue to vest under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below and during which time the running of the time periods for the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are essential economic conditions to the Company&#8217;s grant of PRSUs to Participant.  By receiving the grant of PRSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant agrees to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> below.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:10pt;padding-left:112.5pt;text-align:justify;text-indent:-40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product, or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)        Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">subsections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product, or service in that country.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(g),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exceptions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Notwithstanding the foregoing, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law. If Participant is a resident of any of the states listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as of the Award Date, then the exceptions and acknowledgements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply to Participant.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein. If Participant is a resident of Colorado, Participant acknowledges that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">(d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) contain covenants not to compete that could restrict Participant&#8217;s options for subsequent employment following separation from the Company.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the PRSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the PRSUs. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the PRSUs, by having the Company withhold a portion of the shares of Common Stock</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">At-Will Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Award does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Trust or Fiduciary Relationship.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Law Requirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The Company shall not be required to deliver any shares of Common Stock upon the vesting of any PRSUs until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original Instrument.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> An original record of this Award and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Survival of Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the provisions regarding the forfeiture of PRSUs and shares of Common Stock shall survive termination of the PRSUs and termination of Participant&#8217;s relationship with the Company as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Injunctive Relief, Attorney&#8217;s Fees and Jury Trial.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:10pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:10pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:right;text-indent:17.1pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">  State Law Exceptions to Performance-Based Restricted Stock Unit Award </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">If Participant is a resident of the following states as of the Award Date, the following exceptions and acknowledgments shall apply to Participant, notwithstanding anything to the contrary in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance-Based</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Restricted Stock Unit Award </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is attached.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CALIFORNIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of California as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COLORADO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Colorado as of the Award Date&#58; 1)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall be interpreted to apply to the full extent permitted by Colo. Rev. Stat. &#167; 8-2-113 and shall not be interpreted to apply in any manner that would constitute a violation of Colorado law&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash equivalent to or greater than sixty percent (60%) of the threshold for highly compensated workers as defined by the Colorado Department of Labor&#59; 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns an amount of annualized cash compensation equivalent to or greater than the threshold amount for highly compensated workers as defined by the Colorado Department of Labor&#59; and 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IDAHO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Idaho as of the Award Date, Participant acknowledges that Participant is a &#8220;key employee&#8221; as that term is defined in Idaho. Stat. &#167; 44-2702, and that if Participant became employed by or affiliated with a competitor in violation of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> it is inevitable that Participant would disclose the Company&#8217;s trade secrets or other confidential information.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ILLINOIS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Illinois as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 14 calendar days to review this Award certificate and that accepting this Award before the expiration of the 14 days shall serve as a waiver of the 14 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award&#59; 4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10(a)&#59; and 5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">time of the termination of Participant&#8217;s employment, Participant&#8217;s annualized rate of earnings exceeds the amount set forth in 820 ILCS 90&#47;10b).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">LOUISIANA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Louisiana as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shall apply only in the following parishes in the State of Louisiana&#58; Acadia, Allen, Ascension, Assumption, Avoyelles, Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia, De Soto, East Baton Rouge, East Carroll, East, Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville, Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison, Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River, Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St. Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington, Webster, West Baton Rouge, West Carroll, West Feliciana, and Winn.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MAINE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maine as of the Award Date&#58; 1) the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of this Award certificate regarding Participant&#8217;s post-termination obligations do not take effect until after one (1) year of Participant&#8217;s employment with the Company or a period of six (6) months from the date that Participant accepted the Award, whichever is later&#59; 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns wages over four hundred percent (400%) of the federal poverty level, as defined in 26 M.R.S.A. &#167; 599-A&#59; and 3) Participant acknowledges that the Company provided Participant with at least three (3) days to review this Award certificate before accepting the Award and that voluntarily accepting the Award before the expiration of three (3) days shall serve as a waiver of the three (3) day review period.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:28.5pt">**MARYLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Maryland as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns compensation that is more than the amount set forth in Maryland Code, Labor and Employment, &#167; 3-716(a)(1).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">MASSACHUSETTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Massachusetts as of the Award Date&#58; 1) Participant acknowledges that Participant was provided with 10 business days to review this Award certificate and that accepting this Award before the expiration of the 10 days shall serve as a waiver of the 10 day review period&#59; 2) Participant understands that Participant has the right to consult with an attorney prior to accepting the Award, but that any legal consultation is at Participant&#8217;s own expense&#59; and 3) Participant acknowledges that Participant has had an adequate opportunity to consult with an attorney, Participant has read and understands this Award certificate, and is voluntarily accepting the Award.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEBRASKA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Nebraska as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEVADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Nevada as of the Award Date, after the termination of Participant&#8217;s employment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not prohibit Participant from providing service to a former provider or customer of the Company if Participant can demonstrate that (i) Participant did not solicit the former provider or customer, (ii) the former provider or customer voluntarily chose to leave the Company and seek services from Participant, and (iii) Participant is otherwise complying with the limitations in this Award certificate other than any limitation on providing services to a former provider or customer who seeks the services of Participant without any contact instigated by Participant.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NEW HAMPSHIRE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of New Hampshire as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns at least two hundred percent (200%) of the federal minimum wage.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NORTH DAKOTA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of North Dakota as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply to Participant during Participant&#8217;s employment but will apply after Participant&#8217;s employment only to the extent that Participant uses or discloses the Company&#8217;s trade secrets to perform the activities prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OKLAHOMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Oklahoma as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply after the termination of Participant&#8217;s employment&#59; and 2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will apply after Participant&#8217;s employment only with respect to providers or customers of the Company that are &#8220;established customers&#8221; of the Company per Okla. Stat. Ann. tit. 15, &#167; 219A.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OREGON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Oregon as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time that Participant&#8217;s employment ends, exceed the amount set forth in Ore. Rev. Stat. &#167; 653.295(1)(e).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RHODE ISLAND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Rhode Island as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant earns more than two hundred fifty percent (250%) of the federal poverty level for individuals as established by the United States Department of Health and Human Services federal poverty guidelines.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">VIRGINIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is a resident of Virginia as of the Award Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that, at the time of the termination of Participant&#8217;s employment, Participant&#8217;s average weekly earnings, as calculated in Va. Code &#167; 40.1-28.7&#58;8, are equal to or more than the average weekly wage of the Commonwealth as determined pursuant to subsection B of Va. Code &#167;65.2-500.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">**</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">WASHINGTON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is a resident of Washington as of the Award Date&#58; 1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will only apply after the termination of Participant&#8217;s employment to the extent that Participant&#8217;s annualized earnings, at the time that Participant&#8217;s employment ends, exceed the amount set forth in RCW 49.62.020&#59; 2) Participant acknowledges that, by this Award certificate, the Company has notified Participant that, even if the post-employment provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are not enforceable against Participant at the time of Participant&#8217;s acceptance of the Award, those provisions may be enforceable against Participant in the future due to changes in Participant&#8217;s compensation&#59; and 3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> will not apply to Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Attachment 1 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Vesting Criteria Applicable to</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance-Based Restricted Stock Units</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant&#8217;s Performance-Based Restricted Stock Units shall become vested, and any applicable restrictions shall lapse, based on the Company&#8217;s attainment of the performance goals indicated below over the Performance Period, which begins on January 1, 2023 and ends on December 31, 2025.  As indicated below, the actual number of Participant&#8217;s Performance-Based Restricted Stock Units that vest may range from 0% to 200% of Participant&#8217;s Target Number of Performance-Based Units, based on performance against the performance goals.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Goals</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant&#8217;s Performance-Based Restricted Stock Units shall vest, and the applicable restrictions with respect to such units shall lapse, based on both (1) the Company&#8217;s adjusted earnings per share (&#8220;Cumulative Adjusted EPS&#8221;) and (2) the Company&#8217;s average return on equity (&#8220;Average ROE&#8221;) during the Performance Period as determined in accordance with the tables below.  The aggregate payout as a percentage of the Target Number of Performance-Based Units shall be the sum of the percentages determined in the last column of each of the first two tables below.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Vesting Based on EPS Growth and Average ROE</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"></td><td style="width:15.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00629b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2023-2025 Cumulative Adjusted EPS</font></td><td colspan="3" style="background-color:#00629b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Payout as a % of Target # of Units</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">+<br></font></td><td colspan="3" style="background-color:#00629b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2023-2025 Average ROE</font></td><td colspan="3" style="background-color:#00629b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Payout as a % of Target # of Units</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#61;</font></td><td colspan="3" style="background-color:#00629b;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Combined Payout as a % of Target # of Units</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$80.21</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">24.8%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$81.36</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25.3%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$82.53</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25.8%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$83.66</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">37.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">26.3%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">37.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">75%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$84.85</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">26.8%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">100%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$86.42</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">62.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">27.3%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">62.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">125%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$88.02</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">75.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">27.8%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">75.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">150%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$89.66</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">87.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28.3%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">87.5%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">175%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$91.29</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">100.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28.8%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">100.0%</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">200%</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cumulative Adjusted EPS or Average ROE performance at or above the respective maximum levels shown in the tables above shall result in 100.0% of the total Target Number of Performance-Based Units becoming vested for that goal. If both Cumulative Adjusted EPS and Average ROE performance are at or above the respective maximum levels shown in the tables above, 200.0% of the total Target Number of Performance-Based Units shall become vested. The percentage of the total Target Number of Performance-Based Units becoming vested shall be interpolated for Cumulative Adjusted EPS or Average ROE performance between the levels shown in the tables above on a straight-line basis.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Adjustments</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Committee shall adjust earnings to eliminate the effect of any extraordinary or special item that is not included in or contemplated by the Five Year Financial Projections prepared for the February 23 to February 24, 2023 Board of Directors meeting (the &#8220;Business Plan&#8221;) and that, standing alone, significantly increases or decreases earnings (an &#8220;Extraordinary or Special Item&#8221;).  Extraordinary or Special Items shall include, without limitation, legal settlements, regulatory settlements and other similar non-recurring events.  Extraordinary or Special Items shall also include changes to the Company&#8217;s capital structure, including, without limitation, changes to the Company&#8217;s dividend policy or share repurchase program (as each is in effect at the start of the Performance Period), mergers, acquisitions, divestitures and reorganizations.  Further, the Committee shall adjust earnings to eliminate the effect of any new federal legislation or amendments to existing federal legislation regarding funding of healthcare benefits by the United States government if such legislation or amendment (1) is enacted during the Performance Period and (2) results in a significant reduction or increase in that portion of the Company&#8217;s earnings that is derived from federal governmental sources, as projected in the Business Plan.   </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although the Committee is required to make adjustments to earnings for Extraordinary or Special Items in accordance with the preceding paragraph, the Committee, in its sole discretion, may choose (1) not to make an adjustment to earnings for a particular Extraordinary or Special Item that would otherwise increase earnings and&#47;or (2) to decrease earnings on the basis of other events or items, in each case to reduce the number of Participant&#8217;s Performance-Based Restricted Stock Units that would otherwise vest.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>5
<FILENAME>unhex10512312022.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if52e061709b94245a55fb6955ebff239_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogoclean.jpg" src="uhglogoclean.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Final Vesting Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantCustom2#</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of restricted stock units (the &#8220;RSUs&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each RSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * *</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Rights of the Participant with Respect to the RSUs.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The RSUs granted pursuant to this Award certificate do not and shall not entitle Participant to any rights of a shareholder of Common Stock, except as provided below.  The rights of Participant with respect to the RSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of RSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No shares of Common Stock shall be issued to Participant prior to the date on which the RSUs vest, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.  Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind.  After any RSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries, or heirs, as the case may be, in payment of such vested whole RSUs, at the times provided in Section 2, 3 or 4, as applicable.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If a cash dividend is declared and paid by the Company with respect to the Common Stock, Participant shall be credited as of the applicable dividend payment date with an additional number of whole and&#47;or fractional RSUs (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend Participant would have received had Participant&#8217;s RSUs (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date.  As of each vesting date pursuant to Sections 2, 3 or 4, the number of Dividend Units paid on the RSUs vesting on such vesting date shall become vested, earned, and payable in the form of shares of Common Stock&#59; provided, however, that any vested Dividend Units not converted into a whole share of Common Stock may be converted into a fractional Dividend Unit or a cash payment.  To the extent Participant&#8217;s rights to any unvested RSUs are forfeited, the Dividend Units paid on such forfeited RSUs shall also be forfeited.  The terms of this Award certificate shall apply to all Dividend Units paid on the RSUs.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Subject to the terms and conditions of this Award certificate, __% of the RSUs shall vest, and the restrictions with respect to the RSUs shall lapse, on each of the __________ anniversaries of the grant date if Participant remains continuously employed by the Company or any Affiliate until the respective vesting dates.  Any RSUs that vest pursuant to this Section 2 shall be paid to Participant no later than March 15th of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Early Vesting On Certain Terminations On or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the other vesting provisions contained in Section 2 and Section 4, but subject to the other terms and conditions set forth herein, all of the RSUs shall become immediately and unconditionally vested if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement (as defined below), (iv) due to Participant&#8217;s Disability (as defined below), or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the RSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">days after the end of the cure period, all as provided in Section 3(d).  Any RSUs that vest pursuant to this Section 3 shall be paid to Participant in a lump sum within thirty (30) days after the date of Participant&#8217;s Separation from Service.  For purposes of this Award&#58;</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;&#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;&#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger, or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;&#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause. </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;&#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">further from the Participant&#8217;s principal residence than the original location&#59; or </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;a material diminution in Participant&#8217;s duties, responsibilities, or authority&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60-day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;&#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the RSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty, or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the RSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the RSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination of Employment.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as expressly provided in Section 3 or this Section 4, if, prior to vesting of the RSUs pursuant to Section 2, Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary) and does not continue after such cessation of service to be either an employee of the Company or any Affiliate, then Participant&#8217;s rights to all of the unvested RSUs shall be immediately and irrevocably forfeited on the date of termination.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant dies while employed by the Company or any Affiliate, or if Participant receives disability benefits under the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed for a period of at least three months (&#8220;Disability&#8221;), then all unvested RSUs shall become immediately vested, and the restrictions with respect to all of the RSUs shall lapse, as of the date of such death or Disability.  Any RSUs that vest pursuant to this Section 4(b) shall be paid to Participant or Participant&#8217;s estate not later than 90 days after the date of such death or Disability.  Notwithstanding the foregoing, if the condition that results in Participant receiving Disability benefits is not a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, then the RSUs shall become immediately vested as provided above, but settlement shall be on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (and other than due to Participant&#8217;s death or Disability) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions of this Section 4(c) will apply.  If Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof, then the RSUs shall continue to vest, and the restrictions with respect to the RSUs shall continue to lapse, for the period of such severance that Participant is eligible to receive.  If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the period of such severance that Participant would be entitled to receive under that agreement as of the date hereof.  If Participant is entitled to separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for three months, regardless of the period for which severance or separation pay is payable.  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the RSUs shall continue to vest for the period of time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any RSUs that vest pursuant to this Section 4(c) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.  For avoidance of doubt, any RSUs that are unvested on the date of termination of Participant&#8217;s</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">employment and do not vest under the schedule set forth in Section 2 during the applicable severance or separation pay period identified above in this Section 4(c) shall be forfeited.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> If Participant ceases to be an employee of the Company or any Affiliate and Participant is eligible for Retirement at the time of such termination of employment, then the vesting of the RSUs shall continue as if such termination of employment had not occurred, subject to provisions set out in Section 7 below.  Any RSUs that vest pursuant to this Section 4(d) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the RSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the RSUs shall be void.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon the vesting of RSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon the vesting of RSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the applicable vesting date.  For purposes of this Award, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued upon vesting of RSUs after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local, or other payroll, withholding, income, or other applicable tax withholding required in connection with the issuance of the shares.  The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of RSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the RSUs or be required to repay the Company for the value realized in respect of all or a portion of the RSUs.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;If a participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding RSUs, whether or not vested, may be forfeited, and the Participant may be required to repay the amount realized upon the settlement of previously settled RSUs, to the extent and in the manner provided in the Policy.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;Violation of Restrictive Covenants.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested RSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any RSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;In General.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested RSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this Section 7 are essential economic conditions to the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company&#8217;s grant of RSUs to Participant.  By receiving the grant of RSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment of Intellectual Property.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#8220;Intellectual Property&#8221;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(g) below.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product, or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Geographic Scope.</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under subsections 8(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product, or service in that country.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exceptions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Notwithstanding the foregoing, this Section 4 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the RSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the RSUs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for any or all federal, state, local or foreign income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to Participant's participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company and&#47;or Employer.  Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Awards, including, but not limited to, the grant or vesting of the Awards, the delivery of the shares of Common Stock, the subsequent sale of shares of Common Stock acquired at vesting and the receipt of any dividends or dividend equivalents&#59; and (ii) do not commit to structure the terms of the grant or any aspect of the Awards to reduce or eliminate Participant&#8217;s liability for Tax-Related Items.  Further, if Participant has relocated to a different jurisdiction between the Award Date and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the relevant taxable event, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer (in its sole discretion) to satisfy all tax withholding and payment on account obligations for Tax-Related Items of the Company and&#47;or the Employer.  In this regard, Participant authorizes the Company and the Employer, or either of them, in such entity&#8217;s sole discretion, to satisfy the obligations with regard to all Tax-Related Items legally payable by Participant (with respect to the Award granted hereunder as well as any equity awards previously received by Participant under any Company stock plan) by one or a combination of the following&#58; (i) requiring Participant to pay Tax-Related Items in cash with a cashier&#8217;s check or certified check or by wire transfer of immediately available funds&#59; (ii) withholding cash from Participant&#8217;s wages or other compensation payable to Participant by the Company and&#47;or the Employer&#59; (iii) withholding from the proceeds of the sale of shares of Common Stock otherwise issuable to Participant upon vesting of the Awards either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf and at Participant&#8217;s direction pursuant to this authorization without further consent)&#59; or (iv) withholding in shares of Common Stock otherwise issuable to Participant upon vesting of the Awards.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award certificate does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award certificate shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other person.  To the extent that any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any RSUs until the requirements of any federal or state securities laws, rules, or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company.  To the extent there is any conflict between the terms contained in any copy of this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 8 of this Award certificate and the provisions regarding the forfeiture of RSUs and shares of Common Stock shall survive termination of the RSUs and termination of Participant&#8217;s relationship with the Company as set forth in Section 8.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the RSUs via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in Participant's country.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">nationality, job title, any shares or directorships held in the Company, details of all RSUs or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is Participant's consent. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration, and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is Participant's consent.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor, and securities laws.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary, and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, Participant's salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer RSUs to Participant or otherwise administer or maintain Participant's participation in the Plan.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, Participant understands that Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In accepting the Awards, Participant acknowledges and agrees that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;the grant of RSUs hereunder, and any future grant of RSUs under the Plan is entirely exceptional, voluntary, and occasional, and at the sole discretion of the Company.  Neither this Award of RSUs nor any past or future Award of RSUs by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of RSUs, benefits in lieu of RSUs, even if RSUs have been granted in the past&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;all decisions with respect to future RSUs or other equity award grants, if any, shall be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, and the Awards granted thereunder is discretionary in nature and it may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;the Awards and shares of Common Stock subject to the Awards, and the income from and value of same, are an extraordinary item of compensation outside the scope of Participant&#8217;s employment.  As such, the RSUs and shares of Common Stock acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;the RSUs and the shares of Common Stock subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;the future value of the underlying shares of Common Stock is unknown and cannot be predicted with certainty&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)&#160;&#160;&#160;&#160;the value of the shares of Common Stock acquired upon vesting&#47;settlement of the Awards may increase or decrease in value&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from the forfeiture of the Award resulting from termination of Participant&#8217;s employment or continuous service with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of his or her employment agreement, if any)&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)&#160;&#160;&#160;&#160;for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Participant&#8217;s right to vest in this Award under the Plan or Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any).  The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Award grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)&#160;&#160;&#160;&#160;if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting&#47;settlement of the RSUs or the subsequent sale of shares of Common Stock acquired upon vesting&#47;settlement&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)&#160;&#160;&#160;&#160;unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement do not create any entitlement to have the Awards or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the shares of Common Stock&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)&#160;&#160;&#160;&#160;the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan or Participant&#8217;s acquisition or sale of the underlying shares of Common Stock&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)&#160;&#160;&#160;&#160;Participant should consult with Participant&#8217;s own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to the shares of Common Stock (e.g., RSUs) or rights linked to the value of shares of Common Stock (e.g., phantom awards, futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Award and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Electronic Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.  Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan, and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>6
<FILENAME>unhex10612312022.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7db7a705fac14f749444c3d65cbc7bc5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogoclean1.jpg" src="uhglogoclean1.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NONQUALIFIED STOCK OPTION AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Shares</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exercise Price</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantPrice#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ExpirationDate#</font></div></td></tr></table></div><div style="margin-top:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:18pt;margin-top:18pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Participant&#8221;) the option (the &#8220;Option&#8221;) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), indicated above (the &#8220;Option Shares&#8221;). The Option that this Award represents will expire on the expiration date indicated above (the &#8220;Expiration Date&#8221;), unless it is terminated prior to that time in accordance with this Award. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Option Shares represented by this Award shall become exercisable as follows&#58;  __% on each of the __________ anniversaries, unless the Option shall have terminated or the vesting shall have accelerated as provided in this Award. Once the Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may be, until the Option expires or is terminated as provided in this Award. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By accepting this Award, the Participant acknowledges that the Participant will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the &#8220;Exercise Price&#8221;), and applicable withholding taxes paid in accordance with this Award. The Participant further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), the Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Nonqualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Termination of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if t</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">he Participant ceases to be employed by the Company or any Affiliate, except that&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">General. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as expressly provided in Section 12 or this Section 2, if prior to vesting of the Option as set forth herein, the Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), then the Participant may, at any time within the period set forth in the applicable provision below, exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Participant was entitled to purchase under the Option on the date of the termination of his or her employment. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Death or Long-Term Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant dies while employed by the Company or any Affiliate, or if the Participant&#8217;s employment by the Company or any Affiliate is terminated due to the Participant&#8217;s failure to return to work as the result of a long-term disability which renders the Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then&#58; (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Participant (or the Participant&#8217;s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after the Participant&#8217;s death or Disability or for such other longer period established at the discretion of the Committee, exercise the Option. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Severance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to Section 12, if Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (as defined below) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions will apply.  If the Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof and the Participant is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Participant is entitled to severance or separation pay under an employment agreement entered into with the Company or an Affiliate on or prior to the date hereof, then the Option shall continue to vest and become exercisable for the period of such severance or separation pay that Participant is entitled to receive under that agreement as in effect on the date hereof. In either case, should the Participant be paid in a lump sum versus bi-weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been paid bi-weekly. If the Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the Option shall continue for three months from the date of termination, regardless of the period for which severance or separation pay is payable. Any portion of the Option that vests after the Participant&#8217;s termination of employment pursuant to this Section 2(c) may be exercised during the Exercise Period (as defined below).  For avoidance of doubt, any Options that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this Section 2(c) shall be forfeited.  For the purposes of this Section 2(c), &#8220;Exercise Period&#8221; shall mean the greater of&#58; (i) a period of three months after the date of termination of the Participant&#8217;s employment&#59; (ii) a period of three months after vesting ceases as provided in Section 2(c) if Participant receives severance or separation pay&#59; or (iii) such other longer period established at the discretion of the Committee, but in no event later than the Expiration Date determined without regard to this Section 2(c).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Retirement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment by the Company or any Affiliate is terminated and at the time of termination the Participant is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Participant may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">Anything else contained in this Award certificate notwithstanding, the Option shall in no event be exercisable after the Expiration Date. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">For purposes of this Award, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.   </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">For purposes of this Award, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition.  </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Forfeiture of Option and&#47;or Recoupment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This section sets forth circumstances under which the Participant shall forfeit all or a portion of the Options or be required to repay the Company for the value realized in respect of all or a portion of the Options. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">If participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding Options, whether vested or unvested, may be forfeited, and the Participant may be required to repay the amount realized upon the exercise of previously vested Options, to the extent and in the manner provided for in the Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant violates any provision of the Restrictive Covenants in Section 4 of this Award certificate, then any (i) unvested Options and (ii) Options that vested within one year prior to the Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the &#8220;Forfeited Options&#8221;).  If any such Forfeited Options have been exercised prior to the Participant&#8217;s violation of the Restrictive Covenants, the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(b) below. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the net Option Shares acquired after payment of the Exercise Price and any applicable taxes (&#8220;Net Option Shares&#8221;). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the Net Option Shares. To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Covered Options were exercised. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This section does not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested Option Shares continue to vest under Section 2 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 4 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 4(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 4(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this section are essential economic conditions to the Company&#8217;s grant of Options to the Participant.  By receiving the grant of Options hereunder, the Participant agrees that the Company may deduct from any amounts it owes the Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts the Participant owes the Company under this section. The provisions of this section and any amounts repayable by the Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Assignment and Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 4.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Assignment of Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 4(g) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:3.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:3.57pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Participant&#8217;s obligations under subsections 4(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:26.01pt">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 4(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 4 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:26.57pt">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 4 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 4 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  On the terms set forth herein, the Option may be exercised by the Participant in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee&#8217;s designated agent, accompanied by payment of the Exercise Price and any applicable withholding taxes in cash or its equivalent, or by any of the following methods, subject to such limitations and restrictions as the Committee may establish (i) by a cashless exercise program established pursuant to Regulation T of the Federal Reserve Board, (ii) by delivery of shares of Common Stock already owned by the Participant, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under the Option having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by a combination of any of the preceding methods or such other methods as the Committee may permit.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Automatic Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent the vested and exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award certificate), that portion of the Option will be exercised without any action by the Participant in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01 greater than the Exercise Price and the exercise will result in Participant receiving at least one Share. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Satisfaction of Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding anything to the contrary in this Award certificate, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax&#8209;related items related to Participant&#8217;s participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant's responsibility and may exceed the amount actually withheld by the Company or the Employer.  Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of shares of Common Stock acquired pursuant to the exercise of the Option and the receipt of any dividends&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if Participant is subject to Tax-Related Items in more than one jurisdiction between the grant date and the date of any relevant taxable or tax withholding event, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">applicable, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.   </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">            Prior to the relevant taxable or tax withholding event, as applicable, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy all Tax-Related Items.  In this regard, Participant authorizes the Company and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by (i) withholding from Participant's wages or other cash compensation paid to Participant by the Company and&#47;or the Employer, and&#47;or (ii) withholding from proceeds of the sale of shares of Common Stock acquired upon exercise of the Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant's behalf pursuant to this authorization without further consent). Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the exercised Award, notwithstanding that a number of shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Section 6.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Award does not confer on the Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the Participant&#8217;s lifetime, only the Participant can exercise the Option. The Participant may not transfer the Option except by will or the laws of descent and distribution.  Notwithstanding the foregoing, the Option may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Option was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.   Any attempt to otherwise transfer the Option shall be void. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that the Option is exercised in whole or in part and the Company has theretofore </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">communicated the Participant&#8217;s status as a Section 16 Officer to the Participant, the following special transfer restrictions apply to any shares of Common Stock acquired upon the exercise of the Option.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Participant is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to the Option or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised.  For purposes of the Option, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and&#47;or to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option.  The restrictions of this Section 10 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Adjustments to Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option&#59; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Participant shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award certificate and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Participant if the Participant had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, the Participant may be entitled to purchase or receive. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 2(c)&#59; provided that in the case of a termination for Good Reason, the Option shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 10(d).  For purposes of this Award certificate&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.    </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 4 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)      a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="margin-top:12pt;padding-left:103.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)      a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60-day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Possible Acceleration of Vesting&#59; Payment in Satisfaction of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Option is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Option, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Option.  </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Record of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 4 and the provisions regarding the forfeiture of Options and recoupment of shares of Common Stock shall survive termination of the Option.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 4 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By accepting the Award, Participant acknowledges the following&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.86pt">the Plan is established voluntarily by the Company, and the Option granted thereunder is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">the grant of the Option, hereunder, and any future grant of Options under the Plan is entirely exceptional, voluntary and occasional, and at the sole discretion of the Company.  Neither this Award of the Option nor any past or future Award of Options by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of Options, or benefits in lieu of Options, even if Options have been granted in the past&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.86pt">all decisions with respect to future Option or other award grants, if any, will be at the sole discretion of Company&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.86pt">the Option and any shares of Common Stock acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.96pt">the Option and shares of Common Stock acquired under the Plan, and the income from and value of same, are an extraordinary item of compensation outside of the scope of Participant&#8217;s employment.  As such, the Options and shares of Common Stock acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">the future value of the underlying Option Shares is unknown and cannot be predicted with certainty&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">if the underlying Option Shares do not increase in value, the Option will have no value&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:25.52pt">if Participant exercises the Option and acquires Option Shares, the value of those Shares may increase or decrease in value, even below the Exercise Price&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:25.52pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the termination of Participant's employment or other service relationship with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment agreement, if any)&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, (i) Participant&#8217;s right to vest in the Option under the Plan, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any)&#59; and (ii) the period (if any) during which Participant may exercise the Option after such termination of employment will commence on the date Participant ceases to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant&#8217;s employment or service agreement, if any&#59; the Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of Participant&#8217;s Option grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:25.52pt">if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">U.S. Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any shares of Common Stock acquired upon exercise&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.52pt">unless otherwise provided in the Plan or by the Company in its discretion, the Options and the benefits evidenced by this Agreement do not create any entitlement to have the Options or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Option Shares&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.29pt">Participant should consult with his or her own personal tax, legal and financial advisors regarding participation in the Plan before taking any action related to the Plan.          </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.5pt;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:27.45pt;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the Award via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in the Participant's country.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:27.45pt;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares or directorships held in the Company, details of all Options or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is the Participant's consent. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:28.02pt;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:27.45pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of the Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is the Participant's consent.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:28.02pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage the Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:29.12pt;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary, and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that the Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, the Participant's salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer Options to the Participant or otherwise administer or maintain the Participant's participation in the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:27.45pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where the Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in the Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant understands that Participant can contact his or her local human resources representative.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, the Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Option and on any Option Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to Option Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Options) or rights linked to the value of shares of Common Stock (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">phantom awards, futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information.  Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Electronic Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.  Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan, and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:25.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="margin-top:12pt;text-align:right;text-indent:43.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-top:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>7
<FILENAME>unhex10712312022.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i06cc7566cfc640559c2f7c5da020a3a0_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.7</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogocleand.jpg" src="uhglogocleand.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:410px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.826%"><tr><td style="width:1.0%"></td><td style="width:31.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:21pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Target Number of Performance-Based Units</font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Period<br>(mm&#47;dd&#47;yyyy)<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">01&#47;01&#47;2023 - 12&#47;31&#47;2025<br></font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated, on behalf of itself and its subsidiaries, related and affiliated companies, and all divisions, successors, and assigns of them (collectively, the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to be eligible to receive a number of Performance-Based Restricted Stock units (the &#8220;PRSUs&#8221;), the target number of which is indicated above in the box labeled &#8220;Target Number of Performance-Based Units,&#8221; each PRSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award, the Plan, pursuant to which the Company granted the Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights of the Participant with Respect to the PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The PRSUs granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common Stock. The rights of Participant with respect to the PRSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. </font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of PRSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. No shares of Common Stock shall be issued to Participant prior to the date on which the PRSUs vest, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind. After any PRSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole PRSUs, such shares of Common Stock shall be issued promptly, and in any event, no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code). </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award, including without limitation the terms set forth in Attachment 1, the PRSUs shall vest and the restrictions with respect to the PRSUs shall lapse (i) if Participant has remained continuously employed with the Company or any Affiliate from the Award Date through and including the end of the Performance Period, and (ii) if and to the extent the Performance Vesting Criteria described in Attachment 1 have been achieved during the Performance Period.  Regardless of whether Participant meets the continuous employment or service criterion described in subpart (i) of this Section 2, if and to the extent the Performance Vesting Criteria have not been achieved by the end of the Performance Period, the Participant&#8217;s rights to the PRSUs shall be immediately and irrevocably forfeited on that date.  The Committee will determine in its sole discretion the extent, if any, to which the Performance Vesting Criteria have been met, and it will retain sole discretion to reduce the number of PRSUs that would otherwise vest as a result of the performance measured against the Performance Vesting Criteria.  Any vesting that may occur pursuant to this Section 2 will be effective on the date on which the Committee has certified the extent to which the Performance Vesting Criteria in subpart (ii) of this Section 2 were satisfied.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions contained in Section 2, but subject to the other terms and conditions set forth herein, the PRSUs described in this Award will become immediately and unconditionally vested, and the restrictions with respect thereto shall lapse if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the PRSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Upon a Change in Control, the Committee will determine&#58; (i) the extent, if any, to which the Performance Vesting Criteria have been met, and (ii) the number of the PRSUs that will vest and convert into shares of Common Stock in the event of Participant&#8217;s termination of employment in accordance with this Section 3. For purposes of this Award certificate&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.            </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)      a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)      a change in Participant&#8217;s reporting relationship.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the PRSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the PRSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the PRSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to the provisions of this Section 4, if, prior to vesting of the PRSUs pursuant to Section 2 or 3, Participant ceases to be an employee of the Company or any Affiliate, for any reason (voluntary or involuntary), then Participant&#8217;s rights to all of the unvested PRSUs shall be immediately and irrevocably forfeited on the date of termination. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant dies while employed by the Company or any Affiliate, or if Participant&#8217;s employment by the Company or any Affiliate is terminated due to Participant&#8217;s failure to return to work as the result of a long-term disability which renders Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the number of PRSUs that would have vested had Participant been employed through the end of the Performance Period, and the restrictions with respect thereto will lapse. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment ends at a time when the Participant is not eligible for Retirement (as defined below) and in connection with that separation from employment the Company or an Affiliate pays the Participant severance benefits pursuant to an employment agreement with Participant that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in a pro rata number of PRSUs, and the restrictions with respect thereto will lapse.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus the number of full months during which the Participant is entitled to receive severance or separation pay either the Company&#8217;s severance plan as in effect on the date hereof, or under an employment agreement between Participant and the Company or an Affiliate that is in effect on the date of this Award (provided that in no event shall such sum exceed the number of months in the Performance Period).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In either case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the number of full months taken into account shall be based on the period of time over which severance or separation pay would have been paid had it been paid bi-weekly.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus an additional three months, but not more than the number of months in the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment ends and at the time of separation from employment the Participant is eligible for Retirement (the &#8220;Retirement Date&#8221;), and at least one year of the Performance Period of this Award is completed at or prior to the Retirement Date, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the full number of PRSUs and the restrictions with respect thereto will lapse as if the Participant had been continuously employed throughout the entire Performance Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the PRSUs except by will or by the laws of descent and distribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any attempt to otherwise transfer the PRSUs shall be void.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon vesting of the PRSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award. One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon vesting of the PRSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the issuance date. For purposes of this Award certificate, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued with respect to the Award after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the issuance of the shares. The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of PRSUs and Shares of Common Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the PRSUs, or be required to repay the Company for the value realized in respect of all or a portion of the PRSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        If a participant is subject to and found in violation of the Company Recoupment and Cancellation Policy, as in effect from time to time (the &#8220;Policy&#8221;), the Participant&#8217;s outstanding RSUs, whether or not vested, may be forfeited, and the Participant may be required to repay the amount realized upon the settlement of previously settled RSUs, to the extent and in the manner provided in the Policy.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested PRSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any PRSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">In General.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested PRSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of PRSUs to Participant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By receiving the grant of PRSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#8220;Intellectual Property&#8221;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(g) below.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 24 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under subsections 8(c) and (d) of this &#8220;Assignment and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Assignment and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant acknowledges that, through this Section 8(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Participant is a resident of Colorado, this Section 8 shall be interpreted to apply to the full extent permitted by Colo. Rev. Stat. &#167; 8-2-113 and shall not be interpreted to apply in any manner that would constitute a violation of Colorado law.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the PRSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the PRSUs.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for any or all federal, state, local or foreign income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to Participant's participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company and&#47;or Employer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Awards, including, but not limited to, the grant or vesting of the Awards, the delivery of the shares of Common Stock, the subsequent sale of shares of Common Stock acquired at vesting and the receipt of any dividends or dividend equivalents&#59; and (ii) do not commit to structure the terms of the grant or any aspect of the Awards to reduce or eliminate Participant&#8217;s liability for Tax-Related Items.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, if Participant has relocated to a different jurisdiction between the Award Date and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the relevant taxable event, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer (in its sole discretion) to satisfy all tax withholding and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">payment on account obligations for Tax-Related Items of the Company and&#47;or the Employer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In this regard, Participant authorizes the Company and the Employer, or either of them, in such entity&#8217;s sole discretion, to satisfy the obligations with regard to all Tax-Related Items legally payable by Participant (with respect to the Award granted hereunder as well as any equity awards previously received by Participant under any Company stock plan) by one or a combination of the following&#58; (i) requiring Participant to pay Tax-Related Items in cash with a cashier&#8217;s check or certified check or by wire transfer of immediately available funds&#59; (ii) withholding cash from Participant&#8217;s wages or other compensation payable to Participant by the Company and&#47;or the Employer&#59; (iii) withholding from the proceeds of the sale of shares of Common Stock otherwise issuable to Participant upon vesting of the Awards either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf and at Participant&#8217;s direction pursuant to this authorization without further consent)&#59; or (iv) withholding in shares of Common Stock otherwise issuable to Participant upon vesting of the Awards.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Agreement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, in no event shall the Company, any Affiliate, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any PRSUs until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 8 and the provisions regarding the forfeiture of PRSUs and shares of Common Stock shall survive termination of the PRSUs.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">representations not expressly made herein.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the PRSUs via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in Participant's country.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.78pt;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares or directorships held in the Company, details of all PRSUs or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is Participant's consent. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.78pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is Participant's consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:26.01pt;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, Participant's </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer PRSUs to Participant or otherwise administer or maintain Participant's participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, Participant understands that Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In accepting the Awards, Participant acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the grant of PRSUs hereunder, and any future grant of PRSUs under the Plan is entirely exceptional, voluntary and occasional, and at the sole discretion of the Company.  Neither this Award of PRSUs nor any past or future Award of PRSUs by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of PRSUs, benefits in lieu of PRSUs, even if PRSUs have been granted in the past&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">all decisions with respect to future PRSUs or other equity award grants, if any, shall be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Plan is established voluntarily by the Company, and the Awards granted thereunder is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Awards and shares of Common Stock subject to the Awards, and the income from and value of same, are an extraordinary item of compensation outside the scope of Participant&#8217;s employment.  As such, the PRSUs and shares of Common Stock acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">the PRSUs and the shares of Common Stock subject to the PRSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the future value of the underlying shares of Common Stock is unknown and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the value of the shares of Common Stock acquired upon vesting&#47;settlement of the Awards may increase or decrease in value&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">no claim or entitlement to compensation or damages shall arise from the forfeiture of the Award resulting from termination of Participant&#8217;s employment or continuous service with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of his or her employment agreement, if any)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Participant&#8217;s right to vest in this Award under the Plan or Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any).  The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Award grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the vesting&#47;settlement of the PRSUs or the subsequent sale of shares of Common Stock acquired upon vesting&#47;settlement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement do not create any entitlement to have the Awards or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the shares of Common Stock&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan or Participant&#8217;s acquisition or sale of the underlying shares of Common Stock&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant should consult with Participant&#8217;s own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to the shares of Common Stock (e.g., PRSUs) or rights linked to the value of shares of Common Stock (e.g., phantom awards, futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Award and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Electronic Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David E. Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Attachment 1 </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE VESTING CRITERIA APPLICABLE TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant&#8217;s Performance-Based Restricted Stock Units shall become vested, and any applicable restrictions shall lapse, based on the Company&#8217;s attainment of the performance goals indicated below over the Performance Period, which begins on January 1, 2023 and ends on December 31, 2025.  As indicated below, the actual number of Participant&#8217;s Performance-Based Restricted Stock Units that vest may range from 0% to 200% of Participant&#8217;s Target Number of Performance-Based Units, based on performance against the performance goals.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Goals</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant&#8217;s Performance-Based Restricted Stock Units shall vest, and the applicable restrictions with respect to such units shall lapse, based on both (1) the Company&#8217;s adjusted earnings per share (&#8220;Cumulative Adjusted EPS&#8221;) and (2) the Company&#8217;s average return on equity (&#8220;Average ROE&#8221;) during the Performance Period as determined in accordance with the tables below.  The aggregate payout as a percentage of the Target Number of Performance-Based Units shall be the sum of the percentages determined in the last column of each of the first two tables below.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Vesting Based on EPS Growth and Average ROE</font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.789%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023-2025<br>Cumulative<br>Adjusted EPS</font></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payout as a % of<br>Target # of Units</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">+</font></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023-2025<br>Average ROE</font></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payout as a % of<br>Target # of Units</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#61;</font></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined Payout as a % of Target # of Units</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80.21</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81.36</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$82.53</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$83.66</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$84.85</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$86.42</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88.02</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$89.66</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$91.29</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200%</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cumulative Adjusted EPS or Average ROE performance at or above the respective maximum levels shown in the tables above shall result in 100.0% of the total Target Number of Performance-Based Units becoming vested for that goal. If both Cumulative Adjusted EPS and Average ROE performance are at or above the respective maximum levels shown in the tables above, 200.0% of the total Target Number of Performance-Based Units shall become vested. The percentage of the total Target Number of Performance-Based Units becoming vested shall be interpolated for Cumulative Adjusted EPS or Average ROE performance between the levels shown in the tables above on a straight-line basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Adjustments</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Committee shall adjust earnings to eliminate the effect of any extraordinary or special item that is not included in or contemplated by the Five Year Financial Projections prepared for the February 23 to February 24, 2023 Board of Directors meeting (the &#8220;Business Plan&#8221;) and that, standing alone, significantly increases or decreases earnings (an &#8220;Extraordinary or Special Item&#8221;).  Extraordinary or Special Items shall include, without limitation, legal settlements, regulatory settlements and other similar non-recurring events.  Extraordinary or Special Items shall also include changes to the Company&#8217;s capital structure, including, without limitation, changes to the Company&#8217;s dividend policy or share repurchase program (as each is in effect at the start of the Performance Period), mergers, acquisitions, divestitures and reorganizations.  Further, the Committee shall adjust earnings to eliminate the effect of any new </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">federal legislation or amendments to existing federal legislation regarding funding of healthcare benefits by the United States government if such legislation or amendment (1) is enacted during the Performance Period and (2) results in a significant reduction or increase in that portion of the Company&#8217;s earnings that is derived from federal governmental sources, as projected in the Business Plan.   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although the Committee is required to make adjustments to earnings for Extraordinary or Special Items in accordance with the preceding paragraph, the Committee, in its sole discretion, may choose (1) not to make an adjustment to earnings for a particular Extraordinary or Special Item that would otherwise increase earnings and&#47;or (2) to decrease earnings on the basis of other events or items, in each case to reduce the number of Participant&#8217;s Performance-Based Restricted Stock Units that would otherwise vest.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>8
<FILENAME>unhex102612312022.htm
<DESCRIPTION>EX-10.26
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1812c8f77228489c8efff0a5d37dd550_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.26</font></div></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">FIRST AMENDMENT</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  OF</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  UNITEDHEALTH GROUP</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  EXECUTIVE SAVINGS PLAN </font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(2021 Statement)</font></div><div style="text-align:center;text-indent:11.85pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, UnitedHealth Group Incorporated, a Delaware corporation (&#8220;UnitedHealth Group&#8221;), has heretofore established and maintains several nonqualified, deferred compensation programs (the &#8220;ESP&#8221;) for the benefit of a select group of management or highly compensated employees of UnitedHealth Group and certain affiliates of UnitedHealth Group&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, said programs are currently embodied in a single document which is effective January 1, 2021, and which is entitled &#8220;UNITEDHEALTH GROUP EXECUTIVE SAVINGS PLAN (2021 Statement)&#8221; (hereinafter referred to as the &#8220;Plan Statement&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, Section 11.5 of the 2021 Statement provides that the Executive Vice President &#38; Chief Human Resources Officer may adopt certain amendments that do not materially increase the cost of the ESP&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, UnitedHealth Group wishes to amend the Plan Statement to clarify that for purposes of the special rule permitting persons who were eligible to participate prior to 2021 may continue to participate, the term &#8220;base salary&#8221; includes only base salary in its commonly understood sense and does not include any of the types of incentive compensation that are included in the defined term &#8220;Base Salary&#8221;&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the Executive Vice President &#38; Chief Human Resources Officer has determined that this proposed amendment is within her authority and does not materially increase the cost of the ESP.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NOW, THEREFORE, BE IT RESOLVED, that the Plan Statement is hereby amended in the following respect&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CLARIFICATION OF ELIGIBILITY GRANDFATHER RULE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Effective for Plan Years beginning on or after January 1, 2021, Section 1.3.2 is amended by deleting the phrase &#8220;Base Salary&#8221; where it appears in both clause (iii) and clause (b) of the proviso to said Section, and by substituting the phrase &#8220;base salary.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SAVINGS CLAUSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Save and except as hereinabove expressly amended, the Plan Statement shall continue in full force and effect.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.506%"><tr><td style="width:1.0%"></td><td style="width:25.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; December 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Patricia Lewis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">                          </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia Lewis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President &#38; Chief Human</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resources Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>9
<FILENAME>unhex102712312022.htm
<DESCRIPTION>EX-10.27
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifa75a2e9749c41879074370aee67009b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.27</font></div></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECOND AMENDMENT</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  OF</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  UNITEDHEALTH GROUP</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  EXECUTIVE SAVINGS PLAN </font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2021 Statement)</font></div><div style="text-align:center;text-indent:11.85pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, UnitedHealth Group Incorporated, a Minnesota corporation (&#8220;UnitedHealth Group&#8221;) has heretofore established and maintains several nonqualified, deferred compensation programs (the &#8220;ESP&#8221;) for the benefit of a select group of management or highly compensated employees of UnitedHealth Group and certain affiliates of UnitedHealth Group&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, said programs are currently embodied in a single document which is effective January 1, 2021, and which is entitled &#8220;UNITEDHEALTH GROUP EXECUTIVE SAVINGS PLAN (2021 Statement)&#8221; (hereinafter referred to as the &#8220;Plan Statement&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the Board of Directors of UnitedHealth Group has delegated to the Compensation and Human Resources Committee of the Board of Directors the power and authority to amend the Plan Statement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the Compensation and Human Resources Committee has further delegated its authority to amend the Plan Statement to the Executive Vice President and Chief People Officer with the exception of amendments that would materially increase the cost of the ESP, and amendments that are required to be adopted by the Board of Directors or the Compensation and Human Resources Committee in order to comply with the requirements of Section 162(m) of the Internal Revenue Code or Section 16 of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the Executive Vice President and Chief People Officer wishes to make certain clarifying and administrative amendments to the Plan Statement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the Executive Vice President and Chief People Officer has determined that such amendments will not materially increase the cost of the ESP, and that none of such amendments are required to be adopted by the Board of Directors or the Compensation and Human Resources Committee in order to comply with the requirements of Section 162(m) of the Internal Revenue Code or Section 16 of the Securities Exchange Act of 1934&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NOW, THEREFORE, BE IT RESOLVED, that the Plan Statement is hereby amended in the following respects&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">1.         TITLE OF CHIEF HUMAN RESOURCES OFFICER.  Effective as of March 3, 2022, the phrase &#8220;Executive Vice President &#38; Chief Human Resources Officer&#8221; is replaced by the phrase &#8220;Executive Vice President &#38; Chief People Officer&#8221; wherever the former phrase occurs in the Plan Statement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2.         DEFINITION OF ELIGIBLE GRADE LEVEL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  Effective as of January 1, 2023, Section 1.2.11(a) is amended to read as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;(a)      In General.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For regular full-time or part-time employees&#58; the Executive Leadership Team&#59; the Senior Leadership Team&#59; Salary Grades 32, 91, and 92&#59; Medical Director Grades M2, M3 and M4 (but in the case of Medical Director Grade M2 only if base salary is equal to or exceeds any specific compensation criteria established by the Executive Vice President &#38; Chief People Officer).&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3.         ELIGIBILITY OF CERTAIN PREVIOUSLY ELIGIBLE PARTICIPANTS.  Effective as of January 1, 2023, Section 1.3.2 is amended to read as follows&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8220;1.3.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Special Legacy Eligibility Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        Effective for the Plan Year beginning January 1, 2023, the Executive Vice President and Chief People Officer increased the compensation criteria for employees in Medical Director Grade M2. Any employee (i) who remains in Medical Director Grade M2, and (ii) whose base salary equals or exceeds the compensation criteria level in effect for 2022, shall be considered to be eligible to participate in the Plan for 2023 and all subsequent Plan Years (regardless of whether such employee elected to defer under the Plan for 2022), provided (iii) such employee remains in Medical Director Grade M2, (iv) such employee&#8217;s base salary for 2023 and all later years equals or exceeds the compensation criteria in effect for 2022, and (v) such employee elects to defer under the Plan for 2023 and continues to elect to defer for all subsequent years. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        Effective for the Plan Year beginning January 1, 2023, the Plan Statement was amended so that employees in Salary Grade 31 are no longer eligible to participate. Any employee (i) who was deferring under this Plan as a Salary Grade Level 31 employee in 2022 (or who was participating in a deferred compensation plan of an affiliate that was integrated with this Plan in 2022 and whose base salary in 2022 was at least equal to the compensation criteria level in effect for Salary Grade Level 31 employees in 2022) , (ii) who remains in Salary Grade Level 31, and (iii) whose base salary equals or exceeds the compensation criteria level in effect for 2022, shall be considered to be eligible to continue to participate in the Plan for 2023 and all subsequent Plan Years, provided (iv) such employee remains in Salary Grade Level 31, (v) such employee&#8217;s base salary for 2023 and all later years equals or exceeds the compensation criteria in effect for 2022, and (vi) such employee continues to elect to defer under the Plan for 2023 and later years.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        Any employee described in this Section 1.3.2 who declines to participate in the Plan for 2023 or any later year, or who ceases to satisfy the requirements of Section 1.3.2(a) or 1.3.2(b) for any reason, shall not be eligible to participate in the Plan for any subsequent Plan Year unless such employee satisfies the eligibility requirements of the Plan without regard to this Section 1.3.2.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">4.         PAYMENT OF ACCOUNTS OF PARTICIPANTS WHO FAIL TO DESIGNATE A BENEFICIARY.  Effective January 1, 2023, the list of automatic Beneficiaries at the end of Section 9.5.2 is amended to read as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;(i)       Participant&#8217;s surviving spouse&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)        Participant&#8217;s surviving issue per stirpes and not per capita&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)       Representative of Participant&#8217;s estate.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">5.         EFFECT OF SUSPENSION OF DEFERRALS ON UNFORESEEABLE EMERGENCY WITHDRAWALS.  Effective as of January 1, 2023, the flush language at the end of Section 9.8.2(b) is amended to read as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;Whether a Participant is faced with an unforeseeable emergency will be determined based on the relevant facts and circumstances. To the extent the severe financial hardship is or may be relieved either (i) through reimbursement or compensation by insurance or otherwise, or (ii) by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship), then the hardship shall not constitute an unforeseeable emergency for purposes of this Plan, and the amount of distribution permitted under Section 9.8.2(c) shall be reduced accordingly.  The amount that a Participant could obtain from a tax qualified retirement plan (including a hardship withdrawal or loan from such a plan) shall not be taken into account in determining the extent to which the hardship may be relieved.  If a Beneficiary of a deceased Participant requests an early distribution for an unforeseeable emergency, then the references in this definition to &#8220;Participant&#8221; shall be deemed to be references to such Beneficiary.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6.         LIST OF PARTICIPATING EMPLOYERS.  Effective as of January 1, 2023, Schedule I of the Plan Statement is amended in the form appended to this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.156%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">12&#47;22&#47;2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; Erin McSweeney</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Erin L. McSweeney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Vice President &#38; Chief People Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">UnitedHealth Group</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SCHEDULE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EMPLOYERS PARTICIPATING</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IN THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">UNITEDHEALTH GROUP EXECUTIVE SAVINGS PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Effective as of January 1, 2023</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">U.S. Domestic Corporations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         United HealthCare Services, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         UHC International Services, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         Health Plan of Nevada, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         Sierra Health and Life Insurance Company, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         Southwest Medical Associates, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         Optum Services, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         UnitedHealthcare of Illinois, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         Optum Care, Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>10
<FILENAME>unhex102812312022.htm
<DESCRIPTION>EX-10.28
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie708b9a853a14c7db07e7d3426a25ae1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.28</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group Benefits Handbook</font></div></div><div style="text-indent:11.85pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">Benefits Handbook Supplement</font></div></td></tr></table></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:18pt;font-style:italic;font-weight:700;line-height:120%">Executive Long-Term Disability</font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">UnitedHealth Group Incorporated (&#8220;UnitedHealth Group&#8221;) sponsors the UnitedHealth Group Long-Term Disability Program (the &#8220;LTD Program&#8221;), which is a component benefit program of the UHG Inc. Group Benefits Plan. The LTD Program provides financial protection against loss of income if you are unable to work because of covered illness or injury.</font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The official plan document for the LTD Program is the LTD Insurance Policy that Hartford Life and Accident Insurance Company (The &#8220;Hartford&#8221;), the insurer, has issued. The Hartford is the Claims Administrator for the LTD Program.</font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Summary Plan Description (&#8220;SPD&#8221;) for the LTD Program is composed of the Hartford Life and Accident Insurance Company Certificate of Insurance, together with the following sections of the UnitedHealth Group Benefits Handbook - Disability, Life&#47;AD&#38;D, and Business Travel Accident Insurance&#58; &#8221;Introduction,&#8221; &#8220;Eligibility and Enrollment,&#8221; &#8220;Administration Information,&#8221; and applicable defined terms in the &#8220;Glossary&#8221; section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">The LTD Program at a Glance</font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Executive Long-Term Disability (&#8220;Executive LTD&#8221;) benefit is a component of the LTD Program and supplements for a select group of officers the benefits provided under the LTD Program. The LTD Insurance policy and SPD sections listed above, which are incorporated herein by reference, apply to the Executive LTD component benefit and should be read in conjunction with this summary. The table below describes the key features of the Executive LTD component of the LTD Program.</font></div><div style="margin-bottom:10pt"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Features of Executive Long-Term Disability Benefit</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Eligibility</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%;padding-left:14.5pt">Meet the eligibility requirements in &#8220;Who is Eligible&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:97%"> in the Eligibility and Enrollment and Disability C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%">overage sections of the Benefits Handbook&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:95%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:95%;padding-left:14.5pt">Eligible for Class 1 Executive Leadership Team benefits under the LTD Insurance Policy&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%;padding-left:14.5pt">You have a written Employment Agreement which contains an express provision granting Executive LTD coverage.</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Premium Contributions&#47;Funding</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive LTD benefits are paid exclusively from UnitedHealth Group&#8217;s general assets, and UnitedHealth Group is solely responsible for payment of Executive LTD benefits. Executive LTD benefits are self-insured and no premium amounts are determined.</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">When Coverage Begins&#47;Enrollment</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:97%;padding-left:14.5pt">Executive LTD coverage begins automatically on the first of the month following the signing of your executive Employment Agreement if you are Actively at Work as provided under the LTD Program.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">You do not need to enroll for coverage.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group Benefits Handbook</font></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Coverage Level</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive LTD benefits are 60% of your Predisability Earnings* that exceed $58,333 reduced by Deductible Income as defined under the LTD Program. There is no monthly maximum Executive LTD Benefit.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Plan Sponsor</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">UnitedHealth Group Incorporated<br>9900 Bren Road East<br>Minnetonka MN 55343</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Claims Administrator</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:101%">The Hartford</font></div><div style="text-indent:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">One Hartford Plaza </font></div><div style="text-indent:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hartford, CT 06155</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Claims</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Follow the claims process for the LTD Program. Refer to the SPD and LTD Insurance Policy for instructions.</font></div><div style="margin-bottom:3pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims should be sent to&#58; </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">The Hartford</font></div><div style="text-indent:36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:104%">PO Box 14869</font></div><div style="text-indent:36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lexington, Kentucky 40512-4869</font></div><div style="text-indent:36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; 833-357-5153</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">When Benefits Are Paid</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The LTD Program and Executive LTD component pay benefits only if the Claims Administrator determines that you are Disabled, are receiving Regular and Appropriate Care of a Physician and have satisfied the LTD Program Waiting Period as specified under the LTD Policy.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Refer to the SPD and LTD Insurance Policy for details.</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">How Benefits Are Paid</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-indent:5.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hartford will issue two checks for LTD benefits&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Fully insured LTD benefits equal to 60% of the first </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$58,333 of your Predisability Earnings* reduced by Deductible Income&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.    Self-insured Executive LTD benefits equal to 60% of your Predisability Earnings* reduced by Deductible Income that exceeds $58,333.</font></div><div><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Note&#58; You may make a taxation election on the premiums UnitedHealth Group pays only with respect to the fully insured benefits payable under the LTD Program. The self- insured Executive LTD benefits are taxable income, because benefits are paid exclusively from UnitedHealth Group&#8217;s general assets and there are no premiums on which to impute income.</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:5.6pt;vertical-align:top"><font style="color:#4a93d1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">When Coverage Ends</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive LTD coverage ends when coverage under the LTD Program ends or your Employment Agreement is amended to terminate Executive LTD coverage.</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Claim Administrator for the LTD Program shall serve as the Claim Administrator for the Executive LTD component benefit. UnitedHealth Group has contracted with The Hartford to administer benefits and claims under this Executive LTD component benefit in tandem with administering LTD benefits and claims under the LTD Program. The Hartford shall apply the same claims rules to the Executive LTD benefit component as are applied the LTD Program.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*Predisability Earnings are monthly earnings.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Long-Term Disability &#9632; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>11
<FILENAME>unhex102912312022.htm
<DESCRIPTION>EX-10.29
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i798f68af8dca4d989028439cabd143ac_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.29</font></div></div><div style="margin-bottom:11pt;text-align:center"><img alt="uhgdirectorcompsummarya07.jpg" src="uhgdirectorcompsummarya07.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:682px"></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our compensation and benefit program is designed to compensate our non-employee directors fairly for work required for a company of our size and scope, and align their interests with the long-term interests of our shareholders. Director compensation reflects our desire to attract, retain and use the expertise of highly qualified people serving on the Company&#8217;s Board of Directors. The Compensation and Human Resources Committee reviews the compensation level of our non-employee directors on an annual basis and makes recommendations to the Board of Directors. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses annual retainers, equity-based compensation, expense reimbursement and other forms of compensation, as appropriate, to attract and retain non-employee directors. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Cash Compensation</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-employee directors receive an annual cash retainer of $125,000. We pay an additional annual cash retainer of $300,000 to the Chair of the Board, an additional annual cash retainer of $32,500 to the Chair of the Audit Committee, and additional annual cash retainers of $25,000 to the Chair of the Compensation and Human Resources Committee, the Chair of the Nominating and Corporate Governance Committee and the Chair of the Public Policy Strategies and Responsibility Committee.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash retainers are payable on a quarterly basis in arrears on the first business day following the end of each fiscal quarter, and subject to pro-rata adjustment if the director did not serve the entire quarter. Directors may elect to receive deferred stock units (&#8220;DSUs&#8221;) or common stock (if the director has met the stock ownership guidelines) in lieu of their cash compensation or may defer receipt of their cash compensation to a later date pursuant to the Directors' Compensation Deferral Plan (&#34;Director Deferral Plan&#34;).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Equity-Based Compensation</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-employee directors receive annual grants of DSUs under the 2011 Stock Incentive Plan, as amended, having an annual aggregate fair value of $225,000, subject to rounding adjustments described below. The grants are issued quarterly in arrears on the first business day following the end of each fiscal quarter and prorated if the director did not serve the entire quarter. The number of DSUs granted is determined by dividing $56,250 (the quarterly value of the annual equity award) by the closing stock price on the grant date, rounded up to the nearest share.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The DSUs immediately vest upon grant and must be retained until completion of the director&#8217;s service on the Board of Directors. Upon completion of service, the DSUs convert into an equal number of shares of the Company&#8217;s common stock. A director may defer receipt of the shares for up to ten years after completion of service pursuant to the Director Deferral Plan. Non-employee directors who have met their stock ownership requirement may elect to receive common stock in lieu of DSUs and&#47;or in-service distributions on pre-selected dates. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If a director elects to convert his or her cash compensation into DSUs, such conversion grants are made on the day the eligible cash compensation becomes payable to the director and immediately vest upon grant. The director receives the number of DSUs equal to the cash compensation foregone, divided by the closing price of our common stock on the date of grant, rounded up to the nearest share. A director may only elect to receive common stock if he or she has met the stock ownership guidelines.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company pays dividend equivalents in the form of additional DSUs on all outstanding DSUs. Dividend equivalents are paid at the same rate and at the same time that dividends are paid to Company shareholders and are subject to the same vesting conditions as the underlying grant.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Deferral Plan</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Director Deferral Plan, subject to compliance with applicable laws, non-employee directors may elect annually to defer receipt of all or a percentage of their compensation. Amounts deferred are credited to a bookkeeping account maintained for each director participant that uses a collection of unaffiliated mutual funds as measuring investments. Subject to certain additional rules set forth in the Director Deferral Plan, a participating director may elect to receive the distribution in one of the following ways&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a series of five or ten annual installments following the completion of his or her service on the Board of Directors&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a delayed lump sum following either the fifth or tenth anniversary of the completion of his or her service on the Board of Directors&#59;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">for cash deferrals, an immediate lump sum upon the completion of his or her service on the Board of Directors&#59; or</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">pre-selected amounts to be distributed on pre-selected dates while the director remains a member of the Board of Directors.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Director Deferral Plan does not provide for matching contributions by the Company, but our Board of Directors may determine, in its discretion, to supplement the accounts of participating directors with additional amounts.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Compensation</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We reimburse directors for any out-of-pocket expenses incurred in connection with service as a director. We also provide health care coverage to directors but only if the director is not eligible for coverage under another group health care benefit program. Health care coverage is provided generally on the same terms and conditions as current employees. Upon retirement from the Board of Directors, directors may continue to obtain health care coverage under benefit continuation coverage, and after the lapse of such coverage, under the Company&#8217;s post-employment medical plan for up to a total of 96 months if they are otherwise eligible.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company maintains a program through which it will match up to $15,000 of charitable donations made by each director for each calendar year. The directors do not receive any financial benefit from this program because the charitable income tax deductions accrue solely to the Company. Donations under the program may not be made to family trusts, partnerships or similar organizations.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective October 1, 2022</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>12
<FILENAME>unhex103012312022.htm
<DESCRIPTION>EX-10.30
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i602c605559e84c1f8e1ada0622265a3b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.30</font></div></div><div style="margin-bottom:10pt;text-align:center;text-indent:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS&#8217; COMPENSATION DEFERRAL PLAN </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2023 STATEMENT) </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1 </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION AND DEFINITIONS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Establishment of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Effective January 1, 2002, UNITEDHEALTH GROUP INCORPORATED, a Minnesota corporation (hereinafter sometimes referred to as &#8220;UnitedHealth Group&#8221;), as plan sponsor, established a nonqualified, unfunded, deferred compensation plan for the benefit of certain members of its Board of Directors. The plan document was subsequently restated in the form of the 2009 Statement to incorporate all previously adopted amendments into a single document. This document reflects changes to the plan document effected by a First Amendment adopted effective August 1, 2010, and an unnumbered Amendment adopted as of January 1, 2010. This plan document also reflects certain additional amendments for purposes of revising the payment of benefits on behalf of a deceased Participant, and to make editorial and clarifying changes. Prior to the adoption of this Plan Statement, some accounts in the Plan contained funds that were accrued and vested prior to January 1, 2004 (the &#8220;Pre-2004 Accounts&#8221;), and accordingly were exempt from the application of  Section 409A of the Internal Revenue Code of 1986 and its accompanying regulations (&#8220;Section 409A of the Code&#8221;).  As all Pre-2004 Accounts have been fully distributed, references to the Pre-2004 Accounts have been deleted from this Plan Statement&#59; provided, however, that if it is subsequently determined that any portion of an Account is properly characterized as a Pre-2004 pursuant to Section 409A of the Code, the provisions of the Plan applicable to Pre-2004 Accounts as in effect prior to this Plan Statement shall govern such portion.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. When the following terms are used herein with initial capital letters, they shall have the following meanings&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the separate bookkeeping account established for each Participant which represents the separate unfunded and unsecured general obligation of UnitedHealth Group established with respect to each person who is a Participant in this Plan in accordance with Section 2 and which are credited to the dollar amounts and&#47;or Deferred Stock Units specified in Sections 3 and 4 and from which are subtracted payments made pursuant to Section 8. To the extent necessary to accommodate and effect the distribution elections made by Participants pursuant to Section 8.2 and Section 8.8.1, separate bookkeeping sub-accounts shall be established with respect to each of the several annual forms of distribution elections and pre-selected in-service distribution elections made by Participants. In addition, sub-accounts may be established with respect to cash compensation and Deferred Stock Units, and any reference in the Plan to the &#8220;cash portion&#8221; of a Participant&#8217;s Account shall mean the portion of the Account excluding Deferred Stock Units.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Valuation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; each December 31. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a person designated by a Participant (or automatically by operation of the Plan Statement) to receive all or a part of the Participant&#8217;s Account in the event of the Participant&#8217;s death prior to full distribution thereof. A person so designated shall not be considered a Beneficiary until the death of the Participant. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Board retainer fees, Board Chair retainer fees, Board meeting fees, Board committee Chair retainer fees and Board committee fees, including any such fees as the Participant elects to have paid in the form of Deferred Stock Units, but not stock options or other stock-based compensation. The Committee may designate prospectively that other pay is included in Board Compensation. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors or Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the Board of Directors of UnitedHealth Group or its successor, and any properly authorized committee of the Board of Directors. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the Internal Revenue Code of 1986, as amended. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the Compensation and Human Resources Committee of the Board of Directors (also known as the &#8220;Compensation Committee&#8221;). </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Unit or Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a unit granted under the UnitedHealth Group Incorporated 2002 Stock Incentive Plan, as may be amended from time to time, or a successor plan, evidencing the right to receive a share of UnitedHealth Group common stock (or a cash payment equal to the fair market value of a share of United Health Group common stock) at some future date.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a member of the Board of Directors of UnitedHealth Group who has elected to defer compensation under Section 3. A director who has become a Participant shall continue to be a Participant in this Plan until the date of the Participant&#8217;s death or, if earlier, the date when the Participant has received a distribution of the Participant&#8217;s entire Account. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the nonqualified, unfunded, deferred compensation program maintained by UnitedHealth Group for the benefit of Participants eligible to participate therein, as set forth in this Plan Statement. (As used herein, &#8220;Plan&#8221; does not refer to the document pursuant to which the Plan is maintained. That document is referred to herein as the &#8220;Plan Statement&#8221;.) The Plan shall be referred to as the &#8220;UnitedHealth Group Directors&#8217; Compensation Deferral Plan.&#8221; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this document entitled &#8220;UnitedHealth Group Directors&#8217; Compensation Deferral Plan (2023 Statement)&#8221; as adopted by the Board of Directors and generally effective January 1, 2023, as the same may be amended from time to time thereafter. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; the twelve (12) consecutive month period ending on any Annual Valuation Date. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Termination of Directorship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a complete severance of a Participant&#8217;s membership on the Board of Directors of UnitedHealth Group for any reason other than the Participant&#8217;s death. Whether a Termination of Directorship has occurred is determined under section 409A of the Code and section 1.409A-1(h) of the regulations (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, whether the expiration </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the director&#8217;s term or his or her resignation or removal from the Board constitutes a good-faith and complete termination of the Director&#8217;s relationship with UnitedHealth Group). </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group or UHG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; UNITEDHEALTH GROUP INCORPORATED, a Minnesota corporation, or any successor thereto. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2.15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; any day that the U.S. securities markets are open and conducting business. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 2 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELIGIBILITY TO PARTICIPATE </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each member of the Board of Directors of UnitedHealth Group as of the initial adoption of this Plan who is not an employee of UnitedHealth Group or any affiliate shall be eligible to become a Participant in this Plan as of January 1, 2002. Each person who later becomes a member of the Board and is not then an employee of UnitedHealth Group or any affiliate shall be eligible to become a Participant in this Plan as of such member&#8217;s election to the Board. Each person (a) who is both a member of the Board and an employee of UnitedHealth Group or any affiliate, and (b) who later ceases to be so employed but continues as a member of the Board, shall be eligible to become a Participant in this Plan as of such cessation of employment. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DEFERRAL OPTION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option to Defer Board Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount of Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through a voice response system (or other written or electronic means) approved by the Committee, a Participant may elect to defer between (and including) 1% and 100% of such Participant&#8217;s Board Compensation for Board services for a Plan Year. The Committee may establish prospectively other percentage limits. To be effective for a Plan Year, the deferral election must be received by the Committee or its designee prior to the first day of the Plan Year (or such earlier deadline designated by the Committee or its designee)&#59; provided, however, for a person who is first elected to the Board after the beginning of the Plan Year and was not previously eligible to participate in a plan required to be aggregated with this Plan under Treasury Regulations 1.409A-1(c)(2)(i), the deferral election must be received by the Committee within 30 days after the first day of such eligibility, and, if so received, the deferral election shall apply to Board Compensation earned after the date of the election. Such deferral election shall be irrevocable and shall remain in effect until changed or rescinded. Prior to the beginning of any subsequent Plan Year, a Participant may irrevocably elect through a voice response system (or other written or electronic means) approved by the Committee to change an earlier election by providing a new deferral election to the Committee or its designee. The new deferral election shall become effective on the first day of the subsequent Plan Year.  The Committee, in its sole discretion, may permit a Participant to make separate deferral elections with respect to the Participant&#8217;s Board Compensation payable (a) in cash and&#47;or (b) Deferred Stock Units.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Crediting to Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall cause to be credited to the Account of each Participant the amount, if any, of such Participant&#8217;s voluntary deferrals of Board</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation under Section 3.1.1. Such amount shall be credited as soon as administratively feasible following the time such Board Compensation would otherwise have been paid to the Participant. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Matching Credits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No matching amounts shall be credited for deferrals of Board Compensation under Section 3.1.1. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suspension of Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Anything else contained in the Plan to the contrary notwithstanding, if a Participant requests a withdrawal due to unforeseeable emergency pursuant to Section 8.8.2, and the Committee determines that the Participant has incurred an unforeseeable emergency as defined therein, all further deferrals of the Participant&#8217;s Board Compensation for the balance of the Plan Year shall be cancelled and no amounts of Board Compensation paid during the balance of the Plan Year shall be deferred.   Such Participant shall be eligible to make deferral elections for subsequent Plan Years in accordance with this Section 3.1.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discretionary Supplements From UnitedHealth Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon written notice to one or more Participants and to the Committee, the Board of Directors may (but is not required to) determine that additional amounts shall be credited to the Accounts of such Participants. Such notice shall also specify the date of such crediting. Notwithstanding Section 6, such notice may also establish vesting rules for such amounts, in which case separate Accounts shall be established for such amounts for such Participants. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credits Limited to Outside Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Participant who becomes an employee of UnitedHealth Group or any affiliate shall be eligible to receive credits under this Section 3 while such an employee. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 4 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CREDITS FROM MEASURING INVESTMENTS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designation of Measuring Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through a voice response system (or other written or electronic means) approved by the Committee, each Participant shall designate the following &#8220;Measuring Investments,&#8221; which shall be used to determine the value of such Participant&#8217;s Account (other than the portion consisting of Deferred Stock Units), until changed as provided herein&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        One or more Measuring Investments for the current Account balance, and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        One or more Measuring Investments for amounts that are credited to the Account in the future.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Accounts and such Measuring Investments are specified solely as a device for computing the amount of benefits to be paid by UnitedHealth Group under the Plan, and UnitedHealth Group is not required to purchase such investments. The Measuring Investments may be revised and amended by the Committee, in its discretion, from time to time. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group Stock as Measuring Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board of Directors may (but shall not be required to) determine that the Measuring Investments available for election by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants will include deemed (but not actual) investment in the common stock of UnitedHealth Group, valued at the closing price of the common stock of UnitedHealth Group as reported on the New York Stock Exchange composite tape on the applicable Valuation Date.  For avoidance of doubt, if the Board of Directors determines that a deemed election in common stock is an available Measuring Investment, then the portion of a Participant&#8217;s Account that the Participant designates as being deemed invested in such Measuring Investment shall not be considered Deferred Stock Units for purposes of the Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optional Rules for Measuring Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may adopt rules specifying the Measuring Investments, the circumstances under which a particular Measuring Investment may be elected, or shall be automatically utilized, the minimum or maximum amount or percentage of an Account which may be allocated to a Measuring Investment, the procedures for making or changing Measuring Investment elections, the extent (if any) to which Beneficiaries of deceased Participants may make Measuring Investment elections and the effect of a Participant&#8217;s or Beneficiary&#8217;s failure to make an effective Measuring Investment election with respect to all or any portion of an Account. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Measuring Investments and Rules to be Identical to Executive Savings Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless the Committee specifies otherwise, the Measuring Investments and operational rules for this Plan shall be identical to those under the UnitedHealth Group Executive Savings Plan and any change to the Measuring Investments or operational rules under the Executive Savings Plan shall automatically apply to this Plan. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 5 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPERATIONAL RULES </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational Rules for Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant&#8217;s election to defer Board Compensation under Section 3 shall be &#8220;evergreen&#8221; and shall remain in effect until changed by the Participant for a future Plan Year as specified in Section 3.1.1. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Establishment of Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There shall be established for each Participant an unfunded, bookkeeping Account which shall be adjusted each Valuation Date. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may adopt (and revise) accounting rules for the Accounts. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 6 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VESTING OF ACCOUNTS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Account of each Participant shall be fully (100%) vested and nonforfeitable at all times (except for any special vesting rules that apply to discretionary supplements of UnitedHealth Group under Section 3.2 and any early distribution penalties that may apply under Section 8). </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPENDTHRIFT PROVISION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants and Beneficiaries shall have no power to transfer any interest in an Account nor shall any Participant or Beneficiary have any power to anticipate, alienate, dispose of, pledge or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">encumber the same while it is in the possession or control of UnitedHealth Group, nor shall the Committee recognize any assignment thereof, either in whole or in part, nor shall the Account be subject to attachment, garnishment, execution following judgment or other legal process (including without limitation any domestic relations order, whether or not a &#8220;qualified domestic relations order&#8221; under section 414(p) of the Code) before the Account is distributed to the Participant or Beneficiary. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The power to designate Beneficiaries to receive the Account of a Participant in the event of such Participant&#8217;s death shall not permit or be construed to permit such power or right to be exercised by the Participant so as thereby to anticipate, pledge, mortgage or encumber such Participant&#8217;s Account or any part thereof. Any attempt by a Participant to so exercise said power in violation of this provision shall be of no force and effect and shall be disregarded by the Committee. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 8</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISTRIBUTIONS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Time of Distribution to Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant&#8217;s Account shall be distributable upon the Termination of Directorship of the Participant. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Application for Distribution Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant&#8217;s Account shall be distributed automatically following the Participant&#8217;s Termination of Directorship. A Participant shall not be required to apply for distribution. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution to Specified Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan Statement, in the event that a Participant in the Plan is determined to be a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by UnitedHealth Group), any distribution to the Participant on account of the Participant&#8217;s Termination of Directorship shall be delayed until the first day of the first month that begins six (6) months following the Termination of Directorship (or if earlier, the date of the Participant&#8217;s death) to comply with the requirements of section 409A of the Code. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form of Distribution. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As determined under the rules of Section 8.3, distribution of the Participant&#8217;s Account shall be made in one or more of the forms listed below. Effective with the 2010 Plan Year, the Committee, in its sole discretion, may permit a Participant to make separate distribution elections with respect to the Participant&#8217;s Board Compensation payable in cash and&#47;or Deferred Stock Units.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Immediate Lump Sum of Cash-Based Board Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution of the cash-based Board Compensation sub-account within the Participant&#8217;s Account shall be made in a single lump sum. The amount of the lump sum distribution shall be determined as soon as administratively feasible as of a Valuation Date following the Plan Year in which occurs the Participant&#8217;s Termination of Directorship. Payment shall actually be made as soon as practicable after such determination (but not later than the last day of the February following the Plan Year in which occurs the Participant&#8217;s Termination of Directorship).</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Installments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Distribution of the Participant&#8217;s Account shall be made in a series of five (5) or ten (10) annual installments. If a Participant elects to receive payment in the form of installments, then pursuant to section 409A of the Code and regulations issued thereunder (and for purposes of the re-election provisions in Section 8.3.4), the series of installment payments shall be treated as the entitlement to a single payment (rather than a series of separate payments).</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash-Based Board Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the first installment will be determined as soon as administratively feasible following the Plan Year in which occurs the Participant&#8217;s Termination of Directorship and the amount of future installments will be determined as soon as administratively feasible following the end of each following Plan Year. The amount of each installment shall be determined by dividing the Participant&#8217;s Account balance as of the Valuation Date as of which the installment is being paid, by the number of remaining installment payments to be made (including the payment being determined). Such installment payments shall actually be made as soon as practicable after each such determination (but not later than the last day of February of each year when a determination occurs).</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In payment of vested Deferred Stock Units, UnitedHealth Group shall promptly issue shares of UnitedHealth Group common stock in book-entry form, registered in Participant&#8217;s name (or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be) in equal installments in each Plan Year following the Plan Year in which the Participant&#8217;s Termination of Directorship occurs. The value of any fractional vested Deferred Stock Unit shall be paid in a single lump sum cash payment at the time the shares of Common Stock are delivered to Participant in payment of the last installment of Deferred Stock Units. In no event shall payment be made later than the last day of February of the Plan Year in which the payment is scheduled to occur.</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exception for Small Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing provisions of this Section 8.2(b), if the value of the Participant&#8217;s Account as of the Valuation Date as of which an installment payment is to be determined (excluding the value of the Participant&#8217;s vested Deferred Stock Units) does not exceed Five Thousand Dollars ($5,000), the cash portion of the Participant&#8217;s Account shall be paid in the form of a lump sum. Payment shall be made as soon as administratively practicable after such Valuation Date (but not later than the last day of February of the year when such determination occurs). For this purpose, the value of the Account shall be determined after reduction for any lump sum or other payment that is also payable to such Participant as of such Valuation Date.  Provided, however, that if the portion of the Participant&#8217;s Account attributable to amounts deferred prior to January 1, 2023 (including the value on the Valuation Date of Deferred Stock Units credited to the Participant&#8217;s Account prior to January 1, 2023) does not exceed Five Thousand Dollars ($5,000) as of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such Valuation Date, then such portion of the Participant&#8217;s Account shall be paid in the form of a lump sum (or in the case of vested Deferred Stock Units, such Units will be converted into shares of UnitedHealth Group common stock), and the value of the remaining portion of Account (excluding the remaining Deferred Stock Units) shall be determined after the cash portion of such payment.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Five (5) Year Delay, then Lump Sum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Distribution of the Participant&#8217;s Account shall be made in a single lump sum payment following the fifth (5th) anniversary of the Participant&#8217;s Termination of Directorship, in the manner described below&#58;</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash-Based Board Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of such distribution shall be determined as soon as administratively feasible as of a Valuation Date in the calendar year following the calendar year in which occurs the fifth (5th) anniversary of the Participant&#8217;s Termination of Directorship. Actual distribution shall be made in the calendar year of determination as soon as administratively practicable after such determination (but not later than the last day of February of each year when a determination occurs).</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the Plan Year immediately following the fifth anniversary of the Participant&#8217;s Termination of Directorship, UnitedHealth Group shall issue shares of Common Stock in book-entry form, registered in Participant&#8217;s name (or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be), in payment of all vested whole Deferred Stock Units. The value of any fractional vested Deferred Stock Unit shall be paid in a single lump sum cash payment at the time shares of Common Stock are delivered to Participant in payment of the Deferred Stock Units. In no event shall payment be made later than the last day of February of the Plan Year in which the payment is scheduled to occur.</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exception for Small Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing provisions of this Section 8.2(c), if the value of the Participant&#8217;s Account (excluding the value of the Participant&#8217;s vested Deferred Stock Units) does not exceed Five Thousand Dollars ($5,000) as of the Valuation Date in the Plan Year in which the Participant experienced a Termination of Directorship, the cash portion of the Participant&#8217;s Account shall be paid in a lump sum. Payment shall be made as soon as practicable after such determination (but not later than the last day of February of the year following the Valuation Date)&#59; provided that if the portion of the Participant&#8217;s Account attributable to amounts deferred prior to January 1, 2023 (including the value on the Valuation Date of Deferred Stock Units credited to the Participant&#8217;s Account prior to January 1, 2023) does not exceed Five Thousand Dollars ($5,000) as of such Valuation Date, then such portion of the Participant&#8217;s Account shall be paid in the form of a lump sum (or in the case of vested Deferred Stock Units, such Units will be converted into shares of UnitedHealth Group common stock), and the value of the remaining portion of Account (excluding the remaining </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred Stock Units) shall be determined after the cash portion of such payment.</font></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ten (10) Year Delay, then Lump Sum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Distribution of the Participant&#8217;s Account shall be made in a single lump sum payment following the tenth (10th) anniversary of the Participant&#8217;s Termination of Directorship, in the manner described below&#58;</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash-Based Board Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amount of such distribution shall be determined as soon as administratively feasible as of a Valuation Date in the calendar year following the calendar year in which occurs the tenth (10th) anniversary of the Participant&#8217;s Termination of Directorship. Actual distribution shall be made in the calendar year of determination as soon as administratively practicable after such determination (but not later than the last day of February of each year when a determination occurs).</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Stock Units.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the Plan Year immediately following the tenth anniversary of the Participant&#8217;s Termination of Directorship, UnitedHealth Group shall issue shares of Common Stock in book-entry form, registered in Participant&#8217;s name (or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be), in payment of all vested whole Deferred Stock Units. The value of any fractional vested Deferred Stock Unit shall be paid in a single lump sum cash payment at the time shares of Common Stock are delivered to Participant in payment of the Deferred Stock Units. In no event shall payment be made later than the last day of February of the Plan Year in which the payment is scheduled to occur.</font></div><div style="margin-bottom:10pt;padding-left:99pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exception for Small Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing provisions of this Section 8.2(d), if the value of the Participant&#8217;s Account (excluding the value of the Participant&#8217;s vested Deferred Stock Units) does not exceed Five Thousand Dollars ($5,000) as of the Valuation Date in the Plan Year in which the Participant experienced a Termination of Directorship, the cash portion of the Participant&#8217;s Account shall be paid in a lump sum. Payment shall be made as soon as practicable after such determination (but not later than the last day of February of the year following the Annual Valuation Date)&#59; provided that if the portion of the Participant&#8217;s Account attributable to amounts deferred prior to January 1, 2023 (including the value on the Valuation Date of Deferred Stock Units credited to the Participant&#8217;s Account prior to January 1, 2023) does not exceed Five Thousand Dollars ($5,000) as of such Valuation Date, then such portion of the Participant&#8217;s Account shall be paid in the form of a lump sum (or in the case of vested Deferred Stock Units, such Units will be converted into shares of UnitedHealth Group common stock), and the value of the remaining portion of Account (excluding the remaining Deferred Stock Units) shall be determined after deducting the cash portion of such payment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Election of Form of Distribution by Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Enrollment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through a voice response system (or other written or electronic means) approved by the Committee, each Participant shall elect at the time of initial enrollment in the Plan whether distribution of the Participant&#8217;s Account shall be made (as described in Section 8.2) in either&#58; (i) an immediate lump sum, (ii) five (5) or ten (10) annual installments, or (iii) a delayed lump sum following the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Participant&#8217;s Termination of Directorship. Such distribution election shall remain in effect with respect to the Participant&#8217;s Account for all subsequent Plan Years unless, prior to a subsequent Plan Year, the Participant files a new distribution election for the Participant&#8217;s Account with the Committee in accordance with the provisions of Section 8.3.3.  Effective with the 2010 Plan Year, the Committee, in its sole discretion, may permit a Participant to make a separate distribution election with respect to the Participant&#8217;s Board Compensation payable in cash and&#47;or Deferred Stock Units. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Default Election of Form of Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant fails to elect a form of distribution, such Participant shall be deemed to have elected that distribution be made in an immediate lump sum as described in Section 8.2(a). </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separate Distributions Elections Permitted Each Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any initial or default distribution election made by a Participant with respect to the Participant&#8217;s Account shall remain in effect with respect to the Participant&#8217;s Account for all subsequent Plan Years unless, prior to a subsequent Plan Year, the Participant files a new distribution election for the Participant&#8217;s Account electing a different form of distribution for that portion of the Participant&#8217;s Account attributable to deferrals for such subsequent Plan Year (and any investment gains or losses on such deferrals). Through a voice response system (or other written or electronic means) approved by the Committee, a Participant may elect a different form of distribution for that portion of the Participant&#8217;s Account attributable to deferrals for a subsequent Plan Year (and any investment gains or losses on such deferrals). To be effective for deferrals for a Plan Year, the new distribution election must be received by the Committee or its designee prior to the first day of the Plan Year (or such earlier deadline designated by the Committee or its designee). If a Participant files a new distribution election with respect to the Participant&#8217;s Account with the Committee pursuant to this Section 8.3.3, such distribution election shall remain in effect for all subsequent Plan Years unless, prior to a subsequent Plan Year, the Participant files with the Committee another distribution election for the Participant&#8217;s Account electing a different form of distribution for that portion of the Participant&#8217;s Account attributable to deferrals for such subsequent Plan Year (and any investment gains or losses in such deferrals). </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Periodic Re-Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through a voice response system (or other written or electronic means) approved by the Committee, initial and default distribution elections may be changed by the Participant from time to time, subject to the following.  Each subsequent distribution election filed with respect to the Participant&#8217;s Account shall supersede all prior distribution elections filed with respect to such specified portion of the Participant&#8217;s Account and shall be effective as to the specified portion of the Participant&#8217;s Account. If, however, the subsequent distribution election does not have the effect of delaying payment of the lump sum (or, in the case of installments, the installment commencement date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the date the first installment in the stream of installment payments is scheduled to be paid) under the prior </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">election for at least five (5) years, such distribution election shall be disregarded as if it had never been filed (and the prior effective distribution election shall be given effect).  Notwithstanding the foregoing, any new distribution election shall be disregarded as if it had never been filed (and the prior effective distribution election shall be given effect) unless the distribution election&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         is filed by a Participant who is still performing Board services,</font></div><div style="margin-bottom:10pt;padding-left:103.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        is filed with the Committee at least twelve (12) months before the Participant&#8217;s scheduled distribution date following the Participant&#8217;s Termination of Directorship or, if applicable, the Participant&#8217;s specified payment date,</font></div><div style="margin-bottom:10pt;padding-left:103.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       is filed at least twelve (12) months after the initial distribution election for the specified portion of the Participant&#8217;s Account (or, if one or more prior changes has been filed, at least twelve (12) months after the latest of such changes was filed), and</font></div><div style="margin-bottom:10pt;padding-left:103.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)       such election shall not take effect until at least twelve (12) months after the date it is filed with the Committee.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No spouse, former spouse, Beneficiary or other person shall have any right to participate in the Participant&#8217;s decision to revise distribution elections. Notwithstanding the foregoing, the Committee shall interpret all provisions of this Plan relating to the change of any distribution election with respect to the Participant&#8217;s Account in a manner that is consistent with section 409A of the Code and the regulations and other guidance issued thereunder. Accordingly, if the Committee determines that a requested revision to a distribution election is inconsistent with section 409A of the Code or other applicable tax law, the request shall not be effective. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment to Beneficiary Upon Death of Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment to Beneficiary When Death Occurs Before Termination of Directorship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant dies before Termination of Directorship, such Participant&#8217;s Beneficiary will receive payment of the Participant&#8217;s Account at the same time and in the same form the Participant would have received if the Participant had experienced a Termination of Directorship on the date of death. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment to Beneficiary When Death Occurs After Termination of Directorship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant dies after a Termination of Directorship, the Participant&#8217;s Beneficiary shall receive distribution of the Participant&#8217;s Account at the same time and in the same form the Participant would have received if the Participant had survived. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Election of Measuring Investments by Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Beneficiary of a deceased Participant shall generally have the same rights to designate Measuring Investments for the Participant&#8217;s Account that Participants have under Section 4. The Committee may adopt (and revise) rules to govern designations of Measuring Investments by Beneficiaries. Unless changed by the Committee, the following rules shall apply&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        The Measuring Investments for the Account of a deceased Participant shall not be changed until the Beneficiary so determines.</font></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        If a deceased Participant has more than one Beneficiary, the unanimous consent of all Beneficiaries shall be required to change Measuring Investments for such Participant&#8217;s Account, unless the deceased Participant&#8217;s Account is divided into separate Accounts for each Beneficiary in accordance with rules adopted by the Committee.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Designation of Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Right to Designate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant may designate, upon forms to be furnished by and filed with the Committee (or through other means approved by the Committee), one or more primary Beneficiaries or alternative Beneficiaries to receive all or a specified part of such Participant&#8217;s Account in the event of such Participant&#8217;s death. The Participant may change or revoke any such designation from time to time without notice to or consent from any Beneficiary. No such designation, change or revocation shall be effective unless executed by the Participant and received by the Committee during the Participant&#8217;s lifetime. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure of Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        fails to designate a Beneficiary,</font></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        designates a Beneficiary and thereafter revokes such designation without naming another Beneficiary, or</font></div><div style="margin-bottom:10pt;padding-left:67.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        designates one or more Beneficiaries and all such Beneficiaries so designated fail to survive the Participant,</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such Participant&#8217;s Account, or the part thereof as to which such Participant&#8217;s designation fails, as the case may be, shall be payable to the first class of the following classes of automatic Beneficiaries in which a member survives the Participant and (except in the case of surviving issue) in equal shares if there is more than one member in such class surviving the Participant&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         Participant&#8217;s surviving spouse&#59;</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        Participant&#8217;s surviving issue per stirpes and not per capita&#59; and</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       Representative of Participant&#8217;s estate.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclaimers by Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Beneficiary entitled to a distribution of all or a portion of a deceased Participant&#8217;s Account may disclaim an interest therein subject to the following requirements. To be eligible to disclaim, a Beneficiary must be a natural person, must not have received a distribution of all or any portion of the Account at the time such disclaimer is executed and delivered, and must have attained at least age twenty-one (21) years as of the date of the Participant&#8217;s death. Any disclaimer must be in writing and must be executed personally by the Beneficiary before a notary public. A disclaimer shall state that the Beneficiary&#8217;s entire interest in the undistributed Account is disclaimed or shall specify what portion thereof is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclaimed. To be effective, an original executed copy of the disclaimer must be both executed and actually delivered to the Committee after the date of the Participant&#8217;s death but not later than nine (9) months after the date of the Participant&#8217;s death. A disclaimer shall be irrevocable when delivered to the Committee. A disclaimer shall be considered to be delivered to the Committee only when actually received by the Committee. The Committee shall be the sole judge of the content, interpretation and validity of a purported disclaimer. Upon the filing of a valid disclaimer, the Beneficiary shall be considered not to have survived the Participant as to the interest disclaimed. A disclaimer by a Beneficiary shall not be considered to be a transfer of an interest in violation of any other provisions under this Plan. No other form of attempted disclaimer shall be recognized by the Committee. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. When used herein and, unless the Participant has otherwise specified in the Participant&#8217;s Beneficiary designation, when used in a Beneficiary designation, &#8220;issue&#8221; means all persons who are lineal descendants of the person whose issue are referred to, subject to the following&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          a legally adopted child and the adopted child&#8217;s lineal descendants always shall be lineal descendants of each adoptive parent (and of each adoptive parent&#8217;s lineal ancestors)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)          a legally adopted child and the adopted child&#8217;s lineal descendants never shall be lineal descendants of any former parent whose parental rights were terminated by the adoption (or of that former parent&#8217;s lineal ancestors)&#59; except that if, after a child&#8217;s parent has died, the child is legally adopted by a stepparent who is the spouse of the child&#8217;s surviving parent, the child and the child&#8217;s lineal descendants shall remain lineal descendants of the deceased parent (and the deceased parent&#8217;s lineal ancestors)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)          if the person (or a lineal descendant of the person) whose issue are referred to is the parent of a child (or is treated as such under applicable law) but never received the child into that parent&#8217;s home and never openly held out the child as that parent&#8217;s child (unless doing so was precluded solely by death), then neither the child nor the child&#8217;s lineal descendants shall be issue of the person.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Child&#8221; means an issue of the first generation&#59; &#8220;per stirpes&#8221; means in equal shares among living children of the person whose issue are referred to and the issue (taken collectively) of each deceased child of such person, with such issue taking by right of representation of such deceased child&#59; and &#8220;survive&#8221; and &#8220;surviving&#8221; mean living after the death of the Participant. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless the Participant has otherwise specified in the Participant&#8217;s Beneficiary designation, the following rules shall apply&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          If there is not sufficient evidence that a Beneficiary was living at the time of the death of the Participant, it shall be deemed that the Beneficiary was not living at the time of the death of the Participant.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)          The automatic Beneficiaries specified in Section 8.5.2 and the Beneficiaries designated by the Participant shall become fixed at the time of the Participant&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">death so that, if a Beneficiary survives the Participant but dies before the receipt of all payments due such Beneficiary hereunder, such remaining payments shall be payable to the representative of such Beneficiary&#8217;s estate.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        If the Participant designates as a Beneficiary the person who is the Participant&#8217;s spouse on the date of the designation, either by name or by relationship, or both, the dissolution, annulment or other legal termination of the marriage between the Participant and such person shall automatically revoke such designation. (The foregoing shall not prevent the Participant from designating a former spouse as a Beneficiary on a form executed by the Participant and received by the Committee after the date of the legal termination of the marriage between the Participant and such former spouse, and during the Participant&#8217;s lifetime.)</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)       Any designation of a nonspouse Beneficiary by name that is accompanied by a description of relationship to the Participant shall be given effect without regard to whether the relationship to the Participant exists either then or at the Participant&#8217;s death.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)        Any designation of a Beneficiary only by statement of relationship to the Participant shall be effective only to designate the person or persons standing in such relationship to the Participant at the Participant&#8217;s death.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall be the sole judge of the content, interpretation and validity of a purported Beneficiary designation. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Death Prior to Full Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If, at the death of the Participant, any payment to the Participant was due or otherwise pending but not actually paid, the amount of such payment shall be included in the Account which is payable to the Beneficiary (and shall not be paid to the Participant&#8217;s estate, unless the Participant&#8217;s estate is the Beneficiary as determined under Section 8.5.2). </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In case of minority, incapacity or legal disability of a Participant or Beneficiary entitled to receive any distribution under this Plan, payment shall be made, if the Committee shall be advised of the existence of such condition&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        to the court-appointed guardian or conservator of such Participant or Beneficiary, or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        if there is no court-appointed guardian or conservator, to the lawfully authorized representative of the Participant or Beneficiary (and the Committee, in its sole discretion, shall determine whether a person is a lawfully authorized representative for this purpose), or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        to an institution entrusted with the care or maintenance of the incapacitated or disabled Participant or Beneficiary, provided such institution has satisfied the Committee, in its sole discretion, that the payment will be used for the best interest and assist in the care of such Participant or Beneficiary, and provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further, that no prior claim for said payment has been made by a person described in (a) or (b) above.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any payment made in accordance with the foregoing provisions of this section shall constitute a complete discharge of any liability or obligation of UnitedHealth Group therefor. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-Service Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Selected In-Service Distributions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant has the opportunity, when enrolling in the Plan for each Plan Year beginning on or after January 1, 2004, to elect one (1) or more pre-selected in-service distribution dates for all or a portion of the Participant&#8217;s Account attributable to cash-based Board Compensation deferrals for such Plan Year (and any investment gains or losses on such deferrals), subject to the following rules&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          Such election shall be made through a voice response system (or other written or electronic means) approved by the Committee.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)          No such distribution will be made before the January 1 of the calendar year that follows the third full Plan Year after the Participant was first eligible to elect a pre-selected in-service distribution from that portion of the Participant&#8217;s Account attributable to deferrals for such Plan Year and any subsequent investment gains or losses on such deferrals (e.g., the earliest pre-selected in-service distribution date for any deferrals made in 2004 is January 1, 2007).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)          A Participant may receive more than one (1) pre-selected in-service distribution from the Participant&#8217;s Account in any Plan Year but only if each distribution is attributable to deferrals for different Plan Years. Only one (1) pre-selected in-service distribution may be made in any Plan Year from that portion of the Participant&#8217;s Account attributable to deferrals for the same Plan Year.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)         The Participant who elects a pre-selected in-service distribution date and subsequently experiences a Termination of Directorship will receive such in-service distribution, if the in-service distribution date is prior to the distribution of the Participant&#8217;s total Account.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)         The minimum amount of any pre-selected in-service distribution is One Thousand Dollars ($1,000).</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)          Through a voice response system (or other written or electronic means) approved by the Committee, the Participant may elect to postpone any pre-selected in-service distribution date for at least five (5) years. A pre-selected in-service distribution may be postponed only once. The Participant must file the election with the Committee at least twelve (12) months before the original scheduled date of distribution. Such election shall not take effect until at least twelve (12) months after the date it is filed with the Committee.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)         A Participant may not cancel any pre-selected in-service distribution from the Participant&#8217;s Account.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)          A Participant may elect to have the amount distributed on any pre-selected distribution date distributed in either a lump sum or in between two and ten annual installments, and if the Participant fails to elect installments such amount shall be paid in a lump sum.  The lump sum or first installment shall be actually paid as soon as practicable after such determination (and in any event within the same calendar year as the pre-selected distribution date).  If the Participant elects payment in installments, the provisions of Section 8.2(b) (excluding 8.2(b)(ii)) shall apply to such payment as if the Participant had experienced a Termination of Directorship on the pre-selected distribution date.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-Service Distribution for Unforeseeable Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant who has incurred an unforeseeable emergency may request an in-service distribution from the Participant&#8217;s Account if the Committee determines that such distribution is for one of the purposes described in (b) below and the conditions in (b) below have been satisfied. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant may elect in writing to receive distribution of all or part of the Participant&#8217;s Account prior to a Termination of Directorship to alleviate an unforeseeable emergency (as defined in (b) below). A Beneficiary of a deceased Participant may also request an early distribution for an unforeseeable emergency.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unforeseeable Emergency Defined</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of this Section, an &#8220;unforeseeable emergency&#8221; means a severe financial hardship to the Participant resulting from&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)         sudden and unexpected illness or accident of the Participant, the Participant&#8217;s spouse, the Participant&#8217;s Beneficiary or the Participant&#8217;s dependent (as defined in section 152 of the Code, without regard to sections 152(b)(1), 152(b)(2) and 152(d)(1)(B) of the Code),</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)        the loss of the Participant&#8217;s property due to casualty, or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)       other similar extraordinary and unforeseeable emergency circumstances arising as a result of events beyond the control of the Participant.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whether a Participant is faced with an unforeseeable emergency will be determined based on the relevant facts and circumstances. To the extent the severe financial hardship is or may be relieved either (i) through reimbursement or compensation by insurance or otherwise, (ii) by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship), (iii) by the cessation of deferrals under this Plan pursuant to Section 3.1.4, then the hardship shall not constitute an unforeseeable emergency for purposes of this Plan, and the amount of distribution permitted under Section 8.8.2(c) shall be reduced accordingly.  The amount that a Participant could obtain from a tax qualified retirement plan (including a hardship withdrawal or loan from such a plan) shall not be taken into account in determining the extent to which the hardship may be relieved.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">          Distribution Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amount of such distribution is limited to the amount reasonably necessary to satisfy the unforeseeable emergency. The amount of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution shall be determined as soon as administratively feasible following the receipt and approval of the request by the Committee or its designee and shall be actually paid as soon as practicable after such approval (and in any event within 30 days after such approval).</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions in Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Distributions in Cash or Stock. Unless otherwise determined by the Committee, in its sole discretion, Deferred Stock Units shall be converted into shares of common stock of UnitedHealth Group. All other distributions from this Plan shall be made in cash.  Distributions of Deferred Stock Units necessary to satisfy an unforeseeable emergency pursuant to Section 8.8.2 shall be made in cash to the extent permitted by applicable law.</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 9</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> FUNDING OF PLAN </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfunded Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligation of UnitedHealth Group to make payments under the Plan constitutes only the unsecured (but legally enforceable) promises of UnitedHealth Group to make such payments. No Participant shall have any lien, prior claim or other security interest in any property of UnitedHealth Group. UnitedHealth Group shall have no obligation to establish or maintain any fund, trust or account (other than a bookkeeping account) for the purpose of funding or paying the benefits promised under the Plan. If such a fund, trust or account is established, the property therein shall remain the sole and exclusive property of UnitedHealth Group. UnitedHealth Group shall be obligated to pay the cost of the Plan out of its general assets. All references to accounts, accruals, gains, losses, income, expenses, payments, custodial funds and the like are included merely for the purpose of measuring the obligation of UnitedHealth Group to Participants in the Plan and shall not be construed to impose on UnitedHealth Group the obligation to create any separate fund for purposes of the Plan. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither any officer of UnitedHealth Group nor any member of the Committee in any way secures or guarantees the payment of any benefit or amount which may become due and payable hereunder to or with respect to any Participant. Each Participant and other person entitled at any time to payments hereunder shall look solely to the assets of UnitedHealth Group for such payments as an unsecured, general creditor. After benefits have been paid to or with respect to a Participant and such payment purports to cover in full the benefit hereunder, such former Participant or other person or persons, as the case may be, shall have no further right or interest in any other Plan assets. No person shall be under any liability or responsibility for failure to effect any of the objectives or purposes of this Plan by reason of the insolvency of UnitedHealth Group. </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 10</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDMENT AND TERMINATION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may unilaterally amend the Plan Statement prospectively, retroactively or both, at any time and for any reason deemed sufficient by it without notice to any person affected by this Plan, and the Board of Directors may terminate this Plan both with regard to persons receiving benefits and persons expecting to receive benefits in the future&#59; provided, however, that&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Reduction or Delay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The benefit, if any, payable to or with respect to a Participant, whether or not the Participant has had a Termination of Directorship as of the effective date of such amendment, shall not be, without the written consent of the Participant, diminished or delayed by such amendment.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Lump Sum Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent permissible under section 409A of the Code and related Treasury regulations and guidance, if the Board of Directors terminates the Plan completely with respect to all Participants, the Board shall have the right, in its sole discretion, and notwithstanding any elections made by Participants, to immediately pay all benefits in a lump sum following such Plan termination or to pay all benefits on any other accelerated payment schedule that is permissible under section 409A of the Code.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Oral Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No oral representation concerning the interpretation or effect of the Plan Statement shall be effective to amend the Plan Statement. No amendment of the Plan Statement shall be effective unless it is in writing and signed on behalf of the Committee by a person authorized to execute such writing. No termination of the Plan shall be effective unless it is in writing and signed on behalf of the Board of Directors by a person authorized to execute such writing. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Binding On Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. UnitedHealth Group shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise of all or substantially all of the business and&#47;or assets of UnitedHealth Group), by agreement, to expressly assume and agree to perform this Plan Statement in the same manner and to the same extent that UnitedHealth Group would be required to perform it if no such succession had taken place. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Executive Vice President &#38; Chief People Officer may unilaterally amend the Plan Statement to the same extent, and subject to the same limitations, as the Committee pursuant to Section 10.1&#59; provided, however, that the Executive Vice President &#38; Chief People Officer shall not adopt any amendment that would materially increase the cost of the Plan, or that is required to be adopted by the Board of Directors or the Compensation and Human Resources Committee in order to comply with the requirements of Section 162(m) of the Code or Section 16 of the Securities Exchange Act of 1934. The determination by the Executive Vice President &#38; Chief People Officer that he or she is authorized to adopt an amendment shall be presumed correct and any such amendment adopted by Executive Vice President &#38; Chief People Officer shall be binding on all employees, Participants, Beneficiaries, and other persons claiming a benefit under the Plan.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DETERMINATIONS &#8212; RULES AND REGULATIONS </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Determinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall make such determinations as may be required from time to time in the administration of the Plan. The Committee shall have the discretionary authority and responsibility to interpret and construe the Plan Statement and to determine all factual and legal questions under the Plan, including but not limited to the entitlement of Participants and Beneficiaries, and the amounts of their respective interests. Each interested party</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may act and rely upon all information reported to them hereunder and need not inquire into the accuracy thereof, nor be charged with any notice to the contrary. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rules and Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any rule not in conflict or at variance with the provisions hereof may be adopted by the Committee. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Method of Executing Instruments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Information to be supplied or written notices to be made or consents to be given by the Committee pursuant to any provision of the Plan Statement may be signed in the name of the Committee by any officer who has been authorized to make such certification or to give such notices or consents. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The claims procedure set forth in this Section 11.4 shall be the exclusive administrative procedure for the disposition of claims for benefits arising under the Plan. </font></div><div style="margin-bottom:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Original Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any person may, if he or she so desires, file with the Committee a written claim for benefits under the Plan. Within ninety (90) days after the filing of such a claim, the Committee shall notify the claimant in writing whether the claim is upheld or denied in whole or in part or shall furnish the claimant a written notice describing specific special circumstances requiring a specified amount of additional time (but not more than one hundred eighty (180) days from the date the claim was filed) to reach a decision on the claim. If the claim is denied in whole or in part, the Committee shall state in writing&#58; </font></div><div style="margin-bottom:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)            the specific reasons for the denial&#59;</font></div><div style="margin-bottom:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)           the specific references to the pertinent provisions of the Plan Statement on which the denial is based&#59;</font></div><div style="margin-bottom:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)            a description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary&#59; and</font></div><div style="margin-bottom:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)           an explanation of the claims review procedure set forth in this section.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Review of Denied Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Within sixty (60) days after receipt of notice that the claim has been denied in whole or in part, the claimant may file with the Committee a written request for a review and may, in conjunction therewith, submit written issues and comments. Within sixty (60) days after the filing of such a request for review, the Committee shall notify the claimant in writing whether, upon review, the claim was upheld or denied in whole or in part or shall furnish the claimant a written notice describing specific special circumstances requiring a specified amount of additional time (but not more than one hundred twenty (120) days from the date the request for review was filed) to reach a decision on the request for review. If the claimant wishes to seek further review of the Committee&#8217;s decision upon review, the claimant shall submit the claim (or dispute or complaint) to binding arbitration pursuant to the rules of the American Arbitration Association. This is the only right a complainant has for further consideration. The matter must be submitted to binding arbitration within one (1) year of receipt of notice of the Committee&#8217;s final decision upon review. The arbitrators shall have no power to award any punitive or exemplary damages or to vary or ignore the provisions of the Plan Statement and shall be bound by controlling law.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        No inquiry or question shall be deemed to be a claim or a request for a review of a denied claim unless made in accordance with the claims procedure. The Committee may require that any claim for benefits and any request for a review of a denied claim be filed on forms to be furnished by the Committee upon request.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        All decisions on original claims and all decisions on requests for a review of denied claims shall be made by the Committee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        The Committee may, in its discretion, hold one or more hearings on a claim or a request for a review of a denied claim.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)       A claimant may be represented by a lawyer or other representative (at the claimant&#8217;s own expense), but the Committee reserves the right to require the claimant to furnish written authorization. A claimant&#8217;s representative shall be entitled, upon request, to copies of all notices given to the claimant.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)        The decision of the Committee on a claim and a decision of the Committee on a request for a review of a denied claim shall be served on the claimant in writing. If a decision or notice is not received by a claimant within the time specified, the claim or request for a review of a denied claim shall be deemed to have been denied.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)        Prior to filing a claim or a request for a review of a denied claim, the claimant or his or her representative shall have a reasonable opportunity to review a copy of the Plan Statement and all other pertinent documents in the possession of the Committee.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)        The Committee may permanently or temporarily delegate its responsibilities under this claims procedure to an individual or a committee of individuals.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations And Exhaustion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No claim shall be considered under these administrative procedures unless it is filed with the Committee within one (1) year after the claimant knew (or reasonably should have known) of the principal facts on which the claim is based. Every untimely claim shall be denied by the Committee without regard to the merits of the claim. No legal action (whether arising under any statute or non-statutory law) may be brought by any claimant on any matter pertaining to the Plan unless the legal action is commenced in the proper forum before the earlier of&#58; </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        two (2) years after the claimant knew (or reasonably should have known) of the principal facts on which the claim is based, or</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        ninety (90) days after the claimant has exhausted these administrative procedures.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Knowledge of all facts that a Participant knew (or reasonably should have known) shall be imputed to each claimant who is or claims to be a Beneficiary of the Participant (or otherwise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims to derive an entitlement by reference to a Participant) for the purpose of applying the one (1) year and two (2) year periods. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhaustion Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exhaustion of these administrative procedures is mandatory for resolving every claim and dispute arising under the Plan. As to such claims and disputes&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          no claimant shall be permitted to commence any legal action relating to any such claim or dispute (whether arising under any statute or non-statutory law) unless a timely claim has been filed under these administrative procedures and these administrative procedures have been exhausted&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)          in any such legal action all explicit and implicit determinations by the Committee (including, but not limited to, determinations as to whether the claim was timely filed) shall be afforded the maximum deference permitted by law.</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 12 </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN ADMINISTRATION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as hereinafter provided, functions generally assigned to UnitedHealth Group shall be discharged by its officers or delegated and allocated as provided herein. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as hereinafter provided, the Chief Executive Officer of UnitedHealth Group may delegate or redelegate and allocate and reallocate to one or more persons or to a committee of persons jointly or severally, and whether or not such persons are directors, officers or employees, such functions assigned to UnitedHealth Group generally hereunder as he or she may from time to time deem advisable. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the Board of Directors shall have the sole authority to terminate the Plan. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)          keep a record of all its proceedings and acts and keep all books of account, records and other data as may be necessary for the proper administration of the Plan&#59; notify UnitedHealth Group of any action taken by the Committee and, when required, notify any other interested person or persons&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)         determine from the records of UnitedHealth Group the compensation, status and other facts regarding Participants&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)          prescribe forms to be used for distributions, notifications, etc., as may be required in the administration of the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)          set up such rules, applicable to all Participants similarly situated, as are deemed necessary to carry out the terms of this Plan Statement&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)          perform all other acts reasonably necessary for administering the Plan and carrying out the provisions of this Plan Statement and performing the duties imposed on it by the Board of Directors&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)          resolve all questions of administration of the Plan not specifically referred to in this section&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)          provide adequate notice in writing to any claimant whose claim for benefits under the Plan has been denied, setting forth the specific reasons for such denial, written in a manner calculated to be understood by the claimant&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)         delegate or redelegate to one or more persons, jointly or severally, and whether or not such persons are members of the Committee or employees of UnitedHealth Group, such functions assigned to the Committee hereunder as it may from time to time deem advisable.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there shall at any time be three (3) or more members of the Committee serving hereunder who are qualified to perform a particular act, the same may be performed, on behalf of all, by a majority of those qualified, with or without the concurrence of the minority. No person who failed to join or concur in such act shall be held liable for the consequences thereof. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board of Directors and the members of the Committee shall not be liable for an act or omission of another person with regard to a responsibility that has been allocated to or delegated to such other person pursuant to the terms of the Plan Statement or pursuant to procedures set forth in the Plan Statement. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conflict of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any individual to whom authority has been delegated or redelegated hereunder shall also be a Participant in the Plan, such Participant shall have no authority with respect to any matter specially affecting such Participant&#8217;s individual rights hereunder (as distinguished from the rights of all Participants and Beneficiaries or a broad class of Participants and Beneficiaries), all such authority being reserved exclusively to other individuals as the case may be, to the exclusion of such Participant, and such Participant shall act only in such Participant&#8217;s individual capacity in connection with any such matter. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service of Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the absence of any designation to the contrary by the Committee, the General Counsel of UnitedHealth Group is designated as the appropriate and exclusive agent for the receipt of process directed to this Plan in any legal proceeding, including arbitration, involving the Plan. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The expenses of administering this Plan shall be payable out of the trust fund, if any, established for this Plan except to the extent that UnitedHealth Group, in its discretion, directly pays the expenses. If no such trust fund exists, UnitedHealth Group shall pay such expenses. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Information to be supplied or written notices to be made or consents to be given by the Committee pursuant to any provision of this Plan Statement may be signed in the name of the Committee by any officer who has been authorized to make such certification or to give such notices or consents.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 12.10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Errors In Computations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. UnitedHealth Group shall not be liable or responsible for any error in the computation of the Account or the determination of any benefit payable to or with respect to any Participant resulting from any misstatement of fact made by the Participant or by or on behalf of any survivor to whom such benefit shall be payable, directly or indirectly, to UnitedHealth Group and used by the Committee in determining the benefit. The Committee shall not be obligated or required to increase the benefit payable to or with respect to such Participant which, on discovery of the misstatement, is found to be understated as a result of such misstatement of the Participant. However, the benefit of any Participant which is overstated by reason of any such misstatement or any other reason shall be reduced to the amount appropriate in view of the truth (and to recover any prior overpayment). </font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 13</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CONSTRUCTION </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Since no employee of UnitedHealth Group or any affiliate may actively participate in this Plan (see Sections 2 and 3.3), this Plan is not subject to regulation under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;). </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IRC Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan is intended to be a nonqualified, unfunded, deferred compensation arrangement. </font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">References to Laws.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Any reference in the Plan Statement to a statute or regulation shall be considered also to mean and refer to any subsequent amendment or replacement of that statute or regulation. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect on Other Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Plan Statement shall not alter, enlarge or diminish any person&#8217;s rights or obligations under any other benefit plan for members of the Board of Directors. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disqualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan Statement or any election or designation made under the Plan, any potential Beneficiary who feloniously and intentionally kills a Participant shall be deemed for all purposes of the Plan and all elections and designations made under the Plan to have died before such Participant. A final judgment of conviction of felonious and intentional killing is conclusive for this purpose. In the absence of a conviction of felonious and intentional killing, the Committee shall determine whether the killing was felonious and intentional for this purpose. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rules of Document Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)        Whenever appropriate, words used herein in the singular may be read in the plural, or words used herein in the plural may be read in the singular&#59; the masculine may include the feminine&#59; and the words &#8220;hereof,&#8221; &#8220;herein&#8221; or &#8220;hereunder&#8221; or other similar compounds of the word &#8220;here&#8221; shall mean and refer to the entire Plan Statement and not to any particular paragraph or Section of the Plan Statement unless the context clearly indicates to the contrary.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)        The titles given to the various Sections of the Plan Statement are inserted for convenience of reference only and are not part of the Plan Statement, and they shall not be considered in determining the purpose, meaning or intent of any provision hereof.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)        Notwithstanding anything apparently to the contrary contained in the Plan Statement, the Plan Statement shall be construed and administered to prevent the duplication of benefits provided under the Plan and any other plan maintained in whole or in part by UnitedHealth Group.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This instrument has been executed and delivered in the State of Minnesota and has been drawn in conformity to the laws of that State and shall be construed and enforced in accordance with the laws of the State of Minnesota. </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. It is intended that any amounts payable under this Plan shall comply with Section 409A of the Code (including Treasury Regulations and other published guidance related thereto) so as not to subject Participants to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code. The Plan shall be construed in a manner to give effect to such intention. In no event whatsoever shall UnitedHealth Group and&#47;or any of its affiliates be liable for any tax, interest or penalties that may be imposed on any Participant (or any Participant&#8217;s estate) under Section 409A of the Code. Neither UnitedHealth Group and&#47;or any of its affiliates shall have any obligation to indemnify or otherwise hold a Participant (or any Participant&#8217;s estate) harmless from any or all such taxes, interest or penalties, or liability for any damages related thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>13
<FILENAME>unhex103112312022.htm
<DESCRIPTION>EX-10.31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i82adc815d9314fc5a19fdfed6d6d1226_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.31</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Execution Version</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:134%">AVERY PARENT HOLDINGS, INC.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:134%">2020 STOCK OPTION AND GRANT PLAN</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 1.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">GENERAL PURPOSE OF THE PLAN&#59; DEFINITIONS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The name of the plan is the Avery Parent Holdings, Inc. 2020 Stock Option and Grant Plan (the &#8220;Plan&#8221;). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key persons of Avery Parent Holdings, Inc., a Delaware corporation (including any successor entity, the &#8220;Company&#8221;), and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following terms shall be defined as set forth below&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Adjustment Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">each of the first, second, third and fourth anniversaries of May 15, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Affiliate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with the first mentioned Person. A Person shall be deemed to control another Person if such first Person possesses directly or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership of voting securities, by contract or otherwise.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Awards,&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">except where referring to a particular category of grant under the Plan, shall include incentive Stock Options, Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, Restricted Stock Units or any combination of the foregoing.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Award Agreement&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means a written or electronic agreement setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award Agreement may contain terms and conditions in addition to those set forth in the Plan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the event of any conflict in the terms of the Plan and the Award Agreement, the terms of the Plan shall govern.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Board&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Board of Directors of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Cause&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of &#8220;Cause,&#8221; it shall mean (i) the grantee&#8217;s dishonest statements or acts with respect to the Company or any Affiliate of the Company, or any current or prospective customers, suppliers vendors or other third parties with which such entity does business&#59; (ii) the grantee&#8217;s commission of (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud&#59; (iii) the grantee&#8217;s failure to perform his assigned duties and responsibilities to the reasonable satisfaction of the Company which failure continues, in the reasonable judgment of the Company, after written notice given to the grantee by the Company&#59; (iv) the grantee&#8217;s gross negligence, willful misconduct or insubordination with respect to the Company or any Affiliate of the Company&#59; or (v) the grantee&#8217;s material violation of any provision of any agreement(s) between the grantee and the Company relating to noncompetition, nonsolicitation, nondisclosure and&#47;or assignment of inventions.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Company Charter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> means the Amended and Restated Certificate of Incorporation of the Company (as amended, modified or supplemented from time to time).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Chief Executive Officer&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Chief Executive Officer of the Company or, if there is no Chief Executive Officer, then the President of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Committee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Committee of the Board referred to in Section 2.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Consultant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any natural person that provides bona fide services to the Company (including a Subsidiary), and such services are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company&#8217;s securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Disability&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means &#8220;disability&#8221; as defined in Section 422(c) of the Code.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the date on which the Plan is adopted as set forth on the final page of the Plan.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Exchange Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Fair Market Value&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of the Stock on any given date means the fair market value of the Stock determined in good faith by the Committee based on the reasonable application of a reasonable valuation method not inconsistent with Section 409A of the Code. If the Stock is admitted to trade on a national securities exchange, the determination shall be made by reference to the closing price reported on such exchange. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price. If the date for which Fair Market Value is determined is the first day when trading prices for the Stock are reported on a national securities exchange, the Fair Market Value shall be the &#8220;Price to the Public&#8221; (or equivalent) set forth on the cover page for the final prospectus relating to the Company&#8217;s Initial Public Offering.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Good Reason&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of &#8220;Good Reason,&#8221; it shall mean (i) a material diminution in the grantee&#8217;s base salary except for across-the-board salary reductions similarly affecting all or substantially all similarly situated employees of the Company or (ii) a change of more than 50 miles in the geographic location at which the grantee provides services to the Company, so long as the grantee provides at least 90 days&#8217; notice to the Company following the initial occurrence of any such event and the Company fails to cure such event within 30 days thereafter.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Grant Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the date that the Committee designates in its approval of an Award in accordance with applicable law as the date on which the Award is granted, which date may not precede the date of such Committee approval.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Holder&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means, with respect to an Award or any Shares, the Person holding such Award or Shares, including the initial recipient of the Award or any transferee as permitted under Section 9(a).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Incentive Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any Stock Option designated and qualified as an &#8220;incentive stock option&#8221; as defined in Section 422 of the Code.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Initial Public Offering&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the consummation of the first firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act covering the offer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and sale by the Company of its equity securities, as a result of or following which the Stock shall be publicly held.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Non-Qualified Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any Stock Option that is not an Incentive Stock Option.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any option to purchase shares of Stock granted pursuant to Section 5.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Person&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">shall mean any individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association, trust, joint venture, unincorporated organization or any similar entity.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Restricted Stock Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means Awards granted pursuant to Section 6 and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Restricted Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means Shares issued pursuant to such Awards.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Restricted Stock Unit&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means an Award of phantom stock units to a grantee, which may be settled in cash or Shares as determined by the Committee, pursuant to Section 8.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Sale Event&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the consummation of (i) the dissolution or liquidation of the Company, (ii) a transaction that qualifies as a &#8220;Sale&#8221; (as defined in the Company Charter), (iii) the acquisition of all or a majority of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a Person or group of Persons, or (iv) any other acquisition of the business of the Company, as determined by the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">that the Company&#8217;s Initial Public Offering, any subsequent public offering or another capital raising event, or a merger effected solely to change the Company&#8217;s domicile shall not constitute a &#8220;Sale Event.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Section 409A&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means Section 409A of the Code and the regulations and other guidance promulgated thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Securities Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Service Relationship&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any relationship as a full-time employee, part-time employee, director or other key person (including Consultants) of the Company or any Subsidiary or any successor entity (e.g., a Service Relationship shall be deemed to continue without interruption in the event an individual&#8217;s status changes from full-time employee to part-time employee or Consultant).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Shares&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means shares of Stock.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the Series A Common Stock, par value $0.001 per share, of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Subsidiary&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any corporation or entity (other than the Company) in which the Company has more than a 50 percent interest, either directly or indirectly.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Ten Percent Owner&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than ten percent of the combined voting power of all classes of stock of the Company or any parent of the Company or any Subsidiary.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Termination Event&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means the termination of the Award recipient&#8217;s Service Relationship with the Company and its Subsidiaries for any reason whatsoever, regardless of the circumstances thereof, and including, without limitation, upon death, disability, retirement, discharge or resignation for any reason, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">whether voluntarily or involuntarily. The following shall not constitute a Termination Event&#58; (i) a transfer to the service of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another Subsidiary or (ii) an approved leave of absence for military service or sickness, or for any other purpose approved by the Committee, if the individual&#8217;s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Unrestricted Stock Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means any Award granted pursuant to Section 7 and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8220;Unrestricted Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">means Shares issued pursuant to such Awards.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 2.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">ADMINISTRATION OF PLAN&#59; COMMITTEE AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Administration of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Plan shall be administered by the Board, or at the discretion of the Board, by a committee of the Board, comprised of not less than two directors. All references herein to the &#8220;Committee&#8221; shall be deemed to refer to the group then responsible for administration of the Plan at the relevant time (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> either the Board of Directors or a committee or committees of the Board, as applicable).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Powers of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;to select the individuals to whom Awards may from time to time be granted&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;to determine the time or times of grant, and the amount, if any, of Incentive Stock Options, Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, Restricted Stock Units, or any combination of the foregoing, granted to any one or more grantees&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;to determine the number of Shares to be covered by any Award and, subject to the provisions of the Plan, the price, exercise price, conversion ratio or other price relating thereto&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;to determine and, subject to Section 12, to modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the form of Award Agreements&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(v)&#160;&#160;&#160;&#160;to accelerate at any time the exercisability or vesting of all or any portion of any Award&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(vi)&#160;&#160;&#160;&#160;to impose any limitations on Awards, including limitations on transfers, repurchase provisions and the like, and to exercise repurchase rights or obligations&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(vii)&#160;&#160;&#160;&#160;subject to Section 5(a)(ii) and any restrictions imposed by Section 409A, to extend at any time the period in which Stock Options may be exercised&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(viii)&#160;&#160;&#160;&#160;at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable&#59; to interpret the terms and provisions of the Plan and any Award (including Award Agreements)&#59; to make all determinations it deems advisable for the administration of the Plan&#59; to decide all disputes arising in connection with the Plan&#59; and to otherwise supervise the administration of the Plan.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All decisions and interpretations of the Committee shall be binding on all persons, including the Company and all Holders.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Neither the Board nor the Committee, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Committee (and any delegate thereto) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and&#47;or under the Company&#8217;s governing documents, including the Company Charter or its bylaws, or any directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time and&#47;or any indemnification agreement between such individual and the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Foreign Award Recipients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and any Subsidiary operate or have employees or other individuals eligible for Awards, the Committee, in its sole discretion, shall have the power and authority to&#58; (i) determine which Subsidiaries, if any, shall be covered by the Plan&#59; (ii) determine which individuals, if any, outside the United States are eligible to participate in the Plan&#59; (iii) modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws&#59; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and or modifications shall be attached to the Plan as appendices)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that no such subplans and&#47;or modifications shall increase the share limitation contained in Section 3(a) hereof&#59; and (v) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 3.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">STOCK ISSUABLE UNDER THE PLAN&#59; MERGERS AND OTHER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">TRANSACTIONS&#59; SUBSTITUTION</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Stock Issuable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The maximum number of Shares reserved and available for issuance under the Plan following the Effective Date shall be 1,380,517 Shares (the &#34;Available Shares&#34;), provided that on each Adjustment Date, the number of Available Shares shall be increased or decreased by the amount necessary so that the number of Available Shares is equal to 10% of the total number of fully diluted shares of Series A Common Stock on the applicable Adjustment Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, that no such adjustment shall cause the number of shares of Series A Common Stock that shall be reserved and available for issuance under the Plan to be less than the number of shares of Series A Common Stock underlying awards outstanding under the Plan as of the applicable Adjustment Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, further, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">that the 965,152 Shares subject to Awards outstanding under the Plan as of the Effective Date shall not be counted against the number of Available Shares but such Awards shall, for the avoidance of doubt, be subject to the terms and conditions of the Plan.  In addition, the maximum number of Shares reserved and available for issuance under the Plan, as described in the preceding sentence, shall be subject to adjustment as provided in Section 3(b). For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) and Shares that are withheld upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding shall be added back to the Shares available for issuance under the Plan. Subject to such overall limitations, Shares may be issued up to such maximum number pursuant to any type or types of Award, and no more than 1,380,517 Shares may be issued pursuant to Incentive Stock Options. The Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company. </font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Changes in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Company&#8217;s capital stock, the outstanding Shares are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional Shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities, in each case, without the receipt of consideration by the Company, or, if, as a result of any merger or consolidation, or sale of all or substantially all of the assets of the Company, the outstanding Shares are converted into or exchanged for other securities of the Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate and proportionate adjustment in (i) the maximum number of Shares reserved for issuance under the Plan, (ii) the number and kind of Shares or other securities subject to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per Share subject to each outstanding Award, and (iv) the exercise price for each Share subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise price (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the exercise price multiplied by the number of Stock Options) as to which such Stock Options remain exercisable. The Committee shall in any event make such adjustments as may be required by Section 25102(o) of the California Corporation Code and the rules and regulations promulgated thereunder. The adjustment by the Committee shall be final, binding and conclusive. No fractional Shares shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu of fractional shares.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sale Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(A)&#160;&#160;&#160;&#160;In the case of and subject to the consummation of a Sale Event, the Plan and all outstanding Options issued hereunder shall terminate upon the effective time of any such Sale Event unless assumed or continued by the successor entity, or new stock options or other awards of the successor entity or parent thereof are substituted therefor, with an equitable or proportionate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties shall agree (after taking into account any acceleration hereunder and&#47;or pursuant to the terms of any Award Agreement).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(B)&#160;&#160;&#160;&#160;In the event of the termination of the Plan and all outstanding Options issued hereunder pursuant to Section 3(c), each Holder of Options shall be permitted, within a period of time prior to the consummation of the Sale Event as specified by the Committee, to exercise all such Options which are then exercisable or will become exercisable as of the effective time of the Sale Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">that the exercise of Options not exercisable prior to the Sale Event shall be subject to the consummation of the Sale Event.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(C)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in Section 3(c)(i)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the Holders of Options, without any consent of the Holders, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the value as determined by the Committee of the consideration payable per share of Stock pursuant to the Sale Event (the &#8220;Sale Price&#8221;) times the number of Shares subject to outstanding Options being cancelled (to the extent then vested and exercisable, including by reason of acceleration in connection with such Sale Event, at prices not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding vested and exercisable Options.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restricted Stock and Restricted Stock Unit Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(A)&#160;&#160;&#160;&#160;In the case of and subject to the consummation of a Sale Event, all unvested Restricted Stock and unvested Restricted Stock Unit Awards (other than those becoming vested as a result of the Sale Event) issued hereunder shall be forfeited immediately prior to the effective time of any such Sale Event unless assumed or continued by the successor entity, or awards of the successor entity or parent thereof are substituted therefor, with an equitable or proportionate adjustment as to the number and kind of shares subject to such awards as such parties shall agree (after taking into account any acceleration hereunder and&#47;or pursuant to the terms of any Award Agreement).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(B)&#160;&#160;&#160;&#160;In the event of the forfeiture of Restricted Stock pursuant to Section 3(c)(ii)(A), such Restricted Stock shall be repurchased from the Holder thereof at a price per share equal to the original per share purchase price paid by the Holder (subject to adjustment as provided in Section 3(b)) for such Shares.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:103.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(C)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in Section 3(c)(ii)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the Holders of Restricted Stock or Restricted Stock Unit Awards, without consent of the Holders, in exchange for the cancellation thereof, in an amount equal to the Sale Price times the number of Shares subject to such Awards, to be paid at the time of such Sale Event or upon the later vesting of such Awards.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 4.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">ELIGIBILITY</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:32.39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grantees under the Plan will be such full or part-time officers and other employees, directors, Consultants and key persons of the Company and any Subsidiary who are selected from time to time by the Committee in its sole discretion&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that Awards shall be granted only to those individuals described in Rule 701(c) of the Securities Act.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 5.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">STOCK OPTIONS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:32.39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the grant of a Stock Option, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:32.39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock Options granted under the Plan may be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a &#8220;subsidiary corporation&#8221; within the meaning of Section 424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Terms of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee in its discretion may grant Stock Options to those individuals who meet the eligibility requirements of Section 4. Stock Options shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The exercise price per share for the Shares covered by a Stock Option shall be determined by the Committee at the time of grant but shall not be less than 100 percent of the Fair Market Value on the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price per share for the Shares covered by such Incentive Stock Option shall not be less than 110 percent of the Fair Market Value on the Grant Date.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Option Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The term of each Stock Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten years from the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the Grant Date.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exercisability&#59; Rights of a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Stock Options shall become exercisable and&#47;or vested at such time or times, whether or not in installments, as shall be determined by the Committee at or after the Grant Date. The Award Agreement may permit a grantee to exercise all or a portion of a Stock Option immediately at grant&#59; provided that the Shares issued upon such exercise shall be subject to restrictions and a vesting schedule identical to the vesting schedule of the related Stock Option, such Shares shall be deemed to be Restricted Stock for purposes of the Plan, and the optionee may be required to enter into an additional or new Award Agreement as a condition to exercise of such Stock Option. An optionee shall have the rights of a stockholder only as to Shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. An optionee shall not be deemed to have acquired any Shares unless and until a Stock Option shall have been exercised pursuant to the terms of the Award Agreement and this Plan and the optionee&#8217;s name has been entered on the books of the Company as a stockholder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Stock Options may be exercised by an optionee in whole or in part by the optionee giving written or electronic notice of exercise to the Company, specifying the number of Shares to be purchased. Payment of the purchase price may be made by one or more of the following methods (or any combination thereof) to the extent provided in the Award Agreement&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(A)&#160;&#160;&#160;&#160;In cash, by certified or bank check, by wire transfer of immediately available funds, or other instrument acceptable to the Committee&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(B)&#160;&#160;&#160;&#160;If permitted by the Committee, by the optionee delivering to the Company a promissory note, if the Board has expressly authorized the loan of funds to the optionee for the purpose of enabling or assisting the optionee to effect the exercise of his or her Stock Option&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that at least so much of the exercise price as represents the par value of the Stock shall be paid in cash if required by state law&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(C)&#160;&#160;&#160;&#160;If permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), through the delivery (or attestation to the ownership) of Shares that have been purchased by the optionee on the open market or that are beneficially owned by the optionee and are not then subject to restrictions under any Company plan. To the extent required to avoid variable accounting treatment under ASC 718 or other applicable accounting rules, such surrendered Shares if originally purchased from the Company shall have been owned by the optionee for at least six months. Such surrendered Shares shall be valued at Fair Market Value on the exercise date&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(D)&#160;&#160;&#160;&#160;If permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), by the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price&#59; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(E)&#160;&#160;&#160;&#160;If permitted by the Committee, and only with respect to Stock Options that are not Incentive Stock Options, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">will reduce the number of Shares issuable upon exercise by the largest whole number of Shares with a Fair Market Value that does not exceed the aggregate exercise price.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Payment instruments will be received subject to collection. No certificates for Shares so purchased will be issued to the optionee or, with respect to uncertificated Stock, no transfer to the optionee on the records of the Company will take place, until the Company has completed all steps it has deemed necessary to satisfy legal requirements relating to title issuance and sale of the Shares, which steps may include, without limitation, (i) receipt of a representation from the optionee at the time of exercise of the Option that the optionee is purchasing the Shares for the optionee&#8217;s own account and not with a view to any sale or distribution of the Shares or other representations relating to compliance with applicable law governing the issuance of securities, (ii) the legending of the certificate (or notation on any book entry) representing the Shares to evidence the foregoing restrictions, and (iii) obtaining from optionee payment or provision for all withholding taxes due as a result of the exercise of the Option. The delivery of certificates representing the shares of Stock (or the transfer to the optionee on the records of the Company with respect to uncertificated Stock) to be purchased pursuant to the exercise of a Stock Option will be contingent upon (A) receipt from the optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such Shares and the fulfillment of any other requirements contained in the Award Agreement or applicable provisions of laws and (B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">if required by the Company, the optionee shall have entered into any stockholders agreements or other agreements with the Company and&#47;or certain other of the Company&#8217;s stockholders relating to the Stock. In the event an optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares transferred to the optionee upon the exercise of the Stock Option shall be net of the number of Shares attested to.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Annual Limit on Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. To the extent required for &#8220;incentive stock option&#8221; treatment under Section 422 of the Code, the aggregate Fair Market Value (determined as of the Grant Date) of the Shares with respect to which Incentive Stock Options granted under the Plan and any other plan of the Company or its parent and any Subsidiary that become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000 or such other limit as may be in effect from time to time under Section 422 of the Code. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Any portion of a Stock Option that is not vested and exercisable on the date of termination of an optionee&#8217;s Service Relationship shall immediately expire and be null and void. Once any portion of the Stock Option becomes vested and exercisable, the optionee&#8217;s right to exercise such portion of the Stock Option (or the optionee&#8217;s representatives and legatees as applicable) in the event of a termination of the optionee&#8217;s Service Relationship shall continue until the earliest of&#58; (i) the date which is&#58; (A) 12 months following the date on which the optionee&#8217;s Service Relationship terminates due to death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three months following the date on which the optionee&#8217;s Service Relationship terminates if the termination is due to any reason other than death or Disability (or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (ii) the Expiration Date set forth in the Award Agreement&#59; provided that notwithstanding the foregoing, an Award Agreement may provide that if the optionee&#8217;s Service Relationship is terminated for Cause, the Stock Option shall terminate immediately and be null and void upon the date of the optionee&#8217;s termination and shall not thereafter be exercisable.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 6.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">RESTRICTED STOCK AWARDS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Restricted Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee may in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible individual </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">under Section 4 hereof a Restricted Stock Award under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Award at the time of grant. Conditions may be based on continuing employment (or other Service Relationship), achievement of pre-established performance goals and objectives and&#47;or such other criteria, as the Committee may determine. Upon the grant of a Restricted Stock Award, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee of Restricted Stock shall be considered the record owner of and shall be entitled to vote the Restricted Stock if, and to the extent, such Shares are entitled to voting rights, subject to such conditions contained in the Award Agreement. The grantee shall be entitled to receive all dividends and any other distributions declared on the Shares&#59; provided, however, that the Company is under no duty to declare any such dividends or to make any such distribution. Unless the Committee shall otherwise determine, certificates evidencing the Restricted Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in subsection (d) below of this Section, and the grantee shall be required, as a condition of the grant, to deliver to the Company a stock power endorsed in blank and such other instruments of transfer as the Committee may prescribe.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Award Agreement. Except as may otherwise be provided by the Committee either in the Award Agreement or, subject to Section 12 below, in writing after the Award Agreement is issued, if a grantee&#8217;s Service Relationship with the Company and any Subsidiary terminates, the Company or its assigns shall have the right, as may be specified in the relevant instrument, to repurchase some or all of the Shares subject to the Award at such purchase price as is set forth in the Award Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee at the time of grant shall specify in the Award Agreement the date or dates and&#47;or the attainment of pre-established performance goals, objectives and other conditions on which the substantial risk of forfeiture imposed shall lapse and the Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be specified in the Award Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 7.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">UNRESTRICTED STOCK AWARDS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible person under Section 4 hereof an Unrestricted Stock Award under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 8.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee may, in its sole discretion, grant to an eligible person under Section 4 hereof Restricted Stock Units under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Unit at the time of grant. Vesting conditions may be based on continuing employment (or other Service Relationship), achievement of pre-established performance goals and objectives and&#47;or other such criteria as the Committee may determine. Upon the grant of Restricted Stock Units, the grantee and the Company shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined by the Committee and may differ among individual Awards and grantees. On or promptly following the vesting date or dates applicable to any Restricted Stock Unit, but in no event later than March 15 of the year </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">following the year in which such vesting occurs, such Restricted Stock Unit(s) shall be settled in the form of cash or shares of Stock, as specified in the Award Agreement. Restricted Stock Units may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. A grantee shall have the rights of a stockholder only as to Shares, if any, acquired upon settlement of Restricted Stock Units. A grantee shall not be deemed to have acquired any such Shares unless and until the Restricted Stock Units shall have been settled in Shares pursuant to the terms of the Plan and the Award Agreement, the Company shall have issued and delivered a certificate representing the Shares to the grantee (or transferred on the records of the Company with respect to uncertificated stock), and the grantee&#8217;s name has been entered in the books of the Company as a stockholder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Except as may otherwise be provided by the Committee either in the Award Agreement or in writing after the Award Agreement is issued, a grantee&#8217;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&#8217;s cessation of Service Relationship with the Company and any Subsidiary for any reason.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">TRANSFER RESTRICTIONS&#59; COMPANY RIGHT OF FIRST REFUSAL&#59; COMPANY REPURCHASE RIGHTS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Transferability of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Stock Options and, prior to exercise, the Shares issuable upon exercise of such Stock Option, shall not be transferable by the optionee otherwise than by will, or by the laws of descent and distribution, and all Stock Options shall be exercisable, during the optionee&#8217;s lifetime, only by the optionee, or by the optionee&#8217;s legal representative or guardian in the event of the optionee&#8217;s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the Award Agreement regarding a given Stock Option that the optionee may transfer by gift, without consideration for the transfer, his or her Non-Qualified Stock Options to his or her family members (as defined in Rule 701 of the Securities Act), to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners (to the extent such trusts or partnerships are considered &#8220;family members&#8221; for purposes of Rule 701 of the Securities Act), provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award Agreement, including the execution of a stock power upon the issuance of Shares. Stock Options, and the Shares issuable upon exercise of such Stock Options, shall be restricted as to any pledge, hypothecation, or other transfer, including any short position, any &#8220;put equivalent position&#8221; (as defined in the Exchange Act) or any &#8220;call equivalent position&#8221; (as defined in the Exchange Act) prior to exercise.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:32.39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Right of First Refusal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that a Holder desires at any time to sell or otherwise transfer all or any part of his or her Shares (other than shares of Restricted Stock which by their terms are not transferrable), the Holder first shall give written notice to the Company of the Holder&#8217;s intention to make such transfer. Such notice shall state the number of Shares that the Holder proposes to sell (the &#8220;Offered Shares&#8221;), the price and the terms at which the proposed sale is to be made and the name and address of the proposed transferee. At any time within 30 days after the receipt of such notice by the Company, the Company or its assigns may elect to purchase all or any portion of the Offered Shares at the price and on the terms offered by the proposed transferee and specified in the notice. The Company or its assigns shall exercise this right by mailing or delivering written notice to the Holder within the foregoing 30-day period. If the Company or its assigns elect to exercise its purchase rights under this Section 9(b), the closing for such purchase shall, in any event, take place within 45 days after the receipt by the Company of the initial notice from the Holder. In the event that the Company or its assigns do not elect to exercise such purchase right, or in the event that the Company or its assigns do not pay the full purchase price within such 45-day period, the Holder shall be required to pay a transaction processing fee of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$10,000 to the Company (unless waived by the Committee) and then may, within 60 days thereafter, sell the Offered Shares to the proposed transferee and at the same price and on the same terms as specified in the Holder&#8217;s notice. Any Shares not sold to the proposed transferee shall remain subject to the Plan. If the Holder is a party to any stockholders agreements or other agreements with the Company and&#47;or certain other of the Company&#8217;s stockholders relating to the Shares, (i) the transferring Holder shall comply with the requirements of such stockholders agreements or other agreements relating to any proposed transfer of the Offered Shares, and (ii) any proposed transferee that purchases Offered Shares shall enter into such stockholders agreements or other agreements with the Company and or certain of the Company&#8217;s stockholders relating to the Offered Shares on the same terms and in the same capacity as the transferring Holder.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company&#8217;s Right of Repurchase.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Right of Repurchase for Unvested Shares Issued Upon the Exercise of an Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Upon a Termination Event, the Company or its assigns shall have the right and option to repurchase from a Holder of Shares acquired upon exercise of a Stock Option which are still subject to a risk of forfeiture as of the Termination Event. Such repurchase rights may be exercised by the Company within the later of (A) six months following the date of such Termination Event or (B) seven months after the acquisition of Shares upon exercise of a Stock Option. The repurchase price shall be equal to the lower of the original per share price paid by the Holder, subject to adjustment as provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its repurchase rights.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Right of Repurchase With Respect to Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Upon a Termination Event, the Company or its assigns shall have the right and option to repurchase from a Holder of Shares received pursuant to a Restricted Stock Award any Shares that are still subject to a risk of forfeiture as of the Termination Event. Such repurchase right may be exercised by the Company within six months following the date of such Termination Event. The repurchase price shall be the lower of the original per share purchase price paid by the Holder, subject to adjustment as provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its purchase rights.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Any repurchase right of the Company shall be exercised by the Company or its assigns by giving the Holder written notice on or before the last day of the repurchase period of its intention to exercise such repurchase right. Upon such notification, the Holder shall promptly surrender to the Company, free and clear of any liens or encumbrances, any certificates representing the Shares being purchased, together with a duly executed stock power for the transfer of such Shares to the Company or the Company&#8217;s assignee or assignees. Upon the Company&#8217;s or its assignee&#8217;s receipt of the certificates from the Holder the Company or its assignee or assignees shall deliver to him, her or them a check for the applicable repurchase price&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">that the Company may pay the repurchase price by offsetting and canceling any indebtedness then owed by the Holder to the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Drag-Along Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event of an &#8220;Approved Sale&#8221; (as defined in the Company Charter), a Holder of Shares shall be obligated to comply with the provisions regarding drag-along rights set forth in Section 4.6 (Drag-Along Rights) of the Company Charter.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Escrow Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Escrow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In order to carry out the provisions of this Section 9 of this Plan more effectively, the Company shall hold any Shares issued pursuant to Awards granted under the Plan in escrow together with separate stock powers executed by the Holder in blank for transfer. The Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">shall not dispose of the Shares except as otherwise provided in this Plan. In the event of any repurchase by the Company (or any of its assigns), the Company is hereby authorized by the Holder, as the Holder&#8217;s attorney-in-fact, to date and complete the stock powers necessary for the transfer of the Shares being purchased and to transfer such Shares in accordance with the terms hereof. At such time as any Shares are no longer subject to the Company&#8217;s repurchase and first refusal rights, the Company shall, at the written request of the Holder, deliver to the Holder a certificate representing such Shares with the balance of the Shares to be held in escrow pursuant to this Section.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Without limitation of any other provision of this Plan or other rights, in the event that a Holder or any other Person is required to sell a Holder&#8217;s Shares pursuant to the provisions of Sections 9(b) or (c) hereof and in the further event that he or she refuses or for any reason fails to deliver to the Company or its designated purchaser of such Shares the certificate or certificates evidencing such Shares together will a related stock power, the Company or such designated purchaser may deposit the applicable purchase price for such Shares with a bank designated by the Company, or with the Company&#8217;s independent public accounting firm, as agent or trustee, or in escrow, for such Holder or other Person, to be held by such bank or accounting firm for the benefit of and for delivery to him, her, them or it, and&#47;or, in its discretion, pay such purchase price by offsetting any indebtedness then owed by such Holder as provided above. Upon any such deposit and&#47;or offset by the Company or its designated purchaser of such amount and upon notice to the Person who was required to sell the Shares to be sold pursuant to the provisions of Sections 9(b) or (c), such Shares shall at such time be deemed to have been sold, assigned, transferred and conveyed to such purchaser, such Holder shall have no further rights thereto (other than the right to withdraw the payment thereof held in escrow, if applicable), and the Company shall record such transfer in its stock transfer book or in any appropriate manner.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Lockup Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If requested by the Company, a Holder shall not sell or otherwise transfer or dispose of any Shares (including, without limitation, pursuant to Rule 144 under the Securities Act) held by him or her for such period following the effective date of a public offering by the Company of Shares as the Company shall specify reasonably and in good faith. If requested by the underwriter engaged by the Company, each Holder shall execute a separate letter confirming his or her agreement to comply with this Section.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments for Changes in Capital Structure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Common Stock, the outstanding Shares are increased or decreased or are exchanged for a different number or kind of securities of the Company, the restrictions contained in this Section 9 shall apply with equal force to additional and&#47;or substitute securities, if any, received by Holder in exchange for, or by virtue of his or her ownership of, Shares.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The terms and provisions of Section 9(b) and Section 9(c) (except for the Company&#8217;s right to repurchase Shares still subject to a risk of forfeiture upon a Termination Event) shall terminate upon the closing of the Company&#8217;s Initial Public Offering or upon consummation of any Sale Event, in either case as a result of which Shares are registered under Section 12 of the Exchange Act and publicly-traded on any national security exchange.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 10.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">TAX WITHHOLDING</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Payment by Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Each grantee shall, no later than the date as of which the value of an Award or of any Shares or other amounts received thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and any Subsidiary shall, to the</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&#8217;s obligation to deliver stock certificates (or evidence of book entry) to any grantee is subject to and conditioned on any such tax withholding obligations being satisfied by the grantee.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Payment in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company&#8217;s minimum required tax withholding obligation may be satisfied, in whole or in part, by the Company withholding from Shares to be issued pursuant to an Award a number of Shares having an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the minimum withholding amount due.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 11.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">SECTION 409A AWARDS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that any Award is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A (a &#8220;409A Award&#8221;), the Award shall be subject to such additional rules and requirements as may be specified by the Committee from time to time. In this regard, if any amount under a 409A Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section 409A) to a grantee who is considered a &#8220;specified employee&#8221; (within the meaning of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the grantee&#8217;s separation from service, or (ii) the grantee&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and&#47;or additional tax imposed pursuant to Section 409A. The Company makes no representation or warranty and shall have no liability to any grantee under the Plan or any other Person with respect to any penalties or taxes under Section 409A that are, or may be, imposed with respect to any Award.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 12.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">AMENDMENTS AND TERMINATION</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the consent of the holder of the Award. The Committee may exercise its discretion to reduce the exercise price of outstanding Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting such holders new Awards in replacement of the cancelled Stock Options. To the extent determined by the Committee to be required either by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section 422 of the Code or otherwise, Plan amendments shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section 12 shall limit the Board&#8217;s or Committee&#8217;s authority to take any action permitted pursuant to Section 3(c). The Board reserves the right to amend the Plan and or the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements of the exemption pursuant to paragraph (t)(4) of Rule 12h-1 of the Exchange Act.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 13.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">STATUS OF PLAN</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly so determine in connection with any Award.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 14.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">GENERAL PROVISIONS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Distribution&#59; Compliance with Legal Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Committee may require each person acquiring Shares pursuant to an Award to represent to and agree with the Company in writing that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">such person is acquiring the Shares without a view to distribution thereof. No Shares shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar requirements have been satisfied. The Committee may require the placing of such stop-orders and restrictive legends on certificates or Stock and Awards as it deems appropriate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Documentation&#59; Shareholder Agreement&#59; Other Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for each Award. Each Award under this Plan shall also be subject to the terms and conditions of the Company Charter, including, but not limited to, the provisions of Section 4.7 (Call Rights&#59; Mandatory Exercise Rights) therein.  The Board may at the time of grant of an Award or any time thereafter, require as a condition for exercise of an Option, termination of restrictions on Restricted Stock or settlement of Restricted Stock Units that each Holder execute an investor letter agreement in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and may at any time impose such additional conditions with respect to the issuance and&#47;or delivery of stock under the Plan as it considers necessary or advisable to comply with requirements of securities, tax or other laws or regulations. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Delivery of Stock Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Stock certificates to grantees under the Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company&#59; provided that stock certificates to be held in escrow pursuant to Section 9 of the Plan shall be deemed delivered when the Company shall have recorded the issuance in its records. Uncertificated Stock shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#8220;book entry&#8221; records).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The adoption of the Plan and the grant of Awards do not confer upon any Person any right to continued employment or Service Relationship with the Company or any Subsidiary.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Trading Policy Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Option exercises and other Awards under the Plan shall be subject to the Company&#8217;s insider trading policy-related restrictions, terms and conditions as may be established by the Committee, or in accordance with policies set by the Committee, from time to time.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Designation of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award on or after the grantee&#8217;s death or receive any payment under any Award payable on or after the grantee&#8217;s death. Any such designation shall be on a form provided for that purpose by the Committee and shall not be effective until received by the Committee. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&#8217;s estate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Any certificate(s) representing the Shares shall carry the following legend (and with respect to uncertificated Stock, the book entries evidencing such shares shall contain the following notation)&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">SECURITIES ACT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), OR STATE SECURITIES LAWS AND CANNOT BE OFFERED, SOLD, OR TRANSFERRED IN THE ABSENCE OF REGISTRATION OR </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS AND REGULATIONS PROMULGATED THEREUNDER.  THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED BY THE REGISTERED OWNER HEREOF FOR INVESTMENT AND NOT WITH A VIEW TO OR FOR SALE IN CONNECTION WITH ANY DISTRIBUTION THEREOF IN VIOLATION OF THE SECURITIES ACT.  THE SHARES MAY NOT BE SOLD, PLEDGED, TRANSFERRED OR ASSIGNED EXCEPT IN A TRANSACTION WHICH IS EXEMPT UNDER THE PROVISIONS OF THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR IN A TRANSACTION OTHERWISE IN COMPLIANCE WITH APPLICABLE FEDERAL AND STATE SECURITIES LAWS.</font></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TRANSFER RESTRICTIONS SET FORTH IN THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE CORPORATION DATED MAY 15, 2020 (AS AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME).  NO REGISTRATION OF TRANSFER OF SUCH SECURITIES WILL BE MADE ON THE BOOKS OF THE CORPORATION UNLESS AND UNTIL SUCH RESTRICTIONS SHALL HAVE BEEN COMPLIED WITH.  ANY PURPORTED TRANSFER OR ATTEMPT TO TRANSFER THE SECURITIES REPRESENTED HEREBY OTHER THAN IN ACCORDANCE WITH THE TERMS OF THE CERTIFICATE OF INCORPORATION SHALL BE NULL AND VOID AND OF NO EFFECT.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Information to Holders of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event the Company is relying on the exemption from the registration requirements of Section 12(g) of the Exchange Act contained in paragraph (f)(1) of Rule 12h-1 of the Exchange Act, the Company shall provide the information described in Rule 701(e)(3), (4) and (5) of the Securities Act to all holders of Options in accordance with the requirements thereunder. The foregoing notwithstanding, the Company shall not be required to provide such information unless the optionholder has agreed in writing, on a form prescribed by the Company, to keep such information confidential.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 15.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">EFFECTIVE DATE OF PLAN</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Plan shall become effective upon adoption by the Board and shall be approved by stockholders in accordance with applicable state law and the Company&#8217;s articles of incorporation and bylaws within 12 months thereafter. If the stockholders fail to approve the Plan within 12 months after its adoption by the Board of Directors, then any Awards granted or sold under the Plan shall be rescinded and no additional grants or sales shall thereafter be made under the Plan. Subject to such approval by stockholders and to the requirement that no Shares may be issued hereunder prior to such approval, Stock Options and other Awards may be granted hereunder on and after adoption of the Plan by the Board. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the date the Plan is adopted by the Board or the date the Plan is approved by the Company&#8217;s stockholders, whichever is earlier.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SECTION 16.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">GOVERNING LAW</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Plan, all Awards and any controversy arising out of or relating to this Plan and all Awards shall be governed by and construed in accordance with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflict of law principles that would result in the application of any law other than the law of the State of New York.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DATE ADOPTED BY THE BOARD OF DIRECTORS&#58; May 15, 2020</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DATE APPROVED BY THE STOCKHOLDERS&#58; May 15, 2020</font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">FORM OF</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">INVESTOR LETTER AGREEMENT</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In consideration of the undersigned (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) receiving shares of Series A Common Stock, par value $0.001 per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), of Avery Parent Holdings, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), pursuant to the (i) exercise of Options, (ii) termination of restrictions on Restricted Stock or (iii) settlement of Restricted Stock Units granted under the Company&#8217;s 2020 Stock Option and Grant Plan (each as defined therein),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Stockholder agrees as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The undersigned hereby acknowledges and agrees to be bound by the provisions of the Amended and Restated Certificate of Incorporation of the Company, dated May 15, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) with respect to any Shares held by the Stockholder, including with respect to Section 4.5 (Restrictions on Transfer), Section 4.6 (Drag-Along Rights) and Section 4.7 (Call Rights) thereof.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Stockholder understands that the Shares held by the undersigned are subject to significant restrictions on transferability, and the undersigned must hold them indefinitely and subject to the provisions of the Charter, the Bylaws of the Company, and the Securities Act of 1933. The Shares are held for investment purposes only and not with a view of distribution to others.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Letter Agreement is binding upon the Stockholder and the successors and assigns of the Stockholder and is for the benefit of the Company and all of its stockholders.</font></div><div style="margin-bottom:10pt;text-indent:3.6pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; &#91;&#9679;&#93;, 2020</font></div><div style="margin-bottom:10pt;text-indent:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">STOCKHOLDER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58;</font></div><div style="margin-bottom:10pt;text-indent:3.6pt"><font><br></font></div><div style="margin-bottom:10pt;text-indent:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;  _____________________________________</font></div><div style="margin-bottom:4pt;text-indent:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;  </font></div><div style="margin-bottom:4pt;text-indent:3.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;    </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.47
<SEQUENCE>14
<FILENAME>unhex104712312022.htm
<DESCRIPTION>EX-10.47
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic864d9702e094f60ae7db1368fba01df_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.47</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Agreement is between Rupert Bondy (&#8220;Executive&#8221;) and United HealthCare Services, Inc. (&#8220;UnitedHealth Group&#8221;) and is effective as of Executive&#8217;s first day of employment with UnitedHealth Group (the &#8220;Effective Date&#8221;). This Agreement&#8217;s purposes are to set forth certain terms of Executive&#8217;s employment by UnitedHealth Group or one of its affiliates and to protect UnitedHealth Group&#8217;s knowledge, expertise, customer relationships, and confidential information. Unless the context otherwise requires, &#8220;UnitedHealth Group&#8221; includes all its affiliated entities.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Employment and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. UnitedHealth Group hereby employs Executive, and Executive accepts employment, under this Agreement&#8217;s terms.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Title and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Executive will be employed as Executive Vice President and Chief Legal Officer, UnitedHealth Group.  Executive will perform such duties, and exercise such supervision and control, as are commonly associated with Executive&#8217;s position, as well as perform such other duties as are reasonably assigned to Executive.  Executive will devote substantially all of Executive&#8217;s business time and energy to Executive&#8217;s duties.  Executive will maintain operations in Executive&#8217;s area of responsibility and make every reasonable effort to ensure that the employees within that area of responsibility act in compliance with applicable law and UnitedHealth Group&#8217;s Code of Conduct, as amended from time to time.  Executive is subject to all of UnitedHealth Group&#8217;s employment policies and procedures (except as specifically superseded by this Agreement).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Compensation and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive&#8217;s initial annual base salary will be $875,000, less applicable withholdings and deductions, payable according to UnitedHealth Group&#8217;s regular payroll schedule.  Periodic adjustments to Executive&#8217;s base salary may be made in UnitedHealth Group&#8217;s sole discretion.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will be eligible to participate in UnitedHealth Group&#8217;s incentive compensation plans in UnitedHealth Group&#8217;s discretion and in accordance with the plans&#8217; terms and conditions.  Executive&#8217;s initial target bonus potential will be 135% of annual base salary, subject to periodic adjustments in UnitedHealth Group&#8217;s discretion. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sign-On Equity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In accordance with guideline amounts authorized by UnitedHealth Group&#8217;s Compensation and Human Resources Committee (&#8220;Committee&#8221;), management will recommend to the Committee that Executive be granted an equity sign-on award of $2,500,000 in Performance-Based Restricted Stock Units, $1,250,000 of which will be for the 2020-2022 performance period, and $1,250,000 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of which will be for the 2021-2023 performance period, in each case subject to the performance vesting criteria and other terms of the respective performance periods. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">UnitedHealth Group&#8217;s governance policy stipulates that the Committee can only grant equity awards at regularly scheduled quarterly committee meetings.  Accordingly, Executive&#8217;s recommended grant will be reviewed by the Committee at its next regularly scheduled quarterly meeting following the Effective Date.  The number of shares granted will be calculated the day of the Committee meeting using the closing price of UnitedHealth Group stock on that date. This award will be subject to the terms of the UnitedHealth Group 2020 Stock Incentive Plan, including certain restrictive covenants.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">D.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Annual Equity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will be eligible for consideration for future annual stock-based awards in accordance with UnitedHealth Group&#8217;s governance policy and guideline amounts authorized by UnitedHealth Group&#8217;s Compensation and Human Resources Committee. For calendar year 2022, management will recommend that Executive be awarded an annual equity grant with a target value of $4,500,000. The actual grant value of any such future equity grants and the related terms are at the sole discretion of UnitedHealth Group and will be subject to the terms of the UnitedHealth Group 2020 Stock Incentive Plan (or a successor plan), including certain restrictive covenants.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">E.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Sign-On Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. UnitedHealth Group agrees to pay Executive a sign-on bonus of $2,000,000, less applicable withholdings and deductions.  The sign-on bonus will be paid on the regular payroll date that occurs 30 days after the Effective Date, provided Executive has returned to UnitedHealth Group a fully-executed copy of Executive&#8217;s Agreement to Repay Sign-On Bonus, the terms of which are incorporated herein by reference.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will be eligible to participate in UnitedHealth Group&#8217;s employee welfare, retirement, and stock incentive plans on the same basis as other similarly situated executives, in accordance with the terms of the plans.  Executive will be eligible for Paid Time Off in accordance with UnitedHealth Group&#8217;s policies.  UnitedHealth Group reserves the right to amend or discontinue any plan or policy at any time in its sole discretion.  In addition to the Company&#8217;s generally available benefits, UnitedHealth Group shall provide Executive, at UnitedHealth Group&#8217;s expense during the term of Executive&#8217;s employment, a $2 million face value term life insurance policy and a long term disability policy which covers 60% of base salary in the event of a qualifying long term disability, subject to the policy terms.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">By Mutual Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The parties may terminate Executive&#8217;s employment at any time by mutual agreement. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">By UnitedHealth Group without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  UnitedHealth Group may terminate Executive&#8217;s employment without Cause upon 90 days&#8217; prior written notice.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">By UnitedHealth Group with Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  UnitedHealth Group may terminate Executive&#8217;s employment at any time for Cause.  &#8220;Cause&#8221; means Executive&#8217;s (a) material failure to follow UnitedHealth Group&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, UnitedHealth Group&#8217;s Code of Conduct, as amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Executive&#8217;s employment, (e) material breach of this Agreement, or (f) conduct that is materially detrimental to UnitedHealth Group&#8217;s interests.   UnitedHealth Group will, within 120 days of discovery of the conduct, give Executive written notice specifying the conduct constituting Cause in reasonable detail and Executive will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">By Executive without Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive may terminate Executive&#8217;s employment at any time for any reason, including due to Executive&#8217;s retirement.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">By Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive may terminate Executive&#8217;s          employment for Good Reason, as defined below.  Executive must give UnitedHealth Group written notice specifying in reasonable detail the circumstances constituting Good Reason, within 120 days of becoming aware of such circumstances, or such circumstances will not constitute Good Reason.  If the circumstances constituting Good Reason are reasonably capable of being remedied, UnitedHealth Group will have 60 days to remedy such circumstances.   &#8220;Good Reason&#8221; will exist if UnitedHealth Group takes any of the following actions, without Executive&#8217;s consent&#58; (a) reduces Executive&#8217;s base salary or target bonus percentage other than in connection with a general reduction affecting a group of employees&#59; (b) moves Executive&#8217;s primary work location more than 50 miles&#59; or (c) makes changes that substantially diminish Executive&#8217;s duties or responsibilities. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Due to Executive&#8217;s Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive&#8217;s employment will terminate automatically if Executive dies, effective as of the date of Executive&#8217;s death.  UnitedHealth Group may terminate Executive&#8217;s employment due to Executive&#8217;s disability that renders Executive incapable of performing the essential functions of Executive&#8217;s job, with or without reasonable accommodation.  Executive will</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">not be entitled to Severance Benefits under Section 4 in the event of termination due to Executive&#8217;s death or disability.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Circumstances under Which Severance Benefits Payable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will be entitled to Severance Benefits only if Executive&#8217;s employment is terminated by UnitedHealth Group without Cause or if Executive terminates employment for Good Reason.  Whether Executive has had a termination of employment will be determined in a manner consistent with the definition of &#8220;Separation from Service&#8221; under Section 409A of the Internal Revenue Code of 1986 and its accompanying regulations (&#8220;Section 409A&#8221;) and will be referred to herein as a &#8220;Termination.&#8221;  For purposes of this Agreement, Executive will be considered to have experienced a Termination as of the date that the facts and circumstances indicate that it is reasonably anticipated that Executive will provide no further services after such date or that the level of bona fide services that Executive is expected to perform permanently decreases to no more than 20% of the average level of bona fide services that Executive performed over the immediately preceding 36-month period. In consideration of the Severance Benefits in this Agreement, Executive waives any payments or benefits to which Executive otherwise might be or become entitled under any UnitedHealth Group severance plan or program.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to Section 4.C, Executive shall be entitled to the following Severance Benefits if Executive experiences a Termination under the circumstances described in Section 4.A above&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.          Two times Executive&#8217;s annualized base salary as of Executive&#8217;s Termination.</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.         Any bonus or incentive compensation paid or payable to Executive for the two most recent calendar years (excluding equity-related awards, payments under any long-term or similar benefit plan, or any other special or one-time bonus or incentive compensation payments)&#59; provided, however, that if termination occurs within two years following the Effective Date, the amount payable under this paragraph will be two times Executive&#8217;s target incentive.  </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.        $12,000 lump sum payment, minus applicable deductions, to offset costs of COBRA, which amount will be paid within 60 days following Termination. </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.        Outplacement services consistent with those provided to similarly situated executives provided by an outplacement firm selected by UnitedHealth Group. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Severance Benefits in Sections 4.B.i.-ii. will be paid out, minus applicable deductions, including deductions for tax withholding, in equal bi-weekly payments on the regular payroll cycle over the 24-month period following Executive&#8217;s Termination.  Commencement of payments shall begin on the first payroll date that is at least 60 days after the date of Executive&#8217;s Termination (the &#8220;Starting Date&#8221;), provided that Executive has satisfied the requirement in Section 4.C.  The first payment on the Starting Date shall include those payments that would have been previously paid if the payments of the severance compensation had begun on the first payroll date following the date of Executive&#8217;s Termination. Executive&#8217;s entitlement to the payments of the severance compensation described in Sections 4.B.i.-ii. shall be treated as the entitlement to a series of separate payments for purposes of Section 409A.   </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If Executive is a &#8220;Specified Employee&#8221; (within the meaning of Section 409A and determined pursuant to procedures adopted by UnitedHealth Group) at the time of Executive&#8217;s Termination and any amount that would be paid to Executive during the six-month period following Termination constitutes &#8220;Deferred Compensation&#8221; (within the meaning of Section 409A), such amount shall not be paid to Executive until the later of (i) six months after the date of Executive&#8217;s Termination, and (ii) the payment date or commencement date specified in this Agreement for such payment(s).  On the first regular payroll date following the expiration of such six-month period (or if Executive dies during the six-month period, the first payroll date following the death), all payments that were delayed pursuant to the preceding sentence shall be paid to Executive in a single lump sum and thereafter all payments shall be made as if there had been no such delay.  All Severance Benefits described in Section 4.B shall be paid by, and no further severance compensation shall be paid or payable after, December 31 of the second calendar year following the year in which Executive&#8217;s Termination occurs.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Separation Agreement and Release Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to receive any Severance Benefits under this Agreement, Executive must timely sign a separation agreement and release of claims in a form determined by UnitedHealth Group in its discretion. UnitedHealth Group shall provide to Executive a form of separation agreement and release of claims no later than three (3) days following Executive&#8217;s date of Termination.  If Executive does not timely execute and deliver to UnitedHealth Group such separation agreement and release, or if Executive does so, but then revokes it if permitted by and within the time required by applicable law, UnitedHealth Group will have no obligation to pay severance compensation to Executive.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Property Rights, Confidentiality, Non-Disparagement, and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.28pt;text-decoration:underline">UnitedHealth Group&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive hereby agrees to assign (both during and after Executive&#8217;s employment) and hereby assigns to UnitedHealth Group all rights, titles and interests Executive may have in any invention, computer program, discovery, idea, writing, improvement, process, technique or other works (collectively called &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Executive, either alone or jointly with others, during Executive&#8217;s employment that&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;Relates in any manner to the actual or anticipated business, research, or development of UnitedHealth Group&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;Results from work assigned to or performed by Executive for UnitedHealth Group&#59; and&#47;or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;Is conceived of or made with the use of UnitedHealth Group systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Disclosure of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees to promptly disclose in writing to UnitedHealth Group (both during and after Executive&#8217;s employment) any interest Executive may have in any Intellectual Property created or conceived by Executive, either alone or jointly with others, during Executive&#8217;s employment.   Executive will also promptly disclose in writing to UnitedHealth Group any interest Executive may have in any Intellectual Property created or conceived by Executive, either alone or jointly with others, prior to employment that relates to the actual or anticipated business, research, or development of UnitedHealth Group.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment&#47;Transfer of Web Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees to transfer and assign (both during and after Executive&#8217;s employment), and does hereby assign to UnitedHealth Group all rights, titles, and interests in and to any domain name or social media account (collectively called &#8220;Web Properties&#8221;) registered or owned by Executive that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        Was registered with the intent to be used by UnitedHealth Group&#59; and&#47;or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        Relates in any manner to, or is used to comment on, the actual or anticipated business of UnitedHealth Group&#59; and&#47;or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160; Contains a registered or common law trademark of UnitedHealth Group.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Perfection of Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will at all times, even after termination of employment, do anything reasonably requested of Executive to enable UnitedHealth Group to access, patent, copyright or obtain any other form of protection for the Intellectual Property or Web Properties created, conceived, or registered by Executive, either alone or jointly with others.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">v.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exclusions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Sections 5.A.i.-iv. do not apply to Intellectual Property that meets all of the following criteria&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;No UnitedHealth Group equipment, supplies, facilities, proprietary or trade secret information was used in its creation&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;The Intellectual Property was developed entirely on Executive&#8217;s own time&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;At the time of conception or reduction to practice the Intellectual Property does not relate directly to UnitedHealth Group&#8217;s business, actual or anticipated research or development&#59; and</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;The Intellectual Property does not result from any work performed by Executive for UnitedHealth Group.</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">vi.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Removal of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Executive may not remove from UnitedHealth Group&#8217;s premises any UnitedHealth Group records, documents, data or other property, in either original or duplicate form, except as necessary in the ordinary course of UnitedHealth Group&#8217;s business.</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">vii.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive must immediately deliver to UnitedHealth Group, upon termination of employment, or at any other time at UnitedHealth Group&#8217;s request, all UnitedHealth Group property, including records, documents, data, and equipment, and all copies of any such property, including any records or data Executive prepared during employment.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will be given access to and provided with sensitive, confidential, proprietary and trade secret information (&#8220;Confidential Information&#8221;) in the course of Executive&#8217;s employment.  Examples of Confidential Information include&#58;  inventions&#59; new product or marketing plans&#59; business strategies and plans&#59; merger and acquisition targets&#59; financial and pricing information&#59; computer programs, source codes, models and databases&#59; analytical models&#59; customer lists and information&#59; and supplier and vendor lists and other information which is not generally available to the public.  Executive agrees not to</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">disclose or use</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Confidential Information, either during or after Executive&#8217;s employment with UnitedHealth Group,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">except as necessary to perform Executive&#8217;s UnitedHealth Group duties or as UnitedHealth Group may consent in writing.   </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees not to criticize, make any negative comments about or otherwise disparage UnitedHealth Group or those associated with it, whether orally, in writing or otherwise, directly or by implication, to any person or entity, including UnitedHealth Group customers or agents.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees to the restrictive covenants in this Section in consideration of Executive&#8217;s employment and UnitedHealth Group&#8217;s promises in this Agreement, including providing Executive access to Confidential Information.  The restrictive covenants in this Section apply during Executive&#8217;s employment and for 24 months following termination of employment for any reason.  Executive agrees that he&#47;she will not, without UnitedHealth Group's prior written consent, directly or indirectly, for Executive or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner or shareholder, or in any other individual or representative capacity, engage in any of the following activities&#58;         </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive will not&#58;</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;Solicit or conduct business with any business competitive with UnitedHealth Group from any person or entity&#58; (1) who was a UnitedHealth Group provider or customer within the 12 months before Executive&#8217;s employment termination and with whom Executive had contact regarding UnitedHealth Group&#8217;s activity, products or services, or for whom Executive provided services or supervised employees who provided those services, or about whom Executive learned Confidential Information during employment related to UnitedHealth Group&#8217;s provision of products and services to such person or entity, or (2) was a prospective provider or customer UnitedHealth Group solicited within the 12 months before Executive&#8217;s employment termination and with whom Executive had contact for the purposes of soliciting the person or entity to become a provider or customer of UnitedHealth Group, or supervised employees who had those contacts, or about whom Executive learned Confidential Information during employment related to UnitedHealth Group&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;Raid, hire, employ, recruit or solicit any UnitedHealth Group employee or consultant who possesses Confidential Information of UnitedHealth Group to leave UnitedHealth Group to join a competitor&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;Induce or influence any UnitedHealth Group employee, consultant, or provider who possesses Confidential Information of UnitedHealth Group to terminate his, her or its employment or other relationship with UnitedHealth Group&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive will not&#58;</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;Engage in or participate in any activity that competes, directly or indirectly, with any UnitedHealth Group activity, product or service that Executive engaged in, participated in, or had Confidential Information about during Executive&#8217;s last 36 months of employment with UnitedHealth Group&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, Sections 5.D.i(a) and 5.D.ii will apply only to the extent permissible under the ABA Model Rules of Professional Conduct&#8217;s provisions regarding restrictions on the right to practice law or any applicable state counterpart.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) Executive&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States. </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) Executive&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Executive had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.&#160;&#160;&#160;&#160;To the extent Executive and UnitedHealth Group agree at any time to enter into separate agreements containing restrictive covenants with different or inconsistent terms than those contained herein, Executive and UnitedHealth Group acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive agrees that the provisions of this Section 5 are reasonable and necessary to protect the legitimate interests of UnitedHealth Group.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Cooperation and Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees to cooperate fully (i) with UnitedHealth Group in the investigation, prosecution or defense of any potential claims or concerns regarding UnitedHealth Group&#8217;s business about which Executive has relevant knowledge, including by providing truthful information and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">testimony as reasonably requested by UnitedHealth Group, and (ii) with all government authorities on matters pertaining to any investigation, litigation or administrative proceeding concerning UnitedHealth Group.  UnitedHealth Group will reimburse Executive for any reasonable travel and out-of-pocket expenses incurred by Executive in providing such cooperation.  UnitedHealth Group will indemnify Executive, in accordance with the Minnesota Business Corporation Act and other applicable law, for all claims and other covered matters arising in connection with Executive&#8217;s employment. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive agrees that (a) legal remedies (money damages) for any breach of Section 5 will be inadequate, (b) UnitedHealth Group will suffer immediate and irreparable harm from any such breach, and (c) UnitedHealth Group will be entitled to injunctive relief from a court in addition to any legal remedies UnitedHealth Group may seek in arbitration.  If an arbitrator or court determines that Executive has breached any provision of Section 5, Executive agrees to pay to UnitedHealth Group its reasonable costs and attorney&#8217;s fees incurred in enforcing that provision.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.28pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  All compensation payable under this Agreement will be subject to applicable tax withholding and other required or authorized deductions.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.84pt;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Executive may not assign this Agreement.  UnitedHealth Group may assign this Agreement.  Any successor to UnitedHealth Group will be deemed to be UnitedHealth Group under this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.84pt;text-decoration:underline">Entire Agreement&#59; Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement contains the parties&#8217; entire agreement regarding its subject matter and may only be amended in a writing signed by the parties.  This Agreement supersedes any and all prior oral or written employment agreements (including letters and memoranda) between Executive and UnitedHealth Group or its predecessors.  This Agreement does not supersede the terms of any stock option, restricted stock, or stock appreciation rights plan or award.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.28pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.   Minnesota law governs this Agreement.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27.4pt;text-decoration:underline">Waivers&#59; Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No party&#8217;s failure to exercise, or delay in exercising, any right or remedy under this Agreement will be a waiver of such right or remedy, nor will any single or partial exercise of any right or remedy preclude any other or further exercise of such right or remedy.  Nothing in this Agreement prohibits Executive from making disclosures that are protected under law or reporting violations of state or federal law or regulation to governmental agencies or entities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Narrowed Enforcement and Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If a court or arbitrator decides that any provision of this Agreement is invalid or overbroad, the parties agree that the court or arbitrator should narrow such provision so that it is enforceable or, if narrowing is not possible or permissible, such provision should be considered severed and the other provisions of this Agreement should be unaffected.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">G.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Dispute Resolution and Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except for injunctive relief under Section 5.F, any dispute between the parties relating to this Agreement or to Executive&#8217;s employment will be resolved by binding arbitration under UnitedHealth Group&#8217;s Employment Arbitration Policy, as it may be amended from time to time.  The arbitrator(s) may not vary this Agreement&#8217;s terms and must apply applicable law. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">H.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Payment of Deferred Compensation &#8211; Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent applicable, it is intended that the compensation arrangements under this Agreement be in full compliance with Section 409A.  This Agreement shall be construed in a manner to give effect to such intention.  In no event whatsoever shall UnitedHealth Group be liable for any tax, interest or penalties that may be imposed on Executive under Section 409A.  UnitedHealth Group shall have no obligation to indemnify or otherwise hold Executive harmless from any such taxes, interest or penalties, or from liability for any damages related thereto.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Electronic Transmission&#47;Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The executed version of this Agreement may be delivered by facsimile or email, and upon receipt, such transmission shall be deemed delivery of an original.  This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, and all of which together will constitute one document.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; David Strauss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Rupert Bondy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SVP Total Rewards HCS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3.24.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">21st March 2022</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>15
<FILENAME>unhex21112312022.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if7baeddfc697456988e6bd1d39d1ecc3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries of the Company</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Listed below are subsidiaries of UnitedHealth Group Incorporated as of December&#160;31, 2022. Those subsidiaries not listed would not, in the aggregate, constitute a &#8220;significant subsidiary&#8221; of UnitedHealth Group Incorporated, as that term is defined in Rule&#160;1-02(w) of Regulation&#160;S-X. </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">State of Jurisdiction or Domicile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Doing Business As</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1070715 B.C. Unlimited Liability Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Avenue Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Avenue Pharmacy<br>Genoa Healthcare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 Canyon Medical, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4C MSO LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5995 Minnetonka, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Better Way Therapy, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+ Learning and Development Centers LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+ Solutions</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbleTo, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accurate Rx Pharmacy Consulting, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abacus<br>Abacus 340B Management<br>Accurate Rx<br>Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AccuReg Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACN Group IPA of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACN Group of California, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Physical Health of California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora Cl&#237;nica La Colina S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora Country S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora M&#233;dica Centromed S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgery Center of Carlsbad, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgery Center of Clifton, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgical Hospital, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Therapy Associates, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate Condell Ambulatory Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate Southwest Ambulatory Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate-SCA Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aesthetic Plastic Surgery Institute of Louisville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisville Surgery Center, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affirmations Psychological Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tomorrow Begins Today Consulting</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHN Central Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHN Target Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aliansalud Entidad Promotora de Salud S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Savers Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Savers Life Insurance Company of California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AdventHealth Surgery Center - Lake Mary</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allina Health Surgery Center - Lakeville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allina Health Surgery Center - Vadnais Heights, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aloha Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambient Healthcare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambient Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambulatory Center for Endoscopy, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambulatory Partner Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Indiana II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Network</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Kentucky, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio Care Organization, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio II, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMG Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amico Sa&#250;de Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amigo Family Counseling, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amil Assist&#234;ncia M&#233;dica Internacional S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An&#225;lisis Cl&#237;nicos ML S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angiografia e Hemodin&#226;mica Madre Theodora Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antelope Valley Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apothecary Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AppleCare Medical Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APS &#8211; Assist&#234;ncia Personalizada &#224; Sa&#250;de Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquitania Chilean Holding SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcadia JV Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arise Physician Group</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Physicians IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Holdings of New Jersey, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Network, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASV-HOPCo-SCA Cornerstone, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atlanta Outpatient Surgery Center, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atlanta Surgery Center, Ltd. (L.P.)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atlanta Outpatient Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atrius MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audax Health Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aventura Medical Tower Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avery Parent Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aveta Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare Intermediate Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143943</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.R.A.S.S. Partnership in Commendam</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.R.A.S.S. Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica Colombia S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica Internacional SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Surgical Holdings III, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Behavioral Healthcare Options, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beltway Surgery Centers, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Administration for the Self Employed, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefitter Insurance Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bind Benefits, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BIND<br>Surest Administrator Services<br>Surest, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birmingham Outpatient Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bloomfield ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Ridge GP, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Body Image Therapy Center Intensive LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings I, SRL</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings II, SRL</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings III, S.r.l.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux Holding SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux International Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings I Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings II Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings III Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bosque Medical Center Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon Ambulatory Surgery Center, LC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brighter Financial, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx Infusion Services 102, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Maine, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Massachusetts, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California Medical Group Insurance Company, Risk Retention Group</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Camp Hill-SCA Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital City Medical Group, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capstone Behavioral Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Holding Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus of Texas Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus South Central Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus Wisconsin Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Logistics, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Care Logistics LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Dental Member, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Health Solutions Employer, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Health Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Medical Management</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Holding, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Value Partners IPA, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum IPA of New York</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casa de Sa&#250;de Santa Therezinha Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Rock SurgiCenter, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catalyst360, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST360 INSURANCE SERVICES, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catamaran S.&#225;.r.l.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDC Holdings Colombia S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cemed Care &#8211; Empresa de Atendimento Cl&#237;nico Geral Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center for Quality Improvement, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Jersey Ambulatory Surgical Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CentrifyHealth, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro de Entrenamiento Capacitaci&#243;n en Reanimaci&#243;n SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro de Servicios Compartidos Banm&#233;dica SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro M&#233;dico Hospitalar Pitangueiras Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro Odontol&#243;gico Americano S.A.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centromed Quilpu&#233; S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centros M&#233;dicos y Dentales Multimed Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centurion Casualty Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chalfont HoldCo, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Encircle, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Advocates, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altegra Health Connections, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Business Fulfillment, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Canada Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nova Scotia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Communications, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Express Bill LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Correspondence Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adminisource Communications, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Engagement Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare eRx Canada, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Finance, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare HealthQx, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare HealthQX, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Imaging Australia Pty Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Intermediate Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Intermediate Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Ireland Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Ireland Solutions Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Operations, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Payer Payment Integrity, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Performance, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Pharmacy Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DBA Goold Health Systems Inc.<br>GHS Data Management<br>GHS Data Processing Services, Inc.<br>GHS II<br>Goold Health Systems<br>Goold Health Systems, (INC.)<br>Goold Health Systems, Inc.<br>Goold Health Systems, Inc. a&#47;k&#47;a Goold Health Systems</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Philippines, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phillipines</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Practice Management Solutions Group, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Practice Management Solutions Investments, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Practice Management Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Puerto Rico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coding Source Puerto Rico LLC, The</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Resources Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Resources IPA, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Resources LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altegra Health Operating Company LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBS Envoy LLC<br>Envoy Corporation<br>Envoy LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Technologies, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Technologies, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Technology Enabled Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare Technology Enabled Services, LLC<br>Medaphis Physician Services Corporation<br>PST Services, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change Healthcare UK Holdings Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Channel Islands Surgicenter Properties, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charlotte-SC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citrus Regional Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims Management Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Solutions Systems</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Alameda SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica B&#237;o B&#237;o SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Ciudad del Mar S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica D&#225;vila y Servicios M&#233;dicos S.p.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica del Country S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica San Felipe S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica S&#225;nchez Ferrer S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Santa Mar&#237;a S.p.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Vespucio S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Partners of Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMO &#8211; Centro M&#233;dico de Oftalmologia S&#47;S Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMS &#8211; Central de Manipula&#231;&#227;o e Servi&#231;os Farmac&#234;uticos Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coalition for Advanced Pharmacy Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coastal Counseling Center, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cobranzas Banm&#233;dica SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COI &#8211; Cl&#237;nicas Oncol&#243;gicas Integradas S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Care Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Care Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Realty, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colmedica Medicina Prepagada S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colonial Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colonial Practice Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Innovative Physician Solutions, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Springs Surgery Center, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comfort Care Transportation, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgery Center, Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgery Properties, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ConnectYourCare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ConnectYourCare, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Constructora Inmobiliaria Magapoq S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Wellness Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornerstone Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Country Scan Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cypress Care, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Workers Compensation Services of Georgia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Database Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AccuReg Software, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daybreak Real Estate, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Day-Op Surgery Consulting Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DBP Services of New York IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Network IPA</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Benefit Providers of California, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Benefit Providers, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DBP Services<br>DBP Services Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derry Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SURGICAL CENTER OF NEW HAMPSHIRE AT DERRY</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagn&#243;stico Ecotomogr&#225;fico Centromed Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diasn&#243;stico por Im&#225;genes Centromed Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Health Specialists Endoscopy Center - Arizona, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilab Medicina Nuclear Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Blocker, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Corporate Properties, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discovery Counseling &#38; Consulting, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distance Learning Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i3CME<br>OptumHealth Education</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">divvyMED, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIVVY DOSE<br>divvyDOSE<br>DIVVYDOSE LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DocASAP US, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DocASAP, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doctor + S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dry Creek Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSP Flint Real Estate, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSP-Building C, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCC Convalescent Center at Inverness<br>OCC Surgery Center at Inverness</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DWIC of Tampa Bay, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doctor's Walk-In Clinics<br>MedExpress<br>MedExpress Urgent Care - Cape Coral, SW Pine Island Rd<br>MedExpress Urgent Care - Carrollwood<br>MedExpress Urgent Care - Clearwater<br>MedExpress Urgent Care - Clewiston, W Sugarland Hwy<br>MedExpress Urgent Care - Deland, N Woodland Blvd<br>MedExpress Urgent Care - Fort Meyers, S Cleveland Ave<br>MedExpress Urgent Care - Golden Gate, Collier Blvd.<br>MedExpress Urgent Care - Hudson, State Road 52<br>MedExpress Urgent Care - Jacksonville, Atlantic Blvd.<br>MedExpress Urgent Care - Jacksonville, Merrill Rd<br>MedExpress Urgent Care - Lakeland, N Road 98<br>MedExpress Urgent Care - Largo<br>MedExpress Urgent Care - Lehigh Acres, Homestead Rd N<br>MedExpress Urgent Care - Lutz<br>MedExpress Urgent Care - Mylan - Fountainbleau Aviation<br>MedExpress Urgent Care - Mylan - Rectrix Aerodrome Centers<br>MedExpress Urgent Care - New Tampa<br>MedExpress Urgent Care - North Port, Tuscola Blvd<br>MedExpress Urgent Care - Northside<br>MedExpress Urgent Care - Palm Beach Gardens<br>MedExpress Urgent Care - Port Charlotte, Tamiami Trl<br>MedExpress Urgent Care - Vero Beach, US Highway 1<br>MedExpress Urgent Care - West Tampa<br>MedExpress Urgent Care-Brandon</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E Street Endoscopy, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Coast Endoscopy Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ear Professionals International Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Hearing Healthcare<br>EPIC Hearing Insurance Agency<br>EPIC Hearing Service Plan<br>EPIC Risk Management<br>EPIC Warranty<br>UnitedHealthcare Hearing</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Brunswick Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">University SurgiCenter</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EAVF Acquisition Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ECBC General Partner, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eCode Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edelson &#38; Associates, PSC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EH-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electronic Network Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elual Participa&#231;&#245;es S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EM Orange Tree LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emisar Pharma Services LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emprem&#233;dica S. A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endo Parent, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy Associates of Valley Forge, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy Center Affiliates, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy Center of Bucks County, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise Life Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EP Campus I, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Health Plan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Management Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equian Parent Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equian, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty Recovery Solutions</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRx Network Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRx Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Esho &#8211; Empresa de Servi&#231;os Hospitalares S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Everett MSO, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Everett Clinic</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excel MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excelsior Insurance Brokerage, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Health Resources, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye Clinic Oftalmologia Cl&#237;nico Cir&#250;rgica e Diagn&#243;stico Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye Specialists Surgery Centers LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marion Eye Specialists Surgery Center<br>Muncie Eye Specialists Surgery Center<br>Muncie Specialists Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fairhaven Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fairhaven Real Estate, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Health Care Services</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Associates Home Health</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Home Hospice, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Palliative Care<br>Southwest Medical Associates Hospice and Palliative Care</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Family Insurance, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Risk Advisors, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMG Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Health of Arizona, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geriatrix of Arizona<br>INSPIRIS of Arizona</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortified Provider Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Surgical Center LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freedom Data Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freedom Life Insurance Company of America</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freeway Surgicenter of Houston, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Healthcare Billing Services LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Healthcare Management Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Medex Tanzania Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tanzania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX Kenya Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nairobi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX US, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fundaci&#243;n Banm&#233;dica</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gadsden Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Healthcare LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1073614</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Healthcare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa of Arkansas, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Telepsychiatry, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1DocWay, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa, QoL Wholesale, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gethealthinsurance.com Agency Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedOne Insurance Agency</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gladiolus Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenwood Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenwood Surgical Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenwood-SC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global One Ventures, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G1<br>G1 Administrator<br>G1 Surgery<br>Global 1<br>Global One<br>Global One Administrator</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Traveler Organization (Cayman) SPC Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Outlook, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Outlook<br>Golden Outlook Insurance Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Rule Financial Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Rule Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Triangle Surgicenter, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grants Pass Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Place Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H&#38;W Indemnity (SPC), Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.I. Investments Holding Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hands Across Change Healthcare Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harken Health Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hays Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCAT Acquisition Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hCentive, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCI Acquisition Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCP ACO California, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum California ACO</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care-ONE Insurance Agency, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Inventures Employment Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Inventures, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Plan of Nevada, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Plan of Nevada HPN</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Associates of Irving PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Associates of Texas LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners ASC-LB, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Management Services California, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Services, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners RE, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners RE, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Healthcare Solutions of Georgia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthgrades Marketplace, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthline Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthline Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Group, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Insurance Agency, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex America, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Dental Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex I.P.A., Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of CT, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of DC, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of MD, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of ME, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of NC, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of NJ, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of TX, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Management Services, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthSCOPE Benefits, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HEALTHSCOPE BENEFIT ADMINISTRATORS</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthSCOPE Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heartland Heart and Vascular, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help Seguros de Vida S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help Service S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HHC-SCA Guilford Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlands Ranch Healthcare, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care<br>MedExpress Urgent Care Fort Collins Boardwalk Dr<br>MedExpress Urgent Care Glendale Leetsdale Dr<br>MedExpress Urgent Care Longmont S Main St<br>Optum Everycare Now<br>Optum Virtual Care</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Medical S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honodav SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitais Associados de Pernambuco Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Alvorada Taguatinga Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Ana Costa S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital de Cl&#237;nicas de Jacarepagu&#225; Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Santa Helena S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humedica, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hygeia Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hygeia Corporation (Ontario)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IHD Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois Independent Care Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impel Consulting Experts, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impel Management Services, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana Care Organization, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inland Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo 3001 S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo 3600 Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Cl&#237;nica Santa Mar&#237;a S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria e Inversiones Alameda S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Vi&#241;amed Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INOV8 Surgical at Memorial City, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INOV8 Surgical</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">inPharmative, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INSPIRIS of Texas Physician Group</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Clinic<br>Optum Clinic + Medical Spa<br>Optum Clinic + Urgent Care</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inspiris, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instituto Radium de Cammpinas Ltda</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Behavioral Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Behavioral Health</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-Hospital Physicians Association, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Success-Rx<br>The Portland IPA</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Healthcare Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">InTouch Pharmacy LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inversiones Cl&#237;nicas Santa Mar&#237;a SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Isapre Banm&#233;dica S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Johnston Surgicare, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blackstone Valley Surgicare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jordan Ridge Family Medicine, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Primary Care - Jordan Ridge</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joyable, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JPM Healthcare LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kalamazoo Endo Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KelseyCare Administrators LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kokomo Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KS Management Services, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KS Plan Administrators, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KSMS Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KSMS Intermediate Holdings I, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KSMS Intermediate Holdings II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">La Esperanza del Per&#250; S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratorio ROE S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratorios M&#233;dicos Amed Quilpu&#233; S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Group Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health NY IPA, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health NY PO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of California, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Massachusetts, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of North Carolina, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Oregon, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Washington, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health Technologies Private Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark India, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Primary Care, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laser Acquisition Holdings III, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDI Holding Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDI Diplomat Holding Company, LLC</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leehar Distributors, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CastiaRx<br>CastiaRx Administrators, LLC<br>CastiaRx of Missouri<br>CastiaRx Pharmacy<br>CastiaRx Specialty Pharmacy<br>LDI Integrated Pharmacy Services<br>Leehar Distributors Missouri, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifeprint Accountable Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Accountable Care, Arizona</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LifeWell. Ltd. Co.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lightning Merger Sub Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lindenhurst Holding, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Logan Surgical Suites, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lotten-Eyes Oftalmologia Clinica e Cirurgica Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisville S.C., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisville-SC Properties, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loyola Ambulatory Surgery Center at Oakbrook, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lutheran Campus ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAMSI Life and Health Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care of North America, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Dental Plans</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Physical Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Vision Care, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marietta Outpatient Surgery, Ltd. (L.P.)</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marietta Surgical Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marietta Surgical Center, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Health Ventures, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Specialty Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Surgery Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlin Holding Company LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland Ambulatory Centers, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland-SCA Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts Assurance Company, Ltd. PIC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts Avenue Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Health Care Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Dental Plans</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Systems Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD Ops, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHIEF<br>Community Health Information Exchange Foundation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD-Individual Practice Association, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ME AHS UC LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MED3000 Health Solutions of the Virginias, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MED3000 Health Solutions Southeast</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Development, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care Alabama, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care Maine, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Everycare Now<br>Optum Virtual Care</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care New Hampshire, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care of Boynton Beach, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care - Boca Raton<br>MedExpress Urgent Care - Coral Springs<br>MedExpress Urgent Care - Palm Beach Gardens<br>MedExpress Urgent Care - Royal Palm Beach</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care, Inc. - Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Clinic of North Texas PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Physician Services</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Hilfe S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Support Los Angeles, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical Centers of America, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSynergies, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melbourne Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melbourne Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial City Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial City Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial Houston Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesquite Liberty, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MGH&#47;SCA, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MHC Real Estate Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miami Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Midwest Center for Day Surgery, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid-West National Life Insurance Company of Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mile High SurgiCenter, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monarch Management Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Geriatric Care &#38; Family Practice Associates<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Surgery Center Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morris County Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MSLA Management LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mt. Pleasant Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiangio Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murrells Inlet ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Muskogee Surgical Investors, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mustang Razorback Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">My Wellness Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NAMM Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Decision Support Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Foundation Life Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Information Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Pacific Dental, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Surgery Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navigator Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Naviguard, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Care at Home, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Coordinated Care, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth SM Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neighborhood Health Partnership, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netwerkes, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada Pacific Dental</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Orleans Regional Physician Hospital Organization, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peoples Health<br>Peoples Health Network</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New West Physicians, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elk Ridge Family Medicine<br>HEALTHFIRST PHYSICIANS<br>New West Physicians<br>Physician Alliance of the Rockies</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newton Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nomad Buyer, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American Medical Management California, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Puget Sound Oncology Equipment Leasing Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Nevada Health Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern New Jersey Endoscopy Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Rockies Surgicenter, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northlake Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northlake Surgicare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Spine and Laser Surgery Center LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NW Spine and Laser Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Surgicare, Ltd., an Illinois Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Greensboro, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Lancaster, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Seattle, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Upland, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OC Cardiology Practice Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCC MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OhioSolutions.org LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+ Solutions</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omesa SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OmniClaim, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncocare S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optimum Choice, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Bank, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exante Bank, Inc.<br>OptumHealth Bank, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Biometrics, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Network of Indiana, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Networks, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Network of Ohio<br>Optum Care Network of Oregon<br>Optum Care Network of Pennsylvania<br>Optum Care Networks of Kentucky<br>OptumCare Network of Connecticut</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care of New York Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Services Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Payroll Arkansas</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Clinics Holding Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Compounding Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Digital Health Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Direct To Consumer, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Financial, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies Commercial Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies II, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143853</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Genomics, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions (India) Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telangana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions (Philippines), Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phillipines</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions Colombia S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions International B.V.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Government Solutions, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Growth Partners Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EverCare<br>Evercare Hospice<br>Evercare Hospice and Palliative Care<br>Evercare Hospice and Palliative Care of Colorado Springs<br>Evercare Hospice and Palliative Care of Denver<br>Evercare Palliative Care<br>Evercare Palliative Services<br>Evercare Palliative Services of Colorado Springs<br>Evercare Palliative Services of Denver<br>Evercare Palliative Services of Dover<br>Evercare Palliative Services of Vienna</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Growth Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (Hong Kong) Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (India) Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (Singapore) Pte. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (US), LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology Holdings (US), Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology Servi&#231;os do Brasil Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Networks, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network-Arizona<br>Optum Community Center Layton<br>Optum Community Center Sandy<br>Optum Community Center West Valley<br>Optum Utah<br>OptumCare Medical Network<br>Optumcare Network of Indiana<br>OptumCare Network of Ohio</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Plan of California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Healthcare Partners Plan, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Services (Canada) Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interlock Employee and Family Assistance<br>Optum International</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Solutions (Australia) Pty Ltd</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Victoria</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum International<br>OptumInsight</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Solutions (UK) Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Healthcare of Illinois, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Hospice Pharmacy Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HospiScript Services<br>Optum Hospice Pharmacy Services<br>Optum Hospice Pharmacy Services Administrator</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 100, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Care of New Jersey Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 101, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 103, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 200, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 201, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 202, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 203, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 204, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 205, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 206, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 207, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 208, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 209, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 301, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 302, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 305, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services 305, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 308, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 401, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 402, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 403, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 404, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 500, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2120394<br>Optum Infusion Services 500<br>Optum Services 500, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 501, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 550, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services 550, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 551, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 553, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 554, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insurance of Ohio, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs Topaz, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phillipines</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group Research &#38; Development</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Life Sciences (Canada) Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Networks of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Network-New Jersey<br>OptumCare Network of New Jersey<br>OrthoNet of the Mid-Atlantic</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum of New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Operations (Ireland) Unlimited Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Oregon MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Peak Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Peak Endoscopy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Perks LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharma Services Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 601, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 700, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 701, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143945</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 702, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 704, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 705, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 706, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 707, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 800, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 801, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 803, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 805, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 806, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Public Sector Solutions, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Community Care Services</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rocket, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum SCA CS JV Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Senior Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SeniorScript</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services (Ireland) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services (Puerto Rico) LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business License - USVI</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Solutions UK Holdings Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Specialty Distribution Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Specialty Distribution, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Technology, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum UK Solutions Group Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Washington Network, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Women's and Children's Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360 Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360 Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare ACO New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM Care ACO, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare ACO West, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Clinical Trials, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCP Clinical Research<br>HCP Clinical Research, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado ASC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Disease Endoscoopy<br>Optum Digestive Disease<br>Optum Endoscopy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Springs Health Partners<br>Digestive Disease Clinic<br>Optum<br>Optum Digestive Disease</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Colorado, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Endoscopy Center New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Florida CI, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Florida, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ameridrug<br>Apopka Family Medicine<br>Associated Family Medicine Sabal Palm<br>DaVita Medical Florida<br>DaVita Medical Group<br>DaVita Medical Group - North Westmonte<br>DaVita Medical Group Florida<br>DaVita Pharmacy <br>HCP Care Partners<br>Healthcare Partners Georgia<br>JSA Best Group<br>JSA Healthcare Corporation<br>JSA Medical Group Bayway<br>JSA Medical Group Northeast<br>JSA Medical Group Skyway<br>Lake Mary Family Medicine<br>Northside Family Medicine<br>Optum<br>South Seminole Family Medicine<br>Tuscawilla Family Medicine</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Holdings Colorado, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Holdings, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners<br>HealthCare Partners, LLC<br>Magan Medical Clinic<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABQ Health Partners, LLC<br>DaVita Medical Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare New York IPA, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare South Florida, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Medical Group<br>DaVita Medical Group Florida<br>HealthCare Partners South Florida, LLC<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Specialty Practices Investments, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Specialty Practices, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Care Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group Research &#38; Development</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth International B.V.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight Life Sciences, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ingenix, Inc.<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Administrative Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143946</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Discount Card Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1039765 </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Group Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Health Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Holdings I, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Home Delivery of Ohio, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx at Nationwide<br>OptumRx of Ohio</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx IPA III, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx NY IPA, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FutureScripts Secure</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Illinois, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Maryland, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1048672<br>OptumRx PBM Administrator of Maryland</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FutureScripts</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Wisconsin, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM Administrator of Wisconsin</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PD of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Pharmacy of Nevada, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Culinary<br>Culinary Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2084085 FirstLine Medical<br>Alaska Business License #2108686 FirstLine Benefits<br>Alaska Business License 2084037<br>Alaska Business License 969517 (OptumRx)<br>FirstLine Benefits<br>FirstLine Medical<br>OptumRx<br>OptumRx PBM Administrator of California<br>OptumRx Pharmacy at Collins Aerospace</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Health Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LHI<br>Logistics Health<br>Logistics Health, Inc.<br>OptumServe Health Services, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Technology Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum, Inc.<br>QSSI<br>Quality Software Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oren Meyers, Ph.D., LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orlando Center for Outpatient Surgery, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthology Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet of New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet New York IPA, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet of the South, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet West, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoWest MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OSB &#8211; Tecnologia e Servi&#231;os de Suporte Lda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paran&#225;</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ovations, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Benefit Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Insurance, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (CT), Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (NJ), Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (NY), Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Agency - Oxford Health Plans Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P2P Link, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Casualty Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare Life and Health Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare Life Assurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare of Arizona, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>Secure Horizons</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare of Colorado, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprecare, Inc.<br>Secure Horizons</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pac&#237;fico S.A. Entidad Prestadora de Salud</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Panama City Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Partial Hospital Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daybreak Treatment Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Care Associates, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrimonio Aut&#243;nomo Nueva Cl&#237;nica</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment Resolution Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AIM HEALTHCARE SERVICES</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PDX, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PE Gastro Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PE Gastro MSO Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PE Holdco, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PE New Jersey Holdco, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PE North Ridgeville Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Penzo Enterprises, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peoples Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perham Physical Therapy, LTD</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF2 IP LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PF2 PST Services LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PGC Acquisition Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PGC Endoscopy Center for Excellence, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PGH Global (Cayman) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PGH Global, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PGT Medical Group, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix Mental Health and Wellness PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Alliance of the Rockies, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Day Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Endoscopy Intermediate Holdco, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Endoscopy, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Group of Texas, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Choice of Texas, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Choice</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Plan of Maryland, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians' Medical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians' Surgery Center of Downey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinnacle III, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plano de Sa&#250;de Ana Costa Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus One Health Management Puerto Rico, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus One Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMI Acquisition, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI Settlement Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Settlement Solutions</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Workers Compensation Services of Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Polar II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Polo Holdco, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">POMCO Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">POMCO, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EM Risk Management<br>Pomco<br>Pomco Group Benefit Administrators</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pomerado Outpatient Surgical Center, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pomerado Outpatient Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rancho Bernardo Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Acute Care Center for Research, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH Management Company, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH-Columbia, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH-Gardendale, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Practice Partners in Healthcare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Network of Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Partners Holding, Corp.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Partners, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne Administrative Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier Choice ACO, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier Medical Resources, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier Surgery Center of Louisville, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prevention Healthcare Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prime Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare Medical Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Citrus Valley, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network&#8211;Citrus Valley</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Corona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network-Corona</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Hemet Valley, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network-Hemet Valley</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Inland Valley, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network&#8211;Inland Valley</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Moreno Valley, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network&#8211;Moreno Valley</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Redlands, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care- Redlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Riverside, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of San Bernardino, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network-San Bernardino</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Sun City, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network&#8211;Sun City</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Temecula, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Network Temecula</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procura Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Managed Care Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Progressive Enterprises Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Progressive Medical, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Workers Compensation Services of Ohio<br>PMI Medical Solutions, LLC<br>PMI Solutions, LLC<br>Progressive Medical Solutions, LLC<br>Progressive Medical, LLC of Ohio</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHEALTH Medical Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Physicians ACO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Physicians, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Proton Center Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promotora Country S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pronounced Health Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prosemedic S.A.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Benefits Management,  LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Care Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Management Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence &#38; SCA Development, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pulse Platform, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QoL Acquisition Holdings Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R Cubed, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SeniorMetrix</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rally Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Appeal, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redlands Ambulatory Surgery Center</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redlands-SCA Surgery Centers, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh Intermediate Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh Kentucky, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh Mental Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh New Jersey Psych Health LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refresh Parent Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliant MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research Surgical Center LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of the Rockies</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restore OMH Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restore OMH Intermediate Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Corporate Wellness, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Medical Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Meadowlands, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Rutherford</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Newark, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockville Eye Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palisades Eye Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Health Maintenance Organization, Incorporated</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Health Plans<br>Rocky Mountain HMO</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RVO Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RX Ricardo Campos Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saden S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salem JV Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salem Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northbank Surgical Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salveo Specialty Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sand Lake SurgiCenter, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sand Lake Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Helena Assist&#234;ncia M&#233;dica S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santos Administra&#231;&#227;o e Participa&#231;&#245;es S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanvello Health Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanvello Health Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SC Affiliates, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA AHN JV Holdings II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA AHN JV Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Alaska Surgery Center, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Austin Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Austin Medical Center Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Aventura Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Avon Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Bloomfield Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA BOSC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Cedar Park Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Clifton, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Colorado Springs Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Cottonwood Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Danbury Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Denver Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Development, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duluth Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duncanville Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duncanville MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA East Bay Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA eCode Solutions Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uttar Pradesh</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Englewood Health Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Englewood Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA ESSC Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Global One Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Grove Creek Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Guilford Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Hays Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Health Anesthesia, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Health Value Enterprise, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Heartland Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA High Point Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA HoldCo, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Holding Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Houston Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA HRH Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA IEC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Indiana Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Louisville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Lutheran Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Mohawk Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Murrells Inlet, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Northern Utah Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Northwest Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Outside New Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pacific Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pacific Surgery Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Palisades Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pennsylvania Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pinnacle Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Premier Surgery Center of Louisville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Providence Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Rockledge JV, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA ROCS Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Rush Oak Brook Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Sage Medical, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA San Diego Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Skyway Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA South Ogden Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Southwest Fort Wayne Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Southwestern PA, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Specialists of Florida, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Specialty Holdings of Connecticut, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA SSSC Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Stonegate Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Surgery Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Surgicare of Laguna Hills, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Total Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA West Health Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Westgreen Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Albuquerque Surgery Properties, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Alliance, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Anne Arundel, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-AppleCare Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Bethesda, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Blue Ridge, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Bonita Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Brandon, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Carlsbad Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Castle Rock, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Charleston, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Chatham, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Chevy Chase, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Citrus, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Colonial Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Davenport, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Denver Physicians Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Denver, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Derry, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Doral, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Downey, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Dry Creek, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Dublin, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Encinitas, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Eugene, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-First Coast, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Florence, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Fort Collins, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Fort Walton, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Franklin, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Frederick, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Freeway Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Ft. Myers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Gainesville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Gladiolus, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Glenwood Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Grants Pass, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Grove Place, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Hagerstown, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Hilton Head, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Houston Executive, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCAI Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Illinois, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-IT Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-JPM Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Kissing Camels Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Marina del Rey, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-MC VBP, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mecklenburg Development Corp.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Memorial City, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Memorial, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Merritt, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Midlands, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Midway Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mobile, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mokena, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Morris Avenue, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Morris County, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mt. Pleasant, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Naperville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Naples, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-New Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Newport Beach, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scanner Centromed S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Palm Beach MSO Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Palm Beach, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Panama City Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Paoli, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Phoenix, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Pocono, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Portland, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Practice Partners Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Riverside Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Riverside, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Rockville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sacred Heart Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-San Diego, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-San Luis Obispo, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sand Lake, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Santa Rosa, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Seattle, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Somerset, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sparta, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Spartanburg Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Cloud Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Louis Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Louis, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Lucie, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Surgicare, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-SwiftPath, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Verta, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-VLR Holdings Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Wake Forest, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Western Connecticut, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Westover Hills, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Winchester, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Winter Park, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Woodlands Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCLHS-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCP Specialty Infusion, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SecureMD Management, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seisa Servi&#231;os Integrados de Sa&#250;de Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Benefits, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Care Network of Connecticut, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advantage Plus Network -Connecticut</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serquinox Holdings LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios de Entrenamiento en Competencias Cl&#237;nicas SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios Integrados de Salud Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Amed Quilpu&#233; S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos B&#237;o B&#237;o Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Ciudad del Mar Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Santa Mar&#237;a Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Vespucio Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Atlanta, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Austin, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Hawthorn, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Melbourne, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Dental Plan, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health and Life Insurance Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company USA</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health-Care Options, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Home Medical Products, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Pharmacy &#38; Home Medical Equipment<br>THC of Nevada</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Nevada Administrators, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sistema de Administraci&#243;n Hospitalaria S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SJ East Campus ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denver Convalescent &#38; Recovery Center<br>Denver Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small Business Insurance Advisors, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sobam &#8211; Centro M&#233;dico Hospitalar S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sociedad de Inversiones Santa Mar&#237;a SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solaris JV Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administration Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Alabama, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Arizona, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Missouri, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of North Carolina, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Texas, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Benefit Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Benefits, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Health Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Arizona, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Colorado, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Ohio, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Texas, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of Illinois, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of Minnesota, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solutran, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somerset Outpatient Surgery, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raritan Valley Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Associates, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare<br>OptumCare Community Center<br>Southwest Hospitalist Services Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Michigan Health Network Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopaedic Institute Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Space Coast Surgical Center, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merritt Island Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spartanburg Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialists in Urology Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialized Pharmaceuticals, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Benefits, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EyeFit<br>EyeFit Vision Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Billing Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spectera of New York, IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spectera, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARE Programs, a division of Spectera, Inc<br>Health Benefit Sevices, Inc.<br>Spectera<br>United Optical</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SRPS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Cloud MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Cloud Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Louis Cardiovascular Institute, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Louis Specialty Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Starship Securities LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stonegate Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summit Cardiovascular Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sundance Behavioral Resources, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunSurgery, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Cherry Creek, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Cottonwood, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Grove Creek, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Kissing Camels, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at South Ogden, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center Holding, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Boca Raton, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Des Moines, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Easton, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Ellicott City, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Louisville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Maui, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Muskogee, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Southern Pines, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of The Woodlands, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Centers of Des Moines, Ltd., an Iowa Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Centers-West Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Care Affiliates, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Health</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Care Partners of Melbourne, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of Tuscaloosa Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of TVH, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Health Of Orlando, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Health, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Hospital Holdings of Oklahoma, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Management Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialists Management Solutions</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Jackson, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Joliet, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of La Veta, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Minneapolis, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Mobile, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Oceanside, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Owensboro, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Salem, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicenters of Southern California, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamMD Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamMD Physicians of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Alief Clinic</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamUP Insurance Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tecnolog&#237;a de Informaci&#243;n en Salud S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Advisory Board Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Delaware Advisory Board Company</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Center for Cognitive and Behavioral Therapy of Greater Columbus, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Center for Eating Disorders Management, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Better Brain Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Chesapeake Life Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Endoscopy Center of West Central Ohio, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Endoscopy Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Lewin Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lewin</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Polyclinic MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Surgical Center of the Treasure Coast, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Johnson Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Rivers Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Rivers Surgical Care, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Rivers Surgical Care</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tmesys, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Topimagem Diagn&#243;stico por Imagem Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trails Edge Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformer DE I, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformer DE II, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformer TX Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Travel Express Incorporated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TTCP-SR Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Behavioral Health Plan, California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Behavioral Solutions of California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCHealth HRH-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC Finance (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC International Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC of California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>PacifiCare of California<br>Secure Horizons<br>UnitedHealthcare of California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG &#8211; FZE</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dubai</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG Holdings (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG Services (Ireland) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK IV Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK V Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK VI Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHIC Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OneNet PPO</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UMR, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative Services Group<br>Fiserv Health - Wausau Benefits</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unidad M&#233;dica Diagn&#243;stico S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Life Insurance Company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Life Insurance Company of New York</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unison Health Plan of Delaware, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Behavioral Health</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Strategies<br>Optum Idaho<br>Optum Salt Lake County<br>Optum Tooele County<br>OptumHealth Behavioral Solutions<br>Plan 21, Incorporated<br>Plan 21, INCORPORATED<br>United Behavioral Health (Inc.)<br>United Behavioral Health, Inc.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Behavioral Health of New York, I.P.A., Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Group Reinsurance, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Turk</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Health Foundation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Health Hospice Foundation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice<br>EverCare<br>Health Professionals Review<br>Healthmarc<br>HealthPro<br>Institute for Human Resources<br>UHC Management Company<br>UHC Management Company, Inc.<br>United HealthCare Corporation<br>United HealthCare Management Company, Inc.<br>United HealthCare Management Services<br>United HealthCare Services of Minnesota<br>United HealthCare Services of Minnesota, Inc.<br>United Resource Networks<br>United Resource Networks, Inc.<br>UnitedHealthcare<br>UnitedHealthcare Medicare Customer Service Center<br>UnitedHealthcare MedicareStore</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Resource Networks IPA of New York, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Advisors, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHA Insurance Agency, LLC<br>UnitedHealthcare</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group International Finance (Ireland) Unlimited Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth International, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Military &#38; Veterans Services, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Accelerator, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Benefits of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Health Plan of Texas, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Benefits Plan of California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of California, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Georgia, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Ohio, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Texas, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Europe S.&#225; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Freedom Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tufts Health Freedom Plan<br>UnitedHealthcare Freedom Plans</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Freedom Plans, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global Medical (UK) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Texas</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of America</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of the River Valley</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Designated Activity Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Integrated Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International Asia, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International I B.V.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International II S.&#225; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International III B.V.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International III S.&#225; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International IV S.&#225; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International VIII S.&#224; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International X S.&#224; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Life Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Alabama, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Arizona, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Arkansas, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complete Health</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Colorado, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MetraHealth Care Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Florida, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community and State Plan of Florida<br>UnitedHealthcare Community Plan<br>UnitedHealthcare Community Plan of Florida</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Georgia, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare of Georgia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Illinois, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Minnesota</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Kentucky, Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare of Kentucky, L.P.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Louisiana, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Mississippi, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New England, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New Mexico, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of North Carolina, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Ohio, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Oklahoma, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>PacifiCare Health Options<br>PacifiCare of Oklahoma<br>Secure Horizons<br>UnitedHealthcare Community Plan of Oklahoma</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Oregon, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Pennsylvania, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan<br>UnitedHealthcare Community Plan for Families<br>UnitedHealthcare Community Plan for Kids<br>UnitedHealthcare Community Plan of Pennsylvania<br>UnitedHealthcare Dual Complete</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of South Carolina, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Texas, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Mid-Atlantic, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Virginia</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Midlands, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Midwest, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Rockies, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Utah, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Idaho, Inc.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Washington, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>Secure Horizons<br>UnitedHealthcare<br>UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Wisconsin, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Plan of the River Valley, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Service LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Specialty Benefits, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DCG RESOURCE OPTIONS ADMINISTRATORS, LLC<br>UnitedHealthcare Specialty Benefits<br>WorkUp, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unity Health Network, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summit Dermatology<br>Western Reserve Orthopedic and Upper Extremity Surgery</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upland Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upland Outpatient Surgical Center, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario Advanced Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urgent Care Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urgent Care MSO, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology Associates of North Texas, P.L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Academy, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Administrators, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Advisors, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Career Agency, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Funding, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Group, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Administrative Services, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Affiliated Services</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Physician Services</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD PPM, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Physicians Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network&#8211;Valley Physicians</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Labs of the Rockies ASC, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verta Management Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Via Vitae MSO, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vida Integra S.p.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vida Tres S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vieosoft, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision NewCo, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivify Health Canada, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivify Health, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay Benefits Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay Intermediate Holdings, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wauwatosa Outpatient Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayland Square Surgicare Acquisition, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayland Square Surgicare</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayland Square Surgicare GP, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waypoint Minnesota Sports PC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthology</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellMed Medical Management of Florida, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum of Hialeah<br>Optum of Little Havana<br>Optum of Red Road<br>Optum of Westchester<br>WellMed at 9th Ave North<br>WellMed at Alafaya<br>WellMed at Apollo Beach<br>WellMed at Apollo Beach Blvd.<br>WellMed at Apopka<br>WellMed at Bartow<br>WellMed at Bay Area<br>WellMed at Bayside<br>WellMed at Brandon Regional<br>WellMed at Carrollwood<br>WellMed at Central<br>WellMed at Clermont<br>WellMed at Countryway<br>WellMed at Countryway Blvd.<br>WellMed at Cypress Village Blvd.<br>WellMed at Cyprus Village<br>WellMed at Davenport<br>WellMed at Deltona<br>WellMed at Downtown Clearwater<br>WellMed at Dr. Phillips<br>WellMed at Elk Mountain<br>WellMed at Elk Mountain Dr<br>WellMed at Flamingo<br>WellMed at Fort Pierce<br>WellMed at Gunn<br>WellMed at Gunn Hwy.<br>WellMed at Haines City<br>WellMed at Haverford<br>WellMed at Haverford Ave.<br>WellMed at Hillmoor<br>WellMed at Holiday<br>WellMed at International Center<br>WellMed at Kenwood<br>WellMed at Lake Copeland<br>WellMed at Lakeshore<br>WellMed at Lakewood<br>WellMed at Lawnwood<br>WellMed at Linbaugh<br>WellMed at Linebaugh Ave.<br>WellMed at Longwood<br>WellMed at N. Tamiami Trail<br>WellMed at New Tampa<br>WellMed at North Carrollwood<br>WellMed at North Florida Ave.<br>WellMed at Oak Commons<br>WellMed at Pelican<br>WellMed at Piper<br>WellMed at Plant City - Family Practice Center<br>WellMed at Port St. Lucie West<br>WellMed at Sandlake Commons<br>WellMed at Sanford<br>WellMed at SE Lakeland<br>WellMed at Sebastian<br>WellMed at Semoran<br>WellMed at Sheldon<br>WellMed at Sheldon Rd.<br>WellMed at South Habana<br>WellMed at South Stuart<br>WellMed at Sun City Plaza<br>WellMed at Sun Lake<br>WellMed at Tarpon Springs<br>WellMed at The Villages<br>WellMed at Trinity<br>WellMed at Wesley Chapel<br>wellMed at West Sanford<br>WellMed Medical Group</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellMed Medical Management, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Coast Endoscopy Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Connecticut Orthopedic Surgical Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Westgreen Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Houston Orthopedic &#38; Spine Surgery Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WESTMED Practice Partners LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willow Park Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winter Park, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth Corporation India Private Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xplor Counseling, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divorce Solutions Hawaii</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>16
<FILENAME>unhex23112312022.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9fe3024eb9064ded9b153b56acc5cb05_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in Registration Statement No. 333-236600 on Form S-3, No. 333-105877 on Form S-4, Nos. 333-174437, 333-205826, 333-221642, 333-224253, 333-224254, 333-234018, 333-236349, 333-238854, 333-260604, 333-260606, 333-266949, 333-267716, and 333-269920 on Form S-8 and Post-Effective Amendment on Form S-8 to Registration Statement File No. 333-216153 on Form S-4 of our reports dated February 24, 2023, relating to the financial statements of UnitedHealth Group Incorporated and the effectiveness of UnitedHealth Group&#8217;s internal control over financial reporting, appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;S&#47; DELOITTE&#160;&#38; TOUCHE LLP</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>17
<FILENAME>unhex24112312022.htm
<DESCRIPTION>EX-24.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2e046370fe5f4aae888bfc5ea83a8fe7_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 24.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Rupert M. Bondy, Kuai H. Leong and Faraz A. Choudhry, and each of them, his or her true and lawful attorneys-in-fact and agents, each acting alone, with full power of substitution and resubstitution, to sign, execute and file with the Securities and Exchange Commission (or any other governmental or regulatory authority), for us and in our names in the capacities indicated below, an Annual Report on Form 10-K for the year ended December 31, 2022 for UnitedHealth Group Incorporated, and any and all amendments thereto, with all exhibits and any and all documents required to be filed with respect thereto, granting unto said attorneys-in-fact and agents and each of them, full power and authority to do and to perform each and every act and thing necessary or desirable to be done in and about the premises in order to effectuate the same as fully to all intents and purposes as he or she might or could do if personally present, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the undersigned have executed this Power of Attorney as of the date set forth below. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Timothy P. Flynn</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Michele J. Hooper</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Timothy P. Flynn</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michele J. Hooper</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Paul R. Garcia</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; F. William McNabb III</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Paul R. Garcia</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F. William McNabb III</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Kristen L. Gil</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Valerie C. Montgomery Rice, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kristen L. Gil</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Valerie C. Montgomery Rice, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Stephen J. Hemsley</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; John H. Noseworthy, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stephen J. Hemsley</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">John H. Noseworthy, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 24, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>18
<FILENAME>unhex31112312022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i65c456f8521642579d2c2fa457175e0f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO SECTION 302 OF THE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;I, Andrew P. Witty, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of UnitedHealth Group Incorporated (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty<br>Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John F. Rex certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of UnitedHealth Group Incorporated (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;    J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> F. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John F. Rex<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>19
<FILENAME>unhex32112312022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iacc7255e7c9f4674be32419aaba03ae3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of UnitedHealth Group Incorporated (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Andrew P. Witty, certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty<br>Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of UnitedHealth Group Incorporated (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John F. Rex, certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;    J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> F. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John F. Rex<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>20
<FILENAME>unh-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:unh="http://www.uhc.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.uhc.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.uhc.com/role/CoverDocument">
        <link:definition>0000001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditorInformation" roleURI="http://www.uhc.com/role/AuditorInformation">
        <link:definition>0000002 - Document - Auditor Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParenthetical" roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheet (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinEquity" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofChangesinEquityParenthetical" roleURI="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical">
        <link:definition>0000008 - Statement - Consolidated Statement of Changes in Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessNotes" roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes">
        <link:definition>0000010 - Disclosure - Description of Business (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes">
        <link:definition>0000011 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNotes" roleURI="http://www.uhc.com/role/InvestmentsNotes">
        <link:definition>0000012 - Disclosure - Investments (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNotes" roleURI="http://www.uhc.com/role/FairValueNotes">
        <link:definition>0000013 - Disclosure - Fair Value (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareNotes" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes">
        <link:definition>0000014 - Disclosure - Property, Plant, and Capitalized Software (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNotes" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes">
        <link:definition>0000015 - Disclosure - Goodwill and Intangible Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableNotes" roleURI="http://www.uhc.com/role/MedicalCostsPayableNotes">
        <link:definition>0000016 - Disclosure - Medical Costs Payable (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtNotes" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes">
        <link:definition>0000017 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNotes" roleURI="http://www.uhc.com/role/IncomeTaxesNotes">
        <link:definition>0000018 - Disclosure - Income Taxes (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNotes" roleURI="http://www.uhc.com/role/ShareholdersEquityNotes">
        <link:definition>0000019 - Disclosure - Shareholders' Equity (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNotes" roleURI="http://www.uhc.com/role/ShareBasedCompensationNotes">
        <link:definition>0000020 - Disclosure - Share-Based Compensation (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNotes" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNotes">
        <link:definition>0000021 - Disclosure - Commitments and Contingencies (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNotes" roleURI="http://www.uhc.com/role/BusinessCombinationsNotes">
        <link:definition>0000022 - Disclosure - Business Combinations (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationNotes" roleURI="http://www.uhc.com/role/SegmentFinancialInformationNotes">
        <link:definition>0000023 - Disclosure - Segment Financial Information (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleINotes" roleURI="http://www.uhc.com/role/ScheduleINotes">
        <link:definition>0000024 - Disclosure - Schedule I (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies">
        <link:definition>0000025 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValuePolicies" roleURI="http://www.uhc.com/role/FairValueFairValuePolicies">
        <link:definition>0000026 - Disclosure - Fair Value Fair Value (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIPolicies" roleURI="http://www.uhc.com/role/ScheduleIPolicies">
        <link:definition>0000027 - Disclosure - Schedule I (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables">
        <link:definition>0000028 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.uhc.com/role/InvestmentsTables">
        <link:definition>0000029 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.uhc.com/role/FairValueTables">
        <link:definition>0000030 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareTables" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables">
        <link:definition>0000031 - Disclosure - Property, Plant, and Capitalized Software (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000032 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableTables" roleURI="http://www.uhc.com/role/MedicalCostsPayableTables">
        <link:definition>0000033 - Disclosure - Medical Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtTables" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables">
        <link:definition>0000034 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.uhc.com/role/IncomeTaxesTables">
        <link:definition>0000035 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.uhc.com/role/ShareholdersEquityTables">
        <link:definition>0000036 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.uhc.com/role/ShareBasedCompensationTables">
        <link:definition>0000037 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesTables">
        <link:definition>0000038 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.uhc.com/role/BusinessCombinationsTables">
        <link:definition>0000039 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationTables" roleURI="http://www.uhc.com/role/SegmentFinancialInformationTables">
        <link:definition>0000040 - Disclosure - Segment Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleITables" roleURI="http://www.uhc.com/role/ScheduleITables">
        <link:definition>0000041 - Disclosure - Schedule I (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails">
        <link:definition>0000042 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1">
        <link:definition>0000042 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails">
        <link:definition>0000043 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails">
        <link:definition>0000044 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.uhc.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000045 - Disclosure - Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsShortTermandLongTermInvestmentsDetails" roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails">
        <link:definition>0000046 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>0000047 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails">
        <link:definition>0000048 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.uhc.com/role/FairValueNarrativeDetails">
        <link:definition>0000049 - Disclosure - Fair Value (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000050 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000051 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareNarrativeDetails" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails">
        <link:definition>0000052 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails">
        <link:definition>0000053 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000054 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails">
        <link:definition>0000055 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails">
        <link:definition>0000056 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails">
        <link:definition>0000057 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails">
        <link:definition>0000058 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableNarrativeDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails">
        <link:definition>0000059 - Disclosure - Medical Costs Payable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableRollforwardDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails">
        <link:definition>0000060 - Disclosure - Medical Costs Payable Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails">
        <link:definition>0000061 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtNarrativeDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails">
        <link:definition>0000062 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails">
        <link:definition>0000063 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails">
        <link:definition>0000064 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000065 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails">
        <link:definition>0000066 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails">
        <link:definition>0000067 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000068 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails">
        <link:definition>0000069 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>0000070 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>0000071 - Disclosure - Shareholders' Equity Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>0000072 - Disclosure - Shareholders' Equity Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>0000073 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>0000074 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedShareActivityDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails">
        <link:definition>0000075 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationOtherShareBasedCompensationDataDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails">
        <link:definition>0000076 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails">
        <link:definition>0000077 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>0000078 - Disclosure - Commitments and Contingencies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesFutureLeasePaymentsDetails" roleURI="http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails">
        <link:definition>0000079 - Disclosure - Commitment and Contingencies Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.uhc.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>0000080 - Disclosure - Business Combinations (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAcquiredAssetsandLiabilitiesDetails" roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails">
        <link:definition>0000081 - Disclosure - Business Combinations Acquired Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails" roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails">
        <link:definition>0000082 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationNarrativeDetails" roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails">
        <link:definition>0000083 - Disclosure - Segment Financial Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationDetails" roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails">
        <link:definition>0000084 - Disclosure - Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIDetails" roleURI="http://www.uhc.com/role/ScheduleIDetails">
        <link:definition>0000085 - Disclosure - Schedule I (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedBalanceSheetsDetails" roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails">
        <link:definition>0000086 - Disclosure - Schedule I Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIBalanceSheetDocumentDetails" roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails">
        <link:definition>0000087 - Disclosure - Schedule I Balance Sheet Document (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedStatementofComprehensiveIncomeDetails" roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails">
        <link:definition>0000088 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIStatementofCashFlowsDetails" roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails">
        <link:definition>0000089 - Disclosure - Schedule I Statement of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails">
        <link:definition>0000090 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="unh_OptuminsightMember" abstract="true" name="OptuminsightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.875notesdueAugust2059Member" abstract="true" name="A3.875notesdueAugust2059Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5.950notesdueFebruary2041Member" abstract="true" name="A5.950notesdueFebruary2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_LossofParentCompany" abstract="false" name="LossofParentCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_OtherShareBasedCompensationDataAbstract" abstract="true" name="OtherShareBasedCompensationDataAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A4.200notesdueJanuary2047Member" abstract="true" name="A4.200notesdueJanuary2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" abstract="false" name="PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_TotalOptumMember" abstract="true" name="TotalOptumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PharmaceuticalManufacturerRebatesReceivableMember" abstract="true" name="PharmaceuticalManufacturerRebatesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3125NotesDueMay2060Member" abstract="true" name="A3125NotesDueMay2060Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.450notesdueDecember2048Member" abstract="true" name="A4.450notesdueDecember2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5300NotesDueFebruary2030Member" abstract="true" name="A5300NotesDueFebruary2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ShareRepurchasesTable" abstract="true" name="ShareRepurchasesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A2.375notesdueAugust2024Member" abstract="true" name="A2.375notesdueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.250notesdueApril2047Member" abstract="true" name="A4.250notesdueApril2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2750NotesDueMay2040Member" abstract="true" name="A2750NotesDueMay2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" abstract="false" name="PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" abstract="false" name="DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A2.375notesdueOctober2022MemberMember" abstract="true" name="A2.375notesdueOctober2022MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A0550NotesDueMay2024Member" abstract="true" name="A0550NotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_TrademarksandTechnologyMember" abstract="true" name="TrademarksandTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DividendFrequencyAxis" abstract="true" name="DividendFrequencyAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" abstract="false" name="NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" abstract="false" name="ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="unh_A2000NotesDueMay2030Member" abstract="true" name="A2000NotesDueMay2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_UnitedhealthcareMember" abstract="true" name="UnitedhealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentsAmortizedCost" abstract="false" name="InvestmentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_StockOptionsandSARsMember" abstract="true" name="StockOptionsandSARsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4250NotesDueMarch2043Member" abstract="true" name="A4250NotesDueMarch2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.375notesdueApril2027Member" abstract="true" name="A3.375notesdueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OtherAcquisitionsMember" abstract="true" name="OtherAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3950NotesDueOctober2042Member" abstract="true" name="A3950NotesDueOctober2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_NOLsExpirationBeginning2022Through2037Member" abstract="true" name="NOLsExpirationBeginning2022Through2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicarePartDPharmacyBenefitsContractAxis" abstract="true" name="MedicarePartDPharmacyBenefitsContractAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3700NotesDueMay2027Member" abstract="true" name="A3700NotesDueMay2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4200NotesDueMay2032Member" abstract="true" name="A4200NotesDueMay2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3050NotesDueMay2041Member" abstract="true" name="A3050NotesDueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CreditFacilityNameDomain" abstract="true" name="CreditFacilityNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.500notesdueFebruary2024Member" abstract="true" name="A3.500notesdueFebruary2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PharmaceuticalmanufacturerrebatesreceivableAxis" abstract="true" name="PharmaceuticalmanufacturerrebatesreceivableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A4.750notesdueJuly2045Member" abstract="true" name="A4.750notesdueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ExtraordinaryDividendsMember" abstract="true" name="ExtraordinaryDividendsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5150NotesDueOctober2025Member" abstract="true" name="A5150NotesDueOctober2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_Capitalcontributionstosubsidiaries" abstract="false" name="Capitalcontributionstosubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3250NotesDueMay2051Member" abstract="true" name="A3250NotesDueMay2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A364Day60BillionCreditFacilityMember" abstract="true" name="A364Day60BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ChangeHealthcareClaimEditingBusinessMember" abstract="true" name="ChangeHealthcareClaimEditingBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.500notesdueJune2023Member" abstract="true" name="A3.500notesdueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A6050NotesDueFebruary2063Member" abstract="true" name="A6050NotesDueFebruary2063Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.700notesdueDecember2025Member" abstract="true" name="A3.700notesdueDecember2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_EmployeeStockPurchasePlanESPPMember" abstract="true" name="EmployeeStockPurchasePlanESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A5250NotesDueFebruary2028Member" abstract="true" name="A5250NotesDueFebruary2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PharmaceuticalmanufacturerrebatesreceivableDomain" abstract="true" name="PharmaceuticalmanufacturerrebatesreceivableDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetOtherDomestic" abstract="false" name="DeferredTaxAssetOtherDomestic" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_ExternalCustomersMember" abstract="true" name="ExternalCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_RevenuesMember" abstract="true" name="RevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CoverPageAbstract" abstract="true" name="CoverPageAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_EquityinNetAssetsofSubsidiaries" abstract="false" name="EquityinNetAssetsofSubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A5875NotesDueFebruary2053Member" abstract="true" name="A5875NotesDueFebruary2053Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CMSMember" abstract="true" name="CMSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.750notesdueJuly2025Member" abstract="true" name="A3.750notesdueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OtherDispositionsMember" abstract="true" name="OtherDispositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2750NotesDueFebruary2023Member" abstract="true" name="A2750NotesDueFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.850notesdueJune2028Member" abstract="true" name="A3.850notesdueJune2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_AarpAssetsUnderManagement" abstract="false" name="AarpAssetsUnderManagement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A4750NotesDueMay2052Member" abstract="true" name="A4750NotesDueMay2052Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" abstract="false" name="ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_A4.375notesdueMarch2042Member" abstract="true" name="A4.375notesdueMarch2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OtherLiabilitiesCurrentPolicyTextBlock" abstract="false" name="OtherLiabilitiesCurrentPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_A6.875notesdueFebruary2038Member" abstract="true" name="A6.875notesdueFebruary2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicarePartDPharmacyBenefitsContractDomain" abstract="true" name="MedicarePartDPharmacyBenefitsContractDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.450notesdueJanuary2027Member" abstract="true" name="A3.450notesdueJanuary2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.750notesdueOctober2047Member" abstract="true" name="A3.750notesdueOctober2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicalCostsAndMedicalCostsPayableDomain" abstract="true" name="MedicalCostsAndMedicalCostsPayableDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2.875notesdueAugust2029Member" abstract="true" name="A2.875notesdueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ScheduleIBalanceSheetParentheticalAbstract" abstract="true" name="ScheduleIBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" abstract="false" name="BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_ProductsandservicesMember" abstract="true" name="ProductsandservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.250notesdueJune2048Member" abstract="true" name="A4.250notesdueJune2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetOtherForeign" abstract="false" name="DeferredTaxAssetOtherForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A5.700notesdueOctober2040Member" abstract="true" name="A5.700notesdueOctober2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxLiabilityOtherForeign" abstract="false" name="DeferredTaxLiabilityOtherForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A2900NotesDueMay2050Member" abstract="true" name="A2900NotesDueMay2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ShareholdersEquityAbstract" abstract="true" name="ShareholdersEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_RedeemableNoncontrollingInterestsMember" abstract="true" name="RedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicarePartDReceivablesMember" abstract="true" name="MedicarePartDReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxLiabilityOtherDomestic" abstract="false" name="DeferredTaxLiabilityOtherDomestic" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_FiveYear60BillionCreditFacilityMember" abstract="true" name="FiveYear60BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OptumhealthMember" abstract="true" name="OptumhealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DebtInstrumentExcludingCommercialPaperAxis" abstract="true" name="DebtInstrumentExcludingCommercialPaperAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_OptumrxMember" abstract="true" name="OptumrxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" abstract="false" name="FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A1250NotesDueJanuary2026Member" abstract="true" name="A1250NotesDueJanuary2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ThreeYear60BillionCreditFacilityMember" abstract="true" name="ThreeYear60BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" abstract="false" name="DisclosureonGeographicAreasPercentageofLongLivedAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_NOLsIndefiniteCarryforwardMember" abstract="true" name="NOLsIndefiniteCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentsGrossUnrealizedLosses" abstract="false" name="InvestmentsGrossUnrealizedLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_DebtAbstract" abstract="true" name="DebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3350NotesDueJuly2022Member" abstract="true" name="A3350NotesDueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CarryingValueOfDisposition" abstract="false" name="CarryingValueOfDisposition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3.100notesdueMarch2026Member" abstract="true" name="A3.100notesdueMarch2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A6625NotesDueNovember2037Member" abstract="true" name="A6625NotesDueNovember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_FairValueAbstract" abstract="true" name="FairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" abstract="false" name="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_ShareRepurchasesTableLineItems" abstract="true" name="ShareRepurchasesTableLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_InvestmentsGrossUnrealizedGains" abstract="false" name="InvestmentsGrossUnrealizedGains" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_A4950NotesDueMay2062Member" abstract="true" name="A4950NotesDueMay2062Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" abstract="false" name="DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_DebtInstrumentExcludingCommercialPaperDomain" abstract="true" name="DebtInstrumentExcludingCommercialPaperDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A1150NotesDueMay2026Member" abstract="true" name="A1150NotesDueMay2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2.875notesdueMarch2022Member" abstract="true" name="A2.875notesdueMarch2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ChangeHealthcareMember" abstract="true" name="ChangeHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicalCostsAndMedicalCostsPayableAxis" abstract="true" name="MedicalCostsAndMedicalCostsPayableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_BasisofpresentationAbstract" abstract="true" name="BasisofpresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_ScheduleIAbstract" abstract="true" name="ScheduleIAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" abstract="false" name="BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_DescriptionofBusinessAbstract" abstract="true" name="DescriptionofBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_A4.625notesdueNovember2041Member" abstract="true" name="A4.625notesdueNovember2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_IntersegmentMember" abstract="true" name="IntersegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2875NotesDueMarch2023Member" abstract="true" name="A2875NotesDueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_BusinessCombinationsRedeemableNoncontrollingInterests" abstract="false" name="BusinessCombinationsRedeemableNoncontrollingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3.875notesdueDecember2028Member" abstract="true" name="A3.875notesdueDecember2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A6500NotesDueJune2037Member" abstract="true" name="A6500NotesDueJune2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" abstract="true" name="ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3.500notesdueAugust2039Member" abstract="true" name="A3.500notesdueAugust2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.625notesdueJuly2035Member" abstract="true" name="A4.625notesdueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2.950notesdueOctober2027Member" abstract="true" name="A2.950notesdueOctober2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_IncomeTaxAbstract" abstract="true" name="IncomeTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A2300NotesDueMay2031Member" abstract="true" name="A2300NotesDueMay2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5000NotesDueOctober2024Member" abstract="true" name="A5000NotesDueOctober2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_GoodwillandIntangibleAssetsAbstract" abstract="true" name="GoodwillandIntangibleAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3.700notesdueAugust2049Member" abstract="true" name="A3.700notesdueAugust2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DividendFrequencyDomain" abstract="true" name="DividendFrequencyDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_TotalAcquisitionsMember" abstract="true" name="TotalAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_AARPAssetsUnderManagementPolicyTextBlock" abstract="false" name="AARPAssetsUnderManagementPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_CreditFacilityNameAxis" abstract="true" name="CreditFacilityNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_UsefulLifeMember" abstract="true" name="UsefulLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ZeroCouponNotesDueNovember2022Member" abstract="true" name="ZeroCouponNotesDueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_BusinessCombinationsNonredeemableNoncontrollingInterests" abstract="false" name="BusinessCombinationsNonredeemableNoncontrollingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A4000NotesDueMay2029Member" abstract="true" name="A4000NotesDueMay2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ChangeHealthcareAcquisitionMember" abstract="true" name="ChangeHealthcareAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5.800notesdueMarch2036Member" abstract="true" name="A5.800notesdueMarch2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5350NotesDueFebruary2033Member" abstract="true" name="A5350NotesDueFebruary2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>unh-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_16169faa-0301-4a34-9b02-57ca64f778b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:to="loc_us-gaap_PreferredStockValue_16169faa-0301-4a34-9b02-57ca64f778b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4a43974c-2730-47bd-b686-cf8efe968537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:to="loc_us-gaap_CommonStockValue_4a43974c-2730-47bd-b686-cf8efe968537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c19a0dc4-25dc-4607-9ac9-c426ac2268d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c19a0dc4-25dc-4607-9ac9-c426ac2268d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86b763f8-43e3-40b9-b441-aad5b1f8d94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86b763f8-43e3-40b9-b441-aad5b1f8d94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7a5db5e2-842d-4ec2-8551-c34567696e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d9aac1e-42b0-4de7-ba90-a4cd693d0d8f" xlink:to="loc_us-gaap_MinorityInterest_7a5db5e2-842d-4ec2-8551-c34567696e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_464c9e45-864c-45a9-9718-f66555e98eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_464c9e45-864c-45a9-9718-f66555e98eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_5d023ea3-8c45-40b8-bece-aca91255a681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_us-gaap_ShortTermInvestments_5d023ea3-8c45-40b8-bece-aca91255a681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_00720df1-465c-491c-8b32-ce37fb6a1e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_00720df1-465c-491c-8b32-ce37fb6a1e05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_dc1b5a85-ef33-4de9-a166-01e5d77dad83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_dc1b5a85-ef33-4de9-a166-01e5d77dad83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_e3d343e3-d1ef-4c54-82f8-5adf666bbad5" xlink:href="unh-20221231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_unh_AarpAssetsUnderManagement_e3d343e3-d1ef-4c54-82f8-5adf666bbad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9f3e0a0-0a40-4998-8e90-9c8f472ad03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c112543c-ed1f-4823-8420-b9314de0faaa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9f3e0a0-0a40-4998-8e90-9c8f472ad03a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f495455c-a8cb-4e07-8c64-b88cfecf4f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_AssetsCurrent_f495455c-a8cb-4e07-8c64-b88cfecf4f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_1aa56c06-24fe-4c87-a46b-34b90f82ffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_LongTermInvestments_1aa56c06-24fe-4c87-a46b-34b90f82ffd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9223652b-d974-4f58-a665-fdd3a4779025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9223652b-d974-4f58-a665-fdd3a4779025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3169c8b3-08da-4c4f-9d69-0505fc22f562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_Goodwill_3169c8b3-08da-4c4f-9d69-0505fc22f562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17cf2d4d-2f1f-4933-9c06-b7905bc0eed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17cf2d4d-2f1f-4933-9c06-b7905bc0eed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d4b26fe4-ee66-4c11-b20c-2481c227d6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1f85866c-d429-4f57-aa68-495c7bec24d2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d4b26fe4-ee66-4c11-b20c-2481c227d6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cc1348e-93ee-4a9d-921b-9d3bff191650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a2380fd8-7242-4782-9c02-dc74db7df079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cc1348e-93ee-4a9d-921b-9d3bff191650" xlink:to="loc_us-gaap_Liabilities_a2380fd8-7242-4782-9c02-dc74db7df079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_64fc4562-18cb-41aa-8101-36583d7fbd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cc1348e-93ee-4a9d-921b-9d3bff191650" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_64fc4562-18cb-41aa-8101-36583d7fbd14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_103c27b8-d0c1-49d7-8c80-bb3d47eaf75e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cc1348e-93ee-4a9d-921b-9d3bff191650" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_103c27b8-d0c1-49d7-8c80-bb3d47eaf75e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_560a8a9e-bfc2-4866-9696-d01c05640d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9694ea21-bb1b-4ee5-b593-683b3089baa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_560a8a9e-bfc2-4866-9696-d01c05640d7e" xlink:to="loc_us-gaap_LiabilitiesCurrent_9694ea21-bb1b-4ee5-b593-683b3089baa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_aab0d8db-5955-4341-904d-2c70f1b7fcca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_560a8a9e-bfc2-4866-9696-d01c05640d7e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_aab0d8db-5955-4341-904d-2c70f1b7fcca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b17d666a-9411-4841-a05f-d10157ef80d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_560a8a9e-bfc2-4866-9696-d01c05640d7e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b17d666a-9411-4841-a05f-d10157ef80d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4e9d086e-b63e-418d-a84c-69c2f790c609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_560a8a9e-bfc2-4866-9696-d01c05640d7e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4e9d086e-b63e-418d-a84c-69c2f790c609" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_88a438ac-ac3a-4d7a-acde-63c0e92f8455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_88a438ac-ac3a-4d7a-acde-63c0e92f8455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fa2994ba-3fa2-4f61-b013-4d7dcaa3af8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fa2994ba-3fa2-4f61-b013-4d7dcaa3af8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b0ce9ee6-ca53-4b57-8658-9b8461549de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b0ce9ee6-ca53-4b57-8658-9b8461549de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_205c053c-315a-4164-b51e-94748b626736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:to="loc_us-gaap_DebtCurrent_205c053c-315a-4164-b51e-94748b626736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_93cfd311-dab7-43b4-808d-718cd398197b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19ff6cae-26e4-4dcf-8749-f89c3edb28d1" xlink:to="loc_us-gaap_DeferredRevenueCurrent_93cfd311-dab7-43b4-808d-718cd398197b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_848e858a-8b75-4480-8e66-e5a1a43674cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_ae275147-3d1d-4a4a-a219-19e09b7f1db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_848e858a-8b75-4480-8e66-e5a1a43674cb" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_ae275147-3d1d-4a4a-a219-19e09b7f1db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bac90514-ffc0-4e90-85e2-cb1935969443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_848e858a-8b75-4480-8e66-e5a1a43674cb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bac90514-ffc0-4e90-85e2-cb1935969443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e1f61c8c-d791-4aef-956a-3c53d49d7337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_848e858a-8b75-4480-8e66-e5a1a43674cb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e1f61c8c-d791-4aef-956a-3c53d49d7337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a7e6a68e-16a1-484a-9565-d90b66c070d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_848e858a-8b75-4480-8e66-e5a1a43674cb" xlink:to="loc_us-gaap_DepreciationAndAmortization_a7e6a68e-16a1-484a-9565-d90b66c070d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f9986a9-f4c0-4c5b-a8f0-88963b2edd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f3813752-4c6a-4543-a76c-fa064b0c4eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7f9986a9-f4c0-4c5b-a8f0-88963b2edd8b" xlink:to="loc_us-gaap_ProfitLoss_f3813752-4c6a-4543-a76c-fa064b0c4eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0776338a-1572-4553-8f0b-50622cc2756b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7f9986a9-f4c0-4c5b-a8f0-88963b2edd8b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0776338a-1572-4553-8f0b-50622cc2756b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3605e4-af81-4aae-b97c-aa3d976b2c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f5d6ab5e-78b0-4e90-a129-88ca09f5c196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3605e4-af81-4aae-b97c-aa3d976b2c4f" xlink:to="loc_us-gaap_OperatingIncomeLoss_f5d6ab5e-78b0-4e90-a129-88ca09f5c196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_888b598d-0aab-4b8d-a972-24c5835235af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3605e4-af81-4aae-b97c-aa3d976b2c4f" xlink:to="loc_us-gaap_InterestExpense_888b598d-0aab-4b8d-a972-24c5835235af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_42dc051f-3dcf-4c69-bc36-33892c8b0d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_da81164f-c07d-4a6f-b64d-f690326d24c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42dc051f-3dcf-4c69-bc36-33892c8b0d27" xlink:to="loc_us-gaap_PremiumsEarnedNet_da81164f-c07d-4a6f-b64d-f690326d24c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e875c74-d412-4ef3-8865-b3fde74a876d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42dc051f-3dcf-4c69-bc36-33892c8b0d27" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e875c74-d412-4ef3-8865-b3fde74a876d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_4f6d539e-b909-4323-bafc-4797015214cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42dc051f-3dcf-4c69-bc36-33892c8b0d27" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_4f6d539e-b909-4323-bafc-4797015214cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63ead5ba-e39b-4014-8c21-3797a488ad2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_69a69676-6d59-4d14-bf82-2ff20be03d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63ead5ba-e39b-4014-8c21-3797a488ad2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_69a69676-6d59-4d14-bf82-2ff20be03d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_160a2b9d-ae81-49d8-8340-38657860c1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63ead5ba-e39b-4014-8c21-3797a488ad2d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_160a2b9d-ae81-49d8-8340-38657860c1bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3df6a5bb-6b5f-4ccc-aad1-4b486ac223bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d38233ee-cc9e-466b-b075-8f0ef92d8d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3df6a5bb-6b5f-4ccc-aad1-4b486ac223bc" xlink:to="loc_us-gaap_Revenues_d38233ee-cc9e-466b-b075-8f0ef92d8d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_0f21bcc9-ef66-4fe6-b91f-ab7f5c9a0a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3df6a5bb-6b5f-4ccc-aad1-4b486ac223bc" xlink:to="loc_us-gaap_CostsAndExpenses_0f21bcc9-ef66-4fe6-b91f-ab7f5c9a0a79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_20e55da3-2d91-4a0a-b4de-0ef2a81a08ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db4fcc1e-df8f-4473-8315-5942f49c9546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_20e55da3-2d91-4a0a-b4de-0ef2a81a08ba" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db4fcc1e-df8f-4473-8315-5942f49c9546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bf591c85-18b3-4493-a986-6a79c1ddd64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_20e55da3-2d91-4a0a-b4de-0ef2a81a08ba" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bf591c85-18b3-4493-a986-6a79c1ddd64c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87f958cf-48bb-42d9-876c-0dab7349bf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2e411217-6b56-4ee7-84e6-902d8cb9e51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87f958cf-48bb-42d9-876c-0dab7349bf17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2e411217-6b56-4ee7-84e6-902d8cb9e51b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_5f6f16f2-db97-4929-985d-aded3a08c4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87f958cf-48bb-42d9-876c-0dab7349bf17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_5f6f16f2-db97-4929-985d-aded3a08c4f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0b6f68e0-a2d1-4c7e-8d7c-27accc7b7f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87f958cf-48bb-42d9-876c-0dab7349bf17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0b6f68e0-a2d1-4c7e-8d7c-27accc7b7f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6badb214-bc98-49f1-84b2-bce6f4caa6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f096a06b-a7ad-48a7-a7b6-3a35a5918fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6badb214-bc98-49f1-84b2-bce6f4caa6fc" xlink:to="loc_us-gaap_ProfitLoss_f096a06b-a7ad-48a7-a7b6-3a35a5918fe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faac1fb0-7bd8-4a45-be81-b59489f69408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6badb214-bc98-49f1-84b2-bce6f4caa6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faac1fb0-7bd8-4a45-be81-b59489f69408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c5f35db-ab12-41e4-b8af-231743899342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57176c44-aff9-4e4b-b75c-5d18b5f9a2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c5f35db-ab12-41e4-b8af-231743899342" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57176c44-aff9-4e4b-b75c-5d18b5f9a2a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ae8883fe-5899-4e75-bf30-0d6e831cb2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c5f35db-ab12-41e4-b8af-231743899342" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ae8883fe-5899-4e75-bf30-0d6e831cb2cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_37781d27-775b-48dc-ad36-ecc2f6ddbb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_a05bd365-8f6f-45bc-9ec7-e9e2872fd533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_37781d27-775b-48dc-ad36-ecc2f6ddbb65" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_a05bd365-8f6f-45bc-9ec7-e9e2872fd533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_33cab110-b469-4750-b374-a5b70c7e67bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_37781d27-775b-48dc-ad36-ecc2f6ddbb65" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_33cab110-b469-4750-b374-a5b70c7e67bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9e08413d-ed91-4357-8b04-3f6e04c26352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_a2f1c1db-2952-4d41-817a-31afab195d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9e08413d-ed91-4357-8b04-3f6e04c26352" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_a2f1c1db-2952-4d41-817a-31afab195d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_fd12b7c3-c22b-43c3-bd3e-28a4c7a548af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9e08413d-ed91-4357-8b04-3f6e04c26352" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_fd12b7c3-c22b-43c3-bd3e-28a4c7a548af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cd49bf7f-5523-4c59-8dce-dd4d74f07cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f49a60c-eb8f-471e-b31a-574b8797d32c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cd49bf7f-5523-4c59-8dce-dd4d74f07cb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f49a60c-eb8f-471e-b31a-574b8797d32c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0241a1a8-3ecb-4e51-bf39-da8699821d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cd49bf7f-5523-4c59-8dce-dd4d74f07cb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0241a1a8-3ecb-4e51-bf39-da8699821d35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b19d7930-f502-45a4-9f33-d009ed541a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cd49bf7f-5523-4c59-8dce-dd4d74f07cb7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b19d7930-f502-45a4-9f33-d009ed541a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88bc0b65-49a1-4477-ab2b-5116bd322773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cd49bf7f-5523-4c59-8dce-dd4d74f07cb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88bc0b65-49a1-4477-ab2b-5116bd322773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2cec680c-5136-4056-aad5-bd0e5e74bf57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2cec680c-5136-4056-aad5-bd0e5e74bf57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129fd6aa-e739-4923-9a8b-f5c91d51fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129fd6aa-e739-4923-9a8b-f5c91d51fe34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_aee3f31d-bae9-49fb-aa84-b9a819b559c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_aee3f31d-bae9-49fb-aa84-b9a819b559c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_ffa43f63-8abd-4555-9a40-67a2ec758d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_ffa43f63-8abd-4555-9a40-67a2ec758d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_40cff3d5-e96a-4a34-9f7c-ec35ef55eaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_40cff3d5-e96a-4a34-9f7c-ec35ef55eaa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1c234295-908f-4515-bff2-e9a78f2e40e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1c234295-908f-4515-bff2-e9a78f2e40e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d9554f45-7681-454f-9db4-8e05f4f70fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e7fcf17-e339-4e42-88b5-a877cb704a69" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d9554f45-7681-454f-9db4-8e05f4f70fef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5955abfa-019c-4ae8-ad72-9f44b2da6960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5955abfa-019c-4ae8-ad72-9f44b2da6960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d357aa79-1d8e-4615-8ab7-f4d03ddbb1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d357aa79-1d8e-4615-8ab7-f4d03ddbb1c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3eec0cc0-4c5f-407e-904c-a55768ae5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3eec0cc0-4c5f-407e-904c-a55768ae5b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9a66a2d9-0a8d-4f55-9c84-0b10eb220dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9a66a2d9-0a8d-4f55-9c84-0b10eb220dac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_08221181-05a2-49d0-b222-c3b2e73c1899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_08221181-05a2-49d0-b222-c3b2e73c1899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_207b8d42-1d5a-43fb-b3a8-06f8eddeae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_207b8d42-1d5a-43fb-b3a8-06f8eddeae2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits_d9fd2887-9c0d-4a79-90b4-4487271cc5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_IncreaseDecreaseInDeposits_d9fd2887-9c0d-4a79-90b4-4487271cc5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6532b615-a13d-47a3-88c5-2a316da390f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_6532b615-a13d-47a3-88c5-2a316da390f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_76798257-0f2c-43b4-b4df-88b74f73df56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6d91266-4ef3-4f67-aa41-e88a0e74246d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_76798257-0f2c-43b4-b4df-88b74f73df56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d2714386-fcd9-4315-b4a0-f3d427bda752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_ProfitLoss_d2714386-fcd9-4315-b4a0-f3d427bda752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_354f49a0-e4ba-497f-89d4-98a2bb60fbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_DepreciationAndAmortization_354f49a0-e4ba-497f-89d4-98a2bb60fbf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cc085ce-d09e-471b-ba8a-4f70470d6ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cc085ce-d09e-471b-ba8a-4f70470d6ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a57f5041-27c8-4dce-8981-958c23af9708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_ShareBasedCompensation_a57f5041-27c8-4dce-8981-958c23af9708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dabd38ed-c76e-4f3e-b3d6-daa96b0e177a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dabd38ed-c76e-4f3e-b3d6-daa96b0e177a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_df9f0992-efe0-4286-a329-031c9997ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_df9f0992-efe0-4286-a329-031c9997ec36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_84104e1f-5e4c-4c8a-9ffd-d67e9803e38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_84104e1f-5e4c-4c8a-9ffd-d67e9803e38e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_708dcfb9-74aa-4611-97a5-9a125e787c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_708dcfb9-74aa-4611-97a5-9a125e787c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f1e181aa-5c91-4e59-9653-501413f2bb05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f1e181aa-5c91-4e59-9653-501413f2bb05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f1c66601-a71d-44e5-926a-0727f1c08296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30abd76e-a236-46dd-91b6-1669551f804e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f1c66601-a71d-44e5-926a-0727f1c08296" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b9ca4fbc-2c88-4ad6-8661-0e36025987d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0e63c5bf-3b07-4d56-a090-6f81ce2e15db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b9ca4fbc-2c88-4ad6-8661-0e36025987d8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0e63c5bf-3b07-4d56-a090-6f81ce2e15db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_29389a28-2730-4e45-9de9-11d57a61aaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b9ca4fbc-2c88-4ad6-8661-0e36025987d8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_29389a28-2730-4e45-9de9-11d57a61aaba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c034ba09-e661-4773-87ed-9a658d2ad3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b9ca4fbc-2c88-4ad6-8661-0e36025987d8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c034ba09-e661-4773-87ed-9a658d2ad3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_dfb61e4e-f37f-427e-9325-389d1e5d59be" xlink:href="unh-20221231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_1048be7c-4289-4590-81f0-34e4964a5b00" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_dfb61e4e-f37f-427e-9325-389d1e5d59be" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_1048be7c-4289-4590-81f0-34e4964a5b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_9c3e2d34-9879-40c2-959e-f74565597db8" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_dfb61e4e-f37f-427e-9325-389d1e5d59be" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_9c3e2d34-9879-40c2-959e-f74565597db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_101058cc-f366-4560-8447-3752dceff87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_dfb61e4e-f37f-427e-9325-389d1e5d59be" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_101058cc-f366-4560-8447-3752dceff87c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_efd4a5ff-a7ff-45d8-bd20-c4c83673765a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_24e881c4-311d-40dd-a07c-14005a6a6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_efd4a5ff-a7ff-45d8-bd20-c4c83673765a" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_24e881c4-311d-40dd-a07c-14005a6a6ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9599b886-c554-4d78-8cd3-545a13c60fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_efd4a5ff-a7ff-45d8-bd20-c4c83673765a" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9599b886-c554-4d78-8cd3-545a13c60fbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_8bc0e048-6dc5-4e97-a0bb-c0b32019a849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_efd4a5ff-a7ff-45d8-bd20-c4c83673765a" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_8bc0e048-6dc5-4e97-a0bb-c0b32019a849" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_084aba44-736d-4714-89bd-3aabe54bddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_188fc6da-497e-4446-98b6-c068c4220e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_084aba44-736d-4714-89bd-3aabe54bddcf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_188fc6da-497e-4446-98b6-c068c4220e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6a757544-9f1a-4c0a-8efb-8a84c41d6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_084aba44-736d-4714-89bd-3aabe54bddcf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6a757544-9f1a-4c0a-8efb-8a84c41d6b32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c96b4172-f32b-42b6-9d52-31106c3dbe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_17b86c3e-e638-4ed4-9b66-37eeb84ecfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c96b4172-f32b-42b6-9d52-31106c3dbe1d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_17b86c3e-e638-4ed4-9b66-37eeb84ecfbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9d4544fe-bb4b-45a0-b354-7f0b49b7a602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c96b4172-f32b-42b6-9d52-31106c3dbe1d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9d4544fe-bb4b-45a0-b354-7f0b49b7a602" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_7f8d642b-6d25-46f3-9af8-ba8482dc3760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_77b0c4c2-0bd9-44d5-b2c2-09df1da7caeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet_7f8d642b-6d25-46f3-9af8-ba8482dc3760" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_77b0c4c2-0bd9-44d5-b2c2-09df1da7caeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_d33d9eb4-cc07-4192-bd0a-842fb1eaac67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet_7f8d642b-6d25-46f3-9af8-ba8482dc3760" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_d33d9eb4-cc07-4192-bd0a-842fb1eaac67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e855e989-fee8-4c8e-9d2a-5153871980b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_51aaaccd-6719-4356-b517-f83f78c6e6ae" xlink:href="unh-20221231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e855e989-fee8-4c8e-9d2a-5153871980b3" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_51aaaccd-6719-4356-b517-f83f78c6e6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_b9e3f660-b8d3-40c6-9361-792b39d3316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e855e989-fee8-4c8e-9d2a-5153871980b3" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_b9e3f660-b8d3-40c6-9361-792b39d3316b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:href="unh-20221231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_c42c08f9-555f-4d8d-a3dc-d5ab61d945bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:to="loc_us-gaap_LandAndLandImprovements_c42c08f9-555f-4d8d-a3dc-d5ab61d945bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_db597618-28df-4498-9988-03bf5ab132f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_db597618-28df-4498-9988-03bf5ab132f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_ba1c0f5f-e071-4228-ab8a-9655c42a1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_ba1c0f5f-e071-4228-ab8a-9655c42a1dc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_8351d46e-3856-42c9-80c3-fc5b34132668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_8351d46e-3856-42c9-80c3-fc5b34132668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_5eeaf349-cf09-4c4c-a819-513ac9f1f771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_0c3a8692-dc7e-46ad-8cea-424fdb4d2d2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_5eeaf349-cf09-4c4c-a819-513ac9f1f771" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbf25ed1-7e2f-4596-bb64-8b13cf337182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f01d6c85-0d13-4027-ad11-077b73c15e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbf25ed1-7e2f-4596-bb64-8b13cf337182" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f01d6c85-0d13-4027-ad11-077b73c15e25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c8c082fd-290a-4e23-8723-03ddcfed9678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbf25ed1-7e2f-4596-bb64-8b13cf337182" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c8c082fd-290a-4e23-8723-03ddcfed9678" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f4cbd81b-4310-4b46-84c6-1ba654648cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_f5ce3185-6ab6-45a3-99c3-a393e9b00375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f4cbd81b-4310-4b46-84c6-1ba654648cbf" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_f5ce3185-6ab6-45a3-99c3-a393e9b00375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ba4b90cf-dc45-408a-95f0-e656ed20ac34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f4cbd81b-4310-4b46-84c6-1ba654648cbf" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ba4b90cf-dc45-408a-95f0-e656ed20ac34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_e514532a-29f7-4b4b-8c5c-b7529087d96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8a39de1e-9577-4113-a9c3-0cc7c55b2a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_e514532a-29f7-4b4b-8c5c-b7529087d96e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8a39de1e-9577-4113-a9c3-0cc7c55b2a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_722355b0-37a8-42c3-ba5f-cc3e625446ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_e514532a-29f7-4b4b-8c5c-b7529087d96e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_722355b0-37a8-42c3-ba5f-cc3e625446ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac49eac9-b8e2-4841-86c7-2e2fc88b29bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5f9f470f-0d76-4a83-8ff4-cb32c4c64cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac49eac9-b8e2-4841-86c7-2e2fc88b29bf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5f9f470f-0d76-4a83-8ff4-cb32c4c64cf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ee704358-ab8f-4978-85cb-a28fc22d963e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac49eac9-b8e2-4841-86c7-2e2fc88b29bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ee704358-ab8f-4978-85cb-a28fc22d963e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4c7bf81c-5783-4de3-8c73-fded18ae388c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_f64d541e-85de-4b8f-a8a6-9ea72eef53ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4c7bf81c-5783-4de3-8c73-fded18ae388c" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_f64d541e-85de-4b8f-a8a6-9ea72eef53ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_45b51c84-e4ff-4db1-88d9-1caf5afca4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4c7bf81c-5783-4de3-8c73-fded18ae388c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_45b51c84-e4ff-4db1-88d9-1caf5afca4c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_27f15247-4c7d-4fd5-a820-90b0b5db3448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4c7bf81c-5783-4de3-8c73-fded18ae388c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_27f15247-4c7d-4fd5-a820-90b0b5db3448" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f41da0fb-1544-47b5-8f17-00f7466cbb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f41da0fb-1544-47b5-8f17-00f7466cbb94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e2b8d0fd-1643-4084-a00c-31545eacc104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e2b8d0fd-1643-4084-a00c-31545eacc104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_53679a9d-2120-4ac2-b782-0d3f4e187988" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_53679a9d-2120-4ac2-b782-0d3f4e187988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_66472434-359c-477d-b506-db3c2e59f6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_66472434-359c-477d-b506-db3c2e59f6c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_d13e943d-7dfc-43bf-a991-1b79adb9caf1" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_d13e943d-7dfc-43bf-a991-1b79adb9caf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_48c53f29-9d1e-4227-88f1-dc19af64272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_48c53f29-9d1e-4227-88f1-dc19af64272d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f90d8320-b742-4acf-9201-9916b93ed173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_46a281c7-16bb-4f00-a05d-0cdc91ecc5a3" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f90d8320-b742-4acf-9201-9916b93ed173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_347a43e2-9543-4a75-b4fd-12737b304e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_347a43e2-9543-4a75-b4fd-12737b304e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d7da894a-ca4e-490e-8054-1aeafe01d731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d7da894a-ca4e-490e-8054-1aeafe01d731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_d25e5ec2-e50d-4645-ba68-50d946b40c20" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_d25e5ec2-e50d-4645-ba68-50d946b40c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_b890abaf-68b7-4a53-b802-99b595e7101e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_b890abaf-68b7-4a53-b802-99b595e7101e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_f5e4a1c2-b26f-44c4-adf8-b2fe6a52e842" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_f5e4a1c2-b26f-44c4-adf8-b2fe6a52e842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_5a4d9db3-2f7e-44db-a019-41dc91fb07f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_5a4d9db3-2f7e-44db-a019-41dc91fb07f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3f6deaf4-633a-47ac-9d37-89b5da372793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb07c97-1913-4d96-8975-cd140a2d8d43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3f6deaf4-633a-47ac-9d37-89b5da372793" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_b1798bc9-76fa-49da-9380-1e986b03e74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_b1798bc9-76fa-49da-9380-1e986b03e74e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_51489baf-b673-4445-9941-977f86583bd0" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_51489baf-b673-4445-9941-977f86583bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_a99c59dd-1f9c-4ad6-8e2b-d8c4a5cb0d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_a99c59dd-1f9c-4ad6-8e2b-d8c4a5cb0d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_18cfc5e2-d241-4542-b645-dce1dbccf263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_18cfc5e2-d241-4542-b645-dce1dbccf263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_5060bfa0-0d51-4a65-9697-54d8af11674d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_5060bfa0-0d51-4a65-9697-54d8af11674d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_14e79688-a3f1-40b8-9c7f-40b6c7441168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_14e79688-a3f1-40b8-9c7f-40b6c7441168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a65f211c-20f0-4e2c-8d54-b058fe1d9576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a65f211c-20f0-4e2c-8d54-b058fe1d9576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_06c51ce1-a5a0-4f76-ac01-db36d7bc6f10" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_06c51ce1-a5a0-4f76-ac01-db36d7bc6f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_bfb751b6-51e6-46ac-87d8-30d04cbe4367" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_640aa35b-1397-4d32-98f8-5015f94f3836" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_bfb751b6-51e6-46ac-87d8-30d04cbe4367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_8b99902b-ec41-4526-9584-e4ee37c7342e" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_8b99902b-ec41-4526-9584-e4ee37c7342e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_72033aaf-9cc0-42c0-a6e6-fa5b25e18658" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_72033aaf-9cc0-42c0-a6e6-fa5b25e18658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e76aef14-eb0d-4f3c-b4d6-0e47e901ddb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_e76aef14-eb0d-4f3c-b4d6-0e47e901ddb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_314d3324-20b8-4a16-8f53-8082c90cfeed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_314d3324-20b8-4a16-8f53-8082c90cfeed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e7fc17b8-3437-44cc-b260-84da004d5fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e7fc17b8-3437-44cc-b260-84da004d5fd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_1ae1e79c-e087-47bf-97b4-d25a477f1dbb" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_1ae1e79c-e087-47bf-97b4-d25a477f1dbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_c94ab124-8cba-4095-9595-f56a9949967b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_c94ab124-8cba-4095-9595-f56a9949967b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_e2a196e2-39ba-4c2a-afe4-5331a86f7752" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_e2a196e2-39ba-4c2a-afe4-5331a86f7752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_89bebb42-fb9a-4126-a636-bd36b4811b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5df9cd5c-96b9-4653-8c94-e097c303b687" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_89bebb42-fb9a-4126-a636-bd36b4811b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4294ee34-7d49-4e57-badd-aa14c186efb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d6c741a0-eb42-48d1-b740-3adbbddf329d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_4294ee34-7d49-4e57-badd-aa14c186efb1" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d6c741a0-eb42-48d1-b740-3adbbddf329d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e970619b-955a-46be-ad03-768886d0b305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_4294ee34-7d49-4e57-badd-aa14c186efb1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e970619b-955a-46be-ad03-768886d0b305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1deb89b2-17bb-4cf0-8d91-9244c7d46614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_04904a14-3c9f-4ab1-b478-513d787eb75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1deb89b2-17bb-4cf0-8d91-9244c7d46614" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_04904a14-3c9f-4ab1-b478-513d787eb75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f7da380e-b4b4-4d4a-8cbe-4a96e0e7cc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1deb89b2-17bb-4cf0-8d91-9244c7d46614" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f7da380e-b4b4-4d4a-8cbe-4a96e0e7cc7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2572289d-165b-4693-83ee-72624870e20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_517342d2-059a-4d7d-bec4-f3a3a01c71f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2572289d-165b-4693-83ee-72624870e20e" xlink:to="loc_us-gaap_PremiumsEarnedNet_517342d2-059a-4d7d-bec4-f3a3a01c71f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_303224ea-9aa1-4e21-a04b-ec848e3514a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_2572289d-165b-4693-83ee-72624870e20e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_303224ea-9aa1-4e21-a04b-ec848e3514a1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>unh-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ic3a015e54b7e4946b9bb88ca61b91ac2_ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d169a2c3-6db2-49ad-b179-a7e6d583467d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d169a2c3-6db2-49ad-b179-a7e6d583467d" xlink:to="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:to="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bc75b05a-4758-47c3-98a9-b71aaa09a51e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bc75b05a-4758-47c3-98a9-b71aaa09a51e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2649d8ea-9e25-489e-94a1-ef4dd541181c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2649d8ea-9e25-489e-94a1-ef4dd541181c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended" id="i10323c1dd5db46e180f0f763bfc0ec63_ConsolidatedBalanceSheetParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5a1531a-1f8b-43dd-a5d2-ca5427ccfaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5a1531a-1f8b-43dd-a5d2-ca5427ccfaad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_ad26cfd6-aa0e-44e2-81d4-b8da95031fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_ad26cfd6-aa0e-44e2-81d4-b8da95031fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_981aad68-ef3f-4e72-9f75-7a3d1d4aa404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_981aad68-ef3f-4e72-9f75-7a3d1d4aa404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_db930f0e-58fd-44cc-a0cc-7d63d661a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_db930f0e-58fd-44cc-a0cc-7d63d661a43f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:to="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0c77b279-259b-45fe-a863-4ec77fc503c6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0c77b279-259b-45fe-a863-4ec77fc503c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7544135d-9f71-4936-bbbd-dcec43291dc2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7544135d-9f71-4936-bbbd-dcec43291dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a8f454dd-b739-4363-ad97-30ae1573169d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:to="loc_us-gaap_ClassOfStockDomain_a8f454dd-b739-4363-ad97-30ae1573169d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ab476b9a-3d53-444c-ad76-26ac23703e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:to="loc_us-gaap_ClassOfStockDomain_ab476b9a-3d53-444c-ad76-26ac23703e89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="ia95997ffd3a84a0c948c4b9d72ac51e6_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a12cfac-17e7-4254-b4c0-31442bf4b1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a12cfac-17e7-4254-b4c0-31442bf4b1c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:to="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:to="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3b2ac56f-da78-42a7-a7f8-6d8de05b193a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:to="loc_srt_ProductsAndServicesDomain_3b2ac56f-da78-42a7-a7f8-6d8de05b193a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:to="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_f43e1d56-4855-4239-be44-0b13b2422e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:to="loc_us-gaap_ProductMember_f43e1d56-4855-4239-be44-0b13b2422e6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_07f2b5b1-9fab-45c7-a535-888551d8467a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:to="loc_us-gaap_ServiceMember_07f2b5b1-9fab-45c7-a535-888551d8467a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="if41c3c4fbcb14cfd9ab63e4cb4734869_ConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7d1d410d-e6fb-4f46-a572-bc71e42eab79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ProfitLoss_7d1d410d-e6fb-4f46-a572-bc71e42eab79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9d261546-2bd3-4f7a-b447-0be81a4722a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9d261546-2bd3-4f7a-b447-0be81a4722a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_116e842f-1b07-4b44-9120-3a3b7d616519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_116e842f-1b07-4b44-9120-3a3b7d616519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fcb0b07a-3591-4cb6-b53e-377a26f0434b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fcb0b07a-3591-4cb6-b53e-377a26f0434b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_214255e2-e875-4d0a-bbc4-aa3bfb1aa0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_214255e2-e875-4d0a-bbc4-aa3bfb1aa0c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c6bae31f-a945-40d8-9788-23ad27701b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c6bae31f-a945-40d8-9788-23ad27701b14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_577815ec-5981-4b8b-901a-073071ac9cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_577815ec-5981-4b8b-901a-073071ac9cc3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_26dd772e-0e88-4fee-b7a7-aa2d4add0809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_26dd772e-0e88-4fee-b7a7-aa2d4add0809" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_540d2bec-304b-4b22-b6ab-e4c3ba5a4a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_540d2bec-304b-4b22-b6ab-e4c3ba5a4a72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf1b9c0e-ce69-4877-8bb8-2c02f9ea4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf1b9c0e-ce69-4877-8bb8-2c02f9ea4f36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8a694ed8-fa81-4d11-a281-6b68ead32c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8a694ed8-fa81-4d11-a281-6b68ead32c16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8f8c7c4-76ca-40bb-b829-d278dbab2040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8f8c7c4-76ca-40bb-b829-d278dbab2040" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:to="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8f0a6991-067c-4c6b-abc5-17d0d3a2bd7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8f0a6991-067c-4c6b-abc5-17d0d3a2bd7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended" id="iaed5b406e5d347f2bee325bba1c25682_ConsolidatedStatementsofChangesinEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_be2ad55f-719d-4f14-8f37-40588289149e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_be2ad55f-719d-4f14-8f37-40588289149e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f23f6e47-e9cb-4123-8c05-a6bf1e063d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f23f6e47-e9cb-4123-8c05-a6bf1e063d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d58452dc-dccb-46f2-ba0c-0bf484b4ef07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLoss_d58452dc-dccb-46f2-ba0c-0bf484b4ef07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_dda740c5-ea0c-4b9c-bb48-b9f1121299c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_dda740c5-ea0c-4b9c-bb48-b9f1121299c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_b8c97064-2b4d-4a86-9052-9573a533a761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_b8c97064-2b4d-4a86-9052-9573a533a761" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a2900b33-dde9-461c-bbac-795b73110aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a2900b33-dde9-461c-bbac-795b73110aae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e407271a-add8-4633-9480-a396a9143b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e407271a-add8-4633-9480-a396a9143b03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b1523d8f-0cb0-4d29-ab5a-86d2c32c7e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b1523d8f-0cb0-4d29-ab5a-86d2c32c7e08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2d667b06-8e3d-4c9b-b15d-0203618bcda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2d667b06-8e3d-4c9b-b15d-0203618bcda1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_feea16d9-6bff-4f84-8a4b-61ee1ab19497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_feea16d9-6bff-4f84-8a4b-61ee1ab19497" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_06012fc2-1ba6-4bc2-bd93-33bc4769f8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_06012fc2-1ba6-4bc2-bd93-33bc4769f8c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_9ed21687-707b-4a68-a1fd-c3e2b286c71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_DividendsCash_9ed21687-707b-4a68-a1fd-c3e2b286c71f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_9064df7b-86f0-4166-9808-0376dfb13630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_9064df7b-86f0-4166-9808-0376dfb13630" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a5c879b9-dcdc-476f-becd-ffec8b5149e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a5c879b9-dcdc-476f-becd-ffec8b5149e2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ba031da2-18e2-4f9c-ad2c-2959447b9230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ba031da2-18e2-4f9c-ad2c-2959447b9230" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_394ce4de-aa74-41dd-98e8-7849e6a9fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_394ce4de-aa74-41dd-98e8-7849e6a9fe22" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b680304-afd8-4b1d-8b86-975f4b7e4e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca25a997-6780-4ca4-820b-74802bac18f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6689a9f2-d5cc-4ea6-a7bb-16abf784e389_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:to="loc_us-gaap_EquityComponentDomain_6689a9f2-d5cc-4ea6-a7bb-16abf784e389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:to="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2beb1013-7598-4135-98ea-6f6f93f6e543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_CommonStockMember_2beb1013-7598-4135-98ea-6f6f93f6e543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0d81e8d0-1964-40ad-921f-49f2fb759eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0d81e8d0-1964-40ad-921f-49f2fb759eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_41804153-4002-4278-9cb3-54b836410cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_RetainedEarningsMember_41804153-4002-4278-9cb3-54b836410cbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1f60e13e-70d0-4b2c-b5b6-c9205c45fdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1f60e13e-70d0-4b2c-b5b6-c9205c45fdb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e0ad42bd-d07f-46cc-a756-3f5151fcd826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e0ad42bd-d07f-46cc-a756-3f5151fcd826" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_92b90fc0-9710-4371-b057-378327af73c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_NoncontrollingInterestMember_92b90fc0-9710-4371-b057-378327af73c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_905d5824-9051-4431-8787-bc87f70f397d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_905d5824-9051-4431-8787-bc87f70f397d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_fa8285d1-e8a9-4d81-b0c9-1f2275674496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_fa8285d1-e8a9-4d81-b0c9-1f2275674496" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#DescriptionofBusinessNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="extended" id="ifcca0a88cb9740918cc0d104a6e97e52_DescriptionofBusinessNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_e0536086-0679-492f-8293-0dbd51b6592a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:to="loc_us-gaap_NatureOfOperations_e0536086-0679-492f-8293-0dbd51b6592a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:to="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:to="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e0dc3d34-d996-430d-8599-c9d4d12a4bcd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e0dc3d34-d996-430d-8599-c9d4d12a4bcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ab756a3a-3587-4cf8-a429-7425807d5eb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ab756a3a-3587-4cf8-a429-7425807d5eb6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="extended" id="i23e636e3fc154f3287b9b6609f8d9898_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d368adcf-84eb-4b05-b4f9-964d45118610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d368adcf-84eb-4b05-b4f9-964d45118610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:to="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:to="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d4432631-a45c-42bd-97ae-944af1bb55e5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d4432631-a45c-42bd-97ae-944af1bb55e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cc1c5b18-64d1-438c-b859-ee7295f8324a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cc1c5b18-64d1-438c-b859-ee7295f8324a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="extended" id="if3001a3abdc2453c94c85a65b05535d5_PropertyPlantandCapitalizedSoftwareNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bd9da6f2-dc2a-4957-aa6d-cf29fee11cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bd9da6f2-dc2a-4957-aa6d-cf29fee11cb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01ab0e3e-10b9-43b7-b088-98822a6fe6ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01ab0e3e-10b9-43b7-b088-98822a6fe6ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4e19f2e8-aa19-4021-be75-102c28958d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4e19f2e8-aa19-4021-be75-102c28958d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:to="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_92fc0f43-c07d-4f27-8ff2-c54378b61f77_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:to="loc_srt_RangeMember_92fc0f43-c07d-4f27-8ff2-c54378b61f77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37fe92a5-c279-4d22-8c9d-6bb28e0359da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:to="loc_srt_RangeMember_37fe92a5-c279-4d22-8c9d-6bb28e0359da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended" id="i2ca4c501804943068965e918b70e38cb_GoodwillandIntangibleAssetsNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ab94052a-1597-44f2-9062-c8fcb5899319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ab94052a-1597-44f2-9062-c8fcb5899319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c4513e75-5622-4c66-979e-29e471d8fcd5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:to="loc_srt_ConsolidationItemsDomain_c4513e75-5622-4c66-979e-29e471d8fcd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0e75b18d-0289-4f50-8e62-c94773961006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:to="loc_srt_ConsolidationItemsDomain_0e75b18d-0289-4f50-8e62-c94773961006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de65fd5d-9de9-4363-95e8-63c33fb47af4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:to="loc_us-gaap_SegmentDomain_de65fd5d-9de9-4363-95e8-63c33fb47af4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b129a1cd-7853-4ea3-b522-95bb969b77ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:to="loc_us-gaap_SegmentDomain_b129a1cd-7853-4ea3-b522-95bb969b77ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_559fa74a-e8fa-46ac-9c85-3f3b325142d2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:to="loc_srt_RangeMember_559fa74a-e8fa-46ac-9c85-3f3b325142d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c804c828-66ce-4cb1-9dfd-b137f962a069" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:to="loc_srt_RangeMember_c804c828-66ce-4cb1-9dfd-b137f962a069" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="extended" id="i89c84e1be5274113b723ebf15e32e0ba_IncomeTaxesNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f621dfa-c9fb-455a-bd89-6173b1c5aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f621dfa-c9fb-455a-bd89-6173b1c5aeb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_58ae0318-237f-4d2d-9912-920b30a40a0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_58ae0318-237f-4d2d-9912-920b30a40a0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d0c4e2b2-6220-401b-ad92-cb4c69a12b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d0c4e2b2-6220-401b-ad92-cb4c69a12b5a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleINotes" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleINotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleINotes" xlink:type="extended" id="if9afd069e31f4115aa7fb6d26817ecf5_ScheduleINotes">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_5cd000df-1229-4392-af95-4be8e817bade" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_5cd000df-1229-4392-af95-4be8e817bade" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:to="loc_dei_EntityDomain_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_edb4faed-57f3-4b3d-a0b2-e6eff656d6b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:to="loc_dei_EntityDomain_edb4faed-57f3-4b3d-a0b2-e6eff656d6b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:to="loc_srt_ConsolidatedEntitiesDomain_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:to="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_18f2a6ee-7065-4a4b-a3fc-8dbd47eea47e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:to="loc_srt_ParentCompanyMember_18f2a6ee-7065-4a4b-a3fc-8dbd47eea47e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0706213b-504d-4df8-bc87-5f3c516cde64_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:to="loc_srt_ConsolidationItemsDomain_0706213b-504d-4df8-bc87-5f3c516cde64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5b203967-4b6f-494a-b069-c7525575e5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:to="loc_srt_ConsolidationItemsDomain_5b203967-4b6f-494a-b069-c7525575e5d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ib9cafbce8cbc4272a964f2dc81fa473b_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83b24345-a255-461a-a0af-4cac29dc2175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83b24345-a255-461a-a0af-4cac29dc2175" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_d46f9f6d-3b69-4a9b-a519-c69fdca62f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_UseOfEstimates_d46f9f6d-3b69-4a9b-a519-c69fdca62f76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1d2ef76-f845-4f5d-a7b1-4ffee4c173fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1d2ef76-f845-4f5d-a7b1-4ffee4c173fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_9446b5fb-dc51-4519-a5f3-0df72332d41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_9446b5fb-dc51-4519-a5f3-0df72332d41b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_37294f48-0ad5-4d2f-8340-349ccaf88060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_37294f48-0ad5-4d2f-8340-349ccaf88060" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_53780045-82fe-4f19-874f-76257ea20abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_53780045-82fe-4f19-874f-76257ea20abd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_afb0f766-117c-4d04-812a-f3c9d7a25129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_afb0f766-117c-4d04-812a-f3c9d7a25129" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_6e3a81c5-26f9-456f-9c01-297dd04ad5d7" xlink:href="unh-20221231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_6e3a81c5-26f9-456f-9c01-297dd04ad5d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_e2097787-fd3b-47be-844c-b6e298507009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_e2097787-fd3b-47be-844c-b6e298507009" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_ee61af12-da2f-4935-8f0b-7e0bb338dba0" xlink:href="unh-20221231.xsd#unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_ee61af12-da2f-4935-8f0b-7e0bb338dba0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f73ecfc3-6e49-4bd0-97ab-e73bb0c3a489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f73ecfc3-6e49-4bd0-97ab-e73bb0c3a489" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_8455230a-db9d-4a7c-a69d-c68e698fc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_8455230a-db9d-4a7c-a69d-c68e698fc9ad" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_0a5d8482-9dd3-4679-81c1-dfdf38c04c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_0a5d8482-9dd3-4679-81c1-dfdf38c04c01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_7e683ab6-7da9-4d0a-9f1a-09671240c126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_7e683ab6-7da9-4d0a-9f1a-09671240c126" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_b2004fbf-d593-46a8-9f83-3b9c6423e6ed" xlink:href="unh-20221231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_b2004fbf-d593-46a8-9f83-3b9c6423e6ed" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_5bb4e25a-6824-4270-b340-c043dada22f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_5bb4e25a-6824-4270-b340-c043dada22f9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_96d670a2-7ffb-49ca-aba5-b7a2e0050c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_96d670a2-7ffb-49ca-aba5-b7a2e0050c09" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_234875fa-8e84-4178-8822-7238998c6fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_234875fa-8e84-4178-8822-7238998c6fbd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_aab8bcf1-105c-4b64-8d74-2eab2fd9979a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_aab8bcf1-105c-4b64-8d74-2eab2fd9979a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:to="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_adbc3762-7134-4ca7-887c-617e4b626af6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_adbc3762-7134-4ca7-887c-617e4b626af6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b0a8d4f2-add4-4c4d-83f2-8d68748f09fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b0a8d4f2-add4-4c4d-83f2-8d68748f09fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFairValuePolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="extended" id="icc22a4da0f694895a948f38a3bee9de8_FairValueFairValuePolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d0416075-7b49-4e32-9c15-844bd9fb1fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d0416075-7b49-4e32-9c15-844bd9fb1fd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ddce833-170b-4d10-8c0e-8fe4981a6a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ddce833-170b-4d10-8c0e-8fe4981a6a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e801cf4f-1ffb-4f0a-8444-e5f9e82acebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e801cf4f-1ffb-4f0a-8444-e5f9e82acebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_581195a8-df6f-4b3c-b390-6ffa02023f39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_581195a8-df6f-4b3c-b390-6ffa02023f39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db02cb06-2732-4f07-b68a-98a86e52e281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db02cb06-2732-4f07-b68a-98a86e52e281" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIPolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="extended" id="iae108625d0784b6182565b9a643be161_ScheduleIPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_29084852-e4f3-4ceb-b937-c4f12b5cf4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_29084852-e4f3-4ceb-b937-c4f12b5cf4cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_fbbfa7a2-d596-497c-970d-4ea34039b0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_fbbfa7a2-d596-497c-970d-4ea34039b0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5a02164c-a80a-4065-9545-7ff0e3b067f5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5a02164c-a80a-4065-9545-7ff0e3b067f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e15f95e0-546c-4f98-bbd9-b68d876ea4c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:to="loc_srt_ParentCompanyMember_e15f95e0-546c-4f98-bbd9-b68d876ea4c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="extended" id="ic41814ba470946b8a068e1f3614735b0_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d6eb1dbd-b000-4ec6-933e-5c24ed0925fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d6eb1dbd-b000-4ec6-933e-5c24ed0925fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1c8549e-3426-4c74-9d86-6cd081db928a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1c8549e-3426-4c74-9d86-6cd081db928a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:to="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bae06872-6600-405a-889d-7a16befab786_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bae06872-6600-405a-889d-7a16befab786_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember_255354d5-5b08-4481-b43a-ead4aaaebc2e" xlink:href="unh-20221231.xsd#unh_UsefulLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:to="loc_unh_UsefulLifeMember_255354d5-5b08-4481-b43a-ead4aaaebc2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:to="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3ce4e858-91f1-42a0-9858-c42164d87803_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3ce4e858-91f1-42a0-9858-c42164d87803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0fbdf6a4-e12a-45f0-9f26-b461477cbaa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0fbdf6a4-e12a-45f0-9f26-b461477cbaa4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsTables" xlink:type="extended" id="i2ff64e82bcf34861a25cece67826f260_InvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0503e623-2bb1-4f73-a452-53b0612b6e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0503e623-2bb1-4f73-a452-53b0612b6e0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e9c7547f-c635-4e2b-a515-33aa3c0a6c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e9c7547f-c635-4e2b-a515-33aa3c0a6c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1e9dcbeb-396f-4756-bc98-0411e455294a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1e9dcbeb-396f-4756-bc98-0411e455294a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:to="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_fff724e4-4111-46f1-b24f-5d874ddb8a07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_fff724e4-4111-46f1-b24f-5d874ddb8a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f199def6-8e81-4b92-873a-60d06b8acc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f199def6-8e81-4b92-873a-60d06b8acc35" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueTables" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueTables" xlink:type="extended" id="iae93887b39a94ed398e6b5abe6c5f730_FairValueTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_779a3b75-9f99-49d5-9959-59c5d4e74f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_779a3b75-9f99-49d5-9959-59c5d4e74f59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f91c5b83-44b7-47a0-8e39-de242bfe0725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f91c5b83-44b7-47a0-8e39-de242bfe0725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9c58d12-cad8-4f16-8902-770bc10b8b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9c58d12-cad8-4f16-8902-770bc10b8b43" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="extended" id="i45ce0759ed1548d7b4d639582cd8e918_PropertyPlantandCapitalizedSoftwareTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3515c765-d7cc-4d7f-baed-27b65991400c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3515c765-d7cc-4d7f-baed-27b65991400c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33496c73-5524-47bc-acd3-da7801d9521f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33496c73-5524-47bc-acd3-da7801d9521f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b35a29ec-75f6-48cb-b9fa-25fb72908865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b35a29ec-75f6-48cb-b9fa-25fb72908865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:to="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33ec47ca-07f9-476b-9d6e-0b0d69bdf527_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:to="loc_srt_RangeMember_33ec47ca-07f9-476b-9d6e-0b0d69bdf527_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f572a012-8397-4d5a-a845-90a68720d8c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:to="loc_srt_RangeMember_f572a012-8397-4d5a-a845-90a68720d8c3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="ia5945a644d264269a4a1a4bae056ecee_GoodwillandIntangibleAssetsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9326f39b-6d04-4c15-9c27-616de9c31ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9326f39b-6d04-4c15-9c27-616de9c31ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_7fd2b2e9-5be6-4f80-8c87-f9ecd9b923be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_7fd2b2e9-5be6-4f80-8c87-f9ecd9b923be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_2f0a9ec1-0b50-4267-bd1e-4b2bb1da1e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_2f0a9ec1-0b50-4267-bd1e-4b2bb1da1e92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_99cb332b-841d-4c5e-b0aa-a72a3f877601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_99cb332b-841d-4c5e-b0aa-a72a3f877601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:to="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:to="loc_srt_ConsolidationItemsDomain_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2f008510-cb5a-4581-9a4d-a74982f815f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:to="loc_srt_ConsolidationItemsDomain_2f008510-cb5a-4581-9a4d-a74982f815f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="extended" id="ie6a376244950416a85253689bcf9873a_ShortTermBorrowingsandLongTermDebtTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_001309f6-747b-4cba-9e1c-d856e8489174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_001309f6-747b-4cba-9e1c-d856e8489174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2e27188e-3002-4222-944a-3d5f2cdaa723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2e27188e-3002-4222-944a-3d5f2cdaa723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:to="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:to="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5598f632-c590-4a3a-953c-fc56ccd42bb1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5598f632-c590-4a3a-953c-fc56ccd42bb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9a8acc8e-d205-4a8e-95a7-6a971b1929b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9a8acc8e-d205-4a8e-95a7-6a971b1929b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="extended" id="i433c19062ffb4044b01be8f134625060_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03a1b381-953c-4686-bb49-3dc7fd0f865b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03a1b381-953c-4686-bb49-3dc7fd0f865b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_750db3c1-9092-42fa-aa5f-f197be1e881f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_750db3c1-9092-42fa-aa5f-f197be1e881f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77872b89-2c18-4581-808d-f9d9e7fa4960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77872b89-2c18-4581-808d-f9d9e7fa4960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_7b84b240-9ca9-4eae-ad59-789a665e38d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_7b84b240-9ca9-4eae-ad59-789a665e38d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9aadbf90-8ae8-4716-8f33-355cb21e0625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9aadbf90-8ae8-4716-8f33-355cb21e0625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_69acb4e0-fe27-4531-846e-5be8372956c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_69acb4e0-fe27-4531-846e-5be8372956c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e0679bf2-a3ed-4861-9f19-81d00aba9504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e0679bf2-a3ed-4861-9f19-81d00aba9504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:to="loc_us-gaap_TaxPeriodDomain_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_fd912c35-b2ce-4802-a9d3-96fd74e5b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:to="loc_us-gaap_TaxPeriodDomain_fd912c35-b2ce-4802-a9d3-96fd74e5b054" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleITables" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleITables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleITables" xlink:type="extended" id="i2f061be255d9411c9f7ae8772f4a8234_ScheduleITables">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_0432f004-d568-41ba-a35c-381a84efe82a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_0432f004-d568-41ba-a35c-381a84efe82a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_c670bc96-fe85-4c11-a819-685d622804d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_c670bc96-fe85-4c11-a819-685d622804d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1333b129-7a9e-4a1b-9a4a-b9995ab3a5e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1333b129-7a9e-4a1b-9a4a-b9995ab3a5e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fabffa87-0349-4f3e-8dcf-2c5b177be19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fabffa87-0349-4f3e-8dcf-2c5b177be19a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_27b9b2fc-657d-4cf1-b613-709d8b8c825c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_27b9b2fc-657d-4cf1-b613-709d8b8c825c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8e757eac-f5ee-4368-bb11-8b91f8f5c065" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:to="loc_srt_ParentCompanyMember_8e757eac-f5ee-4368-bb11-8b91f8f5c065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:to="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e75fac1b-540b-4924-a975-661b6bfd8a33_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:to="loc_srt_ConsolidationItemsDomain_e75fac1b-540b-4924-a975-661b6bfd8a33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e6e93ba7-0225-4645-a92a-fdd42af97a9a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:to="loc_srt_ConsolidationItemsDomain_e6e93ba7-0225-4645-a92a-fdd42af97a9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="extended" id="idd4bbb7038824dcca9bd7ae577c0767a_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:href="unh-20221231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:href="unh-20221231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_99d280cb-d2a4-4344-a8f8-a6f47102a986_default" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_99d280cb-d2a4-4344-a8f8-a6f47102a986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:href="unh-20221231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:to="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_5ed72002-96b8-4e4a-b800-edade3796479_default" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_5ed72002-96b8-4e4a-b800-edade3796479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:href="unh-20221231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:to="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_783b3cea-be29-45fd-a209-4a6dcb16ec84_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:to="loc_srt_ProductsAndServicesDomain_783b3cea-be29-45fd-a209-4a6dcb16ec84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:to="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:href="unh-20221231.xsd#unh_ProductsandservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_060f63e2-743d-4349-b07b-19f4fa6ef58c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_060f63e2-743d-4349-b07b-19f4fa6ef58c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a6672b3-4cef-4f19-95ed-ed09d09e1480_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:to="loc_srt_RangeMember_5a6672b3-4cef-4f19-95ed-ed09d09e1480_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:to="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d96b7989-10c7-4f52-8524-2d59ca1ac4fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:to="loc_us-gaap_EquityComponentDomain_d96b7989-10c7-4f52-8524-2d59ca1ac4fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:to="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_714e6be8-9d27-4914-b024-7c15e6e8fdeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_714e6be8-9d27-4914-b024-7c15e6e8fdeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_66136fb0-3c52-41cb-b349-2edd28a7b934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_66136fb0-3c52-41cb-b349-2edd28a7b934" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1" xlink:type="extended" id="i4647fb1934af4c779a87d44ccf1aec49_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:href="unh-20221231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:href="unh-20221231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_99d280cb-d2a4-4344-a8f8-a6f47102a986_default" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_99d280cb-d2a4-4344-a8f8-a6f47102a986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:href="unh-20221231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:to="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_5ed72002-96b8-4e4a-b800-edade3796479_default" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_5ed72002-96b8-4e4a-b800-edade3796479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:href="unh-20221231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:to="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_783b3cea-be29-45fd-a209-4a6dcb16ec84_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:to="loc_srt_ProductsAndServicesDomain_783b3cea-be29-45fd-a209-4a6dcb16ec84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:to="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:href="unh-20221231.xsd#unh_ProductsandservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_060f63e2-743d-4349-b07b-19f4fa6ef58c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_060f63e2-743d-4349-b07b-19f4fa6ef58c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a6672b3-4cef-4f19-95ed-ed09d09e1480_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:to="loc_srt_RangeMember_5a6672b3-4cef-4f19-95ed-ed09d09e1480_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:to="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d96b7989-10c7-4f52-8524-2d59ca1ac4fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:to="loc_us-gaap_EquityComponentDomain_d96b7989-10c7-4f52-8524-2d59ca1ac4fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:to="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_714e6be8-9d27-4914-b024-7c15e6e8fdeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_714e6be8-9d27-4914-b024-7c15e6e8fdeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="extended" id="i43deebed9a8c424b86b6fa33e8fd13d3_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a26b0ece-a919-4597-af66-cf93eacdf197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a26b0ece-a919-4597-af66-cf93eacdf197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_36a2e69c-b794-46d8-beaf-46aec5dc2e5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_36a2e69c-b794-46d8-beaf-46aec5dc2e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f5e1b95d-e1a8-4e6f-bfcb-42b76f39495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f5e1b95d-e1a8-4e6f-bfcb-42b76f39495f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_a9141754-13d2-48c1-96e2-aa1e2e04e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_us-gaap_BuildingMember_a9141754-13d2-48c1-96e2-aa1e2e04e5e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember_6f37d0cd-c5cd-4ca0-b5e2-cf71c3fc7066" xlink:href="unh-20221231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_unh_CapitalizedsoftwareMember_6f37d0cd-c5cd-4ca0-b5e2-cf71c3fc7066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:to="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6db0f65e-2c48-4d11-b767-e832c9a29556_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:to="loc_srt_RangeMember_6db0f65e-2c48-4d11-b767-e832c9a29556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:to="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1991d960-3c74-4e10-a90e-5be4a79982d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:to="loc_srt_MinimumMember_1991d960-3c74-4e10-a90e-5be4a79982d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3ceceada-e053-49eb-af51-05fb09a38e3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:to="loc_srt_MaximumMember_3ceceada-e053-49eb-af51-05fb09a38e3a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="extended" id="ia860fc4bec34420e97701f70896c2a9b_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_05178c12-2f3a-445b-b70d-a83ef828ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_05178c12-2f3a-445b-b70d-a83ef828ac1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_bfb46b0d-e516-4857-abc6-2e2f2accdac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_bfb46b0d-e516-4857-abc6-2e2f2accdac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_12a04348-efd9-4a0f-ae43-13eff7562c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_12a04348-efd9-4a0f-ae43-13eff7562c72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_be12aa85-86d4-4d44-8343-79463265425a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_be12aa85-86d4-4d44-8343-79463265425a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1947366f-1b68-4d0a-a508-827d1eae4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1947366f-1b68-4d0a-a508-827d1eae4dca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a1f0a9f8-37fc-4946-aced-77cf39e38688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a1f0a9f8-37fc-4946-aced-77cf39e38688" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_aa7e4494-6147-46e4-8123-31a95f80b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_17bcf71f-a6f8-4155-a637-126aeb9e4679_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_17bcf71f-a6f8-4155-a637-126aeb9e4679_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember_fe5dcbd3-cd63-460e-b6df-27b8a9be166a" xlink:href="unh-20221231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:to="loc_unh_RedeemableNoncontrollingInterestsMember_fe5dcbd3-cd63-460e-b6df-27b8a9be166a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9440bbed-756f-44e1-8a12-237ea72888a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:to="loc_us-gaap_EquityComponentDomain_9440bbed-756f-44e1-8a12-237ea72888a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b6723bdb-d2de-4575-87ad-adbaa2b4bd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:to="loc_us-gaap_EquityComponentDomain_b6723bdb-d2de-4575-87ad-adbaa2b4bd56" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended" id="ie77078747309436aa5d6f0ca339b83e3_InvestmentsShortTermandLongTermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5162d39b-0b5e-439a-b3d4-3c15e843761e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5162d39b-0b5e-439a-b3d4-3c15e843761e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1c88654f-65f3-4615-aa84-3b740e18eeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1c88654f-65f3-4615-aa84-3b740e18eeff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4a1f0f7f-fe0e-41d2-b073-306f37427c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4a1f0f7f-fe0e-41d2-b073-306f37427c5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3834e26-2e31-46ef-a32b-c33f6cd37d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3834e26-2e31-46ef-a32b-c33f6cd37d6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bcdd6bad-7f21-4269-8e7e-98d9db29673f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bcdd6bad-7f21-4269-8e7e-98d9db29673f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_ed2a2e13-ef75-426c-b1a2-c314966b1cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_ed2a2e13-ef75-426c-b1a2-c314966b1cca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83a66922-6284-40a4-9a5f-e1aa4f2951b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83a66922-6284-40a4-9a5f-e1aa4f2951b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2d599e0a-f59a-4eb2-a46d-4826957deac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2d599e0a-f59a-4eb2-a46d-4826957deac4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_e04ec7e6-8d2f-40d4-aa8c-5846ee05f19a" xlink:href="unh-20221231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsAmortizedCost_e04ec7e6-8d2f-40d4-aa8c-5846ee05f19a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_4acff156-b9ba-446a-8d33-e6f5f6de5550" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_4acff156-b9ba-446a-8d33-e6f5f6de5550" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_ad820703-4913-4d45-9e04-3d740a72de26" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_ad820703-4913-4d45-9e04-3d740a72de26" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2b51dcb0-fd87-47fe-b500-a1c0ab35460e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2b51dcb0-fd87-47fe-b500-a1c0ab35460e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dc1450e-c801-4f27-8a90-fa08202a0834_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7dc1450e-c801-4f27-8a90-fa08202a0834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:to="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_c79817b9-f7fc-4a00-9a22-3ef761b8d789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_c79817b9-f7fc-4a00-9a22-3ef761b8d789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4365ba21-536c-4f60-8416-c3320594d96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4365ba21-536c-4f60-8416-c3320594d96d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1a59c56b-4c5b-4878-85c5-42ef299da64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1a59c56b-4c5b-4878-85c5-42ef299da64b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e7240f2a-896b-48af-8af3-3f7cdb3a6ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e7240f2a-896b-48af-8af3-3f7cdb3a6ead" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_aea6d5cb-aa64-4912-9d4b-45eca0f845b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_aea6d5cb-aa64-4912-9d4b-45eca0f845b5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="i143ffa5f791f4978b7906a695966133d_InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_eee74373-fd18-426e-97c6-c1727f3c998d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_eee74373-fd18-426e-97c6-c1727f3c998d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b3419690-7154-4033-8fc4-7e9040e784ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b3419690-7154-4033-8fc4-7e9040e784ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6cd6d525-985d-4656-97d3-5ddd03e47822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6cd6d525-985d-4656-97d3-5ddd03e47822" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_be4b2aeb-99d9-4b42-a2a2-ab54343e0d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_be4b2aeb-99d9-4b42-a2a2-ab54343e0d1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_0df0c6bd-889c-4dfe-ac8f-76a5e6086328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_0df0c6bd-889c-4dfe-ac8f-76a5e6086328" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce58e680-f3bf-44c7-935e-cd01ed567ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce58e680-f3bf-44c7-935e-cd01ed567ca3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8f3fdab2-f454-4310-b1de-10f6d339ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8f3fdab2-f454-4310-b1de-10f6d339ffd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c9803a7c-6714-4abc-a1a6-7855e7af47b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c9803a7c-6714-4abc-a1a6-7855e7af47b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5a4c304a-c8e6-470d-8c28-9ef87b7de94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5a4c304a-c8e6-470d-8c28-9ef87b7de94a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_aeffbf1d-69f2-469d-9556-a619b8915f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_aeffbf1d-69f2-469d-9556-a619b8915f40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47df29a0-b68a-4a15-81b8-d91169e73d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47df29a0-b68a-4a15-81b8-d91169e73d62" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_2357316d-1399-4522-bc6d-11641da49588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_2357316d-1399-4522-bc6d-11641da49588" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_5f29e0a7-2637-4089-8e8c-a4a700ab5273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_5f29e0a7-2637-4089-8e8c-a4a700ab5273" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_6d0d2ca7-d76c-4b10-a34d-872613305af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_6d0d2ca7-d76c-4b10-a34d-872613305af0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2036033b-f23c-4549-8af4-24a921c98b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2036033b-f23c-4549-8af4-24a921c98b51" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_7e2a8566-761c-48ef-abbc-310d02c2ccbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_7e2a8566-761c-48ef-abbc-310d02c2ccbd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c8a6d758-5fa9-4e3f-8002-b924c61acd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c8a6d758-5fa9-4e3f-8002-b924c61acd2c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_df7878b1-836e-40d6-83cc-c1b7ebd3db4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_df7878b1-836e-40d6-83cc-c1b7ebd3db4c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_70606dd0-f4b2-4b9f-99a0-377d81fdaa48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_70606dd0-f4b2-4b9f-99a0-377d81fdaa48" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3eb963a1-bc4c-4fba-9480-8f08e22854f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3eb963a1-bc4c-4fba-9480-8f08e22854f3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bd4b89b0-a6da-4d8b-a3eb-04b74b5cb98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bd4b89b0-a6da-4d8b-a3eb-04b74b5cb98a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_a28da2b8-6c5e-4778-9f14-616251e88474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_a28da2b8-6c5e-4778-9f14-616251e88474" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_25941cca-c3dc-40b3-b9cb-c487c708db4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_25941cca-c3dc-40b3-b9cb-c487c708db4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_57515ff7-2f11-46c0-92e7-e67a95d23557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_57515ff7-2f11-46c0-92e7-e67a95d23557" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_acd63f18-01c0-4445-8106-a8457456e029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_acd63f18-01c0-4445-8106-a8457456e029" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="id015c0b495b84a978e3c86a690eb8225_InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c9a30a01-6fff-4fcf-9418-98bef0db64b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c9a30a01-6fff-4fcf-9418-98bef0db64b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c9e897b5-43d5-480b-a829-dc239aa4585b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c9e897b5-43d5-480b-a829-dc239aa4585b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b2753165-464a-4be0-a995-dd0e3b7f2819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b2753165-464a-4be0-a995-dd0e3b7f2819" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cc0cd89-e354-4eed-93bf-4a74fcaa2885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cc0cd89-e354-4eed-93bf-4a74fcaa2885" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5c46457e-c16b-489f-ae0d-06abbb375166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5c46457e-c16b-489f-ae0d-06abbb375166" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e7ada39c-e51e-4d93-926e-5265c6ee167b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e7ada39c-e51e-4d93-926e-5265c6ee167b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26a4950d-e728-458f-8778-57664c8bd87e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26a4950d-e728-458f-8778-57664c8bd87e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:to="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_b09ed618-cb30-4cde-a3be-f55967ebafa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_b09ed618-cb30-4cde-a3be-f55967ebafa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_34560549-5365-4be2-999c-4b1ac9471d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_34560549-5365-4be2-999c-4b1ac9471d66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_64009db9-0c92-45eb-9f79-b0e026a73ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_64009db9-0c92-45eb-9f79-b0e026a73ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_bb1dbb51-115b-403a-82d6-8a09241f9804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_bb1dbb51-115b-403a-82d6-8a09241f9804" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_8d288073-beb0-4b2a-a032-e89712b50ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_8d288073-beb0-4b2a-a032-e89712b50ae5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="extended" id="i1e2a086890d3448c9984c2a2271404bb_FairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_379e24dd-13d6-4982-bf2d-204325e1e6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_379e24dd-13d6-4982-bf2d-204325e1e6d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_31609ca0-52c1-4db2-98ac-3cfe5d748694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_31609ca0-52c1-4db2-98ac-3cfe5d748694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_616a6a78-ff57-4496-a2f0-480174b46b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_616a6a78-ff57-4496-a2f0-480174b46b5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f1db4524-a22c-410c-8f96-e7e161d64836" xlink:href="unh-20221231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f1db4524-a22c-410c-8f96-e7e161d64836" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b5d55990-46cf-4aeb-bb9d-19c64618255b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b5d55990-46cf-4aeb-bb9d-19c64618255b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_884312c6-0d9c-4df1-ad3e-fddc477d1aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_884312c6-0d9c-4df1-ad3e-fddc477d1aa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5755b611-41c3-419d-8550-f5e6dd1e576e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5755b611-41c3-419d-8550-f5e6dd1e576e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_c2655df6-49d2-41eb-9469-e2859c4c42c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:to="loc_us-gaap_DebtSecuritiesMember_c2655df6-49d2-41eb-9469-e2859c4c42c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_206f70ee-0a54-497e-a842-2ffa32d5ea8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_206f70ee-0a54-497e-a842-2ffa32d5ea8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4b030ff6-7bca-4b60-828c-b89e4d3bbdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4b030ff6-7bca-4b60-828c-b89e4d3bbdd4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i0dc9935d7db94e9e95d0693e6941bfb4_FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a6ba1f3e-3194-48dc-bd3f-c2ff94d696a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a6ba1f3e-3194-48dc-bd3f-c2ff94d696a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_997e6ce4-25c5-4634-a60d-a0ac0097f969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_997e6ce4-25c5-4634-a60d-a0ac0097f969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7d5c8843-1247-43a2-89e5-90d2e0cc6b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7d5c8843-1247-43a2-89e5-90d2e0cc6b7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_3c023e4e-1b9f-4ddb-8473-d7ec5fd2b2d9" xlink:href="unh-20221231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_unh_AarpAssetsUnderManagement_3c023e4e-1b9f-4ddb-8473-d7ec5fd2b2d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a407cf3a-1bfa-4ade-968a-0197c1da0acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a407cf3a-1bfa-4ade-968a-0197c1da0acd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_825172d1-692e-48f4-ad0c-d766f2cf5259_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_825172d1-692e-48f4-ad0c-d766f2cf5259_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a9f3e665-e2f4-4c83-b6a2-2b9cca663f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a9f3e665-e2f4-4c83-b6a2-2b9cca663f7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_29159cbe-5842-4af3-bdc5-8837f8fe05c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_29159cbe-5842-4af3-bdc5-8837f8fe05c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a90ea74d-92da-420a-b9a1-34ba3fb71960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a90ea74d-92da-420a-b9a1-34ba3fb71960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f0d27a7-1961-45f2-82c3-298f04f02a49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f0d27a7-1961-45f2-82c3-298f04f02a49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:to="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_312f3d9d-24cc-41fb-a147-637e334268f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_312f3d9d-24cc-41fb-a147-637e334268f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c63da247-dccd-4a6b-b41e-265c97ac7771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c63da247-dccd-4a6b-b41e-265c97ac7771" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a23dc12e-1543-45cc-aaee-560396307707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a23dc12e-1543-45cc-aaee-560396307707" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_380a6505-0c9c-4a41-8065-8f07ea42fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_380a6505-0c9c-4a41-8065-8f07ea42fe4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_79cce358-6412-4d32-ac1f-58ae6e1b5b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_79cce358-6412-4d32-ac1f-58ae6e1b5b50" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i78f96989c6ba43939638d2b21c4f2319_FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d7d06122-1137-4860-a5cb-67dfe8863df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d7d06122-1137-4860-a5cb-67dfe8863df7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_789bdd5f-e68d-44a1-b94c-d6c9b34e657f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_HeldToMaturitySecurities_789bdd5f-e68d-44a1-b94c-d6c9b34e657f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f254b687-254b-476b-ab12-99d69d3a7c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f254b687-254b-476b-ab12-99d69d3a7c13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51030cbd-95d1-4a67-bd83-49ffbe41154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51030cbd-95d1-4a67-bd83-49ffbe41154a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62eb6888-f4db-4be4-b5b0-65b26352db1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62eb6888-f4db-4be4-b5b0-65b26352db1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_b6fdfd23-0a80-4e60-9196-8b0a1d870da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:to="loc_us-gaap_LongTermDebtMember_b6fdfd23-0a80-4e60-9196-8b0a1d870da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97575679-7a0c-4454-ba54-311cab2b2e2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97575679-7a0c-4454-ba54-311cab2b2e2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e9dda2ca-f334-4665-a611-7e51fb31fcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:to="loc_us-gaap_DebtSecuritiesMember_e9dda2ca-f334-4665-a611-7e51fb31fcc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_99df7e4e-6518-4205-a85f-68531b15d888_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_99df7e4e-6518-4205-a85f-68531b15d888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_91ad1c81-3bc4-4a9e-9348-b3278a0fa7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_91ad1c81-3bc4-4a9e-9348-b3278a0fa7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_783b2fbe-c6e3-489f-b735-211fbd25ffdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_783b2fbe-c6e3-489f-b735-211fbd25ffdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6160b2c4-33ee-41c6-9664-88037301da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6160b2c4-33ee-41c6-9664-88037301da4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_92c25b5c-0c70-43a7-b1de-08c9f985cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_92c25b5c-0c70-43a7-b1de-08c9f985cdbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a10fd2c0-4be9-4d9a-bba8-3e119c5253cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a10fd2c0-4be9-4d9a-bba8-3e119c5253cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_1c4585f9-d616-4395-ade8-c2712828cdd7_default" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:to="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_1c4585f9-d616-4395-ade8-c2712828cdd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:to="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_fb80c419-0514-4e8b-86e7-5398f49123bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:to="loc_us-gaap_LongTermDebtMember_fb80c419-0514-4e8b-86e7-5398f49123bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="extended" id="ic2f75ef89355449cbb5a1e646ccb7016_PropertyPlantandCapitalizedSoftwareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_31990970-0dd6-4579-bca4-98ee6b8bf563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:to="loc_us-gaap_Depreciation_31990970-0dd6-4579-bca4-98ee6b8bf563" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_81a9f17d-6b03-4053-9e08-fc3aa35f38e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_81a9f17d-6b03-4053-9e08-fc3aa35f38e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a851e8e6-77d5-4af2-ab09-410798a790d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a851e8e6-77d5-4af2-ab09-410798a790d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c54958f-c925-43ae-9848-abf9214c5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c54958f-c925-43ae-9848-abf9214c5f9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended" id="ib6b147dbe2044f79973081496822163e_PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_7bad0c5e-4ab4-4182-bc09-2e30515c8881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_LandAndLandImprovements_7bad0c5e-4ab4-4182-bc09-2e30515c8881" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_3b45d66e-58f6-4b87-8181-e4608a98c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_3b45d66e-58f6-4b87-8181-e4608a98c270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_0629dd20-2dfc-4810-857a-7183086d8069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_0629dd20-2dfc-4810-857a-7183086d8069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_bbe0ff09-39a7-4415-a962-5cc5eb8aa21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_bbe0ff09-39a7-4415-a962-5cc5eb8aa21b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_c3df12c4-772d-4053-aafc-489e426679b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_c3df12c4-772d-4053-aafc-489e426679b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_bf96e56b-81f6-4b4d-8e40-ad6cedbfa7b9" xlink:href="unh-20221231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_bf96e56b-81f6-4b4d-8e40-ad6cedbfa7b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_30e5fae5-df00-4c1b-9b05-2f909c72abbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_30e5fae5-df00-4c1b-9b05-2f909c72abbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_7ac7ef71-4e75-4b32-a920-6181d616c4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_7ac7ef71-4e75-4b32-a920-6181d616c4c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_61334891-113f-4355-8e24-fc700c0d9e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_61334891-113f-4355-8e24-fc700c0d9e75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b38e7bc3-600a-4209-8d45-503c58d818ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b38e7bc3-600a-4209-8d45-503c58d818ce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a96fbf74-f65d-4269-9765-3da6db8cbdcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a96fbf74-f65d-4269-9765-3da6db8cbdcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9457fbcf-879e-4488-98d2-9e7510ee79d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9457fbcf-879e-4488-98d2-9e7510ee79d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i9f277b93104e464e96784136e5fca68b_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e0df2083-a7f7-48f0-87af-bc3566e93576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e0df2083-a7f7-48f0-87af-bc3566e93576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:to="loc_us-gaap_TypeOfAdoptionMember_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3fb69094-a597-4b85-84e2-ca4e59593768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3fb69094-a597-4b85-84e2-ca4e59593768" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="extended" id="i0c8053c037484feca3a19a3cdd1ca39e_GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0becd1fc-33b8-490e-84f5-03a2a527b510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_Goodwill_0becd1fc-33b8-490e-84f5-03a2a527b510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_107a5f0c-7b84-4f31-b1eb-bb3cf2c970a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_107a5f0c-7b84-4f31-b1eb-bb3cf2c970a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d73a7da5-a2e4-4081-8698-202a536d24a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d73a7da5-a2e4-4081-8698-202a536d24a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_49ab1cd2-d612-4d05-abd6-2245790db8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2e74b67-0c1e-4d64-afc4-0340fef12deb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:to="loc_us-gaap_SegmentDomain_d2e74b67-0c1e-4d64-afc4-0340fef12deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:to="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_3236a71c-10ce-44ad-aa83-bff266097c18" xlink:href="unh-20221231.xsd#unh_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_UnitedhealthcareMember_3236a71c-10ce-44ad-aa83-bff266097c18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_133016e1-c1f1-4bfd-8c04-1567f29a39e1" xlink:href="unh-20221231.xsd#unh_OptumhealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptumhealthMember_133016e1-c1f1-4bfd-8c04-1567f29a39e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_b8a573bb-d563-45f8-982c-48487721df81" xlink:href="unh-20221231.xsd#unh_OptuminsightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptuminsightMember_b8a573bb-d563-45f8-982c-48487721df81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_5d6f1bf1-be68-4cdc-bcda-502be05d0ea1" xlink:href="unh-20221231.xsd#unh_OptumrxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptumrxMember_5d6f1bf1-be68-4cdc-bcda-502be05d0ea1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended" id="i8fdeb8b7de544493b7ce6814ae665666_GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d2f6ff79-276d-4acb-9e34-900eb6eb4302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d2f6ff79-276d-4acb-9e34-900eb6eb4302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_610ccd5f-81a0-4da8-b86e-07ad0910dcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_610ccd5f-81a0-4da8-b86e-07ad0910dcd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_815d6436-e076-4ab6-b84a-b17102865054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_815d6436-e076-4ab6-b84a-b17102865054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6ffcb645-84db-4b6d-9279-34fb633b6be0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6ffcb645-84db-4b6d-9279-34fb633b6be0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e8d6031b-bb35-4bcb-99d0-0535a8bb8435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e8d6031b-bb35-4bcb-99d0-0535a8bb8435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_7261f055-ff8d-4890-a961-78c42b473a04" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_unh_TrademarksandTechnologyMember_7261f055-ff8d-4890-a961-78c42b473a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_2d147d3c-99eb-4185-98ae-78d2c29dd2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_2d147d3c-99eb-4185-98ae-78d2c29dd2a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4478ed12-7155-433b-9294-b5d1ee6d6bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4478ed12-7155-433b-9294-b5d1ee6d6bf9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="extended" id="id5ddfc4eab7e43b8bb3045a35b71d99e_GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5546ebed-3ecd-4678-921c-16ab7ca4e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5546ebed-3ecd-4678-921c-16ab7ca4e7dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5fb57930-c9da-4b9c-9c5c-6e427bbc0132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5fb57930-c9da-4b9c-9c5c-6e427bbc0132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2baafc78-07eb-42c5-a390-95974140b756_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2baafc78-07eb-42c5-a390-95974140b756_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_d65af8c7-629e-4aad-9b77-143cfea409c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_d65af8c7-629e-4aad-9b77-143cfea409c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_28acbb65-0362-480b-a4e3-88e12741ca47" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_unh_TrademarksandTechnologyMember_28acbb65-0362-480b-a4e3-88e12741ca47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9c8400ca-72f0-4115-84b8-e9dfd03ed7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9c8400ca-72f0-4115-84b8-e9dfd03ed7e9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="extended" id="icc1ae59649cd4914a60039029e824ba9_GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1723205-ca23-420b-a975-3ee964d5368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1723205-ca23-420b-a975-3ee964d5368a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfce8ead-fced-40b3-b08a-9a16551e8f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfce8ead-fced-40b3-b08a-9a16551e8f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bec0a7b4-4264-49e4-9730-8af43103ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bec0a7b4-4264-49e4-9730-8af43103ae2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_efa01dfe-e92f-4eab-8e1d-e40ae62d0149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_efa01dfe-e92f-4eab-8e1d-e40ae62d0149" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_21b60000-3e4f-4d6a-a2e7-6c933101b55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_21b60000-3e4f-4d6a-a2e7-6c933101b55c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a53a3463-c561-49a4-89f7-514880995ad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a53a3463-c561-49a4-89f7-514880995ad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ac86ed2-6f6e-457c-8af9-00a176e3c967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ac86ed2-6f6e-457c-8af9-00a176e3c967" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="extended" id="ib433bc7b123c4d88b505e14ede1cf6cb_MedicalCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5cfcf9f7-f672-4c2b-8d81-fd5846a3e24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5cfcf9f7-f672-4c2b-8d81-fd5846a3e24c" xlink:to="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98_default" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7382bb57-95a2-4d60-ad8b-73dc7af1763e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7382bb57-95a2-4d60-ad8b-73dc7af1763e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:to="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ee2faf2b-f789-48dd-8a31-43fc0810ca3d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ee2faf2b-f789-48dd-8a31-43fc0810ca3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3a512336-22a5-42a4-b160-79ee18ff0a39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3a512336-22a5-42a4-b160-79ee18ff0a39" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended" id="if0291e65aaea4686b725dc032586be95_MedicalCostsPayableRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43feba76-1840-45fe-9318-11f8f127e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43feba76-1840-45fe-9318-11f8f127e7f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6356e91c-93c1-4484-9600-68c84bcb08d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6356e91c-93c1-4484-9600-68c84bcb08d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_0f6d8b49-47c1-4c00-b262-4abc799d571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_0f6d8b49-47c1-4c00-b262-4abc799d571e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_63899ba9-4db2-489d-9c45-75d47886112c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_63899ba9-4db2-489d-9c45-75d47886112c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_59db9efd-075a-45c3-9d32-dddd994d7ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_59db9efd-075a-45c3-9d32-dddd994d7ac9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_3b8047d2-4e2c-4efd-82f8-9dd6126046c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_3b8047d2-4e2c-4efd-82f8-9dd6126046c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e171b9b8-e957-4f6d-9492-33bc8d034530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e171b9b8-e957-4f6d-9492-33bc8d034530" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b0313b7f-30c4-428c-a440-2bb78807c907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b0313b7f-30c4-428c-a440-2bb78807c907" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6661cabc-6575-4557-b885-c3c3ab68e1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:to="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_83ae0332-5db5-4687-bdcd-053fcdd9b9f1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:to="loc_srt_ProductsAndServicesDomain_83ae0332-5db5-4687-bdcd-053fcdd9b9f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_373147f1-9b78-4726-bd9d-39b90a78908e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:to="loc_srt_ProductsAndServicesDomain_373147f1-9b78-4726-bd9d-39b90a78908e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="extended" id="if4b2052810ee46c9b3b0241af022a91f_MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5a0227fb-5afc-40ac-a7fe-dadb6756f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5a0227fb-5afc-40ac-a7fe-dadb6756f56f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1c6f3cc8-c69d-499d-88da-8536d5904b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1c6f3cc8-c69d-499d-88da-8536d5904b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_18dad5ed-cca4-491b-95de-70f8d7c35dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_18dad5ed-cca4-491b-95de-70f8d7c35dab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_149f1728-22fc-400f-9f19-338a2fc7e1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_149f1728-22fc-400f-9f19-338a2fc7e1b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:to="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_07d4a6c1-5d04-413a-9230-284661d585a6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:to="loc_srt_ProductsAndServicesDomain_07d4a6c1-5d04-413a-9230-284661d585a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:to="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_3b507ecf-23bc-4af4-9697-9d522a02fd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_3b507ecf-23bc-4af4-9697-9d522a02fd94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_10a9dbea-70c8-4831-897c-00453c7fc2c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_10a9dbea-70c8-4831-897c-00453c7fc2c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_f6c275c7-5ed1-47fe-9e9e-3ce2f62873fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_f6c275c7-5ed1-47fe-9e9e-3ce2f62873fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_259acd92-c435-4294-b36a-ad84801df42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_259acd92-c435-4294-b36a-ad84801df42f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="extended" id="i268ca87d793741b99803a8bcb60ddd71_ShortTermBorrowingsandLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_e603ccfa-6f77-4e30-9b44-6b839ea545a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_OtherLongTermDebt_e603ccfa-6f77-4e30-9b44-6b839ea545a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent_81f365b3-b6d1-4329-8350-3454ce23a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_OtherLongTermDebtCurrent_81f365b3-b6d1-4329-8350-3454ce23a84a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab1aa565-4366-452c-bbae-7cd48d08c8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab1aa565-4366-452c-bbae-7cd48d08c8d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_26bba21d-203b-4eba-8125-d195799cf29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_26bba21d-203b-4eba-8125-d195799cf29f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_c6a26c1a-789c-4123-b995-e8dc99d8a0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_c6a26c1a-789c-4123-b995-e8dc99d8a0bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d1803e33-c4b4-4fd7-b88c-899d7055efe9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d1803e33-c4b4-4fd7-b88c-899d7055efe9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_aab2151c-2a81-405b-92d9-715127c089bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:to="loc_srt_SubsidiariesMember_aab2151c-2a81-405b-92d9-715127c089bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_0209cae5-f7e1-4194-85c9-9c66bc0da301_default" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:to="loc_unh_CreditFacilityNameDomain_0209cae5-f7e1-4194-85c9-9c66bc0da301_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:to="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day60BillionCreditFacilityMember_acc731af-570b-4056-b961-e79afc325cda" xlink:href="unh-20221231.xsd#unh_A364Day60BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_A364Day60BillionCreditFacilityMember_acc731af-570b-4056-b961-e79afc325cda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear60BillionCreditFacilityMember_7fbea233-119b-4849-b738-b748ba69d975" xlink:href="unh-20221231.xsd#unh_ThreeYear60BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_ThreeYear60BillionCreditFacilityMember_7fbea233-119b-4849-b738-b748ba69d975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear60BillionCreditFacilityMember_ca0f92f3-2004-49f2-a4d5-2d170280913d" xlink:href="unh-20221231.xsd#unh_FiveYear60BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_FiveYear60BillionCreditFacilityMember_ca0f92f3-2004-49f2-a4d5-2d170280913d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ec99655a-f284-4845-9088-3e285842b12c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ec99655a-f284-4845-9088-3e285842b12c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4ec29c39-0e31-4a23-bc1a-cc1877008273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:to="loc_us-gaap_CommercialPaperMember_4ec29c39-0e31-4a23-bc1a-cc1877008273" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1001163-cdcc-4b79-b727-1b1e2a4c5f32_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:to="loc_srt_RangeMember_d1001163-cdcc-4b79-b727-1b1e2a4c5f32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:to="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4fb11fff-04e1-4e80-9f1d-648096d54b1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:to="loc_srt_MinimumMember_4fb11fff-04e1-4e80-9f1d-648096d54b1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b4eea12-7f38-4a19-808a-e922be643dd8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:to="loc_srt_MaximumMember_8b4eea12-7f38-4a19-808a-e922be643dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ea6bd3b6-4b74-4575-8c83-14976ece689a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:to="loc_us-gaap_CreditFacilityDomain_ea6bd3b6-4b74-4575-8c83-14976ece689a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:to="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9d777612-385b-4c28-83d3-371c10441ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9d777612-385b-4c28-83d3-371c10441ed5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended" id="i002e4eba39ca4ff4941c4f8c83fe6165_ShortTermBorrowingsandLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_66854a2f-5618-4d14-b33b-4eb90db1dc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_66854a2f-5618-4d14-b33b-4eb90db1dc1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6be17f8-e366-43c3-baaa-16758504f535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6be17f8-e366-43c3-baaa-16758504f535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_a0300785-c46d-4a96-bedb-1b6207157809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_CommercialPaper_a0300785-c46d-4a96-bedb-1b6207157809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_0521391c-7f89-402b-8a5f-9791df4085b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_0521391c-7f89-402b-8a5f-9791df4085b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_f06de51b-40ea-4ba4-a1f6-2df8bd48a101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_f06de51b-40ea-4ba4-a1f6-2df8bd48a101" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6385ed3d-551d-44a9-b256-41c76364e7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6385ed3d-551d-44a9-b256-41c76364e7e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:to="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fefd25ea-c1c0-4ccb-971b-02e527a12d3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fefd25ea-c1c0-4ccb-971b-02e527a12d3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2a6f2b77-996a-42b2-84d9-4233e98a4887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_us-gaap_CommercialPaperMember_2a6f2b77-996a-42b2-84d9-4233e98a4887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member_d733c8b7-9d84-4dc6-8cca-89e4870915d8" xlink:href="unh-20221231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.875notesdueMarch2022Member_d733c8b7-9d84-4dc6-8cca-89e4870915d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member_7db8d314-16e8-455f-9df5-eaafd2a25427" xlink:href="unh-20221231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3350NotesDueJuly2022Member_7db8d314-16e8-455f-9df5-eaafd2a25427" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember_223768f3-cebd-419a-9f35-3cd44f298e41" xlink:href="unh-20221231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.375notesdueOctober2022MemberMember_223768f3-cebd-419a-9f35-3cd44f298e41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member_9e0fd6a1-afa8-4333-9e3d-af24c9b84346" xlink:href="unh-20221231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_ZeroCouponNotesDueNovember2022Member_9e0fd6a1-afa8-4333-9e3d-af24c9b84346" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member_5ccfffc6-2536-4be4-9894-bb60da0c48ef" xlink:href="unh-20221231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2750NotesDueFebruary2023Member_5ccfffc6-2536-4be4-9894-bb60da0c48ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member_63fed9e2-9824-46aa-9538-75f2e22ac73b" xlink:href="unh-20221231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2875NotesDueMarch2023Member_63fed9e2-9824-46aa-9538-75f2e22ac73b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member_53538723-fba4-448c-8741-6bf9949e963d" xlink:href="unh-20221231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueJune2023Member_53538723-fba4-448c-8741-6bf9949e963d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member_8c541261-f63c-4f03-b56c-6f1b0f0fd2b1" xlink:href="unh-20221231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueFebruary2024Member_8c541261-f63c-4f03-b56c-6f1b0f0fd2b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member_119cc051-0411-420d-a865-31254c1f155c" xlink:href="unh-20221231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A0550NotesDueMay2024Member_119cc051-0411-420d-a865-31254c1f155c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member_36544652-99e7-45fc-b494-bd330a76d2dd" xlink:href="unh-20221231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.375notesdueAugust2024Member_36544652-99e7-45fc-b494-bd330a76d2dd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5000NotesDueOctober2024Member_75ed35b2-cfb9-4522-9ea6-eac76048c287" xlink:href="unh-20221231.xsd#unh_A5000NotesDueOctober2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5000NotesDueOctober2024Member_75ed35b2-cfb9-4522-9ea6-eac76048c287" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member_b9ef0d19-8fb2-48eb-a636-ca8ca2af28fe" xlink:href="unh-20221231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.750notesdueJuly2025Member_b9ef0d19-8fb2-48eb-a636-ca8ca2af28fe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5150NotesDueOctober2025Member_395e543e-9971-4641-bd64-7c59c39f4775" xlink:href="unh-20221231.xsd#unh_A5150NotesDueOctober2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5150NotesDueOctober2025Member_395e543e-9971-4641-bd64-7c59c39f4775" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member_73ef80fc-6787-4510-9bfe-f39c8cd9bc15" xlink:href="unh-20221231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.700notesdueDecember2025Member_73ef80fc-6787-4510-9bfe-f39c8cd9bc15" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member_e715a358-4673-44cf-ac3c-5a3e36fbbc89" xlink:href="unh-20221231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A1250NotesDueJanuary2026Member_e715a358-4673-44cf-ac3c-5a3e36fbbc89" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member_d3d8063b-404b-40b6-a22d-553f5cf71aca" xlink:href="unh-20221231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.100notesdueMarch2026Member_d3d8063b-404b-40b6-a22d-553f5cf71aca" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member_cb3c59d9-5139-4669-9013-771685c18342" xlink:href="unh-20221231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A1150NotesDueMay2026Member_cb3c59d9-5139-4669-9013-771685c18342" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member_335fab95-f9bb-43a7-9b90-cd4ec2a7fa4d" xlink:href="unh-20221231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.450notesdueJanuary2027Member_335fab95-f9bb-43a7-9b90-cd4ec2a7fa4d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member_35ab0537-8062-47b9-9005-3ce2f5c81cf3" xlink:href="unh-20221231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.375notesdueApril2027Member_35ab0537-8062-47b9-9005-3ce2f5c81cf3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3700NotesDueMay2027Member_ed1ee4c1-84a4-43a4-b74a-589cae88416f" xlink:href="unh-20221231.xsd#unh_A3700NotesDueMay2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3700NotesDueMay2027Member_ed1ee4c1-84a4-43a4-b74a-589cae88416f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member_158ce53c-6d89-44d0-9b9e-cf648d655fd7" xlink:href="unh-20221231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.950notesdueOctober2027Member_158ce53c-6d89-44d0-9b9e-cf648d655fd7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5250NotesDueFebruary2028Member_4c20ab80-7523-4661-95a5-95dd46da3fcb" xlink:href="unh-20221231.xsd#unh_A5250NotesDueFebruary2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5250NotesDueFebruary2028Member_4c20ab80-7523-4661-95a5-95dd46da3fcb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member_c0762afc-5bce-41f4-ab53-2554ebd1d1ce" xlink:href="unh-20221231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.850notesdueJune2028Member_c0762afc-5bce-41f4-ab53-2554ebd1d1ce" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member_39811068-eef2-4a97-9150-0727fc0d74a3" xlink:href="unh-20221231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.875notesdueDecember2028Member_39811068-eef2-4a97-9150-0727fc0d74a3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4000NotesDueMay2029Member_8052ad02-29b2-475c-81b0-865d44cdcc2c" xlink:href="unh-20221231.xsd#unh_A4000NotesDueMay2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4000NotesDueMay2029Member_8052ad02-29b2-475c-81b0-865d44cdcc2c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member_97260d0c-9e9e-4a54-8ee3-71ad2a56174a" xlink:href="unh-20221231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.875notesdueAugust2029Member_97260d0c-9e9e-4a54-8ee3-71ad2a56174a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5300NotesDueFebruary2030Member_8432c583-7bd5-4ffe-91df-e6f78eb24baf" xlink:href="unh-20221231.xsd#unh_A5300NotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5300NotesDueFebruary2030Member_8432c583-7bd5-4ffe-91df-e6f78eb24baf" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member_a1f80415-c412-4837-a665-8cd6886ad3e4" xlink:href="unh-20221231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2000NotesDueMay2030Member_a1f80415-c412-4837-a665-8cd6886ad3e4" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member_d5044ae7-20b9-4f5e-8895-768399eacf5b" xlink:href="unh-20221231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2300NotesDueMay2031Member_d5044ae7-20b9-4f5e-8895-768399eacf5b" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4200NotesDueMay2032Member_5494d9bc-0e5e-447e-9901-903e9f91f2e2" xlink:href="unh-20221231.xsd#unh_A4200NotesDueMay2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4200NotesDueMay2032Member_5494d9bc-0e5e-447e-9901-903e9f91f2e2" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5350NotesDueFebruary2033Member_f9ff2e3d-e975-49ae-8da8-93b7962cbb2c" xlink:href="unh-20221231.xsd#unh_A5350NotesDueFebruary2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5350NotesDueFebruary2033Member_f9ff2e3d-e975-49ae-8da8-93b7962cbb2c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member_f2bb4b19-34d2-4959-a56f-b3a1a2be1ca2" xlink:href="unh-20221231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.625notesdueJuly2035Member_f2bb4b19-34d2-4959-a56f-b3a1a2be1ca2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member_ea24f40d-b905-4aba-a690-93631ce8079f" xlink:href="unh-20221231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.800notesdueMarch2036Member_ea24f40d-b905-4aba-a690-93631ce8079f" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member_57afc1a4-a07e-4e71-8a09-01750d311763" xlink:href="unh-20221231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6500NotesDueJune2037Member_57afc1a4-a07e-4e71-8a09-01750d311763" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member_c5a52ae7-053e-4453-a412-fc65d3137660" xlink:href="unh-20221231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6625NotesDueNovember2037Member_c5a52ae7-053e-4453-a412-fc65d3137660" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member_1a1358be-a3dc-41fe-87fb-b0c9a58e469b" xlink:href="unh-20221231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6.875notesdueFebruary2038Member_1a1358be-a3dc-41fe-87fb-b0c9a58e469b" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member_f8d78492-2f72-4a72-99d2-f20cb11520f5" xlink:href="unh-20221231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueAugust2039Member_f8d78492-2f72-4a72-99d2-f20cb11520f5" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member_9d80e04b-b6f4-45c2-b1dd-1c3d2638e6fe" xlink:href="unh-20221231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2750NotesDueMay2040Member_9d80e04b-b6f4-45c2-b1dd-1c3d2638e6fe" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member_b2db13c6-31de-4c63-ad83-7e576083b59d" xlink:href="unh-20221231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.700notesdueOctober2040Member_b2db13c6-31de-4c63-ad83-7e576083b59d" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member_8135646b-c4b8-427d-9e10-f150b35c93bf" xlink:href="unh-20221231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.950notesdueFebruary2041Member_8135646b-c4b8-427d-9e10-f150b35c93bf" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member_26fc62d5-c9fc-4a44-9b0d-efa23214982a" xlink:href="unh-20221231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3050NotesDueMay2041Member_26fc62d5-c9fc-4a44-9b0d-efa23214982a" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member_e5a09e37-274b-439b-943c-3f4e318360d4" xlink:href="unh-20221231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.625notesdueNovember2041Member_e5a09e37-274b-439b-943c-3f4e318360d4" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member_fdd8fda6-3401-44e8-8c0c-55fb6c47bb93" xlink:href="unh-20221231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.375notesdueMarch2042Member_fdd8fda6-3401-44e8-8c0c-55fb6c47bb93" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member_06c1e9c0-52a8-4114-8ab7-00cb20bc06a7" xlink:href="unh-20221231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3950NotesDueOctober2042Member_06c1e9c0-52a8-4114-8ab7-00cb20bc06a7" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member_c713c9bc-5c5e-4ff3-9a17-abc38acfddeb" xlink:href="unh-20221231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4250NotesDueMarch2043Member_c713c9bc-5c5e-4ff3-9a17-abc38acfddeb" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member_707b8f12-6466-4502-9a58-eadfffe29a0e" xlink:href="unh-20221231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.750notesdueJuly2045Member_707b8f12-6466-4502-9a58-eadfffe29a0e" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member_e1418dbe-df7d-4a6f-9574-8f8cccdfdbd9" xlink:href="unh-20221231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.200notesdueJanuary2047Member_e1418dbe-df7d-4a6f-9574-8f8cccdfdbd9" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member_56cd3b3f-78f8-4356-ac2e-7153a440eaae" xlink:href="unh-20221231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.250notesdueApril2047Member_56cd3b3f-78f8-4356-ac2e-7153a440eaae" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member_2160bb05-9e8c-48fe-9ec3-ef7f2c4deb97" xlink:href="unh-20221231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.750notesdueOctober2047Member_2160bb05-9e8c-48fe-9ec3-ef7f2c4deb97" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member_43cc92f7-4d61-47e1-86ec-e11620348602" xlink:href="unh-20221231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.250notesdueJune2048Member_43cc92f7-4d61-47e1-86ec-e11620348602" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member_15ff6248-0e70-4407-9130-2cb995481166" xlink:href="unh-20221231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.450notesdueDecember2048Member_15ff6248-0e70-4407-9130-2cb995481166" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member_6d30e0d5-b02f-48b7-8fba-6abaa2451fbe" xlink:href="unh-20221231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.700notesdueAugust2049Member_6d30e0d5-b02f-48b7-8fba-6abaa2451fbe" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member_9665d963-3389-4a13-8bd4-3e8f072476a6" xlink:href="unh-20221231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2900NotesDueMay2050Member_9665d963-3389-4a13-8bd4-3e8f072476a6" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member_26be1469-168d-4207-a212-02146343b743" xlink:href="unh-20221231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3250NotesDueMay2051Member_26be1469-168d-4207-a212-02146343b743" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4750NotesDueMay2052Member_31808679-1ee5-484c-8bba-4f09804d0833" xlink:href="unh-20221231.xsd#unh_A4750NotesDueMay2052Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4750NotesDueMay2052Member_31808679-1ee5-484c-8bba-4f09804d0833" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5875NotesDueFebruary2053Member_9417762e-def5-4710-b8ca-e223f34e4795" xlink:href="unh-20221231.xsd#unh_A5875NotesDueFebruary2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5875NotesDueFebruary2053Member_9417762e-def5-4710-b8ca-e223f34e4795" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member_7d0be48d-b149-4308-b58f-a8bb20079038" xlink:href="unh-20221231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.875notesdueAugust2059Member_7d0be48d-b149-4308-b58f-a8bb20079038" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member_f0a19c53-6b87-40ea-8603-7fb9a0d5dcdf" xlink:href="unh-20221231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3125NotesDueMay2060Member_f0a19c53-6b87-40ea-8603-7fb9a0d5dcdf" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4950NotesDueMay2062Member_06fc130a-dd9b-4604-9b8b-530e2ffadb20" xlink:href="unh-20221231.xsd#unh_A4950NotesDueMay2062Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4950NotesDueMay2062Member_06fc130a-dd9b-4604-9b8b-530e2ffadb20" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6050NotesDueFebruary2063Member_5c252b60-14bc-4aee-b004-60207e8aa112" xlink:href="unh-20221231.xsd#unh_A6050NotesDueFebruary2063Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6050NotesDueFebruary2063Member_5c252b60-14bc-4aee-b004-60207e8aa112" xlink:type="arc" order="60"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="extended" id="i43064b2f28ff486894e7c68dfc5062a0_ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_15e2df51-6767-48fc-a038-a27627579454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_15e2df51-6767-48fc-a038-a27627579454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e36c436-3a59-48c4-8568-a1861b004373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e36c436-3a59-48c4-8568-a1861b004373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a7cb47d4-3748-496c-990b-901e997d4fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a7cb47d4-3748-496c-990b-901e997d4fe3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_de7e14d9-c84d-44ee-af12-e1b1fe0255b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_de7e14d9-c84d-44ee-af12-e1b1fe0255b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_53fb1849-d1ed-4ab0-898b-93dcc58a7fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_53fb1849-d1ed-4ab0-898b-93dcc58a7fcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e26262e2-3e0f-4832-843d-4959ef0ac89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e26262e2-3e0f-4832-843d-4959ef0ac89e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e7a0fd9e-949e-482f-b172-bed7e3bc2e75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e7a0fd9e-949e-482f-b172-bed7e3bc2e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2eef952e-7f8d-455c-8c48-8fd6794a716f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2eef952e-7f8d-455c-8c48-8fd6794a716f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_43108f77-e97a-4c22-a323-662187f317a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_43108f77-e97a-4c22-a323-662187f317a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a31dd7aa-3d21-45af-b71c-0ebee61c8bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a31dd7aa-3d21-45af-b71c-0ebee61c8bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2b432379-ba48-4bcb-af14-c3886a3c5f7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:to="loc_us-gaap_VariableRateDomain_2b432379-ba48-4bcb-af14-c3886a3c5f7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d8cd6286-e21f-4e6a-abda-da6a6f57b777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:to="loc_us-gaap_VariableRateDomain_d8cd6286-e21f-4e6a-abda-da6a6f57b777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9599a679-d97b-402f-84fc-4f4c4dbeec41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9599a679-d97b-402f-84fc-4f4c4dbeec41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1604bc4e-0baf-4039-a633-8e6869eaaaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1604bc4e-0baf-4039-a633-8e6869eaaaf7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="iad805e35bca34a959ab540f99b0d20de_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_f979b4a6-97bd-4432-adf3-21028fb779cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_OperatingLossCarryforwards_f979b4a6-97bd-4432-adf3-21028fb779cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_2fe3051e-772b-4bbe-81b2-6b941398d514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_2fe3051e-772b-4bbe-81b2-6b941398d514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9111ac06-aae3-47f1-9e65-d7dd77611900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9111ac06-aae3-47f1-9e65-d7dd77611900" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_18c0f4e4-8bca-4b22-b09a-fe85fa6d4eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_18c0f4e4-8bca-4b22-b09a-fe85fa6d4eea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear_63361bba-d57f-4e81-9c40-2148dfa79650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_OpenTaxYear_63361bba-d57f-4e81-9c40-2148dfa79650" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2c779c11-3d53-4106-b3a5-62315a4dd126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2c779c11-3d53-4106-b3a5-62315a4dd126" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_be8b8407-c37f-4f83-8e0b-13ace6b8aadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_be8b8407-c37f-4f83-8e0b-13ace6b8aadd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_ef96cecb-d7a3-499e-9061-33eb47cdfbf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_ef96cecb-d7a3-499e-9061-33eb47cdfbf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member_bba8d079-367d-4f22-b0f2-c90e727f343a" xlink:href="unh-20221231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:to="loc_unh_NOLsExpirationBeginning2022Through2037Member_bba8d079-367d-4f22-b0f2-c90e727f343a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember_0cce02c3-a60c-4d5d-9e19-85e234d4cdf9" xlink:href="unh-20221231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:to="loc_unh_NOLsIndefiniteCarryforwardMember_0cce02c3-a60c-4d5d-9e19-85e234d4cdf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8da823c2-02f7-490c-851e-0f49040ef7c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8da823c2-02f7-490c-851e-0f49040ef7c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_c2565bf5-2866-434d-b29a-d199149b5bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_DomesticCountryMember_c2565bf5-2866-434d-b29a-d199149b5bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_17799846-0f5d-404a-8b4f-7f2f15d9db22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_17799846-0f5d-404a-8b4f-7f2f15d9db22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_ee0fa835-bbcc-4b1d-844a-5b50dd1d04f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_ForeignCountryMember_ee0fa835-bbcc-4b1d-844a-5b50dd1d04f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_07844224-6c92-4b35-b64d-be059e9dda2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_07844224-6c92-4b35-b64d-be059e9dda2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_369ddfd8-a2cf-4f44-984b-31c9b328b131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_369ddfd8-a2cf-4f44-984b-31c9b328b131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:to="loc_us-gaap_TaxPeriodDomain_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:to="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_de36ca5a-e1cb-4db0-b28d-51f147c54d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:to="loc_us-gaap_EarliestTaxYearMember_de36ca5a-e1cb-4db0-b28d-51f147c54d5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_1fe8b350-3e61-4132-bcf3-46e0a922faee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:to="loc_us-gaap_LatestTaxYearMember_1fe8b350-3e61-4132-bcf3-46e0a922faee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended" id="i6408b785063b4249a5dd77643d7237d9_IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_d069b3ed-0608-4cea-aa6e-1a874a39c76a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_d069b3ed-0608-4cea-aa6e-1a874a39c76a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_db0170a9-865f-41fb-a9a7-9b55df34eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_db0170a9-865f-41fb-a9a7-9b55df34eae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_00533fa7-9bdb-404a-ae85-ae2f09951475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_00533fa7-9bdb-404a-ae85-ae2f09951475" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0466d83-e909-4b24-a71e-f5f40a9baafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0466d83-e909-4b24-a71e-f5f40a9baafc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84a32c5a-3c90-44bd-b9c5-3fbc57c9905d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84a32c5a-3c90-44bd-b9c5-3fbc57c9905d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a05d6697-fbc3-439f-8bc8-85228e574764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a05d6697-fbc3-439f-8bc8-85228e574764" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_81de251d-7b06-4813-b0d7-b06f3aab7d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_81de251d-7b06-4813-b0d7-b06f3aab7d6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:to="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b7d8a29f-c50a-451d-9f06-df6b0322cfbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:to="loc_us-gaap_TaxPeriodDomain_b7d8a29f-c50a-451d-9f06-df6b0322cfbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0ffb4bd6-61b5-440a-a649-519f237cb0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:to="loc_us-gaap_TaxPeriodDomain_0ffb4bd6-61b5-440a-a649-519f237cb0b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended" id="i36e611a85a8e4e60948f90b8961c20f4_IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e4eec130-fd33-43b8-a51c-0156cbf373f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e4eec130-fd33-43b8-a51c-0156cbf373f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6bd8cdec-2d17-4e0d-8527-9b2a7e66749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6bd8cdec-2d17-4e0d-8527-9b2a7e66749b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_509a1957-58cd-4cf3-acd3-fa2b83d0a3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_509a1957-58cd-4cf3-acd3-fa2b83d0a3bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2d331f50-d7c8-4d6a-a002-a7884901822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2d331f50-d7c8-4d6a-a002-a7884901822b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_a20218ed-c842-4b6d-b0c1-f262363947f0" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_a20218ed-c842-4b6d-b0c1-f262363947f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_de07931e-4057-41bf-9210-058effd5efd4" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_de07931e-4057-41bf-9210-058effd5efd4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_42d84e8f-55ff-4f34-845f-1d19b43b6664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_42d84e8f-55ff-4f34-845f-1d19b43b6664" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_7cef5edd-4507-46e6-add1-c8576eb796d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_7cef5edd-4507-46e6-add1-c8576eb796d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_ec131821-7767-476e-bc67-c8840c707e82" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_ec131821-7767-476e-bc67-c8840c707e82" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_3c56f637-440b-408c-ab7f-85b15c1e9257" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_3c56f637-440b-408c-ab7f-85b15c1e9257" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e3e4b0ef-1167-422e-b24f-07d8bbffd33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e3e4b0ef-1167-422e-b24f-07d8bbffd33e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e19ab567-4d01-428c-94af-af2f93aca8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e19ab567-4d01-428c-94af-af2f93aca8a7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6540b883-c35e-4842-9b69-08f0e8095c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6540b883-c35e-4842-9b69-08f0e8095c40" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd6f65c8-f061-447d-b604-9b1e607130f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd6f65c8-f061-447d-b604-9b1e607130f4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01232b7e-0e8c-424d-9631-958cf8969a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01232b7e-0e8c-424d-9631-958cf8969a4b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75fc3158-d602-4b3a-a87d-9bb5e31bbe84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75fc3158-d602-4b3a-a87d-9bb5e31bbe84" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:to="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ed034270-0f6c-4126-9ebc-649c82bbf4bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:to="loc_us-gaap_TaxPeriodDomain_ed034270-0f6c-4126-9ebc-649c82bbf4bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_1a569155-a72b-4d26-9c15-106c92aad900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:to="loc_us-gaap_TaxPeriodDomain_1a569155-a72b-4d26-9c15-106c92aad900" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="idaec002b146f4701a5844cba6c3378f6_IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_e77a1a4c-2306-44b1-89a5-ea55b6bbc57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_e77a1a4c-2306-44b1-89a5-ea55b6bbc57a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_101f44bd-2f86-415e-a5b8-43bdb6ab81ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_101f44bd-2f86-415e-a5b8-43bdb6ab81ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d2e63661-e665-420c-b159-d2570d930353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d2e63661-e665-420c-b159-d2570d930353" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_62a08c47-0b79-407c-9258-107df2db7e94" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_62a08c47-0b79-407c-9258-107df2db7e94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3db94c78-cbae-43f8-b2b4-dfd73aa8f0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3db94c78-cbae-43f8-b2b4-dfd73aa8f0a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_e561c46c-e208-4b2d-8346-a543192b270d" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_e561c46c-e208-4b2d-8346-a543192b270d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_18ab82cd-2aac-4ef0-9a46-0787631df59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_18ab82cd-2aac-4ef0-9a46-0787631df59c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_ca23e517-5478-4690-848f-0f66255241c4" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_ca23e517-5478-4690-848f-0f66255241c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_89724682-2855-4fec-b274-c9066edb7d3c" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_89724682-2855-4fec-b274-c9066edb7d3c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eff7068c-d26b-47e1-a78e-abbf2b6cfe34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_eff7068c-d26b-47e1-a78e-abbf2b6cfe34" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_432deb53-5be1-432e-afb3-199471b5c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_432deb53-5be1-432e-afb3-199471b5c7ee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e66ad4cb-3003-47aa-86cd-fdd200f0bf22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e66ad4cb-3003-47aa-86cd-fdd200f0bf22" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_36469fa3-06d8-4a2b-86d7-3c763022eb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_36469fa3-06d8-4a2b-86d7-3c763022eb76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_f61035d3-8a18-4e2f-bf59-1a01c02363c5" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_f61035d3-8a18-4e2f-bf59-1a01c02363c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_f5f05e23-8820-43ac-b041-3d877d84ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_f5f05e23-8820-43ac-b041-3d877d84ee7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5bbe3acf-a23f-4875-a03c-ec5a9132c69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5bbe3acf-a23f-4875-a03c-ec5a9132c69e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b4a23027-8793-427c-a461-fa2c352611c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b4a23027-8793-427c-a461-fa2c352611c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_92b92737-ae24-4262-a530-c8c2caa0406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_92b92737-ae24-4262-a530-c8c2caa0406b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9961bd6-26c6-4ca4-87d7-5dc56e5df9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9961bd6-26c6-4ca4-87d7-5dc56e5df9ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_84970edd-bc01-496c-87a6-405edb93c0cd" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_84970edd-bc01-496c-87a6-405edb93c0cd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_113a5561-4a92-456d-8412-18dfc4136711" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_113a5561-4a92-456d-8412-18dfc4136711" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6b38bd24-7d2c-49e3-9dfa-9366e78cdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6b38bd24-7d2c-49e3-9dfa-9366e78cdc6a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_11f52496-c465-4612-8575-1fb166bce06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilities_11f52496-c465-4612-8575-1fb166bce06e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:to="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_89b4c91e-55a0-44a5-a044-1da4b7dcc77c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:to="loc_us-gaap_TaxPeriodDomain_89b4c91e-55a0-44a5-a044-1da4b7dcc77c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ab30d3ab-6ed2-46dc-9dea-ebf75a15771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:to="loc_us-gaap_TaxPeriodDomain_ab30d3ab-6ed2-46dc-9dea-ebf75a15771d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="extended" id="i6b2553eeecb24eb08df476db5aac31d2_IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f1fce2b5-c6a5-49ac-9209-444f344fcfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f1fce2b5-c6a5-49ac-9209-444f344fcfbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ccb377e8-23cd-4519-9be2-a8ad91a56e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ccb377e8-23cd-4519-9be2-a8ad91a56e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5a9b0582-2b62-4e08-95b6-46e7584be1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5a9b0582-2b62-4e08-95b6-46e7584be1af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_abf03c18-f34b-4ab0-9834-94a0982ce6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_abf03c18-f34b-4ab0-9834-94a0982ce6d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e362ffb4-c3e2-487a-a9db-9e962900b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e362ffb4-c3e2-487a-a9db-9e962900b9a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77c7b586-71d3-46f8-a193-28397415b3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:to="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_7fe6c962-1485-438f-9431-05d5d2c1f1c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:to="loc_us-gaap_TaxPeriodDomain_7fe6c962-1485-438f-9431-05d5d2c1f1c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_54120d76-36e0-4466-a9ea-d6614b73d9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:to="loc_us-gaap_TaxPeriodDomain_54120d76-36e0-4466-a9ea-d6614b73d9a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="iaf5a44bf8ed541828ab07f4a1ac52584_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8de2914f-5dd0-43a0-8160-4be408908bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8de2914f-5dd0-43a0-8160-4be408908bfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_60956fb2-ff6f-4f80-8641-12bb0bb0dc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_60956fb2-ff6f-4f80-8641-12bb0bb0dc32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_49315bc6-1f3d-4733-812c-e63a747796e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_49315bc6-1f3d-4733-812c-e63a747796e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_7052075d-3b4d-4571-aacd-185a40661980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_7052075d-3b4d-4571-aacd-185a40661980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:href="unh-20221231.xsd#unh_DividendFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:to="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_968d2ddd-0a97-4ba3-a60a-ac3995eb2648_default" xlink:href="unh-20221231.xsd#unh_DividendFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:to="loc_unh_DividendFrequencyDomain_968d2ddd-0a97-4ba3-a60a-ac3995eb2648_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:href="unh-20221231.xsd#unh_DividendFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:to="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember_fab610c5-3ceb-4594-a69d-562a348d1763" xlink:href="unh-20221231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:to="loc_unh_ExtraordinaryDividendsMember_fab610c5-3ceb-4594-a69d-562a348d1763" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i81448f93cbb540498b303d67ba33887b_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9ba38ed0-db94-4520-aad6-4697e02397ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9ba38ed0-db94-4520-aad6-4697e02397ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_af633d0e-282c-428f-8b2f-4681ec6accbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_af633d0e-282c-428f-8b2f-4681ec6accbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a9f1055a-f849-4984-bdb2-671f611e11fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:to="loc_us-gaap_PlanNameDomain_a9f1055a-f849-4984-bdb2-671f611e11fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_154c796f-ed75-47b6-911e-4a4f98547e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:to="loc_us-gaap_PlanNameDomain_154c796f-ed75-47b6-911e-4a4f98547e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:to="loc_us-gaap_AwardDateDomain_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_9bbd4ce6-269d-4589-acfe-33cec48e585f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:to="loc_us-gaap_AwardDateDomain_9bbd4ce6-269d-4589-acfe-33cec48e585f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f1d8e1a9-f688-4b74-83ea-509932c17878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f1d8e1a9-f688-4b74-83ea-509932c17878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_633479bb-ddb6-4933-8f59-43ecf4a4bee4" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_633479bb-ddb6-4933-8f59-43ecf4a4bee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_94672d66-8ce9-4a67-abfe-e5cbcaf76595_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:to="loc_us-gaap_ClassOfStockDomain_94672d66-8ce9-4a67-abfe-e5cbcaf76595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_32c166f3-6068-4a9a-8fc2-7610e1334525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:to="loc_us-gaap_ClassOfStockDomain_32c166f3-6068-4a9a-8fc2-7610e1334525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:to="loc_srt_RangeMember_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d8dfa11-97fd-4d46-8009-52c35eff5a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:to="loc_srt_RangeMember_5d8dfa11-97fd-4d46-8009-52c35eff5a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_638448a4-d4cb-46ab-910b-b7597f1c9059_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:to="loc_us-gaap_VestingDomain_638448a4-d4cb-46ab-910b-b7597f1c9059_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_69fe838b-71d7-4dc6-8e6c-6b4405aecaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:to="loc_us-gaap_VestingDomain_69fe838b-71d7-4dc6-8e6c-6b4405aecaa7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended" id="i3604db5f3f3841099275bd0d12a95f6e_ShareBasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e84e3af1-a2a1-41c4-83d4-5beaf95d02a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e84e3af1-a2a1-41c4-83d4-5beaf95d02a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_732deeba-2e51-4789-b973-ab8491f8346d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_732deeba-2e51-4789-b973-ab8491f8346d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bef159c3-f84d-4f75-8db2-cc516c342e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bef159c3-f84d-4f75-8db2-cc516c342e65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_18860511-e9fa-4c4e-9a51-b5f5eff313c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_18860511-e9fa-4c4e-9a51-b5f5eff313c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8584a79e-62ea-4f4d-8f02-1bf719a37841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f33013aa-11e5-4f5a-b6d3-0cc2f16f1052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f33013aa-11e5-4f5a-b6d3-0cc2f16f1052" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_5fafe60b-4697-4883-89b8-9eb190df0865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_5fafe60b-4697-4883-89b8-9eb190df0865" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0226d54-74ac-468a-aa2a-b0a44c6477aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0226d54-74ac-468a-aa2a-b0a44c6477aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ee1083ac-bf5c-4e47-bf1e-a6bf684a6712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ee1083ac-bf5c-4e47-bf1e-a6bf684a6712" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd6727dc-8de2-498b-9788-c80acd6ab639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd6727dc-8de2-498b-9788-c80acd6ab639" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76ac6c97-b99c-4249-bffe-24fd7a9ff832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76ac6c97-b99c-4249-bffe-24fd7a9ff832" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93ca2414-cc3f-475f-b9d9-8a24a34186de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7cbd8cd-2d54-482c-a673-f99ce0ed47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7cbd8cd-2d54-482c-a673-f99ce0ed47f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6094624c-5711-4835-b5af-d56a413329a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6094624c-5711-4835-b5af-d56a413329a1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_66aa04aa-02b1-40d0-b432-954c5ff1a5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_66aa04aa-02b1-40d0-b432-954c5ff1a5bc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3615c17a-80ab-4597-9d1f-997b21058f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3615c17a-80ab-4597-9d1f-997b21058f2f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_114213ba-4b7e-4355-ad8c-d61042829dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_114213ba-4b7e-4355-ad8c-d61042829dcf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aee97d69-8400-45e7-b537-646385b7e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aee97d69-8400-45e7-b537-646385b7e02d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2fa33e53-e52e-48d6-a165-c9d3693ee25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2fa33e53-e52e-48d6-a165-c9d3693ee25d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4379a587-4647-4239-9700-53247df8eaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4379a587-4647-4239-9700-53247df8eaff" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:to="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b75595c-69c5-4003-ab84-821a111950bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b75595c-69c5-4003-ab84-821a111950bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96fbcd96-9874-4f17-a6f8-6bdaffd64a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96fbcd96-9874-4f17-a6f8-6bdaffd64a77" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationRestrictedShareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="extended" id="ieb560caf48ae4d13b284b0de3c980eb2_ShareBasedCompensationRestrictedShareActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_289af442-1c86-4a29-8a40-eee1006ebc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_289af442-1c86-4a29-8a40-eee1006ebc43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2e3ebbf-cdeb-47c0-83ec-6937e252f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2e3ebbf-cdeb-47c0-83ec-6937e252f264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae4669e3-91c6-4623-a555-d697931522b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae4669e3-91c6-4623-a555-d697931522b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f8f6969b-cb80-4d88-aa72-b601b78b6810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_505cea9d-b6a3-429e-8f2a-75f9db1c135a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_505cea9d-b6a3-429e-8f2a-75f9db1c135a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22d45443-8d2f-4e28-a78a-0806350ac2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22d45443-8d2f-4e28-a78a-0806350ac2b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f3c045a4-cdc9-45b0-91d7-9ba1038e40c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f3c045a4-cdc9-45b0-91d7-9ba1038e40c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6be7473d-1315-4656-869a-2a43624e2630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:to="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c30a54c9-055b-4bb0-b403-345da90fe2f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c30a54c9-055b-4bb0-b403-345da90fe2f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5a5c66f5-5477-42e3-a48a-94ca6c7055e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:to="loc_us-gaap_RestrictedStockMember_5a5c66f5-5477-42e3-a48a-94ca6c7055e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationOtherShareBasedCompensationDataDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="extended" id="i87feafa313cb437fbf648cf7776782b1_ShareBasedCompensationOtherShareBasedCompensationDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_005c19d7-f583-4a1f-bf10-2d3dd767d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_005c19d7-f583-4a1f-bf10-2d3dd767d5a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4f7409bc-f1c4-47d1-8d50-c6d815205739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4f7409bc-f1c4-47d1-8d50-c6d815205739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_049a28a3-82c9-4d82-8d08-dfe1a1f03142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_049a28a3-82c9-4d82-8d08-dfe1a1f03142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_79aa2b8f-4968-4415-8a07-f286b94ba747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_79aa2b8f-4968-4415-8a07-f286b94ba747" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b2c578b1-2a5e-4873-8237-459c764f93a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensation_b2c578b1-2a5e-4873-8237-459c764f93a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e5c84672-f8f0-46bc-b88f-e24a18774b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e5c84672-f8f0-46bc-b88f-e24a18774b17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_daae5174-5a1f-49cc-a23d-c346313218e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_daae5174-5a1f-49cc-a23d-c346313218e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_587ee9a4-e876-402d-ad67-e378e418ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_587ee9a4-e876-402d-ad67-e378e418ca0c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9532fd4-1647-4a5a-8723-a649e90fced3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9532fd4-1647-4a5a-8723-a649e90fced3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a2b622c7-9b4f-430a-83e4-7fd74858031a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a2b622c7-9b4f-430a-83e4-7fd74858031a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:to="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a86d3246-3533-4fe3-9d24-df247fecb907_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a86d3246-3533-4fe3-9d24-df247fecb907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_ac0b87db-74fa-493b-9f5c-f531749518e3" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_unh_StockOptionsandSARsMember_ac0b87db-74fa-493b-9f5c-f531749518e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6a324dad-4783-4c9a-9649-7c4659796ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6a324dad-4783-4c9a-9649-7c4659796ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_ae7c38f5-9fb1-4285-a72e-a3ce1822f09c" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_ae7c38f5-9fb1-4285-a72e-a3ce1822f09c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="extended" id="ia689da2d71ea48a8868dbae49f896de2_ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_76d1c167-69f9-4114-bef4-3e3947bd47b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_76d1c167-69f9-4114-bef4-3e3947bd47b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a83c9d6e-6094-47a7-90c8-ffc3bfe8d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a83c9d6e-6094-47a7-90c8-ffc3bfe8d59d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df7ac615-8874-4293-b257-9920f017a99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df7ac615-8874-4293-b257-9920f017a99a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_6ea30382-f05f-4828-8a41-5306b852e72c" xlink:href="unh-20221231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_6ea30382-f05f-4828-8a41-5306b852e72c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_52310e24-b752-419e-b824-341f583abcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_52310e24-b752-419e-b824-341f583abcb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9fb644d-7215-4980-b0c4-c656cd9453f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9fb644d-7215-4980-b0c4-c656cd9453f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_12afe9cb-0a81-4d84-9902-3716065fb0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_12afe9cb-0a81-4d84-9902-3716065fb0c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cba6ee3-de23-48dd-a6b9-e3db7681176a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cba6ee3-de23-48dd-a6b9-e3db7681176a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:to="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18fd8e09-d915-4819-b137-bb2229594cd5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:to="loc_srt_RangeMember_18fd8e09-d915-4819-b137-bb2229594cd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:to="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c72003af-4761-4d21-9c6d-a76bdc6fcaef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:to="loc_srt_MinimumMember_c72003af-4761-4d21-9c6d-a76bdc6fcaef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8bbdc7b5-2a9b-4683-a9ca-b56ffe47cf89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:to="loc_srt_MaximumMember_8bbdc7b5-2a9b-4683-a9ca-b56ffe47cf89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i58b79d7021644afd9c0d6d595a51cecf_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a86499c8-4195-4c72-ab26-b82e91320612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseCost_a86499c8-4195-4c72-ab26-b82e91320612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_63e588bf-c3a0-4ba0-a3a4-80757358c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeasePayments_63e588bf-c3a0-4ba0-a3a4-80757358c22c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b65b2442-3361-45b6-b193-f3645b6748b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b65b2442-3361-45b6-b193-f3645b6748b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_875b7fa9-aad1-4ef3-a6b1-940c4f2727f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_875b7fa9-aad1-4ef3-a6b1-940c4f2727f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_0f1d0138-0576-408a-a987-d7feea269777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OtherCommitment_0f1d0138-0576-408a-a987-d7feea269777" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription_b6dc8213-8d56-485d-895a-b5206d02103e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OtherCommitmentsDescription_b6dc8213-8d56-485d-895a-b5206d02103e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription_1d51ae4b-ef9d-437b-b6b8-3947c32655b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_SubsequentEventDescription_1d51ae4b-ef9d-437b-b6b8-3947c32655b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_568aec46-8467-4cf8-9114-3c2a550b64a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:to="loc_us-gaap_LossContingencyNatureDomain_568aec46-8467-4cf8-9114-3c2a550b64a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c2ca8b17-10a5-4e0f-aa02-e901a987486a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c2ca8b17-10a5-4e0f-aa02-e901a987486a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_798586af-0b7d-426f-be44-bf6baeec6187_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_798586af-0b7d-426f-be44-bf6baeec6187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43de28ff-d592-443a-804b-eb0893ea6657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43de28ff-d592-443a-804b-eb0893ea6657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8b606431-9790-44a4-9710-ed14c9b3dbe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8b606431-9790-44a4-9710-ed14c9b3dbe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_249e19ea-6a0f-4c67-a566-b135202de43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:to="loc_us-gaap_SubsequentEventMember_249e19ea-6a0f-4c67-a566-b135202de43e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentandContingenciesFutureLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails" xlink:type="extended" id="i6a0dd12c259b4c29882d833d5a82346e_CommitmentandContingenciesFutureLeasePaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ee7515c-3cba-490a-95f0-56f1cc3b3426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ee7515c-3cba-490a-95f0-56f1cc3b3426" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41eb1ac2-7c66-4415-92a9-46800f88bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41eb1ac2-7c66-4415-92a9-46800f88bc7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5576d0f4-73de-40b5-b91b-d85e612f2b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5576d0f4-73de-40b5-b91b-d85e612f2b0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c784315-8ea3-4932-978c-1518d07a91c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c784315-8ea3-4932-978c-1518d07a91c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15c6dc1f-a215-43a8-8b2c-bb61143eee29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15c6dc1f-a215-43a8-8b2c-bb61143eee29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a0211484-1b4a-462e-bf2e-81e5efedffe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a0211484-1b4a-462e-bf2e-81e5efedffe4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d3af30b-84d0-4a3e-a75d-bbfd18225f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d3af30b-84d0-4a3e-a75d-bbfd18225f5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9ab3a07b-f5f8-477c-a6cd-1134e9b66704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9ab3a07b-f5f8-477c-a6cd-1134e9b66704" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f8bde2ea-a47b-4fc4-aa30-908818e8beff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_OperatingLeaseLiability_f8bde2ea-a47b-4fc4-aa30-908818e8beff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_334f9d28-dd7a-4086-b1af-849f1ce0d1e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_334f9d28-dd7a-4086-b1af-849f1ce0d1e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3050c476-4b1f-4e01-8d33-cea00b908394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3050c476-4b1f-4e01-8d33-cea00b908394" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="i26ab2581657044308487db2f781ace37_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_58611f40-d664-4aa0-b974-53e2e1b60c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_58611f40-d664-4aa0-b974-53e2e1b60c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da73fef2-5561-4ca6-b47a-07d04e55a65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da73fef2-5561-4ca6-b47a-07d04e55a65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CarryingValueOfDisposition_5f2e37a5-7b6e-46c7-a7e9-2574fc09e628" xlink:href="unh-20221231.xsd#unh_CarryingValueOfDisposition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_unh_CarryingValueOfDisposition_5f2e37a5-7b6e-46c7-a7e9-2574fc09e628" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7973d835-c64f-48a8-bc37-59e16c04721e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7973d835-c64f-48a8-bc37-59e16c04721e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareMember_51a3fcf5-88e7-4cbb-8b61-5a96c5eb2f93" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:to="loc_unh_ChangeHealthcareMember_51a3fcf5-88e7-4cbb-8b61-5a96c5eb2f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_78d79e24-6d98-4f8b-88b9-543959e76004" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:to="loc_unh_OtherAcquisitionsMember_78d79e24-6d98-4f8b-88b9-543959e76004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1127ff01-d3ca-43aa-9555-2ada61875aaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1127ff01-d3ca-43aa-9555-2ada61875aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareClaimEditingBusinessMember_35e74e25-ed8f-431b-989b-4bbf66b7ffab" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareClaimEditingBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:to="loc_unh_ChangeHealthcareClaimEditingBusinessMember_35e74e25-ed8f-431b-989b-4bbf66b7ffab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherDispositionsMember_8cfb32f3-8ba3-4b64-8664-8d46286fa4ed" xlink:href="unh-20221231.xsd#unh_OtherDispositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:to="loc_unh_OtherDispositionsMember_8cfb32f3-8ba3-4b64-8664-8d46286fa4ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails" xlink:type="extended" id="i8147376296f04c0d8260d803c1cd1856_BusinessCombinationsAcquiredAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2fa2329-70a2-41b1-a3cc-821770d543f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2fa2329-70a2-41b1-a3cc-821770d543f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_36b2d6a2-d0f5-461e-8538-c79056797e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_36b2d6a2-d0f5-461e-8538-c79056797e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_4e66305a-28e4-44be-a64f-187e36dccf80" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_4e66305a-28e4-44be-a64f-187e36dccf80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_02b74068-2e98-42b4-9693-f9ff3e881dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_02b74068-2e98-42b4-9693-f9ff3e881dfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_05812a3c-6ee4-4513-80e5-e69e3e51e5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_05812a3c-6ee4-4513-80e5-e69e3e51e5fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7642a862-7924-4379-a103-47b90487b6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7642a862-7924-4379-a103-47b90487b6e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d117455f-03a8-4b3b-a60c-d58767488496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d117455f-03a8-4b3b-a60c-d58767488496" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9d28a5b-2584-48d6-b0a2-23f9a37c94a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9d28a5b-2584-48d6-b0a2-23f9a37c94a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_146ad082-9d9e-4764-8132-bcae2f660e42" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_146ad082-9d9e-4764-8132-bcae2f660e42" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55ee6a0a-2529-4c4f-b6c8-7186fb5edcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55ee6a0a-2529-4c4f-b6c8-7186fb5edcd6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04072252-3d56-47e7-9c15-9548724c24a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04072252-3d56-47e7-9c15-9548724c24a6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a287c664-1fce-49ab-b3a1-60f1c882e718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a287c664-1fce-49ab-b3a1-60f1c882e718" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3df154c-bac4-49c1-8a05-a684d7300005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_Goodwill_b3df154c-bac4-49c1-8a05-a684d7300005" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests_39762c9e-0a60-4cb9-ad8b-6a0628ad51af" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsRedeemableNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests_39762c9e-0a60-4cb9-ad8b-6a0628ad51af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_2b29b403-a92c-49f5-8203-f1d639b3ff3a" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsNonredeemableNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_2b29b403-a92c-49f5-8203-f1d639b3ff3a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d7a81e8f-5553-4559-a69b-271cddc76432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d7a81e8f-5553-4559-a69b-271cddc76432" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c992eeb7-6b46-410f-b47f-cb855da19dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c992eeb7-6b46-410f-b47f-cb855da19dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf976488-6ebf-4dac-8d04-39fbfeaa354c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf976488-6ebf-4dac-8d04-39fbfeaa354c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_047f119d-d041-4a71-b679-46d7927115c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_047f119d-d041-4a71-b679-46d7927115c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_14e8f289-7892-4ff2-96ae-5e8668934a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_14e8f289-7892-4ff2-96ae-5e8668934a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e23682e0-866f-4268-97ae-7a1f103a12bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e23682e0-866f-4268-97ae-7a1f103a12bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareAcquisitionMember_6f0fbc50-c625-48b3-aaae-9b8ae80fafdc" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_ChangeHealthcareAcquisitionMember_6f0fbc50-c625-48b3-aaae-9b8ae80fafdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_f894cbf1-28e6-4a8a-aad5-3587e727c2ee" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_OtherAcquisitionsMember_f894cbf1-28e6-4a8a-aad5-3587e727c2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalAcquisitionsMember_5013ab52-f845-4965-bb13-544cc786ed12" xlink:href="unh-20221231.xsd#unh_TotalAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_TotalAcquisitionsMember_5013ab52-f845-4965-bb13-544cc786ed12" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="i6611dde86bea420f8162dd361023e02c_BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_057b5992-67b0-4126-85e3-4be83a7eb809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_057b5992-67b0-4126-85e3-4be83a7eb809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d911fb7-6153-4f38-b17f-e3a72fd146e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d911fb7-6153-4f38-b17f-e3a72fd146e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1447bed4-0189-47b6-833e-0abb8e2a6e8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1447bed4-0189-47b6-833e-0abb8e2a6e8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_139391b8-a45f-422e-81ba-42f19358ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_139391b8-a45f-422e-81ba-42f19358ba2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_be03f3ef-5374-42ef-bcdf-2ceb6ed7a6c2" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_unh_TrademarksandTechnologyMember_be03f3ef-5374-42ef-bcdf-2ceb6ed7a6c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8624745b-0983-4c02-b398-add4908c0728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8624745b-0983-4c02-b398-add4908c0728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aae5f5a0-e502-4aeb-b128-c07714c2eef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aae5f5a0-e502-4aeb-b128-c07714c2eef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareMember_4ec75610-ab73-41d3-9e16-eaea97757c00" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_ChangeHealthcareMember_4ec75610-ab73-41d3-9e16-eaea97757c00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_7d902cba-a05b-4b78-adb3-a1fbdf3f2c49" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_OtherAcquisitionsMember_7d902cba-a05b-4b78-adb3-a1fbdf3f2c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalAcquisitionsMember_f65c808e-dd06-4393-a4c0-447ac53d6425" xlink:href="unh-20221231.xsd#unh_TotalAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_TotalAcquisitionsMember_f65c808e-dd06-4393-a4c0-447ac53d6425" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="extended" id="i43b9a78992a74dd7bd3f628df37aef03_SegmentFinancialInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b132929-e26c-4860-9136-a08ac5ec7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b132929-e26c-4860-9136-a08ac5ec7d47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_765eaf20-29f0-4061-a570-a1d491054e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_765eaf20-29f0-4061-a570-a1d491054e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_918a5fd6-153b-4bc8-8c95-6f8d0a023349" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_918a5fd6-153b-4bc8-8c95-6f8d0a023349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_cf6e54f4-8127-4811-9d3e-8631da97b3d1" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_cf6e54f4-8127-4811-9d3e-8631da97b3d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e1dbc873-abc0-48d7-a4f0-611a3a3a0467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e1dbc873-abc0-48d7-a4f0-611a3a3a0467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember_999cba7d-50e1-44e6-b17c-aa22d7c0b51d" xlink:href="unh-20221231.xsd#unh_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:to="loc_unh_RevenuesMember_999cba7d-50e1-44e6-b17c-aa22d7c0b51d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_257dfebf-61e0-4a6d-9303-50f433665dda_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:to="loc_srt_NameOfMajorCustomerDomain_257dfebf-61e0-4a6d-9303-50f433665dda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:to="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember_397c8580-57b4-4893-b9da-c6392cbb89a0" xlink:href="unh-20221231.xsd#unh_CMSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:to="loc_unh_CMSMember_397c8580-57b4-4893-b9da-c6392cbb89a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_19105710-725d-42e1-8069-b5e3739425e9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:to="loc_srt_SegmentGeographicalDomain_19105710-725d-42e1-8069-b5e3739425e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:to="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1448c6be-e242-458a-aa95-082b7cbba700" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:to="loc_country_US_1448c6be-e242-458a-aa95-082b7cbba700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_09e4d3b5-4e07-498e-8e31-5121b7446577_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:to="loc_srt_ScenarioUnspecifiedDomain_09e4d3b5-4e07-498e-8e31-5121b7446577_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2a5598fc-cc87-4c89-b88f-c41df723a9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2a5598fc-cc87-4c89-b88f-c41df723a9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_032a7e75-e351-451d-af24-34d737c40699_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_032a7e75-e351-451d-af24-34d737c40699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_918acd73-9296-4f58-b41c-d655d60a3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:to="loc_us-gaap_SalesRevenueNetMember_918acd73-9296-4f58-b41c-d655d60a3d7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended" id="i993f9d8723984337a5d756e9f6c63a7d_SegmentFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5b3463db-e6ae-4054-8089-599542e0e9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_PremiumsEarnedNet_5b3463db-e6ae-4054-8089-599542e0e9b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1857e123-5878-4a55-9253-ea3ff2907fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1857e123-5878-4a55-9253-ea3ff2907fcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_a1aaefca-1a27-4ea6-889e-253842f70541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_a1aaefca-1a27-4ea6-889e-253842f70541" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fdc2d988-3533-4d8c-8ec3-f82949709482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_Revenues_fdc2d988-3533-4d8c-8ec3-f82949709482" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ff43d329-ad42-449b-9a8c-47d5b5b838b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_OperatingIncomeLoss_ff43d329-ad42-449b-9a8c-47d5b5b838b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3e098ce8-1fd4-4f72-bba2-7903e7615974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_InterestExpense_3e098ce8-1fd4-4f72-bba2-7903e7615974" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1f4a468-ed4f-4532-b855-c9bfd37e1ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1f4a468-ed4f-4532-b855-c9bfd37e1ab8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_de1d81f5-d3d0-434d-8849-4e2f0c406286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_Assets_de1d81f5-d3d0-434d-8849-4e2f0c406286" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0d058aa-a5e8-4ab1-a391-1e9344ec65f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0d058aa-a5e8-4ab1-a391-1e9344ec65f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2b62fc49-3650-4c46-8992-d2dd6f862274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_DepreciationAndAmortization_2b62fc49-3650-4c46-8992-d2dd6f862274" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_69096705-3258-45dc-8a89-c5c4653e73f7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:to="loc_srt_ConsolidationItemsDomain_69096705-3258-45dc-8a89-c5c4653e73f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:to="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42b88644-4d35-4bcc-b0ad-39344418bae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_OperatingSegmentsMember_42b88644-4d35-4bcc-b0ad-39344418bae4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_35018cab-2096-401b-92a7-c7f18fd0438b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_IntersegmentEliminationMember_35018cab-2096-401b-92a7-c7f18fd0438b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_69a96b82-cdaf-4bd3-9ad6-4d4df8b43bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_CorporateNonSegmentMember_69a96b82-cdaf-4bd3-9ad6-4d4df8b43bbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d46f9a85-b695-4140-a62d-a735ca94a1a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_d46f9a85-b695-4140-a62d-a735ca94a1a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember_14165e3b-2d2e-4499-a787-d320ee8b628d" xlink:href="unh-20221231.xsd#unh_ExternalCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:to="loc_unh_ExternalCustomersMember_14165e3b-2d2e-4499-a787-d320ee8b628d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember_b0a23085-f250-40b9-81e4-252d75378622" xlink:href="unh-20221231.xsd#unh_IntersegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:to="loc_unh_IntersegmentMember_b0a23085-f250-40b9-81e4-252d75378622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b10c6fa5-0498-4474-91b9-122c90216922_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:to="loc_us-gaap_SegmentDomain_b10c6fa5-0498-4474-91b9-122c90216922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:to="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_151faf75-7902-4107-aa92-0292ad08c435" xlink:href="unh-20221231.xsd#unh_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:to="loc_unh_UnitedhealthcareMember_151faf75-7902-4107-aa92-0292ad08c435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:href="unh-20221231.xsd#unh_TotalOptumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:to="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_1484104a-3709-4ffc-86b0-86ca0e09bd06" xlink:href="unh-20221231.xsd#unh_OptumhealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptumhealthMember_1484104a-3709-4ffc-86b0-86ca0e09bd06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_15cd4e74-e3e1-4ecb-b17d-3b5cad688c51" xlink:href="unh-20221231.xsd#unh_OptuminsightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptuminsightMember_15cd4e74-e3e1-4ecb-b17d-3b5cad688c51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_260c56bb-5adf-470b-9cdb-8384bb369af0" xlink:href="unh-20221231.xsd#unh_OptumrxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptumrxMember_260c56bb-5adf-470b-9cdb-8384bb369af0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee995ca4-c9d2-42b2-9a18-d508b500e77c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:to="loc_srt_ProductsAndServicesDomain_ee995ca4-c9d2-42b2-9a18-d508b500e77c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:to="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_1b21888f-f853-4d32-82d5-b881b74a027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:to="loc_us-gaap_ProductMember_1b21888f-f853-4d32-82d5-b881b74a027b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3c35bb16-833d-4d25-8fb4-e91ff97274ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:to="loc_us-gaap_ServiceMember_3c35bb16-833d-4d25-8fb4-e91ff97274ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIDetails" xlink:type="extended" id="i688eb0c6401f4772a45a14b2660627f3_ScheduleIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8a5d4fbb-a6cf-4acd-a460-2710c329327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8a5d4fbb-a6cf-4acd-a460-2710c329327e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_093033b1-27b5-4ae8-96a4-b51c7a19c6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_093033b1-27b5-4ae8-96a4-b51c7a19c6ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_81cd262c-6558-4e70-8df6-54ec3ed679f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_OtherLongTermDebt_81cd262c-6558-4e70-8df6-54ec3ed679f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_393f82ea-50ff-460e-9564-156b11cf5df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_NotesPayable_393f82ea-50ff-460e-9564-156b11cf5df0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_af5fe025-c54f-4584-9f31-b2fa3c347da7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_af5fe025-c54f-4584-9f31-b2fa3c347da7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d6504953-6bb4-4258-939d-a7f1cb106191" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:to="loc_srt_ParentCompanyMember_d6504953-6bb4-4258-939d-a7f1cb106191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_ef276e57-40e7-41c2-8d95-d31f532fd9ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:to="loc_srt_SubsidiariesMember_ef276e57-40e7-41c2-8d95-d31f532fd9ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleICondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="extended" id="i0451780157294568ba28ce391446d76d_ScheduleICondensedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8a17d3a6-cc85-47e2-8fe0-550b413e0055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsAbstract_8a17d3a6-cc85-47e2-8fe0-550b413e0055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0b4abe4d-7a07-4061-8132-adf2d3d5c16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0b4abe4d-7a07-4061-8132-adf2d3d5c16b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a18890-57d5-4590-b415-10fb887e2353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a18890-57d5-4590-b415-10fb887e2353" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a2462b36-324b-4009-94ce-b5ef5790176e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherAssetsCurrent_a2462b36-324b-4009-94ce-b5ef5790176e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d9ccaef2-350e-4f48-97d7-8ad9c0e9f2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsCurrent_d9ccaef2-350e-4f48-97d7-8ad9c0e9f2ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries_40be67d0-7fb3-46a4-acab-e145d1cd936d" xlink:href="unh-20221231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_unh_EquityinNetAssetsofSubsidiaries_40be67d0-7fb3-46a4-acab-e145d1cd936d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_748d8128-5e30-480e-a251-d503b4a4e1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_748d8128-5e30-480e-a251-d503b4a4e1d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_44fe6d4b-8264-4bd6-8f1c-ceabd3eb11e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_44fe6d4b-8264-4bd6-8f1c-ceabd3eb11e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0eeab67f-dca3-43cd-8fbc-4dcaaeb39b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_Assets_0eeab67f-dca3-43cd-8fbc-4dcaaeb39b56" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78ab26d2-50b3-476b-89a7-a8c5e0df95bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78ab26d2-50b3-476b-89a7-a8c5e0df95bb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5e40546a-0aa9-4a27-97d7-6a56f785970f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5e40546a-0aa9-4a27-97d7-6a56f785970f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_261b5fae-f14c-47c7-b789-7c2531e617b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_261b5fae-f14c-47c7-b789-7c2531e617b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_08f78e8a-8451-46c9-96ac-8bb4c3768d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_08f78e8a-8451-46c9-96ac-8bb4c3768d87" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_867f3b24-3f78-4859-9547-7a37b4d284a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LongTermDebtCurrent_867f3b24-3f78-4859-9547-7a37b4d284a4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e7d95ffa-bdf6-4c86-9f6a-568742bace1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesCurrent_e7d95ffa-bdf6-4c86-9f6a-568742bace1d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_65618a0b-39e2-4408-a467-5672620d3cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_65618a0b-39e2-4408-a467-5672620d3cc2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8eaefa4f-c6e5-49ce-b6b1-05808720c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8eaefa4f-c6e5-49ce-b6b1-05808720c530" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1d5d6ef6-9b95-4cfd-a5c7-015a6e94e454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_Liabilities_1d5d6ef6-9b95-4cfd-a5c7-015a6e94e454" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0b8f7237-11f9-472b-9343-aa8a3ef59972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0b8f7237-11f9-472b-9343-aa8a3ef59972" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_d619e5d6-f29b-4303-b5bb-0df235c60dee" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_unh_ShareholdersEquityAbstract_d619e5d6-f29b-4303-b5bb-0df235c60dee" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ece73d42-fa60-41d9-8e8e-7eac6769d59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_PreferredStockValue_ece73d42-fa60-41d9-8e8e-7eac6769d59b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_78044bb4-68c7-4ef5-8c6f-a797935546eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CommonStockValue_78044bb4-68c7-4ef5-8c6f-a797935546eb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_435bdc90-e81f-46ad-ad30-49dedad61858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_435bdc90-e81f-46ad-ad30-49dedad61858" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c8bc2b4-d115-4829-855a-baaee2a2a9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c8bc2b4-d115-4829-855a-baaee2a2a9a1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_43e26e6d-aa9a-4f2a-a7f0-d2950ee359e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_StockholdersEquity_43e26e6d-aa9a-4f2a-a7f0-d2950ee359e7" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b049f1c2-a41e-4369-abfe-8b78a784c477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b049f1c2-a41e-4369-abfe-8b78a784c477" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_69477637-10a0-450a-a093-00bffc789372_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:to="loc_srt_ConsolidatedEntitiesDomain_69477637-10a0-450a-a093-00bffc789372_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_f35f45ef-9536-49a5-9a88-2020753e9d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:to="loc_srt_ParentCompanyMember_f35f45ef-9536-49a5-9a88-2020753e9d05" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIBalanceSheetDocumentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="extended" id="i5c2c1d285dae4f5ca8ebd56728d33778_ScheduleIBalanceSheetDocumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a3df5d8-ab91-40b5-bba4-2c2a7fffc138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a3df5d8-ab91-40b5-bba4-2c2a7fffc138" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_45d74ed5-e972-4eb3-b5a7-87effdd07396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_45d74ed5-e972-4eb3-b5a7-87effdd07396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ecb84a68-50d8-4c09-b28c-df4c121c1d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesIssued_ecb84a68-50d8-4c09-b28c-df4c121c1d7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b0757fd5-29ae-456c-b49d-c8030dda474c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b0757fd5-29ae-456c-b49d-c8030dda474c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c1fa983-0cff-4703-a0c0-9d62bc2339c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c1fa983-0cff-4703-a0c0-9d62bc2339c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_cc643095-9721-4147-9213-0e7b77b0dd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_cc643095-9721-4147-9213-0e7b77b0dd45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ca8b50be-1001-4e8c-a5e1-e2d7fe88720e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ca8b50be-1001-4e8c-a5e1-e2d7fe88720e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7f07e971-72d9-4f84-a4af-620a17e5361d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7f07e971-72d9-4f84-a4af-620a17e5361d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_203ecd4a-e9a3-4b92-9bd1-16472d80caca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:to="loc_srt_ParentCompanyMember_203ecd4a-e9a3-4b92-9bd1-16472d80caca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_95318fcc-74b4-4cd6-b593-0bef460f5418_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:to="loc_srt_ScenarioUnspecifiedDomain_95318fcc-74b4-4cd6-b593-0bef460f5418_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6e33bb20-bfdd-42cf-9d64-b998bcc2eb5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6e33bb20-bfdd-42cf-9d64-b998bcc2eb5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:to="loc_us-gaap_ClassOfStockDomain_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ee331f78-2249-4c12-8dff-255e9556f353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:to="loc_us-gaap_ClassOfStockDomain_ee331f78-2249-4c12-8dff-255e9556f353" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleICondensedStatementofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="extended" id="i7e431df7a66a413fbcfac94cacc37023_ScheduleICondensedStatementofComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a9c8ab81-e82c-4f1a-b11e-9dd52111f8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_RevenuesAbstract_a9c8ab81-e82c-4f1a-b11e-9dd52111f8ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_1bfd8ac5-0eb2-424e-944c-376d8de0ac49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_1bfd8ac5-0eb2-424e-944c-376d8de0ac49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0cd96f76-42a7-412b-86f9-111ed9a2bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_Revenues_0cd96f76-42a7-412b-86f9-111ed9a2bf05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_07d06d9c-86a7-4b20-a04a-1372fd04ad76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_07d06d9c-86a7-4b20-a04a-1372fd04ad76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1c2ab0aa-59c7-4956-8630-de16348c0dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_OperatingExpenses_1c2ab0aa-59c7-4956-8630-de16348c0dc5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2b6c23be-98f6-4b46-8dd8-67ac5befba3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_InterestExpense_2b6c23be-98f6-4b46-8dd8-67ac5befba3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_68a43c33-0e95-4972-bff8-30b1b646da39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_CostsAndExpenses_68a43c33-0e95-4972-bff8-30b1b646da39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1517cbd-3a1f-4a56-b5fa-f4b05d8c5e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1517cbd-3a1f-4a56-b5fa-f4b05d8c5e76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20ff0311-9202-46f6-b309-524bf40f44a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20ff0311-9202-46f6-b309-524bf40f44a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany_667769be-c088-4502-9a6b-bf2e54a3a0ce" xlink:href="unh-20221231.xsd#unh_LossofParentCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_unh_LossofParentCompany_667769be-c088-4502-9a6b-bf2e54a3a0ce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_e999ddc6-fd0f-4237-9c05-b73961f2bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_e999ddc6-fd0f-4237-9c05-b73961f2bc4b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c60d2254-748d-4ddc-bbb8-5709c10de13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_NetIncomeLoss_c60d2254-748d-4ddc-bbb8-5709c10de13f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_104c3e16-311d-423f-9c63-4897a7cd2a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_104c3e16-311d-423f-9c63-4897a7cd2a50" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b3fea80-7178-444c-9092-f8051d3a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b3fea80-7178-444c-9092-f8051d3a9af9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:to="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_4297bab3-f35e-4b81-a481-7e485f6ad300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:to="loc_srt_ParentCompanyMember_4297bab3-f35e-4b81-a481-7e485f6ad300" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIStatementofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="extended" id="i18c2b33acc8b4f2c902edf0e2b77bc5c_ScheduleIStatementofCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_365bfc72-fe90-4a8c-8ca3-f92095298c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_365bfc72-fe90-4a8c-8ca3-f92095298c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f973face-c240-4789-b35e-8195ed73e827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f973face-c240-4789-b35e-8195ed73e827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c78dd9fe-9f7e-4b43-8e74-84957413804d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c78dd9fe-9f7e-4b43-8e74-84957413804d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_a82c7d68-f384-499f-9d7b-76155f768e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_a82c7d68-f384-499f-9d7b-76155f768e14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_7cb3d77a-1ec2-4c5d-9f08-b42a9a958478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_7cb3d77a-1ec2-4c5d-9f08-b42a9a958478" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a6dea01e-9797-4674-876c-e285e2b14b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a6dea01e-9797-4674-876c-e285e2b14b16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c665e2cb-9f29-4558-b1b1-a566b86c76d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c665e2cb-9f29-4558-b1b1-a566b86c76d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries_c86fb7a6-4bca-4e3c-a45c-eeac9d44e655" xlink:href="unh-20221231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_unh_Capitalcontributionstosubsidiaries_c86fb7a6-4bca-4e3c-a45c-eeac9d44e655" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd011c8-d9af-4830-b7c8-500a06a14f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd011c8-d9af-4830-b7c8-500a06a14f97" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b2cfb2c0-9d5b-4e81-93c1-88eb6ad60fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b2cfb2c0-9d5b-4e81-93c1-88eb6ad60fd5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67e914cf-3a23-4913-af82-ed0aa992f8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67e914cf-3a23-4913-af82-ed0aa992f8f2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e32a8881-c09c-42b2-972c-85183cff1886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e32a8881-c09c-42b2-972c-85183cff1886" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50df9651-6f51-4e1c-84ef-6d99ac369d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50df9651-6f51-4e1c-84ef-6d99ac369d9a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f6ef350e-1bdf-48b2-a08d-a162653831ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsOfDividends_f6ef350e-1bdf-48b2-a08d-a162653831ff" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_d62cf74d-b2eb-4cf0-849b-f3099b4564ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_d62cf74d-b2eb-4cf0-849b-f3099b4564ff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ec553d87-a92a-469c-b8ef-06592e16a428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ec553d87-a92a-469c-b8ef-06592e16a428" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_046a0972-cfd4-4be0-ac71-2670afe2d954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_046a0972-cfd4-4be0-ac71-2670afe2d954" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_cfe38a2b-e1ab-4994-b7ab-5d901f250708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_cfe38a2b-e1ab-4994-b7ab-5d901f250708" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf580844-b368-4b22-ac7f-995eb4bfc794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf580844-b368-4b22-ac7f-995eb4bfc794" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e8f7bc3-42cb-4382-9cde-cd1567640ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e8f7bc3-42cb-4382-9cde-cd1567640ab8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1673c6b-4b64-4ead-9afd-c491f85a919f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1673c6b-4b64-4ead-9afd-c491f85a919f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cef251e1-df57-4d64-a106-cb016493fdf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cef251e1-df57-4d64-a106-cb016493fdf5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bedbd93e-e254-4e0c-9106-5b66a3cbd6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_87695fef-b87a-42d1-80cf-c12d27d2b166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:to="loc_us-gaap_InterestPaidNet_87695fef-b87a-42d1-80cf-c12d27d2b166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ef7d2b09-428d-4c4d-97bc-cc3ced6dc335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ef7d2b09-428d-4c4d-97bc-cc3ced6dc335" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:to="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_f9834877-d4a1-463f-a81f-155823b9a7ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:to="loc_srt_ParentCompanyMember_f9834877-d4a1-463f-a81f-155823b9a7ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:to="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_df36fd86-e296-4506-b46e-16035c1063d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_df36fd86-e296-4506-b46e-16035c1063d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5be2e05b-9fb7-49d1-bd04-b1a19b082d94" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5be2e05b-9fb7-49d1-bd04-b1a19b082d94" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended" id="i6e5b6e69266a489c88207bea000139f4_ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f131b6f4-e77c-4719-a855-fc451048c436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f131b6f4-e77c-4719-a855-fc451048c436" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_378b29f5-2f1d-46fc-8bd0-ee301c635fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_378b29f5-2f1d-46fc-8bd0-ee301c635fc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7596a9a3-d64c-4d2b-bb09-1410c0f5915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7596a9a3-d64c-4d2b-bb09-1410c0f5915e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ef53e29-85ed-492b-b9d5-765371bb3ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ef53e29-85ed-492b-b9d5-765371bb3ee9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_41aeca1d-ed68-4be7-abca-c7bae0dbd3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_41aeca1d-ed68-4be7-abca-c7bae0dbd3c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_25b711f5-610a-431a-a8f3-354d6c95df45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_25b711f5-610a-431a-a8f3-354d6c95df45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_58ffd36f-60a9-47f4-aeaa-508a96c8a4f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:to="loc_srt_ParentCompanyMember_58ffd36f-60a9-47f4-aeaa-508a96c8a4f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>23
<FILENAME>unh-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_375748fa-de36-43ce-82d5-b57487959273_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_d8377964-a9fe-4077-9464-dc79c5aebbe3_terseLabel_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Long Lived Assets</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_label_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Long Lived Assets</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_documentation_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:to="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_258224b2-eec1-4cd4-bb1a-539ffa7613e4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_bd307eac-b6dd-42d9-a4e5-6213fdd508ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_cbf148f4-3964-4f63-b94d-6897b137103f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_fb26eb27-9cd3-4af2-be9b-87e78725aefd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_58088ddf-fa93-4266-8b2e-983b40d91a79_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_315418fb-76cd-4982-b708-ed9e47f7c96c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_39ddf27a-6819-45af-b79d-0d0cde368e42_terseLabel_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Revenue from External Customers</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_label_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Revenue from External Customers</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_documentation_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:to="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_fb067e6d-13c8-48ef-9272-de88ac697ac7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_1cc7208e-c88c-4194-9046-6cee031913b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_af5058c3-1ab9-494b-82cd-1200676c4e76_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_7982d97a-af35-4e6b-be0d-d369ac10cda4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to nonredeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9955e932-c59f-4bb3-8fd9-dce61d91651c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and other financing obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5350NotesDueFebruary2033Member_8d8bc9ea-619d-4d7f-b1c5-26b5f9c1fab3_terseLabel_en-US" xlink:label="lab_unh_A5350NotesDueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.350% notes due February 2033 [Member]</link:label>
    <link:label id="lab_unh_A5350NotesDueFebruary2033Member_label_en-US" xlink:label="lab_unh_A5350NotesDueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.350% notes due February 2033 [Member]</link:label>
    <link:label id="lab_unh_A5350NotesDueFebruary2033Member_documentation_en-US" xlink:label="lab_unh_A5350NotesDueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.350% notes due February 2033 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5350NotesDueFebruary2033Member" xlink:href="unh-20221231.xsd#unh_A5350NotesDueFebruary2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5350NotesDueFebruary2033Member" xlink:to="lab_unh_A5350NotesDueFebruary2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1c4dd48d-5df9-4890-b8a0-5abdb0f300c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_365630f3-92a9-4507-88fe-40c723dcc97a_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4dc83de8-b427-4111-9296-7a16f674ec57_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2ccafef4-8f22-4dba-83d5-facfd9bb3613_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_779e0736-a804-496f-bda0-09f77e6e7b8a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e872751b-779b-421e-a1d3-5103c25e1e8f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_fd6cfc4d-c365-4776-acd6-06043d300576_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e64b03c1-aa3c-4d8c-a05c-18a22b3cf145_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_a15e247a-ada0-4f0b-8692-3ffd71a39d6d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6b59e3ff-c10b-4beb-824f-efb18a39a47d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f2c2cdbe-018a-4eec-8abd-5563e8abda54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6050NotesDueFebruary2063Member_45065022-0ae7-4c6a-924f-fec3e195a19c_terseLabel_en-US" xlink:label="lab_unh_A6050NotesDueFebruary2063Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.050% notes due February 2063 [Member]</link:label>
    <link:label id="lab_unh_A6050NotesDueFebruary2063Member_label_en-US" xlink:label="lab_unh_A6050NotesDueFebruary2063Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.050% notes due February 2063 [Member]</link:label>
    <link:label id="lab_unh_A6050NotesDueFebruary2063Member_documentation_en-US" xlink:label="lab_unh_A6050NotesDueFebruary2063Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.050% notes due February 2063 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6050NotesDueFebruary2063Member" xlink:href="unh-20221231.xsd#unh_A6050NotesDueFebruary2063Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6050NotesDueFebruary2063Member" xlink:to="lab_unh_A6050NotesDueFebruary2063Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a42e1098-d1f3-4b3f-95ef-c04886e00470_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_f5bb25ed-2ffe-4b2b-b18c-94ac297ce71d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2022 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_45acd94f-f48b-432d-8929-869838ed0ea2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_22a7c178-f164-4a4c-a492-70d63569dae8_terseLabel_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_label_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_documentation_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member" xlink:href="unh-20221231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.450notesdueJanuary2027Member" xlink:to="lab_unh_A3.450notesdueJanuary2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_1c43396d-58b2-4469-8a69-7cfab4fd0a3e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other adjustments of nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_149afb52-bcb7-4fd5-8540-0d723f24f1ff_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_294e40e4-a641-45ee-956f-1181e21bcfba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_da3a1d47-f9b1-4c65-a079-60a278de7690_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_4130d364-04ca-42b3-8582-b5487e2cf4c8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reclassification adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_004c1b70-3ae8-4867-82d6-f9d613c7817a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_84e9b5d8-aee7-4b92-8f29-782b7e79fb21_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4822b6bf-7eec-4acf-9016-76ae4ada14ee_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_cb854463-8f34-48d9-91b9-c68f953b5ec5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_f9e1746e-06a9-4d76-b7b0-8a1a778d9413_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_157b9a81-430b-449e-a647-92321c533c60_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_bed7329f-a03d-41d7-934b-4c1af57a5ee6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e94e1a34-b878-4c6a-8ecc-6201eb94721b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptuminsightMember_4828731f-c141-43f4-a12d-ae3059f71bef_terseLabel_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Insight</link:label>
    <link:label id="lab_unh_OptuminsightMember_label_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optuminsight [Member]</link:label>
    <link:label id="lab_unh_OptuminsightMember_documentation_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumInsight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember" xlink:href="unh-20221231.xsd#unh_OptuminsightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptuminsightMember" xlink:to="lab_unh_OptuminsightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_2e10bd84-6105-4ffd-a956-4216c0330932_terseLabel_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_label_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_documentation_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member" xlink:href="unh-20221231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.875notesdueAugust2029Member" xlink:to="lab_unh_A2.875notesdueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ae1ae0f7-591d-4c9d-b71b-1a1d3be5f630_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_cf07d0a4-eac3-49ae-b3e3-4a1ab6c11944_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_1e7516fb-5af3-4750-b45b-c87dda4f9711_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c36db3aa-baf9-4be4-8cbf-77a9305bc400_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1e94feaf-a0fb-4636-b92c-883178038fd1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_LossofParentCompany_00a8affd-99d4-4f6c-bc17-77a68bc0a933_negatedTerseLabel_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of parent company</link:label>
    <link:label id="lab_unh_LossofParentCompany_label_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of Parent Company</link:label>
    <link:label id="lab_unh_LossofParentCompany_documentation_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of Parent Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany" xlink:href="unh-20221231.xsd#unh_LossofParentCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_LossofParentCompany" xlink:to="lab_unh_LossofParentCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_dc63bbc9-31a9-4774-891b-57aa7586da1c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperDomain_f9dc167f-18ea-4abc-b8ef-1ee4c61ed7e9_terseLabel_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper [Domain]</link:label>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperDomain_label_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper [Domain]</link:label>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperDomain_documentation_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:to="lab_unh_DebtInstrumentExcludingCommercialPaperDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_3c4173b8-90fc-49f7-9a3e-442404beae1a_terseLabel_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% Notes Due July 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_label_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due July 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_documentation_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member" xlink:href="unh-20221231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.750notesdueJuly2025Member" xlink:to="lab_unh_A3.750notesdueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_517af9ab-bf7b-42c9-b5df-9e3d4173a62c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c9d482c9-b4d8-4c53-a89a-190d714d1502_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e8486f47-15e9-4c68-8117-a9a5bbece68e_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_926e7176-2334-4041-90d7-048220c31cbc_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5250NotesDueFebruary2028Member_f264c95c-810e-4777-a2ad-2dba15c5b441_terseLabel_en-US" xlink:label="lab_unh_A5250NotesDueFebruary2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.250% notes due February 2028 [Member]</link:label>
    <link:label id="lab_unh_A5250NotesDueFebruary2028Member_label_en-US" xlink:label="lab_unh_A5250NotesDueFebruary2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.250% notes due February 2028 [Member]</link:label>
    <link:label id="lab_unh_A5250NotesDueFebruary2028Member_documentation_en-US" xlink:label="lab_unh_A5250NotesDueFebruary2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.250% notes due February 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5250NotesDueFebruary2028Member" xlink:href="unh-20221231.xsd#unh_A5250NotesDueFebruary2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5250NotesDueFebruary2028Member" xlink:to="lab_unh_A5250NotesDueFebruary2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_0950fa64-4bc4-4478-8b9b-46f9a9ed260d_terseLabel_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026 [Member]</link:label>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_label_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026 [Member]</link:label>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_documentation_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member" xlink:href="unh-20221231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A1150NotesDueMay2026Member" xlink:to="lab_unh_A1150NotesDueMay2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_d9d83758-3a81-4a40-97cc-135d9ba6dfeb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from dispositions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_24ab29e2-364d-4fa7-9acf-cd7bb0f9ec95_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ThreeYear60BillionCreditFacilityMember_0ce472d0-340b-4efc-bcce-9a984a40cc3b_terseLabel_en-US" xlink:label="lab_unh_ThreeYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_ThreeYear60BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_ThreeYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_ThreeYear60BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_ThreeYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear60BillionCreditFacilityMember" xlink:href="unh-20221231.xsd#unh_ThreeYear60BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ThreeYear60BillionCreditFacilityMember" xlink:to="lab_unh_ThreeYear60BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CreditFacilityNameDomain_608a1ae1-7919-409e-bfa9-9aa359f76eba_terseLabel_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Domain]</link:label>
    <link:label id="lab_unh_CreditFacilityNameDomain_label_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Domain]</link:label>
    <link:label id="lab_unh_CreditFacilityNameDomain_documentation_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Credit Facility Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CreditFacilityNameDomain" xlink:to="lab_unh_CreditFacilityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_efaf6faa-14d3-4523-97f6-7aa4ddd7ba85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72ae8846-bf25-404f-b189-0ff6d384457f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4acb0d95-ac20-4f57-b9e9-b0111ec80399_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3756c457-0134-44a7-8248-f93bcf5b0196_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_f4ca6ae7-0554-40a8-a7b7-bdf2b7dc735c_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_35b615af-037e-4713-8dd8-858e289fb726_terseLabel_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_label_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member] [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_documentation_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember" xlink:href="unh-20221231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.375notesdueOctober2022MemberMember" xlink:to="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_876eb1c1-1154-47f5-a8dd-07df685e51e4_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d6768509-54e7-4527-af20-7458fe6236c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6156300-c46f-4e12-a157-3c2c63795c28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04197226-3b7a-4123-bb1f-bc84910667a4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e3596db8-c52d-43f7-b29e-c019280d2043_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_b0e231ec-b1d3-46ac-b1d5-f30f71084a22_terseLabel_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_label_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_documentation_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EmployeeStockPurchasePlanESPPMember" xlink:to="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_e8ea661b-dc14-4a62-9b85-78725d43d24c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ea715df2-b62f-40a8-942a-31567cff54dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Medical costs payable</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_787b0b46-1854-4110-b604-bf25cc3f2233_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1c5fa02b-c459-4be4-830c-b980dbeda560_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00428c06-f7ac-4a97-995f-267494a89e7e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_165f6c07-c865-48d8-a141-c4f24c195141_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0cf687e3-e819-4579-95e5-0193387e8c0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized Gains (Losses) on Investments [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_21600b7d-0bbf-49fa-b942-14f863a8d1ac_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_5bba3dd0-8173-4574-85de-6b6fbe19e5c2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovements_173b0c9c-4faa-4727-9d28-d584935183f3_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovements_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovements" xlink:to="lab_us-gaap_LandAndLandImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_3590224d-0ae0-459a-9ac4-2e8738a862d9_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_e8be8e9b-618a-4927-af9b-a7532fd11d5c_terseLabel_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87e6ff65-6fcb-4cb1-9cf5-314590a27f80_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeposits_a4facab4-fc13-4502-9451-4e74e523123c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer funds administered</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeposits_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeposits" xlink:to="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3ce83051-a8aa-462f-9dc1-1d172059a31b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31ea0f31-a5d7-431a-baa4-98849b5f7686_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_de421fde-17c3-4f42-a7a7-b0c53f6ec145_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside basis in partnerships</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment in Noncontrolled Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_83979a2d-7ba4-4180-8ed1-75cc73af1788_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c5bab1f1-b142-4df5-9bd9-41be421386c5_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0a6d5308-2cba-4498-be5c-b3df2400bf66_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_fed4621c-b4a1-44a8-9df3-02b343b0c998_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_9fd1ad3a-c8c2-4957-9009-ffb05dbee543_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_7683509a-f8be-43f8-bacb-33031e8217af_terseLabel_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_label_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_documentation_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member" xlink:href="unh-20221231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.450notesdueDecember2048Member" xlink:to="lab_unh_A4.450notesdueDecember2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d189cb67-222e-46b6-9511-6e326f0ac15d_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_fb9e0c79-c9a6-4a54-a789-57efe63ca133_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_8a6efe8e-e634-4b77-bbc3-dfadb9475524_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-non-U.S.</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilityOtherForeign" xlink:to="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_05e58173-3e5f-459e-82b6-32660795a5ec_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptumhealthMember_56bcc352-b155-4e69-aea7-686fd36b23a0_terseLabel_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Health</link:label>
    <link:label id="lab_unh_OptumhealthMember_label_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optumhealth [Member]</link:label>
    <link:label id="lab_unh_OptumhealthMember_documentation_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumHealth Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember" xlink:href="unh-20221231.xsd#unh_OptumhealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptumhealthMember" xlink:to="lab_unh_OptumhealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_55a5c63a-7905-4b0c-9499-2b0fef671133_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b6d6bfae-9d91-4815-9082-2ccebf120bfe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net identifiable assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_78198395-3d29-456c-9303-1019dd81fc28_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7cc713c8-5d2b-45f5-8be4-dcd4895dbd6f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ae3dc870-f8b1-49ea-beef-56ff95946111_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4000NotesDueMay2029Member_94d4520c-7f2b-4c65-8c5c-9af7e8426f91_terseLabel_en-US" xlink:label="lab_unh_A4000NotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% notes due May 2029 [Member]</link:label>
    <link:label id="lab_unh_A4000NotesDueMay2029Member_label_en-US" xlink:label="lab_unh_A4000NotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% notes due May 2029 [Member]</link:label>
    <link:label id="lab_unh_A4000NotesDueMay2029Member_documentation_en-US" xlink:label="lab_unh_A4000NotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4000% notes due May 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4000NotesDueMay2029Member" xlink:href="unh-20221231.xsd#unh_A4000NotesDueMay2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4000NotesDueMay2029Member" xlink:to="lab_unh_A4000NotesDueMay2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_7a189a55-2870-4636-8f60-3c0c38b6191a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized (losses) gains on investment securities during the period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_2659372e-e19e-42c2-a2d5-0098cad75668_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_99aeefab-1101-444c-83a7-ff3f166ff922_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BasisofpresentationAbstract_fd716e68-2ce7-432e-b4bc-a911680473ce_terseLabel_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:label id="lab_unh_BasisofpresentationAbstract_label_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:label id="lab_unh_BasisofpresentationAbstract_documentation_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract" xlink:href="unh-20221231.xsd#unh_BasisofpresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BasisofpresentationAbstract" xlink:to="lab_unh_BasisofpresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4c99945-25fe-48c7-b3aa-a52b021afa2b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_75522ca6-4af4-4924-b018-f4ed29984a25_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_db7de291-d79f-4032-8024-d25c6da87032_terseLabel_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060 [Member]</link:label>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_label_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060 [Member]</link:label>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_documentation_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member" xlink:href="unh-20221231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3125NotesDueMay2060Member" xlink:to="lab_unh_A3125NotesDueMay2060Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6f30b0f6-f5b4-46cf-ad50-411982583f08_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9ea8e59d-a2af-4d0e-8c61-295a6021003f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6d0fbb59-a9d1-4e4c-b90f-13acf6071532_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_d3aab458-678d-4e85-a019-56c016709926_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_8ce9ee48-40a2-46a9-a619-23195adbacc2_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_b7bf4d9e-1817-4540-93d5-4fedd5339a00_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_72f2a4b1-ac27-420c-9aa9-eaa6bcc0a940_terseLabel_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031 [Member]</link:label>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_label_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031 [Member]</link:label>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_documentation_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member" xlink:href="unh-20221231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2300NotesDueMay2031Member" xlink:to="lab_unh_A2300NotesDueMay2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1888b992-91e5-46ea-b5fd-a3f855735fad_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0461b44d-83d1-477c-a01d-f9c9b71a89ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_a76e5824-9bf1-4e0e-aed6-0bb4c0f6affb_terseLabel_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_label_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_documentation_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member" xlink:href="unh-20221231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.875notesdueDecember2028Member" xlink:to="lab_unh_A3.875notesdueDecember2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_0b9f3d82-e9ef-4237-b5c7-68d6f877a133_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of redeemable noncontrolling interest shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_df1e3757-6800-4a0b-a00a-be8be1682573_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemptions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_079e4dac-5f8e-4cd1-9dbe-f356445bd9d1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7450fff2-e1ea-4a4e-bf0a-fbe4226ca6dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_2cd6fddf-75d4-4aa0-a5e7-f30d007de07d_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_41755d1b-3ea8-4182-834a-7f69ffd99cd3_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cf7ec420-0474-412f-b414-d1fa6b3d7c8a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_78a60d65-880a-430e-b408-5453a5e7a460_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3e188f28-a44a-4d13-8307-fffc6c04b0a9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ab791c44-1d14-43f4-8819-ec3c251ae911_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_85ee824f-10f9-4bf8-b63b-ea74c1321ee4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_fcb6b8f0-d898-4367-9c8e-4dd14f582906_terseLabel_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_label_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_documentation_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract" xlink:to="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2304875c-20de-4b14-8add-aea48515a455_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_218abf42-d2ff-4320-8f81-666e9abef373_terseLabel_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_label_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_documentation_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member" xlink:href="unh-20221231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6625NotesDueNovember2037Member" xlink:to="lab_unh_A6625NotesDueNovember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_9ac7db95-cec8-4f92-822d-a0432fb89fb7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Incurred Medical Costs</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_7120414b-8c81-4858-8531-1e451f393a27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_1bc73ba4-1439-4d67-93d6-bbf6bdb995b2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_594e5875-9816-4fdd-b7ee-601794c36711_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_716bdfc1-d57f-4b34-bc06-f7ccf8f64ca8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_011fd4ea-5432-4135-9c30-22cfe5ec9fa1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIAbstract_ac611d93-286f-4f06-aa9c-585cab4e25a3_terseLabel_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIAbstract_label_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIAbstract" xlink:href="unh-20221231.xsd#unh_ScheduleIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIAbstract" xlink:to="lab_unh_ScheduleIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_8fc3826d-9f53-4b9a-99ef-679185ddb16d_terseLabel_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_label_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_documentation_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member" xlink:href="unh-20221231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.250notesdueJune2048Member" xlink:to="lab_unh_A4.250notesdueJune2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b52eeb99-118d-4de4-8272-d96053ac5a62_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0f0cad75-348a-4330-933b-bd5ea727f1fc_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4d474bc2-93ac-4a0c-b8c1-131a1418715a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8ef41130-4d0e-433c-8a2c-598a37a3f5fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ccf13d7d-9d8b-40b7-a57e-efa4d1982654_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5bff37e8-8676-4a8e-9538-e4303f59d291_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_a74a661b-de7c-4b59-94d7-665fe9d5380b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_84be18f1-e1f1-454d-a44e-21c6312d7303_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1af664be-dc9c-46fb-a669-9e96c9cac26d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c62a6b7f-f493-46d0-a496-e711d71a167f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_bab0a0f4-4dd9-4f84-b912-59aff1b6e147_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases, average price per share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_f055cffa-37f5-4cf0-a62a-7e93dee057f8_terseLabel_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Policy Text Block]</link:label>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_label_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Policy Text Block]</link:label>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_documentation_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:href="unh-20221231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:to="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_a410c01b-f837-4797-a32e-dc2f9bad59f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4aaa0bdd-9e53-4b73-a042-bd7e3648a485_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d06a58e-68b1-4b95-838d-7f432cb5fc86_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_3aa21a7e-c032-4656-b28c-ebcf54f6c274_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5196f217-cb80-4ea6-a6ca-07db412337ef_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8948aff1-04da-4a6d-9188-c4b8c9c7e8df_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_e3a3a6f2-b723-47b5-936b-0a5befaee0ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_126d8fef-09ef-4ed4-af9c-6a9eb27d4b7d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_98162240-92ec-4105-a7eb-59240fc7fa54_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1c1369da-4ac4-4e1a-a9f2-dfe2d19220bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cumulative Medical Payments</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_24930326-8b2d-48dc-bbb5-bc9176187f23_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_96794fe7-43a3-43c1-b130-d1752ce2436c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c36036f9-4e9d-4048-8d01-b1ba9da7233a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_72076d23-b22f-4951-b548-ccc5f49e2ebc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fe33eeb4-082b-4010-bcc4-cd1abc5104de_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_b8a47024-18c2-40f3-ac89-dcbede2d4f50_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Current</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtCurrent" xlink:to="lab_us-gaap_UnsecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_81c3312a-28ab-4c99-8380-0186fd62c5ac_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_927f43c0-773b-4f01-ad2f-16e596fb21c4_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_00df56af-7dcb-4f63-898a-ff25d2578003_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_92d0da81-6ea6-44df-9978-f96aa8a221f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of restricted shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_525e8e9e-efbf-4c18-87b4-69aeb4d6a038_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_999ae3d5-0056-4e5d-83f8-403e4b1f057a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CMSMember_b1afb90c-dc7a-4470-bed6-fdd77292731a_terseLabel_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:label id="lab_unh_CMSMember_label_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:label id="lab_unh_CMSMember_documentation_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember" xlink:href="unh-20221231.xsd#unh_CMSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CMSMember" xlink:to="lab_unh_CMSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_069ce8dc-428c-4788-8142-c70336bb48b9_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Long-term Debt, Noncurrent</link:label>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredLongTermDebt" xlink:to="lab_us-gaap_UnsecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d0ca33f9-98bc-4770-919d-04a6c5823e40_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_96d36925-e86d-41ed-87d2-9e6aacb03132_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_af194c3d-1af2-40f6-b99d-f0d0fb5ae0d3_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_c950c121-2c81-48e9-8ea9-035587a69e3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e4832010-e6b7-430b-9852-7740c17ae78f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_383b58d8-709c-4a23-8a87-228870c7fc35_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_8f09ca64-46b4-49e6-94f7-e5d68689be69_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Agency Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-Backed Securities, Issued by Private Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_d08b1f8e-a650-4237-b41d-c7daa74e0b50_terseLabel_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes Due November 2041 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_label_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due November 2041 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_documentation_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due November 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member" xlink:href="unh-20221231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.625notesdueNovember2041Member" xlink:to="lab_unh_A4.625notesdueNovember2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0cdeb02a-55c8-4474-b2a6-ba8efa0612f8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a4ea1f1a-0cce-45eb-aa58-21f9a6ad41d1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e901a1f5-5183-4567-ba46-7f3fbfc71c16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_099fdd79-8642-4571-b8a9-e752ee1021e8_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_aa69a72e-08dd-4adc-b88d-9db4a4bf6c20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_226d7474-1d23-40a3-b072-3c04ec147290_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_a862fad5-8f51-4722-98ad-59ed57865395_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, other receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c11f1cec-db32-4b11-bcd7-bd7dca060e2b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0aad1a14-01cb-4322-aa47-2e249156e9a2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_7b50a230-a785-48c8-bc1c-28724d958d8b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e8e9ecd8-4f60-4597-9b07-0f18e341bcab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_66d1b0be-d4db-4424-98a9-9170196d5780_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f2e05460-e4e8-481e-b069-78052eb9f78d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c0d79ab5-6a3a-4322-a820-bb835725335d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers Into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_45fab68e-f09e-47bc-befe-2d32a415b6ce_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_305e58c6-e415-42d6-b8ea-f96b1a556cef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3e466478-a643-4ed7-9916-147d124abb8a_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9fae152e-e807-4f82-a01b-babb9a7928ef_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DebtAbstract_86187326-1242-48b3-b4c0-9224e6ba7e8e_terseLabel_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:label id="lab_unh_DebtAbstract_label_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:label id="lab_unh_DebtAbstract_documentation_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtAbstract" xlink:href="unh-20221231.xsd#unh_DebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DebtAbstract" xlink:to="lab_unh_DebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsAmortizedCost_fe688d54-2d2f-4d07-98cd-fd3d512cf715_totalLabel_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Amortized Cost</link:label>
    <link:label id="lab_unh_InvestmentsAmortizedCost_label_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Amortized Cost</link:label>
    <link:label id="lab_unh_InvestmentsAmortizedCost_documentation_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments at amortized cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost" xlink:href="unh-20221231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsAmortizedCost" xlink:to="lab_unh_InvestmentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_04411539-ce3b-4e57-b2d9-ef7ecefcfa6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_720be154-f0f1-42f4-984a-05649dc8de29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_68e89e16-a91f-4ab8-9e6d-81d86eb69a7e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_344a28e1-984a-4bcd-8c72-a3e8980bac80_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_f9f3a800-0d3c-41df-b294-0541e85adfd5_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_label_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member" xlink:href="unh-20221231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueFebruary2024Member" xlink:to="lab_unh_A3.500notesdueFebruary2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_StockOptionsandSARsMember_464a7778-f7e4-4cb7-bcc5-d240dd5887db_terseLabel_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_e5fd84ec-fcbf-4468-a5b6-b4d064ae96ef_verboseLabel_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_label_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and SARs [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_documentation_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and SARs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_StockOptionsandSARsMember" xlink:to="lab_unh_StockOptionsandSARsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a368439-c71a-46c1-ba54-f46e179f927c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3a1a7193-383e-4833-9d91-02893e1f64f5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_a9d8e41b-6e18-4c3a-8014-7f1932c0b411_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_20fd297b-ff93-4e68-905e-07076e66a869_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_9660ceaf-44d3-4f3a-9163-2987c2020eee_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_9fcebe56-9fc3-4734-96f1-b59a034a22a5_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_4e274db2-c687-4ed2-a098-772d952e9d7f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_65279a69-d2e0-41e4-907f-ef9bf37d2af4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_645a0444-6e70-499c-8e7c-9bbb5f0ca232_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_5582752f-16ed-4e5f-99ce-5e742ca098a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_f31f007f-b8d7-4a89-9495-ea2286c4a9be_terseLabel_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes Due February 2023 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_label_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due February 2023 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_documentation_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due February 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member" xlink:href="unh-20221231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2750NotesDueFebruary2023Member" xlink:to="lab_unh_A2750NotesDueFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1c11a4b9-d553-4d99-92fd-a9a40b006fca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0ab0dc88-7530-4a79-8bd3-ecd7835c17cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9b880276-883b-44c6-947b-2eafe2cae4ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_317f90d7-f072-4b37-b993-ee2623339b4e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_24b20247-662b-467a-9696-78915cc4f9ae_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_74669a9c-3ccc-41f3-a279-b84751a90110_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_4505d4ca-1fe8-4bff-8bf0-34fa70045f7b_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7613069d-30e9-463c-aa6e-33710537a044_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_9eb0b4d2-6598-419a-8df9-985cc720fc48_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_869be0ad-c649-4934-9b87-d2572cebeb3f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b26e2ddd-bcac-4e3c-84b1-df83df70db6e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_d765ace5-e2dc-4be6-a4db-b51f3ec04874_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_UnitedhealthcareMember_448c5107-3cb8-4acb-9824-7fed57400004_terseLabel_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare</link:label>
    <link:label id="lab_unh_UnitedhealthcareMember_label_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unitedhealthcare [Member]</link:label>
    <link:label id="lab_unh_UnitedhealthcareMember_documentation_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember" xlink:href="unh-20221231.xsd#unh_UnitedhealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_UnitedhealthcareMember" xlink:to="lab_unh_UnitedhealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1bc5ad04-b4b8-4f3c-8415-395d17935ccd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a77245a0-fb29-4ac6-93ec-825e18efa33d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fa2ed18d-f833-4d7a-a6d1-9a7295773a3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4e3ae5d4-6cf4-49d3-a070-2af1aa867796_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e3882fcf-aa72-41b2-bcd9-724a763a7452_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3fc443d6-8ef4-4f3d-8c0c-74d67149c48a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5150NotesDueOctober2025Member_a254605d-65c8-483f-9bd5-0767d798eb49_terseLabel_en-US" xlink:label="lab_unh_A5150NotesDueOctober2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.150% notes due October 2025 [Member]</link:label>
    <link:label id="lab_unh_A5150NotesDueOctober2025Member_label_en-US" xlink:label="lab_unh_A5150NotesDueOctober2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.150% notes due October 2025 [Member]</link:label>
    <link:label id="lab_unh_A5150NotesDueOctober2025Member_documentation_en-US" xlink:label="lab_unh_A5150NotesDueOctober2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.150% notes due October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5150NotesDueOctober2025Member" xlink:href="unh-20221231.xsd#unh_A5150NotesDueOctober2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5150NotesDueOctober2025Member" xlink:to="lab_unh_A5150NotesDueOctober2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_840c6579-a0da-404e-b23b-a0560103ea44_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4044f85a-a1f7-43a4-a383-6d3817b076f7_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_6c39fe10-3707-44b6-9519-4122dc4f7458_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_41af0eed-f3b3-4aca-aac5-72f66b11fdc2_terseLabel_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_label_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_documentation_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member" xlink:href="unh-20221231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.950notesdueOctober2027Member" xlink:to="lab_unh_A2.950notesdueOctober2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ee3a4cf7-d655-4ebd-b85e-7935a1bbfeea_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_13ade1ec-8c30-47c2-ab68-7f199f0ed8b5_terseLabel_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_label_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_documentation_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:to="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d6ebbd9f-191e-4a66-8f57-5090aba2e6b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_ba596da2-5225-4708-a8c7-0665d3cb9992_terseLabel_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes Due July 2045 [Member]</link:label>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_label_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due July 2045 [Member]</link:label>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_documentation_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member" xlink:href="unh-20221231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.750notesdueJuly2045Member" xlink:to="lab_unh_A4.750notesdueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_9f4b8874-fe87-4294-af14-fe1081e40b34_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a396577c-4cb2-4d94-bf26-beb868b57c28_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_38aa03a8-91e0-4d30-b2dd-5480775d2e86_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7ff17f1c-efb7-4428-a094-01afe8546e92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5229e7e8-48e3-43be-81b6-7dfe449e0e76_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_c3f19d7f-8f3a-41cd-bccf-c2fb7138d6fb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_666b6a68-a3f6-4323-9602-09e30e143750_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_label_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_documentation_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:to="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_2fe9de0d-63ac-43df-8869-d51f83b82e0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7f6050e-d76d-46c2-962e-915dd8c1cb56_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b83514c-a006-42ac-a078-7169d6ad224b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_bbfe08b4-5eeb-40b6-8565-64ff96bc4e8a_terseLabel_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_label_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_documentation_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member" xlink:href="unh-20221231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.750notesdueOctober2047Member" xlink:to="lab_unh_A3.750notesdueOctober2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d964c529-f60a-4241-97e0-ddd8de2d96cf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_d5ad6bd4-1a62-40b2-8996-9b417a4bc484_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_746efd5d-703c-412b-8a4b-e74086e629d1_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_0058b1f4-786b-4821-a624-2645e05d42ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_1959e1bd-62bb-4ef2-942f-898747a5829c_terseLabel_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_label_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_documentation_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:to="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0ae46eaf-66fb-495b-937b-118c21655e41_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term and Long-Term Investments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_84f8f910-2bdd-40c2-b199-d1c5b43d9988_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d4e8f73b-fa72-445f-9c17-15589bc8426e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent_7697cc1a-ebb8-4c43-b773-9b42828d1539_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term notes receivable from subsidiaries</link:label>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_068c43dc-6865-4282-9b44-8c3bc3be4f19_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f7726e7b-afd0-464e-b54f-f77adc16249b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_49c4346b-cb10-45ed-8f14-45191d4e7322_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_ea9afbb2-8ece-4f37-8644-38068e12eba3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_51bc6b9e-62bc-4466-a6c8-371fc7a68def_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f4b34825-5ff1-4fb1-8cd5-90de33628b25_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c5dddd46-19de-46be-a80a-51fd6508c6bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_738a6dd3-6bd3-44a8-9cbe-2e7a8f134867_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_a6523ed1-04dd-46a9-aa81-018a49e81af8_terseLabel_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes Due March 2043 [Member]</link:label>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_label_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due March 2043 [Member]</link:label>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_documentation_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due March 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member" xlink:href="unh-20221231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4250NotesDueMarch2043Member" xlink:to="lab_unh_A4250NotesDueMarch2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_995cca8f-de7c-471c-a244-5ef3cf85b479_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_28363058-c3a0-487b-b242-e09c1bcb493c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_32a3a429-4aa4-4bd8-aad6-44064853b5c7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, Available for sale Debt Securities, Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ab667ec2-c556-42b7-9471-806995581b73_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b9a3a081-d737-4980-8bc5-0eaa41e49855_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_015d2f2b-a1df-4b36-acb2-038139a6a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b37b31ab-30ea-4ef0-9deb-0f16f1346f85_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_9c2fc693-f4e9-4a53-9fe7-8c994fc656cf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical payments:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfIncomeCaptionsLineItems_51f4e90d-cfd2-4be4-9db5-ec05d56ff4b9_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Income Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedStatementOfIncomeCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Income Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_b2b588dd-26ed-4d23-ac3d-69bc1064e54f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2021 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year 2015 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_aec1052c-e7a8-45c0-9f37-e3f3d2783099_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_4bc95d3a-a84f-40b3-8223-d0c605d72c07_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7fbfc617-c0d9-482c-a6aa-01449d8c4ab2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_5f7faeaf-b707-4800-b7e4-46c834ea6f3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_553da220-2148-47dc-98e5-6219ac2c1a7a_terseLabel_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes Due March 2036 [Member]</link:label>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_label_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes due March 2036 [Member]</link:label>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_documentation_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes due March 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member" xlink:href="unh-20221231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.800notesdueMarch2036Member" xlink:to="lab_unh_A5.800notesdueMarch2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_11f8fef7-80eb-46d5-8f78-6efc7f602607_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_55ad86e2-5216-46a3-b92e-b88064dd172b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_TrademarksandTechnologyMember_29ade0c5-4a6d-459c-9f96-fb138ab8b9dc_terseLabel_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:label id="lab_unh_TrademarksandTechnologyMember_label_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:label id="lab_unh_TrademarksandTechnologyMember_documentation_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_TrademarksandTechnologyMember" xlink:to="lab_unh_TrademarksandTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_de5c8628-408c-4745-936c-e14d82204efe_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_RevenuesMember_470bf779-a0fa-41c9-b406-d3e3f1fda75a_terseLabel_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_unh_RevenuesMember_label_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_unh_RevenuesMember_documentation_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember" xlink:href="unh-20221231.xsd#unh_RevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_RevenuesMember" xlink:to="lab_unh_RevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_e2e39836-43d8-4654-bb44-c7d9b4e4f880_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and other financing obligations [Member]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a1cbe177-8c7a-4a34-8478-2af86658ced0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_c9c73a48-b5b5-4d38-9c08-9321fd58750b_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_d968b1a6-43d8-4976-9b1f-903a0eddf541_terseLabel_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041 [Member]</link:label>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_label_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041 [Member]</link:label>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_documentation_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member" xlink:href="unh-20221231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3050NotesDueMay2041Member" xlink:to="lab_unh_A3050NotesDueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7f35f1d6-2f34-48ab-aacf-3d56969f9a0f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OpenTaxYear_ee937472-5392-4751-aa92-bd7987abb4bd_terseLabel_en-US" xlink:label="lab_us-gaap_OpenTaxYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Tax Year</link:label>
    <link:label id="lab_us-gaap_OpenTaxYear_label_en-US" xlink:label="lab_us-gaap_OpenTaxYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Tax Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OpenTaxYear" xlink:to="lab_us-gaap_OpenTaxYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_afb26df9-f4df-4517-91b9-392465dca783_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_32b30404-44ad-4893-9b1e-f5506827121f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e2f513c5-ee14-47d9-aef4-4d2ee96f0e64_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d0f8d9bd-6fbb-4c7f-94c0-1424aeec038b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ChangeHealthcareClaimEditingBusinessMember_78c5cf65-6b1d-4607-94cc-5c52a99eca16_terseLabel_en-US" xlink:label="lab_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Claim Editing Business</link:label>
    <link:label id="lab_unh_ChangeHealthcareClaimEditingBusinessMember_label_en-US" xlink:label="lab_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Claim Editing Business [Member]</link:label>
    <link:label id="lab_unh_ChangeHealthcareClaimEditingBusinessMember_documentation_en-US" xlink:label="lab_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Claim Editing Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareClaimEditingBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:to="lab_unh_ChangeHealthcareClaimEditingBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_cf129d62-c42d-4f6d-bf0e-5996c1d5ca53_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_28133e40-0427-43e4-a1d4-809158cb5e8e_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e5f537de-a310-4c03-8b7b-2aae182bb929_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_446bcbec-9a84-4fe0-b114-f44542409ce9_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_21bea1f7-036e-4e24-be00-c822411c3d8a_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a4980a4-8406-48d1-8e16-21c7a9a15dc0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8420f717-5db6-42ec-8f5d-b1828f64bbef_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_UsefulLifeMember_6fc91360-2628-4a75-ae38-158f35e38cbb_terseLabel_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:label id="lab_unh_UsefulLifeMember_label_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:label id="lab_unh_UsefulLifeMember_documentation_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember" xlink:href="unh-20221231.xsd#unh_UsefulLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_UsefulLifeMember" xlink:to="lab_unh_UsefulLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_03a1214e-68bb-4ea8-b4e6-a32b7388aebc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ef8f7ac-fe79-42f4-a405-49a9c2a74a59_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_774cec1b-06a5-490e-9a04-e21596502b34_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_label_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member" xlink:href="unh-20221231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueAugust2039Member" xlink:to="lab_unh_A3.500notesdueAugust2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_bb80bcf8-3eaa-4a8a-a4db-87da42f6cc79_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_ecc4c108-d261-4783-8cd4-36a75d82762d_terseLabel_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_label_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_documentation_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherShareBasedCompensationDataAbstract" xlink:href="unh-20221231.xsd#unh_OtherShareBasedCompensationDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherShareBasedCompensationDataAbstract" xlink:to="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTable_8cdad604-0a80-4d36-86cc-f4e0a45ec449_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table]</link:label>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTable_label_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_a86e3ae2-5eba-404f-9a7d-f392c70e042c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_636909df-d57f-4171-b42f-9e70a8349b84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_92e9b8bb-899e-4cd6-9f46-475b7f444689_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_2f9d225c-38b2-4ba8-97e9-011304656d09_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares repurchases, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_228509b9-f65b-4ec2-8c55-3e94da6198f6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_099f47b7-6e29-430a-a779-4c01d00f9473_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_58cfece1-8eaa-48bf-b273-8ffdc6b0a268_terseLabel_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026 [Member]</link:label>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_label_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026 [Member]</link:label>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_documentation_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member" xlink:href="unh-20221231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A1250NotesDueJanuary2026Member" xlink:to="lab_unh_A1250NotesDueJanuary2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_62e7704d-b24a-4233-9c3c-c6e13c85a1a6_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_031af206-36e7-4f8d-8362-0680288b9a04_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_2108fd15-df11-4dcb-8e48-239fa4a38257_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Lease Liability</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetsLeaseLiability" xlink:to="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_9bfdb0e0-38d9-45db-90c7-3d85d25d1293_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ece40348-fa62-452d-a089-fed42e9ba183_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_e08c3bbe-fac3-4e93-8c4e-67a936e32e01_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_IntersegmentMember_6e65b89d-568a-426e-8b5a-85fca4b10b48_terseLabel_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Customers</link:label>
    <link:label id="lab_unh_IntersegmentMember_label_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:label id="lab_unh_IntersegmentMember_documentation_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember" xlink:href="unh-20221231.xsd#unh_IntersegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_IntersegmentMember" xlink:to="lab_unh_IntersegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e5a5de7d-4329-43b4-ac7a-c43858b642d9_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Financial Information [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_e32a6384-40b9-4f61-9b12-d4460daaf6be_terseLabel_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_label_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_documentation_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member" xlink:href="unh-20221231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.100notesdueMarch2026Member" xlink:to="lab_unh_A3.100notesdueMarch2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_edb24aba-8d2d-4f57-9334-c7955e1901cb_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Manufacturer Rebates Receivable [Member]</link:label>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_label_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PharmaceuticalManufacturerRebatesReceivable [Member]</link:label>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_documentation_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PharmaceuticalManufacturerRebatesReceivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:href="unh-20221231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:to="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_086e1243-0291-4787-88d2-2e0410bcdbca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Than 12 Months, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_8181950d-870b-4b87-906d-a7cc2588fa51_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b71dbfac-df85-4801-a0e8-bfcff8d653ae_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, redeemable noncontrolling interests and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f72bb4b6-5e13-4ba3-8dd3-e940d3955a00_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2e056738-ceb3-4e7b-af16-f7636da62efb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_f3364985-1436-4d86-ba34-a60a4aabcd8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bd765e4a-06e5-4e5a-8d3c-58dd4df69b82_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e9512b73-ff2e-473b-ac9b-1711da3a00cb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_37b88716-814b-4bec-ade2-6086adbb9d9a_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:to="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_eab22080-d768-4c8c-8e33-a13080d83814_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_748277eb-000d-42ac-a33a-c61f481c93fb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_95a906bf-4835-467b-95cb-b71d650b1226_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_09ca1a43-4740-4d77-8957-6b0573ac0a16_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_29d159a9-0ee3-4774-9fe1-87a7919159d0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes to subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_140c42d6-a640-49ab-a60d-6250352eec6f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_5456e28b-a124-4a34-80a0-5bd459d89b2a_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_fd96504f-6a57-4667-a020-9fa48c6269e5_terseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Dividends Paid to Parent, Consolidated Subsidiaries</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CarryingValueOfDisposition_82e6fb0c-674e-44bf-9a14-4b5cb691674b_terseLabel_en-US" xlink:label="lab_unh_CarryingValueOfDisposition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value of Disposition</link:label>
    <link:label id="lab_unh_CarryingValueOfDisposition_label_en-US" xlink:label="lab_unh_CarryingValueOfDisposition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value of Disposition</link:label>
    <link:label id="lab_unh_CarryingValueOfDisposition_documentation_en-US" xlink:label="lab_unh_CarryingValueOfDisposition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value of Disposition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CarryingValueOfDisposition" xlink:href="unh-20221231.xsd#unh_CarryingValueOfDisposition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CarryingValueOfDisposition" xlink:to="lab_unh_CarryingValueOfDisposition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_cfba86ae-e3ab-4dca-8c42-d5d1b0314843_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_0ac0ea21-ff6a-4d10-b77b-0ecf89dec7ad_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a639d47c-f5b7-45b4-9bee-07a78512b826_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest, beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_260103b5-6e80-4fc8-b7f6-1477718308ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ExternalCustomersMember_4498d6e8-c568-4afa-bf69-a58a165a26c3_terseLabel_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaffiliated Customers</link:label>
    <link:label id="lab_unh_ExternalCustomersMember_label_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Customers [Member]</link:label>
    <link:label id="lab_unh_ExternalCustomersMember_documentation_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember" xlink:href="unh-20221231.xsd#unh_ExternalCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ExternalCustomersMember" xlink:to="lab_unh_ExternalCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_a38df670-27a6-4d4b-bd54-37536e089d2a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_1c07d197-0b79-42b8-9505-a2e23722c163_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_8f28d458-cb72-4c5a-894d-e7cd075859d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_e41fd326-dee1-4eb0-a3aa-830f1ca01bfb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_c35bfd57-5014-49b8-b45b-fe609091a32d_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Well known seasoned issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_f94c7999-d5a3-4bab-931f-cc45ff9a004a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_65aa33cc-c5fa-439c-94a6-9067d688212d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_b8ebaaee-6bcd-4c4e-9b92-9691a565212a_terseLabel_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes Due July 2035 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_label_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due July 2035 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_documentation_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member" xlink:href="unh-20221231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.625notesdueJuly2035Member" xlink:to="lab_unh_A4.625notesdueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_efbb1236-4e23-4689-8643-730ab746c530_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_label_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_documentation_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember" xlink:href="unh-20221231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDReceivablesMember" xlink:to="lab_unh_MedicarePartDReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_13262306-c006-4329-a8e5-491f3d4865ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_98dfff66-838e-4985-9dfa-a7a798ecac3f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_78206836-0e0b-4d2f-84bc-8d6182084664_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs (Level 3) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_9d111530-040e-493d-81fa-962c6650d146_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e40f4230-69ae-4d2d-8b31-98f089612a46_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6e86098a-37a2-4c6b-a3cd-b26de2fe548f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_94966dff-86f3-4218-8d11-7bd98fd00129_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable to subsidiaries</link:label>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_80425e85-18cc-4c3f-ab13-7cfeeb6db376_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible compensation, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_08b695ae-8c2e-4ba5-971c-4da56111e695_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FairValueAbstract_8b8a835a-f576-45f5-94a5-d17c91544681_terseLabel_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:label id="lab_unh_FairValueAbstract_label_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:label id="lab_unh_FairValueAbstract_documentation_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAbstract" xlink:href="unh-20221231.xsd#unh_FairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FairValueAbstract" xlink:to="lab_unh_FairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_495277bc-af9d-4869-86d6-3defd5878c4d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_4164105e-5bea-4803-8eb9-a1e0c3950a09_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DividendFrequencyDomain_c75f4f01-9762-4cbc-adb1-39a5d2c659c3_terseLabel_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:label id="lab_unh_DividendFrequencyDomain_label_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:label id="lab_unh_DividendFrequencyDomain_documentation_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain" xlink:href="unh-20221231.xsd#unh_DividendFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DividendFrequencyDomain" xlink:to="lab_unh_DividendFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9b05bafd-3187-40e0-b507-8dd16dc0f784_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_4c00247d-0f46-4ef8-9bf9-c28fa48d33b2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_818c4f93-403e-4916-817a-9db40be38e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_43d58f0e-0fd7-4984-9ad0-81e073580741_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net of cash assumed</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_962d1588-4738-48b1-890e-a21c22f85fc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2f27fd60-53f9-499b-bfb0-72b16c0ad9b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Observable Inputs (Level 2) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_51c42274-53d0-4ca0-a603-ed1d3743a20b_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_TotalOptumMember_bce9c15e-e905-4713-ae75-c99c52dc0a7c_terseLabel_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum</link:label>
    <link:label id="lab_unh_TotalOptumMember_label_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Optum [Member]</link:label>
    <link:label id="lab_unh_TotalOptumMember_documentation_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember" xlink:href="unh-20221231.xsd#unh_TotalOptumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_TotalOptumMember" xlink:to="lab_unh_TotalOptumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4b0a1556-3a41-426a-8a55-d95319b8b064_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_096b1df4-db4f-4dd1-b654-25ca0743a768_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_c5766b16-d146-42a8-a0ca-ee85bc95dbba_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc55df53-af01-4917-a1da-3b691bc4c6cc_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net of accumulated amortization of $6,137 and $5,636</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_7d091140-9134-4790-8fc3-63e8f6d6fede_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_383a3537-ba1f-422a-8232-a00991cab270_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d38281e2-535d-4abf-9bf5-4c029f565a76_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_ec2d7acf-5974-4c28-ae07-ad689a1e044f_terseLabel_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held-for-sale</link:label>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_label_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Assets and Liabilities, Assets Held-for-sale</link:label>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_documentation_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Assets and Liabilities, Assets Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:to="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_95aa178c-2233-4892-9bda-45b99b41e101_terseLabel_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_label_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_documentation_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member" xlink:href="unh-20221231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.375notesdueAugust2024Member" xlink:to="lab_unh_A2.375notesdueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8cdf290c-4c88-4542-8bb8-08efedfb8aa0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_751e4fea-ac2f-4a88-bce8-38195ef9ba44_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDescription_ef657aee-13f9-4112-b5ef-d12e30f4c8c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Description</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDescription_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDescription" xlink:to="lab_us-gaap_OtherCommitmentsDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_053e82b7-a613-4472-a637-1b139b9402dd_terseLabel_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis</link:label>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_label_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis</link:label>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_documentation_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:href="unh-20221231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:to="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_d2644635-18af-4ad0-b600-5bf36bf69926_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on common shares ($6.40 per share, $5.60 per share and $4.83 per share for the years ended December 31, 2022, 2021 and 2020, respectively)</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_a700236e-d166-47bc-b235-190961e3f726_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_ce451718-9286-4d70-9f1d-0375c00fb187_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_3d7555f4-643e-4d74-959a-8e29a8c1592f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c9f074b8-4548-4646-820d-c3ef0ca2309b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_a02a3845-89d0-491a-869e-b31037d79662_terseLabel_en-US" xlink:label="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_label_en-US" xlink:label="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_documentation_en-US" xlink:label="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonredeemable noncontrolling interests acquired through business combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsNonredeemableNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:to="lab_unh_BusinessCombinationsNonredeemableNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f5e75537-27f4-4ce0-b278-c671a1da3011_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b9e907bd-2a48-4685-88c4-2f2b9c59c038_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_62d0581e-7bda-48d2-a912-ade2878567f9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_8ee3417d-5e20-41a3-aaff-9806b75a95d8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reported medical costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_dd0e2758-1803-4a2c-9452-82ff8c23d22f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5ca2b4c1-1eb5-4579-8951-6756d80074ff_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrealized (losses) gains, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_6a43502a-f076-4d89-8d75-5fc4e253396e_terseLabel_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_label_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_documentation_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member" xlink:href="unh-20221231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.875notesdueAugust2059Member" xlink:to="lab_unh_A3.875notesdueAugust2059Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b7935678-7a8e-4ddb-8b68-bf9ac0ef97ea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a034c872-2ce9-494a-9c20-d2cd3e4ba873_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_305df55f-7292-41d5-a683-d7707da89006_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current receivables, net of allowances of $1,433 and $993</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_17c497f3-91a1-4722-8bd9-c308dc0635c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2a287d06-4a32-4c10-997c-2c10d9dd8025_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_b0187e39-233c-4ba8-9b20-0019f8df2ae8_terseLabel_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Notes Due March 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_label_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_documentation_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member" xlink:href="unh-20221231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.875notesdueMarch2022Member" xlink:to="lab_unh_A2.875notesdueMarch2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_b793fee5-4d03-478f-a00d-3b93c1a7491d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceContracts_27cbbbfa-8403-47a9-b61e-2c2ed252cd55_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of security positions</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceContracts_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceContracts" xlink:to="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_1449cb4f-5555-40f7-a420-6c3e27dc6abe_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_52bca15a-0093-411d-ad22-d65908357065_terseLabel_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_label_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_documentation_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member" xlink:href="unh-20221231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.375notesdueApril2027Member" xlink:to="lab_unh_A3.375notesdueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_69d2db57-5d35-4794-8a9e-9553b796c0be_terseLabel_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_label_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_documentation_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member" xlink:href="unh-20221231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.700notesdueDecember2025Member" xlink:to="lab_unh_A3.700notesdueDecember2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_83c12cb3-8bd3-4284-b09f-b0e3f920adf3_terseLabel_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_label_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_documentation_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:href="unh-20221231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:to="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_2a443c10-55b8-4f92-8105-4b99a1918531_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_93260a6c-5cd8-48e3-8fec-99d0dfa7f471_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6bc9dd2f-fa58-4729-9ad2-b9eecb60ac0f_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e73156fd-ac48-48bd-96cd-e73bd1e8fc80_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_118b114d-3295-4417-b0e8-1d7d62dbfd01_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entitiy Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_d032e58a-bebb-42d7-aa2b-814455826599_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_154edd39-77c0-489b-9d21-ee56c7aaa8fc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d3f1014-c278-4f77-9c4d-b8955d34c3fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_6d1b3814-3fc1-4306-bbff-b324b5892b38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_d23bf6d1-25cc-4c94-a3e3-5ff8f5c63cb7_totalLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ff3d7fa1-5504-4d63-8e2b-8346f7bfffda_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_380cf753-b239-4001-9ff1-b223e37004fc_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards - excess tax benefit, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1d73c4bf-b567-4703-a2ce-a8afeac354f0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_955b6a21-d674-485c-88b6-c2f81e1ab75a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareholdersEquityAbstract_86ceb3a4-aecc-4d02-900b-b85d726e4772_terseLabel_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_unh_ShareholdersEquityAbstract_label_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Abstract]</link:label>
    <link:label id="lab_unh_ShareholdersEquityAbstract_documentation_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareholdersEquityAbstract" xlink:to="lab_unh_ShareholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_d4f430a3-9ba2-4191-9453-0bae69489cd7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ChangeHealthcareMember_b45471c5-673e-4a35-84fb-8e30fb2015bb_terseLabel_en-US" xlink:label="lab_unh_ChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare</link:label>
    <link:label id="lab_unh_ChangeHealthcareMember_label_en-US" xlink:label="lab_unh_ChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare [Member]</link:label>
    <link:label id="lab_unh_ChangeHealthcareMember_documentation_en-US" xlink:label="lab_unh_ChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareMember" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ChangeHealthcareMember" xlink:to="lab_unh_ChangeHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_2feb79b9-2d02-4874-9113-d1588c467a2c_terseLabel_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes Due Februray 2038 [Member]</link:label>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_label_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes due February 2038 [Member]</link:label>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_documentation_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes due February 2038</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member" xlink:href="unh-20221231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6.875notesdueFebruary2038Member" xlink:to="lab_unh_A6.875notesdueFebruary2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_5804e16b-16b0-45f7-8934-13b4e1b5d439_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherDispositionsMember_a08458e7-e6e0-40d2-82b2-60c28ecbc660_terseLabel_en-US" xlink:label="lab_unh_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions</link:label>
    <link:label id="lab_unh_OtherDispositionsMember_label_en-US" xlink:label="lab_unh_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions [Member]</link:label>
    <link:label id="lab_unh_OtherDispositionsMember_documentation_en-US" xlink:label="lab_unh_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherDispositionsMember" xlink:href="unh-20221231.xsd#unh_OtherDispositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherDispositionsMember" xlink:to="lab_unh_OtherDispositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_be570e0d-796b-4694-b2d8-3b6090da2ace_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b0a28bf9-f0f5-463f-ad41-b1cec3143bb7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_379c15d4-9437-4155-8d8e-a6098d937262_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, before tax</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_df655647-36a5-44ac-b115-193873382bca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of shares granted, per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_43e99e2c-165f-4d8c-8d6f-ef9944d8c36b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CreditFacilityNameAxis_a876788c-6207-4839-b519-57ce89ffbcfc_terseLabel_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:label id="lab_unh_CreditFacilityNameAxis_label_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:label id="lab_unh_CreditFacilityNameAxis_documentation_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CreditFacilityNameAxis" xlink:to="lab_unh_CreditFacilityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_138b8313-ee9e-494a-b0bc-92c68b1bd600_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_a98c215f-a469-4e97-9669-1c3065c5766d_terseLabel_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_label_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_documentation_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member" xlink:href="unh-20221231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.700notesdueAugust2049Member" xlink:to="lab_unh_A3.700notesdueAugust2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a7ee45c3-bce3-4d68-b56d-c14f2964c98f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2bee8a5c-910d-462c-aafb-4aef58a0283f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_5c0b2382-4839-40a5-90c3-e127847efde3_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a3bd68a7-f91f-4fe5-b4db-a3362330e628_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_b1893afc-3fee-4c79-a713-b9e6de8b70cc_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_4046a174-15e6-4238-91fc-03b1a152d5d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8ebc6214-4d4b-402d-abd9-074bf32cf412_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperAxis_345d6de2-23f7-40c2-86d8-c255ccbe24c0_terseLabel_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper [Axis]</link:label>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperAxis_label_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper [Axis]</link:label>
    <link:label id="lab_unh_DebtInstrumentExcludingCommercialPaperAxis_documentation_en-US" xlink:label="lab_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, excluding Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:to="lab_unh_DebtInstrumentExcludingCommercialPaperAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_6b49e88d-52e9-4201-b23d-b4bfa4e5946a_terseLabel_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_label_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_documentation_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember" xlink:href="unh-20221231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ExtraordinaryDividendsMember" xlink:to="lab_unh_ExtraordinaryDividendsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9f95de9e-afe4-4ddc-a453-4492e2cfc03a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_0aa0167e-f9ad-491b-8267-70ba88149520_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_cfb7b295-291a-4c1d-bb03-d559f517c7c3_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e981fc96-c3fe-4736-ba4f-5ce2f87e6933_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_688bc010-74d1-4384-a9cb-b71831eee8f7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_f49a1367-62ca-4509-b6fb-56a3f034f2f8_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, Held to maturity, Unrecognized Holding Gain</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_84706225-738e-4d8b-b92a-f4182dca0d47_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_98625787-3b11-4960-9e21-3dad7d73b29c_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests fair value and other adjustments</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_94356376-d5cb-4d01-9252-9a43a2d19be4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and other adjustments</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_88e0e61c-11d8-45f8-a4c5-369820af8807_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5875NotesDueFebruary2053Member_032530dd-4155-4c6f-b5ce-ec8c408c28fe_terseLabel_en-US" xlink:label="lab_unh_A5875NotesDueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875% notes due February 2053 [Member]</link:label>
    <link:label id="lab_unh_A5875NotesDueFebruary2053Member_label_en-US" xlink:label="lab_unh_A5875NotesDueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875% notes due February 2053 [Member]</link:label>
    <link:label id="lab_unh_A5875NotesDueFebruary2053Member_documentation_en-US" xlink:label="lab_unh_A5875NotesDueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875% notes due February 2053 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5875NotesDueFebruary2053Member" xlink:href="unh-20221231.xsd#unh_A5875NotesDueFebruary2053Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5875NotesDueFebruary2053Member" xlink:to="lab_unh_A5875NotesDueFebruary2053Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_8a231391-0448-4d6c-ab6e-bf05c70c061c_terseLabel_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes Due March 2042 [Member]</link:label>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_label_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes due March 2042 [Member]</link:label>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_documentation_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes due March 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member" xlink:href="unh-20221231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.375notesdueMarch2042Member" xlink:to="lab_unh_A4.375notesdueMarch2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0182c160-9420-4e8f-8b10-624080749008_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_55753f76-f2aa-4ee9-bfeb-e720fce41ce8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_0d3fd80b-4439-4f88-8942-8eb3d2635223_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance industry tax, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ce559998-88da-41cb-bfa4-69ac56b65e60_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total foreign currency translation gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_7d0eef72-5c6b-4b92-b18e-6394753a199a_terseLabel_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_label_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures</link:label>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_documentation_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:href="unh-20221231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:to="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ef4576e4-b740-42c6-b4bd-6aa8b9b05aec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1803856a-cac0-4f19-a29a-072902a0d21c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_694f6d16-a38c-4973-ba41-67354e2fb249_verboseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Member]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_2facaf79-da76-4450-9577-cd783e193003_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bc8c524-35c1-4bf8-be9b-0aa881c6984d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b0cca31b-dc6a-46d4-ab72-fe21cfddb130_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations lapses</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_e451e935-63ec-446b-84a9-8b55cfe1d6cd_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_5ff34e45-b084-4cde-b92a-062779964893_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_59160d9e-429c-4081-98f9-d227080de243_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b59fd2dd-2b14-4afd-8d17-708854b163f4_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e3f95fab-d143-4927-8771-3ee453953d8d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_474d64e4-885e-4a59-a488-2df517283c0f_terseLabel_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_label_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_documentation_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member" xlink:href="unh-20221231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.250notesdueApril2047Member" xlink:to="lab_unh_A4.250notesdueApril2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_3fc88a61-bfea-4b0a-80ce-247f76bacca1_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_ebdcdd61-d19d-403b-ab56-2a02d0041687_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_62cf2a43-e0be-49b5-95c2-b201b5bdeda8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities - held-to-maturity</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b5df8194-5c61-4e71-8f31-2c049c507af1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bfdbdea7-5e61-4e56-8aa5-b46b26169d68_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_45e03cf3-435d-43dc-b3c5-1017ef9c306b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_8b316ab9-dd7f-4e4b-a2f8-6fc9303720a9_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_a72464d8-b0a1-4ce5-9a0a-056e86e6d307_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_aed634f9-8f53-42e4-aace-c2e84a1c7689_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_c9a2eba0-e3bd-4893-bbf3-309c766cfc3a_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Municipal Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_50bbf4b7-5744-40c3-b5fb-6d584937d2e9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_32270623-eed7-4216-af2e-a316acc08273_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_449764f5-cbb9-4bc4-918f-e6cb7bd5c0f7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, net of tax effects</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_39562c95-1029-4d5d-b1d2-f37ee875a123_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. goodwill and intangible assets</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:to="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DividendFrequencyAxis_4c58d6cf-da6b-486e-801d-efea9c30423a_terseLabel_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Axis]</link:label>
    <link:label id="lab_unh_DividendFrequencyAxis_label_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Axis]</link:label>
    <link:label id="lab_unh_DividendFrequencyAxis_documentation_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis" xlink:href="unh-20221231.xsd#unh_DividendFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DividendFrequencyAxis" xlink:to="lab_unh_DividendFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_70922acc-3af9-4581-a8bb-5df82d08271b_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible liabilities</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_label_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:to="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_ffccc345-9204-49ee-848b-0453946a5a0b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_3c39eb0d-b9d3-49f5-94e3-26f3b030fbe8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_571e892e-ad2c-4b73-bbf6-4d9ea9b3c481_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2192113c-2250-4cff-bb1c-037d0f9f75a1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4919cd3b-ea7f-4d2f-8d5d-c9de22971bed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets (Level 1) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_TotalAcquisitionsMember_686e4a35-c9cb-4ae2-a4f4-849b76ade1e4_terseLabel_en-US" xlink:label="lab_unh_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_unh_TotalAcquisitionsMember_label_en-US" xlink:label="lab_unh_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions [Member]</link:label>
    <link:label id="lab_unh_TotalAcquisitionsMember_documentation_en-US" xlink:label="lab_unh_TotalAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalAcquisitionsMember" xlink:href="unh-20221231.xsd#unh_TotalAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_TotalAcquisitionsMember" xlink:to="lab_unh_TotalAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_3027baac-4647-4c77-82b3-634d9c0c5a01_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtCurrent_a22eb9c3-8327-4a78-a603-bf2bf0ab3dd8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt, Current</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtCurrent" xlink:to="lab_us-gaap_OtherLongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e96a921-8aea-48fe-b987-9706ffc3f280_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_efe32546-0954-45aa-9ae1-842069044f41_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_4c70ac7e-1870-4628-9d11-cc6b927cc44b_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Agency Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_80cb7726-8087-4402-a607-f45620f7f49c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_e4319ea3-eee0-4860-bff0-abcb572ef571_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible compensation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3cbe931f-f706-4c6c-8916-76ef167601db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_1aa6a0ab-c3bb-419d-8ad6-787641b64bbd_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_1e283414-ef02-476e-b9a3-fd3b0a8a4081_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_089b340e-1793-4012-a2ed-7a0c7e73934e_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_769ace42-d742-4112-8b28-67f914ac28f6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_72a1781e-25cd-4243-ad2c-90625c414e14_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_1927a95e-c605-463c-a033-4d0a03815a9f_terseLabel_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net assets of subsidiaries</link:label>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_label_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Net Assets of Subsidiaries</link:label>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_documentation_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Net Assets of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries" xlink:href="unh-20221231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EquityinNetAssetsofSubsidiaries" xlink:to="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_f64cd8c7-cb71-4e9e-b073-56c69d73868d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of capital to parent company</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e9e56ae7-7e5d-4b78-90b8-efa30d5c579c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8d81fe47-db1b-4c5e-89bf-53830b59b5a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_dc56b6e9-919e-45b7-a4bf-54ac97465e62_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock, and related tax effects</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d4d9148f-c153-4e26-a22b-e069f38a2d4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_a394443f-23a5-4a0e-8d9b-97960c61e507_terseLabel_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_label_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_documentation_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DescriptionofBusinessAbstract" xlink:href="unh-20221231.xsd#unh_DescriptionofBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DescriptionofBusinessAbstract" xlink:to="lab_unh_DescriptionofBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8091b2cb-1bff-4ca1-8a1f-77c86854b120_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6149f42f-58b6-4f78-9945-6055e39ece11_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_9ac629fd-246d-493d-8b27-8658157f381b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e05e1d61-ef65-41fa-aa89-d2386cf48d8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0143a56b-41fc-4b7e-8ed4-b4a6ec5ee113_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings and Long-Term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5631ec23-b75b-4872-8607-11a639294009_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9b34bfec-8810-4fb8-931e-535be9130fef_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_affd7076-50ba-4d27-8ba6-ed67cad50ebe_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9de8e862-e285-46e3-8e40-ce2b882978f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions, gross decreases</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dc4f660f-d88b-42a5-a432-ac44bd6885ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_aefaeb03-a77a-4672-a21f-5e06227f3301_terseLabel_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% Notes Due July 2022 [Member]</link:label>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_label_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% notes due July 2022 [Member]</link:label>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_documentation_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% notes due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member" xlink:href="unh-20221231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3350NotesDueJuly2022Member" xlink:to="lab_unh_A3350NotesDueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_23a1baf1-4e02-4115-8aee-842b0c3e72ec_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_beadfc31-7fb0-4cd9-a222-093ec079decf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_695fc93c-e70c-4934-bb4b-1b204691c821_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_3b0cd4c1-1d0b-4924-af48-ea042415d041_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_1dd165ec-3637-4fee-8f1e-a8929bf04995_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_696d8656-e502-470c-a830-c7c953ccf728_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2d120fb5-5450-49ad-a30f-390c4f535b10_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_67b56b54-7fc6-4791-88d8-368a59137b2c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_365b86b5-2249-4ba2-b039-e9d73e7a3aa6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to UnitedHealth Group common shareholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5300NotesDueFebruary2030Member_f10be45d-fec5-45ed-98d3-838a64cf1600_terseLabel_en-US" xlink:label="lab_unh_A5300NotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% notes due February 2030 [Member]</link:label>
    <link:label id="lab_unh_A5300NotesDueFebruary2030Member_label_en-US" xlink:label="lab_unh_A5300NotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% notes due February 2030 [Member]</link:label>
    <link:label id="lab_unh_A5300NotesDueFebruary2030Member_documentation_en-US" xlink:label="lab_unh_A5300NotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% notes due February 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5300NotesDueFebruary2030Member" xlink:href="unh-20221231.xsd#unh_A5300NotesDueFebruary2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5300NotesDueFebruary2030Member" xlink:to="lab_unh_A5300NotesDueFebruary2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_6a5abf4c-dbbe-42bf-af3a-4fa4effc7478_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5000NotesDueOctober2024Member_3525781a-f0e5-47e6-ac77-9981ad671caf_terseLabel_en-US" xlink:label="lab_unh_A5000NotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.000% notes due October 2024 [Member]</link:label>
    <link:label id="lab_unh_A5000NotesDueOctober2024Member_label_en-US" xlink:label="lab_unh_A5000NotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.000% notes due October 2024 [Member]</link:label>
    <link:label id="lab_unh_A5000NotesDueOctober2024Member_documentation_en-US" xlink:label="lab_unh_A5000NotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.000% notes due October 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5000NotesDueOctober2024Member" xlink:href="unh-20221231.xsd#unh_A5000NotesDueOctober2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5000NotesDueOctober2024Member" xlink:to="lab_unh_A5000NotesDueOctober2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_52b99969-00e8-4b28-ad5a-7e8ba8270aae_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_354aee52-d0ca-4efd-ae03-8379b078ac36_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e088bce4-1c6d-4fea-8f08-60bd5ec89982_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_57a790a1-9c75-4fe5-8331-b6ef63c423a9_terseLabel_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:href="unh-20221231.xsd#unh_ScheduleIBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:to="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_eddd3bed-6383-4ddd-a3d7-0232e8272449_totalLabel_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</link:label>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_documentation_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:href="unh-20221231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:to="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_a1609a34-6874-4203-b018-6dc0f20b6c1b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af5cffa1-5088-45b9-bb03-fb5f1d71a0b6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a7fef4f5-4ccd-474b-9195-28869d5594ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_e27819b8-afa7-4217-bff0-3532ad332a07_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e7add75a-dd24-4a09-baad-a8f167478273_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_172d5156-f01f-4a21-8191-43bf029c45ac_terseLabel_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes Due October 2042 [Member]</link:label>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_label_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes due October 2042 [Member]</link:label>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_documentation_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes due October 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member" xlink:href="unh-20221231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3950NotesDueOctober2042Member" xlink:to="lab_unh_A3950NotesDueOctober2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_e0571d4b-ff08-4d4d-880a-1d8da7190c85_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Recorded Liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_f0883c16-cf93-47ab-b111-bc48201c0705_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_cb51114a-cf1d-4e92-a4b4-2da7c49aee7c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_248e7f47-1e4c-4705-ac2e-1392d8468907_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c0707bf-1853-433f-b9c6-029c0d69caa6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_f15cd68d-a12f-47cd-9ec5-ef063be55395_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_98d1410c-4940-475d-88c6-e74af41e8c99_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_71fc5406-14de-4e4b-95b9-95545746b24d_terseLabel_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes Due Februrary 2041 [Member]</link:label>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_label_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes due February 2041 [Member]</link:label>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_documentation_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes due February 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member" xlink:href="unh-20221231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.950notesdueFebruary2041Member" xlink:to="lab_unh_A5.950notesdueFebruary2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_f67bf23a-f7ef-4297-b35f-9f75e395d8eb_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e65e14d2-f647-4a2c-8acd-7323ad86c86b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock, and related tax effects (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e2ced361-15c1-44ac-b159-cfa3610a06ff_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_23bb9021-f9ae-4413-93d0-5a3885409c44_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_d31d8bf1-5084-4223-a202-60f0cbfbfce9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation (Losses) Gains [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1548c050-7da0-4579-aa17-1937d2a7601d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_6ac1dc4a-47c8-4174-8c3a-12e90f64ec35_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_6d9dbbb0-6c2a-45d2-89fe-c1260cddcce9_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_20a71458-72bb-4b6d-b9f7-04dbc98a079a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e1c63fff-57f7-4cde-bf2c-2ec2be9be2b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_10029d2a-5344-43f6-a846-9c4651f2baa6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_9bf9f541-efa8-416f-b808-051e99ac2124_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. tax loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ProductsandservicesMember_cd0d6fd7-2962-4af2-90ab-2875dfe7d39c_terseLabel_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:label id="lab_unh_ProductsandservicesMember_label_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:label id="lab_unh_ProductsandservicesMember_documentation_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember" xlink:href="unh-20221231.xsd#unh_ProductsandservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ProductsandservicesMember" xlink:to="lab_unh_ProductsandservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_403f0b73-7fcb-466f-839a-359055e5ba57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_61c517c3-d47a-4e90-bf6c-718bc3652b89_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1cbc0ecc-b424-44fa-a963-71467f2567d8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_864c7689-9ecd-4df6-b4d7-8585db62abd4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_bb1699f3-1478-4990-b9a4-40c19ebcc42c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions, gross increases</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4628684c-0547-40f9-a6f9-6003b75e1144_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_66a697c2-5d9f-4a9d-9329-d3083ace7666_negatedTerseLabel_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_label_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_documentation_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries" xlink:href="unh-20221231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_Capitalcontributionstosubsidiaries" xlink:to="lab_unh_Capitalcontributionstosubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a1a79ea1-e123-415c-b20e-991dc494c447_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d32a2deb-f34c-4f41-89c8-e8d810caf3d9_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests_c323a1e1-274e-4c59-9168-2ed73518c127_terseLabel_en-US" xlink:label="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests_label_en-US" xlink:label="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Redeemable noncontrolling interests</link:label>
    <link:label id="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests_documentation_en-US" xlink:label="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests acquired through business combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsRedeemableNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:to="lab_unh_BusinessCombinationsRedeemableNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_1a5305ac-8aea-46ae-95db-3ae305eac741_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_f8b6b02c-e886-402c-8e0c-943f1c93d5b5_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_b0c095a3-99aa-4e3b-bd2b-d5f89f6feab4_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_4d515956-9d5a-4bcd-a7df-a2a9e8c26e7c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_cf427691-5cd4-45c4-9aaf-0cedd0c39e68_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains on investments</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Domestic</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilityOtherDomestic" xlink:to="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_4a2a53bb-e5a6-47e7-88f8-4c361adc89d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Than 12 Months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_31385ba1-ba54-4d99-9d68-2bbd22077832_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2046387d-3296-40ed-9de8-2653067b78f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_aca4b93a-548d-4df9-9fda-2e9a6a3cd662_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5816f6f5-43da-4d05-8a5e-3b1939dac4f1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_10b6a6a7-11df-468f-adc5-70fe28a45871_terseLabel_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Notes Due March 2023 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_label_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2023 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_documentation_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member" xlink:href="unh-20221231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2875NotesDueMarch2023Member" xlink:to="lab_unh_A2875NotesDueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_28c2bbf2-7242-4c1c-bf7a-7b8424a53f84_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and other financing obligations, carrying value</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_32ae6d04-f37a-4b60-be61-3f8650c1295b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_628c754f-c2a3-42ac-86ac-413bad14d972_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (repayments of) short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_0c21b158-9ab6-4607-bd63-738581e5c9ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_bfe3585b-fe59-4670-9883-08f167db4d04_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total UnitedHealth Group shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_a6ac6526-ed06-4322-98b6-c8a5c62418af_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementTable" xlink:to="lab_srt_CondensedBalanceSheetStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_4e22cdbc-e22e-4630-b67a-3a05526e9608_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards - excess tax benefit, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_3963646d-8816-487f-8d0d-fa203b35182e_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ChangeHealthcareAcquisitionMember_e522a047-2f6b-46eb-bf49-27a3bed332bf_terseLabel_en-US" xlink:label="lab_unh_ChangeHealthcareAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Acquisition</link:label>
    <link:label id="lab_unh_ChangeHealthcareAcquisitionMember_label_en-US" xlink:label="lab_unh_ChangeHealthcareAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Acquisition [Member]</link:label>
    <link:label id="lab_unh_ChangeHealthcareAcquisitionMember_documentation_en-US" xlink:label="lab_unh_ChangeHealthcareAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareAcquisitionMember" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ChangeHealthcareAcquisitionMember" xlink:to="lab_unh_ChangeHealthcareAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bcf4f9e2-ef48-4126-b4a0-8f13deb96dfe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cdc871b4-28fe-41a7-8ae5-bd9daa56aa6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9ff32eb6-2a26-45c9-8275-6340c21e2508_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_7bfb4803-d91f-4f79-b282-d23dbca2d911_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0d7fd215-c264-4ca3-8d6b-94c1a9315b92_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1da0b989-3942-4afc-9c1b-67f0b6c1b241_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_fac815f7-d324-47b2-8506-bd47a827402e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4950NotesDueMay2062Member_bf59a049-5460-4ad1-ae81-ee104dd06426_terseLabel_en-US" xlink:label="lab_unh_A4950NotesDueMay2062Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.950% notes due May 2062 [Member]</link:label>
    <link:label id="lab_unh_A4950NotesDueMay2062Member_label_en-US" xlink:label="lab_unh_A4950NotesDueMay2062Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.950% notes due May 2062 [Member]</link:label>
    <link:label id="lab_unh_A4950NotesDueMay2062Member_documentation_en-US" xlink:label="lab_unh_A4950NotesDueMay2062Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.950% notes due May 2062 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4950NotesDueMay2062Member" xlink:href="unh-20221231.xsd#unh_A4950NotesDueMay2062Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4950NotesDueMay2062Member" xlink:to="lab_unh_A4950NotesDueMay2062Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_345cfc09-b3aa-4178-b856-0093745a89f0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bbe4a00f-b8de-4894-a7fa-74ff224103d5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5afb7ee9-d872-4dfb-8c92-5792553221b4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_378f5aee-f843-41b9-ab63-3bbfcc17c7ac_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_72625416-a6e8-4c1e-beff-cbf16ad11584_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_0bdcf4df-8edd-465a-81cc-8af27d3092c7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_acc7ab4d-1f00-4eb1-9dc6-ccde94a260fa_terseLabel_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_label_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_documentation_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:href="unh-20221231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:to="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d840de42-5e5f-41e5-bead-75609bfa3469_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_09313ea9-f7ca-456c-9851-c0717a22fe8b_terseLabel_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived NOL carryforwards [Member]</link:label>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_label_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLsExpirationBeginning2022Through2037 [Member]</link:label>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_documentation_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLs expiration beginning 2022 through 2037</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member" xlink:href="unh-20221231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NOLsExpirationBeginning2022Through2037Member" xlink:to="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_966136c0-c345-4b97-b5c9-4a07b3494b6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, Weighted Average Grant Date Fair Value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_23031963-86d2-4772-a408-9ecfd7e8b133_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures and equipment [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_c5029889-9874-4604-aaa1-069cc3f00f1f_terseLabel_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_label_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_documentation_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member" xlink:href="unh-20221231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.200notesdueJanuary2047Member" xlink:to="lab_unh_A4.200notesdueJanuary2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_098c7f53-bbeb-4c99-9443-6f60f867dc42_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_53fe0cf2-e51a-4d82-b658-089ff389c1f1_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Axis]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_label_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Axis]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_documentation_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:to="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a88b1691-d563-4454-846a-133641711d38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_37887667-52ce-4c1f-a471-367b7c3bb610_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal and state intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_afd1d20b-5e65-4870-bdb0-c0a2e2a00f93_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a7671b62-56db-49d8-9168-6f696ccdec30_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $877 and $954</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_67b7ae6e-bf09-489a-bef8-60ddf215c819_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_31738048-ed00-493d-8e64-e95b93499ce4_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government and Agency Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d63e3327-6ada-4796-aead-581e1881b6c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositAccounts_3d2224b8-5047-47c4-a2e6-87ff1fc19dc9_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health savings account deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositAccounts_label_en-US" xlink:label="lab_us-gaap_DemandDepositAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposit Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositAccounts" xlink:to="lab_us-gaap_DemandDepositAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_2b1c11ab-8fc6-4813-a7bc-8e21b7c4ae14_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_ba857b80-3a28-43d3-805b-d02eea683780_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-domestic</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_label_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Domestic</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetOtherDomestic" xlink:to="lab_unh_DeferredTaxAssetOtherDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_4e269d1d-6f46-4585-b472-9933af0d5196_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_0d278872-b755-445f-8470-21b6d1467255_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4ae0300a-973e-4eac-aadb-c81cb1c469a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_c927b042-8d0c-4af4-99db-c19118b3ac7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in undistributed income of subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0519524d-664d-4b1c-9eca-aac72387196d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9b950318-46f9-4044-beb5-10ff87c74987_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_de9be6b0-c11c-4fcc-aaec-adefce6b639a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_9f40bc8f-061d-4ec2-9b81-24ee133e9795_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_90b52905-ed71-4899-8a6d-09824c67d949_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_5ae94e2d-e994-421a-9546-cd39b8037984_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7db05651-9948-457e-b183-759eedde8ac3_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_0e835b9a-bf9d-4500-a6c7-ec3d0d51d3ec_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_704deee5-3243-4ce9-a32e-af063a9dd720_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross reclassification adjustment for net realized losses (gains) included in net earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_10f7f47b-f970-4e38-9c38-0533d2abebcb_terseLabel_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030 [Member]</link:label>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_label_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030 [Member]</link:label>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_documentation_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member" xlink:href="unh-20221231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2000NotesDueMay2030Member" xlink:to="lab_unh_A2000NotesDueMay2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bf07fc69-a707-4959-941c-1522a665f29a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_a7a808b2-5aef-4ee1-a702-7ccc061df201_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5f72f0d3-d109-47f2-8f36-87aa1d5db8eb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e6a16df7-baca-4321-aac4-dc1f7ce9e648_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c4f86259-5104-489d-bf61-c188f1a62a0a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_14f3bfdf-d141-4c1d-b079-372e1c1554fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_b6391190-a2ac-4a6d-9cf7-0b32b39da476_negatedTerseLabel_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held-for-sale</link:label>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_label_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Assets and Liabilities, Liabilities Held-for-sale</link:label>
    <link:label id="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Assets and Liabilities, Liabilities Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:to="lab_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_9885e4b2-868c-447d-8a18-86c8bdde4ba1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal and state net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_906b521c-a32f-424e-a3d9-c3f680504052_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_f5aadb39-9714-43f4-aa10-90bbb23712e1_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0a6e6d94-3673-4fab-aeb5-ff7b18eff032_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d1a5d7a-07a5-4863-a183-dfeed76c9078_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash items:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a3b4a01e-594e-4433-9404-7bac2b2b3ddf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0df3205f-7367-49b6-a3b9-14c392aabc80_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ee1ef46f-ad66-4426-97e9-67dc6019f433_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_01d13c64-b8d4-4948-b535-b6cf8e94c979_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6694bbea-d1fb-449c-8c76-6714aab863b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2651cc71-bc94-4b08-b6d3-52c76deeea12_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_6bd33901-2764-4ff4-b08d-33e3fbda009b_terseLabel_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember" xlink:href="unh-20221231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_RedeemableNoncontrollingInterestsMember" xlink:to="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6e5139cd-41dd-4988-baf7-932ad24062c6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4ce2ee9b-9f45-44de-bc5b-90a08ede8d3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_da4d8087-64f4-417f-892c-77c965c5e78f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe6b1cac-d71f-460d-acc1-1f97580b313d_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_65dc6967-8a33-4308-a974-e0acc1153f36_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_f1d620ff-aaa7-4133-b377-6cb1ca5fac1a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_398e8043-300b-411c-94c8-13e468693141_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_label_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member" xlink:href="unh-20221231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueJune2023Member" xlink:to="lab_unh_A3.500notesdueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_194af324-8e9b-455c-9062-58baa20ed2cc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_231e800b-a83b-48df-bee3-c6f8164e4a0d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_3bd0d254-243f-41d2-b26c-a0832344b097_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptumrxMember_f96a3ccd-92c7-4d2d-b836-03f4d27c3615_terseLabel_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Rx</link:label>
    <link:label id="lab_unh_OptumrxMember_label_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optumrx [Member]</link:label>
    <link:label id="lab_unh_OptumrxMember_documentation_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember" xlink:href="unh-20221231.xsd#unh_OptumrxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptumrxMember" xlink:to="lab_unh_OptumrxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_197869fe-e46b-46f2-8d71-ca588ca319d0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A364Day60BillionCreditFacilityMember_f718c902-487e-489c-b0ee-26a9ad82bb68_terseLabel_en-US" xlink:label="lab_unh_A364Day60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_A364Day60BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_A364Day60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_A364Day60BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_A364Day60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $6.0 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day60BillionCreditFacilityMember" xlink:href="unh-20221231.xsd#unh_A364Day60BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A364Day60BillionCreditFacilityMember" xlink:to="lab_unh_A364Day60BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8eaa1777-2e75-4e67-9b6e-97b70563ce65_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_6c833e04-093f-4898-9f63-3b992e99586a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f58a2477-48d2-4b47-8491-0bf2c0a2cf71_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_0971ab87-1be3-46ec-b293-7abf7b35225b_terseLabel_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Notes Due November 2022 [Member]</link:label>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_label_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon notes due November 2022 [Member]</link:label>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_documentation_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon notes due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member" xlink:href="unh-20221231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ZeroCouponNotesDueNovember2022Member" xlink:to="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_537dd1c9-1129-41b5-910b-f1c1bd609469_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8c9691e4-da8c-4936-9596-194908012c27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_aad3965f-b733-4d84-9ff1-98d402faf09d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_732a94c1-9cdd-4bf4-82fc-70d40e43bb96_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_24c93be9-2da8-4834-8089-480d9da1e6e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_4f246d52-8921-4fa9-81a2-51748d9e5eec_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ac8cc48f-39f2-42ce-a80c-cfae7ef3ee95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea0dc6f9-4a0a-4ddf-b0b2-f969011c902f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0fe581bd-919d-4ff9-a1d6-cabc3a6e7f92_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_109a3c6c-ac42-4b80-8936-2de122addb81_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4750NotesDueMay2052Member_7f830981-b76f-430b-92fa-1b95f2105c0b_terseLabel_en-US" xlink:label="lab_unh_A4750NotesDueMay2052Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due May 2052 [Member]</link:label>
    <link:label id="lab_unh_A4750NotesDueMay2052Member_label_en-US" xlink:label="lab_unh_A4750NotesDueMay2052Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due May 2052 [Member]</link:label>
    <link:label id="lab_unh_A4750NotesDueMay2052Member_documentation_en-US" xlink:label="lab_unh_A4750NotesDueMay2052Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due May 2052 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4750NotesDueMay2052Member" xlink:href="unh-20221231.xsd#unh_A4750NotesDueMay2052Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4750NotesDueMay2052Member" xlink:to="lab_unh_A4750NotesDueMay2052Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_c6459d7d-2ad9-486b-ac83-2573c28415a5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_34372d20-4b66-4556-a6a5-7ebc60911f68_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0a8fab20-f3e7-4247-91fd-791b234958fb_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_8f88b29c-6d65-4191-a1db-6923479457e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5172f854-29d5-4748-99c3-5579a5868c05_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Financial Information [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f7303fa6-29e9-47a6-aa92-fbb686ef899f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_02dc8be4-f402-4e29-a6bb-44552a13d838_terseLabel_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050 [Member]</link:label>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_label_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050 [Member]</link:label>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_documentation_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member" xlink:href="unh-20221231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2900NotesDueMay2050Member" xlink:to="lab_unh_A2900NotesDueMay2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_146218cc-39d4-491e-bf71-2e103ad3c07b_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_14cdef8b-79dc-4ada-b4be-1fcfff54007c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_23122248-9424-4089-8a08-1f0088049880_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_89f21dc2-6bf2-4748-b2a8-14ab48f9ad71_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency effects and adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_524c10d1-d4f2-4379-9ac1-47e126b46f66_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at the U.S. federal statutory rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_cc8b2b25-b608-4b88-bc89-73ccaac824e5_terseLabel_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes Due October 2040 [Member]</link:label>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_label_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes due October 2040 [Member]</link:label>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_documentation_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes due October 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member" xlink:href="unh-20221231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.700notesdueOctober2040Member" xlink:to="lab_unh_A5.700notesdueOctober2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CapitalizedsoftwareMember_15073614-54df-4ff8-bcd3-68eb1fc483e9_terseLabel_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_unh_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_unh_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember" xlink:href="unh-20221231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CapitalizedsoftwareMember" xlink:to="lab_unh_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4200NotesDueMay2032Member_81ce10da-fe9f-4a8f-83d1-6de1a8840772_terseLabel_en-US" xlink:label="lab_unh_A4200NotesDueMay2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due May 2032 [Member]</link:label>
    <link:label id="lab_unh_A4200NotesDueMay2032Member_label_en-US" xlink:label="lab_unh_A4200NotesDueMay2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due May 2032 [Member]</link:label>
    <link:label id="lab_unh_A4200NotesDueMay2032Member_documentation_en-US" xlink:label="lab_unh_A4200NotesDueMay2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due May 2032 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4200NotesDueMay2032Member" xlink:href="unh-20221231.xsd#unh_A4200NotesDueMay2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4200NotesDueMay2032Member" xlink:to="lab_unh_A4200NotesDueMay2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a0205558-d61f-4551-baf3-8ffb00f75ed7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0dfc2e7b-b909-4615-a6f2-baa2dfd8aa73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_4ce80ea5-ea0f-472d-922d-e77cad9a973a_terseLabel_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024 [Member]</link:label>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_label_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024 [Member]</link:label>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_documentation_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member" xlink:href="unh-20221231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A0550NotesDueMay2024Member" xlink:to="lab_unh_A0550NotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7bef1b8e-fc71-4e56-af67-ac3b5934ec35_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a5844f33-d9ef-4a5f-ab3c-bae592454ace_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventDescription_65a7d25f-29df-4fff-b76f-1c41e2699c58_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event, Description</link:label>
    <link:label id="lab_us-gaap_SubsequentEventDescription_label_en-US" xlink:label="lab_us-gaap_SubsequentEventDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventDescription" xlink:to="lab_us-gaap_SubsequentEventDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_e4e27cf6-ef35-4b1b-8d90-7556a0fff4aa_terseLabel_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarliestTaxYearMember" xlink:to="lab_us-gaap_EarliestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CoverPageAbstract_8acd8397-5d41-40fa-a1f3-6db47d6f4ee6_terseLabel_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:label id="lab_unh_CoverPageAbstract_label_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:label id="lab_unh_CoverPageAbstract_documentation_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CoverPageAbstract" xlink:href="unh-20221231.xsd#unh_CoverPageAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CoverPageAbstract" xlink:to="lab_unh_CoverPageAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a02ec470-f0a5-419d-b67b-6f0ab3afba59_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_fefa51c5-a8d8-4116-acf6-c1dfd23a3d83_terseLabel_en-US" xlink:label="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and Other Current Assets Policy</link:label>
    <link:label id="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and Other Current Assets Policy [Policy Text Block]</link:label>
    <link:label id="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and Other Current Assets Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:href="unh-20221231.xsd#unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:to="lab_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4be1db1f-75e4-4ff5-801d-2290fa9696a4_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3cb014ff-a1fc-4134-968d-e2fa71d0ee4a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3cb61f76-1502-4649-813f-8b64bd0eddfa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $6,930 and $5,992</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_366a07af-7498-4b06-9f4d-f0a711ab38a1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LatestTaxYearMember_78d3fd14-8a4e-4f1d-9faa-1ccf3fe8601e_terseLabel_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:label id="lab_us-gaap_LatestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LatestTaxYearMember" xlink:to="lab_us-gaap_LatestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d269cb54-3ae5-4fdc-a6a2-18241560ed82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_aa858699-c716-4131-9741-1806cbb095bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_d83ec327-2086-4a12-a74c-4e268900a44f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_20e91d77-6a1b-4216-b4e4-401421f3a407_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_2305f1cf-150f-4ef9-b332-2805114df6c3_terseLabel_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_label_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_documentation_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member" xlink:href="unh-20221231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.850notesdueJune2028Member" xlink:to="lab_unh_A3.850notesdueJune2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4fa4c05e-8bbe-49fa-a61c-87253dbc0483_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_1fe03797-d3dc-447b-be9b-a72d5a8a7fea_terseLabel_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes Due June 2037 [Member]</link:label>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_label_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes due June 2037 [Member]</link:label>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_documentation_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes due June 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member" xlink:href="unh-20221231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6500NotesDueJune2037Member" xlink:to="lab_unh_A6500NotesDueJune2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7976688d-7de0-43e2-b273-a4e8eb5803c6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3adbff40-f8fc-4827-8dcb-54e5e401d368_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareRepurchasesTable_6563a6d6-5952-4763-9db5-12650be1396a_terseLabel_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTable_label_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTable_documentation_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareRepurchasesTable" xlink:to="lab_unh_ShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherAcquisitionsMember_f927a76b-ecdc-4e83-b07f-84e4f613a46b_terseLabel_en-US" xlink:label="lab_unh_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquisitions</link:label>
    <link:label id="lab_unh_OtherAcquisitionsMember_label_en-US" xlink:label="lab_unh_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquisitions [Member]</link:label>
    <link:label id="lab_unh_OtherAcquisitionsMember_documentation_en-US" xlink:label="lab_unh_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherAcquisitionsMember" xlink:to="lab_unh_OtherAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ab3723a7-be82-472a-8b11-cb2a714c770b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_ca436daf-b773-47b4-ab5b-1c3549c0b589_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7143f689-276e-44bf-a68f-e3b4b5da240c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b153f674-541d-4ef2-aa4f-0361a7974998_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_001fd5eb-d66c-42fe-b10d-2eabbc498986_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_eed3165c-fb72-4133-91d1-8b201f0b7693_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_bd1bfbc2-3a1f-4878-84a1-1f6febf23b65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a0d1f5b3-c9a0-4fda-b4da-224a5f84c4a4_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8f67e18c-0842-418e-9a33-38072aba6227_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_392e5eac-74cd-4d87-b923-755c115c74f1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_e444b375-50c2-4cf7-b288-2b6670b28e94_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_6fb85a14-a3da-4cb5-ba00-9028ddfd1399_verboseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums, revenues - unaffiliated customers</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e7f0f8eb-f6a5-45c4-92b2-5f6c84a6da5a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense related to share awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_22fa6364-68ca-4744-ab66-c6e1bdd3ab11_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit realized from share-based award exercises</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_50847905-9c97-471f-823e-f60286d8ec6d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized losses on investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2a61ab64-7f36-42af-b228-0cfcb9f96945_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a8d98033-b23f-42c2-84ff-3bb376508164_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_33493ade-eac9-44e9-86f8-53b6ce7a6674_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net remaining outstanding liabilities prior to 2021</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5f4422e7-aed5-44cd-906a-2851870c951a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3021e2b8-571e-4d9d-8e61-59fdd1ae00f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d7602f85-b0a0-4472-bd9b-db5d8f1ae97e_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_2438ae35-5989-4888-bd85-4504122f9a82_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_c5691635-8645-40b9-8eab-e219697e64fb_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_689d5b37-e081-4b2c-87ee-5fa468b2d03a_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_bcc4428b-d5b8-4b8f-9b73-a472bd2feeeb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f3b5df8e-1e7f-4715-b7a4-57833f96499d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_055f51a7-cae0-419a-adf1-024dfbbde34a_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance industry tax, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3f7f35ca-938c-4268-a2c6-fdbd2576a418_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b8723073-5ecb-4230-b25b-947b194c1556_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_67d340bf-46b7-4ad8-ad93-8db756342393_terseLabel_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_label_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:href="unh-20221231.xsd#unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:to="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_483b6a1e-23c4-4cf4-ae26-3ad6076581ce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_e2baf78a-1480-49e5-980d-96e560cc2479_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_da1a05f2-1239-484f-bfaa-90717b07e2d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_49491a1e-a7d0-499f-845e-05d72b6163bb_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a85be4a5-26d3-44db-88dc-fd8cdfa7dd60_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities - available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_f239a255-1c30-40e9-98be-f483c196c1f3_terseLabel_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</link:label>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_label_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</link:label>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_documentation_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:href="unh-20221231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:to="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_19d3ae1e-679b-4de4-8833-452371abd393_terseLabel_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite NOL carryforwards [Member]</link:label>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_label_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLsIndefiniteCarryforward [Member]</link:label>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_documentation_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLs indefinite carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember" xlink:href="unh-20221231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NOLsIndefiniteCarryforwardMember" xlink:to="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c81e47a7-e66b-45d4-a4ab-ee50c6f7399a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_00eebdd8-2f88-4b21-bd6e-2270fb3e24e6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e285bc33-c8d9-46de-94ce-fe6a7b8dafc6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Contractual Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_a60fd19f-c3c8-45b3-94d9-0a21662ac201_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_52568e8d-7317-4a63-85e3-c202c31e87a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_cb6473d1-4f03-4a02-ab39-ca5c660be46e_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f5e50e2b-2656-4e8b-a34d-cd63e7d48774_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_fd8bd72d-04e0-444f-843b-a26f1971fecc_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d82f1583-0c05-43e1-bbc1-4af34047048c_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9faae476-aaab-410a-8b90-9fc310ca4a6c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9b3b6a67-b637-4f32-a476-5d3790f0ea8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 4)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5da726b1-2991-4cbd-9db7-fb4549559a31_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c98ac32c-2f7f-418c-b7c6-edd5a14ba04d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4158c79c-b453-4ebc-a2ed-6f2879cb9aeb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2cf20b53-6c5b-489f-bfb5-e2cda1139b4c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fc5933d8-e526-4f9e-b838-17d8f2a68877_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4a735e73-1478-4945-a7b6-787ff5fafb5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_391fdd8a-9158-48af-9c2c-cfb7d4a7a977_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Products and Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_46fd73b8-c050-41ee-b967-fc05196d6e54_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Products and Services - unaffiliated customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_d5ca7132-dbe9-4b5f-a73e-cfa1e301f714_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Provision:</link:label>
    <link:label id="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_label_en-US" xlink:label="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes, Miscellaneous [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:to="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_5eac2541-8c00-4b9e-a8b6-d7d7cbbb357b_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d8a008c7-564c-4c54-8d05-ba7ce43cf855_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_474b5a31-ca13-4097-9dd3-25f9384456b3_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_15fa71ef-b665-407d-bd75-856df8c39586_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_711cd2a4-f1d7-4e16-9611-414ea476aba3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_27155285-5274-4b70-815d-095756347f7b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported medical costs:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_0a1d57ac-6d50-4d60-bff7-5a037f1e3ff0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dcfd3511-4a04-4cfd-b075-7ebc63cf1199_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f813cbab-a704-4a6f-b2d0-3b43a8a2d150_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3ba129e4-211e-4425-8a71-60a6024ae4c6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_577bc990-a32b-4606-bc26-aa6f74b38aed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4e45e564-5ebf-4b23-bcc3-4bd7e6c2e57b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_916d2efa-64aa-4271-9096-c8fc7207bf8c_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_84c5f285-5f4b-40a4-9d70-a407f59d9aeb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_32e26c96-6a33-4b49-b7e0-67242fe250ad_terseLabel_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_8bbbbfb8-d8aa-4950-8792-5dbef14bf3b1_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_6ca3b6cc-f6b2-43dc-b95e-b6e8e1920ba6_terseLabel_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity Disclosure [Line Items]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_label_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table] [Line Items]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_documentation_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareRepurchasesTableLineItems" xlink:to="lab_unh_ShareRepurchasesTableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_6a045ef9-317b-4397-88d6-8809c762f669_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_72418c9a-a513-4cf2-9bbf-a96a4c822ccc_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_78d23538-d367-4038-ba39-9c2b36111645_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_5ef5f777-4c9f-4153-945b-ecdeb741f52f_negatedTerseLabel_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Gross Unrealized Losses</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_label_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Gross Unrealized Losses</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_documentation_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses of investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsGrossUnrealizedLosses" xlink:to="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_582e6db7-da18-4666-8482-9f4fc524a9b3_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c70c0825-ae80-4fae-a3f7-7f381982f7d6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_da2feddc-04fa-4caa-9505-e120ac8671dc_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_63bec8bf-6bad-4677-bd0c-e9db6edfa572_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock_380db6a0-79fa-4330-b571-36672f7436b6_terseLabel_en-US" xlink:label="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations</link:label>
    <link:label id="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock_label_en-US" xlink:label="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations [Table Text Block]</link:label>
    <link:label id="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock_documentation_en-US" xlink:label="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations Change Healthcare and other acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:href="unh-20221231.xsd#unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:to="lab_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_a9da187b-57bd-47a2-96f6-5ca51c68a710_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_674b1bf9-1c9c-4a3d-a452-7455cffab3e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_e0233b20-5622-46bc-bf1e-9213ec827b7d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_c494d2c4-faed-45e4-9e95-c7901fc2fd7a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_99211898-3dc9-455b-9ac8-59f3266cdad8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_f6839d7f-748d-41cc-a446-4ea6872ab9f0_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_978d99ea-aa62-4d3d-8ec4-b2c5f8f29bfe_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-non-U.S.</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_label_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetOtherForeign" xlink:to="lab_unh_DeferredTaxAssetOtherForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_fe81e507-477c-4713-8560-8aea6511179f_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e9582329-6a98-4668-9c97-c314e30cfe09_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_180acf76-b1e8-4857-9828-f36971319b11_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_be3845ee-3372-4551-9e4b-ac452ee2550c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4188b3bf-4652-4c42-8401-e28581fcf1dc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_dd26112b-a3dd-4da3-a59c-0c2bbfdc9c8a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_819ea6e6-b3cf-4f70-b16b-66352ac93098_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d1c7edf5-34cc-4115-9536-de0c675a348b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_a9013390-ea6c-4c9a-a0ec-639e89a71b37_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_388aa837-5755-4244-9827-da655bfac131_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_17e75001-d238-4362-884a-642527ebef56_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_513b7504-6088-4089-b2f8-e32c95196725_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_label_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_documentation_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:to="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_eeaf944a-4715-4c40-9acf-9fc3d62fb9d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of notes to subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_0eefbd87-990d-4a04-90fb-9d3e61916699_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_59efeac8-6522-4873-aee2-4e3f841717bc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_99014008-8bed-4572-89ed-95f078d0bcfb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings and Long-Term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8498f62b-1979-434b-86fd-786b8655b863_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_5405d41d-a41b-4697-a5b8-80768abe942f_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_5e8c9a3f-bf0d-4d04-8eb4-a6c6d13ba2f8_terseLabel_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Gross Unrealized Gains</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_label_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Gross Unrealized Gains</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_documentation_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains of investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsGrossUnrealizedGains" xlink:to="lab_unh_InvestmentsGrossUnrealizedGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_812998c0-f355-4472-a34b-e113ebeed4a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_003c0ea7-7caa-437c-abfa-229ceb0bf99e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_27779230-7651-48a2-8322-ad59beace143_terseLabel_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_label_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_documentation_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member" xlink:href="unh-20221231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2750NotesDueMay2040Member" xlink:to="lab_unh_A2750NotesDueMay2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_ee3bfa7f-0daa-4576-9f6f-d69c72ff8737_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AarpAssetsUnderManagement_ad20142c-e22c-4f3e-bc78-6bdf3d2b8dca_terseLabel_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets under management</link:label>
    <link:label id="lab_unh_AarpAssetsUnderManagement_label_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management</link:label>
    <link:label id="lab_unh_AarpAssetsUnderManagement_documentation_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement" xlink:href="unh-20221231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AarpAssetsUnderManagement" xlink:to="lab_unh_AarpAssetsUnderManagement" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3700NotesDueMay2027Member_182ea8c1-d61f-4af5-9f9c-9bea9d7f756c_terseLabel_en-US" xlink:label="lab_unh_A3700NotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due May 2027 [Member]</link:label>
    <link:label id="lab_unh_A3700NotesDueMay2027Member_label_en-US" xlink:label="lab_unh_A3700NotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due May 2027 [Member]</link:label>
    <link:label id="lab_unh_A3700NotesDueMay2027Member_documentation_en-US" xlink:label="lab_unh_A3700NotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due May 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3700NotesDueMay2027Member" xlink:href="unh-20221231.xsd#unh_A3700NotesDueMay2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3700NotesDueMay2027Member" xlink:to="lab_unh_A3700NotesDueMay2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FiveYear60BillionCreditFacilityMember_b25d1ced-fa6c-4972-9949-9e3ac8fc9587_terseLabel_en-US" xlink:label="lab_unh_FiveYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_FiveYear60BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_FiveYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_FiveYear60BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_FiveYear60BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $6.0 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear60BillionCreditFacilityMember" xlink:href="unh-20221231.xsd#unh_FiveYear60BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FiveYear60BillionCreditFacilityMember" xlink:to="lab_unh_FiveYear60BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_021b4f26-0901-4046-939b-09cae72dee64_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_78daf63e-5acd-494e-831c-191d7f859a85_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common share equivalents</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_d9e72e8b-574e-4ea9-915d-fe35682ec813_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_5b9493c6-cdd9-4d32-9076-65a68e0e4fee_terseLabel_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_label_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_documentation_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member" xlink:href="unh-20221231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3250NotesDueMay2051Member" xlink:to="lab_unh_A3250NotesDueMay2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3fc1a843-0c51-48ab-b7ab-f248cad5ddc9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_87403255-3689-4fe6-af4d-4ea56923382e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_IncomeTaxAbstract_5c7184f9-b22e-4e43-9e74-70d8e6831f04_terseLabel_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:label id="lab_unh_IncomeTaxAbstract_label_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:label id="lab_unh_IncomeTaxAbstract_documentation_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_IncomeTaxAbstract" xlink:to="lab_unh_IncomeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_5f200804-d46b-4bc9-bd89-1260584b60e9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_373e6ce4-81bb-4538-82f5-32488a856910_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_afe06c8c-ec5c-4c4b-b654-a367c522d393_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_35830baa-14b4-4d5b-bb26-288054a6ee85_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_01ada7a7-7bf5-4442-bf59-7cb882b2fec0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_714a69aa-d32f-4771-bc45-4ce53e232f33_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_32a01c66-eecd-4ae3-8b3d-2e0ed97ca5eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_7ee5940a-7373-4158-bba3-e424c7e89904_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from notes from subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_36812568-91c6-4170-9b0a-4710d6487600_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at the U.S. federal statutory rate, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4fd5f4de-24d7-4805-b3af-4ab7f173a187_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_767d87a5-829a-48ea-9b2a-14c1629a4025_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8295ccd5-6eef-4ef8-892c-726050dd9657_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_4fe2c718-b565-49a7-99b2-8dc9a781afbe_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board authorized shares remaining</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_db539cc8-0320-46e8-8618-900e6719d824_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Domain]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_label_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Domain]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_documentation_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Pharmaceutical manufacturer rebates receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:to="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AuditorInformationAbstract_17955597-5db2-4875-b228-e4cf91dbf2fc_terseLabel_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_unh_AuditorInformationAbstract_label_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_unh_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AuditorInformationAbstract" xlink:href="unh-20221231.xsd#unh_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AuditorInformationAbstract" xlink:to="lab_unh_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>unh-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6ce39b19-f873-4d16-a4d2-32c601055a54,g:8609874d-8cd6-4329-a125-368d99e76ff5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.uhc.com/role/CoverDocument" xlink:type="simple" xlink:href="unh-20221231.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:href="unh-20221231.xsd#unh_CoverPageAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c12cbe32-362e-4727-895e-afb5505e50c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityFileNumber_c12cbe32-362e-4727-895e-afb5505e50c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_506311fc-6c41-4f73-8e61-fe6d0e407da4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentType_506311fc-6c41-4f73-8e61-fe6d0e407da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7a4a997b-cbff-43be-8e46-ce76d150ae25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentAnnualReport_7a4a997b-cbff-43be-8e46-ce76d150ae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_797c5489-b88a-4289-ba13-a5a43384a77f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentPeriodEndDate_797c5489-b88a-4289-ba13-a5a43384a77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_afbfcca0-ac23-42d0-a89d-f460023bf37e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_CurrentFiscalYearEndDate_afbfcca0-ac23-42d0-a89d-f460023bf37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_876e3044-5976-4810-a96b-823d336bd17f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentFiscalYearFocus_876e3044-5976-4810-a96b-823d336bd17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_db40cdfd-22df-47b7-a607-d4f66d275cd9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentFiscalPeriodFocus_db40cdfd-22df-47b7-a607-d4f66d275cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5cea5f52-9057-457e-9b85-ce07dd62bd78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_AmendmentFlag_5cea5f52-9057-457e-9b85-ce07dd62bd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_612e6acd-c1b9-467d-bcb0-115b41e58c07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentTransitionReport_612e6acd-c1b9-467d-bcb0-115b41e58c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_441a788c-f1a2-4b3c-a1d5-c06b1721d8d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityIncorporationStateCountryCode_441a788c-f1a2-4b3c-a1d5-c06b1721d8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6c34bdbc-3a7b-4cb2-b38e-8c70c52d89c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityTaxIdentificationNumber_6c34bdbc-3a7b-4cb2-b38e-8c70c52d89c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_346026fe-065d-4f30-9276-c2e4ef814cf1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityAddressAddressLine1_346026fe-065d-4f30-9276-c2e4ef814cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_5b073034-573e-48b1-9c62-cc3f15c155ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityAddressAddressLine2_5b073034-573e-48b1-9c62-cc3f15c155ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6f69d77f-bd40-4c10-8685-2e0d4d22294e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityAddressCityOrTown_6f69d77f-bd40-4c10-8685-2e0d4d22294e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7d3c0cfd-23fd-463d-a790-927706219239" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityAddressStateOrProvince_7d3c0cfd-23fd-463d-a790-927706219239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_62200d46-5f35-4741-a7c7-d8b6d36c542d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityAddressPostalZipCode_62200d46-5f35-4741-a7c7-d8b6d36c542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_583377b0-cdb6-4d0d-9239-258c76f3c67c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_CityAreaCode_583377b0-cdb6-4d0d-9239-258c76f3c67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_20a9bf18-951e-41da-af0e-90f592fa33e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_LocalPhoneNumber_20a9bf18-951e-41da-af0e-90f592fa33e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2d729479-2830-4760-b03b-b05af25e6507" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_Security12bTitle_2d729479-2830-4760-b03b-b05af25e6507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7349148d-b65d-46fb-877e-20907646f8c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_TradingSymbol_7349148d-b65d-46fb-877e-20907646f8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c182f3a9-c9fb-4f98-965f-b47d1a05e9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_SecurityExchangeName_c182f3a9-c9fb-4f98-965f-b47d1a05e9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_19fb7aeb-ec41-43ba-9e6b-eee25d0aa308" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_19fb7aeb-ec41-43ba-9e6b-eee25d0aa308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a1d3fcfb-b21d-4114-8013-8f1c8951944e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityVoluntaryFilers_a1d3fcfb-b21d-4114-8013-8f1c8951944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_22ea86ae-8989-4f86-aa4b-009645993d36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityCurrentReportingStatus_22ea86ae-8989-4f86-aa4b-009645993d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_fe84749a-6fde-4fbf-990d-869bf591fb21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityInteractiveDataCurrent_fe84749a-6fde-4fbf-990d-869bf591fb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2904da84-8343-47c0-9544-1f9c67636249" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityFilerCategory_2904da84-8343-47c0-9544-1f9c67636249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6f8eb25e-8fde-4ae8-b35f-5841fd9e8f8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntitySmallBusiness_6f8eb25e-8fde-4ae8-b35f-5841fd9e8f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b08195ff-ce46-4622-9277-fa20bf3cdc19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityEmergingGrowthCompany_b08195ff-ce46-4622-9277-fa20bf3cdc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2daf7f58-71d8-4bcb-b599-7f9f7c4570bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityShellCompany_2daf7f58-71d8-4bcb-b599-7f9f7c4570bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_ce43f0a4-0b04-4a84-9d04-55f74644e5b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityPublicFloat_ce43f0a4-0b04-4a84-9d04-55f74644e5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2a3a6918-23db-49b2-b177-b29e0860d700" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2a3a6918-23db-49b2-b177-b29e0860d700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6b7aef7f-a102-46ab-bd9b-195474428be6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6b7aef7f-a102-46ab-bd9b-195474428be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7456e1b5-953f-4639-b8b5-6db042c4a186" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityRegistrantName_7456e1b5-953f-4639-b8b5-6db042c4a186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1d021e6d-fb6b-4425-b81d-386e6c43910f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_EntityCentralIndexKey_1d021e6d-fb6b-4425-b81d-386e6c43910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b3fad993-6d79-4ef4-9f6b-6ab77d74dcd2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_735d882a-d324-4ce0-aac4-219170f10931" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b3fad993-6d79-4ef4-9f6b-6ab77d74dcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/AuditorInformation" xlink:type="simple" xlink:href="unh-20221231.xsd#AuditorInformation"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/AuditorInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_AuditorInformationAbstract_185e945b-f9e0-4cc0-96af-c93d3124f697" xlink:href="unh-20221231.xsd#unh_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_1465b3c3-c47b-40d3-95d2-b475a93d5529" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_185e945b-f9e0-4cc0-96af-c93d3124f697" xlink:to="loc_dei_AuditorName_1465b3c3-c47b-40d3-95d2-b475a93d5529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_6f540fd8-5ddc-4573-b046-2292834cb5d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_185e945b-f9e0-4cc0-96af-c93d3124f697" xlink:to="loc_dei_AuditorFirmId_6f540fd8-5ddc-4573-b046-2292834cb5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c12daa50-a7f0-4193-a01b-6236644d5de6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_185e945b-f9e0-4cc0-96af-c93d3124f697" xlink:to="loc_dei_AuditorLocation_c12daa50-a7f0-4193-a01b-6236644d5de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:to="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2649d8ea-9e25-489e-94a1-ef4dd541181c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bc75b05a-4758-47c3-98a9-b71aaa09a51e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2649d8ea-9e25-489e-94a1-ef4dd541181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d169a2c3-6db2-49ad-b179-a7e6d583467d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4cf8faaa-a66d-430e-b79f-7664a12268eb" xlink:to="loc_us-gaap_StatementLineItems_d169a2c3-6db2-49ad-b179-a7e6d583467d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a2dab09c-c2bf-42bf-a77c-bfeca8387c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a2dab09c-c2bf-42bf-a77c-bfeca8387c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e0ac5e74-e6c5-4b05-bc62-d9390abae61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_ShortTermInvestments_e0ac5e74-e6c5-4b05-bc62-d9390abae61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_11d9b28b-e4dc-4416-be0b-94a8ae779c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_11d9b28b-e4dc-4416-be0b-94a8ae779c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6fca8736-4bd3-42d6-8543-83ce551b493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6fca8736-4bd3-42d6-8543-83ce551b493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_0b642c60-c451-428b-b650-42fc66e51be7" xlink:href="unh-20221231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_unh_AarpAssetsUnderManagement_0b642c60-c451-428b-b650-42fc66e51be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8e254f2-3b6c-42be-9f17-a1ee74ee54e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8e254f2-3b6c-42be-9f17-a1ee74ee54e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_56d6231c-7f23-4d2f-9bd0-09c3dd6a9198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e1a8618d-763a-43d2-8560-f7b6d3a03219" xlink:to="loc_us-gaap_AssetsCurrent_56d6231c-7f23-4d2f-9bd0-09c3dd6a9198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_5f51b5b3-ef0c-4c8b-88d9-cbea29c0fc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_LongTermInvestments_5f51b5b3-ef0c-4c8b-88d9-cbea29c0fc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f8f0af71-5cd6-478e-becf-b8d4a031d468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f8f0af71-5cd6-478e-becf-b8d4a031d468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8becc3f-f9d8-4032-a2b4-839ef0d9b096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_Goodwill_b8becc3f-f9d8-4032-a2b4-839ef0d9b096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50e7c3d0-79b7-426a-9430-b13e670e63e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50e7c3d0-79b7-426a-9430-b13e670e63e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_63606cc2-a03b-4f84-88de-22971dc41128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_63606cc2-a03b-4f84-88de-22971dc41128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0aa2dc7f-afbc-4237-a292-a6ed5c3179d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2b37e48-afa7-454b-bf33-381f055ee784" xlink:to="loc_us-gaap_Assets_0aa2dc7f-afbc-4237-a292-a6ed5c3179d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1a311193-d3ff-4ff8-bdd0-4acd1993bbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1a311193-d3ff-4ff8-bdd0-4acd1993bbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cb24ff5e-a2fd-4fd2-b9ff-821910eb5393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cb24ff5e-a2fd-4fd2-b9ff-821910eb5393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_619606e7-a330-49af-b477-6ea041fc66c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_DebtCurrent_619606e7-a330-49af-b477-6ea041fc66c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_f2fb946c-54a2-4a27-b60d-ab4414ec9552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_DeferredRevenueCurrent_f2fb946c-54a2-4a27-b60d-ab4414ec9552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ac8e5d19-1a34-4ce0-ba5c-74ebf0e12ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ac8e5d19-1a34-4ce0-ba5c-74ebf0e12ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6b2f65cc-fd02-4312-b90c-8a313154b9af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b364223d-c9e8-4296-9b11-553e95161ec3" xlink:to="loc_us-gaap_LiabilitiesCurrent_6b2f65cc-fd02-4312-b90c-8a313154b9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_df0f66ce-6f63-48fe-85eb-1e96e42dc177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_df0f66ce-6f63-48fe-85eb-1e96e42dc177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e9ff9773-bc02-4134-8fab-3a0b88d5e678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e9ff9773-bc02-4134-8fab-3a0b88d5e678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_026ef8f2-1df2-4f9a-a15f-b235c58602e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_026ef8f2-1df2-4f9a-a15f-b235c58602e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a25dccfa-fa85-4a99-9692-d4b38536e5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_Liabilities_a25dccfa-fa85-4a99-9692-d4b38536e5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_28eaf332-2ddc-42d5-b73a-45e3dd8bb57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_CommitmentsAndContingencies_28eaf332-2ddc-42d5-b73a-45e3dd8bb57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_568fdb82-2d12-468f-9a41-e6c0e11daa50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_568fdb82-2d12-468f-9a41-e6c0e11daa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e351658f-5fcb-4aa8-925e-6e997d848899" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4dc0a1c6-94f0-488e-831f-cf1b24b13401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_PreferredStockValue_4dc0a1c6-94f0-488e-831f-cf1b24b13401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_812b39db-38c5-423f-acc3-1a4a67240495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_CommonStockValue_812b39db-38c5-423f-acc3-1a4a67240495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_320e4dd2-19a3-4e5c-9157-7a14323c5572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_320e4dd2-19a3-4e5c-9157-7a14323c5572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe1a99a6-ac15-4709-97b0-6932a202bdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe1a99a6-ac15-4709-97b0-6932a202bdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_bb45dc00-6011-42e2-a7c7-dd86dffb993a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_MinorityInterest_bb45dc00-6011-42e2-a7c7-dd86dffb993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c8e4ecde-0d70-4d41-a212-44a5d354e2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c8e4ecde-0d70-4d41-a212-44a5d354e2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ab80f05-bf55-4aea-a874-6fc2beaa7c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9c992b89-d7f7-46a3-970a-ecfe1cb61d2f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ab80f05-bf55-4aea-a874-6fc2beaa7c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0c071c51-20f8-467e-8185-a8bcdc4036b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0c071c51-20f8-467e-8185-a8bcdc4036b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6f5652dd-2c8a-4777-89e6-f908f55a8278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6f5652dd-2c8a-4777-89e6-f908f55a8278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_94c01981-b514-4803-94db-9618d90e6cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_94c01981-b514-4803-94db-9618d90e6cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6e9b9dbc-bbc5-426e-b08d-4c5c1ee5ebad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6e9b9dbc-bbc5-426e-b08d-4c5c1ee5ebad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_036b2b12-4647-4aab-86e7-bd52a56af44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_036b2b12-4647-4aab-86e7-bd52a56af44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b29ea531-d0b3-4756-8edc-1857446df0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b29ea531-d0b3-4756-8edc-1857446df0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ddf09160-95b2-454d-9b17-919f2cac5922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_CommonStockSharesIssued_ddf09160-95b2-454d-9b17-919f2cac5922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_73aeb399-6d5e-4f3f-b78b-92645c1c9f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d84d3b3-1aa7-41ca-8819-00ce89f22fc0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_73aeb399-6d5e-4f3f-b78b-92645c1c9f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0870fcdb-a738-47a2-94ee-52b63b62849c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0870fcdb-a738-47a2-94ee-52b63b62849c" xlink:to="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:to="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7544135d-9f71-4936-bbbd-dcec43291dc2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0c77b279-259b-45fe-a863-4ec77fc503c6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7544135d-9f71-4936-bbbd-dcec43291dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ab476b9a-3d53-444c-ad76-26ac23703e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8f454dd-b739-4363-ad97-30ae1573169d" xlink:to="loc_us-gaap_ClassOfStockDomain_ab476b9a-3d53-444c-ad76-26ac23703e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2e5924ad-109d-4860-9328-7f97ed7559f5" xlink:to="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5a1531a-1f8b-43dd-a5d2-ca5427ccfaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5a1531a-1f8b-43dd-a5d2-ca5427ccfaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_ad26cfd6-aa0e-44e2-81d4-b8da95031fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_ad26cfd6-aa0e-44e2-81d4-b8da95031fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_981aad68-ef3f-4e72-9f75-7a3d1d4aa404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_981aad68-ef3f-4e72-9f75-7a3d1d4aa404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_db930f0e-58fd-44cc-a0cc-7d63d661a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7c6875e6-ca1a-4ac6-9d1c-d61a3d6f898f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_db930f0e-58fd-44cc-a0cc-7d63d661a43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_343d8162-fae0-4772-9bc4-f868ebaebf48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_RevenuesAbstract_343d8162-fae0-4772-9bc4-f868ebaebf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_87b97a9b-ed36-4818-891c-37a963256e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_343d8162-fae0-4772-9bc4-f868ebaebf48" xlink:to="loc_us-gaap_PremiumsEarnedNet_87b97a9b-ed36-4818-891c-37a963256e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_5663a075-56c3-40af-a50c-7df2541f6047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_343d8162-fae0-4772-9bc4-f868ebaebf48" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_5663a075-56c3-40af-a50c-7df2541f6047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d9ef034e-ee5b-42f4-8213-d7b8ec3cd74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_343d8162-fae0-4772-9bc4-f868ebaebf48" xlink:to="loc_us-gaap_Revenues_d9ef034e-ee5b-42f4-8213-d7b8ec3cd74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_25c2f5a5-8991-4d57-9e8c-9d993e1087a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_25c2f5a5-8991-4d57-9e8c-9d993e1087a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e0400986-511e-49d0-be10-6fd86ff07355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e0400986-511e-49d0-be10-6fd86ff07355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4ee25193-ee72-4648-8fb9-c1d77160ec99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4ee25193-ee72-4648-8fb9-c1d77160ec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c2605397-4bc5-4d35-978f-c029c2ce1209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:to="loc_us-gaap_DepreciationAndAmortization_c2605397-4bc5-4d35-978f-c029c2ce1209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f1d76676-1e5b-433b-aabb-d8d61af61158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_70b46c1c-a5a6-46e3-ae07-e10643e20966" xlink:to="loc_us-gaap_CostsAndExpenses_f1d76676-1e5b-433b-aabb-d8d61af61158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_36765768-5552-4673-b2cc-484ef77d8c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_OperatingIncomeLoss_36765768-5552-4673-b2cc-484ef77d8c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1cdd0be4-50fc-47dc-b67f-6d1dc7c6ce0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_InterestExpense_1cdd0be4-50fc-47dc-b67f-6d1dc7c6ce0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_08239071-456a-4cf4-b1d7-303719107cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_08239071-456a-4cf4-b1d7-303719107cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fdef5809-e4dd-4639-bc5f-ab19cc955c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fdef5809-e4dd-4639-bc5f-ab19cc955c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_45a5398b-0fb7-415f-b288-ab287595f700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_ProfitLoss_45a5398b-0fb7-415f-b288-ab287595f700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a22592c6-b980-4681-becd-2a603c5bb845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a22592c6-b980-4681-becd-2a603c5bb845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd5c6129-d85b-4a0d-a25e-a225ef7dd545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_NetIncomeLoss_dd5c6129-d85b-4a0d-a25e-a225ef7dd545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_88634361-5f96-4baf-9abc-411e880873eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_EarningsPerShareBasic_88634361-5f96-4baf-9abc-411e880873eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e6465eaf-4dbb-4356-997f-68189bd64fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e6465eaf-4dbb-4356-997f-68189bd64fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c2df15f-7532-4303-a9ca-4934da08a230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c2df15f-7532-4303-a9ca-4934da08a230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_25eb235d-dad9-4a66-8ca2-d444b5d30215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_25eb235d-dad9-4a66-8ca2-d444b5d30215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc6e044c-e036-474b-97e9-7736ed6e4aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc6e044c-e036-474b-97e9-7736ed6e4aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18e2d05e-df5d-4d47-9720-0b962b7f18c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b2b88b8f-e146-4075-9c24-0ff26114a950" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_18e2d05e-df5d-4d47-9720-0b962b7f18c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63ba1690-813e-420b-98b2-3caa664a2b1c" xlink:to="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:to="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3b2ac56f-da78-42a7-a7f8-6d8de05b193a" xlink:to="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_f43e1d56-4855-4239-be44-0b13b2422e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:to="loc_us-gaap_ProductMember_f43e1d56-4855-4239-be44-0b13b2422e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_07f2b5b1-9fab-45c7-a535-888551d8467a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_481e81f0-6e33-41af-84aa-d1c2197845f7" xlink:to="loc_us-gaap_ServiceMember_07f2b5b1-9fab-45c7-a535-888551d8467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a9d65070-507e-466d-ad87-986c3b1b3558" xlink:to="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a12cfac-17e7-4254-b4c0-31442bf4b1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_938ca7fc-886c-4da4-a4bc-ba7064862037" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a12cfac-17e7-4254-b4c0-31442bf4b1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:to="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8f0a6991-067c-4c6b-abc5-17d0d3a2bd7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f4b3a168-01fb-4bfc-a1fa-d8e24b5de4da" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8f0a6991-067c-4c6b-abc5-17d0d3a2bd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a92d72d5-74cd-46d5-bc0b-23b71bf64832" xlink:to="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7d1d410d-e6fb-4f46-a572-bc71e42eab79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ProfitLoss_7d1d410d-e6fb-4f46-a572-bc71e42eab79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9d261546-2bd3-4f7a-b447-0be81a4722a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9d261546-2bd3-4f7a-b447-0be81a4722a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_116e842f-1b07-4b44-9120-3a3b7d616519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_116e842f-1b07-4b44-9120-3a3b7d616519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fcb0b07a-3591-4cb6-b53e-377a26f0434b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fcb0b07a-3591-4cb6-b53e-377a26f0434b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_214255e2-e875-4d0a-bbc4-aa3bfb1aa0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_214255e2-e875-4d0a-bbc4-aa3bfb1aa0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c6bae31f-a945-40d8-9788-23ad27701b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c6bae31f-a945-40d8-9788-23ad27701b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_577815ec-5981-4b8b-901a-073071ac9cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_577815ec-5981-4b8b-901a-073071ac9cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_26dd772e-0e88-4fee-b7a7-aa2d4add0809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_26dd772e-0e88-4fee-b7a7-aa2d4add0809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_540d2bec-304b-4b22-b6ab-e4c3ba5a4a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_540d2bec-304b-4b22-b6ab-e4c3ba5a4a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf1b9c0e-ce69-4877-8bb8-2c02f9ea4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c815761f-aacb-4fc0-843c-cd8d58cd6499" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cf1b9c0e-ce69-4877-8bb8-2c02f9ea4f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8a694ed8-fa81-4d11-a281-6b68ead32c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8a694ed8-fa81-4d11-a281-6b68ead32c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8f8c7c4-76ca-40bb-b829-d278dbab2040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e971ccd9-c34e-465a-b445-be39f068070c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8f8c7c4-76ca-40bb-b829-d278dbab2040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4fd7501b-f0d3-4127-acb6-4bec02a69281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4fd7501b-f0d3-4127-acb6-4bec02a69281" xlink:to="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6689a9f2-d5cc-4ea6-a7bb-16abf784e389" xlink:to="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2beb1013-7598-4135-98ea-6f6f93f6e543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_CommonStockMember_2beb1013-7598-4135-98ea-6f6f93f6e543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0d81e8d0-1964-40ad-921f-49f2fb759eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0d81e8d0-1964-40ad-921f-49f2fb759eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_41804153-4002-4278-9cb3-54b836410cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_RetainedEarningsMember_41804153-4002-4278-9cb3-54b836410cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1f60e13e-70d0-4b2c-b5b6-c9205c45fdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1f60e13e-70d0-4b2c-b5b6-c9205c45fdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e0ad42bd-d07f-46cc-a756-3f5151fcd826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e0ad42bd-d07f-46cc-a756-3f5151fcd826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_92b90fc0-9710-4371-b057-378327af73c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_041918e7-7d0b-466d-8cfa-d5c7bbfb6b49" xlink:to="loc_us-gaap_NoncontrollingInterestMember_92b90fc0-9710-4371-b057-378327af73c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_905d5824-9051-4431-8787-bc87f70f397d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_fa8285d1-e8a9-4d81-b0c9-1f2275674496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6c385251-aaa7-4614-88d4-d6245c18a070" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_fa8285d1-e8a9-4d81-b0c9-1f2275674496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8dede070-0bc2-4bdf-96a8-86ccfab6b650" xlink:to="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_be2ad55f-719d-4f14-8f37-40588289149e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_be2ad55f-719d-4f14-8f37-40588289149e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f23f6e47-e9cb-4123-8c05-a6bf1e063d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f23f6e47-e9cb-4123-8c05-a6bf1e063d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d58452dc-dccb-46f2-ba0c-0bf484b4ef07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLoss_d58452dc-dccb-46f2-ba0c-0bf484b4ef07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_dda740c5-ea0c-4b9c-bb48-b9f1121299c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_dda740c5-ea0c-4b9c-bb48-b9f1121299c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_b8c97064-2b4d-4a86-9052-9573a533a761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_b8c97064-2b4d-4a86-9052-9573a533a761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a2900b33-dde9-461c-bbac-795b73110aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a2900b33-dde9-461c-bbac-795b73110aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e407271a-add8-4633-9480-a396a9143b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e407271a-add8-4633-9480-a396a9143b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b1523d8f-0cb0-4d29-ab5a-86d2c32c7e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b1523d8f-0cb0-4d29-ab5a-86d2c32c7e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2d667b06-8e3d-4c9b-b15d-0203618bcda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2d667b06-8e3d-4c9b-b15d-0203618bcda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_feea16d9-6bff-4f84-8a4b-61ee1ab19497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_feea16d9-6bff-4f84-8a4b-61ee1ab19497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_06012fc2-1ba6-4bc2-bd93-33bc4769f8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_06012fc2-1ba6-4bc2-bd93-33bc4769f8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_9ed21687-707b-4a68-a1fd-c3e2b286c71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_DividendsCash_9ed21687-707b-4a68-a1fd-c3e2b286c71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_9064df7b-86f0-4166-9808-0376dfb13630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_9064df7b-86f0-4166-9808-0376dfb13630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a5c879b9-dcdc-476f-becd-ffec8b5149e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a5c879b9-dcdc-476f-becd-ffec8b5149e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ba031da2-18e2-4f9c-ad2c-2959447b9230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ba031da2-18e2-4f9c-ad2c-2959447b9230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_394ce4de-aa74-41dd-98e8-7849e6a9fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_394ce4de-aa74-41dd-98e8-7849e6a9fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b680304-afd8-4b1d-8b86-975f4b7e4e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b680304-afd8-4b1d-8b86-975f4b7e4e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca25a997-6780-4ca4-820b-74802bac18f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dab70cba-123d-47a2-9146-f475e8ddc537" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca25a997-6780-4ca4-820b-74802bac18f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementofChangesinEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4587f440-d243-4f2e-aa1c-991ad949b799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4b983eba-84e9-47f8-8fb2-ca34c85a89fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4587f440-d243-4f2e-aa1c-991ad949b799" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_4b983eba-84e9-47f8-8fb2-ca34c85a89fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="unh-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_656a71e4-4131-4033-bcfd-9b28e67d740e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:to="loc_us-gaap_ProfitLoss_656a71e4-4131-4033-bcfd-9b28e67d740e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2b1916e2-4c63-4faf-b344-787f0137c85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:to="loc_us-gaap_DepreciationAndAmortization_2b1916e2-4c63-4faf-b344-787f0137c85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0ca22f96-7bbf-4c9e-b7bb-7b3abd809b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0ca22f96-7bbf-4c9e-b7bb-7b3abd809b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cb31ceeb-6243-4f31-91b2-ed31b2790431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:to="loc_us-gaap_ShareBasedCompensation_cb31ceeb-6243-4f31-91b2-ed31b2790431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9b2bff2a-edaf-4ee3-b895-c961e94f4add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa3e422-89e9-4250-8adf-5487edde5fd4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9b2bff2a-edaf-4ee3-b895-c961e94f4add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_696c5155-9cc8-4ad1-a482-f43d7791ad4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_696c5155-9cc8-4ad1-a482-f43d7791ad4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ad0f1388-1cdc-4f97-b1a6-d6f7f9cada3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ad0f1388-1cdc-4f97-b1a6-d6f7f9cada3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_1782d30a-55b7-4f84-9013-81bbffa89be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_1782d30a-55b7-4f84-9013-81bbffa89be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f0034d3d-697d-4e3e-bea7-9292a4e27c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f0034d3d-697d-4e3e-bea7-9292a4e27c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_35179f90-8f39-4df8-b9cd-2b65171561ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_622a6049-6345-4c5e-a95b-0cf748a5caf7" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_35179f90-8f39-4df8-b9cd-2b65171561ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3816c6d4-7f05-4770-a8f1-6a6c7c165eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_95443f13-da7f-4d2a-9982-4daf28e4106c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3816c6d4-7f05-4770-a8f1-6a6c7c165eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b797aafa-e20e-493c-a607-da54bc18f7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b797aafa-e20e-493c-a607-da54bc18f7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bfc0a66e-66db-4c54-9d4e-317eaccf91b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bfc0a66e-66db-4c54-9d4e-317eaccf91b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_664831a4-e23a-477e-91e6-8a9107cb1af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_664831a4-e23a-477e-91e6-8a9107cb1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc4841b3-74d6-4eac-ba10-6fb789fa8866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc4841b3-74d6-4eac-ba10-6fb789fa8866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_780f06db-d7b4-4a43-b73f-0db528656d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_780f06db-d7b4-4a43-b73f-0db528656d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_706b0728-eec3-4735-ba07-8731cae24821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_706b0728-eec3-4735-ba07-8731cae24821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0e5f92a8-7139-480e-b529-fa799c1f162e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0e5f92a8-7139-480e-b529-fa799c1f162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3249b0c2-ac91-4484-bcf9-64351b975631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4b6a6a9f-3ab9-47c6-94a6-1fff9252df18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3249b0c2-ac91-4484-bcf9-64351b975631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c7599384-c3fb-41f0-a9fd-80f37123428e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c7599384-c3fb-41f0-a9fd-80f37123428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8d9bf9d9-6ed3-41c4-8cbe-f03115758309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8d9bf9d9-6ed3-41c4-8cbe-f03115758309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0eca73c1-aa3b-4850-8acd-9d7faedeeaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0eca73c1-aa3b-4850-8acd-9d7faedeeaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_36f81ae5-1e99-4954-aefb-16c2878435f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_36f81ae5-1e99-4954-aefb-16c2878435f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_83e5b3e0-89b7-4462-a183-653de3b0c0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_83e5b3e0-89b7-4462-a183-653de3b0c0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8e6945e0-41fa-48b3-8057-c55a33f630ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8e6945e0-41fa-48b3-8057-c55a33f630ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits_d69f56f2-466c-4bbd-9fc7-0eb23a15ac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_IncreaseDecreaseInDeposits_d69f56f2-466c-4bbd-9fc7-0eb23a15ac7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_166ce1df-d9fe-4123-93c3-1c56e9405515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_166ce1df-d9fe-4123-93c3-1c56e9405515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f7c5ee76-38b0-4096-b57a-62b2725ede25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f7c5ee76-38b0-4096-b57a-62b2725ede25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe5defc5-98bf-47c9-83eb-a2fc25b0fafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fe5defc5-98bf-47c9-83eb-a2fc25b0fafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_876d28a6-6f62-44d6-b506-3a3edca35fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b05dd8e9-7878-48fc-ba9b-3c3a5ef9b3e3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_876d28a6-6f62-44d6-b506-3a3edca35fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a4812bf2-33ab-405e-8bbd-77e1f8db427d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a4812bf2-33ab-405e-8bbd-77e1f8db427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bff96a20-b0ac-470e-877f-66f1e1f00f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bff96a20-b0ac-470e-877f-66f1e1f00f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0de630b8-7f6d-4525-9492-6f22b7930793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0de630b8-7f6d-4525-9492-6f22b7930793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a9ca405d-892d-4a45-a885-24ba13f53dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_04e6bc72-389a-477a-bd04-cd83f94b8f53" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a9ca405d-892d-4a45-a885-24ba13f53dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b94b6602-f328-4b6e-8143-592458985f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a9ca405d-892d-4a45-a885-24ba13f53dac" xlink:to="loc_us-gaap_InterestPaidNet_b94b6602-f328-4b6e-8143-592458985f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_d737f527-f340-4947-b9c1-0cd8b4382977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a9ca405d-892d-4a45-a885-24ba13f53dac" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_d737f527-f340-4947-b9c1-0cd8b4382977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#DescriptionofBusinessNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_DescriptionofBusinessAbstract_6e6c5ee4-8b62-41c1-a9eb-bffa4a962853" xlink:href="unh-20221231.xsd#unh_DescriptionofBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DescriptionofBusinessAbstract_6e6c5ee4-8b62-41c1-a9eb-bffa4a962853" xlink:to="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:to="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ab756a3a-3587-4cf8-a429-7425807d5eb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e0dc3d34-d996-430d-8599-c9d4d12a4bcd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ab756a3a-3587-4cf8-a429-7425807d5eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b716bff6-1371-4a02-9f8f-e69954f7f2cb" xlink:to="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_e0536086-0679-492f-8293-0dbd51b6592a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0b812a90-e2fb-49c1-ab68-ea02831958fa" xlink:to="loc_us-gaap_NatureOfOperations_e0536086-0679-492f-8293-0dbd51b6592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_8cd3da44-f5b5-4be2-b34e-5e617941a8e9" xlink:href="unh-20221231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_8cd3da44-f5b5-4be2-b34e-5e617941a8e9" xlink:to="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:to="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cc1c5b18-64d1-438c-b859-ee7295f8324a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d4432631-a45c-42bd-97ae-944af1bb55e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cc1c5b18-64d1-438c-b859-ee7295f8324a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4cc8f40-9692-4af4-b75b-e108dbb518c3" xlink:to="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d368adcf-84eb-4b05-b4f9-964d45118610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79cfec8e-ec08-424a-bea7-0eaacf64b4ed" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d368adcf-84eb-4b05-b4f9-964d45118610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_db2b52f6-6ead-4253-938a-20fc2f2c041f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b64eafbc-3c64-485a-b683-1df87c6cdba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_db2b52f6-6ead-4253-938a-20fc2f2c041f" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b64eafbc-3c64-485a-b683-1df87c6cdba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_db020d6b-cf30-4eb0-bd58-b57011ca4996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8b3a34a4-77e5-4d7b-b9fa-317b757a5bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_db020d6b-cf30-4eb0-bd58-b57011ca4996" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8b3a34a4-77e5-4d7b-b9fa-317b757a5bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_dff918c8-a379-4a74-af78-6cd48d5f6bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_dff918c8-a379-4a74-af78-6cd48d5f6bb5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4e19f2e8-aa19-4021-be75-102c28958d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01ab0e3e-10b9-43b7-b088-98822a6fe6ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4e19f2e8-aa19-4021-be75-102c28958d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:to="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37fe92a5-c279-4d22-8c9d-6bb28e0359da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_92fc0f43-c07d-4f27-8ff2-c54378b61f77" xlink:to="loc_srt_RangeMember_37fe92a5-c279-4d22-8c9d-6bb28e0359da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d605499-8dd0-48bd-a42e-f8ec2a42dd66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bd9da6f2-dc2a-4957-aa6d-cf29fee11cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea213b2f-87a8-49a9-b973-9bbf1dfcba4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bd9da6f2-dc2a-4957-aa6d-cf29fee11cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_314680fd-1841-492c-8ae9-6394d90177fe" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_314680fd-1841-492c-8ae9-6394d90177fe" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0e75b18d-0289-4f50-8e62-c94773961006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c4513e75-5622-4c66-979e-29e471d8fcd5" xlink:to="loc_srt_ConsolidationItemsDomain_0e75b18d-0289-4f50-8e62-c94773961006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b129a1cd-7853-4ea3-b522-95bb969b77ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de65fd5d-9de9-4363-95e8-63c33fb47af4" xlink:to="loc_us-gaap_SegmentDomain_b129a1cd-7853-4ea3-b522-95bb969b77ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c804c828-66ce-4cb1-9dfd-b137f962a069" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_559fa74a-e8fa-46ac-9c85-3f3b325142d2" xlink:to="loc_srt_RangeMember_c804c828-66ce-4cb1-9dfd-b137f962a069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_64fc9b65-8e52-47c6-a13c-a02cd319be06" xlink:to="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ab94052a-1597-44f2-9062-c8fcb5899319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_93135219-a281-4165-a0c3-fae55c67391c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ab94052a-1597-44f2-9062-c8fcb5899319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c5f6b1c1-ac29-40ac-bddf-c077aa51fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_236b0cbe-2b2f-4fa8-a96f-bb77495e3b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c5f6b1c1-ac29-40ac-bddf-c077aa51fe4e" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_236b0cbe-2b2f-4fa8-a96f-bb77495e3b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1fc40cb8-a6e6-4dac-aaed-729664526c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_2fb4c1df-2a63-40a5-ad09-d34e01799022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1fc40cb8-a6e6-4dac-aaed-729664526c5f" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_2fb4c1df-2a63-40a5-ad09-d34e01799022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_a7a0dda0-dbe9-42df-94f5-8ff0f317904a" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_a7a0dda0-dbe9-42df-94f5-8ff0f317904a" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d0c4e2b2-6220-401b-ad92-cb4c69a12b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58ae0318-237f-4d2d-9912-920b30a40a0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d0c4e2b2-6220-401b-ad92-cb4c69a12b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_e8a1c6f8-0300-46ca-92ba-ce3c60186e8c" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f621dfa-c9fb-455a-bd89-6173b1c5aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_fab690ce-3505-4e75-b67a-d1c99eae4078" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f621dfa-c9fb-455a-bd89-6173b1c5aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_45e43621-4e31-41b0-9fd8-09107767147c" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f7b9175-4851-47b2-8d31-5421f3573352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_45e43621-4e31-41b0-9fd8-09107767147c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f7b9175-4851-47b2-8d31-5421f3573352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82e54034-7636-4084-aee3-c00791ff8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0bc2301d-edd8-4470-8e35-97ec601ac69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82e54034-7636-4084-aee3-c00791ff8aea" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0bc2301d-edd8-4470-8e35-97ec601ac69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentsandContingenciesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90d228b9-32b1-4c76-8761-af3c0bd9f5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c7ed0ba-08e6-4189-afbe-8eac877d2645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90d228b9-32b1-4c76-8761-af3c0bd9f5c2" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c7ed0ba-08e6-4189-afbe-8eac877d2645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BusinessCombinationsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_46e8c296-5959-4e8e-ab59-3b89e80a3d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_9231d3ef-c987-4488-9595-72b6f094f716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_46e8c296-5959-4e8e-ab59-3b89e80a3d94" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_9231d3ef-c987-4488-9595-72b6f094f716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNotes" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e8590f39-075c-4f47-9a75-3ae798d46cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_248847b5-a771-4578-b4e4-6b8afc2a15a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e8590f39-075c-4f47-9a75-3ae798d46cc4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_248847b5-a771-4578-b4e4-6b8afc2a15a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleINotes" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleINotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleINotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f2b4a48f-f1ae-4538-844c-23110dcd18ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f2b4a48f-f1ae-4538-844c-23110dcd18ef" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_edb4faed-57f3-4b3d-a0b2-e6eff656d6b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f4d9e452-60b6-4c3f-b3ca-e61c50fd1f65" xlink:to="loc_dei_EntityDomain_edb4faed-57f3-4b3d-a0b2-e6eff656d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_56e3b0fb-ce0c-4e55-97c8-73a6ee4ade53" xlink:to="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_18f2a6ee-7065-4a4b-a3fc-8dbd47eea47e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_da523835-9cff-460d-a7d1-9fd7907bda45" xlink:to="loc_srt_ParentCompanyMember_18f2a6ee-7065-4a4b-a3fc-8dbd47eea47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5b203967-4b6f-494a-b069-c7525575e5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0706213b-504d-4df8-bc87-5f3c516cde64" xlink:to="loc_srt_ConsolidationItemsDomain_5b203967-4b6f-494a-b069-c7525575e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_5cd000df-1229-4392-af95-4be8e817bade" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_734a0651-9cb0-428d-9a41-bf53777b465a" xlink:to="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_5cd000df-1229-4392-af95-4be8e817bade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_2c195d48-2c6a-4c47-928e-0d50fba49bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f2b4a48f-f1ae-4538-844c-23110dcd18ef" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_2c195d48-2c6a-4c47-928e-0d50fba49bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_10661295-efec-4241-877b-7dec1a1462d0" xlink:href="unh-20221231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_10661295-efec-4241-877b-7dec1a1462d0" xlink:to="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:to="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b0a8d4f2-add4-4c4d-83f2-8d68748f09fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_adbc3762-7134-4ca7-887c-617e4b626af6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b0a8d4f2-add4-4c4d-83f2-8d68748f09fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54e9ebcf-6bb5-4159-a4cf-417a11b27b61" xlink:to="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83b24345-a255-461a-a0af-4cac29dc2175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83b24345-a255-461a-a0af-4cac29dc2175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_d46f9f6d-3b69-4a9b-a519-c69fdca62f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_UseOfEstimates_d46f9f6d-3b69-4a9b-a519-c69fdca62f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1d2ef76-f845-4f5d-a7b1-4ffee4c173fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_f1d2ef76-f845-4f5d-a7b1-4ffee4c173fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_9446b5fb-dc51-4519-a5f3-0df72332d41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_9446b5fb-dc51-4519-a5f3-0df72332d41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_37294f48-0ad5-4d2f-8340-349ccaf88060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_37294f48-0ad5-4d2f-8340-349ccaf88060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_53780045-82fe-4f19-874f-76257ea20abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_53780045-82fe-4f19-874f-76257ea20abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_afb0f766-117c-4d04-812a-f3c9d7a25129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_afb0f766-117c-4d04-812a-f3c9d7a25129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_6e3a81c5-26f9-456f-9c01-297dd04ad5d7" xlink:href="unh-20221231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_6e3a81c5-26f9-456f-9c01-297dd04ad5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_e2097787-fd3b-47be-844c-b6e298507009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_e2097787-fd3b-47be-844c-b6e298507009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_ee61af12-da2f-4935-8f0b-7e0bb338dba0" xlink:href="unh-20221231.xsd#unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock_ee61af12-da2f-4935-8f0b-7e0bb338dba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f73ecfc3-6e49-4bd0-97ab-e73bb0c3a489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f73ecfc3-6e49-4bd0-97ab-e73bb0c3a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_8455230a-db9d-4a7c-a69d-c68e698fc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_8455230a-db9d-4a7c-a69d-c68e698fc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_0a5d8482-9dd3-4679-81c1-dfdf38c04c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_0a5d8482-9dd3-4679-81c1-dfdf38c04c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_7e683ab6-7da9-4d0a-9f1a-09671240c126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_7e683ab6-7da9-4d0a-9f1a-09671240c126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_b2004fbf-d593-46a8-9f83-3b9c6423e6ed" xlink:href="unh-20221231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_b2004fbf-d593-46a8-9f83-3b9c6423e6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_5bb4e25a-6824-4270-b340-c043dada22f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_5bb4e25a-6824-4270-b340-c043dada22f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_96d670a2-7ffb-49ca-aba5-b7a2e0050c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_96d670a2-7ffb-49ca-aba5-b7a2e0050c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_234875fa-8e84-4178-8822-7238998c6fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_234875fa-8e84-4178-8822-7238998c6fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_aab8bcf1-105c-4b64-8d74-2eab2fd9979a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb3d0202-a9fd-485f-ae1e-b163520ba1eb" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_aab8bcf1-105c-4b64-8d74-2eab2fd9979a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFairValuePolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAbstract_2e229319-0268-4b4f-89a8-78ee9657627f" xlink:href="unh-20221231.xsd#unh_FairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_FairValueAbstract_2e229319-0268-4b4f-89a8-78ee9657627f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e801cf4f-1ffb-4f0a-8444-e5f9e82acebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6ddce833-170b-4d10-8c0e-8fe4981a6a1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e801cf4f-1ffb-4f0a-8444-e5f9e82acebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db02cb06-2732-4f07-b68a-98a86e52e281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_581195a8-df6f-4b3c-b390-6ffa02023f39" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db02cb06-2732-4f07-b68a-98a86e52e281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e04b7321-44c5-432f-b67a-686ba4d51d87" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d0416075-7b49-4e32-9c15-844bd9fb1fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0496d54d-06c4-48a7-917a-616741d8fcf0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d0416075-7b49-4e32-9c15-844bd9fb1fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIPolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_fdd6c116-080f-44c5-8a42-764006a561fd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_fdd6c116-080f-44c5-8a42-764006a561fd" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a02164c-a80a-4065-9545-7ff0e3b067f5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e15f95e0-546c-4f98-bbd9-b68d876ea4c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b8d55a9b-4117-402d-a906-669abb774da5" xlink:to="loc_srt_ParentCompanyMember_e15f95e0-546c-4f98-bbd9-b68d876ea4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_65411652-c127-4684-a20e-3d025ea68cf7" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_29084852-e4f3-4ceb-b937-c4f12b5cf4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_29084852-e4f3-4ceb-b937-c4f12b5cf4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_fbbfa7a2-d596-497c-970d-4ea34039b0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_40349db3-01de-4ca5-b552-db32fc2d8c29" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_fbbfa7a2-d596-497c-970d-4ea34039b0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_5baaa8df-de90-4939-a843-49cee04c7cd7" xlink:href="unh-20221231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_5baaa8df-de90-4939-a843-49cee04c7cd7" xlink:to="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bae06872-6600-405a-889d-7a16befab786" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember_255354d5-5b08-4481-b43a-ead4aaaebc2e" xlink:href="unh-20221231.xsd#unh_UsefulLifeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_94842614-ee60-4aef-bcdb-53044f4b9b78" xlink:to="loc_unh_UsefulLifeMember_255354d5-5b08-4481-b43a-ead4aaaebc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:to="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0fbdf6a4-e12a-45f0-9f26-b461477cbaa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_3ce4e858-91f1-42a0-9858-c42164d87803" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0fbdf6a4-e12a-45f0-9f26-b461477cbaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2abb9485-e178-4639-861e-e6e5d6bf656e" xlink:to="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d6eb1dbd-b000-4ec6-933e-5c24ed0925fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d6eb1dbd-b000-4ec6-933e-5c24ed0925fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1c8549e-3426-4c74-9d86-6cd081db928a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4eb4d9f7-b13d-4f21-9695-08284155924b" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_d1c8549e-3426-4c74-9d86-6cd081db928a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b9714569-306e-47c2-9278-eea48e1d1bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b9714569-306e-47c2-9278-eea48e1d1bdf" xlink:to="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:to="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f199def6-8e81-4b92-873a-60d06b8acc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_fff724e4-4111-46f1-b24f-5d874ddb8a07" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f199def6-8e81-4b92-873a-60d06b8acc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a7b64cca-2de6-4464-ac8d-5dc4a7ee80f7" xlink:to="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0503e623-2bb1-4f73-a452-53b0612b6e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0503e623-2bb1-4f73-a452-53b0612b6e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e9c7547f-c635-4e2b-a515-33aa3c0a6c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e9c7547f-c635-4e2b-a515-33aa3c0a6c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1e9dcbeb-396f-4756-bc98-0411e455294a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_05f4f7ce-1399-42f7-80ed-cb60114ca063" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1e9dcbeb-396f-4756-bc98-0411e455294a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueTables" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d3b44564-b8be-43eb-bd4b-538ae97e2739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d3b44564-b8be-43eb-bd4b-538ae97e2739" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9c58d12-cad8-4f16-8902-770bc10b8b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b1e1f13d-efe5-4a75-98ab-1d73c30f6fdf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9c58d12-cad8-4f16-8902-770bc10b8b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_371819f8-24c9-46b5-b94d-fcd7dcb3a9e3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_779a3b75-9f99-49d5-9959-59c5d4e74f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_779a3b75-9f99-49d5-9959-59c5d4e74f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f91c5b83-44b7-47a0-8e39-de242bfe0725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e5310a0-1922-4b0d-8382-50c6583494c2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f91c5b83-44b7-47a0-8e39-de242bfe0725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_78e0729e-8d88-4327-850e-94037bcb4064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_78e0729e-8d88-4327-850e-94037bcb4064" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b35a29ec-75f6-48cb-b9fa-25fb72908865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_33496c73-5524-47bc-acd3-da7801d9521f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b35a29ec-75f6-48cb-b9fa-25fb72908865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:to="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f572a012-8397-4d5a-a845-90a68720d8c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_33ec47ca-07f9-476b-9d6e-0b0d69bdf527" xlink:to="loc_srt_RangeMember_f572a012-8397-4d5a-a845-90a68720d8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_127e9b5d-5b62-4ac8-83d4-5b06a8ed7ffc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3515c765-d7cc-4d7f-baed-27b65991400c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_381b30f7-9571-4356-92d4-03ef033d0e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3515c765-d7cc-4d7f-baed-27b65991400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_835e1a67-81be-4973-9c98-0c79392d509d" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_835e1a67-81be-4973-9c98-0c79392d509d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:to="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2f008510-cb5a-4581-9a4d-a74982f815f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_06d9e57d-5b7d-4b0a-a0ae-2e82e1e77ce2" xlink:to="loc_srt_ConsolidationItemsDomain_2f008510-cb5a-4581-9a4d-a74982f815f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b99f80b4-f1b1-460b-819c-881aa2137c5b" xlink:to="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9326f39b-6d04-4c15-9c27-616de9c31ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9326f39b-6d04-4c15-9c27-616de9c31ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_7fd2b2e9-5be6-4f80-8c87-f9ecd9b923be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_7fd2b2e9-5be6-4f80-8c87-f9ecd9b923be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_2f0a9ec1-0b50-4267-bd1e-4b2bb1da1e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_2f0a9ec1-0b50-4267-bd1e-4b2bb1da1e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_99cb332b-841d-4c5e-b0aa-a72a3f877601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_32d52581-f322-4e17-add8-f5855b38d1e7" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_99cb332b-841d-4c5e-b0aa-a72a3f877601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableTables" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_600a792b-8292-4364-b345-0d600827aacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_1e1692e4-1437-40c8-b707-5d764096de89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_600a792b-8292-4364-b345-0d600827aacb" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_1e1692e4-1437-40c8-b707-5d764096de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_d6cdf80b-40f1-4600-bed7-d82ab56fbed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_600a792b-8292-4364-b345-0d600827aacb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_d6cdf80b-40f1-4600-bed7-d82ab56fbed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_38f826c9-4f3c-4525-8212-cad941743bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38f826c9-4f3c-4525-8212-cad941743bb7" xlink:to="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:to="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9a8acc8e-d205-4a8e-95a7-6a971b1929b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_5598f632-c590-4a3a-953c-fc56ccd42bb1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9a8acc8e-d205-4a8e-95a7-6a971b1929b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2262ebd9-6e83-4170-9d6e-abee85eed0a2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_001309f6-747b-4cba-9e1c-d856e8489174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_001309f6-747b-4cba-9e1c-d856e8489174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2e27188e-3002-4222-944a-3d5f2cdaa723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_258bed19-6611-4e3d-89fe-818320b20e49" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2e27188e-3002-4222-944a-3d5f2cdaa723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_2f308a53-ace8-42cd-9414-0d1411a70ce3" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_2f308a53-ace8-42cd-9414-0d1411a70ce3" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9aadbf90-8ae8-4716-8f33-355cb21e0625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a7d4d2ec-aab3-47b4-9a93-74d5f00c6c2d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9aadbf90-8ae8-4716-8f33-355cb21e0625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e0679bf2-a3ed-4861-9f19-81d00aba9504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_69acb4e0-fe27-4531-846e-5be8372956c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e0679bf2-a3ed-4861-9f19-81d00aba9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_fd912c35-b2ce-4802-a9d3-96fd74e5b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_a5b97422-326d-4d5a-bf4f-68e1b1ff4c7b" xlink:to="loc_us-gaap_TaxPeriodDomain_fd912c35-b2ce-4802-a9d3-96fd74e5b054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_0df15a8f-03a9-4edc-bdf9-954c268a616d" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03a1b381-953c-4686-bb49-3dc7fd0f865b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03a1b381-953c-4686-bb49-3dc7fd0f865b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_750db3c1-9092-42fa-aa5f-f197be1e881f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_750db3c1-9092-42fa-aa5f-f197be1e881f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77872b89-2c18-4581-808d-f9d9e7fa4960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_77872b89-2c18-4581-808d-f9d9e7fa4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_7b84b240-9ca9-4eae-ad59-789a665e38d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_111359fc-3cc9-4a24-bdec-ef1273d0cd36" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_7b84b240-9ca9-4eae-ad59-789a665e38d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_c56ea0fa-7d54-4e4f-b019-b8a4a6358340" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_f684a02b-ae7d-4800-a912-c45290432cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_c56ea0fa-7d54-4e4f-b019-b8a4a6358340" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_f684a02b-ae7d-4800-a912-c45290432cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_e1a7fe7d-a4e4-4bd3-a977-ca5370796594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_c56ea0fa-7d54-4e4f-b019-b8a4a6358340" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_e1a7fe7d-a4e4-4bd3-a977-ca5370796594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e76cfec7-ff8b-4849-b840-cbfd51da4995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ceb9558c-c972-4e0d-a80d-2c4595819940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e76cfec7-ff8b-4849-b840-cbfd51da4995" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ceb9558c-c972-4e0d-a80d-2c4595819940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_e1b933ed-7d11-4131-9c3c-af9b8f44b4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e76cfec7-ff8b-4849-b840-cbfd51da4995" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_e1b933ed-7d11-4131-9c3c-af9b8f44b4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2f6203a8-e726-48ed-83da-978252d15b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e76cfec7-ff8b-4849-b840-cbfd51da4995" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2f6203a8-e726-48ed-83da-978252d15b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_abf356b1-a620-4540-94ec-e9c120bfb332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e76cfec7-ff8b-4849-b840-cbfd51da4995" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_abf356b1-a620-4540-94ec-e9c120bfb332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d97dec38-119d-4188-9a2d-5c755bd78b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8b211f84-8dc6-4eec-946f-96f11cea4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d97dec38-119d-4188-9a2d-5c755bd78b31" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8b211f84-8dc6-4eec-946f-96f11cea4cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c7427f48-5a16-4c89-87e1-fe4c2f91643e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_85ff3099-3b4c-4ecd-9ccf-23153f349838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c7427f48-5a16-4c89-87e1-fe4c2f91643e" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_85ff3099-3b4c-4ecd-9ccf-23153f349838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1f655785-e4d4-41eb-a736-4f9bcc1d086a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c7427f48-5a16-4c89-87e1-fe4c2f91643e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1f655785-e4d4-41eb-a736-4f9bcc1d086a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock_79ac172e-b4c5-4737-90e0-7ff39b29cc2c" xlink:href="unh-20221231.xsd#unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c7427f48-5a16-4c89-87e1-fe4c2f91643e" xlink:to="loc_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock_79ac172e-b4c5-4737-90e0-7ff39b29cc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationTables" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_64169dec-ac0c-457d-b50a-accd549d78fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ea5cd014-20c9-445d-b023-74835a9a0f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_64169dec-ac0c-457d-b50a-accd549d78fe" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ea5cd014-20c9-445d-b023-74835a9a0f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleITables" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleITables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleITables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_886691b6-4bcc-4ebc-bd22-a881914c1483" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_886691b6-4bcc-4ebc-bd22-a881914c1483" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_27b9b2fc-657d-4cf1-b613-709d8b8c825c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8e757eac-f5ee-4368-bb11-8b91f8f5c065" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b7420841-0188-4978-b206-7ad757d86e8c" xlink:to="loc_srt_ParentCompanyMember_8e757eac-f5ee-4368-bb11-8b91f8f5c065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:to="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e6e93ba7-0225-4645-a92a-fdd42af97a9a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e75fac1b-540b-4924-a975-661b6bfd8a33" xlink:to="loc_srt_ConsolidationItemsDomain_e6e93ba7-0225-4645-a92a-fdd42af97a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a913bc57-7591-40f7-aac0-0d2b96810d5e" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_0432f004-d568-41ba-a35c-381a84efe82a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_0432f004-d568-41ba-a35c-381a84efe82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_c670bc96-fe85-4c11-a819-685d622804d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_c670bc96-fe85-4c11-a819-685d622804d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1333b129-7a9e-4a1b-9a4a-b9995ab3a5e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1333b129-7a9e-4a1b-9a4a-b9995ab3a5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fabffa87-0349-4f3e-8dcf-2c5b177be19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_c1c9101a-d980-4cb9-8c3b-6d5050fa56c8" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fabffa87-0349-4f3e-8dcf-2c5b177be19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_aae62562-1855-4209-8c78-ae4fb10222fa" xlink:href="unh-20221231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_aae62562-1855-4209-8c78-ae4fb10222fa" xlink:to="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:href="unh-20221231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_99d280cb-d2a4-4344-a8f8-a6f47102a986" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:href="unh-20221231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f32ec15a-6043-4740-8a7d-96c5e4d5bbbb" xlink:to="loc_unh_MedicarePartDReceivablesMember_930b570a-0bf7-492f-b9eb-a17602e2ecfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:href="unh-20221231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_5ed72002-96b8-4e4a-b800-edade3796479" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:href="unh-20221231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_ed42f070-f0aa-4442-84de-767ae1b0d944" xlink:to="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_fad4cc6b-d5c3-4287-8098-c7437885f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_783b3cea-be29-45fd-a209-4a6dcb16ec84" xlink:to="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_8aec80ac-b277-49b7-b792-bfba112e80a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:href="unh-20221231.xsd#unh_ProductsandservicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d8869c54-700e-4b85-ae1d-b38a0e3bc3ca" xlink:to="loc_unh_ProductsandservicesMember_4bc924b4-ecdd-449e-8bd9-5ff97c433f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_060f63e2-743d-4349-b07b-19f4fa6ef58c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_us-gaap_RestrictedStockMember_6291dd38-ce72-4001-b847-dedf90c65ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_67aa51a4-d31f-43e5-b026-0064ec8aff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa29d9f0-d612-4b72-927b-efaff3ad810b" xlink:to="loc_unh_StockOptionsandSARsMember_8ea8f3f5-b6b0-4497-b3f2-2ccede2f8940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5a6672b3-4cef-4f19-95ed-ed09d09e1480" xlink:to="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MinimumMember_bdcf5a99-a6fd-40bb-9959-62d812f06c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_49c86bc0-2778-4dd9-b46b-af34830161d1" xlink:to="loc_srt_MaximumMember_68598789-2b48-42af-9b10-ffa3feaa3cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d96b7989-10c7-4f52-8524-2d59ca1ac4fc" xlink:to="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0acee368-4985-4199-8c7f-c254e047ad40" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1873af25-ff7b-42cb-9bcd-7d0e885fdb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_714e6be8-9d27-4914-b024-7c15e6e8fdeb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3238834d-e9b0-4c22-96aa-faefcf39135e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_bc27661c-0432-432d-a11a-441a675523ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_66136fb0-3c52-41cb-b349-2edd28a7b934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_66136fb0-3c52-41cb-b349-2edd28a7b934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73bb3de1-ee71-49de-aeb4-571dedd9780d" xlink:to="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7113229-c9b0-4844-a534-a74ded4b3268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4874c744-0fe2-463b-91ad-b795855a8270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_cd1f6c9d-888a-4a05-830b-7850eae62eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_68e081ed-2d1c-452a-a860-c4cbb6eff35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:href="unh-20221231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6d6792a5-4cd0-4afb-9a3e-6f4778a1bc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_177e4f5e-f0aa-40d3-ac6a-116dec77fff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_InventoryNet_ae749e4a-3009-4786-b096-b667c0ee6613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_680a93ae-d3bc-41d3-9ca7-0f0420cfa96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositAccounts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_DemandDepositAccounts_85188d49-764d-4440-995c-04ad98ef9710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_637bb3e5-a86d-4203-acd2-a2bde9db8648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ff90d70e-5546-42d6-8534-73ed746822a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:href="unh-20221231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_8bb94e98-8c2f-4ecb-aa2e-e1db71cb64c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4e82c858-2eb6-49eb-beff-8e4126402742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e6b71189-4e46-4fbc-98ba-bcd34b9de5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1ddb7bc3-2a73-4c19-b3cd-219da72dc5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a04fcb1-6ab7-4eec-87aa-781bb0d0770e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d0b139-9538-4cbb-b5e2-d5db15a48dfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_e20508af-3faf-4a32-99a3-bb84cd68505b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8e7adaf4-008e-4cc9-9bda-d779593ea322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8e7adaf4-008e-4cc9-9bda-d779593ea322" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_36a2e69c-b794-46d8-beaf-46aec5dc2e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f5e1b95d-e1a8-4e6f-bfcb-42b76f39495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f5e1b95d-e1a8-4e6f-bfcb-42b76f39495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_a9141754-13d2-48c1-96e2-aa1e2e04e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_us-gaap_BuildingMember_a9141754-13d2-48c1-96e2-aa1e2e04e5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember_6f37d0cd-c5cd-4ca0-b5e2-cf71c3fc7066" xlink:href="unh-20221231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ce74f06-7066-4c4b-a977-c897ab5868bd" xlink:to="loc_unh_CapitalizedsoftwareMember_6f37d0cd-c5cd-4ca0-b5e2-cf71c3fc7066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:to="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6db0f65e-2c48-4d11-b767-e832c9a29556" xlink:to="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1991d960-3c74-4e10-a90e-5be4a79982d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:to="loc_srt_MinimumMember_1991d960-3c74-4e10-a90e-5be4a79982d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3ceceada-e053-49eb-af51-05fb09a38e3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3f6058ea-0cd8-4519-bff8-341390952805" xlink:to="loc_srt_MaximumMember_3ceceada-e053-49eb-af51-05fb09a38e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_84eb3ab0-1489-48d6-bd8f-72d960a9fa39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a26b0ece-a919-4597-af66-cf93eacdf197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4688f0e-e990-40a9-97b1-01fe569a86a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a26b0ece-a919-4597-af66-cf93eacdf197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_e7ff4639-71a0-47d0-a1eb-e7c8ae65ec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_e7ff4639-71a0-47d0-a1eb-e7c8ae65ec1d" xlink:to="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_17bcf71f-a6f8-4155-a637-126aeb9e4679" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember_fe5dcbd3-cd63-460e-b6df-27b8a9be166a" xlink:href="unh-20221231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b7a3fe5-c8b4-46a9-9a38-5729747d993a" xlink:to="loc_unh_RedeemableNoncontrollingInterestsMember_fe5dcbd3-cd63-460e-b6df-27b8a9be166a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b6723bdb-d2de-4575-87ad-adbaa2b4bd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9440bbed-756f-44e1-8a12-237ea72888a2" xlink:to="loc_us-gaap_EquityComponentDomain_b6723bdb-d2de-4575-87ad-adbaa2b4bd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_c5380242-54a9-4fd2-874f-136e0a69d74a" xlink:to="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_05178c12-2f3a-445b-b70d-a83ef828ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_05178c12-2f3a-445b-b70d-a83ef828ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_bfb46b0d-e516-4857-abc6-2e2f2accdac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_bfb46b0d-e516-4857-abc6-2e2f2accdac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_12a04348-efd9-4a0f-ae43-13eff7562c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_12a04348-efd9-4a0f-ae43-13eff7562c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_be12aa85-86d4-4d44-8343-79463265425a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_be12aa85-86d4-4d44-8343-79463265425a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1947366f-1b68-4d0a-a508-827d1eae4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1947366f-1b68-4d0a-a508-827d1eae4dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a1f0a9f8-37fc-4946-aced-77cf39e38688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_a1f0a9f8-37fc-4946-aced-77cf39e38688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_aa7e4494-6147-46e4-8123-31a95f80b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9f1fc4c9-f7f1-4f3a-ac5b-3c1dc245b580" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_aa7e4494-6147-46e4-8123-31a95f80b42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_41dcbf70-a3fe-4d87-844f-df0cda7043fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_b44c6781-f97f-41d7-9aff-993f1f3a0585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41dcbf70-a3fe-4d87-844f-df0cda7043fa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_b44c6781-f97f-41d7-9aff-993f1f3a0585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f05e464f-8407-437e-bc78-4831ed76abbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41dcbf70-a3fe-4d87-844f-df0cda7043fa" xlink:to="loc_us-gaap_EquityMethodInvestments_f05e464f-8407-437e-bc78-4831ed76abbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_05b3b2d3-cb91-475b-9459-65a81e01ccee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41dcbf70-a3fe-4d87-844f-df0cda7043fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_05b3b2d3-cb91-475b-9459-65a81e01ccee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceContracts_5852bebf-220d-4349-a8b0-2a3e1461f928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceContracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41dcbf70-a3fe-4d87-844f-df0cda7043fa" xlink:to="loc_us-gaap_InvestmentOwnedBalanceContracts_5852bebf-220d-4349-a8b0-2a3e1461f928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e3bb7a5e-450b-4b91-b5d1-73630c58dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e3bb7a5e-450b-4b91-b5d1-73630c58dfb5" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7dc1450e-c801-4f27-8a90-fa08202a0834" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f92643d9-94cc-4b31-ab5a-fbf2272a3094" xlink:to="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_c79817b9-f7fc-4a00-9a22-3ef761b8d789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_c79817b9-f7fc-4a00-9a22-3ef761b8d789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4365ba21-536c-4f60-8416-c3320594d96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4365ba21-536c-4f60-8416-c3320594d96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1a59c56b-4c5b-4878-85c5-42ef299da64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1a59c56b-4c5b-4878-85c5-42ef299da64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e7240f2a-896b-48af-8af3-3f7cdb3a6ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e7240f2a-896b-48af-8af3-3f7cdb3a6ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_aea6d5cb-aa64-4912-9d4b-45eca0f845b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_9634d555-2ffe-42c1-a55f-b71cf56c688b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_aea6d5cb-aa64-4912-9d4b-45eca0f845b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_51b616c3-16f3-49e3-bcee-4c600a45429d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5162d39b-0b5e-439a-b3d4-3c15e843761e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5162d39b-0b5e-439a-b3d4-3c15e843761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1c88654f-65f3-4615-aa84-3b740e18eeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1c88654f-65f3-4615-aa84-3b740e18eeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4a1f0f7f-fe0e-41d2-b073-306f37427c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4a1f0f7f-fe0e-41d2-b073-306f37427c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3834e26-2e31-46ef-a32b-c33f6cd37d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3834e26-2e31-46ef-a32b-c33f6cd37d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bcdd6bad-7f21-4269-8e7e-98d9db29673f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bcdd6bad-7f21-4269-8e7e-98d9db29673f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_ed2a2e13-ef75-426c-b1a2-c314966b1cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_ed2a2e13-ef75-426c-b1a2-c314966b1cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83a66922-6284-40a4-9a5f-e1aa4f2951b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83a66922-6284-40a4-9a5f-e1aa4f2951b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2d599e0a-f59a-4eb2-a46d-4826957deac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2d599e0a-f59a-4eb2-a46d-4826957deac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_e04ec7e6-8d2f-40d4-aa8c-5846ee05f19a" xlink:href="unh-20221231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsAmortizedCost_e04ec7e6-8d2f-40d4-aa8c-5846ee05f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_4acff156-b9ba-446a-8d33-e6f5f6de5550" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_4acff156-b9ba-446a-8d33-e6f5f6de5550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_ad820703-4913-4d45-9e04-3d740a72de26" xlink:href="unh-20221231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_ad820703-4913-4d45-9e04-3d740a72de26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2b51dcb0-fd87-47fe-b500-a1c0ab35460e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_eb2eeafe-be66-4ea2-acbd-e0892a9478e9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2b51dcb0-fd87-47fe-b500-a1c0ab35460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_bd7063e2-26e3-49cc-972c-151d7683f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_bd7063e2-26e3-49cc-972c-151d7683f4f4" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_25941cca-c3dc-40b3-b9cb-c487c708db4b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_57515ff7-2f11-46c0-92e7-e67a95d23557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_57515ff7-2f11-46c0-92e7-e67a95d23557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_acd63f18-01c0-4445-8106-a8457456e029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7860e9c-24b3-4bdf-899a-e39c1ab6e20b" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_acd63f18-01c0-4445-8106-a8457456e029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3844653c-67d2-4520-87af-71b62e5c7f7b" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_eee74373-fd18-426e-97c6-c1727f3c998d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_eee74373-fd18-426e-97c6-c1727f3c998d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b3419690-7154-4033-8fc4-7e9040e784ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b3419690-7154-4033-8fc4-7e9040e784ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6cd6d525-985d-4656-97d3-5ddd03e47822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6cd6d525-985d-4656-97d3-5ddd03e47822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_be4b2aeb-99d9-4b42-a2a2-ab54343e0d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_be4b2aeb-99d9-4b42-a2a2-ab54343e0d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_0df0c6bd-889c-4dfe-ac8f-76a5e6086328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_0df0c6bd-889c-4dfe-ac8f-76a5e6086328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce58e680-f3bf-44c7-935e-cd01ed567ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ce58e680-f3bf-44c7-935e-cd01ed567ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8f3fdab2-f454-4310-b1de-10f6d339ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8f3fdab2-f454-4310-b1de-10f6d339ffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c9803a7c-6714-4abc-a1a6-7855e7af47b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c9803a7c-6714-4abc-a1a6-7855e7af47b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5a4c304a-c8e6-470d-8c28-9ef87b7de94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5a4c304a-c8e6-470d-8c28-9ef87b7de94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_aeffbf1d-69f2-469d-9556-a619b8915f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_aeffbf1d-69f2-469d-9556-a619b8915f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47df29a0-b68a-4a15-81b8-d91169e73d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47df29a0-b68a-4a15-81b8-d91169e73d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_2357316d-1399-4522-bc6d-11641da49588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_2357316d-1399-4522-bc6d-11641da49588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_5f29e0a7-2637-4089-8e8c-a4a700ab5273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_5f29e0a7-2637-4089-8e8c-a4a700ab5273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_6d0d2ca7-d76c-4b10-a34d-872613305af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_6d0d2ca7-d76c-4b10-a34d-872613305af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2036033b-f23c-4549-8af4-24a921c98b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2036033b-f23c-4549-8af4-24a921c98b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_7e2a8566-761c-48ef-abbc-310d02c2ccbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_7e2a8566-761c-48ef-abbc-310d02c2ccbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c8a6d758-5fa9-4e3f-8002-b924c61acd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c8a6d758-5fa9-4e3f-8002-b924c61acd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_df7878b1-836e-40d6-83cc-c1b7ebd3db4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_df7878b1-836e-40d6-83cc-c1b7ebd3db4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_70606dd0-f4b2-4b9f-99a0-377d81fdaa48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_70606dd0-f4b2-4b9f-99a0-377d81fdaa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3eb963a1-bc4c-4fba-9480-8f08e22854f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3eb963a1-bc4c-4fba-9480-8f08e22854f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_bd4b89b0-a6da-4d8b-a3eb-04b74b5cb98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecurities_bd4b89b0-a6da-4d8b-a3eb-04b74b5cb98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_a28da2b8-6c5e-4778-9f14-616251e88474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_17c261ba-2616-4d84-accc-1784c806889d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_a28da2b8-6c5e-4778-9f14-616251e88474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_989f6940-3945-48c9-ab97-ac86735c2724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_989f6940-3945-48c9-ab97-ac86735c2724" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_26a4950d-e728-458f-8778-57664c8bd87e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72f12086-8e6a-4980-842c-684630dca436" xlink:to="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_b09ed618-cb30-4cde-a3be-f55967ebafa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_b09ed618-cb30-4cde-a3be-f55967ebafa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_34560549-5365-4be2-999c-4b1ac9471d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_34560549-5365-4be2-999c-4b1ac9471d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_64009db9-0c92-45eb-9f79-b0e026a73ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_64009db9-0c92-45eb-9f79-b0e026a73ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_bb1dbb51-115b-403a-82d6-8a09241f9804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_bb1dbb51-115b-403a-82d6-8a09241f9804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_8d288073-beb0-4b2a-a032-e89712b50ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_1c4715e2-883e-4896-b602-6387328865cb" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_8d288073-beb0-4b2a-a032-e89712b50ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_aecdf6cd-5666-4e73-8eb4-b03f084b854e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c9a30a01-6fff-4fcf-9418-98bef0db64b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c9a30a01-6fff-4fcf-9418-98bef0db64b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c9e897b5-43d5-480b-a829-dc239aa4585b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c9e897b5-43d5-480b-a829-dc239aa4585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b2753165-464a-4be0-a995-dd0e3b7f2819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b2753165-464a-4be0-a995-dd0e3b7f2819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cc0cd89-e354-4eed-93bf-4a74fcaa2885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4cc0cd89-e354-4eed-93bf-4a74fcaa2885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5c46457e-c16b-489f-ae0d-06abbb375166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5c46457e-c16b-489f-ae0d-06abbb375166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e7ada39c-e51e-4d93-926e-5265c6ee167b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b8ecd9eb-bd8b-4db2-b8da-8c894b9890cb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e7ada39c-e51e-4d93-926e-5265c6ee167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_587bdaa8-1c27-470e-962a-c7cfa0ce201b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_587bdaa8-1c27-470e-962a-c7cfa0ce201b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b5d55990-46cf-4aeb-bb9d-19c64618255b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_884312c6-0d9c-4df1-ad3e-fddc477d1aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fea003f-b956-4f67-b38d-b4ed060d7c46" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_884312c6-0d9c-4df1-ad3e-fddc477d1aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5755b611-41c3-419d-8550-f5e6dd1e576e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_c2655df6-49d2-41eb-9469-e2859c4c42c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfc02c6-9c97-4d2c-a162-6a6122047c74" xlink:to="loc_us-gaap_DebtSecuritiesMember_c2655df6-49d2-41eb-9469-e2859c4c42c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_206f70ee-0a54-497e-a842-2ffa32d5ea8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4b030ff6-7bca-4b60-828c-b89e4d3bbdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee2ce26c-6ca9-4bc1-b591-bb2b2e495516" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4b030ff6-7bca-4b60-828c-b89e4d3bbdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0ea1c5fa-6f1b-4641-94dd-78deb0a60e60" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_379e24dd-13d6-4982-bf2d-204325e1e6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_379e24dd-13d6-4982-bf2d-204325e1e6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_31609ca0-52c1-4db2-98ac-3cfe5d748694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_31609ca0-52c1-4db2-98ac-3cfe5d748694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_616a6a78-ff57-4496-a2f0-480174b46b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_616a6a78-ff57-4496-a2f0-480174b46b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f1db4524-a22c-410c-8f96-e7e161d64836" xlink:href="unh-20221231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_42f1e750-811d-4a97-875e-be8cee88ac8a" xlink:to="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f1db4524-a22c-410c-8f96-e7e161d64836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2f006439-c4ca-4e34-91b7-3259e44ad58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2f006439-c4ca-4e34-91b7-3259e44ad58a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_825172d1-692e-48f4-ad0c-d766f2cf5259" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a9f3e665-e2f4-4c83-b6a2-2b9cca663f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a9f3e665-e2f4-4c83-b6a2-2b9cca663f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_29159cbe-5842-4af3-bdc5-8837f8fe05c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_29159cbe-5842-4af3-bdc5-8837f8fe05c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a90ea74d-92da-420a-b9a1-34ba3fb71960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94065bae-93e8-4c5a-a8d4-6fc6d052f0c6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a90ea74d-92da-420a-b9a1-34ba3fb71960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4f0d27a7-1961-45f2-82c3-298f04f02a49" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d2a7c32-a1ee-4a15-a9cc-1ff0a5893703" xlink:to="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_312f3d9d-24cc-41fb-a147-637e334268f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_312f3d9d-24cc-41fb-a147-637e334268f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c63da247-dccd-4a6b-b41e-265c97ac7771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c63da247-dccd-4a6b-b41e-265c97ac7771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a23dc12e-1543-45cc-aaee-560396307707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a23dc12e-1543-45cc-aaee-560396307707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_380a6505-0c9c-4a41-8065-8f07ea42fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_380a6505-0c9c-4a41-8065-8f07ea42fe4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_79cce358-6412-4d32-ac1f-58ae6e1b5b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_78ca6666-e031-4c0a-9e71-e919dcb8dd2f" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_79cce358-6412-4d32-ac1f-58ae6e1b5b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0a364c6e-07bc-4086-8f4e-88281acb8b1f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a6ba1f3e-3194-48dc-bd3f-c2ff94d696a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a6ba1f3e-3194-48dc-bd3f-c2ff94d696a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_997e6ce4-25c5-4634-a60d-a0ac0097f969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_997e6ce4-25c5-4634-a60d-a0ac0097f969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7d5c8843-1247-43a2-89e5-90d2e0cc6b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7d5c8843-1247-43a2-89e5-90d2e0cc6b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_3c023e4e-1b9f-4ddb-8473-d7ec5fd2b2d9" xlink:href="unh-20221231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_unh_AarpAssetsUnderManagement_3c023e4e-1b9f-4ddb-8473-d7ec5fd2b2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a407cf3a-1bfa-4ade-968a-0197c1da0acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_25ffd450-e058-4e00-be79-d8c78d4d01a3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a407cf3a-1bfa-4ade-968a-0197c1da0acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_170683ac-b23a-4079-b9ce-b8f352925215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_170683ac-b23a-4079-b9ce-b8f352925215" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_62eb6888-f4db-4be4-b5b0-65b26352db1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_b6fdfd23-0a80-4e60-9196-8b0a1d870da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e55c5b4b-98d7-4589-ae18-b2363bbf224c" xlink:to="loc_us-gaap_LongTermDebtMember_b6fdfd23-0a80-4e60-9196-8b0a1d870da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97575679-7a0c-4454-ba54-311cab2b2e2a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e9dda2ca-f334-4665-a611-7e51fb31fcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dddcfa2c-9066-4dfb-945e-0935682d1782" xlink:to="loc_us-gaap_DebtSecuritiesMember_e9dda2ca-f334-4665-a611-7e51fb31fcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_99df7e4e-6518-4205-a85f-68531b15d888" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_91ad1c81-3bc4-4a9e-9348-b3278a0fa7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e2c8828-672c-40be-9d0c-132b49dc6491" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_91ad1c81-3bc4-4a9e-9348-b3278a0fa7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_783b2fbe-c6e3-489f-b735-211fbd25ffdb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6160b2c4-33ee-41c6-9664-88037301da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6160b2c4-33ee-41c6-9664-88037301da4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_92c25b5c-0c70-43a7-b1de-08c9f985cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_92c25b5c-0c70-43a7-b1de-08c9f985cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a10fd2c0-4be9-4d9a-bba8-3e119c5253cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_027995a0-8c5c-4cbd-9d7d-ded2451a7bef" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a10fd2c0-4be9-4d9a-bba8-3e119c5253cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:href="unh-20221231.xsd#unh_DebtInstrumentExcludingCommercialPaperDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperAxis_1c4585f9-d616-4395-ade8-c2712828cdd7" xlink:to="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_fb80c419-0514-4e8b-86e7-5398f49123bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DebtInstrumentExcludingCommercialPaperDomain_ed69a591-2f69-4b74-9d8e-d0f51cdb8654" xlink:to="loc_us-gaap_LongTermDebtMember_fb80c419-0514-4e8b-86e7-5398f49123bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5ec8f6-ba92-4106-8c93-95a0e4f530c8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d7d06122-1137-4860-a5cb-67dfe8863df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d7d06122-1137-4860-a5cb-67dfe8863df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_789bdd5f-e68d-44a1-b94c-d6c9b34e657f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_HeldToMaturitySecurities_789bdd5f-e68d-44a1-b94c-d6c9b34e657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f254b687-254b-476b-ab12-99d69d3a7c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f254b687-254b-476b-ab12-99d69d3a7c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51030cbd-95d1-4a67-bd83-49ffbe41154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9111b61-df33-4f7e-b975-684ac918a049" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_51030cbd-95d1-4a67-bd83-49ffbe41154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86ce7693-464c-4ca4-bb96-a69ac71665e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86ce7693-464c-4ca4-bb96-a69ac71665e4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c54958f-c925-43ae-9848-abf9214c5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a851e8e6-77d5-4af2-ab09-410798a790d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7c54958f-c925-43ae-9848-abf9214c5f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_404acb6c-fcc9-4808-9010-01381915e855" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_31990970-0dd6-4579-bca4-98ee6b8bf563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:to="loc_us-gaap_Depreciation_31990970-0dd6-4579-bca4-98ee6b8bf563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_81a9f17d-6b03-4053-9e08-fc3aa35f38e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07b4f426-a811-4ffd-8b6c-0d447f788037" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_81a9f17d-6b03-4053-9e08-fc3aa35f38e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_23a5a568-d589-445d-af83-f44469f388b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_23a5a568-d589-445d-af83-f44469f388b1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9457fbcf-879e-4488-98d2-9e7510ee79d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a96fbf74-f65d-4269-9765-3da6db8cbdcb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9457fbcf-879e-4488-98d2-9e7510ee79d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0675cec2-b766-4e98-b3d3-d554ed123063" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_7bad0c5e-4ab4-4182-bc09-2e30515c8881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_LandAndLandImprovements_7bad0c5e-4ab4-4182-bc09-2e30515c8881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_3b45d66e-58f6-4b87-8181-e4608a98c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_3b45d66e-58f6-4b87-8181-e4608a98c270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_0629dd20-2dfc-4810-857a-7183086d8069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_0629dd20-2dfc-4810-857a-7183086d8069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_bbe0ff09-39a7-4415-a962-5cc5eb8aa21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_bbe0ff09-39a7-4415-a962-5cc5eb8aa21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_c3df12c4-772d-4053-aafc-489e426679b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_c3df12c4-772d-4053-aafc-489e426679b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_bf96e56b-81f6-4b4d-8e40-ad6cedbfa7b9" xlink:href="unh-20221231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_bf96e56b-81f6-4b4d-8e40-ad6cedbfa7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_30e5fae5-df00-4c1b-9b05-2f909c72abbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_30e5fae5-df00-4c1b-9b05-2f909c72abbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_7ac7ef71-4e75-4b32-a920-6181d616c4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_7ac7ef71-4e75-4b32-a920-6181d616c4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_61334891-113f-4355-8e24-fc700c0d9e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_61334891-113f-4355-8e24-fc700c0d9e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b38e7bc3-600a-4209-8d45-503c58d818ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e9abef33-fe68-4ac7-a0a8-544c4c9cbef9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b38e7bc3-600a-4209-8d45-503c58d818ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_52129d65-2890-4b8a-94d1-b525d5406a75" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_52129d65-2890-4b8a-94d1-b525d5406a75" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3fb69094-a597-4b85-84e2-ca4e59593768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dde0a3ea-23cf-4e6e-9cbe-a4f46db4b878" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3fb69094-a597-4b85-84e2-ca4e59593768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aea921ac-6350-4647-bb7a-b21ef3185443" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e0df2083-a7f7-48f0-87af-bc3566e93576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a80c02f8-f15c-416c-b5d0-032b84d01515" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e0df2083-a7f7-48f0-87af-bc3566e93576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_07923f64-1f6d-4753-a194-52769eeda082" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_07923f64-1f6d-4753-a194-52769eeda082" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d2e74b67-0c1e-4d64-afc4-0340fef12deb" xlink:to="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_3236a71c-10ce-44ad-aa83-bff266097c18" xlink:href="unh-20221231.xsd#unh_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_UnitedhealthcareMember_3236a71c-10ce-44ad-aa83-bff266097c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_133016e1-c1f1-4bfd-8c04-1567f29a39e1" xlink:href="unh-20221231.xsd#unh_OptumhealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptumhealthMember_133016e1-c1f1-4bfd-8c04-1567f29a39e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_b8a573bb-d563-45f8-982c-48487721df81" xlink:href="unh-20221231.xsd#unh_OptuminsightMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptuminsightMember_b8a573bb-d563-45f8-982c-48487721df81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_5d6f1bf1-be68-4cdc-bcda-502be05d0ea1" xlink:href="unh-20221231.xsd#unh_OptumrxMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4677fcc1-15b5-4761-8278-feabc50f7328" xlink:to="loc_unh_OptumrxMember_5d6f1bf1-be68-4cdc-bcda-502be05d0ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_79659245-c345-4ee8-b027-4548868e34bc" xlink:to="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0becd1fc-33b8-490e-84f5-03a2a527b510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_Goodwill_0becd1fc-33b8-490e-84f5-03a2a527b510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_107a5f0c-7b84-4f31-b1eb-bb3cf2c970a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_107a5f0c-7b84-4f31-b1eb-bb3cf2c970a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d73a7da5-a2e4-4081-8698-202a536d24a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d73a7da5-a2e4-4081-8698-202a536d24a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_49ab1cd2-d612-4d05-abd6-2245790db8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fca95e64-4e07-4ec0-8e37-7444d214fe7b" xlink:to="loc_us-gaap_Goodwill_49ab1cd2-d612-4d05-abd6-2245790db8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_01d9a00f-3144-4efd-8055-a6956cbefb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_01d9a00f-3144-4efd-8055-a6956cbefb77" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ffcb645-84db-4b6d-9279-34fb633b6be0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e8d6031b-bb35-4bcb-99d0-0535a8bb8435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_e8d6031b-bb35-4bcb-99d0-0535a8bb8435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_7261f055-ff8d-4890-a961-78c42b473a04" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_unh_TrademarksandTechnologyMember_7261f055-ff8d-4890-a961-78c42b473a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_2d147d3c-99eb-4185-98ae-78d2c29dd2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_2d147d3c-99eb-4185-98ae-78d2c29dd2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4478ed12-7155-433b-9294-b5d1ee6d6bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aff1af7a-04b5-4de3-8d94-9de5c86a05e3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4478ed12-7155-433b-9294-b5d1ee6d6bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_619e6263-c1e9-42e4-95ce-34e0f2acc85d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d2f6ff79-276d-4acb-9e34-900eb6eb4302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d2f6ff79-276d-4acb-9e34-900eb6eb4302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_610ccd5f-81a0-4da8-b86e-07ad0910dcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_610ccd5f-81a0-4da8-b86e-07ad0910dcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_815d6436-e076-4ab6-b84a-b17102865054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fa580d74-97bb-4caa-8dd4-9967357505d6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_815d6436-e076-4ab6-b84a-b17102865054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6cad9ee-9f5e-41d1-b756-5149d6828cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6cad9ee-9f5e-41d1-b756-5149d6828cb5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2baafc78-07eb-42c5-a390-95974140b756" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_d65af8c7-629e-4aad-9b77-143cfea409c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_d65af8c7-629e-4aad-9b77-143cfea409c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_28acbb65-0362-480b-a4e3-88e12741ca47" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_unh_TrademarksandTechnologyMember_28acbb65-0362-480b-a4e3-88e12741ca47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9c8400ca-72f0-4115-84b8-e9dfd03ed7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_13d08853-48a2-4d58-9a5b-c81e339c86f6" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9c8400ca-72f0-4115-84b8-e9dfd03ed7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e92db9b4-0795-4b8c-8e85-acf3e07a80e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5546ebed-3ecd-4678-921c-16ab7ca4e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5546ebed-3ecd-4678-921c-16ab7ca4e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5fb57930-c9da-4b9c-9c5c-6e427bbc0132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_976a2f90-5901-4150-915a-29097fd3406b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5fb57930-c9da-4b9c-9c5c-6e427bbc0132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_14f09e3a-39ca-4999-ae38-0b691c3b98b9" xlink:href="unh-20221231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_14f09e3a-39ca-4999-ae38-0b691c3b98b9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ac86ed2-6f6e-457c-8af9-00a176e3c967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a53a3463-c561-49a4-89f7-514880995ad7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ac86ed2-6f6e-457c-8af9-00a176e3c967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_37c97db6-1e39-4c49-b63e-2b5c550ab891" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1723205-ca23-420b-a975-3ee964d5368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1723205-ca23-420b-a975-3ee964d5368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfce8ead-fced-40b3-b08a-9a16551e8f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfce8ead-fced-40b3-b08a-9a16551e8f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bec0a7b4-4264-49e4-9730-8af43103ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bec0a7b4-4264-49e4-9730-8af43103ae2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_efa01dfe-e92f-4eab-8e1d-e40ae62d0149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_efa01dfe-e92f-4eab-8e1d-e40ae62d0149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_21b60000-3e4f-4d6a-a2e7-6c933101b55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c4da5c95-3a39-481a-9b95-53e66f199f4d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_21b60000-3e4f-4d6a-a2e7-6c933101b55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_bac2bf37-fa92-4c2f-8a4f-38b3627a667d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_bac2bf37-fa92-4c2f-8a4f-38b3627a667d" xlink:to="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:href="unh-20221231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_c5d670a0-4650-4dc6-9af6-b1f53fbe2b98" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7382bb57-95a2-4d60-ad8b-73dc7af1763e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_cb1ba9dc-e8b9-46de-9b70-1028a88d0fd8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7382bb57-95a2-4d60-ad8b-73dc7af1763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:to="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3a512336-22a5-42a4-b160-79ee18ff0a39" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ee2faf2b-f789-48dd-8a31-43fc0810ca3d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3a512336-22a5-42a4-b160-79ee18ff0a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5cfcf9f7-f672-4c2b-8d81-fd5846a3e24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c8fafe6-c8e3-496d-989f-ea3476fea660" xlink:to="loc_us-gaap_StatementLineItems_5cfcf9f7-f672-4c2b-8d81-fd5846a3e24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_49347ee5-1181-4d6f-b8b5-ee913e881c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_bac2bf37-fa92-4c2f-8a4f-38b3627a667d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_49347ee5-1181-4d6f-b8b5-ee913e881c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_5369b48c-2b8b-4236-8ef4-c96441860828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_5369b48c-2b8b-4236-8ef4-c96441860828" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:to="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_373147f1-9b78-4726-bd9d-39b90a78908e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_83ae0332-5db5-4687-bdcd-053fcdd9b9f1" xlink:to="loc_srt_ProductsAndServicesDomain_373147f1-9b78-4726-bd9d-39b90a78908e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_6d79236c-bc2e-4a82-a1a9-07217a9d734a" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43feba76-1840-45fe-9318-11f8f127e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43feba76-1840-45fe-9318-11f8f127e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6356e91c-93c1-4484-9600-68c84bcb08d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6356e91c-93c1-4484-9600-68c84bcb08d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_0f6d8b49-47c1-4c00-b262-4abc799d571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_0f6d8b49-47c1-4c00-b262-4abc799d571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_63899ba9-4db2-489d-9c45-75d47886112c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_63899ba9-4db2-489d-9c45-75d47886112c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_59db9efd-075a-45c3-9d32-dddd994d7ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40dc0ecf-f4cd-407b-b8e2-699624f77994" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_59db9efd-075a-45c3-9d32-dddd994d7ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_3b8047d2-4e2c-4efd-82f8-9dd6126046c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_3b8047d2-4e2c-4efd-82f8-9dd6126046c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e171b9b8-e957-4f6d-9492-33bc8d034530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e171b9b8-e957-4f6d-9492-33bc8d034530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b0313b7f-30c4-428c-a440-2bb78807c907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_67ddbf23-3432-4902-bbbe-6dcbc2061e00" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b0313b7f-30c4-428c-a440-2bb78807c907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6661cabc-6575-4557-b885-c3c3ab68e1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_8f19987a-1921-424b-a5f3-e465558ef77b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6661cabc-6575-4557-b885-c3c3ab68e1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_2ec96d45-07e4-41ae-adcc-560038875272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_2ec96d45-07e4-41ae-adcc-560038875272" xlink:to="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:to="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_07d4a6c1-5d04-413a-9230-284661d585a6" xlink:to="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_3b507ecf-23bc-4af4-9697-9d522a02fd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5da0d931-e3b1-444b-a930-fb69d4521702" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_3b507ecf-23bc-4af4-9697-9d522a02fd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_10a9dbea-70c8-4831-897c-00453c7fc2c8" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_f6c275c7-5ed1-47fe-9e9e-3ce2f62873fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_f6c275c7-5ed1-47fe-9e9e-3ce2f62873fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_259acd92-c435-4294-b36a-ad84801df42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_e781e256-5ce3-4eb4-92f1-acc5602da181" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_259acd92-c435-4294-b36a-ad84801df42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d674eca4-58c4-4926-85d6-f2302dd98fb1" xlink:to="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5a0227fb-5afc-40ac-a7fe-dadb6756f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5a0227fb-5afc-40ac-a7fe-dadb6756f56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1c6f3cc8-c69d-499d-88da-8536d5904b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_1c6f3cc8-c69d-499d-88da-8536d5904b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_18dad5ed-cca4-491b-95de-70f8d7c35dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_18dad5ed-cca4-491b-95de-70f8d7c35dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_149f1728-22fc-400f-9f19-338a2fc7e1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d17634a9-708c-4c81-a407-fc760d488aa3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_149f1728-22fc-400f-9f19-338a2fc7e1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_84b0029c-a809-45e8-ba9d-bac30e0bfda7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_84b0029c-a809-45e8-ba9d-bac30e0bfda7" xlink:to="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d1803e33-c4b4-4fd7-b88c-899d7055efe9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_aab2151c-2a81-405b-92d9-715127c089bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b4498c37-1c82-4fa7-bf1d-9565cb369eba" xlink:to="loc_srt_SubsidiariesMember_aab2151c-2a81-405b-92d9-715127c089bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:href="unh-20221231.xsd#unh_CreditFacilityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameAxis_0209cae5-f7e1-4194-85c9-9c66bc0da301" xlink:to="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day60BillionCreditFacilityMember_acc731af-570b-4056-b961-e79afc325cda" xlink:href="unh-20221231.xsd#unh_A364Day60BillionCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_A364Day60BillionCreditFacilityMember_acc731af-570b-4056-b961-e79afc325cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear60BillionCreditFacilityMember_7fbea233-119b-4849-b738-b748ba69d975" xlink:href="unh-20221231.xsd#unh_ThreeYear60BillionCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_ThreeYear60BillionCreditFacilityMember_7fbea233-119b-4849-b738-b748ba69d975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear60BillionCreditFacilityMember_ca0f92f3-2004-49f2-a4d5-2d170280913d" xlink:href="unh-20221231.xsd#unh_FiveYear60BillionCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_7e35d6e5-4022-4d05-ae66-3a662047b199" xlink:to="loc_unh_FiveYear60BillionCreditFacilityMember_ca0f92f3-2004-49f2-a4d5-2d170280913d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ec99655a-f284-4845-9088-3e285842b12c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4ec29c39-0e31-4a23-bc1a-cc1877008273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_19bdc752-b989-4ec8-9113-2229c77ab61e" xlink:to="loc_us-gaap_CommercialPaperMember_4ec29c39-0e31-4a23-bc1a-cc1877008273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d1001163-cdcc-4b79-b727-1b1e2a4c5f32" xlink:to="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4fb11fff-04e1-4e80-9f1d-648096d54b1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:to="loc_srt_MinimumMember_4fb11fff-04e1-4e80-9f1d-648096d54b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b4eea12-7f38-4a19-808a-e922be643dd8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2beec1b4-d8ae-47f4-b31f-6d950961fefc" xlink:to="loc_srt_MaximumMember_8b4eea12-7f38-4a19-808a-e922be643dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ea6bd3b6-4b74-4575-8c83-14976ece689a" xlink:to="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9d777612-385b-4c28-83d3-371c10441ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6332253e-366e-415d-8d67-175470524800" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9d777612-385b-4c28-83d3-371c10441ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8c72c472-475b-412f-b9f3-eb4f0f6987b0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_e603ccfa-6f77-4e30-9b44-6b839ea545a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_OtherLongTermDebt_e603ccfa-6f77-4e30-9b44-6b839ea545a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent_81f365b3-b6d1-4329-8350-3454ce23a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_OtherLongTermDebtCurrent_81f365b3-b6d1-4329-8350-3454ce23a84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab1aa565-4366-452c-bbae-7cd48d08c8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ab1aa565-4366-452c-bbae-7cd48d08c8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_26bba21d-203b-4eba-8125-d195799cf29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_26bba21d-203b-4eba-8125-d195799cf29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_c6a26c1a-789c-4123-b995-e8dc99d8a0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_056b56ee-5901-40c2-b252-5febc8e10cd4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_c6a26c1a-789c-4123-b995-e8dc99d8a0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2f81bdbb-c108-48ec-bcb8-66daec77d834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f81bdbb-c108-48ec-bcb8-66daec77d834" xlink:to="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:to="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fefd25ea-c1c0-4ccb-971b-02e527a12d3d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2a6f2b77-996a-42b2-84d9-4233e98a4887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_us-gaap_CommercialPaperMember_2a6f2b77-996a-42b2-84d9-4233e98a4887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member_d733c8b7-9d84-4dc6-8cca-89e4870915d8" xlink:href="unh-20221231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.875notesdueMarch2022Member_d733c8b7-9d84-4dc6-8cca-89e4870915d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member_7db8d314-16e8-455f-9df5-eaafd2a25427" xlink:href="unh-20221231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3350NotesDueJuly2022Member_7db8d314-16e8-455f-9df5-eaafd2a25427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember_223768f3-cebd-419a-9f35-3cd44f298e41" xlink:href="unh-20221231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.375notesdueOctober2022MemberMember_223768f3-cebd-419a-9f35-3cd44f298e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member_9e0fd6a1-afa8-4333-9e3d-af24c9b84346" xlink:href="unh-20221231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_ZeroCouponNotesDueNovember2022Member_9e0fd6a1-afa8-4333-9e3d-af24c9b84346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member_5ccfffc6-2536-4be4-9894-bb60da0c48ef" xlink:href="unh-20221231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2750NotesDueFebruary2023Member_5ccfffc6-2536-4be4-9894-bb60da0c48ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member_63fed9e2-9824-46aa-9538-75f2e22ac73b" xlink:href="unh-20221231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2875NotesDueMarch2023Member_63fed9e2-9824-46aa-9538-75f2e22ac73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member_53538723-fba4-448c-8741-6bf9949e963d" xlink:href="unh-20221231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueJune2023Member_53538723-fba4-448c-8741-6bf9949e963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member_8c541261-f63c-4f03-b56c-6f1b0f0fd2b1" xlink:href="unh-20221231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueFebruary2024Member_8c541261-f63c-4f03-b56c-6f1b0f0fd2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member_119cc051-0411-420d-a865-31254c1f155c" xlink:href="unh-20221231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A0550NotesDueMay2024Member_119cc051-0411-420d-a865-31254c1f155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member_36544652-99e7-45fc-b494-bd330a76d2dd" xlink:href="unh-20221231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.375notesdueAugust2024Member_36544652-99e7-45fc-b494-bd330a76d2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5000NotesDueOctober2024Member_75ed35b2-cfb9-4522-9ea6-eac76048c287" xlink:href="unh-20221231.xsd#unh_A5000NotesDueOctober2024Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5000NotesDueOctober2024Member_75ed35b2-cfb9-4522-9ea6-eac76048c287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member_b9ef0d19-8fb2-48eb-a636-ca8ca2af28fe" xlink:href="unh-20221231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.750notesdueJuly2025Member_b9ef0d19-8fb2-48eb-a636-ca8ca2af28fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5150NotesDueOctober2025Member_395e543e-9971-4641-bd64-7c59c39f4775" xlink:href="unh-20221231.xsd#unh_A5150NotesDueOctober2025Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5150NotesDueOctober2025Member_395e543e-9971-4641-bd64-7c59c39f4775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member_73ef80fc-6787-4510-9bfe-f39c8cd9bc15" xlink:href="unh-20221231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.700notesdueDecember2025Member_73ef80fc-6787-4510-9bfe-f39c8cd9bc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member_e715a358-4673-44cf-ac3c-5a3e36fbbc89" xlink:href="unh-20221231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A1250NotesDueJanuary2026Member_e715a358-4673-44cf-ac3c-5a3e36fbbc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member_d3d8063b-404b-40b6-a22d-553f5cf71aca" xlink:href="unh-20221231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.100notesdueMarch2026Member_d3d8063b-404b-40b6-a22d-553f5cf71aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member_cb3c59d9-5139-4669-9013-771685c18342" xlink:href="unh-20221231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A1150NotesDueMay2026Member_cb3c59d9-5139-4669-9013-771685c18342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member_335fab95-f9bb-43a7-9b90-cd4ec2a7fa4d" xlink:href="unh-20221231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.450notesdueJanuary2027Member_335fab95-f9bb-43a7-9b90-cd4ec2a7fa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member_35ab0537-8062-47b9-9005-3ce2f5c81cf3" xlink:href="unh-20221231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.375notesdueApril2027Member_35ab0537-8062-47b9-9005-3ce2f5c81cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3700NotesDueMay2027Member_ed1ee4c1-84a4-43a4-b74a-589cae88416f" xlink:href="unh-20221231.xsd#unh_A3700NotesDueMay2027Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3700NotesDueMay2027Member_ed1ee4c1-84a4-43a4-b74a-589cae88416f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member_158ce53c-6d89-44d0-9b9e-cf648d655fd7" xlink:href="unh-20221231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.950notesdueOctober2027Member_158ce53c-6d89-44d0-9b9e-cf648d655fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5250NotesDueFebruary2028Member_4c20ab80-7523-4661-95a5-95dd46da3fcb" xlink:href="unh-20221231.xsd#unh_A5250NotesDueFebruary2028Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5250NotesDueFebruary2028Member_4c20ab80-7523-4661-95a5-95dd46da3fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member_c0762afc-5bce-41f4-ab53-2554ebd1d1ce" xlink:href="unh-20221231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.850notesdueJune2028Member_c0762afc-5bce-41f4-ab53-2554ebd1d1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member_39811068-eef2-4a97-9150-0727fc0d74a3" xlink:href="unh-20221231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.875notesdueDecember2028Member_39811068-eef2-4a97-9150-0727fc0d74a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4000NotesDueMay2029Member_8052ad02-29b2-475c-81b0-865d44cdcc2c" xlink:href="unh-20221231.xsd#unh_A4000NotesDueMay2029Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4000NotesDueMay2029Member_8052ad02-29b2-475c-81b0-865d44cdcc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member_97260d0c-9e9e-4a54-8ee3-71ad2a56174a" xlink:href="unh-20221231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2.875notesdueAugust2029Member_97260d0c-9e9e-4a54-8ee3-71ad2a56174a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5300NotesDueFebruary2030Member_8432c583-7bd5-4ffe-91df-e6f78eb24baf" xlink:href="unh-20221231.xsd#unh_A5300NotesDueFebruary2030Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5300NotesDueFebruary2030Member_8432c583-7bd5-4ffe-91df-e6f78eb24baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member_a1f80415-c412-4837-a665-8cd6886ad3e4" xlink:href="unh-20221231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2000NotesDueMay2030Member_a1f80415-c412-4837-a665-8cd6886ad3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member_d5044ae7-20b9-4f5e-8895-768399eacf5b" xlink:href="unh-20221231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2300NotesDueMay2031Member_d5044ae7-20b9-4f5e-8895-768399eacf5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4200NotesDueMay2032Member_5494d9bc-0e5e-447e-9901-903e9f91f2e2" xlink:href="unh-20221231.xsd#unh_A4200NotesDueMay2032Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4200NotesDueMay2032Member_5494d9bc-0e5e-447e-9901-903e9f91f2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5350NotesDueFebruary2033Member_f9ff2e3d-e975-49ae-8da8-93b7962cbb2c" xlink:href="unh-20221231.xsd#unh_A5350NotesDueFebruary2033Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5350NotesDueFebruary2033Member_f9ff2e3d-e975-49ae-8da8-93b7962cbb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member_f2bb4b19-34d2-4959-a56f-b3a1a2be1ca2" xlink:href="unh-20221231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.625notesdueJuly2035Member_f2bb4b19-34d2-4959-a56f-b3a1a2be1ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member_ea24f40d-b905-4aba-a690-93631ce8079f" xlink:href="unh-20221231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.800notesdueMarch2036Member_ea24f40d-b905-4aba-a690-93631ce8079f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member_57afc1a4-a07e-4e71-8a09-01750d311763" xlink:href="unh-20221231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6500NotesDueJune2037Member_57afc1a4-a07e-4e71-8a09-01750d311763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member_c5a52ae7-053e-4453-a412-fc65d3137660" xlink:href="unh-20221231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6625NotesDueNovember2037Member_c5a52ae7-053e-4453-a412-fc65d3137660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member_1a1358be-a3dc-41fe-87fb-b0c9a58e469b" xlink:href="unh-20221231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6.875notesdueFebruary2038Member_1a1358be-a3dc-41fe-87fb-b0c9a58e469b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member_f8d78492-2f72-4a72-99d2-f20cb11520f5" xlink:href="unh-20221231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.500notesdueAugust2039Member_f8d78492-2f72-4a72-99d2-f20cb11520f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member_9d80e04b-b6f4-45c2-b1dd-1c3d2638e6fe" xlink:href="unh-20221231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2750NotesDueMay2040Member_9d80e04b-b6f4-45c2-b1dd-1c3d2638e6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member_b2db13c6-31de-4c63-ad83-7e576083b59d" xlink:href="unh-20221231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.700notesdueOctober2040Member_b2db13c6-31de-4c63-ad83-7e576083b59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member_8135646b-c4b8-427d-9e10-f150b35c93bf" xlink:href="unh-20221231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5.950notesdueFebruary2041Member_8135646b-c4b8-427d-9e10-f150b35c93bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member_26fc62d5-c9fc-4a44-9b0d-efa23214982a" xlink:href="unh-20221231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3050NotesDueMay2041Member_26fc62d5-c9fc-4a44-9b0d-efa23214982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member_e5a09e37-274b-439b-943c-3f4e318360d4" xlink:href="unh-20221231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.625notesdueNovember2041Member_e5a09e37-274b-439b-943c-3f4e318360d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member_fdd8fda6-3401-44e8-8c0c-55fb6c47bb93" xlink:href="unh-20221231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.375notesdueMarch2042Member_fdd8fda6-3401-44e8-8c0c-55fb6c47bb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member_06c1e9c0-52a8-4114-8ab7-00cb20bc06a7" xlink:href="unh-20221231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3950NotesDueOctober2042Member_06c1e9c0-52a8-4114-8ab7-00cb20bc06a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member_c713c9bc-5c5e-4ff3-9a17-abc38acfddeb" xlink:href="unh-20221231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4250NotesDueMarch2043Member_c713c9bc-5c5e-4ff3-9a17-abc38acfddeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member_707b8f12-6466-4502-9a58-eadfffe29a0e" xlink:href="unh-20221231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.750notesdueJuly2045Member_707b8f12-6466-4502-9a58-eadfffe29a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member_e1418dbe-df7d-4a6f-9574-8f8cccdfdbd9" xlink:href="unh-20221231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.200notesdueJanuary2047Member_e1418dbe-df7d-4a6f-9574-8f8cccdfdbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member_56cd3b3f-78f8-4356-ac2e-7153a440eaae" xlink:href="unh-20221231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.250notesdueApril2047Member_56cd3b3f-78f8-4356-ac2e-7153a440eaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member_2160bb05-9e8c-48fe-9ec3-ef7f2c4deb97" xlink:href="unh-20221231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.750notesdueOctober2047Member_2160bb05-9e8c-48fe-9ec3-ef7f2c4deb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member_43cc92f7-4d61-47e1-86ec-e11620348602" xlink:href="unh-20221231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.250notesdueJune2048Member_43cc92f7-4d61-47e1-86ec-e11620348602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member_15ff6248-0e70-4407-9130-2cb995481166" xlink:href="unh-20221231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4.450notesdueDecember2048Member_15ff6248-0e70-4407-9130-2cb995481166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member_6d30e0d5-b02f-48b7-8fba-6abaa2451fbe" xlink:href="unh-20221231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.700notesdueAugust2049Member_6d30e0d5-b02f-48b7-8fba-6abaa2451fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member_9665d963-3389-4a13-8bd4-3e8f072476a6" xlink:href="unh-20221231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A2900NotesDueMay2050Member_9665d963-3389-4a13-8bd4-3e8f072476a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member_26be1469-168d-4207-a212-02146343b743" xlink:href="unh-20221231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3250NotesDueMay2051Member_26be1469-168d-4207-a212-02146343b743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4750NotesDueMay2052Member_31808679-1ee5-484c-8bba-4f09804d0833" xlink:href="unh-20221231.xsd#unh_A4750NotesDueMay2052Member"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4750NotesDueMay2052Member_31808679-1ee5-484c-8bba-4f09804d0833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5875NotesDueFebruary2053Member_9417762e-def5-4710-b8ca-e223f34e4795" xlink:href="unh-20221231.xsd#unh_A5875NotesDueFebruary2053Member"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A5875NotesDueFebruary2053Member_9417762e-def5-4710-b8ca-e223f34e4795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member_7d0be48d-b149-4308-b58f-a8bb20079038" xlink:href="unh-20221231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3.875notesdueAugust2059Member_7d0be48d-b149-4308-b58f-a8bb20079038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member_f0a19c53-6b87-40ea-8603-7fb9a0d5dcdf" xlink:href="unh-20221231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A3125NotesDueMay2060Member_f0a19c53-6b87-40ea-8603-7fb9a0d5dcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4950NotesDueMay2062Member_06fc130a-dd9b-4604-9b8b-530e2ffadb20" xlink:href="unh-20221231.xsd#unh_A4950NotesDueMay2062Member"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A4950NotesDueMay2062Member_06fc130a-dd9b-4604-9b8b-530e2ffadb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6050NotesDueFebruary2063Member_5c252b60-14bc-4aee-b004-60207e8aa112" xlink:href="unh-20221231.xsd#unh_A6050NotesDueFebruary2063Member"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e72a99b-49a0-492b-af91-87dba2c5a335" xlink:to="loc_unh_A6050NotesDueFebruary2063Member_5c252b60-14bc-4aee-b004-60207e8aa112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8a6bea3f-874c-420c-ba28-03d605bc739b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_66854a2f-5618-4d14-b33b-4eb90db1dc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_66854a2f-5618-4d14-b33b-4eb90db1dc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6be17f8-e366-43c3-baaa-16758504f535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6be17f8-e366-43c3-baaa-16758504f535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_a0300785-c46d-4a96-bedb-1b6207157809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_CommercialPaper_a0300785-c46d-4a96-bedb-1b6207157809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_0521391c-7f89-402b-8a5f-9791df4085b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_0521391c-7f89-402b-8a5f-9791df4085b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_f06de51b-40ea-4ba4-a1f6-2df8bd48a101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_f06de51b-40ea-4ba4-a1f6-2df8bd48a101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6385ed3d-551d-44a9-b256-41c76364e7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aab5800-3a39-4cde-b6ea-24c8acde55dd" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6385ed3d-551d-44a9-b256-41c76364e7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtAbstract_997ee8bb-e517-436c-93c0-5b217b822bed" xlink:href="unh-20221231.xsd#unh_DebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DebtAbstract_997ee8bb-e517-436c-93c0-5b217b822bed" xlink:to="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2eef952e-7f8d-455c-8c48-8fd6794a716f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e7a0fd9e-949e-482f-b172-bed7e3bc2e75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2eef952e-7f8d-455c-8c48-8fd6794a716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a31dd7aa-3d21-45af-b71c-0ebee61c8bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_43108f77-e97a-4c22-a323-662187f317a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a31dd7aa-3d21-45af-b71c-0ebee61c8bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d8cd6286-e21f-4e6a-abda-da6a6f57b777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2b432379-ba48-4bcb-af14-c3886a3c5f7a" xlink:to="loc_us-gaap_VariableRateDomain_d8cd6286-e21f-4e6a-abda-da6a6f57b777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1604bc4e-0baf-4039-a633-8e6869eaaaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9599a679-d97b-402f-84fc-4f4c4dbeec41" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1604bc4e-0baf-4039-a633-8e6869eaaaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9db4c3a5-6d1e-4716-9473-2326a88e39b5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_15e2df51-6767-48fc-a038-a27627579454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_15e2df51-6767-48fc-a038-a27627579454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e36c436-3a59-48c4-8568-a1861b004373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e36c436-3a59-48c4-8568-a1861b004373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a7cb47d4-3748-496c-990b-901e997d4fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a7cb47d4-3748-496c-990b-901e997d4fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_de7e14d9-c84d-44ee-af12-e1b1fe0255b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_de7e14d9-c84d-44ee-af12-e1b1fe0255b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_53fb1849-d1ed-4ab0-898b-93dcc58a7fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_53fb1849-d1ed-4ab0-898b-93dcc58a7fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e26262e2-3e0f-4832-843d-4959ef0ac89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3857a918-7dec-407d-a965-cfdb051f3218" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e26262e2-3e0f-4832-843d-4959ef0ac89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_5bfdfbbe-b275-4d28-a4c4-1a4561504a97" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_5bfdfbbe-b275-4d28-a4c4-1a4561504a97" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef96cecb-d7a3-499e-9061-33eb47cdfbf8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member_bba8d079-367d-4f22-b0f2-c90e727f343a" xlink:href="unh-20221231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:to="loc_unh_NOLsExpirationBeginning2022Through2037Member_bba8d079-367d-4f22-b0f2-c90e727f343a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember_0cce02c3-a60c-4d5d-9e19-85e234d4cdf9" xlink:href="unh-20221231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fd07916-916a-4330-a17b-c67c396b2746" xlink:to="loc_unh_NOLsIndefiniteCarryforwardMember_0cce02c3-a60c-4d5d-9e19-85e234d4cdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8da823c2-02f7-490c-851e-0f49040ef7c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_c2565bf5-2866-434d-b29a-d199149b5bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_DomesticCountryMember_c2565bf5-2866-434d-b29a-d199149b5bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_17799846-0f5d-404a-8b4f-7f2f15d9db22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_17799846-0f5d-404a-8b4f-7f2f15d9db22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_ee0fa835-bbcc-4b1d-844a-5b50dd1d04f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4347aa5a-e749-4f3d-98ed-e8d20d304379" xlink:to="loc_us-gaap_ForeignCountryMember_ee0fa835-bbcc-4b1d-844a-5b50dd1d04f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_369ddfd8-a2cf-4f44-984b-31c9b328b131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_07844224-6c92-4b35-b64d-be059e9dda2c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_369ddfd8-a2cf-4f44-984b-31c9b328b131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_947f7d52-6ea2-4e6b-b18a-54bf43c18ee9" xlink:to="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_de36ca5a-e1cb-4db0-b28d-51f147c54d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:to="loc_us-gaap_EarliestTaxYearMember_de36ca5a-e1cb-4db0-b28d-51f147c54d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_1fe8b350-3e61-4132-bcf3-46e0a922faee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_f61a35e9-4625-4aa8-8e58-f596dac89c77" xlink:to="loc_us-gaap_LatestTaxYearMember_1fe8b350-3e61-4132-bcf3-46e0a922faee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_934254bd-2ce2-4354-8eeb-601b121b67c9" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_f979b4a6-97bd-4432-adf3-21028fb779cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_OperatingLossCarryforwards_f979b4a6-97bd-4432-adf3-21028fb779cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_2fe3051e-772b-4bbe-81b2-6b941398d514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_2fe3051e-772b-4bbe-81b2-6b941398d514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9111ac06-aae3-47f1-9e65-d7dd77611900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9111ac06-aae3-47f1-9e65-d7dd77611900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_18c0f4e4-8bca-4b22-b09a-fe85fa6d4eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_18c0f4e4-8bca-4b22-b09a-fe85fa6d4eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear_63361bba-d57f-4e81-9c40-2148dfa79650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_OpenTaxYear_63361bba-d57f-4e81-9c40-2148dfa79650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2c779c11-3d53-4106-b3a5-62315a4dd126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2c779c11-3d53-4106-b3a5-62315a4dd126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_be8b8407-c37f-4f83-8e0b-13ace6b8aadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_fe44213c-4be9-4ae6-95c6-6310102c7ab3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_be8b8407-c37f-4f83-8e0b-13ace6b8aadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_cc13d993-b86e-4c65-8541-9573f4c84215" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_cc13d993-b86e-4c65-8541-9573f4c84215" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:to="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0ffb4bd6-61b5-440a-a649-519f237cb0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_b7d8a29f-c50a-451d-9f06-df6b0322cfbd" xlink:to="loc_us-gaap_TaxPeriodDomain_0ffb4bd6-61b5-440a-a649-519f237cb0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bb07e394-1ab6-4e17-81c1-8ae5b8735c13" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_d069b3ed-0608-4cea-aa6e-1a874a39c76a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_d069b3ed-0608-4cea-aa6e-1a874a39c76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_db0170a9-865f-41fb-a9a7-9b55df34eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_db0170a9-865f-41fb-a9a7-9b55df34eae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_00533fa7-9bdb-404a-ae85-ae2f09951475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_00533fa7-9bdb-404a-ae85-ae2f09951475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0466d83-e909-4b24-a71e-f5f40a9baafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0466d83-e909-4b24-a71e-f5f40a9baafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84a32c5a-3c90-44bd-b9c5-3fbc57c9905d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84a32c5a-3c90-44bd-b9c5-3fbc57c9905d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a05d6697-fbc3-439f-8bc8-85228e574764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a05d6697-fbc3-439f-8bc8-85228e574764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_81de251d-7b06-4813-b0d7-b06f3aab7d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b0a709a1-d51a-4bb9-9278-efcaf419fe26" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_81de251d-7b06-4813-b0d7-b06f3aab7d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_2e31dedd-11e6-4289-8ec8-7f5bc55d8de1" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_2e31dedd-11e6-4289-8ec8-7f5bc55d8de1" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:to="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_1a569155-a72b-4d26-9c15-106c92aad900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_ed034270-0f6c-4126-9ebc-649c82bbf4bf" xlink:to="loc_us-gaap_TaxPeriodDomain_1a569155-a72b-4d26-9c15-106c92aad900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2bc013f1-3c82-41b3-9db9-67f6192c5360" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e4eec130-fd33-43b8-a51c-0156cbf373f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e4eec130-fd33-43b8-a51c-0156cbf373f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6bd8cdec-2d17-4e0d-8527-9b2a7e66749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6bd8cdec-2d17-4e0d-8527-9b2a7e66749b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_509a1957-58cd-4cf3-acd3-fa2b83d0a3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_509a1957-58cd-4cf3-acd3-fa2b83d0a3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2d331f50-d7c8-4d6a-a002-a7884901822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2d331f50-d7c8-4d6a-a002-a7884901822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_a20218ed-c842-4b6d-b0c1-f262363947f0" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_a20218ed-c842-4b6d-b0c1-f262363947f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_de07931e-4057-41bf-9210-058effd5efd4" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_de07931e-4057-41bf-9210-058effd5efd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_42d84e8f-55ff-4f34-845f-1d19b43b6664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_42d84e8f-55ff-4f34-845f-1d19b43b6664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_7cef5edd-4507-46e6-add1-c8576eb796d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_7cef5edd-4507-46e6-add1-c8576eb796d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_ec131821-7767-476e-bc67-c8840c707e82" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_ec131821-7767-476e-bc67-c8840c707e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_3c56f637-440b-408c-ab7f-85b15c1e9257" xlink:href="unh-20221231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_3c56f637-440b-408c-ab7f-85b15c1e9257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e3e4b0ef-1167-422e-b24f-07d8bbffd33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e3e4b0ef-1167-422e-b24f-07d8bbffd33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e19ab567-4d01-428c-94af-af2f93aca8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e19ab567-4d01-428c-94af-af2f93aca8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6540b883-c35e-4842-9b69-08f0e8095c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6540b883-c35e-4842-9b69-08f0e8095c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd6f65c8-f061-447d-b604-9b1e607130f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd6f65c8-f061-447d-b604-9b1e607130f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01232b7e-0e8c-424d-9631-958cf8969a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01232b7e-0e8c-424d-9631-958cf8969a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75fc3158-d602-4b3a-a87d-9bb5e31bbe84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_69d8a5d0-2363-4dcf-905e-9086d1b6c24c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_75fc3158-d602-4b3a-a87d-9bb5e31bbe84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_1a2e93c2-b9e6-4912-851c-f7954a3281f6" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_1a2e93c2-b9e6-4912-851c-f7954a3281f6" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:to="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ab30d3ab-6ed2-46dc-9dea-ebf75a15771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_89b4c91e-55a0-44a5-a044-1da4b7dcc77c" xlink:to="loc_us-gaap_TaxPeriodDomain_ab30d3ab-6ed2-46dc-9dea-ebf75a15771d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f3af0b02-e8a5-4652-bd4e-c1af86dc31b8" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_e77a1a4c-2306-44b1-89a5-ea55b6bbc57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_e77a1a4c-2306-44b1-89a5-ea55b6bbc57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_101f44bd-2f86-415e-a5b8-43bdb6ab81ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_101f44bd-2f86-415e-a5b8-43bdb6ab81ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d2e63661-e665-420c-b159-d2570d930353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d2e63661-e665-420c-b159-d2570d930353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_62a08c47-0b79-407c-9258-107df2db7e94" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_62a08c47-0b79-407c-9258-107df2db7e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3db94c78-cbae-43f8-b2b4-dfd73aa8f0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3db94c78-cbae-43f8-b2b4-dfd73aa8f0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_e561c46c-e208-4b2d-8346-a543192b270d" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_e561c46c-e208-4b2d-8346-a543192b270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_18ab82cd-2aac-4ef0-9a46-0787631df59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_18ab82cd-2aac-4ef0-9a46-0787631df59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_ca23e517-5478-4690-848f-0f66255241c4" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_ca23e517-5478-4690-848f-0f66255241c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_89724682-2855-4fec-b274-c9066edb7d3c" xlink:href="unh-20221231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_89724682-2855-4fec-b274-c9066edb7d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eff7068c-d26b-47e1-a78e-abbf2b6cfe34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_eff7068c-d26b-47e1-a78e-abbf2b6cfe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_432deb53-5be1-432e-afb3-199471b5c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_432deb53-5be1-432e-afb3-199471b5c7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e66ad4cb-3003-47aa-86cd-fdd200f0bf22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_89cf535c-a7c7-4395-9247-c2cc4c96a468" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e66ad4cb-3003-47aa-86cd-fdd200f0bf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bc034592-0c47-447a-b1f7-b51b58dd999a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_36469fa3-06d8-4a2b-86d7-3c763022eb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_36469fa3-06d8-4a2b-86d7-3c763022eb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_f61035d3-8a18-4e2f-bf59-1a01c02363c5" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_f61035d3-8a18-4e2f-bf59-1a01c02363c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_f5f05e23-8820-43ac-b041-3d877d84ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_f5f05e23-8820-43ac-b041-3d877d84ee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5bbe3acf-a23f-4875-a03c-ec5a9132c69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5bbe3acf-a23f-4875-a03c-ec5a9132c69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b4a23027-8793-427c-a461-fa2c352611c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b4a23027-8793-427c-a461-fa2c352611c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_92b92737-ae24-4262-a530-c8c2caa0406b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_92b92737-ae24-4262-a530-c8c2caa0406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9961bd6-26c6-4ca4-87d7-5dc56e5df9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9961bd6-26c6-4ca4-87d7-5dc56e5df9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_84970edd-bc01-496c-87a6-405edb93c0cd" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_84970edd-bc01-496c-87a6-405edb93c0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_113a5561-4a92-456d-8412-18dfc4136711" xlink:href="unh-20221231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_113a5561-4a92-456d-8412-18dfc4136711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6b38bd24-7d2c-49e3-9dfa-9366e78cdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6b38bd24-7d2c-49e3-9dfa-9366e78cdc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_11f52496-c465-4612-8575-1fb166bce06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4caae329-a2e9-4b94-922e-29c770448724" xlink:to="loc_us-gaap_DeferredTaxLiabilities_11f52496-c465-4612-8575-1fb166bce06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_88571bb2-7abd-4c6a-975a-e738f44a3572" xlink:href="unh-20221231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_88571bb2-7abd-4c6a-975a-e738f44a3572" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:to="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_54120d76-36e0-4466-a9ea-d6614b73d9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_7fe6c962-1485-438f-9431-05d5d2c1f1c0" xlink:to="loc_us-gaap_TaxPeriodDomain_54120d76-36e0-4466-a9ea-d6614b73d9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_68160653-7129-45fd-9efd-f25cf011868f" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f1fce2b5-c6a5-49ac-9209-444f344fcfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f1fce2b5-c6a5-49ac-9209-444f344fcfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ccb377e8-23cd-4519-9be2-a8ad91a56e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ccb377e8-23cd-4519-9be2-a8ad91a56e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5a9b0582-2b62-4e08-95b6-46e7584be1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5a9b0582-2b62-4e08-95b6-46e7584be1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_abf03c18-f34b-4ab0-9834-94a0982ce6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_abf03c18-f34b-4ab0-9834-94a0982ce6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e362ffb4-c3e2-487a-a9db-9e962900b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e362ffb4-c3e2-487a-a9db-9e962900b9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77c7b586-71d3-46f8-a193-28397415b3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_8ce97360-1fbf-4e7f-92bd-5990031b7f96" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_77c7b586-71d3-46f8-a193-28397415b3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_7abaf0a0-b76d-4aeb-8d49-1007f58b35bb" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_7abaf0a0-b76d-4aeb-8d49-1007f58b35bb" xlink:to="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:href="unh-20221231.xsd#unh_DividendFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:to="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:href="unh-20221231.xsd#unh_DividendFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DividendFrequencyAxis_968d2ddd-0a97-4ba3-a60a-ac3995eb2648" xlink:to="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember_fab610c5-3ceb-4594-a69d-562a348d1763" xlink:href="unh-20221231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DividendFrequencyDomain_549d1795-0541-48a5-9d2e-385f3439050c" xlink:to="loc_unh_ExtraordinaryDividendsMember_fab610c5-3ceb-4594-a69d-562a348d1763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:href="unh-20221231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTable_cb584305-ba33-46c3-a4e5-c57721f72e7c" xlink:to="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8de2914f-5dd0-43a0-8160-4be408908bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8de2914f-5dd0-43a0-8160-4be408908bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_60956fb2-ff6f-4f80-8641-12bb0bb0dc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_60956fb2-ff6f-4f80-8641-12bb0bb0dc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_49315bc6-1f3d-4733-812c-e63a747796e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_49315bc6-1f3d-4733-812c-e63a747796e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_7052075d-3b4d-4571-aacd-185a40661980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_636554e7-7cb1-45bf-a65c-2fd743d140f0" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_7052075d-3b4d-4571-aacd-185a40661980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ecfcdeb-c150-4b87-bfc6-df44704d1e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_a0636195-388a-4e5b-adf6-112cf287624b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ecfcdeb-c150-4b87-bfc6-df44704d1e1f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_a0636195-388a-4e5b-adf6-112cf287624b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d94e7976-652e-44c6-b02e-479441742f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ecfcdeb-c150-4b87-bfc6-df44704d1e1f" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d94e7976-652e-44c6-b02e-479441742f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2751d253-6ead-4d30-99e2-e8c27118b858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ecfcdeb-c150-4b87-bfc6-df44704d1e1f" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2751d253-6ead-4d30-99e2-e8c27118b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f54df6ae-1515-4d3d-a586-b1537ba83927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ecfcdeb-c150-4b87-bfc6-df44704d1e1f" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_f54df6ae-1515-4d3d-a586-b1537ba83927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_466272f8-120a-4ec3-b7e3-e727cb957863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_50cc38ca-ef97-45eb-83c4-b4f09ed6ee2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_466272f8-120a-4ec3-b7e3-e727cb957863" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_50cc38ca-ef97-45eb-83c4-b4f09ed6ee2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8ae10a58-50c4-4a30-b3dc-b8368f92a158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_466272f8-120a-4ec3-b7e3-e727cb957863" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8ae10a58-50c4-4a30-b3dc-b8368f92a158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_af71d661-30c4-4bd0-bac1-88f3a3b5f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_af71d661-30c4-4bd0-bac1-88f3a3b5f34c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_154c796f-ed75-47b6-911e-4a4f98547e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a9f1055a-f849-4984-bdb2-671f611e11fa" xlink:to="loc_us-gaap_PlanNameDomain_154c796f-ed75-47b6-911e-4a4f98547e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_9bbd4ce6-269d-4589-acfe-33cec48e585f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_77bfafe0-523e-4ff4-8a1d-ce306e9aaf23" xlink:to="loc_us-gaap_AwardDateDomain_9bbd4ce6-269d-4589-acfe-33cec48e585f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1a5bf96e-a6e4-498c-aa77-6cf1a8df2a6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f1d8e1a9-f688-4b74-83ea-509932c17878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f1d8e1a9-f688-4b74-83ea-509932c17878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_633479bb-ddb6-4933-8f59-43ecf4a4bee4" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607f80cd-fb48-4aa5-b05e-c7aa4446b20a" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_633479bb-ddb6-4933-8f59-43ecf4a4bee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_32c166f3-6068-4a9a-8fc2-7610e1334525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_94672d66-8ce9-4a67-abfe-e5cbcaf76595" xlink:to="loc_us-gaap_ClassOfStockDomain_32c166f3-6068-4a9a-8fc2-7610e1334525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d8dfa11-97fd-4d46-8009-52c35eff5a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d25a91a0-eec6-4fdb-831a-b1d02dc2f70a" xlink:to="loc_srt_RangeMember_5d8dfa11-97fd-4d46-8009-52c35eff5a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_69fe838b-71d7-4dc6-8e6c-6b4405aecaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_638448a4-d4cb-46ab-910b-b7597f1c9059" xlink:to="loc_us-gaap_VestingDomain_69fe838b-71d7-4dc6-8e6c-6b4405aecaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b725abe6-d182-4c02-8290-caeba03dc1b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9ba38ed0-db94-4520-aad6-4697e02397ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9ba38ed0-db94-4520-aad6-4697e02397ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_af633d0e-282c-428f-8b2f-4681ec6accbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78edb3cc-ae41-4bda-86b6-e235f5f7a108" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_af633d0e-282c-428f-8b2f-4681ec6accbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a9b103fd-9827-4ff5-acf1-75151928a5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a9b103fd-9827-4ff5-acf1-75151928a5f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:to="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96fbcd96-9874-4f17-a6f8-6bdaffd64a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7b75595c-69c5-4003-ab84-821a111950bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96fbcd96-9874-4f17-a6f8-6bdaffd64a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd466dea-8280-4183-aa97-1664932cb1f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25d9e1-8ffc-4058-a60c-a39b769a171e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e84e3af1-a2a1-41c4-83d4-5beaf95d02a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e84e3af1-a2a1-41c4-83d4-5beaf95d02a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_732deeba-2e51-4789-b973-ab8491f8346d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_732deeba-2e51-4789-b973-ab8491f8346d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bef159c3-f84d-4f75-8db2-cc516c342e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bef159c3-f84d-4f75-8db2-cc516c342e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_18860511-e9fa-4c4e-9a51-b5f5eff313c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_18860511-e9fa-4c4e-9a51-b5f5eff313c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8584a79e-62ea-4f4d-8f02-1bf719a37841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8584a79e-62ea-4f4d-8f02-1bf719a37841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f33013aa-11e5-4f5a-b6d3-0cc2f16f1052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f33013aa-11e5-4f5a-b6d3-0cc2f16f1052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_5fafe60b-4697-4883-89b8-9eb190df0865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_5fafe60b-4697-4883-89b8-9eb190df0865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0226d54-74ac-468a-aa2a-b0a44c6477aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0226d54-74ac-468a-aa2a-b0a44c6477aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ee1083ac-bf5c-4e47-bf1e-a6bf684a6712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ee1083ac-bf5c-4e47-bf1e-a6bf684a6712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd6727dc-8de2-498b-9788-c80acd6ab639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd6727dc-8de2-498b-9788-c80acd6ab639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76ac6c97-b99c-4249-bffe-24fd7a9ff832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76ac6c97-b99c-4249-bffe-24fd7a9ff832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93ca2414-cc3f-475f-b9d9-8a24a34186de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93ca2414-cc3f-475f-b9d9-8a24a34186de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7cbd8cd-2d54-482c-a673-f99ce0ed47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7cbd8cd-2d54-482c-a673-f99ce0ed47f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6094624c-5711-4835-b5af-d56a413329a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6094624c-5711-4835-b5af-d56a413329a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_66aa04aa-02b1-40d0-b432-954c5ff1a5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_66aa04aa-02b1-40d0-b432-954c5ff1a5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3615c17a-80ab-4597-9d1f-997b21058f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3615c17a-80ab-4597-9d1f-997b21058f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_114213ba-4b7e-4355-ad8c-d61042829dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_114213ba-4b7e-4355-ad8c-d61042829dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aee97d69-8400-45e7-b537-646385b7e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aee97d69-8400-45e7-b537-646385b7e02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2fa33e53-e52e-48d6-a165-c9d3693ee25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2fa33e53-e52e-48d6-a165-c9d3693ee25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4379a587-4647-4239-9700-53247df8eaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_66bc1464-130d-45dd-8c7a-011f267b27b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4379a587-4647-4239-9700-53247df8eaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationRestrictedShareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82611bcf-a07e-4d5b-bb01-303e22ca903d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82611bcf-a07e-4d5b-bb01-303e22ca903d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:to="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c30a54c9-055b-4bb0-b403-345da90fe2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5a5c66f5-5477-42e3-a48a-94ca6c7055e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b104fc4-10a7-4b5d-b451-dcc5cf012d88" xlink:to="loc_us-gaap_RestrictedStockMember_5a5c66f5-5477-42e3-a48a-94ca6c7055e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_313cdcc6-0a27-4759-acd9-409f3627596e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73d8c6de-f973-4ea4-ae10-9beecc867de3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_289af442-1c86-4a29-8a40-eee1006ebc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_289af442-1c86-4a29-8a40-eee1006ebc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2e3ebbf-cdeb-47c0-83ec-6937e252f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2e3ebbf-cdeb-47c0-83ec-6937e252f264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae4669e3-91c6-4623-a555-d697931522b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae4669e3-91c6-4623-a555-d697931522b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f8f6969b-cb80-4d88-aa72-b601b78b6810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f8f6969b-cb80-4d88-aa72-b601b78b6810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_505cea9d-b6a3-429e-8f2a-75f9db1c135a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_505cea9d-b6a3-429e-8f2a-75f9db1c135a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22d45443-8d2f-4e28-a78a-0806350ac2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22d45443-8d2f-4e28-a78a-0806350ac2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f3c045a4-cdc9-45b0-91d7-9ba1038e40c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f3c045a4-cdc9-45b0-91d7-9ba1038e40c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6be7473d-1315-4656-869a-2a43624e2630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6269306-1065-4b2e-a328-4fba44428d29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6be7473d-1315-4656-869a-2a43624e2630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationOtherShareBasedCompensationDataDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherShareBasedCompensationDataAbstract_58f76635-e1a7-40e1-9148-f413249b4fa7" xlink:href="unh-20221231.xsd#unh_OtherShareBasedCompensationDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_OtherShareBasedCompensationDataAbstract_58f76635-e1a7-40e1-9148-f413249b4fa7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:to="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a86d3246-3533-4fe3-9d24-df247fecb907" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_ac0b87db-74fa-493b-9f5c-f531749518e3" xlink:href="unh-20221231.xsd#unh_StockOptionsandSARsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_unh_StockOptionsandSARsMember_ac0b87db-74fa-493b-9f5c-f531749518e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6a324dad-4783-4c9a-9649-7c4659796ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6a324dad-4783-4c9a-9649-7c4659796ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_ae7c38f5-9fb1-4285-a72e-a3ce1822f09c" xlink:href="unh-20221231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_910ed4cb-004a-4bbf-9348-ab0d9983a485" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_ae7c38f5-9fb1-4285-a72e-a3ce1822f09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdab5918-c459-48b9-938a-c003e406b4b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_005c19d7-f583-4a1f-bf10-2d3dd767d5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_005c19d7-f583-4a1f-bf10-2d3dd767d5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4f7409bc-f1c4-47d1-8d50-c6d815205739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4f7409bc-f1c4-47d1-8d50-c6d815205739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_049a28a3-82c9-4d82-8d08-dfe1a1f03142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_049a28a3-82c9-4d82-8d08-dfe1a1f03142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_79aa2b8f-4968-4415-8a07-f286b94ba747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_79aa2b8f-4968-4415-8a07-f286b94ba747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b2c578b1-2a5e-4873-8237-459c764f93a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_ShareBasedCompensation_b2c578b1-2a5e-4873-8237-459c764f93a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e5c84672-f8f0-46bc-b88f-e24a18774b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e5c84672-f8f0-46bc-b88f-e24a18774b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_daae5174-5a1f-49cc-a23d-c346313218e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_daae5174-5a1f-49cc-a23d-c346313218e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_587ee9a4-e876-402d-ad67-e378e418ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_587ee9a4-e876-402d-ad67-e378e418ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9532fd4-1647-4a5a-8723-a649e90fced3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9532fd4-1647-4a5a-8723-a649e90fced3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a2b622c7-9b4f-430a-83e4-7fd74858031a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a40dbca2-a9eb-49e3-89ec-b56296a41986" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a2b622c7-9b4f-430a-83e4-7fd74858031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a651158-8f10-4c40-9a0b-cb42d55734a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a651158-8f10-4c40-9a0b-cb42d55734a0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:to="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_18fd8e09-d915-4819-b137-bb2229594cd5" xlink:to="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c72003af-4761-4d21-9c6d-a76bdc6fcaef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:to="loc_srt_MinimumMember_c72003af-4761-4d21-9c6d-a76bdc6fcaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8bbdc7b5-2a9b-4683-a9ca-b56ffe47cf89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d20e608b-ce99-4ad2-ac74-b3bfaa88c58d" xlink:to="loc_srt_MaximumMember_8bbdc7b5-2a9b-4683-a9ca-b56ffe47cf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_062fb422-1d74-4683-ad71-eb6f3c7a5246" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_76d1c167-69f9-4114-bef4-3e3947bd47b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_76d1c167-69f9-4114-bef4-3e3947bd47b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a83c9d6e-6094-47a7-90c8-ffc3bfe8d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a83c9d6e-6094-47a7-90c8-ffc3bfe8d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df7ac615-8874-4293-b257-9920f017a99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df7ac615-8874-4293-b257-9920f017a99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_6ea30382-f05f-4828-8a41-5306b852e72c" xlink:href="unh-20221231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_6ea30382-f05f-4828-8a41-5306b852e72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_52310e24-b752-419e-b824-341f583abcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_52310e24-b752-419e-b824-341f583abcb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9fb644d-7215-4980-b0c4-c656cd9453f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9fb644d-7215-4980-b0c4-c656cd9453f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_12afe9cb-0a81-4d84-9902-3716065fb0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_12afe9cb-0a81-4d84-9902-3716065fb0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cba6ee3-de23-48dd-a6b9-e3db7681176a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_150ac92b-5df8-460a-a4d3-6996bef3fd68" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cba6ee3-de23-48dd-a6b9-e3db7681176a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8369f7f-9e6f-44d7-8e93-1d7f200b7d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8369f7f-9e6f-44d7-8e93-1d7f200b7d1b" xlink:to="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c2ca8b17-10a5-4e0f-aa02-e901a987486a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_568aec46-8467-4cf8-9114-3c2a550b64a4" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c2ca8b17-10a5-4e0f-aa02-e901a987486a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43de28ff-d592-443a-804b-eb0893ea6657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_798586af-0b7d-426f-be44-bf6baeec6187" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_43de28ff-d592-443a-804b-eb0893ea6657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8b606431-9790-44a4-9710-ed14c9b3dbe6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_249e19ea-6a0f-4c67-a566-b135202de43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aec935be-f5ca-4a32-b09b-6363972ccc53" xlink:to="loc_us-gaap_SubsequentEventMember_249e19ea-6a0f-4c67-a566-b135202de43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b666a4fe-5cef-4685-8624-12d6fc96459d" xlink:to="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a86499c8-4195-4c72-ab26-b82e91320612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseCost_a86499c8-4195-4c72-ab26-b82e91320612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_63e588bf-c3a0-4ba0-a3a4-80757358c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeasePayments_63e588bf-c3a0-4ba0-a3a4-80757358c22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b65b2442-3361-45b6-b193-f3645b6748b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b65b2442-3361-45b6-b193-f3645b6748b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_875b7fa9-aad1-4ef3-a6b1-940c4f2727f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_875b7fa9-aad1-4ef3-a6b1-940c4f2727f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_0f1d0138-0576-408a-a987-d7feea269777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OtherCommitment_0f1d0138-0576-408a-a987-d7feea269777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription_b6dc8213-8d56-485d-895a-b5206d02103e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_OtherCommitmentsDescription_b6dc8213-8d56-485d-895a-b5206d02103e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription_1d51ae4b-ef9d-437b-b6b8-3947c32655b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3ffadf4f-60af-4e52-bd57-9cb4fb399567" xlink:to="loc_us-gaap_SubsequentEventDescription_1d51ae4b-ef9d-437b-b6b8-3947c32655b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#CommitmentandContingenciesFutureLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1237a875-ebe3-48c3-bb17-956a616b6854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1237a875-ebe3-48c3-bb17-956a616b6854" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3050c476-4b1f-4e01-8d33-cea00b908394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_334f9d28-dd7a-4086-b1af-849f1ce0d1e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3050c476-4b1f-4e01-8d33-cea00b908394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_7bf0bb6e-0d55-408e-b37d-950990fd7a6d" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ee7515c-3cba-490a-95f0-56f1cc3b3426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ee7515c-3cba-490a-95f0-56f1cc3b3426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41eb1ac2-7c66-4415-92a9-46800f88bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41eb1ac2-7c66-4415-92a9-46800f88bc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5576d0f4-73de-40b5-b91b-d85e612f2b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5576d0f4-73de-40b5-b91b-d85e612f2b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c784315-8ea3-4932-978c-1518d07a91c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c784315-8ea3-4932-978c-1518d07a91c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15c6dc1f-a215-43a8-8b2c-bb61143eee29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_15c6dc1f-a215-43a8-8b2c-bb61143eee29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a0211484-1b4a-462e-bf2e-81e5efedffe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a0211484-1b4a-462e-bf2e-81e5efedffe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d3af30b-84d0-4a3e-a75d-bbfd18225f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d3af30b-84d0-4a3e-a75d-bbfd18225f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9ab3a07b-f5f8-477c-a6cd-1134e9b66704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9ab3a07b-f5f8-477c-a6cd-1134e9b66704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f8bde2ea-a47b-4fc4-aa30-908818e8beff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_7d387b38-9860-4c16-9c92-90a78aaf8421" xlink:to="loc_us-gaap_OperatingLeaseLiability_f8bde2ea-a47b-4fc4-aa30-908818e8beff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1f91925a-bf95-423b-b5c0-f81dce75e5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1f91925a-bf95-423b-b5c0-f81dce75e5d3" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7973d835-c64f-48a8-bc37-59e16c04721e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareMember_51a3fcf5-88e7-4cbb-8b61-5a96c5eb2f93" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:to="loc_unh_ChangeHealthcareMember_51a3fcf5-88e7-4cbb-8b61-5a96c5eb2f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_78d79e24-6d98-4f8b-88b9-543959e76004" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c27f820a-880c-4ea4-ba19-c9332c53a195" xlink:to="loc_unh_OtherAcquisitionsMember_78d79e24-6d98-4f8b-88b9-543959e76004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1127ff01-d3ca-43aa-9555-2ada61875aaf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareClaimEditingBusinessMember_35e74e25-ed8f-431b-989b-4bbf66b7ffab" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareClaimEditingBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:to="loc_unh_ChangeHealthcareClaimEditingBusinessMember_35e74e25-ed8f-431b-989b-4bbf66b7ffab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherDispositionsMember_8cfb32f3-8ba3-4b64-8664-8d46286fa4ed" xlink:href="unh-20221231.xsd#unh_OtherDispositionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_281c6094-6e88-438f-a471-2a8328f9a2fd" xlink:to="loc_unh_OtherDispositionsMember_8cfb32f3-8ba3-4b64-8664-8d46286fa4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_0c6cfbe3-a422-4c05-bf53-eb9fceab1a41" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_58611f40-d664-4aa0-b974-53e2e1b60c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_58611f40-d664-4aa0-b974-53e2e1b60c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da73fef2-5561-4ca6-b47a-07d04e55a65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da73fef2-5561-4ca6-b47a-07d04e55a65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CarryingValueOfDisposition_5f2e37a5-7b6e-46c7-a7e9-2574fc09e628" xlink:href="unh-20221231.xsd#unh_CarryingValueOfDisposition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_386e6c25-e629-471a-bbe0-8f284587536b" xlink:to="loc_unh_CarryingValueOfDisposition_5f2e37a5-7b6e-46c7-a7e9-2574fc09e628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e6dec1f3-9613-4004-b8c9-eb9d197fe7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e6dec1f3-9613-4004-b8c9-eb9d197fe7f0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c992eeb7-6b46-410f-b47f-cb855da19dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_bbf0d98c-9ca4-42ad-97fe-6b21a0b8b5c0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c992eeb7-6b46-410f-b47f-cb855da19dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_047f119d-d041-4a71-b679-46d7927115c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bf976488-6ebf-4dac-8d04-39fbfeaa354c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_047f119d-d041-4a71-b679-46d7927115c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_14e8f289-7892-4ff2-96ae-5e8668934a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b15fe147-6e8b-4131-b2a6-1f40e0e76fa5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_14e8f289-7892-4ff2-96ae-5e8668934a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e23682e0-866f-4268-97ae-7a1f103a12bd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareAcquisitionMember_6f0fbc50-c625-48b3-aaae-9b8ae80fafdc" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_ChangeHealthcareAcquisitionMember_6f0fbc50-c625-48b3-aaae-9b8ae80fafdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_f894cbf1-28e6-4a8a-aad5-3587e727c2ee" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_OtherAcquisitionsMember_f894cbf1-28e6-4a8a-aad5-3587e727c2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalAcquisitionsMember_5013ab52-f845-4965-bb13-544cc786ed12" xlink:href="unh-20221231.xsd#unh_TotalAcquisitionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9347cfc8-f0c2-4ff3-a4de-98e0b4bd15a9" xlink:to="loc_unh_TotalAcquisitionsMember_5013ab52-f845-4965-bb13-544cc786ed12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_9957fe9e-bae5-4701-a5d2-01b4705a89fe" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2fa2329-70a2-41b1-a3cc-821770d543f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2fa2329-70a2-41b1-a3cc-821770d543f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_36b2d6a2-d0f5-461e-8538-c79056797e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_36b2d6a2-d0f5-461e-8538-c79056797e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_4e66305a-28e4-44be-a64f-187e36dccf80" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale_4e66305a-28e4-44be-a64f-187e36dccf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_02b74068-2e98-42b4-9693-f9ff3e881dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_02b74068-2e98-42b4-9693-f9ff3e881dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_05812a3c-6ee4-4513-80e5-e69e3e51e5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_05812a3c-6ee4-4513-80e5-e69e3e51e5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7642a862-7924-4379-a103-47b90487b6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7642a862-7924-4379-a103-47b90487b6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d117455f-03a8-4b3b-a60c-d58767488496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d117455f-03a8-4b3b-a60c-d58767488496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9d28a5b-2584-48d6-b0a2-23f9a37c94a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b9d28a5b-2584-48d6-b0a2-23f9a37c94a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_146ad082-9d9e-4764-8132-bcae2f660e42" xlink:href="unh-20221231.xsd#unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale_146ad082-9d9e-4764-8132-bcae2f660e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55ee6a0a-2529-4c4f-b6c8-7186fb5edcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55ee6a0a-2529-4c4f-b6c8-7186fb5edcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04072252-3d56-47e7-9c15-9548724c24a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04072252-3d56-47e7-9c15-9548724c24a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a287c664-1fce-49ab-b3a1-60f1c882e718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a287c664-1fce-49ab-b3a1-60f1c882e718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b3df154c-bac4-49c1-8a05-a684d7300005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_Goodwill_b3df154c-bac4-49c1-8a05-a684d7300005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests_39762c9e-0a60-4cb9-ad8b-6a0628ad51af" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsRedeemableNoncontrollingInterests"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationsRedeemableNoncontrollingInterests_39762c9e-0a60-4cb9-ad8b-6a0628ad51af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_2b29b403-a92c-49f5-8203-f1d639b3ff3a" xlink:href="unh-20221231.xsd#unh_BusinessCombinationsNonredeemableNoncontrollingInterests"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_unh_BusinessCombinationsNonredeemableNoncontrollingInterests_2b29b403-a92c-49f5-8203-f1d639b3ff3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d7a81e8f-5553-4559-a69b-271cddc76432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_20f8aeb7-6851-4c7a-9b85-4b176029447a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d7a81e8f-5553-4559-a69b-271cddc76432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_124b8290-8743-4d02-8d4b-ae42cfe9b332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_124b8290-8743-4d02-8d4b-ae42cfe9b332" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1447bed4-0189-47b6-833e-0abb8e2a6e8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_139391b8-a45f-422e-81ba-42f19358ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_139391b8-a45f-422e-81ba-42f19358ba2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_be03f3ef-5374-42ef-bcdf-2ceb6ed7a6c2" xlink:href="unh-20221231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_unh_TrademarksandTechnologyMember_be03f3ef-5374-42ef-bcdf-2ceb6ed7a6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8624745b-0983-4c02-b398-add4908c0728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b9c4d76-34dd-49b2-a215-f5fc0c52baca" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8624745b-0983-4c02-b398-add4908c0728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aae5f5a0-e502-4aeb-b128-c07714c2eef2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ChangeHealthcareMember_4ec75610-ab73-41d3-9e16-eaea97757c00" xlink:href="unh-20221231.xsd#unh_ChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_ChangeHealthcareMember_4ec75610-ab73-41d3-9e16-eaea97757c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherAcquisitionsMember_7d902cba-a05b-4b78-adb3-a1fbdf3f2c49" xlink:href="unh-20221231.xsd#unh_OtherAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_OtherAcquisitionsMember_7d902cba-a05b-4b78-adb3-a1fbdf3f2c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalAcquisitionsMember_f65c808e-dd06-4393-a4c0-447ac53d6425" xlink:href="unh-20221231.xsd#unh_TotalAcquisitionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2fee7a0d-7363-476a-b5eb-26051462bd37" xlink:to="loc_unh_TotalAcquisitionsMember_f65c808e-dd06-4393-a4c0-447ac53d6425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_57f14e6a-f735-4e83-893f-affe34e683fc" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_057b5992-67b0-4126-85e3-4be83a7eb809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_057b5992-67b0-4126-85e3-4be83a7eb809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d911fb7-6153-4f38-b17f-e3a72fd146e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba48d82c-9dac-48aa-a9ce-43e7989438f2" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d911fb7-6153-4f38-b17f-e3a72fd146e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fb16d1a5-9223-4156-a4b0-183544aa3f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fb16d1a5-9223-4156-a4b0-183544aa3f53" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e1dbc873-abc0-48d7-a4f0-611a3a3a0467" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember_999cba7d-50e1-44e6-b17c-aa22d7c0b51d" xlink:href="unh-20221231.xsd#unh_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac01b793-b524-4e2b-a769-74f2e3be5892" xlink:to="loc_unh_RevenuesMember_999cba7d-50e1-44e6-b17c-aa22d7c0b51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_257dfebf-61e0-4a6d-9303-50f433665dda" xlink:to="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember_397c8580-57b4-4893-b9da-c6392cbb89a0" xlink:href="unh-20221231.xsd#unh_CMSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0d12f449-18d2-481e-a2b1-9bc3c05519bc" xlink:to="loc_unh_CMSMember_397c8580-57b4-4893-b9da-c6392cbb89a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_19105710-725d-42e1-8069-b5e3739425e9" xlink:to="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1448c6be-e242-458a-aa95-082b7cbba700" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_865f6210-1e5b-4169-9c78-c23f943d19b5" xlink:to="loc_country_US_1448c6be-e242-458a-aa95-082b7cbba700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2a5598fc-cc87-4c89-b88f-c41df723a9be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_09e4d3b5-4e07-498e-8e31-5121b7446577" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2a5598fc-cc87-4c89-b88f-c41df723a9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_032a7e75-e351-451d-af24-34d737c40699" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_918acd73-9296-4f58-b41c-d655d60a3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b06edf5-523b-4665-85d6-2d78a2eee03c" xlink:to="loc_us-gaap_SalesRevenueNetMember_918acd73-9296-4f58-b41c-d655d60a3d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c1d75462-cdfb-4643-8773-16b0e4e9cc5f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b132929-e26c-4860-9136-a08ac5ec7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b132929-e26c-4860-9136-a08ac5ec7d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_765eaf20-29f0-4061-a570-a1d491054e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_765eaf20-29f0-4061-a570-a1d491054e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_918a5fd6-153b-4bc8-8c95-6f8d0a023349" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_918a5fd6-153b-4bc8-8c95-6f8d0a023349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_cf6e54f4-8127-4811-9d3e-8631da97b3d1" xlink:href="unh-20221231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_740e6f32-5e8d-46c9-b209-a9628f9e5f8b" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_cf6e54f4-8127-4811-9d3e-8631da97b3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#SegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b8101e93-136b-417b-91f4-470da15d9d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8101e93-136b-417b-91f4-470da15d9d15" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_69096705-3258-45dc-8a89-c5c4653e73f7" xlink:to="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42b88644-4d35-4bcc-b0ad-39344418bae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_OperatingSegmentsMember_42b88644-4d35-4bcc-b0ad-39344418bae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_35018cab-2096-401b-92a7-c7f18fd0438b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_IntersegmentEliminationMember_35018cab-2096-401b-92a7-c7f18fd0438b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_69a96b82-cdaf-4bd3-9ad6-4d4df8b43bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fcbee197-b93c-47ed-816c-acdbd77d2aec" xlink:to="loc_us-gaap_CorporateNonSegmentMember_69a96b82-cdaf-4bd3-9ad6-4d4df8b43bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d46f9a85-b695-4140-a62d-a735ca94a1a1" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember_14165e3b-2d2e-4499-a787-d320ee8b628d" xlink:href="unh-20221231.xsd#unh_ExternalCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:to="loc_unh_ExternalCustomersMember_14165e3b-2d2e-4499-a787-d320ee8b628d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember_b0a23085-f250-40b9-81e4-252d75378622" xlink:href="unh-20221231.xsd#unh_IntersegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf7f859e-17a4-4b10-a22e-183ef86aef9f" xlink:to="loc_unh_IntersegmentMember_b0a23085-f250-40b9-81e4-252d75378622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b10c6fa5-0498-4474-91b9-122c90216922" xlink:to="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_151faf75-7902-4107-aa92-0292ad08c435" xlink:href="unh-20221231.xsd#unh_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:to="loc_unh_UnitedhealthcareMember_151faf75-7902-4107-aa92-0292ad08c435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:href="unh-20221231.xsd#unh_TotalOptumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b0c45fd-7752-4b64-b11d-51e740a707bf" xlink:to="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_1484104a-3709-4ffc-86b0-86ca0e09bd06" xlink:href="unh-20221231.xsd#unh_OptumhealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptumhealthMember_1484104a-3709-4ffc-86b0-86ca0e09bd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_15cd4e74-e3e1-4ecb-b17d-3b5cad688c51" xlink:href="unh-20221231.xsd#unh_OptuminsightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptuminsightMember_15cd4e74-e3e1-4ecb-b17d-3b5cad688c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_260c56bb-5adf-470b-9cdb-8384bb369af0" xlink:href="unh-20221231.xsd#unh_OptumrxMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_cb86f248-2a1c-4f04-a3bf-1a9354383104" xlink:to="loc_unh_OptumrxMember_260c56bb-5adf-470b-9cdb-8384bb369af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ee995ca4-c9d2-42b2-9a18-d508b500e77c" xlink:to="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_1b21888f-f853-4d32-82d5-b881b74a027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:to="loc_us-gaap_ProductMember_1b21888f-f853-4d32-82d5-b881b74a027b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3c35bb16-833d-4d25-8fb4-e91ff97274ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8fc2a8ea-42c8-4381-bbab-c7af3d16b261" xlink:to="loc_us-gaap_ServiceMember_3c35bb16-833d-4d25-8fb4-e91ff97274ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea3bb5d2-155d-4b7b-83cb-686f785403c5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5b3463db-e6ae-4054-8089-599542e0e9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_PremiumsEarnedNet_5b3463db-e6ae-4054-8089-599542e0e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1857e123-5878-4a55-9253-ea3ff2907fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1857e123-5878-4a55-9253-ea3ff2907fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_a1aaefca-1a27-4ea6-889e-253842f70541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_a1aaefca-1a27-4ea6-889e-253842f70541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fdc2d988-3533-4d8c-8ec3-f82949709482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_Revenues_fdc2d988-3533-4d8c-8ec3-f82949709482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ff43d329-ad42-449b-9a8c-47d5b5b838b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_OperatingIncomeLoss_ff43d329-ad42-449b-9a8c-47d5b5b838b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3e098ce8-1fd4-4f72-bba2-7903e7615974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_InterestExpense_3e098ce8-1fd4-4f72-bba2-7903e7615974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1f4a468-ed4f-4532-b855-c9bfd37e1ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1f4a468-ed4f-4532-b855-c9bfd37e1ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_de1d81f5-d3d0-434d-8849-4e2f0c406286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_Assets_de1d81f5-d3d0-434d-8849-4e2f0c406286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0d058aa-a5e8-4ab1-a391-1e9344ec65f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0d058aa-a5e8-4ab1-a391-1e9344ec65f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2b62fc49-3650-4c46-8992-d2dd6f862274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87fb224b-1581-4ecf-a695-34d4dca3a388" xlink:to="loc_us-gaap_DepreciationAndAmortization_2b62fc49-3650-4c46-8992-d2dd6f862274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_214efe4e-f77f-4a61-aadc-af589da4759f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_214efe4e-f77f-4a61-aadc-af589da4759f" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_af5fe025-c54f-4584-9f31-b2fa3c347da7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d6504953-6bb4-4258-939d-a7f1cb106191" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:to="loc_srt_ParentCompanyMember_d6504953-6bb4-4258-939d-a7f1cb106191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_ef276e57-40e7-41c2-8d95-d31f532fd9ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cbea7fa9-13ee-4c78-87b2-d0648ca4b720" xlink:to="loc_srt_SubsidiariesMember_ef276e57-40e7-41c2-8d95-d31f532fd9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_59fc5fa5-e0c4-4de9-94f7-ae73ae38e30f" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8a5d4fbb-a6cf-4acd-a460-2710c329327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_8a5d4fbb-a6cf-4acd-a460-2710c329327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_093033b1-27b5-4ae8-96a4-b51c7a19c6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_093033b1-27b5-4ae8-96a4-b51c7a19c6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_81cd262c-6558-4e70-8df6-54ec3ed679f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_OtherLongTermDebt_81cd262c-6558-4e70-8df6-54ec3ed679f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_393f82ea-50ff-460e-9564-156b11cf5df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_85839a96-79ec-48c2-a0d1-756b9329b425" xlink:to="loc_us-gaap_NotesPayable_393f82ea-50ff-460e-9564-156b11cf5df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleICondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4ed0229d-d181-46b7-9d60-0d302953d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ed0229d-d181-46b7-9d60-0d302953d399" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69477637-10a0-450a-a093-00bffc789372" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_f35f45ef-9536-49a5-9a88-2020753e9d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b768befd-3601-490a-b792-82eb7a7d7f2e" xlink:to="loc_srt_ParentCompanyMember_f35f45ef-9536-49a5-9a88-2020753e9d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_508af333-ba45-480d-b856-111521a77859" xlink:to="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8a17d3a6-cc85-47e2-8fe0-550b413e0055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsAbstract_8a17d3a6-cc85-47e2-8fe0-550b413e0055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0b4abe4d-7a07-4061-8132-adf2d3d5c16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0b4abe4d-7a07-4061-8132-adf2d3d5c16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a18890-57d5-4590-b415-10fb887e2353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a18890-57d5-4590-b415-10fb887e2353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a2462b36-324b-4009-94ce-b5ef5790176e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherAssetsCurrent_a2462b36-324b-4009-94ce-b5ef5790176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d9ccaef2-350e-4f48-97d7-8ad9c0e9f2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AssetsCurrent_d9ccaef2-350e-4f48-97d7-8ad9c0e9f2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries_40be67d0-7fb3-46a4-acab-e145d1cd936d" xlink:href="unh-20221231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_unh_EquityinNetAssetsofSubsidiaries_40be67d0-7fb3-46a4-acab-e145d1cd936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_748d8128-5e30-480e-a251-d503b4a4e1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_748d8128-5e30-480e-a251-d503b4a4e1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_44fe6d4b-8264-4bd6-8f1c-ceabd3eb11e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_44fe6d4b-8264-4bd6-8f1c-ceabd3eb11e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0eeab67f-dca3-43cd-8fbc-4dcaaeb39b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_Assets_0eeab67f-dca3-43cd-8fbc-4dcaaeb39b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78ab26d2-50b3-476b-89a7-a8c5e0df95bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_78ab26d2-50b3-476b-89a7-a8c5e0df95bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5e40546a-0aa9-4a27-97d7-6a56f785970f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5e40546a-0aa9-4a27-97d7-6a56f785970f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_261b5fae-f14c-47c7-b789-7c2531e617b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_261b5fae-f14c-47c7-b789-7c2531e617b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_08f78e8a-8451-46c9-96ac-8bb4c3768d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_08f78e8a-8451-46c9-96ac-8bb4c3768d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_867f3b24-3f78-4859-9547-7a37b4d284a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LongTermDebtCurrent_867f3b24-3f78-4859-9547-7a37b4d284a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e7d95ffa-bdf6-4c86-9f6a-568742bace1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesCurrent_e7d95ffa-bdf6-4c86-9f6a-568742bace1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_65618a0b-39e2-4408-a467-5672620d3cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_65618a0b-39e2-4408-a467-5672620d3cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8eaefa4f-c6e5-49ce-b6b1-05808720c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8eaefa4f-c6e5-49ce-b6b1-05808720c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1d5d6ef6-9b95-4cfd-a5c7-015a6e94e454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_Liabilities_1d5d6ef6-9b95-4cfd-a5c7-015a6e94e454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0b8f7237-11f9-472b-9343-aa8a3ef59972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0b8f7237-11f9-472b-9343-aa8a3ef59972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_d619e5d6-f29b-4303-b5bb-0df235c60dee" xlink:href="unh-20221231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_unh_ShareholdersEquityAbstract_d619e5d6-f29b-4303-b5bb-0df235c60dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ece73d42-fa60-41d9-8e8e-7eac6769d59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_PreferredStockValue_ece73d42-fa60-41d9-8e8e-7eac6769d59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_78044bb4-68c7-4ef5-8c6f-a797935546eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_CommonStockValue_78044bb4-68c7-4ef5-8c6f-a797935546eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_435bdc90-e81f-46ad-ad30-49dedad61858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_435bdc90-e81f-46ad-ad30-49dedad61858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c8bc2b4-d115-4829-855a-baaee2a2a9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c8bc2b4-d115-4829-855a-baaee2a2a9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_43e26e6d-aa9a-4f2a-a7f0-d2950ee359e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_StockholdersEquity_43e26e6d-aa9a-4f2a-a7f0-d2950ee359e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b049f1c2-a41e-4369-abfe-8b78a784c477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b3e96144-100d-4f63-8e6f-861cd827e930" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b049f1c2-a41e-4369-abfe-8b78a784c477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIBalanceSheetDocumentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIBalanceSheetParentheticalAbstract_435d0306-f0ae-4c6f-8251-10aa68b0c604" xlink:href="unh-20221231.xsd#unh_ScheduleIBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIBalanceSheetParentheticalAbstract_435d0306-f0ae-4c6f-8251-10aa68b0c604" xlink:to="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ae302591-ed5c-43f8-aa36-7a4ec09a1bd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_203ecd4a-e9a3-4b92-9bd1-16472d80caca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ce313944-3d9b-448d-b33f-fc538e381474" xlink:to="loc_srt_ParentCompanyMember_203ecd4a-e9a3-4b92-9bd1-16472d80caca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6e33bb20-bfdd-42cf-9d64-b998bcc2eb5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_95318fcc-74b4-4cd6-b593-0bef460f5418" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6e33bb20-bfdd-42cf-9d64-b998bcc2eb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ee331f78-2249-4c12-8dff-255e9556f353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7fe6d6a8-c88f-48e6-af04-7abc26bb8c21" xlink:to="loc_us-gaap_ClassOfStockDomain_ee331f78-2249-4c12-8dff-255e9556f353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5084d3c8-92b0-455f-940a-8cc6af3ac8a8" xlink:to="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a3df5d8-ab91-40b5-bba4-2c2a7fffc138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a3df5d8-ab91-40b5-bba4-2c2a7fffc138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_45d74ed5-e972-4eb3-b5a7-87effdd07396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_45d74ed5-e972-4eb3-b5a7-87effdd07396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ecb84a68-50d8-4c09-b28c-df4c121c1d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesIssued_ecb84a68-50d8-4c09-b28c-df4c121c1d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b0757fd5-29ae-456c-b49d-c8030dda474c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b0757fd5-29ae-456c-b49d-c8030dda474c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c1fa983-0cff-4703-a0c0-9d62bc2339c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3c1fa983-0cff-4703-a0c0-9d62bc2339c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_cc643095-9721-4147-9213-0e7b77b0dd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_cc643095-9721-4147-9213-0e7b77b0dd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ca8b50be-1001-4e8c-a5e1-e2d7fe88720e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ca8b50be-1001-4e8c-a5e1-e2d7fe88720e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7f07e971-72d9-4f84-a4af-620a17e5361d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ca67b5fa-a09e-4825-be09-ff78f3c9d1e9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7f07e971-72d9-4f84-a4af-620a17e5361d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleICondensedStatementofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_64d2e439-2721-451d-a1e6-8fffb65455a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_64d2e439-2721-451d-a1e6-8fffb65455a2" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0dc59eb1-4a81-44fb-93cf-2695fbb2ea87" xlink:to="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_4297bab3-f35e-4b81-a481-7e485f6ad300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_07ba70ab-3d2d-40b0-b51c-7fddba7f5ed5" xlink:to="loc_srt_ParentCompanyMember_4297bab3-f35e-4b81-a481-7e485f6ad300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_7bc3ec28-4d27-4492-92a7-86dad9c2a62a" xlink:to="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a9c8ab81-e82c-4f1a-b11e-9dd52111f8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_RevenuesAbstract_a9c8ab81-e82c-4f1a-b11e-9dd52111f8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_1bfd8ac5-0eb2-424e-944c-376d8de0ac49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_1bfd8ac5-0eb2-424e-944c-376d8de0ac49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0cd96f76-42a7-412b-86f9-111ed9a2bf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_Revenues_0cd96f76-42a7-412b-86f9-111ed9a2bf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_07d06d9c-86a7-4b20-a04a-1372fd04ad76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_07d06d9c-86a7-4b20-a04a-1372fd04ad76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1c2ab0aa-59c7-4956-8630-de16348c0dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_OperatingExpenses_1c2ab0aa-59c7-4956-8630-de16348c0dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2b6c23be-98f6-4b46-8dd8-67ac5befba3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_InterestExpense_2b6c23be-98f6-4b46-8dd8-67ac5befba3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_68a43c33-0e95-4972-bff8-30b1b646da39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_CostsAndExpenses_68a43c33-0e95-4972-bff8-30b1b646da39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1517cbd-3a1f-4a56-b5fa-f4b05d8c5e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1517cbd-3a1f-4a56-b5fa-f4b05d8c5e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20ff0311-9202-46f6-b309-524bf40f44a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20ff0311-9202-46f6-b309-524bf40f44a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany_667769be-c088-4502-9a6b-bf2e54a3a0ce" xlink:href="unh-20221231.xsd#unh_LossofParentCompany"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_unh_LossofParentCompany_667769be-c088-4502-9a6b-bf2e54a3a0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_e999ddc6-fd0f-4237-9c05-b73961f2bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_e999ddc6-fd0f-4237-9c05-b73961f2bc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c60d2254-748d-4ddc-bbb8-5709c10de13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_NetIncomeLoss_c60d2254-748d-4ddc-bbb8-5709c10de13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_104c3e16-311d-423f-9c63-4897a7cd2a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_104c3e16-311d-423f-9c63-4897a7cd2a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b3fea80-7178-444c-9092-f8051d3a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_173d501c-652d-4dcd-8d88-9ddbf4824812" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b3fea80-7178-444c-9092-f8051d3a9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIStatementofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIAbstract_8647d80a-7cbd-4c7c-9f92-703396ed7519" xlink:href="unh-20221231.xsd#unh_ScheduleIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIAbstract_8647d80a-7cbd-4c7c-9f92-703396ed7519" xlink:to="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8f2029a6-a516-4c8a-b6cc-ffe3b0a44649" xlink:to="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_f9834877-d4a1-463f-a81f-155823b9a7ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_05d45176-05bf-4766-8284-e4a04e8b212f" xlink:to="loc_srt_ParentCompanyMember_f9834877-d4a1-463f-a81f-155823b9a7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:to="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5be2e05b-9fb7-49d1-bd04-b1a19b082d94" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_df36fd86-e296-4506-b46e-16035c1063d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5be2e05b-9fb7-49d1-bd04-b1a19b082d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4e26e284-8aee-4e9d-8a64-8ac3c44d2824" xlink:to="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_365bfc72-fe90-4a8c-8ca3-f92095298c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_365bfc72-fe90-4a8c-8ca3-f92095298c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f973face-c240-4789-b35e-8195ed73e827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f973face-c240-4789-b35e-8195ed73e827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c78dd9fe-9f7e-4b43-8e74-84957413804d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c78dd9fe-9f7e-4b43-8e74-84957413804d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_a82c7d68-f384-499f-9d7b-76155f768e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_a82c7d68-f384-499f-9d7b-76155f768e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_7cb3d77a-1ec2-4c5d-9f08-b42a9a958478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_7cb3d77a-1ec2-4c5d-9f08-b42a9a958478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a6dea01e-9797-4674-876c-e285e2b14b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a6dea01e-9797-4674-876c-e285e2b14b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c665e2cb-9f29-4558-b1b1-a566b86c76d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_c665e2cb-9f29-4558-b1b1-a566b86c76d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries_c86fb7a6-4bca-4e3c-a45c-eeac9d44e655" xlink:href="unh-20221231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_unh_Capitalcontributionstosubsidiaries_c86fb7a6-4bca-4e3c-a45c-eeac9d44e655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd011c8-d9af-4830-b7c8-500a06a14f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cd011c8-d9af-4830-b7c8-500a06a14f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b2cfb2c0-9d5b-4e81-93c1-88eb6ad60fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b2cfb2c0-9d5b-4e81-93c1-88eb6ad60fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67e914cf-3a23-4913-af82-ed0aa992f8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67e914cf-3a23-4913-af82-ed0aa992f8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e32a8881-c09c-42b2-972c-85183cff1886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e32a8881-c09c-42b2-972c-85183cff1886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50df9651-6f51-4e1c-84ef-6d99ac369d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50df9651-6f51-4e1c-84ef-6d99ac369d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f6ef350e-1bdf-48b2-a08d-a162653831ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_PaymentsOfDividends_f6ef350e-1bdf-48b2-a08d-a162653831ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_d62cf74d-b2eb-4cf0-849b-f3099b4564ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_d62cf74d-b2eb-4cf0-849b-f3099b4564ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ec553d87-a92a-469c-b8ef-06592e16a428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ec553d87-a92a-469c-b8ef-06592e16a428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_046a0972-cfd4-4be0-ac71-2670afe2d954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_046a0972-cfd4-4be0-ac71-2670afe2d954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_cfe38a2b-e1ab-4994-b7ab-5d901f250708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_cfe38a2b-e1ab-4994-b7ab-5d901f250708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf580844-b368-4b22-ac7f-995eb4bfc794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cf580844-b368-4b22-ac7f-995eb4bfc794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e8f7bc3-42cb-4382-9cde-cd1567640ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e8f7bc3-42cb-4382-9cde-cd1567640ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1673c6b-4b64-4ead-9afd-c491f85a919f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1673c6b-4b64-4ead-9afd-c491f85a919f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cef251e1-df57-4d64-a106-cb016493fdf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cef251e1-df57-4d64-a106-cb016493fdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bedbd93e-e254-4e0c-9106-5b66a3cbd6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bedbd93e-e254-4e0c-9106-5b66a3cbd6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_15a0477a-529c-4d70-b5b8-1b39672ada4c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_87695fef-b87a-42d1-80cf-c12d27d2b166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:to="loc_us-gaap_InterestPaidNet_87695fef-b87a-42d1-80cf-c12d27d2b166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ef7d2b09-428d-4c4d-97bc-cc3ced6dc335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ec73442f-20a2-4642-bf44-8db86c92fed0" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ef7d2b09-428d-4c4d-97bc-cc3ced6dc335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20221231.xsd#ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_2258e054-a111-4df7-94a6-ed376881645c" xlink:href="unh-20221231.xsd#unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_2258e054-a111-4df7-94a6-ed376881645c" xlink:to="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_698eaaae-7cc9-4f9a-9b65-fe09c96cf7b8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_58ffd36f-60a9-47f4-aeaa-508a96c8a4f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_02b69900-5ec3-4048-98dd-1315ff001d3c" xlink:to="loc_srt_ParentCompanyMember_58ffd36f-60a9-47f4-aeaa-508a96c8a4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2485dfff-1133-46a1-842a-7e9f5e8625aa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f131b6f4-e77c-4719-a855-fc451048c436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f131b6f4-e77c-4719-a855-fc451048c436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_378b29f5-2f1d-46fc-8bd0-ee301c635fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_378b29f5-2f1d-46fc-8bd0-ee301c635fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7596a9a3-d64c-4d2b-bb09-1410c0f5915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7596a9a3-d64c-4d2b-bb09-1410c0f5915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ef53e29-85ed-492b-b9d5-765371bb3ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ef53e29-85ed-492b-b9d5-765371bb3ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_41aeca1d-ed68-4be7-abca-c7bae0dbd3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_41aeca1d-ed68-4be7-abca-c7bae0dbd3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_25b711f5-610a-431a-a8f3-354d6c95df45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_299b511b-61ef-4fa8-9bd1-3fbb7eb63657" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_25b711f5-610a-431a-a8f3-354d6c95df45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>uhgdirectorcompsummarya07.jpg
<TEXT>
begin 644 uhgdirectorcompsummarya07.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$$17AI9@  34T *@    @ ! $[  (
M   3   (2H=I  0    !   (7IR=  $    F   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%U97)B86-H
M+"!*;W-H=6$@0@    60 P "    %   $*R0!  "    %   $,"2D0 "
M S4W  "2D@ "     S4W  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M37/^@SJ'_@4_^-'_  DFN?\ 09U#_P "G_QH^JON'MUV/K2BODO_ (237/\
MH,ZA_P"!3_XT?\))KG_09U#_ ,"G_P :/JK[A[==CZTHKY+_ .$DUS_H,ZA_
MX%/_ (T?\))KG_09U#_P*?\ QH^JON'MUV/K2BODO_A)-<_Z#.H?^!3_ .-'
M_"2:Y_T&=0_\"G_QH^JON'MUV/K2BODO_A)-<_Z#.H?^!3_XT?\ "2:Y_P!!
MG4/_  *?_&CZJ^X>W78^M**^2_\ A)-<_P"@SJ'_ (%/_C1_PDFN?]!G4/\
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MA_X%/_C1_P ))KG_ $&=0_\  I_\:/JK[A[==CZTHKY+_P"$DUS_ *#.H?\
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M10 4444 %%%% !1110 4444 =-HO@74]=\*:AX@M)[1+2P\SS4E=A(VQ YP
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MJ/A:\M[35TCCN)[=;@1H^[8"S#!/3.5/3/UK(KVWXO#0KS5(-*;3YY?$MW#
MEE=!B(D5IB-K#=U^_P#PGJ/PAO?"?PZ\&_V=I?B=9KO4+I07N/-=0@Z;V"L
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MYPR@G\,FNS^+OC+4?#TUEH.@S-8JUMYLDD0 ;82555/5<;3TP>F#UIO@N_\
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ML4,'V^W+AAU!79G(P>*XOXA?#J;P7)#<V\YNM-N&V)(X >-\$[6]<@$@CT/
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M444 %%%% !1110 4444 %%%% !17:_#GP%'XWO+LW-ZUM;67E^8L:Y>3?NP
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M/&L;1>.]=5N"=0G;\"Y(_G587XF*MLC#HHHKO.4**** "BBB@ HHHH ****
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MZ99(;42;3N9"'!DV]<9D)QUP.F>*YX\SNHW:MU-'96;[C/%/_)Q,'_81L?\
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M['/\5+GPK9Z;;16+2SHTJ(1(\Z[G=F[8)##IG/.:?_PDFA_\+D^V_P!LZ?\
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MW_R4BV_ZX2_^@U]&5\Z_!I2WQ&MR!D+!*3[?+C^M?15>=BOC.NC\(5XK\8_
M]R-0?Q+ID+2PR*!>(@R8V P'Q_=( SZ$9[U[51UK&G4=.5T:2BI*S/CBBOJ#
M4/AQX2U.X,]WHD'F,<DPL\63ZD(0*J?\*F\$_P#0%_\ )N;_ .+KM^M0['/[
M&1\U45]*_P#"IO!/_0%_\FYO_BZ/^%3>"?\ H"_^3<W_ ,71]:AV8O8R/FJB
MOI7_ (5-X)_Z O\ Y-S?_%T?\*F\$_\ 0%_\FYO_ (NCZU#LP]C(^:J*^E?^
M%3>"?^@+_P"3<W_Q='_"IO!/_0%_\FYO_BZ/K4.S#V,CYJHKZ5_X5-X)_P"@
M+_Y-S?\ Q='_  J;P3_T!?\ R;F_^+H^M0[,/8R/FJBOI7_A4W@G_H"_^3<W
M_P 71_PJ;P3_ - 7_P FYO\ XNCZU#LP]C(^:J*^E?\ A4W@G_H"_P#DW-_\
M71_PJ;P3_P! 7_R;F_\ BZ/K4.S#V,CYJHKZ5_X5-X)_Z O_ )-S?_%T?\*F
M\$_] 7_R;F_^+H^M0[,/8R/FJBOI7_A4W@G_ * O_DW-_P#%T?\ "IO!/_0%
M_P#)N;_XNCZU#LP]C(^:J*^E?^%3>"?^@+_Y-S?_ !='_"IO!/\ T!?_ ";F
M_P#BZ/K4.S#V,CYJHKZ5_P"%3>"?^@+_ .3<W_Q='_"IO!/_ $!?_)N;_P"+
MH^M0[,/8R/FJBOI7_A4W@G_H"_\ DW-_\71_PJ;P3_T!?_)N;_XNCZU#LP]C
M(^:J*^E?^%3>"?\ H"_^3<W_ ,71_P *F\$_] 7_ ,FYO_BZ/K4.S#V,CYJH
MKZ5_X5-X)_Z O_DW-_\ %T?\*F\$_P#0%_\ )N;_ .+H^M0[,/8R/FJBOI7_
M (5-X)_Z O\ Y-S?_%T?\*F\$_\ 0%_\FYO_ (NCZU#LP]C(^:J*^E?^%3>"
M?^@+_P"3<W_Q='_"IO!/_0%_\FYO_BZ/K4.S#V,CYQL[N>POH+RT?RY[>198
MGP#M93D'!X/([U<UWQ#JGB6^2\UNZ^TSI&(E?RU3"@D@84 =6-?07_"IO!/_
M $!?_)N;_P"+H_X5-X)_Z O_ )-S?_%TOK-.][#]C/:Y\U45]*_\*F\$_P#0
M%_\ )N;_ .+H_P"%3>"?^@+_ .3<W_Q=/ZU#LQ>QD?-5%?2O_"IO!/\ T!?_
M ";F_P#BZ/\ A4W@G_H"_P#DW-_\71]:AV8>QD?-5%?2O_"IO!/_ $!?_)N;
M_P"+H_X5-X)_Z O_ )-S?_%T?6H=F'L9'S517TK_ ,*F\$_] 7_R;F_^+H_X
M5-X)_P"@+_Y-S?\ Q='UJ'9A[&1\U45]*_\ "IO!/_0%_P#)N;_XNC_A4W@G
M_H"_^3<W_P 71]:AV8>QD?-5%?2O_"IO!/\ T!?_ ";F_P#BZ/\ A4W@G_H"
M_P#DW-_\71]:AV8>QD?-5%?2O_"IO!/_ $!?_)N;_P"+H_X5-X)_Z O_ )-S
M?_%T?6H=F'L9'S517TK_ ,*F\$_] 7_R;F_^+H_X5-X)_P"@+_Y-S?\ Q='U
MJ'9A[&1\U45]*_\ "IO!/_0%_P#)N;_XNC_A4W@G_H"_^3<W_P 71]:AV8>Q
MD?-5%?2O_"IO!/\ T!?_ ";F_P#BZ/\ A4W@G_H"_P#DW-_\71]:AV8>QD?-
M5%?2O_"IO!/_ $!?_)N;_P"+H_X5-X)_Z O_ )-S?_%T?6H=F'L9'S517TK_
M ,*F\$_] 7_R;F_^+H_X5-X)_P"@+_Y-S?\ Q='UJ'9A[&1\U45]*_\ "IO!
M/_0%_P#)N;_XNC_A4W@G_H"_^3<W_P 71]:AV8>QD?-5%?2O_"IO!/\ T!?_
M ";F_P#BZ/\ A4W@G_H"_P#DW-_\71]:AV8>QD?.-I=265TEQ"L3.F<":%)5
MY&.5<%3U[BMG4?'/B'5=%_LB]OE.G@*!;Q6T42@*<J!L48 P.*]U_P"%3>"?
M^@+_ .3<W_Q='_"IO!/_ $!?_)N;_P"+I/$4V[M#]E-=3YJHKZ5_X5-X)_Z
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)%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>uhglogoclean.jpg
<TEXT>
begin 644 uhglogoclean.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 <(# 2(  A$! Q$!_\0
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M$)*?-M8UI8J,X2G-./+O<]-HKXP7_@J=\-FA,J^%_%S1?\]!9Q%?S\S%>L_
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M !0UQ_Z)>OFW_@GSX/\ &'CGX4_$_3/ _C%O ^O?VCILJZF+59PR*DVZ(@]
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M#K*48'=GG<HQC.37Z/TM%/%8J>*<7-6Y58,/AHX9247N[GY9?%+X*?&_PO\
MM@>(_B1X.^'U[JZV^MR7^G7$B(]O,K)M!(#@D88^AS7J'_#0'[9O_1(;'_P
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MUH*DDHQ71%T<)&C-U6W*3ZL_.&S_ &;_ (E+_P %"F\9-X3O%\*?\)+)J/\
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M<O\ 9RY/8^T?)VT_/<\H^(7PR.E_LQZ_X"\+6CW;P>&9M*T^WR \S"W*(,G
MW,?U-> ?\$T?@WXV^$>B^/$\9>'+SPZ]_<VC6R7FT&4(D@8@ G@;A^=?:M+7
M%'%SC1G0Z2=V^IURPL'6A6ZQ5D%%%%<1V!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>uhglogoclean1.jpg
<TEXT>
begin 644 uhglogoclean1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 <(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***_.+3_P!I3XE3?\%"I/!K^*[I
MO"G_  D<FF?V.4C\CR!&0%QMSG@'.<YKLP^%GB>?E?PJYR8C$QP_+S+XG8_1
MVBDK\\KC]HWXC?\ #Q1?!2^*+E?"0UI=/_L<(GD>3]G!(QMSG/.<YS1A\-+$
M\W*_A3?W#KXB.'Y>9?$['Z'45YK\?OCUH'[.O@:/Q3XBMKZ\LI+R.R2'3XU>
M0R.&(^\P &$/>N7_ &=?VP/!/[2U_J^G^'(=1T_4M,C6>2UU.)$:2)CMWIM9
ML@-@'TROK6:P]65)UE'W5U+=>E&HJ3E[SZ'N5%>8?M!?M!>'OV<?!=OXD\1V
MU_>6MQ>)910Z?&KR%V5FS\S   *>_I77?#[QMI_Q)\$:'XITI9DT[5[2.\@6
MX0+($<9 8 G!_&H=*:@JC7NO2Y:J0<W33U1T-%?/7PZ_;<\"_$SXUW'PRTNP
MUF+6HYKNW6ZN($6WD:W#%\$.6 (1L9';WK)^-W[?W@#X$_$:_P#!FMZ7KEYJ
M=E%%)+)901F+]X@=0"T@)X([5T+!XAS]FH/FM>WD8/%T%#VCEI>WS/INBOBK
M_AZU\+=N?^$?\48]?L\'_P =KT[]GO\ ;>\$?M'>,[OPSX>T[6;+4+>R:^+:
MA#&L;1JZJ0"KMSEU[553 8JG%SG!I(F&-P]22C":;9]#T5\H_$W_ (*._#KX
M6^/M=\)ZCHWB&ZOM'N3:SS6UO%Y3. ,[2T@)'/I7+_\ #U[X5_\ 0 \3?]^(
M/_CM5'+L7)*2INS)ECL-%N+FKH^UJ*\K7]HSPRW[/O\ PN 6^H?\(S_9_P#:
M'V<P@76W=LV[=V,[N.N.^:\$A_X*G?#:X4M#X6\73*."8[.)@/RDK.G@\15O
MR0;L[/U-*F+H4[<\K7U1]GT5\I> _P#@I5\'O&>M1:7>SZIX6FE?RTN-9M52
MWW'H&D1FV<]VP/4U]50S1W$22Q.LD3J&5T.58'D$'N*RK8>KAW:K%HTI5Z=9
M7IRN/HK\ZK/]I[XFO_P4$;P0WB>1O"/_  D3Z7_9!MXO)\@1D 9V[MV1G=GK
M^5?HI6F)PL\+R\[^)7(P^)AB.;E7PNPM%?GA\4OVF/B5H7[?NF>"+#Q/-;>$
MSK>F6#:2L$1B>*98O,!)7=D[VYSQQZ5]F_';XW:'^S[\/Y_%WB"WO;JPCN(K
M80V$:O*SR-A>&(&.O>KJX.K3]FMW-75O,BGBZ=3G>R@[,]"HKXJ;_@JY\+%X
M.@>)P?\ KW@_^.UWOP-_;Y\ _'KXB6G@W0]+URSU.ZAEFBDO8(Q%B-=S E7)
M'&>U.>7XJG%SE3:2%''8:I)1C--L^F***^3O'W_!2;X8?#_QYK'A>[T_7KV7
M2;MK.YO+.WC:'>IPY7,@)"G(Z=C7/1P]7$-JE&]C>K7IT$G4E:Y]8T56TW4;
M?5].M;ZTE6:TNHDGAD7HZ, RD?4$5X]^T=^U=X3_ &98]#/B2QU2_DU@S>1'
MIL2/M$87<6+,H'WQC\:BG2G5FJ<%=EU*D*<>>;LCVJBL/P/XPL?B!X-T3Q-I
M@E73]7LXKV!9UVR!)%# ,,G!P>>:^?/C1_P4$^'_ ,#_ (C:GX,UG2M=O-3T
M]8FFDLX(C%\Z!P 6D!/##M5T\/5K3=.G&[1%2O3I14YRLF?3]%?%?_#UKX6X
MS_PC_BC'_7O!_P#':[KX(_M^^ /CO\1+'P;HFEZY9ZG>12RQ27L$8B_=H78$
MJY(^4'M71/+\53BYRIM)&$<=AIR48S5V?35%?/OC[]M?P/\ #OXXVOPNU&PU
MB77)Y[2V-U;P(UNCW 4QY)<,1AUR0.,^U?05<M2C4IJ+FK)ZHZ8585&U!W:W
M"BOGWX?_ +:_@CXC?'"[^%^FV&LQ:W;SW=O]JN($6W=[?=YF"'+ ':V,CMVK
MZ"HJT:E%J-16;U"G5A65X.Z"BODW]MK]M3_AG6*T\->&;>VU#QK?P?:"UUEH
M;"$DA9'4$;G8@[5SC@D\8!\/^'OPF_:V^/\ X?@\5W_Q2N_!UAJ"B>S@FNI+
M5Y(SRK"&W4;%(Y&[DC!QTKNI8"4J2K59*$7M?K\CBJ8Z,:CHTXN4EO;H?I%1
M7YW^"[[]J?X&_'CP1X5\6Z[/XI\,:_J<=HU_,/MUL\6<R8E*B2)P@8X;'3N,
MU]A_M ?'[P_^SGX)A\3>([:^O+.:\2RCAT^-7D+L&8'YF   0]_2LJN#E3G&
M$)*?-M8UI8J,X2G-./+O<]-HKXP7_@J=\-FA,J^%_%S1?\]!9Q%?S\S%>L_
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M !0UQ_Z)>OFW_@GSX/\ &'CGX4_$_3/ _C%O ^O?VCILJZF+59PR*DVZ(@]
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M#K*48'=GG<HQC.37Z/TM%/%8J>*<7-6Y58,/AHX9247N[GY9?%+X*?&_PO\
MM@>(_B1X.^'U[JZV^MR7^G7$B(]O,K)M!(#@D88^AS7J'_#0'[9O_1(;'_P
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MUH*DDHQ71%T<)&C-U6W*3ZL_.&S_ &;_ (E+_P %"F\9-X3O%\*?\)+)J/\
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M<O\ 9RY/8^T?)VT_/<\H^(7PR.E_LQZ_X"\+6CW;P>&9M*T^WR \S"W*(,G
MW,?U-> ?\$T?@WXV^$>B^/$\9>'+SPZ]_<VC6R7FT&4(D@8@ G@;A^=?:M+7
M%'%SC1G0Z2=V^IURPL'6A6ZQ5D%%%%<1V!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>uhglogocleana.jpg
<TEXT>
begin 644 uhglogocleana.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 <(# 2(  A$! Q$!_\0
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M$)*?-M8UI8J,X2G-./+O<]-HKXP7_@J=\-FA,J^%_%S1?\]!9Q%?S\S%>L_
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M !0UQ_Z)>OFW_@GSX/\ &'CGX4_$_3/ _C%O ^O?VCILJZF+59PR*DVZ(@]
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M#K*48'=GG<HQC.37Z/TM%/%8J>*<7-6Y58,/AHX9247N[GY9?%+X*?&_PO\
MM@>(_B1X.^'U[JZV^MR7^G7$B(]O,K)M!(#@D88^AS7J'_#0'[9O_1(;'_P
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MUH*DDHQ71%T<)&C-U6W*3ZL_.&S_ &;_ (E+_P %"F\9-X3O%\*?\)+)J/\
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M<O\ 9RY/8^T?)VT_/<\H^(7PR.E_LQZ_X"\+6CW;P>&9M*T^WR \S"W*(,G
MW,?U-> ?\$T?@WXV^$>B^/$\9>'+SPZ]_<VC6R7FT&4(D@8@ G@;A^=?:M+7
M%'%SC1G0Z2=V^IURPL'6A6ZQ5D%%%%<1V!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>uhglogocleanb.jpg
<TEXT>
begin 644 uhglogocleanb.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 <(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***_.+3_P!I3XE3?\%"I/!K^*[I
MO"G_  D<FF?V.4C\CR!&0%QMSG@'.<YKLP^%GB>?E?PJYR8C$QP_+S+XG8_1
MVBDK\\KC]HWXC?\ #Q1?!2^*+E?"0UI=/_L<(GD>3]G!(QMSG/.<YS1A\-+$
M\W*_A3?W#KXB.'Y>9?$['Z'45YK\?OCUH'[.O@:/Q3XBMKZ\LI+R.R2'3XU>
M0R.&(^\P &$/>N7_ &=?VP/!/[2U_J^G^'(=1T_4M,C6>2UU.)$:2)CMWIM9
ML@-@'TROK6:P]65)UE'W5U+=>E&HJ3E[SZ'N5%>8?M!?M!>'OV<?!=OXD\1V
MU_>6MQ>)910Z?&KR%V5FS\S   *>_I77?#[QMI_Q)\$:'XITI9DT[5[2.\@6
MX0+($<9 8 G!_&H=*:@JC7NO2Y:J0<W33U1T-%?/7PZ_;<\"_$SXUW'PRTNP
MUF+6HYKNW6ZN($6WD:W#%\$.6 (1L9';WK)^-W[?W@#X$_$:_P#!FMZ7KEYJ
M=E%%)+)901F+]X@=0"T@)X([5T+!XAS]FH/FM>WD8/%T%#VCEI>WS/INBOBK
M_AZU\+=N?^$?\48]?L\'_P =KT[]GO\ ;>\$?M'>,[OPSX>T[6;+4+>R:^+:
MA#&L;1JZJ0"KMSEU[553 8JG%SG!I(F&-P]22C":;9]#T5\H_$W_ (*._#KX
M6^/M=\)ZCHWB&ZOM'N3:SS6UO%Y3. ,[2T@)'/I7+_\ #U[X5_\ 0 \3?]^(
M/_CM5'+L7)*2INS)ECL-%N+FKH^UJ*\K7]HSPRW[/O\ PN 6^H?\(S_9_P#:
M'V<P@76W=LV[=V,[N.N.^:\$A_X*G?#:X4M#X6\73*."8[.)@/RDK.G@\15O
MR0;L[/U-*F+H4[<\K7U1]GT5\I> _P#@I5\'O&>M1:7>SZIX6FE?RTN-9M52
MWW'H&D1FV<]VP/4U]50S1W$22Q.LD3J&5T.58'D$'N*RK8>KAW:K%HTI5Z=9
M7IRN/HK\ZK/]I[XFO_P4$;P0WB>1O"/_  D3Z7_9!MXO)\@1D 9V[MV1G=GK
M^5?HI6F)PL\+R\[^)7(P^)AB.;E7PNPM%?GA\4OVF/B5H7[?NF>"+#Q/-;>$
MSK>F6#:2L$1B>*98O,!)7=D[VYSQQZ5]F_';XW:'^S[\/Y_%WB"WO;JPCN(K
M80V$:O*SR-A>&(&.O>KJX.K3]FMW-75O,BGBZ=3G>R@[,]"HKXJ;_@JY\+%X
M.@>)P?\ KW@_^.UWOP-_;Y\ _'KXB6G@W0]+URSU.ZAEFBDO8(Q%B-=S E7)
M'&>U.>7XJG%SE3:2%''8:I)1C--L^F***^3O'W_!2;X8?#_QYK'A>[T_7KV7
M2;MK.YO+.WC:'>IPY7,@)"G(Z=C7/1P]7$-JE&]C>K7IT$G4E:Y]8T56TW4;
M?5].M;ZTE6:TNHDGAD7HZ, RD?4$5X]^T=^U=X3_ &98]#/B2QU2_DU@S>1'
MIL2/M$87<6+,H'WQC\:BG2G5FJ<%=EU*D*<>>;LCVJBL/P/XPL?B!X-T3Q-I
M@E73]7LXKV!9UVR!)%# ,,G!P>>:^?/C1_P4$^'_ ,#_ (C:GX,UG2M=O-3T
M]8FFDLX(C%\Z!P 6D!/##M5T\/5K3=.G&[1%2O3I14YRLF?3]%?%?_#UKX6X
MS_PC_BC'_7O!_P#':[KX(_M^^ /CO\1+'P;HFEZY9ZG>12RQ27L$8B_=H78$
MJY(^4'M71/+\53BYRIM)&$<=AIR48S5V?35%?/OC[]M?P/\ #OXXVOPNU&PU
MB77)Y[2V-U;P(UNCW 4QY)<,1AUR0.,^U?05<M2C4IJ+FK)ZHZ8585&U!W:W
M"BOGWX?_ +:_@CXC?'"[^%^FV&LQ:W;SW=O]JN($6W=[?=YF"'+ ':V,CMVK
MZ"HJT:E%J-16;U"G5A65X.Z"BODW]MK]M3_AG6*T\->&;>VU#QK?P?:"UUEH
M;"$DA9'4$;G8@[5SC@D\8!\/^'OPF_:V^/\ X?@\5W_Q2N_!UAJ"B>S@FNI+
M5Y(SRK"&W4;%(Y&[DC!QTKNI8"4J2K59*$7M?K\CBJ8Z,:CHTXN4EO;H?I%1
M7YW^"[[]J?X&_'CP1X5\6Z[/XI\,:_J<=HU_,/MUL\6<R8E*B2)P@8X;'3N,
MU]A_M ?'[P_^SGX)A\3>([:^O+.:\2RCAT^-7D+L&8'YF   0]_2LJN#E3G&
M$)*?-M8UI8J,X2G-./+O<]-HKXP7_@J=\-FA,J^%_%S1?\]!9Q%?S\S%>L_
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M !0UQ_Z)>OFW_@GSX/\ &'CGX4_$_3/ _C%O ^O?VCILJZF+59PR*DVZ(@]
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M#K*48'=GG<HQC.37Z/TM%/%8J>*<7-6Y58,/AHX9247N[GY9?%+X*?&_PO\
MM@>(_B1X.^'U[JZV^MR7^G7$B(]O,K)M!(#@D88^AS7J'_#0'[9O_1(;'_P
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MUH*DDHQ71%T<)&C-U6W*3ZL_.&S_ &;_ (E+_P %"F\9-X3O%\*?\)+)J/\
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M<O\ 9RY/8^T?)VT_/<\H^(7PR.E_LQZ_X"\+6CW;P>&9M*T^WR \S"W*(,G
MW,?U-> ?\$T?@WXV^$>B^/$\9>'+SPZ]_<VC6R7FT&4(D@8@ G@;A^=?:M+7
M%'%SC1G0Z2=V^IURPL'6A6ZQ5D%%%%<1V!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>uhglogocleand.jpg
<TEXT>
begin 644 uhglogocleand.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  2     $  0!(     0 !_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(                  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?
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M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X $T%D;V)E &0
M     04  DE$_]L A  " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%
M!04%!04%!P@(" <%"0H*"@H)# P,# P,# P,# P,# P, 0," @,# P<%!0<-
M"PD+#0\-#0T-#P\,# P,# \/# P,# P,#PP.#@X.#@P1$1$1$1$1$1$1$1$1
M$1$1$1$1$1'_P  1" !% 9@# 1$  A$! Q$!_\0!H@    <! 0$! 0
M    ! 4# @8!  <("0H+ 0 " @,! 0$! 0         !  (#! 4&!P@)"@L0
M  (! P,"! (&!P,$ @8"<P$" Q$$  4A$C%!408382)Q@10RD:$'%;%"(\%2
MT>$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&
MI+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^A$
M @(! @,%!00%!@0( P-M 0 "$0,$(1(Q0051$V$B!G&!D3*AL? 4P='A(T(5
M4F)R\3,D-$."%I)3):)CLL('<](UXD2#%U23" D*&!DF-D4:)V1T53?RH[/#
M*"G3X_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H
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M )S+\I>>_P#G(WS+_P X\:?Y2U2UOO+]UJVG+K<LL1AGO-%+K=H;<#DB<H9
MC\F)HM5'+X=KJO9_+@T$=29"C1KW\G3Z3VEPZCM&6EC$V+%^[F^F?-OYA^0/
M(*64GGOSSY?\E1ZD76S;7M3M=-%P8N)<1&ZEBYE>0K2M*C-?@TF?/?AP,J[@
M3]SLM1K-/IP#DF(WWD#[V%?]#&?\X]_^7W_+S_PJ-)_[*\N_DC7?ZC/_ $I_
M4T?RUV=_JT/],/UO4=%US1?,FEV6N>7=7LM?T34H_5M-0TZXCNK6XCJ1SBFA
M9T<5!%03F-DQSQR,9"B.A<O%EADB)1((/(A!^9?-GE;R7I;:WYQ\RZ5Y3T5)
M$A;4-9O(+"U$DFR(9KB2-.34V%:G#AP9,TN&$23W 6QSZC%AAQ9) #O)H*^@
M>8_+WFO2[?7/*VO:=YET6\KZ&H:5=17EK+Q-#PF@=T:A%#0XY<4\<N&8(/<=
MDXLV/+$2@01WC==KWF#0?*VE7>O>9];L/+FAZ>%:ZU'5+F*SM( S!%,D\SHB
M@LP J>II@Q8IY)",02>X+ES0Q0,ID #J=@OT77-%\R:79:YY=U>RU_1-2C]6
MTU#3KB.ZM;B.I'.*:%G1Q4$5!..3'/'(QD*(Z%.++#)$2B00>1#$/,_YN_E/
MY)U/]"^<_P S_*7E'6?12X^H:UK5A87/I2$A)/1N)XWXMQ-#2AIEN'0:G-'B
MACD1W@$M.?M'28)<.3)&)[B0/O8[_P!#&?\ ./?_ )??\O/_  J-)_[*\L_D
MC7?ZC/\ TI_4U?RUV=_JT/\ 3#];._*GGKR1Y\M+F_\ (WG+0_.=C93?5[BY
MT+4;;48H92H?TY'MI955N)!H36F4Y]-FP&LD3$^8K[W(T^KP:B-XYB0\B#]S
M7EKSYY'\Z2:I#Y.\Y:%YLET240:BFC:C;7[6<K%@([@6\LAC8E&V:AV/ACFT
MV;%7'$B^5BK7!JL.:^"0-<Z(->]'>9/-/ECR;I4NN^;_ #'I?E71+=TCEU#6
M+R&QM$>1@J*T]P\: LQH 3N<CAP9,LN&$23W#=.?/BPPXIR '>301^FZGINM
M:?9:OH^H6VK:5J4*7-I>V<J3V]Q#( R212QLR.K U!!((R,X2A(@BBSA.,X@
MQ-@I9YK\U^7O(_ES6/-WFS58-#\NZ!;-=W][<&D<42_($EB2 J@$LQ"J"2!D
ML&">;((0%D\F&?/CPXS.9H#F7YFW_P#S\LO?-'F6Y\O_ )&?\X^^8_S/2UY-
MZPDF6ZEC4D>HMA8V5^ZH>H9G!IU4'8=#'V.&/'Q:C,(_CO)#S4_;<Y<ACIL$
MI_CN *8>5O\ GXSK-OY]T'R#^;W_ #CWYA_+B_\ ,=[:V5LSS3?6D:[F6"-W
ML;ZQL7*!VW97)\%)R.?V2@<$LF',) "_EY@EEI_;.?YB.+/@E D@#X^1 ?I'
MYF\V^5?)6F'6_.7F;2?*6C+*D!O]9O8+"U$LE>"&:XDC3DU#05J<T&'!ES2X
M81)/<!;T>?48L,.+)( =Y-!YV/\ G(O_ )Q\8A5_/;\O&9C0 >9])))/_1WF
M1_).N_U*7^E/ZG'';79Y_P M#_3#];U;3-4TS6K&WU/1]1M=6TV[7G!=V<R3
MP2K_ #))&S*P]P<Q9PE$T11<N$XS%@V$)K_F+R_Y4TJYUWS1KFG^7-%L@#<7
M^IW,5I;1 ].<TS(@K[G)8L4\DN&()/<&.7-CQ0,ID #J=GC6G?\ .5/_ #CA
MJNHKI-E^=7E)[UW,:++J4,,;OR"A4EE9(V))VHV_:N94^Q-?&-G%*O<X<.WN
MSIRX1FC?O#WN.2.6-)8G62*10Z.A!5E(J""-B",PB'/!8O;^?/(]WYHN_(]I
MYST*Z\ZV$7KW/E^+4;9]4AB"HW.2R64S*O&134K2A'B,M.FS#'XAB>'OK;YM
M0U6 Y3C$QQ=UB_DGNI:GINBZ?>ZOK&H6VDZ5IL+W-W>WDJ06]O#&"SR2RR,J
M(J@5))  RN$)3D !9;)SC"),C0"#T#S)Y=\UZ1;>8/*VOZ;YET&\Y_5]2TJZ
MAO+27TV9'].>!WC;BRD&AV((R67#DQ2X9@@]QV8X<V/+ 2A($=XW#S>3_G(C
M_G'^&1XI?SS_ "^BEB8HZ/YGTI65E-""#=U!!S('9.N(_NI?Z4_J<8]L]G@T
M<T/],/ULT\J_F!Y#\]13S>2/.V@><8;7::30]2M=06/M\9MI90/IRG/I<V$U
MDB1[P0WZ?5X,XO',2]Q!^YEV5-KL5=BKL5=BJ4Z__P <+6O^8"Y_Y--DL?UA
MCD^@OQK_ .?2_P#QW?SO_P"8#0?^3NHYUGMW]&+X_H>,_P"!W]>;_-_2^_O^
M<X/_ %E7\X_^V7:_]1]IFC]G/^-+%[_T/0^T_P#QEYO<\:_Y]B?^LUW'_@7Z
MK_R9LLR_;+_C1_S0X?L-_P 98_K%^->J^2_,NJ^9?SU_,3RO/)%>?E+YG_2\
M_H*3+%#<:M/"MU&17>&81D[?9)8T"YU>/4XXXL.*?*<:^P;/&Y=)EGFSYH'>
M$K_V1W^#]VKK\V;+\[?^<'/S!_,:U*)=:U^5WF:/5($V%OJ=MI5Y!>Q4ZA1*
MC%*]4*MWSC8Z&6C[9AB/2<:]UBGN9]H1UW8>3*.N.5^^C;QO_GU;_P"L]^<?
M_-AZA_W2=$S+]M_\>C_4'WEPO^!__P 9T_ZY^Z+Y6T/_ .2H3_\ @6ZC_P!T
M6XS8Y/\ G&O@/]TZS'_SE?Q/^Y?I-^:W_.%/Y"_G)YUU'\P/.>AZD_F;5XK>
M*]GL=1FMDG-K$D$3M&"5Y"*-$J*;*.]2=!H?:+7:3",<)"AY/2:_V8[/UF8Y
M<D3Q'G1(?CA_SAC^0OY>?G9^>_GKR!Y[M+VZ\NZ!Y>U34;2.TNGMI1/:ZII]
MK$6D3<CT[EZCQWSJ_:#M34:30PR8SN2!\P2\=[-=D:;6=HY,607$ D;]Q ?L
M!YG_ "/_ "]_(7_G%7_G(/RI^7.FSZ?I>H>2O->I71NKF2ZFFN7T:>+DSR$T
M 2)0  !MXDG.6P=I9];VEAGE-GBB/M>NU'9>GT'96>&(4.&1_P!B_.3_ )P!
M_P"<8OR<_/CR7Y^UG\S/+MQK6H:%K=O96<D.H7=F$ADMA(RE;>:,'XNY&;[V
MI[:U>BS0CBE0(OD#U\WG?8_L'1:_3SEFC9!KF1T\GZB?E7_SB%^0GY,^:X_.
MWD'R?-IOF6"VFM(;NYU&]O/2CN %EX)<3R(&913E2M"1W.<YKNWM;J\7!DE8
M]P#U'9_L[H-%E\3%"CRYD_>7Y,_FAY.\N?F'_P _*-3\F><-._3'EKS#YETZ
MUU"S,TT'K0_H:V;CZMO)%(NZC=6!SI]%J,F#V>$X&B :_P!,\GK]+BU/M,<>
M07$D6/\ -'<^[OS3_P"?;WY >8/)FL6OY:>7+CR'YTBMY)=+O8M3U"]@DN56
ML<-S%?W=ROIN1Q)7BRUY5-*'2Z+VOUT,H.67%'J* ^X.]UWL3V=DPD8H\,NA
MLG[R7F/_ #[-_//S3YHLO.7Y*>==1N=4O/(]M'J6A27KM)=0V(E^K75F[N2Q
M2&1XO3!^R'*_950,CVQ[-Q8Y1SXQ0EL:[^A<;V'[5S98ST^4V8[B^==1\'SG
M_P Y2:KINA?\_&O)FMZS?0:7I&C^9?(=]?7ERXCAM[:W?3Y)II78@*J(I9B>
M@&9_8<)3[!G&(LD3 ^UUOM#DC#VBQRD: ,"3\0_6_P#Z&F_YQO\ _+X^2O\
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MW*L&I/I=M'8W"FG<2VS C-#VWCE#M#*#_.)^9MZ/L#+')V;A(_F@?(4^*?\
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M>,"BG=(FI\(V7MG8^U_H[-Q0/.Q]D2\/[%?O.ULTX\J/VR%(+\K/_DI^J?\
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MNK@K5J!I'/%23Q0*M32N:'M/7SUFIEEEU^P='HNRNSH:'2QPQZ=>\]2^0_\
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MOA*UHU5&)[4=HX-9JQ/$; B!?+J3^ES/9'LO4:'1&&843(FKOH!T]SPC2_\
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M,L5P=2O[.[M#<Q,L3&#T5M=8U!F8R!10Q\>-:L-LU':6G[%C@)P9)&70;_I
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M_:SJ%QJNI_7;6TU1K,2B.*&T6X>.12$CA4L$)3FS<2P^(S[?[<EJM698I$1
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M'EG0ZW4]B=J 3G,PE^.>Q!>9[/TO;_9!./' 3A[_ +MP0D/Y@_E%_P YB_\
M.5_YL>1_-/GK\G[#\N+'RLMK8O=-.MO!%:)=&XDD=)KVXFE>LC4$:=*#WR>E
MU_979NEG#'E,B?U>YCK.SNV.U=9CGDQ" C77SOO?='_.?/Y-?F'^>'Y,Z%Y7
M_+/1(_,'F#2?-]EK$MD]W;69:UBL=2MG9)+N6"*H>[0T+C:M*G;-/[+=HX-'
MJS/*:!B1W]0>GN=S[7]F:C7:(0PBR) U==".OO>O?DE^5]UHG_..'DC\IOS'
MTB![A/*@T37],,B3Q<;F-TN+=I(F9&^&0J2I(KT)ZYB=HZT3U\\V,_Q6"YO9
MFA,.SH8<H_AHC[WQK_SA[_SC[_SD'_SC=^=WGKR]?:&NI_D7YD%S''KGZ2L6
M#O:%GTV\%FMQ]865T8Q2KZ0%6K4JBD[;V@[5T/:&CA(&L@Z4?B+=-[-]C]H=
MFZW) B\1ZV.G(US]^R9?\Y4_\XE?F7J'YM:/_P Y)_\ ..MQ;+^8>FS6MUJ.
MC32QVS75U9J(DN8))6CA;U(5$<T3LH8 FI+$9'L3MW3QTITNI^@\CW6S[?\
M9[4RU8U>E^L<QWTD_GC\U/\ G/W\R_)][^7NB?\ ..$?D+6M?MI-.U3S$FH0
MA$AE'IS-9FXN42 E21R,DK &J?%1A+3:+L33Y1DEGX@-P*^]CJM?V_J<)Q1T
M_"3L96/L?1'_ #AK_P XLQ_\XU>2M3&MWMOJ_P"8/G&2&?6[FUJ;:WCMPX@L
M[=W5694]1F9R!R8]**N8/M#VV>T,PX141R_6Y_LUV .S,!$C<Y<S^@/FO\_?
M^<5OSJ\G?\Y#6_\ SE!_SCA9V'F359+P:G?>7[F6."6.\D@:UO."RR6Z2P7$
M3,9 )5D#.W&NQ&P[+[;TF70?E-38'('[1\G6]K]@:W%VB-9I0">9B?=1[N:!
M_-O5/^<X?^<G?*#?E*GY V?Y5>7]<DM?T_JVHZFG&1()5F4!F=76(R1*66.*
M5S0"M":G00['[.R^-XW&1R ".T9]N=IX? \ 0!YDG\?I?<OY4_D9;_E!_P X
M_P 7Y.Z)>IJFH1:-J,-Q?NOHK=ZEJ*S-+*1\15/4EXJ-R$"UJ<T^N[2.KUIS
M2%;C;R#O.SNRQH] ,$3>QW[R7RW_ ,^[_P#G'G\VOR'A_-V3\T_+4?EI_-DF
MA)ID2WUG>O*NG#4S-(39SW"JO^F(!R()WV\=E[6=K:76G'X4KJ[V(YUW^YU/
ML9V+J] ,OC1JZK<'E?=[WZ4YS[TKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>unh-20221231_g1.jpg
<TEXT>
begin 644 unh-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 <(# 2(  A$! Q$!_\0
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M$)*?-M8UI8J,X2G-./+O<]-HKXP7_@J=\-FA,J^%_%S1?\]!9Q%?S\S%>L_
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M !0UQ_Z)>OFW_@GSX/\ &'CGX4_$_3/ _C%O ^O?VCILJZF+59PR*DVZ(@]
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M#K*48'=GG<HQC.37Z/TM%/%8J>*<7-6Y58,/AHX9247N[GY9?%+X*?&_PO\
MM@>(_B1X.^'U[JZV^MR7^G7$B(]O,K)M!(#@D88^AS7J'_#0'[9O_1(;'_P
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MUH*DDHQ71%T<)&C-U6W*3ZL_.&S_ &;_ (E+_P %"F\9-X3O%\*?\)+)J/\
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M<O\ 9RY/8^T?)VT_/<\H^(7PR.E_LQZ_X"\+6CW;P>&9M*T^WR \S"W*(,G
MW,?U-> ?\$T?@WXV^$>B^/$\9>'+SPZ]_<VC6R7FT&4(D@8@ G@;A^=?:M+7
M%'%SC1G0Z2=V^IURPL'6A6ZQ5D%%%%<1V!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>unh-20221231_g2.jpg
<TEXT>
begin 644 unh-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ?B"7\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOZ9X7TJ?5-9U&TTC3+< S7E].L,,>2%&YV( R2!R>I%<=_PT)\+/^BE^#_\
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MW0(%=Y=5M[V*2UC5/OEI0VT!<'))X[T ;M%>?_\ #0GPL_Z*7X/_ /!]:_\
MQRC_ (:$^%G_ $4OP?\ ^#ZU_P#CE 'H%%>?_P##0GPL_P"BE^#_ /P?6O\
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M"?"S_HI?@_\ \'UK_P#'*W_#?Q$\*^,FV^'_ !-H^N-@G&FW\5P<#J?D8^E
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M0ANC$&SM+"-CMS@XSZ&NBH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_V-MY_Z2VE?G7_P4T_Y/C^)_P#UVL?_ $@MJ_13_@C#_P FH:W_ -C;>?\
MI+:5^=?_  4T_P"3X_B?_P!=K'_T@MJ *7PI_P"">/QO^-7P_P!)\:>$_#=G
M?>']461K6XEU6VA9PDCQME'<,/F1AR.U8GQ@_8;^-_P)\/SZ_P",/ EU9:%
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M.Z5!)<ZEJMY#96T,*EG:21PJ@ >YH _IO^(7_(@^)O\ L&7/_HIJ_F7^'O\
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MA;PMJ<GB>ZN$LM:UJVLYFC-O:@.$D=6*DJPSC&5/I7VM_P -8_!#_HLGP_\
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M"9/Q,_X5G^V1X*,TGE6>O-+H%QSC=YZXB'_?]8:\6_:$_P"2^_$O_L9M3_\
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M)S_L)_&+]GG]HI?%GCCP_::;H@TBZM//AU*WG;S'*;1M1R?X3SBN4_X+@_\
M(_?"S_L&7O\ Z-CK]=*_(O\ X+@_\C]\+/\ L&7O_HV.@#1_X)._#BP^+_[-
M_P ??!6I8%GKK0V+2$9\IGMY0D@]T;:P]U%?G!;S:]\'?B5'* VF^)_"VKAL
M'[T%W;3=/JKI^E?J=_P0^_Y$'XI_]A.R_P#14E?,7_!6KX+_ /"L?VI+GQ%:
M0>5I/C.T754*C""Z7$=RH]RRK(?>:@#]JOACX]L/BE\.O#/C#2R#8:YIT&H0
MKNR4$B!MA]U)*GW!K=U35+71-+O-1OIEMK*SA>XGFD.%CC12S,?8 $U\'_\
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M^GDN=273SIUW-*27>6VD:W+L>Y81AB>^Z@#\E/\ AT_^TE_T*&G_ /@[M/\
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M"G6M-AM_&L^B:[9)9)=1R(9;EKDPCS58IR)4YSQGGI7<?\-^?L\_]%8\/_\
M?U__ (FO=M+U2UUS2[/4;"=;JQO(4N()X_NR1NH96'L00?QH _"#_AT_^TE_
MT*&G_P#@[M/_ (Y7@/QQ^ WC+]G7QHGA7QSI\.FZT]I'>K##<QW"^4[,JG<A
M(ZHW&>U?TSU^('_!9+_D[BS_ .Q9LO\ T;<4 >)_ []ACXP?M%>"W\5>!M M
M=2T5+N2R::;4H+=O-159AM=P>CKSCO7U+^Q[_P $Y_CI\(?VEO 7C#Q/X:LK
M/0=)OFGNYX]6MI61#$ZY"*Y)Y8=!7TY_P1M_Y-'O/^QFO?\ T5;U]U4 ?GK_
M ,%L/^3;?!O_ &-L/_I'=5\Z_P#!$O\ Y+[XZ_[%D_\ I5!7T5_P6P_Y-M\&
M_P#8VP_^D=U7SK_P1+_Y+[XZ_P"Q9/\ Z504 ?LI7Y@?\%QO^15^$G_7[J7_
M *+MZ_3^OS _X+C?\BK\)/\ K]U+_P!%V] '*?\ !#G_ )&KXM_]>6F_^C+B
MO:_^"U?_ ":SX6_['.U_](;ZO%/^"'/_ "-7Q;_Z\M-_]&7%>U_\%J_^36?"
MW_8YVO\ Z0WU 'Y0? 7]G7QS^TKXIOO#O@'38=4U6RLFOYHI[N.W"PATC+;I
M& )W2+QUYKW7_AT_^TE_T*&G_P#@[M/_ (Y7H7_!%W4K33/VC?&$EY=0VD;>
M%)E#SR! 3]LM>,D]:_9'_A+=#')UG3P/^OJ/_&@#^;?XK_ WXF_LR^*=/MO&
MGA_4?!^KM_I%C=+,K*Y0C+0SQ,R,5)7.ULKD9QD5^LO_  2J_;'U[X_>%=;\
M"^-]0?5?%GAN*.YMM4N&+3W]FS%293_$\;;%+'EA(F<D,3Y+_P %D/CS\/O&
M7@CPAX%T'6]/U_Q39ZM_:=P^GRK.MG;^1(FQI%RH9V=#MSG$8) R,\!_P1/\
M(ZA>?'?QMXF2*8:58>'6L)9E4^69I[F%T0GUVP2''M0!])_\%J_^36?"W_8Y
MVO\ Z0WU?DO\ OC5KG[/?Q:\.^.] <F\TNX#2VY8A+J!OEE@?_9="1['!'(%
M?K1_P6K_ .36?"W_ &.=K_Z0WU?CQHG@'6_$7A'Q'XETZS:ZTKP\;;^TI$Y:
M!)W9(Y"/[N]0I/8NOKP ?TN_"_XD:'\7_A[H/C/PW<_:]%UFU2ZMW_B4'[R,
M.SJP*L.Q4BOA[_@MA_R;;X-_[&V'_P!([JO /^"0W[67_"#^,YO@WXDO=FA^
M()C/H<LS<6]^0 T ST68#@?WU  S(:]__P""V'_)MO@W_L;8?_2.ZH \?_X(
M<_\ (U?%O_KRTW_T9<5^M5?DK_P0Y_Y&KXM_]>6F_P#HRXK]:J "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M K^9/X_6\UK\=_B/#<9^T1^)-223.<[A=2 _K7]-E?@O_P %2O@7>_"']J;7
M-:6 _P!@^,RVMV4X4A?.8@7,9/\ >$N7/^S*GK0!^S?[,-[!J/[-GPIN;8KY
M$GA32BH4\#_1(N/PZ?A7IM?GG_P2G_;$\->+/A'I'PE\1ZM!IGC'P_OM].CO
M)0@U*T+EHQ$3@&2/<4,8YVJK#/S;?O+QAXST'X?>';W7_$NKV>A:+9IOGOK^
M98HHQ[L3U/0#J3P.: -JBOY_OVH?VXO%_P 1OVF]?\??#WQ3KOA72HUCT[2O
ML-Y);L]I#G:9%4@$.[22;&!QYF#G%?L7^Q#KWQ#\6?LT>#_$'Q/U)M3\4ZQ"
MU]YDEM' ZVKL3;AEC55),6Q\XS\_/(H _GU^*EO-:_%#QA#<<W$>L7B29_O"
M=P?UK^D?X$ZA;:M\$/A[>V;*]I<>'M/EA9#E2C6T9&#]#7X??\%,O@7??!G]
MJCQ-?&V9-!\6S/KVG7"H0CM*V;B//3<DI?(_NLAXW"OM3_@EK^W-X9U+X;Z7
M\(?'&L6^B^(M%!@T:\U"81PW]J6)2$.QP)8\E IQN4)MR0: /TFKY@_X*8W\
M&G_L0_$UIV $L%G"@/=VO8  /QY_"OIJXNH;.WDN)Y8X8(U+O+(P554=22>
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M/<-Q9WK')MP3T28]!VDZ#]X30!^M'Q"_Y$'Q-_V#+G_T4U?S+_#W_D?O#/\
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M]?D;_P $1/!%[-XZ^)'C!K>5=/MM-@TE+@@B-Y9)1*R@]"5$*$^@<>M?KE0
M4V2-98V1U#HPPRL,@CT-.HH _GZ_X*,?LTV/[-'[1%[IVAF-/#.OP?VUIEJG
M6T1Y'5X/HKHVW_8*CJ#7OW_!'C]E^Q\=^,-3^,&NK%=67ABY^P:1:-ALWYC5
MVG8?],TD7;_M/NX*#-+_ (+:?\E]\"_]BR/_ $JGKZ*_X(G_ /)MOC+_ +&V
M;_TCM: /T*K\]?\ @MA_R;;X-_[&V'_TCNJ_0JOSU_X+8?\ )MO@W_L;8?\
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MPOXHN[RT;2M7MM#UBVNY4:([X)F2)V.&5W0L1@>6@[UQO_#H?]H;_H&^'_\
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M+ID6I6%@VI2G5+AH8_*62.,X*HV6W2+QCIFOH[_AS;\>_P#G\\'_ /@TE_\
MC%;'_!%W4K33/VC?&$EY=0VD;>%)E#SR! 3]LM>,D]:_9'_A+-#_ .@SI_\
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M3_@F5\?]!_9]_::MK_Q3>1Z;X?U[3I=$N=0F.(K1GDBDCE<]EWPJI8\*')/
M)H _?>OS _X+C?\ (J_"3_K]U+_T7;U^F^GZA:ZM8P7MC<PWMG<()(;BWD$D
M<B$9#*P."".XK\>_^"RGQX\+_$3QIX'\%>&M6M=9G\,K>3ZI-9R"6**>;R52
M'<."ZB)BP!.-X!P010!T7_!#G_D:OBW_ ->6F_\ HRXKVO\ X+5_\FL^%O\
ML<[7_P!(;ZO._P#@AWX4N;?P]\6?$TD1%G=W6GZ=!)C@O"D\DHS[">'\Z]$_
MX+5_\FL^%O\ L<[7_P!(;Z@#\E/@W\!_'?[0.O7^B_#_ $!_$6J6-FU_<6T=
MS#"RP!T0L/-=0WS2(,#)YZ8!I?BU\ ?B)\";ZUM/'OA'4O#,ET";>2[C!AFQ
M]X)*I*,1D9 )(R,]:^RO^")__)R7C+_L4IO_ $LM:_5C]H3X$^'/VCOA3K7@
M?Q+"IM;Z/=;7@0-+97(!\JXC_P!I2>F>064\,: /PJ_8T_9/T;]J[QC)X?O/
MB9I7@W44^>+2Y[62:]O(P,L80=D;$#/&\L "=I S7[I?L_\ [/?@W]FGX>V_
MA#P58O;6"N9[FYN'\RXO)R &FE? RQ"@<      #%?SN_$CX?^+?V<?B]J/A
MS5&FT?Q3X;OE:.ZM79"&4AXKB%^#AAM=6ZX(Z&OW8_8+_:RMOVKO@O;ZE>RP
MQ^--&V66O6L8"YEQ\EPJCHDH!8=@P=1]V@#Q3_@M7_R:SX6_['.U_P#2&^KY
MS_X(V^$])\>:M\:?#FNV4>H:-JNA6UG=VLOW9(G>56'MP>HY'45]&?\ !:O_
M )-9\+?]CG:_^D-]7A7_  0^_P"1^^*?_8,LO_1LE 'QA^TY\!]?_9+^/6I^
M%I+BXC^P3K?Z+JRDH]Q;%MT$ZL.C@KM..CHV.E?5_P"V)^U%;?M3_P#!/GX>
M:W<2QCQ9I?BRWT_7K9< BY6QNL3!>R2K\X[ [UYV&OM;_@I7^R;_ ,-)?!23
M5="L_/\ '?A59+W3!&OSW<. 9[7W+*H9!_?0 8W&OP<6]N8[.:S6:1;661)9
M( Q",Z!@C$=R [@'MN/K0!^F_P#P0Y_Y&KXM_P#7EIO_ *,N*_6JOR5_X(<_
M\C5\6_\ KRTW_P!&7%?K50 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>4_M)_LW>$?VHOAM<^$?%D#JN[S
M['4K? N+"X (66,GKP2"IX8$CT(]6HH _ OXX?\ !,/XY_!_5;H:;X9F\?Z$
MAS!JGAI#</(O8-;#]\K8Z@*R^C-7F'_#-/Q_\7WD5C/\,_B%?RP'RE6]T6]V
MP9YP6D3:F>O)'6OZ0Z* /R-_8[_X)'^(+SQ)IWBKXVP0:7HMJZSQ>%(YEFN+
MQA@J+AD)6./IE 2QY!V=_P!;X84MXDBB18XD4*J(,!0.  .PI]% 'DO[3'[,
M_@_]J;X<S>%/%D#QF-S/I^J6V!<6$^"!(A/4$'#(>&'N 1^-OQL_X);_ !T^
M$NHW+:5X>/Q T-,M%J7AW][*R]@UL3YH;'4*K#T8U^]E% '\W#?L\?'^^MUT
M5_AI\2)K>( BP?0K\I&#@ [#'@#Y5YQ_"/2OHK]G?_@DC\5OB7JMK>?$"$?#
MKPQN5Y?M#I+J,Z9Y6.%21&3R,RD8Z[6Z5^WM% '(?"?X4>&/@EX!TKP;X0TU
M=+T+38]D40)9W8G+2.QY9V8DECW/IQ7R;_P5B^#/C;XV?!GPAI7@;PW>^)M0
MM-?%S/;V*@M'%]GF7><D<98#\:^X:* /S9_X)'_L\_$?X'^(OB5/X\\(:CX8
MBU&UL4M'OD51,R/,7"X)Z!E_.N8_X*M?L?\ C_XL?&3PQXR^'OA&^\2K=Z/]
MAU$:>JDQ2PRL49\D<LDH4?\ 7*OU-HH _,C_ (),_LD^.O@[\0O''B_X@^%+
MWPS=#38=,TU+]5#3"67S)F7!/W?(B&?]OZT?\%:?V<?B7\;OB)X"OO O@W4O
M$UI8Z5/#<S6**1$YFR%.2.2.:_3>B@#XX_X)7?"7QA\&?V<=6T+QMX?O/#>K
MR^)+F[2TO5 =H6M[95?@G@E&'X&OA_\ ;Z_8_P#C/\3/VN/B#XE\+_#O6-;T
M&_EM&MK^UC4QRA;*!&QENS*P_"OVGHH ^??V!? FO_#/]D?X?>&O%&E7&B:]
M817:W-A= "2(M>SNN<'NK*?QKZ"HHH S_$&I2Z+H.I:A!8SZG/:6TD\=C:C,
MMPRH6$:?[3$8'N17X$^,/V+_ -IGXI?$'5_$6L_#'7/[6U_49+RZN)E58UDF
MD+,22WRH"WX >U?T#44 <G\)?AUI_P (_ACX7\%Z7@V.A:=#8(^W!D*( TA'
M]YFRQ]V-=9110!\(_P#!5O\ 94U_X_?#[PKXA\$Z)-KGB[0+QK=K.U \V>SF
M'S8R1G9(D9 [!W->%_\ !+[X/_'']G;X[7MKXI^'>N:3X-\2V+6M]=3QJ(K>
M>(&2"5L-_P!=(^G_ "VK]8J* /YW]-_8'_:$AU&U=_A1X@5%E5B3$G !'^U7
M]$%%% ''?&#X4^'_ (W_  WU[P3XGMOM.CZO;F&3;C?$W5)4)Z.C!6!]5%?A
M/XO_ ."=?[07@;QQJ>GZ3X$U?6H=-O&6SUO2PHBN%5LQS1G=E<C#>H/'45_0
M310!X+\!_%/Q"^(W[,4D?Q$\*ZAX=^($.G7&FWMK>1A3>RK$52XCP<8D!!(X
MPV\= "?QJ\$_L'_M :?XST"ZN?A7KT-O!J%O+)(T2855D4DGYNP%?T'T4 <O
M\3OAMH'Q@\ ZWX-\460O]"UBW-O<PYPV,@JZG^%U8*RMV*@U^*O[0W_!*;XO
M_"C7+J;P;ILGQ&\+,Y-M=:9M^VQKR0LUN3NW#&,Q[E/!^4G;7[I44 ?S<0?
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M.!D$[!'@CYFYQ_$?6OZ1Z* /P<^!?_!*_P"-WQ:U*VDU[1?^%=^'F(,NH:\
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MLIQ,TS#D"ZF0[0F>J1EMW=AR#^KU% $=O;Q6L$<$$:0PQJ$2.-0JJH&  !T
M':ORI_X*M_LP_%3XU?M$>'=;\#^"-4\2Z3;^%K>REN[%%*),MW>.4.2.0LB'
M_@0K]6J* /CC_@E=\)?&'P9_9QU;0O&WA^\\-ZO+XDN;M+2]4!VA:WME5^">
M"48?@:^QZ** "BBB@ KYG_;H_8RTS]KSX<PVMO-;Z3XVT<M+HVJS ^6-V-\$
MVT$^6^!R 2K $ \JWTQ10!_/=/\ LL_M1_LW^)KJ]T3PCXXT2_@!B;5O!YGF
M62/KGS;4G*$#)#?B >*U_AW^P3^T=^TCXW:[\1>'O$&CM<2J-0\2>.O.@D50
M,;B)_P!],<# "J>P)4<C]^J* /,/V;_V?_#O[,OPGTKP+X;,D]O:EI[J^G $
MMY<OCS)G X!.  .RJHR<9KT^BB@ HHHH _+?_@K%^S3\4/C9\9O"&J^!O!>I
M^)M/M- %M/<6**5CE^T3-L.2.<,#^->X?\$H?@[XT^"OP)\4:/XY\.WGAK4[
MGQ)+=PVM\H#O";6V0.,$\;D8?@:^V** "OB?_@J]\'?&GQJ^!/A?1_ WAV\\
M2ZG;>)(KN:UL5!=(1:W*%SDCC<ZC\17VQ10!_.M_PP'^T-_T2?Q!_P!^D_\
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M2VV]1U]:H:?^RM\?_B)J4&/ACXZU&>;(2ZU+2KF.,\\YFF4(.<]6]:_H_HH
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M (<TCPY9S7EF=010+B\8>5&H )^Z'>3/8HOK7[ 444 %?B%^V9_P3U^*-O\
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M_ OAE7>SL@9)[N8 2WEPW,DTF/XF/;LH51P!7SO_ ,%6_A#XR^-7[._AW1/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HKYT_;G_:JF_9/^$5KK^DZ?:Z
MSXHU348=.TO3;O>4D8Y>1F5"&("*1P1\SIZX.3^P?^U]?_M7>#_%'_"2:39^
M'_&7AO4OL=_IEEO"+$P/EOAV+ EDF4C/6/WH ^H:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBOCO\ X*(?MI^*/V.[/P)-X:T/2-:;Q!)>I.-6$N(_
M)$!79Y;KU\ULYST% 'V)117/_$+Q%/X0\ ^)=>MHHYKG2],N;Z*.7.QVCB9P
M&QS@E><4 =!17RW_ ,$_?VL?$7[77PU\1^)/$FCZ7HUUIFKG3XXM+$FQD\F.
M3<=[,<Y<C@]A7U)0 4444 %%?,O[*?[17Q,^,WQ)^)NA>./ ?_"):/X=NA#I
M%]]AN;?[>GG3)NW2DJ_RQHWR?WO<5T?P_P#VO/#'Q/\ VEO%GP=T"PO9K[PM
M83W.IZK.!'")XYXH3!&A^9\&4Y<X&5X# Y ![O1110 4444 %%%?)'_!/_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ_:6_9WT6[57M=2N/L<RL,@I)>P(P(],$U^HL,,=O#'%%&L44:A4C0 *J@8
M '04 ?+G["_[<5C^U[H.LV=_HW_"->-M!V'4=-5RT,L;E@LL.[YL J0RL,J2
MO)R*K_MH_MU6O[,M]HW@_P ,>'I/&_Q/UY0UAHD.XI"C,41Y @+N6<$+&O+;
M6Y7C/SK^P[;QV7_!4+]I&&!!%"8]5?RUX&XZG;DG'U8_G4?P#C3XB_\ !8;X
MK:EX@C$MWX>L+QM,6<?ZLQ?9;2,H.W[F1S_P(GKS0!V<W[8'[6?P9T^#Q?\
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M_P!G_P /1^&'B\Y--N9&7498R"0PC:Z63. ,#RLG=PIZCQ7_ (**>+-:N_\
M@HI\.K6P\)W/CN3P[IUC<6/A=-Q74)1+-<, H5L@X4-\IR(L=J]V_P"&[_VE
M_P#HT;Q!_P!_KG_Y'H ]X_8\_;*\/_M9^&M3\G3;CPUXPT-EAUKP_>'+6[L6
M >-B 60E6'(#*1@CH3R_[:7[=EG^S'>:/X0\-:!)XV^)VNJK6.BQ%BD*LQ2-
MY0@+L7<$+&N"VUN5XS\O?LH^'_B[J7_!12Y^)^M?!SQ#\-_#OBNWNX]5BDMY
M?LD+FUWEGD*(#YD\"MR/OR5;^"%O'\1O^"QOQ*U'7$2YG\/VUV]@LX_U;0I;
MVL94>HCD8CZD]>: .^3]L#]JWX+P6OB[XW?!+2D^'#,K:A=>%W#7NFQM@!V0
M74V%'!(<+RV"ZG@<=_P1)F6XT/XR2I]R34=/89]"MP:_2K7-%L?$NBZAI&IV
MZ7FFZA;R6EU;R?=EBD4JZ'V*DC\:_.'_ ((PZ2N@Q_'+3$<2)9ZQ9VRN#D,$
M^TKG/X4 <E\2=?TSPO\ \%J-&U36=1M-(TRW@B,UY?3K##'G1G4;G8@#)(')
MZD5^C/\ PT)\+/\ HI?@_P#\'UK_ /'*_+_]I;X0Z%\>O^"M\7@/Q*]W'HFL
M6UNERUC*(Y@(]*,J[6*L!\T:]CQFOI;_ (<V_ 3_ )_/&'_@TB_^,4 <_P#\
M%8?BSX'\9?LHOIWA_P 9>']=U#^W;.3[+INJ07$NT"3+;$<G R.<=Z^G_P!B
MG_DT?X0_]BS8_P#HI:_.[_@H!_P3Q^%O[,OP!;QGX0N/$$NKC5;:RVZE?1RQ
M>7('W?*L2G/RCO7U?IWB:[\'_P#!)^WU6P:6.]A^&RI#+"2'C9[7RPX(Z%=^
M[/;% ''>+_\ @HI\0OBA\6=:\ _LU?#&W^(,FC,T5WX@U28K9%@2NX8>-5CW
M*P5GE&_!VCU@L?\ @H!\7O@#XTT71/VGOA9:^%=#U5S!!XH\..9;=7!^\P$L
MJL,8+*'#@<[#TKYQ_8'^/WQ:^!_P4FM/ /[.FJ>/].U34IKR;Q):-*HN' 6/
MR\I"W";",;N"6Z9-=S^U-\9OV@?VI/@YJ?@+5?V4_$.DBXG@NK;4XUN)GM)8
MY V]5, R2F]#R.)&H _3SQ7XXT/P3X+U/Q;J^HPVWA_3K)]0N+X-N00JF\LN
M/O9'0#KD 9S7P;X8_;H_:0_:6?4]0^ OP4TMO"-O.]M%K?BF[ WD#K_KH5+]
M,JADVEADGJ?;/V=M#M8?V!?#6D?'32&TG3--T:6VUVP\3*T7E6UM<2+&90QR
M!Y<43*/0KCL*\%\)_P#!2?P#X'TF'P)^SU\#/%GC70]*=H[6WTR&2&$EW9R5
M 2:7YG8GYU!YZ=J +?@K_@HC\7/A7\:?#_P[_:2^&FG>$O[<EBM[;6M)<I%'
MO8(LK$RRQRH&(WE'79DG'&*[[_@KS_R9MJ/_ &&K#_T-J^%O^"@_QE^+_P 8
M)/ACJ/Q(^%'_  J_2H+N[_L5;B9FO)V)M_/#ABK*!B(C,:YSP3CC[I_X*\_\
MF;:C_P!AJP_]#:@#L/ASX@^(_AC]@?X4W_PI\+V/C#QBOAG1E@TK4;E((7C,
M$8D8N\L8!"Y(^;\Z_/[_ ()H^-?CKX=\5?$&/X9?#[2/%=A?:K8#Q+-?WT4#
M:</,N,&,-/'OX:8\!_N#UY_4;]CO_DU#X/?]BEI?_I+'7Q7_ ,$8?^0K\??^
MPGI__H5[0!Q/[9GQ7TOX'?\ !4KPCXYUJVN[S3M&T6":2VL4#S2LT%TB(@)
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MOV@--A^*'_!8;X:>&_$4*7&C:;96SV]O<?ZM_*M[B]7([YF&.>N #D<5^HE
M'SE^QS^VIX<_:VT'4HX-.G\,^,M$V+J^@7;;FB))'F1-@%X]RE3D!E/##E2W
M*^*?VQO$V@_M_>&O@+#HNDR>'-4M!<2ZDXE^UHWV2:?"X?9C=$!RO0FOG*UM
MK?X8_P#!:M+708UM;/Q-:R/J%K:_*"\VFM-(6'JTT2S'W.>M7OB.ZQ_\%J_
M)9@H_LU1DG')TVZ 'YT ?IM7R1_P3_\ VQO$W[7%GX^F\1Z+I.C-X>N[:WMQ
MI8EQ(L@E)+[W;D>6.F.IKZWK\R_^"*'_ ""OC1_V$['_ -!N: .I^)W_  5
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M\5V%]JM@/$LU_?10-IP\RXP8PT\>_AICP'^X/7G]1OV._P#DU#X/?]BEI?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-5G7;-?1VR+/(#C(9P-Q' ZGL* ,SXG>!+/XH?#GQ1X.U"5X++7],N=,FFC
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MW[1O[&OQ"T/0OVE=&L_$GA'59#''XBTV&)9=BD!Y(F@"H^P,"8W17(P<C.2
M?I]15>PO[?5+&VO;.>.YM+F-9H9HFW)(C %6![@@@YJQ0 45\)?\%%OVJOB/
M^SS\2_A%H_@C5[?3;#Q%+,NHQS644YD"S0(,%U)7B1NGK7W;0 4444 %%%%
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M?"7QY_:J^(_@7_@H=\-?A1H^KV]OX)UJ*P:]LFLHG=S++,KXE*[UR$7H>,4
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MQZ#/2@#],:*^5?V#_P!MZW_:X\,ZO9:OI<?A[QYX?*#4]/A+>3,C$A9H@QW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFU2"3X4>&KEK#1K6*SB4R2-,RQ2><!O;]U [$9(_?+[5]IU\B_\ !+3X1_\
M"K?V0_#EW<0^5J7BJ637[C(YV2X6#GT,,<3?5S7UU0 5\Z_\%#O^3+?BK_V#
M%_\ 1\5>QM\4/!R>.D\%'Q5HW_"8.AE&@"_B-]L";]Q@W;P-GS9(QCFO'/\
M@H=_R9;\5?\ L&+_ .CXJ .)_P""3_\ R9+X0_Z_=1_]*Y:\E\;?MN_&3]I7
MXX:M\+_V8=/TVSL-%D=;_P 9ZJBRQD*2AE&]61(B^0OR2.^ P &17;?\$[Y]
M0T__ ()M17.FATU*.TUR6S9<@^:)KC81_P " _*N+_X(E:7I\/P)\>:E&D?]
MJW'B3[/.P4;S#':PM$">I&Z6; [9/K0!G_$+XJ_MF_L765MXS^(NI^&OB]X
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MS?8IY<B4KO'SQJ>#VQ7EW["^CV&@?\%*_P!I*QTQ8X[*-+YDCA7:D9:_B9D
M'0!B1CVJO\2I%@_X+5> &D^56TU0#CJ3IUT!^M 'Z;U\0_\ !,G]J#XA?M*6
M'Q+E\>ZK!JCZ)?6L%D8+.*W\M'$Q8'RU&[[B]?2OMZOS+_X(H?\ (*^-'_83
ML?\ T&YH ZOX@?M0?'K]HS]I'Q=\)?V>+G1/".G>#9&@U;Q-K44<S--'(8Y
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MZ^-6@_L]_"C7_'?B)B;#2X=R6R,!)=3,=L4*9_B=B![#)/ -?#'PW\>?MO\
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M#XK:XJ%I)D$J6"R ^6H0D*9"H+DN=B( S AN/(_V)%6/_@J1^T@%4*/)U0X
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M'\0]+^(>C6VCVVIW5G=Z<MM?17(9@LRS [&;;@>3UZY]C7#_ /!9+1?!6G^
M_!7BM[^32_BK9ZBL6@O8\7%Q K!Y0Y!!"1L4=7Y*NP 'SD@ ZK]KC]L;X@7'
M[07A?X#?L_S6DOC>:<-K6IS6Z7$-H"A;RB'5E 1,RR-@D *HYW"ON#PW8W^E
M^'].M-5U-M:U.&W2.ZU%X4A-S*% :38@"KDY.T=.E?G-_P $<;/P?JEC\1?$
M%_=7%]\9IM09=:?5!_I,=JS;@R%CN(>7>9"<'>J@CA2?TKH *^*/VQOVT?&W
M@?XQ>&_@?\%="L]>^)FLHDL]Q?KOBLE<%E4+N4;MBM(S,=J)@X)/R_:]?%O[
M5W[;7@_X%_&'3O"7A'X<)\3/C3,B*D-C;J)K3S4&V-I5C>4NT9!\M!]PC) (
MH X'Q?\ #O\ X*#>&]%F\36GQ3\*:_>VT)ED\.:78V^^100?+B$EDJNQ&>KJ
M>RD\5[5_P3Y_; O/VN/A7J=]KUC:Z=XNT&[6SU&.Q5E@F5TW13JK$[=V'4KD
MX,9/ ( \EM?B?^WO\5&\K2?AMX.^&>GS$JFH:M(&FASSEE::1C@8_P"6'KQZ
M>??\$1VE:/XW&=E><W>EF1E  +?Z9D@ # S[4 6_B#^WY\9/!_[8GQ)^%?AO
M2X/&MS)(NE>$M#:VBB2&\80OYLTHVNR+'YQ(+ <@D@ D1_%74_V_O@5X6O/B
M5K/C#PUXBT33X_M>HZ'IEG;S"U@4DMO3[-&Q10<LT<A8*,EL*2(?@3IL-]_P
M62^*4\JY>RL[NXB/HQAMH\_]\R-^=??_ .T.JR?L_P#Q,5E#*WAC4P589!'V
M27B@#F?V1/VC;3]J;X':/XZAL5TN^DDDL]1T]'+K;W49PP5B!E64HX] X!Y!
MKY(\<_MC?&_]J+X\:U\,OV8CIFBZ+X?=DU#QEJ,4<L;E6*%\R1R*D3,"J!8W
M=]NX8&0'?\$LKZ[TS]@/XDWE@S)?6^JZO+;M&<,)%T^W*D'UR!2_\$2;&SC^
M"'Q OD"?VE-XB6&9MHWF)+:,QY/<;I)<?4^M 'E7[9GC#]IWX,_ 'Q-X&^-D
MNC_$/PIXL6WM-/\ %VC(L36%S%/'.(I0L,>=Z0M]Y,D\AS@K7VW_ ,$WO^3)
M?A;_ ->5Q_Z5SU%_P4GT>PUC]BGXEB_6,BVM;>Z@DD7)29+F(H5/8D_+GT8C
MO4O_  3>_P"3)?A;_P!>5Q_Z5ST ?2M?B[^V)X<^/%K^W1\+[7Q#XI\,W?C&
M\O[=O!U[:Q$6UC"VH.+5;D?9UR5?EOEDX[MTK]HJ_,O]O#_E)9^S)_UVTO\
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MS%H.M^*/&US%J7Q+\38^VR1R^<+.#=O\D2?QNS_/(W0E5 SMW-]BT4 ?"/\
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MY)' V@1S2W#')Z#-?MK10!0T'1+/PSH>G:1IT(M]/T^VCM+:%>D<4:A44?0
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MWX1_M-Z3^T_\(=)E\2SVZQ-K>CP(TLH*0BW8^4OS/#)  K;<LI!;OE?TDHH
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M /\ P5,UOX1^#;7P=\8?A/XN'Q'TJ(6*FTME2/46C&/,?S"&5B!DE!(I.6&
M<#]*J* /SS_89^"?Q"^+'[0_B;]I[XNZ'+X<U*^C:W\.Z+<QO%)#&T8B\T(V
M&5%@'EJ6Y?S';'0GOO\ @I!^RUXJ^-7A_P (^/?ALF_XB^!;LWEG;QE5DNH=
MR280MP9(Y(D=%)P<N.20#]G44 ?G!;_\%=KNQ\(KHVK?!GQ3'\6EA,9TA;8I
M9O.!MWX8^>J[ROR;"1G&[/-=Y_P3A_9J\9>#=0\;_&GXJVLEE\1/'4SO]AN$
M,<UG;/+YLGF(?N-)($/EGE%B0<$D#[CHH *\;_;)L;G4OV4_BQ:6=O+=74WA
MN]2*"!"[NQB; 51R3["O9** /A#_ ()H^'M5T/\ 8/\ $%AJ.F7FGWS7FK%;
M:ZMWBE(,*@$*P!Y[5E_\$9_#>K^&?@5XW@UC2[W2IY/$A=([ZW>%F7[+",@,
M!D9!Y]J_0.B@#XD_X*\Z#J?B+]E.TM-)TZ[U2Z'B2S<P6<#3/M$4^3M4$XY'
M/O7I:_ NW^/7[!?ACX;ZQNTZ;4O!>E0I+-&0UI=1VT+Q.RGGY9$7<.#@,.,U
M](44 ?E7\ _VSO%_[ OAD_"'X[_#OQ%+8Z)))'HNM:/$LHFA9V8(K2,B2Q[F
M^5U?(!VE<KBO(?VR?'WQ9_:R\6> O'\GPXUSPW\.;6_^P>'[&XMY)+B<ET>>
MZ=0O 8+&N[[OR *6(8U^V5% '@7[;W[-(_:H^ .J^$;:5+?7[65=4T6:5ML8
MO(U=55SV5T>1">V\-@[<5\B_!;_@H9XE_95\$V/PV_: ^&/C"#5O#:)IMKJ^
MF6L<HNH4&V(,9)$1R%VJ)(W8.,'KR?TWHH _,GP]XO\ CI_P4 _:*\+>(="M
M/%GP?^"WAY\S7,=]/82ZC'O5I4W1E/-DD"A,+E8UR<DD[O3?^"EWQP\:QZ%I
MWP5^%^BZMJ7BKQALM]0O["V=H[6UE;8(/- VJ\IR&)/RQY)QO!'W310!\@Z%
M_P $Z?!UE^QG-\%;OR'U>[3^T;CQ L>776-ORW"]#L0_NPO!,60>6)KS[_@F
MC\7/'7A";5OV?/BCHNJ6.K^%WEBT34[BVD,$L$9.^V$Q&U@GWXVS@QD@8"+G
M[_HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** &2PQSJ%DC610P8!@" P.0?J" ?PI]%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]U&8,?P%= CK(JLK!E89#*<@CUH =1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#'G9^\C95_AP^.#@?5'_  3)4+^PW\, H 'DWQX]]0N:_.'_ ()A'[+_ ,%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\P_:7_ .2)>(_^W;_TIBKT^O,/VE_^
M2)>(_P#MV_\ 2F*@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#]I?\ Y(EXC_[=
MO_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /3Z*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M,/VE_P#DB7B/_MV_]*8J]/KS#]I?_DB7B/\ [=O_ $IBH ]/HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *\P_:7_ .2)>(_^W;_TIBKT^O,/VE_^2)>(_P#MV_\ 2F*@
M#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KS#]I?\ Y(EXC_[=O_2F*O3Z\P_:7_Y(
MEXC_ .W;_P!*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,/VE_P#DB7B/_MV_
M]*8J]/KS#]I?_DB7B/\ [=O_ $IBH ]/HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P
M_:7_ .2)>(_^W;_TIBKT^O,/VE_^2)>(_P#MV_\ 2F*@#T^BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KS#]I?\ Y(EXC_[=O_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /
M3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **@OIVM;*XF4 M'&S@-TR 3
M7YX?LPR?M7_M1?!_3?B)9_M%6/AJWU*XN8UTQO!FGS^3Y4S1\/Y8R/E[\^YZ
MT ?HM17Q_P#\*!_:Y_Z.HT__ ,(33_\ XBC_ (4#^US_ -'4:?\ ^$)I_P#\
M10!]@45\3?!'QQ\;_ O[:Y^$/Q*^)UM\1M)N?!K^((Y8M!M=.\F3[2(E \E
MQ("/U)!W],C-?;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_P D
M2\1_]NW_ *4Q5Z?7F'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8&
MM^/_  OX9W_VQXDTC2MF[=]NOHH=NT9;.YAC'>@#?HKR/7?VN_@AX;63[?\
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MLS6VCZ09#&L[J 9)'< [8XPRDX&2651C.X?GX?\ @HA^V)>>$9?B/;^ [-?
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MG@R2VQBK J<E#P2<AB ?4%%%% !7F'[2_P#R1+Q'_P!NW_I3%7I]>8?M+_\
M)$O$?_;M_P"E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M +4TVC3>/+/4+F;1TDCLGLK^2 1+(5+_ "CY23L3DC/RBN9_:N^)O@3]D_\
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MQXR_;4U7Q%'$YM[+2=0U"61APIED2-03TR?-/'^R?2@#]M**** "O,/VE_\
MDB7B/_MV_P#2F*NG\;?#C1/B!]B_MF*XD^R;_*\BY>'&_;NSM(S]T=:\=^.7
MP5\+>$?A;K>K:=!=I>V_D>6TM[+(OS3QJ<JS$'AC0!]%4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&$ '8?E6M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !117Y\S> O&'[2?[;WQW\,3?&?XB>!M"\)Q:0=/L/">N26D \ZT5G!C'
MR_>!;(&26.2: /T&HKX__P"'?FN?]'/?'#_PJI/\*/\ AWYKG_1SWQP_\*J3
M_"@#[ HK\O?VJ?#FI_L3ZM\,?$4?[2?Q*\03S>*K)=3T/7O$SW0.F*6>>4VR
MG=(GR!3E2IWXQDBL3X[?\%HKZ^FFTGX.^$/(WL8DUOQ$OF2N3P#%:QM@'/(+
MNV<C*#I0!^J&L:UI_AW3+C4M6O[73-.MUWS7=Y,L,42^K.Q  ]R:^.OC9_P5
MC^"/PL^T6>@7MU\1=9CRHAT)=MH&']ZY?"E?]J,25\*Z3^RC^UQ^W)J5OK7C
MR]U/3]&=_,CN_&$[6=O&#U,%DBY7(Z%8E4\?-7V/\$?^"//PE\ +;WOCB]U#
MXBZJN"T,Q-E8!O:*-M[?\"D(./N]10!\G>*_^"F7[2O[1VM3:%\*O#TF@1R<
M+9^%]-?4;X(?^>DS*VW_ 'U2/&*7PG_P2]_:/_:!U>/7OBEXC70#-R]UXEU)
M]3U#8>?EC1F _P!UI$QZ5^Q/@_P/X=^'NBQ:/X7T+3?#NE1?<L]+M4MX@?7:
M@ S[]:W* /A7X0_\$??@OX#\BY\5S:M\0M13!9;Z8VEGN'<0PD-^#2,#Z5]B
M>!?ACX1^&.F+IWA'PQI/AJR50ODZ591VX;W;:!N/N<DUTU% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>8?M+_\ )$O$?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2__ "1+Q'_V[?\ I3%7
MI]>8?M+_ /)$O$?_ &[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M+_\D2\1_P#;
MM_Z4Q5Z?7F'[2_\ R1+Q'_V[?^E,5 'I]%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%=74
M-C;2W%Q+';V\*&22:5@J(H&2Q)X  YR:XGXS?&[P7\ ?!-SXI\<:W#HVEP_+
M&&^::YDQD10QCYI'/H.G). "1^/WQY_:\^,/_!1#Q\GPV^&6B:AIWA.X?]UH
M-FX$MU&"/W]_,#M5!D':2(U)&2[ -0!]$?ME_P#!6RP\-M?>#O@A)#K&K?-#
M<>+I$#VL!Z$6J'B9L_\ +1ODXX#YR/*/V6?^"8_CC]HC6S\2/COJ6K:3I>HR
M"[-G=RL=8U4G^*5GR8$(QRWSD= HPU?6G[&/_!,SP=^SI'8^*/%XMO&7Q$0+
M(MQ(FZRTU_2W1A\S@_\ +5QG@%0G.?M>@#F_A[\-_#'PG\*V?AKP?H=GX?T.
MT&(K.RCVKGNS'JS''+,2QZDFNDHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KS#]I?_ )(EXC_[=O\ TIBKT^O,/VE_^2)>(_\ MV_]
M*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "OF/]L3]O+P/^R;H\EE,Z>(O'EQ%OLO#EM* R
M9'RRW##/E1^F?F;^$8R1X/\ MV?\%2--^%O]H^ _A)<V^L^,5W07OB!=LMII
MC="L759IA^*(>NX@J/#/V-_^":/B?X^:Q'\4/CI/J5OH>H2_;DTR\E<:EK)8
M[O,G<G=%$W_?;CIM&UB ><?#GX.?''_@J-\5)/%OBK4Y+#PI;2F*;6IHF6QL
M8\Y-M8PYP[XZ@'T,CY(S^OO[/O[-O@/]F7P6GAWP1I"VB.%:\U&?#WE](!]^
M:3&6/)PHPJY.T"N_\-^&]*\'Z#8Z)H>G6ND:18Q+!:V-G$(H88QT55' %:5
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MA^TO_P D2\1_]NW_ *4Q5Z?7F'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_R1
M+Q'_ -NW_I3%7I]>8?M+_P#)$O$?_;M_Z4Q4 >GT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;4]=ND'VJ_D'=B/NH,G;&.%]R2Q]IHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P_:7_ .2)>(_^W;_T
MIBKT^O,/VE_^2)>(_P#MV_\ 2F*@#T^BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\P_:7_ .2)>(_^W;_TIBKT^O,/VE_^
M2)>(_P#MV_\ 2F*@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH X?XW?"NR^-OPG\4>![Z=;.'6[&6S%XT"S&V9E($JH2,LN<CD?6F_ WX5
M6WP0^$?A;P+:7G]HPZ'9):"\,(A,Y7JY0$X)^IKNJ* "BBB@ IDT,=Q"\4L:
MRQ."K(X!5@>H(/44^B@"CI&AZ;X?M?LNEZ?:Z;;9+>39PK$F3U.U0!FKU%%
M&=>^'=)U+4+:_N]+L[J^MO\ 474UNCRQ?[K$97\*T:** "BBB@ KS#]I?_DB
M7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8
M?M+_ /)$O$?_ &[?^E,5>GUYA^TO_P D2\1_]NW_ *4Q4 >GT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3C.]R21N_9OX0?![PG\"? >G^#_!FE1Z3HUFO"KS)-(<;I97ZO(V.6/L!@
M:G@+P#X>^%_A'3/"_A72K?1=!TV(0VUE:KA4'4DGJS$DDL22Q))))KH* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL/QAXZ\.?#W2'
MU7Q1K^F>'-,3AKS5;N.VBSZ;G(&?:OE;QA_P5A_9Z\*>)+32(->U3Q$LLXAG
MU'1].9[6UR<%W>0H74=<Q!_;- 'V+17SQ^VY\2/BEX#_ &>Y_$7P5TIM>\1/
M=0!Y+6T^VRV]DZL6N(H<'S"&\L?=8!79B,+D?F>O[-?[;G[5G[_Q9<^)+/2K
MCED\5:I_9MJN?^G($,OX0]J /VS@N(KJ(2PR)+&W1XV# X.#R/>OD#XP?\%5
M/@9\(_$.JZ#]KUGQ7J^FRM;3Q:#9*\2S*<,GFRO&IP1@E2PX.,]*Z/\ 8"_9
M+U[]D7X7ZKH/B+Q/#K^HZI??;GM[#?\ 8K,A FV(N S%L LQ5<X48XR:6L_\
M$P?V>_$?CG5O%&J>$KN\N=3NI+R>R&J7$-J)78LQ5(F4J-Q)V@X&<8QQ0!XS
M\.?^"R'AOXB?%OPOX0A^&NJV6GZYJ4.F+J;ZDDDL+2NL<;&!8_F&YAN ?( R
M-QXKVC_@H5^TYX__ &7_ (::%K/@'PS;ZW=:C?M:W5_>VTMQ;V*!"PW)&RG<
MYS@DX&QN"2*]5^'?[*?P?^$]_:W_ (3^''AW2-3M?]1J*6*27<7!&5F<-("0
M3DAN>]>._P#!0SXBZQ-X/\-_!/P7-CQU\4KW^QXRA)-KIPP;N=L<A=AVGU4R
MD<K0!^85A^UG^T3\0?C8WQ@T/0)=5\62:;_8]C<Z;X>DO+>RMU.76W0AU5B=
M^YCN/[QQP#BOMY?"7QJ_:X_8=N?$?C_0[CP]\8O".M/KOA"[-@;&\N!;K'(I
M\G VF0F5%X4,4B;'&3]W_"_X=:/\(_AWX>\&:!#Y.D:)91V4 (&Y@HP7;U9C
MEF/<L3744 ?B98_MT?ML_$QKKQ3X.L=>N?#!N'*IH/@N.]L(0IRT7G&VD8[1
MP<OD>U>I_LW_ +7G[9/BOXX>#=%\3>$]4U'PY?ZE#;ZFM]X4-E%#:LX$TQF$
M:;"B;F&3@D 8.<5] _##_C$7]N'Q!\.I?]%^'/Q;\S7_  [GY8;35D'^DVR]
MAO'./3[.HK[?H ^5/^"@W[67C#]DKX>^']=\(^%;/7I-2OFMKF]U-)7M+)0H
M*AQ&RG<Y)"DL!\AZU\9^'?\ @N!XNM6']N_"[1=27/(T[4YK0_\ CZ2U^N]<
M;XB^"_P^\8*PU[P)X:UL-P1J.CV]QG_OM#0!PO[(O[4&E_M;?"<^-=,T:ZT
MP7\NFW5A=2"7RYD1'.R0 ;U*RH<X'.1CBN,_X>7?LXQ^);_0Y_B+%;75G.UL
MTTFG79MY'5BK%)EB*%<C[V<'@@D5]#^%?!^@^!-%AT?PUHFF^'M(A+-'I^E6
MD=K A)R2L<8"C)Y.!7Q7\1O^".OP4\9ZI?:EHM_XC\'3W,C2K::?<Q2V<1/.
M%CDC+A<] ' &<#C& #ZU^'_QP^'OQ64?\(=XWT#Q-)MW&'2]1BGE0=]T:MN7
M\0.M=O7YS_ G_@D6_P $?CQX6\=P_%*34].T*\%ZEG'I)MIYB 0(VD$S *<X
M;CE21@9S7J'_  44\0?M)>&]&\*WOP'MKV;3X7F?66T6SBO+[?\ +Y*^2ZL6
MCQYF=BGG&>V0#[(HK\9?"_\ P5T^//PMU--*^(_A#3-<DB_UT.HV$NDWY[=5
M^1>__+*OU,_9T^.VF_M%?!?0/B+8:==:'9ZG'*7L[\C= \<C1R#>.&3<C8?C
M(P2 <@ 'IU%<CX%^+_@7XGM<CP?XRT'Q0ULS),NCZE#=&,@X.X(QP/?H<@CK
M774 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>8?M+_\D2\1_P#;M_Z4Q5Z?7F'[2_\ R1+Q'_V[?^E,5 'I]%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV8;O6O%>@3^$)=9%[H\C:>[QK/"4V?:;5GRRCYV4'+8>-N>,4 8WQV_X*4?
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M9U/XA:I;LLFW5I!%9;U((/V>/&Y<C[LCNIZ$$5]P44 -CC6*-410B*,*JC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2__)$O$?\ V[?^
ME,5>GUYA^TO_ ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M. <;B IC QR!]W:8OJJ@ HHHH **** "BBB@ HHHH **** "BBB@#%\8>"]
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M:1<GJ%MDXX(R,=.N:CD_X*>?M5:/;.-4\+Z?-#-\F=0\,3HO0Y4890<CL<T
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M^S=!MTW&*WBCR1Y@#'<P/7C+'+-]#444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7F'[2_P#R1+Q'_P!NW_I3%7I]>8?M+_\ )$O$?_;M_P"E,5 'I]%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH **** "BBB@ KR;X[?LK_##]I#3OL_COPK::G=I'Y<&JP@P7UN.H"3IAL
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M"P\,^))([D>$ R_V=870SYLT"XRF\;1M!  &.0$">ST %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7F'[2__)$O$?\ V[?^E,5>GUYA^TO_ ,D2\1_]NW_I
M3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7F'[2__)$O$?\ V[?^E,5>GUYA^TO_ ,D2\1_]NW_I3%0!
MZ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB)P[;G4,R[FP/G;I7[ ?L@?L/_#7]FGPWINK:1IW]M>,+JU1[CQ)J2*]P"Z
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M>_X)?^-?&GQ.U[XK?"C7%U#5=2N?[0N-!O)_L]U'/@9:UN"=IR0"%<IM[,>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KS#]I?_DB7B/\ [=O_ $IBKT^O,/VE_P#DB7B/
M_MV_]*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGWUGX;9O+FTKPV&M;*-#VN[MF&[(_A=PIQE4S7TM^SG_ ,$9_#OA_P"S:O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45G>(O$6F>$M"O]:UJ
M_M]+TFPA:XNKVZ<)%#&HRSLQX  [TWPWXETKQCH-CK>AZA;ZMI%]$)[6]M)!
M)%-&>C*PX(/K0!IT444 %%%% !1110 4444 %%%% !7F'[2__)$O$?\ V[?^
ME,5>GUYA^TO_ ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/%NM:#=2:5$\UMH]ZUO]HNKFX=(T;! )Q&F,]/,K])?A-_R2OP;_ -@6R_\
M1"5^.W[7_@GXR_$7_@HAJVL^"O NO7.JV>JV8\/S7&F.MJQLXHMLHDF B,7F
M(7W,=A#<\&@#H/\ A1__  48_P"@EXP_\+6Q_P#DNOO+XG?'CQ#^R3^P[HGB
MSQK"VH_$2ST6PTZ2UU"X$YN-7>)5;S9$8B0*PDD8JWS!&P>0:^%O&?[5G[9_
M[&?BW0[WXM-'KFAZDY9;.^ALI+6Z"_?C6XMEW12 '(&?0[6'%=[_ ,%4OC5I
M?QI_8_\ @WXH\/22?V)XDU?^T5B?K')';RQM&_\ M1N\B''&5- 'C'@/1?VR
M_P!J+P+K_P 9]#^)&M6^FZ?+</!90:[/8&Z,8W2):6T0$1 ^[AMH8@KR0:^P
M/^"7O[;FO_M':3K7@?QW<QWWB_0+9+NVU-4"27]GN",90.#)&Q0%@!N#KGD$
MGU#_ ()AVD5K^PW\-!&@7S$OY'_VF.H7.2?\]J_.?_@EI(WAO]O2ZTNU^2WD
ML]5LF5>!Y:'>!CTS$OY4 ?M[1110 5YA^TO_ ,D2\1_]NW_I3%7H&J:]IFA^
M5_:.HVFG^;GR_M4ZQ[\8SC<1G&1^8KRG]HGQ=H6J?!SQ!;6>M:?=W,GV?9#!
M=1N[8N(B< ')X!/X4 >RT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\\@L'8?WJ^N** &QQK%&J(H1%&%51@ >@IU%% !1110 4444 %%%% !1110
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MP[XBT[2O$%_XCNM<NHY[BYO(UB55C#"-$C4G! =LMGYLCI@"OHFBB@#\_/\
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M/BW\#]-_=>#-6T^+QSX?LL_)8AY$AN84'9=[ *.RPKW)S]J4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4==N+VST/4)]-M
MDO=1BMY'MK:1]BRRA240MV!; SVS5ZB@#\H=4_X*?V_[0GPB^-G@3QKX?L/
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M<9(%?.7[5/\ P3U^&?[5FK)K^K_;O#OBU8E@.M:0ZAIT4$(LT;@J^ <!N&P
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M9E-?8-% &)X2\$>'? .E+IGAG0=,\.Z:OW;32K..VB'_  % !6W110 4444
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MG&>3R37?>+/&GP6_9(\(?#[7/@O\3(+OXW>&K5+?6DTF":[TKQ$DC[[B*YD
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M!>@> =$AT?PUHFG^'])A_P!78Z9:I;PK[A$ &?>MFB@ HHHH **** "BBB@
MHHHH **** "BBO,_C!^TK\,/@+9M-X[\::7H,NW>MC)+YEY(/5+= TC#W"XY
MH ],I&8(I9B%4#))Z"OR\^-G_!:[3;/[18_"GP5)J$HRJ:QXF;RHL^JVT;;F
M'<%I$/JM?/R^'OVR_P!OQA)>-KG_  B=UR&O&_L?1?+/0A %$X&>H61O<\T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N8\6_"_P;X^!'B?PEH7B,$;<:MIL-UQ@C
M'[Q3V)_.NGHH ^=_$O\ P3U_9T\6%C>_"G18-W7^S6FL/3IY$B8Z?S]37P=^
MRO\ \$[OA/\ &*7XE>!/&U[XBT;XC^!M?FL+DZ7>QQ"XLF.;:X6.6)P5;:_3
MMM/\0K]>:^7OVD_V6O$NO?$+3OC+\&=;M?"GQ<TR#[-<)>*?L&OVHQ_HUT!W
MPH ;'902NU'0 ^:=>_X(>^&;BX4Z+\5M6T^#<"R7^D173%>X#++%@^^/PK]&
M/ '@^U^'O@3PWX5LIY[FRT/3;;3()[EMTLD<,2QJSGNQ"@D^IKY2L?V\_'?@
M>--.^*?[-OQ%TW6HQLDN/"-@NK6$[#^*.3<J@'KMWL0,<FLS7?C)^T=^U3:-
MX<^&OPXU/X(^&KY?+OO&WC53#?Q0G[WV6U&&#D9PXW#GAHSA@ 7_ (/WL?QD
M_P""D'Q1\<:41<^'/ _AF#P8+Y.8YKYIQ-*JMT)C*S(P[''8BOM"O-?V>O@'
MX:_9M^&&G>"O#$;M;0%I[J^GQY]]<L!YD\I'5FP![*J@< 5Z50 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>8?M+_\D2\1_P#;M_Z4Q5Z?7F'[2_\ R1+Q
M'_V[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNJG_ '0* /S3OO\ @H!^US^TQ=2:?\/-(N-.MG;RVC\%Z&\I4=M]Q()6C/\
MM!D_#I5K0/\ @EY^TK\=]3CUKXH>)(=%9AN>Y\3:N^IWH4\_*B,X'^ZTBXK]
MG[.SM]/M8K:U@CMK:)=L<,*!$0>@ X KR/\ :@^#OBSX[>!;/P?X>\:-X*T>
M_O53Q%/;0%KNZT[:?,@ADSB-F. <@@@D$XRK@'Y1_#'_ ()X^'OC7\9&\(^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>8?M+_\ )$O$?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %%%%
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M)ED55SSGKW]Z]Q\%_P#!)7]HKQ.%:\T;1_"<<BCYM8U>,_*?5;?S6'T(S[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_P D
M2\1_]NW_ *4Q5Z?7F'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_037R5_P2?\ ^3)?"'_7[J/_ *5RU'<:E^W1=6\L+:%\$0LBE"5DU/.",?\
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ML3Q'X?L/%OA[5-#U6W%WI>IVLME=VY8J)(9$*.N001E6(R#GFOCCP#_P2'^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXUIJGA#Q?I?_  AOQ?\ #/[G7_#%Q\I)&!]IM\D[X7R"""=NX<D%&:2X^/\
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M (*^&GA?7=-\,0-$FG7>@^'#?/>Q-&I,IN&BD ^8MG;MV;<'D$GXT^-?P/\
MVDGOM%\:?&236-(@URZA\/1^(O%&J@QVZR,SK%,$=W@@!+N04"_>(&<U_077
M,?$KX;^'?B]X'U?PAXKTV/5=!U2$PW-M)QWRK*>JNK ,K#D$ CI0!^6W@/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,
M/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HKSOXA?M%?"_X4^:OB[Q_X=T&>/[UK=ZC$+CCJ!""7)^BU\Q_
M$3_@L!\!_!_FQ:%)KWC:Y7(4Z7IY@AW?[3W!C./=5:@#[@HK\@OB!_P6T\:Z
MLSV_@;X=Z/H@8[$FUBYEOY3GC(6/R@#['</K7"_\+&_;Q_:>XTJ/QK:Z;<<1
MMI=HN@VFT]A<8BW#UW2'KR<4 ?LUXL\>>&? -B;WQ/XBTGPY98S]HU:^BM8_
M^^I& KYM^(?_  5"_9W^'_FQKXRD\47D><VWAVRDN<_24A8C_P!]U\+>$_\
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M+\,M%GNH^5N]7C;49@W]X-<%]I_W<5[M:VL-C;QV]M#';P1C:D42A54>@ X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7F'[2_P#R1+Q'_P!NW_I3%7I]>8?M+_\ )$O$?_;M_P"E
M,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RWQ.^)_
MACX-^!]2\7^,M531/#NG!#<WLD4DNS>ZHH"1JS,2S*,*">:ZFODK_@JI_P F
M.>/O^NVF_P#I?;T 6_\ AZ-^S%_T4S_R@:I_\C4?\/1OV8O^BF?^4#5/_D:O
MH#PIX4T1O"^CDZ/IY)LX22;5/[@]JU/^$3T/_H#:?_X"Q_X4 ?-?_#T;]F+_
M **9_P"4#5/_ )&KVGX*_'[P#^T1X:NM?^'OB!/$.E6MTUE/,MM-;M',%5RI
M29$;[KJ<XP<\'@UTMYH'AO3;66YN]-TJUMHANDFF@B1$'J21@"OSU_8[_:J^
M$/P%N_V@!XR\;:9H:7GQ(U6[LH(E>X>:W+ +)''"KLR'& 0,<<4 ?I-17P#X
M\_X+.?!SP_YL7AK0O$WBRX7[D@MX[.V?_@<C^8/^_=?.OCC_ (+7?$;7)#;^
M"_ &@Z!YK;$;49IM1FYX&W;Y2[OJI^E '[$5FZ_XFTCPII[7VMZK8Z/9+]ZY
MU"X2",?5G(%?BW_PM3]O3]HQC_9,?C>SL9N(WTG3ET2W /9;C;%GZF0GGK6A
MX>_X)*_M#?%*^74_'OB/2M%F?_6R:UJLFI7G/_7,.I_&04 ?HAX^_P""CO[.
M_P /3)'=?$C3]8N5SB'0(Y-0W_22)6C_ #<"OFKX@?\ !;CP9I_F1^"_AWK6
MN..%GUJ[BL$S_>VQ^<2/8[3]*L?#_P#X(E^ M+$<GC+Q_KWB&5>6BTFWBT^(
M_P"R=WG,1[@J?I7TM\/_ /@GA^SU\.%C:Q^&FEZI<+R;C7B^I,Q]=L[,@_X"
MH% 'YQZU_P %6?VDOB]J$FF?#_P_I^E3MQ'#X=T634KL ],^9YBD_2,507]G
MS]N?]I(EO$,_BZVTV?\ UB>(M8&FVRY];3>I_**OVIT30-,\,Z>EAH^FVFE6
M,?W+6Q@6&)?HJ@ 5?H _(OX>_P#!$7Q1>^7+XW^)&DZ0O!:VT*RDO6/MYDAB
M"GWVM7TY\//^"1'P"\&^5+K%GK?C6Y7DG6-1:*+=ZA+<1\>S%O?-?;%% '"?
M#[X#_#GX4QH/!_@;P_X<=1CS]/TZ*.9O]Z0+O8^Y)KNZ** "BBB@ HHHH **
M\]^)'[0GPS^$,<A\9>.]!\/2H,FUO+Z,7!_W803(WX*:^4/B9_P6.^"OA'S8
M/"]EKWCFZ7.R2UM?L=JV/5YB''X1F@#[QHK\:O&G_!87XT?$?4/[*^'/@O2O
M#LDYQ#'!!+JU_P#120J'_OU7/?\ "@_VX_VK^?$\_BBSTBX_UB^)-0&DV:Y[
MFS!4_P#?,)H _5?XG?M>?!GX.^:GBSXC:#I]U%G?8P7(NKM<>L$.^0?BM?)?
MQ-_X+4?#3P_YL'@GPCKGB^Y7A;B]9-.M6]""?,D/T,:UYU\,O^"(<K>5/\0_
MB2B?\]+#PS9EOKBXFQ_Z*KZT^&?_  3/_9Z^&?E2IX&B\3WL>,W7B:9K[?CU
MA;$/_D.@#\^];_X*>?M._'K4I=)^&OA^/26;Y5M_"NBR:C>!3_>>02 'K\RH
MN/UJK9_L#_M>_M,W4=[\0=4N["U=MZR^--=>0(.^RWC,C(?12B#Z=:_:/1-!
MTSPSIL6GZ/IUII5A%Q':V,"PQ)]%4 #\JOT ?FC\,_\ @B7X1TWRI_'OQ U7
M791AFL]#MDLH@?[ID?S&8>X"'Z5]9_#/]A'X#_"7RGT/X;:/<7D>"+W6(SJ,
MX;^\&G+[#_N8KWNB@!D,*6\211(L<2*%5$& H'  '84^BO$_C=^V=\'?V?5F
MA\7^-;&+5HQ_R!=//VN^)]#%'DIG!Y?:..M 'ME5-6U>QT'3;C4-3O;?3K"W
M7?-=7<JQ11KZLS$ #W)KY*_9;_X*4>#?VIOB]?\ @71_"^M:)(MK)>6%[?-&
MXN4CQO$B(3Y38((^9@>1D' /CW[=7["?QU_:C^/RWND^+=-_X5R;>W6RM-2O
M9(HM,98P)OW"(?,=G#N'QD[U4D!1@ ]P\;?\%1/V>O!/BFVT/_A+I=>DDF6&
M>^T2T:YL[;) WM-PKJ,Y)BW\ _2M[]N[4/C0/@2LGP(CDN=>N+R);R;3]KWB
MV3*V6MMW&XMY8)&6"DD8ZCP?X5?\$J?@E\ [6U\4?%CQ3'XIFLW65VUJ>/3=
M'1A\PW1ELN 1R'D*L!RF,BO3_BA_P5,_9]^&"R6UGXCN/&5]"-HM?#%H9D]L
M3.4A(_W7/TH ^(/A]_P2A^.OQQU@>(OBSXI3PRUUAII]7NVU;57'494/M[_Q
M2@C/W:_3_P#9?_9H\+_LI_#%/!GA>:\O(9+I[^\OKYP9KJX=45G( "J L:*%
M X"C.223\T?LP_\ !4^S_:3_ &@-/^'<'P[N]$L=4BG-EJ7]HBXD5XHFE)FC
M$:A%*HPR&;#;1SNR/O.@#D?B?\6O!WP7\,-XA\;^(;+PWHZR"$7-Z^-\A!(1
M% +.Q )VJ"< GM7QC\3/^"S'P>\*^;!X1T;7O'%RN=DRPBPM'_X'+^\'_?JO
MHK]K3]DOPS^UYX'TWP[XBU'4-'?3;T7UI?:<5+JVPHRLK JRL&^H(&#U!\U^
M&7_!*W]GSX<^5+=>&KOQE?1\BY\27C3#/?,,82(C_>0T ?$?BO\ X*_?'#XE
M:@=*^'G@[2="FFSY,5G:2ZK??AGY#_WZK$'P9_;L_:BYU^X\6V.E7'^L77-0
M&C6F#W:T4H3^$1Q7[+^$_ _AOP'IXL/#/A_2_#MB, 6NDV4=K%QT^6-0*W*
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M;<(R1U4*W4_/WK]%?@AXZL?B=\(/!_BO3=&D\/6&L:9!>0:7(BJ;5'0$( H
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M@?A?\ _AS\%;=HO _@O1O#3,GER7%C:*MQ*O!P\Q!D<<#[S'I7?444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M+_\ )$O$
M?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%-DD2&-I)&5$4%F9C@ #J2:\^\5?
MM$_"SP.77Q!\2/"FCR+P8;S6K>.3.<8"%]Q/!Z#L: /0Z*^6/%7_  4Z_9O\
M*JRGXA+JTZ\B'2M.NKC/&>'$>SV^]W^M>-^*_P#@M5\)-,WIH'A'Q9KDJYP]
MQ%;VD3=,8;S7;UZH/QH _0NBOR0\5?\ !<'Q%<,Z^&OA9I>G@'"R:KJLEWGG
MJ5CCBQQVR?J:X+_AY3^UQ\6V"^#-"2%I#A!X5\*R7I]./-$^>3[]* /VLJMJ
M&I6FDVKW5]=0V=M&,O-<2"-%^K$X%?BW_P (G_P4'^,W^ME\?V,4WWUEU"/0
M4P1@Y3?#Q@<C'X<\V+#_ ())_M%_$B\CO?&7BC1+*3DO)K.LSWUP,\G&Q'!.
M>OSCI0!^HOB[]L+X(>!?,&L_%7PI!+'G?;V^J17,RX[&.(LP/X<UXIXN_P""
MMG[.WAG>+'7=8\4.F?ETC2)5R1V!N/*!^N<>]?/GA'_@AY;+LD\4?%>67IOM
MM(T<)CCG$LDISS_L=O?CVOPC_P $=_@'X>V-JA\3>*'&"RZCJ@B0G'.!;I&0
M/Q)]Z /+/%W_  7 \+VOF+X7^%VKZGU"2:OJ<5G]"5C2;\L_C7CGB#_@LQ\9
MO%-U]A\)^#/#.ER396-5MKB^N<XXV_O%4D<_P&OT@\(_L(?L_>"?+_LWX3^'
M)C'C:VJ6QU!A@=<W!D.??\:]D\/^$]$\)VOV;0]&T_1K; 'DZ?:I F!T&$ %
M 'XR_P#"[OV^OC9\NEV?C6TLIO\ 5OIOA]-,@ (_AN#$AZ=RYQFD7_@G/^U]
M\:L/XWUF2!9,$MXO\5/>=^,B)IR/ICBOVPHH _)KP;_P0]U68I)XK^*EG: '
MYK?1M)>?</:221,?]\&O=/!O_!&OX':!L?6M0\4^*)L?.EU?QV\)/LL,:L/Q
M<U]XT4 >!^#?V"_V?? IC;3/A1X?F>,Y5M5A;46!QUS<M)_^OFO:=!\,Z/X5
MLQ::+I-CH]H, 06%LD$?'3Y4 %:=% !1110 5YI^T=\&-!_: ^#7B+P/XFO;
M[3M&OTBEFN].(\^+R94F5E!5@>8QD8.03CFO2Z* /@7X+_LPZ+\=/ ]OXD\!
M?M:?&G5=#WM;?N_$TL3V[IP8GB90T; 8.T@<$$<$&K'BK]EW3/!/CSPCX,UK
M]K7XX67B7Q8UPNC6/_"07,GVHP*'E^=8RB;58'YV7.>,UU'QT^!?BW]GOXAW
M_P =_@18?:Y[C]YXS^'\.5@UV$$EKB!0/EN5RS?*,L22 2767S'XG_M'> OC
M)^TM^R+\1=$UVVM_#D9\0/?R:A*L#::Z6D1DCN<G$;)WR<$88$@@D ].U3]A
M&_T/3+O4=1_:I^--AI]I$T]Q=7/BUHXH8U!+.['A5 !))Z8KL_V!_ ?P]\)_
M"76=8^''C#7?'>E>)-=NM1NM<\0@BYN+D$12-DHA8$QEMQ!+%B2>P^4OBY^U
MKX"_;"^(%QX>\1_$6Q\ _L\:#=+]NC:Y9-4\73H=P00H#+':@@')49X/W\"+
MUN__ ."KG[-/POT&ST7PFNLZQI>GP+;V=GX?T4V\,<:C:J*+@PX 'M^9H ^Z
M:*_+/QI_P7!M4WQ>$?A7-*<G9=:UJHCP.V8HXVS_ -_./>O'[K_@J%^U-\8K
MIK7P'H-I9REMBQ^%O#DFH3 ]@?-\X$\C^$?2@#]K*Y;QI\5/!?PWMS-XL\7:
M'X9BQG=J^HPVN?IO89_"OQV7X/\ [>_Q\V_VI<^-[.QFSYBZIK*Z/  ?[UOY
MD9/T$9KIO!?_  15^)OB"47/C+Q[X?T#SCND^Q)/J4XSUW!A$I/T<_6@#[;\
M>?\ !4?]G7P/OC3QG+XDNDZV^@Z?-/GZ2,JQ'\'KYR\>?\%OM"MQ+'X*^&.H
M7Y.1'<Z]J$=MM]"8HEDS] X^M=UX$_X(N_"'03'+XF\2>)O%4Z_>B26*RMV^
MJHC/^4E?1?@/]A'X _#G8='^%F@2RIRLVK0'49 ?4-<F0@_3% 'YDZA_P4S_
M &J?CE=2V'P_T6.P=CL\GPCX>>^G /8F438..X ]L56_X9%_;8_:07/B^[\0
M0Z9<=5\6:_Y%NN>H^RAV91](J_:_3]-M-)LXK2QM8;*TB&V."WC$<:#T"@8
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M;SPKI_B:6UT/X8ZGK&A)*R#4KK54M9G0' =8/*?KUP7!K[6_9I_:>\%_M4>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8$O\._!/QWXP\5?\(UH/A;4=:U_[#'J?]GZ?%Y\QM9$C=)0J9^4I+&P/HX-
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MXMFD(XQABI8GCCC-?M'10!^+*_\ !'[]H?787BU#Q7X2CB4AA'?:S>2*QYY
M6V;I[XZUH6/_  1,^*TBQ?;/''@V!B?W@@>[E"C/;,"YX]<5^RU% 'Y%V/\
MP0^\4R*_VSXJ:/ ?X?(TJ67/KG,BX_6NGT__ ((:VJ-F^^,LTR[?NV_AH1D-
M]3=-D=>PK]3:* /S6TW_ ((A^!HC%]O^)7B"Y '[S[-900[OIG?C]:Z33_\
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M<'YH;./!661?4A@3GA5Q(?*/B-\-[SX:_%SP/X$\9_M@_%"/XA>+CBR.FO\
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MF+X3_P#!-OX _".2WNK3P5'XBU2$JRZAXDE-\^X<@^6V(00><K&#^E?3M%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!P:6Z_;R^'WQ:\(>+=+^!GBFS\7_ !/M](N;O1M#NK"ZM6NIDC+ 1K/'&)6
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M>MV<'B1=.:RLH8[M!<I--(EOO1<[MT?F[^G&WFOS9_:J_P""KFI?M$_"75?
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M:YHNL^+KK7=+U72[9K..[T*ZBB:6$L7".)8I%(5F<@@ _.<D\8\.7_@BK\$
MP)\4>/S['4;'_P"0Z^_Z* .!^&_P.\'_  K^$-G\,]$TTGPC;VDUFUI=2&5I
MTF+M,9&/WBYD<GH/FP !@#YP3_@D?^SJMX9SH>M/%N+?9FUF;RP#_#D'=@?[
MV>.IK[-HH \!^"O["?P4_9_\61^*/!O@_P"R>(H4DCAU*[OKBZDA5UVL$$CE
M5)4D;@N[#,,X.*](^(WP3\ ?%[[$?&W@W1?%366[[,^JV4<[0AL;@I89 .!D
M#K@5VU% 'F>C_LQ_!_P_M_LWX5>"[)E"CS(?#]HKG;]TEO+R2/4G-=UJVJ:9
MX-\.7FI7LL.F:-I5H]Q/*1MCMX(D+,V!T554].PK2JKJFF6>M:;=Z=J%K#?6
M%W"]O<6MQ&'CFC=2K(ZGAE()!!X(- 'X\?"/5Y/$7C[QK^TEX$^,/PQ^%GC7
M6M;O$L_!'BJ_L[>.[TPNA_T@&0/#)(\>XD*"Y!?<H;)]T7_@I]\0]/C.FWGP
M^^&FH:OD*NH6/Q8T>.S<_P!X*TK$ ^C2 C/-?67_  Q3\!/^B0^#_P#P4Q?X
M4?\ #%/P$_Z)#X/_ /!3%_A0!\"?&;2=1_:]\&:QJOQ=_:/^%?A^ZT^TFNO#
M'@'PQXGL6M$O0AV-=3O*=S$93(+8WDJRC<K?=_[$O[0%M^TA^SKX9\4 Q)K%
MO'_9FL6\("K%>0JH?"CA5=2DB@=%D [5<_X8I^ G_1(?!_\ X*8O\*]$^'WP
MP\(_"?19-(\&>&M+\+Z9+,;B2UTJU2"-Y2 "[!0,MA5&3SA0.U '3T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7F'[2_\ R1+Q'_V[?^E,5>GUYA^TO_R1+Q'_ -NW_I3%
M0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5YA^TO_ ,D2\1_]NW_I3%7I]>8?M+_\
MD2\1_P#;M_Z4Q4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M+_P#)$O$?_;M_
MZ4Q5Z?7F'[2__)$O$?\ V[?^E,5 'I]%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[
M2_\ R1+Q'_V[?^E,5>GUYA^TO_R1+Q'_ -NW_I3%0!Z?1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5YA^TO_ ,D2\1_]NW_I3%7I]>8?M+_\D2\1_P#;M_Z4Q4 >GT44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %>8?M+_P#)$O$?_;M_Z4Q5Z?7F'[2__)$O$?\
MV[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2_\ R1+Q'_V[?^E,5>GU
MYA^TO_R1+Q'_ -NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_ ,D2
M\1_]NW_I3%7I]>8?M+_\D2\1_P#;M_Z4Q4 >GT444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7S[X@_;L^#_AOXX:3\,+KQ/9
MMJ6H6C7+:U'?V9TJS<>9BWGG,X,<Q\OA-O/F1_WJ\/\ ^"P'QF\1?#3X Z+H
M'AZ\N--/BK46L[Z\MF9'^RQQEGA##[N\E ?559>A-?!/@_\ 8:TOQA\2?A%X
M)L_$TTU_X\^'\GBO[;&$,5O>,ER\4 &/N+Y*(^3NSO(QP  ?O';7,-Y;Q7%O
M*D\$J"2.6-@RNI&0P(X(([UE:WXV\.^&;E+?6-?TO2KAT\Q8;Z\CA=ER1N 9
M@2,@C/L:^4O^";OP-^-/[//@77/"GQ/EL7T R17.B6L%_P#:9;)CN\^(X& A
M_=L K$!@YQ\V:^%_^"@&E7G[2G_!2*R^'.G7@MW4Z9X;CNV0R+;AU$\LFT$9
M"&XD)&1G:>1UH _83_A;/@?_ *'+P_\ ^#2#_P"+KIX)X[J&.:&1989%#I)&
MP964C(((Z@BOR9_X<<ZY_P!%;T__ ,$<G_Q^OL[]K+XK7_[(7[%]Q>:5=I)X
MDT_3;/P_IEWY?R_:618?."G(RJ+)( <C* '(H ]S\0?%3P5X2U2'3-<\8:#H
MNI3,%BL]0U.""9R1D!4=@2<>@KI;>XBNH(YH)$FAD4,DD;!E93R"".HK\3OV
M1_\ @G??_MH?"_Q-\3/$OCN^TW6+S49[>QDGA^U-=SJJL\]Q(S;F4NY7CG*L
M<] ?3_\ @D%^T!XDT3XE>(/@=XEOI[G3%MI[G2K>XD+_ &&Y@?$T,>>B.I=R
MHX!CR -S$@'ZS4444 %>8?M+_P#)$O$?_;M_Z4Q5Z?7F'[2__)$O$?\ V[?^
ME,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!X?^V!^R]I/[67P?NO"%]=C2]3@F6^TK5/+W_9;E00"RY&49696&>C9'
M(%?C'JW@7X[_ +!/[0&B10(LOBW2M-FOM-;3P-4M7T]S,LSK&5)2,XG+;E1A
M\S<9!K]-?^"H7Q4^-/P1^&_AWQA\*]>ET;1H;F6T\0/#86URR"0(+>3,L;E%
MW!U++CYGCZ9Y^-?"O_!07PKXF_:H^$GQ;\:K?6<GAOP3/H^NK#;>8US?A;H;
MH57C;*94(W;0I8@G W$ ^W?^"?\ ^WS'^UW8ZIH.OZ7;Z)X\T:W6ZGBLF;[-
M>VY8(9HE8EDVLR*RDG[ZD$Y(7Y'^(/\ P30^/GQ:_:I\7^*KB\TWPIHNM:Q?
M7\7B&+41(T%N\C"*-8XR)"YC*KCY1@'+#H=?_@D3X(U'QG^T-\4/B];Z0VC>
M$Y8+JQM84&R(37-U'.(4P &$4<>"!P-R>U;&F_\ !2[XG?!/]J[4_!7QYMK2
MR\)6$\]E.=)TLI)&IP;>\4;F:2-E"MA3]V0D D!: / ?CC\%_B]_P2\\>^%O
M$?A;XA2:II6JO)Y-U;QO!#/)&5,D%U:L[JP964@[CGDC:5!KZ4_X*??%2+XR
M_L!_"CQK86[6EGXAU^QO9("^3"YL;PM$2/O;7##/^P#7B7_!2[]KSPK^UMK7
M@+P/\*1>^)[:RN9)3=I92Q->74VV.*&&)U60D8.<J,EU Z5]5?M'?LBZU'_P
M3(T7X=V=L=3\5>#;.UU@VMJ-YDN$+M=)'C[Q"3W&W'+;0 .<4 =U_P $GU _
M8E\(D#DWNHD\?]/<M?G]^Q8/)_X*M1I:LQM_^$@\2*2O0H+:^QGVR%_'%>C?
M\$]_^"B7P^_9V_9[U;P9X\_M*/4M+O9[W2HK*U,PO(Y0K>2&!PCB0/R^U<..
M<@UE?\$C?ASK/Q._:<\5?%N_MG33-)ANG:Z*G8]_=L?W:D]<1M*QQTRF?O"@
M#]D**** .7\;>/K;P/\ 8OM&EZMJ7VK?M_LNS,^S;MSOP>,[N/7!]*\=^.7Q
M>L?%'PMUO3(=!\0V4D_D8GOM.:*%=L\;?,Q/&<8'N17T57F'[2__ "1+Q'_V
M[?\ I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *\P_:7_Y(EXC_P"W;_TIBKT^O,/VE_\ DB7B/_MV_P#2F*@#T^BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_
M^W;_ -*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]
M/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P_:7_Y
M(EXC_P"W;_TIBKT^O,/VE_\ DB7B/_MV_P#2F*@#T^BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[
M=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P_:7_Y(EXC_P"W;_TIBKT^
MO,/VE_\ DB7B/_MV_P#2F*@#T^BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#]I?_DB
M7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ*** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+U+Q-INDZQI6
MEW=SY5_JC2+:1>6Q\TQKN?D# P.>2/:M2O,/B-_R5_X6?]=M1_\ 2<4 >GT4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5EMXFTU?$J
M>'S<XU=K4WJV_EMS"'V;MV-OWN,9S[5J5YA<?\G*6G_8K/\ ^E5 'I]%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9>B>)M-\1R:BF
MG7/VAM/NGLKD>6R^7,F-R_,!G&1R,CWK4KS#X)?\?WQ$_P"QIO/Y)0!Z?111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %;4M0M](TZZO
MKN3RK6UB:>:3:6VHH+,< 9. #TINDZM:Z[I=IJ-C+Y]E=Q+/#)M*[D894X(!
M'![BL?XD?\D[\4?]@JZ_]$M57X2_\DN\)?\ 8*MO_1:T =;1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &7XF\3:;X/T.YU?5[G[)IU
MOM\V;RV?;N8*.%!)^9@.!WK4KS#]I?\ Y(EXC_[=O_2F*O3Z "BBB@ HHHH
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M_P!"Y_Y/7/\ \<H_X9H^&W_0N?\ D]<__'*]/HH \P_X9H^&W_0N?^3US_\
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M_'*]/HH \P_X9H^&W_0N?^3US_\ '*/^&:/AM_T+G_D]<_\ QRO3Z* /,/\
MAFCX;?\ 0N?^3US_ /'*/^&:/AM_T+G_ )/7/_QRO3Z* /,/^&:/AM_T+G_D
M]<__ !RC_AFCX;?]"Y_Y/7/_ ,<KT^B@#S#_ (9H^&W_ $+G_D]<_P#QRC_A
MFCX;?]"Y_P"3US_\<KT^B@#S#_AFCX;?]"Y_Y/7/_P <H_X9H^&W_0N?^3US
M_P#'*]/HH \P_P"&:/AM_P!"Y_Y/7/\ \<H_X9H^&W_0N?\ D]<__'*]/HH
M\P_X9H^&W_0N?^3US_\ '*/^&:/AM_T+G_D]<_\ QRO3Z* /,/\ AFCX;?\
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M]"Y_Y/7/_P <H_X9H^&W_0N?^3US_P#'*]/HH \P_P"&:/AM_P!"Y_Y/7/\
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M&W_0N?\ D]<__'*]/HH \P_X9H^&W_0N?^3US_\ '*/^&:/AM_T+G_D]<_\
MQRO3Z* /,/\ AFCX;?\ 0N?^3US_ /'*/^&:/AM_T+G_ )/7/_QRO3Z* /,/
M^&:/AM_T+G_D]<__ !RC_AFCX;?]"Y_Y/7/_ ,<KT^B@#S#_ (9H^&W_ $+G
M_D]<_P#QRC_AFCX;?]"Y_P"3US_\<KT^B@#S#_AFCX;?]"Y_Y/7/_P <H_X9
MH^&W_0N?^3US_P#'*]/HH \P_P"&:/AM_P!"Y_Y/7/\ \<H_X9H^&W_0N?\
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M_P!"Y_Y/7/\ \<H_X9H^&W_0N?\ D]<__'*]/HH \P_X9H^&W_0N?^3US_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"5C*GY64\'O0![I17S5_P\A_9M_Z*EI__@%=_P#QFO6_A#\<? WQZ\/W>N>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCX3_ !M\"_'3P^^M> _$]AXFT^-@DKV;G?"Q&0LD; /&2.0&4$UV] !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?)/\ P4$_;6U3]D/P
M]X7M?#WAJ+7O$GBO[9%8374K""T:#R 6:-1NE)-PN%#+T//8_CG\8M.^)L/Q
MUTS5OBXE['XTU^2TU>9-1($ZQ228C#1C_585,"/ V* ,#&!_1=J'A?1M6UK3
M-8O=)LKS5M,65;&^GMT>:U$FWS!$Y&4W;$SM(SM&>E?B_P#\%6?^3ZM)_P"P
M9I?_ *->@#]DOB)-X@M_ 'B23PG;)>>*5TVX.E02.J(]WY;>2&9SM W[<D\8
MS7Y=?LD?\$M_$'C;QQXQU[]I;0]3A<E)K6W&KQ2-J5Q,TC33236\CME<+QN&
M3)D],']9Z^9_VV?VW?#?[(O@U1B'6O'>I1DZ3H._'&2/M$^.5B!!]W(VKT9E
M /R^_:"^'<'[#O[>GAVU^%=]>B.WFL-0M+5IO,FB\]BDEHS'[RNNX?-SME )
M/4_LA^TE\1/^%2_ 'X@^+EE\FXTG1+J>U;./](\LK /QD9!^-?F7_P $_/V8
MO&7[47QP?]HGXK>==Z-#?G4+22]7!U:^0@1F-.UO"5&,?+F-44$*P'TC_P %
MBOB,/"?[*]OX;BEVW/BG6;>U:,'!,$.;AS] \<(_X%0!Q?\ P2XL8?@7^Q!\
M1?BY?6+WKSOJ&LF&-@KW%K86[;8PQZ$R)<#)X^:OC?\ :L_:,^,_[:'@O4O'
M%[H,GA[X/^'+R..&TMW/V47,C!$WR-@W,X#'D !%)X7=\W[#?LT_"*P\"_LL
M>!O &J:?!=V@\/16^IV-U$'BF>>,O=(Z,,,K/+("".03FO#O^"KFG6FD?L/Z
MS96%K#96=OJ&G1PV]O&(XXU$Z@*J@8 'H* ,C_@C;_R:/>?]C->_^BK>NB^-
MG_!+'X4?'GXI:_X]U_Q!XRL]8UJ5);B#3;VT2W4K&D8V*]J[ 80=6/.:YW_@
MC;_R:/>?]C->_P#HJWK[0\;>+;#P#X-U[Q-JKF/3-&L)]1NF7&1%%&TCXSWP
MIH _$#]N[]E#X4?L[^,O"_P\^&>I>+?%7Q$U26-[BRU"[MIXX(Y#LAB"16Z,
M9I&((&[A0,@[U-?JM^PY^R\G[)_P-M/"]Q>-?Z]J%P=5UB53F);IXT0QQ?["
M+&BY_B*EN,X'P3_P34\*7W[5'[8'CWX[>+X3<G1Y6O;=)/FCCO;DLL"*3U6&
M%'"CMB(\8%?KS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?GO^WM^W!\2?!'Q/'P,^
M$7AB:;QCJ=I"PUF &XN0)E/RV\(7"N ,F5B0HR<#&X?#?[ _A_6?"?\ P4;\
M(Z'XCW?\)#IFL:M9:EYDPF;[3':7:2Y<$[SO5OFR<]<U^[-MX9T>SUZ\UN#2
MK*'6KR-(;G48[=%N)D7[J/(!N91V!.!7XO?L^?\ *8K5?^QY\3_^@W] 'Z<?
MMR>'?B=XS_9S\0^'/A+9/>>*M8:.RD\J\AM9([1CF<K)*ZJ"RCR^N<2''3(^
M0OV1?^"2WAB\^%UW>_'+0M3A\97EU+''I\&IB-;"%"51@T#,KNQR^267&P8Z
MY_3FOS^_X*)_\%&+3X)V6H_#;X<WBWGQ#N(S#?:G"0T>BJPY (ZW&#P.B9R>
M<+0!\G?L OJGP._X*1:A\./#VJ7&I>'I-2UC0+TJ1MN[>U2X:*5Q]T,KPHV1
MTRP'#8/W!_P5P^(O_"$_L@ZCI44WEW7BC4[72E"GYO+#&XD/TQ!M/^_CO7G7
M_!++]B/6?A6MQ\7_ (@VLEKXIUBU,6DZ;=9\^TMY"&DGF!Y660  +U52V[ER
M%Y?_ (*D3-\9?VHO@'\%;>1C'<W"7%ZL9/"W=RD.YL=TC@E;Z.?6@#V7P_\
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MUMK][:REYKFWMG=97FFPJP0-Y;?NQ\S_ '=S;ME5?^"(?_)5/B7_ -@6W_\
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MR"O[)OPADM=7%O/XYUZ1+O6KB [ECV@B*V5OXEC#-SW9W()&*^7]!V_M"?\
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MF2R%8EC 5CO  W?-FOZ+J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+QUXJB\"^!_$/B2>
M![J'1].N-1>",@-(L,32%03T)"X_&MVJVI:;::UIMWI]_;17MC=Q/!<6TZ!X
MY8V4JR,IX*D$@@]0: /PG_:N_:9^,G[:O@S5O%[^'IO#?P=\,W$0-K;R$VWV
MB1UC3S9F"_:)@7'"J BDG:,DM]V?\$8?^34-;_[&V\_]);2NK_X*EZ38Z#^P
MGXGT_3;*WTZPM[K38X;6UB6**)1=Q8554  >P%<I_P $8?\ DU#6_P#L;;S_
M -);2@#SS_@H'^RC\=_VHOVF/#\5AHD[?"FQ-GI]OJ4>H6I2U69D-W=&W:42
M%E+$'Y<E85Q7-?M^_P#!.OX0_ 7]F>[\:^#?[1TK7=&N+2)C>7S7 U)994B9
M65N%<;C)E H^5AC&,?J+XP\8:+X \,:EXB\1:E;Z/H>FPM<7=]=/MCB0=SZG
MH !R20 "2!7XP?M#_'OXA?\ !3CXWZ7\./AQIEQ!X*L[HR65K*"JX&5;4+UA
MD( K':O.T-M&YWY /N?_ ())^/->\<?LBVD6NSS7(T/5[C2+":<[F-HD<+QJ
M#U*H9709Z! .@%>&>.5_X:$_X+'>'M))%SI'@&WA=BO*JUM"UUG'J+J=$/\
MN^PK[V^!'P?\/?LR?!/1?!VF2*FFZ):-+>7\@VFXFP7GN'_WFW''.!A1P!7P
MC_P2:L9?BI\</CQ\:KZ-A-J=X;:V9QDC[5</<S)GMM$=N,>AH Q/CE^P_P#&
MC]J+]N636/'^C7MA\)Y=1:SM]6MM3M)/L^EPHS1K'$)"\9E*]TX>8D@UP/\
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M -*IZ /U^\)_\BKHW_7E#_Z+6M:LGPG_ ,BKHW_7E#_Z+6M:@ HHHH ****
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M*O[N('L7<JN?]JOYV-3^-MUX_P#CHWQ(^)>G?\)W)<WWVV_TJ2Y:VBN54?)
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M ';T55TO5+/6]-M-1TZ[@O\ 3[N%+BVN[619(IHW4,CHZDAE8$$$'!!!JU0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNLUQ-Y84R, [HH5=Z9)8?>'6OFO_ (?5_!#_ *%;X@?^"ZQ_^3* /O\ HKX
M_P"'U?P0_P"A6^('_@NL?_DRC_A]7\$/^A6^('_@NL?_ ),H ^_Z*^ /^'U?
MP0_Z%;X@?^"ZQ_\ DRC_ (?5_!#_ *%;X@?^"ZQ_^3* /6OC;\;?C3_PT[8_
M"#X06/@,7(\'_P#"67=]XV%Z4*_;6M?+C^S-D$$(>0<Y/(P 8O\ C-[_ *M_
M_P#*Y7Q__P /0/A9_P -H?\ "W?[ \8?\(W_ ,*__P"$4^R_8[7[9]J_M'[5
MOV_:=GE;.,[]V[^''->U_P##ZOX(?]"M\0/_  76/_R90!ZK_P 9O?\ 5O\
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MT'1K7QE<FXU'4[E+:WA#6=@JEY'(5<LR@9/)('>NT_X+"_\ )G[_ /8P6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:2/S8[?4K^.*>5.1N2(G>PR#]T&OD+P#^S?I7_!+OX-_&?XF6NM?\)IJ#V$
MTYKJT%N8<,4CB?#G(:>:,L01D(, $<_$/[%_[-,7[=WQ'\:>+OBSXZU"&RL6
MB>\NOM<:WU_<2[]JJ\H941%CYPIP"BK@<@ _:+X;_&GP%\8;26Y\$^,-&\41
MP@&9=,O4FDAST\Q =R?\" KM*_"']JGX)W7_  3O^.W@[Q-\*?&]S>V-VCW>
MFW4LZ/<PO$RB:WG\H*LD;!T_A4,KLI7C)_;'X1_$*V^+'PM\)>,[./R;?7M+
MMM1$.<F(RQJY0GU4DK^% '6T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=<?LQ?\ 1,__ "OZI_\ )-:_QL_99\<>.?CQ9_%7X>?%YOACKT?AI?#$Z_\
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MUQ^S%_T3/_ROZI_\DT?\.N/V8O\ HF?_ )7]4_\ DFOJJB@#Y5_X=<?LQ?\
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M&=W/'SO^T1X)\"?#7]LVZ\+?#B7S?"FCZMI]I%(URUQF=5A^T R,>2)O,![
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M ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"NB>#=+33?#^CZ?H>G(2RV>FVJ6\*D]2$0 ?I6K110 5^ /[&?\ RD0\'_\
M8S7G_H,]?O\ 5^>'P3_X)5ZK\)?VD-&^*,WQ%L]2@T_5)M1.FII3QLXD$@V;
MS*0,;^N.U 'Z'U^!?_!3#_E(!\0/^NVD_P#IMLZ_?2OSU_:B_P""66J_M$?M
M$>(OB9;_ !#L]$@U5[-UTZ72GF:/R+6& Y<2J#DPENG&[':@#;_X+*>$[_Q!
M^RGINI6<4LT.A^)+6\O-@RL<+PSP;V_[:2QKG_;]Z^-OV!OV%OA9^UY\/=7O
M=8\:ZYI/B_2KUHKK2=/DMP!;E5,4P5XV;:Q+J3GJG;(K]GO&?@[1OB%X3U;P
MUXAL(]3T35;9[2\M)<A98W&",@@@^A!!!P1S7YC>.O\ @B]KNC>)KC4?A;\4
M4TZS<MY%OK$4L-Q;H?X#<09\P8SSL7L,=Z /._'G[(/['GPQ^)U_X!\3?&WQ
M=IOB*R,:31K9+<1"1U#"/S(K9P'PPR#C!XZ\5](_\%0?VAO%?[,/P6^'W@;P
M'J-SI-SK\$UE)KD>4NH;:TC@4K&XQLD?S5RPY4*<8)!$G[*G_!)?P]\%?'6G
M^-?'?B1?&^MZ;,+FPT^"U,-G!.I!29RS%I64C< =H!P2&P*^C_VN_P!DOPU^
MUU\-XO#FM74ND:G8S&ZTK6;>,2/:2E=K H2-\;#&Y,C.U3D$ T ?!?['/_!-
M+P/\?/A'HOQ:^)7C;6=;FUH374EG8W:1QQA)71A<3N'=V^0EL%,'C)QD_,?[
M/-MX8LO^"C?A>V\%,'\'P^.'BT=Q(T@:S6=Q"P9B68% IR3DYKZM\%?\$<O'
M^GR7&AZO\:1I_@JYE62[L-%CN,W8P VZ)G6,,1P&._'H>E=U#_P2+_X03X\:
M+X\^''CZ+0-*T6_LM0L=)U*P>[E#PB,N'F\U=PD=')^48#X X% &/_P7!_Y$
M'X6?]A.]_P#14=>U_P#!/E2__!-?PNJ@LQTS7  .I_T^]KI?V[OV,;W]LCP[
MX3TRS\4P>%VT.ZGN6DGLFN1-YB*N  ZXQM]^M>C_ +*WP)D_9U_9]\,_#6]U
M2'Q"VD"[62]2W,23B:ZFGQY99L "7;U.<>] 'Y+?\$=[ZWL_VNI5GGCA:?PY
M>QQ"1@-[!X7('J=JL?HIK[C_ ."OUQ%=?L<>=#(DT,FO6+))&P96!67!!'45
MX#\1O^")NK77C6]N/!7C_3;7PQ<3-)#:ZM:R_:+1"21'E,K)CIN.WCMZ_5WQ
M7_8?U#XD_L:^$/@<OC*"WN]!%F#KDFGL4F6!74 0B3(X8#[Q^[0!YE_P144?
M\,L^*CCG_A,[H9_[<;&OE;_@M7_R=-X6_P"Q,M?_ $NOJ_2']AS]E6[_ &0?
MA/JW@Z\\10^)I;[6YM7%W!:&W"!X+>+9M+MDCR"<Y_BZ<5Y+^W'_ ,$X]1_:
M^^+&D^,;/QS:^&8K'1(=(-I/IK7!<I/<2[]PD7 /G@8Q_#UYH ^K?@C_ ,D7
M\ _]B_I__I-'7:UA^!?#;>#O!'A[0'G%T^E:=;V+3JNT2&*)4W 9.,[<XSWK
M<H _#7_@K)\'=4^&'[55SXTMX98M&\6Q0ZC:7B [([J)$BFCW?WP463Z2BOU
M&_9F_;5^'/[0GPWTO6$\3:5I'B);=1JVBW]TEO/;3J@,NU7(+Q9R5<9!'7!!
M ]&^-WP,\&_M#> [OPCXWTI=3TJ8^9&ZG9/:S $+-"_5'&3ST()!!!(/YI^.
MO^"(>N1ZM,_@SXE:?<:8SYCAUVRDBFC7T9XMRN1ZA5SZ"@#M/^"B7_!22?P)
MKWAWPI\$?&-M+K.GW+7FM:MIZ0W=K@*42TRRLCGYF9\?=*H,[L@?3?P*_: \
M?:G^Q'=_&+XAZ9I[:_!HE_KMO8Z;!) L]M#$[PEU+-AI!'NRN!M=>!S7SQ\
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MKX?I')\2KV_^(\^H+=7WB;4K9Y89(-C*8%A\W.=Q1O,9V)V= #B@#UCX%_\
M*)MO^R?ZQ_Z*NJ^._P#@B;;(W[0_C:X/WX_"SQCZ-=VQ/_H(K]$?@_\ LPZW
M\.OV0=4^">J>*K76)IM+U+2;36(K)HEBBNEDV[HRY+%&E;^(9  XKS#]A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?&>C?$3PCH_B?P]>?VAH>K6L=Y977E/%YL+C*ML<!ER#T8 ^U?D-_P %M/\
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MATZWEDTV6.2VNU7[7!EA%*JLR@XRR@@9'/(KRK_@AK_R"OC)_P!=M)_]!O*
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MAXD^(7Q"^$7A2SO_ !MJKZIIOAO4= M771-- VVT"QM&1&S+EV"A<[ER 00
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M2?&J0CYU&BJ#['[?G^0J[_P7*_Y!7P;_ .NVK?\ H-G0!]<?L9_$F]NOV%?
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M"2X(R%;'F_\ P0U_Y!7QD_Z[:3_Z#>4 ?->I_P#*6=/^RIP_^EZU^Q/[6/\
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MKFG)<6^H:-HMM:7'DR ,8V:) 00>&7/!4@]* /&_VVO^"AVF?L=>)]"\._\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMOG.&E>0EMH ZN1P.U>"?M2?\$T_AC^TUXBD\4-->>#?%LP_TG4M)5&CO#C
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M&A?$CPGJGAGQ-ID&LZ#J<)M[NRN =DB'W!!!!P0P(((!!! -;E% 'YO^,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015296880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_CoverPageAbstract', window );"><strong>Cover Page [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-10864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1321939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">UnitedHealth Group Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">9900 Bren Road East<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minnetonka,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">936-1300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UNH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Well known seasoned issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 479,550,880,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">932,846,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#8217;s definitive proxy statement relating to its 2023 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UnitedHealth Group Incorporated<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entitiy Central Index Key</a></td>
<td class="text">0000731766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CoverPageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover Page [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CoverPageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015407104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Auditor Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Minneapolis, Minnesota<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015494592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,365<span></span>
</td>
<td class="nump">$ 21,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">4,546<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $877 and $954</a></td>
<td class="nump">17,681<span></span>
</td>
<td class="nump">14,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables, net of allowances of $1,433 and $993</a></td>
<td class="nump">12,769<span></span>
</td>
<td class="nump">13,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">4,087<span></span>
</td>
<td class="nump">4,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,621<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">69,069<span></span>
</td>
<td class="nump">61,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">43,728<span></span>
</td>
<td class="nump">43,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $6,930 and $5,992</a></td>
<td class="nump">10,128<span></span>
</td>
<td class="nump">8,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">93,352<span></span>
</td>
<td class="nump">75,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net of accumulated amortization of $6,137 and $5,636</a></td>
<td class="nump">14,401<span></span>
</td>
<td class="nump">10,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">15,027<span></span>
</td>
<td class="nump">12,526<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">245,705<span></span>
</td>
<td class="nump">212,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="nump">29,056<span></span>
</td>
<td class="nump">24,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">27,715<span></span>
</td>
<td class="nump">24,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term borrowings and current maturities of long-term debt</a></td>
<td class="nump">3,110<span></span>
</td>
<td class="nump">3,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenues</a></td>
<td class="nump">3,075<span></span>
</td>
<td class="nump">2,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">26,281<span></span>
</td>
<td class="nump">22,975<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">89,237<span></span>
</td>
<td class="nump">78,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">54,513<span></span>
</td>
<td class="nump">42,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">2,769<span></span>
</td>
<td class="nump">3,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">12,839<span></span>
</td>
<td class="nump">11,787<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">159,358<span></span>
</td>
<td class="nump">135,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">4,897<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">86,156<span></span>
</td>
<td class="nump">77,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(8,393)<span></span>
</td>
<td class="num">(5,384)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Nonredeemable noncontrolling interests</a></td>
<td class="nump">3,678<span></span>
</td>
<td class="nump">3,285<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">81,450<span></span>
</td>
<td class="nump">75,045<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and equity</a></td>
<td class="nump">$ 245,705<span></span>
</td>
<td class="nump">$ 212,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AarpAssetsUnderManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AarpAssetsUnderManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638013383120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, accounts receivable</a></td>
<td class="nump">$ 877<span></span>
</td>
<td class="nump">$ 954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for doubtful accounts, other receivables</a></td>
<td class="nump">1,433<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="nump">6,930<span></span>
</td>
<td class="nump">5,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">$ 6,137<span></span>
</td>
<td class="nump">$ 5,636<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015604608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 257,157<span></span>
</td>
<td class="nump">$ 226,233<span></span>
</td>
<td class="nump">$ 201,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">324,162<span></span>
</td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Medical costs</a></td>
<td class="nump">210,842<span></span>
</td>
<td class="nump">186,911<span></span>
</td>
<td class="nump">159,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">47,782<span></span>
</td>
<td class="nump">42,579<span></span>
</td>
<td class="nump">41,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">33,703<span></span>
</td>
<td class="nump">31,034<span></span>
</td>
<td class="nump">30,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">295,727<span></span>
</td>
<td class="nump">263,627<span></span>
</td>
<td class="nump">234,736<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">28,435<span></span>
</td>
<td class="nump">23,970<span></span>
</td>
<td class="nump">22,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,092)<span></span>
</td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">26,343<span></span>
</td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(5,704)<span></span>
</td>
<td class="num">(4,578)<span></span>
</td>
<td class="num">(4,973)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">20,639<span></span>
</td>
<td class="nump">17,732<span></span>
</td>
<td class="nump">15,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Earnings attributable to noncontrolling interests</a></td>
<td class="num">(519)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 20,120<span></span>
</td>
<td class="nump">$ 17,285<span></span>
</td>
<td class="nump">$ 15,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to UnitedHealth Group common shareholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 21.47<span></span>
</td>
<td class="nump">$ 18.33<span></span>
</td>
<td class="nump">$ 16.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 21.18<span></span>
</td>
<td class="nump">$ 18.08<span></span>
</td>
<td class="nump">$ 16.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average number of common shares outstanding</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">943<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of common share equivalents</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average number of common shares outstanding</a></td>
<td class="nump">950<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 37,424<span></span>
</td>
<td class="nump">$ 34,437<span></span>
</td>
<td class="nump">$ 34,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 27,551<span></span>
</td>
<td class="nump">$ 24,603<span></span>
</td>
<td class="nump">$ 20,016<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638016488432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 20,639<span></span>
</td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 15,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Gross unrealized (losses) gains on investment securities during the period</a></td>
<td class="num">(4,292)<span></span>
</td>
<td class="num">(1,028)<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Income tax effect</a></td>
<td class="nump">984<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total unrealized (losses) gains, net of tax</a></td>
<td class="num">(3,308)<span></span>
</td>
<td class="num">(780)<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Gross reclassification adjustment for net realized losses (gains) included in net earnings</a></td>
<td class="nump">139<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Income tax effect</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="nump">107<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Total foreign currency translation gains (losses)</a></td>
<td class="nump">192<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(3,009)<span></span>
</td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">17,630<span></span>
</td>
<td class="nump">16,162<span></span>
</td>
<td class="nump">15,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(519)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 17,111<span></span>
</td>
<td class="nump">$ 15,715<span></span>
</td>
<td class="nump">$ 15,167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007780160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Net Unrealized Gains (Losses) on Investments [Member]</div></th>
<th class="th"><div>Foreign Currency Translation (Losses) Gains [Member]</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 60,436<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 61,178<span></span>
</td>
<td class="nump">$ 589<span></span>
</td>
<td class="num">$ (4,167)<span></span>
</td>
<td class="nump">$ 2,820<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance (Accounting Standards Update 2016-13) at Dec. 31, 2019</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">15,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">15,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) gains</a></td>
<td class="num">(236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">(4,250)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(1,576)<span></span>
</td>
<td class="num">(2,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($6.40 per share, $5.60 per share and $4.83 per share for the years ended December 31, 2022, 2021 and 2020, respectively)</a></td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(277)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">68,328<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69,295<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="num">(5,150)<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">17,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">17,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) gains</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(913)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">$ (5,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(940)<span></span>
</td>
<td class="num">(4,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($6.40 per share, $5.60 per share and $4.83 per share for the years ended December 31, 2022, 2021 and 2020, respectively)</a></td>
<td class="num">(5,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="num">(995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(319)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 75,045<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">77,134<span></span>
</td>
<td class="nump">423<span></span>
</td>
<td class="num">(5,807)<span></span>
</td>
<td class="nump">3,285<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 20,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">20,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) gains</a></td>
<td class="num">(3,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,201)<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">$ (7,000)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(1,892)<span></span>
</td>
<td class="num">(5,107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($6.40 per share, $5.60 per share and $4.83 per share for the years ended December 31, 2022, 2021 and 2020, respectively)</a></td>
<td class="num">(5,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(387)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 81,450<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 86,156<span></span>
</td>
<td class="num">$ (2,778)<span></span>
</td>
<td class="num">$ (5,615)<span></span>
</td>
<td class="nump">$ 3,678<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of net income (loss) attributable to nonredeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015416752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2022</div></th>
<th class="th"><div>Sep. 20, 2022</div></th>
<th class="th"><div>Jun. 28, 2022</div></th>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 6.40<span></span>
</td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015656384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 20,639<span></span>
</td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 15,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Noncash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(673)<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(331)<span></span>
</td>
<td class="num">(944)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,523)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(1,374)<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(2,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Medical costs payable</a></td>
<td class="nump">4,053<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">1,964<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Unearned revenues</a></td>
<td class="nump">126<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">26,206<span></span>
</td>
<td class="nump">22,343<span></span>
</td>
<td class="nump">22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(18,825)<span></span>
</td>
<td class="num">(17,139)<span></span>
</td>
<td class="num">(16,577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales of investments</a></td>
<td class="nump">5,907<span></span>
</td>
<td class="nump">7,045<span></span>
</td>
<td class="nump">6,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investments</a></td>
<td class="nump">6,081<span></span>
</td>
<td class="nump">8,251<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash assumed</a></td>
<td class="num">(21,458)<span></span>
</td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(7,139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="num">(2,802)<span></span>
</td>
<td class="num">(2,454)<span></span>
</td>
<td class="num">(2,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="nump">3,414<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(793)<span></span>
</td>
<td class="num">(1,269)<span></span>
</td>
<td class="num">(727)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(28,476)<span></span>
</td>
<td class="num">(10,372)<span></span>
</td>
<td class="num">(12,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common share repurchases</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid</a></td>
<td class="num">(5,991)<span></span>
</td>
<td class="num">(5,280)<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,015)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Proceeds from (repayments of) short-term borrowings, net</a></td>
<td class="nump">732<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">14,819<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeposits', window );">Customer funds administered</a></td>
<td class="nump">5,548<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Purchases of redeemable noncontrolling interests</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(1,944)<span></span>
</td>
<td class="num">(295)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from (used for) financing activities</a></td>
<td class="nump">4,226<span></span>
</td>
<td class="num">(7,455)<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">1,990<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
<td class="nump">5,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">16,921<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">23,365<span></span>
</td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">16,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 5,222<span></span>
</td>
<td class="nump">$ 3,966<span></span>
</td>
<td class="nump">$ 4,935<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3095-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=d3e60009-112784<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011401904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
<td class="text">Description of BusinessUnitedHealth Group Incorporated (individually and together with its subsidiaries, &#8220;UnitedHealth Group&#8221; and &#8220;the Company&#8221;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011518096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation, Use of Estimates and Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, product revenues are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue includes a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $7.1 billion and $5.4 billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $12.5 billion, of which approximately half is expected to be recognized in the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">three</span> years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_211" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Investments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $8.2 billion and $7.2 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s Medicare Part D receivables amounted to $1.3 billion and $3.4 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $3.5 billion and $2.9 billion as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ROU assets are included in other assets, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet</span>. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($13.5 billion and $11.4 billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside of the Company&#8217;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">four</span> years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. </span></div>Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638018179376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments [Text Block]</a></td>
<td class="text">Investments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,681)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nearly all of the Company&#8217;s investments in mortgage-backed securities were rated &#8220;Triple A&#8221; as of December&#160;31, 2022. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company held $3.7 billion and $3.5 billion of equity securities as of December&#160;31, 2022 and 2021, respectively. The Company&#8217;s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#8217;s investments included $1.5 billion and $1.3 billion of equity method investments in operating businesses in the health care sector, as of December&#160;31, 2022 and 2021, respectively. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2022 and 2021 was not material. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2022, by contractual maturity, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,914)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrealized losses from all securities as of December&#160;31, 2022 were generated from approximately 35,000 positions out of a total of 41,000 positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#8217;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2022, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2022 and 2021 was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011374592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value [Text Block]</a></td>
<td class="text">Fair ValueCertain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the years ended December 31, 2022 and 2021, the Company recognized $211 million and $840 million, respectively, of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based upon transaction of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt securities and equity securities reported at fair value on a recurring basis are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities reported at fair value on a recurring basis are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,617&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,357&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015224688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text">Property, Equipment and Capitalized Software<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>&#160;Depreciation expense for property and equipment was $1.1 billion for the year ended December&#160;31, 2022, and $1.0 billion for both years ended December 31, 2021 and 2020. Amortization expense for capitalized software for the years ended December&#160;31, 2022, 2021 and 2020 was $1.0 billion, $0.9 billion and $0.8 billion, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638018260336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,389&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense relating to intangible assets for the years ended December&#160;31, 2022, 2021 and 2020 was $1.3 billion, $1.2 billion and $1.1 billion, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011357520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Medical Costs Payable</a></td>
<td class="text">Medical Costs Payable<div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206,577)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,530)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December&#160;31, 2022, prior year&#8217;s medical cost reserve development included no individual factors that were significant. For the years ended December 31, 2021 and 2020, prior years&#8217; medical cost reserve development was primarily driven by lower than expected care activity. Additionally, prior years&#8217; medical cost reserve development in the year ended December 31, 2021 was driven by care patterns disrupted by COVID-19.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable included IBNR of $20.0 billion and $17.1 billion at December&#160;31, 2022 and 2021, respectively. Substantially all of the IBNR balance as of December&#160;31, 2022 relates to the current year. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and paid medical cost development as of December&#160;31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370,993)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011322240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Short-Term Borrowings and Long-Term Debt [Text Block]</a></td>
<td class="text">Short-Term Borrowings and Long-Term Debt <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 2.875% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.350% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 million 2.375% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15 million 0.000% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 2.750% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 2.875% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.500% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.500% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 0.550% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 2.375% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 5.000% notes due October 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.750% notes due July 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 5.150% notes due October 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300 million 3.700% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 1.250% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.100% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 1.150% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.450% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 3.375% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 3.700% notes due May 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$950 million 2.950% notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 5.250% notes due February 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,150 million 3.850% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 million 3.875% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 million 4.000% notes due May 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 2.875% notes due August 2029</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 5.300% notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 2.000% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 2.300% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 4.200% notes due May 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 5.350% notes due February 2033</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 4.625% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 million 5.800% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 6.500% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$650 million 6.625% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 6.875% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.500% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 2.750% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300 million 5.700% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$350 million 5.950% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million  3.050% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 4.625% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$502 million 4.375% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 3.950% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 4.250% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 4.200% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$725 million 4.250% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$950 million 3.750% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,350 million 4.250% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 4.450% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.700% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 2.900% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.250% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due May 2052</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 5.875% notes due February 2053</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.875% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.125% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 4.950% notes due May 2062</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 6.050% notes due February 2063</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,756&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt obligations also included $0.9 billion and $1.4 billion of other financing obligations, of which $192 million and $611 million were current as of December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $6.0 billion <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMDU_6c33a52c-1144-4e22-89da-18fc6460dbfe">five</span>-year, $6.0 billion <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMjI_945de3a2-7233-4e80-9a06-96283be1135b">three</span>-year and $6.0 billion 364-day revolving bank credit facilities with 25 banks, which mature in December 2027, December 2025 and December 2023, respectively. These facilities provide full liquidity support for the Company&#8217;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2022, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#8217;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2022, annual interest rates would have ranged from 5.1% to 7.5%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011264480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">Income Taxes <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. The components of the provision for income taxes for the years ended December&#160;31 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:75.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:47.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Net unrealized losses on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,366)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,813)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $490 million expire beginning in 2023 through 2037 and $611 million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2023 through 2042, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company&#8217;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:71.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $260 million as a result of audit settlements and the expiration of statutes of limitations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $64 million, $66 million and $52 million of net interest and penalties, respectively. The Company had $253 million and $194 million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2022 and 2021, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2022, there were $1.7 billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#8217;s 2017 through 2020 tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the 2014 tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years 2015 and forward.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007762928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text">Shareholders' Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s regulated insurance and HMO subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the NAIC. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#8217;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#8220;ordinary dividends&#8221; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#8220;extraordinary dividend&#8221; and must receive prior regulatory approval. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.8 billion, including $7.4 billion of extraordinary dividends. For the year ended December&#160;31, 2021, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.0 billion, including $4.7 billion of extraordinary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $33.8 billion as of December&#160;31, 2022. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $15.4 billion as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank must meet minimum capital requirements of the FDIC under the capital adequacy rules to which it is subject. At December&#160;31, 2022, the Company believes Optum Bank met the FDIC requirements to be considered &#8220;Well Capitalized.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its Board of Directors&#8217; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#8217;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain restrictions. In June 2018, the Board of Directors renewed the Company&#8217;s share repurchase program with an authorization to repurchase up to 100 million shares of its common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.433%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share, which the Company had paid since June 2021. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2022 dividend payments:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011238752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payment Arrangement [Text Block]</a></td>
<td class="text">Share-Based Compensation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2022, the Company had 59 million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. As of December&#160;31, 2022, there were 18&#160;million shares of common stock available for issuance under the ESPP. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Shares</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Recognition and Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9% - 4.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6% -30.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#8217;s common stock and the implied volatility from exchange-traded options on the Company&#8217;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Employee Benefit Plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $1.6 billion and $1.8 billion as of December&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011367280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs, including immaterial variable and short-term lease costs, were $1.3 billion, $1.2 billion and $1.1 billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Cash payments made on the Company&#8217;s operating lease liabilities were $996 million, $921 million and $865&#160;million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2022, the Company&#8217;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were 8.6 years and 3.4%, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company has entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $9&#160;billion. The Company completed the acquisition of LHC Group, Inc. on February 22, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#8217;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Investigations, Audits and Reviews</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, Consumer Financial Protection Bureau, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#8217;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#8217;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#8217;s health plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#8217;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#8217;s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company&#8217;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#8217;s motion for partial summary judgment and dismissed the Company&#8217;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007762928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text">Business Combinations<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2022, the Company acquired all of the outstanding common shares of Change Healthcare Inc. (Change) and funded Change&#8217;s payoff of its outstanding debt and credit facility for a total of $13.9 billion in cash. The combination of the Company and Change will connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients. Change brings key technologies, connections and advanced clinical decision, administrative and financial support capabilities, enabling better workflow and transactional connectivity across the health care system.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing and as planned, the Company sold Change&#8217;s claims editing business to an affiliate of investment funds of TPG Inc. for $2.2 billion in cash. The net assets and net liabilities associated with this sale were classified as held-for-sale at the time of acquisition. There was no gain or loss associated with this transaction.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company completed several other business combinations for total consideration of $8.8 billion. The Company also sold other businesses for $1.2 billion of cash, with a carrying value of $600 million, and the difference reflected in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired assets (liabilities) at acquisition date were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable liabilities acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net identifiable assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and financial condition of acquired entities have been included in the Company&#8217;s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through December 31, 2022, acquired entities impact on revenues and net earnings was not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaudited pro forma revenues and net earnings for the years ended December 31, 2022 and 2021, as if the business combinations had occurred on January 1, 2021, were immaterial for both periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011238752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Financial Information [Text Block]</a></td>
<td class="text">Segment Financial Information<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used to determine the Company&#8217;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#8217;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the types of products and services from which each of the Company&#8217;s four reportable segments derives its revenues:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the combined results of operations of UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement and UnitedHealthcare Community&#160;&amp; State. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. Domestically, UnitedHealthcare Employer&#160;&amp; Individual offers an array of consumer-oriented health benefit plans and services for employers and individuals. Globally, UnitedHealthcare Employer &amp; Individual provides health and dental benefits and hospital and clinical services to employers and individuals in South America and other diversified global businesses. UnitedHealthcare Medicare&#160;&amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs. UnitedHealthcare Community &amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Rx </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx; care delivery, care management services and certain product offerings sold to UnitedHealthcare by Optum Health; and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#8217;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a percentage of the Company&#8217;s total consolidated revenues, premium revenues from CMS were 38%, 36% and 36% for 2022, 2021 and 2020, respectively, most of which were generated by UnitedHealthcare Medicare &amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately 97% of consolidated total revenues for 2022, 2021 and 2020. Long-lived fixed assets located in the United States represented approximately 81% and 78% of the total long-lived fixed assets as of December&#160;31, 2022 and 2021, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Employer &amp; Individual&#8217;s international businesses. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,379&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,436&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,435&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107,094&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,950&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,090&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,476&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,516&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,905)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245,705&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,234&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,967&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,474&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,181&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,523&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,284)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,206&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,496&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,639&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,229&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,073&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,778&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,718)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,289&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011296912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedStatementOfIncomeCaptionsLineItems', window );"><strong>Condensed Statement of Income Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,547)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from dispositions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,373)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceed from (repayments of) short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from (used for) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Basis of Presentation </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Subsidiary Transactions </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends and Capital Distributions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends received from subsidiaries and included in Cash Flows from Operating  Activities in the Condensed Statements of Cash Flows were $15.6 billion, $10.8 billion and $10.0 billion in 2022, 2021 and 2020, respectively. Additionally, $1.4 billion, $0.2 billion and $0.9 billion in cash were received as a return of capital to the parent company during 2022, 2021 and 2020, respectively.</span></div>Short-Term Borrowings and Long-Term Debt <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of short-term borrowings and long-term debt can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_184" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $0.9 billion and $1.4 billion at December&#160;31, 2022 and 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company had notes payable to subsidiaries of $8.7 billion and $8.1 billion as of December 31, 2022 and 2021, respectively, which included on-demand features.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    Commitments and Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#8217;s parent company in the event of insolvency. UnitedHealth Group&#8217;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a summary of commitments and contingencies, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data</a><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</a><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8221;</a></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfIncomeCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfIncomeCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -URI https://asc.fasb.org/extlink&amp;oid=126898705&amp;loc=d3e5864-122674<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5283-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015700448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, product revenues are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue includes a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $7.1 billion and $5.4 billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $12.5 billion, of which approximately half is expected to be recognized in the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">three</span> years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_211" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Medical Costs and Medical Costs Payable [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text">Cash, Cash Equivalents and Investments Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div>New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AARPAssetsUnderManagementPolicyTextBlock', window );">AARP Assets Under Management [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivable [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $8.2 billion and $7.2 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s Medicare Part D receivables amounted to $1.3 billion and $3.4 billion, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock', window );">Prepaid and Other Current Assets Policy</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $3.5 billion and $2.9 billion as of December 31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div>The Company&#8217;s ROU assets are included in other assets, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_OtherLiabilitiesCurrentPolicyTextBlock', window );">Other Current Liabilities [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($13.5 billion and $11.4 billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside of the Company&#8217;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Payment Arrangement [Policy Text Block]</a></td>
<td class="text">Share-Based CompensationThe Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">four</span> years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text">Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AARPAssetsUnderManagementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>AARP Assets Under Management [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AARPAssetsUnderManagementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_OtherLiabilitiesCurrentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Current [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_OtherLiabilitiesCurrentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid and Other Current Assets Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011357520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Fair Value (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the years ended December 31, 2022 and 2021, the Company recognized $211 million and $840 million, respectively, of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based upon transaction of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt securities and equity securities reported at fair value on a recurring basis are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities reported at fair value on a recurring basis are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638010563168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation, Use of Estimates and Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, product revenues are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue includes a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $7.1 billion and $5.4 billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $12.5 billion, of which approximately half is expected to be recognized in the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">three</span> years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_211" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Investments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $8.2 billion and $7.2 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s Medicare Part D receivables amounted to $1.3 billion and $3.4 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $3.5 billion and $2.9 billion as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ROU assets are included in other assets, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet</span>. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($13.5 billion and $11.4 billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside of the Company&#8217;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">four</span> years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. </span></div>Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside of the Company&#8217;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data.&#8221;</a></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text">Subsidiary Transactions <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015264832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Redeemable Noncontrolling Interest [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2022 and 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember', window );">Useful Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text">The useful lives for property, equipment and capitalized software are: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011267504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Short-Term and Long-Term Investments [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,681)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,860&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments by Contractual Maturity [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2022, by contractual maturity, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,914)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015295376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,617&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,357&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Fair Value Measurements, Nonrecurring [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011486400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008573904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,389&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011495120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206,577)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,530)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and paid medical cost development as of December&#160;31, 2022: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370,993)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011436448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Short-Term Borrowings and Long-Term Debt [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 2.875% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.350% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 million 2.375% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15 million 0.000% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 2.750% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 2.875% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.500% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.500% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 0.550% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 2.375% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 5.000% notes due October 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.750% notes due July 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 5.150% notes due October 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300 million 3.700% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 1.250% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.100% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 1.150% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 3.450% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 3.375% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 3.700% notes due May 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$950 million 2.950% notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 5.250% notes due February 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,150 million 3.850% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 million 3.875% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$900 million 4.000% notes due May 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 2.875% notes due August 2029</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 5.300% notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 2.000% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 2.300% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 4.200% notes due May 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 5.350% notes due February 2033</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 4.625% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$850 million 5.800% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 6.500% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$650 million 6.625% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 6.875% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.500% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 2.750% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$300 million 5.700% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$350 million 5.950% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million  3.050% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million 4.625% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$502 million 4.375% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$625 million 3.950% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 4.250% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750 million 4.200% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$725 million 4.250% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$950 million 3.750% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,350 million 4.250% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,100 million 4.450% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.700% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 2.900% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.250% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due May 2052</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 5.875% notes due February 2053</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250 million 3.875% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 3.125% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million 4.950% notes due May 2062</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500 million 6.050% notes due February 2063</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,756&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638005188928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text">The components of the provision for income taxes for the years ended December&#160;31 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:75.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:47.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Net unrealized losses on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,366)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,813)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:71.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638016498512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Share Repurchase Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.433%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Dividends Declared</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2022 dividend payments:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638010584256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Share Activity [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2022 is summarized in the table below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Other Share-Based Compensation Data [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9% - 4.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6% -30.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011367280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015599936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired assets (liabilities) at acquisition date were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable liabilities acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,175)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net identifiable assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,761&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations Change Healthcare and other acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011276496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Financial Information [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">249,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,379&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,436&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,435&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,032&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107,094&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,950&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,090&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,476&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,516&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,905)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245,705&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,234&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,967&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,474&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,181&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,523&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,284)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,206&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,496&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,639&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,229&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,073&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,778&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,718)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,289&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008618048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Condensed Balance Sheet [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock', window );">Condensed Statement of Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,547)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Condensed Cash Flow Statement [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from dispositions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,373)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceed from (repayments of) short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from (used for) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009743072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 17,681<span></span>
</td>
<td class="nump">$ 14,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">12,769<span></span>
</td>
<td class="nump">13,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 27,715<span></span>
</td>
<td class="nump">24,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">$ 26,281<span></span>
</td>
<td class="nump">22,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract', window );">Number Of Days Notice Required To Cancel Health Insurance Contract</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DemandDepositAccounts', window );">Health savings account deposits</a></td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days', window );">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=unh_ProductsandservicesMember', window );">Products and services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 7,100<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember', window );">Pharmaceutical Manufacturer Rebates Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">8,200<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember', window );">Medicare Part D Receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Days Notice Required To Cancel Health Insurance Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DemandDepositAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of money in accounts that may bear interest and that the depositor is entitled to withdraw at any time without prior notice.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DemandDepositAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=unh_ProductsandservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=unh_ProductsandservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638005248928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, Fixtures and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, Fixtures and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember', window );">Capitalized software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember', window );">Capitalized software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009720976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest, beginning of period</a></td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisitions</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(319)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value and other adjustments</a></td>
<td class="num">(114)<span></span>
</td>
<td class="nump">995<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, end of period</a></td>
<td class="nump">4,897<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember', window );">Redeemable Noncontrolling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest, beginning of period</a></td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net earnings</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisitions</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Redemptions</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value and other adjustments</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, end of period</a></td>
<td class="nump">$ 4,897<span></span>
</td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="nump">$ 2,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012965056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Narrative) (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>positions</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Equity Securities, FV-NI and without Readily Determinable Fair Value</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | positions</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceContracts', window );">Total number of security positions</a></td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14.Column B)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611322-123010<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.Column B)<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008445424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Short-Term and Long-Term Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 45,926<span></span>
</td>
<td class="nump">$ 39,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(3,664)<span></span>
</td>
<td class="num">(274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">42,321<span></span>
</td>
<td class="nump">40,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_InvestmentsAmortizedCost', window );">Total investments, Amortized Cost</a></td>
<td class="nump">46,622<span></span>
</td>
<td class="nump">40,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_InvestmentsGrossUnrealizedGains', window );">Total investments, Gross Unrealized Gains</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_InvestmentsGrossUnrealizedLosses', window );">Total investments, Gross Unrealized Losses</a></td>
<td class="num">(3,681)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, Fair Value Disclosure</a></td>
<td class="nump">43,000<span></span>
</td>
<td class="nump">40,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">42,321<span></span>
</td>
<td class="nump">40,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,809<span></span>
</td>
<td class="nump">3,198<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">7,702<span></span>
</td>
<td class="nump">6,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,248<span></span>
</td>
<td class="nump">7,106<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">23,675<span></span>
</td>
<td class="nump">20,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(1,798)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">21,894<span></span>
</td>
<td class="nump">21,174<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">7,379<span></span>
</td>
<td class="nump">5,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(808)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="nump">5,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">2,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(294)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 2,784<span></span>
</td>
<td class="nump">$ 2,838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments at amortized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross unrealized gains of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsGrossUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross unrealized losses of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsGrossUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007683744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Amortized Cost</a></td>
<td class="nump">$ 4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Amortized Cost</a></td>
<td class="nump">13,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years, Amortized Cost</a></td>
<td class="nump">12,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years, Amortized Cost</a></td>
<td class="nump">5,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">45,926<span></span>
</td>
<td class="nump">$ 39,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">4,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">12,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years, Fair Value</a></td>
<td class="nump">10,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years, Fair Value</a></td>
<td class="nump">4,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">42,321<span></span>
</td>
<td class="nump">40,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</a></td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</a></td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</a></td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt Securities, Held-to-maturity</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage-backed securities, Amortized Cost</a></td>
<td class="nump">7,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">7,379<span></span>
</td>
<td class="nump">5,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="nump">5,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage-backed securities, Fair Value</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage-backed securities, Amortized Cost</a></td>
<td class="nump">3,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">2,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">$ 2,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage-backed securities, Fair Value</a></td>
<td class="nump">$ 2,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009657680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">$ 24,899<span></span>
</td>
<td class="nump">$ 17,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(1,750)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">12,320<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(1,914)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">37,219<span></span>
</td>
<td class="nump">18,004<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(3,664)<span></span>
</td>
<td class="num">(274)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">2,007<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(189)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">3,297<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">4,630<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(288)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">1,178<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(191)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">5,808<span></span>
</td>
<td class="nump">1,417<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">13,003<span></span>
</td>
<td class="nump">9,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(893)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">6,637<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(905)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">19,640<span></span>
</td>
<td class="nump">9,733<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(1,798)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">3,561<span></span>
</td>
<td class="nump">3,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(345)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">2,239<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(463)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">3,194<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(808)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">$ (294)<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012904544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers Into Level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Equity Securities, FV-NI, Unrealized Gain</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis', window );">Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009464512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,365<span></span>
</td>
<td class="nump">$ 21,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">42,321<span></span>
</td>
<td class="nump">40,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,148<span></span>
</td>
<td class="nump">2,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">4,087<span></span>
</td>
<td class="nump">4,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">71,921<span></span>
</td>
<td class="nump">68,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">42,321<span></span>
</td>
<td class="nump">40,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,809<span></span>
</td>
<td class="nump">3,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,248<span></span>
</td>
<td class="nump">7,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">21,894<span></span>
</td>
<td class="nump">21,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="nump">5,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">2,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">23,202<span></span>
</td>
<td class="nump">21,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,043<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">30,545<span></span>
</td>
<td class="nump">28,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">3,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,505<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">2,203<span></span>
</td>
<td class="nump">2,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">41,018<span></span>
</td>
<td class="nump">39,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">38,617<span></span>
</td>
<td class="nump">36,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,248<span></span>
</td>
<td class="nump">7,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">21,695<span></span>
</td>
<td class="nump">20,916<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="nump">5,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">2,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AarpAssetsUnderManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AarpAssetsUnderManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008690560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt Securities, Held-to-maturity</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt and other financing obligations, carrying value</a></td>
<td class="nump">56,756<span></span>
</td>
<td class="nump">44,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DebtInstrumentExcludingCommercialPaperAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt and other financing obligations, carrying value</a></td>
<td class="nump">56,823<span></span>
</td>
<td class="nump">46,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">53,626<span></span>
</td>
<td class="nump">52,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">53,626<span></span>
</td>
<td class="nump">52,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DebtInstrumentExcludingCommercialPaperAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DebtInstrumentExcludingCommercialPaperAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015653248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized Computer Software, Amortization</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012868064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Land and improvements</a></td>
<td class="nump">$ 697<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">5,519<span></span>
</td>
<td class="nump">4,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Computer equipment</a></td>
<td class="nump">2,093<span></span>
</td>
<td class="nump">1,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation', window );">Less accumulated depreciation</a></td>
<td class="num">(4,499)<span></span>
</td>
<td class="num">(3,857)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet', window );">Property and equipment, net</a></td>
<td class="nump">5,923<span></span>
</td>
<td class="nump">5,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software</a></td>
<td class="nump">6,636<span></span>
</td>
<td class="nump">5,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(2,431)<span></span>
</td>
<td class="num">(2,135)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software, net</a></td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">3,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, equipment and capitalized software, net</a></td>
<td class="nump">$ 10,128<span></span>
</td>
<td class="nump">$ 8,969<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011254592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015247520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 75,795<span></span>
</td>
<td class="nump">$ 71,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">17,710<span></span>
</td>
<td class="nump">4,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">93,352<span></span>
</td>
<td class="nump">75,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">27,389<span></span>
</td>
<td class="nump">27,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(456)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">27,395<span></span>
</td>
<td class="nump">27,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember', window );">Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">24,224<span></span>
</td>
<td class="nump">19,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">4,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">29,238<span></span>
</td>
<td class="nump">24,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember', window );">Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">8,619<span></span>
</td>
<td class="nump">8,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">8,623<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">17,244<span></span>
</td>
<td class="nump">8,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember', window );">Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">15,563<span></span>
</td>
<td class="nump">15,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">3,910<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 19,475<span></span>
</td>
<td class="nump">$ 15,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638013335568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 20,538<span></span>
</td>
<td class="nump">$ 15,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(6,137)<span></span>
</td>
<td class="num">(5,636)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">14,401<span></span>
</td>
<td class="nump">10,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">16,303<span></span>
</td>
<td class="nump">13,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(5,179)<span></span>
</td>
<td class="num">(4,697)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">11,124<span></span>
</td>
<td class="nump">8,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">2,398<span></span>
</td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(704)<span></span>
</td>
<td class="num">(739)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">1,694<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638013339968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 3,927<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 776<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015653152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">1,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 1,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638011367808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Costs Payable (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</a></td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI https://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015391904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable Rollforward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable, beginning of period</a></td>
<td class="nump">$ 24,483<span></span>
</td>
<td class="nump">$ 21,872<span></span>
</td>
<td class="nump">$ 21,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Reported medical costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">211,252<span></span>
</td>
<td class="nump">188,631<span></span>
</td>
<td class="nump">160,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(1,720)<span></span>
</td>
<td class="num">(880)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total reported medical costs</a></td>
<td class="nump">210,842<span></span>
</td>
<td class="nump">186,911<span></span>
</td>
<td class="nump">159,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Medical payments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Payments for current year</a></td>
<td class="num">(184,049)<span></span>
</td>
<td class="num">(165,524)<span></span>
</td>
<td class="num">(139,974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Payments for prior years</a></td>
<td class="num">(22,528)<span></span>
</td>
<td class="num">(18,864)<span></span>
</td>
<td class="num">(19,556)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total medical payments</a></td>
<td class="num">(206,577)<span></span>
</td>
<td class="num">(184,388)<span></span>
</td>
<td class="num">(159,530)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable, end of period</a></td>
<td class="nump">$ 29,056<span></span>
</td>
<td class="nump">$ 24,483<span></span>
</td>
<td class="nump">$ 21,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012867696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Costs Payable, Incurred and Paid Medical Cost Development (Details) - Health Insurance Product Line [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">$ 399,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">(370,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">Net remaining outstanding liabilities prior to 2021</a></td>
<td class="nump">390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Total Medical costs payable</a></td>
<td class="nump">29,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Short-duration Insurance Contracts, Accident Year 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">188,407<span></span>
</td>
<td class="nump">$ 188,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">(186,944)<span></span>
</td>
<td class="num">$ (165,524)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Short-duration Insurance Contracts, Accident Year 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">211,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">$ (184,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008296080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_A364Day60BillionCreditFacilityMember', window );">364 Day $6.0 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Line of Credit Facility, Expiration Period</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_ThreeYear60BillionCreditFacilityMember', window );">Three Year $6.0 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Line of Credit Facility, Expiration Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_FiveYear60BillionCreditFacilityMember', window );">Five Year $6.0 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Line of Credit Facility, Expiration Period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other Long-term Debt</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Other Long-term Debt, Current</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_A364Day60BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_A364Day60BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_ThreeYear60BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_ThreeYear60BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_FiveYear60BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_FiveYear60BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638001399568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Carrying Value</a></td>
<td class="nump">$ 56,756<span></span>
</td>
<td class="nump">$ 44,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member', window );">2.875% Notes Due March 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member', window );">3.350% Notes Due July 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember', window );">2.375% notes due October 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member', window );">0.000% Notes Due November 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member', window );">2.750% Notes Due February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member', window );">2.875% Notes Due March 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member', window );">3.500% notes due June 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member', window );">3.500% notes due February 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member', window );">0.550% notes due May 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member', window );">2.375% notes due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5000NotesDueOctober2024Member', window );">5.000% notes due October 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member', window );">3.750% Notes Due July 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5150NotesDueOctober2025Member', window );">5.150% notes due October 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 747<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member', window );">3.700% notes due December 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member', window );">1.250% notes due January 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member', window );">3.100% notes due March 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member', window );">1.150% notes due May 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 893<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member', window );">3.450% notes due January 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member', window );">3.375% notes due April 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 622<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3700NotesDueMay2027Member', window );">3.700% notes due May 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member', window );">2.950% notes due October 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 943<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5250NotesDueFebruary2028Member', window );">5.250% notes due February 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,008<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member', window );">3.850% notes due June 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,145<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member', window );">3.875% notes due December 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 845<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4000NotesDueMay2029Member', window );">4.000% notes due May 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 849<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member', window );">2.875% notes due August 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 886<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5300NotesDueFebruary2030Member', window );">5.300% notes due February 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,269<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member', window );">2.000% notes due May 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,237<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member', window );">2.300% notes due May 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,256<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4200NotesDueMay2032Member', window );">4.200% notes due May 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,393<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5350NotesDueFebruary2033Member', window );">5.350% notes due February 2033 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 2,037<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member', window );">4.625% notes Due July 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member', window );">5.800% notes Due March 2036 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member', window );">6.500% notes Due June 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 493<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member', window );">6.625% notes due November 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member', window );">6.875% notes Due Februray 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member', window );">3.500% notes due August 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,242<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member', window );">2.750% notes due May 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 967<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member', window );">5.700% notes Due October 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member', window );">5.950% notes Due Februrary 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 346<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member', window );">3.050% notes due May 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,483<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member', window );">4.625% notes Due November 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member', window );">4.375% notes Due March 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member', window );">3.950% notes Due October 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member', window );">4.250% notes Due March 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 736<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member', window );">4.750% notes Due July 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member', window );">4.200% notes due January 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 739<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member', window );">4.250% notes due April 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member', window );">3.750% notes due October 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member', window );">4.250% notes due June 2048 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,331<span></span>
</td>
<td class="nump">1,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member', window );">4.450% notes due December 2048 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,087<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member', window );">3.700% notes due August 2049 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,236<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member', window );">2.900% notes due May 2050 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,210<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member', window );">3.250% notes due May 2051 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,971<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4750NotesDueMay2052Member', window );">4.750% notes due May 2052 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,965<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5875NotesDueFebruary2053Member', window );">5.875% notes due February 2053 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,968<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member', window );">3.875% notes due August 2059 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,228<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member', window );">3.125% notes due May 2060 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 966<span></span>
</td>
<td class="nump">965<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4950NotesDueMay2062Member', window );">4.950% notes due May 2062 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 981<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6050NotesDueFebruary2063Member', window );">6.050% notes due February 2063 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,466<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5000NotesDueOctober2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5000NotesDueOctober2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5150NotesDueOctober2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5150NotesDueOctober2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3700NotesDueMay2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3700NotesDueMay2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5250NotesDueFebruary2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5250NotesDueFebruary2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4000NotesDueMay2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4000NotesDueMay2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5300NotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5300NotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4200NotesDueMay2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4200NotesDueMay2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5350NotesDueFebruary2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5350NotesDueFebruary2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4750NotesDueMay2052Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4750NotesDueMay2052Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5875NotesDueFebruary2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5875NotesDueFebruary2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4950NotesDueMay2062Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4950NotesDueMay2062Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6050NotesDueFebruary2063Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6050NotesDueFebruary2063Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638016519792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 3,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">3,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 43,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008425456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</a></td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-U.S [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-U.S [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member', window );">Finite-lived NOL carryforwards [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember', window );">Indefinite NOL carryforwards [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638013339136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Reconciliation of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract', window );"><strong>Current Provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal</a></td>
<td class="nump">$ 4,842<span></span>
</td>
<td class="nump">$ 3,451<span></span>
</td>
<td class="nump">$ 4,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">855<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">4,448<span></span>
</td>
<td class="nump">4,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred (benefit) provision</a></td>
<td class="num">(673)<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 5,704<span></span>
</td>
<td class="nump">$ 4,578<span></span>
</td>
<td class="nump">$ 4,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638001190880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax provision at the U.S. federal statutory rate, Amount</a></td>
<td class="nump">$ 5,532<span></span>
</td>
<td class="nump">$ 4,685<span></span>
</td>
<td class="nump">$ 4,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at the U.S. federal statutory rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit, Amount</a></td>
<td class="nump">$ 621<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit, Percent</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount', window );">Share-based awards - excess tax benefit, Amount</a></td>
<td class="num">$ (110)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent', window );">Share-based awards - excess tax benefit, Percent</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible compensation, Amount</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible compensation, Percent</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount', window );">Health insurance industry tax, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent', window );">Health insurance industry tax, Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential, Amount</a></td>
<td class="num">$ (265)<span></span>
</td>
<td class="num">$ (246)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential, Percent</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net, Amount</a></td>
<td class="num">$ (224)<span></span>
</td>
<td class="num">$ (324)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net, Percent</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 5,704<span></span>
</td>
<td class="nump">$ 4,578<span></span>
</td>
<td class="nump">$ 4,973<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision for income taxes, Percent</a></td>
<td class="nump">21.70%<span></span>
</td>
<td class="nump">20.50%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007610512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Accrued expenses and allowances</a></td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">$ 723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. federal and state net operating loss carryforwards</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities', window );">Nondeductible liabilities</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Non-U.S. tax loss carryforwards</a></td>
<td class="nump">631<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">972<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Net unrealized losses on investments</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxAssetOtherDomestic', window );">Other-domestic</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxAssetOtherForeign', window );">Other-non-U.S.</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">4,888<span></span>
</td>
<td class="nump">3,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowances</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(198)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total deferred income tax assets</a></td>
<td class="nump">4,597<span></span>
</td>
<td class="nump">3,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">U.S. federal and state intangible assets</a></td>
<td class="num">(3,520)<span></span>
</td>
<td class="num">(2,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign', window );">Non-U.S. goodwill and intangible assets</a></td>
<td class="num">(550)<span></span>
</td>
<td class="num">(512)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware', window );">Capitalized software</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">(520)<span></span>
</td>
<td class="num">(349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(275)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates', window );">Outside basis in partnerships</a></td>
<td class="num">(653)<span></span>
</td>
<td class="num">(565)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Lease right-of-use asset</a></td>
<td class="num">(958)<span></span>
</td>
<td class="num">(1,267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxLiabilityOtherDomestic', window );">Net unrealized gains on investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DeferredTaxLiabilityOtherForeign', window );">Other-non-U.S.</a></td>
<td class="num">(342)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(7,366)<span></span>
</td>
<td class="num">(6,813)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">$ (2,769)<span></span>
</td>
<td class="num">$ (3,265)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetOtherDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Other Domestic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetOtherDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetOtherForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Other Foreign</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetOtherForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilityOtherDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Other Domestic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilityOtherDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilityOtherForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Other Foreign</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilityOtherForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015296112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, beginning of period</a></td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,829<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">538<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions, gross increases</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions, gross decreases</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations lapses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, end of period</a></td>
<td class="nump">$ 3,081<span></span>
</td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007714528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareRepurchasesTableLineItems', window );"><strong>Shareholders' Equity Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</a></td>
<td class="nump">33.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Statutory Accounting Practices, Statutory Capital and Surplus Required</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember', window );">Extraordinary Dividends [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareRepurchasesTableLineItems', window );"><strong>Shareholders' Equity Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareRepurchasesTableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Share Repurchases [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareRepurchasesTableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638013613504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity Share Repurchases (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common shares repurchases, shares</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Common share repurchases, average price per share</a></td>
<td class="nump">$ 501.67<span></span>
</td>
<td class="nump">$ 389.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Board authorized shares remaining</a></td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638107308432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2022</div></th>
<th class="th"><div>Sep. 20, 2022</div></th>
<th class="th"><div>Jun. 28, 2022</div></th>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 6.40<span></span>
</td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of Ordinary Dividends, Common Stock</a></td>
<td class="nump">$ 1,541<span></span>
</td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="nump">$ 1,545<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="nump">$ 5,991<span></span>
</td>
<td class="nump">$ 5,280<span></span>
</td>
<td class="nump">$ 4,584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638016435168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred Compensation, Recorded Liability</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009208848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning of the period | shares</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeitures | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end of the period | shares</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period | shares</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, end of period | shares</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeitures, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">4 years 4 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 8 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 5,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 5,854<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012714992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Restricted Share Activity) (Details) - Restricted Stock [Member]<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period | shares</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period | shares</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share | $ / shares</a></td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per share | $ / shares</a></td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">$ 401<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015267920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Other Share-Based Compensation Data (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense, before tax</a></td>
<td class="nump">$ 925<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of tax effects</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">719<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Income tax benefit realized from share-based award exercises</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense related to share awards</a></td>
<td class="nump">$ 1,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of shares granted, per share</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 1,419<span></span>
</td>
<td class="nump">$ 1,519<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share</a></td>
<td class="nump">$ 483<span></span>
</td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted shares vested</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares purchased</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638005155184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures', window );">Forfeiture rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life in years</a></td>
<td class="text">4 years 8 months 13 days<span></span>
</td>
<td class="text">4 years 9 months 19 days<span></span>
</td>
<td class="text">5 years 1 month 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 4 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 8 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">30.60%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">22.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">30.80%<span></span>
</td>
<td class="nump">29.80%<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012751072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 22, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 921<span></span>
</td>
<td class="nump">$ 865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsDescription', window );">Other Commitments, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As of December&#160;31, 2022, the Company has entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent Event, Description</a></td>
<td class="text">The Company completed the acquisition of LHC Group, Inc. on February 22, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the nature and terms of commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638007744400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies Future Lease Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">5,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(808)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 4,830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015505216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 03, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,414<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_ChangeHealthcareClaimEditingBusinessMember', window );">Change Healthcare Claim Editing Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_OtherDispositionsMember', window );">Other Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_CarryingValueOfDisposition', window );">Carrying Value of Disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember', window );">Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CarryingValueOfDisposition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying Value of Disposition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CarryingValueOfDisposition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_ChangeHealthcareClaimEditingBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_ChangeHealthcareClaimEditingBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_OtherDispositionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=unh_OtherDispositionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009779840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Acquired Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 93,352<span></span>
</td>
<td class="nump">$ 75,795<span></span>
</td>
<td class="nump">$ 71,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareAcquisitionMember', window );">Change Healthcare Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and other current assets</a></td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale', window );">Assets held-for-sale</a></td>
<td class="nump">2,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, equipment and other long-term assets</a></td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">4,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="nump">7,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Medical costs payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and other current liabilities</a></td>
<td class="num">(1,017)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale', window );">Liabilities held-for-sale</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="num">(1,193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total identifiable liabilities acquired</a></td>
<td class="num">(2,311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net identifiable assets</a></td>
<td class="nump">5,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsRedeemableNoncontrollingInterests', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsNonredeemableNoncontrollingInterests', window );">Nonredeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="nump">13,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember', window );">Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and other current assets</a></td>
<td class="nump">696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale', window );">Assets held-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, equipment and other long-term assets</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">1,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="nump">4,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Medical costs payable</a></td>
<td class="num">(308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and other current liabilities</a></td>
<td class="num">(843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale', window );">Liabilities held-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="num">(713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total identifiable liabilities acquired</a></td>
<td class="num">(1,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net identifiable assets</a></td>
<td class="nump">3,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsRedeemableNoncontrollingInterests', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsNonredeemableNoncontrollingInterests', window );">Nonredeemable noncontrolling interests</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="nump">8,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and other current assets</a></td>
<td class="nump">1,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale', window );">Assets held-for-sale</a></td>
<td class="nump">2,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, equipment and other long-term assets</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">5,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="nump">12,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Medical costs payable</a></td>
<td class="num">(308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and other current liabilities</a></td>
<td class="num">(1,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale', window );">Liabilities held-for-sale</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="num">(1,906)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total identifiable liabilities acquired</a></td>
<td class="num">(4,175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net identifiable assets</a></td>
<td class="nump">8,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">17,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsRedeemableNoncontrollingInterests', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_BusinessCombinationsNonredeemableNoncontrollingInterests', window );">Nonredeemable noncontrolling interests</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="nump">$ 22,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Assets and Liabilities, Assets Held-for-sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Assets and Liabilities, Liabilities Held-for-sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_BusinessCombinationsNonredeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonredeemable noncontrolling interests acquired through business combinations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_BusinessCombinationsNonredeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_BusinessCombinationsRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redeemable noncontrolling interests acquired through business combinations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_BusinessCombinationsRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638009277936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations Acquired Finite-Lived Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 4,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember', window );">Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 1,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 3,927<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member] | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 3,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member] | Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member] | Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 3,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member] | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member] | Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member] | Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 776<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member] | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member] | Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member] | Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_ChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_OtherAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=unh_TotalAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008425584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers', window );">Disclosure on Geographic Areas Percentage of Revenue from External Customers</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets', window );">Disclosure on Geographic Areas Percentage of Long Lived Assets</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember', window );">Revenues [Member] | CMS [Member] | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DisclosureonGeographicAreasPercentageofLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_CMSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_CMSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638001663872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">$ 257,157<span></span>
</td>
<td class="nump">$ 226,233<span></span>
</td>
<td class="nump">$ 201,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">324,162<span></span>
</td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">28,435<span></span>
</td>
<td class="nump">23,970<span></span>
</td>
<td class="nump">22,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,092)<span></span>
</td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">26,343<span></span>
</td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">245,705<span></span>
</td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">197,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">37,424<span></span>
</td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">27,551<span></span>
</td>
<td class="nump">24,603<span></span>
</td>
<td class="nump">20,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember', window );">Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">182,768<span></span>
</td>
<td class="nump">155,565<span></span>
</td>
<td class="nump">136,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">14,056<span></span>
</td>
<td class="nump">11,995<span></span>
</td>
<td class="nump">10,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">14,056<span></span>
</td>
<td class="nump">11,995<span></span>
</td>
<td class="nump">10,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">147,516<span></span>
</td>
<td class="nump">117,523<span></span>
</td>
<td class="nump">106,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">257,157<span></span>
</td>
<td class="nump">226,233<span></span>
</td>
<td class="nump">201,478<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">322,132<span></span>
</td>
<td class="nump">285,273<span></span>
</td>
<td class="nump">255,639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">37,424<span></span>
</td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">27,551<span></span>
</td>
<td class="nump">24,603<span></span>
</td>
<td class="nump">20,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">18,374<span></span>
</td>
<td class="nump">13,852<span></span>
</td>
<td class="nump">9,799<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">73,314<span></span>
</td>
<td class="nump">63,231<span></span>
</td>
<td class="nump">55,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">37,424<span></span>
</td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">17,516<span></span>
</td>
<td class="nump">14,942<span></span>
</td>
<td class="nump">11,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_IntersegmentMember', window );">Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_IntersegmentMember', window );">Affiliated Customers | Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">108,347<span></span>
</td>
<td class="nump">90,867<span></span>
</td>
<td class="nump">80,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">249,741<span></span>
</td>
<td class="nump">222,899<span></span>
</td>
<td class="nump">200,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">14,379<span></span>
</td>
<td class="nump">11,975<span></span>
</td>
<td class="nump">12,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">14,379<span></span>
</td>
<td class="nump">11,975<span></span>
</td>
<td class="nump">12,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">107,094<span></span>
</td>
<td class="nump">102,967<span></span>
</td>
<td class="nump">98,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">928<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">71,174<span></span>
</td>
<td class="nump">54,065<span></span>
</td>
<td class="nump">39,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">6,032<span></span>
</td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">3,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">6,032<span></span>
</td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">3,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">68,950<span></span>
</td>
<td class="nump">60,474<span></span>
</td>
<td class="nump">52,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">14,581<span></span>
</td>
<td class="nump">12,199<span></span>
</td>
<td class="nump">10,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">3,588<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">3,588<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">31,090<span></span>
</td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">15,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">698<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">99,773<span></span>
</td>
<td class="nump">91,314<span></span>
</td>
<td class="nump">87,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">4,436<span></span>
</td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">3,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">4,436<span></span>
</td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">3,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">47,476<span></span>
</td>
<td class="nump">40,181<span></span>
</td>
<td class="nump">39,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">238,783<span></span>
</td>
<td class="nump">212,381<span></span>
</td>
<td class="nump">191,679<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">248,818<span></span>
</td>
<td class="nump">222,042<span></span>
</td>
<td class="nump">200,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">10,035<span></span>
</td>
<td class="nump">9,661<span></span>
</td>
<td class="nump">8,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">18,374<span></span>
</td>
<td class="nump">13,852<span></span>
</td>
<td class="nump">9,799<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">29,363<span></span>
</td>
<td class="nump">23,778<span></span>
</td>
<td class="nump">16,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">10,917<span></span>
</td>
<td class="nump">9,894<span></span>
</td>
<td class="nump">6,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">5,176<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">4,996<span></span>
</td>
<td class="nump">3,936<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">38,775<span></span>
</td>
<td class="nump">35,358<span></span>
</td>
<td class="nump">35,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">37,172<span></span>
</td>
<td class="nump">34,246<span></span>
</td>
<td class="nump">33,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">1,603<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">40,883<span></span>
</td>
<td class="nump">29,234<span></span>
</td>
<td class="nump">22,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">9,288<span></span>
</td>
<td class="nump">7,867<span></span>
</td>
<td class="nump">6,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">60,936<span></span>
</td>
<td class="nump">55,779<span></span>
</td>
<td class="nump">52,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(2,760)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(2,760)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(108,347)<span></span>
</td>
<td class="num">(90,867)<span></span>
</td>
<td class="num">(80,042)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,092)<span></span>
</td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="num">(2,092)<span></span>
</td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="num">(8,905)<span></span>
</td>
<td class="num">(8,284)<span></span>
</td>
<td class="num">(7,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (108,347)<span></span>
</td>
<td class="num">$ (90,867)<span></span>
</td>
<td class="num">$ (80,042)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_ExternalCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_IntersegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_IntersegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638015466912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">15,600<span></span>
</td>
<td class="nump">10,800<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Return of capital to parent company</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">$ 943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other Long-term Debt</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638001400016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Condensed Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,365<span></span>
</td>
<td class="nump">$ 21,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">69,069<span></span>
</td>
<td class="nump">61,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">15,027<span></span>
</td>
<td class="nump">12,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">245,705<span></span>
</td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">$ 197,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">27,715<span></span>
</td>
<td class="nump">24,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">89,237<span></span>
</td>
<td class="nump">78,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">54,513<span></span>
</td>
<td class="nump">42,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">12,839<span></span>
</td>
<td class="nump">11,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">159,358<span></span>
</td>
<td class="nump">135,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">86,156<span></span>
</td>
<td class="nump">77,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(8,393)<span></span>
</td>
<td class="num">(5,384)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">245,705<span></span>
</td>
<td class="nump">212,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">753<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">2,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_EquityinNetAssetsofSubsidiaries', window );">Equity in net assets of subsidiaries</a></td>
<td class="nump">136,562<span></span>
</td>
<td class="nump">116,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesNoncurrent', window );">Long-term notes receivable from subsidiaries</a></td>
<td class="nump">6,201<span></span>
</td>
<td class="nump">5,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">144,286<span></span>
</td>
<td class="nump">125,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Current portion of notes payable to subsidiaries</a></td>
<td class="nump">8,699<span></span>
</td>
<td class="nump">8,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Short-term borrowings and current maturities of long-term debt</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">3,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,452<span></span>
</td>
<td class="nump">11,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">53,838<span></span>
</td>
<td class="nump">41,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">66,514<span></span>
</td>
<td class="nump">53,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">86,156<span></span>
</td>
<td class="nump">77,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(8,393)<span></span>
</td>
<td class="num">(5,384)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total UnitedHealth Group shareholders&#8217; equity</a></td>
<td class="nump">77,772<span></span>
</td>
<td class="nump">71,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 144,286<span></span>
</td>
<td class="nump">$ 125,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EquityinNetAssetsofSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity in Net Assets of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EquityinNetAssetsofSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due after 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008428176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Balance Sheet Document (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638008413440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I Condensed Statement of Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">$ 2,030<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">$ 1,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">324,162<span></span>
</td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">295,727<span></span>
</td>
<td class="nump">263,627<span></span>
</td>
<td class="nump">234,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="nump">5,704<span></span>
</td>
<td class="nump">4,578<span></span>
</td>
<td class="nump">4,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">20,120<span></span>
</td>
<td class="nump">17,285<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(3,009)<span></span>
</td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">17,111<span></span>
</td>
<td class="nump">15,715<span></span>
</td>
<td class="nump">15,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating costs</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,583<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">2,231<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
<td class="nump">1,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(1,976)<span></span>
</td>
<td class="num">(1,129)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_LossofParentCompany', window );">Loss of parent company</a></td>
<td class="num">(1,547)<span></span>
</td>
<td class="num">(898)<span></span>
</td>
<td class="num">(1,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in undistributed income of subsidiaries</a></td>
<td class="nump">21,667<span></span>
</td>
<td class="nump">18,183<span></span>
</td>
<td class="nump">16,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">20,120<span></span>
</td>
<td class="nump">17,285<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(3,009)<span></span>
</td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 17,111<span></span>
</td>
<td class="nump">$ 15,715<span></span>
</td>
<td class="nump">$ 15,167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_LossofParentCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss of Parent Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_LossofParentCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638005080128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I Statement of Cash Flows (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">$ 26,206<span></span>
</td>
<td class="nump">$ 22,343<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(21,458)<span></span>
</td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(7,139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="nump">3,414<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(28,476)<span></span>
</td>
<td class="num">(10,372)<span></span>
</td>
<td class="num">(12,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Proceeds from (repayments of) short-term borrowings, net</a></td>
<td class="nump">732<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">14,819<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,015)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(1,944)<span></span>
</td>
<td class="num">(295)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from (used for) financing activities</a></td>
<td class="nump">4,226<span></span>
</td>
<td class="num">(7,455)<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="nump">1,990<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
<td class="nump">5,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">21,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">23,365<span></span>
</td>
<td class="nump">21,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">5,222<span></span>
</td>
<td class="nump">3,966<span></span>
</td>
<td class="nump">4,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">14,754<span></span>
</td>
<td class="nump">11,439<span></span>
</td>
<td class="nump">8,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Issuances of notes to subsidiaries</a></td>
<td class="num">(567)<span></span>
</td>
<td class="num">(444)<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties', window );">Repayments of notes to subsidiaries</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(20,728)<span></span>
</td>
<td class="num">(4,953)<span></span>
</td>
<td class="num">(7,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Return of capital to parent company</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_unh_Capitalcontributionstosubsidiaries', window );">Capital contributions to subsidiaries</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(747)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash received from dispositions</a></td>
<td class="nump">2,787<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(17,373)<span></span>
</td>
<td class="num">(5,862)<span></span>
</td>
<td class="num">(6,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid</a></td>
<td class="num">(5,991)<span></span>
</td>
<td class="num">(5,280)<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Proceeds from (repayments of) short-term borrowings, net</a></td>
<td class="nump">732<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">14,819<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,015)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Proceeds from notes from subsidiary</a></td>
<td class="nump">594<span></span>
</td>
<td class="nump">3,223<span></span>
</td>
<td class="nump">2,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(674)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(438)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from (used for) financing activities</a></td>
<td class="nump">718<span></span>
</td>
<td class="num">(3,668)<span></span>
</td>
<td class="num">(2,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(1,901)<span></span>
</td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 4,298<span></span>
</td>
<td class="nump">$ 3,050<span></span>
</td>
<td class="nump">$ 4,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_Capitalcontributionstosubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital contributions to subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_Capitalcontributionstosubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139638012750592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 3,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">3,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">43,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">3,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 43,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>unh-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:unh="http://www.uhc.com/20221231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="unh-20221231.xsd" xlink:type="simple"/>
    <context id="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4bfe1147b61f43029e188dfba9f8d0a1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i85e6f017f088486bb2c8d3093e1e73c3_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i03d7421f2e1846c2b83800db841f59f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icae360a97ab14698993e6432980a16a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4783b4127e2144999741c7d04d466e2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i528146a5cf87439684c37a24329083d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8d105042b9242e3a67b99461ff390ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2f53e27fa72436f92deccfb277741ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib75f2b5ddba14b25908ed51f2abe23fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6440bd164d594884b755b5b9ff031b02_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c689a8c0bca4e019433ec7246f933af_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6830c5f79e56472094427c9ea2e3da03_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d1d3ede72ca4733addec1bb1964c823_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i07259315a0ea49d0a13dfb8fe399859f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99ac1e3a85a14762b31fc51bf6a90599_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idca043d8fcb44c53b5284ba8accffdaf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib659d7c82a274ea4ac648525c4eb7212_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i642edb7da896454ab4d981b104a7469f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0fc49c4edc654514bf73d5c1b5463ae8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8b06c57980640a89660ca89168bc707_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4b41b5d5d1d4902a2666ab91615d999_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i664e92201b31457e977924ad47542638_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id0ff020430204014941338a161a89f7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85f91212be8041f595a89ca53aaeab7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07801d8cba1b4ab3b50d8ac8a9f97af6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6eaac53b8934e608d29bd0c5b4e5994_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5c1cb17ce614ea6a4262e7a44095444_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5959c75efd0045959418fd2933c336d6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i357524a3e1674a958342f4b2ad6fd285_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c551595134e4820a2b39138e15877c8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2616b12a521428ba669ce47e3572232_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93029ecb097b460c94d2bd8336e2c900_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic40da61c03d244ee8b7fafcd8416abe9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d32db37f4024063a8ce510f51ab5d0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34dd7920ba894909b8d0e5c2cfaceb6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0843668ba2f34d53b6ff8c06a2fbd0b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5123593bd7e943ff983843139569f7ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3b889e044c1942f18b7b6118ae4e47fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7667d069e974d27b0f62b9b62fe36f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id5b13550b61146f3942355d988fb9045_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4b04f90dfec4d62aef785c70b201486_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44f74baf509a410c99fa46e489fb4347_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76cf18e9b55b4c90b1d62f83afeffdc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4af60408a5014dadb511e21f1afca7e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2964324674894490aab04f2d6bd37235_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15b306bfc47b4634b1d61ddb91da4cb0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib35aa732c7b44d8785be61e048bb0572_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fb6042d781646119f05a8e3d8d9bfdc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib03e24ff12c14c668abeebbd373c12f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3b26ce245bd427daad3c1e0c98d2988_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8cc912aa74747edbaa48cf71f83621d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2ca0721d6424e0ebe624cfdfd71cff7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:UsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib7bfd1f6234d46cca896b895ffb4eb00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaef840008a9949d4bf08759afb52eeb0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ice44079f0ac84af382d947db2570bb57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i862cb01850c54123912d7e326e09b865_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5723f6eb484244a1b9c07c5e1b663d23_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f37409e996040ec89badf7f24f413b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24f6c70b54f343a196c9df60d4d8fdec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i844bf68d4f4345e3970236cd396c9f66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i541081ea074d4ecd8b8c1ce4752c8ce2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57ef3e9119e24c1bbb54fbf615fcab1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf429de67ae248a68c7cb4da5ce8428c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife04c89dd39a402eb363a5aa452772d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia18d6beb6b1c4b2987106d01727d38dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95e69fa331194b15a906c00c27162164_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if05937365d074cadb89e64039541d02d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4133bc7b7654a80873db5b16de03f74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib275e6a73d0440148b42d342275a5ec2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4bf3e83c042412faa2721b20b445a19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i011f48e345274d1f9d386cb6032974c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26d227da923f4bafa3e23635ffa3e63d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9ea388a069444c4931adafec448408a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idef199e9d5164b839dff15f1d15b655d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3100e960b47a458dbc9b0427cfe50a57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9eacf249beb84261b10dda890a8c7b1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i398125db28a248afa78be5dde2f802de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4b697d303c246c990d7e9e55449aa31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b5a2a5290514b42a50323b2c2b06755_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27447352b0ab4986955366c4e6e7c8ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i188beb504ffd4cf1811a05b9122ba936_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic133da4ac5694c2ab3ebbb7920479054_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i036507f5da394189a07761f27ce7e50f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i65c3951e41d5448f93f5d245e448b353_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie787f6065b7145838ac2375afc47c02e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb07718b5c854d9cbe58e30453c54be2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3373ab24aca44874b727df09174bb908_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i869ae145fa344284be424032a072bd49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b6663e1ca24400db968c0f30349d738_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0790ce8dc806474baab7039cd2473ef4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0485953f893b49d693502de2df2048e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief6fab63019041c7a43aa25dabe91d73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf77a1a93e4449e79e9e7ecb7ca12b9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b874edc14f445189ce46feb9f2c4f83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iece3fb1e3e9b4d8190443f2996222c31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb02468002ee402a8d58d3f0b459ea93_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a1a835311424287bdea3b0f166d0ee4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id829c67b8dcc4173a26141ccf0fc20bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if14e7f1d47d24ce5849f9b9b561f7e16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5784b258ad7c4a2fb80cf028d4eabdb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c699d8d9ea945a59bfac2890b0ad12a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i657a012885e24d5eaacd841fab51c280_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd889a008b09458f83587b1ac62ff127_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id88f51dc85eb4f388b644b2df135e040_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06af4dfd1cfd4c9da60ac57537b11dc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifecbdb30ca8f48bd9c6d49d82fbc8d3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10fb3889577743e99907b617e43c8ba8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i443d6329218e4e968f2b21276f5ad0b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8f630fda39a4043bfe6128ff91152bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i50f797283d0f468a9e019cd793e5de27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iddcca2f61bd741edb945e23a517102e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf402af8c08c4d1cbb8e1ee5013f8985_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1029e91d76ab42b3ac1bfc3d43571bee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib08f479dfe434d749660a45e73e5ae3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55ab6c56958a464c87ff17c070fbaacb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3ddbe32d07a43fc9952719ea94c5a31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc9058fdfbea43dabe2bae0df36bd3bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i307873d9bcfb48f8a290730f26815add_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b3392265deb4106aab31600904e9cb4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87d93ef8431b471ca93d9465e2c95484_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63222ef16b814f569ad4ba0cf601d3a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib77ad19c6e4440028848176be54ff601_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibde696a897d44556b79a1a65c2668c22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47a18e6ecf3d47f986ea7a8767797311_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93cad82084bb42bf84e6e79e8cf2b3de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DebtInstrumentExcludingCommercialPaperAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c131978c8aa4c9fac20a4b9db444b5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1288c646ac474cb6a528ecddc4cf9eaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6ccb32154264ba6a1a64b7d12112f3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia87829c660a8467182b6e1a92c6cd8e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7837dbff77c4c7ab715987e4d24c08a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0be0aab5247d49e8bea8b75041ffa84c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f993c029dde4f2188f1debf7eab46d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e929c44eac543b9b65151f9f6e42da0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie941b4c35ceb4d50a09440e37ae44046_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DebtInstrumentExcludingCommercialPaperAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5b9cb689c4849b186802ae057c4f620_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i273fb22e9e294cc583d6ed2a1dccb45e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib18968b1b98748ebaf2b70232a383b48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3aab5eedface463d8e9937c9f349bdb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93aff990939e4d999543f7925550419f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie588118f5a224050a60787106be9f4ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idef850d28ac94a98ab6c49a6ff13ef23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i954001ec6080467d9308272e6879d3cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0520b9f9d7f64354b0aa489f5bd5b095_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e4082841ae445839156ed080b909db1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia71332b1e4da424482d4374941a68deb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i029dc3b772ba45fcae3cdfb1cf328398_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i306fc774c45e4efda5c854e3d3882a81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id38495f03da740dc92c5e3241a80f075_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73959cf508b94532976280692bebc7fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8087abc490604b24b4842f47239d6ca4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0d27f00edd24f95bcc8effc5ab51935_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i497a918740ed4cf8849340ca44bb4e4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia808efbb58284bd29fa2015876ed6e9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65240804f5fe4ff18092e64dd3c64e1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd81928a29434336a9c57994d73a7bc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i99a9202de2dd47f3af460db253742fae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie2145059193248b48874a80710b28e8b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib99b38b33f024bd5b838c545e73f79f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i495eaae432e44afdb66418768a361a4b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie94f6f0f1fd94551b44b1faa876e0832_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37c49ae972864155b1415b8cc9d945ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7467c05cf504bf382c1187f5f7e597b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24e57b760f1943638a139219471fd6fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e95ea910ec747ac9770d7cbc2da1ce2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1e6c96ce7884253a99f1fca5a7339dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5493d49ac1284b54884fdb86718f9e02_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3892320018df450c9ac4e6bf65e11fe3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7c819f8af694a74897e26538e141f60_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2367432c1c4e45439729594f68a2ec11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60e5672e23b94f19be7191790d53cc3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6d9d96731c340fa9d78902e0bc3b278_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i728d9550a35f4f138ff2c097381dc033_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if5ef92fae8bc4c0084253bd7bb7088bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1940f3a1e6f9417694b22ff49c35186e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i786714661e7f4838a42693234789771e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c66b2e1270a46d6a8d5cd1309dea3ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5d9fc280e4544109fecfdc02a37666f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf8f66195a594ab1b336d142ef13ede2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4eb4001ca6264871a7ad00d325a345ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5000NotesDueOctober2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6383fe7786fe4e7bbdd981e396552bd7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5000NotesDueOctober2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2686d11283f46719d18fa8e4dfc6455_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i416a9d226e564e5abf36acd74b65f94f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32d0059f0624475da7bd80920ef148f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5150NotesDueOctober2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9fa26a59c1843ad803fbad414557dc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5150NotesDueOctober2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d5b47862f5348ef9dcf07e7a185c79b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i203f45d0024846889fd3a1fa6fffb8bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i75cc738c6f9848178e80519e6cbbce38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8de494dc062d4199875121594f393220_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2c732b02ee74c73bbfc3705c75e0da0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42ac3b21a19f4ca9b38339c305baac7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63ea0c95de6e4a9b9e2536e70fefb4ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic82463e4fdc5489ab448089bf76d312f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21504223e65b4686844531611b0b07d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i305adfb9c01244c5afe018e176540852_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a55401292cd487bab7b21375cc65e7b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3700NotesDueMay2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if181822fd1384c01988e0d46a4385545_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3700NotesDueMay2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4692ab26301b477380a51e6a6a781217_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5677b8572412413b81509f643c9ef745_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5250NotesDueFebruary2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c64464c7bc74ed6bc24597231e8ab76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5250NotesDueFebruary2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d23392f899d43788e933044d9acb8b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i129276d6c48048318c0627db9c328f51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7dab2cbb62404492925d5e152cd76361_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i512cc51902184d4c92e7d2dd8755c1ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4155c0e3c9b946bea71e235628460254_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4000NotesDueMay2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b14d6d4df8b4cfaa24978b6086e472e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4000NotesDueMay2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id34aca5e0b0748ed989035c239f6915c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86903b7949ae4788981d28620e873889_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5300NotesDueFebruary2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id80a1eb5f9d341648fd7677e8828af62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5300NotesDueFebruary2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a5b0b53fa8240879de83b80861c2037_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76155e2aae45448fae0e6e595a1abba1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8de06ca26b3340e78175d0fa4155ceee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c7c9dc5c92d4b699d0ace37c4d35756_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c6a66c306ca44bbbfee561f09c05af1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4200NotesDueMay2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if33ebc317b78463795ee17f17e4687e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4200NotesDueMay2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if99d5f53340d46e8bd01203577453158_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5350NotesDueFebruary2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38506247ccc740b692752b50a39ff3bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5350NotesDueFebruary2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i663d30885efc49f1b283db95c351ef37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e481989fbfb4b4bae07e9cdb93241db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fe27021be7848fb8ac2a70eb45943d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9f537d010f04ef2b408ff0b5e4a6240_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8358f864c6a94934b2ee1ed4c5380631_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d45d08ecf834726abad93ca937d8c57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c5629c7537c453dbdc9f344362a08b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i950071dee1cf4f1287c79566cbab2cde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fa1a2d080b742208f733a624feb7cc7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iada8fff11b964f0bb11cb946276b397a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i853b4b0cb13d41eab1caaefa962bea5d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i472b6a573ea24ab69839d586a4f2fc76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebaa87cecf5849d389bb300eb4709582_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifaeebd9e870e4ae4a60d0c58ad726851_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd52088b565542199acbe6f00c32c2e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9cc71855ae94636a016e4748db5e5bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c68342188ac441f993ea148f6163a3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8af022449e6a4052bbbe3d69f40cc5ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if96339900834441a90061dd06cd0727f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0467e40cfdc04f9da3be269b79fd4132_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if241f86fec94483e9fbedb583dc64e67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6ff2097150a4198a7408f57b7751209_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i178f10eeffe540c5b55f43219adb4530_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14f7e1b784e143aaa8c2fb4ee90e847b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5a73599312a49f2a409f094bbd99ae9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88ed0e3cddfb4ccd9187bd8407096c4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3290167c6c224581a5a44faf7d6e5ef4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6269a5a11644842a3cdb93e77b08b21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibfa1bdbe5afa44219cc32a23f3330036_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80325b3ceb8844d0bc983f1570151700_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if96f0c553fcd40a1a3f553dd366c0f73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d92492d202e4193b143e3b5fc891c52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i721180c4c3834dad88660c0cb0c92351_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id511dbd83f2c482f9a759b209e1292b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icff31eaf98fc4021bcccf6be5c93a0d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c973547dd8641f8bb987bf6ab8add1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibcfbf9e7699242f79053b6b8ba023aeb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i452493f8b4dd4009ad2e916fee82afdc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if51d52d41c444e478616b97fb188f33c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icab462ccd24d47938ac7bf5582916526_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i051acdfdac5443078c32017b27ef25f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48fe787e4f084d5aa237c9cb3982524d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i052454650bb34a24989f6fcdc6ad6074_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i435285040d2540dfad739c13df074973_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1cbcf2205a4446ea4843ad64f479218_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i174e953a70e649b0abb9a33cee93913f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4750NotesDueMay2052Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc19b7d8253640e1b39dcef330c1e8fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4750NotesDueMay2052Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5875NotesDueFebruary2053Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice983114f0894876a852c31fe9eeaded_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5875NotesDueFebruary2053Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia73b3065191a436988023a7ff6a43503_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i261cd0420bde47508c9875c124b4bfb3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86f9496f2f4045c2b66ee552d15fa61e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4950NotesDueMay2062Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3ed6067252342b3beb9989231672adc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4950NotesDueMay2062Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6050NotesDueFebruary2063Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d2eaa671ac44220bee9863ce3993ecf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6050NotesDueFebruary2063Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2c84ad3559147a5ab4604796f8bb30e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b889aeec8304b17a5381fabcfec7d9a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7dacb950b06e40cab3d250d7cdfde2ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4b90c42a12c946ec837aea2ac692cc5d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b01b3c71cd442d4844511a24216e1d5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i845de76c9b49482181876168457d3339_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3fbec7cfe19d43a8adf0ec061d38e36f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day60BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8eb087bedb274e389574fb540aacd661_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i967155a249994885831ed4f111f8cf37_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1da65d71f0dd4e81aa84de4084ebc16a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsExpirationBeginning2022Through2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if899e2bbae2a4cdcaba077976895f315_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsIndefiniteCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idec27badcb0040c193fecdd2c470c893_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10213ff0021745a28cd943688e293bc1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf652515b3f946d697a8265de969e276_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd5a3b32f141485db532001e40320ac0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6047cb915ab94ef08b29f7f33d60fce9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7c30621aa864465bb27533b234d6d21f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i725ab79c24d84374a71ef19f38657b54_I20180601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2018-06-01</instant>
        </period>
    </context>
    <context id="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-03-22</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-06-28</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-09-20</startDate>
            <endDate>2022-09-20</endDate>
        </period>
    </context>
    <context id="iab961e9490f040f8918f115ab2c74510_D20221213-20221213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-12-13</startDate>
            <endDate>2022-12-13</endDate>
        </period>
    </context>
    <context id="i5a9c77c9d2b940b8b4fb2feac66444f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cab9cb169cd4921a81a836726f5c3e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id58b7079211c4824b326bc35e2a79767_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i377663e135b146dbb9746caf29f61b57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc90f35441624e0781cac8a40b7b7e81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42347a2d22d847debe1ed99a8365998d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25a75221adee4bf19a028253ecab255e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if0040f0d323849ad809533e304a3b462_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibccf866bd05a4a2896a41120665646f8_D20230222-20230222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <context id="ibf85f3e8a0654801b32e765fe9e7b3c6_D20221003-20221003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-03</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="i484b05acf027495b8f4198fab7c44136_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">unh:ChangeHealthcareClaimEditingBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf8ade8a004149ceaea32126b946100e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">unh:OtherDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f48b3f3d16f409680853a60e0d463c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i33c272509ca243539b39dea750264213_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i417f470589084c168d167ef0c775d160_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:OtherAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iec887b8824d84342853f880a3d055fb6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:ChangeHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">unh:TotalAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i754570ab58fc4d7182d6cd5710942586_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i891eefd12c57404d9108f080872897e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50a501c583d645a99b8b9b5c5bd3990c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ecaa939f056424d93be40e9396e2d1b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5097e65e14e04df196818d6c688b1082_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5047c8cbb98d45d0ad2ec2d032462297_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if2456563e97441d1bb80a0655bda7af3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97182827e3a4490ab017b6b0ccdcf452_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i732a42f2250b413f9bf4d79507a6ca84_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fc651b1637d4ead98ae3d64f8fce1ac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i689a6bbc96bd48d585f1f0fbc711fc9f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e748f6babd44bad9db0b025d2907061_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3f024c91b7e04d99baa714309ff7e49d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22c12c65b54c4b4fa1799a4218c9359f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i47084b8e436448078c0d24c71476b120_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibad33ae2f3254e8eaa1c802d749df410_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d26bfed4a2840dbac69a2395c82ff6d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7cb993a994a549efade727a478d56969_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0409df6d86b94be7842cd2257a37957c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i248d4ab66d70471bae1895c28d10a5be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if41ca363996f43829716a67d979d12e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if345a50f546e449795e2b25318c9818f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0cd0dd9677e344fda1596618b18f13c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9d02f6e1b404ac4bfcb813025f3065c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad0e74178d75403b9dcc51a6a87d03de_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i40545db690df4fdab1edc363f3348827_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45c894858093498e826481908286c841_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35b418a686c3435f81ce58838debdcce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia79e6c55d1d440638042cab7fe05cad5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc5c6cb54c3b4b49bb104be3515415dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3f5aa82904754e72bda157c7a338ea81_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i36880bfb1c5e4252b9402bba5e8bb110_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i76e7a0df6f814853afea44e68161c529_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d927be6127444c59445557fe053bd65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id5960c3bd03745bd867211187b5890af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i59011503ab204f80b7e61b66d70a9f7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic696f2244b5b45a0a03c0ca407b18556_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iac00fded2bdc4a4dac5850a70ce34a56_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5ac679ac440453dbbb5734791641a4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b28e9f7a35f4490a7d651ae18c391b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia00c94487ebe47df9a45f96208eac209_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2342d40e00cb40539947ec67002a66b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d726a752eb3479e98a520f141c7da23_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice1915ab53004f139ae31ddb9f72017a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26f4f96795bf481cb58883eb91460381_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i169c3a6f69ec49c6ac21ea20f6face13_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3aa0861fc9d04b6b8a9cf15131f4eb4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i223709dbe1e1454e8275ba382402b2fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6809afc52ece49fcacd58ddeb9beed63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd994d74ba1e442eb1b7b78abad56ccf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbb19a9943ea410184b0ee7221e62372_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if552e01372d149efa80b89bd7e2901fa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieb6feddcc5aa4962a0a4685dc88ff2d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7d4124c98cc489db6bc12d6a7c0fa1b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec876717223b46bdb349de450e145cd6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f8c8b06009844a89aad8bfadcab6675_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f4aaba57e6c4369864d20305d9597f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e74aa00cb7f48a593354c1c326ec9d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4cc12cbad2f4be496364d6a29805345_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icbf5875ebba543508498353a5881cd21_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa3958921a164d51bdd2c4a6807a726f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i159f89cf2a8346398f76a7f71b7df182_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf477982ea1a42dc804d174211e45675_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4076c2027b2e4431ac707ea49e17d9e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i504afca956b443a6a9e4f9d9b46f543c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied0c09925613478d8fc3af0f46b15762_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if31927965e124d538b3490c3dadc7f93_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9491e68da6045a1a105dfe059072466_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic858c9047c604ac982e25d4ac7f8174d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa393fe15c9145e3b9ec03b58beca5dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07f6e178ccba45fab8978aea98c8fff1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic46ffe7b0c3c4ef38af41f18db200faa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01f93fadef4f46a5bc4fb990ddee2fc8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9edf57345d9043c1b11e892820ff85bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i233c15dc654d469288951d04a08c0455_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibba020e43c45460cb04de6fcc9b74a76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34bb0b4a48194f55ba64445c9848a45d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i564486a1b728438ca7fbb3d76dfad1cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i19bd530a243c4e92be077f1a53ed69e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d4008ea094942efa92959f01e189555_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i796f9087920a40eca6b04eca756a0128_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ideb0b864fd8c4a6782eef98e1bafa761_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71cf336cf55d404f864835404f2b5d2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1c572dcc2604feabe05f8761531ce09_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifefb573c3bb8436dbf231adeb4c351db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9734c2c7137d4a14a49e90c235063d38_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i276a8b65f2b4434dbee38c4c9687ce8d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86e84564ba4746deab13cdd483c38f04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb51ddb53efb4127a03b364bd9fb3504_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5476d1544885436791b5b43717779607_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7245c7c22b7746e094b0d6835d7ae680_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a5f2ae790b74bfabb249a00198978be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee98fc17838d4daf98c0b0585eb7ed06_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97245d594a044b1f8d34eb031374888c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9dcfadfac12645d4b3082944a122cc9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0caf62223ca54bb185679fac378d4f52_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c6a40d1db7f44589224803d71e3e1e6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7465d3a1afe74c3d8718ba6192a453ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14f892617f3049c3a1e27ad2c9dec0ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7caba0486123421da056d84dc2fa69de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i110b9761945d4e40813f9a8bbed2a310_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29c821411e9b45e392b05177c8f28d1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idec591a925cd42b7a547da2ee176f02d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd6ee17d39bd4e0bac8d7e0aa55cc85f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia51588dda918456aa393e95440d4bdc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d4c76f5de1d474bac108f73781f88df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ad8c812d379411bb81c7ce92abd8232_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8a17770576849b184901ef11ae7bade_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3f868329b34b47d3b53f4028690c339c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93b5990f30984481b9bc048adaeb8fbb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff2e15c2a33d49639d714c65b404e2cc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="positions">
        <measure>unh:positions</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF8zLTEtMS0xLTUxOTM1_d9b4e970-d03c-462f-8cee-b58fa6072f78">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF80LTEtMS0xLTUxOTM1_445af4b1-ad07-4e78-9981-5a70a6f4087d">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF81LTEtMS0xLTUxOTM1_f37da0b3-78a0-422f-8585-cf721cbf8f29">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF82LTEtMS0xLTUxOTM1_84aac7fd-d0d2-419b-ab44-6d9abf173641">0000731766</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN180L2ZyYWc6NTFiMzIwZjY3N2I2NDhjNThmYzkxYmIwNjAwZWE5ZWYvdGFibGU6NWYxNTcxYWY5OWFiNDY1YmJkNDU4YTA2NGMxNzZlMDgvdGFibGVyYW5nZTo1ZjE1NzFhZjk5YWI0NjViYmQ0NThhMDY0YzE3NmUwOF83LTEtMS0xLTUxOTM1_23f311e0-a29a-4eda-a556-6f28ea35ef55">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8xLTEtMS0xLTY2MTI2_545fe2fc-d00e-453f-bd4b-4ba4491b8ec3"
      unitRef="usd">877000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8xLTMtMS0xLTY2MTI5_b2158bb1-41db-42af-8bb6-fde9bfbd78d0"
      unitRef="usd">954000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8yLTEtMS0xLTY2MTMx_a285ae78-23f8-47cf-a826-8a9a31f89e09"
      unitRef="usd">1433000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8yLTMtMS0xLTY2MTMz_195eff6e-e463-4e6d-88ed-ef36d34f839b"
      unitRef="usd">993000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8zLTEtMS0xLTY2MTM1_0770cf37-46a3-425a-8de8-58a3e0f3acc4"
      unitRef="usd">6930000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF8zLTMtMS0xLTY2MTM5_80ca054b-92bc-44f5-8d9d-77b8ff5677ad"
      unitRef="usd">5992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF80LTEtMS0xLTY2MTQy_4d7d4ed5-521a-48b4-9482-002e9534785d"
      unitRef="usd">6137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzYwL2ZyYWc6MjBlOWI2ZTg1Y2VjNGI5MzlhYWIzN2E5ZDExYWJlOTYvdGFibGU6M2I4MjgyYzIxOWIyNGJiYThjYzhlMzMwMzAwYmU5NDQvdGFibGVyYW5nZTozYjgyODJjMjE5YjI0YmJhOGNjOGUzMzAzMDBiZTk0NF80LTMtMS0xLTY2MTQ1_e69e1899-a4e8-414a-a377-6394dcecf5ef"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDkvZnJhZzowNDEzZDVlMWMzNzI0MWEwOWM4MmIzYmNhMjc0YmZiMi90YWJsZTozZDNlOThkNDViZTE0YzY4YmM5MjNkODc2NzVkYTk0ZC90YWJsZXJhbmdlOjNkM2U5OGQ0NWJlMTRjNjhiYzkyM2Q4NzY3NWRhOTRkXzAtMS0xLTEtNTE5MzU_3ef67c95-993f-4f7a-9bd1-425732e886c2"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDkvZnJhZzowNDEzZDVlMWMzNzI0MWEwOWM4MmIzYmNhMjc0YmZiMi90YWJsZTozZDNlOThkNDViZTE0YzY4YmM5MjNkODc2NzVkYTk0ZC90YWJsZXJhbmdlOjNkM2U5OGQ0NWJlMTRjNjhiYzkyM2Q4NzY3NWRhOTRkXzEtMS0xLTEtNjQ3MjQ_509864c5-b1d5-4efc-97ac-0561255c309a"
      unitRef="number">0.50</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib5ca65e3b5464e3a90bff8be81bf61c2_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86">http://fasb.org/us-gaap/2022#OtherLiabilities</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i7dacb950b06e40cab3d250d7cdfde2ee_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMDU_6c33a52c-1144-4e22-89da-18fc6460dbfe">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i8b01b3c71cd442d4844511a24216e1d5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMjI_945de3a2-7233-4e80-9a06-96283be1135b">P3Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEtMC0xLTEtNTE5MzU_1fcf593b-97e3-4fdc-8b3b-53005b0552d2">2023-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEtMS0xLTEtNTE5MzU_a4beafee-2dbb-4018-b2c9-48879a12b97d">2037-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzMtMC0xLTEtNTE5MzU_8b79f4db-eabe-4fc4-9afb-6dce3861c501">2023-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="iaf652515b3f946d697a8265de969e276_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzMtMS0xLTEtNTE5MzU_71d7326d-da50-4575-9475-dff034ec3bdf">2042-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:OpenTaxYear
      contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzYtMC0xLTEtNTE5MzU_508c77c5-15ac-40b4-b08f-f0f87e96e2e2">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzYtMS0xLTEtNTE5MzU_cd69f7b9-195a-4b13-8c92-1e83e7e46879">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzgtMC0xLTEtNTE5MzU_7847cd2c-e2e9-414e-8a19-4d94ce360902">2014</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="iaf652515b3f946d697a8265de969e276_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzgtMS0xLTEtNTE5MzU_98bad51a-8b59-44ef-943c-2eb19bed6a7c">2022</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i10213ff0021745a28cd943688e293bc1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEwLTAtMS0xLTUxOTM1_06e8d468-fd91-440a-8482-fb4766bc21f8">2015</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="icd5a3b32f141485db532001e40320ac0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTMvZnJhZzo0MjFhMTM2YTcyNzA0OWViYjczYmI5NzUwYWIzM2Q3Yy90YWJsZTo4NzUyYWIwOTE0ZDM0N2Y5YjNkNWJhNjAxNjM4ZWNmNS90YWJsZXJhbmdlOjg3NTJhYjA5MTRkMzQ3ZjliM2Q1YmE2MDE2MzhlY2Y1XzEwLTEtMS0xLTUxOTM1_62c41117-5839-4840-9066-7652e8283787">2022</us-gaap:OpenTaxYear>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtMS0xLTEtNTE5MzU_3dc9af03-3d3b-4cec-8d04-5b22246cb637"
      unitRef="number">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtMi0xLTEtNTE5MzU_b4f2151e-5ead-43de-8790-0eba17c87a62"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNC0xLTEtNTE5MzU_a964805a-c382-4be8-ae87-3b03e3eea080"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNS0xLTEtNTE5MzU_79dd3db8-aae1-42f1-a61b-682cc603a98a"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtNy0xLTEtNTE5MzU_6a0a2fba-2a08-40cd-94cb-76331c2f2ce8"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEtOC0xLTEtNTE5MzU_6ff9c569-a7ce-429a-bee6-ee1d00dcf3f2"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItMS0xLTEtNTE5MzU_819f923c-8bde-4b9d-bcee-4866c960561e"
      unitRef="number">0.306</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItMi0xLTEtNTE5MzU_15a15be1-e5cb-4d97-80e0-434435c23ed3"
      unitRef="number">0.308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNC0xLTEtNTE5MzU_f902f861-a6c9-4db9-97a5-5d4cf91c54a5"
      unitRef="number">0.292</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNS0xLTEtNTE5MzU_80cc383b-364c-4bc8-8518-115b962d5186"
      unitRef="number">0.298</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItNy0xLTEtNTE5MzU_71fcf6c2-a468-42da-8e48-0125c2a91774"
      unitRef="number">0.222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzItOC0xLTEtNTE5MzU_b3ab6237-10f7-4c49-b2b5-7a870d2a4ebe"
      unitRef="number">0.295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i25a75221adee4bf19a028253ecab255e_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtMS0xLTEtNTE5MzU_5b996c45-bc15-4419-961d-7ed41f2563fe"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i314f05ac3f69476d94f652fb89931e2c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtMi0xLTEtNTE5MzU_bb16e5b5-b009-4089-abc3-a2416ba5e24b"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i8526a75b0a714b5d8cadf749bc91bd05_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNC0xLTEtNTE5MzU_322e7800-34bc-4409-8924-89e52caf5fb1"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if0040f0d323849ad809533e304a3b462_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNS0xLTEtNTE5MzU_54c90838-64d8-423e-ad71-b559b1779b7c"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia4922f1726e842b4acdef5ad341f7821_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtNy0xLTEtNTE5MzU_40eb6c11-1efb-430a-aabb-4c7f70c185c6"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2697651ab2cc43c2adaae8f4897b5a6f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzMtOC0xLTEtNTE5MzU_392e7ff0-f1b8-490c-a572-f4fcf4964b33"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtMS0xLTEtNTE5MzU_89ac1ba6-58b1-43c7-a5d9-0e9993d08b73">P4Y8M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtNC0xLTEtNTE5MzU_2642ae31-98dc-44b7-98e5-ad3e221d490e">P4Y9M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzUtNy0xLTEtNTE5MzU_8ed53612-22db-449d-8a31-fa168f9024b4">P5Y1M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzgtMS0xLTEtNTE5MzU_ac427e08-c1c1-4f4b-8e76-6e38161f4274">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzktMS0xLTEtNTE5MzU_e822140b-edb6-40c1-b246-14d471ef689b">P4Y4M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEwLTEtMS0xLTUxOTM1_a20890c0-9424-4144-a770-12f86d89d140">P5Y8M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDUvZnJhZzo5YWRiYjJiNThmYWY0MDQyYjU5N2EyM2MyMDVhYmZlOC90YWJsZTo4MmZlNWQwMjlmZjU0N2VmYmJhYWRlNWQyNzIxYjA2MS90YWJsZXJhbmdlOjgyZmU1ZDAyOWZmNTQ3ZWZiYmFhZGU1ZDI3MjFiMDYxXzEyLTEtMS0xLTUxOTM1_754625ea-1efd-4e08-b692-ef0b8843dbb3">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dei:DocumentType
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xNDU_3094c49a-e43d-43a8-8a73-79ba219df9e3">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZjQ1YmM4OWFiYWU1NGM3NTljYjJhZTcwYzA4Yzk1MWMvdGFibGVyYW5nZTpmNDViYzg5YWJhZTU0Yzc1OWNiMmFlNzBjMDhjOTUxY18wLTAtMS0xLTUxOTM1_55a05a34-95d0-4219-8af3-d31d62d450ee">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF81NDk3NTU4MTc1MzY_160634fb-12be-4349-a3a9-06fa253bfa87">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTEyZDU3NjNiMDk1NDIzMDg5ZjI1MTAyODllYzYwNDMvdGFibGVyYW5nZTphMTJkNTc2M2IwOTU0MjMwODlmMjUxMDI4OWVjNjA0M18yLTAtMS0xLTUxOTM1_0a2086f6-c7c7-4c25-b767-6bf06a65b474">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yNjQ_7769b47e-3696-4928-918c-f9d5b2fd95ec">1-10864</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zMzA_94e1aee1-9bcb-4d27-bf0d-390fe5b431b0">UnitedHealth Group Incorporated</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8wLTAtMS0xLTUxOTM1_7415e08b-cbe7-4954-8730-7d94366cfcd4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8wLTMtMS0xLTUxOTM1_a7a5454c-dc04-4b7a-8044-f8d1fc4f6c57">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8zLTAtMS0xLTUxOTM1_56b59762-93aa-4498-86f3-6757f9155e56">UnitedHealth Group Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl8zLTMtMS0xLTUxOTM1_e9c23f3c-6f40-4639-a77f-4817c0efbe98">55343</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressAddressLine2
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl80LTAtMS0xLTUxOTM1_b8b008ea-4c9d-41ef-bea5-1792fbc8b821">9900 Bren Road East</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl81LTAtMS0xLTUxOTM1_8bacb667-77fd-4b6f-b658-980cb7ab3e13">Minnetonka,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6NDYzMmVmNGVmMWQzNGNhZDg5ZWQ3ODBlODQzOWJjYzYvdGFibGVyYW5nZTo0NjMyZWY0ZWYxZDM0Y2FkODllZDc4MGU4NDM5YmNjNl81LTEtMS0xLTUxOTM1_cbd3b502-7dbd-40a1-a1ce-c252486ca8a3">MN</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zOTI_25d06060-d678-4745-9204-cd216876128c">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zOTY_be1f2cc8-a989-489d-8651-af464ef0a185">936-1300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTAtMS0xLTUxOTM1_6e0c8cb5-47c7-400c-b0fa-ddfb879f9cca">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTItMS0xLTUxOTM1_b555b280-f981-4a75-9273-7e8b6cfec54f">UNH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6ZThmNTVhMDQ4YTJiNGQ1MTk0MjQ0MDM2YTQzNzNjMjEvdGFibGVyYW5nZTplOGY1NWEwNDhhMmI0ZDUxOTQyNDQwMzZhNDM3M2MyMV8xLTQtMS0xLTUxOTM1_6a323db3-1a36-4e10-8a6c-50054b0c8342">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF84MjE_ab8372c7-97f6-4187-aa21-e694016fdced">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF85NjY_d7ab3626-dcc5-4cc5-83fb-3881c81b4cdc">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xMzE2_4d9e98ee-3caf-4b71-83db-72f4e9b5ab7e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8xNjMx_0e8ac010-eb7d-4b26-866c-888077082a26">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8wLTAtMS0xLTUxOTM1_9b5d750d-8272-4997-971e-03679f467b59">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8xLTEtMS0xLTUxOTM1_0e36d528-d1a6-4faa-ab98-539b4ebdf3d0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGFibGU6YTkxYjk4Nzc2ZTIxNDQ0ZTk4OGUwZDViM2UzMDgyZDEvdGFibGVyYW5nZTphOTFiOTg3NzZlMjE0NDRlOTg4ZTBkNWIzZTMwODJkMV8xLTctMS0xLTUxOTM1_a9ebe594-9a8c-43b2-98c8-cafc0d25c715">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zNjEx_94cca75c-8d0e-4c46-bcc6-c95e1c7ec39f">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yNjk2_916be1d4-3c27-480e-bc19-2aaca7c26232">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i4bfe1147b61f43029e188dfba9f8d0a1_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8yODEy_cb6652b2-233b-4889-8e22-09e0826031df"
      unitRef="usd">479550880245</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i85e6f017f088486bb2c8d3093e1e73c3_I20230131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zMTAx_36e82fad-6365-4b61-977f-ee53e6178516"
      unitRef="shares">932846602</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xL2ZyYWc6M2ZhYjA3MTdmZDM0NGRlM2E4YWQ2YmRkMjFkZGEyNTgvdGV4dHJlZ2lvbjozZmFiMDcxN2ZkMzQ0ZGUzYThhZDZiZGQyMWRkYTI1OF8zNjEw_49721ca8-c6e0-4cff-91aa-acbd4e3c8f97">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#x2019;s definitive proxy statement relating to its 2023 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183MC9mcmFnOjE4OThlOTAzOTUyNDRhNzFhNWQwYTNiNTNmOGY0NjUyL3RleHRyZWdpb246MTg5OGU5MDM5NTI0NGE3MWE1ZDBhM2I1M2Y4ZjQ2NTJfMzU0OA_ea80e291-1ec9-438c-a3ac-6a291c343771"
      unitRef="usd">3700000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <dei:AuditorFirmId
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183My9mcmFnOmVlNzVhZGRiODM5MjRmODE5NmI2YjJiYjNlMTI1YWY5L3RhYmxlOjdkNmIxOGE0ZDJkZDRmYjlhMzZlN2Y4OTkwMDI1N2Y3L3RhYmxlcmFuZ2U6N2Q2YjE4YTRkMmRkNGZiOWEzNmU3Zjg5OTAwMjU3ZjdfMi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjMwOWJkMDA5MDI2MzQ0YmI4YWY5Nzk4NmEyMTEwYWNlXzc0_8d782c06-09cc-4639-801c-3e1b300fb245">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183Ni9mcmFnOjczZDIxNGVkOWFkYjQ0YjlhMGZiOTNkN2ZmYmYzM2I5L3RhYmxlOjhlMjc4Nzg0MmEwMzRkN2FhMjk3ODViMzkyMzJiNTA4L3RhYmxlcmFuZ2U6OGUyNzg3ODQyYTAzNGQ3YWEyOTc4NWIzOTIzMmI1MDhfMC0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg2NWIyYTA1ODI1YzQxN2FiZGZlNjYzMzc5NDY2MDFlXzg_8542e41c-29b5-44c7-82cc-ba87ccca8a33">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183Ni9mcmFnOjczZDIxNGVkOWFkYjQ0YjlhMGZiOTNkN2ZmYmYzM2I5L3RhYmxlOjhlMjc4Nzg0MmEwMzRkN2FhMjk3ODViMzkyMzJiNTA4L3RhYmxlcmFuZ2U6OGUyNzg3ODQyYTAzNGQ3YWEyOTc4NWIzOTIzMmI1MDhfMi0wLTEtMS01MTkzNQ_b40ae886-6eca-4fe5-b83c-29303a5ad1ec">Minneapolis, Minnesota</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMy0yLTEtMS01MTkzNQ_616088fa-ec78-4c3e-a5e3-097fae718923"
      unitRef="usd">23365000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMy00LTEtMS01MTkzNQ_3f93c4d5-909c-454d-a6f4-f049cc3c973d"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNC0yLTEtMS01MTkzNQ_a4043e1f-f6f2-443b-9385-9136517cbcb5"
      unitRef="usd">4546000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNC00LTEtMS01MTkzNQ_737e2b3b-8882-4cd7-924f-bf62dddbec11"
      unitRef="usd">2532000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOmJmNjJmMzM0ODc5YjQ5YWNiN2IyZTg1NmViZTY5Mjg4Xzc2OTY1ODEzOTQ0OTU_545fe2fc-d00e-453f-bd4b-4ba4491b8ec3"
      unitRef="usd">877000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOmJmNjJmMzM0ODc5YjQ5YWNiN2IyZTg1NmViZTY5Mjg4Xzc2OTY1ODEzOTQ1MDI_b2158bb1-41db-42af-8bb6-fde9bfbd78d0"
      unitRef="usd">954000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS0yLTEtMS01MTkzNQ_ba065e18-73e3-4349-8794-c2fa1a4f8455"
      unitRef="usd">17681000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNS00LTEtMS01MTkzNQ_f6a32f2f-b34f-4e2a-a69d-e48a39baadcf"
      unitRef="usd">14216000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg1NzBmYjYzMmNmNjQ5ZjE5Yjc5YzMyYTMxYmZjMzZhXzc2OTY1ODEzOTQ1MDU_a285ae78-23f8-47cf-a826-8a9a31f89e09"
      unitRef="usd">1433000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjg1NzBmYjYzMmNmNjQ5ZjE5Yjc5YzMyYTMxYmZjMzZhXzc2OTY1ODEzOTQ1MTI_195eff6e-e463-4e6d-88ed-ef36d34f839b"
      unitRef="usd">993000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi0yLTEtMS01MTkzNQ_2d6da204-dba0-4485-a2bc-145ce172b8fc"
      unitRef="usd">12769000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNi00LTEtMS01MTkzNQ_e737fe45-dd0f-4a0d-b333-6573879a8abf"
      unitRef="usd">13866000000</us-gaap:OtherReceivablesNetCurrent>
    <unh:AarpAssetsUnderManagement
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNy0yLTEtMS01MTkzNQ_e491355a-3ba1-43af-a151-b545ab7a610f"
      unitRef="usd">4087000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfNy00LTEtMS01MTkzNQ_c60dc09f-d90f-4019-bf48-244bf9fa8fe8"
      unitRef="usd">4449000000</unh:AarpAssetsUnderManagement>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOC0yLTEtMS01MTkzNQ_2e7d0b36-debf-4d7e-9839-c11f05ca8232"
      unitRef="usd">6621000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOC00LTEtMS01MTkzNQ_af67c83d-a65c-4578-8e8d-26a711e7fa06"
      unitRef="usd">5320000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOS0yLTEtMS01MTkzNQ_ac4162fb-1de6-4234-9306-55958f47c5db"
      unitRef="usd">69069000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfOS00LTEtMS01MTkzNQ_95c5b739-2f27-49b0-94c4-0cd6f2682bc1"
      unitRef="usd">61758000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTAtMi0xLTEtNTE5MzU_0b1ca43d-d230-45a1-b0dd-28d78d17b71a"
      unitRef="usd">43728000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTAtNC0xLTEtNTE5MzU_93ff0895-42e8-4ee1-bc57-4dccc36162a1"
      unitRef="usd">43114000000</us-gaap:LongTermInvestments>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjphYjcwNzI3M2NlYjg0YzQyYjhjMzYwYWZiM2RiZTExMV83Njk2NTgxMzk0NTU3_0770cf37-46a3-425a-8de8-58a3e0f3acc4"
      unitRef="usd">6930000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjphYjcwNzI3M2NlYjg0YzQyYjhjMzYwYWZiM2RiZTExMV83Njk2NTgxMzk0NTY2_80ca054b-92bc-44f5-8d9d-77b8ff5677ad"
      unitRef="usd">5992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtMi0xLTEtNTE5MzU_72d5cce9-7ab8-4f84-9045-a5fb9b2c7e78"
      unitRef="usd">10128000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTEtNC0xLTEtNTE5MzU_9209cebe-1033-45cf-b942-70bf5a5ac76d"
      unitRef="usd">8969000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTItMi0xLTEtNTE5MzU_ac1b5c93-463a-4097-a796-cd1a0aff0763"
      unitRef="usd">93352000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTItNC0xLTEtNTE5MzU_e3028456-cc32-4576-aceb-3adefc52438b"
      unitRef="usd">75795000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjozN2MzNTVmMjJiN2U0YTViYTYyZWY2YjNiMjc4OGI3MV83Njk2NTgxMzk0NTE5_4d7d4ed5-521a-48b4-9482-002e9534785d"
      unitRef="usd">6137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjozN2MzNTVmMjJiN2U0YTViYTYyZWY2YjNiMjc4OGI3MV83Njk2NTgxMzk0NTI4_e69e1899-a4e8-414a-a377-6394dcecf5ef"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtMi0xLTEtNTE5MzU_9b37214f-ce4d-4a57-b29e-e9f553bc2f1e"
      unitRef="usd">14401000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTMtNC0xLTEtNTE5MzU_aaba994a-bcfc-4d6d-bc6c-e54c5c0a6b32"
      unitRef="usd">10044000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTQtMi0xLTEtNTE5MzU_c545b6a1-eee2-41fc-9704-186845172e92"
      unitRef="usd">15027000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTQtNC0xLTEtNTE5MzU_b7a238de-9c71-4160-a41c-a73a2a085b13"
      unitRef="usd">12526000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTUtMi0xLTEtNTE5MzU_c8b758cd-a0e5-4689-8ab3-8b5dbe21601d"
      unitRef="usd">245705000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTUtNC0xLTEtNTE5MzU_49f39d10-28e5-4ce3-a5c6-409186127ac5"
      unitRef="usd">212206000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTgtMi0xLTEtNTE5MzU_3f701722-8f8b-4bcb-a013-47744474bd3a"
      unitRef="usd">29056000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTgtNC0xLTEtNTE5MzU_219718d6-7036-4263-8c14-000497d27d08"
      unitRef="usd">24483000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTktMi0xLTEtNTE5MzU_89a3820f-01ba-43a1-a34c-449adce21658"
      unitRef="usd">27715000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMTktNC0xLTEtNTE5MzU_8ce5862b-dfde-4d6a-8f99-34b0d9250dac"
      unitRef="usd">24643000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjAtMi0xLTEtNTE5MzU_c13484a4-e534-4cb2-8f5d-22e6b2db712d"
      unitRef="usd">3110000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjAtNC0xLTEtNTE5MzU_04943911-b874-4d9d-a7fd-91658ff38374"
      unitRef="usd">3620000000</us-gaap:DebtCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjEtMi0xLTEtNTE5MzU_0ec26411-9537-497b-b9d0-1a8387676a8b"
      unitRef="usd">3075000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjEtNC0xLTEtNTE5MzU_3898a4a7-ddab-461e-aa2d-0ad88f614a7f"
      unitRef="usd">2571000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjItMi0xLTEtNTE5MzU_1c810ca8-8d7f-4420-b403-c3bcad502e96"
      unitRef="usd">26281000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjItNC0xLTEtNTE5MzU_ef30296e-41db-4179-b0e2-7b908905f356"
      unitRef="usd">22975000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjMtMi0xLTEtNTE5MzU_77a02135-0833-400f-8607-67840942ef4b"
      unitRef="usd">89237000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjMtNC0xLTEtNTE5MzU_cc28956f-4515-474e-99e4-34ac5908a258"
      unitRef="usd">78292000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjQtMi0xLTEtNTE5MzU_46af7479-9c07-4408-83bc-4091178e54a9"
      unitRef="usd">54513000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjQtNC0xLTEtNTE5MzU_3b915ad9-b67f-45bb-b46f-b3512f927697"
      unitRef="usd">42383000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjUtMi0xLTEtNTE5MzU_9c0f699a-8f2c-4b2b-aae7-dbe88c66e9b3"
      unitRef="usd">2769000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjUtNC0xLTEtNTE5MzU_2835a5f4-365e-4d0e-a1d3-c8457f34db4f"
      unitRef="usd">3265000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjYtMi0xLTEtNTE5MzU_8a0360bd-a03c-455a-ac2b-1c9908812b91"
      unitRef="usd">12839000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjYtNC0xLTEtNTE5MzU_9544a769-cb5b-4fed-b653-285770d59a81"
      unitRef="usd">11787000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjctMi0xLTEtNTE5MzU_b51b335a-05e2-4922-a9bc-4bd6ec57e8b8"
      unitRef="usd">159358000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjctNC0xLTEtNTE5MzU_faabdff6-6bd8-4afb-8b97-4b1329fd20a9"
      unitRef="usd">135727000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjgtMi0xLTEtNTE5MzU_f83097fa-e63c-4565-a967-12eb99ef48c7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjgtNC0xLTEtNTE5MzU_7319a1b4-f7e1-44f5-b900-95601cea20bd"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjktMi0xLTEtNTE5MzU_981460fe-e6dc-44e2-8b6c-f7ef4e81cb82"
      unitRef="usd">4897000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMjktNC0xLTEtNTE5MzU_72a440c5-0afc-4b1a-8c1e-1026da9a51b8"
      unitRef="usd">1434000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTM5_2a7f541c-d2a9-4297-bdfb-f08e72e65d8f"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTM5_5b0ac684-3b4f-4454-9c51-07ff08845f86"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ0_773eb662-6d8a-4dc6-a88a-f5287e5285d8"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ0_caa978fd-4c12-4d4b-b711-268b3a8d88aa"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_2b72dbe4-14fd-4e7a-825d-11e0eb4fa0d7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_e01f5cd9-307b-454f-979f-c60d8162ad26"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_e631b875-21e9-4694-800f-f4973b828fff"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowMmY4ZDI1MDk5MjE0M2U1OTAzOThjZGFiYjJjYTIyNF8yNzQ4Nzc5MDY5NTQ5_f78796cb-a186-4625-8862-73ae6fb0d457"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtMi0xLTEtNTE5MzU_36b9888f-f44f-407c-9f94-8c83a61c0cac"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzEtNC0xLTEtNTE5MzU_d577dc9c-a36a-40e3-8fa9-288c46084f13"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQw_340668c6-872c-439d-baf9-4dcf625590fb"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQw_c8ecb272-995c-4850-b02b-87b54f086e67"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQ4_0dfbad99-02c8-4b64-8750-e68ba16ff27a"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTQ4_79d10d26-59ad-47d7-9bfb-66b646670946"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTU0_b231a3a8-d2b6-4cc3-b2e1-7189f3304521"
      unitRef="shares">934000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTU0_e671cfad-3398-4fe1-b57a-c468617e2029"
      unitRef="shares">934000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTYw_39a42b5c-ba9a-40c8-979b-e206ad1c91e2"
      unitRef="shares">941000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpjMWJkMDY4NDNkNDU0ZjdkYTdmMzFlZjlhNDc2MTZlN18yNzQ4Nzc5MDY5NTYw_7af98c72-ff45-4425-a8f9-c0d1a15a4ab0"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItMi0xLTEtNTE5MzU_0d0beb59-44c9-4f74-a6b1-f2e96f8ac024"
      unitRef="usd">9000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzItNC0xLTEtNTE5MzU_26972b29-c656-4941-b1ce-27b3d12614c0"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzQtMi0xLTEtNTE5MzU_3cce2527-6876-4db7-991e-b3f98312cffb"
      unitRef="usd">86156000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzQtNC0xLTEtNTE5MzU_6b328e6d-12bc-4b34-b4ef-e27880d5a0b2"
      unitRef="usd">77134000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzUtMi0xLTEtNTE5MzU_03737753-4e12-456f-bf5e-f1dcd49b4582"
      unitRef="usd">-8393000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzUtNC0xLTEtNTE5MzU_4848ae1b-648e-4c15-ab27-347fae066ad9"
      unitRef="usd">-5384000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterest
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzYtMi0xLTEtNTE5MzU_40ad620f-f9a7-4383-a9d0-17af25a139db"
      unitRef="usd">3678000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzYtNC0xLTEtNTE5MzU_3da19188-d922-46f7-a4e2-2d5f99f1d9ac"
      unitRef="usd">3285000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzctMi0xLTEtNTE5MzU_1841acb0-d52c-472a-ac25-1c399baeff56"
      unitRef="usd">81450000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzctNC0xLTEtNTE5MzU_9570e275-d0d4-44bd-9c54-43a4b73001d4"
      unitRef="usd">75045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzgtMi0xLTEtNTE5MzU_19387f8f-31f8-408e-ace3-94d75e757ee9"
      unitRef="usd">245705000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN183OS9mcmFnOjc0MWNhZTFhNmQzZDQ5YjE5NmRkNGQ2ZTU1MThiMGUxL3RhYmxlOjIxZjY0OTRhNzk1MzQ1ODQ4YjIyOTJmNDY1ZmZjODViL3RhYmxlcmFuZ2U6MjFmNjQ5NGE3OTUzNDU4NDhiMjI5MmY0NjVmZmM4NWJfMzgtNC0xLTEtNTE5MzU_c9c1ca87-0100-4928-9112-e1897e46955e"
      unitRef="usd">212206000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy0yLTEtMS01MTkzNQ_bf54ea8b-1b85-46af-94b0-20ded80ae384"
      unitRef="usd">257157000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy00LTEtMS01MTkzNQ_15eb6cc0-97aa-44d7-b6f5-0228b0e32e66"
      unitRef="usd">226233000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMy02LTEtMS01MTkzNQ_f7a73e8c-52c9-49c7-a019-6fccb56d61ba"
      unitRef="usd">201478000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4783b4127e2144999741c7d04d466e2e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC0yLTEtMS01MTkzNQ_f4bde60a-2fed-4938-bbd0-003a64a69f90"
      unitRef="usd">37424000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i528146a5cf87439684c37a24329083d0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC00LTEtMS01MTkzNQ_c18e3db6-df9b-4ee2-b502-7ff67619baa2"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8d105042b9242e3a67b99461ff390ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNC02LTEtMS01MTkzNQ_0a6469bc-61d1-4bb0-bf33-4f0a3ca2927a"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2f53e27fa72436f92deccfb277741ef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS0yLTEtMS01MTkzNQ_89396db2-0b3a-450f-981e-f6299ca29e7e"
      unitRef="usd">27551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib75f2b5ddba14b25908ed51f2abe23fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS00LTEtMS01MTkzNQ_82c2b641-93f9-4744-b21c-0c211143147c"
      unitRef="usd">24603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6440bd164d594884b755b5b9ff031b02_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNS02LTEtMS01MTkzNQ_76b38cac-915a-45a0-9ee2-e5230988ac82"
      unitRef="usd">20016000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi0yLTEtMS01MTkzNQ_be7d6e51-1aed-416c-b5c0-2b59df9de5af"
      unitRef="usd">2030000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi00LTEtMS01MTkzNQ_74dcdeba-c11a-47f0-9cf5-59ae717ad40b"
      unitRef="usd">2324000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNi02LTEtMS01MTkzNQ_5145e732-9ab1-45d0-92dc-302a24ff9d38"
      unitRef="usd">1502000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy0yLTEtMS01MTkzNQ_a2a0e424-a40f-4fc4-81cf-ad8359881979"
      unitRef="usd">324162000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy00LTEtMS01MTkzNQ_ac8faf32-93b1-433e-868e-98a53760ce74"
      unitRef="usd">287597000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfNy02LTEtMS01MTkzNQ_7829dd87-fc84-4bd0-9410-358bac3c5e93"
      unitRef="usd">257141000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS0yLTEtMS01MTkzNQ_8cf6dfda-38b5-428a-83c3-ef4dc26b1ea3"
      unitRef="usd">210842000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS00LTEtMS01MTkzNQ_b0b9ebb9-1edb-4b38-a0e4-ea3b9e1c94d9"
      unitRef="usd">186911000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfOS02LTEtMS01MTkzNQ_8537c6a1-3a33-4976-9349-bbc332b57b27"
      unitRef="usd">159396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtMi0xLTEtNTE5MzU_a846f1d2-bcdf-4d84-8a3b-291afe6c51d9"
      unitRef="usd">47782000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtNC0xLTEtNTE5MzU_17f3223e-ed1f-4d25-a6ee-15c4bc73ed4b"
      unitRef="usd">42579000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTAtNi0xLTEtNTE5MzU_a9535560-8d48-44de-abad-8f109b465ed7"
      unitRef="usd">41704000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtMi0xLTEtNTE5MzU_3d1d5c78-195b-4e5f-a68a-d31e3390b8de"
      unitRef="usd">33703000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtNC0xLTEtNTE5MzU_e93061f7-c1d0-4ebb-b66f-4d8a0d794702"
      unitRef="usd">31034000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTEtNi0xLTEtNTE5MzU_4010f949-032c-4887-98e1-593f008d668c"
      unitRef="usd">30745000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItMi0xLTEtNTE5MzU_742c6195-1133-4c38-882d-d633a39604e0"
      unitRef="usd">3400000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItNC0xLTEtNTE5MzU_16fb8eed-b2fd-42ae-b722-f6f2605e65b8"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTItNi0xLTEtNTE5MzU_2b93013b-b141-49e0-9f8e-5c6f16133291"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtMi0xLTEtNTE5MzU_33452e65-e6e2-40c1-acf4-85d2f69e2a6b"
      unitRef="usd">295727000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtNC0xLTEtNTE5MzU_f286399e-b1ec-4d67-82c4-05d19c8ed5f3"
      unitRef="usd">263627000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTMtNi0xLTEtNTE5MzU_f51da3cc-b842-494e-8715-7b8e2c3bc658"
      unitRef="usd">234736000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtMi0xLTEtNTE5MzU_15461e80-89f6-4789-9c28-bb418ba877b2"
      unitRef="usd">28435000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtNC0xLTEtNTE5MzU_36527cba-5784-4b04-92ce-02eeca50f5ab"
      unitRef="usd">23970000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTQtNi0xLTEtNTE5MzU_eb7ddb76-d115-436c-b2fa-4418b1bdc8d4"
      unitRef="usd">22405000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtMi0xLTEtNTE5MzU_c0c2c376-7548-4887-9b4a-5448275b7a28"
      unitRef="usd">2092000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtNC0xLTEtNTE5MzU_b929f3dd-69d3-43ca-8b16-7388f408d5db"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTUtNi0xLTEtNTE5MzU_cbf52fa1-2ce0-4d29-a4de-74cc6971a78a"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtMi0xLTEtNTE5MzU_0b9d8b54-041e-46d7-a1df-cf6305060cea"
      unitRef="usd">26343000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtNC0xLTEtNTE5MzU_d9ce15ba-9e7a-46fb-bea0-33f4a6da18b5"
      unitRef="usd">22310000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTYtNi0xLTEtNTE5MzU_4ee2e052-5597-4090-a2a6-39b345eb3b52"
      unitRef="usd">20742000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctMi0xLTEtNTE5MzU_1c0e9c4c-b154-4967-a1c4-e84e1c682a9c"
      unitRef="usd">5704000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctNC0xLTEtNTE5MzU_007977df-835b-4c01-9a2f-8bf2b6ec4920"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTctNi0xLTEtNTE5MzU_647ef021-36e1-4cda-b0bb-4ff477025690"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtMi0xLTEtNTE5MzU_ccb5d3cc-4ffd-40b9-b1e0-f5316a8b7f13"
      unitRef="usd">20639000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtNC0xLTEtNTE5MzU_0d812d44-bbf5-4652-8877-8dd08bd312b1"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTgtNi0xLTEtNTE5MzU_866d2656-12b7-4a2a-b316-f17a0a48754a"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktMi0xLTEtNTE5MzU_cfe059fb-a05f-411c-8c36-fa779a91f996"
      unitRef="usd">519000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktNC0xLTEtNTE5MzU_df19e8fc-95b1-4d74-b926-ec7cc9f40521"
      unitRef="usd">447000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMTktNi0xLTEtNTE5MzU_1dd74a01-a66a-403b-99d8-09cac64822f5"
      unitRef="usd">366000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtMi0xLTEtNTE5MzU_1a9d5bca-7160-4bd9-90d4-931110c01d1e"
      unitRef="usd">20120000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtNC0xLTEtNTE5MzU_e7a36418-623c-45f0-b36b-d15a27acdaee"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjAtNi0xLTEtNTE5MzU_8c2d4856-1932-4745-aaf0-207993bad738"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItMi0xLTEtNTE5MzU_ed43beaa-f032-4df0-b733-3477a0caeb9c"
      unitRef="usdPerShare">21.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItNC0xLTEtNTE5MzU_71ff456d-15c3-4550-9a78-8604d6d2b0a7"
      unitRef="usdPerShare">18.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjItNi0xLTEtNTE5MzU_dcb3acbf-cf66-4536-bf55-637da0407980"
      unitRef="usdPerShare">16.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtMi0xLTEtNTE5MzU_4ebe49b9-04ef-4731-a785-4b70caad8af6"
      unitRef="usdPerShare">21.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtNC0xLTEtNTE5MzU_2417d976-c3a2-489d-89fd-54aa297a8587"
      unitRef="usdPerShare">18.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjMtNi0xLTEtNTE5MzU_3cbd325e-09af-4b78-b761-5bf625090b5f"
      unitRef="usdPerShare">16.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtMi0xLTEtNTE5MzU_38d5375b-5fb9-48f6-9f45-6501ccc65411"
      unitRef="shares">937000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtNC0xLTEtNTE5MzU_c6fea43e-2b57-4630-99af-f36fba8d9c5c"
      unitRef="shares">943000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjQtNi0xLTEtNTE5MzU_e2c46368-f69b-4fd5-927e-6e34f9fa10f9"
      unitRef="shares">949000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtMi0xLTEtNTE5MzU_65523574-f926-4989-84fc-46733edb86d2"
      unitRef="shares">13000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtNC0xLTEtNTE5MzU_9391b6f9-6b3b-4116-a795-eeb76d3d4dbb"
      unitRef="shares">13000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjUtNi0xLTEtNTE5MzU_58796974-d063-45e8-bdef-7bf5c6572216"
      unitRef="shares">12000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtMi0xLTEtNTE5MzU_874810fb-97a4-4c9b-905b-370b0301c1e6"
      unitRef="shares">950000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtNC0xLTEtNTE5MzU_9099bd8b-34b9-4033-b728-cd5763bf5516"
      unitRef="shares">956000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjYtNi0xLTEtNTE5MzU_fc52963e-bc44-4d77-b633-5974ae596183"
      unitRef="shares">961000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctMi0xLTEtNTE5MzU_e2fcf18c-93fb-438f-aece-0b384196bdb2"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctNC0xLTEtNTE5MzU_d3a1a168-05bb-4467-b729-9298d0b674e2"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184NS9mcmFnOjIxMWExNWQ3NDkxOTRkN2U5Njg4Y2FhMmM2Y2MyMTg3L3RhYmxlOmNmYmRiZGVhMDg3NjQ1YmU5OTcyN2M2NjM1ZTdjZDMyL3RhYmxlcmFuZ2U6Y2ZiZGJkZWEwODc2NDViZTk5NzI3YzY2MzVlN2NkMzJfMjctNi0xLTEtNTE5MzU_e18d12b7-4e5b-490b-8c46-c6ec735ac86e"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ProfitLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi0yLTEtMS01MTkzNQ_545e9a03-5c42-44c6-b71d-0e3a8ee40b5e"
      unitRef="usd">20639000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi00LTEtMS01MTkzNQ_adef770b-a3d6-4d4c-9bf9-7b2dc5f5c532"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMi02LTEtMS01MTkzNQ_ee9ab9f6-7001-422a-ae38-758a7898a337"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC0yLTEtMS01MTkzNQ_5ea022f1-0342-4073-a237-f0ac7959c327"
      unitRef="usd">-4292000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC00LTEtMS01MTkzNQ_e0abe542-64b1-477a-b0a8-129759bcf171"
      unitRef="usd">-1028000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNC02LTEtMS01MTkzNQ_933988a2-a550-44e7-8abd-287c767e07ab"
      unitRef="usd">1058000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS0yLTEtMS01MTkzNQ_31103b90-7bf5-40dd-8487-a1ef75a5d91f"
      unitRef="usd">-984000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS00LTEtMS01MTkzNQ_72bc9d22-4230-4422-87d7-d2dd3c992a54"
      unitRef="usd">-248000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNS02LTEtMS01MTkzNQ_d2893da8-e271-4c08-9b2e-4cc29ddd2eac"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi0yLTEtMS01MTkzNQ_f7a1da11-59c1-4cde-82fe-8139545afe79"
      unitRef="usd">-3308000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi00LTEtMS01MTkzNQ_5c1ebc40-71e1-4b7d-a3c3-e5cad7f8e56d"
      unitRef="usd">-780000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNi02LTEtMS01MTkzNQ_0feda877-9c57-4e5e-a03b-e89541ceb9bf"
      unitRef="usd">805000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy0yLTEtMS01MTkzNQ_eb2ab43e-6803-44ac-a307-aba19a6898b7"
      unitRef="usd">-139000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy00LTEtMS01MTkzNQ_796c05f1-3fb9-4033-bc84-6340fe3cab0f"
      unitRef="usd">173000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfNy02LTEtMS01MTkzNQ_e2924665-7f2d-4b66-892b-3eaf0af697f5"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC0yLTEtMS01MTkzNQ_f70d6224-a561-470c-8940-8c5eb5a433ff"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC00LTEtMS01MTkzNQ_b5119861-5fa5-407a-a8fe-20a813633d5d"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOC02LTEtMS01MTkzNQ_1cf77379-d144-4669-8a0b-69dd32e92c30"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS0yLTEtMS01MTkzNQ_a08e11e6-f4ce-4292-81e7-fb5978003742"
      unitRef="usd">-107000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS00LTEtMS01MTkzNQ_67d9e9ac-6854-4e36-a32c-226f274d24a9"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfOS02LTEtMS01MTkzNQ_2c1c6eaf-445f-4763-81aa-192b3be4ff9c"
      unitRef="usd">58000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtMi0xLTEtNTE5MzU_025d7d0c-2eee-4607-a67e-4a245d4d1849"
      unitRef="usd">192000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtNC0xLTEtNTE5MzU_3885fd25-5d7c-4585-9aca-7e5ac5c09252"
      unitRef="usd">-657000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTAtNi0xLTEtNTE5MzU_6dc3f4a8-70e8-480e-b47d-b113da76b969"
      unitRef="usd">-983000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtMi0xLTEtNTE5MzU_04fc3dec-57d5-48f5-a542-dfca4446aa7d"
      unitRef="usd">-3009000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtNC0xLTEtNTE5MzU_3b567aac-dfe6-4164-a74d-20c9d79d07b6"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTEtNi0xLTEtNTE5MzU_5ea33df9-fd3c-45b0-b015-e6acf97b2664"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItMi0xLTEtNTE5MzU_80f612e8-9cce-431d-93db-f30f20af1e25"
      unitRef="usd">17630000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItNC0xLTEtNTE5MzU_0b691fe5-db70-4c96-85d1-635f35dfde6d"
      unitRef="usd">16162000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTItNi0xLTEtNTE5MzU_f4710004-8e7a-4598-ba71-87e6af3aba13"
      unitRef="usd">15533000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtMi0xLTEtNTE5MzU_a11b5ef8-28ff-4135-a03c-9c029252df53"
      unitRef="usd">519000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtNC0xLTEtNTE5MzU_eba8de6d-8bd8-4f14-ac79-55614756657b"
      unitRef="usd">447000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTMtNi0xLTEtNTE5MzU_8a83c8c4-3dd9-4233-8ece-655f2b6f08af"
      unitRef="usd">366000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtMi0xLTEtNTE5MzU_6a507cf1-966e-4507-889d-8de3fd0469f3"
      unitRef="usd">17111000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtNC0xLTEtNTE5MzU_5fcf2c11-cca9-44b4-9f3f-4ef51d381125"
      unitRef="usd">15715000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN184OC9mcmFnOjgwY2I3ZDkxZWRhZTRjYjRhZTY2NTk3ODU4OWIyMjdiL3RhYmxlOmVhNGI4MzFmZGE1NzQzZTg4MWZmYTE4NTNkMWViNmQwL3RhYmxlcmFuZ2U6ZWE0YjgzMWZkYTU3NDNlODgxZmZhMTg1M2QxZWI2ZDBfMTQtNi0xLTEtNTE5MzU_848beafc-b9dc-4691-b207-6de6f373f734"
      unitRef="usd">15167000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0c689a8c0bca4e019433ec7246f933af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0yLTEtMS01MTkzNQ_5547b0ed-600f-4b44-b42c-544f96e2aa23"
      unitRef="shares">948000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c689a8c0bca4e019433ec7246f933af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi00LTEtMS01MTkzNQ_086ffeab-7b35-4456-9294-f3138a4f6785"
      unitRef="usd">9000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6830c5f79e56472094427c9ea2e3da03_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi02LTEtMS01MTkzNQ_8c3410ae-d5d4-4db9-bc03-d27f235fdc41"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8d1d3ede72ca4733addec1bb1964c823_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi04LTEtMS01MTkzNQ_ab5bc717-db05-484b-8809-1cd291b93cbb"
      unitRef="usd">61178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i07259315a0ea49d0a13dfb8fe399859f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xMC0xLTEtNTE5MzU_3f1bddb4-28ef-4c3a-8cb9-83450e8d12e6"
      unitRef="usd">589000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99ac1e3a85a14762b31fc51bf6a90599_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xMi0xLTEtNTE5MzU_0d899504-24fe-4e0d-9857-e9724d28cf32"
      unitRef="usd">-4167000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idca043d8fcb44c53b5284ba8accffdaf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xNC0xLTEtNTE5MzU_2e39c8bc-b6c1-46dd-bd71-016049dfc8ad"
      unitRef="usd">2820000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMi0xNi0xLTEtNTE5MzU_9bc0b42a-8b9d-4d63-a768-f9ece9a66f22"
      unitRef="usd">60436000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i642edb7da896454ab4d981b104a7469f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMy04LTEtMS01MTkzNQ_1cab1965-6295-4b2e-a091-40d14ba2487b"
      unitRef="usd">-28000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fc49c4edc654514bf73d5c1b5463ae8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMy0xNi0xLTEtNTE5MzU_80ac73e3-3b9a-4071-a6d9-8d15b121b3a1"
      unitRef="usd">-28000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC04LTEtMS01MTkzNQ_9eea1c5c-3e1b-47d7-814c-9d7250f51c4d"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC0xNC0xLTEtNTE5MzU_945b0464-5423-444d-bddd-396746552e73"
      unitRef="usd">254000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNC0xNi0xLTEtNTE5MzU_f5d61094-a684-4c45-a502-63343cdc3f53"
      unitRef="usd">15657000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8b06c57980640a89660ca89168bc707_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xMC0xLTEtNTE5MzU_89339112-a0c5-497d-b66f-5fc673bebfd6"
      unitRef="usd">747000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia4b41b5d5d1d4902a2666ab91615d999_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xMi0xLTEtNTE5MzU_82e3fefe-2d69-422b-8571-6cd382eac8d1"
      unitRef="usd">-983000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNS0xNi0xLTEtNTE5MzU_a2073cc4-188c-42a7-8dfc-ef7e83a1cf4b"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi0yLTEtMS01MTkzNQ_f18fdf55-6b66-46bc-af8a-e2c7031b6960"
      unitRef="shares">12000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi00LTEtMS01MTkzNQ_0172725e-78d5-449c-be3a-91f142a9db0d"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi02LTEtMS01MTkzNQ_0bf6a8a6-f2bf-41c1-af59-88737e2faed3"
      unitRef="usd">1119000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNi0xNi0xLTEtNTE5MzU_cdf695a2-7774-4121-81ca-749f0206b9ce"
      unitRef="usd">1120000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNy02LTEtMS01MTkzNQ_d68aed4a-0c18-4240-9a74-3aae6e7033d1"
      unitRef="usd">647000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfNy0xNi0xLTEtNTE5MzU_66188a3a-b450-4e66-86b6-64b667aba0e3"
      unitRef="usd">647000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC0yLTEtMS01MTkzNQ_4f294d83-c45a-47a0-af8a-6c2b65aaddc9"
      unitRef="shares">14000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i7b17e3a2e3e9405097194766f6f85ae9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC00LTEtMS01MTkzNQ_40dfa3c9-6eb3-40a9-92d3-91c861039c7a"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC02LTEtMS01MTkzNQ_5f8bbce6-2a9d-42a5-b75e-ca34cf620c55"
      unitRef="usd">1576000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC04LTEtMS01MTkzNQ_03921823-d3cc-4c1c-bcee-129856dc8dc7"
      unitRef="usd">2674000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOC0xNi0xLTEtNTE5MzU_9fe036b8-1714-494d-83d2-78293fdcbc94"
      unitRef="usd">4250000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS0wLTEtMS01MTkzNS90ZXh0cmVnaW9uOjA1YmI1NzJjZTNlMDQzMjA5MTVjODgwZTIyMTVjOWNkXzI3NDg3NzkwNjk1MDI_62c831e6-096d-4fa1-9c80-a4eac1f054f8"
      unitRef="usdPerShare">4.83</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="i5971045c770a4166a2c27dc5bd279113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS04LTEtMS01MTkzNQ_e47292f0-493d-4ad9-a95c-de2b2881555e"
      unitRef="usd">4584000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfOS0xNi0xLTEtNTE5MzU_840e61d8-00e9-41bd-81cd-f987d7e833ee"
      unitRef="usd">4584000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i44804322b29e4a0ab1284e36075d5634_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTAtNi0xLTEtNTE5MzU_cd9f28db-cd54-43c3-92cf-d1587ac7dfe3"
      unitRef="usd">197000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTAtMTYtMS0xLTUxOTM1_fe6c2497-fdd0-4b48-9b3e-e68ff0ea68f0"
      unitRef="usd">197000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTEtMTQtMS0xLTUxOTM1_cec46fb9-66bc-4de7-8c80-c6afc927e60d"
      unitRef="usd">40000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTEtMTYtMS0xLTUxOTM1_b2b6b34c-caea-4fdd-a062-8521f7ffdae1"
      unitRef="usd">40000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i30c05ae36bee4dfb95e3be5399b3a816_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTItMTQtMS0xLTUxOTM1_c66e54fc-8fa0-438a-ae14-950b838ec4df"
      unitRef="usd">277000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTItMTYtMS0xLTUxOTM1_f297e143-600a-4443-aca6-fcd352fa4ecb"
      unitRef="usd">277000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i664e92201b31457e977924ad47542638_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMi0xLTEtNTE5MzU_0f2356f1-2717-441c-8807-79f929fae42c"
      unitRef="shares">946000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i664e92201b31457e977924ad47542638_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtNC0xLTEtNTE5MzU_80388260-d41d-4510-b023-e95dfe2fc2e2"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0ff020430204014941338a161a89f7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtNi0xLTEtNTE5MzU_ecdf4c5a-ccab-46a4-87cc-c6e1e99d7fd7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85f91212be8041f595a89ca53aaeab7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtOC0xLTEtNTE5MzU_c0849cae-f58a-4eb3-a760-33fb0be81c55"
      unitRef="usd">69295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i07801d8cba1b4ab3b50d8ac8a9f97af6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTAtMS0xLTUxOTM1_98728818-f61c-4d8c-8bdc-f4076141dac5"
      unitRef="usd">1336000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6eaac53b8934e608d29bd0c5b4e5994_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTItMS0xLTUxOTM1_60fc91bc-26b3-49e9-967e-11dca886dbaa"
      unitRef="usd">-5150000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5c1cb17ce614ea6a4262e7a44095444_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTQtMS0xLTUxOTM1_9d31ce97-2212-4c0e-a0b1-2f81922a9f54"
      unitRef="usd">2837000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTMtMTYtMS0xLTUxOTM1_8ac87ceb-7a55-49b6-867a-40b628f01455"
      unitRef="usd">68328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtOC0xLTEtNTE5MzU_71a89d0b-f1f4-4b09-91eb-323ccfa61779"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtMTQtMS0xLTUxOTM1_712574ae-aadf-472d-beae-20458d407ab2"
      unitRef="usd">360000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTUtMTYtMS0xLTUxOTM1_922bafe4-00af-4852-9acb-68f661b8a1cd"
      unitRef="usd">17645000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i357524a3e1674a958342f4b2ad6fd285_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTAtMS0xLTUxOTM1_b0653bb7-87d0-45ce-a601-dfb65f72e3e3"
      unitRef="usd">-913000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c551595134e4820a2b39138e15877c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTItMS0xLTUxOTM1_2d1c46df-5a1e-488c-8e6b-759bf3b130c5"
      unitRef="usd">-657000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTYtMTYtMS0xLTUxOTM1_939a9606-4c64-4b0b-946a-dec6d7f90b65"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctMi0xLTEtNTE5MzU_56767ea4-a7d2-48c4-b54e-7f6f50117e84"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctNC0xLTEtNTE5MzU_14062eae-84eb-45a3-992b-daef625a9944"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctNi0xLTEtNTE5MzU_b6268808-c93e-4021-b085-af1012f82ac2"
      unitRef="usd">1100000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTctMTYtMS0xLTUxOTM1_1a9c749b-9459-40c5-abeb-34c145a558db"
      unitRef="usd">1100000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTgtNi0xLTEtNTE5MzU_670cc341-a9b5-4f9d-819f-738dfbc675b9"
      unitRef="usd">729000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTgtMTYtMS0xLTUxOTM1_d7ca2f0f-706d-434a-9fd7-2718b2c28288"
      unitRef="usd">729000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktMi0xLTEtNTE5MzU_97920d1a-b867-43fc-92a1-3d32e24617d2"
      unitRef="shares">13000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i49edbc69defd4a98b1c83573d372d6dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktNC0xLTEtNTE5MzU_97d45165-6091-42ba-961d-efeba3d0db58"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktNi0xLTEtNTE5MzU_655908c8-73c2-4a66-a185-8e31d586d97d"
      unitRef="usd">940000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktOC0xLTEtNTE5MzU_3c95866f-080a-4fa9-9342-c4f4fab50d95"
      unitRef="usd">4060000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMTktMTYtMS0xLTUxOTM1_e4eda2eb-8f27-48d6-9622-5e913c6cc73d"
      unitRef="usd">5000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjo5OGI2NTJkNzI2Mjg0YzQxOTI3Y2IyNjZhODY1NTI4YV8yNzQ4Nzc5MDY5NTAy_8ea2fa0f-aee0-47ae-8e01-9dede6d19bc9"
      unitRef="usdPerShare">5.60</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="i5959c75efd0045959418fd2933c336d6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtOC0xLTEtNTE5MzU_8a0b7515-dc7e-4d6f-bcf5-0a7958105f0e"
      unitRef="usd">5280000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjAtMTYtMS0xLTUxOTM1_fef45884-49a9-4e19-b39c-39de45e101bb"
      unitRef="usd">5280000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ib2616b12a521428ba669ce47e3572232_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjEtNi0xLTEtNTE5MzU_c48ed847-b236-4358-9105-24bb183351d7"
      unitRef="usd">889000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjEtMTYtMS0xLTUxOTM1_d3418fe3-ab40-438c-b1a2-933b2ebb69e6"
      unitRef="usd">995000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjItMTQtMS0xLTUxOTM1_25098e1a-76fa-4ad0-b496-41cd78f93552"
      unitRef="usd">407000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjItMTYtMS0xLTUxOTM1_48ac4764-2289-48e9-b927-d25042820bf2"
      unitRef="usd">407000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib7d3067e190a4f348c1b2f1242920e05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjMtMTQtMS0xLTUxOTM1_f5e1ca63-d82d-42ac-ab70-049e6b7c806d"
      unitRef="usd">319000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjMtMTYtMS0xLTUxOTM1_618637a0-a55b-4423-9475-fa6a5c6e8afe"
      unitRef="usd">319000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i93029ecb097b460c94d2bd8336e2c900_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMi0xLTEtNTE5MzU_98a3b74a-5ce0-43be-9275-66851889c71e"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93029ecb097b460c94d2bd8336e2c900_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtNC0xLTEtNTE5MzU_c3d8b03c-110c-41a8-985a-46204c32369a"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic40da61c03d244ee8b7fafcd8416abe9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtNi0xLTEtNTE5MzU_e33a05a7-bc1f-4bf3-84d0-42c7dd1ac3c3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d32db37f4024063a8ce510f51ab5d0a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtOC0xLTEtNTE5MzU_d409d8a7-39ed-4176-96e6-057ec5385f00"
      unitRef="usd">77134000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34dd7920ba894909b8d0e5c2cfaceb6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTAtMS0xLTUxOTM1_c84095cd-eab3-4391-8ccb-8cd86e1e8744"
      unitRef="usd">423000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0843668ba2f34d53b6ff8c06a2fbd0b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTItMS0xLTUxOTM1_0d38c51a-bfcb-4877-851a-6305f665c1b1"
      unitRef="usd">-5807000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5123593bd7e943ff983843139569f7ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTQtMS0xLTUxOTM1_94e8f891-3d0a-45a8-bc16-d284b4a88de4"
      unitRef="usd">3285000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjQtMTYtMS0xLTUxOTM1_f649dd5d-bc17-446f-a13e-9b26ac8d657a"
      unitRef="usd">75045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtOC0xLTEtNTE5MzU_76113985-03bc-43c3-9c7a-67b9e3e424dd"
      unitRef="usd">20120000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtMTQtMS0xLTUxOTM1_24cd3a5f-c427-44f3-bea6-8d530c09bdfa"
      unitRef="usd">406000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjUtMTYtMS0xLTUxOTM1_79f72b98-aaba-4867-b076-c4448df84429"
      unitRef="usd">20526000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b889e044c1942f18b7b6118ae4e47fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTAtMS0xLTUxOTM1_bf1d8080-a2c4-4f81-9ef5-3d38cf398d83"
      unitRef="usd">-3201000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie7667d069e974d27b0f62b9b62fe36f6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTItMS0xLTUxOTM1_32216b99-ce6d-4802-979a-5ae0ea29b720"
      unitRef="usd">192000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjYtMTYtMS0xLTUxOTM1_b2183fb1-60fa-4ca0-968a-12239da59bee"
      unitRef="usd">-3009000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctMi0xLTEtNTE5MzU_c3322c26-5126-4505-b3c4-a6d7b5e533a3"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctNC0xLTEtNTE5MzU_4375ae42-1c4b-4f37-82f1-310510bdca56"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctNi0xLTEtNTE5MzU_39177777-eef6-46d7-ad04-5848477abde4"
      unitRef="usd">903000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjctMTYtMS0xLTUxOTM1_63fdaab5-a9aa-4844-a3b9-7b2209843a5f"
      unitRef="usd">903000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjgtNi0xLTEtNTE5MzU_67b49b8b-c69e-44f6-93cc-dedbd1d3265c"
      unitRef="usd">875000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjgtMTYtMS0xLTUxOTM1_64ed0ddb-7a61-4986-8fd6-7da6f6c0dc67"
      unitRef="usd">875000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktMi0xLTEtNTE5MzU_f91fa186-06ca-4fce-afcc-8d9d57215e6d"
      unitRef="shares">14000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5590cb539b414dc5b26f66e350c81654_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktNC0xLTEtNTE5MzU_7c812a9c-47b9-470a-b3e0-419678ed7546"
      unitRef="usd">1000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktNi0xLTEtNTE5MzU_b4417203-46ee-4c13-b030-361007e4f469"
      unitRef="usd">1892000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktOC0xLTEtNTE5MzU_befa078e-1867-49f8-83c1-b2be4e3fbf4c"
      unitRef="usd">5107000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMjktMTYtMS0xLTUxOTM1_08014432-7958-4864-ad59-653e53232181"
      unitRef="usd">7000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjowNmZkZjIwNzY3ODY0ZmRjOWJlOWUzNmRkNDI2NDZkY18yNzQ4Nzc5MDY5NTAy_c118495b-61e8-4023-ad36-fc0111e97a44"
      unitRef="usdPerShare">6.40</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="ibe4f4464ae9d4aa8b0b64fc0bc8d8967_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtOC0xLTEtNTE5MzU_2fd32ef8-fbc9-4936-8494-bd8eb8bb43a1"
      unitRef="usd">5991000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzAtMTYtMS0xLTUxOTM1_021eac04-0a1a-4d25-8793-1036c834eeb9"
      unitRef="usd">5991000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i1097f29cadd64338b4ff19b692b5499b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzEtNi0xLTEtNTE5MzU_29b992f0-1249-4d57-9d16-3586eb58aea1"
      unitRef="usd">-114000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzEtMTYtMS0xLTUxOTM1_84d6b3b3-e846-4d55-bcb2-5ad52b9a4a36"
      unitRef="usd">-114000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzItMTQtMS0xLTUxOTM1_afc8e53b-bec9-4203-8862-778dbe3129ca"
      unitRef="usd">374000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzItMTYtMS0xLTUxOTM1_c659f93c-f851-4242-b513-d0e7714ffe4e"
      unitRef="usd">374000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if82ac08e003140ae9eb5f9d04b320595_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzMtMTQtMS0xLTUxOTM1_d74e977a-d579-4882-8c1c-247e2709558a"
      unitRef="usd">387000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzMtMTYtMS0xLTUxOTM1_65077702-c4f8-4994-b4c3-ef0b00744694"
      unitRef="usd">387000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id5b13550b61146f3942355d988fb9045_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMi0xLTEtNTE5MzU_1d1dc29b-d7ca-460d-bc06-2dc6053309d2"
      unitRef="shares">934000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5b13550b61146f3942355d988fb9045_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtNC0xLTEtNTE5MzU_22ccaa7e-9ba0-44f6-8316-197651bbb933"
      unitRef="usd">9000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4b04f90dfec4d62aef785c70b201486_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtNi0xLTEtNTE5MzU_c364bf86-d805-4ce4-922f-cf7872d325d3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44f74baf509a410c99fa46e489fb4347_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtOC0xLTEtNTE5MzU_5236cd9c-ca90-4476-ab87-d43ba96a0b2c"
      unitRef="usd">86156000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76cf18e9b55b4c90b1d62f83afeffdc5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTAtMS0xLTUxOTM1_5165187a-9cc0-4ca7-8b52-1117b297776d"
      unitRef="usd">-2778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4af60408a5014dadb511e21f1afca7e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTItMS0xLTUxOTM1_7a676a74-8d82-48f0-b3ea-cc5b12a772ec"
      unitRef="usd">-5615000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2964324674894490aab04f2d6bd37235_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTQtMS0xLTUxOTM1_e1c89170-0ef1-4109-b881-cc3fe1a9e48b"
      unitRef="usd">3678000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185MS9mcmFnOjRkZTA3NDIwOTUyNjQ4MGNiYWEwNmFlYzVhYjViMzk0L3RhYmxlOjA5Njg2YjJiNTAwNjRkODg5MWQxZWIxNDMwYTZjYTk3L3RhYmxlcmFuZ2U6MDk2ODZiMmI1MDA2NGQ4ODkxZDFlYjE0MzBhNmNhOTdfMzQtMTYtMS0xLTUxOTM1_65c5da23-b0f8-46ba-b64a-801b1bcd58b2"
      unitRef="usd">81450000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy0yLTEtMS01MTkzNQ_417336a6-f650-4f05-9cfa-3c5228edf3ac"
      unitRef="usd">20639000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy00LTEtMS01MTkzNQ_76257bc2-8b45-49eb-a359-ba3596a2890e"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMy02LTEtMS01MTkzNQ_56c23b13-12df-4192-8936-08a1b79d6be5"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS0yLTEtMS01MTkzNQ_0d1682ce-9dc4-43f6-a214-72f0d72935f5"
      unitRef="usd">3400000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS00LTEtMS01MTkzNQ_d5194a2a-64f8-4517-91ca-d1b83cfa874e"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNS02LTEtMS01MTkzNQ_05af463e-c57c-49d8-b156-3cef4a7e8704"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi0yLTEtMS01MTkzNQ_b246a887-9571-4284-a659-5541d11a0552"
      unitRef="usd">-673000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi00LTEtMS01MTkzNQ_d27cfd24-1976-41b5-9814-551f9caeea13"
      unitRef="usd">130000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNi02LTEtMS01MTkzNQ_c8e172e5-8c65-4b3b-b3ed-d3097b395be4"
      unitRef="usd">-8000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy0yLTEtMS01MTkzNQ_59f20938-816c-4fb8-bb7e-32ee06083f6b"
      unitRef="usd">925000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy00LTEtMS01MTkzNQ_84d498fd-e64e-4db7-8c2e-2d08b7fe1283"
      unitRef="usd">800000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNy02LTEtMS01MTkzNQ_53ffad3b-47e3-4163-8384-f38ed80a2722"
      unitRef="usd">679000000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC0yLTEtMS01MTkzNQ_c914ef52-0bb1-4abb-8e41-592c46c39ff0"
      unitRef="usd">331000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC00LTEtMS01MTkzNQ_e82b190b-75f1-4735-80a4-0d3acef99744"
      unitRef="usd">944000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfOC02LTEtMS01MTkzNQ_c746afb4-fadc-47c1-9056-02b1b23e6f13"
      unitRef="usd">52000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtMi0xLTEtNTE5MzU_11e721da-3429-49d0-b3e0-0bb46335529e"
      unitRef="usd">2523000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtNC0xLTEtNTE5MzU_42ed2aa5-c049-4045-b570-2487c5b4048f"
      unitRef="usd">1000000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTAtNi0xLTEtNTE5MzU_a239b517-6778-460f-a2d6-1ea996c1d006"
      unitRef="usd">688000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtMi0xLTEtNTE5MzU_d5d06e96-f637-42d8-b702-5b85c3c6cd87"
      unitRef="usd">1374000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtNC0xLTEtNTE5MzU_2a50548c-739b-4e3d-b93c-c9c2a79f6cc8"
      unitRef="usd">1031000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTEtNi0xLTEtNTE5MzU_a24c2224-1e17-4124-92b3-37a12d8cb8ab"
      unitRef="usd">2195000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItMi0xLTEtNTE5MzU_68b197a3-68c5-4642-864c-e61c807b4e00"
      unitRef="usd">4053000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItNC0xLTEtNTE5MzU_2575869e-94d5-409b-a138-714dcc5bf00f"
      unitRef="usd">2701000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTItNi0xLTEtNTE5MzU_7c196650-8f15-485f-a9ca-369d5fc10b93"
      unitRef="usd">152000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtMi0xLTEtNTE5MzU_873cf071-55ca-4d54-95b1-5761aa2e8129"
      unitRef="usd">1964000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtNC0xLTEtNTE5MzU_08f0a97b-c0ef-4c2f-a51c-6cd997557fd5"
      unitRef="usd">1162000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTMtNi0xLTEtNTE5MzU_9daed054-c332-4d33-9bf8-66283ee4b520"
      unitRef="usd">5348000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtMi0xLTEtNTE5MzU_f9316f00-e17a-47ce-9de8-998aebdb8073"
      unitRef="usd">126000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtNC0xLTEtNTE5MzU_c2571d55-68d3-47d3-84c7-9b02db5fbc34"
      unitRef="usd">-310000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTQtNi0xLTEtNTE5MzU_063b061a-d55d-4d7a-bb1a-5311688beeaf"
      unitRef="usd">278000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtMi0xLTEtNTE5MzU_955fce02-4efa-46c9-93d2-62df38fe3bf6"
      unitRef="usd">26206000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtNC0xLTEtNTE5MzU_1c963ec6-99be-4449-8ede-342cf7eaf73f"
      unitRef="usd">22343000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTUtNi0xLTEtNTE5MzU_5ff1b553-04d7-4cac-ab5b-a416d25af279"
      unitRef="usd">22174000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctMi0xLTEtNTE5MzU_39942a26-e205-454e-96af-07716736fd20"
      unitRef="usd">18825000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctNC0xLTEtNTE5MzU_734e0dd1-0c98-4db5-8657-526cde24dbfb"
      unitRef="usd">17139000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTctNi0xLTEtNTE5MzU_69e36765-79c2-4954-8570-f0f97c64f54d"
      unitRef="usd">16577000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtMi0xLTEtNTE5MzU_5c843bba-d3f1-4055-96f4-74bfde438aae"
      unitRef="usd">5907000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtNC0xLTEtNTE5MzU_3a7e5573-c540-451f-ad59-f571370fa1ac"
      unitRef="usd">7045000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTgtNi0xLTEtNTE5MzU_d18ee8b8-9c60-4fc5-bd02-11477071f688"
      unitRef="usd">6489000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktMi0xLTEtNTE5MzU_236f41ac-91ae-4603-bf09-8510693009dd"
      unitRef="usd">6081000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktNC0xLTEtNTE5MzU_425adeee-3116-4e46-b883-dac48b2f95e3"
      unitRef="usd">8251000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMTktNi0xLTEtNTE5MzU_ad1419b4-e170-4248-9b9e-1a753da45de0"
      unitRef="usd">7252000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtMi0xLTEtNTE5MzU_7d201901-ac8a-4d3f-8aa9-ae217ebd89ba"
      unitRef="usd">21458000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtNC0xLTEtNTE5MzU_130d5bd3-f122-41fd-a580-7a6cdd774211"
      unitRef="usd">4821000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjAtNi0xLTEtNTE5MzU_22a6ff35-2152-459a-98fd-5ff56fdf08d7"
      unitRef="usd">7139000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtMi0xLTEtNTE5MzU_15b3f09d-ef35-4f4d-9dda-6e968f17af75"
      unitRef="usd">2802000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtNC0xLTEtNTE5MzU_4e44d84d-2ed2-488f-b2f8-a9543a65349b"
      unitRef="usd">2454000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjEtNi0xLTEtNTE5MzU_7077292d-d97a-4f0e-8fc6-d631d648336d"
      unitRef="usd">2051000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItMi0xLTEtNTI3NzM_dbc5cee5-b7c3-40cd-a15a-3f3bc0bd807f"
      unitRef="usd">3414000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNC0xLTEtNTI3NzM_ccc2cee2-af99-46ae-8267-42fd91f18e3f"
      unitRef="usd">15000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNi0xLTEtNTI3OTY_410132f5-5bd8-4260-8fbd-92cafe73013b"
      unitRef="usd">221000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItMi0xLTEtNTE5MzU_9d28f507-54de-4e13-82ac-89b69d630275"
      unitRef="usd">793000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNC0xLTEtNTE5MzU_e5db8480-8912-443c-887f-45044df0d811"
      unitRef="usd">1269000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjItNi0xLTEtNTE5MzU_d5308ec3-a35d-45e1-b61d-17b2630910ff"
      unitRef="usd">727000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtMi0xLTEtNTE5MzU_19eac471-83bc-4817-aa86-bf7f1b554e55"
      unitRef="usd">-28476000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtNC0xLTEtNTE5MzU_f0b54c3c-4b6e-4761-a2e2-82da2a875df8"
      unitRef="usd">-10372000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjMtNi0xLTEtNTE5MzU_16267b07-6b54-4a7f-8b36-0fde143e67c3"
      unitRef="usd">-12532000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtMi0xLTEtNTE5MzU_eb1cb64a-e877-4397-ad3a-5c31b452f50c"
      unitRef="usd">7000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtNC0xLTEtNTE5MzU_5444c916-1d46-4680-a622-86a55013db13"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjUtNi0xLTEtNTE5MzU_073bf2a1-51b2-48ba-859b-398060d4eafe"
      unitRef="usd">4250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtMi0xLTEtNTE5MzU_fa4db264-0aac-46cf-b888-0d1bd9daefa3"
      unitRef="usd">5991000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtNC0xLTEtNTE5MzU_2ee3a3ed-4580-4299-861e-3d0ea27cbb41"
      unitRef="usd">5280000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjYtNi0xLTEtNTE5MzU_c32417cf-11f5-4c78-bfdc-fbc7be68e63f"
      unitRef="usd">4584000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctMi0xLTEtNTE5MzU_f5b0ebb9-3d18-49b7-aa66-97b7a61df0d9"
      unitRef="usd">1253000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctNC0xLTEtNTE5MzU_7f298ef3-7871-4fdf-a8e0-ef2c87e75e09"
      unitRef="usd">1355000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjctNi0xLTEtNTE5MzU_2a393ec1-7e08-4f2d-af2b-4127ca9fe21d"
      unitRef="usd">1440000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtMi0xLTEtNTE5MzU_3aa3f6e6-09d7-4528-a0b4-c5b103058d9a"
      unitRef="usd">3015000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtNC0xLTEtNTE5MzU_9b5e6274-8147-4def-ab98-043340fd4833"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjgtNi0xLTEtNTE5MzU_e3a121fa-c586-4ca2-8a5b-9ae38b4287bc"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktMi0xLTEtNTE5MzU_cd6f724f-f8c8-4b05-957f-75f94efdc4a6"
      unitRef="usd">732000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktNC0xLTEtNTE5MzU_d0b5438f-be82-4a8d-b09d-90944566b218"
      unitRef="usd">-1302000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMjktNi0xLTEtNTE5MzU_5d214baf-2660-4517-997a-f65934ae0337"
      unitRef="usd">872000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtMi0xLTEtNTE5MzU_38927476-fdf5-4c7d-9ac4-230511d9e99a"
      unitRef="usd">14819000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtNC0xLTEtNTE5MzU_f96383d4-159b-4854-a554-7c446cd75e5e"
      unitRef="usd">6933000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzAtNi0xLTEtNTE5MzU_65c8eb63-8dab-4c69-98b6-e503b1e0e5c6"
      unitRef="usd">4864000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtMi0xLTEtNTE5MzU_02ed3bad-61be-4cc5-993a-6d400ddc2ef9"
      unitRef="usd">5548000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtNC0xLTEtNTE5MzU_24ebd7ae-20fd-482e-bb0a-ae9e5992957a"
      unitRef="usd">622000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzEtNi0xLTEtNTE5MzU_1943bc71-40e0-4d67-8263-81e9e25266ff"
      unitRef="usd">1677000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItMi0xLTEtNTE5MzU_e059fbd7-2a35-4ab8-8694-ef62dde74ae8"
      unitRef="usd">176000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItNC0xLTEtNTE5MzU_2547a300-d24b-4488-a703-86cbb9612356"
      unitRef="usd">1338000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzItNi0xLTEtNTE5MzU_ae4f4fb9-70f8-4973-8fbb-c054390072e2"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtMi0xLTEtNTE5MzU_330976a1-a2b0-4435-9dc2-e5c01aeacd92"
      unitRef="usd">-1944000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtNC0xLTEtNTE5MzU_1e40855c-e31f-4878-a57b-f4d9abac6cd2"
      unitRef="usd">-295000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzMtNi0xLTEtNTE5MzU_6e88adf9-d241-49a3-aca1-6a7e6fee1d02"
      unitRef="usd">-459000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtMi0xLTEtNTE5MzU_8407b0d8-07f6-4e40-b77e-702067895fef"
      unitRef="usd">4226000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtNC0xLTEtNTE5MzU_9026cf98-1d52-4d61-b5be-e5b70d731d24"
      unitRef="usd">-7455000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzQtNi0xLTEtNTE5MzU_2f828a88-dafe-4191-93dd-5346c76b7b50"
      unitRef="usd">-3590000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtMi0xLTEtNTE5MzU_9aacac72-35b2-407f-9581-2ce3acdad99b"
      unitRef="usd">34000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtNC0xLTEtNTE5MzU_13e67876-011c-4870-afec-9ab75a62b6f5"
      unitRef="usd">-62000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzUtNi0xLTEtNTE5MzU_eb1dee6e-feaa-4b70-a5e6-9284f9d7e443"
      unitRef="usd">-116000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtMi0xLTEtNTE5MzU_c4c9ed65-fcb5-4f48-ace0-70581068da3b"
      unitRef="usd">1990000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtNC0xLTEtNTE5MzU_d732c6c3-0e9d-4984-a2e3-04b27617ccd3"
      unitRef="usd">4454000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzYtNi0xLTEtNTE5MzU_1371cba2-81fd-440b-89c1-62eaf10046f5"
      unitRef="usd">5936000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctMi0xLTEtNTE5MzU_3f93c4d5-909c-454d-a6f4-f049cc3c973d"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctNC0xLTEtNTE5MzU_eaf714b5-cc98-4f28-a4cc-5e641884ca61"
      unitRef="usd">16921000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzctNi0xLTEtNTE5MzU_a57f44d6-d940-42df-936b-474b1f62a674"
      unitRef="usd">10985000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtMi0xLTEtNTE5MzU_7ddd4ff7-a7eb-472c-b511-35a872863068"
      unitRef="usd">23365000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtNC0xLTEtNTE5MzU_fb01f847-f3db-4661-83fe-d3883cc44d82"
      unitRef="usd">21375000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfMzgtNi0xLTEtNTE5MzU_512d65b8-6610-4112-a301-5be2bafdfcd7"
      unitRef="usd">16921000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtMi0xLTEtNTE5MzU_10130b0e-6472-4044-a037-645a415fe3a4"
      unitRef="usd">1945000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtNC0xLTEtNTE5MzU_fbb34cad-4f53-4ed8-a8d0-bdd69905bdfb"
      unitRef="usd">1653000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDEtNi0xLTEtNTE5MzU_fff111b8-3050-4b44-817b-495a22606d2c"
      unitRef="usd">1704000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItMi0xLTEtNTE5MzU_2e777899-c171-4c54-a7b8-5c02fd5eeb6f"
      unitRef="usd">5222000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItNC0xLTEtNTE5MzU_dfb20e13-2515-493d-bdfb-f985a262fda5"
      unitRef="usd">3966000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN185Ny9mcmFnOmQ3YjlkNWI2MzE5ZTQyYzNiOGU3ZjM5MTQxYzg4NjhjL3RhYmxlOjYwODFkNTBjOGUwYzQzZTBiYjRjNGU2ZGFhNmVjNWQ1L3RhYmxlcmFuZ2U6NjA4MWQ1MGM4ZTBjNDNlMGJiNGM0ZTZkYWE2ZWM1ZDVfNDItNi0xLTEtNTE5MzU_28f18c3a-5669-4f6d-b4ae-f9f58ac57293"
      unitRef="usd">4935000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NatureOfOperations
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDMvZnJhZzo2NDFkY2FmMDJmZTI0ZjhlOGZiYzg3MDQwZWVlOWI0NS90ZXh0cmVnaW9uOjY0MWRjYWYwMmZlMjRmOGU4ZmJjODcwNDBlZWU5YjQ1XzU4Mw_6f1dcfeb-3543-48f0-aa49-eeaf164d6ad6">Description of BusinessUnitedHealth Group Incorporated (individually and together with its subsidiaries, &#x201c;UnitedHealth Group&#x201d; and &#x201c;the Company&#x201d;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#x2014; Optum and UnitedHealthcare &#x2014; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDYvZnJhZzo2M2M0N2NjZWVlZjI0ZDBmYTA5MGEwZTY0MDM2MWYxOC90ZXh0cmVnaW9uOjYzYzQ3Y2NlZWVmMjRkMGZhMDkwYTBlNjQwMzYxZjE4XzMxMg_355df200-dda8-4a6e-89cd-9b9b95c7cc13">Basis of Presentation, Use of Estimates and Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These Consolidated Financial Statements include certain amounts based on the Company&#x2019;s best estimates and judgments. The Company&#x2019;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#x2019; health care and related administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#x2019;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#x2019;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp;amp; Medicaid Services (CMS) quality bonuses based on plans&#x2019; Star rating. Certain of the Company&#x2019;s Medicaid business is also subject to state minimum MLR rebates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#x2019; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#x2019;s plans are subject to review by the government, including audit by regulators. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding these audits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#x2019; members and accordingly, product revenues are reported on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue includes a number of services and products sold through Optum. Optum Health&#x2019;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#x2019; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#x2019; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $7.1 billion and $5.4 billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $12.5 billion, of which approximately half is expected to be recognized in the next &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107"&gt;three&lt;/span&gt; years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_211" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for disaggregation of revenue by segment and type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Costs and Medical Costs Payable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of medical costs payable represents management&#x2019;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs and medical costs payable include estimates of the Company&#x2019;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#x2019;s transaction processing services, system sales, maintenance and professional services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#x2019;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#x2019;s investment policy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&#x2019;s agreement with AARP, program assets are managed separately from the Company&#x2019;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#x2019;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.&lt;/span&gt;&lt;/div&gt;The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#x2019; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $8.2 billion and $7.2 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, the Company&#x2019;s Medicare Part D receivables amounted to $1.3 billion and $3.4 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $3.5 billion and $2.9 billion as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Equipment and Capitalized Software &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s ROU assets are included in other assets, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86"&gt;lease liabilities are included in other current liabilities and other liabilities in the Company&#x2019;s Consolidated Balance Sheet&lt;/span&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#x2019;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities include health savings account deposits ($13.5 billion and $11.4 billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#x2019; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests in the Company&#x2019;s subsidiaries whose redemption is outside of the Company&#x2019;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#x2019;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c"&gt;four&lt;/span&gt; years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb"&gt;four&lt;/span&gt; years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#x2019;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#x2019;s stock at a discounted price, which is 90% of the market price of the Company&#x2019;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMDYvZnJhZzo2M2M0N2NjZWVlZjI0ZDBmYTA5MGEwZTY0MDM2MWYxOC90ZXh0cmVnaW9uOjYzYzQ3Y2NlZWVmMjRkMGZhMDkwYTBlNjQwMzYxZjE4XzM2Ng_e88df875-8b47-4e2f-ad02-110715a7c6c3">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTIvZnJhZzo3ODE0ODIzMzUzYTY0NzFiYjI2ZDExZGI2N2EwN2VjZS90ZXh0cmVnaW9uOjc4MTQ4MjMzNTNhNjQ3MWJiMjZkMTFkYjY3YTA3ZWNlXzU1OA_c216d68a-32cc-4507-995f-c0dd2e0ba1ad">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These Consolidated Financial Statements include certain amounts based on the Company&#x2019;s best estimates and judgments. The Company&#x2019;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0Xzc3NDc_6eff9062-acff-4105-b0a8-01e3e506f022">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are primarily derived from risk-based arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#x2019; health care and related administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#x2019;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#x2019;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp;amp; Medicaid Services (CMS) quality bonuses based on plans&#x2019; Star rating. Certain of the Company&#x2019;s Medicaid business is also subject to state minimum MLR rebates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for patients. In exchange, the Company receives a premium that is typically paid on a per-patient per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#x2019; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#x2019;s plans are subject to review by the government, including audit by regulators. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding these audits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#x2019; members and accordingly, product revenues are reported on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue includes a number of services and products sold through Optum. Optum Health&#x2019;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#x2019; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#x2019; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, accounts receivables related to products and services were $7.1 billion and $5.4 billion, respectively. In 2022 and 2021, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $12.5 billion, of which approximately half is expected to be recognized in the next &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzE2NDkyNjc0NTA0MTI_460addae-4f04-4e5b-ad44-82c453b30107"&gt;three&lt;/span&gt; years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_211" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for disaggregation of revenue by segment and type.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i15b306bfc47b4634b1d61ddb91da4cb0_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzY5MTU_afa2cbdc-1642-431a-9d2c-142ea08cb1d7"
      unitRef="usd">7100000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib35aa732c7b44d8785be61e048bb0572_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzY5MjI_0648eb5c-32ec-4a8f-be67-e792b1e8e52b"
      unitRef="usd">5400000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTUvZnJhZzo0NDNhN2JkMGU5ZDE0NmY3ODlmZTdjNTA4YjhkM2I5NC90ZXh0cmVnaW9uOjQ0M2E3YmQwZTlkMTQ2Zjc4OWZlN2M1MDhiOGQzYjk0XzU0OTc1NTgyMjYyNg_36a3b9fe-2e01-42b6-9b0d-4f1dd273cb5f"
      unitRef="usd">12500000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTgvZnJhZzpjYjhlMDhmNjQ5YjU0Njc5YmU2MWJmYTcyZWZiNmZlYy90ZXh0cmVnaW9uOmNiOGUwOGY2NDliNTQ2NzliZTYxYmZhNzJlZmI2ZmVjXzI1NzU_04bbf8c1-8bb2-4513-846e-e5142390b827">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Costs and Medical Costs Payable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of medical costs payable represents management&#x2019;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs and medical costs payable include estimates of the Company&#x2019;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, care activity and other medical cost trends, membership volume and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.&lt;/span&gt;&lt;/div&gt;</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days
      contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMTgvZnJhZzpjYjhlMDhmNjQ5YjU0Njc5YmU2MWJmYTcyZWZiNmZlYy90ZXh0cmVnaW9uOmNiOGUwOGY2NDliNTQ2NzliZTYxYmZhNzJlZmI2ZmVjXzU3Ng_7424ab9f-afd7-411c-860e-48f3216dc1d3"
      unitRef="number">0.90</unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjEvZnJhZzoxYTc0MWIxMDEwZTU0M2IxYjk4MzAwOGU5NmZmNjNkZC90ZXh0cmVnaW9uOjFhNzQxYjEwMTBlNTQzYjFiOTgzMDA4ZTk2ZmY2M2RkXzgxNA_9c3b53c4-66d9-4642-9fa0-85b494b9e89d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#x2019;s transaction processing services, system sales, maintenance and professional services.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjQvZnJhZzphNDAzNWYyMWZiZmQ0NDgyOGY2OTc3NzQxMDJkZTAxYS90ZXh0cmVnaW9uOmE0MDM1ZjIxZmJmZDQ0ODI4ZjY5Nzc3NDEwMmRlMDFhXzIzODI_de4d9506-50f8-4a2b-ad19-4345dba089fb">Cash, Cash Equivalents and Investments Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjQvZnJhZzphNDAzNWYyMWZiZmQ0NDgyOGY2OTc3NzQxMDJkZTAxYS90ZXh0cmVnaW9uOmE0MDM1ZjIxZmJmZDQ0ODI4ZjY5Nzc3NDEwMmRlMDFhXzIzODQ_0ca5e5a9-b4f3-40f0-a179-18f1bfb8c306">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#x2019;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.&lt;/span&gt;&lt;/div&gt;New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#x2019;s investment policy.</us-gaap:InvestmentPolicyTextBlock>
    <unh:AARPAssetsUnderManagementPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMjcvZnJhZzoyZDcwNmNhMTRlNTE0MTczYmUxOTNhMmZlZGU1ODkyYi90ZXh0cmVnaW9uOjJkNzA2Y2ExNGU1MTQxNzNiZTE5M2EyZmVkZTU4OTJiXzE2MzY_6806a9f5-4347-4cd5-838b-d5aaca632053">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&#x2019;s agreement with AARP, program assets are managed separately from the Company&#x2019;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#x2019;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.&lt;/span&gt;&lt;/div&gt;The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.</unh:AARPAssetsUnderManagementPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNzk_08935d30-9580-44a1-bcb9-5da6ca82ee74">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#x2019; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2022 and 2021, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $8.2 billion and $7.2 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, the Company&#x2019;s Medicare Part D receivables amounted to $1.3 billion and $3.4 billion, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i7fb6042d781646119f05a8e3d8d9bfdc_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzEwNjA_fd924bfa-91b8-4950-aad0-9ae567245142"
      unitRef="usd">8200000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib03e24ff12c14c668abeebbd373c12f5_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzEwNjc_762f0939-a042-4154-989f-9181068c8a66"
      unitRef="usd">7200000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="id3b26ce245bd427daad3c1e0c98d2988_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNTY_88a81f8b-7b10-4584-9d8d-68a44b0a5dd3"
      unitRef="usd">1300000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib8cc912aa74747edbaa48cf71f83621d_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzAvZnJhZzpjNzM4ODQwNDFkNzU0YWU3ODhiM2U1OGQ1ZjYzZWNlMC90ZXh0cmVnaW9uOmM3Mzg4NDA0MWQ3NTRhZTc4OGIzZTU4ZDVmNjNlY2UwXzExNjM_2f47ed6e-4173-4535-a10e-eb6a46211d89"
      unitRef="usd">3400000000</us-gaap:OtherReceivablesNetCurrent>
    <unh:PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTI3_fb408010-882c-4493-bd44-f3d9830bdc5b">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets include pharmaceutical drug and supplies inventory of $3.5 billion and $2.9 billion as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</unh:PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTA4_a0caf11c-dc4d-4dd2-b5a8-a03ea64504fb"
      unitRef="usd">3500000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQwL2ZyYWc6NTk3ZDgwMGExOTUzNGFjN2I3ZmViMThlYWFmYzQ2ODMvdGV4dHJlZ2lvbjo1OTdkODAwYTE5NTM0YWM3YjdmZWIxOGVhYWZjNDY4M180OTQ3ODAyMzI1OTI0_7a44283f-9655-45b1-98e5-bca1f04e2fd9"
      unitRef="usd">2900000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90ZXh0cmVnaW9uOjBkNDgwMjgzOTdlZDQxYjY5ODNhOTU4YzBlOWU3M2ZlXzc1MA_ea67578e-ca42-416a-8ead-9ab3863ec3e7">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Equipment and Capitalized Software &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ie2ca0721d6424e0ebe624cfdfd71cff7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90ZXh0cmVnaW9uOjBkNDgwMjgzOTdlZDQxYjY5ODNhOTU4YzBlOWU3M2ZlXzc0OQ_a801266b-8016-4ea0-91e3-d838d7e2fe06">The useful lives for property, equipment and capitalized software are: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzAtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjoyYmU0ZmY3Y2VkMWU0ZjU0YWMxOTZlYjgzOGI5YzU1MF80_49d875dd-f19d-4a92-9f83-21720ad78c90">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib7bfd1f6234d46cca896b895ffb4eb00_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzAtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjoyYmU0ZmY3Y2VkMWU0ZjU0YWMxOTZlYjgzOGI5YzU1MF8xMA_8b6bc2b4-56ae-4e01-be6c-98d7d63cb519">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaef840008a9949d4bf08759afb52eeb0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzEtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiOWJkZTc5NjlmNjU0OTdmODI2YTU5NThkNTJiN2FhN180_e4b436ac-1875-4be7-b2db-7512d67c59e7">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ice44079f0ac84af382d947db2570bb57_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzEtMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiOWJkZTc5NjlmNjU0OTdmODI2YTU5NThkNTJiN2FhN18xMA_286c9fe6-a302-4a19-94b9-4728ee2e0bf7">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i862cb01850c54123912d7e326e09b865_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzItMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiMmU0MTU4ODczNmQ0YzcyYmY5YzAyZjdhMDJmOGI5ZF80_c159b88c-d0bf-4c2e-b87d-595b661840b9">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5723f6eb484244a1b9c07c5e1b663d23_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzMvZnJhZzowZDQ4MDI4Mzk3ZWQ0MWI2OTgzYTk1OGMwZTllNzNmZS90YWJsZTplMWY0YzRjOGUzZmY0OTcyYmVhOTIwMjFmOThmZTVhZC90YWJsZXJhbmdlOmUxZjRjNGM4ZTNmZjQ5NzJiZWE5MjAyMWY5OGZlNWFkXzItMS0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiMmU0MTU4ODczNmQ0YzcyYmY5YzAyZjdhMDJmOGI5ZF8xMA_f126cd7a-c10f-40c4-b31a-7d629e24aacf">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzc0NA_42febb82-f760-45bf-ab3d-e3856f4dfc8d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s ROU assets are included in other assets, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzYvZnJhZzozNmE2ZjAyZGU1ZTk0YzZiOWI3ZDBiMzI3MDYwZWIyMS90ZXh0cmVnaW9uOjM2YTZmMDJkZTVlOTRjNmI5YjdkMGIzMjcwNjBlYjIxXzU0OTc1NTgxNDYzNA_97a311e4-a949-4f7f-b1c7-8412836aaa86"&gt;lease liabilities are included in other current liabilities and other liabilities in the Company&#x2019;s Consolidated Balance Sheet&lt;/span&gt;.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyODM_ebf7cc2a-440e-494e-a859-6c93a741ba69">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value and discount rates. Comparative market multiples are used to corroborate the results of the discounted cash flow test. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment of goodwill during the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_757ced8b-ca6f-451b-8e7a-4f9a09077b8f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_815a1197-f67c-4d4b-9e31-3f039eee6845"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xMzkvZnJhZzplZDQ1M2Q3ZDAyZGM0OWMyYmIwOTg3MjNmMTc1MDA3OC90ZXh0cmVnaW9uOmVkNDUzZDdkMDJkYzQ5YzJiYjA5ODcyM2YxNzUwMDc4XzEyMjE_e4e110b8-658f-48fa-ae84-a00c364e1688"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzM1Ng_fc09c4da-06f3-4aea-b5e6-aceb07cfa8db">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#x2019;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_08a58acd-a630-4287-a18a-c1338c0ee0e8"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_cb9087b8-1886-4d9c-941e-6f0589a08b10"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDIvZnJhZzo4OTZhNWZjYTc5MDY0MWJhODhkOTI5ZTJkYjZmYWMzNC90ZXh0cmVnaW9uOjg5NmE1ZmNhNzkwNjQxYmE4OGQ5MjllMmRiNmZhYzM0XzI3OQ_f7f80ba8-6efc-4dfa-83c5-dbec522e53bc"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <unh:OtherLiabilitiesCurrentPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzI5Mw_bd114980-dba2-4569-9173-a448e64dd5e6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities include health savings account deposits ($13.5 billion and $11.4 billion as of December&#160;31, 2022 and 2021, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.&lt;/span&gt;&lt;/div&gt;</unh:OtherLiabilitiesCurrentPolicyTextBlock>
    <us-gaap:DemandDepositAccounts
      contextRef="i9f37409e996040ec89badf7f24f413b6_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzk5_286815db-8d27-48ee-bde9-a9a74fd65677"
      unitRef="usd">13500000000</us-gaap:DemandDepositAccounts>
    <us-gaap:DemandDepositAccounts
      contextRef="i24f6c70b54f343a196c9df60d4d8fdec_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDUvZnJhZzphZWU1NjZhOTI4MzY0MGRiYjQxNDI0MmI5MjBmODhhMi90ZXh0cmVnaW9uOmFlZTU2NmE5MjgzNjQwZGJiNDE0MjQyYjkyMGY4OGEyXzEwNg_7b11080a-5a49-4494-bde2-6c1631142245"
      unitRef="usd">11400000000</us-gaap:DemandDepositAccounts>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzMxOQ_2ef062ff-a149-4dbb-9880-5831e4b91b7d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#x2019; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzE2Nw_58ba7ae8-ad1c-49a7-8472-e9f483e07e25">P30D</unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract>
    <unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNDgvZnJhZzo0NjNhNDcwNGFiN2Q0YWQ4YTc5NGI4ZGQ2MWNjZGUwMy90ZXh0cmVnaW9uOjQ2M2E0NzA0YWI3ZDRhZDhhNzk0YjhkZDYxY2NkZTAzXzMxOA_720dd8fb-3b09-4098-a164-51f607a6b7f5">P30D</unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90ZXh0cmVnaW9uOmYxNmU2ZTRlODAzZjQ0OTFiY2FjMTZjNWFhNDI3NmYxXzMzMQ_c6499b8c-ed15-4775-91f6-960dc2155c47">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests in the Company&#x2019;s subsidiaries whose redemption is outside of the Company&#x2019;s control are classified as temporary equity. These interests primarily relate to put options on unowned shares, which are typically redeemable at fair value after a certain time period. The Company accretes changes in the redemption value to the earliest redemption date utilizing the interest method. If all interests were currently redeemable, the difference between the carrying value and the estimated redemption value is not material.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90ZXh0cmVnaW9uOmYxNmU2ZTRlODAzZjQ0OTFiY2FjMTZjNWFhNDI3NmYxXzMzMA_3694f179-a5b3-435f-856d-82bbaebf67c6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i844bf68d4f4345e3970236cd396c9f66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzEtMi0xLTEtNTE5MzU_bc939c22-f762-4427-830b-4a03c189a1f9"
      unitRef="usd">1434000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i541081ea074d4ecd8b8c1ce4752c8ce2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzEtNC0xLTEtNTE5MzU_5cabea88-2ee8-4e33-9524-dfa0ea1bab58"
      unitRef="usd">2211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzItMi0xLTEtNTE5MzU_d7f821cd-20e5-42ea-9cd3-cdb475ed7790"
      unitRef="usd">113000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzItNC0xLTEtNTE5MzU_ec900862-add3-429f-9284-d6dfff9ae673"
      unitRef="usd">87000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzMtMi0xLTEtNTE5MzU_c241a0e4-f7c3-46e9-960d-c565857a4e32"
      unitRef="usd">3108000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzMtNC0xLTEtNTE5MzU_905ad300-80c2-4106-b673-4875171e6f46"
      unitRef="usd">28000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzQtMi0xLTEtNTE5MzU_28b5b5ed-c6be-4832-9e48-175864ee4cab"
      unitRef="usd">-176000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzQtNC0xLTEtNTE5MzU_a2606297-919c-4353-9a3c-5c70d551a2a4"
      unitRef="usd">-1338000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzUtMi0xLTEtNTE5MzU_6f134d36-efea-47f5-a968-9bdd127330e6"
      unitRef="usd">82000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzUtNC0xLTEtNTE5MzU_459f41ca-66f3-4ddb-b482-04fb6f62522d"
      unitRef="usd">255000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzYtMi0xLTEtNTE5MzU_90f7d4c0-6271-48f9-920e-cd67289c151e"
      unitRef="usd">500000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i55c4b763425e4204bffaee4b75392cde_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzYtNC0xLTEtNTE5MzU_13d226f9-d531-48fd-8aef-3f26babadb94"
      unitRef="usd">701000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i57ef3e9119e24c1bbb54fbf615fcab1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzctMi0xLTEtNTE5MzU_b0db5cb2-843e-4155-b5af-4e59488d5be3"
      unitRef="usd">4897000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i844bf68d4f4345e3970236cd396c9f66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTEvZnJhZzpmMTZlNmU0ZTgwM2Y0NDkxYmNhYzE2YzVhYTQyNzZmMS90YWJsZTo3NmRkM2EwMWQ3Yzc0MWIxOWI3Mzc4ODI5MGExNTFkYi90YWJsZXJhbmdlOjc2ZGQzYTAxZDdjNzQxYjE5YjczNzg4MjkwYTE1MWRiXzctNC0xLTEtNTE5MzU_bc939c22-f762-4427-830b-4a03c189a1f9"
      unitRef="usd">1434000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzEyMjE_6d496973-19d6-4ba3-829a-5a38f71a8554">Share-Based CompensationThe Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#x2019;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzQzOA_e430ccec-d4b4-4d70-b292-3569c57c257c"&gt;four&lt;/span&gt; years, and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzU5Mw_79955690-60b5-4a44-8f50-193c14bfc3bb"&gt;four&lt;/span&gt; years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#x2019;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#x2019;s stock at a discounted price, which is 90% of the market price of the Company&#x2019;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTQvZnJhZzowMTM0NjlkMGNiYTE0YzQ4YjBjNzRhNzI4YzBhNjYxZi90ZXh0cmVnaW9uOjAxMzQ2OWQwY2JhMTRjNDhiMGM3NGE3MjhjMGE2NjFmXzYyOQ_88270c56-975d-4baf-893a-52ae6f06dc2b">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNTcvZnJhZzo4OTQwYWExMjk0ZGI0YzMyYjMxMTBiZjJkZGRlOTllYi90ZXh0cmVnaW9uOjg5NDBhYTEyOTRkYjRjMzJiMzExMGJmMmRkZGU5OWViXzExMzA_4b3bdec5-2667-44c8-8788-acca657d88d8">Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyODQ_d14c25ee-6fb6-4a65-a9fd-fe87344c4443">Investments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of debt securities by major security type is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nearly all of the Company&#x2019;s investments in mortgage-backed securities were rated &#x201c;Triple A&#x201d; as of December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company held $3.7 billion and $3.5 billion of equity securities as of December&#160;31, 2022 and 2021, respectively. The Company&#x2019;s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#x2019;s investments included $1.5 billion and $1.3 billion of equity method investments in operating businesses in the health care sector, as of December&#160;31, 2022 and 2021, respectively. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2022 and 2021 was not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities as of December&#160;31, 2022, by contractual maturity, were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unrealized losses from all securities as of December&#160;31, 2022 were generated from approximately 35,000 positions out of a total of 41,000 positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#x2019;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2022, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2022 and 2021 was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNDc_ed5cb5e9-2ac6-43a0-8877-1b748a06e8f3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of debt securities by major security type is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtMi0xLTEtNTE5MzU_85d592ec-1df1-4bcc-b2a4-967c2e9ea5a5"
      unitRef="usd">4093000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtNC0xLTEtNTE5MzU_0e15fe0a-f01e-4e46-9113-ae42f56e16e2"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtNi0xLTEtNTE5MzU_6d315b68-fc23-448d-9d1c-abd59c5736ea"
      unitRef="usd">285000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzMtOC0xLTEtNTE5MzU_2048de31-97b6-4141-8c70-f90932a60070"
      unitRef="usd">3809000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtMi0xLTEtNTE5MzU_7b4465a3-9981-4661-b2fa-c84a40a274d9"
      unitRef="usd">7702000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtNC0xLTEtNTE5MzU_eb2e8825-20d2-4b89-9074-087e39dc2b59"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtNi0xLTEtNTE5MzU_14ec0a96-6bbf-4ab6-b152-c59a3b16602c"
      unitRef="usd">479000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzQtOC0xLTEtNTE5MzU_54e2df87-b0b1-46f0-9dce-859464355c43"
      unitRef="usd">7248000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtMi0xLTEtNTE5MzU_f27a6b66-a734-473b-a7cf-58b780c994d5"
      unitRef="usd">23675000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtNC0xLTEtNTE5MzU_8a2625ed-b626-4d45-9f10-629f49f4d051"
      unitRef="usd">17000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtNi0xLTEtNTE5MzU_9c393de4-e051-4fd0-b429-8630cbefc2ac"
      unitRef="usd">1798000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzUtOC0xLTEtNTE5MzU_4d26b0d7-e78b-466a-a3e6-fe2e29a9c336"
      unitRef="usd">21894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtMi0xLTEtNTE5MzU_8e6f618f-de83-4726-9fb6-fc88d21732d0"
      unitRef="usd">7379000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtNC0xLTEtNTE5MzU_e67513ce-12dd-4a2c-a23f-a5cf4d873051"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtNi0xLTEtNTE5MzU_cad8ee6f-da4d-448d-bf27-64c0fbeeb52e"
      unitRef="usd">808000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzYtOC0xLTEtNTE5MzU_553cbd7f-f333-4645-b930-b1617d2ff2c0"
      unitRef="usd">6586000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctMi0xLTEtNTE5MzU_38d415e6-7aab-4fcd-95f4-e3070763b1fa"
      unitRef="usd">3077000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctNC0xLTEtNTE5MzU_ec6d59e0-c8b9-4265-bd5e-802f81418950"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctNi0xLTEtNTE5MzU_a01569be-4a2b-484f-9949-dcd2ecb8800d"
      unitRef="usd">294000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzctOC0xLTEtNTE5MzU_2c255373-f603-4719-a60a-9cb02aa15704"
      unitRef="usd">2784000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtMi0xLTEtNTE5MzU_1b449e68-99c5-476d-990d-62579fbebc26"
      unitRef="usd">45926000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtNC0xLTEtNTE5MzU_945cc9ac-49d2-4c68-8231-6944e2683770"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtNi0xLTEtNTE5MzU_5da4d6e9-faac-4a95-8b96-939deca5f4ea"
      unitRef="usd">3664000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzgtOC0xLTEtNTE5MzU_9610a3d5-50a0-4f62-9221-813a0a0cbae9"
      unitRef="usd">42321000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTItMS0xLTUxOTM1_34239c1f-e88c-4eba-9f0c-15dd81419b8b"
      unitRef="usd">578000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTQtMS0xLTUxOTM1_b0020d0f-7bbf-4dcc-a9e1-82ddd9aa1856"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTYtMS0xLTUxOTM1_4b04851e-6a81-4217-99db-ecd267f73a47"
      unitRef="usd">14000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEwLTgtMS0xLTUxOTM1_d51655ed-f966-4568-8dbe-6111e20b1273"
      unitRef="usd">564000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTItMS0xLTUxOTM1_5d11a486-d1b4-4c1a-9c95-201c7246fd15"
      unitRef="usd">29000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTQtMS0xLTUxOTM1_de1f7db4-1095-4ea1-9392-e57bc297fd16"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTYtMS0xLTUxOTM1_a60d8341-bb88-40c6-9dd6-7d7396d4c8e9"
      unitRef="usd">3000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzExLTgtMS0xLTUxOTM1_397a7fa3-8ec9-49b4-b845-89c2a9a318d1"
      unitRef="usd">26000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTItMS0xLTUxOTM1_ae2a80f8-2faa-4f8e-ab19-218a75276ee8"
      unitRef="usd">89000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTQtMS0xLTUxOTM1_af35911c-6960-4a95-b6d7-d243bdaaec9a"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTYtMS0xLTUxOTM1_15b9b1cd-a339-436a-80fd-198848c8cc7f"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEyLTgtMS0xLTUxOTM1_37618659-3792-44e9-8a73-8cc77aa4539f"
      unitRef="usd">89000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTItMS0xLTUxOTM1_ee0db646-a832-47c6-b22a-d0171979640a"
      unitRef="usd">696000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTQtMS0xLTUxOTM1_b3ae2349-26a9-4143-b978-6b45c22db9c2"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTYtMS0xLTUxOTM1_a78b4438-41ef-49d4-b422-20dfe0f8c8dc"
      unitRef="usd">17000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzEzLTgtMS0xLTUxOTM1_b6264b32-a8dd-4fce-895b-eebaa4ee4a3c"
      unitRef="usd">679000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <unh:InvestmentsAmortizedCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTItMS0xLTUxOTM1_0a59c40f-efb3-420d-806e-f9dd8ed3491c"
      unitRef="usd">46622000000</unh:InvestmentsAmortizedCost>
    <unh:InvestmentsGrossUnrealizedGains
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTQtMS0xLTUxOTM1_7c6e11b0-b6cc-49ad-822b-6a94f0666640"
      unitRef="usd">59000000</unh:InvestmentsGrossUnrealizedGains>
    <unh:InvestmentsGrossUnrealizedLosses
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTYtMS0xLTUxOTM1_250e4250-8b62-43bc-8fce-ced5e9266329"
      unitRef="usd">3681000000</unh:InvestmentsGrossUnrealizedLosses>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE0LTgtMS0xLTUxOTM1_5346d822-0f72-426b-bb57-d203b17ca3bf"
      unitRef="usd">43000000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTItMS0xLTUxOTM1_ae5a9911-41b6-4d0f-84f3-13633dc4a904"
      unitRef="usd">3206000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTQtMS0xLTUxOTM1_950ed389-659e-4f43-bdd1-317222c04c8c"
      unitRef="usd">23000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTYtMS0xLTUxOTM1_30f2a914-fca8-46a3-b907-5496a50d4430"
      unitRef="usd">31000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE3LTgtMS0xLTUxOTM1_93d828cd-20e9-4cf2-b0ab-619e835955d7"
      unitRef="usd">3198000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTItMS0xLTUxOTM1_b58953c2-00a1-486e-83c8-f1a301c96efc"
      unitRef="usd">6829000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTQtMS0xLTUxOTM1_e40396f5-1f80-455e-8c70-062f947f48d9"
      unitRef="usd">297000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTYtMS0xLTUxOTM1_208aa8ec-4745-49ff-8f65-0f84bb4822b0"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE4LTgtMS0xLTUxOTM1_861bb008-4490-4685-ad27-206479b0588c"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTItMS0xLTUxOTM1_039e3f4e-dcc0-4fcc-84f0-0c92b4143277"
      unitRef="usd">20947000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTQtMS0xLTUxOTM1_ebb559bd-3ed1-4f8d-ae71-d8e727d9630c"
      unitRef="usd">372000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTYtMS0xLTUxOTM1_56812a4f-21b1-4326-a1f1-1c5c1dc2c7bb"
      unitRef="usd">145000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzE5LTgtMS0xLTUxOTM1_ac3e3970-be70-45e7-8f02-2c7ba0d4e5c9"
      unitRef="usd">21174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTItMS0xLTUxOTM1_5d5c5a1b-6e9a-4333-9b86-95714ee58778"
      unitRef="usd">5868000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTQtMS0xLTUxOTM1_ccdd320b-923c-4d0b-ac1c-025301f0a681"
      unitRef="usd">88000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTYtMS0xLTUxOTM1_f3522772-1b4f-4b72-92d4-125e49613f61"
      unitRef="usd">55000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIwLTgtMS0xLTUxOTM1_d11188f3-7b41-4f15-b199-a60a301d68cd"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTItMS0xLTUxOTM1_5dc3398a-8bba-4e4c-a7cc-c7620a9c582a"
      unitRef="usd">2819000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTQtMS0xLTUxOTM1_ee0de519-e80a-451d-82c2-cb70eb08f6f7"
      unitRef="usd">42000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTYtMS0xLTUxOTM1_efa0ac74-4a20-4bd5-91e0-bead3281f083"
      unitRef="usd">23000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIxLTgtMS0xLTUxOTM1_8c95925e-dab8-4c8d-983b-08c2d6828c65"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTItMS0xLTUxOTM1_0993ab1c-1dd4-476e-b792-9bb42d566b98"
      unitRef="usd">39669000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTQtMS0xLTUxOTM1_f194f2f9-ee33-4551-a687-0ba09ab35e97"
      unitRef="usd">822000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTYtMS0xLTUxOTM1_5a9124b9-c2b5-4b53-aa1b-419770ba1feb"
      unitRef="usd">274000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzIyLTgtMS0xLTUxOTM1_ab4a9489-fdca-44a6-85c2-3fec5ab790ba"
      unitRef="usd">40217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTItMS0xLTUxOTM1_a1d146f9-3b0b-4c44-af5e-c584ae6a1a1c"
      unitRef="usd">511000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTQtMS0xLTUxOTM1_7e6cd6d5-c390-41fa-967a-5260f9cd19a2"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTYtMS0xLTUxOTM1_abe1f2a1-a9db-4299-b998-27e1426ca5e0"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI0LTgtMS0xLTUxOTM1_78c38b38-45bf-4aa2-b35e-f4a582ad9fc2"
      unitRef="usd">511000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTItMS0xLTUxOTM1_b07d0d65-c281-44c0-87f4-2cd731f0a97b"
      unitRef="usd">30000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTQtMS0xLTUxOTM1_f090f77e-7da5-4b56-a222-66079f4f197c"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTYtMS0xLTUxOTM1_2ae070c7-6094-4375-8bbe-8cf3c1b2ead3"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI1LTgtMS0xLTUxOTM1_70748f5b-6f54-4695-befc-270f7deec8ef"
      unitRef="usd">32000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTItMS0xLTUxOTM1_d182cc86-a2ea-47a0-88f9-a0b13cab0658"
      unitRef="usd">100000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTQtMS0xLTUxOTM1_5e77b06b-4ad5-492d-a55c-ce9952c9e6c8"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTYtMS0xLTUxOTM1_fe7a44d0-eea5-4cb0-92f2-8a3d98eccff5"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI2LTgtMS0xLTUxOTM1_c09735a7-5456-44ae-a735-0c0aa4d768f9"
      unitRef="usd">100000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTItMS0xLTUxOTM1_b79ffa79-7ea5-4a7f-9d86-0d533e5957ae"
      unitRef="usd">641000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTQtMS0xLTUxOTM1_fa8787c0-f9b1-43a5-bed8-7dea34d3f631"
      unitRef="usd">4000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTYtMS0xLTUxOTM1_f0718c2c-809b-4d5c-a455-3ac2c0337f05"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI3LTgtMS0xLTUxOTM1_bef42427-3ed6-4d83-9926-2f48ede8c650"
      unitRef="usd">643000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <unh:InvestmentsAmortizedCost
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTItMS0xLTUxOTM1_4a659f5f-7d31-40fd-b0e1-799fc5877c91"
      unitRef="usd">40310000000</unh:InvestmentsAmortizedCost>
    <unh:InvestmentsGrossUnrealizedGains
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTQtMS0xLTUxOTM1_41660f01-355b-4075-bd78-29c6036d35bd"
      unitRef="usd">826000000</unh:InvestmentsGrossUnrealizedGains>
    <unh:InvestmentsGrossUnrealizedLosses
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTYtMS0xLTUxOTM1_346e96df-dfb5-4218-80a8-79ff84aa66b8"
      unitRef="usd">276000000</unh:InvestmentsGrossUnrealizedLosses>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo2YTBkMTc2NDQ3MTU0NzdiYTc3ODk4NmZkMDBlNWIwNy90YWJsZXJhbmdlOjZhMGQxNzY0NDcxNTQ3N2JhNzc4OTg2ZmQwMGU1YjA3XzI4LTgtMS0xLTUxOTM1_f5bbb027-c1e7-491a-9207-5470051b6be3"
      unitRef="usd">40860000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIwOQ_ea80e291-1ec9-438c-a3ac-6a291c343771"
      unitRef="usd">3700000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIxNg_fad1380e-4731-47fe-86af-920d0ef307a1"
      unitRef="usd">3500000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquityMethodInvestments
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzU1Ng_9ce41910-5e60-4a1c-8738-e28bd0f1dd6d"
      unitRef="usd">1500000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzU0OTc1NTgxNjIxNw_1270c581-9ac1-4605-bb5c-4c67837044b2"
      unitRef="usd">1300000000</us-gaap:EquityMethodInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNjc_8b957f1f-59e9-4b5b-875b-51ede3214a44">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities as of December&#160;31, 2022, by contractual maturity, were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItMi0xLTEtNTE5MzU_9a3f1d37-f1e3-4711-ba6c-a47d08cd85d1"
      unitRef="usd">4713000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItNC0xLTEtNTE5MzU_b3d388f2-aa58-42b5-8cde-d05c2652c5e2"
      unitRef="usd">4682000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItNi0xLTEtNTE5MzU_5d0af63d-2649-41ab-8ce3-078e77032286"
      unitRef="usd">374000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzItOC0xLTEtNTE5MzU_61daeb31-8eef-42b1-98e1-80bb055c8d35"
      unitRef="usd">369000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtMi0xLTEtNTE5MzU_d5628495-8a6e-45d8-a5f8-8cc2ad4d1ec0"
      unitRef="usd">13135000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtNC0xLTEtNTE5MzU_e4408eeb-b46b-4736-8e8a-c5236dd160f6"
      unitRef="usd">12404000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtNi0xLTEtNTE5MzU_47b214cf-60f6-491f-b81c-523d276c41cb"
      unitRef="usd">265000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzMtOC0xLTEtNTE5MzU_1d2f27d4-bdac-4a20-a71a-4b7c1c669991"
      unitRef="usd">256000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtMi0xLTEtNTE5MzU_fe0c2e72-7452-4fb7-9d8e-5f1ac5b1e120"
      unitRef="usd">12210000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtNC0xLTEtNTE5MzU_035fc22f-03f4-428c-82d7-329d90b2007b"
      unitRef="usd">10897000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtNi0xLTEtNTE5MzU_288c98e7-1337-4892-abdd-7d491b7cb9b1"
      unitRef="usd">37000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzQtOC0xLTEtNTE5MzU_88a9a103-c2f6-41b5-997b-a8e80a94029f"
      unitRef="usd">36000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtMi0xLTEtNTE5MzU_69fb1694-8942-4cfe-a920-b83a3035b5dc"
      unitRef="usd">5412000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtNC0xLTEtNTE5MzU_5531df24-192f-4899-9d42-4a9c7be1037d"
      unitRef="usd">4968000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtNi0xLTEtNTE5MzU_58bbc31e-328a-4f17-8cf8-1680dca6c3a0"
      unitRef="usd">20000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzUtOC0xLTEtNTE5MzU_b42eb9f0-583b-4e90-8bc3-824aaa7a6dfb"
      unitRef="usd">18000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzYtMi0xLTEtNTE5MzU_2ed21843-60d3-48ad-a3fa-6b2917e61ce3"
      unitRef="usd">7379000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzYtNC0xLTEtNTE5MzU_dfcfe0af-8440-497b-bbef-08c050782345"
      unitRef="usd">6586000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzctMi0xLTEtNTE5MzU_a6157261-c6d4-41b7-a1d0-e409549c8b17"
      unitRef="usd">3077000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzctNC0xLTEtNTE5MzU_48f8f0a6-fcbc-487d-97ec-c5da2fc49556"
      unitRef="usd">2784000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtMi0xLTEtNTE5MzU_c29b10a2-4b71-48a8-b7e4-1866298117e0"
      unitRef="usd">45926000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtNC0xLTEtNTE5MzU_d892410c-1f34-4ac8-a5c4-74aa02dab972"
      unitRef="usd">42321000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtNi0xLTEtNTE5MzU_2efa5b0a-d368-4cca-915b-a3c971f5a039"
      unitRef="usd">696000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZToxZmVhZDNjZjkzNWE0NGZkYTA1MDEwYmEwYTljNjE5ZC90YWJsZXJhbmdlOjFmZWFkM2NmOTM1YTQ0ZmRhMDUwMTBiYTBhOWM2MTlkXzgtOC0xLTEtNTE5MzU_64404067-de13-421d-b413-3fac8ae0d0ab"
      unitRef="usd">679000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzIyNTk_24bde963-612b-4112-8761-ab6d7d7801a6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMi0xLTEtNTE5MzU_eb2a7c47-578e-4449-8815-0bdaf6f24312"
      unitRef="usd">2007000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtNC0xLTEtNTE5MzU_71e8c0f8-3e66-419e-8483-e7d02d6f4612"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtNi0xLTEtNTE5MzU_1643d923-5518-407b-9783-7e5868c45189"
      unitRef="usd">1290000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtOC0xLTEtNTE5MzU_7ece395b-ac3f-498f-8e59-e8b17f9c8a73"
      unitRef="usd">189000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMTAtMS0xLTUxOTM1_036e12c2-3829-447d-9d26-f818cd21455c"
      unitRef="usd">3297000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzMtMTItMS0xLTUxOTM1_11227906-785e-4a72-ab57-306dd148c2f9"
      unitRef="usd">285000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMi0xLTEtNTE5MzU_07e804d8-5ea0-4bea-ad7f-614d4c3480de"
      unitRef="usd">4630000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtNC0xLTEtNTE5MzU_8502b0ab-6804-44e0-8745-636dbcd22830"
      unitRef="usd">288000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtNi0xLTEtNTE5MzU_6deb1651-b671-481a-aaa2-cd9aff278a4c"
      unitRef="usd">1178000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtOC0xLTEtNTE5MzU_c56cdc7f-e000-40b2-9b9c-47aae776061b"
      unitRef="usd">191000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMTAtMS0xLTUxOTM1_f8b3de20-e2ef-4f5b-814e-3241c70e4839"
      unitRef="usd">5808000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzQtMTItMS0xLTUxOTM1_f674ff16-7603-4e3b-9c6a-994b1fa11d90"
      unitRef="usd">479000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMi0xLTEtNTE5MzU_2dfbbb7e-2375-43be-a3be-3b06448ffde4"
      unitRef="usd">13003000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtNC0xLTEtNTE5MzU_04710f11-af96-4cb7-8650-53613474cb9c"
      unitRef="usd">893000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtNi0xLTEtNTE5MzU_3497ec78-98a4-485a-b597-92626d0f5a5b"
      unitRef="usd">6637000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtOC0xLTEtNTE5MzU_de50b97e-8823-4e4f-b199-604ac09509eb"
      unitRef="usd">905000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMTAtMS0xLTUxOTM1_16b7d356-7edc-4eee-9fbc-c8610adfc889"
      unitRef="usd">19640000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzUtMTItMS0xLTUxOTM1_39a4fba6-edda-4c33-8c11-c56bdc1e9418"
      unitRef="usd">1798000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMi0xLTEtNTE5MzU_f948eaa5-d861-40f8-a153-c047d688037b"
      unitRef="usd">3561000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtNC0xLTEtNTE5MzU_3d7dc469-4985-4754-a9d6-ba91b7a8064f"
      unitRef="usd">345000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtNi0xLTEtNTE5MzU_98130498-367d-4d3e-94df-7a9b59938526"
      unitRef="usd">2239000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtOC0xLTEtNTE5MzU_ccfe82e8-b2b5-4ef3-9788-d94ea7c4ec60"
      unitRef="usd">463000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMTAtMS0xLTUxOTM1_afe407d4-6166-4ae8-9dd7-cea896d5cc44"
      unitRef="usd">5800000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzYtMTItMS0xLTUxOTM1_4640e4b1-835d-42d9-9dc4-e049dee0af20"
      unitRef="usd">808000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMi0xLTEtNTE5MzU_eba02c4a-1137-47dc-b51d-36faf155f8db"
      unitRef="usd">1698000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctNC0xLTEtNTE5MzU_6908efd5-7236-4e55-b087-5003ff166d61"
      unitRef="usd">128000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctNi0xLTEtNTE5MzU_42015bf4-4efe-4ea3-a9c1-55f7f73382e2"
      unitRef="usd">976000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctOC0xLTEtNTE5MzU_2e6fc50b-406a-48a2-9ecf-e4b71cd37287"
      unitRef="usd">166000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMTAtMS0xLTUxOTM1_ea51b8e7-96c9-4663-a526-ef9a4a0e33a7"
      unitRef="usd">2674000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzctMTItMS0xLTUxOTM1_1d486710-be54-4d0d-9ab6-2b318e7a48b9"
      unitRef="usd">294000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMi0xLTEtNTE5MzU_f2a524bf-4c85-4079-a5c9-1c89755d63cf"
      unitRef="usd">24899000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtNC0xLTEtNTE5MzU_f18df4af-cad5-4bf0-b0e8-783318b32074"
      unitRef="usd">1750000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtNi0xLTEtNTE5MzU_52adbaef-d28e-4d69-9c25-cc2ae265316c"
      unitRef="usd">12320000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtOC0xLTEtNTE5MzU_887b295e-29c8-483b-a40a-cf3bbb2891bc"
      unitRef="usd">1914000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMTAtMS0xLTUxOTM1_58371f7e-63c5-4f16-8c42-4a8a7d1fd9ec"
      unitRef="usd">37219000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzgtMTItMS0xLTUxOTM1_ddc5caaa-5046-4738-b701-be67ca532f10"
      unitRef="usd">3664000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTItMS0xLTUxOTM1_a09534a2-f6ba-40b2-a307-c45f9c50b94d"
      unitRef="usd">1976000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTQtMS0xLTUxOTM1_7421282a-22c9-4232-be0f-1886a47f6fd1"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTYtMS0xLTUxOTM1_bee742c7-2596-47c5-aa5a-8f1d2b765744"
      unitRef="usd">249000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTgtMS0xLTUxOTM1_bda7a404-bfe0-4f75-8733-c6a661ae13c8"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTEwLTEtMS01MTkzNQ_84c66297-f84c-4a33-bc09-73c2ec0c8439"
      unitRef="usd">2225000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEwLTEyLTEtMS01MTkzNQ_f32c055c-b4ba-4a0a-a7ae-c1eeae3957c5"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTItMS0xLTU3NTM3_ef2b02c9-2568-49bc-9ffe-31a84e22d503"
      unitRef="usd">1386000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTQtMS0xLTU3NTM3_9fed5847-3a28-4935-aa82-76292678d1a5"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTYtMS0xLTU3NTM3_0778aa4a-8dd5-45f3-8691-fc92fde5d6fb"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTgtMS0xLTU3NTM3_2d696a48-3c2a-4462-a142-17ddd69211e8"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEwLTEtMS01NzUzNw_ad1da6c0-b5e0-4c57-b328-88a40d059880"
      unitRef="usd">1417000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEyLTEtMS01NzUzNw_e1d6f7d2-7d3c-49d8-9efd-af0dc82e5cd3"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTItMS0xLTUxOTM1_a75ebde6-02c0-4340-8a58-b57975dfb18e"
      unitRef="usd">9357000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTQtMS0xLTUxOTM1_0796a8bb-2e8f-4695-ae51-f76ee67f09aa"
      unitRef="usd">130000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTYtMS0xLTUxOTM1_d89a773b-c609-4f25-84c2-086c5bf414e9"
      unitRef="usd">376000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTgtMS0xLTUxOTM1_7d46836c-8f63-4626-a8b0-6f97d6d51669"
      unitRef="usd">15000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEwLTEtMS01MTkzNQ_0e7509b7-5680-4be5-9307-8edccd8176a5"
      unitRef="usd">9733000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzExLTEyLTEtMS01MTkzNQ_1df0632f-1d95-4c8f-b05c-54e981254c22"
      unitRef="usd">145000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTItMS0xLTUxOTM1_174154e5-302c-4268-b576-16905106164f"
      unitRef="usd">3078000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTQtMS0xLTUxOTM1_df955b3f-f059-476b-b99d-5bd5897d0a41"
      unitRef="usd">52000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTYtMS0xLTUxOTM1_2b8cae0a-18b8-4a2e-8e18-d00f1b1fd3af"
      unitRef="usd">116000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTgtMS0xLTUxOTM1_7f9a4203-dcae-4ffb-aca8-c038ec0b4175"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTEwLTEtMS01MTkzNQ_50adbee2-dfdc-46e7-a797-4859af26fc7d"
      unitRef="usd">3194000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEyLTEyLTEtMS01MTkzNQ_18008776-ad4a-47d6-93c0-3ae5bd5f8651"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTItMS0xLTUxOTM1_561e7a46-c7a2-43b6-9364-c35ced42894c"
      unitRef="usd">1321000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTQtMS0xLTUxOTM1_ab97791d-77dd-4f25-9bd7-bd54943c555f"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTYtMS0xLTUxOTM1_9607cf42-2e30-4089-929f-80eaafc47c0e"
      unitRef="usd">114000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTgtMS0xLTUxOTM1_88c41c7d-b4f4-4297-8a14-13e289415a1a"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTEwLTEtMS01MTkzNQ_481eaeb5-177d-486c-b31d-b97f624adbd8"
      unitRef="usd">1435000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzEzLTEyLTEtMS01MTkzNQ_720affd5-2d5f-4c57-964b-f296b078c67e"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTItMS0xLTUxOTM1_c54e6ece-e5c1-4414-b325-df390408f33c"
      unitRef="usd">17118000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTQtMS0xLTUxOTM1_5d4be846-4830-401c-b5f4-cfb75bc9a9b9"
      unitRef="usd">237000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTYtMS0xLTUxOTM1_6365ed41-59e6-4372-9c40-eb2f896253a3"
      unitRef="usd">886000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTgtMS0xLTUxOTM1_1e235d10-74aa-4b78-8889-87e00fef33ee"
      unitRef="usd">37000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTEwLTEtMS01MTkzNQ_0f35fb64-e688-4352-88e8-d7b4b467a5df"
      unitRef="usd">18004000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90YWJsZTo4OTZjMWQzNmY1MDM0MmJkYmI4ODk1MzNkYjUyMTEyNC90YWJsZXJhbmdlOjg5NmMxZDM2ZjUwMzQyYmRiYjg4OTUzM2RiNTIxMTI0XzE0LTEyLTEtMS01MTkzNQ_f75e68b4-ca93-4656-8548-9e26839946fc"
      unitRef="usd">274000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzExODI_067736be-b43f-4e21-b7cc-2f2b4b56bf85"
      unitRef="positions">35000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjMvZnJhZzo4NmU3OGYzNjAzOWI0MjdhYTFlZWNlN2IyZTdjY2Q2Yi90ZXh0cmVnaW9uOjg2ZTc4ZjM2MDM5YjQyN2FhMWVlY2U3YjJlN2NjZDZiXzEyMTM_3817de09-9a77-4422-ae79-aff45c56129a"
      unitRef="number">41000</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NTM_4d34f3a6-3852-4a08-a599-d5667169db4f">Fair ValueCertain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Quoted prices (unadjusted) for identical assets/liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Other observable inputs, either directly or indirectly, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets/liabilities in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs corroborated by other observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs cannot be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the years ended December 31, 2022 and 2021, the Company recognized $211 million and $840 million, respectively, of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based upon transaction of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of debt securities and equity securities reported at fair value on a recurring basis are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#x2019;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates for Level 1 and Level 2 equity securities reported at fair value on a recurring basis are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Throughout the procedures discussed above in relation to the Company&#x2019;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#x2019;s investments in debt and equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s long-term debt are estimated and classified using the same methodologies as the Company&#x2019;s investments in debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair and Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NzI_6b30f36f-ab4a-4cfb-beae-34d5f0dad156">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Quoted prices (unadjusted) for identical assets/liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Other observable inputs, either directly or indirectly, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets/liabilities in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs corroborated by other observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs cannot be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the years ended December 31, 2022 and 2021, the Company recognized $211 million and $840 million, respectively, of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based upon transaction of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of debt securities and equity securities reported at fair value on a recurring basis are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#x2019;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates for Level 1 and Level 2 equity securities reported at fair value on a recurring basis are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Throughout the procedures discussed above in relation to the Company&#x2019;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#x2019;s investments in debt and equity securities.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s long-term debt are estimated and classified using the same methodologies as the Company&#x2019;s investments in debt securities.&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_66888705-8e37-4ecb-b140-9df15828db4e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_973335ab-9c5b-492f-861c-70caf055e30f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_bbb66069-8060-48d7-9858-43980fb2afcb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzE1MzA_c6cd9939-9cbd-4c53-a085-53cedd63d3f9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI3MA_50d39058-74ae-4f1a-bb86-ed92938c7380"
      unitRef="usd">211000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI4Nw_88145a82-e90b-48b3-a27f-9c6f02530819"
      unitRef="usd">840000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis
      contextRef="idef199e9d5164b839dff15f1d15b655d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI5NQ_6c2e47e2-1920-4f0b-b52f-9e80fd49fcba"
      unitRef="usd">0</unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis>
    <unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis
      contextRef="i3100e960b47a458dbc9b0427cfe50a57_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzU0OTc1NTgyMTI5NQ_f22e1136-d48c-4c6e-948f-26de1eefebcf"
      unitRef="usd">0</unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1NzU_a2611d9a-cf2a-4a4b-beb1-3ab3935773cf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair and Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItMi0xLTEtNTE5MzU_bd3c0c30-8b70-41e1-a42c-f67dbe43eb4f"
      unitRef="usd">23202000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i398125db28a248afa78be5dde2f802de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItNC0xLTEtNTE5MzU_1d1528c2-da73-40aa-bb7d-91158a4d4f6d"
      unitRef="usd">163000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItNi0xLTEtNTE5MzU_47843101-0a11-4ab6-8890-ec6f5d558a81"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzItOC0xLTEtNTE5MzU_69b53e41-6d16-4a65-8056-76a843d483e3"
      unitRef="usd">23365000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b5a2a5290514b42a50323b2c2b06755_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtMi0xLTEtNTE5MzU_ebd6ef0f-98d9-4258-802a-065c1bde61d9"
      unitRef="usd">3505000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27447352b0ab4986955366c4e6e7c8ab_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtNC0xLTEtNTE5MzU_12c15aea-f4df-45f7-a1ff-7a5c80cd0426"
      unitRef="usd">304000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i188beb504ffd4cf1811a05b9122ba936_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtNi0xLTEtNTE5MzU_e487fdda-c24b-419e-b424-068ef0820f39"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf429de67ae248a68c7cb4da5ce8428c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzQtOC0xLTEtNTE5MzU_c826806e-0433-4dea-bedc-79ed2072309c"
      unitRef="usd">3809000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic133da4ac5694c2ab3ebbb7920479054_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtMi0xLTEtNTE5MzU_a0bba4f9-aae7-4b6c-9f37-30ef6cf79f89"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i036507f5da394189a07761f27ce7e50f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtNC0xLTEtNTE5MzU_8c0a473b-5830-44d4-85df-44aae17320f6"
      unitRef="usd">7248000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i65c3951e41d5448f93f5d245e448b353_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtNi0xLTEtNTE5MzU_002de2b0-49b9-4dc4-93b9-8be49b2f76bb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5b36c5ce67a460091fdcbbcf205c0cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzUtOC0xLTEtNTE5MzU_7e57617c-1527-4f28-942e-4f1c14a27c66"
      unitRef="usd">7248000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie787f6065b7145838ac2375afc47c02e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtMi0xLTEtNTE5MzU_6628ead5-ff3a-403b-aa6a-0672caaaeb9e"
      unitRef="usd">7000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb07718b5c854d9cbe58e30453c54be2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtNC0xLTEtNTE5MzU_fec567aa-5bbe-43f9-a189-892ed8888dd4"
      unitRef="usd">21695000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3373ab24aca44874b727df09174bb908_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtNi0xLTEtNTE5MzU_2c98cbb1-03e6-4254-8909-a70110b61261"
      unitRef="usd">192000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife04c89dd39a402eb363a5aa452772d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzYtOC0xLTEtNTE5MzU_9807767f-74d2-41d7-8672-2c333c35431f"
      unitRef="usd">21894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i869ae145fa344284be424032a072bd49_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctMi0xLTEtNTE5MzU_a8d46fe7-d00e-45d5-bf1a-e0cb5c85c048"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b6663e1ca24400db968c0f30349d738_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctNC0xLTEtNTE5MzU_580c4d14-c495-48b2-9a5b-45e4cab8367b"
      unitRef="usd">6586000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0790ce8dc806474baab7039cd2473ef4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctNi0xLTEtNTE5MzU_4b3b9177-1073-4dbb-9b09-38b8532a7bce"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia18d6beb6b1c4b2987106d01727d38dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzctOC0xLTEtNTE5MzU_3769b429-71f6-46d7-bb49-d766c2d0b639"
      unitRef="usd">6586000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0485953f893b49d693502de2df2048e6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtMi0xLTEtNTE5MzU_0034ff78-8729-4496-93d4-82d557122b2b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief6fab63019041c7a43aa25dabe91d73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtNC0xLTEtNTE5MzU_c73c9974-4c2e-457b-b4b7-286dc98895e1"
      unitRef="usd">2784000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf77a1a93e4449e79e9e7ecb7ca12b9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtNi0xLTEtNTE5MzU_442c6a56-7c14-4617-b949-e8482cd7610d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i95e69fa331194b15a906c00c27162164_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzgtOC0xLTEtNTE5MzU_98554686-c56c-4eea-abd8-e2caffbb4ef2"
      unitRef="usd">2784000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b874edc14f445189ce46feb9f2c4f83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktMi0xLTEtNTE5MzU_b9fdf42a-fc47-4a09-b6a7-82d0ee0d3080"
      unitRef="usd">3512000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iece3fb1e3e9b4d8190443f2996222c31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktNC0xLTEtNTE5MzU_0a4dbd94-200c-4392-a6ff-817dfabb3823"
      unitRef="usd">38617000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb02468002ee402a8d58d3f0b459ea93_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktNi0xLTEtNTE5MzU_07194180-bc20-4998-863c-dad843c645ca"
      unitRef="usd">192000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i26d227da923f4bafa3e23635ffa3e63d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzktOC0xLTEtNTE5MzU_8bbe5c8a-a1be-458a-b6b7-b33cf78ede0a"
      unitRef="usd">42321000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTItMS0xLTUxOTM1_acc53cb4-bd8e-417a-b8a3-48f13f0aebaa"
      unitRef="usd">2043000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i398125db28a248afa78be5dde2f802de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTQtMS0xLTUxOTM1_20969992-41e3-463f-8fa5-82cbc75c7a99"
      unitRef="usd">35000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTYtMS0xLTUxOTM1_4cadf753-a11e-4692-8b6f-e082bb7e7704"
      unitRef="usd">70000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEwLTgtMS0xLTUxOTM1_43fc1f93-45da-4e54-8e17-4ddd45b83b8e"
      unitRef="usd">2148000000</us-gaap:EquitySecuritiesFvNi>
    <unh:AarpAssetsUnderManagement
      contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTItMS0xLTUxOTM1_e997bb6f-ca83-4dd0-899f-b85f43826df5"
      unitRef="usd">1788000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="i398125db28a248afa78be5dde2f802de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTQtMS0xLTUxOTM1_73a4f48a-0fb1-4475-92c7-6d67c960a37c"
      unitRef="usd">2203000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTYtMS0xLTUxOTM1_4259f92a-a4c3-4f3e-b629-f52c1997d2c3"
      unitRef="usd">96000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzExLTgtMS0xLTUxOTM1_b999657d-31c1-4550-8338-8c1bf70be370"
      unitRef="usd">4087000000</unh:AarpAssetsUnderManagement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9eacf249beb84261b10dda890a8c7b1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTItMS0xLTUxOTM1_9fab9c02-52d5-4656-bf63-cff65527cda8"
      unitRef="usd">30545000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i398125db28a248afa78be5dde2f802de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTQtMS0xLTUxOTM1_5084a58f-ed8a-4d4e-80e8-c241e929ac7c"
      unitRef="usd">41018000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if4b697d303c246c990d7e9e55449aa31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTYtMS0xLTUxOTM1_de0dbea8-0c78-4ce6-9357-284268894ab6"
      unitRef="usd">358000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzEyLTgtMS0xLTUxOTM1_a5303620-42d8-441e-be20-69ab5e9081ca"
      unitRef="usd">71921000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTItMS0xLTUxOTM1_1a561e52-beb6-4717-8b4f-90f5794e23c8"
      unitRef="usd">21359000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTQtMS0xLTUxOTM1_0ceb272a-c29a-4be7-8755-c39dc8c2c2ff"
      unitRef="usd">16000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTYtMS0xLTUxOTM1_b94efb24-ec63-47e1-a5ec-5209500a9198"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE1LTgtMS0xLTUxOTM1_3ab4ac20-3a26-4a30-9368-d7f5d42d6faa"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if14e7f1d47d24ce5849f9b9b561f7e16_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTItMS0xLTUxOTM1_6ba09e76-8ce2-4fd7-88ff-f51700accd64"
      unitRef="usd">3017000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5784b258ad7c4a2fb80cf028d4eabdb0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTQtMS0xLTUxOTM1_1fadd3d8-f93a-461e-99d7-761bd9f22214"
      unitRef="usd">181000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c699d8d9ea945a59bfac2890b0ad12a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTYtMS0xLTUxOTM1_6f912669-495c-40b0-b55e-7bcfe71f9b6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if05937365d074cadb89e64039541d02d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE3LTgtMS0xLTUxOTM1_200cfa67-daf8-4983-8447-c1343e6b02f6"
      unitRef="usd">3198000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i657a012885e24d5eaacd841fab51c280_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTItMS0xLTUxOTM1_4549b641-5939-42df-9e3b-87ff75363830"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd889a008b09458f83587b1ac62ff127_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTQtMS0xLTUxOTM1_63e29fae-3933-4791-915c-f830bb551240"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id88f51dc85eb4f388b644b2df135e040_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTYtMS0xLTUxOTM1_09c8db2d-00c5-4aaa-82d6-4c45e81a7bbd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4133bc7b7654a80873db5b16de03f74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE4LTgtMS0xLTUxOTM1_2c9bdcdf-ce5d-41f4-b21e-49c110da3983"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06af4dfd1cfd4c9da60ac57537b11dc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTItMS0xLTUxOTM1_a91ffc70-242d-4c00-a084-9b3ddc815ad5"
      unitRef="usd">40000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifecbdb30ca8f48bd9c6d49d82fbc8d3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTQtMS0xLTUxOTM1_3911c682-8af3-4e8f-ae10-dbd46afa1b1e"
      unitRef="usd">20916000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i10fb3889577743e99907b617e43c8ba8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTYtMS0xLTUxOTM1_440bfebc-3718-4e5c-9c73-9d533e6e43ae"
      unitRef="usd">218000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib275e6a73d0440148b42d342275a5ec2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzE5LTgtMS0xLTUxOTM1_538148e2-eaf2-4234-b402-44ebfdd26cae"
      unitRef="usd">21174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i443d6329218e4e968f2b21276f5ad0b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTItMS0xLTUxOTM1_c51215a9-e858-4592-a5be-e43c751aef7f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8f630fda39a4043bfe6128ff91152bb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTQtMS0xLTUxOTM1_b2d9a6f6-9027-412e-8d7d-8a223d3f553a"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50f797283d0f468a9e019cd793e5de27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTYtMS0xLTUxOTM1_b8d9dd53-5c8b-44d4-8c97-2474c1bb0015"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id4bf3e83c042412faa2721b20b445a19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIwLTgtMS0xLTUxOTM1_b350e902-80b7-4dec-bdee-c76f3f909afa"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iddcca2f61bd741edb945e23a517102e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTItMS0xLTUxOTM1_aa99698e-3016-41cc-8f38-459e3de1be17"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf402af8c08c4d1cbb8e1ee5013f8985_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTQtMS0xLTUxOTM1_8938c5a4-d4f0-4a2c-b16e-77c22fb6987e"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1029e91d76ab42b3ac1bfc3d43571bee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTYtMS0xLTUxOTM1_982388f3-8f9c-41b5-b07e-fa9798d99303"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i011f48e345274d1f9d386cb6032974c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIxLTgtMS0xLTUxOTM1_7ebf60fa-5bca-4768-8898-42c1ce9de7c7"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib08f479dfe434d749660a45e73e5ae3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTItMS0xLTUxOTM1_29c7045f-7ea3-4ca6-b3bf-89a73b417890"
      unitRef="usd">3057000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55ab6c56958a464c87ff17c070fbaacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTQtMS0xLTUxOTM1_65b45a2f-a79c-4b92-bb5a-d87bd05c9df0"
      unitRef="usd">36942000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie3ddbe32d07a43fc9952719ea94c5a31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTYtMS0xLTUxOTM1_2d01b747-3723-449c-a653-eda6f04dd5af"
      unitRef="usd">218000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9ea388a069444c4931adafec448408a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIyLTgtMS0xLTUxOTM1_a9d13433-8805-44c5-bf6b-885c32597e7e"
      unitRef="usd">40217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTItMS0xLTUxOTM1_ad1a9728-2eb7-42bc-ab21-a2f437038408"
      unitRef="usd">2090000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTQtMS0xLTUxOTM1_e461a458-30a7-4c14-88d6-b8c30abea310"
      unitRef="usd">23000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTYtMS0xLTUxOTM1_27ef58bd-2f72-4739-8d86-81452da2a771"
      unitRef="usd">64000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzIzLTgtMS0xLTUxOTM1_14927fa3-6191-4a37-a9cf-875c06f3a20e"
      unitRef="usd">2177000000</us-gaap:EquitySecuritiesFvNi>
    <unh:AarpAssetsUnderManagement
      contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTItMS0xLTUxOTM1_55352d48-ab71-4d6a-809d-906aca58bad9"
      unitRef="usd">1972000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTQtMS0xLTUxOTM1_34fc2505-6226-48ae-994f-228c9750b9d5"
      unitRef="usd">2376000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTYtMS0xLTUxOTM1_15f7b05a-bcea-4603-9443-f9a93280a7fe"
      unitRef="usd">101000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI0LTgtMS0xLTUxOTM1_5c3dea2d-ea74-41dd-870d-8dd278f9a212"
      unitRef="usd">4449000000</unh:AarpAssetsUnderManagement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9a1a835311424287bdea3b0f166d0ee4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTItMS0xLTUxOTM1_55e376ff-afe0-4cc9-a637-d075ec694b36"
      unitRef="usd">28478000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id829c67b8dcc4173a26141ccf0fc20bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTQtMS0xLTUxOTM1_3e43570e-4543-4a31-981c-45075f5172a1"
      unitRef="usd">39357000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i83c7e5e162de4dbc88d5494b2ce0f2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTYtMS0xLTUxOTM1_033b97ba-5f69-4c17-99b7-2fe9c5b4c580"
      unitRef="usd">383000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTozMjFiNDdlYWNmNDM0MzFmOTBjZGYxNDJlMGYxNTA3ZC90YWJsZXJhbmdlOjMyMWI0N2VhY2Y0MzQzMWY5MGNkZjE0MmUwZjE1MDdkXzI1LTgtMS0xLTUxOTM1_0a2e58ac-f003-4581-8bdc-907dc1e92dcd"
      unitRef="usd">68218000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90ZXh0cmVnaW9uOmZlMDE1NDQzNjVkMTQ2MmFiZjMwMTc1Mjk0ZGRmYjg0XzY1Njk_3ea832a9-e998-43a2-8254-c74cffe1945d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ibc9058fdfbea43dabe2bae0df36bd3bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItMi0xLTEtNTE5MzU_a7f8088d-6413-4f0d-8ce4-d5f5826872f0"
      unitRef="usd">577000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i307873d9bcfb48f8a290730f26815add_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItNC0xLTEtNTE5MzU_c490d12f-1248-4115-81a3-9b439d3f4a78"
      unitRef="usd">102000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i2b3392265deb4106aab31600904e9cb4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItNi0xLTEtNTE5MzU_866a1edf-bf18-4d3d-a3bf-613265516b04"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i87d93ef8431b471ca93d9465e2c95484_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItOC0xLTEtNTE5MzU_a7f58ab3-da2e-402d-9579-28092bd7f909"
      unitRef="usd">679000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzItMTAtMS0xLTUxOTM1_338d383a-81bb-4339-935c-6aa7e66fcb50"
      unitRef="usd">696000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i63222ef16b814f569ad4ba0cf601d3a7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtMi0xLTEtNTE5MzU_de857da9-4514-414e-b206-cf65049e5abb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib77ad19c6e4440028848176be54ff601_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtNC0xLTEtNTE5MzU_e20f65da-7220-408d-9ff8-3332d9a456a9"
      unitRef="usd">53626000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibde696a897d44556b79a1a65c2668c22_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtNi0xLTEtNTE5MzU_f6066dcd-4ef8-48b2-89c9-3e1cf7962210"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i47a18e6ecf3d47f986ea7a8767797311_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtOC0xLTEtNTE5MzU_ea114870-df8e-4d40-a246-d668702c59ae"
      unitRef="usd">53626000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i93cad82084bb42bf84e6e79e8cf2b3de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzMtMTAtMS0xLTUxOTM1_0f1c62e5-9ffe-44e5-9659-31ec6027f719"
      unitRef="usd">56823000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i8c131978c8aa4c9fac20a4b9db444b5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtMi0xLTEtNTE5MzU_4fee3120-8b5b-404d-8ec0-949dd95c8893"
      unitRef="usd">534000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i1288c646ac474cb6a528ecddc4cf9eaf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtNC0xLTEtNTE5MzU_646eb18c-237b-446b-a8b4-63af5618bb60"
      unitRef="usd">102000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ie6ccb32154264ba6a1a64b7d12112f3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtNi0xLTEtNTE5MzU_2ae490ec-acab-4499-9292-9ec3cfb895de"
      unitRef="usd">7000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ia87829c660a8467182b6e1a92c6cd8e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtOC0xLTEtNTE5MzU_2b4d4ae0-8623-41cc-b812-fc1521bfa8eb"
      unitRef="usd">643000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzUtMTAtMS0xLTUxOTM1_940a3c6f-b7db-4e21-8709-01f817e87262"
      unitRef="usd">641000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie7837dbff77c4c7ab715987e4d24c08a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtMi0xLTEtNTE5MzU_48e88748-f8d6-4e64-9919-adf0d7666a11"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0be0aab5247d49e8bea8b75041ffa84c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtNC0xLTEtNTE5MzU_291f75e4-c37c-4aa1-9882-d865aabe6b7a"
      unitRef="usd">52583000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3f993c029dde4f2188f1debf7eab46d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtNi0xLTEtNTE5MzU_a879cb07-6d5f-4eac-a46d-d708cc85f448"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7e929c44eac543b9b65151f9f6e42da0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtOC0xLTEtNTE5MzU_e539756f-5ed1-409b-a484-b98c43f7bbab"
      unitRef="usd">52583000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ie941b4c35ceb4d50a09440e37ae44046_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNjYvZnJhZzpmZTAxNTQ0MzY1ZDE0NjJhYmYzMDE3NTI5NGRkZmI4NC90YWJsZTo0OWM1ZGVjZTAxOGE0MzI0YTQzNjQ3MTlmYjAxZmJkMi90YWJsZXJhbmdlOjQ5YzVkZWNlMDE4YTQzMjRhNDM2NDcxOWZiMDFmYmQyXzYtMTAtMS0xLTUxOTM1_98f8af66-fc99-46c3-90cd-e253e6fc6014"
      unitRef="usd">46003000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM1OQ_baf14b3b-6e50-4d8c-9a65-1c937fc98ca3">Property, Equipment and Capitalized Software&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment and capitalized software is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, equipment and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&#160;Depreciation expense for property and equipment was $1.1 billion for the year ended December&#160;31, 2022, and $1.0 billion for both years ended December 31, 2021 and 2020. Amortization expense for capitalized software for the years ended December&#160;31, 2022, 2021 and 2020 was $1.0 billion, $0.9 billion and $0.8 billion, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM2OQ_0303561c-c8a7-4f9a-9c5f-5afb196320df">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment and capitalized software is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, equipment and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:LandAndLandImprovements
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEtMi0xLTEtNTE5MzU_b4c1634a-cca3-400f-967c-d2b361ca73bd"
      unitRef="usd">697000000</us-gaap:LandAndLandImprovements>
    <us-gaap:LandAndLandImprovements
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEtNC0xLTEtNTE5MzU_0c911f46-b59b-43fa-b61f-c0db8016348f"
      unitRef="usd">502000000</us-gaap:LandAndLandImprovements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzItMi0xLTEtNTE5MzU_adf9996d-3fb2-45b3-89ec-3ebafef70466"
      unitRef="usd">5519000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzItNC0xLTEtNTE5MzU_56554d73-23de-4ae5-b842-322616f66035"
      unitRef="usd">4882000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzMtMi0xLTEtNTE5MzU_d233fe99-3b1b-4406-8cad-e17ba56b6fee"
      unitRef="usd">2093000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzMtNC0xLTEtNTE5MzU_d6202c37-df3e-4320-905c-f5c0bd1c1281"
      unitRef="usd">1851000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzQtMi0xLTEtNTE5MzU_1a52af11-ff30-4988-8b90-b6caa6d80c78"
      unitRef="usd">2113000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzQtNC0xLTEtNTE5MzU_7c1526d8-fe44-4fa1-8825-fc81fcef4c51"
      unitRef="usd">2014000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzUtMi0xLTEtNTE5MzU_6c475a6d-10f6-453a-8baa-0d20ce6d67d8"
      unitRef="usd">4499000000</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzUtNC0xLTEtNTE5MzU_f40412bf-1c50-49ed-9a9e-bd55876babd7"
      unitRef="usd">3857000000</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzYtMi0xLTEtNTE5MzU_2d6ce81d-d1e2-4a01-8594-0ef5a31855ad"
      unitRef="usd">5923000000</unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet>
    <unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzYtNC0xLTEtNTE5MzU_70fef6df-5d23-4178-836f-e7f0e0b38571"
      unitRef="usd">5392000000</unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzctMi0xLTEtNTE5MzU_39214f5f-fb27-490f-8bdc-b1538a81a097"
      unitRef="usd">6636000000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzctNC0xLTEtNTE5MzU_81d053c4-3e81-4db6-9be9-9eefd1fdf351"
      unitRef="usd">5712000000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzgtMi0xLTEtNTE5MzU_8c3449aa-70ea-4f38-92a4-fd37e1c413a3"
      unitRef="usd">2431000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzgtNC0xLTEtNTE5MzU_beb8b594-861d-4620-8f92-d0902b7d4078"
      unitRef="usd">2135000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzktMi0xLTEtNTE5MzU_eb8b9925-faff-4391-a361-877bf087240c"
      unitRef="usd">4205000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzktNC0xLTEtNTE5MzU_88ccc15f-a572-4ad5-96e8-e0125e7b0b10"
      unitRef="usd">3577000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEwLTItMS0xLTUxOTM1_bfc71446-3b29-45d4-96cd-2285b8d8518a"
      unitRef="usd">10128000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90YWJsZTo5ZGFjNDUwZTc5YTg0OGNiYWY5ZDI3NmI5ZTZkN2ExZC90YWJsZXJhbmdlOjlkYWM0NTBlNzlhODQ4Y2JhZjlkMjc2YjllNmQ3YTFkXzEwLTQtMS0xLTUxOTM1_a1ef041b-53a2-4e17-8934-1ff690c49d15"
      unitRef="usd">8969000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIxNg_be66f2b7-fec1-4453-bcba-5a8dbfd649e3"
      unitRef="usd">1100000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIyMA_7aa7c8ef-81e9-4852-8b0b-7640b8bb043a"
      unitRef="usd">1000000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzIyMA_97f78df4-78bb-4127-aafa-53336cb5044f"
      unitRef="usd">1000000000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzMyOQ_552f24a3-6eed-46a4-a18a-54e84082e5c4"
      unitRef="usd">1000000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzMzMw_674a4e8d-ecac-4146-976c-0c20d7d48d12"
      unitRef="usd">900000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzIvZnJhZzpjYmNmNGJlNzQ1MGI0ODQyODdmZGM2ZWQ5NTYyYWU3NS90ZXh0cmVnaW9uOmNiY2Y0YmU3NDUwYjQ4NDI4N2ZkYzZlZDk1NjJhZTc1XzM0MA_74efbdb2-f30d-4f1d-a541-7761e201e277"
      unitRef="usd">800000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxNg_6232c332-b640-4e8b-97e8-4408acb680f4">Goodwill and Other Intangible Assets&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense relating to intangible assets for the years ended December&#160;31, 2022, 2021 and 2020 was $1.3 billion, $1.2 billion and $1.1 billion, respectively.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcyNg_927e5c9d-0842-4887-aa90-3377ca7ce9f4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ie5b9cb689c4849b186802ae057c4f620_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtMi0xLTEtNTE5MzU_767f3783-42f7-420f-8b3d-2c631112f4dc"
      unitRef="usd">27785000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i273fb22e9e294cc583d6ed2a1dccb45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtNC0xLTEtNTE5MzU_5d9ca41c-1739-4d1c-ba06-cd4626ce4d5d"
      unitRef="usd">19844000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib18968b1b98748ebaf2b70232a383b48_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtNi0xLTEtNTE5MzU_531930fc-6170-4880-92aa-ec98f7ed6eb6"
      unitRef="usd">8173000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3aab5eedface463d8e9937c9f349bdb8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtOC0xLTEtNTE5MzU_f424a20b-d3b4-485f-bd16-f4b00394ac13"
      unitRef="usd">15535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzEtMTAtMS0xLTUxOTM1_33b8fed8-1d6d-4d94-9e7c-371c721948f8"
      unitRef="usd">71337000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i93aff990939e4d999543f7925550419f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItMi0xLTEtNTE5MzU_9205d038-a0c6-4c41-9b5a-7c34a1e5f4e6"
      unitRef="usd">60000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie588118f5a224050a60787106be9f4ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItNC0xLTEtNTE5MzU_8fc38495-d08d-414b-8ad2-4ce92724fa55"
      unitRef="usd">4648000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItNi0xLTEtNTE5MzU_c91cd59d-291b-4c76-b50f-474e9bb89a41"
      unitRef="usd">96000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItOC0xLTEtNTE5MzU_d0185656-e1d5-468d-8266-f0d2cd0bc465"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzItMTAtMS0xLTUxOTM1_ec6800d1-041f-485f-8872-d62cfa7949cb"
      unitRef="usd">4804000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i93aff990939e4d999543f7925550419f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtMi0xLTEtNTE5MzU_0faef82f-3028-41a3-87f0-d3ceacadb37a"
      unitRef="usd">-456000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ie588118f5a224050a60787106be9f4ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtNC0xLTEtNTE5MzU_7bb28409-8c2f-43ba-92da-9d007c08b5bf"
      unitRef="usd">-268000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9ac266753da64dfbbf143a6f1318b983_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtNi0xLTEtNTE5MzU_fa39defb-8d65-4d39-90a4-56b215d95ab5"
      unitRef="usd">350000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i1b48753b952845ddb5b2ec36dd7cb6c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtOC0xLTEtNTE5MzU_32dc76b5-c1d2-4357-a171-7275d6bca8c2"
      unitRef="usd">28000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzMtMTAtMS0xLTUxOTM1_b5c1484e-e279-470e-a590-3700692812cf"
      unitRef="usd">-346000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="idef850d28ac94a98ab6c49a6ff13ef23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtMi0xLTEtNTE5MzU_92779e8b-3545-455f-bf73-dbb20da4bfd6"
      unitRef="usd">27389000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i954001ec6080467d9308272e6879d3cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtNC0xLTEtNTE5MzU_1e5f5d5a-16f9-4e04-b19d-2c0a49ad29a9"
      unitRef="usd">24224000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0520b9f9d7f64354b0aa489f5bd5b095_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtNi0xLTEtNTE5MzU_e1106f09-915e-46b6-a652-21e564eb7e00"
      unitRef="usd">8619000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0e4082841ae445839156ed080b909db1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtOC0xLTEtNTE5MzU_1689122a-3156-414d-a9db-30c0f564f21e"
      unitRef="usd">15563000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzQtMTAtMS0xLTUxOTM1_ca391370-45cb-4eb3-8dd9-9042cb139059"
      unitRef="usd">75795000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtMi0xLTEtNTE5MzU_ba492457-2ea8-4040-ace9-8a76a0f0d6a6"
      unitRef="usd">19000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtNC0xLTEtNTE5MzU_26dcb3b7-590a-4237-b3bb-2af1e4d192da"
      unitRef="usd">5158000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia71332b1e4da424482d4374941a68deb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtNi0xLTEtNTE5MzU_b6961454-376c-4616-815e-68b4b45bc246"
      unitRef="usd">8623000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtOC0xLTEtNTE5MzU_e32bbe79-755b-40e7-b4a5-e37b1f0eacec"
      unitRef="usd">3910000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzUtMTAtMS0xLTUxOTM1_0a5ebcbf-7726-43a2-a9d4-fbe1a89b3483"
      unitRef="usd">17710000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="if16f8ec9e48e48cb8b1601e08eaa7d74_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtMi0xLTEtNTE5MzU_1ff254d8-c8fe-46f1-9180-eadecac90f8d"
      unitRef="usd">-13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5cff06ded3de493caf6f7a344f2b829e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtNC0xLTEtNTE5MzU_b82a20fb-8a53-4d8b-8471-6ded1fecd089"
      unitRef="usd">-144000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia71332b1e4da424482d4374941a68deb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtNi0xLTEtNTE5MzU_35b97e0b-0d4b-4796-896f-3b62e620e05f"
      unitRef="usd">2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i15671669b9e0436fbb599e8e106c1ef7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtOC0xLTEtNTE5MzU_e6e514f7-17a0-4150-800a-ce61a72efdf5"
      unitRef="usd">2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzYtMTAtMS0xLTUxOTM1_7ed3892b-0759-43ca-99f9-a8c75585c1a1"
      unitRef="usd">-153000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i029dc3b772ba45fcae3cdfb1cf328398_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctMi0xLTEtNTE5MzU_8fc21e83-84c0-4340-8f60-642eabd6079a"
      unitRef="usd">27395000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i306fc774c45e4efda5c854e3d3882a81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctNC0xLTEtNTE5MzU_92b633c3-90f1-42be-8d2d-c1eaa1c141ab"
      unitRef="usd">29238000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id38495f03da740dc92c5e3241a80f075_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctNi0xLTEtNTE5MzU_fa7a421e-c023-443b-9760-40ebe8f09b24"
      unitRef="usd">17244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i73959cf508b94532976280692bebc7fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctOC0xLTEtNTE5MzU_a13c2812-494d-4ac2-a9e1-e8f2840e3d80"
      unitRef="usd">19475000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTpjMDJkOGE5YTFmNjk0ODM1OTM4YWU4NDM5ODRlOTM2OS90YWJsZXJhbmdlOmMwMmQ4YTlhMWY2OTQ4MzU5MzhhZTg0Mzk4NGU5MzY5XzctMTAtMS0xLTUxOTM1_7655cbc8-ef97-48bf-9887-e1d9bf56af94"
      unitRef="usd">93352000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxMQ_734467bc-4f37-48db-8007-2f3988afb6d3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMi0xLTEtNTE5MzU_37e70295-0d2f-4399-8e93-39f5d6fbaded"
      unitRef="usd">16303000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItNC0xLTEtNTE5MzU_4491ca74-8d38-401f-8f02-86e1fbdf7f37"
      unitRef="usd">5179000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8087abc490604b24b4842f47239d6ca4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItNi0xLTEtNTE5MzU_0a921b7c-149c-4f17-9bab-7b6f8c29ef22"
      unitRef="usd">11124000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItOC0xLTEtNTE5MzU_c44a23d7-caf2-42ed-b443-e1a34fbd36a7"
      unitRef="usd">13011000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMTAtMS0xLTUxOTM1_6a1007eb-2835-4bb9-9993-46aa30e3cb6d"
      unitRef="usd">4697000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0d27f00edd24f95bcc8effc5ab51935_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzItMTItMS0xLTUxOTM1_46bbcade-f39f-465f-85fd-21f9d4bbbb23"
      unitRef="usd">8314000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMi0xLTEtNTE5MzU_d6793e1e-fe44-41f5-bb07-948737079b5a"
      unitRef="usd">2398000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtNC0xLTEtNTE5MzU_ccbda395-6120-4bcb-87f7-6d6725ee9e63"
      unitRef="usd">704000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie3833e735e7a446aa35b4a2169cd0cdd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtNi0xLTEtNTE5MzU_84b9244f-4767-41e8-8b54-4679e15255a4"
      unitRef="usd">1694000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtOC0xLTEtNTE5MzU_821c3204-f7e0-4e44-b05e-d02c80d0a47c"
      unitRef="usd">1630000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMTAtMS0xLTUxOTM1_6a79602a-db10-471e-9dc3-79a6474ee452"
      unitRef="usd">739000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i497a918740ed4cf8849340ca44bb4e4b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzMtMTItMS0xLTUxOTM1_4b9c16e3-ce85-4737-8a6f-a3587b56b278"
      unitRef="usd">891000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMi0xLTEtNTE5MzU_159b33b2-f32c-429f-b300-234e2290b89a"
      unitRef="usd">661000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtNC0xLTEtNTE5MzU_ccd15ce6-5b40-4db3-aeb7-180e57d45842"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia808efbb58284bd29fa2015876ed6e9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtNi0xLTEtNTE5MzU_67c31fab-b3ae-40aa-80af-e00662f9f7be"
      unitRef="usd">661000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtOC0xLTEtNTE5MzU_7d8dd690-ef6d-4c16-96f1-65c22cb1d77b"
      unitRef="usd">617000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMTAtMS0xLTUxOTM1_3292b737-754b-40b3-9c47-bb665e0d60f5"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifecd27b3c7404fdeb2d6ea3a596ad0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzQtMTItMS0xLTUxOTM1_82613c55-55f8-4a05-aeec-52a0face73ba"
      unitRef="usd">617000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMi0xLTEtNTE5MzU_a659088f-c667-4f79-a602-9c24c56b26b2"
      unitRef="usd">1176000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtNC0xLTEtNTE5MzU_a7826358-c41f-486a-a800-8a2bc01454a8"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i65240804f5fe4ff18092e64dd3c64e1d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtNi0xLTEtNTE5MzU_a17e16a5-7ada-4704-b106-9b15da0c1a0e"
      unitRef="usd">922000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtOC0xLTEtNTE5MzU_51a13332-c41e-4e8c-a233-be9f56dc53fb"
      unitRef="usd">422000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMTAtMS0xLTUxOTM1_67eeaf0e-9aab-4d45-8dd7-4012c160d849"
      unitRef="usd">200000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="idd81928a29434336a9c57994d73a7bc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzUtMTItMS0xLTUxOTM1_28687b48-4415-458a-b045-e7d429f73133"
      unitRef="usd">222000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMi0xLTEtNTE5MzU_86a5bb6d-5f29-43fc-b9e6-36c474c5e69d"
      unitRef="usd">20538000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtNC0xLTEtNTE5MzU_45cc06f1-e003-497a-97c4-86fc7123adae"
      unitRef="usd">6137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtNi0xLTEtNTE5MzU_7c10fe10-e45d-4414-a2e9-354a0c8e76c5"
      unitRef="usd">14401000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtOC0xLTEtNTE5MzU_f57b339f-b37c-41d8-be80-8fb2e938421a"
      unitRef="usd">15680000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMTAtMS0xLTUxOTM1_30145a30-ecd5-474e-8400-da905379aa66"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTo4MGZmNDUyNTA0ZTQ0ODYyYWM2ZTM5NTVhNDlkZTE0NS90YWJsZXJhbmdlOjgwZmY0NTI1MDRlNDQ4NjJhYzZlMzk1NWE0OWRlMTQ1XzYtMTItMS0xLTUxOTM1_06fcb95c-a519-4ed9-872f-d531e522b655"
      unitRef="usd">10044000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcyNw_a430a2e0-a168-4d4d-8215-4ce53239e9a0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItMi0xLTEtNTE5MzU_4b7a2286-a765-4d01-9596-41ef3eb21412"
      unitRef="usd">3927000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id01ab44b6c814384acd3204bdada0f72_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItNC0xLTEtNTE5MzU_ce93accc-9f78-49ed-a7e6-d132b8e17536">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItNi0xLTEtNTE5MzU_2a2ad881-ed81-45a1-99ac-af2aa2ebc391"
      unitRef="usd">484000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i410f10b415f349b99b1d00acf9d6e8db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzItOC0xLTEtNTE5MzU_88455aa5-234d-4e42-af8d-601ad09c3885">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtMi0xLTEtNTE5MzU_25e984cb-b0c6-41d1-aeb6-9e3bb3acaa94"
      unitRef="usd">1058000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i49fdd338841c45f0a3bc2c9d913173b0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtNC0xLTEtNTE5MzU_8552db7e-6012-48b7-bc50-eb013caf1cd6">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtNi0xLTEtNTE5MzU_b49d0069-2c78-4a4a-854c-149d996fcf01"
      unitRef="usd">147000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ibbe1095748ab4dadb477cf559b865d45_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzMtOC0xLTEtNTE5MzU_45c8971d-c804-407f-8c7b-59401f6db9b4">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i99a9202de2dd47f3af460db253742fae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtMi0xLTEtNTE5MzU_d9018391-6989-412b-b0e6-7b89750cb72e"
      unitRef="usd">776000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i99a9202de2dd47f3af460db253742fae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtNC0xLTEtNTE5MzU_167f707e-69fe-4b6c-996c-384256a5b992">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtNi0xLTEtNTE5MzU_2419549c-4a20-4538-ab9d-a982a8a42003"
      unitRef="usd">29000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ice0c89f6f4334db9be012baa8a72a2db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzQtOC0xLTEtNTE5MzU_b3bdbd2b-788d-4bee-b551-5ee22a58e92b">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtMi0xLTEtNTE5MzU_72f5dd51-d6b8-4acc-a6ef-da15bd188c95"
      unitRef="usd">5761000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtNC0xLTEtNTE5MzU_b796db5a-628d-4cc5-abd5-200b51460fff">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtNi0xLTEtNTE5MzU_4c8cdc73-e90b-4e9a-8e21-a994d42db3c0"
      unitRef="usd">660000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTphZTlkZjQ4MTMyYWI0YTE0YTU3NjUyNDUzNjk1ZTYzNC90YWJsZXJhbmdlOmFlOWRmNDgxMzJhYjRhMTRhNTc2NTI0NTM2OTVlNjM0XzUtOC0xLTEtNTE5MzU_c28ec358-be00-4d5b-b356-bf9e701cc75d">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzcxMw_2e5cd6fc-17a8-403b-8e7f-e471ad9c51de">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzEtMi0xLTEtNTE5MzU_874d2880-c2bf-470d-842c-b8e6fd897f57"
      unitRef="usd">1562000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzItMi0xLTEtNTE5MzU_10c688b7-96c0-43ba-9c93-d1084c0dd613"
      unitRef="usd">1478000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzMtMi0xLTEtNTE5MzU_19a96251-8231-4c73-8714-361574fab595"
      unitRef="usd">1360000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzQtMi0xLTEtNTE5MzU_0d7a8b47-9809-4932-9fcc-01d4a226064f"
      unitRef="usd">1206000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90YWJsZTplY2M0NWM1NTg1MzY0OTQwYjVhNzVjZmViNjhmYjRhYi90YWJsZXJhbmdlOmVjYzQ1YzU1ODUzNjQ5NDBiNWE3NWNmZWI2OGZiNGFiXzUtMi0xLTEtNTE5MzU_1e199570-2c85-44e0-88e7-84487d1d0e5d"
      unitRef="usd">1154000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY3Nw_c63d09f2-d469-4d05-bd74-0097345bda12"
      unitRef="usd">1300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY4MQ_d274fbca-5edd-4b11-b2cf-f9508fc118c6"
      unitRef="usd">1200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xNzUvZnJhZzpjZGI1ZTg5Nzk5Njg0ZGIwOGYxNTcyM2ZjZGU5MThhMi90ZXh0cmVnaW9uOmNkYjVlODk3OTk2ODRkYjA4ZjE1NzIzZmNkZTkxOGEyXzY4OA_0ea5312f-4f76-408d-b49f-f12acbde73a7"
      unitRef="usd">1100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzczNg_83610fdd-aa5a-4b95-80d1-f93c18f2bc9c">Medical Costs Payable&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the years ended December&#160;31: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported medical costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reported medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended December&#160;31, 2022, prior year&#x2019;s medical cost reserve development included no individual factors that were significant. For the years ended December 31, 2021 and 2020, prior years&#x2019; medical cost reserve development was primarily driven by lower than expected care activity. Additionally, prior years&#x2019; medical cost reserve development in the year ended December 31, 2021 was driven by care patterns disrupted by COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs payable included IBNR of $20.0 billion and $17.1 billion at December&#160;31, 2022 and 2021, respectively. Substantially all of the IBNR balance as of December&#160;31, 2022 relates to the current year. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about incurred and paid medical cost development as of December&#160;31, 2022: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Incurred Medical Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Cumulative Medical Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net remaining outstanding liabilities prior to 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzc1MA_20a3a252-f0c2-493b-8af1-47ffc3f5fa22">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the years ended December&#160;31: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported medical costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reported medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtMi0xLTEtNTE5MzU_83b05bb5-e60d-438b-b4e6-5a60c42dae0a"
      unitRef="usd">24483000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtNC0xLTEtNTE5MzU_7a29eea6-61a7-49a2-bce4-b36b000fa39e"
      unitRef="usd">21872000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEtNi0xLTEtNTE5MzU_a0460c9d-4563-4e97-870b-f2ae82953761"
      unitRef="usd">21690000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItMi0xLTEtNTE5MzU_28ab5768-184e-45f6-aae3-dd3847781226"
      unitRef="usd">308000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItNC0xLTEtNTE5MzU_0242ed62-ab2f-414e-9fbf-085ba1981a5f"
      unitRef="usd">88000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzItNi0xLTEtNTE5MzU_7b1cb7ed-a3c4-4590-99d6-74cf7e920cb8"
      unitRef="usd">316000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtMi0xLTEtNTE5MzU_726af1a2-8bef-440c-8548-d1e2dcacade2"
      unitRef="usd">211252000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtNC0xLTEtNTE5MzU_65da0755-8424-4cc5-81bf-c771a2164d61"
      unitRef="usd">188631000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzQtNi0xLTEtNTE5MzU_9809358e-a4c1-4e80-8088-7f775abead1b"
      unitRef="usd">160276000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtMi0xLTEtNTE5MzU_e600a1e4-3a70-44d8-bdf2-0e72754866e0"
      unitRef="usd">-410000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtNC0xLTEtNTE5MzU_82cad67a-bff9-40bb-bfe8-71cda9733975"
      unitRef="usd">-1720000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzUtNi0xLTEtNTE5MzU_dc32d73d-0b92-41fd-ba8a-e4f5ad0341a2"
      unitRef="usd">-880000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtMi0xLTEtNTE5MzU_034672ff-de6c-4d24-a938-491f2330ad4f"
      unitRef="usd">210842000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtNC0xLTEtNTE5MzU_3ba7e741-9aed-4aa5-b56c-a451f61a6462"
      unitRef="usd">186911000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzYtNi0xLTEtNTE5MzU_f2cf5cad-14ba-42a2-87b2-75c3e447dcae"
      unitRef="usd">159396000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtMi0xLTEtNTE5MzU_c31759ea-ebc0-4c44-bd4d-31f5180787d9"
      unitRef="usd">184049000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtNC0xLTEtNTE5MzU_faab8a54-7ec0-41f0-b9c2-5277798a3c4a"
      unitRef="usd">165524000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzgtNi0xLTEtNTE5MzU_f34386dd-b4a0-42b1-99f6-c9953428311c"
      unitRef="usd">139974000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktMi0xLTEtNTE5MzU_7637373a-34ef-4a8b-a856-1e3c459023c1"
      unitRef="usd">22528000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktNC0xLTEtNTE5MzU_50519fef-35a0-4af2-8e49-1737909fc892"
      unitRef="usd">18864000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzktNi0xLTEtNTE5MzU_025938ac-6157-447b-bf13-4d198110719d"
      unitRef="usd">19556000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTItMS0xLTUxOTM1_af761579-0ff0-4280-8730-24caa63cd6f6"
      unitRef="usd">206577000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTQtMS0xLTUxOTM1_4f7aab37-ffe6-437f-a65c-0e8bb3466d7f"
      unitRef="usd">184388000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzEwLTYtMS0xLTUxOTM1_66c85adc-414c-47f7-9cce-2b5965fa14ac"
      unitRef="usd">159530000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTItMS0xLTUxOTM1_dc1e9f13-f7da-49ee-9b35-3578083b80ce"
      unitRef="usd">29056000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTQtMS0xLTUxOTM1_3160ba14-1bb6-4672-8c9a-c05c3b6f63d9"
      unitRef="usd">24483000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTowZjMwMDJmMGYxMzQ0Mzc4OGRkODAwNmQ4NjA3YTgyZi90YWJsZXJhbmdlOjBmMzAwMmYwZjEzNDQzNzg4ZGQ4MDA2ZDg2MDdhODJmXzExLTYtMS0xLTUxOTM1_3d25b4a2-28ce-4443-98b3-7d3c5000c961"
      unitRef="usd">21872000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzUzMQ_4c55fd22-01bb-4d8c-899b-5403cb4df8b1"
      unitRef="usd">20000000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzUzOA_a8c017da-8613-4b9c-aa4b-6762a1e28762"
      unitRef="usd">17100000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90ZXh0cmVnaW9uOjgwZWViYzZhYzcwMjQ5MzlhNjFmYzI5ZjMyYjJkMmZmXzc0Mw_6a7e5f65-9296-4bb9-b30a-d44b032c29d4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about incurred and paid medical cost development as of December&#160;31, 2022: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Incurred Medical Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Cumulative Medical Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net remaining outstanding liabilities prior to 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ie2145059193248b48874a80710b28e8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzMtMi0xLTEtNTE5MzU_fddae31e-efbe-468f-91a7-7400b2c840b2"
      unitRef="usd">188631000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ib99b38b33f024bd5b838c545e73f79f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzMtNC0xLTEtNTE5MzU_a258a7bd-45fc-4c45-adf0-212dd081d7be"
      unitRef="usd">188407000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i495eaae432e44afdb66418768a361a4b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzQtNC0xLTEtNTE5MzU_56ab4f31-f33f-4433-a6fe-04b8fb3967a4"
      unitRef="usd">211252000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzUtNC0xLTEtNTE5MzU_a8ca0532-8811-42cd-981a-64ebe1c893ef"
      unitRef="usd">399659000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ie2145059193248b48874a80710b28e8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEwLTItMS0xLTUxOTM1_5b75feb9-6a0e-46d7-bc5b-bcdace357869"
      unitRef="usd">165524000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ib99b38b33f024bd5b838c545e73f79f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEwLTQtMS0xLTUxOTM1_a5a9a970-ffb8-423f-8e95-70af55bf65b3"
      unitRef="usd">186944000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i495eaae432e44afdb66418768a361a4b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzExLTQtMS0xLTUxOTM1_3ca5d8ab-a336-4d42-be37-363beafc07b0"
      unitRef="usd">184049000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEyLTQtMS0xLTUxOTM1_9ff9fce6-d099-4822-86a6-be81f48fb3ee"
      unitRef="usd">370993000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzEzLTQtMS0xLTUxOTM1_2594055b-1251-4d63-ab5e-64feb1b5ffb8"
      unitRef="usd">390000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODEvZnJhZzo4MGVlYmM2YWM3MDI0OTM5YTYxZmMyOWYzMmIyZDJmZi90YWJsZTo5MDY5YTFkMTRiNjg0ZTkxYmVkNjk0YzZlNjE3OGQ1MS90YWJsZXJhbmdlOjkwNjlhMWQxNGI2ODRlOTFiZWQ2OTRjNmU2MTc4ZDUxXzE0LTQtMS0xLTUxOTM1_a6a994ea-1549-413c-a0f9-13e9cb8e3818"
      unitRef="usd">29056000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1Njg_969c6572-352d-4644-a30f-b5c53c183346">Short-Term Borrowings and Long-Term Debt &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and senior unsecured long-term debt consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 2.875% notes due March 2022 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.350% notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$900 million 2.375% notes due October 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15 million 0.000% notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 2.750% notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due February 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 0.550% notes due May 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 2.375% notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 5.000% notes due October 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.750% notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 5.150% notes due October 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$300 million 3.700% notes due December 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 1.250% notes due January 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.100% notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 1.150% notes due May 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.450% notes due January 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 3.375% notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million 3.700% notes due May 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$950 million 2.950% notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 5.250% notes due February 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,150 million 3.850% notes due June 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$850 million 3.875% notes due December 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$900 million 4.000% notes due May 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.875% notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 5.300% notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.000% notes due May 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 2.300% notes due May 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 4.200% notes due May 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 5.350% notes due February 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.625% notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$850 million 5.800% notes due March 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 6.500% notes due June 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$650 million 6.625% notes due November 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 6.875% notes due February 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.500% notes due August 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.750% notes due May 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$300 million 5.700% notes due October 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$350 million 5.950% notes due February 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million  3.050% notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million 4.625% notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$502 million 4.375% notes due March 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 3.950% notes due October 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 4.250% notes due March 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 4.200% notes due January 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$725 million 4.250% notes due April 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$950 million 3.750% notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,350 million 4.250% notes due June 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 4.450% notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.700% notes due August 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.900% notes due May 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.250% notes due May 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due May 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 5.875% notes due February 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.875% notes due August 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.125% notes due May 2060&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.950% notes due May 2062&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 6.050% notes due February 2063&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt obligations also included $0.9 billion and $1.4 billion of other financing obligations, of which $192 million and $611 million were current as of December&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $6.0 billion &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMDU_6c33a52c-1144-4e22-89da-18fc6460dbfe"&gt;five&lt;/span&gt;-year, $6.0 billion &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzMjI_945de3a2-7233-4e80-9a06-96283be1135b"&gt;three&lt;/span&gt;-year and $6.0 billion 364-day revolving bank credit facilities with 25 banks, which mature in December 2027, December 2025 and December 2023, respectively. These facilities provide full liquidity support for the Company&#x2019;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2022, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#x2019;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2022, annual interest rates would have ranged from 5.1% to 7.5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#x2019; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1NjQ_078f2c29-a109-47ad-9599-67eec16e2482">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and senior unsecured long-term debt consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 2.875% notes due March 2022 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.350% notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$900 million 2.375% notes due October 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15 million 0.000% notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 2.750% notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due February 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 0.550% notes due May 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 2.375% notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 5.000% notes due October 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.750% notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 5.150% notes due October 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$300 million 3.700% notes due December 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 1.250% notes due January 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.100% notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 1.150% notes due May 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 3.450% notes due January 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 3.375% notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million 3.700% notes due May 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$950 million 2.950% notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 5.250% notes due February 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,150 million 3.850% notes due June 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$850 million 3.875% notes due December 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$900 million 4.000% notes due May 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.875% notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 5.300% notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.000% notes due May 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 2.300% notes due May 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 4.200% notes due May 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 5.350% notes due February 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.625% notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$850 million 5.800% notes due March 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500 million 6.500% notes due June 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$650 million 6.625% notes due November 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 6.875% notes due February 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.500% notes due August 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.750% notes due May 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$300 million 5.700% notes due October 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$350 million 5.950% notes due February 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million  3.050% notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million 4.625% notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$502 million 4.375% notes due March 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$625 million 3.950% notes due October 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 4.250% notes due March 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750 million 4.200% notes due January 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$725 million 4.250% notes due April 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$950 million 3.750% notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,350 million 4.250% notes due June 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,100 million 4.450% notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.700% notes due August 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.900% notes due May 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.250% notes due May 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due May 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 5.875% notes due February 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.875% notes due August 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.125% notes due May 2060&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.950% notes due May 2062&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500 million 6.050% notes due February 2063&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:CommercialPaper
      contextRef="ie94f6f0f1fd94551b44b1faa876e0832_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzItMi0xLTEtNTE5MzU_19861b0e-b011-48bc-a813-35290fcdca50"
      unitRef="usd">800000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i37c49ae972864155b1415b8cc9d945ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzItNC0xLTEtNTE5MzU_01c37017-4e71-4ad4-bf46-a4a0f3ad421c"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiNDU5NGRhYTY4ZGE0YzgyOGFmMWM1OGYzOWU1OTE4NF80_50eae4d8-cebd-4b05-864f-96e4396bcabb"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMC0xLTEtNTE5MzUvdGV4dHJlZ2lvbjpiNDU5NGRhYTY4ZGE0YzgyOGFmMWM1OGYzOWU1OTE4NF8xNjQ5MjY3NDQxNjk2_dc38e8ef-aaf5-4986-9c65-f759ab494e38"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ic7db67db0f7c4e9c8a2fb0e6de858bcf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktMi0xLTEtNTE5MzU_06b28d2b-efa9-4445-aec0-c45264588e54"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ie7467c05cf504bf382c1187f5f7e597b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzktNC0xLTEtNTE5MzU_c7078c2e-3cd2-4cb9-a39b-f3ef887c8987"
      unitRef="usd">1097000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i24e57b760f1943638a139219471fd6fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTgzNjZlZjBhYzU1NGJhZWFmNzIyYzk4ODY4YTMyNDhfNA_66b3bd49-4b85-44d8-b2a2-015088f78e38"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i24e57b760f1943638a139219471fd6fb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTgzNjZlZjBhYzU1NGJhZWFmNzIyYzk4ODY4YTMyNDhfMTY0OTI2NzQ0MTY5NA_e017a244-3bf3-4462-b4b3-a6a279e56611"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i24e57b760f1943638a139219471fd6fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTItMS0xLTUxOTM1_68e54a4e-f895-41d2-b890-4353a9dc9437"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i3e95ea910ec747ac9770d7cbc2da1ce2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEwLTQtMS0xLTUxOTM1_d278c4d4-6ac5-4c0d-a01c-8b39d65258e6"
      unitRef="usd">999000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTAtMS0xLTUxOTM1L3RleHRyZWdpb246M2E3YmJiMTYwOWIwNGRiZWI5MjUyZWExYjRmYThlZDlfNA_6a25abd5-4c0f-4d1e-94b7-d33aff42f43b"
      unitRef="usd">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTAtMS0xLTUxOTM1L3RleHRyZWdpb246M2E3YmJiMTYwOWIwNGRiZWI5MjUyZWExYjRmYThlZDlfMTY0OTI2NzQ0MTY5Nw_31a774a7-bc1a-4c0b-b35e-066551349bd6"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i4fbf0291edfa46e1ba0a7ea2429945e3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTItMS0xLTUxOTM1_87ed7f76-a72a-435a-ba98-33c627c4e50b"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ia1e6c96ce7884253a99f1fca5a7339dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzExLTQtMS0xLTUxOTM1_0d647245-173c-4400-8043-6a0fb9abd29a"
      unitRef="usd">899000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NzY5MmM0Yzk2NDk1NGQyMmI4YmM0MjgzOTBlOGU3YWRfNA_fd4f42fb-b7e9-4c4b-9c85-7918cdf97d04"
      unitRef="usd">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NzY5MmM0Yzk2NDk1NGQyMmI4YmM0MjgzOTBlOGU3YWRfMTY0OTI2NzQ0MTY5OA_d6c42d1d-78c1-48ac-b31e-f3ec6db01f2b"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i5493d49ac1284b54884fdb86718f9e02_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTItMS0xLTUxOTM1_ab688e58-d74c-4365-bef4-7c55209e74a0"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i3892320018df450c9ac4e6bf65e11fe3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEyLTQtMS0xLTUxOTM1_a3887060-bf32-4b0f-a72e-9d518d7b92f3"
      unitRef="usd">14000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic7c819f8af694a74897e26538e141f60_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IxZDkzYTE3YmVjNDkzY2IyNWUxMTc5MDViMzcwNDZfNA_c6b651bd-23ec-45c5-845b-44ae7c825a17"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic7c819f8af694a74897e26538e141f60_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IxZDkzYTE3YmVjNDkzY2IyNWUxMTc5MDViMzcwNDZfMTY0OTI2NzQ0MTY5OA_18177b0f-1a99-48ab-b798-d0941934b882"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ic7c819f8af694a74897e26538e141f60_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTItMS0xLTUxOTM1_daa01cb0-a09c-4d06-9547-97a264cca3b3"
      unitRef="usd">622000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i2367432c1c4e45439729594f68a2ec11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTQtMS0xLTUxOTM1_fede50ac-9d27-40d9-9fb5-48f469c220f7"
      unitRef="usd">632000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NmYxYjJiMDQ0MWNiNDVlZjkzZWJkYzc1OWQ0MjZhNWFfNA_f61f58b6-2732-4cea-9189-3a7e977c2037"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NmYxYjJiMDQ0MWNiNDVlZjkzZWJkYzc1OWQ0MjZhNWFfMTY0OTI2NzQ0MTY5NQ_d9d07b0e-e20a-48d9-9edf-c993e937e6d7"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i60e5672e23b94f19be7191790d53cc3f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTItMS0xLTUxOTM1_34fe7516-1c8c-4ae9-9961-656732f4db83"
      unitRef="usd">746000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie6d9d96731c340fa9d78902e0bc3b278_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE0LTQtMS0xLTUxOTM1_5bfcc036-8cff-4f51-a6c0-e884858bbeb5"
      unitRef="usd">768000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmYzNWFkNzVmYzg5NDA3NzliZWFjZWQ1MGI5ZTM4NGNfNA_30a656db-6714-4794-9980-e995b4bbbd95"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmYzNWFkNzVmYzg5NDA3NzliZWFjZWQ1MGI5ZTM4NGNfMTY0OTI2NzQ0MTY5NA_84c6d7b2-92f5-4579-b519-747c3f9b03aa"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i728d9550a35f4f138ff2c097381dc033_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTItMS0xLTUxOTM1_dd0d6127-2123-4e77-9f00-998276ade03b"
      unitRef="usd">750000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if5ef92fae8bc4c0084253bd7bb7088bf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTQtMS0xLTUxOTM1_92f5bae2-26d6-4b2b-8283-78a3131a1196"
      unitRef="usd">749000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjQ0Y2E0MmQxNGE0NDRjYjkzODRjMDdmMzAzNjQ1MTRfNA_453f3e83-a6df-4d7c-8442-184fc0f85145"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjQ0Y2E0MmQxNGE0NDRjYjkzODRjMDdmMzAzNjQ1MTRfMTY0OTI2NzQ0MTY5OA_9cd0fc98-d146-4f84-b92d-450b052067ae"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1940f3a1e6f9417694b22ff49c35186e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTItMS0xLTUxOTM1_80bd0dd8-8d1c-4c42-8f4d-6624194c74a9"
      unitRef="usd">749000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i786714661e7f4838a42693234789771e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE2LTQtMS0xLTUxOTM1_53ecff1b-bac7-49a2-bbd2-1685bc100b41"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDU5Yjg0ZmJlODk3NGIwZDgxNjg5MTNkMWU4YTBmODZfNA_dd796d9c-3c55-4fc6-bd32-8a9055235f92"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDU5Yjg0ZmJlODk3NGIwZDgxNjg5MTNkMWU4YTBmODZfMTY0OTI2NzQ0MTY5Mw_26082034-02df-44a8-a41d-a6f32493de76"
      unitRef="number">0.00550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0f03aec2f0d24135bac2d21ff4f0ba0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTItMS0xLTUxOTM1_7ae0dcfb-3db8-4c8b-8b0b-12f34774c5a1"
      unitRef="usd">998000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4c66b2e1270a46d6a8d5cd1309dea3ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE3LTQtMS0xLTUxOTM1_f9084ff9-a492-4713-83c1-1361cb8f96ce"
      unitRef="usd">996000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODY2M2FlYjY0Yjg3NDQ3MjliMGY3NGZlMDEyN2M3MzdfNA_09dbed4f-1838-458a-8d11-9d5cc1e0e1bd"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODY2M2FlYjY0Yjg3NDQ3MjliMGY3NGZlMDEyN2M3MzdfMTY0OTI2NzQ0MTY5Ng_c7a3a924-3d96-4b95-909a-31d8ded915b7"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic5d9fc280e4544109fecfdc02a37666f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTItMS0xLTUxOTM1_d072000d-0b44-48cb-9523-95a7fecc7cb9"
      unitRef="usd">749000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iaf8f66195a594ab1b336d142ef13ede2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE4LTQtMS0xLTUxOTM1_b0e034db-d141-4545-bc69-066d3853a718"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTU4ODk1L3RleHRyZWdpb246NzMwMmNhNmE4YjNlNGNkYmIyZmQ3YTVhOGMyN2YyMDdfMjc0ODc3OTA2OTUxOA_6e0b3b37-5863-4261-939e-7192b2a2f1cb"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTAtMS0xLTU4ODk1L3RleHRyZWdpb246NzMwMmNhNmE4YjNlNGNkYmIyZmQ3YTVhOGMyN2YyMDdfMTY0OTI2NzQ0MTc5NQ_5548d718-deaa-405e-a520-730cde4120ec"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4eb4001ca6264871a7ad00d325a345ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTItMS0xLTU4ODg4_fbebc3ba-e1ff-4dfa-84a5-fbc5f8f75b1c"
      unitRef="usd">499000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6383fe7786fe4e7bbdd981e396552bd7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzEzLTQtMS0xLTU4ODg4_8e800c37-ea65-4a9e-b0ea-5480df83434a"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2VjYTMyMjk4MGU3NDNlZDg0Y2QxYzRkNGU1ODc1MWZfNA_00ba1fd9-004b-4f25-b842-5fd6f161485b"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2VjYTMyMjk4MGU3NDNlZDg0Y2QxYzRkNGU1ODc1MWZfMTY0OTI2NzQ0MTY5NA_33d859e8-3125-471d-85f1-480dfde2ad54"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ia2686d11283f46719d18fa8e4dfc6455_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTItMS0xLTUxOTM1_5b46c21e-54fc-45eb-ba9c-4acb3bb3b207"
      unitRef="usd">1995000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i416a9d226e564e5abf36acd74b65f94f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE5LTQtMS0xLTUxOTM1_84337acb-4610-4298-a7e3-4b03ca398eed"
      unitRef="usd">1994000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTU4OTExL3RleHRyZWdpb246MDJlMTQ5ODhlYTk2NDk3ODlkYTA3NjE1NmExMzRkMWFfMjc0ODc3OTA2OTQ5OA_5894a1be-6208-49e2-8d0b-06e1f2f04c1d"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTAtMS0xLTU4OTExL3RleHRyZWdpb246MDJlMTQ5ODhlYTk2NDk3ODlkYTA3NjE1NmExMzRkMWFfMTY0OTI2NzQ0MTczNw_f8dcb601-020e-4891-9edb-3327be63c4be"
      unitRef="number">0.05150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i32d0059f0624475da7bd80920ef148f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTItMS0xLTU4OTIy_5356b7b0-eba0-474c-b48b-36c9a06b33dd"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic9fa26a59c1843ad803fbad414557dc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzE1LTQtMS0xLTU4OTIy_f6a4fbb5-3634-40eb-847a-a43c79b4a0b2"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTA1ZGU3MDc2ZjJjNGIxYWJjZTVlNTkzMDg5ZWZhOTNfNA_864f462e-8541-4308-96c5-55f0641bfe71"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YTA1ZGU3MDc2ZjJjNGIxYWJjZTVlNTkzMDg5ZWZhOTNfMTY0OTI2NzQ0MTY5OA_db0f24bf-b09d-4fd1-86dd-532808190db9"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6b90c770ff4f438da7f1e1de5c65ff49_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTItMS0xLTUxOTM1_63a3debc-1656-4b3f-8c9f-246d3c58829a"
      unitRef="usd">299000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9d5b47862f5348ef9dcf07e7a185c79b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIwLTQtMS0xLTUxOTM1_64d5fd22-d1c7-420a-9072-37934f87335c"
      unitRef="usd">299000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjdhZTYwNTc0YmZjNGM0Y2EyMWZhYThhMTFmZDkzNDNfNA_b6750f87-45e7-4742-890c-bf74b14c31c7"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjdhZTYwNTc0YmZjNGM0Y2EyMWZhYThhMTFmZDkzNDNfMTY0OTI2NzQ0MTY5Nw_36382faf-0e7f-4d93-8a48-236abc6920bb"
      unitRef="number">0.01250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i203f45d0024846889fd3a1fa6fffb8bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTItMS0xLTUxOTM1_14ee971e-b590-47a1-80a3-46e2551c980b"
      unitRef="usd">498000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i75cc738c6f9848178e80519e6cbbce38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIxLTQtMS0xLTUxOTM1_03b0d332-e516-4194-820f-0626ded238b0"
      unitRef="usd">497000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8de494dc062d4199875121594f393220_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzRmYzdhMGEyZjRiNGFlMGJiMTk3ZTEzNjk1NmQ2MTlfNA_7cc37dd7-cff6-4749-b9ae-bf739b031777"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8de494dc062d4199875121594f393220_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzRmYzdhMGEyZjRiNGFlMGJiMTk3ZTEzNjk1NmQ2MTlfMTY0OTI2NzQ0MTY5NQ_1613f629-805c-4076-b35b-e03aa19b7af0"
      unitRef="number">0.03100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8de494dc062d4199875121594f393220_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTItMS0xLTUxOTM1_92da89f0-7ef7-4ed6-8984-e27f8d0ad5a3"
      unitRef="usd">998000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib2c732b02ee74c73bbfc3705c75e0da0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTQtMS0xLTUxOTM1_17bc6778-db05-4131-b2d8-a144a19f6ca2"
      unitRef="usd">997000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IyOThiYTczN2FjNDA2MGE0YmQ0N2FjMTdkNGI0ZmNfNA_f59945a7-be9f-47aa-80d1-d29aabb6fcbd"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246N2IyOThiYTczN2FjNDA2MGE0YmQ0N2FjMTdkNGI0ZmNfMTY0OTI2NzQ0MTY5Mw_c711eee4-26c4-4ae6-943f-c953fd6cc56f"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i42ac3b21a19f4ca9b38339c305baac7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTItMS0xLTUxOTM1_06d6da9b-ce4a-4249-a4fe-0b1ca9019b62"
      unitRef="usd">893000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i63ea0c95de6e4a9b9e2536e70fefb4ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIzLTQtMS0xLTUxOTM1_18c459da-8cd8-469d-988a-7b00d8d66073"
      unitRef="usd">972000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU3NTRkY2Y3ZWZlNDliYzk1NzMxYTgzZDllMDViNjRfNA_37e3a0ae-13f9-4fcf-9bb0-12f4c5943008"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU3NTRkY2Y3ZWZlNDliYzk1NzMxYTgzZDllMDViNjRfMTY0OTI2NzQ0MTY5Nw_fa5c990a-3381-459b-9611-ea57685e6ff5"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic82463e4fdc5489ab448089bf76d312f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTItMS0xLTUxOTM1_5aa92e05-bce2-4e84-b586-a3c0e663ace0"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i21504223e65b4686844531611b0b07d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTQtMS0xLTUxOTM1_b8a1394e-53ad-4d52-8ccd-6fab166e36a8"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDBmMjJlZmIwOWExNGYwNjlmYTFjYTljNGQwMjI1NGZfNA_e16e93bb-2d1e-46a8-9b50-cda1333c1f38"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDBmMjJlZmIwOWExNGYwNjlmYTFjYTljNGQwMjI1NGZfMzI5ODUzNDg4MzM1OQ_f1028936-9a46-43a1-b317-9aee902221e2"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0aabf0a873f34f7c8173bd8ee83fbdfb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTItMS0xLTUxOTM1_39f4af83-c82f-491e-9b10-690a164b95af"
      unitRef="usd">622000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i305adfb9c01244c5afe018e176540852_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI1LTQtMS0xLTUxOTM1_8cca06d4-3f4c-4cdd-830e-2e7d8654a043"
      unitRef="usd">621000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTU4OTMxL3RleHRyZWdpb246Y2EzNzJkYzEwNTVmNDcxM2EwMzk5MDI5NmJmNWYzOWVfMjc0ODc3OTA2OTQ5NA_114da682-919f-4620-847e-e9106e1e5b2d"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTAtMS0xLTU4OTMxL3RleHRyZWdpb246Y2EzNzJkYzEwNTVmNDcxM2EwMzk5MDI5NmJmNWYzOWVfMzI5ODUzNDg4MzM5Nw_fb21fb32-59b8-4a8a-a59a-3c7e1773fa73"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4a55401292cd487bab7b21375cc65e7b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTItMS0xLTU4OTM4_75e85fa3-b40c-4afd-8e69-78334bb191a1"
      unitRef="usd">597000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if181822fd1384c01988e0d46a4385545_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzIyLTQtMS0xLTU4OTM4_397a6b6c-39c7-4f75-936b-fc31cc3abc46"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4692ab26301b477380a51e6a6a781217_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MzE5M2IwYjMwNjQ3NGNjODg3NTEwYjNlODIyODJmNDNfNA_29286f28-5d64-4f40-8e5b-da7d046eab9d"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4692ab26301b477380a51e6a6a781217_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MzE5M2IwYjMwNjQ3NGNjODg3NTEwYjNlODIyODJmNDNfMzI5ODUzNDg4MzM2MQ_f89a696e-fe8b-41aa-afcc-c589fc8f6d79"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4692ab26301b477380a51e6a6a781217_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTItMS0xLTUxOTM1_82175aef-ab50-495f-b37b-473df3b2aa24"
      unitRef="usd">943000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5677b8572412413b81509f643c9ef745_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI2LTQtMS0xLTUxOTM1_322c00d4-7c89-4967-979c-b1ec810a384c"
      unitRef="usd">942000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTU4OTQ4L3RleHRyZWdpb246YWVhMTQ1YjNiNDFhNDExNmJjNWYxNzM2ZTRkNDI0Y2FfMjc0ODc3OTA2OTQ4NQ_098618bf-720b-486a-b2bb-256101f44ec4"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTAtMS0xLTU4OTQ4L3RleHRyZWdpb246YWVhMTQ1YjNiNDFhNDExNmJjNWYxNzM2ZTRkNDI0Y2FfMzI5ODUzNDg4MzM4OA_c05e6bfb-aa30-4e03-9b07-4b863e33329c"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie0dcfe57e0ae4aefa51b2e0262d83583_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTItMS0xLTU4OTU1_6e8c1536-d875-4807-90cb-a87ef134013e"
      unitRef="usd">1008000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5c64464c7bc74ed6bc24597231e8ab76_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI0LTQtMS0xLTU4OTU1_af65a515-8c47-44d9-b721-44e4ef8073c9"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MTg2NTdmYWY1MTdkNGY5ZGE0N2ExMDQ1Njk3NjBmNjVfNA_30e5875d-739d-4817-b5a1-497b9bc0f7bd"
      unitRef="usd">1150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MTg2NTdmYWY1MTdkNGY5ZGE0N2ExMDQ1Njk3NjBmNjVfMzI5ODUzNDg4MzM1OA_ccce6591-c354-48c1-be39-ffd865f1c138"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4d23392f899d43788e933044d9acb8b0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTItMS0xLTUxOTM1_b944058d-f5a1-460c-bf8b-4f3c47378f93"
      unitRef="usd">1145000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i129276d6c48048318c0627db9c328f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTQtMS0xLTUxOTM1_26e7e22b-0029-4c2e-ba46-ea36f1f3fd2f"
      unitRef="usd">1144000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDc4Njk2NjNjZWNmNDdlNGIwNmVkMGJiNDlhNWEyY2VfNA_b58289e7-e9f1-4f4d-850b-7878cbfc0f71"
      unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDc4Njk2NjNjZWNmNDdlNGIwNmVkMGJiNDlhNWEyY2VfMzI5ODUzNDg4MzM2Mg_300af5c3-56d9-488c-915e-54caf6c16b74"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i7dab2cbb62404492925d5e152cd76361_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTItMS0xLTUxOTM1_88a32c4c-84af-430e-a7bb-cea5d6d44202"
      unitRef="usd">845000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i512cc51902184d4c92e7d2dd8755c1ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI4LTQtMS0xLTUxOTM1_1d6f355a-39a5-4476-b801-c662f1e9f80d"
      unitRef="usd">844000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4155c0e3c9b946bea71e235628460254_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTU4OTY1L3RleHRyZWdpb246NDYyMTQyN2M1YjE1NDllMWFlYjhlMWZiNWViZTJjN2ZfMjc0ODc3OTA2OTQ3Nw_fc9266be-a7b3-4bd5-a942-ce3f91c782a6"
      unitRef="usd">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4155c0e3c9b946bea71e235628460254_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTAtMS0xLTU4OTY1L3RleHRyZWdpb246NDYyMTQyN2M1YjE1NDllMWFlYjhlMWZiNWViZTJjN2ZfMzI5ODUzNDg4MzM4Mw_2cf97778-ed18-4b36-9883-fb70e4d55cf9"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4155c0e3c9b946bea71e235628460254_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTItMS0xLTU4OTcz_a34b9ee3-ebaa-4884-961a-c24e34d0e50a"
      unitRef="usd">849000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6b14d6d4df8b4cfaa24978b6086e472e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI3LTQtMS0xLTU4OTcz_33d6faeb-bd7a-4616-bccd-8cb82abde226"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODNmMDY1NTRjMzhjNDQ3MzllMTI1MzA2ZDQ4YjVlYWNfNA_f452b6ce-4f0e-4f38-a719-c1188b01a488"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODNmMDY1NTRjMzhjNDQ3MzllMTI1MzA2ZDQ4YjVlYWNfMzI5ODUzNDg4MzM2MA_3c786027-f020-4acf-ad7c-1a929c13568e"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="id34aca5e0b0748ed989035c239f6915c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTItMS0xLTUxOTM1_55e5ff56-652c-4d3f-94df-1d86a0a68d39"
      unitRef="usd">886000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i86903b7949ae4788981d28620e873889_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTQtMS0xLTUxOTM1_876ac13f-3000-426a-acec-2d089cf488a1"
      unitRef="usd">1023000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTU4OTg2L3RleHRyZWdpb246MTAxM2I5MDYxM2NiNDQ2Yzk2M2I5ZTUyN2QyYzI4N2NfMjc0ODc3OTA2OTQ4NQ_f0fa19d5-9bda-4a9c-87dd-bc3f9cd22190"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTAtMS0xLTU4OTg2L3RleHRyZWdpb246MTAxM2I5MDYxM2NiNDQ2Yzk2M2I5ZTUyN2QyYzI4N2NfMzI5ODUzNDg4MzM4OA_f5f44297-c0d1-4cb4-8f2c-66194a1757f4"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i806a5e7065f94c2b8e3ab12746cdaee1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTItMS0xLTU4OTkz_db858a92-a083-4c6e-b38b-87eac48b27e1"
      unitRef="usd">1269000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="id80a1eb5f9d341648fd7677e8828af62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzI5LTQtMS0xLTU5MDAy_d5777a96-073a-4c98-a1df-7108ecf61c82"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODg5ZDRkMDJkNGM5NDE2NGJiODcwYmVjMTYxYWY5MGZfNA_45e2f237-8995-41a6-914a-709664e2d106"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODg5ZDRkMDJkNGM5NDE2NGJiODcwYmVjMTYxYWY5MGZfMzI5ODUzNDg4MzM1Nw_b46ab10f-50db-4ed9-b45d-4502aa3e9475"
      unitRef="number">0.02000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9a5b0b53fa8240879de83b80861c2037_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTItMS0xLTUxOTM1_26a7a22c-00b5-4d32-898f-71931559a457"
      unitRef="usd">1237000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i76155e2aae45448fae0e6e595a1abba1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMwLTQtMS0xLTUxOTM1_18918c07-707e-483e-8e39-f5e9b38a6187"
      unitRef="usd">1235000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGQzODUxMzRiMmY5NDkwYWI1YTIxYWQzNmYzOWJjNjdfNA_60971582-9d41-40b5-8747-df54d611b93d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGQzODUxMzRiMmY5NDkwYWI1YTIxYWQzNmYzOWJjNjdfMTY0OTI2NzQ0MTY5Mw_4d664ec5-48dc-4b45-b8ac-62ee34b90047"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8de06ca26b3340e78175d0fa4155ceee_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTItMS0xLTUxOTM1_fb23bcfb-85ee-4896-8271-69d55303d951"
      unitRef="usd">1256000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5c7c9dc5c92d4b699d0ace37c4d35756_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMxLTQtMS0xLTUxOTM1_f2adfb0b-29fb-4a78-8a4a-0998f611f3f3"
      unitRef="usd">1482000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTU5MDMxL3RleHRyZWdpb246ZGZmZmFmOTY0NmIzNDM5MWIyZmNmZjQ5M2I3ZjVhNGVfMjc0ODc3OTA2OTQ4MA_04381cdd-92ee-4a77-b9d2-81c6389baa2f"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTU5MDMxL3RleHRyZWdpb246ZGZmZmFmOTY0NmIzNDM5MWIyZmNmZjQ5M2I3ZjVhNGVfMTY0OTI2NzQ0MTcxOQ_a6f50555-28bb-4bcd-8c53-09e6456221c1"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4c6a66c306ca44bbbfee561f09c05af1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTItMS0xLTU5MDE3_064045f2-1940-46c1-9565-2b7e64e95a24"
      unitRef="usd">1393000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if33ebc317b78463795ee17f17e4687e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTQtMS0xLTU5MDQw_f367e415-45f3-43fa-92d5-05ec9f283f2d"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if99d5f53340d46e8bd01203577453158_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTU5MDM1L3RleHRyZWdpb246OGQ1MmJkN2ViYzQ2NDIxODgxNzUwZWIzYTU3NDA4MDNfMjc0ODc3OTA2OTQ4NQ_bebf6754-d52b-47c5-9fc9-df13606a7938"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if99d5f53340d46e8bd01203577453158_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTU5MDM1L3RleHRyZWdpb246OGQ1MmJkN2ViYzQ2NDIxODgxNzUwZWIzYTU3NDA4MDNfMTY0OTI2NzQ0MTcyNA_d22daa1f-67ac-4c8e-bc1b-2adc96616367"
      unitRef="number">0.05350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if99d5f53340d46e8bd01203577453158_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTItMS0xLTU5MDE3_8aa917c4-36ac-4c38-a8ca-9c6202f74aed"
      unitRef="usd">2037000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i38506247ccc740b692752b50a39ff3bf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTQtMS0xLTU5MDQw_9dcb375f-c6da-4c31-aa5c-bf187e47fc69"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i663d30885efc49f1b283db95c351ef37_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjY0NjAxM2YxMDE2NGI4NmE3OTQ2NDg3YmYzNzUxMzRfNA_512ea73d-5ee6-43ec-9e9c-80bfc0a8e481"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i663d30885efc49f1b283db95c351ef37_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjY0NjAxM2YxMDE2NGI4NmE3OTQ2NDg3YmYzNzUxMzRfMzI5ODUzNDg4MzM1OA_badd94bc-06fd-4edb-ba0d-4d119c11295c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i663d30885efc49f1b283db95c351ef37_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTItMS0xLTUxOTM1_e2b07efd-bc19-4117-8a87-e83ea8340ece"
      unitRef="usd">993000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9e481989fbfb4b4bae07e9cdb93241db_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMyLTQtMS0xLTUxOTM1_70ef1052-92af-4114-8c49-2e2252dd8d2d"
      unitRef="usd">993000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjdiOTgxYmNjZmRhNGIwMDhiZWZmZjg5NDEzZDI2MzdfNA_a11eb26e-5f96-4e34-92ee-da1dce41afeb"
      unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjdiOTgxYmNjZmRhNGIwMDhiZWZmZjg5NDEzZDI2MzdfMzI5ODUzNDg4MzM1OQ_c95f89dd-adb2-4862-9141-67d9820ba7cf"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9fe27021be7848fb8ac2a70eb45943d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTItMS0xLTUxOTM1_9c85e8a6-999b-49cb-88b1-d819c124c5c9"
      unitRef="usd">840000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic9f537d010f04ef2b408ff0b5e4a6240_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzMzLTQtMS0xLTUxOTM1_2a1630ce-f162-4ab5-b844-2a6a23d65810"
      unitRef="usd">839000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OWM5YTAxZWFlZWFkNDRiY2I3ZTExODRkNDk1YmI3OTdfNA_0551e483-b39c-4c61-87ee-73c704911873"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OWM5YTAxZWFlZWFkNDRiY2I3ZTExODRkNDk1YmI3OTdfMzI5ODUzNDg4MzM1OA_688563b9-45f5-4278-b2d8-30576330b5ed"
      unitRef="number">0.06500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8358f864c6a94934b2ee1ed4c5380631_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTItMS0xLTUxOTM1_97d2609d-29f9-43c7-925c-6defff196236"
      unitRef="usd">493000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4d45d08ecf834726abad93ca937d8c57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM0LTQtMS0xLTUxOTM1_93678ce4-ecca-4f7c-b88c-5eea5ad8b294"
      unitRef="usd">492000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MWE1ZDY0NGRjODIxNDU3YjhkOTE3NTAzYmRlZmUwMzBfNA_0437a39d-6d57-428e-ae7b-cc3f825b44e9"
      unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MWE1ZDY0NGRjODIxNDU3YjhkOTE3NTAzYmRlZmUwMzBfMzI5ODUzNDg4MzM2Mg_08add6b4-6fce-4ec4-90fb-62e837fb3b39"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5c5629c7537c453dbdc9f344362a08b8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTItMS0xLTUxOTM1_0469cf58-21e9-4f09-998f-e4ea3bdc493d"
      unitRef="usd">642000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i950071dee1cf4f1287c79566cbab2cde_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM1LTQtMS0xLTUxOTM1_c6b5edbc-746e-4fa7-b637-52160f77409e"
      unitRef="usd">642000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGMzYWJhNWNkYjFjNGYwOTk5ZjdmOGFiYjg2NjIwZWJfNA_bdd80a64-3844-4f4e-83be-12a57ecd1abc"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGMzYWJhNWNkYjFjNGYwOTk5ZjdmOGFiYjg2NjIwZWJfMzI5ODUzNDg4MzM2Mg_8f773cf5-1497-47f6-9ae1-93d80c53df22"
      unitRef="number">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8fa1a2d080b742208f733a624feb7cc7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTItMS0xLTUxOTM1_5a8e2db2-46cf-47d8-95f5-c6d8e5f10663"
      unitRef="usd">1079000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iada8fff11b964f0bb11cb946276b397a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM2LTQtMS0xLTUxOTM1_4ab7b2dd-7f47-4f19-8bba-84165c24affb"
      unitRef="usd">1078000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NGU5MWEyZWI2YzZlNDY5M2E2YTQ5ZDMzYzY5ZjYxNjFfNA_c927cbab-6b36-4c8b-9822-77b0fdb3874c"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NGU5MWEyZWI2YzZlNDY5M2E2YTQ5ZDMzYzY5ZjYxNjFfMzI5ODUzNDg4MzM2MA_b480f28e-0b70-4c65-a38c-64cbb854924e"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i853b4b0cb13d41eab1caaefa962bea5d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTItMS0xLTUxOTM1_074de825-c1fb-4297-b9c8-1ce9a8be900a"
      unitRef="usd">1242000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i472b6a573ea24ab69839d586a4f2fc76_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM3LTQtMS0xLTUxOTM1_836c07ab-ae68-4cda-a01c-04ea038396b6"
      unitRef="usd">1242000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGM5MTkwODNhNGZlNDljMzk1OTA4ZTJmNDEyOTllZDdfNA_c4e80ab2-b9c2-40a3-9cfe-a6ce4164fcf7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MGM5MTkwODNhNGZlNDljMzk1OTA4ZTJmNDEyOTllZDdfMzI5ODUzNDg4MzM1Nw_1ba2086e-6363-4623-a058-7061edadd9d9"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iebaa87cecf5849d389bb300eb4709582_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTItMS0xLTUxOTM1_895fcf0f-d507-46be-a4f7-8df5b16541fc"
      unitRef="usd">967000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ifaeebd9e870e4ae4a60d0c58ad726851_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM4LTQtMS0xLTUxOTM1_2004f76e-6d5d-4357-b26b-64d39c662d11"
      unitRef="usd">966000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OTZmMzgyZDVhZjFhNDNlMmE5ZTFiOTJjYzU4MzBhMzVfNA_e55c7860-1e12-451d-9c84-b00d0efce58e"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246OTZmMzgyZDVhZjFhNDNlMmE5ZTFiOTJjYzU4MzBhMzVfMzI5ODUzNDg4MzM2MQ_d0f234bb-7aa1-4496-bb4b-900e648e3062"
      unitRef="number">0.05700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="icd52088b565542199acbe6f00c32c2e9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTItMS0xLTUxOTM1_8e992d37-3c11-447c-b731-7422ce9254ac"
      unitRef="usd">296000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic9cc71855ae94636a016e4748db5e5bf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzM5LTQtMS0xLTUxOTM1_7ed95865-ea21-436a-a71a-c1aee098db19"
      unitRef="usd">296000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGRkMTI4YmM3MGY4NDAyZmJhYjQ2ZjNjOTYwYjhjZTBfNA_c6e3f74c-491c-4f08-abbb-492aaf1d0eed"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZGRkMTI4YmM3MGY4NDAyZmJhYjQ2ZjNjOTYwYjhjZTBfMzI5ODUzNDg4MzM2Mg_4e78bf3c-545d-4b2e-925b-105702de2295"
      unitRef="number">0.05950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6c68342188ac441f993ea148f6163a3f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTItMS0xLTUxOTM1_63fa618d-55fd-4a9c-871c-7e9f5c88837a"
      unitRef="usd">346000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8af022449e6a4052bbbe3d69f40cc5ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQwLTQtMS0xLTUxOTM1_45742084-1932-45f9-9fd6-5b1c3961b35d"
      unitRef="usd">346000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if96339900834441a90061dd06cd0727f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmZlMzUzYWRmYjM1NDU5Yzk3MjJhZWZiM2RlZTlmNTFfNA_c824e452-3179-4687-84b4-13d50c607e81"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if96339900834441a90061dd06cd0727f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmZlMzUzYWRmYjM1NDU5Yzk3MjJhZWZiM2RlZTlmNTFfMzI5ODUzNDg4MzM1OA_79c98417-c854-48be-b6f6-30e28df23021"
      unitRef="number">0.03050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if96339900834441a90061dd06cd0727f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTItMS0xLTUxOTM1_062b0e1c-56c4-4794-a252-9c21e1c019f3"
      unitRef="usd">1483000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0467e40cfdc04f9da3be269b79fd4132_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQxLTQtMS0xLTUxOTM1_56199cc1-ec55-4993-bddb-9b83388005ec"
      unitRef="usd">1483000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU1NjdhNGViODZlNGE2MGIyMWM4OTVjMjdiMzIyZWZfNA_7ebee62a-d676-469d-b28a-159eb0453983"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU1NjdhNGViODZlNGE2MGIyMWM4OTVjMjdiMzIyZWZfMTY0OTI2NzQ0MTY5OA_6c74a2d6-6c40-4aa6-bf7e-e1ee47bf474c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if241f86fec94483e9fbedb583dc64e67_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTItMS0xLTUxOTM1_fbbc7328-e0b4-404d-b639-941f30dc8f87"
      unitRef="usd">590000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie6ff2097150a4198a7408f57b7751209_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQyLTQtMS0xLTUxOTM1_6c5a1234-da7b-42a0-bb66-321a67d330fc"
      unitRef="usd">589000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NTZmNzQ5OTg2MjBiNGIwMWI3OTBmZDY1YTliYTFmNDRfNA_75996dea-b2da-49e9-a617-e8897bccd2ea"
      unitRef="usd">502000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NTZmNzQ5OTg2MjBiNGIwMWI3OTBmZDY1YTliYTFmNDRfMTY0OTI2NzQ0MTY5NQ_0f6f12d0-e072-4d4c-96c5-7259279648d4"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i178f10eeffe540c5b55f43219adb4530_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTItMS0xLTUxOTM1_c8120461-d736-4dde-b886-852c86bd1c13"
      unitRef="usd">486000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i14f7e1b784e143aaa8c2fb4ee90e847b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQzLTQtMS0xLTUxOTM1_2d94460a-d43d-45e7-859c-83d9bfef6bb1"
      unitRef="usd">485000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzA2ZjM4ZjQyNTc5NDFkYzgzNmFlYTMxNWJjMmE1YWNfNA_d2ee322e-6efc-4cb2-ae19-1c9fc873046d"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YzA2ZjM4ZjQyNTc5NDFkYzgzNmFlYTMxNWJjMmE1YWNfMTY0OTI2NzQ0MTY5Nw_9ea8e498-1bfb-4b4b-9289-c56ab0f9d8bb"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie5a73599312a49f2a409f094bbd99ae9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTItMS0xLTUxOTM1_d32add7d-c1d5-425d-9b1d-01ea06aba7b5"
      unitRef="usd">609000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i88ed0e3cddfb4ccd9187bd8407096c4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ0LTQtMS0xLTUxOTM1_4c61921e-cadf-4121-87e7-d170edfff2c1"
      unitRef="usd">608000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjFhY2IxOGQyMzM3NDM3NjljZTkzNDIwMzdkMzI3ODRfNA_8c6cb9b8-6cbc-453b-88f8-3b41cd932324"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246YjFhY2IxOGQyMzM3NDM3NjljZTkzNDIwMzdkMzI3ODRfMTY0OTI2NzQ0MTY5NQ_632a5936-7164-4801-8831-1f89e69886f8"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i3290167c6c224581a5a44faf7d6e5ef4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTItMS0xLTUxOTM1_66f4431a-78ff-4164-a63a-218fb1e12ec5"
      unitRef="usd">736000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if6269a5a11644842a3cdb93e77b08b21_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ1LTQtMS0xLTUxOTM1_0eb1208c-86fe-4312-bf13-ad862314afdb"
      unitRef="usd">736000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZTc0MDJhMDA3YTBjNDQ1Y2E1MThmOThlMGQ4OGI0ZDZfNA_9f182f5e-32ed-47a6-b6dd-3b12effea51f"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZTc0MDJhMDA3YTBjNDQ1Y2E1MThmOThlMGQ4OGI0ZDZfMTY0OTI2NzQ0MTY5NA_819ddda3-f249-42f7-be74-6d0c4b527ffd"
      unitRef="number">0.04750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i17e5bb4c7caf47ec8406617d410fdf1e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTItMS0xLTUxOTM1_810d139d-dcbe-403e-ae41-450c64eef827"
      unitRef="usd">1975000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ibfa1bdbe5afa44219cc32a23f3330036_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ2LTQtMS0xLTUxOTM1_1d12ac01-151f-4b94-871d-ba710e2b75ea"
      unitRef="usd">1974000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmZmNDE1ZWY0MjAxNGRiMmJjN2QxZTYyMThiZmQwNjJfNA_4196d3c5-d462-4cb6-b3c6-a3c48eba0402"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZmZmNDE1ZWY0MjAxNGRiMmJjN2QxZTYyMThiZmQwNjJfMTY0OTI2NzQ0MTY5Nw_e9366864-6be7-4375-a99a-ac8fd4edfcfd"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i80325b3ceb8844d0bc983f1570151700_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTItMS0xLTUxOTM1_145d8720-c145-4f09-806e-c37a27ece3e2"
      unitRef="usd">739000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if96f0c553fcd40a1a3f553dd366c0f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ3LTQtMS0xLTUxOTM1_0facb1e0-e3b1-4b2b-bc07-539cbe79dd26"
      unitRef="usd">739000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODQwY2U2NjlkZmVmNDEwZWFhMDAyMDM0NDc0Mjk2MWJfNA_bb6ae06b-9cbb-4471-97e0-243b2cf48428"
      unitRef="usd">725000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODQwY2U2NjlkZmVmNDEwZWFhMDAyMDM0NDc0Mjk2MWJfMTY0OTI2NzQ0MTY5NQ_a8bf7dbc-96cd-439c-be5d-a72bad5b5ad2"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5d92492d202e4193b143e3b5fc891c52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTItMS0xLTUxOTM1_22923fc3-11d2-4bba-a132-8b72a74758db"
      unitRef="usd">718000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i721180c4c3834dad88660c0cb0c92351_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ4LTQtMS0xLTUxOTM1_cf9f39b0-ce62-45f1-b5a3-eaa005be17f9"
      unitRef="usd">718000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDI2MjUzZmM3N2MxNDE3YTg2YmFkMDdkZDMzYWE5Y2ZfNA_b6457f68-02a2-44ba-8e3b-92de670f61e7"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDI2MjUzZmM3N2MxNDE3YTg2YmFkMDdkZDMzYWE5Y2ZfMTY0OTI2NzQ0MTY5Nw_9c79b8a3-4c22-4f6c-8517-5360657e9d54"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="id511dbd83f2c482f9a759b209e1292b0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTItMS0xLTUxOTM1_d01196a4-b15c-466a-8603-febd1b99843a"
      unitRef="usd">935000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="icff31eaf98fc4021bcccf6be5c93a0d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzQ5LTQtMS0xLTUxOTM1_23cda099-e02d-4c18-9352-33c11f7ab9c3"
      unitRef="usd">934000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDMxMzU1YzQ5OTA3NDMyNTk4NWVmMjNjNjdlNTRlMmNfNA_037faee6-900e-4163-b7aa-b51deb2a1e91"
      unitRef="usd">1350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MDMxMzU1YzQ5OTA3NDMyNTk4NWVmMjNjNjdlNTRlMmNfMTY0OTI2NzQ0MTY5NA_e9a0ba77-8c04-4d76-82ac-d5ffb7de8582"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4c973547dd8641f8bb987bf6ab8add1c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTItMS0xLTUxOTM1_83c343ab-857c-482d-8ea1-6719f1e6455c"
      unitRef="usd">1331000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ibcfbf9e7699242f79053b6b8ba023aeb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUwLTQtMS0xLTUxOTM1_e74bae5e-a650-4880-befa-6fbbdb62a160"
      unitRef="usd">1330000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU2MDFkZDQ3YzA3NGM2OGFjZWYzYjFmZTFmNmY1NjRfNA_13fad203-c222-49fb-8679-563b891725dd"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmU2MDFkZDQ3YzA3NGM2OGFjZWYzYjFmZTFmNmY1NjRfMTY0OTI2NzQ0MTY5OA_1a2680e7-6ffd-49ca-b627-463ed45ce618"
      unitRef="number">0.04450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i452493f8b4dd4009ad2e916fee82afdc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTItMS0xLTUxOTM1_ae0b07d5-22f2-47a6-b05a-a078fa5957f3"
      unitRef="usd">1087000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if51d52d41c444e478616b97fb188f33c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUxLTQtMS0xLTUxOTM1_3e9567c4-1b12-4f16-8778-331fd289fa7e"
      unitRef="usd">1087000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icab462ccd24d47938ac7bf5582916526_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODFmMmNjZjk1NDcwNDhjNTgxZjhlNTNiMDFjYjJlNTdfNA_b09ecfdb-f076-41e1-9a22-c8ddb996a853"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icab462ccd24d47938ac7bf5582916526_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTAtMS0xLTUxOTM1L3RleHRyZWdpb246ODFmMmNjZjk1NDcwNDhjNTgxZjhlNTNiMDFjYjJlNTdfMTY0OTI2NzQ0MTY5Ng_a89177d6-54f8-4658-b98e-55e262ae8e81"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="icab462ccd24d47938ac7bf5582916526_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTItMS0xLTUxOTM1_a1143743-2b2f-4d6c-a292-b0d2fd4b1660"
      unitRef="usd">1236000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i051acdfdac5443078c32017b27ef25f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUyLTQtMS0xLTUxOTM1_5b08076c-993c-4d02-b82f-3254756444a1"
      unitRef="usd">1236000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjViZTgwMzgxYmZhNDFiZGIwMzU2NDc4OWViNzViNjBfNA_da0d9cef-5cbb-40b7-8346-61177649ac32"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTAtMS0xLTUxOTM1L3RleHRyZWdpb246NjViZTgwMzgxYmZhNDFiZGIwMzU2NDc4OWViNzViNjBfMTY0OTI2NzQ0MTY5Mw_082e309b-dad0-4fe8-8174-07e1d3330a51"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i48fe787e4f084d5aa237c9cb3982524d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTItMS0xLTUxOTM1_230c9204-6c6b-4a57-81f5-5d7c4c52b623"
      unitRef="usd">1210000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i052454650bb34a24989f6fcdc6ad6074_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzUzLTQtMS0xLTUxOTM1_8881d0ac-624e-4532-a297-c8017ef08c66"
      unitRef="usd">1209000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i435285040d2540dfad739c13df074973_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZDYxODYyMzNhYWViNGMxOWI4NjFiMmViYTFkN2MzMDNfNA_f0642a12-e077-410f-81f2-602c4d85353e"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i435285040d2540dfad739c13df074973_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTAtMS0xLTUxOTM1L3RleHRyZWdpb246ZDYxODYyMzNhYWViNGMxOWI4NjFiMmViYTFkN2MzMDNfMTY0OTI2NzQ0MTY5Mw_62fbbf6b-bb03-440b-9fe9-aa9871c1d8ff"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i435285040d2540dfad739c13df074973_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTItMS0xLTUxOTM1_0f78d39a-50a6-4ea3-9e44-883689f3b4ca"
      unitRef="usd">1971000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie1cbcf2205a4446ea4843ad64f479218_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU0LTQtMS0xLTUxOTM1_8e134584-873b-4c56-85c9-8659c0a12f73"
      unitRef="usd">1970000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTAtMS0xLTU5MDU0L3RleHRyZWdpb246NDViMDdhMmU1NWU2NDY3ZWIzZmNmN2U3NmQ2ZWRmNTBfMjc0ODc3OTA2OTQ4MA_382aeb47-954d-44a1-ab33-b9e4a36578b6"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTAtMS0xLTU5MDU0L3RleHRyZWdpb246NDViMDdhMmU1NWU2NDY3ZWIzZmNmN2U3NmQ2ZWRmNTBfMTY0OTI2NzQ0MTcxOQ_2063a9eb-6643-4d5b-b1b7-5ae7e83303df"
      unitRef="number">0.04750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i174e953a70e649b0abb9a33cee93913f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTItMS0xLTU5MDcw_23b72616-bc75-40ad-8498-c5b69beec5a3"
      unitRef="usd">1965000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ifc19b7d8253640e1b39dcef330c1e8fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTQtMS0xLTU5MDcw_43c2035a-0ba1-4377-8cc1-b89260ad1b0b"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTAtMS0xLTU5MDYwL3RleHRyZWdpb246MTdiODJkMDhkOTI5NDBkODgwYjkxNTU4Y2VjZmM0NmZfMjc0ODc3OTA2OTQ4NA_8e4fe1ac-7c6e-450e-80f4-e7f0a58817e6"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTAtMS0xLTU5MDYwL3RleHRyZWdpb246MTdiODJkMDhkOTI5NDBkODgwYjkxNTU4Y2VjZmM0NmZfMTY0OTI2NzQ0MTcyNA_9aa3bfe8-6970-48c1-932e-1080f037d519"
      unitRef="number">0.05875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i73d1a0731c8b4b14ab6c5f2e43a0a96d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTItMS0xLTU5MDcw_ee746243-d195-4822-96cc-e1cd43bad049"
      unitRef="usd">1968000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ice983114f0894876a852c31fe9eeaded_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU4LTQtMS0xLTU5MDcw_539c9665-0dad-40b0-9adf-aa0ce771a52a"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmM0MzAxYzE1OWI3NDUxM2ExM2U0OGZkYzI5ZDQ3MmVfNA_c5b393e6-3e1d-4f59-b84f-1e4449d1e0a8"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTAtMS0xLTUxOTM1L3RleHRyZWdpb246MmM0MzAxYzE1OWI3NDUxM2ExM2U0OGZkYzI5ZDQ3MmVfMTY0OTI2NzQ0MTY5Ng_94e3cd8a-3f28-42fd-9b2b-f40a06b4c6c2"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5297bdacb8224fc7a733be5e8e83ffe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTItMS0xLTUxOTM1_af82d387-2e2b-4c30-924c-a2b8de6c5196"
      unitRef="usd">1228000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ia73b3065191a436988023a7ff6a43503_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU1LTQtMS0xLTUxOTM1_0c003dc7-6bf8-44d6-b090-7e34767e39de"
      unitRef="usd">1228000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDJlM2Q0OWQ1YWE5NDNjYjk2YWZiMDMxNzgyOGFjMjdfNA_a7f169fb-94a6-46c2-87e4-1962a30cf1c0"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTAtMS0xLTUxOTM1L3RleHRyZWdpb246NDJlM2Q0OWQ1YWE5NDNjYjk2YWZiMDMxNzgyOGFjMjdfMTY0OTI2NzQ0MTY5Mw_85516d41-d2fe-4169-b193-4ba7bea0d752"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i261cd0420bde47508c9875c124b4bfb3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTItMS0xLTUxOTM1_de1b275c-7bcb-4cf6-a7dd-0ff3dca894c0"
      unitRef="usd">966000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i86f9496f2f4045c2b66ee552d15fa61e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU2LTQtMS0xLTUxOTM1_86ae341d-a263-428f-92fe-f7a78e80094a"
      unitRef="usd">965000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTAtMS0xLTU5MTI4L3RleHRyZWdpb246MmYyNjMzMDU1ZGYzNDg3Nzg1NjVjMTU0Njc1OWJkYWZfMjc0ODc3OTA2OTQ4MA_b448446b-8be2-4f49-b5e2-d1aee62799f1"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTAtMS0xLTU5MTI4L3RleHRyZWdpb246MmYyNjMzMDU1ZGYzNDg3Nzg1NjVjMTU0Njc1OWJkYWZfMTY0OTI2NzQ0MTcxOQ_4dc0d1e7-8ea1-4fc7-a234-9dcdf2e9cabc"
      unitRef="number">0.04950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib26873bbc3ea4f1db934d8b4b681e0d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTItMS0xLTU5MTUw_5c345906-5bbb-4c5e-9d6c-8986a4a734fe"
      unitRef="usd">981000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib3ed6067252342b3beb9989231672adc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYxLTQtMS0xLTU5MTUw_e51c488e-957f-47d9-bb44-09dc2be60733"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTAtMS0xLTU5MTQxL3RleHRyZWdpb246ZWVjNmM5M2Y5ZjA4NDEyODkyNDE0OTY4NWEzODEwN2VfMjc0ODc3OTA2OTQ4NQ_1af6f143-4257-429f-b35b-a6636a058c3a"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTAtMS0xLTU5MTQxL3RleHRyZWdpb246ZWVjNmM5M2Y5ZjA4NDEyODkyNDE0OTY4NWEzODEwN2VfMTY0OTI2NzQ0MTcyNA_8d3bdd0a-a568-44e9-a877-728c5872bf78"
      unitRef="number">0.06050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5fb3c68be3a447c0a3f2c93a7b225dec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTItMS0xLTU5MTUw_469d3890-fe1d-4b9c-a184-1e2f8f9341c3"
      unitRef="usd">1466000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0d2eaa671ac44220bee9863ce3993ecf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzYyLTQtMS0xLTU5MTUw_f5af7179-a2c8-468a-8e96-4a8bc77126fd"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTItMS0xLTUxOTM1_c0383577-5d24-4914-85f9-6f0905361f1a"
      unitRef="usd">56756000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZToyM2ZiYTg4MTllMzk0N2E3OGQ2OWY4MzZiZTczODFmYS90YWJsZXJhbmdlOjIzZmJhODgxOWUzOTQ3YTc4ZDY5ZjgzNmJlNzM4MWZhXzU3LTQtMS0xLTUxOTM1_9982d7f8-e4db-4c04-bdde-cff9d55ea8cc"
      unitRef="usd">44632000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:OtherLongTermDebt
      contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE5Mw_b4030a30-85e0-4361-9264-5657d3c6b963"
      unitRef="usd">900000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzIwMA_9d354267-5549-40ff-91dc-2d396849302f"
      unitRef="usd">1400000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebtCurrent
      contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzI0NA_a8a39e04-f487-41bd-a855-9520179c0987"
      unitRef="usd">192000000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:OtherLongTermDebtCurrent
      contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzI1MQ_cc323835-dc6c-4509-b089-c76cafd210b6"
      unitRef="usd">611000000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE1ODE_4f71481b-6a0c-48ed-954e-18fbd5f26d76">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzEtMi0xLTEtNTE5MzU_1f2d5af4-9e89-4324-87cf-0bb84a7f980f"
      unitRef="usd">3117000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzItMi0xLTEtNTE5MzU_92e35756-e296-4df1-832f-4402ba689171"
      unitRef="usd">3136000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzMtMi0xLTEtNTE5MzU_29ddf5b0-2df2-4a68-a300-17339cabbc01"
      unitRef="usd">3186000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzQtMi0xLTEtNTE5MzU_83a6dbf1-7261-4285-8942-2b5c64c38a1f"
      unitRef="usd">2636000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzUtMi0xLTEtNTE5MzU_44d8e3dd-64b1-48e6-ad9d-97f108b9522c"
      unitRef="usd">3061000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90YWJsZTplNTUyNjdiMDNmNzg0N2VjODM1ODlmOWY2MDIyZDE0OC90YWJsZXJhbmdlOmU1NTI2N2IwM2Y3ODQ3ZWM4MzU4OWY5ZjYwMjJkMTQ4XzYtMi0xLTEtNTE5MzU_0c6fd942-72d3-4655-99b9-9c6e3832abd8"
      unitRef="usd">43638000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1b889aeec8304b17a5381fabcfec7d9a_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzU3Mg_54da8e69-eb67-4186-b2a1-c474f8c9a282"
      unitRef="usd">6000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4b90c42a12c946ec837aea2ac692cc5d_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzU4Ng_5fd99411-6bab-4e4f-a207-71cf4b9c37c8"
      unitRef="usd">6000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i845de76c9b49482181876168457d3339_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzYwNA_d4cadaa7-3722-4aff-8d4a-4dd15b437bbf"
      unitRef="usd">6000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i3fbec7cfe19d43a8adf0ec061d38e36f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzE2NDkyNjc0NDMzNDM_32715365-06de-4d93-a203-f28cf8dd4c1b">P364D</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i8eb087bedb274e389574fb540aacd661_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzEyOTM_d1807cfd-5f9c-47ae-afec-7cf1e3d8b4b5"
      unitRef="number">0.051</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i967155a249994885831ed4f111f8cf37_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xODQvZnJhZzo2N2FkOTgzZDMxZWE0MjE2YjMzNmI2MmE4NDhmOGU2Ni90ZXh0cmVnaW9uOjY3YWQ5ODNkMzFlYTQyMTZiMzM2YjYyYTg0OGY4ZTY2XzEyOTk_dd293b62-3bbf-43af-8a4f-c6e662a59a90"
      unitRef="number">0.075</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzM0MDA_56c85904-6129-4116-b0c2-0f2c41076de3">Income Taxes &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. The components of the provision for income taxes for the years ended December&#160;31 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards - excess tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. tax loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Net unrealized losses on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-domestic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis in partnerships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $490 million expire beginning in 2023 through 2037 and $611 million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2023 through 2042, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company&#x2019;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitations lapses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $260 million as a result of audit settlements and the expiration of statutes of limitations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $64 million, $66 million and $52 million of net interest and penalties, respectively. The Company had $253 million and $194 million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2022 and 2021, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2022, there were $1.7 billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#x2019;s 2017 through 2020 tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the 2014 tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years 2015 and forward.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzg_eda5805b-620f-4a94-81de-9242c416cb3b">The components of the provision for income taxes for the years ended December&#160;31 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItMi0xLTEtNTE5MzU_6409f33f-2509-40e4-8c4e-4cc97e968084"
      unitRef="usd">4842000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItNC0xLTEtNTE5MzU_f2517050-9d60-423c-881d-997f6b321431"
      unitRef="usd">3451000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzItNi0xLTEtNTE5MzU_8ca8907e-cbc1-40f0-9570-dd393651d114"
      unitRef="usd">4098000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtMi0xLTEtNTE5MzU_945a8307-05dc-4a85-8c59-f3169d47d185"
      unitRef="usd">855000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtNC0xLTEtNTE5MzU_790b44fc-5bf2-4551-9161-77d0a5a99749"
      unitRef="usd">481000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzMtNi0xLTEtNTE5MzU_16fcc69e-5acf-4368-a344-7788eaf240ef"
      unitRef="usd">392000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtMi0xLTEtNTE5MzU_16873314-1c99-49fc-88b2-79ca92e5ef0a"
      unitRef="usd">680000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtNC0xLTEtNTE5MzU_5cef49ca-4095-4bb8-a104-a667d3ef6606"
      unitRef="usd">516000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzQtNi0xLTEtNTE5MzU_5459c223-0eab-4bd9-b979-f87494d57e94"
      unitRef="usd">491000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtMi0xLTEtNTE5MzU_b8057739-ad08-4312-9726-abf276bbe169"
      unitRef="usd">6377000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtNC0xLTEtNTE5MzU_233c66fe-1c0d-475d-ac9b-5541a5128948"
      unitRef="usd">4448000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzUtNi0xLTEtNTE5MzU_9b976601-a381-46af-82bf-7786be04f681"
      unitRef="usd">4981000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtMi0xLTEtNTE5MzU_38af0599-1e46-4c25-9f46-53f96e20777b"
      unitRef="usd">-673000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtNC0xLTEtNTE5MzU_626d5554-b3de-45d4-8210-cab6da99c77c"
      unitRef="usd">130000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzYtNi0xLTEtNTE5MzU_7502939c-3aa3-4498-b73b-36ed5a962337"
      unitRef="usd">-8000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctMi0xLTEtNTE5MzU_84ac5b91-d391-457c-974e-78c6ec73551f"
      unitRef="usd">5704000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctNC0xLTEtNTE5MzU_1d2ac1e7-57da-4406-90d2-5c2fb36bb9a7"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTphMWEzODU2NmZjNmI0MjY5YjI2MzNlMjYwZTFjODY5ZS90YWJsZXJhbmdlOmExYTM4NTY2ZmM2YjQyNjliMjYzM2UyNjBlMWM4NjllXzctNi0xLTEtNTE5MzU_fcfa8ecf-130a-4322-b0b1-ac8f25858a5d"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzk_8956a96c-a83f-4cb9-bcf7-78d61d88fd05">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards - excess tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMi0xLTEtNTE5MzU_3b056348-a78f-4a10-83c5-bac5e67a47fe"
      unitRef="usd">5532000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtNC0xLTEtNTE5MzU_30f9f66a-b8df-4620-b290-03df2d835b47"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtNi0xLTEtNTE5MzU_8a76da39-638b-4ff7-a4ab-4849e2ebfcf5"
      unitRef="usd">4685000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtOC0xLTEtNTE5MzU_0d7d761a-e618-434f-99e1-707bdb87cbec"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMTAtMS0xLTUxOTM1_1c836022-2650-4584-931f-f6de1eafb967"
      unitRef="usd">4356000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzEtMTItMS0xLTUxOTM1_7c3e59fa-100e-4efe-aa4c-84c7db0afe9e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMi0xLTEtNTE5MzU_5120149e-cb09-426d-84ff-079839226c67"
      unitRef="usd">621000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItNC0xLTEtNTE5MzU_f88dd4da-b0c8-40e5-b55e-015b981d0a0d"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItNi0xLTEtNTE5MzU_b98bd33e-4da6-4bce-8f51-06bc1dfbf99a"
      unitRef="usd">419000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItOC0xLTEtNTE5MzU_0caa2520-156c-431b-b619-98b43f1a56b5"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMTAtMS0xLTUxOTM1_702c6c1b-c5f8-443f-8421-2d1011480731"
      unitRef="usd">315000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzItMTItMS0xLTUxOTM1_1c3cf8c3-c078-4f12-8779-041c20c0808b"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMi0xLTEtNTE5MzU_e4d9e36f-32fb-44d1-af78-22a7002d75ab"
      unitRef="usd">-110000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtNC0xLTEtNTE5MzU_d90ebddd-c269-4d29-9fe6-c6c70bb5b1b9"
      unitRef="number">-0.004</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtNi0xLTEtNTE5MzU_484984ca-2768-4421-8f8a-d787531714c4"
      unitRef="usd">-100000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtOC0xLTEtNTE5MzU_16a453e6-0956-42f4-a6c4-c0b5931e07ea"
      unitRef="number">-0.004</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMTAtMS0xLTUxOTM1_86b856d6-290a-4fe4-a82e-5ffb6abae8ba"
      unitRef="usd">-130000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzMtMTItMS0xLTUxOTM1_519c9309-6373-400f-a682-f6d923b1c157"
      unitRef="number">-0.006</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMi0xLTEtNTE5MzU_f65676e8-2a5a-4e68-b5b8-11add98917bf"
      unitRef="usd">150000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtNC0xLTEtNTE5MzU_803db960-0fa9-4416-a4aa-6dd7fba1a483"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtNi0xLTEtNTE5MzU_0439e714-8b2c-41da-bc85-1c97e533139b"
      unitRef="usd">144000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtOC0xLTEtNTE5MzU_0559966f-9c61-44d0-a896-7a9245953c52"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMTAtMS0xLTUxOTM1_4719fdb8-6c72-4b5c-b11e-39c65530cecb"
      unitRef="usd">134000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzQtMTItMS0xLTUxOTM1_546cd9a4-4499-4ea2-86a7-2ab744c3c727"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMi0xLTEtNTE5MzU_04bb5dd1-b1d0-4d3a-b395-e192e1ee69dd"
      unitRef="usd">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtNC0xLTEtNTE5MzU_544b7792-e497-4e88-994a-dabd5527a00d"
      unitRef="number">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtNi0xLTEtNTE5MzU_60ae6c7a-1a26-4f3c-a4c8-9135fc6f1b3b"
      unitRef="usd">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtOC0xLTEtNTE5MzU_0f32643b-d06e-4dfa-9d23-afd8d532f556"
      unitRef="number">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMTAtMS0xLTUxOTM1_89cd01a6-4343-4606-b9af-7b1616c46489"
      unitRef="usd">626000000</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzUtMTItMS0xLTUxOTM1_46da3248-cd24-4ac6-9e6e-25a2e165dc19"
      unitRef="number">0.030</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMi0xLTEtNTE5MzU_079a1064-bf87-49ac-993c-335f0220dc33"
      unitRef="usd">-265000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtNC0xLTEtNTE5MzU_93cad0fd-978c-482e-ab32-b7847c9d64ea"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtNi0xLTEtNTE5MzU_4d1faa24-aee1-42b4-a52a-f98bf38907ab"
      unitRef="usd">-246000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtOC0xLTEtNTE5MzU_0599e90c-ddad-4e21-9954-c429ad47d109"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMTAtMS0xLTUxOTM1_175217a6-94ce-4eb8-b37d-44d40830d046"
      unitRef="usd">-164000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzYtMTItMS0xLTUxOTM1_758c63bf-5fe7-4001-84b8-99666b99420e"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMi0xLTEtNTE5MzU_e9c9b6ab-df19-4af9-b9d0-6085aa6b3148"
      unitRef="usd">-224000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctNC0xLTEtNTE5MzU_820f2573-6139-4b20-9f2c-ce5742efbe8a"
      unitRef="number">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctNi0xLTEtNTE5MzU_b217102a-e79c-44b4-be59-7e43a896af95"
      unitRef="usd">-324000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctOC0xLTEtNTE5MzU_03b30b90-4677-4fd3-9b86-8c42b131ab95"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMTAtMS0xLTUxOTM1_327020e6-c9d4-4589-b083-aa286806fa9e"
      unitRef="usd">-164000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzctMTItMS0xLTUxOTM1_f67563f1-5886-413d-aaa5-0cef980352e5"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMi0xLTEtNTE5MzU_aec365e6-dbf4-480a-a574-2d0ef62cd9fe"
      unitRef="usd">5704000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtNC0xLTEtNTE5MzU_b58a1dc4-7aa9-4626-bc89-bfbf47edf3c2"
      unitRef="number">0.217</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtNi0xLTEtNTE5MzU_a7d1c245-f101-47b1-8863-0f7c003ceaba"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtOC0xLTEtNTE5MzU_87074e59-eead-4d25-aeaa-59818d294be8"
      unitRef="number">0.205</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMTAtMS0xLTUxOTM1_1811b6d7-ce33-4461-af30-703931541e97"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTo5NjI5YzgwZGU2MjY0MTY4OTNlODE3OTUzYmU1MGZjMy90YWJsZXJhbmdlOjk2MjljODBkZTYyNjQxNjg5M2U4MTc5NTNiZTUwZmMzXzgtMTItMS0xLTUxOTM1_ee93aa4d-ecef-4568-918e-efcb15dbe014"
      unitRef="number">0.240</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzOTY_15bf3689-81f5-42e6-8768-65e9212a0034">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. tax loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Net unrealized losses on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-domestic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis in partnerships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzItMi0xLTEtNTE5MzU_012e687a-e0e5-42e7-a7c3-1ddc5b962d44"
      unitRef="usd">707000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzItNC0xLTEtNTE5MzU_529e87b9-89ae-4bdb-957e-66cd40132daf"
      unitRef="usd">723000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzMtMi0xLTEtNTE5MzU_981683d1-c057-4007-8a31-ecc426c9d7e5"
      unitRef="usd">540000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzMtNC0xLTEtNTE5MzU_7ea6537a-962f-45fc-9a88-d86d1a790347"
      unitRef="usd">287000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzQtMi0xLTEtNTE5MzU_1bfc9ff7-c7ef-4ed3-a9cc-f24d8ad3e358"
      unitRef="usd">154000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzQtNC0xLTEtNTE5MzU_e5e9ad11-da02-4c9c-a651-22754cb14934"
      unitRef="usd">117000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzUtMi0xLTEtNTE5MzU_a8d35169-6e17-47a0-a5c1-f82757dd59c7"
      unitRef="usd">341000000</unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities>
    <unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzUtNC0xLTEtNTE5MzU_0e795eda-def6-4dd0-be64-31004f437f5d"
      unitRef="usd">296000000</unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzYtMi0xLTEtNTE5MzU_b0ea3f4e-0dae-4b85-8146-a3c3f3a3af9b"
      unitRef="usd">631000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzYtNC0xLTEtNTE5MzU_3f1983f1-a7b5-437a-9cd6-ee6288bc2904"
      unitRef="usd">435000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <unh:DeferredTaxAssetsLeaseLiability
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzctMi0xLTEtNTE5MzU_e79248ca-2687-4b74-8193-9ce626e8f73d"
      unitRef="usd">972000000</unh:DeferredTaxAssetsLeaseLiability>
    <unh:DeferredTaxAssetsLeaseLiability
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzctNC0xLTEtNTE5MzU_2fbd8145-5290-4575-83d3-d142ff2fbc7d"
      unitRef="usd">1284000000</unh:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtMi0xLTEtNTk3MDc_e1bab5b7-802e-473b-a5f0-d7de7e2bdb7f"
      unitRef="usd">829000000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtNC0xLTEtNTk3MDc_98aa30f3-e49f-4c2b-a331-9776f3a28a83"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInvestments>
    <unh:DeferredTaxAssetOtherDomestic
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtMi0xLTEtNTE5MzU_38c04ade-9b82-4565-83cf-9e3e7c93b90d"
      unitRef="usd">291000000</unh:DeferredTaxAssetOtherDomestic>
    <unh:DeferredTaxAssetOtherDomestic
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzgtNC0xLTEtNTE5MzU_b87e5576-4733-4c33-820e-a53f5a324661"
      unitRef="usd">228000000</unh:DeferredTaxAssetOtherDomestic>
    <unh:DeferredTaxAssetOtherForeign
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzktMi0xLTEtNTE5MzU_637d821d-72c8-4fff-8e78-1f1d7e9f138c"
      unitRef="usd">423000000</unh:DeferredTaxAssetOtherForeign>
    <unh:DeferredTaxAssetOtherForeign
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzktNC0xLTEtNTE5MzU_50e98110-88bd-47d9-8d98-f2dfd72a2f21"
      unitRef="usd">376000000</unh:DeferredTaxAssetOtherForeign>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEwLTItMS0xLTUxOTM1_60c29908-24f1-476c-87b6-b3a08ef007a9"
      unitRef="usd">4888000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEwLTQtMS0xLTUxOTM1_a60ad6b3-465f-493c-896f-24b5ec6f73cd"
      unitRef="usd">3746000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzExLTItMS0xLTUxOTM1_7837d86d-4ee9-43ea-a5bf-14645cc56990"
      unitRef="usd">291000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzExLTQtMS0xLTUxOTM1_2905866b-389a-4cb2-b774-620ed10550a1"
      unitRef="usd">198000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEyLTItMS0xLTUxOTM1_d0de641a-8b0e-4939-99aa-f04a7b2fd37c"
      unitRef="usd">4597000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzEyLTQtMS0xLTUxOTM1_edc119ea-37c6-4fe1-b0a7-2031f84e7915"
      unitRef="usd">3548000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE0LTItMS0xLTUxOTM1_d44b3d21-4380-4c46-9108-6f4e0c67eee2"
      unitRef="usd">3520000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE0LTQtMS0xLTUxOTM1_09c463ca-fe2d-4c9f-b7bd-f6c8f03bbfa2"
      unitRef="usd">2658000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE1LTItMS0xLTUxOTM1_e7d37eb1-d879-43df-8e26-4e53b9d7a398"
      unitRef="usd">550000000</unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign>
    <unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE1LTQtMS0xLTUxOTM1_72df2548-cbad-4dcb-993a-a27e92d9cae4"
      unitRef="usd">512000000</unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE2LTItMS0xLTUxOTM1_408a6436-2b76-4f81-b64e-58de09bf375f"
      unitRef="usd">548000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE2LTQtMS0xLTUxOTM1_12844cbf-78b5-444e-9868-44bc36885fc1"
      unitRef="usd">833000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE3LTItMS0xLTUxOTM1_897db44c-ea53-4d90-bef9-07f45f5855e0"
      unitRef="usd">520000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE3LTQtMS0xLTUxOTM1_6b64cdd3-3051-40b2-a937-a5af47dd05ef"
      unitRef="usd">349000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE4LTItMS0xLTUxOTM1_a2193f58-1fb9-41f8-901b-23cc11794c04"
      unitRef="usd">275000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE4LTQtMS0xLTUxOTM1_e2d8c2cb-b044-44cf-83b1-50861ef8e333"
      unitRef="usd">256000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE5LTItMS0xLTUxOTM1_eeb284cf-1567-409b-87f5-e1e15136f2a2"
      unitRef="usd">653000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzE5LTQtMS0xLTUxOTM1_7fc410f9-164b-4998-8038-4b2ca3e18164"
      unitRef="usd">565000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIwLTItMS0xLTUxOTM1_2e4e3c58-a9a8-4893-867a-4b6910ffd3e8"
      unitRef="usd">958000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIwLTQtMS0xLTUxOTM1_559bd7e0-98aa-411b-97fb-f30716ccc794"
      unitRef="usd">1267000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <unh:DeferredTaxLiabilityOtherDomestic
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIxLTItMS0xLTUxOTM1_a5321969-534a-47ce-903a-21989b381a3b"
      unitRef="usd">0</unh:DeferredTaxLiabilityOtherDomestic>
    <unh:DeferredTaxLiabilityOtherDomestic
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIxLTQtMS0xLTUxOTM1_90f71bdb-3a96-4b47-90ac-13a73fa4c49a"
      unitRef="usd">125000000</unh:DeferredTaxLiabilityOtherDomestic>
    <unh:DeferredTaxLiabilityOtherForeign
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIyLTItMS0xLTUxOTM1_0425cac8-fcd3-4707-965a-b1a853015ae0"
      unitRef="usd">342000000</unh:DeferredTaxLiabilityOtherForeign>
    <unh:DeferredTaxLiabilityOtherForeign
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIyLTQtMS0xLTUxOTM1_c82ff1f8-15f3-45d1-ae72-93398c830cfc"
      unitRef="usd">248000000</unh:DeferredTaxLiabilityOtherForeign>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIzLTItMS0xLTUxOTM1_10296831-57b4-43fa-b527-474bfc9f8033"
      unitRef="usd">7366000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzIzLTQtMS0xLTUxOTM1_37421117-e07e-464c-8bd9-d0e18645a4c1"
      unitRef="usd">6813000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzI0LTItMS0xLTUxOTM1_d588c533-8684-4447-b9a1-67a58d9e43b1"
      unitRef="usd">2769000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTpiMjZjZjExZmU4YWU0MzdmYmIwYzU1MWNmYzZlNTU5NS90YWJsZXJhbmdlOmIyNmNmMTFmZThhZTQzN2ZiYjBjNTUxY2ZjNmU1NTk1XzI0LTQtMS0xLTUxOTM1_ef988cf9-62e5-4ee4-b4d3-907bf276fc6a"
      unitRef="usd">3265000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1da65d71f0dd4e81aa84de4084ebc16a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzEzMDA_d2fe5966-ecee-4793-96b7-4b38265adbe9"
      unitRef="usd">490000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if899e2bbae2a4cdcaba077976895f315_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzEzNDU_fa16c2a4-9295-4761-aeb4-9c11f34f76b9"
      unitRef="usd">611000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNzc_c3e38837-c3b9-4962-83b8-bd2a99f51580">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitations lapses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtMi0xLTEtNTE5MzU_7d8613b7-41de-432d-8569-4a11b56081e8"
      unitRef="usd">2310000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtNC0xLTEtNTE5MzU_fb7c1bbe-6cf9-48b8-bd6e-839b97f37b14"
      unitRef="usd">1829000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib659d7c82a274ea4ac648525c4eb7212_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzEtNi0xLTEtNTE5MzU_ca4004c5-67b8-498b-b504-7a965da9f507"
      unitRef="usd">1423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtMi0xLTEtNTE5MzU_d556508a-bd90-4460-8d0a-6079622a3a40"
      unitRef="usd">586000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtNC0xLTEtNTE5MzU_243e420d-def5-42ff-8ee3-68902d039298"
      unitRef="usd">538000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzMtNi0xLTEtNTE5MzU_071efbf0-f99d-435e-b377-ffb335f881ff"
      unitRef="usd">416000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtMi0xLTEtNTE5MzU_20d7e328-bf34-47c2-a528-aca145ca4fa4"
      unitRef="usd">206000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtNC0xLTEtNTE5MzU_11b3da8f-6a98-464f-b64a-4af3996f2b1d"
      unitRef="usd">10000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzQtNi0xLTEtNTE5MzU_a0d8414e-cb70-4445-853f-316802beb089"
      unitRef="usd">120000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtMi0xLTEtNTE5MzU_c5eef640-3dd0-47da-b1c7-29fa4b0c0e84"
      unitRef="usd">21000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtNC0xLTEtNTE5MzU_947be618-7b0a-44eb-aa9b-9d78afeb1422"
      unitRef="usd">47000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzYtNi0xLTEtNTE5MzU_2f37442b-0e87-4b46-aeb2-ac07d7e4a174"
      unitRef="usd">130000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtMi0xLTEtNTE5MzU_a4759f54-359f-44bd-94c8-a4f131f02aff"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtNC0xLTEtNTE5MzU_3f1df1c8-8773-4dfc-87a3-cc08acf7ff3c"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzgtNi0xLTEtNTE5MzU_e929a464-89d8-4297-92a2-560150ccd2e1"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktMi0xLTEtNTE5MzU_a2c4f2ac-d08a-423e-a774-fe19789a38f2"
      unitRef="usd">3081000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktNC0xLTEtNTE5MzU_cb0bfb6d-5ee9-4103-a60c-31f26a15a3c4"
      unitRef="usd">2310000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90YWJsZTplZjBkMWY3YmIzYmQ0NGM1YWUxYWE1NGZmZjM5OGI5MS90YWJsZXJhbmdlOmVmMGQxZjdiYjNiZDQ0YzVhZTFhYTU0ZmZmMzk4YjkxXzktNi0xLTEtNTE5MzU_1acb0782-a9f2-4a18-818d-bc5319ad8d02"
      unitRef="usd">1829000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzIxMzA_953ac070-358a-4f7d-9e45-90ebba92b489"
      unitRef="usd">260000000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0Mzc_8079ce31-cf4a-428f-abd2-f293fb1e238c"
      unitRef="usd">64000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0NDE_30b62149-91fb-40ba-9ca1-7bac8ea0b9ad"
      unitRef="usd">66000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI0NDg_6859362c-9aa6-45ba-9b4b-e0cab1ed5594"
      unitRef="usd">52000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI1MTI_21d3e0b1-5bf2-4448-879f-6c7fd64c0699"
      unitRef="usd">253000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI1MTk_9fe18520-aa3f-474b-b28d-17f4111e9109"
      unitRef="usd">194000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzI2OTY_7516e5e8-ca78-44dd-a368-3b14e393464b"
      unitRef="usd">1700000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:OpenTaxYear
      contextRef="ic5c9d65022cf4f9fac1f1bf7c205a420_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMwNjA_508c77c5-15ac-40b4-b08f-f0f87e96e2e2">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i8918e2ed87fb4f4987dfba8e50d897f5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMwNzE_cd69f7b9-195a-4b13-8c92-1e83e7e46879">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="idec27badcb0040c193fecdd2c470c893_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMyNjE_7847cd2c-e2e9-414e-8a19-4d94ce360902">2014</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i10213ff0021745a28cd943688e293bc1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTAvZnJhZzpiNTVkZGI2MmY1YmI0YWI5OWVjMWUwN2NlN2I2NDc2Ni90ZXh0cmVnaW9uOmI1NWRkYjYyZjViYjRhYjk5ZWMxZTA3Y2U3YjY0NzY2XzMzNjA_06e8d468-fd91-440a-8482-fb4766bc21f8">2015</us-gaap:OpenTaxYear>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0MjE_5de072b2-f8b2-4357-893b-7f18b2533f34">Shareholders' Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Capital and Dividend Restrictions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s regulated insurance and HMO subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the NAIC. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#x2019;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#x201c;ordinary dividends&#x201d; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#x201c;extraordinary dividend&#x201d; and must receive prior regulatory approval. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2022, the Company&#x2019;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.8 billion, including $7.4 billion of extraordinary dividends. For the year ended December&#160;31, 2021, the Company&#x2019;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.0 billion, including $4.7 billion of extraordinary dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $33.8 billion as of December&#160;31, 2022. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $15.4 billion as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Optum Bank must meet minimum capital requirements of the FDIC under the capital adequacy rules to which it is subject. At December&#160;31, 2022, the Company believes Optum Bank met the FDIC requirements to be considered &#x201c;Well Capitalized.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under its Board of Directors&#x2019; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#x2019;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain restrictions. In June 2018, the Board of Directors renewed the Company&#x2019;s share repurchase program with an authorization to repurchase up to 100 million shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common share repurchases for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Board authorized shares remaining&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company&#x2019;s Board of Directors increased the Company&#x2019;s quarterly cash dividend to shareholders to an annual rate of $6.60 compared to $5.80 per share, which the Company had paid since June 2021. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company&#x2019;s 2022 dividend payments:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE0MzI_517715e5-37fd-47ae-a9d0-ccdfa7cc7181"
      unitRef="usd">8800000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i6047cb915ab94ef08b29f7f33d60fce9_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE0NDY_6b9fecf6-88ef-4fba-8df4-4e0760f1843c"
      unitRef="usd">7400000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE1OTU_2af5aedf-9208-4313-9928-07c609bf8ba1"
      unitRef="usd">8000000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i7c30621aa864465bb27533b234d6d21f_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE2MDk_37ddc447-d94a-4978-a46e-a306d2f45ecf"
      unitRef="usd">4700000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE3NTM_3dd81fb3-4805-4bd6-964d-0dbdd8805460"
      unitRef="usd">33800000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzE5MzI_2713fd21-56bf-4e33-bede-69c7d64c706f"
      unitRef="usd">15400000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i725ab79c24d84374a71ef19f38657b54_I20180601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzI4NjA_c2213320-29bf-415a-9768-c96ed97d923e"
      unitRef="shares">100000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0MjM_9b54b438-cc69-4bc3-887b-4f866342f6d8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common share repurchases for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Board authorized shares remaining&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzItNC0xLTEtNTE5MzU_89d4c2d7-ae61-451b-99a0-f89831519099"
      unitRef="shares">14000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzItNi0xLTEtNTE5MzU_a1e2ea33-62c1-4ac6-bd54-f0bb6ea1392c"
      unitRef="shares">13000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzMtNC0xLTEtNTE5MzU_524c05a2-e4f9-44eb-9522-f2aee4d9248c"
      unitRef="usdPerShare">501.67</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzMtNi0xLTEtNTE5MzU_cfcdc272-cc40-4220-86ea-edd63cd237d4"
      unitRef="usdPerShare">389.92</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzQtNC0xLTEtNTE5MzU_183b71b1-995b-42f5-8912-a145a5807b9b"
      unitRef="usd">7000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzQtNi0xLTEtNTE5MzU_c61d165a-df67-4829-b04c-5055d038e04d"
      unitRef="usd">5000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzUtNC0xLTEtNTE5MzU_57b314a7-e6b8-469c-b49c-d5b05cdc7e47"
      unitRef="shares">31000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTpkZWJiYTYwMTQ4NGM0MjgzYjk1MTYzOTcxYmNhYzcwMy90YWJsZXJhbmdlOmRlYmJhNjAxNDg0YzQyODNiOTUxNjM5NzFiY2FjNzAzXzUtNi0xLTEtNTE5MzU_8f4bc3f7-db73-46f6-b970-cf581ed3951d"
      unitRef="shares">45000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90ZXh0cmVnaW9uOmVhZWRkY2MyYzBmNjRkNjY5MmU5NWVhYzgyYjc2NjhlXzM0Mzg_b51856e8-51f4-441b-9c3d-a3c4bc3782e3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company&#x2019;s 2022 dividend payments:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzItMi0xLTEtNTE5MzU_456cc796-a75b-473a-8ad3-7c9047e7c542"
      unitRef="usdPerShare">1.45</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i8fc88c4a62db4d68a89f750a974dc792_D20220322-20220322"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzItNC0xLTEtNTE5MzU_78291d3d-7d02-404e-a81c-bc3e23e62013"
      unitRef="usd">1363000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzMtMi0xLTEtNTE5MzU_854f10e8-98ef-4aba-9fc4-c74f1e749f4f"
      unitRef="usdPerShare">1.65</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i88c2f74baf9140e680b91ddeeab9c086_D20220628-20220628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzMtNC0xLTEtNTE5MzU_5430380e-7b2a-4b15-91ca-0562ed1b9a33"
      unitRef="usd">1545000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzQtMi0xLTEtNTE5MzU_11c7dda8-5f6f-4e31-b2ff-937df788305c"
      unitRef="usdPerShare">1.65</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i7d1a5dbb0dd4437abb3eb1e44a6d9bcc_D20220920-20220920"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzQtNC0xLTEtNTE5MzU_807b4988-51bd-477c-88ee-3fbd16be3ae5"
      unitRef="usd">1542000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iab961e9490f040f8918f115ab2c74510_D20221213-20221213"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzUtMi0xLTEtNTE5MzU_14084934-d40b-4b25-9fc9-6a45bb725252"
      unitRef="usdPerShare">1.65</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iab961e9490f040f8918f115ab2c74510_D20221213-20221213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18xOTYvZnJhZzplYWVkZGNjMmMwZjY0ZDY2OTJlOTVlYWM4MmI3NjY4ZS90YWJsZTo2ZGY5YmY1MGZlNTQ0NzMyOTg2NTM5NDc1YTk3MTFkMC90YWJsZXJhbmdlOjZkZjliZjUwZmU1NDQ3MzI5ODY1Mzk0NzVhOTcxMWQwXzUtNC0xLTEtNTE5MzU_46fadce5-0cde-4fd7-997c-84c55db84c17"
      unitRef="usd">1541000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNTQ_39c4902e-8109-452c-bddb-ecdc9ebcb184">Share-Based Compensation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2022, the Company had 59 million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. As of December&#160;31, 2022, there were 18&#160;million shares of common stock available for issuance under the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the year ended December&#160;31, 2022 is summarized in the table below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share activity for the year ended December&#160;31, 2022 is summarized in the table below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Share-Based Compensation Data&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of stock options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of restricted shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share-Based Compensation Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit realized from share-based award exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation expense related to share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average years to recognize compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Recognition and Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9% - 4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2% - 1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.6% -30.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2% - 29.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2% - 29.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#x2019;s common stock and the implied volatility from exchange-traded options on the Company&#x2019;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Employee Benefit Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $1.6 billion and $1.8 billion as of December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzE3NA_532853e2-4c97-404b-a9b3-17dc292d7527"
      unitRef="shares">59000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i5a9c77c9d2b940b8b4fb2feac66444f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzM3OQ_cdadab9d-7ff8-4a59-b960-6c34b88baa16"
      unitRef="shares">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNzk_1efcf76b-a2b7-43dd-b08e-5e1c83cd8bac">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the year ended December&#160;31, 2022 is summarized in the table below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzItMS0xLTEtNTE5MzU_a8ad653b-2dd8-4409-97c0-15bab4484572"
      unitRef="shares">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzItMy0xLTEtNTE5MzU_fd30e70b-86ef-4c47-a20b-dac811500385"
      unitRef="usdPerShare">241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzMtMS0xLTEtNTE5MzU_854bd3ca-0521-49e7-9ebf-7897c9e94fdf"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzMtMy0xLTEtNTE5MzU_1fb89f33-43fc-432b-9aaf-78dac95ab20a"
      unitRef="usdPerShare">459</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzQtMS0xLTEtNTE5MzU_489d84bf-089d-4267-b38b-46cf5c2a525a"
      unitRef="shares">5000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzQtMy0xLTEtNTE5MzU_4ba17797-b82c-4d33-a9e6-b293e1344e5f"
      unitRef="usdPerShare">215</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzUtMS0xLTEtNTE5MzU_59603094-874b-4cf1-9d39-f4b222fba8c1"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzUtMy0xLTEtNTE5MzU_12f2c787-1fe3-4393-83dd-09d144618fb1"
      unitRef="usdPerShare">356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtMS0xLTEtNTE5MzU_f2f9edc2-3e4f-436e-9ef4-b3d200bde893"
      unitRef="shares">23000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtMy0xLTEtNTE5MzU_6154c365-7eb7-4f1f-80ec-5c226d6c01bf"
      unitRef="usdPerShare">281</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzYtNy0xLTEtNTE5MzU_bf6a0b84-08fc-482a-ab00-a8144a4492af"
      unitRef="usd">5914000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctMS0xLTEtNTE5MzU_d693e0dd-62c8-425d-b4ca-decff2cca803"
      unitRef="shares">13000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctMy0xLTEtNTE5MzU_73eecb86-f000-44d3-87ad-0516ed8548ee"
      unitRef="usdPerShare">213</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzctNy0xLTEtNTE5MzU_18109026-576e-4e8b-ac7b-7f13c9b677e1"
      unitRef="usd">4170000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtMS0xLTEtNTE5MzU_740821ca-7668-4911-ad2e-f88621b0a028"
      unitRef="shares">23000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtMy0xLTEtNTE5MzU_74d6373d-8162-4d5d-9ad7-b8d2784f8279"
      unitRef="usdPerShare">278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2ZGYxMzEzZTJhZTc0YTRmYjRhMzQwNjY3MDI4M2Q2Yi90YWJsZXJhbmdlOjZkZjEzMTNlMmFlNzRhNGZiNGEzNDA2NjcwMjgzZDZiXzgtNy0xLTEtNTE5MzU_55347001-da2f-45a3-b1c4-7c3828abd04c"
      unitRef="usd">5854000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNDg_def339d9-1db0-4a2d-b9bd-5e1b7525146a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share activity for the year ended December&#160;31, 2022 is summarized in the table below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4cab9cb169cd4921a81a836726f5c3e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzEtMi0xLTEtNTE5MzU_7f13c148-3648-42c6-8a31-1a3cb7540c31"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4cab9cb169cd4921a81a836726f5c3e9_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzEtNC0xLTEtNTE5MzU_a8df50cc-9626-492d-b044-d22a6c1febef"
      unitRef="usdPerShare">303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzItMi0xLTEtNTE5MzU_07cac772-6242-4576-8ab0-df90c5dc3aca"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzItNC0xLTEtNTE5MzU_6be32d88-dc74-456d-a3a2-be71cba2c3f8"
      unitRef="usdPerShare">483</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzMtMi0xLTEtNTE5MzU_cdfbc64b-4454-4114-a7b8-725cc6baee60"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i54a5693b6062450e8cf28c32bce81028_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzMtNC0xLTEtNTE5MzU_3d954e48-4ebe-4468-b46a-ad32b63426b7"
      unitRef="usdPerShare">287</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzQtMi0xLTEtNTE5MzU_fa187cc9-5caf-4bf7-820c-e6723c4b3cc0"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8dbe71b69ba04f7f9cabd20188e62c9d_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo2NDgzYWRiZWRmZTQ0YjRjOGEzYzRiYzY5NzI1MjY2ZS90YWJsZXJhbmdlOjY0ODNhZGJlZGZlNDRiNGM4YTNjNGJjNjk3MjUyNjZlXzQtNC0xLTEtNTE5MzU_bb7ec6ce-732e-4a06-b067-d38fdcc143ed"
      unitRef="usdPerShare">401</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxODA_1b2c71e8-2064-4140-9838-0d45c29cb9ab">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Share-Based Compensation Data&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of stock options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of restricted shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share-Based Compensation Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit realized from share-based award exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation expense related to share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average years to recognize compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtMi0xLTEtNTE5MzU_f59aa0ff-e39d-430b-befd-a6bccddb48d1"
      unitRef="usdPerShare">116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtNC0xLTEtNTE5MzU_8aeda680-925f-4d68-8252-4914d5733ae6"
      unitRef="usdPerShare">71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzMtNi0xLTEtNTE5MzU_e6828db7-f269-4337-924c-7580fa85652b"
      unitRef="usdPerShare">54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="icf2116900a0f43f39a0dde10681a10cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtMi0xLTEtNTE5MzU_6f3fa73c-0a28-4a89-a6a6-3d94e9ded9b6"
      unitRef="usd">1419000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i37ac1e2974f14a249ae5f0a3bc2eafcb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtNC0xLTEtNTE5MzU_9c697f6b-8913-4dbe-bc78-3df1868ff4dc"
      unitRef="usd">1519000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1e2831a343ed4b5681194bd077cfcfc9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzQtNi0xLTEtNTE5MzU_d25928f7-e135-48a0-936d-e63d39aed0a4"
      unitRef="usd">1736000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id58b7079211c4824b326bc35e2a79767_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtMi0xLTEtNTE5MzU_3c236cdb-6510-46f6-988c-c824f351645e"
      unitRef="usdPerShare">483</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i377663e135b146dbb9746caf29f61b57_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtNC0xLTEtNTE5MzU_811573ef-b362-4c7f-97c8-6b78e1f0f324"
      unitRef="usdPerShare">352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzYtNi0xLTEtNTE5MzU_6518f63a-73e7-4d09-96a8-f3a757a34853"
      unitRef="usdPerShare">303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id58b7079211c4824b326bc35e2a79767_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctMi0xLTEtNTE5MzU_f0291ddc-c8af-469b-80fa-1642be05c213"
      unitRef="usd">760000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i377663e135b146dbb9746caf29f61b57_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctNC0xLTEtNTE5MzU_07caaaa6-7cdb-4616-9243-deca53c49f92"
      unitRef="usd">560000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i80d83ea7f53b4d8a80d31f034029e73d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzctNi0xLTEtNTE5MzU_486a5333-ae18-4cf5-9fbb-8c116af7e304"
      unitRef="usd">574000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia35a7d1ed98245a4859a82517f4d3fbe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktMi0xLTEtNTE5MzU_b0f569eb-31bd-4a6c-b90a-1e6a3e0480f4"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idc90f35441624e0781cac8a40b7b7e81_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktNC0xLTEtNTE5MzU_498ccb92-42c1-4bd7-8c0c-ba7b6b6396e6"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i42347a2d22d847debe1ed99a8365998d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzktNi0xLTEtNTE5MzU_fdf36365-792d-42e1-9c25-ed7544c39ab8"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensation
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTItMS0xLTUxOTM1_44f74d4b-ea22-4dd3-8cd3-89108c610d8b"
      unitRef="usd">925000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTQtMS0xLTUxOTM1_f374f1db-b21c-49cf-907c-e06809840654"
      unitRef="usd">800000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzExLTYtMS0xLTUxOTM1_7a02dbb4-5b25-4291-989f-1e0c481b114c"
      unitRef="usd">679000000</us-gaap:ShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTItMS0xLTUxOTM1_04bb86d7-748f-4ba9-a666-e8c05c6c92ac"
      unitRef="usd">836000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTQtMS0xLTUxOTM1_5a435ee4-ec46-4de9-8e59-bf5d3eaafa35"
      unitRef="usd">719000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEyLTYtMS0xLTUxOTM1_34aae59f-0ee5-48ac-86db-56b74764d947"
      unitRef="usd">619000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTItMS0xLTUxOTM1_cfda2b91-8129-41c4-8eab-bf4720acc7cf"
      unitRef="usd">207000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTQtMS0xLTUxOTM1_42eea138-bfcf-4765-9fe0-1bb0ef94d747"
      unitRef="usd">173000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTowMzE0NWEyNDljZDk0OTBhYjIzYWVkYWFhMDEwNzA1NS90YWJsZXJhbmdlOjAzMTQ1YTI0OWNkOTQ5MGFiMjNhZWRhYWEwMTA3MDU1XzEzLTYtMS0xLTUxOTM1_28c04fe8-c806-4730-90fa-65f9544d8523"
      unitRef="usd">208000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTphNDVmNTBkOTQ3MGI0YTA5YjgzMjQwMGQwMzY2ZTMyNy90YWJsZXJhbmdlOmE0NWY1MGQ5NDcwYjRhMDliODMyNDAwZDAzNjZlMzI3XzEtMi0xLTEtNTE5MzU_9117be9a-01c5-4502-beae-860699c6158b"
      unitRef="usd">1165000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxNzA_8cccc953-0a95-4344-a6f6-b84998da00ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9% - 4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2% - 1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.6% -30.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2% - 29.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2% - 29.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtMi0xLTEtNTE5MzU_96af3b84-0329-4c6c-9e8c-07fbd77e9033"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtNC0xLTEtNTE5MzU_835b0e65-877d-431a-9028-344e87996095"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90YWJsZTo1YTQ1ZDkwNDgyYTg0N2MzODk5MmRiMjI3Y2ViMTkzYi90YWJsZXJhbmdlOjVhNDVkOTA0ODJhODQ3YzM4OTkyZGIyMjdjZWIxOTNiXzUtNi0xLTEtNTE5MzU_a38db8ca-1bad-4615-bb43-fde027ce8580"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIwOTM_07c15353-03c4-445f-8587-853f345ee198"
      unitRef="usd">1600000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDIvZnJhZzo3YTdkZWJiYTMxZjQ0MTc4YWUyYmNmZWQ1M2I3MWEzZi90ZXh0cmVnaW9uOjdhN2RlYmJhMzFmNDQxNzhhZTJiY2ZlZDUzYjcxYTNmXzIxMDA_8bd6ffa9-797f-4de4-8d1c-ba1d67badb11"
      unitRef="usd">1800000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU1MTc_9b2f2c73-c692-4ea1-b2e1-6336c811a124">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease costs, including immaterial variable and short-term lease costs, were $1.3 billion, $1.2 billion and $1.1 billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. Cash payments made on the Company&#x2019;s operating lease liabilities were $996 million, $921 million and $865&#160;million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2022, the Company&#x2019;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were 8.6 years and 3.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, future minimum annual lease payments under all non-cancelable operating leases were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pending Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company has entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $9&#160;billion. The Company completed the acquisition of LHC Group, Inc. on February 22, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#x2019;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government Investigations, Audits and Reviews&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, Consumer Financial Protection Bureau, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#x2019;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#x2019;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#x2019;s health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#x2019;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#x2019;s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company&#x2019;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#x2019;s motion for partial summary judgment and dismissed the Company&#x2019;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzcz_b9e03d46-cbef-459e-8ad4-0ab1058ce2fe"
      unitRef="usd">1300000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzc3_502811b2-bb1b-40b8-9d42-afc075577409"
      unitRef="usd">1200000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzg0_4a259e2f-6574-4941-8ff7-dfb3b8cbe04d"
      unitRef="usd">1100000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMyMg_27a74c93-cf88-4122-bb99-791fb04f9e3a"
      unitRef="usd">996000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMyNg_7c8e8420-6da7-4050-9e00-5b9586493aa6"
      unitRef="usd">921000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzMzMw_fe3a90a6-09a2-4c4b-abe0-be72d0a29f0b"
      unitRef="usd">865000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzYxMg_3a7204e8-6c62-4c31-a498-32b227f08c7e">P8Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzYxOQ_c1b7e37f-6117-48a3-a2b9-b7a6822efacf"
      unitRef="number">0.034</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU1MDY_d38830be-cdaa-49b7-b207-46d7047b9a25">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, future minimum annual lease payments under all non-cancelable operating leases were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzEtMi0xLTEtNTE5MzU_dd457a1c-a0e9-434e-8f05-8a329be55f61"
      unitRef="usd">997000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzItMi0xLTEtNTE5MzU_99504ca4-7aad-46d4-bfb6-06b033a0e826"
      unitRef="usd">858000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzMtMi0xLTEtNTE5MzU_e447f4a4-e1d8-4207-9056-836e4910188b"
      unitRef="usd">702000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzQtMi0xLTEtNTE5MzU_f14f3acf-f63a-457a-aec6-5bac69227250"
      unitRef="usd">578000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzUtMi0xLTEtNTE5MzU_a632bc16-8159-4f6c-b702-ecfc3c7f6940"
      unitRef="usd">475000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzYtMi0xLTEtNTE5MzU_671dca26-d60a-4270-81ee-2ee1c730c321"
      unitRef="usd">2028000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzctMi0xLTEtNTE5MzU_e0115685-39ec-4acd-89f4-ee25ee366407"
      unitRef="usd">5638000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzgtMi0xLTEtNTE5MzU_92f8875d-91d5-46f3-ab54-5a472072b8db"
      unitRef="usd">808000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90YWJsZToxMmI2N2I3NjI5OWI0ODM1YTNjM2IxZTVmMzM4ZDc4ZC90YWJsZXJhbmdlOjEyYjY3Yjc2Mjk5YjQ4MzVhM2MzYjFlNWYzMzhkNzhkXzktMi0xLTEtNTE5MzU_8c50359d-03ac-4244-a547-5530bafaaf7f"
      unitRef="usd">4830000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OtherCommitmentsDescription
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzE2NDkyNjc0NDg2NjA_4c64bd71-2ae8-40ce-9959-5f890991c4d8">As of December&#160;31, 2022, the Company has entered into agreements to acquire companies in the health care sector, most notably, LHC Group, Inc. (NASDAQ: LHCG), subject to regulatory approval and other customary closing conditions.</us-gaap:OtherCommitmentsDescription>
    <us-gaap:OtherCommitment
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzE4Njc_e6616d12-8ad4-46cf-9b2c-2cdfd1fa7fe7"
      unitRef="usd">9000000000</us-gaap:OtherCommitment>
    <us-gaap:SubsequentEventDescription
      contextRef="ibccf866bd05a4a2896a41120665646f8_D20230222-20230222"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMDgvZnJhZzoxNzE3ZjA5YmZmZTE0NmEyOTg5MTQ4YzhjNDExZDY0Mi90ZXh0cmVnaW9uOjE3MTdmMDliZmZlMTQ2YTI5ODkxNDhjOGM0MTFkNjQyXzU0OTc1NTgyMDk3NQ_007ba79c-4add-4aff-b251-97dc7b661d52">The Company completed the acquisition of LHC Group, Inc. on February 22, 2023.</us-gaap:SubsequentEventDescription>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYw_aa6dc827-30f7-415e-85a4-768ce54b5e28">Business Combinations&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 3, 2022, the Company acquired all of the outstanding common shares of Change Healthcare Inc. (Change) and funded Change&#x2019;s payoff of its outstanding debt and credit facility for a total of $13.9 billion in cash. The combination of the Company and Change will connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients. Change brings key technologies, connections and advanced clinical decision, administrative and financial support capabilities, enabling better workflow and transactional connectivity across the health care system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to closing and as planned, the Company sold Change&#x2019;s claims editing business to an affiliate of investment funds of TPG Inc. for $2.2 billion in cash. The net assets and net liabilities associated with this sale were classified as held-for-sale at the time of acquisition. There was no gain or loss associated with this transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, the Company completed several other business combinations for total consideration of $8.8 billion. The Company also sold other businesses for $1.2 billion of cash, with a carrying value of $600 million, and the difference reflected in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired assets (liabilities) at acquisition date were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, equipment and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonredeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations and financial condition of acquired entities have been included in the Company&#x2019;s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through December 31, 2022, acquired entities impact on revenues and net earnings was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unaudited pro forma revenues and net earnings for the years ended December 31, 2022 and 2021, as if the business combinations had occurred on January 1, 2021, were immaterial for both periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibf85f3e8a0654801b32e765fe9e7b3c6_D20221003-20221003"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTU3_bd79a0ba-5007-42db-b176-a56882e5baa7"
      unitRef="usd">13900000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i484b05acf027495b8f4198fab7c44136_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTcz_00747611-532d-4266-9c9a-914f393e8026"
      unitRef="usd">2200000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MTg5_dbc7f690-69f4-4760-84f2-955ac7c8ebfd"
      unitRef="usd">8800000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5MjA1_e359e8b6-e002-4786-9e45-033e8fa6538c"
      unitRef="usd">1200000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <unh:CarryingValueOfDisposition
      contextRef="ibcb25a6efec3483493d420e0dd0e0b22_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg5Mjkx_4a2eb3d7-8911-4bba-93d6-184126680c28"
      unitRef="usd">600000000</unh:CarryingValueOfDisposition>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYx_a077bf0f-972f-4574-a056-54c4eb27ef27">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired assets (liabilities) at acquisition date were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, equipment and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonredeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTItMS0xLTU0NzMw_fcb75f7a-cbbd-4625-822c-909dbe4cb290"
      unitRef="usd">222000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTItMS0xLTU0NTk5_a4c75740-a4cc-4cdb-b857-50606eb32c03"
      unitRef="usd">523000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xLTYtMS0xLTU0NzMw_544ca60e-5a51-4d34-abc7-d9a6f67e9baf"
      unitRef="usd">745000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTItMS0xLTU0NzMw_5980089a-47cb-448c-b37b-1935a366f745"
      unitRef="usd">925000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTItMS0xLTU0NTk5_2aa63d9e-4645-4182-bd1b-537e00d55346"
      unitRef="usd">696000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8yLTYtMS0xLTU0NzMw_79eb76b1-715d-4122-8401-39de8b6bb748"
      unitRef="usd">1621000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTItMS0xLTU0NzMw_53c94e68-fb4e-480f-a6b4-8194d39f446b"
      unitRef="usd">2310000000</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTQtMS0xLTU0NzMw_15d30bc3-8adc-4fc0-a5cd-1f9cb4203e29"
      unitRef="usd">0</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTYtMS0xLTU0NzMw_f25e79b5-9b2f-413a-bb9c-22267d4107ef"
      unitRef="usd">2310000000</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTItMS0xLTU0NzMw_6730284b-5e39-44ea-8ca5-2a6285d90221"
      unitRef="usd">254000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8zLTItMS0xLTU0NTk5_c7ce9afc-067a-4298-911a-ee5be973eb00"
      unitRef="usd">1882000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTYtMS0xLTU0NzMw_fb1774e5-b26a-4cf0-899b-6e78fc541a00"
      unitRef="usd">2136000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTItMS0xLTU0NzMw_f66df2a4-5835-4170-9135-b354803ce488"
      unitRef="usd">4050000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV80LTItMS0xLTU0NTk5_ff427ad9-b8b4-486d-acf4-705f0ef25a50"
      unitRef="usd">1764000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTYtMS0xLTU0NzMw_af6d30fc-7cdf-4d8c-9193-b23c805ea230"
      unitRef="usd">5814000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTItMS0xLTU0NzMw_b65cd019-cce1-42c8-95f4-aefa928dc7c9"
      unitRef="usd">7761000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV81LTItMS0xLTU0NTk5_fcad761a-ca4a-4a99-97f7-20dcaa33e876"
      unitRef="usd">4865000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTYtMS0xLTU0NzMw_d64f537e-0bb1-4ad0-bd8f-743aa5e53c89"
      unitRef="usd">12626000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTItMS0xLTU0NzMw_7dee6b54-df98-4c9b-927a-718d27517410"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV82LTItMS0xLTU0NTk5_1e3ee618-48a0-42a0-9e1c-6a6babff413c"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTYtMS0xLTU0NzMw_db468658-37e6-4e22-9903-7f0d570d215e"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTItMS0xLTU0NzMw_c5af988b-ecf8-4777-b07c-858f08ab1776"
      unitRef="usd">1017000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV83LTItMS0xLTU0NTk5_f996b4bb-d789-4f72-83fe-696d453478b2"
      unitRef="usd">843000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTYtMS0xLTU0NzMw_bf2ddd10-010e-413d-bd57-9181a440e845"
      unitRef="usd">1860000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTItMS0xLTU0NzMw_0be12049-cc8c-49f0-b86a-927794e716fa"
      unitRef="usd">101000000</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTQtMS0xLTU0NzMw_62cdf9e4-3afa-4d69-9f32-f955a9858e31"
      unitRef="usd">0</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale>
    <unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTYtMS0xLTU0NzMw_a786b0bb-dc68-4a27-8f29-7f358b474b46"
      unitRef="usd">101000000</unh:BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC0yLTEtMS01NDczMA_a127f914-acf0-41de-bbc1-86714b8c771e"
      unitRef="usd">1193000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV84LTItMS0xLTU0NTk5_473ee1c7-da03-4791-8297-5f9f2be6bbb9"
      unitRef="usd">713000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC02LTEtMS01NDczMA_a63baa2e-d0cb-4d0f-b8c4-e8f679fed5cf"
      unitRef="usd">1906000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS0yLTEtMS01NDczMA_df35af77-4785-4500-a201-a142220e6550"
      unitRef="usd">2311000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV85LTItMS0xLTU0NTk5_2581e394-32f0-42ec-9355-c13b731c6d9b"
      unitRef="usd">1864000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS02LTEtMS01NDczMA_301af435-6251-47eb-9fe6-678007c7a6e9"
      unitRef="usd">4175000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi0yLTEtMS01NDczMA_fc7edaf8-a8b9-4aa2-82d4-0010d55b9929"
      unitRef="usd">5450000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMC0yLTEtMS01NDU5OQ_9e5186b3-5882-4238-a4b4-fef10f7aef4a"
      unitRef="usd">3001000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi02LTEtMS01NDczMA_8a74dbc8-eb68-49b8-998d-713e1361f9c7"
      unitRef="usd">8451000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy0yLTEtMS01NDczMA_e6c8340b-ca7d-4725-afed-9bfa51cca2b5"
      unitRef="usd">8496000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMS0yLTEtMS01NDU5OQ_dde16251-9c01-4407-9e8f-d244c8c39d80"
      unitRef="usd">9214000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy02LTEtMS01NDczMA_ef5cfc1d-24b5-4e6b-b996-e9032205f111"
      unitRef="usd">17710000000</us-gaap:Goodwill>
    <unh:BusinessCombinationsRedeemableNoncontrollingInterests
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC0yLTEtMS01NDczMA_acdb7aeb-9f15-4377-a62f-ce2c67864e1d"
      unitRef="usd">0</unh:BusinessCombinationsRedeemableNoncontrollingInterests>
    <unh:BusinessCombinationsRedeemableNoncontrollingInterests
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMi0yLTEtMS01NDU5OQ_bf1ea063-0457-49ad-8bd7-bb708db72227"
      unitRef="usd">3108000000</unh:BusinessCombinationsRedeemableNoncontrollingInterests>
    <unh:BusinessCombinationsRedeemableNoncontrollingInterests
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC02LTEtMS01NDczMA_2e149c1b-9bce-499d-be5c-0f84490988c7"
      unitRef="usd">3108000000</unh:BusinessCombinationsRedeemableNoncontrollingInterests>
    <unh:BusinessCombinationsNonredeemableNoncontrollingInterests
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNS0yLTEtMS01NDczMA_49674c9f-49be-487d-a8f5-e1c03b5fcdea"
      unitRef="usd">0</unh:BusinessCombinationsNonredeemableNoncontrollingInterests>
    <unh:BusinessCombinationsNonredeemableNoncontrollingInterests
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xMy0yLTEtMS01NDU5OQ_23752e01-d228-4bac-87d4-cb9b80015c26"
      unitRef="usd">370000000</unh:BusinessCombinationsNonredeemableNoncontrollingInterests>
    <unh:BusinessCombinationsNonredeemableNoncontrollingInterests
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNS02LTEtMS01NDczMA_02c89b61-eaca-4447-9e5c-2c506d06f6da"
      unitRef="usd">370000000</unh:BusinessCombinationsNonredeemableNoncontrollingInterests>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i9a80b92c26b04f6bbfece8f78a3b1958_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNi0yLTEtMS01NDczMA_4931b08b-eee4-4c28-9cab-c159df5d91c6"
      unitRef="usd">13946000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i5f48b3f3d16f409680853a60e0d463c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNC0yLTEtMS01NDU5OQ_ce794324-281c-4511-b992-58ce65680600"
      unitRef="usd">8737000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="ib60fdcb7f2b24d8fa14e1890a559e41e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6YjM1Nzk5NThiMjVlNGZmYmE1MjFiOTAxN2NlYTQ0NjEvdGFibGVyYW5nZTpiMzU3OTk1OGIyNWU0ZmZiYTUyMWI5MDE3Y2VhNDQ2MV8xNi02LTEtMS01NDczMA_79064907-289f-40db-a57c-31fd9110046e"
      unitRef="usd">22683000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <unh:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGV4dHJlZ2lvbjo4NTRmNGIwZTRmOTA0YzhhYjFhYjgzMTU1NWVhN2NkZV8zMjk4NTM0ODg3NTYy_1186bff1-2c3d-446d-81ce-b0b82d76c61c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</unh:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8xLTItMS0xLTU0NzU2_e6bbf7a3-1a48-4845-a360-43f8ec685bf4"
      unitRef="usd">3063000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6f1e384a0c104adfb851755d9abfdb5f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8xLTQtMS0xLTU0NzU2_7fb3b02f-8dd4-4e60-bdf4-6c6e54b85cee">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTYtMS0xLTU2Mzgx_b3554a00-9458-4e11-8a45-f581eb12ccb3"
      unitRef="usd">864000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaab92015d2d44294a1939b3ac0350742_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTgtMS0xLTY2MzI3_279e9e3b-9e25-4d18-9d9f-6204cac16a86">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i33c272509ca243539b39dea750264213_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTEwLTEtMS01NjM4Mw_326a8881-c69b-4f2e-aab5-71444a4f296e"
      unitRef="usd">3927000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i33c272509ca243539b39dea750264213_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTEyLTEtMS02NjMzOA_eaef8ce8-96f6-4f4c-a081-b5374212f68d">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTItMS0xLTU0NzU2_d7223aab-e71b-46fe-9560-1e2f471a7c3f"
      unitRef="usd">977000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if7fd4cec8cdb475083e2c9d14721faa6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8yLTQtMS0xLTU0NzU2_44a506c5-f7d9-4c35-a761-59868c68a7a6">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTYtMS0xLTU2Mzgx_ada1db46-503d-4fa8-9f4e-eb269912d857"
      unitRef="usd">81000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icaf18a57e1294cc8b81778d3a7f1fb53_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTgtMS0xLTY2MzI3_c45db599-03d5-4b28-87d1-81fa43e480a6">P4Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTEwLTEtMS01NjM4Mw_32c604b9-4344-4edb-bfa4-9e04dbc6f565"
      unitRef="usd">1058000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iff6e496d57f0460b8ddcd1df61b1d2dd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTEyLTEtMS02NjMzOA_bd66e269-9e45-4e90-b580-a6be2d95afce">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTItMS0xLTU0NzU2_f58cc533-1f5c-4209-a894-2901f97f73ee"
      unitRef="usd">10000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i56ff6fe4c2ac4b3487b847eb15179e4a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF8zLTQtMS0xLTU0NzU2_5a76ce01-02db-404d-9c81-02f1ebf22cdb">P1Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i417f470589084c168d167ef0c775d160_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTYtMS0xLTU2Mzgx_8ad08b08-db98-4791-ae15-55dc1f0c749c"
      unitRef="usd">766000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i417f470589084c168d167ef0c775d160_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTgtMS0xLTY2MzI3_4e7828d7-b9d5-4e5d-8d62-56596b98b9eb">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTEwLTEtMS01NjM4Mw_3cb7df7f-5bca-4c12-a154-a28f6a4d5b5d"
      unitRef="usd">776000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1f044a3381d44abb89ad8624ef18fb28_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTEyLTEtMS02NjMzOA_b87989b9-5c28-4c70-8fc9-5e60478f3f61">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iec887b8824d84342853f880a3d055fb6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTItMS0xLTU0NzU2_346af59f-f547-4109-9677-259e9901163e"
      unitRef="usd">4050000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iec887b8824d84342853f880a3d055fb6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF80LTQtMS0xLTU0NzU2_4ce8f4a4-13a8-4d4b-a98b-711f5b7aed7a">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTYtMS0xLTU2Mzgx_6b65658e-9c46-44e0-b70d-eeaf53483f2d"
      unitRef="usd">1711000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idf8ade8a004149ceaea32126b946100e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTgtMS0xLTY2MzI3_ce7467df-05ee-4971-9c0d-eb490d67d193">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTEwLTEtMS01NjM4Mw_214167e4-e18f-4c75-9bb3-46f1d18903d0"
      unitRef="usd">5761000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i16c755cdc6004ec386add3e7d31dff98_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjk5L2ZyYWc6ODU0ZjRiMGU0ZjkwNGM4YWIxYWI4MzE1NTVlYTdjZGUvdGFibGU6NWM4NDI4ZjhkYTVlNDZmNjlhNDIzNWI1ZDMzNGRkN2QvdGFibGVyYW5nZTo1Yzg0MjhmOGRhNWU0NmY2OWE0MjM1YjVkMzM0ZGQ3ZF81LTEyLTEtMS02NjMzOA_e55f5c48-0917-4e5a-a006-2a42ffa87f8d">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzU2NDA_19790612-1ebc-4d9c-9feb-2f7083b687e7">Segment Financial Information&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors used to determine the Company&#x2019;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#x2019;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the types of products and services from which each of the Company&#x2019;s four reportable segments derives its revenues:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;UnitedHealthcare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;includes the combined results of operations of UnitedHealthcare Employer&#160;&amp;amp; Individual, UnitedHealthcare Medicare&#160;&amp;amp; Retirement and UnitedHealthcare Community&#160;&amp;amp; State. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. Domestically, UnitedHealthcare Employer&#160;&amp;amp; Individual offers an array of consumer-oriented health benefit plans and services for employers and individuals. Globally, UnitedHealthcare Employer &amp;amp; Individual provides health and dental benefits and hospital and clinical services to employers and individuals in South America and other diversified global businesses. UnitedHealthcare Medicare&#160;&amp;amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs. UnitedHealthcare Community &amp;amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Health&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Insight&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Rx &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx; care delivery, care management services and certain product offerings sold to UnitedHealthcare by Optum Health; and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#x2019;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a percentage of the Company&#x2019;s total consolidated revenues, premium revenues from CMS were 38%, 36% and 36% for 2022, 2021 and 2020, respectively, most of which were generated by UnitedHealthcare Medicare &amp;amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately 97% of consolidated total revenues for 2022, 2021 and 2020. Long-lived fixed assets located in the United States represented approximately 81% and 78% of the total long-lived fixed assets as of December&#160;31, 2022 and 2021, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Employer &amp;amp; Individual&#x2019;s international businesses. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reportable segment financial information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Corporate&#160;and&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;108,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;249,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;182,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;245,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;287,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;191,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;255,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;197,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzY0MQ_445892c6-959c-4e7e-91b3-6e285553419d"
      unitRef="number">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i754570ab58fc4d7182d6cd5710942586_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMTA_50948799-5666-4f4d-be01-13cabf595e65"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i891eefd12c57404d9108f080872897e0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMTQ_1e8e15fc-a198-4d53-8f09-ca394e94efdf"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i50a501c583d645a99b8b9b5c5bd3990c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUwMjE_69a80195-525b-4aa1-9579-8b18330ef436"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="i6ecaa939f056424d93be40e9396e2d1b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_7467657d-78ca-48dd-aff9-9ce0c5855297"
      unitRef="number">0.97</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="i5097e65e14e04df196818d6c688b1082_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_9ad968fa-4084-4e6b-8e97-f67d91689776"
      unitRef="number">0.97</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="i5047c8cbb98d45d0ad2ec2d032462297_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUyMjI_ba53702b-42fa-4f98-baa1-c3cd1511461e"
      unitRef="number">0.97</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofLongLivedAssets
      contextRef="if2456563e97441d1bb80a0655bda7af3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUzNzk_de9332c0-cb4b-49ee-9434-3870c28db749"
      unitRef="number">0.81</unh:DisclosureonGeographicAreasPercentageofLongLivedAssets>
    <unh:DisclosureonGeographicAreasPercentageofLongLivedAssets
      contextRef="i97182827e3a4490ab017b6b0ccdcf452_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzUzODY_de043dfe-1fad-4976-8d7e-4d7f5e081076"
      unitRef="number">0.78</unh:DisclosureonGeographicAreasPercentageofLongLivedAssets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90ZXh0cmVnaW9uOjM4NGYxZDRjMGFmZjQwYWFhMDAxY2NlYmZjZmIyNTMxXzU2Mzc_92641bcd-4f23-46ab-ba52-7f66a8749cd8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reportable segment financial information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Corporate&#160;and&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;108,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;249,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;182,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;245,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;287,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;191,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;255,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;197,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMi0xLTEtNTE5MzU_cd0796f5-9d3a-4393-93e6-d8acf5c80c3a"
      unitRef="usd">238783000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtNC0xLTEtNTE5MzU_a6cc3374-d0f2-4258-8718-749bb909c7ce"
      unitRef="usd">18374000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtNi0xLTEtNTE5MzU_2316b8a9-8c5b-4cf4-952e-83d72c76a450"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtOC0xLTEtNTE5MzU_ffea32bc-21ac-4a42-961e-2f8bf4177d58"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTAtMS0xLTUxOTM1_435cbcce-fd02-4e5c-a103-591ba15f8b80"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTItMS0xLTUxOTM1_3f7d513f-ce06-4db8-9817-b3998c1f4cc9"
      unitRef="usd">18374000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTQtMS0xLTUxOTM1_027d8b40-3eee-4517-8c46-e0f5866f5fb1"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQtMTYtMS0xLTUxOTM1_9e396eff-85ba-4478-9946-29cbb66e561a"
      unitRef="usd">257157000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i732a42f2250b413f9bf4d79507a6ca84_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMi0xLTEtNTE5MzU_dddec100-efc6-43f5-a68b-5a510de57e89"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fc651b1637d4ead98ae3d64f8fce1ac_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtNC0xLTEtNTE5MzU_515d5401-316a-4c09-9f35-67e1662ecd35"
      unitRef="usd">72000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i689a6bbc96bd48d585f1f0fbc711fc9f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtNi0xLTEtNTE5MzU_6d1a3afb-8687-4876-9d19-991158f2173a"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e748f6babd44bad9db0b025d2907061_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtOC0xLTEtNTE5MzU_0a19409e-d9b1-488e-8ff5-7a25f8d0c620"
      unitRef="usd">37172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f024c91b7e04d99baa714309ff7e49d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTAtMS0xLTUxOTM1_f20129e0-b1ca-4040-b92d-8060d4ebefb6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22c12c65b54c4b4fa1799a4218c9359f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTItMS0xLTUxOTM1_fd4c0bfb-2521-4e9b-aeb9-f90c10e3b086"
      unitRef="usd">37424000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47084b8e436448078c0d24c71476b120_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTQtMS0xLTUxOTM1_abe62839-d92a-47cd-8769-3dd21952e606"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibad33ae2f3254e8eaa1c802d749df410_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzUtMTYtMS0xLTUxOTM1_035bf5a8-6958-4a65-bc08-c5a2eae3e760"
      unitRef="usd">37424000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d26bfed4a2840dbac69a2395c82ff6d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMi0xLTEtNTE5MzU_c7ae1b13-a645-40c2-8823-ccc5d0f22af5"
      unitRef="usd">10035000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cb993a994a549efade727a478d56969_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtNC0xLTEtNTE5MzU_1f0ffd73-34c4-4a9f-926c-cc9bf7b01f60"
      unitRef="usd">10917000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0409df6d86b94be7842cd2257a37957c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtNi0xLTEtNTE5MzU_8d711b68-e1a4-4cfb-8e74-538e1267abcb"
      unitRef="usd">4996000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i248d4ab66d70471bae1895c28d10a5be_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtOC0xLTEtNTE5MzU_1d10b9d0-9fa1-4720-ab57-fa0daa97530b"
      unitRef="usd">1603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if41ca363996f43829716a67d979d12e3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTAtMS0xLTUxOTM1_36c83ee3-118f-4828-aec7-a76cce1e7662"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if345a50f546e449795e2b25318c9818f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTItMS0xLTUxOTM1_ff91c08b-f9b2-442a-8528-71b45b59c96a"
      unitRef="usd">17516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cd0dd9677e344fda1596618b18f13c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTQtMS0xLTUxOTM1_c1df27ee-bdf9-491a-9ce6-0eae6c014900"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9d02f6e1b404ac4bfcb813025f3065c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzYtMTYtMS0xLTUxOTM1_cba1e344-7578-49a9-9370-bb2c942b7451"
      unitRef="usd">27551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i6be8134d25834e25b5885f79dd485f98_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMi0xLTEtNTE5MzU_64cb80f7-39b8-40bd-8bd9-cd56cf2f5522"
      unitRef="usd">248818000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad0fb34134024b2aa17419f6ba4e0cb4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctNC0xLTEtNTE5MzU_ea8d8787-fdff-4677-8a0a-a43a4e034df4"
      unitRef="usd">29363000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7001a641a42f4940b8311f6a4f96e4e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctNi0xLTEtNTE5MzU_89967b97-87c2-43dc-97a0-f9ffc0ae1365"
      unitRef="usd">5176000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd1bfd915c26402c864bdfe90f207bb7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctOC0xLTEtNTE5MzU_2b9a9206-da37-45de-b10c-7e060dd5fc7a"
      unitRef="usd">38775000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0454e9a3f6094bc2a0afd8a828f74190_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTAtMS0xLTUxOTM1_26c4d7ce-55a3-4236-b7bc-562dd7a686ba"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c2e94434a2d4626871868f5922dffa8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTItMS0xLTUxOTM1_26d5b388-a892-43df-917a-6e651f1cb115"
      unitRef="usd">73314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a9c6fc3597d428ea49a867a123511cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTQtMS0xLTUxOTM1_e21e45f8-e4b2-4e84-a6bc-261f1a023413"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcbebb447ef44d69a28fa6682ea84eb4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzctMTYtMS0xLTUxOTM1_4baa45a3-262f-40fd-a980-ebf7925b4b42"
      unitRef="usd">322132000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad0e74178d75403b9dcc51a6a87d03de_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMi0xLTEtNTE5MzU_dccb03e1-e87d-4437-93ff-c0ec6d2e2e0e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40545db690df4fdab1edc363f3348827_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtNC0xLTEtNTE5MzU_ecc0dce1-a713-4114-bdd2-c8e5f24d4e1a"
      unitRef="usd">40883000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45c894858093498e826481908286c841_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtNi0xLTEtNTE5MzU_ef45e84f-ccad-481d-ba25-523b4f0d2273"
      unitRef="usd">9288000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35b418a686c3435f81ce58838debdcce_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtOC0xLTEtNTE5MzU_0dbf5c4e-3ebd-40c1-955a-0d585a59473d"
      unitRef="usd">60936000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia79e6c55d1d440638042cab7fe05cad5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTAtMS0xLTUxOTM1_9edddedb-f423-43ff-a4e8-2da0c12aaae8"
      unitRef="usd">-2760000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc5c6cb54c3b4b49bb104be3515415dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTItMS0xLTUxOTM1_294bb222-4da5-43ef-99c3-828c4e642802"
      unitRef="usd">108347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f5aa82904754e72bda157c7a338ea81_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTQtMS0xLTUxOTM1_6143a4a7-0f7c-49e7-a038-c774cf095431"
      unitRef="usd">-108347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36880bfb1c5e4252b9402bba5e8bb110_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzgtMTYtMS0xLTUxOTM1_64424cb0-5322-4556-b928-e5833b13079b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMi0xLTEtNTE5MzU_81fce41c-2e8c-4e7e-968c-f26919afb570"
      unitRef="usd">923000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktNC0xLTEtNTE5MzU_0444e2b5-c45e-43e4-b282-8407bb3529b3"
      unitRef="usd">928000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktNi0xLTEtNTE5MzU_b0db7f92-0ee2-4ff0-9025-5444b9408aeb"
      unitRef="usd">117000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktOC0xLTEtNTE5MzU_62d5ca15-88f0-4a1f-aadd-2a484a0afea4"
      unitRef="usd">62000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTAtMS0xLTUxOTM1_cbf376bb-bed8-41e3-b285-c62401588a8b"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTItMS0xLTUxOTM1_97b3d2eb-6a3f-4519-b08b-363a8761fffc"
      unitRef="usd">1107000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTQtMS0xLTUxOTM1_3fb72c83-dfaf-44f9-9db7-a690561f6c79"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzktMTYtMS0xLTUxOTM1_2af90c97-6b4a-4239-8883-f6000b943435"
      unitRef="usd">2030000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTItMS0xLTUxOTM1_79f0daaf-1391-4782-85cd-e53e302fcc31"
      unitRef="usd">249741000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTQtMS0xLTUxOTM1_785dcf8f-4c18-46e9-af01-e9e541987d1a"
      unitRef="usd">71174000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTYtMS0xLTUxOTM1_f1340598-1c45-49c7-81a7-c60b72cfaff9"
      unitRef="usd">14581000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTgtMS0xLTUxOTM1_53aedb58-7161-4826-9264-836d20256046"
      unitRef="usd">99773000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTEwLTEtMS01MTkzNQ_c0dbfa53-ba7a-4df7-a989-ae0ac42b6ad8"
      unitRef="usd">-2760000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTEyLTEtMS01MTkzNQ_94756916-74bf-4c11-a517-a8440717958d"
      unitRef="usd">182768000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTE0LTEtMS01MTkzNQ_e346d933-0474-4c51-aa90-0d7df4ccbf3e"
      unitRef="usd">-108347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEwLTE2LTEtMS01MTkzNQ_c7e02574-655e-4b5d-bc60-3063ec50fcd8"
      unitRef="usd">324162000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTItMS0xLTUxOTM1_0b284ed7-81ba-4af2-b3a6-7f9b906ea612"
      unitRef="usd">14379000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTQtMS0xLTUxOTM1_9aea0694-0d8c-4698-a769-be2593b724e0"
      unitRef="usd">6032000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTYtMS0xLTUxOTM1_6cab2bb1-f5ce-430a-a67f-b93c4543739e"
      unitRef="usd">3588000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTgtMS0xLTUxOTM1_29ec5d1e-d326-4187-9737-b9b9887b6da5"
      unitRef="usd">4436000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTEwLTEtMS01MTkzNQ_8c23a35c-d197-4354-bf39-46f419706c66"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTEyLTEtMS01MTkzNQ_1986d398-556d-41e1-b264-5873a6f423db"
      unitRef="usd">14056000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTE0LTEtMS01MTkzNQ_3d1fb904-2b1a-4316-be03-1ee1265ee163"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzExLTE2LTEtMS01MTkzNQ_6e6be6f9-28ae-4a56-b0b8-a226d6a98af4"
      unitRef="usd">28435000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTItMS0xLTUxOTM1_9b01c0e3-c02a-4816-bc59-d2723142f971"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTQtMS0xLTUxOTM1_1aea3be0-9b4a-43fa-b997-d091e676ae9b"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTYtMS0xLTUxOTM1_38f3b73b-8936-4885-8490-fdbaf40b392a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTgtMS0xLTUxOTM1_6617a59f-4ff8-42dd-8478-6a7eb6bc1a6f"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTEwLTEtMS01MTkzNQ_1baa3b91-34db-4101-ad12-287d710e7708"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTEyLTEtMS01MTkzNQ_5db6b33e-52a1-4b02-85f0-a00eab7c8052"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTE0LTEtMS01MTkzNQ_0d556dff-fb52-4230-9b7d-bc08c81c33ba"
      unitRef="usd">2092000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEyLTE2LTEtMS01MTkzNQ_3e4d0c5b-041e-4185-b478-18fff7207a6e"
      unitRef="usd">2092000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTItMS0xLTUxOTM1_91a2b2f4-4ee5-4a93-8142-735e02b4f6c9"
      unitRef="usd">14379000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTQtMS0xLTUxOTM1_e7922e37-9bb9-4fcd-9fce-b228715a7da9"
      unitRef="usd">6032000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTYtMS0xLTUxOTM1_50c4268c-00dc-4745-93d5-30b4669d8d61"
      unitRef="usd">3588000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTgtMS0xLTUxOTM1_cc7e7167-655b-4821-8d96-b0c26d5eb3af"
      unitRef="usd">4436000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTEwLTEtMS01MTkzNQ_17ca8994-9ab7-4d66-a0af-f1f61710bc06"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTEyLTEtMS01MTkzNQ_d287c389-e3ed-4a43-84d5-4033887cc058"
      unitRef="usd">14056000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTE0LTEtMS01MTkzNQ_89431cb4-37c4-45e9-bffa-0639da4d1d7f"
      unitRef="usd">-2092000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzEzLTE2LTEtMS01MTkzNQ_43914e0f-a0f4-48ab-9cf9-57dd56314ea3"
      unitRef="usd">26343000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="i59011503ab204f80b7e61b66d70a9f7c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTItMS0xLTUxOTM1_f907f9b9-c599-4ba1-a1f0-fdb1135585f5"
      unitRef="usd">107094000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic696f2244b5b45a0a03c0ca407b18556_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTQtMS0xLTUxOTM1_222804d8-8eac-447c-ac05-159f71789ab5"
      unitRef="usd">68950000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iac00fded2bdc4a4dac5850a70ce34a56_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTYtMS0xLTUxOTM1_3987a99f-7b09-4da4-9905-7e7fabe01bba"
      unitRef="usd">31090000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic5ac679ac440453dbbb5734791641a4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTgtMS0xLTUxOTM1_1a58e8e6-22ef-4df2-b46a-2a0de526012a"
      unitRef="usd">47476000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8b28e9f7a35f4490a7d651ae18c391b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTEwLTEtMS01MTkzNQ_81aea6ab-1c2e-47d0-8c31-63c4cef1201f"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia00c94487ebe47df9a45f96208eac209_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTEyLTEtMS01MTkzNQ_6f3a0835-036d-4512-ad1a-7e7ac5f738e0"
      unitRef="usd">147516000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2342d40e00cb40539947ec67002a66b3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTE0LTEtMS01MTkzNQ_eef12ac7-ce55-4e27-8ecd-5ced308ee1f3"
      unitRef="usd">-8905000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i03d7421f2e1846c2b83800db841f59f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE0LTE2LTEtMS01MTkzNQ_72f6c58a-bcfe-45f7-8f4c-e89ce00ff07d"
      unitRef="usd">245705000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTItMS0xLTUxOTM1_0c1a3626-5421-4835-a38e-9750d4e9e6d3"
      unitRef="usd">799000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTQtMS0xLTUxOTM1_748de43c-7d1d-4c66-b393-c37a38190626"
      unitRef="usd">997000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTYtMS0xLTUxOTM1_53c6b336-4ac9-4042-adc5-cedc2957ae4c"
      unitRef="usd">698000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTgtMS0xLTUxOTM1_9a1e967b-17da-4bd4-b1ce-75e6cff4bfb6"
      unitRef="usd">308000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTEwLTEtMS01MTkzNQ_6318ba99-5314-4911-881c-7a85e6a0ad3d"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTEyLTEtMS01MTkzNQ_b1a2f515-af7b-4af4-a65f-e425f6ee1380"
      unitRef="usd">2003000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTE0LTEtMS01MTkzNQ_6e14e822-9466-47b0-b040-3d662397fd52"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE1LTE2LTEtMS01MTkzNQ_4d63514b-0174-4bb1-94b0-588c6c4b76a8"
      unitRef="usd">2802000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i1fb7436683a142a0b46b5cdcfd4afee7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTItMS0xLTUxOTM1_8ecad128-0170-4878-a0b7-65548466de0a"
      unitRef="usd">973000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifdb4e2d6c436483d8c6b9e1bd58427d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTQtMS0xLTUxOTM1_a3dbe046-0ee7-44e1-83e0-7725f1022510"
      unitRef="usd">943000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i76e7a0df6f814853afea44e68161c529_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTYtMS0xLTUxOTM1_e61c1e8f-2633-4a51-8adc-7db1a49f3fa3"
      unitRef="usd">841000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0d927be6127444c59445557fe053bd65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTgtMS0xLTUxOTM1_d744ae16-cbbe-44d7-88fc-56cce5ba1e9f"
      unitRef="usd">643000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="id5960c3bd03745bd867211187b5890af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTEwLTEtMS01MTkzNQ_a208b71d-f5a4-4312-a69b-4dd98544bac3"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i96a086b49b4443f78ff994848f0e055a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTEyLTEtMS01MTkzNQ_103a3c88-2e8c-4712-bf7c-05f3f6d2fe07"
      unitRef="usd">2427000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i49d455ef16044dd4b74845c22221f2e4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTE0LTEtMS01MTkzNQ_167d21d8-7802-40bd-bc63-670a6429e5cc"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE2LTE2LTEtMS01MTkzNQ_0b8c930d-d2b3-41b7-bc0d-64d2887a2a67"
      unitRef="usd">3400000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTItMS0xLTUxOTM1_2dc249c5-2573-4827-8396-8e1df129c221"
      unitRef="usd">212381000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTQtMS0xLTUxOTM1_865ccea1-51be-4346-9924-d181b89c5c22"
      unitRef="usd">13852000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTYtMS0xLTUxOTM1_fb976f2d-fe86-44b3-901c-daf1a53b683b"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTgtMS0xLTUxOTM1_d694b85a-b9bf-44b2-9017-721cbd942453"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTEwLTEtMS01MTkzNQ_8007c5aa-0145-437a-8478-7712bd0c45e5"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTEyLTEtMS01MTkzNQ_92ac912f-3240-4387-bd17-985c6c275c65"
      unitRef="usd">13852000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTE0LTEtMS01MTkzNQ_95bc356f-da93-46c7-b0a5-95a0b31fe63c"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzE5LTE2LTEtMS01MTkzNQ_c3f7a0d9-5805-40bd-8199-9308dabd5396"
      unitRef="usd">226233000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d726a752eb3479e98a520f141c7da23_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTItMS0xLTUxOTM1_14c92d77-54b1-4896-9f9c-fc2501082aec"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice1915ab53004f139ae31ddb9f72017a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTQtMS0xLTUxOTM1_79fa2288-c63a-4cbb-8cbe-9a5a01869ec4"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26f4f96795bf481cb58883eb91460381_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTYtMS0xLTUxOTM1_fde6f79b-e97a-4b7a-86a3-06bf6e608db0"
      unitRef="usd">159000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i169c3a6f69ec49c6ac21ea20f6face13_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTgtMS0xLTUxOTM1_b99906a9-7c5e-47a7-a778-b02efd2687b7"
      unitRef="usd">34246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3aa0861fc9d04b6b8a9cf15131f4eb4c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTEwLTEtMS01MTkzNQ_ab6ad869-a577-4875-af38-0e83e25a6676"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i223709dbe1e1454e8275ba382402b2fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTEyLTEtMS01MTkzNQ_252ef28b-4026-4ccf-afd4-e96d12d3d921"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6809afc52ece49fcacd58ddeb9beed63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTE0LTEtMS01MTkzNQ_f962c8ed-693d-4a97-a6a4-146a2263c8d6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd994d74ba1e442eb1b7b78abad56ccf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIwLTE2LTEtMS01MTkzNQ_4c0c06aa-2033-4940-828d-15f6ddbe2756"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbb19a9943ea410184b0ee7221e62372_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTItMS0xLTUxOTM1_caedb220-37c5-4576-bbda-93921814fec7"
      unitRef="usd">9661000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if552e01372d149efa80b89bd7e2901fa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTQtMS0xLTUxOTM1_07e48c0e-2f63-43d0-94a8-165252b7fbbc"
      unitRef="usd">9894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6feddcc5aa4962a0a4685dc88ff2d8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTYtMS0xLTUxOTM1_e5aaa18c-e123-4a04-945f-3005c04b2d8a"
      unitRef="usd">3936000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7d4124c98cc489db6bc12d6a7c0fa1b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTgtMS0xLTUxOTM1_84c207a5-2d68-4605-9f40-5c7e5da2d742"
      unitRef="usd">1112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec876717223b46bdb349de450e145cd6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTEwLTEtMS01MTkzNQ_01fb4d92-6d0e-4b26-b3c3-a0e58c1866ca"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f8c8b06009844a89aad8bfadcab6675_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTEyLTEtMS01MTkzNQ_3607c305-a929-4665-a961-036febb30050"
      unitRef="usd">14942000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f4aaba57e6c4369864d20305d9597f1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTE0LTEtMS01MTkzNQ_d2bbfc0b-4350-4f2c-bb7e-71ae5f64ac17"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e74aa00cb7f48a593354c1c326ec9d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIxLTE2LTEtMS01MTkzNQ_d1eebbaa-ccd8-4d1d-8baa-832aa0950575"
      unitRef="usd">24603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ic2a9d0f91dd44747a719882c1ba71222_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTItMS0xLTUxOTM1_272d9add-1f58-4d21-902e-dcc813de37f1"
      unitRef="usd">222042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0125667e2fd45d9ad8c517759abf17a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTQtMS0xLTUxOTM1_a1ccbc18-c96e-42a5-a39b-2435976d5215"
      unitRef="usd">23778000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i140b8ec16fcf43e2af921ff3c1e4bfb8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTYtMS0xLTUxOTM1_cc1b01ec-efc3-4db9-92d5-7b99f8d7ff83"
      unitRef="usd">4095000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7b24a4e26957474d844ef0c394af06e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTgtMS0xLTUxOTM1_f8e96984-7980-4a0c-80db-f1c1d789b35f"
      unitRef="usd">35358000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37002b665fee4507ad1053ed2bc896c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTEwLTEtMS01MTkzNQ_b4e00c7b-ebff-49c3-a49c-6fb567a72844"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2911f9df292e42e1b6a623170d0b9a56_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTEyLTEtMS01MTkzNQ_34b6a0c8-4553-4bfa-b30b-4f45f9609ef2"
      unitRef="usd">63231000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia315fa186bfb4d37b367d534a5fea5b5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTE0LTEtMS01MTkzNQ_43b99f74-96b7-41e0-8307-c125db0746c8"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45c0c4be86814c9fb38a090d38285cb9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIyLTE2LTEtMS01MTkzNQ_bb2b6997-49a2-47b5-ae21-511a08d3173d"
      unitRef="usd">285273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4cc12cbad2f4be496364d6a29805345_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTItMS0xLTUxOTM1_8360d888-720b-41d4-8895-53051fce57c4"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icbf5875ebba543508498353a5881cd21_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTQtMS0xLTUxOTM1_2d2aa56f-47c4-40c3-84f5-efbe8d07c98c"
      unitRef="usd">29234000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifa3958921a164d51bdd2c4a6807a726f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTYtMS0xLTUxOTM1_658ac134-1851-4d2e-8185-dbb60e138b3f"
      unitRef="usd">7867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i159f89cf2a8346398f76a7f71b7df182_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTgtMS0xLTUxOTM1_e4717285-6a1d-442e-a7eb-e94fc2d7e3ca"
      unitRef="usd">55779000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf477982ea1a42dc804d174211e45675_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTEwLTEtMS01MTkzNQ_18ccb6e5-a297-4658-862d-b597a15abd26"
      unitRef="usd">-2013000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4076c2027b2e4431ac707ea49e17d9e6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTEyLTEtMS01MTkzNQ_45b8c9a3-a26a-4256-92b4-cbb5cb1385ab"
      unitRef="usd">90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i504afca956b443a6a9e4f9d9b46f543c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTE0LTEtMS01MTkzNQ_cc6b3b35-2ee5-4be6-8232-e1731b130bc7"
      unitRef="usd">-90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied0c09925613478d8fc3af0f46b15762_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzIzLTE2LTEtMS01MTkzNQ_fee6c4b3-7137-4cae-b0b6-01a12a27e205"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTItMS0xLTUxOTM1_671347a7-40d2-47b6-a673-e6f64509aa92"
      unitRef="usd">857000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTQtMS0xLTUxOTM1_d88ca15b-35ed-47e1-977a-163d6df2276a"
      unitRef="usd">1053000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTYtMS0xLTUxOTM1_b1dc17b6-5e36-4d6b-ae8e-aa3a6af30328"
      unitRef="usd">237000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTgtMS0xLTUxOTM1_fdb69e3b-ed3f-4b1c-8705-d7167bec6b90"
      unitRef="usd">177000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTEwLTEtMS01MTkzNQ_866ed08c-3c98-41ca-9cf2-8edc037d9949"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTEyLTEtMS01MTkzNQ_3ed069fc-9822-407e-afcf-e479b9ba4fe2"
      unitRef="usd">1467000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTE0LTEtMS01MTkzNQ_8552de19-7477-4501-b30b-72936a717d61"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI0LTE2LTEtMS01MTkzNQ_c48f1a34-f650-4499-9c1f-f232de93fa45"
      unitRef="usd">2324000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTItMS0xLTUxOTM1_75660291-0903-4278-9ed7-0fb2c66da008"
      unitRef="usd">222899000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTQtMS0xLTUxOTM1_2316f93b-7978-4633-adba-9cb213717f3a"
      unitRef="usd">54065000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTYtMS0xLTUxOTM1_b7604858-14bf-4cf3-89eb-08eb5a2bac6f"
      unitRef="usd">12199000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTgtMS0xLTUxOTM1_bf2ca69b-1d77-4949-aa08-05c104557543"
      unitRef="usd">91314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTEwLTEtMS01MTkzNQ_fdfdf3b1-b316-4b4d-a63e-dafcdf9cc619"
      unitRef="usd">-2013000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTEyLTEtMS01MTkzNQ_b666f8e4-ad90-4b2f-b158-8d68a2715d1e"
      unitRef="usd">155565000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTE0LTEtMS01MTkzNQ_4271e3f8-a371-486e-a6a7-4298e409e45f"
      unitRef="usd">-90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI1LTE2LTEtMS01MTkzNQ_40ed2bdc-d3de-41b8-b40d-a931ead02350"
      unitRef="usd">287597000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTItMS0xLTUxOTM1_fed81db4-fa93-4108-8282-e53c01c2324e"
      unitRef="usd">11975000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTQtMS0xLTUxOTM1_f8dde058-81da-4bda-81e4-cf1d8bfa66d8"
      unitRef="usd">4462000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTYtMS0xLTUxOTM1_d8f6cf12-6437-4c3a-8333-e3ef97ea357b"
      unitRef="usd">3398000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTgtMS0xLTUxOTM1_f3f11cb2-3ef3-494d-8002-858324e9c3be"
      unitRef="usd">4135000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTEwLTEtMS01MTkzNQ_e6b2c45e-e978-4f48-8c1d-f83f04173f24"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTEyLTEtMS01MTkzNQ_c8010ad1-e3b4-45d3-b061-82d24cae93ec"
      unitRef="usd">11995000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTE0LTEtMS01MTkzNQ_c64ee453-7891-488a-83a2-af9bcaafa300"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI2LTE2LTEtMS01MTkzNQ_88f05238-d00e-4786-b072-399c7a1f1cb1"
      unitRef="usd">23970000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTItMS0xLTUxOTM1_52e47d15-a458-484e-a92a-4fab19500375"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTQtMS0xLTUxOTM1_d481d6ad-bfbb-47fb-a930-3ff27ef40580"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTYtMS0xLTUxOTM1_c9cf3a7e-599b-4893-8e37-0807527b4464"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTgtMS0xLTUxOTM1_edf73614-1e00-44a0-a5b0-bfb1c0087409"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTEwLTEtMS01MTkzNQ_74fdd1fa-0226-4a9a-8592-e3cddad3d5c1"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTEyLTEtMS01MTkzNQ_755dc61a-cf2b-4406-807f-7de8d8ed0c1b"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTE0LTEtMS01MTkzNQ_c8d9eb0a-fd2e-48d9-ba73-612f1d56cb03"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI3LTE2LTEtMS01MTkzNQ_dd7bb8aa-8b0d-4ceb-a050-f0d082bade03"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTItMS0xLTUxOTM1_c4a390be-edd7-4530-9f0a-f42e5a42c807"
      unitRef="usd">11975000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTQtMS0xLTUxOTM1_2f20d66b-881b-4ccd-901d-0bcd25fe40d8"
      unitRef="usd">4462000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTYtMS0xLTUxOTM1_7de82f9c-3401-4e26-981c-240185234b4b"
      unitRef="usd">3398000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTgtMS0xLTUxOTM1_b1d55b3c-ca58-461b-a65b-0a494a3668bc"
      unitRef="usd">4135000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTEwLTEtMS01MTkzNQ_fcb1da95-ecb5-45fb-9ebe-c987981a8246"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTEyLTEtMS01MTkzNQ_e5b4b837-3c61-442f-8426-d04c1f0f4043"
      unitRef="usd">11995000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTE0LTEtMS01MTkzNQ_765e559d-fe73-440b-b84b-86b21a28632b"
      unitRef="usd">-1660000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI4LTE2LTEtMS01MTkzNQ_a6787544-9e18-4f81-b128-609343c28e23"
      unitRef="usd">22310000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="id9491e68da6045a1a105dfe059072466_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTItMS0xLTUxOTM1_f2cfb821-5b73-4b01-922b-db1fc1e2e8ac"
      unitRef="usd">102967000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic858c9047c604ac982e25d4ac7f8174d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTQtMS0xLTUxOTM1_bd6711c2-a0b8-433f-8f56-aab6b2f2d265"
      unitRef="usd">60474000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaa393fe15c9145e3b9ec03b58beca5dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTYtMS0xLTUxOTM1_14811e03-2174-4a29-a2e3-8c75d9150fd6"
      unitRef="usd">16868000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i07f6e178ccba45fab8978aea98c8fff1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTgtMS0xLTUxOTM1_9aa7413e-3d28-4069-b7dc-345bd81990cf"
      unitRef="usd">40181000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic46ffe7b0c3c4ef38af41f18db200faa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTEwLTEtMS01MTkzNQ_cb1d2a97-fd7c-46ce-8d13-759b6a237b44"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i01f93fadef4f46a5bc4fb990ddee2fc8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTEyLTEtMS01MTkzNQ_41682798-c830-463e-893b-df1a7fc8c394"
      unitRef="usd">117523000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9edf57345d9043c1b11e892820ff85bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTE0LTEtMS01MTkzNQ_3c879df5-80d7-4e9c-87c6-924c26e59125"
      unitRef="usd">-8284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzI5LTE2LTEtMS01MTkzNQ_263c9edf-0449-485e-9e65-423448119fb3"
      unitRef="usd">212206000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTItMS0xLTUxOTM1_c74f9117-f5f1-465c-834b-11ec4c466e19"
      unitRef="usd">795000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTQtMS0xLTUxOTM1_28038215-07ef-4a81-8463-bc5c5f894d14"
      unitRef="usd">791000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTYtMS0xLTUxOTM1_5191b1c2-6a63-4847-9da6-e1bb97461573"
      unitRef="usd">567000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTgtMS0xLTUxOTM1_574fba1e-44fb-443d-9201-a98d0208ca0e"
      unitRef="usd">301000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTEwLTEtMS01MTkzNQ_236b70b6-60b9-4f5a-a6bf-7e7ea38437e8"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTEyLTEtMS01MTkzNQ_0574bcf2-3cbe-4427-b5c6-96ea5c86ae8e"
      unitRef="usd">1659000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTE0LTEtMS01MTkzNQ_ad57e2e1-507f-45e8-812b-8431a7c44a56"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMwLTE2LTEtMS01MTkzNQ_78f41839-312e-4762-bc1c-5131cfb12c0a"
      unitRef="usd">2454000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i05eab8128c1042aebb6d7967fcd131d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTItMS0xLTUxOTM1_0da0906c-d808-4323-bb8f-8305a895f6ec"
      unitRef="usd">1004000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i28fa9b6c390f45b2b729f277163ea9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTQtMS0xLTUxOTM1_9adbfedd-f315-49c0-9700-1195832ec24e"
      unitRef="usd">818000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3a5344bb53af4ef488f6deeaf8cb0eae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTYtMS0xLTUxOTM1_fb659cf5-60b4-4ed4-a026-8c65106dfbd7"
      unitRef="usd">684000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if2eb9114f8a8478ab7e9231ef44f3851_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTgtMS0xLTUxOTM1_a760a93d-2eca-4540-9ea8-07581556f9c4"
      unitRef="usd">597000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i95319570f3f043e8abeca46160dc1cc2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTEwLTEtMS01MTkzNQ_622185c1-050f-4ee6-8f66-c04e76b859f3"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if31927965e124d538b3490c3dadc7f93_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTEyLTEtMS01MTkzNQ_01c400b8-96eb-48df-a3cd-2fcdfb755dd0"
      unitRef="usd">2099000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i35b6fe19a07943e8807800f8a6f882ce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTE0LTEtMS01MTkzNQ_0b60c75e-61ee-4db4-93d4-311323f715b6"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ida6af34929a64358bcb2fd06d063b1a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzMxLTE2LTEtMS01MTkzNQ_9fe3b674-af70-440e-b812-6c04e4adee33"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTItMS0xLTUxOTM1_47c11468-e069-4a0a-96fb-96169f64deb2"
      unitRef="usd">191679000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTQtMS0xLTUxOTM1_e335fa35-46c0-4921-b73f-72fd210d6301"
      unitRef="usd">9799000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTYtMS0xLTUxOTM1_6b893a43-47a9-4e72-9f4c-ea22a505a160"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTgtMS0xLTUxOTM1_cf4f53df-aa77-4b3e-9853-b145336ef5c3"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTEwLTEtMS01MTkzNQ_dceb7075-44eb-4cd6-b376-75066a5a2752"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i233c15dc654d469288951d04a08c0455_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTEyLTEtMS01MTkzNQ_e20b56e6-a1d1-4451-b814-8f45075bb111"
      unitRef="usd">9799000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTE0LTEtMS01MTkzNQ_2087e320-6b12-42fc-9fa7-f7e648f12ae6"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM0LTE2LTEtMS01MTkzNQ_07640f26-698e-4dc7-b518-bbd36295f9fb"
      unitRef="usd">201478000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibba020e43c45460cb04de6fcc9b74a76_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTItMS0xLTUxOTM1_b25448bf-3067-4b20-8b8d-d90ce1f39f67"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34bb0b4a48194f55ba64445c9848a45d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTQtMS0xLTUxOTM1_fcb6144e-e47c-4ca4-aaba-72930edf3d6b"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i564486a1b728438ca7fbb3d76dfad1cd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTYtMS0xLTUxOTM1_9ba06bf8-7a02-4609-8329-d25f9bb5f698"
      unitRef="usd">135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19bd530a243c4e92be077f1a53ed69e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTgtMS0xLTUxOTM1_bb1dea96-5a8c-4c14-be35-1dd2ada92c9f"
      unitRef="usd">33977000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d4008ea094942efa92959f01e189555_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTEwLTEtMS01MTkzNQ_ab292a03-5f20-4c46-bf36-5687422cdb84"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i796f9087920a40eca6b04eca756a0128_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTEyLTEtMS01MTkzNQ_bf9eea9c-05da-4659-836c-ad3092ff7f12"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideb0b864fd8c4a6782eef98e1bafa761_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTE0LTEtMS01MTkzNQ_a2c8d9c9-d719-4677-9e31-f5319c2801e6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71cf336cf55d404f864835404f2b5d2c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM1LTE2LTEtMS01MTkzNQ_142a23d6-6794-4027-9e87-97001d4f9cda"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1c572dcc2604feabe05f8761531ce09_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTItMS0xLTUxOTM1_6838372b-d9ab-4531-9288-2dae05750ced"
      unitRef="usd">8464000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifefb573c3bb8436dbf231adeb4c351db_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTQtMS0xLTUxOTM1_85611ab4-ac4d-448b-8842-d8a6ec6a4d34"
      unitRef="usd">6815000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9734c2c7137d4a14a49e90c235063d38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTYtMS0xLTUxOTM1_e0986e87-f2f8-47ec-8c68-31b0cd7352e5"
      unitRef="usd">3687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i276a8b65f2b4434dbee38c4c9687ce8d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTgtMS0xLTUxOTM1_deb4f42c-b066-41ef-8507-aa9987ac11c2"
      unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86e84564ba4746deab13cdd483c38f04_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTEwLTEtMS01MTkzNQ_e01b4fb9-6620-449b-aecb-326dcf5250c7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb51ddb53efb4127a03b364bd9fb3504_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTEyLTEtMS01MTkzNQ_0ce21f87-6d2f-4341-96f9-44d57d7e1a4d"
      unitRef="usd">11552000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5476d1544885436791b5b43717779607_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTE0LTEtMS01MTkzNQ_1977d301-9ac9-4fd2-8711-dde6c95abb02"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7245c7c22b7746e094b0d6835d7ae680_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM2LTE2LTEtMS01MTkzNQ_4ecabc8f-1faf-4245-a0a7-ca9608efa7ae"
      unitRef="usd">20016000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="if62c74c3558c4bc799516c53c7bcb140_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTItMS0xLTUxOTM1_b15ac054-561c-4630-8c3e-f42908a16cb0"
      unitRef="usd">200143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5614e7f0602474faef54b5d5991b974_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTQtMS0xLTUxOTM1_7d23e401-1b45-4eb5-9be0-7ab0c0915b30"
      unitRef="usd">16647000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a089a5d2fbf4885940a231cdf87b00f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTYtMS0xLTUxOTM1_8cc8132d-850c-4fb4-92df-3215d9d29e83"
      unitRef="usd">3822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieaa6c5351c6841efbf839f7cc521e6bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTgtMS0xLTUxOTM1_4e5a6569-6fae-4df9-a69c-8d9cfdc4d7fa"
      unitRef="usd">35027000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04ec2523797a49c4b7dc99482a867e26_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTEwLTEtMS01MTkzNQ_53d9dc03-8ec9-4616-9bdb-1a9ac9e4df70"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i233c15dc654d469288951d04a08c0455_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTEyLTEtMS01MTkzNQ_40e854f8-8a3f-4995-95ca-a763295cab3f"
      unitRef="usd">55496000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a83813f615f4c5a8362eb68e272711d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTE0LTEtMS01MTkzNQ_12f610ec-0a96-402d-aadc-39bf4484ad9f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if9f3f53e8ece442287633d77a8ace99d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM3LTE2LTEtMS01MTkzNQ_5bab175e-636c-4382-8792-e146f76201b6"
      unitRef="usd">255639000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a5f2ae790b74bfabb249a00198978be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTItMS0xLTUxOTM1_649ccbed-54ea-4215-96a2-1ce828098206"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee98fc17838d4daf98c0b0585eb7ed06_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTQtMS0xLTUxOTM1_19a61192-c7c2-4c18-ab7a-c2a9573956d1"
      unitRef="usd">22481000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97245d594a044b1f8d34eb031374888c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTYtMS0xLTUxOTM1_b5bc0d0b-d151-444e-94b8-1dda83cd400b"
      unitRef="usd">6941000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9dcfadfac12645d4b3082944a122cc9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTgtMS0xLTUxOTM1_d5d5d565-88ff-4862-8c54-da23118bdf61"
      unitRef="usd">52420000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0caf62223ca54bb185679fac378d4f52_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTEwLTEtMS01MTkzNQ_76e60ddc-4cc4-4a0a-987c-853ef505adeb"
      unitRef="usd">-1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c6a40d1db7f44589224803d71e3e1e6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTEyLTEtMS01MTkzNQ_6c7f3d71-c7f9-4501-b923-6f6ff5ecde4e"
      unitRef="usd">80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7465d3a1afe74c3d8718ba6192a453ae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTE0LTEtMS01MTkzNQ_29d4045c-fb5c-4bdb-a4f7-99a36b511ba7"
      unitRef="usd">-80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14f892617f3049c3a1e27ad2c9dec0ec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM4LTE2LTEtMS01MTkzNQ_be32d420-7c8c-4102-8c7d-ef7a135f6206"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTItMS0xLTUxOTM1_575ed292-1a2a-41f1-9188-a8a1701aa004"
      unitRef="usd">732000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTQtMS0xLTUxOTM1_8f21705c-720a-4e75-b6b6-efd5a97f16bd"
      unitRef="usd">680000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTYtMS0xLTUxOTM1_1846b8c5-8d74-4235-b592-a4fc7cd45997"
      unitRef="usd">39000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTgtMS0xLTUxOTM1_1e8fcab2-3b0e-4406-96a0-57e225e95fe3"
      unitRef="usd">51000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTEwLTEtMS01MTkzNQ_a59b2dbd-3bdb-4be3-93e3-ea795329a07a"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTEyLTEtMS01MTkzNQ_7c468a61-d0b0-42a4-a237-68502f496638"
      unitRef="usd">770000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTE0LTEtMS01MTkzNQ_16f15e4e-5dec-4da9-84cd-613b62a689c0"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzM5LTE2LTEtMS01MTkzNQ_949f1c46-acf9-4189-aa1d-07eefc8ce4e8"
      unitRef="usd">1502000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTItMS0xLTUxOTM1_ba17f734-fb02-40eb-beff-49aab9d1e16f"
      unitRef="usd">200875000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTQtMS0xLTUxOTM1_b64a02a0-35e7-4e88-98be-eb97e926642e"
      unitRef="usd">39808000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTYtMS0xLTUxOTM1_0c65db70-d566-40be-835b-a5d718ed4086"
      unitRef="usd">10802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTgtMS0xLTUxOTM1_9ee2f2cd-b3c4-4922-8b87-58fcee1a3bf1"
      unitRef="usd">87498000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTEwLTEtMS01MTkzNQ_f758588b-2412-4e18-a28b-5a7133b16dd5"
      unitRef="usd">-1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTEyLTEtMS01MTkzNQ_c8f3217f-2871-4958-ad51-2b9229b535d7"
      unitRef="usd">136308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTE0LTEtMS01MTkzNQ_d3721046-fc49-4881-bf2e-ce4df9f1b00a"
      unitRef="usd">-80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQwLTE2LTEtMS01MTkzNQ_e4e6b903-17de-4e36-a370-2d4114d61b0e"
      unitRef="usd">257141000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTItMS0xLTUxOTM1_aea8bd24-9060-46ef-8cb1-a02ee24a6be1"
      unitRef="usd">12359000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTQtMS0xLTUxOTM1_6baed609-16c7-41c4-b5c4-3df45cfcd34c"
      unitRef="usd">3434000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTYtMS0xLTUxOTM1_36f680f3-2397-4c2d-8835-602de2d7a303"
      unitRef="usd">2725000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTgtMS0xLTUxOTM1_abfb00e5-5744-4f6e-a258-e19edcc9e826"
      unitRef="usd">3887000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTEwLTEtMS01MTkzNQ_96c20a49-b9d2-46c3-b554-14194feed9fc"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTEyLTEtMS01MTkzNQ_d48379d8-c99d-4b76-8500-fd48578c9499"
      unitRef="usd">10046000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTE0LTEtMS01MTkzNQ_ceb6e1dd-f7ee-4405-9cfc-360ef1ff0178"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQxLTE2LTEtMS01MTkzNQ_23ea1a24-039d-4208-a4b9-146f287a0633"
      unitRef="usd">22405000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTItMS0xLTUxOTM1_cd024dfe-e1f2-49f7-9863-1d43c7bea685"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTQtMS0xLTUxOTM1_8f7b5c45-74ad-4e81-b69f-2d66bb572b3f"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTYtMS0xLTUxOTM1_4ed459ba-09c7-4a2d-b868-ecc97e0ecb23"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTgtMS0xLTUxOTM1_c89f45b8-391a-4121-bf62-f1fcd1f55b11"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTEwLTEtMS01MTkzNQ_95293bd4-d037-43c2-98e3-313d7efe644d"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTEyLTEtMS01MTkzNQ_60a341f0-edc8-4b91-aa10-3bac806599d7"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTE0LTEtMS01MTkzNQ_5064df0e-a68e-43b9-a074-7ddfb81ace87"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQyLTE2LTEtMS01MTkzNQ_342538da-ce61-4dcf-b4ae-92f1adca308e"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTItMS0xLTUxOTM1_cd033b99-d8f2-4ac1-bfe7-c4bf48afe029"
      unitRef="usd">12359000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTQtMS0xLTUxOTM1_8dbdec47-9eac-4003-8c57-a179e36fb67c"
      unitRef="usd">3434000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTYtMS0xLTUxOTM1_2c0514e2-f2ad-4470-afef-e44fa1524029"
      unitRef="usd">2725000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTgtMS0xLTUxOTM1_1c08e03d-4d9f-4d6b-ab70-be34e5d4129e"
      unitRef="usd">3887000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTEwLTEtMS01MTkzNQ_c07d13a1-247a-472d-b210-dd0ab6edf9d8"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTEyLTEtMS01MTkzNQ_cda9203a-4a52-4a0d-99f3-5eb3fa6db65e"
      unitRef="usd">10046000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTE0LTEtMS01MTkzNQ_4fcc3004-6908-4334-9b71-ae64087517af"
      unitRef="usd">-1663000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQzLTE2LTEtMS01MTkzNQ_65d20fe5-0d6d-4370-be43-d2886f99ce0b"
      unitRef="usd">20742000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="i110b9761945d4e40813f9a8bbed2a310_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTItMS0xLTUxOTM1_d39bca53-2535-45de-be7c-1e3dac8f36b2"
      unitRef="usd">98229000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i29c821411e9b45e392b05177c8f28d1f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTQtMS0xLTUxOTM1_17d074ef-107c-4a1f-b093-cc51953bd077"
      unitRef="usd">52073000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idec591a925cd42b7a547da2ee176f02d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTYtMS0xLTUxOTM1_65b3abdb-a295-4713-b715-11778383e4e9"
      unitRef="usd">15425000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idd6ee17d39bd4e0bac8d7e0aa55cc85f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTgtMS0xLTUxOTM1_466f6c11-44fc-4c19-99be-dd4079a6dfc4"
      unitRef="usd">39280000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia51588dda918456aa393e95440d4bdc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTEwLTEtMS01MTkzNQ_eba90355-ddb9-446a-85cc-5fa5f188865f"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0d4c76f5de1d474bac108f73781f88df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTEyLTEtMS01MTkzNQ_42613caf-48ad-42ff-8b38-655d54266857"
      unitRef="usd">106778000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ad8c812d379411bb81c7ce92abd8232_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTE0LTEtMS01MTkzNQ_b39afebe-6be5-41a3-902d-10df9632708d"
      unitRef="usd">-7718000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i226ffaf34a5b4f0cb3d9e005e5f05443_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ0LTE2LTEtMS01MTkzNQ_7a684d5d-017c-4a3e-a293-8721717a29f1"
      unitRef="usd">197289000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTItMS0xLTUxOTM1_8c2d2eca-7003-4aa8-89f6-ae89a8bafb16"
      unitRef="usd">687000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTQtMS0xLTUxOTM1_590429e9-f21d-4b8b-82e2-f46a6d39da3b"
      unitRef="usd">715000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTYtMS0xLTUxOTM1_38f07e45-77d3-4cff-b698-44294f982d19"
      unitRef="usd">461000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTgtMS0xLTUxOTM1_c9c29af2-a6e7-4eb3-88e8-a9a588bd4960"
      unitRef="usd">188000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTEwLTEtMS01MTkzNQ_8f7bb437-9f5b-40ad-b39a-c2a8592e0b63"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTEyLTEtMS01MTkzNQ_68752e5f-72c8-4226-8352-f0aed0d96525"
      unitRef="usd">1364000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTE0LTEtMS01MTkzNQ_68c3deeb-cf10-4519-a831-bf9424349642"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ1LTE2LTEtMS01MTkzNQ_f86ee3cc-efe6-44b2-9047-3713a45bb79f"
      unitRef="usd">2051000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i63f7feed7efb41c9822c293fc07278cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTItMS0xLTUxOTM1_6efff960-c92c-4181-b2aa-dd426ce731a2"
      unitRef="usd">920000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9ffdd65febd145629ef3bf0f1d98f3a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTQtMS0xLTUxOTM1_31e7cd66-abd3-4086-9822-1eaeb13d6994"
      unitRef="usd">703000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib3eb7982ad324062a35132e28a1a48f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTYtMS0xLTUxOTM1_0b4bb79a-3bb7-49ce-914c-6b80d9647729"
      unitRef="usd">670000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icebaa0ee710b4a7db07488b5f2e04651_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTgtMS0xLTUxOTM1_fb93df62-771c-4e73-9bb3-7bd1abb7b967"
      unitRef="usd">598000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i791e78275f124c8caf9919dea17c86a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTEwLTEtMS01MTkzNQ_30d411a2-4c0c-450b-88b0-e0c7b5833d99"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i281e6060dd6c4a87ae1853af2814e0cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTEyLTEtMS01MTkzNQ_c9c684ea-1d0c-4c4e-b624-88253be1e1aa"
      unitRef="usd">1971000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7caba0486123421da056d84dc2fa69de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTE0LTEtMS01MTkzNQ_babb9faf-920f-4581-978b-659de631f2c4"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icae360a97ab14698993e6432980a16a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yMTEvZnJhZzozODRmMWQ0YzBhZmY0MGFhYTAwMWNjZWJmY2ZiMjUzMS90YWJsZTo0ZGE4YjMyMTE2Njc0ZTNlODE1MTg4ZDZlMjViNzRhMC90YWJsZXJhbmdlOjRkYThiMzIxMTY2NzRlM2U4MTUxODhkNmUyNWI3NGEwXzQ2LTE2LTEtMS01MTkzNQ_bd322e47-ce3a-4a92-b62b-37424707efee"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
      contextRef="i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3NjY_baacb837-ec01-4e8f-bbfd-defb385d2d94">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net assets of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term notes receivable from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of notes payable to subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings and current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies (Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total UnitedHealth Group shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss of parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in undistributed income of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of capital to parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceed from (repayments of) short-term borrowings, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from issuance of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from notes from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from (used for) financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_268" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes to Condensed Financial Statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1.&#160;&#160;&#160;&#160;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data.&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2.&#160;&#160;&#160;&#160;Subsidiary Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment in Subsidiaries. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends and Capital Distributions.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash dividends received from subsidiaries and included in Cash Flows from Operating  Activities in the Condensed Statements of Cash Flows were $15.6 billion, $10.8 billion and $10.0 billion in 2022, 2021 and 2020, respectively. Additionally, $1.4 billion, $0.2 billion and $0.9 billion in cash were received as a return of capital to the parent company during 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;Short-Term Borrowings and Long-Term Debt &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discussion of short-term borrowings and long-term debt can be found in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_184" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data.&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $0.9 billion and $1.4 billion at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company had notes payable to subsidiaries of $8.7 billion and $8.1 billion as of December 31, 2022 and 2021, respectively, which included on-demand features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4.    Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#x2019;s parent company in the event of insolvency. UnitedHealth Group&#x2019;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a summary of commitments and contingencies, see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data&lt;/a&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&lt;/a&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_208" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3ODI_74e5583a-3943-43f7-a189-f9370877ab56">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net assets of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term notes receivable from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of notes payable to subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings and current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies (Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total UnitedHealth Group shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzMtMi0xLTEtNTE5MzU_0e59b86b-b68c-4f54-aae6-fbab3474675c"
      unitRef="usd">266000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzMtNC0xLTEtNTE5MzU_debf1bf4-7105-4888-a14d-cc01c819c807"
      unitRef="usd">2167000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherAssetsCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzQtMi0xLTEtNTE5MzU_7c73f539-8fd6-4488-8d11-6a3d3460cd9c"
      unitRef="usd">753000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzQtNC0xLTEtNTE5MzU_a9c570e9-9f88-4927-a35e-4d0e61990a31"
      unitRef="usd">503000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzUtMi0xLTEtNTE5MzU_f00f80c1-6f2e-4b92-a5c7-ef43b19bc37e"
      unitRef="usd">1019000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzUtNC0xLTEtNTE5MzU_3a2e7323-a5ed-4937-a581-90c33cfaa735"
      unitRef="usd">2670000000</us-gaap:AssetsCurrent>
    <unh:EquityinNetAssetsofSubsidiaries
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzYtMi0xLTEtNTE5MzU_ea0a7f1d-670a-4751-853d-c283c69179c5"
      unitRef="usd">136562000000</unh:EquityinNetAssetsofSubsidiaries>
    <unh:EquityinNetAssetsofSubsidiaries
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzYtNC0xLTEtNTE5MzU_5abedf1f-5012-410b-acbb-1f60d1c4b1c2"
      unitRef="usd">116907000000</unh:EquityinNetAssetsofSubsidiaries>
    <us-gaap:NotesReceivableRelatedPartiesNoncurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzctMi0xLTEtNTE5MzU_2eade7d3-6ceb-4f41-b06b-a6bd3fbd24fc"
      unitRef="usd">6201000000</us-gaap:NotesReceivableRelatedPartiesNoncurrent>
    <us-gaap:NotesReceivableRelatedPartiesNoncurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzctNC0xLTEtNTE5MzU_bbc0d765-e788-4ba3-bce0-c9ac76b55470"
      unitRef="usd">5680000000</us-gaap:NotesReceivableRelatedPartiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzgtMi0xLTEtNTE5MzU_c2439a8e-4810-449b-9082-ccae3b0abf0a"
      unitRef="usd">504000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzgtNC0xLTEtNTE5MzU_c8c71bdf-2d6d-496d-8307-b9562e035e88"
      unitRef="usd">32000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzktMi0xLTEtNTE5MzU_d39f0860-8fb3-4eb8-a2aa-3a83449108de"
      unitRef="usd">144286000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzktNC0xLTEtNTE5MzU_08f16ae3-3d19-44fc-a364-aea48d532744"
      unitRef="usd">125289000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzEzLTItMS0xLTUxOTM1_cae57793-3bbb-405e-bcc6-b1ca55b49e99"
      unitRef="usd">835000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzEzLTQtMS0xLTUxOTM1_f2e2e685-b003-4aea-8726-9e1b80ff69ac"
      unitRef="usd">605000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE0LTItMS0xLTUxOTM1_0be5e2c7-07b7-4dad-a616-5578e305c631"
      unitRef="usd">8699000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE0LTQtMS0xLTUxOTM1_aa878c18-1f6e-45b9-a71a-c077e7fe7249"
      unitRef="usd">8105000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE1LTItMS0xLTUxOTM1_73a113b9-91c5-41f8-9261-3c1ca4c4d12d"
      unitRef="usd">2918000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE1LTQtMS0xLTUxOTM1_41c38a19-54d4-4289-bcde-d7c3fd411eac"
      unitRef="usd">3009000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE2LTItMS0xLTUxOTM1_6986e577-80dc-4af4-b72d-a6e26cd820d7"
      unitRef="usd">12452000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE2LTQtMS0xLTUxOTM1_1f6be1d4-1941-4062-a41a-cb7d40647c86"
      unitRef="usd">11719000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE3LTItMS0xLTUxOTM1_04089967-1bed-4146-aa49-79fd89d33c6a"
      unitRef="usd">53838000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE3LTQtMS0xLTUxOTM1_091a6690-242f-4c18-8c38-624b23d56066"
      unitRef="usd">41623000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE4LTItMS0xLTUxOTM1_911676bd-986e-45ae-a04d-09eddb1a8434"
      unitRef="usd">224000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE4LTQtMS0xLTUxOTM1_2b52ffca-7098-4f93-965b-91cdd4874daf"
      unitRef="usd">187000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE5LTItMS0xLTUxOTM1_b571616e-e935-4e40-9756-77379979835e"
      unitRef="usd">66514000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzE5LTQtMS0xLTUxOTM1_698cba12-be9b-47d4-9ca4-e203bf0032aa"
      unitRef="usd">53529000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTUzOQ_1aecc172-2e9f-4709-80bc-d6f7fda4af4a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTUzOQ_e4012a5a-2053-4db1-ae8a-ba76bdb3d4e9"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU0Ng_c21e2761-5016-4a0a-ba9e-2e329151f4de"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU0Ng_c5870579-a030-426f-8558-f9475cefbc53"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_0af4f31c-f2b2-4a3d-9f64-e24677ba3bc0"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_38c7d3c9-feee-48cf-bad5-0ff13aa0da14"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_5add7a35-35db-4404-8277-e3324a0a3a77"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTAtMS0xLTY1NjU0L3RleHRyZWdpb246MjM5N2EyMzAyMTJjNDE0ZWIyNWE4M2EzY2FmMDBmNjFfMjc0ODc3OTA2OTU1Mg_785f5284-de3a-4a8a-b591-ea5c81f78931"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTItMS0xLTUxOTM1_b62d59dd-0efb-430e-b566-c78721bda7eb"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIyLTQtMS0xLTUxOTM1_5077cfbe-fc39-4464-9c8d-0c8f1fe13995"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU1Mw_e5a7459c-9b2f-4279-855d-3ab31cf33b20"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU1Mw_fba8f39b-2f87-498a-aa2b-b3ff542cb806"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2MQ_463e1df6-6d5a-44e7-938a-2827418626b4"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2MQ_bc74a5c3-3b63-41bc-acd0-238fc71b7b25"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2OA_bb378609-759c-48c3-86b2-393f8587d512"
      unitRef="shares">934000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU2OA_fef29353-044f-4c91-9b0e-69943a8d4624"
      unitRef="shares">934000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU3NA_1e0d603e-767a-46ff-9a7b-507f967a404c"
      unitRef="shares">941000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTAtMS0xLTY1NDk4L3RleHRyZWdpb246Yjk2NmE3NDczZDdiNDA4NTg3ZTVlZjhlNTdkYzQyZDZfMjc0ODc3OTA2OTU3NA_7a0fc801-d15d-4603-a9c4-7d1d54d130db"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTItMS0xLTUxOTM1_9b8f6f41-d760-4aef-b811-306d505b0ec0"
      unitRef="usd">9000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzIzLTQtMS0xLTUxOTM1_3f42af5f-c441-48b9-ab17-58924fd3516d"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI1LTItMS0xLTUxOTM1_04cc2c0a-3eff-4ac6-84eb-e9ba62552ee5"
      unitRef="usd">86156000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI1LTQtMS0xLTUxOTM1_aa784b56-c72d-4306-86a7-247500155076"
      unitRef="usd">77134000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI2LTItMS0xLTUxOTM1_990bb69b-deee-4979-82c1-24dcb24f8c4a"
      unitRef="usd">-8393000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI2LTQtMS0xLTUxOTM1_5e78aad0-e1db-4d2a-b1ea-e74084959f8b"
      unitRef="usd">-5384000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI3LTItMS0xLTUxOTM1_c9d81e77-822a-40d4-9161-9f7580666621"
      unitRef="usd">77772000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI3LTQtMS0xLTUxOTM1_6353733c-30ff-4215-9faf-d0c0649010b5"
      unitRef="usd">71760000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI4LTItMS0xLTUxOTM1_2a626652-b84d-48b5-889a-71c75223126c"
      unitRef="usd">144286000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTpjN2RhMWQyOWRmZTI0ZTMxYjAzODljZTg5ZGEwMjI3ZC90YWJsZXJhbmdlOmM3ZGExZDI5ZGZlMjRlMzFiMDM4OWNlODlkYTAyMjdkXzI4LTQtMS0xLTUxOTM1_083dc558-5660-4b94-8d79-13329e815024"
      unitRef="usd">125289000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <srt:CondensedStatementOfComprehensiveIncomeTableTextBlock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3Nzg_0a78c974-0a89-4950-9142-8f05910d7851">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss of parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in undistributed income of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:CondensedStatementOfComprehensiveIncomeTableTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtMi0xLTEtNTE5MzU_db2f42a3-e661-48f0-865a-7327e098ddb4"
      unitRef="usd">255000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtNC0xLTEtNTE5MzU_9cf1e23f-fc5c-4671-bd0e-e73f77bab348"
      unitRef="usd">494000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzMtNi0xLTEtNTE5MzU_ecf5ef47-d683-43c8-8b89-0908c6ae4932"
      unitRef="usd">194000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtMi0xLTEtNTE5MzU_8338c5dd-cf99-416e-954c-feed1694dde2"
      unitRef="usd">255000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtNC0xLTEtNTE5MzU_2ba45323-cef7-45be-a8d1-44a10a0fc26a"
      unitRef="usd">494000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzQtNi0xLTEtNTE5MzU_b22b295e-d891-4ad9-8cce-041a1e2a5b4c"
      unitRef="usd">194000000</us-gaap:Revenues>
    <us-gaap:OperatingExpenses
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtMi0xLTEtNTE5MzU_366f3379-763f-4a5c-b8fe-138c4095e116"
      unitRef="usd">121000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtNC0xLTEtNTE5MzU_395ab74c-ed73-4b1b-a132-97ff176a191d"
      unitRef="usd">40000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzYtNi0xLTEtNTE5MzU_a9ab0f0e-7d20-4b7f-b845-7b7d8dc9bdbc"
      unitRef="usd">27000000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctMi0xLTEtNTE5MzU_beaa99ec-37d6-4c27-b2da-1b02867c6b75"
      unitRef="usd">2110000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctNC0xLTEtNTE5MzU_9a17c5a5-0d13-47b5-b644-e5f6b8cd3762"
      unitRef="usd">1583000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzctNi0xLTEtNTE5MzU_ad8d8fca-5cfe-4736-a9f7-b284ac8b3d9f"
      unitRef="usd">1594000000</us-gaap:InterestExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtMi0xLTEtNTE5MzU_d42e372c-9982-406c-a796-20ce8735a0aa"
      unitRef="usd">2231000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtNC0xLTEtNTE5MzU_5150d6d5-8a4c-4fb0-858b-922be1fdbf1d"
      unitRef="usd">1623000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzgtNi0xLTEtNTE5MzU_c384de20-ef2b-4bf0-ae63-d0bee69bb454"
      unitRef="usd">1621000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktMi0xLTEtNTE5MzU_3e5be5ea-9c70-4c44-a573-4f63799ecfaf"
      unitRef="usd">-1976000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktNC0xLTEtNTE5MzU_6a2bacb8-f904-4c6b-821f-9010c261e9f4"
      unitRef="usd">-1129000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzktNi0xLTEtNTE5MzU_ae101f4d-c51f-465d-a879-be82156a7423"
      unitRef="usd">-1427000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTItMS0xLTUxOTM1_9a929de4-1c66-4f82-9fd9-377ee1f80208"
      unitRef="usd">429000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTQtMS0xLTUxOTM1_046691fd-3094-4007-b339-7b4a58e66a55"
      unitRef="usd">231000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEwLTYtMS0xLTUxOTM1_6829d4ea-8ab3-4748-aa32-7b1365552a7e"
      unitRef="usd">300000000</us-gaap:IncomeTaxExpenseBenefit>
    <unh:LossofParentCompany
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTItMS0xLTUxOTM1_8b105093-7b6f-4945-b6d6-9927713de391"
      unitRef="usd">1547000000</unh:LossofParentCompany>
    <unh:LossofParentCompany
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTQtMS0xLTUxOTM1_ed0e6998-523f-4cc3-a018-3449f6e78fa5"
      unitRef="usd">898000000</unh:LossofParentCompany>
    <unh:LossofParentCompany
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzExLTYtMS0xLTUxOTM1_2f321509-6931-48f7-83a9-458a59ec9802"
      unitRef="usd">1127000000</unh:LossofParentCompany>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTItMS0xLTUxOTM1_669dfdd5-48b2-48d4-8d57-c7b80cdeeb7b"
      unitRef="usd">21667000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTQtMS0xLTUxOTM1_840e1d21-75b5-4805-8750-4ed17e6845ab"
      unitRef="usd">18183000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEyLTYtMS0xLTUxOTM1_b7a91b76-3736-48d4-97ae-50bc459a1c5f"
      unitRef="usd">16530000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:NetIncomeLoss
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTItMS0xLTUxOTM1_76ea5d33-c1d5-4801-ae85-1d6bdfa67fda"
      unitRef="usd">20120000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTQtMS0xLTUxOTM1_03252443-ef19-457a-bb41-36e0f9ecbe4c"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzEzLTYtMS0xLTUxOTM1_45ab0fea-b89f-414b-a01a-e2342ac2365d"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTItMS0xLTUxOTM1_137e83b6-df57-4fee-921a-95dbd731c42f"
      unitRef="usd">-3009000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTQtMS0xLTUxOTM1_8a409ff4-4771-4d87-8287-5abe7377f270"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE0LTYtMS0xLTUxOTM1_16762ae6-fec5-4cd1-b0fd-58d1a0a23335"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTItMS0xLTUxOTM1_7f5bd2f1-a8e4-42e7-93ee-7ddb5072f22c"
      unitRef="usd">17111000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTQtMS0xLTUxOTM1_b927680e-557b-4cdf-aef5-28311207a1d2"
      unitRef="usd">15715000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTozZWU5M2I5YTI4MmY0YzBkYmYyMTA1OWUyZWM3NDBmNS90YWJsZXJhbmdlOjNlZTkzYjlhMjgyZjRjMGRiZjIxMDU5ZTJlYzc0MGY1XzE1LTYtMS0xLTUxOTM1_8070d863-4537-4807-a114-16c1e215f2a2"
      unitRef="usd">15167000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90ZXh0cmVnaW9uOmI1ZTNkM2U1ZTM2YzQ2MzU4ZWI4MGVkMWVjNzNlZDhkXzE3ODQ_3c112170-b4aa-4152-9c00-5d0bd2360892">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of capital to parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceed from (repayments of) short-term borrowings, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from issuance of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from notes from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from (used for) financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtMi0xLTEtNTE5MzU_0fa98d1d-c8a3-4100-a470-490a9434e281"
      unitRef="usd">14754000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtNC0xLTEtNTE5MzU_90571d70-20a8-4811-b8d5-2b225959a41b"
      unitRef="usd">11439000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzMtNi0xLTEtNTE5MzU_05373122-3d57-48ea-82fa-f3dfb78257e3"
      unitRef="usd">8842000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtMi0xLTEtNTE5MzU_0eeca91c-1505-4869-826f-342c12421024"
      unitRef="usd">567000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtNC0xLTEtNTE5MzU_e483a05e-dcfe-4a9e-98a9-c22c16116589"
      unitRef="usd">444000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzUtNi0xLTEtNTE5MzU_909a6fc4-13c5-4ac9-ae2e-033bb4ef9ad3"
      unitRef="usd">628000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtMi0xLTEtNTE5MzU_76a85aac-50c2-4005-b2f6-88cc0642adc9"
      unitRef="usd">281000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtNC0xLTEtNTE5MzU_260744e0-e52a-4cfa-b9cd-2f3b87d5c85a"
      unitRef="usd">37000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzYtNi0xLTEtNTE5MzU_b4a3c783-f5f9-4c71-9166-cf70fcbba6ae"
      unitRef="usd">1089000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctMi0xLTEtNTE5MzU_d2efd25f-3067-4c67-b27e-89e66abc6c6d"
      unitRef="usd">20728000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctNC0xLTEtNTE5MzU_7b1ccc3c-a419-4878-be59-0e55efb550a1"
      unitRef="usd">4953000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzctNi0xLTEtNTE5MzU_902209d7-e38f-487f-a53d-d242b099b3d8"
      unitRef="usd">7706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtMi0xLTEtNTE5MzU_ada44ae1-21a2-42d4-9152-8ac950b4191a"
      unitRef="usd">1424000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtNC0xLTEtNTE5MzU_a080b39d-a003-4bc8-8d11-c44f90dcba3e"
      unitRef="usd">245000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzgtNi0xLTEtNTE5MzU_8307589f-1cf0-4978-adce-5c4ad33104a9"
      unitRef="usd">943000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktMi0xLTEtNTE5MzU_28722279-62b6-4f8d-9723-a360b8b11245"
      unitRef="usd">570000000</unh:Capitalcontributionstosubsidiaries>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktNC0xLTEtNTE5MzU_b43d7209-d4b9-46db-ba4c-c17e0df81e98"
      unitRef="usd">747000000</unh:Capitalcontributionstosubsidiaries>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzktNi0xLTEtNTE5MzU_ca5c2c3b-588e-4b03-9d5a-6f5b36ceaa16"
      unitRef="usd">43000000</unh:Capitalcontributionstosubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTItMS0xLTYyMjEy_485e8994-fa37-4836-afa6-6af110fc9516"
      unitRef="usd">2787000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTQtMS0xLTYyMjEy_26256461-2634-4faa-bfa9-21afda52ee4f"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEwLTYtMS0xLTYyMjEy_ba9bbfae-40af-4db3-a572-688622dea6d3"
      unitRef="usd">143000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTItMS0xLTUxOTM1_cf5b7af9-a92d-4ce6-9a1e-764ea69494af"
      unitRef="usd">-17373000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTQtMS0xLTUxOTM1_60190787-e7a4-4f4f-ae22-86503ebbcdcf"
      unitRef="usd">-5862000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzExLTYtMS0xLTUxOTM1_942377b7-3b40-4ab6-b40f-a4044b1aaa9e"
      unitRef="usd">-6202000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTItMS0xLTUxOTM1_4e1cce62-6f07-4573-a437-72e42672f888"
      unitRef="usd">7000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTQtMS0xLTUxOTM1_f49965aa-49e3-4e79-8227-4d6b10c57918"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzEzLTYtMS0xLTUxOTM1_657eb1bb-006d-4d6a-8b8d-ab20c48833c8"
      unitRef="usd">4250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTItMS0xLTUxOTM1_c291842f-f5ce-4d5f-8660-37a75b046976"
      unitRef="usd">1253000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTQtMS0xLTUxOTM1_7164204d-1b72-41de-b928-bbe21311fccc"
      unitRef="usd">1355000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE0LTYtMS0xLTUxOTM1_00e4e1dc-c0a7-441d-be58-d46e4a60a124"
      unitRef="usd">1440000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTItMS0xLTUxOTM1_e31a0610-747b-49f8-a2b8-6be6d2ac2ff2"
      unitRef="usd">5991000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTQtMS0xLTUxOTM1_b1eb218c-239f-4976-b2be-f4a9c500f2a5"
      unitRef="usd">5280000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE1LTYtMS0xLTUxOTM1_61733064-8cc1-44da-9ac9-7a36f330f74b"
      unitRef="usd">4584000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTItMS0xLTUxOTM1_4f9b3303-0494-4452-b0cb-65e242f3e2ca"
      unitRef="usd">732000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTQtMS0xLTUxOTM1_72c6b741-68e4-467f-90a2-b968ae029260"
      unitRef="usd">-1302000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE2LTYtMS0xLTUxOTM1_e426fbe1-697d-4274-a2bd-23dab8915479"
      unitRef="usd">872000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTItMS0xLTUxOTM1_b26e98c6-9e28-4945-933d-756105783f43"
      unitRef="usd">14819000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTQtMS0xLTUxOTM1_da9d5cf1-8556-48ac-a59e-2e07e97ac7ab"
      unitRef="usd">6933000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE3LTYtMS0xLTUxOTM1_2d5bed66-db35-4c19-aa7c-06d1a5d57298"
      unitRef="usd">4864000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTItMS0xLTUxOTM1_d44c2983-a14e-451a-904e-26a8a3db9ace"
      unitRef="usd">3015000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTQtMS0xLTUxOTM1_ee24f5cb-fa1a-47aa-b88c-78d79550eb05"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE4LTYtMS0xLTUxOTM1_f9335627-593f-442a-bced-e773fe3bd477"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTItMS0xLTUxOTM1_b9f235ba-bb19-4ec5-aac2-50c47e55fbbb"
      unitRef="usd">594000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTQtMS0xLTUxOTM1_84350204-1c64-4fb6-81dd-cc5247e00f4c"
      unitRef="usd">3223000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzE5LTYtMS0xLTUxOTM1_f0eac9d8-ea72-4e9a-b4f7-dd9bbaf27e99"
      unitRef="usd">2818000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTItMS0xLTUxOTM1_04e62746-eb38-44a2-b1d6-b94484201cf1"
      unitRef="usd">-674000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTQtMS0xLTUxOTM1_5b56340c-9b3b-44b7-ad73-39c7d67ecd61"
      unitRef="usd">-447000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIwLTYtMS0xLTUxOTM1_a8773ad7-a767-4bd4-ac38-d63e2c72a08b"
      unitRef="usd">-438000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTItMS0xLTUxOTM1_3bdf28f6-eaa1-4c09-8276-c1ffc2b2401f"
      unitRef="usd">718000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTQtMS0xLTUxOTM1_5c199a88-23d7-4850-89bb-6628e10efe03"
      unitRef="usd">-3668000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIxLTYtMS0xLTUxOTM1_6e97e2cc-bfe7-440e-b0db-a4e50ee47800"
      unitRef="usd">-2428000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTItMS0xLTUxOTM1_60055fb7-6ef3-49bf-bfbd-1e2784d82c43"
      unitRef="usd">-1901000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTQtMS0xLTUxOTM1_d2f87eab-e69e-4cc7-8b98-349180410e17"
      unitRef="usd">1909000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIyLTYtMS0xLTUxOTM1_c9479806-fa89-4bd9-9414-73f49b0c6501"
      unitRef="usd">212000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTItMS0xLTUxOTM1_62306646-a9a6-4b45-9626-df418ec3837f"
      unitRef="usd">2167000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i93b5990f30984481b9bc048adaeb8fbb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTQtMS0xLTUxOTM1_6e256ef7-f318-45d6-b3f8-20283f55c2c2"
      unitRef="usd">258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff2e15c2a33d49639d714c65b404e2cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzIzLTYtMS0xLTUxOTM1_f9e4c8df-ce76-47d5-8c4b-8b511d59c454"
      unitRef="usd">46000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTItMS0xLTUxOTM1_24b52254-9395-4a1f-ace8-8d51b4b2a5f4"
      unitRef="usd">266000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTQtMS0xLTUxOTM1_69196088-3b53-4c69-8bdd-3ca83714e0ed"
      unitRef="usd">2167000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i93b5990f30984481b9bc048adaeb8fbb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI0LTYtMS0xLTUxOTM1_4c9bde98-89c0-4fff-b710-942e7961474d"
      unitRef="usd">258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTItMS0xLTUxOTM1_087d5101-212e-4359-b2f6-ca3138cfeaba"
      unitRef="usd">1969000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTQtMS0xLTUxOTM1_4e06ad25-d0a4-41ab-a3b3-5076b46ad8da"
      unitRef="usd">1575000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI3LTYtMS0xLTUxOTM1_af42d04f-3e6e-468d-867e-03d75d7e1f14"
      unitRef="usd">1633000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTItMS0xLTUxOTM1_5c2806ae-9c71-4e33-9c54-d07688df9205"
      unitRef="usd">4298000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTQtMS0xLTUxOTM1_e1ef4199-10c5-4f84-8642-8d45fe86d7be"
      unitRef="usd">3050000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjIvZnJhZzpiNWUzZDNlNWUzNmM0NjM1OGViODBlZDFlYzczZWQ4ZC90YWJsZTplZmQ1NGNhOTdiZDA0NDZmYTFiMWFmZjkwYjNlMDdlNS90YWJsZXJhbmdlOmVmZDU0Y2E5N2JkMDQ0NmZhMWIxYWZmOTBiM2UwN2U1XzI4LTYtMS0xLTUxOTM1_705e407b-defa-46b1-87a4-a5cc6bd1605f"
      unitRef="usd">4185000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNjgvZnJhZzo1YmJjM2I3ZDJmMGM0Zjg2OTQ2OGIxMDNkNmY5NGYyYS90ZXh0cmVnaW9uOjViYmMzYjdkMmYwYzRmODY5NDY4YjEwM2Q2Zjk0ZjJhXzYyMA_8ebf0156-2d3d-4208-b346-e20f60e483b7">Basis of Presentation &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i6b660947fab7488cb4d33baca2cb3a37_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data.&#x201d;&lt;/a&gt;&lt;/span&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzU1Ng_46866d6f-0fe2-4682-b574-9b8193d2f9d1">Subsidiary Transactions &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment in Subsidiaries. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.&lt;/span&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM2NA_682283eb-2ca8-4bfd-9f89-0dc41d4aad69"
      unitRef="usd">15600000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM2OA_a5feb08b-edb5-40c4-bd2c-2e84be7525c0"
      unitRef="usd">10800000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzM3NQ_02eb81f1-9b65-4264-8600-3e5f3da8541e"
      unitRef="usd">10000000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQzMA_09c34764-61cc-48c0-af3a-ceebcbca0642"
      unitRef="usd">1400000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="icf2f82ec80c64e699788ff6611e93710_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQzNA_036a73f4-dd30-4794-8d2d-1b70cf94872a"
      unitRef="usd">200000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i100ba8b846de4f95954316fba8b7cee4_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzEvZnJhZzpkOGQ3ODM2YjA2ZGQ0YzNhOTM1ZDU5MDA1OTNjMDc2Ni90ZXh0cmVnaW9uOmQ4ZDc4MzZiMDZkZDRjM2E5MzVkNTkwMDU5M2MwNzY2XzQ0MQ_6e437682-2eb3-4a03-9768-40ecf7d2fac8"
      unitRef="usd">900000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:OtherLongTermDebt
      contextRef="ib4fff4265a4e4d199f1a2c9eaaf5f04a_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzM4Mw_b4030a30-85e0-4361-9264-5657d3c6b963"
      unitRef="usd">900000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="if2c84ad3559147a5ab4604796f8bb30e_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzM5MA_9d354267-5549-40ff-91dc-2d396849302f"
      unitRef="usd">1400000000</us-gaap:OtherLongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ib8a17770576849b184901ef11ae7bade_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzcwMg_f353fa25-153d-4678-ad75-220e7a898688">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzEtMi0xLTEtNTE5MzU_a433ed9a-c28e-470a-8310-99186e26ebac"
      unitRef="usd">2925000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzItMi0xLTEtNTE5MzU_55ace68b-172a-411b-8eef-9b13822480eb"
      unitRef="usd">3000000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzMtMi0xLTEtNTE5MzU_5375021c-58b0-4a70-a0c5-c435b4f434ec"
      unitRef="usd">3050000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzQtMi0xLTEtNTE5MzU_22151592-c371-4d02-bbb6-e98737096af6"
      unitRef="usd">2500000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzUtMi0xLTEtNTE5MzU_bda16aeb-aded-4edf-afc1-e24b417bcd1f"
      unitRef="usd">2925000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90YWJsZTowNWY3OGMwMTk1YmQ0ODkwYWU4ZTYxMWQzZWI1NjA1MC90YWJsZXJhbmdlOjA1Zjc4YzAxOTViZDQ4OTBhZThlNjExZDNlYjU2MDUwXzYtMi0xLTEtNTE5MzU_e40fbfb7-c01e-41ad-817e-333f8bb3c230"
      unitRef="usd">43502000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:NotesPayable
      contextRef="i3f868329b34b47d3b53f4028690c339c_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzYwMw_02c827c3-b565-4439-9ab4-ac96dc8df80a"
      unitRef="usd">8700000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i1ca5ac6a0bbf44b6b43f86f4eba09da5_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiNjYwOTQ3ZmFiNzQ4OGNiNGQzM2JhY2EyY2IzYTM3L3NlYzo2YjY2MDk0N2ZhYjc0ODhjYjRkMzNiYWNhMmNiM2EzN18yNzQvZnJhZzpkYWIzMTNkYmFhYTg0ZGMxYjhlNzJkZWY0MDhjNDkwMi90ZXh0cmVnaW9uOmRhYjMxM2RiYWFhODRkYzFiOGU3MmRlZjQwOGM0OTAyXzYxMA_59fc559e-d49a-4eb0-9e03-18ee3a3b16c1"
      unitRef="usd">8100000000</us-gaap:NotesPayable>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>124
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MDF0X0D]DQ;A0@=+K")ZI\'K:JK:@#(G50%V6H"Z/ S4CG+) SNH(+C'*,75
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MLPLO5MX7&X*M\K7H"R8$B_.W(<$P$\L#8/^2,;';D%]0_OW#^!]02P,$%
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MT/MJKDK67:,VM"A=I6Z%-G7OIH5IM""M@]G?":&/ACV@;=WI7U!+ P04
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MT0<46G^9+%7[%SWVML$*90>E9=4/-@JJHN[^\R_]1(P&8+8P@/0#R','T'X
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M5O"N'#(C>67R9?%7]X7=IM$ZI4&W3<-UFD*8?=>KG.S! +NSX)HE:;2P"_!
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M[D#+??O*P9W46E;MQYW@N6BL@?G]7IJ6JC^P;S&<WEK9_A]02P,$%     @
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M+J\(;ZH)6#FHMWZ(+#722/+FAGX:8%P K:^TQG?'S:7F-S3^!U!+ P04
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M=+R2-]+\#9Y[;3@+RKWL^+8OK&JPK=O#:_&S;XB3 BB>*(#[ M@N0"<*D+X
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M2!IBVS(DHY$-_Z LC":R2#RP#?:SC>G< VDJ/V;#J6JYXWT/@\9<,B$4V20
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M<FMS:&5E=',O<VAE970Q,"YX;6Q]5=N.TS 0_951D!!(I6E3+BNVK41WN3T
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M! W5LVF4G*?"\-A6(X7]5,5*0 )]4;''? +^$K.&$@,KZCM.PDB**.J13?5
MG@M(<F_7%H4OP 5Q41!RUPD@0("6(M:X!N?W@D\[M748)0 IFI@%Y5F8&WJ
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MP8\!CCJ SP"^>=7B+XQ'P86H5/7,YG( W,IO2OJW^.F/$8ZU#8GR]R%7[WD
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M<7&S>/Y]Q#[OUN L516_OX5E3KT;-DU&FH$OPX>K0IN,$KRBINZK'M,C0SJ
MTOSLOZNJ"3$ Q\(<&J"/&BA M[E$PC),RHD="F6J&4.G!=WH$![!;:=WG!#[
ME<,Z.P'+.00M2#9T0W_:\/\_/J7T*3Y3\0F]VVI3/ZMW@TK[!ET>"-I( ?IS
M?DDZ^0D\COW;:]N1U\+==!@>?55<E2]N7L#_U^7UU57Q2]HA<W5U4[Q^E2HG
M7]R45Y>OB^O7M*6Z66=7K_YZ#O^6-S>OSXL?\2N"F'[E=Z^OX=7URY?GQ;N$
M^T+@DURV+UY>7A:O+I^(#K9)IXB\*%]__2H@=(\R<?&&(F$\(] =QQ\_#=X-
M=_Z$,:IK\'A(N/0K4ONJQP[DQ/$<7/TIR"1K.\2>>ESXY>Q#]MS/Y"LY9*+*
M;!2)-%@M2I#GR2/.C(<@7;7OY*N&9S%IC:,>)([AM^<AM80845<&E?Y"9BS>
MX=(O.6(ULX^IBJ0V36O$>FZ)T1PK@1XU] 0G@D0^YT=?H0C?"4&$5F[D?^8^
MX/L\^>@Q6(TU?=H9CPX\!_[^<7A:Z->C;_FCR7$X?WKZ ]@5;+YJS0JF7BY>
MO7S&61?],;@=?4)YZ08P4?0GV%M &0? ^Y5S@_[ #<(WM7_X-U!+ P04
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M\K>T96"6O3W@AGU>3^SS9!?13<I&W8[BD<:+X>H%G*BO+6&P,?T1Y]Z:%F8
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MTK;J*0D \FVZZG*$FAA3A])*-:'KNQPQ@ 5!0/$K<2OMFK?G+]\BIMBT;;C
M)L9LR;R03$O<"0OXB^H6"+G9&/V)[;,[QB$WI6M 0GF'_:WG8]^<E3Q*(#UZ
M_6*S5;=#SR@;6IM,"R([("D+F6[4BGL.G^0']6R_481NH?9>(-0+GPO?>F2_
M:Y%]H%E&K_:03ZL.\\$H OYQ1CI&1VT[%ZI48.FFY#UR"L@'B=1 "'=:,Y"[
MX\RFII<7,/09'DT2]?)S:70))=PZ-]DY=6K\,"5UJ$;0\N=[-UY$P><K50&/
M!:0 U;;1E2K%\::E+:T-P%OP=C[QMNRK4%$'0!NAST,,K:>(GC4IWS.Z1B\
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M>X<%[^U2Z >X<+[$!6% =H GH.):W\AN ;Q5?6=!S6$QJ(E@=H,9NU+:<J?
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MYML)?V;R7';N@3S9*'5/#S]MKQ8N&21SF1J2(/#G0=[)/"=!:,:_C<Q%JY*
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MFTUTQ\MMI6V@5^,-N'41N]N#,!@D..4BI=TWQAZV69FJ"@.]$2@/8Z!5M3_
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M W?)7F=9W8A!#:1E.0GD%J8SEGHI_0;A8?C1.&W#R 8.8IE;H%#M44AY73\
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M$B1JF8RDXUI+4&DY5,F2S,6H#9J]C!9LVV>V_2NV4D3Y2KF<.*2Z:(U=4BM
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MQ%_]5//0$9CM$YC4 A/!'0\2E+<ZZ,MS9]?*\6YHXPLQ5:0!SA3LE/O@\-1
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M)4JQA5;EZ];0!M, 9%,63Y'XP]EQ#(>"^!JCWRLM,K6LG)QCBD.+@H=R$[+
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M;G=IAP1:T1Q[CLF;XKX#21#\'N_HK7@<,6!?,#-N5OO]-9<YFV^[LJ+NW$M
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MLE:5[G8E4.8T;<#Z0BF[>R ![3>YF_\"4$L#!!0    ( )"+6%9X*H-8XPH
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MZG6G$FSA3M9(*\=T/Q!W&D<+8H2^L+6+C;QA?3%S4U.90&3A;;<I^SG$H12
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M^H[23@B@B$*01!\YI8_=DE<;KNH U]%T.$3G#.))S$><5<BR!'(H 1HM:$:
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M,ARF;([KE/UJ3!$Z&Y;(C;,D0R12X(S(?Q"%P L![==&HYR]-2IP/L*)S";
M]T G:80Z_K\WVO[0]MGPI/E]WZ'5UMTCEHZ2L_$4%_-D-IJ%6DBF\U&@D37_
M;"PU%Q3LLG5($D%Z-+FB!ON1%40E$H: 5#U_8E5M*P.*B52$F4U)=$&\I]"3
M?(7!'S<EZ +CC<F[] ;Q#;?2U.X;)!@Z6KWX3*,"]9SB<]WT&- V\50[A'*U
M==1-<1#>D*3:HI)58"%L>UTT@18 )$!\D:Y).).:MI+_%47TZ14?E5S:R)-1
MUV-XA1'%*2=B!RO53I2U@N)-;&!RJ:,MT"R].*4'Q2'#VD %TG?D0#-)E8BY
M>83!Y__(?%V>!-L\Y:+RH4^!-7\AR_\,#/]7:_1U8_2G:/0?LA3_=[G;\$(F
M[&D;ER,JG^F(I9-H&F4D*"P=[99(U&RV?_Y@>8$RP"MW;$7MD+9E9[,9FS92
M<]!:<PG>F<QW#R):J,8TMNS9=+H_;#;K+"*(NTC\0\2.6@;>&PXR3M/NC4F@
MV_T!*VJ=#F^_84HRN];X8F!$#A2R;?H[>XB-(FTBV3 U"IJF<E47W38<QH']
M&-=MR^W);3_O6-(,X+A3F?A6T-B&*R>6;>$UDD4S^;V8JJRIEZM#L]!K#S#X
M8Z)BX2/%1NBVFHAU 90. WD<T#RX"5P'5/KLD^8U<($B#/LL?%WYSOZ6:"+T
MWQC4PC9<8(GC9/3O,"6M.$HR#XTNO%'\F^N:N"YJPF\82N6ZM3<8L$![9(!2
MFL+U#[W%#CK?(5 ER_"UA4Y&HXV?)'9W=Q]TKN-WC+UX_!KTCMNEA*%*E-@Z
M[,\F/6;C%Y:X\*8*7S5@%$HR7.(- @,F">!Y:8QO%W3 [C/7U?\ 4$L#!!0
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M_H:^AS,0.[#[&DOM9>C/6&W^,)I!4U;ZK]ZJ;)IRJQ\W:-=$31/P?5W"4-V
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MVF7OF\I4Z01/ 2N/VI6B]N;JZ(SO3#G+GLWS[.KRZNK(?,\\J9[1?,\?(U5
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MX2(A#*,[4\/_N,<'9LQ @V<;4\' .BMA(N"D8E<L:D/OK=JVNK=U/<O>"@Y
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MD&U- ]Q=&W@1(K%5TR+/D-CHVL!<E0W&#2S7X2GNURUM N-B31=D&7A\#]!
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M5PHVSY(E#^&SV%+&$NA!+I!N\C:BBF@.Y&L- _5Q)?XVN/N!3LSE-3JE0!Y
MIE^;;NP'HM5)<5 '5A(KE60]0/M8MU92 OC(XN"^0%12L1B.>!'\(P.40+<7
M!C'N%81PCC,Q"Y.D3U X08Q!W\$RI$E9(W+NW4^PS_%3D[$"53%9&@F54->
M/& J+L3[;.UX-6]I:Q"<[31WH.$VXGI!#.2<NEI>7^S%+D7$I<'+04,R*>VD
M5V:)%^QUCH;F>R**4J@V:N\E'[U'VMUO*3X6P>@X9""6 3>DO4=G3WQW860*
M KUN=YQY&<E-X5)G3IET1JH4V7;I,Z#^1=HGW/=\Y/\3BSG4'F*](>1!O,%#
M9OL")$"5!SB!<UH@.V*"QRD%/X+V6:W[X.JX=MG?:WHG-@NZ'3DF1"PP"?O,
M& JAP4DB%1BJJP44AMZU \35\+87_%PX=P.2O?"*&3D(_F,_#LB R:P]B!/.
M6_F4>T1IF@-L.^.R@5B.$C"F@ 7%UTZT)87>N+L8T6!TM[=5[.3CB&[DA"=*
M>(+=26E0C.$XWT,[EE@WOU18AGC+JRST#$'DEQ><2B*88_^)D\X^M6$VZ&Q[
MQM!O*MK@BQOP*\F\L(.IDH&F*-JAR>B+XBA4!)J5Q$'H'^LZNK/6C9C?4\0E
M,PO2F,9&VGY!L)6X>9P01V)[4DDB16G$NCI6\IP=4D<8Z<["!4RX3SIQP[Z&
M=A/)54F%2BCI?6W,X:MM)Q$DI:O.,B_4DA$:^<1+8$GRTASSB<YR@;.0VFJ^
M^'+1++M.Z8I&MS'66[<H.$5T-=L[R4MYUHAWQP89]Y\LA 6=B&X2Q>RD.70.
M7P"!25+6J5J@9M/V@1WV\EDLIG$%178DSJN@"4,M^6C1:*:^J2.6EEC>[\'A
M1(C7A65+!J_PV4V(&Q%Q7Y118)4??XC]+)P'PQ0@S0]^V9R5)@& WMYXCZ.I
MQ.:*0MKW<1T[G,I (2([B9=F4GL[H.#$W(+2%O^65_?>X36M_@[4 =ENK0+3
MRO !OOH")NL,E%NMHK&_$8<3'HI[S)=\\W(V9[,K=/_FQ>RY/LB)"0TU&V"Z
M]F,S7CEE?Z!7B_4O !S(NRBJB\HL>@K4&F=4?&%56CI^UR-=. A@71X>U+8@
M"9"@HC)@G3FW+R\P]WK/PA<H(Y9]4]24+;K%U@*'ZG"2H# ]8N69F8UA9DCT
M]UZG?^=*B\O<BU:D@SF4FLQ7C3;(MEI#@DB&LA0/!>;EP7D=V.)1@HYK @GC
MPUZ>9_<%"[P2%()?@684):>I,-RVY4!A/U6Q(I! 7Q3L,1^ /\>LH<3 BOJ6
MDS"2(@IZ9%W<D><"DMS9E47A\W!!7.2%O&T$$"! 31%KF(/S>]ZG'=LZC!*
M%%7(@O(HS W=08!#QDPSCQI]>VQ1O:L_=!!?)/(W\ZO9BR ?%,]((JUK'RBY
M4:,HU$L$\2CQ.3AX0*GOP**'E,%STL40V16K%<9.2AW%'8(<9Z@2S2*UVYIC
MQ=MO??'VVZ/UUD^B8=^20(4,ICZYD1+[B<7=?\]B4_E67Q^(S$+:!>"SQDZ<
M8R36=+,"3H(V3O4,6]JAH2QH.OL!O3'+W@<W=^S#7: <8_8%+?"=;0?'!0X?
M\DPC$!)EWFV6F*>L"[OA9!?9E]@"13IB6:B^+VU7#ANL(I2&?99-2UX'JA?
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M]4@[\RDM7'V+GL,1UIQ*KL:^J:K/6*P?[X0B46,#_<VKV57:"?8R/!AW@IV
MT+&#<J(B8F@34.:S9RDHSPXVI1U3PU=!#5\=U9HW> ^)9=%,-:AXSZR;)_7Q
M:3._YQXX=V0)>=/$;[:)TE8++/IZQ"VD<+DK06I#Z $TE >#S0(:ODB)>C7[
M+CQX=$-/IGJX@V9^_(X8\(>P80R\GINZD+ 3$TK;?R7;>/):?@5)29//3I'@
MK?;CAY=-\G(9O1R:]SO#!ZO).^5H4C(^H,.'C9SPK[ E";T8);]$H/1@EL#A
MIXZ;V,/YQG$9EAP[KG%K]S/9V*:H+]!,Z71Q#())$'Q!CP[[?G9M(!R%1@1P
M,!G@YF'_0Q@6FK@!DE;$V.<[/$(1F*.$:3A*>910TK5!F2ZP 7@ZX0*W6FKQ
M<@YA'1]1!Q(L!TP:W(5V&A8D!B'Y7;JLOVKWO\\^0%1@44OGV*&/'Z29W8]_
MAO287TI ]V:P=46)Q&<O\(?G^L,D%]#8%_+&+P9,^IJJD1L*94("QA/.1'2@
M%'F(0T)79XT3D?G,0BO^F&C^QI+:+H_V&,[#I4?SX_<2_8+. 1"*$'$G2_?Q
M2:4 !VC)M#%OU?Q(&LKMWMYPS!#R_JV?3$9*AR>U+#<7)1K0VA<W05UCTJAM
MJ"L'_=>*G:1K#KF8SG03"8S3<Z@FEQ\Z8N%V29)Z]OFW/\Y]W(NY77HGB86.
M7,NPES&ER)#;>_72!Y[1GX?V?!+88:_="BL-?/ D[CH#9/DPI68'%%'VS2C%
MAVD\]?8[N6X(PVN\<<26>/X073\:F$:^8-%0"!SYMP!(IVF71=L!Q^D1,;F$
M1YHPRAK"5?#/@(-+?SXPX#4[0,U])TK-[72$&C\]<$_)89?KF B%2Y;FQR]&
M^EGNMY+29E\T?(?/M42T^OM7F] 3E_V]]2<JC3_.J9=N4<Y4<K>YO^J%3AIA
M.G;9\2576'C -A]3F5'/K)Y.BO.P(%!C?QRSY$O;.?:*G),[5;@:$'7!!$CM
M4HZ\$B"21*94/_(D!19IN14MN)1Y\"%V7U ]RU3,F$%=AO3+/I!4V*?3HV03
MO]@MK16#B^AQ;;GBPCWZ"[Z9H]7W,4F3#)AE_UAS$Q)2#&>8>BLE+],LM).E
MV2.G[= IVLY?7\#A?%*$F:4,$4V6KKP97$_'S=*+U19X\*7(J$,%5:CA4K:Z
M,*)DY8N_32*^OC&>CM*-(I81 _F^+_6=0R5'KJK1ZLH2R_@>N>PL^$SNP)*,
M0:C1Y.HI)-5G;8F6$B =4 \V9P5*H%]+II&Z_Z,CR_R)^CYK.;JE&\$C9DQC
MN1%,:K8;;-VBNP_C-"RVU[2@1;7E"W0SO.<=HZD-)C[R)9M#Y;)I^>$E8E;*
M0W%'2RSQ@1GI\]%^2\R<#UM_]E#G#_UIX:Z_W_ED$1V$B1>(7HK/X'_-V9ZC
MGD\X7C$_?N3A,;4]\>@K]??Q]??FG\RFV?!6E("/[L08JV6^G>!021/+&R4=
M\&WVIL[.T'S3)[K$ZUS/)JO]F,[W87F%[D@S%[7E>P&F0":]VW/9@ HML3;0
M"\B.,,W^K/\?W!-:(^?'FQ?3G,$OD1-R*G?\J_/_=M I4F6J=P%1AY33XX@8
MD+0.C<?9-_.]Y,-\'E(Z7YE].)=D,AW3;?W%<CY#EA0A/M]^>+3BQ&\JAG(C
M$E_02,[SE@GL+[M(+@]9L']WO" 06N7FQYO8WNGY1MG4ZQ),B.-.@[=\4/@K
ME<+Q]0XM,REYW'#F#^SM%8M# V6X'XQ.9$0799*YXUL+2-8YG I]TYZNW*'0
MD]<. 30?Q]'T.GALMI1>RN1( $7W$3*<&6[,/=Z>M!QC$-T XUL_DRM%]5X1
M[)364ZPA^W)TRT.#W?QX)UR(%BB[>1M=,XSZE,7O8]QAE<07[]'ALU]_??!Q
MJ/ &]>_=MBC-3T\HKNSNS)/7G\%=-QN*?7]M&ST&@TKQH\1Y+HO>:=)WK'_G
M0-P4W[",5S!0Y: R[&BAIX 76Z"?>.!4E%Y^MU_TZV$2<'JZ76BKDAJI@A3V
M/%P_O"6_3ES#!MR7]A[K+@Z8POC[-'"QP.Y=P#[M<..*0!&NT<2S/WK$>USX
M,3W?:>-/_*X32O",6KLM.DSV]O$+5.?E(%HME@_$.5/&\3F&:YX"="A;E&""
M23YRR7R?PH3/IU<TA-AH#VX[/JJ,V"];[$TB8#G#J!TI%5VT,SX(]U\NIO0A
M/E-MX<\TJ7MYU'Q[J_,]>O_9AFV4.^<?R;2?P.-XKFEE&W+@N8D;<Q3?9//\
M^;/G\/]5?C6?9[_&787S^;/LU<M8%[OL63Z_?)5=O:(E->(XF[_\]AS^S9\]
M>W6>O</+@+'4Q;^]NH*?KEZ\.,\^1-SGTQ?1G3G9B\O+[.7EB>C@\:$8D>?Y
MJ^]>>H2.W7$?NJ&NCK<JW:)@R>41-W*7QW5HWCE5LYVTRAM:!=D)M#JIWE@(
M?4C"?9WZBC<"R$@N@K:X+SH\0Q1%BSV Y[4'FR'<)^I@Y!\G'W*X?2;7\I&_
MDR=OD?(!%XC*IFD2G.NE/J>G9G%TC?)9*&7B6W>2?.!?SWV*'#&BGCOJ4O$9
M_G *6Z^.QL:;+F0VHS8JFB.T'N68@F%UU>%!DQ%.!(G<'TS77OF+R1"A93OP
M/\<X+?1=7!UODWBO,G<#4Q-#?*WY?&0!%.QD$;SJ&+:,UAK=AKH!.\.]!=@;
MJH.VW#R)@X@^>Q7MB3]5$+^/10*ZI6Z748<9[G':Q/POSX=[>T]_(\14%WJ&
M,%PM%H]BFXU7V([NP)LR?3Z)A!U=]2 7L/S[21**2/\>+/)P[2?%(RUV$W&;
M/N&!61F99QR*)&IB0M"]07U_>W,S5@L*(LT1'24YSR,4\6I0<-!W\IJ:_]\/
M_>2OK"^R]6Z+1H/+R]ARK)>S"VS4=8NGYJ74M*\/?;C%D_KTI@M]@4,'CHZ4
M2#PRTJ^FNQ(?0_!&/-R/,YHZOBU2V^30)1$-QHE([$?D^^<>\ ;R<#V-7Q3/
M$?C$5&(%^#S&[X>=HNB:/;_M!"/U;7.?P<%WE")5?(T%>V )+TU&'T^C/Y\#
M@<V*_D@0&C&@ O\E'?\TTS]$=,U_?B>\SG_%Z!.$/GC(H#9+&'HY>_GB"9>K
M]$O?;NF/\2S:'J(H^@@A(4@8O@"_+UL0!/F""_@_S_3Z_P!02P,$%     @
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M45SD=$6CVQD;K%L2G"*ZFNV=Y:6RZ,2[8X.,^T\6PH).1#>)8G;2'#I'J#C
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M"V_P8FA E)^&ZJXPX&ER,0UUG<<C%.2EPQ3 [FR5#9$6<'2QJZ=X$#.2/$0
M1D]PR/T*,HLKZ98+H7:N,JE.EE024<-."([[(YF 3Y&1,RXU;+P=3M2[QYY5
MV]/LR]B"%\OHW&07]%/P7$@_K5IW*X$"TAM]H;!84.>Y")7B  WD<SEQ91-6
M Y\QZIVYL;$V&WJZ: ^B*PN*DM+3P;Y:[T=)]RO9"S1C ^GB+'&35$-MMP*
MT*Q0U28:QVQ6L"R'*!H;-K0U'5'2NK6Z"FA=5]X0-9*]CF$A\^RB^,EU)[Q[
MQ2?74M=)\E4S8@':/TMY4..HU,2\:;&56J:G$C)O*GEHZ<F09=[LS0,CPRW-
MR@E8U!ZK^2M@]M[,<P8_2MAR<G D5SX_01B3IM2T%+@#]2N1!07_=0AYQ1C,
MG_N1+*8GES/9#-0R*_":'"+96FR"PS= &AS7@1WES-%,"J]1"97T-A #S" '
MVBWV"I #L:45LE7\A ,@M 9O5WK"L: =E&'C;CMZVD@3_@X/C-UK"S?PP@J[
M!W=C#SA[$WI0T*FGUDC2A'/NXTQO?4($7 0SFUB+D8KU^Y#VS>@8^S8Y-T+U
M<EIIONA$N4-N= '8+BX^7$F/:P4F5\-7$'EINK@,TUUQLWYQA,#3./F%CSO
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M+-/C"_!\Y8!AY0LN$/[<S.O_!E!+ P04    " "0BUA6_3'_.6@$  #P"@
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M86Y9T3#3L+$KD3?-*>L6%>)?EH!RTV.7,URG^,>.V,?:-<WR^X,I:@;/V=G
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MW2P,I]:,;$T;\/O8.;^:T 'K5U@7_P)02P,$%     @ D(M85IU&.#08!0
MK X  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULS5=M;]LV$/XK![<K
M6H".1>H]30S4:8,5:+8L2;L/PS[0,FT3D4B7I)/FW^](R8[CN%ZR#L,^6"8I
MWL/GCL\=Q:-;;:[M7 @'WYI:V>/>W+G%X6!@J[EHN#W0"Z'PS52;ACOLFMG
M+HS@DV#4U ,61=F@X5+UAD=A[-P,C_32U5*)<P-VV33<W(U$K6^/>[2W&KB0
ML[GS X/AT8+/Q*5PGQ?G!GN#-<I$-D)9J148,3WNO:.'H]3/#Q.^2'%K-]K@
M/1EK?>T['R?'O<@3$K6HG$?@^'<C3D1=>R"D\;7#[*V7](:;[17Z:? =?1ES
M*TYT_;N<N/EQK^C!1$SYLG87^O9GT?D3"%:ZMN$)M]W<J ?5TCK==,;(H)&J
M_>??NC@\Q8!U!BSP;A<*+-]SQX='1M^"\;,1S3>"J\$:R4GE-^72&7PKT<X-
M3[DT\(772P&OK_BX%O;-T< AL'\]J#J040O"O@-"&9QIY>86/JB)F#P$&""C
M-2VVHC5B>Q'?B^H 8DJ 18SMP8O7;L8!+_Y;-PF\LU8X"UQ-X)/D8UE+)X6%
M,\'MTH@)H%8N1+4T1JI9F/6+5F8],.)66OCC$RX 'YUH[)^[XM6R27:S\8EV
M:!>\$L<]S"0KS(WH#5^]H%GT=H^OR=K79!_Z\%0JKBK)Z^]X2NY=Y0XV!'"Q
M[600!%R);PY&M:ZN=[JZG\S57,!4UYC['M<%P."S\L16M0#T%*:>R$T@TK3\
MFC!I? >UN!%U<*/BQMQYI##1(K0!Z7=A91-\VH#RB0_WNS<.CDD%#GF=:&5U
M+2?<H=F(UQ@U 9<^E>PAO,9)C:QK+!WV#?RVU'[2N9$5KOHK6AOXK/38[UT;
M).TPX"A;T8SQW4JZ<,+MO&..#?%U*9%7\.LEL)C@'&S0+,;GJQ<%H^QM^R+.
M4D0;.[">>ZO0/O ;+FN_7A\=[UM$.H3/!Y<',-,WPB@?L+ 8EE-5853'M9QQ
M7_TLQ"2-4HBC9+U.3(JHA$N'[@>C9JED)1?HQJ;=:G9.6%)L]4ZT66CC[3<M
M<F"49&4*M&2^691)2[)CU6CC9MCNCWEUC4'=\' %GY&TR+9ZF(7]9\(PDA?)
M5J_=J,D30NM#AI4M+DA&\^!,PDC,*'S 771WF^:,1$D,<0IYA&V*H>E2;XGU
MT&"]5D@T[ Y%$@7.85$,908)B8J\X\2[;'V@WY>X921-4FPDE$2T\".I?^:4
ME$CF7)@*@1'?)Y'[/E+"X"=(<WQ0_XLB?&[KE>[7*R5Q6@:]/I0KCN?_NEPC
M'_2";LB5EL4SY$JC;*NW6ZX);EE$2O2)8731%YH_6Z\I*2.ZU?M'>BWB8JOW
M++U&N+]Q1LJ$!6>2B#",XDZ]ENAV#%GB]9KG>_1:Y@B&&YRA9B@*-DG*_8)E
M!4GRH-,2]9+[1N'K6U803^I'!+OG=$S7IV.Z_W2\/^_.-HX9\O"4?]K1MW>E
MW:?\?W >5L(X_!J'Z?H[0"KKS+(U5]K]/\[*]GFR<J#=DL<'Z..J,A?UI.]T
M'S_)_> =2BO-O<QH.$SOZU*6^V*589G]I-6L[X1IVD3RD=.!5Q<C7'^S)&R"
MI#')6+9[*,U(@4GTN(H^C72<K$E[^ED2LB2A/T27X6$9[QY*,A+AL;,KB08;
M-XA&F%FX)UFH]%*Y]C*Q'EU?Q=ZU-Y#[Z>T][HR;&0H.13I%T^@@QRPQ[=VH
M[3B]"/>1L79XNPG-.5XGA?$3\/U4HWZZCE]@?4$=_@502P,$%     @ D(M8
M5M+:K$4? P  "@<  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&ULE55M
M;]LV$/XK!ZT88D"()$KR2V8;B-,6+9 "1I-M'X9]H*63380B59**T_[Z'25;
M=1'7VSZ(XLO=\SS'(X_SO39/=H?HX*66RBZ"G7/-31398H<UM]>Z044KE38U
M=S0TV\@V!GG9.=4R8G$\CFHN5+"<=W-KLYSKUDFA<&W MG7-S=<52KU?!$EP
MG/@LMCOG)Z+EO.%;?$#W>[,V-(H&E%+4J*S0"@Q6B^ VN5EEWKXS^$/@WI[T
MP4>RT?K)#SZ6BR#V@E!BX3P"I]\SWJ&4'HAD?#E@!@.E=SSM']'?=[%3+!MN
M\4[+/T7I=HM@&D")%6^E^ZSW'_ 03^[Q"BUMU\*^M\V)L6BMT_7!F<:U4/V?
MOQSVX<1A&O_$@1T<6*>[)^I4ON6.+^=&[\%X:T+SG2[4SIO$">63\N ,K0KR
M<\NUH?P:]S6$M>3*A<!5"7>\$8Y+\0U+>-"5VW.#</7(-Q+M:!XYXO7>47'@
M6/4<["<<"8-/6KF=A7>JQ/)'@(@$#ZK94?6*741\B\4UI$D(+&;L EXZ[$+:
MX:7_;1>Z37CWI14-'3\'?]V3.7QT6-N_ST7?8V?GL?VMNK$-+W 1T+6Q:)XQ
M6/[Z2S*.?[N@/!N49Y?0_TUYES-XQ!<'*ZF+I[/Z+S*<UW][O,6@*V@&#3@P
M>QW%R3&RQV,D+' +E994#NP-7 E%QUI*NJ%V!)17K#=HAMR^FDG@WD/[3]1$
M_(R>SL(;&,\FU.8Q@U4K9"G4UKXVR\,\F4$63J<,[G3=M(Z@OZMF83Q+(0FG
M>0+O6Z.$:TFR1ZG$B^];,DF2U!LF&=RC)8ZB:.M6<D=1EDA;5 C>%9RK+,QF
MLQ%<I80W&<$Q51W>P!F"HM*;AS.64IO.V ^W;]BV<3A.QV0PH<OTBI;7VCCQ
M[4#+PBQ-1OZ?I/GH+%Q/FH4LSB$-\\D$'C79_*],]AAO((G#A$VI,PUGXQF<
M.]/127VJT6R[*FRAT*UR?:D:9H="?]O7M^_F_2OQB9NM4!8D5N0:7T_R $Q?
M>?N!TTU7[3;:4>WLNCMZK-!X UJOM';'@2<8GK_E/U!+ P04    " "0BUA6
MR3B#>M,%  #M#@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6RM5VMS
MTS@4_2MW L.D,X98?J>TF6F[%+H#2P<*?-C9#XJM) ;;"I+<M/OK]TAVTI2&
MT-G=86CTNE?GZIYS91VMI/JF%T(8NJFK1A\/%L8L#T<CG2]$S?4+N10-9F92
MU=R@J^8CO52"%\ZHKD:![R>CFI?-8'+DQB[5Y$BVIBH;<:E(MW7-U>VIJ.3J
M>, &ZX$/Y7QA[,!H<K3D<_%1F$_+2X7>:..E*&O1Z%(VI,3L>'#"#D]3N]XM
M^%R*E=YJDXUD*N4WV[DHC@>^!20JD1OK@>/G6IR)JK*. .-[[W.PV=(:;K?7
MWL]=[(AERK4XD]67LC"+XT$VH$+,>%N9#W+U1O3QQ-9?+BOM_M*J7^L/*&^U
MD75O# 1UV72__*8_A\<8!+U!X'!W&SF4OW'#)T=*KDC9U?!F&RY49PUP96.3
M\M$HS):P,Y/74A:KLJJ(-P5=-(8W\W):"3K16AA-PRN.GCXX&AEL9DU&>>_X
MM',<_,0Q"^B=;,Q"TZNF$,5]!R.@W$ -UE!/@[T>?Q/Y"PJ91X$?!'O\A9O0
M0^<O_%7H?[[%#%T84>N_=@7:N8EVN[&J.=1+GHOC 62AA;H6@\FS)RSQ7^X!
M&6U 1ON\3SY"A46+A,@9W0%V6:$K<6/HM)+YMYVP]SK>#?ML@?P+365#9B$H
MYTK=ELV<>"W;QE@,\QZ#1]-;B'(IE7%8M)A#JL:CE5""N*:9K"!X?4A#.*MA
M 0WJ _K4E$84;P2OS +N!;U?FK:F;J#O7$#RT%+?^W!#9S"555EPF-(IKWB3
M8P]#O_.F126ACA.,GE*0>FD6H\'&7A9%:&0>2T,[$'MQ:&=2YH5A2B?Y][;4
MI2T-FA*?(B^),AHG].Q)%K#@)08R/R)('\)N($6E1)/?DIC-4%"TTXO$(2GB
MQ5?HU$:O/6I01X=1G!S0,$BR PICGX*,AF&$H2WH(+.HI[ .U^ !/<S&%$1>
M$$2 G;"Q YV$E,9>.H[O0\9L[+$XLRN#D$)OS'QB"!\__PHT"X&91=$!!?@W
M9'&X%W#0G78XMF<:C+T@S.PIIU[@CAWG'Z5V:AQZ81S0'BG$&RG$CY:".PH%
M-IR7EE#/WZ*T[ZI?(.D[_E4J.JNXUH\4SEX8NX5S!;7,E<06&\U<\ZH5'JZ=
MO*W;RE$7,E*F_)MW]Q%R80_^OH$-KLM0>1<,[X)Y(*V'.7E(J_OR>^TPGJVW
M_.RV/-F">+(-\0_ ^V'M?W9PYNXTH9XKT1F *XD7^E:C0S Z'1_8(>:QP/$H
M]'QFE3V$0,?I@5-TR"*Z4KS ]PF^7=Q)&I$O&EG)^2T%("44E_J@,H-19/^&
M/D9"^,[&[$?;]7GC,N_85#DV)0G;% /;3EAZUT?[O3,#T#2!V&/L-D8&(OP?
MXI,(,D+K2AI>68'XJ#Y6(,/$8Z$+@T5>Y+.N,B69WX6?A(F;\ST?,MHCFF0C
MFN31HOF%5C:: L4NN7+E_K35<&@S+NMIV719?9R*]N.R@N%W]8QL;:<9+U4G
M@RXQ*_=-)8KG_%HH?")2J\6LK<CF1UM5H,@!KY%T+W$/E</7H4$,TW5(^5U(
MMH-+1UL^(FI[]W4BL[Q%#;D57-F)+<2'G> >:,PC<9.+I7$V4-RYC:FC_I=U
M."=].)^Z<-Z6,_'H=3OT@]H?I*!1MR4&HBRB<=_[N4Z8Y^/Z2/IU+$II[:%C
M=@I>L[ ?"G 9L;5+1^K-F?[B[)_BGDHAGXVKIU"33UG7VT/Q=$/Q]'^BN$?G
MK6E11.\5J5<W>.%H\4A:[\6R^W)XI4U9NUPABU5'IGM7@>@1N)1:RH'1#P\2
M+S 2/%^L&=I8H#-$VI^K: IKNW4%4*GW?(J!NN[#")\8CL>V3D9I9ILQFB&2
MA"8XX 5^8INI+7;Q[K(TVGJ"@)US]]"RLL)W8_<:V8QNWG(GW1/F;GGW$'S'
MU;R$)"LQ@ZG_(L5]K+K'5=<Q<ND>-%-I( 777. ]*I1=@/F9E&;=L1ML7KB3
M?P!02P,$%     @ D(M85F8LFTI#!   /@H  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S,N>&ULK5;;;N,V$/V5@1H4#J!&=UER;0.)D\4&: HCR;8HBC[0
M$FVQD40M2<7)WW=(R;*]<(P\]$4:D9S#,YHY0TZW7+S(@E(%;U59RYE5*-5,
M'$=F!:V(O.(-K7%FS45%%'Z*C2,;04ENG*K2\5TW=BK":FL^-6-+,9_R5I6L
MIDL!LJTJ(MYO:,FW,\NS=@./;%,H/>#,IPW9T">JOC5+@5_.@)*SBM:2\1H$
M7<^L:V]R$^GU9L$?C&[E@0TZDA7G+_KC/I]9KB9$2YHIC4#P]4H7M"PU$-+X
MWF-:PY;:\=#>H7\QL6,L*R+I@I=_LEP5,RNQ(*=KTI;JD6^_TCX>0S#CI31/
MV/9K70NR5BI>]<[(H&)U]R9O_7_XC(/?._B&=[>187E+%)E/!=^"T*L131LF
M5..-Y%BMD_*D!,XR]%/S!YJSC)2PX%))6))WLBHIC)[U2UY.'85[Z)5.UN/=
M='C^!WB>#P^\5H6$NSJG^3& @^0&AOZ.X8U_%O&69E<0>#;XKN^?P0N&B .#
M%WR =U_+5I ZH_#W]4HJ@77QSZDX.Y3P-(K6RD0V)*,S"\4@J7BEUOSGG[S8
M_?4,QW#@&)Y#GS^A]O(6$\'7\!LC*U8R]0XH0?A6-X3EL"@)JR20>C"O\W^Q
M6E N"N[>4+(2XS-9A&?ZIN"FY-G+R3C/,CD=YW-!D4R)@F;U!I39119\*T'A
M3,:KAM=(1&KZ9J0@]88"JZ'JRRTSY=;TY:8#T^O>*1$2J"X<P+33:D4%IGX"
M(^W*RA)U+"]-(>B'IQ\N/)S"M&%%-ZRN-4%DT5#!> X7X(=VF 3:\.QD['=&
MG+IPG7UOF62Z54@(W 22!+>.X9$V7"@D=$1] HM6"/VS-6?$\&P_\L%+$CL.
M/, RL/UQ#$O<5?1AC4+/O8219X]]_4X2?#YSA8CBY!8(ZMI)J$%C._40-$KM
M((V'>#%2G6[DLNPM\R.S0V(C+PEM-TSUQG%D1WZHK2"UTS%:1W[-(5??Q[6)
M7IO826R<4CN*XAWEZ@<.Z.'&=C0>7W9;!HEQ1L91@'%^D"+,]'%R4MN-XA-9
M.B.I:)!4=%Y2!?[C7W*4OCD-]EU@@>U*-P%I8ZXS7F<HMFX-4NO%=4M?\?AJ
MC+H4/Y#DYR1VEMEG),8DBJ<[@<U1ML+C%4=,JG/3!4Q7.*P?/)KVG(F1XH&D
MNFXZ@=_QV+_?X1R?!<>:^])+]"]3'W<_2M0V$X,H>WE>#(+HK- =][.]7KIB
MNH @3>TX2@V=15NU)=%G]4!HJ-/_A=->"=K6X@K#OJGLY=(Q&P5CUT[3X-(P
M$U3?<DQ':954^-NU7?;%P*CL-8058K8*L*T<R^6X[0T%?ZJ\G8,SO:)B8VXN
M$A':6G7'^S Z7(ZNNSO!?GEWLWH@ ENAA)*NT=6]&F,]BNZVTGTHWI@;PHHK
MO&\8L\ +'A5Z <ZO.5>[#[W!<&6<_P=02P,$%     @ D(M85JCUOW%>!@
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M1EU5KHUMCU@<02/-</SREZ1G7E(^1CM OR(<(Y7M>]YH$01-O <0O^]2DZ
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M61?'M"H.V! N^5K:UJ5&+>R6N.DA3A3(0CRHKP2V.'E[2CF.54I;^;V9\!H
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M#4MZ6U'9#;2^E=(<)S9 ]UHO?@)02P,$%     @ D(M85CJF2KMU!0  QPX
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M'87J(P6JX+LEFP^ %X+V_^UT\X]HNHFQ,ASP#M%"+DM#N_ZV0?0O3MOZ1#@
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MC7>@\U)KMUOX!.T_Q>P/4$L#!!0    ( )"+6%8F(:&4-04  *8.   9
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M 6&)N;$6.+UN\1++TAJB,+ZU-@>]2ZNX_=U9?^6P$Y8IUW@IR\^B,(NS03:
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M:0(X]:)8,,YC+_.3K4Q5-P;?.Z@#Z<B;RZY9[VZ./>%S%GEQZ@^R#EPB'SE
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MTE0O)\%>@%+(2,GTI5A]A]JA'8N7"*;<+UK5>Z, ):72(J^-#8.<\NI*'NI
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MQZO8J3SI'/7DJS1,0%9)TX4]F^.Z.J]TM?S7NH[N_+>ZW)U>:_]SMTS-.)V
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M$J4-,-^G0NC5Q&[0W+GQ'U!+ P04    " "0BUA6!U5;8&X#  !$"P  &0
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M?>+[=] &%!A_*6>R_D?[5NM8**VDXGEKK ER6C17<M\FXL@ ^Q,&;FO@/M3
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MFQ1RS=(\+"AM@9E?"*$W';M _U2E?P%02P,$%     @ D(M85CNHTBP+!0
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M]#+X?HAX)(9:M\QV3BX*71>:'6K]*,LS+34SIV;F:)E)49.2E4K-R#*:!B^
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M* EIE@?(\QO&Q.M.?H'ZZ]#R/U!+ P04    " "0BUA6 ;!6K5D$   $&
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M8,I /E]3*EX7:A"<#_[G_P-02P,$%     @ D(M85E(7+T[E P  >!(  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULQ5A1;^(X$/XK5FYUVI6V31P@
M@1X@M?3VKE*KJ]KM[L/I'DPR@+5.S-H&MO_^;"<$ L%==*![@=B>^3SSV9\S
M<7_%Q3<Y U#H1\9R.?!F2LVO?%\F,\B(O.1SR/7(A(N,*-T44U_.!9#4.F7,
M#X,@\C-"<V_8MWV/8MCG"\5H#H\"R466$?%Z XRO!A[VUAU/=#I3IL,?]N=D
M"L^@7N:/0K?\"B6E&>22\AP)F R\:WPUPK%QL!9?**SDUC,RJ8PY_V8:=^G
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MKPW?7.,]#=HMP/FE4O:EX^Z._N;/_P)02P,$%     @ D(M85B63C=PH @
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M=:A\XLU<V=Q(5M63UI))-;?5EQLUBQ.N >K]BC&YO]$+=-/][#]02P,$%
M  @ D(M85N8D+>!A P  7PP  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N
M>&ULK9=;C],Z$(#_BA40 FEW<T^;I:T$K1!(9U'%<A%"/+C)M+5PXF [+?S[
M,W:RH;<-RZHOK>UX+M_,>.*,MD+^4&L 37X5O%1C9ZUU=>VZ*EM#0=65J*#$
M)TLA"ZIQ*E>NJB30W H5W T\+W$+RDIG,K)K<SD9B5IS5L)<$E47!96_7P,7
MV['C.W<+']AJK<V".QE5= 6WH#]5<XDSM].2LP)*Q41))"S'SBO_>NI; ;OC
M,X.MVAD3@[(0XH>9O,O'CF<\ @Z9-BHH_FU@"IP;3>C'SU:IT]DT@KOC.^UO
M+#S"+*B"J>!?6*[78V?HD!R6M.;Z@]B^A18H-OHRP97])=MVK^>0K%9:%*TP
M>E"PLOFGO]I [ CXT3T"02L0/%0@; 5""]IX9K%F5-/)2(HMD68W:C,#&QLK
MC32L-&F\U1*?,I33DQO(648YF0JE%9G3WW3!X8*\*[-:2L@)+7-<93G9W4AF
ML,$"J#"=FCR?@::,JQ?DDKP%RO4:I54M:9D!F4N1UYDF_Z%9\NT&B@7([[CQ
MT^V,/'_Z@CPEK"0WC'-,J1JY&HF,7V[6>O^Z\3ZXQ_L99%<D]"](X 7!"?'I
MP\7]?7$7X]@%,^B"&5A]T3WZWN.QZR*W%]E3:(VNV.HRIVTS"=,TB=.1N]E%
MZ#5I3OFUJF@&8P>/L0*Y 6?R[(F?>"][@,(.*/PKT+0N:D[-8>N0L$Q,ZD]2
M-0J3':K+<."E:7B U6OXD5A1AQ7]%4N":7*L7!%L;DICG9LQ9W3!.-,,%*DD
M$Y)H<:(Z&M3H"#5,O0/,7D<>B1EWF'$OYD>A,5EW2<OL":^:$WX*)S[""5(O
M3@Z >DT^$BCI@))>H-NUD/HRQ]YB7P%_VLQ4E%KB&T%=D%=9QG+3E[X"E39U
M7=\Y!=UK\.$X36S.I&PO-H,N-H,S]I[!4:[]X3#R!@?)'ARU*-R6A'ZW;<_5
M8>?J\-Q=97C<5?QADD;1@</#(X<O_22.@^BTQVGG<7K^P@MZ"Z_7X+\6WIF4
M[<7&]_Y<(;PSEEZK;*_/^'X0!P>I[#?Z6*B=>Y%_[B)M->Y7'YZJZ/"5WF_Z
M7]'<G=N?N7K?4+EBI2(<EJC>NQJ@0[*YS383+2I[(5P(C==+.USC%P!(LP&?
M+X70=Q-SQ^R^*2;_ U!+ P04    " "0BUA6@#'8^FL$  "#&0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970V,BYX;6R]66MOXC@4_2M6MEJU4H?$YM'' M(4
MIMI*TYFJS.QJ-=H/AES FB1F;0.MM#]^[20DA 9/RYC]TB;$]_B<FWMO3TUW
MS<5W.0=0Z"F.$MGSYDHMKGU?3N804]G@"TCTDRD7,57Z5LQ\N1! PS0HCGP2
M!!T_IBSQ^MWTLP?1[_*EBE@"#P+)91Q3\7P#$5_W/.QM/GADL[DR'_C][H+.
M8 3JZ^)!Z#N_0 E9#(ED/$$"ICWO/;X>D)8)2%?\P6 MMZZ1D3+F_+NYN0M[
M7F 8000392"H_K6" 4210=(\_LE!O6)/$[A]O4&_3<5K,6,J8<"C/UFHYCWO
MTD,A3.DR4H]\_3OD@MH&;\(CF?Y$ZWQMX*')4BH>Y\&:0<R2[#=]RA.Q%8 [
M>P)('D!V UI[ IIY0#,5FC%+90VIHOVNX&LDS&J-9B[2W*316@U+S&L<*:&?
M,AVG^J,Y%^K=%Q QNN%"![-D)A%-0O21)[/LP1#&"IU^HD)0D_,S=#H$15DD
MS] []'4T1*<G9^@$L03=LRC2+T=V?:6YF1W\2<[C)N-!]O# !-WS1,TE^I"$
M$%8!?,VK4$8VRFZ(%7$(DP9JXG-$ D)J" U>'XXM=)I%HILI7FL/WCU+6+R,
MT;=[B,<@_D;_HD=8\6BE$XX& D*FT"V=L(BIYV)171ZMVYBNOY8+.H&>I]M:
M@EB!U__U%]P)?JO+@2.P2D9:149:*7IS;X9U6=TE4HFEG@L*??NH%Z [!;&L
M%=YR*=P16$5XNQ#>MI;"CO!S?:U ;Z/0(U6 ADMA:N(!!.-A72(R=)Q5KIG3
MJW[0"-JZ2E?;$JTD#I38*21V[-5.G]Q4NW6;M[YT1V"5C%P4&;EP6NT7+H4[
M JL(ORR$7QZUVB]KJ_VBO5/M5A('2KPJ)%Y9)38[+32DS^BDTPC03?8W<&^5
M']P*5@YOK0A'8)5TX: T'8'39LCA'&EWA585O^6XL+5:4JU\FK_[\]T:.$>;
MX5D8,C2@FH]^5IN;;+?V5G]T@B#8:0\[IT,UDU(S>8/F+:T?GA;,V$K=,/M'
MP _ 3?N%]+G.=0[LH8?J+DT?MKN^+W,!@/X"*HX\'.P\WMPAQ_"%N#2&V*TS
MQ$ZMH2NTJOC2'&*[.W0]'MJO&@_',(NX=(O8;A=_<CS8P9OH6?=?_70XAB/$
MI27$5N/5O]7_3?\OP\&IF72%5DU::2?QI=OAX,@9YN*/X3-Q:32QW6FZ'@Y7
MKQH.QS"+I#2+Q.K'?G(X_ "\O7\XV",/E5W:1&*WB:/E6+*04<% 6KO;CO/6
M G>%5E5=&D5"G'8W<>3O<O''<(ND=(O$[A8_JSF([.!5;0Y>:T4W7[3MU8NN
MK5F$6UNKJAQ+;T:L]J>6HYY#2R'TZZHEVWK)XXKLDGVYJ(/Q#E=_ZY@[!C%+
M3_\EFO!EHK(3[^+3XAN&]^FYNE\NS[Z>N*=BQA*)(ICJT*!QH7<6V8E_=J/X
M(CTT'W.E>)Q>SH&&(,P"_7S*N=K<F V*[UWZ_P%02P,$%     @ D(M85I)J
M8(=$&   _10! !D   !X;"]W;W)K<VAE971S+W-H965T-C,N>&ULO9UM<]PV
MDH#_RI1N[VJWRBNQ&WS-V:I*K-JZI-995[S9^[!U'\8R;:DB:;0S(WOS[X\S
M&@I-= .8(1O,AUBRR08:([8>@L##U]]6Z]\V-VV[7?S[_NYA\^;L9KM]_.[B
M8G-]T]XO-^>KQ_:A^Y?/J_7]<MM]N_YRL7E<M\M/^Y/N[RXPR\J+^^7MP]GE
MZ_W?O5]?OEX];>]N']KWZ\7FZ?Y^N?[]A_9N]>W-&9SU?_'+[9>;[>XO+BY?
M/RZ_M!_:[:^/[]?==Q<O43[=WK</F]O5PV+=?GYS]CU\]]9DS>Z,_2'_N&V_
M;<C7BUTN'U>KWW;?_/CIS5FVZU)[UUYO=S&6W1]?V[?MW=TN5->1?QVBGKTT
MNCN1?MU'_\L^^RZ;C\M-^W9U][^WG[8W;\[JL\6G]O/RZ6[[R^K;_[2'C(I=
MO.O5W6;__\6WYV.KXFQQ_;39KNX/)W<]N+]]>/YS^>_#2) 3(/><@(<3\-@3
MS.$$LT_TN6?[M*Z6V^7EZ_7JVV*].[J+MOMB/S;[L[ML;A]VG^.'[;K[U]ON
MO.WEAYO5>OOGO[?K^\4/JW5W\NW#E\UB^?!I\=?5PY?G?[AJ/VX7?[QJM\O;
MN\V?%G]>_/KA:O''/_QI\8?%[</BW>W=7?>!;%Y?;+O^[*)>7!_:_N&Y;?2T
M?=5>GR\,O%I@ABB<_O;XTV%X^D67R,M0X,M0X#Z>\<;KTOSQ8;-=/W4_J-O%
M/__:';#X<=O>;_Y/2NXY6BY'VUU_WVT>E]?MF[/N MNTZZ_MV>5__0>4V7]+
MJ2H%&R1N7A(WH>B7;Y?K]>_=Y[[XQ_+NJ952?3Z_V)^_JPQ?+XNR*LK7%U]I
M#ORH/"\-OAPUZ%S^TKD\W+G5_7V[OKY=WBW>+Q_;]>*?[]K[C^U:_$B"H4[]
M2)2"#;(N7K(N5'\6"\W$E8(-$B]?$B]/^KBE9)\CE.3GK,XRYV>1'Y/)/X?5
M2\>J8,?PO*Z*_US\O-JVF\754[MXMUQ?W^Q+5_!',ACUU$]&*=A@ .J7 :A5
M?R1KS<25@@T2;UX2;X*?_/OEVE\9&U;S -@/8S#^R-Y#9G_#9\'^.Q_<J^[K
M;=LUM%W\LMRVKQ8?MMT?GQ;ON\NN^^<.WL3?Y,]M@*%7U'F&W47A)!ONS=AL
M"<] ,-M?'S;M]=.Z2VB7]ZO%VZ?UNDM+S G8A^=^<H=#:!V!K*GD4@*6-"#X
M^_S2G)LBH\7DIZ>[W^.U)!SUU&M**]IP#"QT@%&M)Q"$F).35XHV3-Y"#82I
M)EA3#N<.BDK&BDJXA;$96$"!( 8H597G-@"'5<485E12, E8*($PE9Q25,IX
M4>%PTC2-IZ98/H$8H)@=H#SL:\JGKJ;\[7J[ZBK)$65%E5&TH@V'P5(*Z&(*
MJ'**5K1A\I948 *J &>5AE>5%*R"EE5P!E9!#ZL8QBKAWHS-UK(*JK$*QED%
M.:O4OK*"9%(DC"K=P&4#5/EY]75?2N)U)1SYY!F2%+B"%E=0%U=0%5>TH@V3
MM[B"$W %!5QA%UH*6$$+*S@#K!S::$*78 I,08LIJ(8I&,<4Y)@"N:><6$K!
M&*54PSN?O[0?UT_+]?[NQX3+B2JF:$4;CH/%%-3%%%3%%*UHP^0MIN $3$&.
M*26R>I("4XS%%#,#IAS:<&]^D%%*N#-CD[648M0HQ7!**1'==(+-C4W' HT)
M XU-9_^$:]L_X7K5%:6'ZT!NJC1SB$:+J_=1B2$/<L)/<OR3U.'2&@Y[<FXI
M8,586#&Y:FDUJD^-M*(-D[>D8\*D$RRMAW/IY=G]-G8OSQ0,8RS#F###Z)36
M\MC9ZG!OQF9K<<B$<>B4VEKQ#R]GCV!34(VQ5&."X#"^MJK2S2$:K:U567MJ
MJX46$X86<U[L;H3M_-I/3UU9B9=6)5(YI):">W++/7FF6EIS)7(Y/)!/P4&Y
MY: \S$'!TIIS\N&E-=S V 0L^>1A\E$IK8<VV)2]6UC#?1F;JR6A/$Q")Q36
MG*];$3ZZ%$R3DT4PX0F8L84U'/;D"S#GA37WS##F%EGR,+*PPDJG!/+P>A_5
M=2]:T8;C8,DG+W6+JQ*Z'))/ 4*Y!:$\#$+AXBJ@#[]"4Z!/;M$G#Z./3G&M
MCRRN*>9O<HM">1B%1E<C/K5#Z\<AMT8H,AYZ*RRY%.$9F^R\* 9%YMWRB/H2
M#GKRNKH4_%)8?BE M;X42K1R2#X%^Q26?8HP^P3KR^'<R(*+< MC,[!$4X2)
M1J7 '-IP"TQ6N!4FW)FQR5K>*=+P3L&?135-[>;&,:9I2D^%(2MVPQC#UE]\
M__3EJ?MTXD5&=_%N"H@I+,04NA!3J$*,5K1A\A9BB@D04QP#,>$&QB9@(::8
M 6(.;1RQ_"+<F['96HPITF!,<0S&%"=@3&DQI@QC3/&\&D-<Y!6N,N' IUYH
M6M&&PV!1IM1%F5(59;2B#9.W*%-.0)F2HTS!-T>D()G2DDPY \D<VFB&1<:M
M,.&>C,W48DR9!F-*CC%YXU:8DF.,9X]+:2&FC,W%5/+"]")<7%011BO:< S(
M#B1=A"E5$48KVC!YBS#E!(0I.<(@OT\*MS V \LPY0P,4WHF8AC"A#LS-EF+
M,&4:A"F%?4M-PY+C#-,=Y5D#5EF(J6(0 X4/8L)U)ASXY-UT*2"FLA!3Z4),
MI0HQ6M&&R5N(J29 3,4AAM\JA1L8FX"%F&H&B*GDZ9B"K9\-=V9LLI9CJC0<
M4W&.J?+*S>UHCJDLQU11CAG>)UVUUR^KUB,U1I5EM*(-Q\&R3*7+,I4JRVA%
M&R9/=FQ/8)F*LXQA*!-N8&P"%F6J&5"F\J&,FVL*DJDLR51I2*;B)(/L5JGB
M((.^K3&UY9@ZS#%PCD..^6GYT#^W+H,U)ASXY,WQ*3BFMAQ3ZW),K<HQ6M&&
MR5N.J2=P3'W,9$RX@;$)6(ZI9^"86N888.OVPYT9FZSEF#H-Q]32?(S[6*GF
M')/[5 &U)9DZ1C*0.0^N#TNZ(R5&%6.TH@T'P6),K8LQM2K&:$4;)F\QIIZ
M,37'&.'1=;B%L1D0<\P,'%-[. ;<7%-P3&TYID[#,;6P.YN7&,XQC:_$-)9C
MFAC'@+@V)EQ@PD%/O<:TH@V'P#),H\LPC2K#:$4;)F\9IIG ,,U1:V/"+8S-
MP$),,P/$-!Z(89,QX<Z,3=9"3),&8AH.,75CW-R$M3&59U]:8R&FB4%,[KU3
MJL)51A5CM*(-A\%B3*.+,8TJQFA%&R9O,::9@#'-,8MCP@V,3<!23#,#Q30>
MBLE9D4FBO"/.NS08TTAK8UR,::2U,3ZI6D9%=V&0,6P)WN/Z]BY>9")Q3Y8
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MMA=-,"\/#G,Z3J@G(E\V=)/H0(J1AZ48D<"G7WE)N(?HEU%9OXRZ^F6U<,X
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M:EEA!;>"_B2EKJ=>ZJ$2*KRA^E'LOD-7S]CZ%8(J]XMVW=[ 0\5&:<$ZL4G
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M(.T&LUX)H?<3VZCZSTS^#U!+ P04    " "0BUA6&Q-!,0H&   ]+@  &0
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M'01A /K]BG-U&)@)A@:S^ 502P,$%     @ D(M85@7W(B#*!   >!0  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C<N>&ULK5AM;ZLV%/XK%KN;6JE),&])
MNB126W9U*ZU;U9?MP[0/+IPDZ +.;*=I__V,H20!8Z*K?FD#/.?8SWG,\8-G
M.\J^\S6 0&]9FO.YM19B<SD:\6@-&>%#NH%</EE2EA$A+]EJQ#<,2*R"LG3D
MV'8PRDB26XN9NG?/%C.Z%6F2PSU#?)MEA+U?0TIW<PM;'S<>DM5:%#=&B]F&
MK. 1Q//FGLFK49TE3C+(>4)SQ& YMZ[P98BG18!"_)7 CA_\1@65%TJ_%Q>W
M\=RRBQE!"I$H4A#Y[Q5N($V+3'(>_U5)K7K,(O#P]T?VKXJ\)/-".-S0].\D
M%NNY-;%0#$NR3<4#W7V#BI!?Y(MHRM5?M*NPMH6B+1<TJX+E#+(D+_^3MZH0
M!P$XZ APJ@"G&>!U!+A5@'MJ@%<%>*HR)155AY (LI@QND.L0,MLQ0]53!4M
MZ2=YH?NC8/)I(N/$XC:/: ;HB;RA!XAH'B5I0I0B=(G$&I"03S:,OB9*:2+4
MS>?AXQ!]A1@82=&C(&(K*'M'#T0 .@M!D"3EYVB GA]#=/;E''U!28[NDC25
M.?AL).3$B^%'437)ZW*23L<DL8/N:"[6'/V6QQ ?)QA)QC5MYX/VM6/,&$(T
M1"Z^0([M.)H)W9P>CC7AX>GAMH&-6XOHJGQNOX@WLDY)OH(\>D?__"YQZ%9
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M9<%9><Q57@BZ40<_+U0(FJF?:R#R8Z  R.=+2L7'13% ?=BX^!]02P,$%
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M7E0_=T"U%AL#_7S#N7J^,!^WFH^9R_\ 4$L#!!0    ( )"+6%9U"'(19@,
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M@C ==/N.<_52, -4)]+%/U!+ P04    " "0BUA6P"%9&!$#  #4"0  &0
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MOD/-QU=X$4VY?J)5[6L9*"JYH%D=+#/(2%[]XY=:AU: W3\0X-0!SFZ =R#
MK0/<4P.\.L#3RE14M XA%C@8,KI"3'E+-#708NIH29_D:MNG@LFW1,:)8)I@
M!@E-8V#\$[I]+HEX1=J('J H691(43GZ'(+ ).7GZ MZG(;H\]DY.D,FXLJ3
M(Y*CQYP(?B&-<GQ'TE1N*A^:0J:H%C*C.IUQE8YS(!W;07<T%PE'MWD,\3:
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M<CP4*QWR&.\DJ%44,;F]PE!L1@YQ=AWW?+[0ML,=#Y=LC@^H'Y=WTK3<?):
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M'[EETIS$%(0X,Z:MBYZ!ENDGA[2AQ3*YYD^%UB)*7A?( I1V@/E_)H3>-2Q
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MNN5<$6G6N@*&2Y,:G(P,LJPN#E5#B\(=U@NAS='O/C-SV4)I \SX4@B];5B
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MO1Q'G<PT3>;CHNH;&3I5AMUR=S U6?4J/83):I#K1HHT3\TWKNTQ)T^R^K/
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MJ\#A>?LW'TBVSAJB,R8E2[+'%9 (N!90ZPO&Y&&@-RB;\)/_ 5!+ P04
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MY44B5<5?LBW'GGL.B=9*BZP*-BO(>%Y^LA^5$'L!=/A"@%\%^(<!XQ<"!E7
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M^LK2-1"QV$]CK8IW\GHK3H\4'Q\+CCEEB$5K"N[O!/?[O?2VBMS)Z"TR)BU
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M6O"E**H-U-^O\ES^>%)]M\7ART]F_P-02P,$%     @ D(M85A)X0"<&!P
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M(#&)Q7'?ELJPAMMA;F24&?'>,.)ZZ)91&0ET21>PV">PU8R+:7N[:8^\6L8
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MC<J<LDOW?Y4P5Z:.$BAD:RJS.W716]1J0U.A'/2/= UGZHI7FJP O,5\1:A
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M'6!%C<,U4:P!+Q7:=$U_9  TV$KC&5&K1#7#>((V7;S0IRN/3-,>'>";F4P
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M4);S8KG0(B\FJ+70.(\5KPG.V""- 7[?"+SVJH4)4$_MP?]02P,$%     @
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MUG49],DS"Z]JJ5>UI2^U?K]TM 7=N'4CV!U3T]X&5)*OO[P&+X*W00#58DT
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M6J]=01B!OK[D7.T.S.HH7PU/_P-02P,$%     @ D(M85DM35 1T!0  M1H
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MK!Y_-V>;=R^?RS<.VOEK?!56;U!:FNJ%SBW--W$F4,+6BM+^%*@UY=4[DNI
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MQ5A=. '5,J#ZPP20$2\R]93D'&0'';$!31LF'O8W@@B&JV[[F7;VDRH;+IC
MN:>DZ$8I:!2@FBC25@1=1:E'59^ZRHN(;[ I 0A-("#(SUMGPQ[SJNJZ4TQ
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M;-#K2\[5V\1<0^I;9/P/4$L#!!0    ( )"+6%805;R$5 ,  *X5   -
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MB63 RDC.^,J&NQ"8%KR0GM)5KE.%$*G^6#BT/;@!:IV<B4*:W#:#_3VIA^\
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MZ_+[(KXO5E><Z_N*X>DO4$L#!!0    ( )"+6%;"@ QK.@(  &@S   3
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MV-S^!%!+ 0(4 Q0    ( )"+6%8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ D(M85E'QJ:SM
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ D(M85IE<G",0!@  G"<  !,              ( !RP$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "0BUA6VX]Y21 (   +,0  &
M            @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ D(M85EN])[ _ @  Q@4  !@              ("!4A   'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( )"+6%94+E77L0<  ,$B
M   8              " @<<2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " "0BUA6N A!8)P"  "2!@  &               @(&N&@
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ D(M85J]I91>'
M!@  *QX  !@              ("!@!T  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( )"+6%9\/3:6@ 0  %,0   8              "
M@3TD  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "0BUA6
MGQ0%/[T+  " <0  &               @('S*   >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ D(M85H-=1F3L @  -PH  !@
M     ("!YC0  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M )"+6%:Y%)SVJ0@  (PI   8              " @0@X  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " "0BUA65RYOH1H#  !C!@  &0
M            @('G0   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( )"+6%:[PE*2)AX  %];   9              " @3A$  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ D(M85C,2]'<E"0
MR!D  !D              ("!E6(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " "0BUA6_S(L9X\,  ":)0  &0              @('Q
M:P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )"+6%8;
MC!L"*@,  #L'   9              " @;=X  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ D(M85FE%N.%S!0  ;0P  !D
M     ("!&'P  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )"+6%:%;RW-QP<  )\3   9              "
M@0>A  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ D(M8
M5G@J@UCC"@  OQH  !D              ("!!:D  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " "0BUA644%VEQ0(  #R$@  &0
M        @($?M   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( )"+6%8D+] @%PX  -HF   9              " @6J\  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ D(M85C!^ Y&K"@  \AT
M !D              ("!N,H  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " "0BUA62%U#(6H@  "J:0  &0              @(&:U0
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( )"+6%;\8FS
M1PH   P=   9              " @3OV  !X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ D(M85C8 +Z'%'P  >F8  !D
M ("!N0 ! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "0
MBUA6_3'_.6@$  #P"@  &0              @(&U( $ >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( )"+6%8HI]U;FP8  ,X2   9
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M970S,RYX;6Q02P$"% ,4    " "0BUA6J/6_<5X&   J%   &0
M    @(%//P$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M )"+6%;M.9+2Z 8  /P1   9              " @>1% 0!X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ D(M85B^FW1), P  N0<  !D
M             ("! TT! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " "0BUA6.J9*NW4%  #'#@  &0              @(&&4 $ >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( )"+6%:ZD''3X@(
M #4&   9              " @3)6 0!X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ D(M85B8AH90U!0  I@X  !D              ("!
M2UD! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "0BUA6
M7..10>L&   K$P  &0              @(&W7@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( )"+6%:3YQC6D0@  , 8   9
M      " @=EE 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ D(M85GJT@;6!!P  7BD  !D              ("!H6X! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "0BUA69E]^*F$#   -$
M&0              @(%9=@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M 0(4 Q0    ( )"+6%80*(R:2@0  /L3   9              " @?%Y 0!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ D(M85D" ]7#1
M @  S <  !D              ("!<GX! 'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"% ,4    " "0BUA6,L0PPH<'  !^,P  &0
M@(%Z@0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( )"+
M6%973*UIOP4  ,$B   9              " @3B) 0!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&UL4$L! A0#%     @ D(M85D-N#S[D!@  E2H  !D
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M=#4R+GAM;%!+ 0(4 Q0    ( )"+6%8'55M@;@,  $0+   9
M  " @1>L 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @
MD(M85E,-<$)_ @  M@8  !D              ("!O*\! 'AL+W=O<FMS:&5E
M=',O<VAE970U-"YX;6Q02P$"% ,4    " "0BUA6.ZC2+ L%   I&@  &0
M            @(%RL@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4
M Q0    ( )"+6%8!L%:M600   08   9              " @;2W 0!X;"]W
M;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ D(M85E(7+T[E P
M>!(  !D              ("!1+P! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX
M;6Q02P$"% ,4    " "0BUA6'ED@E&$"   %!@  &0              @(%@
MP $ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( )"+6%8E
MDXW<* (  &8$   9              " @?C" 0!X;"]W;W)K<VAE971S+W-H
M965T-3DN>&UL4$L! A0#%     @ D(M85LY:ME,G!   Z0\  !D
M     ("!5\4! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )"+6%8;$T$Q"@8  #TN   9              "
M@2'M 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ D(M8
M5C\Z4J@T P  ; H  !D              ("!8O,! 'AL+W=O<FMS:&5E=',O
M<VAE970V-BYX;6Q02P$"% ,4    " "0BUA6!?<B(,H$  !X%   &0
M        @('-]@$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0
M   ( )"+6%8[S-\?+@4  -@4   9              " @<[[ 0!X;"]W;W)K
M<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ D(M85G4(<A%F P  $PL
M !D              ("!,P$" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q0
M2P$"% ,4    " "0BUA68'%0I;,#  "=#@  &0              @('0! (
M>&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( )"+6%; (5D8
M$0,  -0)   9              " @;H( @!X;"]W;W)K<VAE971S+W-H965T
M-S$N>&UL4$L! A0#%     @ D(M85IUW"D\[ P  FPL  !D
M ("! @P" 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " "0
MBUA6S/@9_=L"  #0"0  &0              @(%T#P( >&PO=V]R:W-H965T
M<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( )"+6%8=*?X%7 0   02   9
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M970W."YX;6Q02P$"% ,4    " "0BUA6^SU)T\$"  #(!P  &0
M    @(&-*0( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    (
M )"+6%9>_;K^-00  &H<   9              " @84L @!X;"]W;W)K<VAE
M971S+W-H965T.# N>&UL4$L! A0#%     @ D(M85F\(#^<="   "$4  !D
M             ("!\3 " 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"
M% ,4    " "0BUA6$GA )P8'  !-0P  &0              @(%%.0( >&PO
M=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( )"+6%9;(P\$A0,
M .4.   9              " @8)  @!X;"]W;W)K<VAE971S+W-H965T.#,N
M>&UL4$L! A0#%     @ D(M85D:/6_XP%   6<P  !D              ("!
M/D0" 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    " "0BUA6
MF[//M)T#  #!#P  &0              @(&E6 ( >&PO=V]R:W-H965T<R]S
M:&5E=#@U+GAM;%!+ 0(4 Q0    ( )"+6%85J1#H=0@  "8]   9
M      " @7E< @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%
M  @ D(M85EY)RQ=< P  &0\  !D              ("!)64" 'AL+W=O<FMS
M:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " "0BUA62U-4!'0%  "U&@
M&0              @(&X: ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+
M 0(4 Q0    ( )"+6%9#_[/#<@@  +4P   9              " @6-N @!X
M;"]W;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ D(M85C!R]YP$
M P  40H  !D              ("!#'<" 'AL+W=O<FMS:&5E=',O<VAE970Y
M,"YX;6Q02P$"% ,4    " "0BUA6$%6\A%0#  "N%0  #0
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:+GAM;%!+!08     8@!B .4:  "5B@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>530</ContextCount>
  <ElementCount>494</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>140</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Auditor Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/AuditorInformation</Role>
      <ShortName>Auditor Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheet (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>Consolidated Balance Sheet (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statement of Changes in Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical</Role>
      <ShortName>Consolidated Statement of Changes in Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Description of Business (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/DescriptionofBusinessNotes</Role>
      <ShortName>Description of Business (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Investments (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsNotes</Role>
      <ShortName>Investments (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Fair Value (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/FairValueNotes</Role>
      <ShortName>Fair Value (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Property, Plant, and Capitalized Software (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes</Role>
      <ShortName>Property, Plant, and Capitalized Software (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Goodwill and Intangible Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes</Role>
      <ShortName>Goodwill and Intangible Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Medical Costs Payable (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableNotes</Role>
      <ShortName>Medical Costs Payable (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Income Taxes (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesNotes</Role>
      <ShortName>Income Taxes (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Shareholders' Equity (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityNotes</Role>
      <ShortName>Shareholders' Equity (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Share-Based Compensation (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationNotes</Role>
      <ShortName>Share-Based Compensation (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Commitments and Contingencies (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesNotes</Role>
      <ShortName>Commitments and Contingencies (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Business Combinations (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/BusinessCombinationsNotes</Role>
      <ShortName>Business Combinations (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Segment Financial Information (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationNotes</Role>
      <ShortName>Segment Financial Information (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Schedule I (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ScheduleINotes</Role>
      <ShortName>Schedule I (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Fair Value Fair Value (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFairValuePolicies</Role>
      <ShortName>Fair Value Fair Value (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Schedule I (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIPolicies</Role>
      <ShortName>Schedule I (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueNotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Property, Plant, and Capitalized Software (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables</Role>
      <ShortName>Property, Plant, and Capitalized Software (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Medical Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableTables</Role>
      <ShortName>Medical Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/MedicalCostsPayableNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/IncomeTaxesNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareholdersEquityNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/CommitmentsandContingenciesNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BusinessCombinationsNotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Segment Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationTables</Role>
      <ShortName>Segment Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationNotes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Schedule I (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleITables</Role>
      <ShortName>Schedule I (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ScheduleINotes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails</Role>
      <ShortName>Investments (Short-Term and Long-Term Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Fair Value (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails</Role>
      <ShortName>Property, Plant, and Capitalized Software (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails</Role>
      <ShortName>Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails</Role>
      <ShortName>Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Medical Costs Payable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails</Role>
      <ShortName>Medical Costs Payable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/MedicalCostsPayableTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Medical Costs Payable Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails</Role>
      <ShortName>Medical Costs Payable Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails</Role>
      <ShortName>Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes Reconciliation of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails</Role>
      <ShortName>Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails</Role>
      <ShortName>Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareholdersEquityTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Shareholders' Equity Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Shareholders' Equity Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails</Role>
      <ShortName>Share-Based Compensation (Restricted Share Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails</Role>
      <ShortName>Share-Based Compensation Other Share-Based Compensation Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Commitments and Contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Commitment and Contingencies Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails</Role>
      <ShortName>Commitment and Contingencies Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Business Combinations (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BusinessCombinationsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Business Combinations Acquired Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails</Role>
      <ShortName>Business Combinations Acquired Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Business Combinations Acquired Finite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Segment Financial Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails</Role>
      <ShortName>Segment Financial Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationDetails</Role>
      <ShortName>Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Schedule I (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIDetails</Role>
      <ShortName>Schedule I (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ScheduleITables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Schedule I Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails</Role>
      <ShortName>Schedule I Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Schedule I Balance Sheet Document (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails</Role>
      <ShortName>Schedule I Balance Sheet Document (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails</Role>
      <ShortName>Schedule I Condensed Statement of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Schedule I Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails</Role>
      <ShortName>Schedule I Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="unh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails</Role>
      <ShortName>Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 45 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment, us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent, us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent, us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1, us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization, us-gaap:LineOfCreditFacilityExpirationPeriod, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:RevenueRemainingPerformanceObligationPercentage, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1, us-gaap:TaxCreditCarryforwardExpirationDate -  unh-20221231.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 6 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:OpenTaxYear -  unh-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="unh-20221231.htm">unh-20221231.htm</File>
    <File>unh-20221231.xsd</File>
    <File>unh-20221231_cal.xml</File>
    <File>unh-20221231_def.xml</File>
    <File>unh-20221231_lab.xml</File>
    <File>unh-20221231_pre.xml</File>
    <File>unhex10212312022.htm</File>
    <File>unhex102612312022.htm</File>
    <File>unhex102712312022.htm</File>
    <File>unhex102812312022.htm</File>
    <File>unhex102912312022.htm</File>
    <File>unhex103012312022.htm</File>
    <File>unhex103112312022.htm</File>
    <File>unhex10312312022.htm</File>
    <File>unhex104123122.htm</File>
    <File>unhex104712312022.htm</File>
    <File>unhex10512312022.htm</File>
    <File>unhex10612312022.htm</File>
    <File>unhex10712312022.htm</File>
    <File>unhex21112312022.htm</File>
    <File>unhex23112312022.htm</File>
    <File>unhex24112312022.htm</File>
    <File>unhex31112312022.htm</File>
    <File>unhex32112312022.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>unh-20221231_g1.jpg</File>
    <File>unh-20221231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="2016">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>130
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "unh-20221231.htm": {
   "axisCustom": 5,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 3,
    "http://fasb.org/us-gaap/2022": 2016,
    "http://xbrl.sec.gov/dei/2022": 38
   },
   "contextCount": 530,
   "dts": {
    "calculationLink": {
     "local": [
      "unh-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "unh-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "unh-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "unh-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "unh-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "unh-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 828,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 51,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 56
   },
   "keyCustom": 34,
   "keyStandard": 460,
   "memberCustom": 90,
   "memberStandard": 49,
   "nsprefix": "unh",
   "nsuri": "http://www.uhc.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.uhc.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Description of Business (Notes)",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.uhc.com/role/DescriptionofBusinessNotes",
     "shortName": "Description of Business (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Investments (Notes)",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.uhc.com/role/InvestmentsNotes",
     "shortName": "Investments (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Fair Value (Notes)",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.uhc.com/role/FairValueNotes",
     "shortName": "Fair Value (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Property, Plant, and Capitalized Software (Notes)",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
     "shortName": "Property, Plant, and Capitalized Software (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Goodwill and Intangible Assets (Notes)",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
     "shortName": "Goodwill and Intangible Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Medical Costs Payable (Notes)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.uhc.com/role/MedicalCostsPayableNotes",
     "shortName": "Medical Costs Payable (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Income Taxes (Notes)",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.uhc.com/role/IncomeTaxesNotes",
     "shortName": "Income Taxes (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Shareholders' Equity (Notes)",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.uhc.com/role/ShareholdersEquityNotes",
     "shortName": "Shareholders' Equity (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Auditor Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.uhc.com/role/AuditorInformation",
     "shortName": "Auditor Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Share-Based Compensation (Notes)",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.uhc.com/role/ShareBasedCompensationNotes",
     "shortName": "Share-Based Compensation (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Commitments and Contingencies (Notes)",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesNotes",
     "shortName": "Commitments and Contingencies (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Business Combinations (Notes)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.uhc.com/role/BusinessCombinationsNotes",
     "shortName": "Business Combinations (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Segment Financial Information (Notes)",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationNotes",
     "shortName": "Segment Financial Information (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Schedule I (Notes)",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.uhc.com/role/ScheduleINotes",
     "shortName": "Schedule I (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Fair Value Fair Value (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://www.uhc.com/role/FairValueFairValuePolicies",
     "shortName": "Fair Value Fair Value (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Schedule I (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.uhc.com/role/ScheduleIPolicies",
     "shortName": "Schedule I (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib8a17770576849b184901ef11ae7bade_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.uhc.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.uhc.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.uhc.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Property, Plant, and Capitalized Software (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
     "shortName": "Property, Plant, and Capitalized Software (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Medical Costs Payable (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.uhc.com/role/MedicalCostsPayableTables",
     "shortName": "Medical Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.uhc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.uhc.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Share-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.uhc.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Business Combinations (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.uhc.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheet (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
     "shortName": "Consolidated Balance Sheet (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Segment Financial Information (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationTables",
     "shortName": "Segment Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Schedule I (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.uhc.com/role/ScheduleITables",
     "shortName": "Schedule I (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib8a17770576849b184901ef11ae7bade_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i1936c5724a9f4e77bfbc667eaa19c7f8_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i64aa1382f53944b293d5a4cc26ebcaba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Investments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.uhc.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails",
     "shortName": "Investments (Short-Term and Long-Term Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i26d227da923f4bafa3e23635ffa3e63d_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
     "shortName": "Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i26d227da923f4bafa3e23635ffa3e63d_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Fair Value (Narrative) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.uhc.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i93cad82084bb42bf84e6e79e8cf2b3de_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
     "shortName": "Property, Plant, and Capitalized Software (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
     "shortName": "Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
     "shortName": "Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
     "shortName": "Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails",
     "shortName": "Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Medical Costs Payable (Narrative) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
     "shortName": "Medical Costs Payable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Medical Costs Payable Rollforward (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
     "shortName": "Medical Costs Payable Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib659d7c82a274ea4ac648525c4eb7212_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
     "shortName": "Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03b9795eaf4e4ed98e8e554b2e4b5433_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i8eb087bedb274e389574fb540aacd661_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInterestRateDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i8eb087bedb274e389574fb540aacd661_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInterestRateDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ie94f6f0f1fd94551b44b1faa876e0832_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Income Taxes (Narrative) (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes Reconciliation of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
     "shortName": "Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
     "shortName": "Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib659d7c82a274ea4ac648525c4eb7212_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib659d7c82a274ea4ac648525c4eb7212_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Changes in Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib659d7c82a274ea4ac648525c4eb7212_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Shareholders' Equity Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "iab961e9490f040f8918f115ab2c74510_D20221213-20221213",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Shareholders' Equity Dividends (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.uhc.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "iab961e9490f040f8918f115ab2c74510_D20221213-20221213",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation (Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "if37c7b7efa9b4e0da04f5ac3b4452ffa_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i4cab9cb169cd4921a81a836726f5c3e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
     "shortName": "Share-Based Compensation (Restricted Share Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i4cab9cb169cd4921a81a836726f5c3e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
     "shortName": "Share-Based Compensation Other Share-Based Compensation Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
     "shortName": "Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Commitments and Contingencies (Narrative) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Commitment and Contingencies Future Lease Payments (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails",
     "shortName": "Commitment and Contingencies Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "iab961e9490f040f8918f115ab2c74510_D20221213-20221213",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statement of Changes in Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical",
     "shortName": "Consolidated Statement of Changes in Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Business Combinations (Narrative) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i484b05acf027495b8f4198fab7c44136_D20220101-20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Business Combinations Acquired Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
     "shortName": "Business Combinations Acquired Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9a80b92c26b04f6bbfece8f78a3b1958_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
     "shortName": "Business Combinations Acquired Finite-Lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "unh:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "iec887b8824d84342853f880a3d055fb6_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Segment Financial Information (Narrative) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
     "shortName": "Segment Financial Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Segment Financial Information (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationDetails",
     "shortName": "Segment Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i96a086b49b4443f78ff994848f0e055a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Schedule I (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.uhc.com/role/ScheduleIDetails",
     "shortName": "Schedule I (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib8a17770576849b184901ef11ae7bade_D20220101-20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Schedule I Condensed Balance Sheets (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
     "shortName": "Schedule I Condensed Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i3f868329b34b47d3b53f4028690c339c_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Schedule I Balance Sheet Document (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
     "shortName": "Schedule I Balance Sheet Document (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i3f868329b34b47d3b53f4028690c339c_I20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
     "shortName": "Schedule I Condensed Statement of Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib8a17770576849b184901ef11ae7bade_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Schedule I Statement of Cash Flows (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
     "shortName": "Schedule I Statement of Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "ib8a17770576849b184901ef11ae7bade_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i9bc50771c1474d6da70f88b88f8f63a5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherNoncashIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i03d7421f2e1846c2b83800db841f59f3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
     "shortName": "Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20221231.htm",
      "contextRef": "i3f868329b34b47d3b53f4028690c339c_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 140,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entitiy Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Well known seasoned issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "auth_ref": [
      "r337",
      "r847",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet Statement [Table]",
        "terseLabel": "Condensed Balance Sheet Statement [Table]"
       }
      }
     },
     "localname": "CondensedBalanceSheetStatementTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Balance Sheet Statements, Captions [Line Items]",
        "terseLabel": "Condensed Balance Sheet Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedStatementOfComprehensiveIncomeTable": {
     "auth_ref": [
      "r337",
      "r847",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.",
        "label": "Condensed Statement of Comprehensive Income [Table]",
        "terseLabel": "Condensed Statement of Comprehensive Income [Table]"
       }
      }
     },
     "localname": "CondensedStatementOfComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": {
     "auth_ref": [
      "r941",
      "r1052"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.",
        "label": "Condensed Statement of Comprehensive Income [Table Text Block]",
        "terseLabel": "Condensed Statement of Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CondensedStatementOfIncomeCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Statement of Income Captions [Line Items]",
        "terseLabel": "Condensed Statement of Income Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedStatementOfIncomeCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r337",
      "r646",
      "r647",
      "r651",
      "r652",
      "r722",
      "r838",
      "r845",
      "r978",
      "r981",
      "r982",
      "r1053",
      "r1056",
      "r1057"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r337",
      "r646",
      "r647",
      "r651",
      "r652",
      "r722",
      "r838",
      "r845",
      "r978",
      "r981",
      "r982",
      "r1053",
      "r1056",
      "r1057"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r337",
      "r378",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r505",
      "r506",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r979",
      "r980",
      "r1054",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r337",
      "r378",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r505",
      "r506",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r979",
      "r980",
      "r1054",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r406",
      "r888",
      "r986",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r562",
      "r754",
      "r793",
      "r839",
      "r840",
      "r885",
      "r894",
      "r903",
      "r983",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r562",
      "r754",
      "r793",
      "r839",
      "r840",
      "r885",
      "r894",
      "r903",
      "r983",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r406",
      "r888",
      "r986",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50 percent) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.",
        "label": "Parent Company [Member]",
        "terseLabel": "Parent Company [Member]"
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r402",
      "r755",
      "r886",
      "r901",
      "r975",
      "r976",
      "r986",
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r402",
      "r755",
      "r886",
      "r901",
      "r975",
      "r976",
      "r986",
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r555",
      "r562",
      "r592",
      "r593",
      "r594",
      "r730",
      "r754",
      "r793",
      "r839",
      "r840",
      "r885",
      "r894",
      "r903",
      "r972",
      "r983",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r555",
      "r562",
      "r592",
      "r593",
      "r594",
      "r730",
      "r754",
      "r793",
      "r839",
      "r840",
      "r885",
      "r894",
      "r903",
      "r972",
      "r983",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]",
        "verboseLabel": "Range [Member]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r354",
      "r563",
      "r915",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r941",
      "r1052"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "terseLabel": "Condensed Balance Sheet [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "auth_ref": [
      "r941",
      "r1052"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "terseLabel": "Condensed Cash Flow Statement [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r337",
      "r856",
      "r866",
      "r867",
      "r868",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r403",
      "r404",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r844",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r887",
      "r902",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r403",
      "r404",
      "r823",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r844",
      "r846",
      "r887",
      "r902",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r354",
      "r563",
      "r915",
      "r917",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r989",
      "r1026",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity owned or controlled by another entity.",
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries [Member]"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A0550NotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.550% notes due May 2024",
        "label": "0.550% notes due May 2024 [Member]",
        "terseLabel": "0.550% notes due May 2024 [Member]"
       }
      }
     },
     "localname": "A0550NotesDueMay2024Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A1150NotesDueMay2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.150% notes due May 2026",
        "label": "1.150% notes due May 2026 [Member]",
        "terseLabel": "1.150% notes due May 2026 [Member]"
       }
      }
     },
     "localname": "A1150NotesDueMay2026Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A1250NotesDueJanuary2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.250% notes due January 2026",
        "label": "1.250% notes due January 2026 [Member]",
        "terseLabel": "1.250% notes due January 2026 [Member]"
       }
      }
     },
     "localname": "A1250NotesDueJanuary2026Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.375notesdueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.375% notes due August 2024 [Member]",
        "label": "2.375% notes due August 2024 [Member]",
        "terseLabel": "2.375% notes due August 2024 [Member]"
       }
      }
     },
     "localname": "A2.375notesdueAugust2024Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.375notesdueOctober2022MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.375% notes due October 2022 [Member] [Member]",
        "label": "2.375% notes due October 2022 [Member] [Member]",
        "terseLabel": "2.375% notes due October 2022 [Member]"
       }
      }
     },
     "localname": "A2.375notesdueOctober2022MemberMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.875notesdueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due August 2029 [Member]",
        "label": "2.875% notes due August 2029 [Member]",
        "terseLabel": "2.875% notes due August 2029 [Member]"
       }
      }
     },
     "localname": "A2.875notesdueAugust2029Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.875notesdueMarch2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due March 2022",
        "label": "2.875% notes due March 2022 [Member]",
        "terseLabel": "2.875% Notes Due March 2022 [Member]"
       }
      }
     },
     "localname": "A2.875notesdueMarch2022Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.950notesdueOctober2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.950% notes due October 2027 [Member]",
        "label": "2.950% notes due October 2027 [Member]",
        "terseLabel": "2.950% notes due October 2027 [Member]"
       }
      }
     },
     "localname": "A2.950notesdueOctober2027Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2000NotesDueMay2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.000% notes due May 2030",
        "label": "2.000% notes due May 2030 [Member]",
        "terseLabel": "2.000% notes due May 2030 [Member]"
       }
      }
     },
     "localname": "A2000NotesDueMay2030Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2300NotesDueMay2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.300% notes due May 2031",
        "label": "2.300% notes due May 2031 [Member]",
        "terseLabel": "2.300% notes due May 2031 [Member]"
       }
      }
     },
     "localname": "A2300NotesDueMay2031Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2750NotesDueFebruary2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.750% notes due February 2023 [Member]",
        "label": "2.750% notes due February 2023 [Member]",
        "terseLabel": "2.750% Notes Due February 2023 [Member]"
       }
      }
     },
     "localname": "A2750NotesDueFebruary2023Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2750NotesDueMay2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.750% notes due May 2040",
        "label": "2.750% notes due May 2040 [Member]",
        "terseLabel": "2.750% notes due May 2040 [Member]"
       }
      }
     },
     "localname": "A2750NotesDueMay2040Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2875NotesDueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due March 2023 [Member]",
        "label": "2.875% notes due March 2023 [Member]",
        "terseLabel": "2.875% Notes Due March 2023 [Member]"
       }
      }
     },
     "localname": "A2875NotesDueMarch2023Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2900NotesDueMay2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.900% notes due May 2050",
        "label": "2.900% notes due May 2050 [Member]",
        "terseLabel": "2.900% notes due May 2050 [Member]"
       }
      }
     },
     "localname": "A2900NotesDueMay2050Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.100notesdueMarch2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.100% notes due March 2026 [Member]",
        "label": "3.100% notes due March 2026 [Member]",
        "terseLabel": "3.100% notes due March 2026 [Member]"
       }
      }
     },
     "localname": "A3.100notesdueMarch2026Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.375notesdueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.375% notes due April 2027 [Member]",
        "label": "3.375% notes due April 2027 [Member]",
        "terseLabel": "3.375% notes due April 2027 [Member]"
       }
      }
     },
     "localname": "A3.375notesdueApril2027Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.450notesdueJanuary2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.450% notes due January 2027 [Member]",
        "label": "3.450% notes due January 2027 [Member]",
        "terseLabel": "3.450% notes due January 2027 [Member]"
       }
      }
     },
     "localname": "A3.450notesdueJanuary2027Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueAugust2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due August 2039 [Member]",
        "label": "3.500% notes due August 2039 [Member]",
        "terseLabel": "3.500% notes due August 2039 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueAugust2039Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueFebruary2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due February 2024 [Member]",
        "label": "3.500% notes due February 2024 [Member]",
        "terseLabel": "3.500% notes due February 2024 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueFebruary2024Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due June 2023 [Member]",
        "label": "3.500% notes due June 2023 [Member]",
        "terseLabel": "3.500% notes due June 2023 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueJune2023Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.700notesdueAugust2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700% notes due August 2049 [Member]",
        "label": "3.700% notes due August 2049 [Member]",
        "terseLabel": "3.700% notes due August 2049 [Member]"
       }
      }
     },
     "localname": "A3.700notesdueAugust2049Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.700notesdueDecember2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700% notes due December 2025 [Member]",
        "label": "3.700% notes due December 2025 [Member]",
        "terseLabel": "3.700% notes due December 2025 [Member]"
       }
      }
     },
     "localname": "A3.700notesdueDecember2025Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.750notesdueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.750% notes due July 2025 [Member]",
        "label": "3.750% notes due July 2025 [Member]",
        "terseLabel": "3.750% Notes Due July 2025 [Member]"
       }
      }
     },
     "localname": "A3.750notesdueJuly2025Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.750notesdueOctober2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.750% notes due October 2047 [Member]",
        "label": "3.750% notes due October 2047 [Member]",
        "terseLabel": "3.750% notes due October 2047 [Member]"
       }
      }
     },
     "localname": "A3.750notesdueOctober2047Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.850notesdueJune2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.850% notes due June 2028 [Member]",
        "label": "3.850% notes due June 2028 [Member]",
        "terseLabel": "3.850% notes due June 2028 [Member]"
       }
      }
     },
     "localname": "A3.850notesdueJune2028Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.875notesdueAugust2059Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.875% notes due August 2059 [Member]",
        "label": "3.875% notes due August 2059 [Member]",
        "terseLabel": "3.875% notes due August 2059 [Member]"
       }
      }
     },
     "localname": "A3.875notesdueAugust2059Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.875notesdueDecember2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.875% notes due December 2028 [Member]",
        "label": "3.875% notes due December 2028 [Member]",
        "terseLabel": "3.875% notes due December 2028 [Member]"
       }
      }
     },
     "localname": "A3.875notesdueDecember2028Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3050NotesDueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.050% notes due May 2041",
        "label": "3.050% notes due May 2041 [Member]",
        "terseLabel": "3.050% notes due May 2041 [Member]"
       }
      }
     },
     "localname": "A3050NotesDueMay2041Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3125NotesDueMay2060Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% notes due May 2060",
        "label": "3.125% notes due May 2060 [Member]",
        "terseLabel": "3.125% notes due May 2060 [Member]"
       }
      }
     },
     "localname": "A3125NotesDueMay2060Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3250NotesDueMay2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.250% notes due May 2051 [Member]",
        "label": "3.250% notes due May 2051 [Member]",
        "terseLabel": "3.250% notes due May 2051 [Member]"
       }
      }
     },
     "localname": "A3250NotesDueMay2051Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3350NotesDueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.350% notes due July 2022 [Member]",
        "label": "3.350% notes due July 2022 [Member]",
        "terseLabel": "3.350% Notes Due July 2022 [Member]"
       }
      }
     },
     "localname": "A3350NotesDueJuly2022Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A364Day60BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "364 Day $6.0 Billion Credit Facility [Member]",
        "label": "364 Day $6.0 Billion Credit Facility [Member]",
        "terseLabel": "364 Day $6.0 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "A364Day60BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3700NotesDueMay2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700% notes due May 2027 [Member]",
        "label": "3.700% notes due May 2027 [Member]",
        "terseLabel": "3.700% notes due May 2027 [Member]"
       }
      }
     },
     "localname": "A3700NotesDueMay2027Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3950NotesDueOctober2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.950% notes due October 2042 [Member]",
        "label": "3.950% notes due October 2042 [Member]",
        "terseLabel": "3.950% notes Due October 2042 [Member]"
       }
      }
     },
     "localname": "A3950NotesDueOctober2042Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.200notesdueJanuary2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.200% notes due January 2047",
        "label": "4.200% notes due January 2047 [Member]",
        "terseLabel": "4.200% notes due January 2047 [Member]"
       }
      }
     },
     "localname": "A4.200notesdueJanuary2047Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.250notesdueApril2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due April 2047 [Member]",
        "label": "4.250% notes due April 2047 [Member]",
        "terseLabel": "4.250% notes due April 2047 [Member]"
       }
      }
     },
     "localname": "A4.250notesdueApril2047Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.250notesdueJune2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due June 2048 [Member]",
        "label": "4.250% notes due June 2048 [Member]",
        "terseLabel": "4.250% notes due June 2048 [Member]"
       }
      }
     },
     "localname": "A4.250notesdueJune2048Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.375notesdueMarch2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.375% notes due March 2042",
        "label": "4.375% notes due March 2042 [Member]",
        "terseLabel": "4.375% notes Due March 2042 [Member]"
       }
      }
     },
     "localname": "A4.375notesdueMarch2042Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.450notesdueDecember2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.450% notes due December 2048 [Member]",
        "label": "4.450% notes due December 2048 [Member]",
        "terseLabel": "4.450% notes due December 2048 [Member]"
       }
      }
     },
     "localname": "A4.450notesdueDecember2048Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.625notesdueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% notes due July 2035 [Member]",
        "label": "4.625% notes due July 2035 [Member]",
        "terseLabel": "4.625% notes Due July 2035 [Member]"
       }
      }
     },
     "localname": "A4.625notesdueJuly2035Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.625notesdueNovember2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% notes due November 2041",
        "label": "4.625% notes due November 2041 [Member]",
        "terseLabel": "4.625% notes Due November 2041 [Member]"
       }
      }
     },
     "localname": "A4.625notesdueNovember2041Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.750notesdueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.750% notes due July 2045 [Member]",
        "label": "4.750% notes due July 2045 [Member]",
        "terseLabel": "4.750% notes Due July 2045 [Member]"
       }
      }
     },
     "localname": "A4.750notesdueJuly2045Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4000NotesDueMay2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4000% notes due May 2029 [Member]",
        "label": "4.000% notes due May 2029 [Member]",
        "terseLabel": "4.000% notes due May 2029 [Member]"
       }
      }
     },
     "localname": "A4000NotesDueMay2029Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4200NotesDueMay2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.200% notes due May 2032 [Member]",
        "label": "4.200% notes due May 2032 [Member]",
        "terseLabel": "4.200% notes due May 2032 [Member]"
       }
      }
     },
     "localname": "A4200NotesDueMay2032Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4250NotesDueMarch2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due March 2043 [Member]",
        "label": "4.250% notes due March 2043 [Member]",
        "terseLabel": "4.250% notes Due March 2043 [Member]"
       }
      }
     },
     "localname": "A4250NotesDueMarch2043Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4750NotesDueMay2052Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.750% notes due May 2052 [Member]",
        "label": "4.750% notes due May 2052 [Member]",
        "terseLabel": "4.750% notes due May 2052 [Member]"
       }
      }
     },
     "localname": "A4750NotesDueMay2052Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4950NotesDueMay2062Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.950% notes due May 2062 [Member]",
        "label": "4.950% notes due May 2062 [Member]",
        "terseLabel": "4.950% notes due May 2062 [Member]"
       }
      }
     },
     "localname": "A4950NotesDueMay2062Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.700notesdueOctober2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.700% notes due October 2040",
        "label": "5.700% notes due October 2040 [Member]",
        "terseLabel": "5.700% notes Due October 2040 [Member]"
       }
      }
     },
     "localname": "A5.700notesdueOctober2040Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.800notesdueMarch2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.800% notes due March 2036",
        "label": "5.800% notes due March 2036 [Member]",
        "terseLabel": "5.800% notes Due March 2036 [Member]"
       }
      }
     },
     "localname": "A5.800notesdueMarch2036Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.950notesdueFebruary2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.950% notes due February 2041",
        "label": "5.950% notes due February 2041 [Member]",
        "terseLabel": "5.950% notes Due Februrary 2041 [Member]"
       }
      }
     },
     "localname": "A5.950notesdueFebruary2041Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5000NotesDueOctober2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.000% notes due October 2024 [Member]",
        "label": "5.000% notes due October 2024 [Member]",
        "terseLabel": "5.000% notes due October 2024 [Member]"
       }
      }
     },
     "localname": "A5000NotesDueOctober2024Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5150NotesDueOctober2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.150% notes due October 2025 [Member]",
        "label": "5.150% notes due October 2025 [Member]",
        "terseLabel": "5.150% notes due October 2025 [Member]"
       }
      }
     },
     "localname": "A5150NotesDueOctober2025Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5250NotesDueFebruary2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.250% notes due February 2028 [Member]",
        "label": "5.250% notes due February 2028 [Member]",
        "terseLabel": "5.250% notes due February 2028 [Member]"
       }
      }
     },
     "localname": "A5250NotesDueFebruary2028Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5300NotesDueFebruary2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.300% notes due February 2030 [Member]",
        "label": "5.300% notes due February 2030 [Member]",
        "terseLabel": "5.300% notes due February 2030 [Member]"
       }
      }
     },
     "localname": "A5300NotesDueFebruary2030Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5350NotesDueFebruary2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.350% notes due February 2033 [Member]",
        "label": "5.350% notes due February 2033 [Member]",
        "terseLabel": "5.350% notes due February 2033 [Member]"
       }
      }
     },
     "localname": "A5350NotesDueFebruary2033Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5875NotesDueFebruary2053Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.875% notes due February 2053 [Member]",
        "label": "5.875% notes due February 2053 [Member]",
        "terseLabel": "5.875% notes due February 2053 [Member]"
       }
      }
     },
     "localname": "A5875NotesDueFebruary2053Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6.875notesdueFebruary2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.875% notes due February 2038",
        "label": "6.875% notes due February 2038 [Member]",
        "terseLabel": "6.875% notes Due Februray 2038 [Member]"
       }
      }
     },
     "localname": "A6.875notesdueFebruary2038Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6050NotesDueFebruary2063Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.050% notes due February 2063 [Member]",
        "label": "6.050% notes due February 2063 [Member]",
        "terseLabel": "6.050% notes due February 2063 [Member]"
       }
      }
     },
     "localname": "A6050NotesDueFebruary2063Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6500NotesDueJune2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.500% notes due June 2037 [Member]",
        "label": "6.500% notes due June 2037 [Member]",
        "terseLabel": "6.500% notes Due June 2037 [Member]"
       }
      }
     },
     "localname": "A6500NotesDueJune2037Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6625NotesDueNovember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.625% notes due November 2037 [Member]",
        "label": "6.625% notes due November 2037 [Member]",
        "terseLabel": "6.625% notes due November 2037 [Member]"
       }
      }
     },
     "localname": "A6625NotesDueNovember2037Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_AARPAssetsUnderManagementPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AARP Assets Under Management [Policy Text Block]",
        "label": "AARP Assets Under Management [Policy Text Block]",
        "terseLabel": "AARP Assets Under Management [Policy Text Block]"
       }
      }
     },
     "localname": "AARPAssetsUnderManagementPolicyTextBlock",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_AarpAssetsUnderManagement": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.",
        "label": "AARP Assets Under Management",
        "terseLabel": "Assets under management"
       }
      }
     },
     "localname": "AarpAssetsUnderManagement",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]",
        "terseLabel": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_BasisofpresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation [Abstract]",
        "label": "Basis of presentation [Abstract]",
        "terseLabel": "Basis of presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofpresentationAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Assets and Liabilities, Assets Held-for-sale",
        "label": "Business Combination, Recognized Assets and Liabilities, Assets Held-for-sale",
        "terseLabel": "Assets held-for-sale"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedAssetsAndLiabilitiesAssetsHeldForSale",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Assets and Liabilities, Liabilities Held-for-sale",
        "label": "Business Combination, Recognized Assets and Liabilities, Liabilities Held-for-sale",
        "negatedTerseLabel": "Liabilities held-for-sale"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedAssetsAndLiabilitiesLiabilitiesHeldForSale",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_BusinessCombinationsNonredeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonredeemable noncontrolling interests acquired through business combinations",
        "label": "Business Combinations, Nonredeemable noncontrolling interests",
        "terseLabel": "Nonredeemable noncontrolling interests"
       }
      }
     },
     "localname": "BusinessCombinationsNonredeemableNoncontrollingInterests",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_BusinessCombinationsRedeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable noncontrolling interests acquired through business combinations",
        "label": "Business Combinations, Redeemable noncontrolling interests",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "BusinessCombinationsRedeemableNoncontrollingInterests",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_CMSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CMS [Member]",
        "label": "CMS [Member]",
        "terseLabel": "CMS [Member]"
       }
      }
     },
     "localname": "CMSMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_Capitalcontributionstosubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital contributions to subsidiaries",
        "label": "Capital contributions to subsidiaries",
        "negatedTerseLabel": "Capital contributions to subsidiaries"
       }
      }
     },
     "localname": "Capitalcontributionstosubsidiaries",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software [Member]"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_CarryingValueOfDisposition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying Value of Disposition",
        "label": "Carrying Value of Disposition",
        "terseLabel": "Carrying Value of Disposition"
       }
      }
     },
     "localname": "CarryingValueOfDisposition",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_ChangeHealthcareAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare Acquisition",
        "label": "Change Healthcare Acquisition [Member]",
        "terseLabel": "Change Healthcare Acquisition"
       }
      }
     },
     "localname": "ChangeHealthcareAcquisitionMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ChangeHealthcareClaimEditingBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare Claim Editing Business",
        "label": "Change Healthcare Claim Editing Business [Member]",
        "terseLabel": "Change Healthcare Claim Editing Business"
       }
      }
     },
     "localname": "ChangeHealthcareClaimEditingBusinessMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ChangeHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare",
        "label": "Change Healthcare [Member]",
        "terseLabel": "Change Healthcare"
       }
      }
     },
     "localname": "ChangeHealthcareMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_CoverPageAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover Page [Abstract]",
        "label": "Cover Page [Abstract]",
        "terseLabel": "Cover Page [Abstract]"
       }
      }
     },
     "localname": "CoverPageAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_CreditFacilityNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility Name [Axis]",
        "label": "Credit Facility Name [Axis]",
        "terseLabel": "Credit Facility Name [Axis]"
       }
      }
     },
     "localname": "CreditFacilityNameAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_CreditFacilityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Credit Facility Name [Axis]",
        "label": "Credit Facility Name [Domain]",
        "terseLabel": "Credit Facility Name [Domain]"
       }
      }
     },
     "localname": "CreditFacilityNameDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_DebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt [Abstract]",
        "label": "Debt [Abstract]",
        "terseLabel": "Debt [Abstract]"
       }
      }
     },
     "localname": "DebtAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_DebtInstrumentExcludingCommercialPaperAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, excluding Commercial Paper",
        "label": "Debt Instrument, excluding Commercial Paper [Axis]",
        "terseLabel": "Debt Instrument, excluding Commercial Paper [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentExcludingCommercialPaperAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_DebtInstrumentExcludingCommercialPaperDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, excluding Commercial Paper [Domain]",
        "label": "Debt Instrument, excluding Commercial Paper [Domain]",
        "terseLabel": "Debt Instrument, excluding Commercial Paper [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentExcludingCommercialPaperDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_DeferredTaxAssetOtherDomestic": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Other Domestic",
        "label": "Deferred Tax Asset, Other Domestic",
        "terseLabel": "Other-domestic"
       }
      }
     },
     "localname": "DeferredTaxAssetOtherDomestic",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetOtherForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Other Foreign",
        "label": "Deferred Tax Asset, Other Foreign",
        "terseLabel": "Other-non-U.S."
       }
      }
     },
     "localname": "DeferredTaxAssetOtherForeign",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities",
        "label": "Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities",
        "terseLabel": "Nondeductible liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Lease Liability",
        "label": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign",
        "label": "Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign",
        "negatedTerseLabel": "Non-U.S. goodwill and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilityOtherDomestic": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Other Domestic",
        "label": "Deferred Tax Liability, Other Domestic",
        "negatedTerseLabel": "Net unrealized gains on investments"
       }
      }
     },
     "localname": "DeferredTaxLiabilityOtherDomestic",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilityOtherForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Other Foreign",
        "label": "Deferred Tax Liability, Other Foreign",
        "negatedTerseLabel": "Other-non-U.S."
       }
      }
     },
     "localname": "DeferredTaxLiabilityOtherForeign",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DescriptionofBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business [Abstract]",
        "label": "Description of Business [Abstract]",
        "terseLabel": "Description of Business [Abstract]"
       }
      }
     },
     "localname": "DescriptionofBusinessAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_DisclosureonGeographicAreasPercentageofLongLivedAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.",
        "label": "Disclosure on Geographic Areas Percentage of Long Lived Assets",
        "terseLabel": "Disclosure on Geographic Areas Percentage of Long Lived Assets"
       }
      }
     },
     "localname": "DisclosureonGeographicAreasPercentageofLongLivedAssets",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.",
        "label": "Disclosure on Geographic Areas Percentage of Revenue from External Customers",
        "terseLabel": "Disclosure on Geographic Areas Percentage of Revenue from External Customers"
       }
      }
     },
     "localname": "DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_DividendFrequencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend Frequency",
        "label": "Dividend Frequency [Axis]",
        "terseLabel": "Dividend Frequency [Axis]"
       }
      }
     },
     "localname": "DividendFrequencyAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_DividendFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend Frequency [Domain]",
        "label": "Dividend Frequency [Domain]",
        "terseLabel": "Dividend Frequency [Domain]"
       }
      }
     },
     "localname": "DividendFrequencyDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount",
        "label": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount",
        "terseLabel": "Health insurance industry tax, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent",
        "label": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent",
        "terseLabel": "Health insurance industry tax, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount",
        "terseLabel": "Share-based awards - excess tax benefit, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent",
        "terseLabel": "Share-based awards - excess tax benefit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_EmployeeStockPurchasePlanESPPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP) [Member]",
        "label": "Employee Stock Purchase Plan (ESPP) [Member]",
        "terseLabel": "Employee Stock Purchase Plan (ESPP) [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanESPPMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_EquityinNetAssetsofSubsidiaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity in Net Assets of Subsidiaries",
        "label": "Equity in Net Assets of Subsidiaries",
        "terseLabel": "Equity in net assets of subsidiaries"
       }
      }
     },
     "localname": "EquityinNetAssetsofSubsidiaries",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_ExternalCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External Customers [Member]",
        "label": "External Customers [Member]",
        "terseLabel": "Unaffiliated Customers"
       }
      }
     },
     "localname": "ExternalCustomersMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ExtraordinaryDividendsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extraordinary Dividends [Member]",
        "label": "Extraordinary Dividends [Member]",
        "terseLabel": "Extraordinary Dividends [Member]"
       }
      }
     },
     "localname": "ExtraordinaryDividendsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_FairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value [Abstract]",
        "label": "Fair Value [Abstract]",
        "terseLabel": "Fair Value [Abstract]"
       }
      }
     },
     "localname": "FairValueAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis",
        "label": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis",
        "terseLabel": "Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis"
       }
      }
     },
     "localname": "FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_FiveYear60BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year $6.0 Billion Credit Facility [Member]",
        "label": "Five Year $6.0 Billion Credit Facility [Member]",
        "terseLabel": "Five Year $6.0 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "FiveYear60BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_GoodwillandIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Abstract]",
        "label": "Goodwill and Intangible Assets [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "GoodwillandIntangibleAssetsAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_IncomeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Abstract]",
        "label": "Income Tax [Abstract]",
        "terseLabel": "Income Tax [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_IntersegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intersegment [Member]",
        "label": "Intersegment [Member]",
        "terseLabel": "Affiliated Customers"
       }
      }
     },
     "localname": "IntersegmentMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_InvestmentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments at amortized cost.",
        "label": "Investments, Amortized Cost",
        "totalLabel": "Total investments, Amortized Cost"
       }
      }
     },
     "localname": "InvestmentsAmortizedCost",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_InvestmentsGrossUnrealizedGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross unrealized gains of investments.",
        "label": "Investments, Gross Unrealized Gains",
        "terseLabel": "Total investments, Gross Unrealized Gains"
       }
      }
     },
     "localname": "InvestmentsGrossUnrealizedGains",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_InvestmentsGrossUnrealizedLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross unrealized losses of investments.",
        "label": "Investments, Gross Unrealized Losses",
        "negatedTerseLabel": "Total investments, Gross Unrealized Losses"
       }
      }
     },
     "localname": "InvestmentsGrossUnrealizedLosses",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_LossofParentCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss of Parent Company",
        "label": "Loss of Parent Company",
        "negatedTerseLabel": "Loss of parent company"
       }
      }
     },
     "localname": "LossofParentCompany",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_MedicalCostsAndMedicalCostsPayableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Costs and Medical Costs Payable [Axis]",
        "label": "Medical Costs and Medical Costs Payable [Axis]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Axis]"
       }
      }
     },
     "localname": "MedicalCostsAndMedicalCostsPayableAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_MedicalCostsAndMedicalCostsPayableDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Costs and Medical Costs Payable [Domain]",
        "label": "Medical Costs and Medical Costs Payable [Domain]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Domain]"
       }
      }
     },
     "localname": "MedicalCostsAndMedicalCostsPayableDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_MedicarePartDPharmacyBenefitsContractAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Pharmacy Benefits Contract [Axis]",
        "label": "Medicare Part D Pharmacy Benefits Contract [Axis]",
        "terseLabel": "Medicare Part D Pharmacy Benefits Contract [Axis]"
       }
      }
     },
     "localname": "MedicarePartDPharmacyBenefitsContractAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_MedicarePartDPharmacyBenefitsContractDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Pharmacy Benefits Contract [Domain]",
        "label": "Medicare Part D Pharmacy Benefits Contract [Domain]",
        "terseLabel": "Medicare Part D Pharmacy Benefits Contract [Domain]"
       }
      }
     },
     "localname": "MedicarePartDPharmacyBenefitsContractDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_MedicarePartDReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Receivables [Member]",
        "label": "Medicare Part D Receivables [Member]",
        "terseLabel": "Medicare Part D Receivables [Member]"
       }
      }
     },
     "localname": "MedicarePartDReceivablesMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NOLsExpirationBeginning2022Through2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs expiration beginning 2022 through 2037",
        "label": "NOLsExpirationBeginning2022Through2037 [Member]",
        "terseLabel": "Finite-lived NOL carryforwards [Member]"
       }
      }
     },
     "localname": "NOLsExpirationBeginning2022Through2037Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NOLsIndefiniteCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs indefinite carryforward",
        "label": "NOLsIndefiniteCarryforward [Member]",
        "terseLabel": "Indefinite NOL carryforwards [Member]"
       }
      }
     },
     "localname": "NOLsIndefiniteCarryforwardMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Days Notice Required To Cancel Health Insurance Contract",
        "label": "Number Of Days Notice Required To Cancel Health Insurance Contract",
        "terseLabel": "Number Of Days Notice Required To Cancel Health Insurance Contract"
       }
      }
     },
     "localname": "NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "unh_OptumhealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumHealth Member",
        "label": "Optumhealth [Member]",
        "terseLabel": "Optum Health"
       }
      }
     },
     "localname": "OptumhealthMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OptuminsightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumInsight [Member]",
        "label": "Optuminsight [Member]",
        "terseLabel": "Optum Insight"
       }
      }
     },
     "localname": "OptuminsightMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OptumrxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumRx [Member]",
        "label": "Optumrx [Member]",
        "terseLabel": "Optum Rx"
       }
      }
     },
     "localname": "OptumrxMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Acquisitions",
        "label": "Other Acquisitions [Member]",
        "terseLabel": "Other Acquisitions"
       }
      }
     },
     "localname": "OtherAcquisitionsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OtherDispositionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Dispositions",
        "label": "Other Dispositions [Member]",
        "terseLabel": "Other Dispositions"
       }
      }
     },
     "localname": "OtherDispositionsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OtherLiabilitiesCurrentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Current [Policy Text Block]",
        "label": "Other Liabilities, Current [Policy Text Block]",
        "terseLabel": "Other Current Liabilities [Policy Text Block]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentPolicyTextBlock",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_OtherShareBasedCompensationDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Share-Based Compensation Data [Abstract]",
        "label": "Other Share-Based Compensation Data [Abstract]",
        "terseLabel": "Other Share-Based Compensation Data [Abstract]"
       }
      }
     },
     "localname": "OtherShareBasedCompensationDataAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_PharmaceuticalManufacturerRebatesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PharmaceuticalManufacturerRebatesReceivable [Member]",
        "label": "PharmaceuticalManufacturerRebatesReceivable [Member]",
        "terseLabel": "Pharmaceutical Manufacturer Rebates Receivable [Member]"
       }
      }
     },
     "localname": "PharmaceuticalManufacturerRebatesReceivableMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_PharmaceuticalmanufacturerrebatesreceivableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical manufacturer rebates receivable",
        "label": "Pharmaceutical manufacturer rebates receivable [Axis]",
        "terseLabel": "Pharmaceutical manufacturer rebates receivable [Axis]"
       }
      }
     },
     "localname": "PharmaceuticalmanufacturerrebatesreceivableAxis",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_PharmaceuticalmanufacturerrebatesreceivableDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Pharmaceutical manufacturer rebates receivable",
        "label": "Pharmaceutical manufacturer rebates receivable [Domain]",
        "terseLabel": "Pharmaceutical manufacturer rebates receivable [Domain]"
       }
      }
     },
     "localname": "PharmaceuticalmanufacturerrebatesreceivableDomain",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid and Other Current Assets Policy",
        "label": "Prepaid and Other Current Assets Policy [Policy Text Block]",
        "terseLabel": "Prepaid and Other Current Assets Policy"
       }
      }
     },
     "localname": "PrepaidAndOtherCurrentAssetsPolicyPolicyTextBlock",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_ProductsandservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products and services [Member]",
        "label": "Products and services [Member]",
        "terseLabel": "Products and services [Member]"
       }
      }
     },
     "localname": "ProductsandservicesMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment Excluding Capitalized Computer Software, Net",
        "label": "Property, Plant, and Equipment Excluding Capitalized Computer Software, Net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_RedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests [Member]",
        "label": "Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests [Member]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_RevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues [Member]",
        "label": "Revenues [Member]",
        "terseLabel": "Revenues [Member]"
       }
      }
     },
     "localname": "RevenuesMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ScheduleIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I [Abstract]",
        "label": "Schedule I [Abstract]",
        "terseLabel": "Schedule I [Abstract]"
       }
      }
     },
     "localname": "ScheduleIAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_ScheduleIBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I Balance Sheet (Parenthetical) [Abstract]",
        "label": "Schedule I Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Schedule I Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "ScheduleIBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]",
        "label": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]",
        "terseLabel": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]"
       }
      }
     },
     "localname": "ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "unh_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations Change Healthcare and other acquisitions",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combinations"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationsTableTextBlock",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_ShareRepurchasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchases [Table]",
        "label": "Share Repurchases [Table]",
        "terseLabel": "Share Repurchases [Table]"
       }
      }
     },
     "localname": "ShareRepurchasesTable",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShareRepurchasesTableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Share Repurchases [Table]",
        "label": "Share Repurchases [Table] [Line Items]",
        "terseLabel": "Shareholders' Equity Disclosure [Line Items]"
       }
      }
     },
     "localname": "ShareRepurchasesTableLineItems",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShareholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders' Equity [Abstract]",
        "label": "Shareholders' Equity [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "ShareholdersEquityAbstract",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days",
        "terseLabel": "Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "unh_StockOptionsandSARsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options and SARs",
        "label": "Stock Options and SARs [Member]",
        "terseLabel": "Stock Options [Member]",
        "verboseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "StockOptionsandSARsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ThreeYear60BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Year $6.0 Billion Credit Facility [Member]",
        "label": "Three Year $6.0 Billion Credit Facility [Member]",
        "terseLabel": "Three Year $6.0 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "ThreeYear60BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_TotalAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Acquisitions",
        "label": "Total Acquisitions [Member]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "TotalAcquisitionsMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_TotalOptumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "total [Member]",
        "label": "Total Optum [Member]",
        "terseLabel": "Optum"
       }
      }
     },
     "localname": "TotalOptumMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_TrademarksandTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks and Technology [Member]",
        "label": "Trademarks and Technology [Member]",
        "terseLabel": "Trademarks and Technology [Member]"
       }
      }
     },
     "localname": "TrademarksandTechnologyMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_UnitedhealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnitedHealthcare [Member]",
        "label": "Unitedhealthcare [Member]",
        "terseLabel": "UnitedHealthcare"
       }
      }
     },
     "localname": "UnitedhealthcareMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_UsefulLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful Life [Member]",
        "label": "Useful Life [Member]",
        "terseLabel": "Useful Life [Member]"
       }
      }
     },
     "localname": "UsefulLifeMember",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ZeroCouponNotesDueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero Coupon notes due November 2022 [Member]",
        "label": "Zero Coupon notes due November 2022 [Member]",
        "terseLabel": "0.000% Notes Due November 2022 [Member]"
       }
      }
     },
     "localname": "ZeroCouponNotesDueNovember2022Member",
     "nsuri": "http://www.uhc.com/20221231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r408",
      "r409"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowances of $877 and $954"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r115",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r307",
      "r315",
      "r316",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Net Unrealized Gains (Losses) on Investments [Member]"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r31",
      "r32",
      "r298",
      "r781",
      "r801",
      "r805"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r27",
      "r32",
      "r191",
      "r315",
      "r316",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation (Losses) Gains [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r601",
      "r602",
      "r603",
      "r942",
      "r943",
      "r944",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r342",
      "r343",
      "r344",
      "r345",
      "r354",
      "r412",
      "r413",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r601",
      "r602",
      "r603",
      "r626",
      "r627",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r699",
      "r700",
      "r703",
      "r704",
      "r705",
      "r706",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r757",
      "r758",
      "r759",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Noncash items:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense, net of tax effects"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r299",
      "r410",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts, accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for doubtful accounts, other receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r58",
      "r103",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r215",
      "r241",
      "r290",
      "r333",
      "r386",
      "r392",
      "r398",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r646",
      "r651",
      "r678",
      "r900",
      "r979",
      "r980",
      "r1029"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r282",
      "r302",
      "r333",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r646",
      "r651",
      "r678",
      "r900",
      "r979",
      "r980",
      "r1029"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Securities, Available for sale Debt Securities, Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r415",
      "r456"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Total debt securities - available-for-sale, Amortized Cost",
        "totalLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r84",
      "r418",
      "r777"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r84",
      "r417",
      "r776"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r84",
      "r419",
      "r778"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r84",
      "r416",
      "r775"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Mortgage-backed securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r89",
      "r779"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Mortgage-backed securities, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r81",
      "r414",
      "r456",
      "r762"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r567",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/ScheduleIPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r640",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r640",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r177",
      "r178",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r180",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure [Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Total identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Total identifiable liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Total net identifiable assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, equipment and other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Combination, Separately Recognized Transactions [Line Items]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Line Items]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Table]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Table]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r1044"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "negatedTerseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r272",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized Computer Software, Amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r1044"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r841"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "totalLabel": "Capitalized software, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r60",
      "r284",
      "r869"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r54",
      "r60",
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r54",
      "r205"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "(Decrease) increase in cash and cash equivalents",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries",
        "terseLabel": "Cash Dividends Paid to Parent, Consolidated Subsidiaries"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses.",
        "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r333",
      "r357",
      "r358",
      "r360",
      "r362",
      "r366",
      "r367",
      "r442",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r535",
      "r536",
      "r538",
      "r542",
      "r549",
      "r678",
      "r842",
      "r914",
      "r936",
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r0",
      "r216",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r24",
      "r225",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 4)",
        "verboseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r488",
      "r489",
      "r825",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParenthetical",
      "http://www.uhc.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r942",
      "r943",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common Stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r900"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r34",
      "r311",
      "r313",
      "r322",
      "r767",
      "r786"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income",
        "totalLabel": "Comprehensive income attributable to UnitedHealth Group common shareholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r184",
      "r185",
      "r195",
      "r311",
      "r313",
      "r321",
      "r766",
      "r785"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r183",
      "r195",
      "r311",
      "r313",
      "r320",
      "r765",
      "r784"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r203",
      "r204",
      "r406",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r203",
      "r204",
      "r406",
      "r807",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r203",
      "r204",
      "r406",
      "r824",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r68",
      "r69",
      "r203",
      "r204",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r203",
      "r204",
      "r406",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "auth_ref": [
      "r279",
      "r337",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "terseLabel": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/ScheduleIPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r889",
      "r891",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Obligations [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r76",
      "r391",
      "r392",
      "r393",
      "r394",
      "r400",
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and Eliminations"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r41",
      "r755"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service [Policy Text Block]"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs",
        "verboseLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r939",
      "r1020"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r166",
      "r624",
      "r633",
      "r939"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r939",
      "r1020",
      "r1021"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Short-term borrowings and current maturities of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r331",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r524",
      "r531",
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Short-Term Borrowings and Long-Term Debt [Text Block]"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r217",
      "r219",
      "r239",
      "r337",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r702",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r207",
      "r209",
      "r508",
      "r702",
      "r881",
      "r882"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Par Value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r522",
      "r677",
      "r881",
      "r882"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt and other financing obligations"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r21",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r22",
      "r337",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r702",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r22",
      "r135",
      "r138",
      "r139",
      "r140",
      "r206",
      "r207",
      "r209",
      "r237",
      "r337",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r702",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Debt and other financing obligations, carrying value",
        "verboseLabel": "Carrying Value"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r438",
      "r461",
      "r878"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Greater Than 12 Months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r438",
      "r461"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Greater Than 12 Months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r438",
      "r461",
      "r878"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less Than 12 Months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r438",
      "r461"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less Than 12 Months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r435",
      "r457",
      "r878"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r436",
      "r458"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r434",
      "r878",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r437",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities - held-to-maturity"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred Compensation, Recorded Liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r166",
      "r625",
      "r632",
      "r633",
      "r939"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred (benefit) provision",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r4",
      "r5",
      "r218",
      "r238",
      "r620"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r607",
      "r608"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r920"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "verboseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Net unrealized losses on investments"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r1018"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "U.S. federal and state net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Non-U.S. tax loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances",
        "terseLabel": "Accrued expenses and allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r153",
      "r1018"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Software",
        "negatedTerseLabel": "Capitalized software"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.",
        "label": "Deferred Tax Liabilities, Investment in Noncontrolled Affiliates",
        "negatedTerseLabel": "Outside basis in partnerships"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "negatedTerseLabel": "U.S. federal and state intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r163",
      "r1019"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositAccounts": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of money in accounts that may bear interest and that the depositor is entitled to withdraw at any time without prior notice.",
        "label": "Demand Deposit Accounts",
        "terseLabel": "Health savings account deposits"
       }
      }
     },
     "localname": "DemandDepositAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r58",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r58",
      "r113"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r566",
      "r596",
      "r597",
      "r599",
      "r605",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r141",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Cash dividends paid on common shares ($6.40 per share, $5.60 per share and $4.83 per share for the years ended December 31, 2022, 2021 and 2020, respectively)"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Dividends Declared"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarliestTaxYearMember": {
     "auth_ref": [
      "r1017"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earliest identified tax year.",
        "label": "Earliest Tax Year [Member]",
        "terseLabel": "Earliest Tax Year [Member]"
       }
      }
     },
     "localname": "EarliestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to UnitedHealth Group common shareholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r323",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r355",
      "r357",
      "r360",
      "r361",
      "r362",
      "r364",
      "r664",
      "r665",
      "r768",
      "r787",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r323",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r357",
      "r360",
      "r361",
      "r362",
      "r364",
      "r664",
      "r665",
      "r768",
      "r787",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r66",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Provision for income taxes, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r335",
      "r610",
      "r634"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax provision at the U.S. federal statutory rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1016",
      "r1022"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r1016",
      "r1022"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Non-deductible compensation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1016",
      "r1022"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1016",
      "r1022"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to share awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Income tax benefit realized from share-based award exercises"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r134",
      "r276",
      "r314",
      "r315",
      "r316",
      "r339",
      "r340",
      "r341",
      "r343",
      "r351",
      "r353",
      "r365",
      "r447",
      "r550",
      "r601",
      "r602",
      "r603",
      "r628",
      "r629",
      "r663",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r721",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r100",
      "r387",
      "r918"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r291",
      "r676",
      "r871"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "terseLabel": "Equity Securities, FV-NI and without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Equity Securities, FV-NI, Unrealized Gain"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r667",
      "r668",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Nonrecurring [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r198",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r522",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r668",
      "r727",
      "r728",
      "r729",
      "r881",
      "r882",
      "r889",
      "r890",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r667",
      "r668",
      "r669",
      "r670",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value [Text Block]"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r522",
      "r556",
      "r561",
      "r668",
      "r727",
      "r889",
      "r890",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets (Level 1) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r522",
      "r556",
      "r561",
      "r668",
      "r728",
      "r881",
      "r882",
      "r889",
      "r890",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Other Observable Inputs (Level 2) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r522",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r668",
      "r729",
      "r881",
      "r882",
      "r889",
      "r890",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Unobservable Inputs (Level 3) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfers Into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r522",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r727",
      "r728",
      "r729",
      "r881",
      "r882",
      "r889",
      "r890",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r667",
      "r668",
      "r669",
      "r670",
      "r672",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r334",
      "r609"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r425",
      "r429",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r460",
      "r462",
      "r463",
      "r533",
      "r547",
      "r653",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r878",
      "r955",
      "r956",
      "r957",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r288",
      "r481"
     ],
     "calculation": {
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r478",
      "r480",
      "r481",
      "r482",
      "r756",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "verboseLabel": "Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r104",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Non-U.S [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 4.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, Fixtures and equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r287",
      "r464",
      "r761",
      "r879",
      "r900",
      "r961",
      "r968"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r467",
      "r879"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r476",
      "r477",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r58",
      "r465",
      "r470",
      "r476",
      "r879"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r167",
      "r969"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency effects and adjustments, net"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r1040"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line [Member]"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r90",
      "r411",
      "r453",
      "r959"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "terseLabel": "Debt Securities, Held-to-maturity",
        "totalLabel": "Held-to-maturity securities, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r92",
      "r427"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Securities, Held to maturity, Unrecognized Holding Gain"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r93",
      "r428"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss",
        "negatedLabel": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r96",
      "r232",
      "r432",
      "r777"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount": {
     "auth_ref": [
      "r423",
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r95",
      "r231",
      "r431",
      "r776"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
     "auth_ref": [
      "r422",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r97",
      "r233",
      "r433",
      "r778"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": {
     "auth_ref": [
      "r424",
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r94",
      "r230",
      "r430",
      "r775"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
     "auth_ref": [
      "r421",
      "r771"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r91",
      "r426",
      "r762"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "terseLabel": "Debt Securities, Held-to-maturity, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r58",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r37",
      "r213",
      "r226",
      "r251",
      "r386",
      "r391",
      "r397",
      "r400",
      "r769",
      "r877"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r386",
      "r391",
      "r397",
      "r400",
      "r877"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "terseLabel": "Equity in undistributed income of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r483",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesNotes",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesNotes",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r335",
      "r611",
      "r619",
      "r623",
      "r630",
      "r635",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r336",
      "r352",
      "r353",
      "r384",
      "r609",
      "r631",
      "r636",
      "r788"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes",
        "terseLabel": "Benefit for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1016"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax provision at the U.S. federal statutory rate, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r1016"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible compensation, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1016"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1016"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r872"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeposits": {
     "auth_ref": [
      "r61",
      "r229"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.",
        "label": "Increase (Decrease) in Deposits",
        "terseLabel": "Customer funds administered"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "verboseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Net change in other operating items, net of effects from acquisitions and changes in AARP balances:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r102",
      "r107"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net of accumulated amortization of $6,137 and $5,636"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r208",
      "r228",
      "r317",
      "r380",
      "r701"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r326",
      "r329",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r378",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Optum Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r300",
      "r870",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, Net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Investment and other income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceContracts": {
     "auth_ref": [
      "r269",
      "r270",
      "r1043"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of contracts.",
        "label": "Investment Owned, Balance, Contracts",
        "terseLabel": "Total number of security positions"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceContracts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r441",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments by Contractual Maturity [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, Fair Value Disclosure"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r214",
      "r234",
      "r271",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments [Text Block]"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandAndLandImprovements": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.",
        "label": "Land and Land Improvements",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LatestTaxYearMember": {
     "auth_ref": [
      "r1017"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latest identified tax year.",
        "label": "Latest Tax Year [Member]",
        "terseLabel": "Latest Tax Year [Member]"
       }
      }
     },
     "localname": "LatestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r18",
      "r333",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r647",
      "r651",
      "r652",
      "r678",
      "r876",
      "r979",
      "r1029",
      "r1030"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r221",
      "r247",
      "r900",
      "r938",
      "r958",
      "r1024"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "terseLabel": "Total liabilities and shareholders\u2019 equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable noncontrolling interests and equity",
        "verboseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r283",
      "r333",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r647",
      "r651",
      "r652",
      "r678",
      "r900",
      "r979",
      "r1029",
      "r1030"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Total current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r254",
      "r257"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Medical costs payable, end of period",
        "periodStartLabel": "Medical costs payable, beginning of period",
        "verboseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Medical payments:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedTerseLabel": "Payments for current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedTerseLabel": "Payments for prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total reported medical costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Reported medical costs:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Line of Credit Facility, Expiration Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit, Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Short-term borrowings and current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r122",
      "r337",
      "r984"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r122",
      "r337",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r122",
      "r337",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r122",
      "r337",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r122",
      "r337",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r122",
      "r337",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term debt and other financing obligations [Member]"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r22",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r119",
      "r120",
      "r490",
      "r491",
      "r492",
      "r973",
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r490",
      "r491",
      "r492",
      "r973",
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r119",
      "r120",
      "r490",
      "r491",
      "r492",
      "r973",
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 3.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r26",
      "r220",
      "r246",
      "r333",
      "r442",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r678"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Nonredeemable noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "negatedLabel": "Redeemable noncontrolling interests fair value and other adjustments",
        "terseLabel": "Fair value and other adjustments"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions",
        "negatedTerseLabel": "Distributions to nonredeemable noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r141",
      "r186",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "terseLabel": "Acquisition of redeemable noncontrolling interest shares",
        "verboseLabel": "Redemptions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r26",
      "r40",
      "r182",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember": {
     "auth_ref": [
      "r80",
      "r988"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by non-governmental sponsored enterprises.",
        "label": "Mortgage-Backed Securities, Issued by Private Enterprises [Member]",
        "terseLabel": "Non-U.S. Agency Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": {
     "auth_ref": [
      "r988"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac).",
        "label": "Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]",
        "terseLabel": "U.S. Agency Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r368",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations [Text Block]"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/DescriptionofBusinessNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows from (used for) financing activities",
        "verboseLabel": "Cash flows from (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "terseLabel": "Cash flows used for investing activities",
        "totalLabel": "Cash flows used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r54",
      "r56",
      "r59"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Cash flows from operating activities",
        "totalLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r38",
      "r59",
      "r227",
      "r250",
      "r281",
      "r309",
      "r312",
      "r316",
      "r333",
      "r342",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r353",
      "r359",
      "r386",
      "r391",
      "r397",
      "r400",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r665",
      "r678",
      "r877",
      "r979"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings attributable to UnitedHealth Group common shareholders",
        "verboseLabel": "Net earnings attributable to UnitedHealth Group common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r188",
      "r194",
      "r309",
      "r312",
      "r352",
      "r353",
      "r925"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings attributable to nonredeemable noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net earnings"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r128",
      "r188",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r142",
      "r173",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition and other adjustments of nonredeemable noncontrolling interests",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r181",
      "r550",
      "r942",
      "r943",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r3",
      "r219",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r13",
      "r211",
      "r940"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Current portion of notes payable to subsidiaries"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r210",
      "r940"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due after 1 year (or 1 business cycle).",
        "label": "Notes Receivable, Related Parties, Noncurrent",
        "terseLabel": "Long-term notes receivable from subsidiaries"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open Tax Year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r386",
      "r391",
      "r397",
      "r400",
      "r877"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Earnings from operations",
        "totalLabel": "Earnings from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r711",
      "r899"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r709",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r714",
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r713",
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r301",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other Commitment"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the nature and terms of commitment.",
        "label": "Other Commitments, Description",
        "terseLabel": "Other Commitments, Description"
       }
      }
     },
     "localname": "OtherCommitmentsDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r28",
      "r29",
      "r687",
      "r688",
      "r690"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Total foreign currency translation gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r35",
      "r134",
      "r310",
      "r313",
      "r319",
      "r691",
      "r696",
      "r697",
      "r764",
      "r783",
      "r923",
      "r924"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive (loss) gains",
        "totalLabel": "Other comprehensive loss",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r29",
      "r33",
      "r98",
      "r308"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Gross reclassification adjustment for net realized losses (gains) included in net earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r29",
      "r33",
      "r98",
      "r308"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTotalLabel": "Total reclassification adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r30",
      "r98"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Income tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r303",
      "r306",
      "r439"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Gross unrealized (losses) gains on investment securities during the period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r303",
      "r306"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "totalLabel": "Total unrealized (losses) gains, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r30",
      "r304"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedLabel": "Income tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r900"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r3",
      "r219",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Other Long-term Debt"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtCurrent": {
     "auth_ref": [
      "r1",
      "r2"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Current",
        "terseLabel": "Other Long-term Debt, Current"
       }
      }
     },
     "localname": "OtherLongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other current receivables",
        "verboseLabel": "Other current receivables, net of allowances of $1,433 and $993"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r55",
      "r256"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total medical payments"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r927",
      "r929"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Common share repurchases",
        "negatedTerseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r932"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Purchases of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Cash dividends paid",
        "terseLabel": "Payments of Ordinary Dividends, Common Stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Cash paid for acquisitions, net of cash assumed",
        "negatedTerseLabel": "Cash paid for acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, equipment and capitalized software",
        "terseLabel": "Purchases of property, equipment and capitalized software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r928",
      "r1026"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "negatedTerseLabel": "Issuances of notes to subsidiaries"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Medical costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r900"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r763",
      "r782",
      "r789",
      "r806"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums",
        "verboseLabel": "Premiums, revenues - unaffiliated customers"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r922"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r926",
      "r1026"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.",
        "label": "Proceeds from Collection of Long-Term Loans to Related Parties",
        "terseLabel": "Repayments of notes to subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Return of capital to parent company"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Cash received from dispositions"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from common stock issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r79",
      "r324",
      "r325"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r931",
      "r934"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r930",
      "r933",
      "r935"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Proceeds from (repayments of) short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "terseLabel": "Proceeds from notes from subsidiary"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r44",
      "r79",
      "r324"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r281",
      "r309",
      "r312",
      "r327",
      "r333",
      "r342",
      "r352",
      "r353",
      "r386",
      "r391",
      "r397",
      "r400",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r645",
      "r649",
      "r650",
      "r665",
      "r678",
      "r769",
      "r877",
      "r897",
      "r898",
      "r925",
      "r979"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r826",
      "r827",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment Disclosure [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r116",
      "r248",
      "r780",
      "r900"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, equipment and capitalized software, net of accumulated depreciation and amortization of $6,930 and $5,992",
        "totalLabel": "Total property, equipment and capitalized software, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 5.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Property, Plant and Equipment, Other, Accumulated Depreciation",
        "negatedTerseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOtherAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r951",
      "r952",
      "r953",
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivable [Policy Text Block]"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r126",
      "r127",
      "r129",
      "r130"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Redeemable Noncontrolling Interest, end of period",
        "periodStartLabel": "Redeemable noncontrolling interest, beginning of period",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interest [Table Text Block]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayments of long-term debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r141",
      "r244",
      "r800",
      "r805",
      "r900"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r276",
      "r339",
      "r340",
      "r341",
      "r343",
      "r351",
      "r353",
      "r447",
      "r601",
      "r602",
      "r603",
      "r628",
      "r629",
      "r663",
      "r796",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r377",
      "r378",
      "r390",
      "r395",
      "r396",
      "r402",
      "r403",
      "r406",
      "r553",
      "r554",
      "r755"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Products and Services",
        "verboseLabel": "Revenue from Products and Services - unaffiliated customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r318",
      "r333",
      "r377",
      "r378",
      "r390",
      "r395",
      "r396",
      "r402",
      "r403",
      "r406",
      "r442",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r678",
      "r769",
      "r979"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r406",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r22",
      "r135",
      "r138",
      "r139",
      "r140",
      "r206",
      "r207",
      "r209",
      "r237",
      "r881",
      "r883",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Short-Term Borrowings and Long-Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsTables",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r104",
      "r108",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r879",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r36",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Segment Financial Information [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r146",
      "r147",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Other Share-Based Compensation Data [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r145",
      "r147",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Restricted Share Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r125",
      "r132",
      "r133",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r406",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r879",
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r386",
      "r389",
      "r394",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Financial Information [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation expense, before tax"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period",
        "periodStartLabel": "Nonvested at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share",
        "periodStartLabel": "Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of restricted shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, Weighted Average Grant Date Fair Value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Exercisable at end of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeitures, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r997"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of shares granted, per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Outstanding at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end of the period",
        "periodStartLabel": "Outstanding at the beginning of the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period, Weighted-Average Exercise Price",
        "periodStartLabel": "Outstanding at beginning of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Vested and expected to vest end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Vested and expected to vest, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Vested and expected to vest end of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r567",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r570",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected Life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Exercisable at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Medical Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r222",
      "r223",
      "r240",
      "r921"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2015 in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year 2015 [Member]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year 2021 [Member]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYear2015Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2016 in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year 2016 [Member]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year 2022 [Member]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYear2016Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "negatedTerseLabel": "Net Cumulative Medical Payments"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Net Incurred Medical Costs"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r261",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Total Medical costs payable"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "terseLabel": "Net remaining outstanding liabilities prior to 2021"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r280",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r406",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r484",
      "r486",
      "r487",
      "r879",
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r333",
      "r357",
      "r358",
      "r360",
      "r362",
      "r366",
      "r367",
      "r442",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r535",
      "r536",
      "r538",
      "r542",
      "r549",
      "r678",
      "r842",
      "r914",
      "r936",
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r25",
      "r134",
      "r276",
      "r314",
      "r315",
      "r316",
      "r339",
      "r340",
      "r341",
      "r343",
      "r351",
      "r353",
      "r365",
      "r447",
      "r550",
      "r601",
      "r602",
      "r603",
      "r628",
      "r629",
      "r663",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r721",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsTables",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r365",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsTables",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r245",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Statutory Accounting Practices, Statutory Capital and Surplus Required"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Number of shares purchased"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuances of common stock, and related tax effects (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuances of common stock, and related tax effects"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r141",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Board authorized shares remaining"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Common share repurchases (in shares)",
        "terseLabel": "Common shares repurchases, shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r7",
      "r8",
      "r134",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Common share repurchases",
        "verboseLabel": "Common share repurchases"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r10",
      "r11",
      "r78",
      "r900",
      "r938",
      "r958",
      "r1024"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total UnitedHealth Group shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r181",
      "r182",
      "r193",
      "r276",
      "r277",
      "r315",
      "r339",
      "r340",
      "r341",
      "r343",
      "r351",
      "r447",
      "r550",
      "r601",
      "r602",
      "r603",
      "r628",
      "r629",
      "r663",
      "r691",
      "r692",
      "r697",
      "r721",
      "r797",
      "r798",
      "r938",
      "r958",
      "r1024"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r332",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r550",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventDescription": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.",
        "label": "Subsequent Event, Description",
        "terseLabel": "Subsequent Event, Description"
       }
      }
     },
     "localname": "SubsequentEventDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r698",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r698",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r698",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r791"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r791"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format.",
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "Tax Credit Carryforward, Expiration Date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes, Miscellaneous [Abstract]",
        "terseLabel": "Current Provision:"
       }
      }
     },
     "localname": "TaxesExcludingIncomeAndExciseTaxesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names [Member]"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r425",
      "r429",
      "r533",
      "r547",
      "r653",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r955",
      "r956",
      "r957",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "verboseLabel": "Common share repurchases, average price per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r342",
      "r343",
      "r344",
      "r345",
      "r354",
      "r412",
      "r413",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r601",
      "r602",
      "r603",
      "r626",
      "r627",
      "r628",
      "r629",
      "r642",
      "r643",
      "r644",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r699",
      "r700",
      "r703",
      "r704",
      "r705",
      "r706",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r757",
      "r758",
      "r759",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r889",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "State and Municipal Obligations [Member]"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r770",
      "r889",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. Government and Agency Obligations [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r790",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Policy Text Block]"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Short-Term and Long-Term Investments [Table Text Block]"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r606",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits, end of period",
        "periodStartLabel": "Gross unrecognized tax benefits, beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Prior year tax positions, gross decreases"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r616"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior year tax positions, gross increases"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitations lapses"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtCurrent": {
     "auth_ref": [
      "r1",
      "r217",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.",
        "label": "Unsecured Debt, Current",
        "terseLabel": "Unsecured Debt, Current"
       }
      }
     },
     "localname": "UnsecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredLongTermDebt": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Unsecured Long-Term Debt, Noncurrent",
        "terseLabel": "Unsecured Long-term Debt, Noncurrent"
       }
      }
     },
     "localname": "UnsecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r369",
      "r370",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r947"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Dilutive effect of common share equivalents"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r356",
      "r362"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted weighted-average number of common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r355",
      "r362"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average number of common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.Column B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14.Column B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=126898705&loc=d3e5864-122674",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3095-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r904": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r905": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r906": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r907": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r908": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r909": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r911": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r912": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r913": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5283-111683",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>131
<FILENAME>0000731766-23-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000731766-23-000008-xbrl.zip
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M?//BT[9<TZGS%K->_VW=;OSV6!ST[M[Z;V+:>T\._GGRXF3SX5L&J[)(PJZ
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M31>,;9,5477B!7V7O(168JVMHSNKI>QR*MX),KE"32)1=14)+%Y:2>YMU%?
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M6NQX-OC(Y>E0;L.[ >WSP\F$IY-?C]=Q;S1^M(^3R?5ZF4>'D^GH@,<O>5\
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M3N0WFFGT!!,;VFHL;IMUBV4[1UK^IIC;Z(#$C)ZW&;M/3&87P7,0/RO_5U7
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M+G-!9H8;6ZB2*[O "B6MY"H60X8E S,E6A?[7-7OS*VKDV)?;"9[  \Y4 [
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M.@S,35#ZTN>R6LN4Y4Y1B.!M2$X4<:@Z,/@8N,]3E?<-RNPLI8K#<M6U@%+
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M2493J\ \NT\]U 5K+U[!VP[=RWK)/7]8M;PX_/3'WVF:,&!P>A E+!D0ANF
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M2_84WJO_<6X?"%_:R$:'O$H0[2A5Z+*L_OD=%H V0N@Z(?3M<FI((F*6)GC
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M^WAZN'L0'>"#BX,_88WS3KU$AY)*$8-E80O>PE .1&CX0"DC:,H,DY+[>AQ
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M/G--\H!)2%@&,)/AU-7/C?F%PY)YK(&%#W/_50=)MH"E&1V4LJ)=SQ5K;))
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M!>\< CQ@Z6?3X22#,YSXY8T<E"UO:0EP/(6M2WB-RP5K7^,E0K.,AOP6+/Y
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MO?>20CNUF;[.(&H#.-W.%(T5V^8.=@I&9\R4K28;<&;X1<>*J@MYFRD0P#3
M;!K9B%ME'E_5&]XY3GV>PFSVXVP#G[I1D]7%;8[3I1SF$A9<^E;ILSWNZT3+
MCJ:^XK#<]V$L#U+?WW21R5+%%GWQDTN+F(XFS:22NLU1IT9HXNM8G7MAZZK8
M7"V4=8"VTZ:<Z-J&?-V0K+\FV2*VSKI.>>U6)C3-^VX$".+)=#7(*G/C@3Y9
M?YEM>-8HGNTT"; 03JJ4V>W@2-MBP<)MVX)H6M8>>]\(W5V9%Q<SN7I"#_/S
M*J!\#;/<9$W</&L"L4H$A<_;O+W@70.M:H94-Y%B&2A710PWD+\[R,?XR8NW
MO)@$^_M;@1MUG6[5 \0.&M]E(R=W6T*UL-BQ4JW,'+ML:P!?UJTNW37OM'6"
MESZQI6[=M+T HU8OZ?%F7K]K&GRO.A_?M4[PB7>Y+Q"E5P]!:0:YS.4IUOD"
MM:XQR*UJ,6D;+UQ.CIXI5KXB]G/U6)1NS6/G0U_ZV!V&-5N:6&X'.U<)^EL<
M0QL@;Y2+A378..DJ#2["N!V\=ET<;WGP5?BL*EA.+SVV&NS5,5J5ZQ;3&:XS
MN1A7099-'FB'%J)-'N@CD6L_GP>Z3)Y\;6,+F[59A<]<2[;,CW8KP$"Q+8A=
M@63P:\&_9<.MX*4M/8!_8/%G(O,I\6]U,;63 B=U7XQN$Z@XK*ONK-WD9GW^
M@&!8U-W196_88&"]TKJ/K?=#7VK;0.)N96!CT;IE8K"A\NFD-L>=)_5,U%:#
M]Q55XL7V@K*?.=Y2S@\\O68[]0JK8.6,Z\/S8E<[Y$_,E]>OO/'6C07:TJHJ
M'VI!+.&6VD[3P,4/32A=YA=(A%EYM+#T\G*,,+-IGI-I,;J""*K)*V5'G/'
M9%]MMK#UA5@BR>;D9E6J%>1P)#;'N<I_;OL+V24LJ!;WX.UD&772,]M$9N=:
M:-9OTQWUL#*(2STT ]OJXE*%MM^^#X)GC5Y3]\^H_ZK[R?LR;M\DYK; J9J,
ME\TQU2=:AR-L(YR%IU;/9VPWYY*Y1C-PKJH(;8OI"M@S<^1NO3U?,W7;338*
M6=M]LJK&FFG3Y*KVO+ME/O.AJA+V"<;=Y)9F]UMSS=NN]/=L+2@=<ZVX;.6D
M3]Z758,_1QB-#CG3IJ>313G31&"!!^D[*^F$E+P^Z!OOE=4ZVDMOQ>VSTL^
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MP\_%G+Z3 ?3)CZ5QRHM;6MM.2"\*G#=8W);JNL$;RO*+2>9GS59WV>$9>K3
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M'3&4CB$ULZD_6W]KMO,6SLG.JVDZ-62Y/?KY[:O^8UAOBB5B9 1I.*0?$#P
M/B2IQ5:@JO%%GW?ADT/&'--;2&!"$1B!1H63.S3*&9[D-XSQSO)LATD9K>%;
M8GQ3E9K[ Z'C/BDDTAT21A<=H W* 6+H@YW7%<>&=61'Z\>!&1,?F)M)5$Z2
M0CA_]&LY^UQ-TF*$VFY!#K)?$X:@#PP6<US5SMKDGH*5JIN6V6IKT8HJ'1G<
M4[LM=GV*AC[5-N\<M+"=)I%T5^#2(6 0]ZS+815['0^IV.Q0647E]!"V1KZ=
M:7[CK>P.QY8>CD\!^:5'M677WVS-:P!NG*$)K'99D>896LN<WE!/]/C\Y*)_
MO\WL06T=BQ^E4*4G&30O\RZR\_2>/PD]/9S#XUA9,'!\094%_65U1 LEGLEX
M^,Q5BSE9(PZ=AB1(>;&$U;47X7NQVQCX8O#5SA",\I ;Z4LNZ<0H^6L#!Y9Y
M#**W0/\3/7I]^O:Q[B*IX_G6"RXJ-PIT!JT84G29W4CH\\PKX2XS4$)T,$;*
MOD'-X5FG /W!L_<N;M<BQ(S@LI,ML&>O8$>DC7;@+?.ZG:O%,7:T5KF6$U_A
M:B?MUJPN&=$C8.666=7F'O/D,12O<J%*9- @D*#5!P9RV12G" !NB#*BH#^-
MJ7%$-C1_18'AC4Q<W5$EL8N"Z+FO%P.[8X7\O6I,<!##&@"HWX:&K>F( 7GH
M--IKWL[&FO7^</W;ZM)RE'(LR=4/(PQ.C&K1"KVH/YU*7([QC^X;J%[U&[%B
MM6-8#M(OZIFU1$!0XX.*KHRO\@XD$UA"';,SM\A#XGI542(NE#9,B-XIAS8+
M!!I%.&.)V0  G06:A%[Z7O+7?55Y8*?O8Y'>Q0(M^>A]_\2Z69",24;6F,-*
M\9&9=MDS,A,JQ;6?) V#3_7&AL]:(3IP>FVR(3;3M+O!W278+^Q%[P#"S^M$
M$#D> ^4XP*2V/I;5RU;G)61*8L^*N4M;#NVJP_R6YPNH7L_HP:IL_]2U-(3Q
M7Y-7"^[UNU,!-#F*N7QFWXN)/X>=P@6A/)Y<%@G-7I'<C*W?8)!IAJSM*4,!
MQV2!(7FGO6!:2T0W&MF9?A@N2T3CP,=Y0<K(/Z+49YYE8$D.ZRI&69^:1.&A
MR*[&3\*9_MT.$&T2-RL^;F6 *2_:VFPS/4E0,"W4;<=N-E!P=)LV%WV23T?4
MF >^%?@'O>BB]J$G%,"V_U8 **W29(A@S:=#M+WI92-G/)7D[FHEA$93.N4R
M==GN$3E"S*6%RL*^Q"JD&GH9Y3<9\>7$2N4XG&[LL0AC>#(Y",T@/<_$&UE:
MR?G3NV*EEF3T6"=:E1@TD<'LVS624]L#:3]4J@[1 M1KC7C,W6GA!%7D9SEK
M4\]H8*H;8S*=;#4C+0FTTE 5;84"R)&"R:!J*/S;';C;^6FBIREKY)M,J58Y
M9A1>.>"3@2$+L0V,\#'2H_7J#<@0KH;F@:/3B&6)4ETTN@ZU.'!WQ$5M81_5
M#:?C,6=GIW'TCB'^:&:%!"_OCDZM-Z4[/Q?F.K4S??3AW/[A\JP?+VWH-;*B
M#.=2H!DPA#EY-44(Q5XZ;#)9ZJ+CBBY#T.PH19L#*W[H+$%EDP.E@51)CHWY
MRF(=3HX=91.NEOU:S"\7;EU_]I<'97L24P_VHML3A#:D0A ;9OL<>SR4C?J<
M.+DI<71EY?V:0A8(LV*/!D)&G)-/1G9,L"&-!'O SRI=P.*(,OY"HY%C;8".
M_KB02CLV[]@+<2B:P+!AR4A0U14H:":]GD!9U%B[L @.;$#N8H9G&ND;L*C4
MU=IZ$T2+NH,PX"(+6(%J,I 2+8X&4!'$-6\U7/IVM:"$J]7AA,/A18[%9L+8
MUFOFQY?#S$@RY5I _K.8B7UI:8  .*21ZX:?KULDHD!S2\!R*U+XUH*A 7N@
M48APEWHX#ATRR[9RP$4=MY%*8?$07AV,T0O^P %KQZ:E.:\"2!!9E1#H"_&/
MO.(.@(BX;I5^Z=R@OQ8"V1R"QD#>^Z5T1\^<Q.I,!4Q=<.Y<R^=]^L;]**LQ
MQ"-KW_"..G=7Q9P]LG]U8-A3$RNI\5C1BG(QL4[$$)&,UK)<:^2>3D,O]2<[
M41MPF7J(GRY^<WD3BL[G+B8.9/0  K5G!SGX 4-#B$BE+2@MF-360V?,E56E
M4)MEIS1=$!.5)-8@E5=4(N8RKZ"4CZO<R56KT",:5[&D*73156O/L"Y%RCKX
MOH4?E>I" *B]49W/OQA T%;6TM^O,#/,S2X:A6E^X2F#B_.]MFXWO&D+C%&G
MZMD6&+,%QMR[F]2=DB3UM6X.\*_.^&EKLP7]IZ>$?51"NN1>]!J=&,Q/@ -/
M:L@9(WJLK3B6F!S %(DX"07>F$]2>^WD]O\,K8$JU4/3IZN83=QN>CVJ3[L]
M?!MV\8DGPP*P]WP%@F:FKK?;.K-MG=E:=6;-DI.VU+L36G29F _%=#YRL?0S
M5C2P).B_0/4-3!2X<B_L8A"C)F3R[M>27N[7CNN,"2]*QV >>LLA'SQ&%<%<
MCIL>E\KL=KNZ&!G3=KQ/2LS50LYD(?$I+F0 :&V)M_C\OGB :)SR4UQ'+ZR%
MDJPWQC1\\W.\._BE\F$(Y1:&R-%+-5@9@_/ P]=BGQ:Z,["NK'0;KSP,X?8%
MD]0@ZH>_03@ "JDZ^B<(@H3A'GF4HA;SH12X$P8"G(+X<1!-QN)K_@B!]CQS
M^[]KF+IDUUS\.00W4$JMNR@[_&2I<8)ZJP<0;]8%+E!%8L?AWM\H46^@*SH<
M?&[.L.&I_#.)K<(,W ^O)*KB>U9'C\Y>O7L<X"GN72^NSBMA^.G\D\N(*:4B
M#3*04$3"H;%J"D0A12N+-0$\.02-$3^5M2".8.GVZ#XC/GXS+VZ_H3[$9ZN9
M[,;T.%*3Y,B@U0KZJ4?@&P0TB10M'K4-2!^ZOU\#6^RQLM?Z823IT>OC_N-F
M=4HIEF[%'+"0#2$77/OLU,!C#O/K_##!:$7UDAJ>8+F5@P=W!4G"M;G!^KW&
MW-4249$QVMV-;*^&LB][$6I2@%X2F7E6A:^]<1(B;S<UTC9TU._ZV &!B=J[
M,L@A)H*-!_FL\53; Q!-VC4TG[F$7A]L4>O5@1+,')K0^#76X(I W):N*O2S
M7;HZ+':4(*3I-@H'TH)>3.O86#R.)N'"@I#WW>T,[;N'2T6>1JVXO (JKU;4
MMA%65J;""DE1.=_NJE!Y#%%^M"V)4\R;=0J<+SAM3$QT4IOTP.&-F\\*0X#3
M9&"FE&I*AA_QQH_)]:I2WQ$36)B,!["U:*5=T<2<<U.4H.DZV%OG:^M\W8GD
MHSN1J_D4-MND>-,ZFH[$"*,P=#(AZ_WJG<8IT9DOJ1ZT$?M 0S-H5*L[%I*6
M<0VPP :>V4/O?J-B.Z$"Q4)WUM3TBL9["??4A+0EGS"\C>W+$FK;*+VD\<K!
M[HM-C=&+?FN4OD-H"F"Z"YU?5H%WE:(25T5?ID?O+F)7?+0:=>.1V*T*X"4*
MSJ<,FUVB1/.Z"A$A @4,C5K/H$HEA+>M8NEO8*M=%EX:3Y'!@)U9*-^C'X:]
M.0I77Q)'[XX8^.8NI8!(T;<I:. 8B%Z*10+;"M"U\RA][,D^5.?@V/[%_DG\
M(9_5M[^VOZ]+FK=#9C=;M&'/6=VLS'6T?91>VU?F@B\826PR1>M@EJ-_JCN]
M/;*?]Y)EA:8(?-@-5QYOE:HHC?G()K"3HX;.2.'*A6[+R(*(*2KP(*H E^\D
M%1F[>6^9'"W ]_B(,QHXB.OQ1&2B<)!#' 4R#6+-H>D&@E9#DQ^J=,*,5UL=
M*:L_;K3H!;I%?#%@6AW>EB+?2%;70K9RZW)(*Y* H&&B'QJKIPJT%A&T564H
MF?\_3!W3+R6R_>C]T?^PXX,.DP(AG1,(J3^D3";]4A<]?CCO'SV.,6KAU:=/
M ](>R%7@%MCO+^"=@:^8&G.577-FY<=/'.605Z1@!8H $O91'4A,3B,,)LW&
MTQIZAXBR0H\+JK_((+?''8AP[$-5B(0$!A69W,G*ZQ&&+NH%N/'%"4>2G%%D
MN1#@W&SML#P VG!U* 9J1[OCLE#:TFC'H0*1\HX-[&J&_3N9PW2H)()P?X(>
M6IKN:E<?$4HAJ!<&@/01%<?TH4>Y_N.9M2Z :YH#N7V&Q^%'+H]<Y.;23(UO
M6WF!T*7S>FI"8#K341'Q!X+1EPU\ T+Z:PD#133UJL)*S"?0**=+S'%]KU+6
M$'8%P]4^"C<ZJ.$^HAIN0316UL?(S,(%&@*@K+JU$)M.CLJ@:*8%!<ZK\$QV
M0,%>-D!\@G2NJWR&CD->5P.(P1&V$FQH60U:!;@UH-+<NE\EA=*3=%IRW(M:
M^[FJ\+ XNPH1P:Y8U^5/&3DB?>")WXS!?Q!R_M47H#O**7P<W<),^YEFXC)3
M 8&+@/MB='_@K,S0DFUZU/A5DJ']XJ/!FWV@*!8,HVX G$,,HIA5 YZ>+^%H
MEIC+D7IM$%\3E.UPXRD\5J]/CAPM$(/UI/H#6]>E&8L0MN1#Y!9&"7FDC.*G
M1 P J8J13U_*:*&ZFD/6)9P5-/A"/+8H5:<TWCBPL5(?K^SKDUI71?.0?4W4
M&F/>8IF4X#W?8IF^D>C<0\8RP>W7P#XH2[#+2I*0<SN?BL#L1715I^ ?  B'
M+MM0Q3;Y JUG"39>*;G24.^2]Y5,&%X5EJ=[577B^P.XA/4P*:@BM*[^*KW*
M0??;M*H&8)=+-"0'0^&USIA=L1/T9KE][KX'3%B#=1;P[CH;)]<Y%<FH<;%M
MPN@ "&PY T9@][%?+C)G!@8)$@)^ 43K&E50BXN/N4"!GU&Q6W@9<>O948B5
M1X0_VEA83F.-NRK19M*FFT3O\VP'R14>C%&TW.6D#34AT[9@^986<7 T:575
M-S;%I; -Q;7:9>!!Q!(,9<BAPJRQ135*K'X#C$'_W P\U<2J@SO3X'A>3BZ)
MGV8PN(OI:RHH7(B@#AF^PCB UD)B[FU0Y,DH=.;>Y(7=#X@K%44]KQQ:JR2Z
MHC='9YY34N TI>O6C%54,\SLQ>R^4%1,\O-_X(\4Z;.3NJ)&"XMJPEF]ZV1*
M31JP9PZ.1,7E[6L(^ *!@@$)"H2/\%^^S+2@-]RD2,H[Q-(#558H/;PV(6IT
M5Q3=Z;NSX\N3!]",I%]B"@X5Z#AM]3C#^EZ$2/ASC1QKV"Q^-C>0@+EV]*."
ML\4@([28I#95IEGLMZ32CKFV\:EYX=/:80@82NFP$([+*8NJIFZ2/"X$$Y<5
M]Y![@X16)GJZ&UU-\P%55@'\*D6B-^!)!RQ:6G'Y128_NJ+<F,M<R)?'BFDG
MZHI[1Y)1U"_$0/%4YFO+W )I,CW[BH&[[REKD3>6 !<(0NLIQLM=Z1BD1/@
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M4U:RS?P:L&%0@D JT'[? .?WKL1J'][UWT='_;.32ZL<SH\O3C^<'QUON%H
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M4E102U-F*"QKA"+EC/P=U=B5D;K3@3+#*E<H<\:V$?J; /N#&HF12:H)%"P
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MYE42/7UZ\.3@D D)I'D/=T*T5]6CET_W'Q/]X\N#9SM[![N[F\Y4]'M>(VL
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MO^F$K)?2F%QZ1)15"AW 2N08^;?A;@+(S51-\_PC-01#^CTAXUQQ!%QO[;P
M_I0=>(*TV&#*:Z K%!I.DV3,D0\_GC%KN#KO;^W_74FG2.R0!(S]]O-[+U\^
MC1Z=7;P][]MS_QN0RV X<XTQ(N5+9E4.4L_P&2464=\^WA[?6/C%,H,-"J;
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MMS'66![N"X6N,3>C)?JF27[3" 3$WG@1KF$: [13=6E4B(,&(;QF[4<7>5@
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MDSR_1PV=?[J-/H5Y_Y9 E;M83P)F$VT4 \)QZ,TWQ5_BJRVH EXS(W",R V
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MW.;J12B,1Z>%U!MT!T.TVLIT\ZPE9\P_W#LP%V%5#RP%,'O93YL!LL8L1#2
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M_ O^D^YI9(77KD]F:8](X84W;,QO/ZFXOATR'/ZB. E3XD !Y-S%0_A<&;,
MO#D%WG4+7\=#P-HU?@&G<IT$/#PL'$-<CI4Y"X\]V&A#N1SF[UB\:-H.2;FS
M(F4<N@ M.+WBA.XM\Y7^!*W#&.!@PQ%=/P$ZP:W2FB%S6,S"D>M;L1OX\.__
M)6Y(3FB4[O#! QWB42[&C/)33AES(N4+[3W#[@.XU(W*D#E[*41UE)V]""
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M:_ZOH ]:1ZANL??<IU?NAB[9'NR'B->-0%O'J+$7P67@L9]N'RR3&(YZ &>
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MOX,="+H&&X& Z>:.<:\#+['CQ.+:RN7OL:ZO0W9-WUINJ, ""4M?-,CHT(I
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MIGB99'[)_#5F_B^,]YC<+Y0?UU[/WS*%W K"(#)OWOT2_V63#<E9U\>6!L+
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MO+]'R>*-0).<D,2,T_SX4V)(;!?DL44>8MH74Z4>GCS (?9/# JX)]?#"L5
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M-YW2F_BV^%T!"36GWJ4F _W+_;GK!_Y''"B!6, QI>?8^SZ)G#<T:@*,!_K
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M.>&Z;I'^LJV$MQ$D+ZQ@%Q>A/A?E*76D&C)[(5*O&^4V3*KS+3[I,J,X#G0
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M<0G$E)X A&0PBFA0V@AB!4M9^(U-8_OLDAJ<';V;5I&_BE9.1?YRD3]OX(3
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MM=Z=%L\K :=80RLK)5'*&N[F7T:CV#2L/2TF\@(7LI);>^3V?$&6\$BC#-H
MM;(4T)(9+1?C('*:.+?$FY@V-CE'<JO7T-<8T*W+D@KHNP'TO!1)EA-%LX9
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M:%\KE50Q?FV,S^LC+RFU!N$MLRN)Q]J!,SGABCI#N>(\RKBQ*6[=9;@"O;M
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MD,%&;2/17I42TE+?IJI')8:U)(:[EU\7B:%B_WK8GS,*9'*<QVPA1UX<+YZ
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MV)%L70F?C\B+W(#1]BSM+FF31IK(N*;:2,Z$2C7ZH\<2_H]98D@&(U*#$6G
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MHP*# H>E\H;9'.NWP@;6.-$:<%E[:E,#+H\77):J41>,.ND8PD%[Q+7BR-
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M+ @L(^SG$HN&H^/&J +^PS5GNB &$VZ\-(1A$1\A9ZBNQ[#UW5G"C1-?S21
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MIG_KCT<U^:?G+\^OAFV0.X#@ +S*60[#*+':1<#.$1*S(F[>;L 'E_8B!3Z
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MU7FT,SBELDSS]91F@ZG*=60$25DF[4[5/;U\[*>W?_W^\US=B&6ZF_MTZ<+
M'/*.UCNY4T^N!)AI0M *2U0=]#-3R***;IY>Q_J):2O#<@MF9M44J[YC;"]O
M8GM_P-C>;>.3JU6F;ZI "R(VMY(JQHB01')/J8K8B*!![3'82.EN>L\W1?,L
M,U:6S^R/F]JB2WRT5:6<8:J4,XG]^!9++4,IRK"4&O/[N:YF9Q(9/,NI2CWV
MO-^I6N.4YJ#T,4!W/8?GN4GVI%3M7*SJEYF@C7(Y.9TC)7K,+&FI2MY\#$GV
MA?Z>K(0K-.I5?UD4T&ZI4#/\=87ZFZ>]&(KNHV78@3*L JAL4FOF%58N!J\%
MB1M4J">U5";5XK9,C;[>G23W'5X?\*.]-Y\/]WX'M?@=/GG_CL&S\%U0G_]X
M0TXO3JY3Z^N#Q=#"[@$[N#[CAWN[^.#]&W9X_/;\]-C!//>OD_I\NO=W"DGL
MG-!WGT&-!A7[XP>L-!.>8:2%PHAS0Y!U5B/AC71&T1 *_@C5XJ,,"56MM=;,
MJ6^YLE+.NQ;$9FL;UII@#6RI:%59_&HNIC!)>.,4Z#P>U-7(Z[BW5>IIJOB=
M=80\Z,XD/J^=JZ0/9\WE7?A6Z "^A?YX.#>-><5JV_7!52&<WV@1D.N)5II)
MYB)?V_.=UC"7E*Y+!%7VC<DQ3#RX,Q$A<P/4E6HGA@);%IV?B4Y,I[(J7'&A
M95,^S&FD95FV]ZKL:UIV#*V&KJ,=<]GTJCYP63A]O@9T<@--_#0S17UG2@[/
MY!>4B0VYI<!@-C^D[NGT[5U/!9<J!6,F>G-IQ^;G#5<>5,$!S'6RB+DLE-FB
MJ$EE+!<UC>*<[M="5.NJF-;Y",[9].;<+'?N/.;*<)>UF">K^IR] [$]252N
MS/!5>?5<&. V=5%'_60%^LK]7!5W.^L'JI7-6>3Y=EG"C :E.>,N)=**:"7F
MU!<*Y =)B(Y8&!5 */#:1N]N6R(MP^8,RC^Z.IL/S_T_'U[L?HA>4VZC09I8
MA;@6&!GC01@P04B0^5/1F&<OU'.ZQN*JF 7*8R04Q#@GI3(V!&L]*Y@C-(K;
M%E=MCOR?'+G[4$@:L68:&9SJZ1+!D58ZP@U0!$OE%,CMJ9[NS4>^4%IUN[G]
M;6%SA5"P*"O-8N(_!3S/+)4."$!8SVGA@=K@V@?LM/)4*]4 W@;5G>.3#TH9
M1:*RJ+ $U!VAX/8#LT$ 0YQ;4%Y]*F9"GK,U IYR3A-J3 %::Q&\-8:#QEO
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M%P$2="IQ,)*6UNKN,7K>>DS<6K-5@@INM+4^^K+E&H4VJ9PY8EQ6UX6IG_2
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M,&X'SO,(B1NILH@YF#AS'%I;JFS(RB8I4HY.66=)F7"7@B['IY<NY3[1KT<
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MH!24&)H<T2**%*+Q)M"0A)8LF)!80X-7J&>N-/C0--C[[2(-RN!\<L8 2\F
M2)R#E4Q S(XD1[WSTJ#=NHJ;W++0X%.04NZEPQ):W;^Q^'_KF;_I:+'KC=NE
ME+_4U*>$<Y0;EB6W: PRRZ-T(@2FDD?LN&L?W<&I>].(@I1SWB\.#T=]?]1$
MN#:&/Z+'RG;78KLW,T9?U-DP&B).59(@6')@T9B'$#WN92EJ73K64,IORW67
M4\J=6G45T5<U9F007BLNF$R"$73PLDL)?X4(9R&F:Q_?J8B^/T2W[9<4+"$&
M/3A<LAP1;3-89M!^41%7LG5):;ZR9O0" ?HI="8Z5^DXE^9$-V*S2\;M\;'9
M_.V32XGJ3='!=0?IU6BX]VN1ADL'![\-]WQ_ORD.JD[:_$BN.V.V!"8HNF,"
ML@Y(<BK9IHX(@E322.W0;6,K:WP5G?0Y.6D+%(ZJ4+\[P^5F4*]HOA::VR:+
M)=)%3@@8$A@(2A1XM%) &"VIIDEEH5;6V")!^2F$5/X\K02K$97KC]Y/]VNR
M%&56_*E-:-W^_G#4/SR>4MEZ.J.R<_-;*>Q:%/9NQB!AQDLO$ZY;Y1,2%V=@
MDS! M31*X)Z$T[BR1K6:X;"9XI<:0EE&",_!%+DMA*O#,3]\MTT4QQ11S&JP
MU(92]<K!.AY !DVBE-0Q)TIRG/-9*^5!$/X48BKK_8-Q:+&I^*]1E46W4:[.
M:Q=F=F-XN5OVO\-!3*-JNUR/V][/V"XJ4RXB5Y!R<B!TEN"L,F!]C)1ISDE"
M]\NP6Q!;#:(L,++G'D6IR'X@9+>M%B%M%C0X4(U$;(P>O# ,B,A>9<4D8W%E
MC<E9-9X'@?93"*J\.G?$\+2_F(N[1Y-CPS72LE2YH3;5_=8< GVS?^:8_5WF
MNC+9M9AL<\9&L23K* (!Q30M70XL6$82A*@T,S902=/*FB1D@=+:%;V+GNZI
MZ+T;]+;M$,HC8PHQ&R5OT!O!N)2!9Z8\TF[T5JRL:7+KBMH:0)G_6;-4S)0%
M.&4V.>?,<3[C\*C<\W2 ZOF+N0W0X]DK=,H\64IM8B)0[XL^J,^*RHR&'LW?
M4("M!S06;#,)L^?42/0R> 9&\ 2"2@E>N@PB22N,B=(GOK(F5HV]=8WCW/&U
M' ?9*M-6IJTG@I\>T[;-]@<[$?R 3-N8_3\WAQ4N$4.\?L_"BQIOLV(<$WRO
M_=N/?EZ;58J[JM"B^$%;BQ\))[:$%CVWSI(0N$94J[*]4HINMD-?VS*M]%)(
M\]VQ6-A?15;N5W>08E&/2OL'8RWK)FS0M*XK$]S_)_UG@$^U(,J/[Z;BJ5^Z
M&UW2VQU\ZN+UD0/()G[7YNZOR!%_[O1.WHC-DU]W\%Z^;K5EXG=??.V>O&-O
M/[S[LHGWU-WX<[>WOM/OON[RWNN7O+N[LXM\Q'J[K_:F+4I5%%99S8':J$!X
MQ\$P6V3CN<F:.B-Q_;:E/K4SA"9.17"EOMMH+YQ()A*7I2>A+3'6S 8TT]$Y
M/Q^S:%UD,<9OH/='8W%>F/JLE7@16#P;B%/MUZ)6UD@B@F]&RWUQHXA^_KDN
M[X?#\.E427&L/ENR=J'H XY?O/27Q4@XZ/Q45,NF6OVK%][5"#'^:[6(,Y96
MG"-7'AW*,'3P7HI@)'+S1#UQK(:+X_A//TR5%SL_;:?]-&J4&\N[BMAJN>'Q
MJ_^:JKDU3[1:&ND=#DO3O+3W>3 \3NE4>#(A 3?=BD;I<-*<?J+!6!ITGEVC
MX[9'J7D9AR=/I!M'SSI_MI^IN9/2B![W#7SF,W'*YH$N+*6BI0S]K[#3CS'M
M/W]"9/#NY.V+CTEPW%=P"*+P D34!#RS#+A4-D@=&/ZWLI:'1Z,)4L>J>JOC
MI@N7K>=SPLDS:ZV(5XY7^7 L?]G\NLP/KJG)KYJ)+^V-1V[_\%GGKPN+__R\
MUFF]=%K?EW9+VEJ),TA $2_10!0"3)8$&1\M1?0/ O?^DFD]+WJ?OJ91Z)>Y
M.OI<)O-[VW?(Z%'@UQ%'T.O(:*T0''9*E*&.DN"ONGW[]O;]8C0J*8 "^5^/
MS][R'W=<?O6BD,++KY_[8^GM_S2T<ZE2>GFZ)[?;;QZ_???1&*9)D JLEK%L
M]AF,Y;C9,Y=4)BH&5BJA9Z32)PLBCX9[E\'RMQ] _^*>U8;]>6'?P]G+3[6!
M\6-G0KB7T4.GG/[9QLW+]_>'>_VBQ]Y\(Q1&*:_L#6,:/.N\/]U'VIK'+R=[
MT81G_G,T"CMXIYUB)79^>OG7?_Z#^^/I_C3=N:;M6 ?#+^/'_3S]W*6ZS.,M
M^A#O,_8/FD9&^*F&],X]J27_9[IA(JM]2H=36OR66//>WG#_[-J-:O X-= 0
M*W(?OGZX<W9K4[7DO\X9&]^T2(JV\>=Q.YYF^DZMF-*;%D<Y%<CA (?A!4'J
M,XUU'%#\W]ZXA6[NO!U_ M_P;-9!:S5+NYW&O5YY0&OR!B[1K'WY0V^O99L'
M'9)A42J'AKNGW-@L,@^&.U^.FM,[=[U>3H1>D(";Q;5@'0\WPKEVGTB<'UY^
M[>Y^(ENOWR#Q=H\W=[M?NQN_]K=V?_^T]?K/P=N-P6!SAGBW96_]UQTDZ^.W
M&W]^PN_:[9[\WN^>X+5>_[[7W?L3/_M>OOWP=U$Q0I)^\5%X[F,*$IA2&H0(
M!HPV!EP(3DD=C8FF/972H"MA>/ )S3&<>H\>F<\\&B9Q!B)KNUE%9F<Z^IW_
ME%:$8UIHIJ%SA=#($KI?5UONLY_[X=A><-L*,QX5'?GB"853+:/"HJ?<VPRR
M.Z>G4;:"]Z6-=QRW<>F\+DW +[Q_9UQ+65H)X7#W&P=O_YQ8TBVN5RAX/)XI
M@D.3V&VGSG[3<:90\/E/C7L!'**Y5[[_7'?8RR3U8RH-D<HQ6[SEP5$A]PMW
M/*\A&6_F\WN*U4DAWZ1;^N?A88D -=YJ\QSH$4^OTVY)=\%\N<1I/A7J+Q9"
MV\6^L#67A@EHZ91]$"V)LT<\+"6X:)A.WC9M*[#QK9?*+1X5;+G.SO'G4J?8
M!$UQ;SXX:AI;-9UHFGLKYE<Z/!RD,Q>K%5LX;;LWOF@Q1H8AI5CFH&707&9G
M3&?E@ITR55V?KJ 7[4M/.XLV5VC2!6.C96J![>%4E6:!Z&\TQLC8_3@=Z>F7
M'NV?LT4NV"_%%AF/X#>:+9RMHK-I;^ZQ#&(9'ORJ;[YG.B(ET/(97V@LFW%G
MAPMKZ1+[YH<6SSGBG1"@8,]TD9!ONE_B)YXWMC5^RYER_/^Y&/6=!.G)V4><
M1VL,X?K-CWPK^GW?/"]4RP \]^<U3#_%3TV_G=&9_/8VKGY$U"=H>H@\=X,O
M[OA@Y>>+VQWN=:V1_]:@775GS/G.1FR<MD#;8CBVJ9\W<;+R+KP=MS#WTMD9
M%0OS__GQU*'-WO3R*+ K'<_&E==N[;)E<?E44'D/5LKE1CQ_-DZNS?YYQV;W
MN>Y6;_;7DS]\L1^[#267L1SG9_]* ;?%TNP*7_QMW#QG8^3*AOFB:0V_CA[I
M8(C;S>(T4MGMGMKKO;WW_.WKS9/>[HN3MQ_>D.YN1!O\U6#K0V_08V^.MS8B
M7OD=N\1>9UL;06SM=O%[NW)S]]UQC[W:Z7[X>[#)WO/-W=_Q\[W=K?6MHMIU
M_';]W<=(16 R)5#9*Q!HHX.S.4).1G,TWX40,YU;%14I&6N-MU*@0>J=TRK$
MB!Z<,"G:MKU^;LJ^GPFYU(+]\;==O+M$'$M4^Y)5+,ICQFJ\@'2Z-*-UE/^
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MA&,$A(\2+$TE8^HB9X9F8OBETCFUX&%AX;P :*Z1A_M!<_M@1;#2,ID@.F]
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MP5-OIU2R\3PF1B"QE$%DZ<%04?JB"QHT2<(4:3^Y:DC=R)<-X8NWD=<<Q-V
MNI6#R$J+G*D"W)HYB,0]V* <V-*W*3M*HRT"\I?HSCW(?OT4SGG]-AQ]'HY*
M'N*.CW5=B=.NFC)>/$Z[!J7E1$0P-D9NG2 L(<%Q)YT3DFG-HJV9AV6GOO>S
M+=!C]M[K!(QK"8+[!*[\P3U10IB<8Q+HJ?!50OCC*Q%YY-B_CCVSF."OEL[M
MX-Y./1"A*<F4@LM6@0A>@U&2@.2*<J'Q%S:LK!D[B_5E+EU]Y#!?.I37U,.=
M8KZUQ7-1NI!J ]8X <)(!UY:#98IIB+)TLDBJKVJ^",L GWDT%^^';ZF'N:+
M]G;J(29)/ (>C&$EE"$R>&HM*")<(%82FQ#MEBQ(.66%^5+N\#7U< ^N>COU
M0)77D4L%.L6 T$X);/8!@E&4N)B#:0[-VE4E'N&IV4<.\<7;R:^8>ZB0GR?D
M6XF),L'9.P4I1H?^.N=@ KKO02H? TU64%/*AK2]3;'@$A^/.-<<9W()*.]_
M3ODS.;U,?S^F_</G,/[=0^K6383J2GOH;?P9RG"D>%DC]:;S3TW=WLEY5VJB
M\LDK3X/PS!I-"?K!5#/<74V,-<VQ[$2Z.9/FR%:8Y)R$B+82B**=Y*CD$(C0
M41E#N/;E(*Q4M^Y@6ZLV%MAR6DSLUQC([=#>SG+PJ&,0RA9M#@E"2P'.1H7;
MK:5>.T.4R(AV<9L82(5YW>%KEN,!,=_:X:VAG"#>@2L=042>P(J803OKI;7<
M2*:*H"OCMVX>6J%?=_B:Y;A7M,\<L @Y&98,>.9QAT^9%_U  ]&*5'2=4U"E
M8%/=IHZAPORI[_ URW$/GGH[R^%R$D1' 8H6<6.'(+<Q:@C)&:NB#$&(\0&+
MJH6P; A?O(V\'K"X&U"W\AA""9*$IV"X1.N<18N@#@(2FNPQ)>(RP_WZLC-3
M3^* Q=)D,7K#?;CS3,;33@1?@R*M3,IFQSFEY:"2=):H0$A@FBI&E:B9C&6G
MTG!)XQI'6! .*.4:A(X!O*01N,HN4RFSB>5H^:JZ)"-<:T 6&_K7,8\6$_O5
M<+H=VMN9#&6)23E*T(RC,Y2D!$^,!DD(+P=6552T=$E?D.J/"O-'N<//9C(J
MK*\'Z]8F+ABATF=1(I<)_W <G T4</O667-N6"H-G/1L!Z>ZA2\VMI=O"Z^I
MBOEBO9VJ8$GE((D'090#81P#FT*&)+RF(7+-C,8M7#VN;FV/'.8+A_*:JK@'
M5[R=JDA.4F^2!JN"!:$4;N.2*4C9.N%(XMSI4G.@M*@;^9(A?/$V\IJJN!M0
MM_M11&&4I@1\DFB@1Q+!.J^ >4X1ZTX87_I1V%E(/XD#%P^!Q8WAH1L@<OSA
MN01#!SINBA# ;0X.<-W?16N*'WW.#T<QC>!P^/EYF<2#X: ?.]-!><Q-AJ[]
M_(O-^-<@?*8B8SHZRW@6WB'U)\85E[G\I'@]0K+T&\/V[!$2AK:=\!E$*$7E
M1%LT]M#LH\%8+654/&3<%\2JL?.J,+TRLAZX:J4RY--@R.O8Q(M)D?7T\ATR
M9CMYE:F)6;@,P45D3)_1IB;)@#;H*1G/&=&B.;PL9ROYKEWV4[FR<N4B/?C2
M464]KG2GW-BR)B5ST;N4(3*30$1EP08F(03F$E.24U7ZP;!59,EJ35:&?(0,
MN7S6Y ]3I94QY\>8[3RJ,=HS*Q,P&PP(PSTX01R$S+WWS%CJFPY:EMXF,OM4
MN/))$^4RL>3"D63---]#[+&=:9:&:YIU L4#NM*E58D)@H%PQNE(<[0)R8_K
M54;O//A8^:_RWU.V$JLNX@/P82M)'V.0P3D'D@@%0G,#7A,*/BD=G.0L4U+T
MO)2Z2V/P/A+XBYFGUY=B=3V%M.?3J,/I:@>A1J^0CO]A>=&YW>%L'C@.=AP>
M(2AGK/(K7*A^9_W.F>^\_ N?0GE-<Z!W>XBWM+^7]@\[;C].S_?>MO?:+<VW
M)V"D+9$I=AV%:B(MUUS)2+0(+GICDQ*$6REH)&QLB=%:(+.\1MG++W^TC3)'
MK.3",<C*NW'7:\>)AB!DMN4(A!6QB=#=_ES3XBFW5"I;)BJ[EMK^0G)9K?N^
M+7N]N\A>6C#*#'/ 6#G,P3A#;Y)DH,8H)W16.9:CU@NB4%-9ZPFRUM*15CTX
M?FN6VKS(4CXE)*J@@<G2P%,'"<Y)!R;3R+Q64A=U/"8>H<AMY:IEXJKEL[#J
M0?AY<]=VB[NBTTX0 3XG B)K"49S#D$YI:A+E(?2S.AQ:?96UEHFUEHXTJK5
M%O=!5,U_A:QH=^/32>_=1R."4LQJR/@3"(<LY0.QH'E@*9!@!+=--P$VVT.D
M&EJ5LIZTH56%"NZ(I8Y;+)4Y"T3* %Z4@+LC#M#"2A!H2B[AK*)[N++&9UN:
M/0E1Y8< XU^'N+Z;!.H>PC#T/[O!K7.H3UN'Y3J*\8)R[H,N81#A#$'G(GKI
MJ8J)\*Q%33HN/0M^/9=TY#U\UH\I,T]*Q)Y)94!8'\#FG(!39T1B+$K"2]*1
MFRJFN&S8OU:[B(4$?S5Z;@OW=Q?A;G.*T@@-W+$"=U[BWX:!1F^-*6TB=6CR
M7%($7\44%Q;F2X?RFM:Z-:PW+\*::&V<$PY,+%(1,G,PRE+(P;(<DXPJ^TL]
MF;J%+S:VEV\+KVF@>6-]^R+66516.6& !^9 ",7 4<& ZACQ)9SA5-) =0=?
M'I0O',AKVN0^@'V6-NF=O#_I??GH(HU.!0)>E@QOD!H\1SO=&"=()-(:0XHS
M+JBN._F287SQ=O*:9[@C6!^W8)THVM\ZHI<=>4"G.QJP*4=PF<1@6)(A\I6U
M2X2*JB+R'8'QM^'H\W!4<@UW?$+K2J2VO UIK\%IGFF9E$,F(T(0*HP7+'+!
M\-=.IL!J=N$Q<%_[2!/.N8]) 6%HU0@N"!@G#=HWVFH9LZ<FK:S952YO;= L
M7AW((\?^=0R:Q01_-77FEET8PYUHJYSQ'E@R&82R$ER2%+)6*2F=B76N5*C.
M0:^VXKSN\36]<.?IA8E<C+%.:^XA*&)!9";!B," &!5*'T8JDBWR68_P7/(C
M!_?R;>(UOW!G^87)0=XHE.$J@,F*XR;.%.">3D!EJZ.*DBJ%8*>SA=MU#U]8
MF"\<RFN"X7X3#).*9Y*T)-9KD,J@/^Z3!%LD1DR*(41#M2KE/W95\]E39'4K
M7VR,+]Y67A,,=YU@F,":QDP49QEH1)=;!'2^/9$!)-KEAC*)MCK#+5LLR)Y]
MWR<98O^?EM0=E/<_I_R9G%ZFOQ_3_N%S&/_N(97D)M)Q>\/1X3;^#&4X4CS7
MN?%TRO"Y:@KV;JR@*'SFR?! !!.49>>89M0SXH60CMJ:K5AZ(CV>R590+2A2
MI@1.6 #!5).H4$"5)9(2197(1167Z%D5HUI^L=C8OXYUM)C@KW;3;>'>RE;$
M;*7T/$,YU@M"*P_>V@C21VFLCL0)NK(FV6*49528/\HMOB8K;@WK5K*">1-<
M(@ZH\0:$8PE,H@8B(9EZFB-WN(M36L\S+ANXEV\/K\F*>8.]G:S(U@E&.$3$
M/(B</;C@# 3"30HXV507"8>ZA2\/RA<.Y#57<1_ GLE52.*B3XE!S!&]<94T
M.&TU"".MRTSEH&/QQJF=[5%3=_+%QOCB[>0U5W%'L)[)51A"C-8*7!0.O>ZH
MP.+< G>I.-[9*%F\[MND*I;X,,32I"IZPWVX\W3%TT[H7H,C":59F,2%9%I$
MFFWD1@6O"&=6BR!KNF+IN?1D)ETA%4W:"05!.P:"^\*D2D#@,J0HF+&BZ>C,
MV:UU'VHQQP(;2(L)_FHZW1;NK72%\U9K2R-H'>.X"-OZJ &-)F$%#U+*_.@:
MK#QRF"\=RFNZXM:P;J4KK"(Z9,& )4Y $&/!,IO!D.1<#D('DDJZXM9!C@KN
MNH?7=,4]@[V5KC F"!IT!"^R %$4\HVC EWY5,QU*AUU*VL+4J994;Z46WA-
M5]P'L&?2%<+0Y)*70-$^!X$3"YZCM8Y6>U9,N.BC:;2;^"-L>?'(,;YX.WE-
M5]P1K-OI"LV(RSE*8%'FL22;5<)#9E9YHDU0&LUSMB!-MYY"CXB-X:$;('3\
MX;DD0P<Z;@H1P)T.#G#AWT6[B!]]S@]',8U@/$+/.<YC'![A376F S-YP^'P
M\_,RRP?#03^>OOB86P/-?X 6>].X3HK;)L>-<419(400EE,774Y!"".(<35]
ML_1["YE)WP0IDDHA09*!@A#H!GK.),3,+<%9SYR7](U>I9?$=&]6X#(_[#UP
M>4QEX<K"=U!IM) T7(WZVQ)O*Y$FH_#)"(5.>A-QI^BIRRP@9*^E#]997YI3
M\EE)PFN7(%7"K83[Q AWZ?BVIC1O3;"ME*;B2J8H*$B;D&6Y9F"#() \R\8J
M)OG_S]Z[-K65).O"?T7!V>>-V1$J=UVR;NX)(FC;W<<3 [2[<?? %T==0;:0
M&$G8QK_^S5H2("1L;A((J!VSW0*QUJI5E?GDDUF9E4ZLK9N%=92K*%M1]IFA
M[..CM75O>=&H.[.WS!(7,C)*-#A'P.O2-\188G2B-*<L1$KED,[*:BO>5KQ]
M[*RV[O+?!\3.'Z"8A<Q> 4G*&*2VDB/()D.B]N!!:2=CDX3;IG1158D5;2O:
M/C.T73UV6_,ME@2PL_D6N1Q,:CR0X&PY?5HJ8B24AEE<&6$MJ!S6UKF>1]='
M2&.;=(V?1D7.UD_?9^OX$)4FG-9+3A6$'KK!?J<W'@Y_B,)/WJ1?'*36J_XA
M/OGD__L_AC/]\Q#5\U0[6EW4 WQ8'O0/6Z[;G4[1<,-6/[=>IY .?1J,C:%@
M[1;J)V]]28/4VD^]5+IRQ<GU1T>#_E?4V%'JGK2^BPE'$VT<SF9BB:B!L\P3
M,Z "]T882J,WP+*T633(P&>1@2X"&' 1\16W\^_G0[L.,:./%#?V_G- P^%?
M/?>W/48,X'L[ 1!!\+F;<O?CNY,M_NO!YM]_=7?Y>['[\5]X_=;'O==[G7*<
M[?;KMQ^HTEHHGX@'D0DDSHC7(1">.=(JJ7PVY107B:QJOG5,ZVS]6_WC41$Q
MUQHU.4+X\;M"TVM6:#D2\[;W.0U'AZDWVO[22_$7UW6]T 1(RC"J+'Q/%M"F
M;'X0ANF8J"6EY0@!X)RXI"UQ.8,,4C%NW=HZL"MDX45K"JA:/G4["1>EU1FU
MOG00EA MNRF,6B/\HQ'"(^++T:#3"YTCE!O7BZT.BL4 5[$5CU,+!:<S&L[E
MG!VXSV@!\,];KI2_-_@7^GA-I]=*7T,:-H"776?0^NRZQVD\IGFP;+ /'X\
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MUG,MDW):1(KRP- @(S,3P/'7I>IM"1RZ6N-%ZO1,E$ *@VN8.$DN<P)< /%
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M>H&_T*4UY5%_V"E7O!RDKBM]S28=*2>8-W7AI)\E/;_$>9R^X]'W+YEKJ/1
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MR?F_ A<U]H_+:<*GL_1L3S=;_ 0]&=.R]%3S:E@6>T#:EW_OO+W8$\CGH!F
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MQ]TX&CDH+?Y.DANT4B^BIWO:F&&L Z>=*MJ-E-Q$+H)+0E%GM?,,E#76BJ1
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M.V.#@V4A2AL)M\RCJFI%O*29@(9DO3?6 5M;MW?N45,U=G4UEGDPJ*_>2FY
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M*:)&/I-Y8@94X-Z(TI7*&V!9VBPJ?#YH['-N$TQ)&7PP)&6K"1B?B35&E\:
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M'3&),^+* %3@T8M 5]>5>K(Z>LU,7D!F\BB,U\RD+>"?W7 *W*2 RTA\HI1
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MW05C=(8R4>%I%(*35&9@EW$$Q'"*D5!Q%5/DPGA:,-JF,G$M,\V"S,0$%F+
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M1 ML1H^LM"52"6\LTUS&6$#,%E=VXG[KK>JME5UFUW3098XK0Y-&9Y$C+KN
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M^]@ZWRMY=;_-[&>6QE,EKXZC6N:[ N]#['UH0_OB'>#GY!X^<_O@C\/VSEM
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MG, X."W5YBY'Y&&&LG'3\-_WK :^B %Z/A[D<3. JN]8H.^XIKBO-"9(43*
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MTU!+<'>2X)HS5KD@A!186]!0#4:<2XQTP!9)K(RDU#*0\)96A9Y-C;^?_+9
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M1AM?.:7./6I%=+0[;;2/LLD^J][C4,HLV4TXG OGVTF&<EM\UTMI4!T%H0V
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MUK(O[8__4T@LA9A4.N[+S_]9GLRCHOY^^=$YME[XR8LB]!,OR<[RTOZ?[<4
MD-:76E(J HI*3SW<=Q>_N4M:)!:UQ5)PC8EC-"HI4C11.>9ER?0$8X;&O]S<
M2.@*",A:3Q80BS] >^L.RO:?Y&5XUY\9+P1\QW9=4,9B9Y' N>(U#0XYHB2R
M0FI-HW#6J@+Y9[WMYSV'LCQI!_OEZ>PO]F=*XRA;$Y;T>P*W9H+I9L6P$._;
M61M*IY7 4;1_ &'49U/ I"OM9VE[J,3Z\L NE;1K-0>X-O\:XG'L%A(E"%;9
MV9;]E* *=G/(7C4LU\^F_\9AA'%$O]\%E-@K?)+54,_E1QM^VD+.'H_R7-B^
M<KCGP7UC/2@'NYP[FY8;,<LOF15=+"22DU[_,.4FUOGF8:;L<LWM^:+E[A<9
M/OJ]2CR\%.QS.AC&HSM4HG\.:+P(G\@;,@X;*A:W[''>S:&)D_0SZ'5F4*T2
M%3-N%>LW/IJR\QD4FP2R<':^%;!WWH2[0,@"3K?^_E0":(:ZN^ ;U]QA87W"
M5'$CG$Z<&)V%/\\Y8?+.?1#_+EU/@X\@G:ZW"S-)3JC=3'^>&R)J6+L=K/FS
M''_"E20$"48#P)J4R'ACD<G%?0R<2SC72J0WM<Z[A&K=."PTXLI8E?^<]!;#
M5SW?+A3*PI93:!<#V(Z93C8V(U4G(-A)5%Q@2U41%)=X'L-6^NJ*-\/=62'N
M]AI[A0VG7]KXKWSA!% L..^OC_IC/W9NE#+5,*AQ=1CD1830(/XL++93L0<3
M1T_E6"DD%S\I)MQ5C@E)VY#%&,P)-S[::!EPLW2&2Q!:XIWYO)9CYL_P>V(W
MN*+.#48RIT,#[V.D>:+(" #IW-S,I9 []5S?J_RR<:&T7.<#YS*152Z[.XG"
MWH%N(V.*GG'-N&&!4QQQ"/##45H?%<]&.0=K9#<R8:)V$D6,*5".AJ,B<H$P
M@V,B62F8]K_ILIH#3^"H6"ZQV&8AK'^: >ZG[8SBG56GN=%+=__=^VHHW_-(
M-M-Z>S .!7D9&6S/3R*'OW)?UNA84$@;$"FX W4)-D4BHCD<!5)C3_72JL2S
MR6@7#3$+27X_%@%:.5C+YT9RJ7+1W-C#+M-/E878F_%/U'%#TW%#M(X;JN.&
MJKBA^Q@,*]K/59>>N&/;5[\?PZ@#,/T%%FZO"ZL=-K+5OU =U@KU8ZTR&*YU
MP[\O%!#X#L84%JJ;VP*8PW_M6M@2EW!"1M&4B[ER9'/]:<$]CXZJF*A:C-9N
MYX;@4LO\QX1Z^<^L)$YF1!3>]JQ9OGN>GFP ?RNXA,"[-F43>D5P\PA-V9CF
M\V_*1E:4%/5@'VFPMR.#E]#NSM3M[NZP#J4)]PTO0%DEX<IL\K>W&+-EA>;>
MY/!%E5DJNI47WMC\2XX!_ F:^",5T9S/DK[NLDJ_F_RK*9EDK,;.4$^EPSQ)
MYU+T42>E+7/$"'W;DDE7F+AG%9HL>]Y"I<G< %]\N&"#5V":^MAVG[[)[8,F
M:9T=BM;6?KMY\+W3^K1SM'WT@30//K9!T?D%2@W<\QFW8#[E/=_A7:*[LW7<
M;IY]8YM;AV3ST\9IZP>\\VBGO;WU[;3Y8T,TUS^P;0I*T?IGVORN?_U[:V/8
M_)H++'W#K;/FR6[R3HFD+/+.Y49B5"!-J4>@)P<7N7?4X*552N?5E.?6N'RO
MNDDU$M9(.&\D%(EKQQ(+1":.C=18"V9E-L)SR?RMB\?52+BX2+AU*'8M]THH
MCA'\XA'W.?I)"X4$EEA&QZC';&E5Y);3-1+62/@&D=!)G +("XDZRH-.EO!(
MM,%6"!,YB342OE DW+XL$PK.?3[@D+""(!X81]9YA8*Q,DD5C;-I:57Q>;40
M>EPD? LUY:N,UEQ#Q$=@A"(#?*(@6Y&96+D3ZE+S;TYO+O>_O/++.8742'E'
MI#R=T9Z%T1AK8Q%7WB'.M4>.*8>(8<(R*1. Y-*JH0]&RCF6IZ]9_BTHB#7+
M/P++9S616BM9,!%QR07B1%/D G%(,!4Q#D(P+I=6I9$UR[]>EE](3>A:EG_=
ML9U/C0=3RI(RT2GI"%)$!, #2I'FF"!F0HXD=CF>;6F5+$M*%@@1WD*/FI(3
M+J?8/'?SP=<-BP]6?KK[-T-B!8/3\ >?_0_L\L=>_ROL<0UX<P2\LUF=AWG#
MH]0H.0Y2D,8)6>DXTL3PP$SB7+K<A961>?5C62![>,WK<]-Z'H'74_M7#.@L
M]GLUF]^9S3]?9G.09AAVGN6Z^Q[QY#&RP@=$DO&.4\PB-4NK1>XU_:-F]-?+
MZ _6=>I#?0&Y?4J+251$99S(O342:#',(N>,1Y12J0(G6,6T>(?Z6W#M_'U>
MO#^'?QZ?%T\K73N=7G</Y2KMM7/G)>@WCV#V&=/'WQW;'5:>\..RK5 -BG<!
M13RCZ4C%,-7<(1&909Q'B[2W E$KJ1;!Y+T&4!1\@0P[-<\OFI[SM#Q?2TF/
M9/K(OA^O?#0V>82ELHA3HY$AQ*(8A8M&L>@PSK9>K1\<+EU#PN)"PB)Z?VI(
M>"(985IQ<D0I'@5R5 (D^(21-L8A&95.7G!B,R309<(6R2'\%MP_96)E+BC?
MW6L7 7'WUY!J8]$+UI VSDF@O+@@C*U]V_W4ZX5<?+2&R#E"))E-,9,R)&HY
M$IKEB!F%06J"WQS+U8"9CUSKI56^C,4BV99J:'@#BE0-#<]G8<D*54J<*AL,
M<MIQQ+4,R/K$D<(BX9B*,O!9H5+RP3:6&AH6%QH64:&JH>&)I88IQ<HF&1A.
M'BD?$@*J\" U& 9Z%O,:BV@I V@0RYHL$C3,R2-5<CA;< VKJ-8"Y'W!5^=U
ML2O.>FYWU /24U\TH"ZB&E9>4J/F'%&3SNA:3@H?,#$(,(T@3KU&!@1O9&.R
MANK@E3=+JPH$JGE%(R]&&GN-&:]2/ZLQXY'M,X42YFT /+#(6VX1M\8@HY)"
M% =O;:Y\KF2VSV@YKS3&&C->"68LHN)68\9CR!E3VEF0/.6,1X2= SG#!HP<
M[#]2G%DKH@ =#>0,0I<EG9??:\&J1+Q CUC9+3HWP1D,BQZ F:.>VQ_V5J%S
M$56T*H5TXHO"ZE4G6<P'1MF,NJ9"C-()CD(R&G%O'#)46:2(#E0)HCC!\TZR
M6 SAJT:0JQ'D'R]<8[L60FJHN+]E)VMI)#+ "@(HH2U&G,(/$XE'TDIG74J<
M,+^TRO!L4[.9\O(U0KP5A%A$_:Q&B'D)$],ZF>-22Z$1Z&42\4@I,@8SI!(.
M0N% B8@O B'>0EK7><6^2@V[HES?1->?Y_:CO7*8?!FZV)AD_BXIIK9PS1%-
M^8QJYH4%G4P[%'T"H4LIA1Q6'FFA$]8VAWW+')J$B7H GM9I'@L,"R]#OYJ!
MA9KS[V^4*?QAQDC'G4-!:8-X4A1IEB*21@8N&%?:T:55S6<+P==\_RKX_F5H
M3;4X\*CBP)1RY1(-(1",,,$Q%\@(R(%6A0S1Q'*.H\Z5?LFREK-)#,\""V_!
MH37!#769OY>D+]VG)-#$KY?J M7(=A=D$S.*#G:14,QSR*#VB)N$D=/29D>4
M,CPJ$'XM(!N>#1B\L]GHA9J/7R W+WHAO^N8N78TSXG)IZKY2>I# N$5,9LL
MXD$:9!*C*!DAK-%"1]C>NIK?"^7V)U5NZK/[&=EZ.DE*:1#!LJG"2XVXI0KI
M1 U2B0GMN.(N-R-8F+/[+3AV-J?J\M5>G!>CE3R"V:;5Z_K;!-75]IJ'];!K
MOL>G_][ZD-&1M-;]_\_>NS:W<219PW\%P6>?-W8CD-JZ9-T\3S#":\NSFAC)
M,[8\7OF+HJXB;)+@ J1U^?5O5H,0J08E\=(@ ;!V9S0D 32ZJ^J</%F9E?GA
M^;>O/1>F.([U1#D#Y"E#")&#U89CL-$8GNN.#7=M(W='&6$3 SA?8H0&^MO'
M;&OD!HW,F==.E9Y)0.,([<(94,61W,UD$D(]_<@;X'<4\)L8N6D2X-XD@.A+
M "V#]R)#8K4]8V(%R/ CD"K4QI6<5"Q5 CBV>DAIFX,V6UL^XI*S=+<:$BUY
M>#?]J4M_:>PY*'O^O.) I2*5+\:0D+(*4#$&7C .9%2%$"QKI=BB)\0 VTOM
MS,&NT,8F.EV--NXCFMRUQU669^D0I*B[+B)'<%(IB%P&(WG4R85%GLQJV:Y&
M&H^6-#;1<6NDL3ZMT??4)..^H%2@A>(D.'( \L\T:&,9,]%XG5VM0</-:@V:
M#:.-(4L "K45/MQQ/KVJ#.!#Q[MVBDVWW'%[D5LGBF%)=++BL)5H<O+%@K?!
M 7HOP(J$P!AG2:G@7&W9J<9X]T+KK9#7;E'&)CIMC3+6&B3_1?WXS]<N*VYU
MD*"L%>2N22(/# @E%\Z*\;F@W]N78W9%"E&CC$=-&9OHLC7*&%YE]%TUZPVF
M$"WD4',.7;#@G$U@N,Q<ZMH?W.SM6U(9VT$9C^&@U+)G08NE;;='UGI/K(7D
MWJ^X4EE'*Y$%B-XD0",4^)(3N%"\XC%Z$51'<N[.Y4W;7O9N87TH5ZIA??UQ
M[LX'2BGS;MO91<8!D1EP1,Z0!&*T4;IDV=Z^&XO!.LTTK.\(UH?R@1K6UV37
M^\Y++BJ6R!,(# HPZP#!.0W9,2D$4X5SOK?/S=CPH9I1;ICWLH5'JG[**>>C
M+K!$TU$!.)L>TMO>U.Z^>9;G#Q]JVFV:6U.]A_G%Q+[X9%Z?+:>U'0@?B I?
M7'$^*J9@?!=HYT2%TACP6A2(641MK"9+E@8[$MY.36QP\LV:*D#<%-Y-[@P9
M$>Y<FU!X]DQ+8*@,H/,);$@&0C#,$OR%$*:&=_B=B@(W<&\PN-=4[Z&!^]X-
M>-^7$9FCBYP,>(B9P.T2A*PBL&(1'7/6QLT"]V.(M! 89FMR5QYWC9L-<%<^
MF=OFL:R9\%8/)*'3!J,K->A,A&=- F^+@LPCDT&5F+)O1:RV%>";X+%<#^$-
MR7<(KW9^B9!&B<PX)"$L("UC(#0CQ.""98PKXFZ2+N8NM70;@#<8P.OR2AJ
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M)UM;'Y"UEC#41#(E8Q0^8I!H3;!H<N"*&UJCOOG.F\$DO=WDHFR,2DK@145
MP1QXZQ"$8[PX4XSLDFN'ZL_:8LT/*P1NA=(F!#8'OKW-9.6-CK6W!Q.DXI'T
M.[AHZZ^%YU"$B"D0?*^4 <T>KM,>(C<%#;E0CEF,7-O$M<F%16,4_<B:/=P
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M&>*UH\I=[R]_Z.=3L@YUJR./?GGR\Y./GC<]R_R@?FI.7NFDT)?19>G)CH@
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M\*:3&B-MP*/=9"LIAAP"HLD%,6GGR67S6EN1O<7< FZ;1TNO/J4EEVMMTU+
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ML,I#<*%41A*5D0P8P6-(#@6JX9+T&B,U1KH71I*U 4G06I6<43'C$V=*UL;
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MQ$P]:$L:R(V%'*I^0@/^+@&_>.F4=8)[3E9>\9"2B.BU976_7-^Z<%P#_L#
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MV)7AE41X4DK(,A=GLI?*A+U].9;.-L)KA/?("6_P),-&>&LGO'X1,5DXCT$
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MK )Q%/B1\5^A]<5DQH\'&"_@^;&@!$:\3+>0 .G" 09'W*OYJ0%(AQ,-YV%
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MN.O'N-89KUHY)Q T5(O4P!#T8UB&':2<S=\=-C+N,AAW) 0 .9E9;3 @!CI
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M&SPO 3X12KV0>XHL]\'Y5M$^WJ]#53=:[GWOEP^!0ZOZ_GU>*V95W/3AX=$
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MK+K'TKQ6='^[\\]*OH;C?4^;R5F_89:^*_J6]K(]NE<,DCU:KERB8B3A9=M
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M9BVT_7[B@#MX2_):5F_>EL^P?A3:OSE-"I0IOK]QNGA7<$%A^"$:\2_0>F:
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MD1)+1A-@K(? *FT%-XQ1 =<VV3J7985B<K3E(?4IN2YE>8R4L;SW.'UEAGH
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MFH@CH()@$O+X'T:%CR=$GIJ8H3_'<$^&_KRA/]E5ES B"+& P!2OQ8A%U.L
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M#UY%8)?N-V5@/Q+8D\X1-IHR@@FP/@A F?% 2X< I1K!U* =<UV*<Y2!O8K
M+MT/R<!^++ G-+;!V&#%/'!213AKIX",?@& %&GDL68F3>DHP=G(I_K+RQKO
MG?E46M\^CD_8Z\^4/'Y\2[<9KE%:04.^R?EGBI_H>4^6#(^F)".YL"G)$VAX
MPC27W+9Y41[X]1Z^^7Z6JK^S8G^88C^<<L4)YX$0H8#@)'589Q88&3Q T4.G
M,&I\A'@Z #P]-BFW5U\9G);N4&></A6GDYXU42R=@;3 .T$ -<@ C0@&2H2
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M=/W&E588>^,(L?#F+=I$< [Z][]E##N\0M@18F*]QKXVNE=W<Z://3!=KT^
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M'_=]]_3O3GR>@\Y^JECU[KWN#A5]UN4/T.6?IF,EWENMD 6(P=2,E:NHRWD
MA&*+,(W^)*9KF^R.@P /GL93(9\CHW=^486,WOFA=S)RX*DD&C(/G T>4*T\
M4%(K8'%$;]Q"SJ1:VZ1T.LR9T;L2Z"W=Q\[HG2-ZFY-Q/Z5YL!0@DEH+::N
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ME.([Z R##Z/8PQ\7XZIB'*2S)0+5B],G=;R[]24JD.@5>0.PU1)0$QQ002H
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M! J7U7FL>D-^E[ #4,0=S;U^5H[[#J,5?W#>R917'N7M3%$>8]IZ+@U  FM
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MAH/A:# NU&0%*5F^FME1].,!PD' G'D8D&O*5E?$QJ'+24+OSQ"[CNT0BUN
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M?6YO7PU82EPJA^ EDD,2? 8O>"2])6,IW'.C66O/[P%,#<<\"$(Z5K(#*Y0
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ML! RY\"LC;5YCT;1OOC5-LAZ$<!VQ:/;U_*:"ZN=TS@D1P3?#K_@+4UPUSY
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M6E1;FI#S]^L?,<SPKW_X_U!+ P04    " "0BUA6X]O[JYKJ   HY H %
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MHEH-F'V[Z[KY#96S/NMV"\D.D'/](N>%$,/9NS#*K\>OPI?1/)Q=%?;/M4=
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M^';OMC1FS;(-.YARAG!;TBGF\]JU>"WJ"P/.9,.T\AY<KBFXCM;UH 1"<4C
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MLY]>DV-%L_'B'L8MM#PYK3R9]4K4AG56@<^.=H*4F:-A>.':UT#>!.&3I\R
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M7P_)#3%!KU)_M!6!<4$\]);<)QT@.*7!LU"O9K/L4HL+K8,K\(';;6WUMXG
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M-L$P50O[JEJ-UV;P)FE464?ZOZ= D'45S Z.'YL(?$A>W,K9N+S5YR6+VK(
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M-Q]G\^7D?U8P^97CP1=.#J*)3()BFBQ_9 Y*DB%(7:3#UG5?7;%=G((,0LH
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M:E+K.HC#DZEFR&:O!58DD]9M7PY'^24I4@NBGJN6'5"UZNYHN)1TM/+:X;^
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MD*H'XYM:U$SR0[3"N7,A[L:[=0 S4.CI"9#3Q)P:$K6I KVE/#CUREA;4N+
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M,!LR\YQE^LOQ7J&SN50\N$(-3-4 H8]GU=NX?/X".$YK5M( ,FMJSS%#&%6
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MBY=4;AQ2AQABM+F2NQC!]/V/)*S'$_D6ZU$\5YSQLFK>(HHCR)Q<T:"CJY>
M<C0A.HZMK[P= ?.R%:XQ30/<9>CPCE2CA/Y[>\UGFM<#ZA\J3!__PMO98GF5
M!1II# <T1H,2+-$YH3UDH2W+7C*I6[?A&&(=EZV;8Q/=^%+$L_4\^L'=>GZ<
M3=\O<?[Q^L%JOC(B,%>M%Q:M!\5L(A%J1PZ6S47D:-%WJ4H_[NF7H5#C"'_
MSF(=MN>[BH,KF:-7R3H@APU)0,5!%%%!+MG*$%QAH?6,N,-17H9:C4-2RSL,
MVUZ$'Y$VRK6;_OD*M>%)F00H:A_@*#(XJ0P=\4IR+Z*@;?*8[>;I8RY# 1J+
M<X#+!L_@_3 EW^$NX<\=&6LBD2$70@*%A8$/=<BA==9(GHOV@]O;C_!<ADZT
M%GSCFP&;N%95(/>F?0I"HN86M*+-21G/P"E7:IS8"*V%(ET^XN5_\I#+H+FI
M*!M7VF\%MCYZG+>"%B1 .$T&<$$R@(55D#PS!LFBR3(=2_%%G>XM!3E S?KV
M)5]A*989E\BA,1&415[O>Y.''F,1T:2"<JA>LT^17(82M!/V$!7ESV#][W!]
M<^L,KP.!5TJ*C%%+T)'@T9\(7HD2N/?*\JB3;3X\J .LR]:.GC0,4>_]W$Y]
M\')_QN45&A.R2A$D8Q+J'&5PABR4DK-@K#!2Z,'=QJ>0+EM%>HA_B,+N1_@>
M(;M?NDHAH!0>@JCCM\AYI:63"HLZ<HLIY>@H'$X[MB"ZT#QC7]D/F\AYA.[6
M$JI")U_W3\RW2GTE#1FZ)4A@)I/1&T0D-<X69"*_AAC&:%NWY3L$WTFWE-[<
M=E*;!L2T5**G1O0CG/^<S?)?D^OK-]/\PW09IN_KS?E;L&L#NQC.I,X27."$
M&46!2)XQ\,!X8K5F->G#/)6#GG\9RC(6 <,F^IY4$3W- (5/DV6XGOP/YM]F
M9?E7F.-5T85I%(3;"48'=2#/C"D.,CMK:^\/M*TOC!R+]3*4;$S"!ICLLQWW
MN_GL$\Z7G]]=A^FR#LW[[YO)IQJ_N](Q(F$L)"-9@$2B(3"9 ),.GDN1C!_0
MI>H"\0M0JS;T#)NS>P(7/X7)^B4@@Y'.8#IX+3CKR> 7EMP*97AM")FD%H8_
MB[0.ID-/@'T1FG,\%0,T%-L.\B%=\$/MJ5'OO9!0K\F@*V5U@Y. >Q&]L-+6
M\7B*@!L!04L&R9%+&@)3S(QSSG4 ^P7H56O*ADT'/@)>4Y;DT;Z9S\D,Q-L4
M5?#>\#I 09AD@(2EZ/4@AT'GI WJ7'P:L"9T/[@O0)?Z4C)<UO ^M?TTW>64
MMZPV.ZLWQ4!YDPA<,+5)(^;H96+IP+*![0^Z#.Z;BW2X#.)3<&O7D',9M*YM
M H(7H+3)X!07P%TN27%I+.=]Z/X"?/#C!3I@-O$^ROEH\5<F2A<SG5<VBT2*
MB/7V9PG@I3%H7<JI^;CV?7@N0RE:"W[@_.)C6)P7+6@_@J1J#:TA-76:O"Q>
M(C<F)F1F'/_W(C6AA[ ';13U[%)XD:&PR 2@"Q69%A"S0D@\%&=RDCRVOGQV
MY@T5^F2!VLCY/!LJ.!]5\AQ!ZU#G,X<:D5$*> XJVISHY6A=:/C[>3=4.(C3
MO0T5#I'M"/?KN\#Y<AHJ'$3."Q?MCY'L"(2'*%F6(8+!3(8KZ2[9*!@ 8[$Z
M<&TM'VPL[=DT5&C)\R$"';.API9QB1'?3Z93VMC"-.,TUV]6;:9GY68ZIU]_
M/ZUIGF7X.]Y=S&K2::$ED&8M& :3SD9O!A.%UA(14Q0*(R/W4%F3HPZ!#HTL
MK@;"-&33!I?06VE8M6D+*+1UHD?,H+UGC$Y"6_Q@PQR':-KPQR-1_GX_OV1Q
M57A)**(&<MOHT/>A7B9CY">H.H1"E52:]Y7: >7<RJ<.T8#-_;.%M ?HS[ #
M%LEA7F\(T<NYH(.:)/$]R>KMS;PV!KX]!^J!,%M,;OOII12EM>A R#HX3G,/
M/J* X$+VM?<.LM9.5AOD7X"*#<GE );;0:MX1^CG6]:@@X],UUL/T8@Z%=.!
MU]'4\296.Q61')A3ZN,.W%^L-K;@<8#:KAUK^!8/64.(A<G$'=!^'D&%R, [
MJ6HC=>:=2&ARZU[X+7!_ ;HX'(\#E'_M6,.OMP.="."31?P8/BW^__;>M;FM
M'$D;_+[_)7=QOWS9"-=MWHJH+CM<[IF83XP$D+"Y+8L>4G*7Y]=O@I)L72CI
M'!*'I"[=76J)4IWS(/,!D GDA=[6-U^^G,QS.\NY:!_,'_TQ_SP_NRR#2]JI
M6I.!K'F!-\$C8"P)(D6G6*PIHMT/-7<9Q@M@ZMZT/$&DV7V6K_?9)QL<>%DT
MK^@U ,JH004=O9$VZ=K[?F:0G]'S\L$%Z82SFL>HV*:WM;#4^4M5-E<A97"A
MMQURY)</NTR./G(^SLL'7\EEGH\@36 _4 >6B]$2A"VVJ"RKS)-5?#W.RX=1
M.GWP\F&,;/=P%CT$SLNY?!BEG$<.I;>1[!X4;HU4HG@'FGUG,,8YWH )H3@G
M3?*Z1.Q]<GA\EP\]]3Q&H)-?/JS+N'U:G/"S5RV\_^S;G[ALE96^TO87"0,>
MNMNEP%C4MP[XL5HT)M5 A9415&!WR%>#$K-5[)G/!CQ_^\"_]</?TY?S9?[4
M_+?UAO'#QG#:6<NF!?B<).\<;&B@LQE4+=[H(HVHXA'Y/_Z671>)GW'UZ9?Y
MUWF[X%B]PWGYL'B'[4BN%0/$TV\_?>,=<;4XF1<\H_+7>5K-RQR7+=@F%%)1
MF@JVE'4BDH"V5X))9$2((J3:.Z)^>[1[],[Z,N/V(K0GA4UPR'_A%2Z6W][D
MW*[1V,QZUP+!YIE6WW]WF?'VYI2A+[^<G*]^PI-U30@GHG4U*:C5M4;D@<$[
M(T&JE 3_KV3=N^;"3H"?#>'VI[8);*#MP+\GWBJ65&8F:FE3=NPFZ@+&:\TS
M1F4@I]$;[Z.CWI5N=T/\PEFWE>(F.+'_ZVR1__5#,.^6BX]+_/SG>1/EV[H6
MV^K-^=FGQ7)]!K3XZ9H4R\P+JX2W!70R[>K+2T#,!61@:T>P<1E#;R=\)\#/
MB'3[4EOG:LD;93++B4U@+2PDU.UH,VM 0Q:R]5[)ZA7=CB0=;H!.?HPWD::[
M".O@9W<M2>;2!OQMR6M>.ZY:N[?1A:)**2 P>C;LD$?A! )F':.EI)P) U2^
M\>%[/YOKHZM%3YGU+O=R&]#ER<(02)O/YH:I\R#G;GT4\) Z=Y#>GA1K32S2
M1PO"LA%L6CQ[+(I !UNUT5%8,:B@Z#X5>M_YVM[T.49HG?7XZ]]G2^0'S4]Q
M^>V[V_V/M7DRJYB<%-F"SI1X XJ&QQD+6*=0F\"8G1Z@S(?>L5_3JHL"%A-(
M[][3B*ZGIW>:8/0Z07W\P1U.44>BOW62&J0QH4:=4[)&F!B2%KHXWW;8$'R:
M#7S'CG[3QI=<2^S_Z=N//WF'W]I';UJS@!]6H0]4DLX9D!I74VG%(9,#4MI6
M6SW*[C&@NZ/>V=_<%L$MW^8KZ[!96+\MEO_!_^[9+++^6: "6@\&GJ1*L$]3
M6N1;]"24YJ^]D]&F&LO^XW/VS.8[WNPQD&+"9G[71_6]3L#/)[A:S>N<2JLJ
M<Q%=/,/JM"Z"0(66&JY"A9!49<"M_9;#G+OG$HP&^>+H.:T:ISA+SI^HG)_0
MY<1X2'*K^T1WX;\FKRP_WT&1K4-X%@J"B@(R4D+>=K-,O>N9=0._K_BM0R^>
M!U'VP0^6+D??Z@3^B9]I[<YAK%)8BU"#B<"FH8%4D@+G9752DI2U=T63Z^\_
M5$C8@1BPZ*2)"1; *RQ7N;<#T$P40'83R6'BQ[;7S#TJWD&LTRM;6I-]=!6H
M> O&\S(:&0P8-#4&:SR%WC'Z^U#R([%C4^EXC#0GT.UZ;?H%SR[&Y7VJ6$F
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M)GA..]2PV/9-_>-<1H_O5NA+D,9K[U1T5;"-7X)R_$7H+'.1P;J-H2]#7GK
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ME5NX7G%X8-E5M"!,#*U%B8$H&:%4*D>AI(NW%;G[V?Y#@)Z[-=9?*U,4M[[
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MZP\<^>])Z6/D.L$9PB6P*^L@*1E:S;4:;$OYU J"*K;586M%W5 HW_L^_P:
M_9XH=U+*G;H-VTIT@D">RW%=Q9%D;5.2CG<FS7M4419"36P+1EEK],J;/*A9
MR*@CHFL GH-ZMY?HO;.W6S6@2[/E]QUJ_]Q^Q(Z5?AY$=*NN#SL?E$1V1LAJ
MO%=H+$K#NG#"*5_U[,[3=@IF+2WAM7PO$O3])''U,WY99QO^\2-#P ;= G#
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M>6/"VP[RGBRY\0>FJ[:Q U!-DMMZ&\DALUMWT=0CJM]!S/LC04Z$OF($J8G
MM*9&P2<%13A>1-$DKP:9&4>F_$%9KM/K?HQT>U]X7/>9+P_UBK/"1*O!I=92
MLJ7S1AU;9'^5.4GA9.QRU7'WU8?*8=M-(XM^XNS=UNO:L<<E&JK*.[(>C"#^
M(MD""B6V^E&R6JUJB51Z6(EWWOSD=;NC,/=W_/W==/D)3]ATH;\^$9VM.AR*
M/_S@3D?E(]#?.D 7QDH?A+1>16-=2*A")AVE,:YX5V8#W]'A6/WZ<Q_R1Y*F
MZ!@?2"$*F.HT!'(5@I.Y!.4IZD[[ZBA<?>K]O4FK=>'M64#IBT;7.EO9EA/,
MTX3W4+!6),.S4 C;NRC3300'.J:8@@6;ZP!N)>H)SK8OT/Q\OFS;X'=0_&K^
M4U/ 8^N5QCL>!*G9]2Y5%5ULEJ[WM?I&(,^>!KL(?HK"";CZ].:TM/]KQ0:_
MXLDZ->'L9UPNO\U//_XGGIS3S+<(DA!;!_/"E+7\'5/5LA1J"H$9K*V>X#KM
M46#/F"W]%3/!.??ZX/T&KV>HC%-).]"M7IT1HAVY9&J]DJOU44BVQJ:XY[B!
MXAGS8D>13Y#>=Q-,B3DC&]V@K6#3O1IVI7SQ$)!_(RA6A8.<EVTWDF>L^NT%
MW;/V?4LJYP7IC!>A/^GL M.BWKB]-R*1\T6 KTF#:?>NV&H#D32V\#BC=H-2
M\A]^S7/4=&?A3E#_?GWM]IXR\9:4FMM[TOSW=[AL[GLK;7Y)3V]""5(%L*0%
MF, <165E"T/5;/(8DJ6W0S$0VG/DS83*F:#6_+4][!HH8RJYPCM84*[52"B.
M_2*9(1.FHBE)2;V['VP$\HSYL;O@)RA0?UDF7Q"_SOD*K: Q&)U+BU/-T H<
M(R4=DWWJG0<.9#&,$NT$Q>/_F&.:GUQ<SYR6O\X6^5^?%B?\[-7%7O?=%_8!
MDW)%@15M:_..*1G1 X9L290:;?=:?4.Q/6.23**>"6K-7\-Y^Q#%4FLUZ1 $
M8@33>KVM;6&'=IW:%OVPN)KMB/-RCK ZJ6##.=;NQYHY+\YYP)<18:U/0L[+
M<RIW,<^4D\E6)*C2M *8V4/R(8+/RFI)3OK4_;![.+QGS)^IE+2!4#N?C%Z/
M+[QI2/]\@JO5O,ZI7&$5@2E. 2&8UM#=Y=BBC3.$E$S6WK&UW3NX=P2\9TRH
MJ92T@5 ['Y9>#U"^PA38*M-)&="U];/E91*B-1X\:I],48&=L=X;UUT8SY@@
MNPI] Q%V/C#=L-B1+]'6BI!:E+K)P4&LO)E:%[Q1"3-[Y),;,,^9!KN)? ,+
M=FX>>IV9UYQQ9YT,*!+H2*VEJ0@M\\DS+*^<$D7GW+N"XF8DSYD-NXM^ R-V
M/EJ]2&/YP=1KT (A5305LB,+)K;;'9<D"!M$\$ID.RP(973VT"8TSY@9G52P
M@1T['YI>0S63Q19'O&S%U H[YUH +1O(0EIT% T9V]UL^/'Z9ZS_;86\0>$[
MGXO^O/C\>7YV42KRM%PTF_U(I[EA$XF-6:4]2%G9V_8J0=1& V) 3=7&Z'OO
M$@_ ><:$Z*6$#039_ESU]-/LKT^XI,W'=,7)2$Q=J"HF,%IH2#8E$*4J;;,3
MA1X+)WWX#<]1W?U$ND'3.Q]]OF,U$6]#%Z>S%Z$_E,GKUO:^HA-@9(D\S$#@
M";/S+A8;^Q?"N0/C.7*AD] WQ%OM?,K9EJ/%Z35 /@AC6M*""[PU&5YU(&0>
M(/KHH[;6..K?WN@FAF=,@9W$O4'_.Q]*OF_Q[Z=4?L7E*6]$JS<YGW\^7Y][
M_<*"S_.SF=$VE1P%4) M%1K9;"GMEC\6*L@K6;"]K]$?1_6,.=)9)1M8L_/)
MXS5(:P>G)3_Q5M=2[+[2[Z=Y\9G^6*Q6?]+9V_H!_YZY'%)6S/(B)5N^0?$J
M9RU"0B12J# .:YXU[GYD#,1GS*<IE;6!7+MW=[AS8<Q\)^7(E5;"''GX"ELF
MG8"BHA5$VD;J?1UR%\4SILB.(M_ @MU/,Q\)(I@E86)MV7=H)+$)[2)@J@0A
M^8 ^F&Q\;TX\AND9,Z2K.C;P9>NSSL<E<5FY002L6K.?A::M:BR!%*QC5UM:
M)=&WB((A=-DIZV[_%5*FY,84HC_JXB@N,HE=.Y\1R,:6%;PFBJA!B%1K]B'J
M88=D3Z@X2G?]#BF*,D;.^ZN',0352RN*,DI3PPIC;"/F_9$@>1<2U0+:"<G^
M%J-+/K8"QY0\^N*K&I2-=F3*WZ8HR@2Z'R/=/11%J=I68ZE"M-HQ'+00,82F
M*N$M[YA%]*B!>\Q%449IY)&B*&/$>6^>>O?*&=<WME\6["JW!D^[U\UXZ+&=
MJF8,1GZK9H;-*LNB@BU(IMJ,@5)I,0FA:,V[]6S0&SIU_?QA@F9TO@5HME6$
MVKF#A40B0JT^5)UCD33(0A_EY-]&T?$\G:? V^7Z#65]UON.ENL;H9E!7:HM
M@1VD*%O#5=M*L1M06;&+S6NGU+T/5 ? .D WM=TX\,#9>A?13U JXQK$-9[5
MF_.S3XOE_'^IS(PMWE"Q0-$K,)3:E2!Z")YJ+45X'7NG*ST YSFQ82=13U$B
MXS:TWU>K<X9%.06#+H 5S%"3>:1)A0REFBR5Y#6[>R>2>Z \/^UO(>()REO<
M@?7V_&QUAJ=E?OIQEM@(\I59J2+R>*W+D$PLD(/0HA0TW@QJ.K:+^J_A>7X<
MV%;8$Y2XN!D*<.]VI;.L& /[5+FN^^)I%D06$(M3*2NM8^Y=)F<8LB=/C@D4
MT+,FQD:4=_:QG)W1(K(;Y15;,])XB$HR6/+)^\0\-KW3SAY&],QHL9/ )RB5
ML0G=Y<;&3ERR(E$[OV\]3GE/0TL22+&+3J'%$_>NDG0_FF=)@RT$/4&EBTW(
MKN]KO@K/5JT$KTIK3AP,H,$*3@F4GJQVW?-^'H'T+,FPK<@GJ'9Q]S+&%)T#
M+TRIG<K:"M$(A,!K%U:-.6#OPX7]7F].I.4=Q'C4=Y9(6B@;>8$J-H/1-0"B
M=N#1$+L_*-.PLDE/Y,ZRASH']6T8(=8]]FT8@.JE75&.TM3 O@U;B'F/?1M(
M2QV- 5U:;H$)!9+6%6JVK4%)8*MU4"[7D2E_J[X-_74_1KI[N*)40E,N!H%B
MJ\24HH*8B@3I#)LC060<UM[V"5]1CM+((U>48\39NV_#U8[U5Z937,X7:P9'
MJV6H.8,WK9%$+@Z2;9?LB:IQHEHC!YESC[5NV/3R)[YW[R[0CB? %XVF+G#\
M\W3UA?*ZE,@EA8> ZKAOWPMD_]MV!R4MII)PY^7[?G".M$Y)"4BUE-:@N[8#
M1@,IQI!R5I1LCT5\SVI_8,/>E];'"':"B[[OPUS7#GI;UP<(ZZ'Z5B#388 <
M0F5/E1Q@%88-DY252REDU3LAYEXP3WB9[ROH">YYKN.YY.001&/6^C'7?7?0
M['?![ZRNV_=]?60]Q87_763$*Y-LU:*4,A':Y7/K)UQ!64O16E<G:("Q)^W?
ML^[O7?EC1'R 1EW?Y;"H&S+R>G;N&O:FWJV\MAC?K3A%3T;+4CTZAT;JFG+%
M' W[8%E[H?2&WE[#7MHAT^C[B][6BV??3:F17A<K9&L9KDHKC5R8?X'WMU)2
M-4&9(#MEBPR%M'NR^%<Z/:<?G:<P\JZ<@@0**H.I$J$5]VY#M$I*6<.PQH*C
M4L-O8CA0SEUG_=_- =]!TA,$+OY^^I56ZZHU%Z/]_?2,EOS)F]/RR_SKG&52
M9I*-[(#9@J"DV-@VC,Z8#-J[$@H)S*9W_.X 6,^3'[WU,8'1<T7AF<@ENNH=
M0\#6,%,E"*[&EAY&):)*=5@6Q1:+Q/-4_E:2G22:<;4N8O7KWU_:L'\L5L(7
MX4K,C*;A:@XX"H,@M5>U\'?%]P]EWHSE>3*@B^0G<'??LON/K:#9%;"9S J3
M0 0;6WV;:!U#TX)]1.FT"5F4W'ORWP'Q/#FPFZPG"%:\VH,N\<Q4<EGIQ+M.
M:/5PDV$XI01PGC>E1#6A[FT<WH+P/!6_BYPG"$J\O1;-7$"CLVY1D:W,94NQ
M2+4&T"+)Y(PKJ'O;@;<Q/$_%[R3I"6(1?]0.^HWE<5'*\IP7I,N5B<?]$]7%
M\M+Y_H!_T^H?\]/%<G[V[9J]>O,I%]5$_D%GGQ;EAY&[FF5II<^I@,96\0IM
MNQNH"-4D84OK%]/=I-CC\)XG7X^5'Q,$87X?PN7<_(E.68EG,R5J%5I*B$PO
M,(X7Z*1%!*L,BT]48W :VMZ!\IPIMIO<>S8H._TT:TQ=U!O!)3/GO'>1M^@L
M>&#&,J:(+O%JK<@:U"CRD JZ&Q[]S-3:07X3- H;M 2MZ^==';ZLWBY_F;-/
M-D_G:[',*$8>>'; 7ABO3ZW(<\S"0FJYIK*JE$WOW,[=43\S<AU&FU/T)F-T
M/T8Q:^6BE;(&6A=6%D;)D%(*8+V(60IV_W3O9G4W #Q/FFPOXRF:APVJW"F%
MR9J=?>"=KX6[Z,JT=!I,B!Y]+@KM)$T]CK.VZM3G+[TU,D6+L WXOF/325?"
M(,#+UK6J70U$$174(*PL&B/6_G[ZO7">)TEZR;]GU[#[QK\!ZT5DED_,X:P8
M8U&>@;:@Z';A$%S!$K-"IWJ$)X[!M-<:FA-Q9%(]''5.6CN(CI0D^^F!OYC:
M^ISD"LI%6U-2/"L&E>Y](CEITRIZ2+;:&('O+U%I"*J7EJTV2E/#,I:V$?,>
M2> 3>H$)=&DKIT@"DN6%U%=>.M%72Y/EIQY;MMH4NA\AW3UDJQD5&5#24+4E
M,"V>"7EK!$\FV.I:#XM!#LH3SE8;I9%'LM7&B'-_!36OQV#BZM-O)XM_KSJ$
MLS[TV$ZQJX.1WPI4E2&KI#7F')*I*D>AJ%1!JA6%R3;/!KVA>T%-:5$8[Q&L
MBIEM"=^HE@+(I*/S"@MV+RC6OZ FNTM-4N^6BW865W[Z]D\VHGX__1[]\":?
MS;]>K*%703#:V52S9T^*HFB+:8:0D6=)5"*R+$(VO6OAC$=Y%&51QC!DP_G8
ME(J9((AU..)9C5Y7S 19&4;J0X34UM@@(R_07E-0O9N+#$?W@J@S2A$3!+'>
M@_3BHF SR;,/I<1*$*MOF[)IG32\@6"B]4;J($SOL*?Q*)\KA7HI9H)HV7?X
M;7VS]&'QV_EI:1W#SVCY^8\%GO)'[VG=GXN-O#7K,:CLBPMLV 4#)L:6M^H3
M>">MK=X%DKW;,8^ ]^3),Y4J)BD4NLA$Y3*"YN2$<I/TV_HP:)^3+DTXDK("
MDVUATHL R;3N;=$&7DA[\V<;H$^?29.K9XJJHM_I_R;_S_E\23^=KU@:JQ5=
M7%RUA?7R-V6&KA"*EFGDHP?CVH+I7092P;*#(TV2O2.8QN![^@R:2AF3U!^]
MSO;3'P$1[8,WM<Y/YBR;=EGN&$Y.S&H56RH_4ULF"6B=2\%E[TKOZ@8#H3U]
MNDR@@IZAP:>?9C_CE_D9GN3KZ,X6J_.TFI<Y+ML"F(.KR6.+5L\(AG0&-)9Y
M3)AC,8:<O77HNS$>[O$W/5U]]Q?D!&&OU]GXRWQM>I^=+^EM_;&(S4(N0LH<
MH$1L6?V:1^]SJ\ O4#B4AEV\"1>#>V ]76),)/J>4;"C?;194KGR/ZVPNDVM
MJK)L5Q\20J#DL#A1A]T"3>(T/WFN3*2("2)M[T'ZV_P43_-FM]YYBM+D"AJ5
M9@=-:L :%% 1B#&J&NJ@,@N[4^<!E,^50KT4,T60[)5E_=MB^9Z^G"_S)US1
M.NKBJBW(C+3"$)CC632)J*1:9?\,P<J@<ZTRA*F<F_M1/7FN=!;\%.&TUW?/
M5MB_=;F[B="*4J.S$ERUK<Z_9'"&*K@2(V;M(N^I$YHM&T$]?69T%?L4 ;-7
MW+T6_#^KCJJV@GB(I9E13%84H0!*IYS50<O:.[Y^ XRGK_P=1=LS!G83(7FM
M^HZP49*6>8XG[_ ++6?%L5WD38&DB,VB7$6[-DA0M8@Q&>M,?PH,@_;T:3&!
M"C90I4,OIDUK5SOH_4#+S[]0.IM1ME:7X &C8F_<L2Q2X,5+.!L528=&37GL
MOAG5LR)(!\%OX,;.!Z/7>7L#F# .1<O+S[48,(D$8/82E/,"*ZD2;>^+O/NP
M/'D>=!'R!NUWZ,FT>06[=NOS;0TT5](!50*2F-I=HH'D^3M;HI!56>'%E.O#
M0]B>/#LF4<(&MG0],[WF*:W3R3:XTXS7!A$,H]0NM)).JK&[0HR6DFGQ5+%[
M+, XB,^*.[U5LH%"4QVL;H*J*-263M**GS/;=6!'.Q>"7*1UWAF!J?>2,QS=
MDR?.1(K8P)F=3U8;SO9/RW?_BB>-XN^IY;1G7AW7E\RGY>8'U_[R'2WG+3T^
M+PE7] M=_#__?')>UA7(\B<\_4CO6;B_UDJM7JET7F?'(TV.]V3" A%K@6RB
MK,%BE+&WP[3?$3YY[AXQ(39$W^U\&GPYHEOC>,/S=[G\QI#7?7]GF=@"D"2A
M5.M9H P5I7"0DY#.1%WY\PEH^RBP9\&VON+?0)+="_4/0IFHI!(U ;6"$(9$
MAMA0VN0<ZIR*HR,@R18I).=?OERD_^+)57;*[Z=UL?R\KM;U_6*'LM?&J,HP
ML157,JWL'%M#H;3(DJ@JE=YE)@9">_+39 H5;)@H.Y^;7M5G>X?SPD;0+/B6
MHT@54N"!&U4D!)$K9*F*\D4EZ?K7.;L!X0"JGT)7]]3ZW$;.$Z1#7*O4=X6(
M:GNMB RF%<;)AO=UMG,A9YVIN)*U[KT8WD7Q7)6_D[0GR&&XU;+)D'*D H\&
MB7@CC(6_<^U'AF-,44'U/IHXFE[3.ZWRVXOQJ.MZA,KZBN@ K73,SH"07,[
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M7Z=MS[U,;-W>7MH>(W@$JOA[*TJO;(W_"KFBI?2C&!7[D<K>B*N&:[+&=-
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M"9W 1:PBL<ST'E9WL1UQF2A=3FP;-F3ATCSI"YJY8#S]K3H_YE)B7S@+J[K
MR3\0&?4^=MO.?(N\MM:;(F*/+Z7!O(R-%>>,,>('NB8S= 6GAFW$I_3U@/A:
MP/(OR.>=!7E<GG&:259Y]9YS],YLSOR=_(+QQG,.&#+T%M$QG_X'*X?SKFOW
MYVV+A+@-7 1M"ST]2V<[N\B+R%J;2 $5?)JL^HQO\>Z[.\7+_T ,3AJ?+IH?
MR"]1D_ [A+-XM=?*W40??SQ'9_#;4NRU1+&1&<421459Y2<E7>(H^V'A,J0
M&8R?(QS@I:+KRC#1[\!<+<*% V/"1V&#=57LHUG;%>+,7RTM^Z2D,I-&,V11
M)*,#DK=S:U$84J[2EP:X7#-QQ(*DO, WAZ\0(W%?MY"U%S!+\AR/;LYU+'^H
MJ]!>O'CCF]S Q?[VGWU'*DMTT0^*0*@2]3X3\3><E@>'S[12ON=92V[\<#J=
MPG+Q%/P\/4O<1Z?X??P2A']L206<9/EV=DQ&/JVVN@WAA_),_Y=:^N\82-K,
M_P!02P,$%     @ D(M85ND.DC?.U@( M0L$ !,   !U;F@M,C R,C$R,S%?
M9S(N:G!G[+MW5%-=ORZZ:-*-=*E! 4$1D8ZT@$@3$5#I2E1 NA&0H@2"H%0!
M 0$%(1:*TB*]$WJST'L-H'1($#"0=I;OWO?><=_O'>=\^YP_SUXCD\$866NN
M^6O/[WG6FJ&-T^:!8Y<-30P!.O"X3'<9 &A3@#[ 0$__YP,>C."'B86)B9&1
MB8V9^0@+!QL'!SL;.SOG4>YCG$>YCK*S'^,_QL7#R\?'QP$1.,[/>YR;EX_W
MSR1T#. UC$RL3$RLO)SLG+S_Y8/6#'"Q,"^PHACH3@+T7'0,7'2T=@ * '1,
M='\=P'\>=/3@&H\PL["RL8,G5!X#Z.D8&.@9&?ZL&OPV!/P>8.1BXCZAH'>$
MQ_(.\TD?7L4G2>]8)"Z6MO!=&\!+*MWU#6=EXQ<X+B@D=4I:YO099155-?4+
M&OJ7# R-C$TN7[]A96UC:V?OY.QRS]7-W</OH7] 8-"CQQ%/GT5&1<?$)J>\
M3$U+?_4ZX_V'G-R\_(^?"LK**RJKJFMJZUK;VCLZN[I[>@>'AD=&Q\8G)G$+
MBTL_?BZOK*X1=G[M[NW_)AX<_K&+#F"@^W^.?[2+"[2+GI&1@9'YCUUT](%_
M3N!B9#JA<(1;SY+YC@_/2<4G++P7D]Z5MK!**%W#\]WU'6#CEU3&21'^F/:7
M9?^>8>'_6Y;]OX;]?W9- AP,=&#P&+@ &$"Y_CY6!OCO\=_CO\=_C_\>_X51
MBQ8AF^&CVD352/H=5)D!LH)SZ,9DY6Y [^R7QLC%C0L8E3)*C0Z=A]"3LKB%
MY6?\MP.V,BV-/WSW:8]_!LL"@I_QF1N//J0!Q]P_>PC=VJO*O:.Q%;OVW27M
M-'-!73++H5"M+A.OC=(B.B:;B^B41P/<@NK;#V&19^O-"N%&7L4;]>/W==HR
M@-6/&,ZX_24BG<JO2?F./K88"^=R#[;2_97E']K!4+B^8ST.R^?6I#BX.$R&
M%=EZ9GBA?7^9U9E&.ZRL&(,+\1@PN$O,[YP5Q6N_L0F5'*O 0B:_2:>*'.8N
M!71OAP=$!@!OZ!]H<P+>EHXH&L#)BB^GQL(C:  ^Q),&=,G6EC95#6\4;Y_=
M.EE?41-_+W*!&2(2W7:FMRV<13Q<7;R?<=?JEOF-\H&'I$S*Q2UV=G:W2?>M
MDAS;A1A>E]>OH]F I90.'QB^'\T.6\DEPF@ \RB6[!NF31_;C>]ZK@P5=M]$
MX6805\>*K/79;[D'^DRWBP"7^2\:SA\7\5]Z/'JNGI")HP'/]NQV&UV[=(0'
M531]&4<#)QL;E(Q>'+]O^,!0CSFI/Q;8<,. DT<^)=K1  /Y%AI U*FD 8NI
MKN;$'_@YZUJ'8&BT#G]##:*>LZG2:RLT3,>-H?I]DJU&Y#5!XVZ)=[EOZ6/[
MQAKT<HD.)N@;HY6RVA)7JB?O-6*SQ".U/EO6CH<I&C-(?Z*OC5=;3&^+][2H
M^CQ$%0^R/SQ<,XAD=_#VF#1Q"5"_864C]2H98$C1%6WDM=1EXEL&/?DWVQ.)
M;N;/T+O7R% :$+$.IU[0%7MBX".$ZI*/$JKLG1HGZ^(K?[0]C)VSKTKJ4U^!
M:G<$E':7=98\%SWN8G=53^Q]F*B!HON'ZD@3%_]8F>'R[B4F*P;)Y,=LN#M$
M"KYUP3E6/IK*E69W_(QAQN:G>W<? /17S8# "LN;-"!>1SS("?<]V1_&1XPS
MQ<^^4:*F%CH:>0MVW;X99O[Y9Y@&FVPK"E>'==VN#DFA\L\](\]MAU0\"E&B
MEF]1&X/6'2MQ4-$@Q,*1=$H^#G7,/51RJ-J;="\I6'38KM.G254"%@_<MS3@
M!2QMJ6<(:4_FO4^976_/^)F)HZCJ./ZZ49\PR7=8_P)FOV-(J0T%C!ZGY8/E
M<Z5$[8C FM/V2%<O1)1U=X^7;NNAC?8\-CJ;GYB4"Q8'T;P]PSS&2_U;9TJP
M:"_'OM3Q>1+T\HH;\+Y\;_O8JB/?H.N(2N/5/J,AN?V#L>I?.<>Z:L-+EGUY
M75[1I?2(!Y:@](@]\U ^CW[WQ_()6FI%'GY;.T5%*IZ/?J9XI'E_3#!I9GQS
M-"P#V)!Y7]Z@MV FW?KXQF1>;8&=VZ2SU*7JC&>M>FSW3]CXU0+.+XZ82\8"
M ^]KX1QD&[Q1O I//C&X4^-(?:B$8N8MI1OA"Q9A80X>%]09$T(Z_&\ ?WG#
MX!$-2,2ZR4?"V1'<0QVS,/QR%,)A:W)-Z(W"E1!RV53I=L+BZ)^R(*".4B>A
M] U6_GQ5F02G5HR/[(%/ATZN",?F\WE6MF6,6*/LA-S6R8;JA" IDW=)^CE)
MGUU<),3#-2)TN2T-?*DRQ/QY+,,:US@QL>/PZ),0R8L/JT94U.5RW'K.B,A^
MEC*Q%EQ-U7E)-_R/%2_S#T7TDFZ%UP;ZENR,A\16NBDW\G2)"8^J:,;/FJ5&
M%B.T!KVO?:OD^B)R)OF!.I ],FY!9\#;XV+L]$C2/T&9Z?7XO(RHB<Y+X%!6
MFLK]#4*-T$!1F8RHRJA6NW<TH-_5G 8T?Z0!G6$J'PM&-5+S\H5-7/TYIST"
MTL-UYZ%7(D:+^ND,G(/0G4*0\(=[6 )_=;Z;JISXL_N5IC6;[\_IG6"XP.##
M=E4#'R++;D0<P_]JM\]JRLP-^M6FD?WAP=2)BO)1N1]IUKLW;"31MV48*OX"
M^!I!F!OD67_W0 ]!HE5F[7)95;T'B\1'B:_%Q:8+KD^5$9 )S\FHV I3T:/$
M9Y7#6_['G:IJ)+D9?=/8VI\YM6@QK.J*2OW;U0T&GZPLW=IW>#H40@-:]C T
M0*0$VT:5'$3:Y>H7N#W.32O/NV)K\"A_6A+?-&A55<=]E$5\'J_WEE-(I@C%
M0VS3PU_-3J>>'-V=H>]8.E8\^BE0M,+L!.-3CB7Z=ED1__E#BR,=?-U!J$6!
ML :[@K;<E5 U_,_R3U^/=[CFKXW^^DK2NS<9O?0&,&F>9[@5 O!:A>A;5 XJ
MDS+7UU]Y%7G?=5^NK7EA)&+Y\>SWC:M\NHS)08 -Y!^R@Z%?YI]Q%F5$_#(/
MX;K%[BT+HO3PE@F@[UHX]74I.X)M:?_MT<Y8&1!@_PS9Y\0GA _-,#:G^ :7
M13/FUI_F>^X%:PH.#>BMPO-R1#9@8P7#UX_RAH=1I9H<-"%Q.GR>:2&QZ4(O
M']QWZC_]XB,LJKHX6*YX6&UTX*;#%]&.A@*Q"W=O=Z\9ZC$^T!-=H;>7*1$B
M+5:WW3IWN-#[>P'ZS%M>;LGM7C7:H<KDI+^DHF)Z]VT]1C$]7KKI 8N)68<U
MU0>W)LU%1XH(1:7F[%$F7)%6J5&,Q_08_;^9@1#>W$/219Z+-$PPCQ'C,KIF
ME5HY9:$GJB?F$IC4G6)89MB[TJQ8]B8<<I$3T(C%(72TD,I#&.F*>F(,SM3A
MHZ1;;KCW_0DQM>N1UM<.P%F9\V3-6VD KY;P8MR$%_G"P@Q[NX"/T;()(G?-
M8KH[YH4:GZ$DQPNE(4D+9G,#OB]!F0O5X4B>CW)1T<@[;]W4-H^_]O;7OLKN
M?IE;]W9)\_P+P\</W!@^O:_Y]QK3+;5H+9,<HOGES!MC*J9RPE>>?DS[95%C
M?,*L_<Q6H#A',M"SE*0KI&PC@=M^+L9 "/@D]OI=T%1;W6BN^#U3;9AU^*-7
M,E^._95+BY7^PX"EG<XI0L"S^49U#[$3HQ44MN;NDP+V6<,!! 'Q%_5OGB33
M+6K'NQ!=%[#A6NX?LV!MLPK]*E,$P9>3JQDY MQ/&>FG+'N:)?VV9!@*WA>L
M912GQ3C);7UXA+CCRL^1+G"MR"?/F.%L.UT/ Z$H7GY!^IE*_4I1Q3:/V^_?
MR4M&"$\4;[(.G31;D<D\#]&"6=^ ]P_\@,-/3(:8.]_',&?DL@ 3<'.$-B0K
M*#JL9;Q4'=1R?O$'"'V+E(;$#ZT2V9"Z>&PB_X\&E04SB793CQM7'V822YXZ
ME%>CTKKN!U0IC3$/AJFM% AM8?."X)=!=N O; :R ^#;HQ"--HY')PR7[P(]
MXKZ/DVX&_DN9OX7HOF^@ 50A'IPKA1?+3 /F#\=H0(+E/Q=7R?4V%#\2LBAG
M2M)LHRKBJ?4?O11#TLU&Q&O2W=:FN'J:NY=%U[IBFR2#3)O+'3H6X+PK36)I
M.%-]L<*/^EZ#,NI2EYXK'C$RMP=65DJN]BTL/_&7.TH#["H(^5$E%2%:[V<]
MCJU]UFXL]:5GE814LDK2)2N:60U2U<@7QE1DO6%FA#]DBYV4SJ7GZ5DT97JV
MY/&9@MJSYF]YZ:;^ZF0W0QL)*<TZ?"/Y@WL8D2"$T?#\U,\)^-HHWDSL!T=]
MTC37"SU!41:5_'SB=IM]=>0R@3,Q^F'A##U38+I5=6.LJ>V(SH&[OC?= U^3
MQ4;@_L!_J0NA:4#;1>19&O ^?1X$5:@]#2#TSN'SV\W9@@@E-FV.T@/D2Z/O
MKBR:8&-7.NHU P^\ I8]G;0?A,@PO/L/Y(\W_5,G A:UGX=!-F3?>3AJ&!GL
MD.4Q>>&NO[JSBRN3+5BD2598W#L=?M2 *1Y%A12CB#^ Q_\^FU,4_% 3"4Z7
M=II7T?@IWU_=.=;&/][N=7C!\S2G,.9B$"IV('RA8"8P-O"$^+@4D:_CBW,W
M:^D=7(87TFQ[M-E.2$*]G(]ZFC=C*_I:$3'5 ^-$AP6U2/_&B[JY9XO]U>/;
M7/-.GCV.]O*9#=-6C#T368]9S188S!]1R3(<,AZ2:U9RA%_]W"9F_!_<520[
MQX+I4+:/!OS-+N@_<?-?H-/_9I=]DS"Q?!XEZ &?F(42TJ/V9O3OI&S4W?_$
MU%YO9#V></6(D?JVKN@M7AN%A<181PZ\]FZ HP2(##A2CP2/5-.G3_K>$ITF
M=*WU]#9GVK05(;G PUUKYF=@#.!=<;ZS0H1320M2E6>D-<S(-A?E)J:P7YRJ
M-1T$UR-6'79!E#D<BU;&<D[*C6(^V:T&%"THJ&RLLO&#$//JR1N&KM("D-<A
MU19,JRH'M?1RU](O1^ISIF[XJ5OHRE7:OG$&J=A_\M+_X*8R?[AIB([F-M=Z
MQOTG3I+O&6M'SBU6Q>>(?];]KGOV8FG7S=.[)?!_*5L+YK?_+)10;2@N+=G%
M4U.@6.%Q.UR\_<:]FG!3Y&C^DA-(%3AYK=5BM=S![QC&.X(7M .OX"EORAXI
M3'ND)TT9;H$<1A-P -[X-RO3E?\C6_CP[Z_DXQ#2Y:VGF CB&"@'O??#2WMD
M/=+&?'H\N+4.GKLPE@AX.B\_%]E]RQG[?Y --@_A\7 (TJC 8;7./%%+J<!#
MC;-*6%/N[JQ[KI<K6^Q22MCCH\-T$P.VLS(@\I A3GS;T7LS2FW[OCU+73X%
MH.80K@7IRP:=%[W/&# BSXZ\B@],D)>JP,_%*<..W=*'9DH*.>9R?GGOS-EA
M&<,@R8&VU!55X;6&Q#:$X!+IC;RE8Y!&.<1'YTS/<A;,&7A(R<:W7'FNYB2A
M#LJ'1@._)CYB/ XFVN,'C6RP_!#T;#.\8CW7X]C,\0A7]SO"HK4MG2&<]@2C
MYQ40AE7"7%#BS:&'[()2QZ2^_Z%6WB>8PH_XTMWE2]# F><"7O\UJJR- Y4+
M'R'%&T\#8BI"?#Y?59XBEAQEOKZCL%L2&<8F"^T04^S7@N1WA2QH^YGUGW5^
MJ9NND3L=,%#QE)]%L)LIVEI]_9E.*AJ'B@UE)S22TW1$"*$1F-DNP=>;%8U7
MV5_SG]<]9W7\1:V+X&JRMAO#Q_>QG02C>"W8?/!Q#-*H9#4;6IYF?DHS_MJ.
MIMM,MZ2XZVWVVSP)-4?"5-U* ENQ7 W2B[7GG/!CL<J(8XV?K;,>%E\4_G#,
M:_.LA%.UNGK?NY+8,#:9]_]WC ,&*ILHZ4'^!GJ^7ENB+7SVU\*Y1F&5YWXE
MQ WO3JN2'/B"9M.-ZVWG[_H>^W1(Q6;U3=& !9>^#O/)]06==\J;*E59GWK>
M3WPBE;9Y7%&'W^W>WO,-[F=6P$$ \AU*>9/4K2S%.5MBQ$*,;O(.=6?1=ZK3
M9-(YPY"5VY\MYTDG;P &3L@G<^?O1^(143]&;-JL-0[U!9--S00L3+9NT/LR
MNKK[/7ES:L%7X;M!:!ZJ18W*N3K'@G+N8]+BC^,O7C"]-+8GG%63[%IC0: /
MX980>K)A?LUS]1"@^L#N)4Z6=]& ,E3BB6$D+.3!PU+U6S9M@5=;)PD,P$IW
MZ-(K1E9@.G_8Q7SW!#Y_P3J.$(?KBVKPQ*W:WX(Z5)C6:#4SY 4Y/X!P% D:
M;]P8Z\4*P>9349RA%Y /1D/%UPY_EN8XK,W>K+;7B7[1C'E0P/?CER!T>YZ?
M3N^L[;(<_ J9ARB+0TW\QFVFAY.A3"--S^[MF/(&IIL_P&7%79ANG^>7Q#U0
M-.DZ%:;C10/"GX?.1.W;X+_E1R)/+TTCC<;$E1PJNL6T5:>D0OM[@US/%G&9
M"UK+M6XBNLS9B6H+F$UOPKD%[3-C]J!_27US-Z?[%))2_>('OTDPQ1S197I]
MXP'SG5L"FY4$U?6%L<WK!(E;-8^$CN\]JEB_Y)>5MO]MR1#83$WT8:B'%H=^
M0[5<H#*ZHQEA+GTL%=;N8HT+#NJ5,]:K*=S=O]X&?7 :9EET-FNDXWA<^A;R
MU72.*(G8Y/'\D#F^ZWUT9]$=L4'TCWY*INMT\'H$V]['L.+1B3IRH5THWG,\
MYG6C6JP+<:PW'%?3Z3Z8-!^$F[$>N#R/2'JAQ\BGS8DRV3L@T0"F:"(DE]@V
M?Q;*O;G)#>,*NOKS>%Z]@?"/TFP]KOC&BU\DO6J_3S?I$-Y"WL+NHB>'+E-*
M=+CSL"(*[DW20[>\5;Z=4;S<<H&Q*"8;^0DX6[L:>3,Y!YT)FZ]"[^@VL-,
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MA:)DTPS%6\,FH%3^L387X@=<O;Q21Q-/-:*ZBXW\N\Y-"KW6G_P=-J%X].J
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M@7U_0M^F[$+F]E$BLUG4C1&OH@RJ6WY]PO39$X.*4SFW66=.$L8R?L.)#VG
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M(AKL\)'0,- T,P0?D5_**M,$?_1MNE>6V.JF<S*NJS1U"791=J<-A$H\G"H
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M3>#)I<Y@X$%103H-?P7%WT0<\(5RH\:V<L'(;*[O4K'G8?,U<SMGR*"DPLR
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M%IL7QKAM,55Q-$R8!E))[AN/RNH6Z88/WM7T3YKT9P8.&EG6=,Z]7+?P%_Y
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M.@QTR-QC."(';S<U?'AFZV)_Y%&5D&78*WXT)!2Q)F@"\<?PHF4\MB%[V!(
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MZUF)B$0SKK O>1].[2Q2AF,8B"#0YU S/'30,%IV[+KZ.^)<EF.[R@5H%O!
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MIXASQ#6KAI;6R7H(W_G"AAKM_8<CC!/B%R59,_U$<F_9%6''T"N$J<D#06B
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M7VPOJ@+J$U=H3FQ#C"LE,O?W"=VGWII<@/2]O?'>MNR<I+J#1CM/A/^:R)J
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M =BVH-\)(']^=J/2:8$(UJF;N3*-F;AN/UW,Z-2>/,\71-=W3^_LRG<_S2B
M-ZQ>BOQ.+@Y&N+X).S:X#$W_WZH*TX==E!D.>IY+8VU/"U,&/M&RWPNGQ\C-
M-/F[C\'1.T*S>I.O#EK,?2Y%#S%$L5R@@WP!C +6YHR9?L^2N0JHCPT(62>
M:EK;<%H-VHW##]^CQ--X0-&2D-)2[!N/2O<"8H1P.C)K=.';B[HQQA[OL-X
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M!^X@).LB-[XO?)D-;$A\L+SU57%'SG9JAYQ2!G[$D)HN2&J!A &<A9_5,#;
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MX)HA\2B7T]WKHG3J0T=MH.O%;;C_2GB?O@C'-K5<BLP'7!&JC3:?V TW%V2
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MFWX9,0<:W<-UZ7VR]84H"VMW^#+H%(B':9E3ZK3XR29X,)F[VP1'*"@=Q)X
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M[/T"E</I1FM<*]AH9VF8D9CV&[N 2.?)4";\J<ASC+C8TOCHVV.+,-/?6UF
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M3B(YA)97Z4$,;?\"]8K\P"=4>%X^FI5X,3'8*]OSON?J[BL0]@"44$%[B_2
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M:I(SQO:VHI".N!"(D&^>1V.;2K-9"4@HQ^Q:\B!O8G?M;L;O;(05->KP=>(
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M"[9%C(M@CO':>!RCY+HQ,*R7+8YB/@!)0UY6>=,YSIQ"E\/M :&B&5S/@ZK
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M-2MCUI<P7CM2 *K?C1W8("+8U(Q. )"[-J7=%S*_+RCX>OA\S?B8_<K4Y^]
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M?;QOPT[E)T:-X&9O3-UEAS)E2-NRZKM9'E7OYQ/KYJPQ6(XVFJ$U8>YE4&[
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MO?B(^=*3^5KPC/@H%2^IHJ.,XD^SDX+D:"H^; 0Z]QQ991R:/PJ7G3..WO?
M2U2*R7Z%3O&G<T[K#01]G!!S>& &!,.&WP;UDSBH'9G0M< YY]7["$4,WZKN
M)477VWH5T"3AI-:"Y!/I=JF]7 9=S.AK@W_7Z_\!F"U]G3U,B,1)DMSAOOAV
MS''J*3_!*_AL2ZWA-37)$@,G8*N8-UN@JW<WQ"4DQ7PQ$Z PO&FF*>M(A#-J
M^RE&"(K_F$J6^M??Z=:8I3=WB1_P/PM(W"L85K@.!"=)D&[G_C9?>'ID6SVP
MO=^+_<7;''^CBE=#DMT\/ZZ] COUBXP3,'A+Z=7E=T,(=E"[>[93?)1\M=F^
MQ!CH<!:\)[3)TN H)G7Y)N-*1'FQ$U5X6$Y1UI(Z=GVX> P^YILJ<_YJ<]&:
M)MUT)KBZX$CF39Q+;.VOLOC%7POC]'ZQ^4;XJ,\D V3V$_P,C)C'9=9:;[R6
M1[)&3&>F-5<O],X8&P^^(G>OD^^K6DQU<I@>29$S$WMMGF8,40Q*Q.M1F;;P
M&9]9W ,78F>TY^4^ULFRMD^8,Q!CE&8Q^#-,*J0F'0#^:AX-GLG 29/TG$T?
MP9@;U25"A+)E4<^VQT;<0R%[RQ>D70^ H%MJ#S):D7A#S"24&/)]8:SYC%^\
M%YVRO/>\C<&.NO;]I1_QQX,/ ._\ZP%F:\9A9 XL)K)>QA+Z;%M6N:W^-NQ)
MOV&UH5_(SF0P*VFG^ L FF$YR)R[<^A@<BR*]ULA_,J(Z9'T?3LGQSK?8ZW:
M"#8QNF78 S]^;&(X0F YML!/K^V$<411VI6]RW>>^V";IAX))G[J41S^T[;X
MOYB_D>=/ G<F*1T 7[2AC]'["[G(98'2-\T7X' \Q]H!@,TK\=MJ3P]@RV/8
M/)56:VU=)E1T7LY6>W@]+&YQ[BDL%G&.4M5\TJ^?F (6%)&9:KY7]29&#5M8
MZ? V):'NGK?2/&5RS A[G/KP]).VN',MXG1$1F(PI42#'_%UWPG5216/P)C8
M8]S?6'!H4!>&743)N0> _Y=2TIV]5X0,*G,E(7"AL_H 8,IH0;+;^-D*=I[7
M(C(94:N]H!.3;^VZUV+,?0(F*2C:-#%91!E,^R ?0[WD%[&DG;!N7&7\ML5#
M;L?JC;^$TWB%KC&ERBWWF>*^,]Z=& #ZDJ"_4!,YA_'%$2&"4A8E#XQVS00V
M9+YE(/SW7H2,,P/D&P34FC3!M V*#_-KF*=,C1LL(/G&?RFT>,+==ERF^635
MBGRE3IH&?_V6VBU0.NX>C"[W;96?Z!2PQT>&X_HJ3V"K<<;\9NN>H5>+H+XY
M\^=B<;:_3T*3/@"2S#[+D\X&0*EABD%I?]X _A1_W?Z/8!9&'8'4(-L2)XRO
M*H"H6R3?J(>)01F1%XEFC77;#X^WFRR!&+JP^*X8@(@SO5,QL#WU2OM68^WP
MFJR=4T%]?=J#&'&ZTZ_&@W/9\[/-?H[AG&A6C1@DGR?VL\%Y(F21=XXGP'AF
M.XV>,[XFJ3DR/!1^599]F"X,)N?7-I^!XZ1=?85 P!-#"@R=L?JGS:C=E3ZQ
M!L-C4)G:I\FD+KHD*_&YO4>7>/<Y21+(%@4-840?YL%8HV8RN-5E@DMZS#^0
M6&&!IJA^?J+ 80"136)>6]:$L,$Y?RM\LBNELE$7?4Q#UKD^(W+;>5[<U=AF
M1NZM/^1FF>;XYD++GJ'K3::S12JEN50!\C$P@W04,0#C? ?:X"5(\^ZAU<Y&
M&F,&(Z<)PM5%@T4>A3<L9HY'^[_<;+@)SZ,3]-RWH$D+Y ' 9D4R0 [F/H:
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M>2)75<J,>;<AA7KI)L];C_;D)#7!4&G(F[\.);4)-Y[OX''F,7E_.QY@_L@
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MBUX$K66+;.%!L/:PRZK!%MX[],]F;G[1Z1JP+-WZ",$OHI^AMM7]VJC[U0?
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M7!O6IXFHTHXD[ & %1U+>YBB#.F@]YM@9_>X[=[2\A1F/,!("Z, ="[M &!
ML%"R;HX60>;EH^S:!+\%\4SFL1,F6=]!5PM>Z-G![D]9:3NZ\_ 1Q(]=?2T6
MH\C\/O<>P @<FGS[)IA9BL;9YM?O+9>5+MC"K-L<'0]GI,_/:PEYOE^QB/XL
M\K/9 FRA!=U+(",^L;\6QJL<MZ,/DCB>V?&'07<PTARV=4G)RYH0L]MFRN<F
MIGK4VS_0<WYP3-%E_ICW07R;%Z00+E!9CA.TY_E>4V+Q!2U*.<(IBWL>AA==
M/Z[(!0H,2,5!B-<,=DJN]1.5*>5(Y^6QFP3BZP_+F2Y%XG<))6^(@Y+(E!ZZ
MBXY37TPV-"%OD3SHN5P40.6*SON...54_Y;L#[DW<'3$008:_D+[%&1WPGF1
M(P:&MWJEP9N.P7:U%<:^H[)IMX^=.@VQ\C/D@N)HP\)6^NP P%_%,"TCC+K:
M.416,LEYK$1+X7J+*QR[UQ-_7DCT.$:17NU_ABF7_+P1]H8?O]06+V#;]F7E
MQ'-=ZJ+R;GAEA@-T?2[ 4Q.244@R0TS!JMF16-;*L6*OK+ VT%B')/O1L79*
MV%!^0=9F"/U[F*IJ.PW;OR/$_#)[#5]LB<^>'CL]4@JH>_[8BS$>U8)5?7Q]
M&SC'"##O[1)+0!A!>R&2+#9+AR^I=<5"(^O+,ZA<N">S=I1WKF-NLO>NWSNJ
M=<]*\C7CCR_=A_8L\+74HPNNA-@%ACPLF@'L<Z<%G#;[TBBR)UMP3<6%D/2J
M\B.8?L3LPRMQZ9.Z,ZMX#J+#<*,\WKT%5277-/<6+,13?C34$(PC?;]D6-I[
M3JL]V)_673E]YXY@\B:C^)PP@3KL1X>%16IPDU4K\8YAVW477;DZ)W)K:Q-'
MPC)\5OK:4[X^,1#/W#(>1\V)-)!4: E6LFV#UWHY(/V#H_ITJL';'O&:OHJ^
M38 U.0^2%GS)]M.J)A^5"7X*I"OT4]4CP-K<Z4 E5Q$J;^;P[8JA>PIERQ')
MJ5]9\X_=2="B%Q(:J]%FMFI/OAHKI/_ZSK%[4D( XWV8C)\DT8'@N[9*TM+Y
M2#[]J1P6+G*F+@7&!6I0[80LKY..\ONH, I&,=O1"87L^KQH_OA_66S("A/P
MD]<$P["K38SMDXH)Z#<S@&392/&HGWU+]VESSB1-T1WZPY=*GR%4::%/B'H<
M7'9$@]X?;>$:WZU^\CWA:QJ>WND<<S]_844H9,)YFRL&V,,0S4#)]]1.5*5B
M9TBQLZ_MQ?HAG9^EIRQTO_*X8(C.M^VRX>'!GAG)_P=[[QG59-BTBSXTH[0
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M$RP9RH44H&RV+K9-ZY-_%28$]'40#T9]G*B7G!%--.[\N?;&]34QXMSZV!Y
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MKL=D>VX?#1[4Z"8M=Z)-]T%IP;2;KXRY[X?.B![NV"BSMU(1.M8\YMUSF2^
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M=>]Q^-5A+N4=E<RA%Y-Y@F'->##R#+FKK787'%,M!VUKT(<\ZKU:9^O4&Z0
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MSP^J5ON\2=W/GQ*W=A+Q_=%[NAB#)^5I?"L$)%*H%)1^ )+NZ#E:_>I(E]$
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MH W/9AW@N"::#1S_I'R*'=J#.RT]_X1D&#,7F.$A /-]/EX,7X>??8WE"]G
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MHZ 9PJ!.:Y?>6-P1-[L*EG")K:731'UR[PPCO'A[+1%@6.T!<7+,&AR?/T'
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M^[^?2?U7L/]\?%;JVO7?I=7&LM@0^>X(H:,6<YJ:A3<GS\Q_;P5!:]:PK3W
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M,IXE*4TS,#"*3RTK(Z\DI1TT+^J(VTAV_D?YSUSU)",//%)2IECH?61RN'!
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M*EDEL$"[/5H*RM'-08L%8_4&+?*):W4GLD:VV]+.7O$;-5TU '\LYW7>K:N
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MW>2[VJJJ>\N[+FV<QX6DKB_PKQFIHY=E]L+1,T;'35A/OF*@\O=>>$6^IXC
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M,(O5J(;*9,.!)HK-2Z)SWCL7W7S]I1'#:G%(3]T%R,VKL&<(358.Q,,=<-&
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MR*W=!CP5]#?8@)2MH(@ES);D4PH.C&?.M<5EU\1ZI$AS_+ZCS:X 7SJ*X\V
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MBB=,&+[2=UD'*0W/_0S)N_*A(^?8M)O;7^/81 ?3(?*3._>]>=A6(I#"36#
M\?S0:L+;%6-P]N7Q[:AX"DMSJJ\5C5\9W6A@.Q;1-U]M\5G(YH=<*:CVQQ+T
M-B8=PH^Y#9F5Z'<\CTE?TT&S^Y\W^E58#B29-?AGO:JWE1P5%D /*TQZ^QB"
MU?W.\<*4_L X8@/+YN$EDSM]. =<B5BF[_>UVV<4FI+3DI\.O1@66T!UV#D>
MK3QWTXIN0+8=0IRE.-)E7<#)35*!,!I?-(J*0(F@-)IR9,.>G/']>5KE#K@L
MZ2#CJ[!&^'@L9"QRZ"4<-E"T507/M9!I2OXPQ.?MLXP]O0S L?\FG[W)N/\I
MGQT.Y+.R9 BI12)[LNOX=XPW,F-/TMX*22X<$GY_B5D?96@0^5.]:Q^D?M=H
MT\V-R48QJNGKT4O5\?.]8#4DGU'UF?.:B8=&TJX=)\Y8^<# #C'2=8J?RKM^
M%( 90>O#DF-#9M=4]7"HRQ3L">8<"M+AW1$ %>ZP%?RT4VC3J7LFFN\6?Y)D
MV-Y>4<\(7;T,[DB(73A)0?9A3^"MPZMJ,E/>4@E>E9ZWU%5NBXH577TB^ZOG
M,)GG^=:"$%!-YK7-A:[AXV<JJMJ%G%]2^BE\^Z#C0<)TE$DK&]8%M*$:,^""
M25>_5=QO+#L1WNSS93@\1/5K.DYQY\'MC9@=G8:R998T^WZEJ!9#K/1>#O)]
M.:N$0"Y5>TAU(-\'_@FR)PZMPEX"YGTMD\@&[,/P&AOZ95S!3I=29XO5M<S&
M,Y_K\PN-X*;=@U'G:O/Z4$TBJU9!T&=(FF[ Y/2N;?Y]]0L>^KSRGS.6#I:;
M0,[[(4XQBK<<'JW'"E%$^L>\=M)#B!(&2@VK=3,-T?L@"( K_8UJ@JPN$TR#
M5S'3YP>I!-<?'W"&ON'1$OR/713CT39]V6AD!5V?YL#LKKG[D"4\)*Q!(H/E
MA*>*=Y;^YM9_0F&%5CPD&568FV:M\X%E<$6S5N3\+UM0HVEATI>:EZ#;D;+E
MH-C"EZRY=$T;?*011G[('$:!.\X=N]G4:%%KH_'B$X\D"2>W-[F&HPN/$_,:
M,3YDQ0>G.(UA16JHX(H0S27R8%SU7^11YABD[N<$M_0S(CB%:D>*'E)]('PS
M=%DN,*ED/O!W-J<[_%+_C'LMAF 99NUJ\URCY;MV1(K?;;$SL_+9,IN/[\69
M@A#&:+JP%C4!]S)\O$-Q<7[TL8>5U"GJQ?.+DO-GQ?8B7MD"IUO6O-^92PUG
MIP3=:O&,GT2(O!@E6RBJN"[WK,$:)^PXB>MTW<(U7+6[MH.'.$7PBUK$I<#%
MBS_AV,_\[<<3L/K+5]%#V8!2!(:W7QLKW?_&1 Z0YC5;'^WZ^)K)@?%_4PH>
M*)B$+KZ<V1C0SQZJ [>5.O<$1.^X5^_FV.Z#DEFJ_ @85UZDW@+_JU 8JK$/
M>E"U,,&W/8/WM^OJ%F#=0QCK'K!T3?4U"OKBT3(TO%5TZD$6C7CHHSE[3O-R
M/)UFS\H_<YAFX99[<AC*)94\ME]64<3IU[(9GFD%BEGGAA&CHQ<@Z0=OKA",
ME]M3'JJ7!A""6?(G'T3.#/](&RJYX.JSO)[5]-*+=<05H.;4 !4K"=?E4-Q)
MY&Q_HH2]T_V!A!.BJ;*ZTY0E/WK '?:G,+/&9_S($,*&]EMO;&WH*=)V+8K5
MFD3QF3(?&DEE7 W?'DQX*<:_K6>=@WN/GIA18M]T934U\20@+BLRRY2')_Y@
MHV$;G$V.KE=$LOZ==_#OTW2QY.L+\)8AO6L<V+_K*L2+1ERTT] :1"*K <><
M6->61OK2K)D!\%<[$1I+?[J#5L9O!^+P1LIOQJ&+^= &!Q2SO;O%):%;K VG
MGBJ+^:2Y3:]>.2B/7J/,Y-ZA&?BMBH.3Q24?L%3JUDO5;NR8^5VC-D>OU\S/
ML".-,AA/P'+QJ93)(1A@OB9^1;HL*J..OO)=J?1HL!402)#BO[C<)30:MLUS
M3+7V!=\EO]_&-R1YEI7^PP+1?XLSRVW>)>F>1[)0_D<RG_#6*P?Z3;*TF>D-
M$-M6]0U*82;2/_@12W7J];\()>!6"4=1GN6_[26LD42?NF-%8Y/W$'YW2#W.
MMV'71(^7"(6<W,A^B.=?-Q:GNY&A"8:^M)MTNVRB2'J62E812S:,E_GX_*,Y
M^RCBU2?%CR^BKIU;C >/7:ZN]"^(-D)/OU.5J6]9V(C2I;SS[YQJ;P8-.C][
M6O(C-QK7CX.)&Y]##)P?3HR]T]D,5)+3_A""D 3CL=7DKI>O&XZ]"9:QX?'-
MR!Q"=0T_@ ;YM^57-%7,! B+:'A,S??GS<YU$T@%NG:?__0EOCYF(F52RJM]
M0'!O2'FYC<<:^>"*:E\&5KB<[FGM>'8K ]G]-,%#@H2=7:$B@-!?M=44\TMM
M189)')FR ;:M2/#>^:ZC\"71]330WJ$T.H6R1!>N)/@\K#<GV'+!\P9$>$?_
M=E3S1NQI^$,V,QR_&1NR!LU8K",N(P=NV^LA0>[@XQ9T4VG9X1[R47FT.^C'
M3KV?1C\_A@Q S\*H1>/$<;I\"-'JB^YGH_64,/CJ2*ZM>D3.FXRLY^>SC*+0
M(^N 8G /.G,?Q&4()MX&1HD&F0XD^[:4. .KSHEO948IWT,THEK.[FY"/M9^
M-JR/KBOE0\\<9_*4D],780^;D'S.?54 ;D#\=G902%"Y6=U,S[W,II>YQ(MG
M30X?%_^4>#:*$R(.?&'RJE-2!UU>-TMSD'U3M[AJ'V9-*J3$V3!<&05S#Y=F
M/Z%;.TP/UA<"W,3U-)>AS.U,L'T7ZD9K[L:2!7,L5^*X=FIHJQ/UHV9_L^'P
M!\6,$(]]$)FT6!F/..82A^KQX!\U/%NA<?Q3Q=30B?HWR[\L.';![8)^[)1V
M)T",%H"82?G> ?,DBH6%%V(S#2THR\)7-0YS"T\\^-0CHSEHP[T:.-TE@NP1
M"/YU=B[6%,@,OH/9&+<E#[]]@BKO[[FP#\*889R42L%/NXZSYJ0N$T27S5WX
M,]YS%4B__J!:[271TGKSKV32S^:3AZ7OUR7M.8XW_A=8-???\9\3EZ)\C[[T
M-ZKY:F74\7O4ZGA&=37?,?.7'!6OXJ%'D7[H*11)?36\%K[N2):++,+T,ERM
MVQO:)NY<_NHU+D\C+YB9F5PXL1L?]#GEB,V%:4"$ID@/9S1KHY,+F+K\!'R2
MM%B=A?;L!\/6C.;V0F3.,?D%YXL)OUJG#B6>/P*M8QJ2S7(HRCW1N.1P0'S%
M=%)5KKXC6<YOFAA^IEOSL3GG&VUL:A?[*$NF*IJ24:DU"^/_C*X5C'WCEO<7
MD_6(;Q"TG2@"X<:VOKB+7&D<7_5TC5&VN+; Y7C.8O1B5085Q 9[!B4[!$^W
M$(,'L6DEW!.QO(O#5OV3NM'*LW.VM](<]/G^]MA8+!T69UQX%:^/3=F+&\PC
MK_=.ZCUNZIQOS@_D&\%<#T^^='KGL "L&-F\LZI.,>_#-,HAI9@<%_9*RG16
MH_,'7_@VK#E$ON%8SH'\+-#G^5F85W#S^EO2MG0:B.[7RBB&!D!G]T'$R00D
M)<:LC1R<&O9QH*.P</)BCVK-3I),XAQ]G970X1GW-'LN".W9TBP17XH4A[*G
M!]<)[M5#KTR"@NZVJ=!XY9\T+W*=6VGQFPKY-GGN5V<OZ_37R=E)R"#T='$/
M4P8P)61S!12*<[S5_M-2%)X&,X<\;9?+7?@1<BP<1 =DGL?7%-$4F=S%-/ *
MI($S=1LM!)^721]DRJ08A'CQ/H(VU%Q?U]!"?[X=.>-T^HQA8X\A;NZZ'=L-
MG>#=(RQ4PK%T\8BUZ^N5GA]VG)LBA!<(:_FM1XUQES>MQ.'6E^P>SYD_:;/\
M\4]K\Z-YO2^2UP:OL[>>C3@,LF#P L,4*/5^ POA[P*%W2Q,[KCJKU =JH *
M"?6J0I"<,!]$"M:T&V3C;]]CDZOXR8,Y/:.\'HB=@BT>84RT'(^5)P\5*PL'
MJWTT^V"<ULI.%OJ%:@2O7B(KF@#6-7]<@OND> ;W\!\U;(./RZHMD^Q'VQ/-
M21<@RLR%?9!4%SO=G#STH+#G/#VZ<M#5U4][Q=W5 DZL%QY3RHH)I#V[W$_6
M-$RZ2VJLFV]RWOR%)%L$6C;B9[6NU[<5B-6J=AC$W1USG2OOOW(M,'Q7SNQV
M>#?A2;[,(6ZAO;N8][!5:MJ)6 7R+]"0[@\45@='UV8\8PK1)7$*D[%"B]8B
M?47O1B1\.^I;>$\_?'R90U]&L,I"ZIZ1$ONXWZLT4'FU7QL"<WLR^D5R<YE?
MOW!+>[)W1LY(_DW3>^([JT/DI $V3%.7,*#+F,K[95TZ\XSMW"?^GS^.)WPT
MJAYGP;;Z=Z@W_H$X+J41 \;':I%KOJ67/^//+%X^N]JL*?G1:Q?A/G2D;B+>
MQ@+-23&G"\*H$12AB<U9/_&6U)EKKCZ%U9<%+/4-'&!GV=9&?!/&NCZ^BC?F
M'M\'+69 V>]L)[<5NU#*&:7\Q1*99G,G%2N_%OR9DGZ&E<P;^W# >,BF4%"@
M>!AGM['V9(?.FS+F#LU;=D(FWPAT];ALS,]4T2%]].B>$CMEZ, G4(Y^I07/
MR";M@[CQ^Z#(M2^A024Q:UE70K (^ YZ!#(52/7!(;VA\?R+PS#GADD=6CHM
M\[*S*E^F_^'<,Z>&Q+P=E X'].=+-H3 S%@T,E-:[<!SZV4)!T6W,EP>G]&D
M&YB"U+,HD:"9[[9J7&Q/?#G?N^IVM/0FZ9M/':,5H4\W2YS\!7TTN7"2!OU+
M_XDR:<HZ-_%XH(Z/R\:8TN,CFVN-^,LZ<2)&J".$YH/XO ^:+CN0U8-)0KLY
MJKZ=.+/R$^]T&Y0>6Y[YRY9Z>$ELZ)*S.)1^@D;-'WW(3C3P,,V]$EEDFO'A
MX]#"V;]T-F83;:W*7_C\S[SI/PX.>\EE#%K,FP*G62G-=UPZ2ZPG7$<.[/\*
MNP[8+W[Y9/GIV9;$5<5K",!ZWG)](1ZJL 4%E$76U+TJ!MX,E_^._E8R?>K/
MBLF3?VC&^R#L\=*]1<J:N^Y!B?@F ,6!7PMF@U_>26I?-?LSJVCH%5;OE67<
M07-<:4F-%2*P^ASN@.]S44CW+(='+P@GJJI]FY=ML9B5?V+&<=9*P_"^I6)-
M; (Q&Y"#K-*(O,6/:E1CS0GK^L\>1'M4/\DV>G(E]YZ!+S03%%VY.DX+B=5@
ME&MW\N"L<*MA> G83-2.M%")%_7I[1L*%J//KELW'IJVB<AXK#_T8:5$;LQ0
M*UAR;_"M=[F)[!U+]5I!(9_!>[P">?%P*OIQUV%DCS)3E,X.?'@-IUVF@!\U
MQ<R?_)'[&7NMA%VP75;&5Z,_^;U8ZZ*OV!:+ZP>CI_2N,>KNTA7?^!MK9/>U
M1$O:=P<%U\P$1CF8F2WH/KXZ."=]U.R\UV,.H(_)TTX6Z4&<^T[7BHRIG;<N
MG_OD;\0H*))K\I>5=Y,-YNL^*WO/3?*VX-E *TO6"'V#&':I&%7/]AU_D1;?
M$BU/_K'W)/F)UP=%(;("AD7C8,!L1;7Q"S1<S^F"IJ#!RL/7BF*#TJ!.. V?
M'X--@BZF=XDBD]Y#A(%4!]BCQ#$"GB:\)S^.&(D4/;9;L/K3\0>?V=R+J8/O
M/?[_JD4PZS"40X']<Z4+NX72/0K?!Y4\[ C%E8='!Z^%DPT<NIL!S.+]KTR7
MUR4R39G366</-<:7="8C1%8P[VW7N FSCVY] &R)I[_>]5+UNJLVD3,GFG[(
M:$BHFBQ!Y0 :*.G$_-1D'20G4-P='5;W276AO<9/1,#$YY7>;16YC9W@<"[0
M'7I_?$01B+$\BE"#B_3GF0OGD&S! ;D?F2[FWE4]6EK[H+ CH7G8RRN!N\N,
M!NBMM5"J#@6<JEJ[W4R1+ZBY.SY0[3IE].[JYRR3!X)KA>R!X9)GT:\Z%%G#
M\AWE6VKY,O5\8=^\B(/P^W>JYS E^CX\+R]IL1[D4Y+<COZB'>>JMQ 1R87Q
M:S760GPY2W=SY>Z0EQK,BXF1TY.98^34?*WZ>Y:S*+[?Z9X>WSVP$* ?2G.+
M#6EK+8@$AD@#49+M7'3+*/%$&QNAVVSF[T%')]@8BJ,PK$@?<L:>^AS()P[K
M]3(%@7R2>[!'&YCJ>F)2SE]A@^0O&KN><E(@B_O34*A[:G_V3""U!^"O<7*!
MSPXBE,@+9>&\;JZS 1Z7GLE^ND;C>3]XGTWVS;GE"Y#.1L?-*0SY&G3&TNDL
M4(Y\'#J<^0RRI]"5RGB^#PK$SIH/+6B3LQI"&-5$<&J+X\?@;:MU7E=7?XB7
MI>[<QYVZV5>O!JL5G"Q[+IZU&  A!J_"5-R0/790'RO_'\E,A9?PJ9<:OZ/S
MWLJ04EQO<>UP<A2L4#> .$I@K[3J&),#7H$=V <=7]M*+^Z4N-3VOJTI\&VN
M9K=9PY!H?OR1YM.?9J="+T#LK\*2I0T9&,P=3,K>$X<%-5P3BG-N_FW1PK@S
M.3F_V#"F[LEQ%PYOSHS-\9K0 \.;F<A_&=YH8YAFI6#\'V4RWI)1CKP;+ (W
M!,:O?#=T1!*B3A6LT'S&+S711+,T>QT7WM^Y<3$+?$'W.4GH!VN<]%Q ^J4_
M*C$#T&@.KUQ9OU$DZ!@;8,>Y96V*8#&<'I;$"T!G0@21@6@N/_&=_F%;QS$=
M2)/$O(%+F[_G"^$%2Y[!!YYN)_C:0W9L[R3M8-<.+ J/D-=78]"_7?B7DK?!
M)P+/E[_M$G#]UCS2=W0C_IF8JXJSZT_>;C&YV[?9_^SMXJDD8-F?G$[U M+?
M+D?//Y>6<]=_]^YEUMJ1S];:CX([10Q:S'^M+P\N!&[Z4JM84[XVX&"#C+MC
M=Q$TX6_L<>F7*HB(2LZ'?&.6/*T*"J:)T/SN/O[^B!_A).:!0CI+CZ/$4*.R
MB<TYM<L+UI/%X4C/TK@2GZXV/Y<; FR-2O[B)]\GFARMB(=:0'W5,_ -ZZM]
M- ,XM!=-,>^9W'%P"7#[XQ]4;6+47UB;:%5P._/9CLBM0SG/E:[N!"ZJ"\=Z
M $:T"[]A$L;R]$L4-!72SXA>.]Y=%!81:6_]VM4Y/_"FA]*TK.9C@4>RHKZ2
M3;&>!# (*"1R/BP=,=0J#7!AMFAX2J,J73HVFT<+#4X<3Y;,FPI'UR%OXP$%
M2+_Z0];0>>=(K$QJPG #'.?D"S:6E](FE_%?C*^997ZH=WNK?P4D*GA4B?VW
M ZMS/L2>H:1V!P;STB^1@Q\9FM;^B=8?;Z*Y6JB.??/G\Y8+SZG@:\=^._OL
M6MQU'Q3]> N31W\Q^'"L1C8!W5_C$,2![ZN[/&/3&==VO;5)"ZPV7Z#C(RB3
MEW%(]_2/H*5NZ%WTE&,?I@$U" 8/E:_8PY$$S$,5Q0(I6WO'=MV6"(K6I[L1
M_%]O]\<8N5P\?UIV#.H- >3BT(.V#[HD*;BL6/<J $F[*QO)D>GI*YH?E([X
M<TFY ;P@<Y3C&SNZ$X0HA[>3])+IBN3(:T QM>\=W 9K%>1^M_&QHMZQPW-\
M3N?T10<MV T?L^D RS179(\]/9#R=\AZS)#W: VYW:(YRN.ONX%3<%. 1.*#
MHY37/CIV$"6QI."E4O2T;2J2FZY''B*DY)'W01;UF[%:E<YQ":K!#U'##Y,Z
M+%L]6^[>R;CYU] K[>4B:GJ'D-T7DQ!""$[M$AM12[HK<AZ1=]C>ET%NQ[B
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MQ@.RC?X<-$%DZ\>)CH=REO=2)UNT:K4UOMBR3L%5S6,<3C *8G25^$O(W H
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M^Z=?G:_<=NY7\F!3$L[)N-,.=,O$-&/F]6CY+$5>#O?&IR<@Q(C8I+WOY4Q
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M["WVQ[P/$VTD3G_9)NH'$Z*9LYL4?RV3B7C?69QCT_?9QJR7S>U9+[>2O "
M=&1T8:LJLZF!X<YV8"Y9GRC_L<Q:_@U%R-L_]$CK[<?I+1'?10[(H'@ESDK-
M#T/T&:/R/"3E+MB<]EKGHN"1;<3QUS]Q4<4V6H,N7B&.R!'^E(C#\-/R[3%<
MDIBJ.@BHB.I.YUMSF&K1Z9T)9FDW_10QDB_RV1WE%-&X3,X,Q:"9@91I*S(?
M@[OT]0+L1V:X$)%C 1(_UGL6(V-?JW-OWK6\5B;:?D1!H6AF__[/RYE6P(,^
MFK@$XS*=":S?K&;83$-94)@%I[*<R-;TM##8GJF[VQ_J#>3G/.R&!14Z ^Y;
MZIYJN5"9JYV;>P,SDW>Q)%/I)O6V(&^\EQ+B:^0$JFIEO3R,JD!3GFR5BR >
M0UBI4AJU*T_AZ[0)[!UP\:&2.:4(CA5HSS@+K!72\W&&:@S>J#='ND=[%<F]
M)>*4FV6. W>+//XH11M:B.VQ#)IS?TO\-D4%K!RQDOW4<O?<:-5-29<+W&=_
M"?GM1E**6)9LLH"P QLQX>/M;6?&=WRTUOJPK6._([V[S_3/E?@LI^M>O_WY
MX-O>H$R]R,:'J%L?'3JQ5;\^D$36>J]/A^%*"QP<+?<+.T=D*95P>%UNXG0N
MJ P+EBP2>L9R6?'J[[*6G)]LOQVU@[A3:$S@T*[],'C*@1;3)O"WY)@S$S"I
MQ92@;J)G0JD4=1:*6]EH.]5(MJ8IH6_-+CO6-SZAH.J\=4/G/PS+/YO;M$4N
MH*KE_FP\]\6_#6AU@A/<"2NMH;[K-U:&M[L5W 4_!"VC77Y1B@0PX-$_M.=J
MG8M[6TU,8*QY;?7&MM!L+GYYD<4LV[$\-*.F2<6I-R/X3'%LFBCO8(NO4O^Y
M/LG%M-*2!U$ \AJJP\^(8W&@+-R4N/#"9WMU+9 >5VXAV?\P&V?I?>O'@L>[
M#T4G8LMY62@9/#J],8Y'B2/$2)M=PY)@EC5I)<7@C%]+,%_9Y9R1Q1OF<='=
MO\[E.E(.7?ZEKP.8G*6^[D&*CK:&$.9-C<F"S_W?_VAY=$&F7*;_T9-+";7'
M_W1P50-I9D@XXB9+.\=^Z/56&#*!+I2<-6'-R:5J3.N#>YBL$S3DZ/7KO/K[
MKQN]?S#"584<E=99=\5G3]/LE_+5.!? >(;%G>])N*"PMZY?+UJ*'^C]5O,9
M26:[$'$8>_8O*=]"(-F80*5>+B/#Q0$+.C"X8XGO?G-C"4? _-<S,_%'K=?+
M>>YXJLP(G>YE,]C^8BATB=I%<:?'M8DS/JU1%OE7:_T*E3/53L"%_7X=:3F!
MW.J+%C^B:Z# D;)?E34YO[':/H,:& C78?0<0^W4_,3:H[PB8=7((9:'":1P
MTS \JQ;U#_B=NM5AVHRO6-*5C^:4=O#%*[!RN$^\33+=>G3<4KMV=>B>R_MQ
M2^S=)W>AD2GN]5$AI)5.#-XZH4V"-)&K$KZGG>M?JM7YIN-XO%A*DTN!]YV@
MPATVD 6[.)$D^S\L7^S_X<4=GV=.X0D7:S\T/"THE\Q:__5Z)/: $JI.Z $]
M%E0C3W="I-I$5MUT1W[G'QWSJK6H_',YD<*SCUW)EI^H;9IALM/?KS!EOJ%.
M/16N3"DC'6,I6+7$(K!@J-2O(4#D9Z_-:2?)&-XGT?WMY3?#>,U73C7_ZYZ3
M%VWOR3_0HIKZ%4<*TK7W/OD<Y>F0.G^J^#?CT(@\#4!L4V^ ,<.41GKK[\<(
M7A:O"KWQO=S]Y>J?J\<.+PVFJ80^OXA_Z1$J,'Z3*XFJR."+<S]9R G:AQ_<
M/?W38:36/7KXH)GY-QFD_0[7^M^,^@K)81V-6%#,8UA+@JM$]5/5]X%X%<U;
M\<[A-7.6[#'K/8_Q@9P/?V-Q"11_TN*&/:ELK0.IF.-_:$7U6WQ) %O.IV^F
M)_K9"/%RV4]_7S>(C0$,$A@\,.*0C@O],4TBD'-=X^N/6MCL8N_[,W>80$">
MO</.9YO>KQ0_6B.]BH9Z1;ORKYQ">K>\_,=DF[$CT\%SCG?P@:.? @D-C:&V
M-,NVHQVRPC$:@OZK45P,;O22C"LRTG\X:2\$$__]T-&\SD_PNN$#NKA1<>XS
M#R=GV(?/KHP@6.B=PW\<1;CU(P\;0X/+QQ;Y^OLFRZSM;VXNO/C8]TCFM<,Q
M8Z>5XP /X#10)&3,:L( :N#U[-^,@2>+=E6J?$'AD[ 2!G_KX8[W+ K\TN*+
MA(N:5QC5PKU53A@.M>:0>GO5"YHO1/_J,UZ;(?_X'W/R]ZGRK.!H& S'+5+<
M\[OW4(^]2+FI.XLB\TXEY,?#\*!]'0$_TAX^+5?1/_#S_O8!TZ Z=BRK&;.(
MJR/UPP<1^J0++R(%OM>^.O+M5ZGL94G<+N-2EXS[ZR<RU;8Q;*:C<5%SK#[2
M2:DK#YF .RJNQ95F:Q(<W/O19^7+;PE1B[M%L>/?G@;-E2">DR08W'VW"&C)
M&_[H@ZVN<&(^GY/!:-%JZ*:LSF5!\Q=G,GH,K]F)HC^FQ.[Y_X\KC.QO_[.7
M^/X7R)9:*A.H@77"<?I7Q^%MA\.-( =@OJ.:XM.'M[Y/G4]YT<-G<EC<93EZ
M%LA*\9A^CNJJA'JI[1U%[<(FH;M'V\I>11O9_U<2\6TF0$FF9[!&GD61^CJ"
M?N(:.W?K7?VOYJX_@"0$:&U<VPSQ;VB_>-ODWA4-A_LWXSA"CMC15I;40.7"
M9%(CX:]O%@87S9.ZN@NUP?37OF%&,N,8;W]7F<M-OF&S)U,5#3(/2 3'#7 :
MVW9XT2]]  7P\^9+9HT]^O-ZEDQ \H9OU^7:II87WY*^&'YV>IF8Z#@?F^%D
M?':O(82A0%,E]?581O%"#OJB<4$^#^K;/I1B<$<2!CY&5\?#YFM^S371*K)U
MEZ4!VJ<$RBE0AZJ.@+$"J<-26 P3(!P&0XC^0VV2X..]DHVW-<];'/WX^ >D
MY8V<0J,CE%,7'*;*65.OF?[,R03"OR6DD(JR_==BD#*1BX5+A1!VI-!W!)B8
M[UU_/<%2GOCO7_">CB$<\F7M^'C)$\8*,<>1\B#D"NB-CQ+JS-.?MRCY07DR
MZZSUN\OELKO)P^:9Y0(D>]'?@HE?%O][#;UFR 51U5&C9UA,@/&."0QH_;8_
MR+:%^3<=^?R;KJ/LS0!$^;^O8/VQ?@3EI$F0)#K6"' VG]-@Y#FGA>4Y\Y.9
MN=DDJ=EEK]#;8A><TGFYC%4:7D5K&+AHA9(*ZPR,2'V8J"3X^I\FU]&*X9R%
M:[>>9"\V*BHFT=[2LU#X,C>="2-#LY>TNU-U=/W.W&J+VQZ,X;11S;GVP>IO
M-W5.>+K*!'7F<N"/*_YN:9.A5T+QV0Q!^DN:;>22&K^_-1XN >L_@NVI*NPE
M[VFF'CAA8SI14Z ^<,)"U1ABAKA!1G<81A+FYX>[5;T[<)A'TA*A43;$!:*$
MR\UGNTJ-EP-V:U/N)]&NT),J;.WH;0A^!)_ Q(-S8*;O^N@?*??QW,]>(L),
MX+*&C%&IULX1+$U8ABCC9Z(,)A*>K>O<-[CK8M#T>^O30W3@[S\.ZY'4?2"$
M<CYMTZ;Z [I'7OUC<G_3-.:E8Y)9P3/\8]%OQP]9#)X1X1I* =C^WD.R+Q#&
M$,7$D2]Z,-JE ^>,-4*C2H=,U!I"N:/6UM SC9UH'H8BL@,I1:IHU7,K(93/
MRYH0+:][\C=^/G//"QJA)++//HV;3\HV^LW'9,I3>AX-0K5!Z.9VNIV*MS/+
MVM#62WW)%^1^EH/G0(8)/L,NAMNH27';MAM&.@^3F_N9^2:.+-/5N >GU>9?
M:RC$N:]?XXA&+=JQD<U[%_EG:*(L[@'C"5?N)8/HKH>X;K\6EY7!UOJ3-1$:
M&@27\A/[YYZJRIO[T?^NY:O/ABM:@8I$Y;%ZJI5IWXV<ERMK-_R^*=?&&)34
M9!NTW'I!Z]F]?]SEFY4IR9G!/4!BV;5>X!KM(EE@,^6W?KEW_+$=_)0XY7*7
M_.T#G\<N?K1K$YTZXXI:O\\RH+YQE)=0RH.^-"UK$;6DPMD;0H)EG2-:+1>+
M+936,J6MBHLZ5&*<@8R#[-OHI:E<WTI4QZ7Z(?VK#6E;G=M$#O$_XMO'/')T
M6E*=).6+8DSD?U-UW*DR-)[Q;QIF)%3'J9Y08A0O[MJNGG"AWO2@O#:K/TY^
M;:KTLE-(->5N?7U_WU9+02S]*<ZV-LXBTUKE\W905J-,PY]5V$L[MFP"EO='
MH<#8N!6)D5[ZX\$]D4'O-[B2UA/6-L( I,1OU P0 ]FI4BQ+/&\ 8?E!K15&
MK.'?PS K"1U0\(A;.2F7DC':=FR(+#YL$VL]>73B2EZ>;>\7)1&!_,_%_/"U
MM FV/0CL(8ID*[1[D:M;Z%];XU<;OF"C5+:G*:_^U5ILG?F&,%$M,8<)'%C?
MN:CE4!LR7C)6Z)7>7Q_/GBOR5O=TSFKO>FB1 !8\6?IHDV9"/;[:DEU@,R28
M0+1T'AR*59%5XR?!X53?D_YH"GUM"3XC0Q$'G:AN",/)S9!TZ;4\Z^2=\JFD
M-8OQY4; .=OV8(>;=N![RW>Z/U_4J% B>Y&"HVV'PJVODZ8?!RA.[%A=G]U0
M4SW2[^0>%*/!K;!WP(2+XS[LV8(>J[EJ_BTZB95:D#CL0=LKM?<6S-JJ#U9]
M=7[)8 _:C^A(V:Z.Y \K$M(GKZS'4N41ZN +%!XBB@@DA^83512EK:1G5;O/
MF5_MA&JH>+.1NA26N-):'<:@)#L(3J8'52O4 4]8V$^2?WV_^.L:R<KS:+.\
MS4\9_XMXF^JFW@'(D$O5MW,%-S/.HVM*:2*PKD5.1$@I.-V'5(+)K#T(Z/S>
M91TST>7-\=/$HJ!6//MI:KM<D:R(S+ZV='HE$_# "B"G80)$TO?ZD%-/WLU\
MOE-7X;6@KHB[Y."_[U$JN:IWN?_+I"X'NS&$D]$')5FIL=,0H/DKV@TP>RG0
MVSG_AJBKA;=[Z),^20M729<KA/FYY2-5MEPI!1ZT/JK!7/CM00:O#B$2SGD:
MQ=6UE)!L'J1X47K(.XAO_VVGA\:E2LO?VRI(#C3AP;X]1*ZT/(9<[,O@;<[V
M^% UZMXT--,NT'(T)$5==K\^^<<#AQ AFH@:XX!UNK1:NI%L^)XJ^Z51^'H]
MGYRR355DLVFGXBEYN%88CYPL^NE-(P!_=3^4)L'%. ^)0U-$_ZZG7OM[ J[#
MR Y+$X5U_BRJE3OC @B6THTH+;"Y#Q3UC_0: WV"H<9PS^EPUSK]=[]N6*SG
M+5M]/US)BAZ]B\CZ'RPLTMC^'.H-F_W3!16 AUQ$G,,9?W!2L_G:G958^08M
M[^35OL_UXY6@36-(YB+)/'(M$HK[:5\83O"EZ4;*GKO 'LD5UR]?ZE>]=QS#
MXIIXS+2P*[)//EA#:60 XUAC(;/_.J=G!T>(&!XJC,4GMM1/I\+O&(@MT;6G
MNR1$-3-P/Z=JZ*]&>93,GWX:2,M/6]!_0'<EPRB0"2,E1F_; 5"V32-F8=-$
M_.8:R^7;>#YT-3Z0J''VIA&96L?V'48R,X.0!HU.G%UAB.J_1%.#JC'96'P]
M:BMX09P)5&M,,P%+3/E. D66GLW"[!Z01WN-L1@#,Z'$DK:I[Y,]7\7CORJ$
MJQ)GZSYXI"L4K( M06Z6U"#6H)[]#<%1B;U92S)061SHI2(G(J> LWY3WW$O
MZ^N_")E0X7YUFF%$D5 YDIL5P"5(0O3D/10CR]RUXA8HT16(W^0(CS2.Z!E?
MO1'R,?E*>=W%VXFV=Z7.?OFZ9+AV+QHJ@,*_1W.%6,=#ZNV'4U4).:HR/=6F
M;W%N"OJ*+8DBQU_/TTG7//8NJ?R6H7C1ZY&RC!&TP,['6P96);[RAYU#I!N2
M4<$YVW-7WO)_L.]7$[]GWVLB=]>$?;1-!\'R%!L">'TL-[AXR=7ZTK/=)RTO
MLG"?V?@TU29E/;9'8DPX1(2^H].P^,</EA_4#>.'$V]$]3X;?D:8#BA.\ID>
M+53]M/P@SF6/%]B XE_!2#86-!Y,>%@GF@/A'GBJMO1K_??Z<M]5@?G*?4\M
M+]?4Z.X^1T."R_A_]4.L:+ST(H.H=XSN,)1DVZ'5O$A_DD_NWL;'M'R.C).4
MD>Y-GI"3,[X<D35-,J[ALM/#$( U;U(8$B38XXIZ3"+RN-$9\9KWU3X-XEBO
MVB=/5T1KQ7T/,(%@CC]*(BH[UZEF51,[SJF'?WZ1VOF0'%J?,Y018<UW_'H*
MQJK$0G*G2*@K?7:ZP^@XRX\5($>DER&B2,5%W-SL;%M9H$+@G.WG\P=PY_H\
M+G[H=61/TY"LUL22;&"S:(+..B8$#^$%]Q'WUKK#3L^[KJF]<]O](W_EMO/M
MGR^OZ0@;:;_],EXXN:.3@L6G2C,2R#R_,7&P@Q)=.'BA9[WSMSS].4[=3\5D
MV8&'[=!#"OB=@1\&)JSH>'L\!).P*HL6P< 9BL-O52?_)-:K>.=(*<Q\NNF(
M^+H2=&%;:N;%"^!LD9#CWQU;Q_+A5.6]/D92"R:--3*)#?V+==#42J'%],YA
MR3VM^6KH'C=F%!++!&H%&TEK%)-)(YZ?A2?JIX[F6T[4Y5O=5CF:>#MIU6.N
M16.Y^D(V]K$'<!9SFA['>E?AC?3U2#(?C*RZDEJ!N)+W)I=>H(H?SYOI1?Q8
M7FSJGZ4^Z]4?X8K\6XN5](()I&!OHQ.O/PBP&0Z!PP/?2KZ2.JH2^=;KZ9.O
M)WTVF  ;YM,FJ+RXGD^:HS1,T*R+P-J>EL:$5LO2]P[243D%),R<ZA>""MMA
M]2/<EY=J8]=@K8VA&8NXH<#[(M9P#<U[/8?C'6Q.V\5.' B"/4=+8O$IU:[A
MG4LPT&*I@^"C]'1(\$F9F2*?MN[9I._:BW7R@.=)KNM^P#8D9;$:LIY+A883
MASN1^N @D2[CT-(@<<MF2C\[4>HQ[,Q X[U'&V?[5X>O^/_FHX20[CS$"SUL
MXQE!J+QS63.2J1\_K!?Z,CS_2-/#WITGN7[XC';ZZ XFKFW_WXQ50#!4Z@:8
M11Q.&>]5X1^\NZ?Z2+!J_J*N$6)+[E=^RUM[U31K)8=5CZ!B]?=!9:^.\9:]
M!MA&V(P%7_TO<#W/_\'"WLX$ N&S:6N4&E!?*"90"T3HG'Q0+)T^=[1>A_>\
M[^%UG-2#W1?W<2_ICYF YR!F%D(0^Q/SBV8JE.C9/'5TDG-9^\V\G<'5OEI?
MK^4(IR^HI+:8_\2=:__(/_*/_"/_R#_RC_PC_\@_\H_\(__(_SQ120!'R;F=
M3 !@R/LASY"C5FO' HS9%%VW72Y]55(_>F%7DL0UD0DH(79?_5RL1_7EWZKT
M'2*@HQ>DFV :G5WVU8'.-YX(G9CF[G%/5H2<8C]U43%EA&LZV*&/H0"F4BT8
MGQLV,"!ET 0<(FU-P"=^"_$Y?8ROOW6@=W>H^NCQ:Q<L['7;E;+9M7:80-<F
MY ?D8*M$<3BF<^_IC8;8LO93JG<(!AJ%W(IE50KEQ[]=5, G 3]\_IL,L<J*
MFARJPQ3KO1C?=GJ2IDJTAC !;W^<5=>-!1S*W4]DUP9COY"S7O';QBQ*!C8,
MW[ @K,$E4!W&K;XOW0RJ<7Z%FN*V!AP\8DHOA),RN;GX@S(N1%[E6KN$ZK@&
M]=*5LD-8 =7M\T4_;R*]YI+^",6A91%LY,;+F4R@O4UUC&8-%S?X5MTD<%)W
M]?N%NZMH2C0F10L"'D[O:#[I92DD&?X=1ZH\G$?\^<5G\J,39YFX?$?"%-:(
MH1S.3H321&&4O*I M1L:"T[OP_;N5/ 'BK65>_4)R5;_@AX_T4_.O'O!A%KQ
MKV-* S1E,/D6^3X!'4?S+7EMYH[Q'?$3[EY1E7CV,$FG)=..&NOBW;N)FR.H
MK6\JA3(,R"]RGKSMC[FXTY_]"RYUY>["Y4M?RN[>_;R//!5MB$S:+2<,TP[Z
M4Q @FLBM::721Z$\R.[BB#%T&XL\F)UN)G(IZ;ER--\^"X#=;9)L2<R-1_*!
MD&ODA)00\3&$;FD$RN^CLU.E0<762;]+Y].6)4*D^'HCB-%Z+2I##&[&*$J0
M"?AL2%R;1,J!J0@S]]*O?,[OC :" D8OVIWF/)HJ&2-T57W".]8%W2LT%XE'
MM\,DL7&(D"7/4:V=&/V<6E<-RO)[^(OBNM,M,4'CNJM]AZ,-QY(^P0[Z6A&"
MB.I1$(I4+6.$ZMMO7;N^;3#L$O"]]34>NX$FA5'BR78,63"*N$(6K(7[3(_-
M569%WA$1\SSW[7O<0<276*F!X8-L&T^OF0$>8&V/'NPA3>4]F.7<0A5/?CUK
M]1;FL@M7SN*X5I=I-,&9SUM,,%&6W>?_J8V7,8OF0OFDB[F&PPF;*5""PE1%
M /IJWAQ58VLN@$\IJ/97WD';^!SUZ/O;P>UGI^CO4<M32 W4S//W3&"5?W+7
MX?_>\/>&;$U/S(7MN;H;0^HUKTNDMH80%N,9LBW3-/N*&1!E5L_^I6W"V_&V
M"VF_XY8%GFW @'?W!1/ E\%J;?PNC#-$/\1;48TF6E0WLW\/9Q5$$J.-ZE\U
M+P*T\Z3A'B@_#DSNU-M(?UQGB?X=UH+H//]EO]U2]JTGV0'"7WF_&9U%CJ$%
MH5YTZ*6/8#(1"IH'AEBXR>@:==T/^=X".-[F_IJR3V^IXF_E4#SC%+VYC0N$
MM.L)I83 Y6]TO?8?D7FA>AT7VO(A1??<6F#M$%^SXQU/=L4*2Y(M!0>J44W\
MDU^%J_0V_&E94]1;#0O=ON%RUB6KVM-,Y*9 ]Z';^RUZ!0'#+TD!F2>OU7[@
M,)/R<H_F>H=YUAK(!#A5Z2\,^"JLBQ<0)LE7/S:&IL'6\_GRFYX\[*"O!SV;
MRT"N20-[R"2"D3 BF"31AQ9JJ\=##CJ".9W:/.KU7DXWW4<L1:/)6;'1/\\D
MX<@KW6K\-#72T/!CA'/E#!AFUL $G"+?7JZ^P//C-30B[>RUS$AV8SD!L2T#
M)D"RA\^6R0P?082$:$:P;PC_")O3W?Q\J&DO=$EK1Z<3FX+D!><)U1A0HCO'
MZ,A88P1<J^"Y#QI8?\(M(',SMK[]K&(2L%Y> ":2^;J8 "]"H@QL[&'I?!8)
M&2.*NKE%:%A].W2S>5:Z5MXQF*LB.&0;\_<>]LN-1 P]5H()F/<8R\';F0!N
MF&"]<>BM7P-,L-6>"?"(3>6*6$5 *"'SF*=I%VV?$XWOF:P69J_97JHZOZ6+
M>USR;*E(-H^6Q@1B(*A^.MF:T9$#V].^1/>=Q"Z+13(!%Q@3,-%D(V!YL7"A
MAV@9@Z!;>-9@@TO_%W/O'=14]+6-!D%ZD=X)"@B*@( T00(J342*TKOTKM(A
M)!0!J1%04%I$JE(B'0$)O8B @! Z"0A(3Q!B)(4;?_/-G?N^]YNY,W?NS'TS
M<_[(3&:???9ZUEK/<_;.6D2O_O!="7M;J+NS;J>!L.$90.O35=9+BAM)3X=4
M#EI/$UORW)Y&1P>S%15U!EQ#\;-SJ4_JV[Z% 6A&+B/I_ITS_Z]G Q=7L79!
M+U;$L1,]J^<CW(R+_4R _7;I6X^R^60W:Q@S1*X96'J^[-)\DUP.B)9.1Z(_
M !LK$TXT_$&8&P4.Q=+S$K\60OYPTHX;YGD;B(3>-I 0K".B5_>16./U\4_M
MH 12I$=H[77A&XN_/!K:7L$Q&5YW?YLV>;Q Q"-=@@C2>3V@!0:T)2P=;%RW
M(R:.8_O1,!1=X8/:#<RW-1*U4-4[_T<I$5S?PWI=<00#\IL@2!VF:_.0;D\>
M=C%L:XOCK.(B,I[PJ5FW3QU(/+G]-R'PT<8]536VVNRGV31$([W(RKWY&L*H
M$X$7/3KQPBYF_.WZ0Y=ZW]D_62\VE ?'A#6O8M7V.8: (-_C=@ .D8%LX>]5
MF)]P_C2I?9'02N'<?W"*VL_%0CU7' Z3HR_O?^_=T?9PC===+X^RC@=[E8+O
M8C-A:U .)ZBW=U1S37BNM=/#@<W>]:N+(O0."9.QVC-_V:AV:SH#9!/1SD0^
M \IK4^=W9X!&KWX%#M(5\G.*<,3_B3C2%5>5C:T<R14+@<G@!A5/K4^_..P
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MB*FP_^N7KG_M,Y(>_&M'<3<(<P:@<.%!)%_8_^,@79WD%%# %V7\V'>227
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MG@&$?1$??;J$?X2P6#MRF] &-+$(Z]_U'\US*0G^_(R&#L!!1XW96] 9[C/
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MR5G:(I#QF\ !9T&G[2Y%M[*A*J=5W_;<GT1=6$CNY(+LQSR.-_W^-7\=0L<
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M>!2/XE$\BD?Q*![%HW@4C^)1/(I'\2@>Q:-X%(_B43SDL?W_FP!02P,$%
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MS\K7JTX#MA)GC-!>\8M8&A_IOH)/[&%]2B]5JZ77"]( ;$3X"UBNI%H9'_B
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M>W,P@7L$FGT?+?US]4RSG8VO.A+-TDK%?O0(2!O$]FZ3P<N:<LR N"=*/NV
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MI\/D&'ZK F 54+95MP;W]9MS!3JM0*L6V.@%=A0#5C/P4[&H2]N4/WM&7;[
MBZ0()IG&.42IHK8J!H$$H1PRRE+.E5 947[MOB?^*HW3++S6$-8J@ET8P X.
M@#^"W>M:+,!U$^G>PF%^V +B]1Y._^5S<V4F_D(-[/LT;\AKQS?I];AODG^$
M\\O9,E2T] MH,&[D]<N9:"^*^P5%Z9F_:T>W1:&O?Q3EC,:9RE&>P3BQU=TC
MC*#USV!D>SY$(D&">RVKGSQ]:OY3+5Q;EMS*YUO,] ER;C-#;SP&YFQW*/SS
M90^I'"HI]LFSQ\U\/:367GKKP8MZ'#JD<1K5N^MOU^J]XJLU6]GM.-+56(\S
M+&@JC"<<*1OC9-SAF$D82\Y0*E*.L5M2V?FQIO81IZ_BIYO G<AV(YCTV4L_
M@[7#"40X! ?^[$<'S^,L(AR((QU'7 JFWY&$&SRG3B7./&&\@PDW59Z<33C>
MTH-I$=H^^5=F'YJU[VY$TTBSS+A%7)C_PSF!A%.;>:,IHTK&622=2?;H,%/C
M5_0*/7VKC;3VA<[ZL,-Q<!U8-0AD Q/J2&AYT&@0U$9BT*/H!>+,LUB<HLOC
M-X_'E&<5>$*2YZ_NF42\6@JE9&FK)+\M'E19%=5ZI3[KU^NR6-CFK>5,4DF2
M/"4PJ9MK,!Q!F@L!49)*REDFM?*J7>PPYM28L\["7RFAZM8.=35R690]"\>[
M8.ZV! V,Y,"$VDG;X+<CKSWJV$H<,'79'9Y0^<P.(XZ;Y.P.P5[FL\>M_<CG
MS;*LRNN%?/?#;J^I<A-E$&/&8ZIBF&180JR9C;T3&@J9<QYIJLP"V8=QC@TT
M-9K9MD@75F+/\(ZC<+J120B0!F:06D3 %A)T0@X2;W$.B4!D<72841GBG++/
M:>'L]?X+M>\&4&6;OV?1ZV(^-S-J4]SI/1-UG_ANT284SF,9P03;_EY*V]1H
MH0PU4&*]$B$2-S_$><BI\4,M-;!B@_\W>Q6!5O2N6%DG?(\%BJ,)SB_MP@,[
M,*>\.*;N"\#PV(ZT& R&L=<:T0^N$^M%QP>-MG;T4VQW'>EYIS^5/WW<3H6E
M++)-8A6".444XH@JR#6CAKQ98AM*9(H[IU,<&V1J=/W\]>Y3K^H4IN?9. 12
M0_MT X/D3J\AP!J)4#M\@%ZN]EBT03#4T:\#,">H\^BMHY'E.>%WZ?'LM?W6
MN=V"^<WRCA>++M^Y;5[V09K7I= %VW25[!I/&B?[H_FUE:50-B?:O%FR;676
M7/FUWI&R=Y8SI9G.-&,089E G,8)I+G.8,X8EM(LG!GQ6C./(?34"/M:B.5Z
M89:8JXV,]6ISV>1?M/T'6:V&W]I\E%? ;9T_-<,./+]TZH(=?>N:&%WSR5V5
MNU:]FY:^UOH[:H-6[ZM-,\KFAOJ!G?+A-B+&-%6@38U11!YU@V1,(SS?;!EU
M[)>?W+ZLEO=J53W:HIN5W6,RU]Y;=VJ6QTP1@C.S:(A3&\RH(4>$PDCK3"8$
MXS1WZT<WIM13F]XZ0:^ ZD3<F=[FR\4-K&P*R4M/<,=?@_%GN"#&_<><XK:O
M2ZW\5;/QWND_S5GNK+DF.,T=E_D?=IX[:X8A)[KS@_>;Z3X:@K1A^K8ZR2>#
M:3.?SC 3/)(TA4S$$<0ZS2&GBD(>(824(%%"W6I%G1QF:G/)Q\UL(8V<5V!N
M^:=;(=VQJFWVXS>)'$'8C?4OQVU@FJXAJW,TW]:0O=O6'&IQ^_4\;M[L>AJ6
M0'1X9)!1^>NTHL\)Y\S5/1EBRT6S)$\S8=Q2&"&;?H-9#DF,"=0TX4*GAAUH
M-JN6%9L[TL+VV5Y<L!EAP.,=.P:8;P7T_.IW4--8L(PI@UJ:VJ0E1B#+N6%4
MJ6.>2Y$GJ5?24E_4QCC,#8>:(T'VPV)H5G0 P)_T]E4-Q70[3QZ7WO95VN.T
M Y?TZK&<;%N,?A;5DJN5Q:$Y'.S*HZ4\0RG3,$IRFZ:$$DBD))"D1,6$:I['
MF4>KY?,C3NWSK67>#7!NY;9!SG&_SL$.L)\_\@L.YL#?OQN.@P'JU9$Y++"C
M-68. [!OBV9WL$YW:G9XSI@-F]W5>M:WV>-&/](N5]7LS7(A;3B>?&]6SPM;
M(K-N4V)?K_(-:Q+2/YH5]@?SNW)&;+@%$@@B9+VL7)O%JV%O&.529R15*5).
M/5*]1YX:B6^$!QOIP5;\*] I 'ZW*H!:!T<*\K?*:6X?%.NA8SR"PNQ,1+TA
M.^4KFH?N^(GF7UL?T7^\48BK-PP=@?5_0,^:DET8_$=;*.U8\8SZCW8)CV8R
MRPUM112FV"P=<1KGD.DX@CE.B599G&3"JR"9KP!3H[5M'D$MX\ER._45/4HV
M>1O);9$Z)/0#LUQ@U/W+1/:$+E112-_AQRT!V1.<O8*/?9]S07G'U^>+$+U^
M7H1HZU9HLT[/DBB" F<:8H5BR%":PT3$(DMRFHJ8>%=KO$BDJ='EQ?7R>KB'
M 0T<843S.,Y@PG,&L5D_0<Z1AEP03%&493G#/:HHCF;B?Y"BB"]K9+?9<US#
M#3R?7EQ\,/!R(CS((:L"7B;0^$7^@@!XL&9?F"?WFZ\_J<K6"JB;PTHE7S_^
M9@;ZL/BPJ/.G%S?7HBH>FF"%+CM7)2G-)"=0I+&$.-$YM,G/4$2(QB22<803
MG_G97X2IS<<;40';R.I'N#W,X$:PPX([,*':,O5U)8M.?,N>/UD-0+'X&6QA
MWVHQ2'YU?Q #$68/ 48ER/X /2?$"Y[D?W+X[NY^OGQ4ZENU%']\,6_MK:%9
M&X7U[MN7+^UY"X]4G" E($<V325C]4\IU$FD<Q01S&*WK1JW\:9&;9W(H)89
M=$+7$9;@)ROWSSV.NER /W]R&!C.@<GLY9!T/S(,C.A(!X9!D/4Z+?3 Z<19
MH<M31CLI]%!I]YS0Y[80F^NRB:?=KC,542S+$(=2( PQRV)(.4EA3O(XE3B1
M,?9KQG1RN*G1\[,M7-D%R_=?^I^!N\^F^"4@CKL%[H??A1O>QV 99'M[;[ 7
MW,P^IOCIK>NC=_7=J%ZN*KE>U7/3AT5I?C*J= 7NRRXT[?']<O7;XIX5\LV<
M%7>VD-#UO+:T:GYS+?]C759-V\^ZP)#Q8&>*Y2B5.H8\BW43%4IQS&""TBP7
M6J=8NI5K'4'8J5%:$V;ZJY*%,/^MZXJ!>_9H<RE\-S$'M+#K]N8T[#;XQJ=1
M$[YM]00;13>M4<JK3<;68UT"HM$6-.K6>5H;A9M?@JW*7>VTNFU=R%W1X6T3
M;+]T0%%'WDD='O3]/=81QO2;A*0J9N\6E1G4MHA>+FKON=[HW>W",C,^+(\X
MSB B-NP-H<A,*!&N<XJ%2'0<)TX[K6[#36TB:"0&C<C-VNZJ.3LI=WLSN4T*
MCHB?IO7P. Z]YW AA,ZDZH?, 5HLE7AULWSXQ3RH843SPY8('1\_"I7YJ=J1
MD>==_7S:]ZQ8_3N;K]6OQF%>KYI@M\TO_ZTP[K19H#^VA::02#6+8@X%3BG$
M7&%(DDA 3DDDN9(LS2(?)]5K]*F1C943U(*"C:2U7_+I^M]]JWOULD84X9B(
M*(,Z9P)B1G-(::IAG.688D:HRCU;2PYFCW'B'U[<(FXN_F H#SPU7 :OM[?=
M"Z9 [K/?V*/ZP[U@>>[@]GM(ORGFJWI8SA]L*\!#I6%1ENI,1#D4)$LA)I)
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MTHQG,N.:*4@E11 3E$(:D1C&0BBN41QQ[=6\+;!\4Z/;[TMC;[!0E3',5A?
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M<D%1GB&2Z]BM2ZG#8%-S@O=WAC;;TT;<"_?5=D'NN:?6$[K1]].<4+M\*^T
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M>2;C!/(XUA#3U'!-:EA'")%J3%6LN)<K%DZTJ=%3YP"H1HMF@XAMQ.V7+!'
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M70#HT0K-A;39;UC[HC>\7&C5UHJ]E?+Q^^/<Y?R^L4.K+#<S0E0JH-! (24
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M:@.>H.GI2)9/;P[;,3SAFT3;*9 =U1\J;:R;I/4%-,XDK3?U1OU(V1F!;\?
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MA!9.!,PI^C *BB)3#&>:J2)(PO!\<U/[@%MKDW)W7F*^,SNPON8%J/V^]'@
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M!#/+<"GC@"K# *,V;"PR:"2BX04S3K0VM=&A*;#0'$?LF!NZF^$%M=]W' W
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M9B,\R>?NV>ZIW7\VIX":%8\TYTJG+LE:.I',0F: "T)!8>Q+9(,U185?O8^
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MPZ8PW)50%04L+*M :'_2"" B:8XT)W9"VU__N&UF:F1R(/7;&GJ-#O(64[\
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M/BKZ0;S?&[TS8T'X,T<;'WJ[VQTS^C_D)3;TVTV;3Y5RD5X]W\V%E.@T0SF
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M;Y1=;U"_T?OS:BFU5NMW%N+WZ_6C6P*M)@[?EXLJ0W+&,&>0" ,0S3% I!"
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MK8DSM9?2Q#F(_=@P$G!#+_KVPRR8OCS0B,1-YUH:E7@\7'[.*CZWA.]'MTF
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MGE/LE4_K1Z7-(:$OVLF].T;7*SOS_,ZM_Y_$O+RKURUS56",#0($N?H4JD"
M8<8!U1GC5*:897Y9]B&M3HTH&Z-=6G!C=M*Q.]D9?I/<?E\^GLE^N*(G_*@P
M.KX#,U\\:(/)+@BJ2-SFU^:H5!8$PW/F"KNYY^EOMRHF^%JKU\OO#WJQKAYZ
MNUK9]TB[I=-73[M+&KGQJN3NVY\/97UNR9I5+M5,,@,+)*KT/_L?@@B@&51
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M/-ITY+H#[>F%P]7](I@WBJ_W%4H_*ZF^5K5)ZV.:]8$!I%$:LQ10SFSU4)H
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MM0ZG%DNW"SR4C:'!BF34$+M1<DC@!N;7*T4Q*G-'J89Q ,SP53#J[J92_>+
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MTL=^4)Q41?:\O<>T;2O%]ZM:/J[8\U,AV+Q:]C0<A#.F<I K+*V6+C$3-TZ
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M'/HA2O(@ZO-7G:+_CA1EW69T@1&*$L1"P!*8 DAQ!J@N!@1)F-$$8DB1523
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M^?_<ED7%B[JH3^N,Q2&B:1PQ'4 N 8RA4#]Q#%@B41ZF(0S3V+J[P.7QYD:
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M!1 0J3T5DC'(>18!1M(\9R2), \7ZFZZ'CUGQ;=N-E]87\/Q@\MVX7P/6NB
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M]STPW&&]U-R.O4MJ]=)96?LIN[LPQ?L95N1ZP[3:;W#&@-_7)L6K;--N-,:
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M' HH4900B*@INUT88V[\UE@*?3G-O]Y+,%ZG-@_@C$QNI[@XG#A< LB<X#P
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M47N :J;^N%[]$)5ZW^__14I>U3'0_;]KS^W']>8?8K/? RQ$)D.9"PHD(BF
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M;[G]Q_XS[CUJDD_S5/3N<SOS%]<&J(^/1>,4N%_QIL/J@UBQ0E0++ D1,$.
M$$(!C$("<HI#@"5+HI 12!"S[>-Y<32;%W":EIX]8>M*;JPO;O"7C^N-"*+X
MK[9-/@?PIKJ2%\H 14D&H$QBW2H1@90G&0YE*$AN=;#B">TI2,X$:^@1:C,;
MRQ. (_/E,78'<OILN'H5#&^]5R^/-'$;UJLJGW9DO7Z+_<%,FYOY_/8G^ZYK
M$>C#W47*218C&H$88V7P,,H!YC0#DL(4XC3%)#%VI)X;8&X<T<D8=$+6W@;S
MLYFS(%X_G+D5FI&_?DM4K(YGAE1W.I\Y^\#)#FB&U.F?T Q>]S*=E3]M-]5&
MD;LBD\':10SGA"4Q ['4/3JCG &:,00$YRF)("4AY(NGNCK)UPTI-V:&Q$32
MVWQ5QSJ,]X'UA _(II>KN9;!TU'=HFEJ77EZ5Z#:-[,,JS<$I@F @C) 8J4#
MDG&N?DTQ$;1]5]ZN#)-,9ONF=!I,]IX(98G]V=\0,RMYAG,^]IKKL4]X3_LY
MU3_S.V<S:21N*O6\ZI[YG0K?K<=MAW>L=Z:[KY:"#U0C/AK]]TK([?)#(<4B
M9C(.J5KC$$LI@#G6U3UI"D3,.(FB!%-HY?"Z19BY;:HZ78*VQO?R;(WOZ@PU
M-3H%6BG+@ENWS*79DC35#(V\SAQ/SOD"[*Z38U^:RP.JOLITW2+*M"6[/(!V
M4K[+QS,=>U20HOP[66[5>K#4Q4F^?A=B\VNYWCZI!4#)HWY7D*7:EVWJQ>,U
M:5:)#UTS^H5D*4X2G@.1Q@A B06@>9*#*..YC G*\\RJU/*M LV-D+4^0:U0
M\(<6,JBEM(PXN'F6S&AV2NQ'IMH]['=!JTU0JQ-T^N@"7*U&P4ZEH-/);++L
M.UYX0MA7\XM;Q9FV#X8G\$Y:8OAZKAL%O]I6ZDE5I>QUJ@;3S];]BA]6NF3C
M>UTKK) %V7?I:!>+^Q7O^I3J&H]5M7T47 =IZ")DJTWO;W6E@04D69**+ $1
MS'( ,4P!R2@"69Y)F4JB+&C152#Y9L[7TTAOQ"R'94R^34#N3?&-I<YNW^CL
M]N5>;#N"G^@=,%L&9C2ETRP6G<)!3^.[8*]ST%>Z-=*#G3%?=X7;*Q>TFM\%
M>]W[?[]K2K;X6U.FG2Y/*\]$0D^Z/DT[$<>KV,2CNX8V_Q"KK7BGL.ORE/^K
MV'Q_O:TVZT=1OOW)EEO>EL-1_\>_D9^+!$>2\YP '*5JX<J)!)C%##!),ZY6
M-8+M=A@.,LQM4]&J$.AW,/A<KOF6M<$B7T7YHV"VRX_+M$ D>9;0'+ P#0&,
MA-KX890!J?X=8<212*%=--G($S--E-GUJ0E L%T1*=5GI>V4@+7Z33!G9NO_
MR/,P\F)^, &=_$TAWDX#W>*PU2'HE-"9KSZCTITA]!::;B_!Q/'ISA"=!JF[
M/\IM'5-/$-7NN4VVKEI)U6^*2M1_W+=53AG)HB0&G H,($VEVG<E0BU?)!))
M&,DL,DJXLQ]Z;JO6Z]885JSXHZB4??(?=HQG ;H9T8T#Y<C\5LMU%_Q65$PL
MU5_$>EOY;4/MC(XGZK(8>%+&L@?DF*@<GN":]?OW]7*[VI"RR4RL%JD@+$YA
M!'(6*G.-8@%(3A'@&<\8I31),VJ7]WLTPMS8IDUSW4G9)+P:&EF7<1QF%B_H
MC$P@ML X9 !?4/Z&'.#C)TZ<!7Q!H=,\X$L7NID9OZ[7_%_%<OG^\8D4I3Y\
M_K"NJH7:#(=ASC*0(L@ 9"D$.0]30$G&!$R8S-/4QJ0X/\S</NA.RKM@+V>@
M!;6S(BY@:F8QW([4R!^W/4C6=L$P!IYL@ N#3+K>#RMZO+9?N=J- -Z(IU*P
MHHGA6O%^A_8%S-1F@B018"1*  QQ!C#G"8A3B9,<PA11L_X=U\>:&Q7T1:W/
M5DA/6#LZ&$+8C!,\X38R,?2EO O4OY9BAUY?Y-IM\=2<6WDI[F<!DR?N&!II
M4@(Q4/F814QN<4Q9$0^:E+Z()_W(U<-NKQREDF21D( BE"H>R3B@/$M!GB(N
M<Y;@-+<JA7QIH+F12"MGL!/49!=M!ZT9@?@ ;&3V<,+*/HK]"A"^PLXO#3-M
MG/@594\"NZ]=?V, 8.,6_$V0:EL*_FFEEH%2)\Z5:JRZ:>B^HDT618S'! (9
M\0Q $2& 410!&$&A,]P))5:6AX,,<R.37IA?*WZ=,UROICL5;JX\Y#)99APT
M\A2,3$_>T7</[+/'SW<LGX4$+Q.^9P_1Q8@]AT<YMM9IXR">WZW+WU=JA\>;
MGHVZ*$#S __O;5.-_>U/G78CWK?M0-L_=R9!G$5I&N<I2.,, DBS$.11RD&(
MTRQ%"<RDV3FL;\'F1JC-.B=X\"AXW3^7K:M-9>DQ\C9K9B3Z$G,Q,K/N5*H;
MU#9*=:V,Z^(DS8][Q8)6L[N@TZV[9@R+T3?BOMK_^!)KVHY GL$\:1+D^_FW
M]@WZIA[0UNQL]]AMS]&01#S-" .(Z]@FCD) I<Q 2L(DDY%(I S=N@-=&G)N
M]-OO.O/'F_4C*5;.'7XNPFS&JG[!&YDOK7"[H??.-2B\=]BY.. +]=&Y!L#E
M;CE7[YRX)$S?F-T^-KDE7XKJ?]Z50G1E-K\H>1><29ZD>I]-0F4ZJG\!&F8I
MR 1E*&$R4F^GU4'=V!+/C=2TC$ J(8.B*TU;*C$G*M9A/,^&IX9SFKVQCQ]O
M+]#1.R+HZ7T7:,T#K?J^7/&7H7=BNM(<MO/TTD4YC.7]<Y3CL(7?6R$.ZX'M
M0\3>M-WM*QV"5JJ-M@Y$?_7\14CU= 5KK[A\'B6,$@I(IM<<@B2@,0]!0F%"
M<A+S*#6RA*U&G=NZL1,\Z$NN"6<GNWE8F3GVP^O :(B.[8B^#J;G-C-.2#G%
MJIF/,EG\FK7B_9@V^YMO.UW5&6@K_G6CGOA]O53W5V__N2TVSXN$DBC& H(X
MB@2 ,$Y!3K((H)"@,(9$0-VN=[TA2[M3TTL#6C'0;MCQ/IIO>HQ^>O%=4.[[
M+JP.^RYTQFUS0B=JA=S.32_.1YIEE&$< I+$%$ 4(D!9K"N+(YE!FN1$<)=3
M;"_S,<&*<#(?-=257L];N?_O_RN/H^S_'0=^N^-H'Z!.=,S<(?EV&#7G<^)K
M4'@^_[TXW(N<ZUY3_M)Y[=7[IG*I-;_^K*]L4HET)_EH 05,18H@2 65 -(X
M463$$O43SP1BL="I#?:5+7S)9_2935^[HMUR5+5CIZM3\*P$'MO%=F$6QW*Q
MW3 ILW>QM7_2RJE_M'/XCZ$YG,##-@SXBWG8+H@U<P_;,)BW>]BN/-^-V?\F
MR'+S_?VJVI:ZGE*;!?^A6(G6\8,CQ&,A"4"0$ !C9<GC$"/ <LFR.,RH-.OR
M9#K@W,S'1MY@)W!7*"#0(@=_-$);^MNN@FY&L#ZA')DX;T31F@I-H?%$<5>'
MFY2Z3)4_IB3C^QR-R/7J09?>>B-H[=BKV[+GD*6RCK&24.U.0P(!YIG:K,(P
MDRGF=25\F]WIF4'F1BD?=D7(M)1W@9;3J=W]640-C;,;<1K;T-(0?;.#R-Y>
M&L# E^US;HAI[9@!)4]LDJ%K'9O<D6TEJD_R_8J5@E3BC6C^]_W*W@"J8X(7
M22QBQ)0%@DBB-XX0 YJ)$* LAK$4<1H2J_,L[Q+.C6X:!75'C$[%X"^=DG\-
MBE7@O*MIP[0M6<O_*V%&>2\ZT2/SY0O.L7TWN['FP5<//._R3=LY;RQX3_KM
MC3:0:P*V%#H"]1OYV>0:_%KJ:@$Y5?]/TASP7&]@<1J"/,,Q2#D5,H)4)C2R
M\4>='V9N7JBO6UH/8YMA?19",WZ]'9BQW=FM@+I^W*Y_0RVDS]3I(1"\94V?
M'63BA.DA14]SI0>OMOS@5]^;D)TOXDF]&]\5YU0U@7S8%=%'C"04,08DHC&
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M3K.4@(*2NE(8 \() CQ+H,QBKF1,6O"_S"S5!X-!OQ[Q'8&7YBA66,CMXOL
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M<TVM0S+=4X'HLJ*3P[,RK?7)8_3TX#8UP4TSIG< H'\L%OF/Z6PVB8[(3+)
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ML9^2<6.1@^'E;*9W<:%MHAQ[M&-(#C7=P>30R%VCBAAT JLP%H9<Q- Z-/D
M*>-&(P>"3PNV=X&?/7LP412C4X*2:TLKR>O%RA(X,O8DURJ20AW<N1LW##FP
M;7TBLWL(1^W>A^MU>R.JF@LK=*N2,UN,!.4*@M,8@:,WJ$1.W#XVL>F<5_C;
ME'1C%0\8"SA?!!T9/;7!WB=\'_Z\P;OZ9HQDRGMK)<14SP4G;>I*B" #B\YE
MC<:V?@YY@J1NS.;AH-52*!U@[.XE?>.T,&&PN"* 9_I#%1\@\#H224B=M#-,
MX""O;7NIZ<; '@Y9C431 :AN;&(2A,XIE0 E.$T<\1Z\\0*RBM)I:<@4;%V
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M5K'6N9>]3.H>6LX/3_(^AND=P.5&K?C[Q5LD/S=-9W@KL?G]XEA6NA(D*B'
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M1IOL6_M!AU,W;G!H;$BV$5H_M?4W;X@?IQLFTC5!-L_UV9M89B*SP@%BDL1
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M.AQ-6P=1H0(372A)!*Y#\Q+UI\D:N=*K!38>*/)J)HPNDY N2R%>G:QL;G_
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M-6[YQ4B >0BVC:37$R#W;>BR(Z!C/!4ZWWSCT106:@*! M3%HQ,A86P]T>@
MLCH!9"LH/ 2U1G+I"6H_?+WZ\M^FN"2B/G[]!;_@;#?"EW.OZ2+)I?;HB3)!
ME)Z!*254RU86V3H6<AAEXU83=:<!6\FP)V3>.&RK^_N[;'47F4B1&1#$Q7KL
M+/'/!? N.(.:["+7^N'U* *[48S-$'* ;FPCKIZP>,8YOPX',.5-UBH#,TF!
M<L&"Y_6L<V,5'?222NL"E*8;&+< KS.=^^R(Z.DXW#CK^[,2,U/<,*O!QIHK
MAG38?>*ZFD1U,%KDY6X/H$'4<H>UZR,"Z #-?;XT.XPU7LTN.2/$>/\SFDU4
M&22@V*J37<XF<6Z .5:V^M(%)< :Q9@)VI#H#SG'70]5N91$[4UYEXZKJ/[N
M[C!:$3NT@,2%!67JA%M!;F0-]&L,QJ72HBOL$21U, 7C>?!UNU?0,"(;O\_L
M RW?R0[G1B4(C@50M16WUTK79VU6F\$;6X9J@S_NI)7!!'W0"(4CN-XA<BZ[
M9[FL=6U)0MPAMC"1(7ARP8SQ(49K50[__QNA<(QD#QNA< R;.QRA@%P7KY&!
M5J9.Y/,.(AEWU3TG=\A@4.F@0,I?9(3"4=)\8H3",:P=7XT\J&3O=]-63"J?
MHP3&,]8^6!JB)OU+/Q(EB5Q'S YB'3Y"U'B-HY_IJAI(/AV$%W9]V&[V.W[Q
M1(/C&SVO/7/*T>90U4E9"2-$+RTD5;B(.A65#AK_>$3$X1QZ>[+:FT%H?U^]
MX>79 7;;I*N6&$NP0=3L?P/*VP3>L@P*@R1)^,A2ZXJ>YTL]?J9N_4.A^?DE
MW&$H[?R6])O[;YS&_+NEQV_+OX\' S?EUS&$X'*!C)[5-@&>7!\E:TH\(E/)
MIH/ZPCQ?4WY!9K:G"P"P9DHK0P0[P[%.OM39Q#K\LG7BU;?0E/\8.3[1E/\8
M#G=PPS[8I^"'K^_I(S9N?0S(C+."W#1&W&$Z@',^@PW<1"PA6M?Z_CR K$Z:
M)9\@]4-;19PH@IY153>TBP40NY0P7 &BH2T%+!!3CJ E4ZJHZ&E/SX6J:[+&
M155S*!P*M1/E,G)M-1D(Y6+VR[3@+B8DM)9:90TZ,CJ&RG&(2@; D!5I>(Q)
M/&40[?O<3D%QJM 6C3@X]NR0O7,R9$*%3COPO'!0(C#P]=ND:F@Z.^M8B[G8
MI\^4>:Y1$*=<26W8.C8N'IQXPDK,Q00Z);4AI=*%-E&$(833T;$VD1788F;M
M-S-3YBBA'C13YA@.=V"G[*DN5!A5]L5"Y#*#*H*#-UX#<\(IKK47JI.9,L/W
M%CK?MCV3P1U Y.';]SJ1RV#D.6:(K%IDF QX*1%T$@HS\T*7UI!YFJI.W*,3
MY7ZPW7J2$#J U5O,B)_J^?IM,4^+^9H^GW[WPZLYK8&K[=&[L3N>G%8>09*9
M!RI9!3X[ R9EYFC;7KCVDT..H; 3TZ<-W 843H?1YQLA]I/#R/<_X]QX\!-4
MG1O8W4GZQBI7P<#H+5?:>)#,("B;!'A!-Q]B4 YYYF3B-#YK>\AH'/@--AJ5
M4@"1D3"JC(*07 :=DPH6T;'#,BR_M<!O(SD_$?0]AKL=7#[7W+B**I52+%V4
MM84*)U? D#\0A2JT V=5SM$%UAH?]ZGHQ&8Y0:8/3D<XB<'=0>0E<>;#8KEK
M<[8+%17N?<9B:NL=VA%=<^"L#&!89H;VDY)L/4;Q::IZ43.GR?U1&)TMA Y@
MM<=08[JH8A,"E]Z#$F2R.8894C2,<Y4",P<%[(9WN)\K<G>.YCF3P1U Y/?Y
M$FM'1<S_"-/Y+XO5ZO7\KC%X;7LSS20:(4'$S10_*R$H+4#7=&,NHD'6NG'#
M401V<J6=B(9[@^Z&$DT'N+N9:30+J]4FK/G#UY?5_2-S\2+,?@WKB^5T_?5'
M8NJ=O:)/5BM;(!FI0:'8C"K5(&4(,K%@$F_MGY]#;R?JK@TJGTUP'8#T1XSK
M=[5J=5MT\25,9W4_/R^6=4[@]?FL9_/-8MMZ]JHB]<[6.?J<(D:0OO8GL-I
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M=W352L;(6Q5"@%<*029=1$R(5C0?V+PCC3U=8ZV1-X"6.O3>WTWII_D+_G/
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MGW4$RFH0R:Q<_[/P\\_\O<IG^O5S_EH?CD'<SL-(&=!';2BC(SFTS'HABU'
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MKWY1)72-?I&XLDE&PGP.=3JA!N\P$S-)Q-5$,&P],^%9@D9>+WK$VZF=7CH
MV6K<TH8+5BGKZC16L%S7Q462+EA!0@HZ\9Q-,J'YA-MGR!EY8>@1 =9*)QW
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MKBN")M.P;DFA+PV3Z8K:8;++1Z%XP&3S\24^2NXYFXC)YPR^U#T.O$[KL=J
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MKI[ L8\V9P.*=F2HK#:;UUJ!YSFR)6049&MQ[HDCISP$*\F!L\H%-#YYJ[<
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M!6NRR(-NDV=7&8:,,PF5MN7IV.B@D^\:XS?^^982JS%+'06D$FLO54$T83"
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MVZU(O-,V>.[ 9B3N,)LA>*,AE1R9YD62N=A1\MB)'L!:'U?[\;L#V#P>5/^
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M(20>"ND9J49TQ[KT>JZ-VD62PVNC=N%V!Y;2W6(/YZ-*GB-H'6H9/%$0F%+
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MDBX1V(_&QI?Y%7>V'*X'K;Z=S]9%NI?AXB,NO@B2;PA,!1*HB,0D5J="*2G
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M$96"6$P,B,EPUSK&\,16QLTV.,(QU8+EG2*G?KG K2HH28Z(*P6R]H),!1G
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M=#G7QC1<"H@IH"C&,%1#7JD;;6?<H07G$2=K(,@.('P$-?]M/DM/7*1:(YK
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M9D%Q18LI6BEKS<#9T_3Q.YZ"_G3C)1[^YG%3OA&.H08&&!D^M6'C8[FUANW
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M9FHKSTB*2+: 85P'7UD--0N"5B2D3(%+8<-=$!Q?\7U*H%X>GITV\&AOFQZ
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MG?,OOA^J\0[ \F;^_?OT<CU9?I;79,9?<9;J4GBD/$'6AGQ1 N6L,K*@M&(
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ML"08,Y&.LL]!(D8R@1_T;34=:*"'"*0(IP&,"8^>P]-A,U"$X"#LW'+FFJ5
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M@M8CXA;GS3,N37Q!>8QP7VNYGCY1!]4M8J2RI"R6;VF-=;K_/\VKD/9$[HU
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M27',0Y*I8DO,>#%N,911%E4![)>,J3'M]<!V6ZNB-,8,P 1*03#HQ$T8]<_
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M8M3!6J.EV1;AV(<"I0=*)\N=^*GM&PCS\(O3Z7V\4]V>U.97;:HV%A FL38
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MR$8K3!K:F?*]&E9SX_C^*BX[/.B/2#A:)Q*NQ.?@/5DS?V@3>N-=VJAV%9^
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M(UE,3/1WOLPNFL7Z>@J9*Q%G>O>4K7=.N]\O;5SSE_3VWP7._@!02P,$%
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MKL3/GI8OM K@!BYJP!ERD *^O2$U>I1F>=E7#"(=F9B<(_:0["DB6<1#Q*8
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M N$*;LBA]1&)*)+K'#;.%]DND0#!;?#;;!]T2@5Y.%T-*59T; 1.D*\\?&.
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M<" (MP9[*/1N2<.NSR@[*D:S;EK(G RV7XZTE?Q,3%<O&BJX7,2?Z)_&) P
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MVJ('/7BVL[3DGT@0N@NOCD4-(2Q%.P6J^FJ\6N)@&_R-"]I^(JP<[BP4G1Y
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MF)@<Q=ULV6.>76:F8DSN.FD94J:F,083J6ZJ.!< UX2_L84?UL$:?E_P^UH
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M;=C?#4ML64)[^E5<!9 XW)&2_LE"H"RXK!(_ W4^,7D4.NWT8^S:P7QLEOR
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M,0--^[8;>ML70=-K_*K).?Z.#A?Y=IG6+AXQH]Q_P"'D_QXC_10^#J.%Y&V
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MJU916GJS/ K**/2J(DX7WF]A5'SR]O;DJN-L?9/'BV7I'1T</?5^R_)/\57
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MQS3@6;:*G#^9!%)3++B#ZW=NKU\I/3LAHM8'<W'VS#O[PMH#;?FH+V^=+1(
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MB3<9CC^,S@8X["W15["-WV0H8(E*RV+<A%_@O*JF.](8+3+[WH):V#WEVN_
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M2#-G#O7DNPQ8 =(.,.N MC%1-@BDW[K660"R?]=@6JLO.T8J_F(_V^D:4I_
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M[4V:E4(EZ<*L/FGHQ!45L[5)EH!JSB<:EAC$:<DGOWD\6IO"1*2!_U3)PE"
MZ ?,H<0ZG:$AM(9!N8:LY4^D,,QF"=R'A(5SQ.G2\JC/,*>9BJ-UK.FBL32C
M*H>1<W\1::1QKMWU% 6$J#+2"9[< 3(&C?I*GJ5Q"#_%"6]/!9.7)3Y!Q2#5
M)<J#,*EXNA,0.^,)_7ZE0:LJ[>5JC+%.>,TLKED/CZ[3@KDV3N]M!006G.DB
M X$'\T01%)>EM@]ZG2&O@C^.X:R$):A<YA?S)DT)1K>[LE1%<+#B N9/]ZT3
MG =[!WLL _%[> U8H^!CHGR1C5_4,M*=#[PPZ&.ZQ"6!O1SS"<]P>ZZ &@8!
M7P0,9<KK$&8P3)[RBMKG#-J'!>< BD&!7BQ\L:M)'$Z\L:TFZ-Q*5- 8,M?_
MJ6 ][;Z<Z[#*XQ(8>' (1P56>/_%HT?$QT 12R,MSZ'#5B5"6[D>5PD]D!C6
MM$K&BD?7N:[@KOPV,JP+7#OA!C&9"[\[[,,<-&37O JP?5',BU# KL,B UT-
M-<A/7C*^CZ\7TL6=W T.X=;9POT.QU-S.'[$&:J9[!1(R%V@1>8_<SQ8R.E@
M2V'H$?"1$H8KKY!I=8XD.^<34_LJ%L!CX&(Y3@X>S]<@PXWT"-8I"G!C8U^B
MP^U3K8AZZ]>/4^<]OX0$-AK]_GM@_O<5U,M?@7R -WGYZ.GL^R=)=+_,_FY@
M_EOC/?R.T^#%B$ Y8XW])7$'O.K!3Q^R]#\5+!W9NWSN-C?1!S^Q;#4,-<HT
MGP 48W2,1(YZNNT0M1%'6K#TD$OX1-6\EE0[<B3@\3M'-P%<]?C@P!>U*@&Q
M"(>]PLE$FGGR\Z<N3VZ(ODC7%M@=(-R#OA/NA6CL8@;TA70]RK16A;&P&U;S
MREL<B[EU8Q"/6OIYJ,'>*? &.!!Z.DNRA:_ZD<J>D^@Z-+ZV :C4:![0T6*#
M<RGQNKEILXPS\UZ2!P].W=)L-?'^[]6WJ&&1)579OF5YL,+Y_TENGHS:W<XP
MU^IR1XU@W5ZJY$HM"G_XKTRJ6SJ96WFHM]3V'W2HZ8DOXQ*6(;S&Q'[1J<Y5
MLKM!7H/!%CH)P.'U9W3;%&""NIZ ?O)!(\+V]S:Y=NQ/ B6WWXMTL,DU&B#7
MMES=>-Y\%Y9RS1C6]]N^&H_3@^HCS%XW;?,FLV<W&GP#/+- )_@<^'!:JIPN
MC5/[)]O4:6O@J0+#&%0P? :Y<-$S(M;&#!8EB]I6B.-LL;H7&VB#VIWCK( (
M/-A+,;78[D/?D_7#^UXD-L2O8+%\1RHHC+6-[GFR\(BGE,$=>>Y^HAAW,B*V
MR1LN4RE]O0-I'A8/C5+>!DP/OQ,:X-9PNY>RXE@KH"Y8\W=9.MY!-3 XQBT'
M&B\7FY4@)VVM+(J90I.;Z&1X&EN/0O-B_]FKPJ&S=4]J>+8CL&;D>'4]=Z3B
MI,KIDER754YG\2K++XU#'0Y;E;#[(TAP\?'9\(9F\>6XY6@>Y45K*>(T5#,Z
MFO $8!?H$$,.Z!RAJ"(O&(P7:9XXUFK84^D;;_A-YS3BM*AR\MS"#>-<33L8
M(_Y9K]-PL815Q$6];5MBZ]74YKD@4U:?M^)M"E54*7)X:U0;9F6=<Z+OQ].I
MCG .H&S@#<2VAAXG8^??5AQOMZ:W)6_2M9VPP@66SM1!*%+4,3XB+EF0D^31
MS8-QI7*81<K!DYIE#PQ)\</P+_Y4L <TF[K<$JD-:W9&.A?O)L4,9(Z.($C4
M%>U@I(N0/-7P?A%.*!Y6^*3ME9*FF(!\84&PM;_=:1YY0I5>8NM@&P-0+*3@
MYQ%Z"A9:P?N3\;!T&2/#;NIMQ[]&)A1%KF6B0YV;Y\,^PGO&Q00C$^RQ@-<+
MX50Y02OK+>^4@W=#A(0]M3?.]5P3A]BLO#BOO=O]UILW:UR0XKQ&$DJ,KB$+
M'19OY6!!?$6X"FJY#7Z/_D8-IRDV@><S.+:YIE&V2#*Q-YYT6 HH#HRN&\9Y
M6$WA\ -E 2MM"A)'Y2P, 5)(6\^4<*^9DHPES@% \>@(/6*GR$=!SPDZE(VE
M@]0BU$F!HB6LKX&A@QD%+ I\'ST:(6FZ&C#*KFQD0U%?N6[,%VD;D"/Z:G6]
MLXXIXCG*0B";.&6-QA&<G0D(CGV"63S(MHN: YR,;K*(UMZB%Z, +WVBD DY
M"E RKJ-&D:6NB\]9XN_]SNQ(7_'2N0XU"DA#-\I]TS7T0<$R'9-8Q!2, 0KL
M*FG3S%#7P?8@J:8SF.4TP&26J@B&,? $?8DN&$5+70RNL1[FQ4U^$2MU*PX;
MZ+<X-0JF4>(!S6BB,%G1^<+.9O=&QZX]G- 0'S0D"G=513'P"('5"]B!]&:'
M./M&E"JDV.VM:.P"KSX,$TSAJPE8%+DHB-: KD\Y)G^.0>ND?"5YK- K/F?]
MSL68J[% >N=X:7=.$-$NSGZ=GK>4 7E!_]O@XP*M:Z.N0$ZY<K)WHBHWZ15U
M5@YO=5LP@&3[&6EPGL6<?8-V0E8-2T[=X&V5E!I,H;1V5M-7X^_G&O6!+)",
M9!@QDOJL%2%H\176-3?\<NYK.;;-*I(5^HY1+W<SC$V:V3UAK20L&^Z%;1AI
MS",28B'>4>6SK-#"2^X7<ZU.W<J3(^(4EX:L->:6T.J."3<#;6['R^'H%Q[;
MKQGMDL.XWK,%H[QXQ3Z/-<,8R21.\4;VYCT1K#Q1OEUEU+YB%1/CG4&/2HR[
M\\U\(,,*/83 @27)*E&E47RZ/#R.?Q!5F*PJ19^XE]+7RU:X"^ZEJ)\1BMKP
M[5LXXNMC")3/NMQT[S*-NGT"8EALB5?[B^Q<M$3%MEVNOJ,QAWI=%H85^:67
M>M/_>*?SFJG_ 7[F+XZWHNY-.^ALR)U@*MHP%3 J<?O'0,&P9$B3BN2-5Q0"
M>D>.NCR6(2"9(<F@ Q!3]#L\%JZ$&S:(V6I-K2RQN["L([.LJ+"WE'7)C1:=
MM.821AU%1;3HBK^[IP7CDEZ<?Y)13O=8!T^>4!E 79<"QR4!C1$.#9 P'TFX
M_PQXS#B%UXJ"-^M\RRZ/=+PT0YM>@:P"N,R2 !)QH"-5%7K7E6!_?-9=C]#/
M"%?NX#[W[[L<P/&-#F#'.?!-0RY$0D\V5FK5AZ6(36%@E]XQS0HV,S U0H3F
M!$M0UVDA*+1Y8,X'Y\&; 2 EI>-8]>;7V"Q]\%"#B-6>M4KREA[ 9V=WQ?&\
M/03PJ.\9W>]5F@(7W:3&G(WZN336;[K9!/<[< KJ%.A^V8PG:2!)T)O=XN#4
MK6/KSD45C;;EYQ=6Z^=\H1:6:$XP10R$4J)":%^A[8'_#FTU+*K;P.!C]OM;
M>V6+8H28,$:"8,J<@BN;27D6*T:X_';C;Y."Y!6H2G8/8H>P93LFJQ3K?AE]
MA%Y(HH_&,/*KBFUUY\J*8IA[J I2 1$!!8L_YRJAP> K&,.II:[#_E-=3K*(
MX$YLD@@)IB2&=Y"Z3ZX#Q<2I4+XH_!>E3;)F(NFC."!-B")O3D4UI\JY-J4;
M^3JSY:;!A9GMSSI"BL4*8IW/I5QXP*IMO:<+'SK#Q;D(5 (Z7 177*6=!#00
M-R/EDM4+N^1I-MY89G#N.H$[_-&-DD#%GG8I6FG $S7'416F2.:PI/DEG O"
M\AC4V!ER<\15-5A49ZA0C<?HFRR_B'S8D1#/S<9ETZ%C_CBD,T.U*G)()_!=
M!^;;3A*9H555W@G[O:=IRX<5&&2P;V%/9'EPX3E^\*,$4I$J7<=$=V"=43H0
MP\&!:;"1_##)&+U@B$CK%.)WPK/.8PP,QU:G1TT(&,SS),;T8+Y9,;@,IO^B
M!1])0DV=P;M,0/F1?*\,N\N?0WF],%CW E REO=X$XA@^X,NZA:);6R)YER.
M'*^2I(+_C+SG/?.>WPA'B!P>Y)0+3*9#)!Y;Z][XRQYB#YGPG1-.:3$BCXL)
M$ OE>\=I1Y"(^*$9)$LUS^-NJ(AA/SG(.9R,8B2$Q<7+!C;BG;HJ-LQ./OB^
M3SP$[#V5LX;^TQQ+C9:Z3WT@C]K8'^H:,:-$CUY1$6L0]2*0J[L$O"_715[*
M^:W!9^3IE&5F+AJ):H,LJ"14N'JU,7U]($@<\+L+Q&&P1B3%/9>KMES8%@/B
M(2,Y#]:?0SB@8[V-G%2XEQ/H;+@RI/ZKUAWJ+#9!QK!!%+BN(.I!K=:9C#)Y
M?!B8@/?@H@"'UQ4&J <U(K,FY(OI6I3M.Z% ]#2J>*$^!Y]J[7##Q_T$4PQ)
M3<[(YY8LQ ,G&<I"DJUC!+2'43Q0;>LC4I\?GP7@"2C5I38..5,A&2,DBIY2
MH4J>S7+.[\X"C74_HB"LFP?8=3G86@-7X1Z8V=E3+!JX%_%"J%E1W<6E3B!7
M,/O8>/='O@F#-](P.HGPV8)/"4>1#!;G6EC81O0TB6TQHQW% 41C"S.[XK 4
M'/E4\@NL7B&.73_9TM%0/(X"BUVT<+OXE\^>:9*!B3A67BH><MA5<T"5$SZ#
M1A%/:<.0!&*)B)@UCEME8]94]Q=YP);MYU SY%&@IEDE;F!:9Y]9MO1==YD)
M?8LJFIA)+I:,+S)(:&G E,3564D6 G6M(JJ!1U5+%Q.F+=:FNS'FZC:&WA+!
M9P&OA/N+K-2"/]2R8QN/LZN(BTR)_?5"3]7G>%I-S8*[HGGHT+ED.C>+OKSC
M?A?$Q>.^N]4_9,$OE2)H,MKF.J"S:;04JP1:G!^$U$*/33N1A,K6\7X6.*S:
M1(UD"?*&T!'C "F0V"2>U7RHGQLDAWS3\ V-&N04D_#1"HP9?BD?88$]&J_(
MC]2B7E7>ED:)+6K]%LK&V\@ZO\:7=M>JZF+3%N=U%WC'DUO .RZDHG>SS.*X
MSK7O(IDD'FFDJ &'HYO,(U1I=XWM13L#C/B0*6/V/54$#].H:EY7RMQA&;.?
M'\1@ULP1$I.OG[3@E'9OE%611HJM Q&FC35YK9>[]A1(ERGFB(>U4!#3!8M/
M; 9>06JZK459U-AP^X^W9MLU?XO0+VASS$GYW>I()D1.Y4"SN#F3Y ==-BDN
M)F-5S68I&I<C.EBKLO:Q?,E#)?U1GFPIO=88C:>@( NCZ1RA]S2XELB2V_$H
MYP8WFE1KY!QXV.4<.WB+$I:)=LY16SM.H*W_P-J@.^%J?-IW 7".O1 XPF>"
MC*B=&:% =BCZJI7O)-ZT,[*[2!/+(D'!"3DFV+2O)-'7P*DZZ)#[3\WUCLOU
MC?CJ',C>QT3_9U@LMO]4[>RSJ])%Y"5X#:[%A2-3%4%OZQ0XAQ'.[F;U4L?[
MV9DV@)MR#9!J91+;G"T]95*H,5S<S.\FTFA<.'&>KJ0&$T$Q0TXXS)KK,J/\
MLOO\3I/?V=DL^/;F=VY(<H0@1:M4T.^7J<7"9!#2)VA3?@<65!-[HA#V;Z6Q
MGVR"2!3&0WBM% LOQNB%4RGS2.\ &X:SO+5/[:,>6:T+ =WK;(YO,%P3 Z1+
M6G0MF1<[63H+Z^ESXB,-)'.91KW4Y)*-D*C(\IVJJ*W4&E2Z329)7J>X[=EF
M?1FUDKH=3&%!.8+(U1L#22!;F-!BD;%3OJUZDK8\XL8EMH3'BWECW8"SA5WY
M#:[@V.W*O:X+AO"SB*D;T_N2LMVU&5!2\1EU-NN8T8&H$GA)>XJX2@5&K$(A
MX)4!6-<=CQ8S0</IJ)&?1[YQW@A1PL@U/6!?W]R6Q7@Y"XWSG'++N2RO;W+B
MN-99SXYZ>T"O%P9RO-A-W[UU?R\)?2SE=A<4>':XZ>VH6W^ZT:.MQ 49<<\'
MV&H^SUP3 *:HK@*!S_$7-Y[BD3-1"=Y5HZK-,MC<V'1L\0,6=\+*?+;;:QOS
M9T9SP-!M76OHG&<L1JEF)@O7[Y*\P=!%(2>BT&4A2=(>_I?06C>N)/-IP;%8
MTR"+HF:-))A<(YZ(:W 8Z",.YX'FG%#Y3IQ:KHZ2I&.@?A(%O,I&.8TL_9TX
M_P[L^TFS1M+OL8,<<)15*='-/,X2+QG(D)IS(/&&(R3W1"[]B,QT,?!!PMJF
MN]?,B6[QVSEU63.NYU.V!],&-#%SH&H#WH-JFWC2+5!,W4"IG^3NO&\?L)NZ
M68V-^ MOZ;2Q9KD&PJD*P;.U +C%H%%JKM+(X"9*/8=UJH_8L4*$0,1Q%X)]
M?4U,_\T]YM;/.\?C/M=I/YVYS)I(95LXL/+"ISI?HO]H0,\W;S4O3<OEL#_&
MN1JXUD4-I^%!L\E%XEBWQK*'>'DS&+YK5.'GG@]W.<1&/^E ]R(Q1P2EDCZ?
M["6I83YTW;K6PRX/60F0\I'<V/DI HG@-QBR\PHD3&$=.<F1X;LJP<]&;ANB
MJGMKD0J##@?<U]9U3@ZT4_:QCNA:FDXG!VDWXK KT9:7GD<IU_%T6.62?&"=
M'B0_(STE"&&,J+)\=>H%/5^*K4)C%=\O,>-;,0LACX<.2$D_2=TZ"D$H;I38
M"7/R3BCYS7(N.,!T1!KM!^SQ0'?;P*4=2\RE5[((TA53/XO:54C:/ <Q%3=S
MZ">1;=J$1">NO_HV.L&BZ<:UQ9SM;?I0?&@^WVD!WR8&_+MU1X/'DPO632JQ
MC1B)2:&QB'&)ZY!-9[5:]QR:E8%MIN[V]M%W(_,CL%5F_;(&>H-#X/G8W 1A
MV,:R*CU16J>.?@Z3JN!B)M!-:J_8ETM]+MB83N/"F!BC7%6(")S2=# 0 M,]
M+$Q>G_%ELAYDSKB#XH].;'P7.$D@PDN9:\R-"1)UU2Z"*;2^E  A.[Y!\"=P
MSLB9AZH'@R#P.[L]PN/T]RHUU5U)K$>#.F"##-PN0>$U@J2&"TL:V+2P^=C-
MV4\1T(N^;XT(83]7RK&0-FV&?E&GCT43LG[0&=*\G:Z!(GB^::3@WN8<;$4]
ML" &7F64@U<M/F\. OFES0@=X'2-:+%JSD%A)!-\U%5&>**,5>BSE)MAW5_C
M +&HQ0IIR4RA%Y'WZFH>TA4NN#]K=^^L;7)=MOFL<8D%UX-(<-7DO^=5:G)W
MK0G#1%M83=!+"_"ZE?9SS5VRW.SJX[KW<XTV39?6=VY[[-16<<9.T4(@EDHN
MA/#33,1);<ST)AD[G-]CQ 8L>PI#AH+$F>&G-G.F$OW81YSIY,]<$^58*\:1
M:$PQM%YT@>TD,3$4MB/-IG%(EE L_O^LTS8;8PEJG>%1=#ADP8YZO7  9O#G
MUFU.,GW3'TL]CHIZ(5T;*J*4-79>D2E%[@L"$\BN=+M;:4?,FF$(BN!*C;4#
M]8%KJ]-"NAI%6MI?NE\'(7P3HPMYKD*GTQOC?SB]%FQ6FM3;7%$TU.:(KFJ3
MAA/3Z&TOG#I8\Y;TH/:"-ZKDMQLA6H,4( ]IWFS7S:RS 4ZKR:5%3N:H6'(R
M7BX9@RQF.A<=T$EU\U1.!*-T0E-Y[N>%U07#A77*FWB#1Q?D >.'&FOQT=YC
M6_"A\J%*=;%S^CG1"U/K<;"W=S"PE[]X8B\_SJ)HYV?8S<O@$Y[-\Q((LH23
M9J$+CV 1JBD,]C'/2GD /)7S$UK9AL ;5GB[_G2E X_O5NE 7WR1S_M>A798
M($JG33CJ%EP;5=D1#P=]DS%F&[M&T!J(N6;=4%VZ,5&YZ #]W!-@9"-N9+99
M5S&L/#)7Y:==>S4MW2F8HBPX'F7KD"6 JPI+/F*DN7YNP+0J*Y QFZW/HT6,
M?-)?KI>M\L'5IAA;>4;OM-DQ=R+LTU?X:8?# L<Y 1E/$%6880"*"M@;Y6+#
M#+9%3Z3DT;3IO*)NB(85?4.T9K0\JF(G31 H$_UMA>0>8D$\-@9M(D"02AA3
MG94HDG&*'5N(MN,TS>9"YZCB5R5G+B)X\B HLE$)/%X/,)RIAM3^%EOR8#T*
M1F8BK8 ?84D8U9E,43.6=D@4:"]PCCJ<I/%_*L<@N,KRRR+8$N P.#A@Z?WM
MAT>/7W7N%/VRW4R-G2G4Z4FM9!0F OO#/UG[#;/90J!<0)>*81,5@Z7!&\*L
M0H(0%?RR5%(!A@N?TTK;7Y5@PA=<^7L&JVR@X>A5X$GBNUGCI40CKNXU2%HM
M8VFSXDX)HR;YA5^?W)C\2+*R!7D6L<\*,)W#R8!1(V'U,EM.8.6N[3?(J*?2
MO!877FB*#8V,FB^AQ&F]/A?#N\]SBA@8<2$NG,6#T;.<"_VLW*HXB=9ZBA=%
MJ:<%X4G',Z:3HD+[ +<$8=1R$+_P<:1"A$6CKYM425_5PAK6L!:8;ME4CC,!
MNRS7I7=-D^PH^:#.!2^R*@_=Y ,.W:J:H]CHK2T8[21;MMNG&NLIJ%"A"8D>
MPKG!%Z[)(LV"UD0X6Z"20FU$7"?2A3=Q-AD?W#V)*^I(2S2"^%(I=B(BOXJ'
M;X" Y>05L,^,6RW-::=MQ69=,@?O/\L1?4_ZI'3/PRX:D[[#T.QIJ2F\^P08
MNF^0O:5-AA6_UA0("-CZ3NA47.<8-/ ,V6&%_)#@H1L\>LDD[%ZT^<9_>QRC
MR)B"?*^/X >X_H 8V7Q:\WGRZW2.?A<TCIZFG7_(TIUCIH0JWS06NN=D4N3;
M,_#>8V![A-B-T)E2(F,+%8AO%SI%1\I<^WR6)/HLCW6)J,<W9K2#FM,ZO-LQ
M=@S#-9428489IFOC?_"Z;SXK^-.4ZW8_WO98LKH/\)D45AS>BCRIF4&0Q$.)
M/>>+08WV3CC"H&*(KB4_3W4^IKK<R&VO%, "C35J9Z,8; $"'.!5AI>@)!8[
MJ4[AQGP??HE(*,(_"8^**EB .AARR%0E"U@5>#9? 8^"@YJA*RZ)J3T\Z83.
M4&P%DK#E.<,Z1)E[.2MG[A9:%%-DFV-.I +IH>8*U"FG4<FL&L(QZ62/>*=E
MD3 <J@3+-LEJ7,(;40!0:N$-0\ V^X?Z.L/L-9([TBT**V;TG<^,*M8YN%-S
MT?*NHF&H.:?9:KU6&VH&1?II9UL#=&O<@TR#.U$)U5. ?11)YU0,7FX\$0I8
MP_&U["0NV<PI2NBVEL63F"C3LM:@O7U=HHC)'90&EU>@;149AJ]L0TL>M8#E
M"B<:DR0CVZ"=\GN="%%'H5$G,QS8LI$N/RG7=B!OP4:>PF[0YD8HJ&3!$$WF
M+\Y^]$)8N7TI";V!B<H*.R7G<"6KM(8R8'X# R-FQLER$OVH)),9C-V,<I3_
M($-A'%0%8$SZCG R)M2(="#X4?7@.%-0+$25S_4,-?BTI'A.$*H9&'EHW8/U
M<VTN,,.86#K>2?0(2&OO^7K&L+-)SA#;2F4YB.)O((W#:A>,- _+9K^A8&M)
M6E@'V1J[I;FY8D@>;E.KV"O"2;*H$*SC$6E;3<'!B=L_ $4B+2>%Z2"YSI_A
M'#T\LS1+&';:4#ZY<0,8= +9WH "MX]& W).!"H*&?=[TOD<*).[1B%EMT:P
MNJNYE+OLS/"OPB(JH[L6U\3!N41UQ'N\&N*A; V0 !-"9\E2Q5)T%6=MV,1M
MHL(X9]PI\+1O2^J9>0?3'*U]?)$SO=Z6S86;*1T4R:1S@UVR*9@"ZRK&/V;;
M3:*2"Q,D4S&TT'Q+CH 39HWJ?B^_@G^P<L]Q,KS=,J7;L]WDVKBSO-$RQS,5
M1P/JFVN$$CHYP[QB?BG40BS/$+,%HF5^*J**SWA6%)C14RS?PS:X-VS[O%&#
M<:>7GM?^! 61X#Z.DHK2KKI6N:$.Y/6A_.(%K]'407D:!.+8IX:2'@;^*OQ[
MSSF=Y?>))2:QY,EM3BRY;6=I+FP,8XX%<2F,%AE%>&1".JC=4&.IF+L2#K.Y
MOA/6;T_[2Z'U>V34Z%MF_%I\B7O;]][VO;6,T?"%-^D85ETR$&9FQTK+(XWI
MQ^$N-GW1)ENV\=9<MM&VINWHF([M\AY-TT'G^,"=#7\!-Z*]L%218:MA1<B?
M3LS!8V-5K<9\6:NYW'82L#3P9Q6.VBS +QKC.[-)_+VK7FXH)H/S,)MM.EYY
M9^E_^V\_[#_=>]7^_TY 0*=O7I^KT(MJ6/2FN+#/55P;+KN4)&V)N]<ID<7R
MK'.+NVW 8">F\2BE#*F %4ZP C5&HJD)R>)J(JW4D)G_FI*+\1SAJ6_0$/&V
M'>RO/=G?:F>2(I/M$9E*9<[Y@M!%<9=:>]+"$> 8?]-]V^@!:S1K?M1;K1)X
MR"]Y5LW:VM? 5;_BU*AU-*^;,/O^BO5@:]1/H_=,EU7.]F CY6LSDGU9-2/W
M^DW'U/S7YGT&6W6.;PRD@%]AKE]%!61 N]L.& QFYY2474(=N\C_3I7^>IAE
MET[>*"7B))H29Q$GNN!,IJR@3-,9@5-1#LQ 4F&P3- F(,ZR4LP $WPP$29*
MI,'\9D78.?((-!6J1&D:I,S*Q4P35&R6^&FO)FN'6I*0T2R@LI0MC7D]F.Z#
M.49@,$>P8>-8.[F_)JT7;RC*^J\ZY8AOYS;U%/-0IIJ7UB;G QZASQ=,K2RL
M[$^2D13%Q67AIH [N4IQ6B*#&7C)0K \6"A*[8?SC%X"S;6IGH)T3"-EL>TU
MW=AI/HDOF7.C<,$CCN[0>V2)24BJVW;6Z:1=+@4;4*58E6U[/8)#PDW<X+Y&
M_2BY7X*A!OXZ:OJML]QYR R+,*FI!BY,G' RN<5$:V21PGU ZIAI2H7^E$">
M&S=$L[VSCT)&#;IG)H'4GQ)"-3D8H1;"&!$<D3":@3)!*2;G_ER G*8S-++Y
MUJ]R*O&1]!Z?9N*Y@F.?VM)ONRV16A1+@$V[7$C2]IG8!UU?LPZ? #B\9O//
MN%L*VYPN9P'3!ZU.IPN.3[Q4"N\/=#<$V-:XG_+K0]9LS2=UQ7!$#JV;8,/6
MZH<,P^=C6]+5KH*$0S4!S:E1BT-Y&Y(*V4@$Q6>-LRS"3N9XIKA,9XQE-J08
M8@KI&%@U'+$$*UTX=!4,#7LD)R9R_3K)@IJ*PL7HMG6A;!"?(7/;EOO8KC.[
MWET=SSWY:WRY=<=,+I7[H 33[9T:4K\+T[R3"L.IKER/-!S0"\H</J?,X:(N
M&R>W=&7K>LPTD5-5R5B5-;MT^A?BC;:'X9$%N%LS(^JUQ]>\(?S9NIMX<#I#
M;:%*4?UU'^CYF)O]>#"?EEKRU'LG.]=(CE7A99I=@= 8BTZ$LP!]>CP);@'0
M[::31WU,04QQMYD]GM"E[!0)*( @,/[@0:L5V7**?![\>GX4H&WW[%6P__S1
MHZWA]L#MA=L*CAN=*Y-N5^;*W.W315VDPCQ&<9>PCSL$]H8?D]@I8W.:/I'>
M69*VXZ;<XX$V23:1K4!H#%T#DCNWDG8'](K<0OIX.@\0=%12/Q*36Z:VI3,4
MN<=#KEJ\UBDP+*K.\5[BWC=EBMA(-\M3+5H+3Z.93H2OR6J]Y(O'!/-(UC8A
MC!05&;H=7+!=TS:DEU.,+@,*@Y. 8!1D,B58A:*&2I*B(@$GQA;F6DA1'!"#
M#'F]+"9O*NCP"6IN%OX2W]LE7+J,NH,4'02[WZ3)_0#HH-#_V27"=$)/F)Y!
MQH\SW1&Q593(O!I89>K0*/]L5G35 G)%DDGM5SY5FEI&V4.CB#ISPTVM!$-\
M:0V)4PQ2-M>W\3QY3X3W-9M%"5]Q:G'EW%'JG>#B"E,<5I=S->ZP107N5O#$
MJ"NU-$&SK= 13QZE!THGRYUXU.4;"//P2POI?;Q3[<6F[G->3,[+T]N<\]*;
M/JQ>TI9?VU4L$REA$HOKP'A(1 Q62 X48I446P%@8F[)O5'EY]V.5I+ ,^%7
M16$S8?^VBLR=F'&-2H]BV_+:0\-K';D7=R*^..FG'??FLY0*]\!60R70-MHJ
M70X]N!6J]D:#2%0V:N(_+)$<0#4J=P.SJ%97F]!H.CA\?1B\1V<G=9(OQ#<]
M8B<?2+ CKH:P=I5C<+*RZ_ 1Q[SU>XV*TXO@'MQZ= (<PQ8KK6;(<#\)4<N3
M>+8%QT@D#Z&W*)IO/I-_(3C<;.RUWF1R@1S7[9682 P3D!)9:_%RK.L6H)7V
M8YW=**SOL+X3,JPNDNJ7$#NT!&O054[K..YFY=KK!97PSVP)#1W P=)X6]F-
M6MG/0]</R8<A'DZ.)5E$H2NOC)P=I9PFJ\=@+4TYI]' ,+4"-9XO&,Q&@A9J
MN@&[6X5VYP_<;]_J[>MJK2WV-?FL&;"69!/B\SB+3%@WN74<%&JJ;5]9V.:2
M(%MC\N+7;KH;NLI#;H:&CA3R;Q$T50;$A=^PI8[#HP,'%*08R8[A"1ADT;7,
MT/7@*68>'_ A&05MS.TL"&.0Y8[$F\$ST>I"V$ ;,'8=*;F3G1*Z7664A[D6
MN_@S-GA)#MDH'HW@C+![#7O3IY@;:JH+"PD5UA5[,=;C88Y1W @*MMZL/DQ_
M1%[8#<4)+>=&ST3=16W=%M2A4R?4KKC[,:5(<UL'/5?B R89= U8T]:.[J[5
MSH]P>524#5;'3_K-#>\S)7N<*2DTZ; SI'SR[E(M@LU@2R++_KKEM)@[(\H0
M&A:8A($5!W50L49_$S:+LHFQV1U=X0YH]2]Z#\(<X8JQ>(.M]KJ";5:Y/Q'S
M>6Z;'7(0 ",(:>3$I!#Q,AY6#+9E4N<D8D(01XC:IXJ)E"H)/E;=@G4@#RKJ
M,+H;RR*1O4VEV&I&8N[_1'4IJ(%K >I.B3_/-2)U-;[,\K%*[1T,E<6ATBR)
M(_,@O'JGFN$GH.ML-"*]:&AS@'(]J_)PHA@[2IL /[R(Z;:8=[Q$*VM++A$4
M4""'699+(#4M5&C<W;SD+.>,[B?C7-'I'SHV 09J+S6;Y((H*&L?852WL@]-
M$P0$F[:=34.=ZE',VE.=9VB_;30$H/AAC;QE[ !M2'?K&JD9:T9D@ )C);HZ
MJ*DX'-@:0-H.:F&I)$=8WHJGLVU#] 2(I5FE&%A\0H$\501?:+*[]-1I_Y=1
M\@EASDFQ&(79V/;BG1)=9LUJTU6KWQPL 6('@>D?Q7B=&.[&MTBKZ5! TS"A
MD[+"F"RV.NFO=8BL\2!+*5M&H)7#;='<I5TJ9Z1V=7OCNSAN;2**@V"27>$)
M'-26ODRWGB7A]=9I,S*Z22''"!@2F,)P<6)NWPT^N434X3R/>7F%.32./"?O
MA E:!2:]U5"(N8,Y1@>6A\<E")F/D?8:!UL* 7FM'8 4-MFXER_M)$MC3-"(
M&;^NAF-MX= 4A2X%&=%_<-WFC/@#NX>YAPJIQ]QDG,I!FRS(/MUK@-W9-TW:
M$O/:#!RJ&M@NVM)6@R?:I!.N0[6,DC41[&U,E+"LY_?$H%_4+G3#=KGO)T_*
MII>:VH^H_HH-!_S*Z9TCV<U. ^_NE@'P:Q+KRGKA.\55<_O=?NVX)+K,",)&
MIF[=-CQ[9IIFMO:T>4S+U)8Z;$?Y:H+A/"N9SC?EZP-W_^A,=XON)?2AC.BJ
M6V7'15%QLK+DTW;WTI$,BV9A2-V'OL'(N&I$P* ;<_:VT?:OIXN:FD*3:;1T
M!L,+<CKCW)''SYNF! HV5BW_;PZS\J&P"0FF)]N9<@X*MKJ1V#C1FZ'6BM!4
M:_BB+5@Z$^-6J4NS!HX;N6G==WSEW%SVQW0AHPB9DRW!G9QHPX6K%]B6!QF^
M27^+4] 6*]LSJ/9VX?N9Q.H.,NBFOFO0'<EZ%8*R%?F-NNH,F5K9:#,F3"YJ
M\$97%11*NQ-=%/;W=GMM*AT!MT;[^*+.SJ>8*VS#(>7N'[&P@4N.,JK3V*P!
MU17T9^(TRJNCY=912.-BQ"*&AKXFI[E3Q+7N;ZE8@F4VJE#WD"[4^!2K/P/'
MB<'RX24UZ&P= )BL>: D)@0.5&_::]\^2J%&T& 1-T[F:H>AY#5.);P,8]O0
M8$O[M1$L24>+,]0_?L'$]C,RFP19MU'MTAK7F"]'JL*.$Q:.7K&_^@HCS V?
M(3 PKB8;48(WPMQSH14!]$3<X+O+9W-L#1@&UYO7"-1Q'E93I"+$:(MT$8*U
MW>>L -L>?,.N1M]"8<78K*DJ=)N46E32.D+4FKU#(T$X\Z*9XFW,#&__;&,D
M//_.8#<[;T2V[1,7^P=I!,H<G;<0<S9O/I>G>UP9)0.2K)N5MAA)7M.$/]SU
M0,<Y]HN1!SW:<TNL6'F([/K@Y+CWYB!@I:'>M-X3^?[>AMW&(+,[<Q9;%LYJ
ME)\_7:+NL]N<J.OA%#Q^LEZM/#C8?=*#]EP&:L"(6 LG0-P5,V89*Q\+-P6#
ME<H.NHLT;*F2]$6:9M*_-">+/">S@)L#(7],V@6NW*[%'S%.G=9V;FV/"I"I
MT6G": IZ"!<VT8)0O6Q?%'<@=CS6<8@OQ9GI_S8/&]M,>E/'%G?I/T@CIKJ5
M!!>)K$PB59U>+"<MABG"9(O7S14H8L'9"H[#'*N2J3@:KK=C<CX%-ET8.C-Q
MBTT8_;F>&L(*DR?'EJH$& Q.V='7*E<IZ!'=[KC(E%1P#JHJC-VIINRC:?5-
MAGF&VTC9<U.D.I(BK21#]R7B(8:V7-#\:BJ]!O! 52&:GA2+17$Q@5.$KN>P
ME-JJ5):4+.;5-=@PG@9]&M88^R)YT87N^#N,8!-T5O3Q1)6\W@S_^2Y@H>T0
M/M3EE6ZHY<W\C*:>;US(K'B/MBTR.FN,A9U 0IV/8 FY%'9)L;]-O9)*G-I-
MC($'T8A !EG=RG:RLQJ1H0-4*_U*0E_#9+_FPAB79MZ>7D>'$-?;/2Y8B,X%
M1WZ=HO'!&LV//,' 3,5[92=FRLK,B+%WOA!7<,A^[Z'F9!UDR#K:I8ZNW/J/
ME=" 47O<[;&] L? W+'RC#I?L0EF3E^#C9<64GV)#MYZU.I]L"YQ=*F31PI3
MB;"/MO%+HWLI+\7OQC:Z60N2%.R9IBK!AH%!PW\A(E'_14#8% %-(Z5#''R#
M.(D<:1/>;7HRO9@M;@DYMS-,/F)93TY"8BXA-9>DDU!'4U40VO>@'-;LBKV4
MA-,0/-G[JU4_9)Y3C<$K:SI1@3?^<2SHGNW0S*IHFH1W<)%<'[$$AB@2,*6P
M(>(P.:UWI<255"JS(_Z;$*XHPEF;?>F(;<FEIIX)KKC PU[EV![0UL7O[S[>
M>W&X\P@&VWJRO37?-NV+N@>N;=K0)XQO-@'XYW![:W\[V +AG"AJ>B53 7L4
M-(10I[9HBV2<_/JD]2L<:=/Y4#SE9M1MM_&2H1)Y3G.)V>'@D'9 Y:UU0)*)
M^=LO1+Q]9_E-U. WCA=C":?)PK#*<RH:]Q65.B?*^/VZ=)X6+G"#<4SHMRE!
M\MCJXSQ'NN#H'5[/02$W<.B%>#J8YE< ]#[:O<8N[CS:W^0VUK47# 9MFGHN
M@6?"[G/(#3$9&9>-.MT%PRRM0"G]C!C'>%JY-PF?9#6VK'G- P=NS$RY#49%
M&W3KKI7I1N=<5^?M*-([9K6+6F-#UZ]HZ' KMM+N94MJ&O!J0F7@M2J7M)$G
MA5*L-,>>0RL!$W^I-Q^'_<3GB3T4[6/A*F#B4ZK$-X+9E#K8+,=.W"\[14G]
M9:0.X1R"V63'68N;O&:GT%NTZ=X;@6M@.>D$2TZ>674/EU&2C50%;!/8XPT2
M1SWZ?M:K$O2F8;3>=&.+R/6PBP7GB?'5%MSU_//+K+D!^R.Z'?4^6(V3<.,8
M>S<,%*#ON;;(W!6[D476$7KH7&3/ =,1Y>,,2&Q=?YVX0].4>+JW$V%O33<<
MT6D(=IV+E8:ALY;KK$-W<>^JSJ;["1;P,9,2\L,P!+LNM^'EWSA:S]S^HV*7
M$SJPX(IBI*S[C2.%&XX%G;B)9"@(;8>CJ*&YM+1,3H&3GO*4N$-N;$7@&(NE
MRFFPQ7B:TCN,KJ7<+J1T%,N*W'ID.PV%C0BUEW7)Z&KO>2N-%YU$AL'@DZPN
M72<&^QEUQ@F(,U.B_"]+1_=SN->]/Z>*4GZ[N"&<U'&3H45V F9>@);I4TT]
MR15)1'^ZZ-SS^^C<'U9W]*U2U_:?;RYU;7^WSYEKP7M08722J%1G57&#9,';
M14EUG/=HDHFN]PY+D/\)[+2(.%#5J$ 7/XI%SB5<T!$L6)KJ(BL5.FZ3J@ V
MERPDFD %SFP7<KS *X1&QPT\(#/=^DSA2'=_*./J8407O#+FZM!1@M5U@C G
M9F'"+>\C;TYLG18$(L.][;WZ[-^=5S>&, /*4)<M@50D_+;"?W&#=0_J+^)=
M7^-U\*4[E=-5;0MOL9IY0P6OCD\''[+@(H<9;QH62AST9,@ =P MRJNE8O,C
M! G'FSOD].\RKYC\Y1?$/$3W/_4[D*KY4<66#E+09<SU>LJIX?=HPD1-FZD1
MC;YF-6C:1Z+X5KV_K1+DWPT*.:5O&@/)%'',6)$N6F6G[3Q,3V]-C<;(GGAZ
MK#730 L=TYHX.>]\B2Q%E9)RIQ'T%!1& 4==-?HM/A_7#-7US X[0Q%*M$L;
MO>$C>IC6?K_<SFQ%#1'UE+"%2$;[UY^![,I6 A*E)Q$&+UI$",WO_[[;.F":
M(7'9S! IY1Y?'K:&-UA=\+3T#L?;2=-K3KN^48[/JLL-'V-[Z>ZJ/SUM07I>
MY?-XKC9<#4&Y,$N3@?JIM_<$0T@.JE<3;0 (I9)I!)J$ /.>.F!WR+&JF2D(
M7%((QZ>S("II-71UW!-W]=CVU!]YDOY>I7Q4SC08/"!%#@7&VFKV/VO!8?HG
MY@!<8!!GT_Y'%S6"O&<F:P_USW)"VAFY^&PRGR.?_"C".J@=/STBP;Q1;/65
M4T<<+F>"-82%X1BCI%0BZ% <8F8/:M J":M$"ONC+$%<AKJ^JC5*JU9ZT$#W
M,JENA=/+HBZJ5:7I>X%9 )1 /. N]%-$@B"U'!BD0%P1S@!/9 ;J.F5NY@MZ
MIS2LS_B(Q*[[K=O=>)99=ZC""#D8K^GO&0_ B 1V>UJ; ]MY/J&J76\-N,Z4
MR\@T C53$<C"SV;I5#F&FBJCT5Z).9:"CE#;M!AL^&%<YK;/AD597[D%9!5P
MAABEZ#E@><WC,C+')<P*DCN4"A(U"\SXI9B[=JM.8X4)C!X$II])J:@@"*=%
MYD=AVS\GG*=*'GBBS9(SGDT&VY<[,^XL?Q[UU%"AM&VC(F#*U:99+Z5-U&7]
MS+PLJ9B>-FJ*2,8(:K[P*OWMA7S"Q#4Q))""Z4SZ!A$JQA018,F/U%H"MXD5
MGEJ;GU:GS/$)%&22:IAP![1Q%7-]=DWHC*6PC<U!E,7",NZU9K!9PG)BYBO;
MTB(HU>=!, --,RFE?(33LX-XB@53IA="ZTVXHK\#K;3-#BQ+JITSC":!>-'P
M#L*CYEDL,2AL8&<U+(L-<)U)+YELL-#8ET)CNTL=;(DO-=6*;A+CT<G0GDFL
MDS%?+,D(-H0EC0;*;Z>[ARQ!+$S(<HOVU-@-^UBOVXU=2@:&X#H)[5N6[CMV
MA0!S/8]-CXPE<R#\-&HG@!_]'5Z'RQZC1TYT&=YDSPAN5!%TY/W:V3;Z-;''
MF-,O\%OLM>-W.+T)!6=^O<-P(5O=7$&OQ=:=%1?][2GWB5)(-NUSSIQ4%CJ=
M7E6-97BKU+@E72+KG&X!+HE%(E$.$)TH2160&70P3D$':,R1=$Y2!EUS K6V
M:19YP$Z<A&!>0MP.-^/B!6;>(_^3/I777QA*ZD''.S4S6MBV/%:QY1S?(2Z0
M:,X\#M4<9HPV!I\QX8#Y"9@3*I9JA=433W'6< LM/*G']OGT&L.869P@#]F&
M)[Z-18V<W0ZYG>^ K)<6?B'%/',X!& +89;6,,\411N\5R26ONH=,J?2@1'>
ML B.-I>LK"*@,3C\YCRWNSV@-=ZZYX\.5$Y6_#\F.1)H+)P3G8[+R=KJM7N'
MU7*'U?)M-M*-\^OH0A3;MN2VD0(,W[MN@F7;P;S@.K#HMN/K?::-R;1Y<=<S
M;3:DAW@(_#:<\S-GH3<\6Z!#4K<K2BB0WB]-%'XJ00<C2(K3Z!.Y,E3*O86I
M-X[43Y ID)9B;^'O4A:1+!CHS:!>DWAT CFK! QWC#05R8V$7ZQL%'U ^M.)
MEB #-PMGFF'71KCYSFJG/>V4=83)_)%)>OU([)D37L],X/Z(VXL:PQ\CZ9MV
M-K]NY8#7A:'4EX0\"D.=9%=M."K/GTS.D4:G$D.:#H)0HQJ;4!I+$#"J0,CZ
M--C:WVNV%2>?\#S65P:QB]9Y=5 6GCD'Z0$'.(\3O\?**K^J'+>X3EU>,B>)
M^)"S@+3H6MMF\UONBL3$ALFSQ&:G2),KU5D6DD&LHCE#,V:F*2VO5<A4@^/
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MFTLJ93FT%_)(::X\&]@OW)'J7?J\>!=I" 06"N!QRD_# >?1[ ALH62B /P
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M:HFO0B4&\-X,]#*X=0^NUAY4/TS]?(*'%G/C-\"8LQZR/7^M42?./2"61OY
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M4H[$/2,J2$7D3E4D(<YTD&MRJNLE@V0X2N O=O7P&=4HK^;U)LTYML7KY.D
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M,-.,5:MNMM"E2/BJNFH:B8BA* JJ(5V5I*W,LD@:M_4TE;!,%"W@'P(SM'(
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M:!']]/CDZ0LJRB+5B'+B/5;^*%?)A+9Y^N0<Y4>2[9XKK"GG!M1@D/O<_"<
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M'R?:X\N-I364A]V6 !2?!A32.J\C')F0&C.85NT%ZR@30*4O'/?88.^$RUG
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MV":E_N=VYVTG^=;S]K5K"L3:29MSM3]3]+ND M!1".=UP8Y70L4</ORAY<P
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M!MJ_IFNC89R),G$N203?VYNS:SCU98;*1>2@(8G=EDM4P578;(5G'95%(B^
M8<\ "MYQZI2?7!SRCUDJ&#VM>;4ZJZRNR^PMJY -(B1JR;YC%606PR:$1,U:
MBE# 69=%--19B>"UL*HJ-^?!V?W_0A2S2CAZ(=:9M5W=#YU<?W\EQLL=NXEO
M8!&/_@1(_W<)>'K#-_#EZGD?ER 4XL. R'6)ATR4Q43GT'#2KO8-8'T#O?U6
MPB"C&VETF<>2'IBJHI#2J\_])TYSW0,VDXFQM IPN"*Y1-E0L@89;V/5"@DJ
M%16!RS3.05)#<3>+)"UPA*+>$8YG(?($[]G/I[W[P(-A;?'ZO&:Y$>=_A/ B
MP>$6N8JQE3>%CM_1C($-_SSHG=[G]Z"5Q42!H.GN,#1!0SL].3TY@A^G3AZE
M=>6KRU)QT$KGE0R-7T[8?<*:[[GL-(?9&WQ2O2*&P(_+8O45/F_/GPWSYVT&
M*_XYR5W+,]B/HR'(@^^.Q C(WQ.1+L32W/N25KO.P7P^J=H085IW2 9'9%EM
M.R1P)J6 MV+B Q7])SX4/#^'8XI8,,[A/N9*T.EBQ8<WX> [*+];"]%J=^;+
M,X8-K?8:LC36<YEG/&O4 0!-*-0,(#):IKP6I*(J,1 /4D41,7%TA.@'$,/"
MX6M4$5ADG41_EX!6)'X6^W:F4N(.(3BX<- ]!::^BA0\B8.6N%-W9G(Y5W+A
M5!#A*&$@:(K*T*JU?D1V''#^TE0O2'Z ENJ&0QCC+7R8E=,A'" X.F8B4#GB
MZ*D;3RS2F%8NH4:LS;(^,M<?^Q:0]2W5]/LL1\5CJ\8&]@1IK;;:IX3&1$9,
M)MQN (T;43OJ+:TB0;9DO(+ KP'.]:Q5CZZ0-7WFEO(SDIQ+.#/%QQGV=@HY
M757:H"U5!UTP)-X*J+1&6$'"'J..-+$Z6_ID5!:H9K6PGH[WT9 0AB4E+<+&
M1U$Q)/C?!*WUHU]PAB(%"B7R:"GA!X*<M5AM!9K1K!F:V36QE-51/%0C.V%I
M+M*2*,7/YPZM]8E"B;C 5_D=_Y3(EJSYMXL>MFR]#X@56LK%$EQ.1!2_:*@M
M.B@4-O.ER5!T "LK<.RPX@9^1U'S\ =Q>GZ][:IJ)\>]0+%^ZRS0 BT5AM4H
MR]#B[.4A5D>P/'3"-^RC])(6,=2;<]=C)E3"O%RNJ".1M3-YT'%<YB8Z.T$<
M@5XUA<Q;L$D/K35SA;2CFLA$(&R"RV[M>&UK -0@39='DEZ2J*^9+=N-=Y6[
M&#1U(W'-:OO;J]]RQO5(0.">ZGR&QP/:1[,_W-0AVMU&\#O<]/V]H+]L^P6]
MMF;-[; A?3EMIS/7HNE[!&>PA_= Y9+=1_"2,I2NM**L"+77T8BI1"6C(LLX
M"XQ&P919?E# 7LFOS8W6]+JTHC6F1WW<#9->(V' E44G@X]$0,Z "[VTW';@
MCS*?2W;W8^]EM! 3&(&.D;O#+JFLE(06<+SXN<-2!7U*=F<8%4I635L&:\L2
MUO@&NJ@9O%BA-#3ZLZ/ 7,":XKR']ORU^5.@G(5.%$S@:IY":]TDT3<R,S"^
M,G="%F['77Z;T"S0^PAV.R68*E"10""*WD[5"*=ORKR),T64:NP'GX(U$=8;
MP#[!]!!1"9#S!R>DS@X-2(J/GIPCA46XAM(I=+;$L;<UW%O1?'!'[/^TD[;W
MLVVGE[>PMBH3#@!OB7O=%^"?6\ L=\[0OHS^*$G0\LAHP]P3L2;Q2&@5[=&%
M/:URO9]Z2-<!ETUY4L)-ZN/4GW>@L>!\M6BSOZ5^OT77_HUB2U;VCT)D3K\#
M*\/6T)I=<TUXT1I*@F!0ET5T*4HC-TQ[6H;W$22H-I.HG %[?<P2K_,HF.4*
MD.@B1V5;%F4:!($]%AQWS6#??3[WX'"&_!'E,YH1M.K,\_BG"X.:2A0C5YL[
M$(?0)1DA4Q I5%IR;!G;F]9[JGGWY 0DV)BQ9V[=7<B?&T=G';D##VX;O$4Z
M)M\U_ *_@9AU, P&-%<Z=:"VAXT'(T1G9KJ0&B/+9N@?C?%G]+<IR6X*??@6
M##7QI?R:89SQ(=H-YBIVH!MG.Y(@$8$$=) <LC'1F.#;.%>XKVD/&A0EFOI0
MJF,!=Z(S:8K*13O+[))V.-*'<N&!#-8,N3"ZT8\:;L_4T<&(1HT39#6>,OY-
MV)I$%C!$>!@]G];Z*2I$)#!@%.C;KU@*T[0^Z0 D6$L(@R)9GOS;K?(A=NL]
M1L5#H(*HD53KWKWT5DD["33=%*HHR6C)5)KT[=79E 6<F4;L#JDW)@)^>V!'
M!K-%+4QB31%^4&I4^P#7*SC*L9A1)R@R2QP!M:%D8A4.&8K/&(" &A+4,(9Z
M![KJ-(@Q+%F6F.H2]_Q!KTS'] K'89*ZH;$^=C57FEJ_!ZS!0 -/M!"P,KF+
M_ZR4,,9@W"UIGZQ8[]8"+XC51I%[1""#!N1H;WGAU>[QPO &,+#Y56OTFL(3
MO34JUL]@@?@'W\_0#)>4LMU1NE*^[B]DN][E8XI[NHM'U/\+SFIC+@0P$CE2
M: 0; FY8U'N 8\0LL8V[=O+&5N9'#%/E<3EE7F3J;+,VJ!9V,43' 'P0O0"(
MTS!+#%OL,>QJ?LR<%H99]2C#_I!/CCYB?,UHP$X&W*JOOYOMAX- 9&.A=# "
M!ZBI+?E>P2ZI5H^#0KRC>#4/="H7+N&B0QP57CU N  4/'S_T5,"Z3D:;V4;
MA ^5]<B&:Q[K,D?ED1A+YUXX$5D;P!3.^L$=L5\)6W)QP(0K9E6*"RE! +[_
M^"G#=3UO'1B(QE,*H='YNRC5,4.#J>;XQ2RZ?X+&#-<2HM/XD (@8?KP_=AY
M^-6#.!/$T("7.P,S62 ( A_)[+2W]'WK;;E77=SW2@HX>;!;5]YVM"T$OET7
M!#>^(OJBA/,"D^6 4Q78[N"((D%LYHYAG\M"MMOY$ER,SU8)="*=P.Y'=RI'
MP38/X\H!+E7$U$KP3MJ2QMC EU&9Q4Z<;NGF+SUDJH;;ZJA;P)#08CR=ZL0F
M>6F(9#^4[D[I?O8=*-TW1"\1C*!G0T;9S\C_Z T&W).0[MQ-;":/-Y9%GJ]8
MP4-AM_O2.0)7W;[=M'^?;SN/6=W!#7.2O84;%_WM/@F7-3F"K_%;<G%IN>6O
M.3I[6U!'Y7:UGCA1@(NZ(\N;,A5HZ' G;YBW@%#58(Q_W:P18V'\;R>29(NZ
M@^=$H.=147=,:<*I(<FH](SD"%YT2P=!A'WR3>%3Z1%Z0FE9N;:L;/9&SH3S
MW$<UO<WUY^2T!B$_>7SAL-A+Y.\98)H;I.JE]!: P>-'#SBB&/W/$;&@[I6E
M2W2'9?QSX/NOFJZE#ZS"@$8RSWDSK9<I:4[M^X'K3M\-FGSV?;J_%E7^ZI%Q
M,0RV'Q1R*0>?0D]6W(G01:@!2'T<U0@D4QL>7;M&0'< Y[HG55,-CK(9NS^N
MQ YPFB&KLLXTX,><O19M1D;K.,P)B @<Y]5P4M@82A(#PJR(,%%@]5ZC'\5N
M=63S"2Q0\#^<)U@R,FY@XE3#GM4PE$H0/66O-^Q2X&4;?U37MB\T:,VM#[2:
MHA8"I@/=SG()&X"GY^S!T13HP<3&[_711% //;&#:+GRA#\ZSP"J[EG7,!-+
MCBZ'=72^BSA?]O*K7JER*4Y)TS^4_ 8<]H#\\.7!=MN\'_THO3]FKL>YF.ZO
M+G77W#.V#A:]J3Q#/=WL7X9GV5ND0AY85Y^U78^0;U5TSS3HGLO/UU0W)M+$
MN1HR"ZH&=A&)H4;N>O_1TT\^TX.31]M]J%402GB[8/MVFSJ/ [\X."U0.78E
MQ@WYVAXO7K!Z%T G;61.WIG7A()K<I\7*)0;?9!YL4#N9%!S$E/"[S!ZCY.>
M6<L6Q\H=N> X#D[L55R@(N#HJ7W$;N8^9L!Q""+@I,$G=34S:+0I #CBM,!'
M[(1YY^2XVT/6Z+K(GUXTT0N\LSV+'^KBLXTD<OGK8.X\S74ASQS3PV&3?BV#
M[)L("8$5S:H _F+-R;8J<S^KSY'?=N#$5D?VYP'%CT5I.05^7D[=#O8 %>!6
M!]%D85(K.+1Z-,+TTS&<4KK_EW^^N+GHN> JWI=:0)G=7F=XJ38WI!/[O.QS
MO^I_E@5<N)ACUCRJ7!5X /Q7T7.8[WM=I$_UY! !>:3#3D8*LVO*E/%QJRSX
M1;VI$<?]\*9N4^R>_U#L?JT;=MLI.5E$9P#2O>BK_A%2P'JT:WD7R0N<2?RG
MS*_%^S#2EG/ _$W)P!2,5[Y+0Z&L/:HV7L9H=G'2X^EY34X,:.5ZE!51U#_B
MWJG54ON.':H>8W9:'@07+E@-[%64)R4%2;GPU+J*[NTV8(4X.RQR\*; R \8
M?%CC( @+;DC3J#I".&%&2KK(?_(79:56",\O;6B)GPE/FZ=7Z];.W]8"<*35
M+0Z-8*'+-&&]R1#K3<PP>XLN#6T?'!%E0R7]5O+?E1!<0T*H_(+5+M>M=AW?
M?-#"]MM4?BPGN0#HCQADF]13NR->%BMLQ1G!$9J-+@4R,<6**L/:N& ,HX8J
M*]27]:,OKRG?$/5Y.:IKH[Q^[PWG)<8 >.LZX;1\!SYELR3_;#P*C06R<?M>
M0PH+:4K!RQZD01:)GG5R]D.7*8,P_)UWER)&00RP("ZX'(Y:UF26((C5J/==
MA"OLH/($,FZ-KIR*-,QK\A'+=-AC#:(=,Y];:^A;'3(\8IVB4&HBE]<#=8C#
MCVCX'TWO.'+[0$$CP?7S^LPXI,KTH?%G8D6O1_>%)F.;.3"'<$W^#,E(:U:&
M.CF1[V>J4BIR%O?F]APT%?[HM[!N0WL?2,K0[ E;0L'1=2*++M )P+MEXRS3
MLGE%*3H;X()5!&AU$\E6@(FI,&NY$U]LLAB@5K2!M0'XMB@5KC"6HN?2$FMR
MI[.*:!PA9OZ"%UH018>VZ$5CN,,EGXN:UKN5$-??"[0#-(U>= 4+0[F]S@85
M24<O[$9>G_HVT$<PPH;JM_72LPS>OT,[.!I]10*ZOR;370N:"BQJ%5G"DWPC
M$19*^)\C>#:? %7GI/+1I"DC5RO@7)WN'-T6%/*V1?Z8<M)1PC1^%41M%7*[
M"G 3XU2H*2<#B\C>%+#J=HNKS4\1IJ:X,[%$C>[9CBJH]2$#!!+$K([,7<4D
MQRRN9X=-54R+!XME?W4QHX9U$BT-\5J[?#9CCT4N*065M.?X8:YTQRQZ*V9I
MZM#H7C0L"=>@Q_-<H]>H(MTBVOS0/=IJ0KSJR4,@'X"&W]=J7]SA-0S+J(=
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M*JUL2F-RG:B<(%T]P1YE-A1Y/.$T#^A4J&?..M/&&>X_WN=%'JY99%.F:"U
M%UX*& P+/:)*S'M9#IL!PAWKB$3C'S^=/WRJ\SU>TKAS25^:@#+ <8.5(M6G
M=Z<N36<^_Z4IY!1CV$!2GC%9-"6*RDAZ7,(0@VDJ8AMAN4IPZ:/V\M[!UD1
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M#H?S"$LDBYF13]PO3Q'$I6+Y1&5T0NBEI_7V[L-QFF-9P5BDEB+0T>>O*UU
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MK^N"^!Y\0;]N*IOB)M/P?NA@"9+7QM9= _R:"+!H6^->]&V-VP[_>%$ 1;?
MS_6*SJ1/C/1X>&K3?%54A87QTW.XZ;/H#3!$8,^FQ4D O>/2U7#HX);FHK &
M!0C>M*B;%8\<J!.HNM(SYR3&HZ=?T0_"./2?_,5UUUC4P'%(%\LB6T9C< (B
M?IRVL/?UQOR[@\5PB_K&9%T#YP:&?0I'#I;G^.F#!S!JH("5J7*4MGINFJX4
MPFC,65>F?-K63;WJRK-4!M"8#IYJ=O-$G,+NK#=*)'3D@7NDYT#4Y,'LUK*$
MP(X.$Z!KNL^<([W6"UILV-Y%"9P*%)3VPIB0386OY35UK GY'&@$R-AG$T\
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M)-! <R!4":5O=CP 8=]IOK*-L3BU/D>;I-LF.Y1/8"X$B/2"0F2:<)MVH B
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MP%Q'3JA/XMT2EQJ<SF+\S"&_!FWSS B2T#7RF?K)6<.#Y5:;K0E?X:794\3
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MROUSGY7:VCAL "SN-2+E.:@ \W:;9%63HA%)6O U!D9V_T1 QV, ^#SM& K
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M^\[,FPXC?@]FV-GR^!!8<1"1[%U^,'#;!(G9(WCZ#E1R).81^*<"@A[ , :
MD!,U7N-6K@/\Z<]P9-7G6+. : TX9>)O*]/VE;%4Z$!77K)"N'2>$GKE58/-
MOF:3BEO,[:8K'J[-[4:83EQ.P\U #>?G!'ML"W;=C->CKFK+88VJ=7;ALAB"
M9XQJ#C[?4C_>][BFTAL:V4/<*G/RQ7-#/&L0W:$7L-GX1_W]-T0.CPYW3?=V
MOBG4;MZ":65!*MRPKS_D1E@0@N37RM"\[B45"'-&U$$J$[HKTPLN030V<S9H
M@1.==TQ;ET4,?:&-P"_IUS7EK7+57>1A-*:G8X:"&^S?%6J F2^XA<&B"H+0
MODXEYH8-#NEWXY74XX=[Z_T(MWS6@_'5=.9^*G=@)H2Z/1V\J4&Q7]:0^NUR
ME7DQ+M"UV[4^2_Y#WBG C_)BMZT^NYDK:5!-X?Y^@4Q1%!!M"(MLI2Q612M?
MXU:[P0,89)Z7A5V.X4)*>C7\O5ISCRLWAB&U.2L!_7&[V:SW\8XQIS=8@( M
M?L:9%*,H"7A\0/FWH-G2\!S6(/PRKCWH:X33A13'C_7^H.OT2P72].VGJ? C
M>8VFY?'C].#8]:!S]:6<P4ZA'C@KG>T!=07%&0. .3TW5^@-[DI'@@G\PA/W
M.3#29T>81MI.=6=+&]>_C0H;>HX&;G'3,U"6W&W-644(?-=5I&=-!#YX-:CH
M>#CHGC.@'VBU0I^.642!2M?\9NR[6AGX"] /E@H 2SRFYE8/'*/'%NF^AY)4
M_X\N5*!V#<I!1E=M:^Q[="'V?!_Z+2-QB*A!I27'U'R_57ETT!\I@(C-0]3_
MS_$)C4\\_AR?^$A,6LY3FN,PR))9I7E?A7/&6E!A]R340/89\I?-6VKQP<J-
M:JQP 2@KC_$- D5R-IU0B*C:(YUV M,[; &T%?&<F9;PY6OSE E8/O\.>3YD
MU -V0UX5C[&F*=83GT:1N#0EL3.'%>WA^8354\HH+Z^(3^I_-^,60N?23W1A
M<LR'GQ&?!U,;09?* +D95'=$)V<H!^Q:S?F"%>;&!;<%Z]ZF[\.;?2',2%%U
MVZM+IZ@735H;7H?RHI^K\Y@EH&^)"%-C F-K'!1?TSDHV>A5Q0H)07W1/ <5
MD>L:ID+*->K/?F)H-.VF6OMDQ]3:[SC@V#%8N=-CWHP>AQMO'Q]0Y).$L-XY
M<A%C#3&EL9@?ENM*B%7!Y=,^[#:M =KO)@D+RQJ#4=U0O]/4D7/J<@E2KB1_
M&2$K<498O=CZE;OB=9PN67JER!:!2A=$T9#2%@CBA(L6@EI'ZXR^R&[M OC/
M<9-+N?579"";69SD-[0:PI:L_$B4!C^J%8>^!4ZH @65N!?LIZ80H. 4[3'H
M;CG6=T?N&B<IKJKV-.2TY2#1&0$T?"]7OI#+R**"2*T#9D$$4J#IE>P;6;:[
M0G_3]3/_"&EJ%/-[:"(S'9),&L N3 &'C\90O^0HL!9:#%JB7K,.2N,U-"R!
M%B#S$FZ1[#J1S3.GU<2A9WE)47F5S@62QD[ -8"OAM'')K*M@TJT[3'\\2;.
M>FH$G2XW*TI<=F<HTFH;4ZSFH#W'J'F!T3AWRZHF)'=Q-#E%#TPEE7(<N[,]
MCDZ3$#"'J8S/JJX.L,4S)_Y$+]6&D90'BJ@!E9[^97K.6+\L4%R/:&(09V>8
MBME.]%?VRMQ @V593_" ?N1A8IZ3>7.3I:ZM\5WA#=,5#G!@I$)UJ%J$I93:
M/65LG\U[H"E;4%=N J1?3-07#83;.!_!6INH/8)OB*!([MP(6T($JKJQJUFY
M0I"<HC 98%$".;5&0>_)[P):=HSHB#+*&O-.#%+7_+P$TB,UAIH=D8;.\YTE
M_E05U>]=Q1-J#)@#"\^&N)&V:SDQTV@)-W4J%CW&.$C2Y8/FD65B0_3RM-)K
ML2[FU[/QW/Y+VD988/J8SX>Y%/E^P/]A:=\7JV[5SS-V[J@85+.7X3Y86G:-
M<=-X?-5%G>R=:/;!)UX=/A8(9"/,DR8B\QJK7AC3[:ZPD/UUY,@9YV%*XI.&
M>IJNJH*4KV! UFGID4TZ)J_EDQ01RO>]W\*E++BM:;F'6&H#X+#YIF>_BK!;
M2EBJ/\1@QZ(%U$PU4 G(4,?@>HU_#1>5FA,7W*]"MVU*QT$#/V +_234)\0H
M$.R>.Q&!QEW5JR(+^[SR$?CL 54/Z)//'M"/)*3[4I7;EZL[(E9.@9:_W01U
ML4CT\?U!F"E*'\-S;/V!#&5>3NY MAO3 .2J@+=>P$-1!]^A<<GI(C:Y@,VV
MWE$7JGVS[2KF#'2^+*BA(TD0)I<[#Z&$GB],B)ZU!:.63.,+PVTU@[0]A?&Z
M\,[,<)8]V+.>@:DN:WE)E*)Z86RTOJHDH^7/W&;(COK>QB<NGJZ?(.6&6&LO
MKN1V6QR4OG?[O.^O9"@-AT_A]:4^.5"&6:QS/#AZZ**?:3-/*V,/?GE?FHT&
M/D^.CDX\]./31^[V%W6>'WP'&_DN^2>R]C<MT&$+C%I:@>4(<8DPJ* X-G4K
M+SC-I.1PX/,%T;*;GM$O=\PS>FH1!]RYG48EZTT'][F94)$'6,%1NL\$4&0O
M4NT#T&!"BI("1+G@VA50!UY52*QI'$R(8M'C>!7"<P,CRMDAE,[784"WX'Z5
M;<?=/?&1/)[6T#&@S)RYTE5V*E#Y6)OLJT!?WIFB_EU#D JV#PCO%;#P$ANI
MHO<#."+HQ02K<9-';4!Z M./?0*0XE (H0%@N;4Z7'1)W)@T1B('B!CM.2O>
M6>G&-W 1D^PIM&,D-Z5#+$<Z!D55U>=R)%"-Z%KV[2*JS"RQ]:*%HPXF6IZ"
MD4YEMD'C SA.Z8Q:*7!<<84"6/+L"?C4XAA-MJR*?W>!TG%1-^\L6+4U[0H<
M*CBEXDH?W2OUK/?=Y>L4=0=NP8<1V#-,@J1_LJC-ZO6&>R!@,%70GBDEID4X
M M"44DG-R- @@H'TDTQF#LJJE$[0OV."?LF933P=>)/8D)=8PJ@H4O,TRF<D
M0X822+BU,+O5U3G'"T"F,K^2+,+. B%9;A #9E[&B*LYJ'5EO59RCSK^4H:C
M0L&0HHF++W3%6@V&UKEEU3#'AE+0PO<!J5$>3ZT]:;D)MBP>?!V!83#9P#%U
M*@58>&_$QK9FA0Z;?W?%FFG%=JB,X)9HKQR++1 SU_VF3YGT4R!-BD":!",$
M8L@QX($8XM$]HZ3G@T.V[IK,:)_<?77FI9ZK.&^>RX(:)5RV#58&PXH!?)%7
MLS,X.SAA3Q95G0P& MIV8UR#8/0?$^D6VEW)I;&.#^*""BJ(1A#LN,):!?(!
M1%F%V$:8K _W3NPX'%?,T4ZO62\(4QZH?(U@8\V6<;A%8](/F)KO=><H?/P$
M*-WWR-[19H*=@ZXV!((D<O89G8JK'(->^C8[5Y GEK4U?3X],0BW%T.^\;>(
M8]B:*2BV+"67,30^"F3UE>?U9#].R+T[HI/L&L3=SW5U\(+II&MN&FTHLG=3
M\C!H+1,VAP(NFF4$M<41=1?L):YN386>-43."KDPR?QU4QB"D[PV&YYY/CQN
M)S@M0,&%:HK(7>J!)KS.%/ZIH:P),T0+@)QV!%P(VX# K,B70Y(-@V0$0H2A
MMIGC5PDJ'BTH(**-R64PP<\H52L/:W^D)RC*N (L"<JQY54N,@Y[N$&-BCZ6
M"G E)Y$)_RGYJZBD4;M0@FI)RTU+6&U\![P*3G"-7H&RL*UJC<&GV( B4<QC
MAG7(Z_!V5M_"+738\LA4SQ2>->P!Q K-NIN713;*//%)QT#A<Z@P3&V2T\>$
M<Z)XF$0_WQ*$</$B%+E _Y4A--,&1?EG?[3ZH[_\[(_^2"Q7>\)N:_I(6EQJ
M![Y#:>Y, $)J:CGUNQ\Q<KX'1#MGR( [(N]W#5@0Y?T;2D;EZJT;EO@OKF2B
M<OI<0\%$#OUZH%)&,0V:B_S!.' /BOH"%%U;FW,V[YU)0ZB@BBR11WGA_2#^
M1"<5W\ANS$')Z4J#1NHY%0&5 HNM_YKULS&H]V/4V0I.HV7SB,+MG$@(+))\
M"5*L.--R*?T.MN/ 3X-)0DX',,7PHNNT.Z.,1_J-<G*6!/$@#0>"C^-(05$3
MPZDQB$V.'A)R7&;I&DQJ:A_[%^W?+L=1'#ZDU#D%CFN]827=+Q15:TG1'2%>
M-1S[^RV6_.D^X7)<4*6/RTUG-9H(W"EC08F<P[35"O++'$K! 60X A@E?';5
MT^_)^=V"12W@>QKE[)\%M.#/B69%Y[6,0D7H!]S)DD'Z>E]PYH'>2H]U:_R7
M#?HK65J3H+07-;[H]>D<S^G@ R6P(O163>KNH@X&:\,^AGY917#L@RQ,-]L
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MZMJE)PO6_S;XK2WH3U^2H] UA&&LF+#F3TUJSF$"Z[TM5IS*H*@: W=?Y#4
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M_?'1CDGZM^G[Y"?2RV]6PM\1*WS7L"I?#W/_@")N/(!^21R4'3TEYHXH=+-
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MB&I-Y8NR;G#&Z3R2VC_;SB>O1MK,G!!207_C*D1W]O?'6KUIETY.=F1&-+I
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M398V!;Q<1,H3.'&:&8.BON46G1?^M&Z$/3VPOSV/!+\H+9+K5TX =7P@#:C
M?)^;8B$%B9J;A[& MS[2_UY'^YV$@N%XL34<+1*N)XBZ7U-ZN48Z&LSC5BZF
M -LMVQ"4>TR )L)W,=M$$[OE;BQ9*+U$*^X[J6][NJ:&*=7JID)--R?IKN',
M''LW,'4+-Y^9J,?C?IQ1S#GN2>-Z/_P)\1'2CW-=N&HU"_+!@>BLD9\Z"T2'
M41&NA[U^.BHB3"9R)SRT6T'A]!R,:@QLI7MRS@_ZHEAMTX4R&G:I'VW!Z/H0
M=Z4_#HSSK8209^YA!OW.)G(;BXWO,?_/NA;^8$E_*3V\2)RMJ8E72'YLN$&Q
M5L1P/]0RX'#==ESULVZ7\,Q2F@\>-CX!RGGE;Q_V^#*I)C=&#D@\<>HL)L&/
MQ_(BR%U+JF&TBXSA]A,\NT;F(F]\A_E_.YH>'2<+HJ=4!,CXJ1;I-.F!3L1V
M,4PH(,5W#T'0/(WC;IB/MX*#Z!WLDV8N8H;M9GWF_4=SL6^13M@2#-&0G<<Y
MZGJS';(1I]B]2]QK.9<W#5/!.EP27SUV^,=GOIRELINQ-4CA8%NN_;=<-,B
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MGL^P*33A-D-B\=K..^XHH5&2P)OO"T9//GO6T-SD7.E%('5!4ER&C!FQH'$
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MZ3>)"8 -0OC4?S3:'M]C/XNWY#)YRJ:=SU77Y87I$*G&2<]>0+07# 7EM7"
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MAX^,N\L.UG1A/S(6Y0 5PX H02LM6BGH1+J$"YUZI)(F2=U[$*RBNN"H%S4
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M&^K-DG%J8J2Q%MOE-?)+8+TMCL'T6PT$.X-#;7=)J,O]$>HP->$$E:NFO+E
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MDR=OWW\7?3>OZ^4/3YY<7U^/KT_&13E[<GG^!&_U]$E6%)4>)W7RW=_^@I_
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MY892N(&EFI-)VJ=SUU&;R?V0*,N:Q9). P&E@>@G*:Q!?\22"LY65J,UC,"
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M&7@^WFBN,R)!BY?L$#2%.ZD4A3=91)XJ/V)&@"9^7LGLXJE.L %H1*P)^X'
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M4<+-JO8F!KM'%2)2:<W[O7#Q-0/A:88RAK)DY,L2O*=_HM*1C>LB30FBIGO
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MY4$%^9-U:4HN0>C-FC0AN>1J5]'<J8M]Q$=1+"-I$!9;7=W KU\OX7$?%_Z
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M]\V[B0\?+&#D^\]P:WXWF:>7@6AR@A7345(+RYDFARZU+,CK8@P>DR>6%3/
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M5>\,3+*]WQ+DF]<9;"]!N*I S C+=+7#]M\@1,0CN"'7N5&SZ(<L,V7@)X6
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MQA.;I8+U13M\P@PNF-&N:LY!/%KPM4X"F@V&@:%F_8=N4QI7-(@Y&-+42OS
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M4N>*(/DVX,X)S!W;D,3,RI?0\$72Q.8A1EBSZ:%P;&1I)HCUB13'B:++8%^
M?61&I-DF]W(HS@J0-1I% ZHL4E\.9BY0-2 -;@8^>TOPW!E*8AF%XB166IGQ
M733*:Z$^:I%?CI[,[J'&WJ _!A #ESC;A2<D*C N2[6<MT3G\.04Q/J,YP7.
M6$.20C/$+C3WUMI9JI*I, VJP[7K9KJXII&!;A"GI3)[5V_<+V$R%M92<-<(
M9"M9NS3^E+0RZU^B7=PG>EM27+'BD9]$WZP=OB9::ON=4+%MC7FXU0"(AZ>@
MG@\KJ">3(EG!_\SK1?:W_Q]02P,$%     @ D(M85L,[ED3EC   (AT0 !0
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M ('3##P!GF@Y?0N9SZF!50&K B21!QTP,4 =H(Z6*SXJ?!@5>468"0QL47)
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M&CHM_(U<]]EJ#H=*<]\52RLJ:<1T@_#F/(2R!NA/SJ2RT&FU&^NBQ%>6<:E
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MM-'WZ&3YDB65XA*$"JRE7SE5KA3_\QJ9M#J+A<=9_B\^\R5XYG)V]Z)<]>F
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MP=BY;-&I+3<X6$'*K[SB?DP1G4_D"Y.J=\^J 3'/ W1/49^YM;>Z929RM1I
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MA79 Q;V%$F@!Q=(K1PKG'?18 A%4EPBL_B=!PJ[Q*C5L# ;2 AV #JI(!T_
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M]Z3'L^KB" K QD_U&.^$-$X[Y&L37CML]E2/%DZ.=^P51FS;<9VE+!=H5Q+
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MM@+[F>0%K\T+=LB/B8WO#A072>T_NVPZXS?L8<5J%U!RS81@6K.7?QZ^>93
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M+]NW0X\<,,2SR%VMI7U)(*.89\BU=+Y''8?K*W/PRL(M%9K6*<DUH^V#H=V
MV7]]/OCTAWT9W45V][O;M?T]*Z%(:NZ2- Z5%83A U:_X[[I9]*9/C&[O<W)
M*;2K78K'PU/2G_*3\Y^/Y9I\//W:5Z.1(]IC&UW%Z.T&O;':<4B#.SK4LY</
MN=BX-_<%+SLUV .%M ,D IO<;")U^SL'--+L</2F[G,=!71XR$6B2\E)]9"J
MGIU>)B$WM?OZ[:Z7'I[,NK:9SCQ[,&97S@[7DD,C;9PYMKM;.]C;?O+P9FWK
MR6//#;NU;Z5ZL/9A=W9J!Q_S#8N5TSP:^,P%%1ZG <QI+)8J:TY_5O:+G"ER
MW6>*1CS=,;%K(H>,*0,;'N3R>)!A8J\*$9C98 XPQP-8M%KPQ.:,.UFZ'1E8
MXJW  >20;[N8>WW>HP4O'%AX+6P$5-]2<A1K[L)XR)EK^:49>;>]M;OS<6\'
MP94+P?D+$S)<+8NG4HP&RZ>,( ADUWD!1L6'R"])9LJOI*WX@!I&LJ8!(+GY
MP94!%3VT%"P[/MI]'O#(=?#1OX(Z<I8@L3*S0G,R WN4&1U->_FPRVE2G*>#
M'9>Y<AP)#*119EBTG-()ZOZPGQ_5OH$S<CC07(]K5[<'G%$J<$@[(>%2&"<
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M0Y0=$/M@B)<'!!CB[0#B(Q@B9RB'5-B.J XN#D 4)0KR+[PB-GZP@#;O![:
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M<O&@8[DF'T^_]M5HY(CVV$97,7J[06^L=AS2X(X.]>SE0RXV[LU]P<M.#?9
M(>T B< F-YM(W?[. 8TT.QR]J?M<1P$='G*1Z%)R4CVDJF>GETG(3>V^?KOK
MI8<GLZYMIC//GHG9E;/#M>302!MGCNWNU@[VMI\\O%G;>O+8<\-N[5NI'JQ]
MV)V=VL''?,-BH;0  Z#O-6KVPW*V4/B(0LRYC885>C'!=BX\#E""N$P]R< '
MR^)@!WP /@ ?.%\J^ !\4'D^6)^SM.0X0"^O<D(A[@;<(QWF&:E(Q_EL738M
MV*%,@81O0Q==<@-S*=MA++@9IL4F1AD/R)=:"-97TKME!E&0)8J"!+$MUNRE
MV2#-#OGSVU2N%*)'2D-IL'@6;'TDN%O?96P*8GCQ0"I$QX^DF.I>QU,\0BW8
M16&;Y?M.BAN=I:6-P&-S><Q9MNBT7$XXM&,[,TFNN"=_!9?E*GX^D5BQ^0QV
MSE*8@,>N3.9-X97O0:[C!OG:^=:"FVXQ\([\[>3K7V,_Q4I+O$IQ6MJ&@OQE
MI^O+$+16)F2,^\4=<VT4[R8X@2]OT0R6 5VRV@MLH+<$##CTL--35:JX9EY?
MV"OVAF"%$IE X(6%4& -B(DUD;9D@QT!.Z+JY/"=ZKZ=KK&V0]:7!B212WP3
MP8$FRH0'&3+Q7YI0X9-FGP>^2OY,6WG"BH 545&BP/8);(>JDL+.[YOKV$8$
M!X #WCX.)ADP,!/ !U7E U@"8(&*LD"2=M9H7B:#GK,?W)/@@A)Q0>&U\.*<
MC'3PH>*!O/+"]SO32( $C56:QIKVH)L2N5:<!K!IP&.O*,;39GNB@%=,,ZJ\
MOBO ^^@!4-V2$'=7I+XDC4X3=)>OE$TFLF+37>%U\)CW[!*+#YB+1&14LU%W
M8]?>V,(\W7!\\*W)H34U0ZXFLX]@WXD4 J)?!_J@]OMB'&E?%C] VE09P91V
M&'_X>$@Y?XS_YYX16 <L^T# &@!K@%=<XR>X3Q1PA/UG-!'4G@?)XV41:2:@
M@2-Z80_J6&#%YGGTP%H[>+(&YZ396A<15KP)UAI]PVB"A298:(*%)EBO0P%8
M*V&SXQ5+!8;V/%_%/?=P;40RNJ7D<W(ANQ+UN6=/2(YH+3U.7;;9O:.D0[LT
ML%94D#A&CNDW;FAZU'Z<Z?0C1Y)4OZ<^)QOD0BK33S;#0WL3[,EO/KS"N$K^
M>,]FVLQ+/DRL/V_&^OO"I'W6)^/\V6F0(WOAR1S=)U,G-:6*K*GHN')T='92
M1W1HB>[Q8\F-,:K-XX<[MZ-3S^@M(^=4#1_[09)1-/?98P?';JJ.C*T0.\QR
MK P>_>IUK#UZQRT)/C@*7]:B3_!Q)1PXM4KHU$(<Q]* P)HF'P[HVVCK67@-
M?,R]^[0N@MSR8/F<"FO.AQ8R8+770#,V:YY!\V05/_-QJIGVV#GM43%>6=_?
MP,7>SJ+@QU8.W!/_B'OBZ-_W8S3&&'_4H0!>7P;:?TMU2UKM!K*H\V_4.ID5
MF]AAL"X,AM1A!D_\(M(;>6#!="LM&!9QCT\YO1\S=1_1XO6L?2M)D)/*M6U%
M/9,T\FB)@=N9L$A$3RKDZE6;,A_" \19(AL1-4@6@41FK&:+R95K\H B"D<1
MA=?#M"IPIHCI>G&4K$K>O]OY6"?';, "&;GE"WRA2Z ;VYK@.?"<0T++:9I(
M(J&L<7I4^P;G80[GH>DSY;JBZF(S'8RA11#1$MI]!'( .52='$90..,WU@KR
M.!.HT%LR*PC<L 0@4*R]3)Q0>-5KB1X3_$>F==@!6@:Y5S](PP^Y<#T+DS3*
MJ8KS<.KED.(U^T$+;N<47A,; =6WE#SH7?UN>VMWYV#W=SCQ%H3T,=>>%8%Q
M?GI_#8@&.X.=UP;JK<V=@_W?]PB(>D%4IWL=$_\+[$W8FY6EN,Q!OX8]:)!;
MX<@-[LA%T3#*S%Y;>27@ *SP=G$ -@ ;5)D-0D;L;\OMS(9$WI#+/D>MCIPR
MM*(J-BF\&36DAEPDH3-WW)_4[;$',HV$6V]!@;;:#=)JM;#-]@I9C&"WHJ+@
MXF^D\B*5M^)48"FTS830PV! !4<J;YGLG<(KX>?8Q(IU/,4CHTF'>;%".<5%
M$=P^.G<H;@7V*Y)C.P>.NR>>-.@@,$&+*Q?K,@O6Q7<5;R)PP09T+94M_L$6
M H57X6<"(78__KZ_/>T9<6H^%8\GU;32/Z18-$MX<%DT2RA;LX3JK@W78^%5
M:GDX+;)B+Q$+KXPS5AY\]<M!^+N+Q!66^>&AR26^L;S@HEF;&CY84#XN9!!S
M#G$>@Y=+SLO8BE@4$Z-^1!89J4,!&]2O['ZI,M,U8_L954E+J='[L4Z"X!8#
M,W8AT/NB&,[1[<V/NYL?]\AGKK0Y<XWXLA+!2;N^IQ-&-S_^_O'WJ;..F& W
MW.CG3DNNM;/_W%<.?C_8V]HGOV0X^=5]]_&+/#KA[+2YKMXIO9K^ZHAAJ7&M
MUZP4-6DP):VB>2MNO%9MO>)R8=DX>6B<&(OU"HSSUY/CV6DK:8 I>Q;[W-.9
M/C[VV;WB%GG5%TN=7,^!:^;UA;UL;[B.9T&E5D"/;DIB_;.4,H[A/4'[OSN=
MY!GQ[]C.T%CUE#?F+BFZG.DI:#^OA!5SG=*&26NE=K]V7(,K_F4S81 Z7SP,
MN$>U),U$Q8BU,,AE;")JN/V =&+58VIH85%K@_GF"G/42;W0Q <O=FYHF'ZZ
M H0-6)X0>C##(NI_P0S*"B$.O?(TX'  TZ TF;5O1^F2G?-'1 KFRB$\-/A%
M5C#8:_P@,?VLS2]VM6#15)D7OC.]2D>"2O$!K)GR8<#I/SGO7&*[ S1001KH
M')'W[SYN;VW5W39_LLO/*<DV4-^_V][9JDM-?/M!'$EE&#GS*9ABKES;5%%A
MQ;>]5P=9E ,I YI5T(:] **H'E'\N+'W,0KA)>=4T!YSK:-A.^2,A9=",,_.
M)39@A#)!8MP#6<>6\ST&@BC3[@@(8BDTM ,[%/FE>?TK^ '\ 'X8(^+BSU40
M43F"^),IS8:@B!(#XF]0!+:CP0\I'+ '41K7TEO1OT:/"6](-LAC^HB4R46<
M_MMM<L;%+8H=83>]>G36IAZ_X1YI4AW;)\B0-&5HY3.$N9-/?J<6#)P7F]-@
MZBP$AJ9+13[C-XQ0\=!1/ ((F&*>-%O"YU04/)>P\#KY57##_%0++P4JXBR+
MY89>!X KQ6U-=QWJ%SQ1OO":N%8$5Y.-Y0UI*/Y3BE7*;U:*?#-Q@7S7I(*N
M7DW:#(R<RD2VJ%*S')!'K (+$RS\JF(,(\4\JX230E1K!72UF-D%F>_7;[@G
M2:?6J)$38;A/?=)63!NKK8HFX><TB%^^BMJ;AWB;J;C83(V>?VN#CJ A)<VD
M[EU:FRJK7(6V?^OI[&,OP]]ZW[^'<$,WO >713<\=,-[PSQ@)T(#N_;4$3?V
M36>H#0M1HBJG_*Z9<#7L6<'WH0NOA\=TF#RIR;5]-2XU*%N.P+N1&\EII='$
MO]'06GJ<&E=K^ZQV5FO"P3%7@(@8+A\B% ^EX)(T8O/^W?;N3EW(4)*+F VL
M[1.DS@-A)PNBR^/^"[LHR5L:; P3DKUBB:UES:ZI[@R((W[QE1\<XN,=PM8Y
M.3UIG%V?-AM7)Z1S<O6MU3SIP F>%\G'_PMC+2]D?U - BN'VI^0+U0;)6>J
M28"Y2I,! S-G<21T+J=JS".-!&DD%60%!P!/@@I !96D@HD7<V4D5(H(5O3^
M@@J*B 6I3)]<<;_'!CP(V!H61Y5B!W0G+ \:F/@I770D4Y'B>A4O;Z5H ?9!
MR6 @HX#=:_P-'IC72UW&7"^=0PLR*!X*5)^&I-T?:C<?<MUGBD:N.>WU,2AA
MGO3.N=OXDP9;X25!P^=MTFK#(H"_J'I$8%6_W;D>AW[ )H!-4+WG_Y<F:7C_
M<4O<) X*3J)%/0M"#X,!%4L&!X(6BHB($^%+[<EHE!9(;J0B)S\\%@0LZ5,
MJG@-<( NB@>.4_(ED%UK-__2I$,[WJ_DC(>NM@[(8I[POBA7RRX5&\BB9'@
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M#=^<\ZM6C#]\; !&5,8PSE4_%I.Y-N0* RO BB<F@6$E#"N%C8?V1M9L PE
MPC:;P9=8=WC,KM4F!E?!!#!AJXW!Z)%@#2,$=C  #<&C(95QCYX&8  8 @?#
M!1]C_P*($#H1\H'4NA+6#825'$0 $0(EPL04[GB<"G;NU2TQT@JP 6P(F0T
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M.S5:8UDWN! Z%]H44K.FB'R#@ 5@(4PLM+EB9U+T-8@ (H1.A/OQ XXV!Q0
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M;B#L.JOS0 /08*LM(*9(^49&?<0%H$"H%-!*.L[:B<%$ E@0, L,5Y%6  %
M$"8(*"J.;8='F%0&"P)G08-;%XLL9R1X !X$RH,! 4%8MTZ?""  "+;<!MR
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MW"58H/9-^60?D\7L6;!7CZ7HL09]4W:Q.FT%R_S6(B.TJ<G.(V\+,Y+9&>0
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M.?NX(2_7L"P>>6X!_OP7D+=S;4O.Q(A!-2P#"$CWO\2ZP^-\*T_,_N?;7SB
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M=CDU66BK>SB4XJ?D1X;'+LM[NY-6:N5K:VCTM-'3WGY]'LG>8S*M!E<\PA'
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MKHTZX1D7P9FEOT&I,99DP[)]\#%B&RIA1G>PX!N2?[R0N V&I((M*T/)/M/
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MPQ(VH\.KL/>7/'AO_JW7ZM$X_Y#>SA]02P,$%     @ D(M85H,J7W!@"0
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MFXW9-0![#+!P@#T$E[L[X)JQH?7>.@KP+)RF7*9D!62O8#^,R<)Q$HE>7@B
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M;KV69;7]-ESY?WZ"DFD[X N29$PRGI#(LCJ] A2F4J8URYK/Y^;<,[F86/[
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MF4LC?$?]]EJ!?EO]TY-2I9[I9WX8-I_-'Q+LSG>"UVL/.K=["K8:@"Y\]FB
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M:"TR,#(R,3(S,2YH=&U02P$"% ,4    " "0BUA6CI=A[TL:   &.@$ $
M            @ $'>P0 =6YH+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    ( )"+
M6%92>,G'QBH  +FQ 0 4              "  8"5! !U;F@M,C R,C$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( )"+6%;CV_NKFNH  "CD"@ 4
M  "  7C ! !U;F@M,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( )"+6%:9
M@P"KGA\  '<A   3              "  42K!0!U;F@M,C R,C$R,S%?9S$N
M:G!G4$L! A0#%     @ D(M85ND.DC?.U@( M0L$ !,              ( !
M$\L% '5N:"TR,#(R,3(S,5]G,BYJ<&=02P$"% ,4    " "0BUA6R&WT1VZ.
M 0#XK!  %               @ $2H@@ =6YH+3(P,C(Q,C,Q7VQA8BYX;6Q0
M2P$"% ,4    " "0BUA6S CI()D4 0 "L0P %               @ &R, H
M=6YH+3(P,C(Q,C,Q7W!R92YX;6Q02P$"% ,4    " "0BUA6SN*A_L9&  #I
M!@( %               @ %]10L =6YH97@Q,#(Q,C,Q,C R,BYH=&U02P$"
M% ,4    " "0BUA6_L&.7/T&  ")(   %0              @ %UC L =6YH
M97@Q,#(V,3(S,3(P,C(N:'1M4$L! A0#%     @ D(M85@%+]XP8#@  MDT
M !4              ( !I9,+ '5N:&5X,3 R-S$R,S$R,#(R+FAT;5!+ 0(4
M Q0    ( )"+6%:#JI$"V@L  )9-   5              "  ?"A"P!U;FAE
M>#$P,C@Q,C,Q,C R,BYH=&U02P$"% ,4    " "0BUA61X:Q]6L+  "U+0
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M,#,Q,C,Q,C R,BYH=&U02P$"% ,4    " "0BUA6[XBBA8U.   K: ( $@
M            @ $LH0P =6YH97@Q,#0Q,C,Q,C(N:'1M4$L! A0#%     @
MD(M85ER\%^N]*   (Q0! !4              ( !Z>\, '5N:&5X,3 T-S$R
M,S$R,#(R+FAT;5!+ 0(4 Q0    ( )"+6%8Z'P<YY4X  &7" 0 4
M      "  =D8#0!U;FAE>#$P-3$R,S$R,#(R+FAT;5!+ 0(4 Q0    ( )"+
M6%:S 5/V@U   $;' 0 4              "  ?!G#0!U;FAE>#$P-C$R,S$R
M,#(R+FAT;5!+ 0(4 Q0    ( )"+6%;R0U2$*5D  "-1 @ 4
M  "  :6X#0!U;FAE>#$P-S$R,S$R,#(R+FAT;5!+ 0(4 Q0    ( )"+6%;#
M.Y9$Y8P  "(=$  4              "  0 2#@!U;FAE>#(Q,3$R,S$R,#(R
M+FAT;5!+ 0(4 Q0    ( )"+6%89C_X*'P0  /X+   4              "
M 1>?#@!U;FAE>#(S,3$R,S$R,#(R+FAT;5!+ 0(4 Q0    ( )"+6%:.D/E1
MI@8  /\W   4              "  6BC#@!U;FAE>#(T,3$R,S$R,#(R+FAT
M;5!+ 0(4 Q0    ( )"+6%:#*E]P8 D  (M-   4              "  4"J
M#@!U;FAE>#,Q,3$R,S$R,#(R+FAT;5!+ 0(4 Q0    ( )"+6%;88^VY;04
M !4B   4              "  =*S#@!U;FAE>#,R,3$R,S$R,#(R+FAT;5!+
4!08     &@ : *\&  !QN0X    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
